<SEC-DOCUMENT>0000049071-23-000011.txt : 20230216
<SEC-HEADER>0000049071-23-000011.hdr.sgml : 20230216
<ACCEPTANCE-DATETIME>20230216151158
ACCESSION NUMBER:		0000049071-23-000011
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		125
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230216
DATE AS OF CHANGE:		20230216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUMANA INC
		CENTRAL INDEX KEY:			0000049071
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				610647538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05975
		FILM NUMBER:		23638238

	BUSINESS ADDRESS:	
		STREET 1:		500 W MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		5025801000

	MAIL ADDRESS:	
		STREET 1:		500 W. MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXTENDICARE INC
		DATE OF NAME CHANGE:	19740404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HERITAGE HOUSE OF AMERICA INC
		DATE OF NAME CHANGE:	19671129
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>hum-20221231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:be062877-2225-41e8-b603-0f500ed981f8,g:73ed13b8-2607-407e-984b-2bfb1b06116c,d:10e87e90a96248dfbd5b204f2b8c4b03--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2022" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:hum="http://www.humana.com/20221231" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hum-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM180L2ZyYWc6NzcyZmI2Yjk3YWZhNDgzMGIyNmQ3MWNhZGRjYTE2ZjAvdGFibGU6OWI3MjFhNjMwMTlmNDI4Y2FlMmVkMWI2M2E5MDE5NTkvdGFibGVyYW5nZTo5YjcyMWE2MzAxOWY0MjhjYWUyZWQxYjYzYTkwMTk1OV8yLTEtMS0xLTE0MDY0NQ_269f71f8-953b-4d59-8c64-438110976f64">0000049071</ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM180L2ZyYWc6NzcyZmI2Yjk3YWZhNDgzMGIyNmQ3MWNhZGRjYTE2ZjAvdGFibGU6OWI3MjFhNjMwMTlmNDI4Y2FlMmVkMWI2M2E5MDE5NTkvdGFibGVyYW5nZTo5YjcyMWE2MzAxOWY0MjhjYWUyZWQxYjYzYTkwMTk1OV80LTEtMS0xLTE0MDY0NQ_99671e65-2fd4-4565-b692-d4c2d65c9870">2022</ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM180L2ZyYWc6NzcyZmI2Yjk3YWZhNDgzMGIyNmQ3MWNhZGRjYTE2ZjAvdGFibGU6OWI3MjFhNjMwMTlmNDI4Y2FlMmVkMWI2M2E5MDE5NTkvdGFibGVyYW5nZTo5YjcyMWE2MzAxOWY0MjhjYWUyZWQxYjYzYTkwMTk1OV81LTEtMS0xLTE0MDY0NQ_dd82a8c7-75e7-42f5-af8a-8b6815bd5f0e">FY</ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM180L2ZyYWc6NzcyZmI2Yjk3YWZhNDgzMGIyNmQ3MWNhZGRjYTE2ZjAvdGFibGU6OWI3MjFhNjMwMTlmNDI4Y2FlMmVkMWI2M2E5MDE5NTkvdGFibGVyYW5nZTo5YjcyMWE2MzAxOWY0MjhjYWUyZWQxYjYzYTkwMTk1OV82LTEtMS0xLTE0MDY0NQ_e864da1e-b1a2-4aab-afb7-9b709003716b">false</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjcvZnJhZzpkMTUwMWZiODBmYmE0YjRjODEzM2FmMDcxODI4ZDI4MC90YWJsZTo0Nzk2MGFhNDkyNWQ0Mzg1YWYyNzBjYmYwYjBhMDdhZC90YWJsZXJhbmdlOjQ3OTYwYWE0OTI1ZDQzODVhZjI3MGNiZjBiMGEwN2FkXzEtMS0xLTEtMTQwNjQ1_420ffb7e-45fb-4b11-bac8-47a78c0ae39b">0.1667</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjcvZnJhZzpkMTUwMWZiODBmYmE0YjRjODEzM2FmMDcxODI4ZDI4MC90YWJsZTo0Nzk2MGFhNDkyNWQ0Mzg1YWYyNzBjYmYwYjBhMDdhZC90YWJsZXJhbmdlOjQ3OTYwYWE0OTI1ZDQzODVhZjI3MGNiZjBiMGEwN2FkXzEtMi0xLTEtMTQwNjQ1_bb945b37-be87-497e-ab9f-ca581e14d094">0.1667</ix:nonFraction><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMC0xLTEtMTQwNjQ1_256dbbe4-e72d-43cb-856f-f86c3ab31032">http://fasb.org/us-gaap/2022#HealthCareMember</ix:nonNumeric><ix:nonNumeric contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMC0xLTEtMTQwNjQ1_63a0ed7e-2224-43f9-9b9a-e3b0d3ae6fad">http://fasb.org/us-gaap/2022#HealthCareMember</ix:nonNumeric><ix:nonNumeric contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMC0xLTEtMTQwNjQ1_e463531f-2ae3-4151-ab6a-b78870f1c964">http://fasb.org/us-gaap/2022#HealthCareMember</ix:nonNumeric><ix:nonNumeric contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_aa3c46cd-ae1d-4dbb-b466-6a345a4c4ee1">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" name="us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_fb3c77fb-1c01-43eb-9b8e-b8c8b202045a">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_0f510c82-dcff-42e3-bbab-71fc1ed8e909">http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_f7698f80-d9e2-4b51-aa84-637d028779f0">http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_bc2d9dd9-e2c4-4f69-a280-01a78070d904">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" name="us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_e06b9087-2af6-4553-b278-719cfd049d22">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:TRICAREManagedCareSupportContractBaseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMyOA_c266142d-523a-4672-8755-4dc23319d78b">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:TRICAREManagedCareSupportContractTermWithOptionExercises" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMzOA_961b1df7-1bbf-49b4-94e1-c81bd4087591">P9Y</ix:nonNumeric><ix:nonFraction unitRef="usdPerShare" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDcvZnJhZzpjYjBiZDBhNjk0YjM0MTFiYWFmOWVhNGZlZWYyZmRkYy90YWJsZTo1NGZjNjViNmJmOWQ0NGJiODFhY2E3YzA1N2M4NzdkNi90YWJsZXJhbmdlOjU0ZmM2NWI2YmY5ZDQ0YmI4MWFjYTdjMDU3Yzg3N2Q2XzEtMS0xLTEtMTQwNjQ1_eb9b270e-8d82-444b-ba85-99c9fdb95e2e">0.1667</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="4" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDcvZnJhZzpjYjBiZDBhNjk0YjM0MTFiYWFmOWVhNGZlZWYyZmRkYy90YWJsZTo1NGZjNjViNmJmOWQ0NGJiODFhY2E3YzA1N2M4NzdkNi90YWJsZXJhbmdlOjU0ZmM2NWI2YmY5ZDQ0YmI4MWFjYTdjMDU3Yzg3N2Q2XzEtMi0xLTEtMTQwNjQ1_023d2074-a761-4158-9b9f-2fd2c1e15646">0.1667</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hum-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac825e81fd674052afb8ee0b15e037c5_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i197c35ec7c824ce1bc66227545a36037_I20230131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia97140e6b0864c928e72d49d1130c508_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28bf61673f944bc1ac5aa3fe90724e55_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae3316eaa1ab4c63b284379afe39c1c3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e3e965bd7f546cb8bdfffae17fa5c03_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99ec67bd37c741fcae4bda5f42e6b771_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d04f982d8e74a8d8291aa9c72da676e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389e820acaed4f94986088bd4c6ee7e8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fd1f8bbcda74c90a7dfd0297a038626_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i571f2e6b6e774b29a93ccb70f106840c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7285850bb8c54632823083969a16a30b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae0e22f86a6949a8a48e01671ed1c284_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7781da092ad41ee8990573fd28577bd_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7f017f098bd40b1a9bdb0c3ec9f1caa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbcbb10618b845c1add87e9d45a78991_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fe1870a9b49406daaf2ba671fa7e631_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe78b6c543d6497ba9c3f17b26297551_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47316da3a3ca4462a4861e765c936186_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fe62d64db7e4bf4972bf02ec4c90535_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65031e9551cb4c5e98bf719298231efb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36906efe5bd14a959e87de9672f63b52_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06d4dc5e79574b798135918a523c5afb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90fb72011b3b41c089fdc685a8b914a1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52688808256645f9b0b3dadea8649a92_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90291fd2d2ea45d0aff5e33822dee463_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i518fee92d21348d4bac22ba846904d99_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc29f8ee3dbf4eca981b29f3496e9b8f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib31d3b30f3a84c83be93331f0c89a3b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3e2a44f0beb4bac9ff346a4269524b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7f3f59a5f394d4faae0211463973ead_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53ef7bd107114170bc009542db1e7bcc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c643278b48c4671a48980681e36ec67_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35f272177b134f6b8a1b91bc0c09280b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaae6442e790a4944978a3019753b8334_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i287579c2615947bd90df9271fb6c17d1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57dca7a5679246a790f3f371e95e7dd7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9143bd79088c45919a393886eedf2fed_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f85c8b4a084c0bbd1a7804fa2fb617_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d2b054f3fb47ad90e22fc446758bc3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a0a21d7c6d4429b8a0de15cd71eb93f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9a733dd9abd4513bb45837c142b7106_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28901f9b5d9648d3bcdd517445a5b77e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a3b5852afb54656981769e75c1661ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8521cad256a441f09269040aa936b3c2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff654d59997d4f00bf56601509888261_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04f20e9ecbc842eb84ec33df7c1e03ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7cc33f8e79b44da9048bfcf1f0d1520_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafc3e3d48014423a92047239f09e25bd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3ecfbb6c22b417ebc6482a6408f9cdb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FederalGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9069595e8b1946288939814801ab0b92_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>hum:segment</xbrli:measure></xbrli:unit><xbrli:context id="icb9c2813455d48969d1c9c193176fa13_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hum:ValueCreationInitiativesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a4c2fcb56be4c3697d752d81e29b9d4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hum:RegulatoryMattersAxis">hum:HealthCareReformMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic581aed5cfed42a7a2f64bd4ed501897_I20171102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">hum:USRiskCorridorPremiumStabilizationProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72beb26dbcd64e57a53b102d2216d4e3_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">hum:USRiskCorridorPremiumStabilizationProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia736406081164b128479b1d1f0573b44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">hum:USRiskCorridorPremiumStabilizationProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98b5cd0e14da45a2a65ccbb7b999b126_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>CMS reinsurance subsidies and discounts</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0a1f1c3b72a40b3b4bdbf0a7f076fe1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>CMS brand name prescription drug discounts</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie78f1bb938b8481f8841f9c8c53b4b44_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis"><us-gaap:ReinsuranceContractAxis.domain>CMS brand name prescription drug discounts</us-gaap:ReinsuranceContractAxis.domain></xbrldi:typedMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea3fc08d0e0f43fe959d292fad010549_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2987740b0cdb40188339b7acd6a0181b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id079b2db40e84b14a641fb9b1eb51da6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaab669d71af421191ca3584d7396347_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60d881bff54b49609993a08aa88212dd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05e6d98d428a4d49940ae089d750047d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i864645f1e72a4441a86287765a3dae2b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44ae02ca45e24424b2e1bd6d8003c7bb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieab9cc19ff1c48b3834f6647ccd0c104_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">hum:HomeSolutionsReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95a27ca7ed954826900c752a38aa4c67_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">hum:ProviderReportingUnitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19ce21448fc64f32b2239d5bd098448e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if48fb53a53e34a27a1de24c4a5da8121_I20220811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a53b141d0e477195c76cb94f076fd4_D20220811-20220811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:TermLoanDueOctober2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-11</xbrli:startDate><xbrli:endDate>2022-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94ffd24e1fbd46079ca060beb77c46db_D20220811-20220811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-11</xbrli:startDate><xbrli:endDate>2022-08-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82bf2d71677045cb89ab8202ad71abfb_I20220811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:MedicareLicensesAndCertificatesOfNeedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e9445cef15459ca1a4443266fda6db_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i794c5dbf39734709be53637e3659df79_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f2bc940567f4a69ac536078fddf515b_I20210817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hum:KindredAtHomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fe4d9a70fd54514aadcf5bc01daa43c_D20210817-20210817"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hum:KindredAtHomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-17</xbrli:startDate><xbrli:endDate>2021-08-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e64b83f1ebc4e4c9cef19a100effeb3_I20210731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hum:KindredAtHomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48a47654fd0f48f7903a22655de0905d_I20220811"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hum:KindredAtHomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">hum:KindredAtHomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9f8031ffe444ed9b9343359a58376a4_D20220811-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">hum:KindredAtHomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-11</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="primary_care_center"><xbrli:measure>hum:primary_care_center</xbrli:measure></xbrli:unit><xbrli:context id="i0243358af036489b9db890af0f19a8da_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:WelshCarsonAndersonAndStoweMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8badefbc5e124dd3aa6c797258e8343d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0c91010e34245c3976100a5e9202503_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaca4131ba9f4188af49410407b10d27_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11cd665f1547467c8350d08512260dd4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i126217602c624f2ebda161c66e36c104_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16730b092e6c42b38643174820335d57_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie926287dd7f8457b97691b76be5611a9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1df5272756d4e92b091873e633f3429_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58cabae69b214817826771be532892eb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief49b2992b1d4ac9b764f4b88eede797_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35b2694e329a46c09a0bc95ee97db01c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAAMinusRatingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="position"><xbrli:measure>hum:position</xbrli:measure></xbrli:unit><xbrli:context id="idb72dad613204f368ff4a26fd335a8af_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19ce7d0320634c71911eb129b62cdd75_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1d051e2a57c4934876ddc48b5f49744_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4600bbd96e654f4bb87bb99cc75e8721_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id37e3970a9a245bf992b7f2bf10aaf9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4e412987c124923843c11133670979d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2d065eb8ec814e6fb943f186f38242fb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a05fc957d0846f4b011a965962086b6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i568af216307e4b179878b2da53d4122b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i185a7e76a1d24172bb01a134f7adc9c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa6ce38b809041c9968dfc78a7b6929e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i100f7d2a885e4239994500a96187a154_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i663f713df5004ce691b805cccc0c3c41_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35d173bcc08f401d8448c3429d521e73_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa5a405115aa4a9e80c1d4170818b435_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6fbd362be394a77a0bae5d4e503c621_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf95ac00e96b4da2b61537caecf2a63f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01fe7de4b48b4757bdba67c3c30223dc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7892d0ce35f4c4d809ca56ec7b8ed92_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6016170130d84d3f9c5fe6be1493ed7b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf26e22bb6694373b3ec116c8848c087_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8f2d76839dc425e9923d094887a6852_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia42d9264fe60436397893746d07f5344_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10a317cf3f8749508994c7c0895c690c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ffca985b624437598892a6a46f6e67f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0951e2e238645f2ae9ad57771d70f73_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2617a33f07e4ea1ae164ff1bd350258_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f87bad1dca649f6acab6b67b66ef008_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb5c00bb1f8b464b98779dcffeb0bc99_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i099d522bfaf0457cbb3b97f0e040976b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf1e6a604f94423babd31a467494b284_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1173c14adecf46f78881e3a27f37aec1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d65e744f83e4ad98d0958df7c78c34a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3faa3637d1e54906a31aad04f195a8ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14db3e8f943f46e786c81127e5ea0564_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie60cdd956a6640969d47e0833e86ba9f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib385aa21fe4c4616838ee0d0ca6d2cba_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0146b48a0e5489eaa956daf6df2d528_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6fc8277fc204250b7480ed77aecc8e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa72a9d84a68409eac53fed976508820_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia64dce68a9ab4a58acdbb1db7d67bb70_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5acccdd82ff846ff8ef892b418bb1485_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i081e21499a8c458baa615ff77f0ac1cd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20264b95ebc04dcabbb626a171f3e744_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3fa38cc574124cecb80a041e6b188e3d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia7d7ed7bd6f64ee0acfeb9cbb1fae2f9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cfec53bb2494f19a47c713e3227de97_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2235b6260df49a1a6c11eed924939df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f54148e6d2c499a806b66f7dca47359_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0fb95db0bf242dbab96b217510a895a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3c7b37cedae462f862afaec00b4bc46_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cf29001a702470bacacce5139c387a6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3338f1806f36453abbd7a52e1b0790e9_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e0593849c444ccbbeb42e1512fa4a1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fb42a9cbf7b4e7cba7da4a133439c55_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85753dd3a8f54f9fb0d831cf7c5c43f2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bea5d25f6cd43a8a70162eca920c430_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb0684f421e64ce79522d2eb9a6a8413_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i642f883149c04810939d034bfa0a52ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f49ba358e744656a0580c671549df4d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78acbd1a53b04291b66fdbb04a15ae30_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie39ae48296ce4b29aa8bbe2041ed8eb4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae1d525c8d394981a6e5be40d156b6c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i212f1e342411493daed02b16d1a256c7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">hum:FairValueRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c27e561235648b8b13b0b1006fe90ec_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">hum:FairValueRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d2d71ecd0c84d618d11b24ea25820ea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57df0c8d81b2453f8a238e040f1b0da0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e44bcbe607149f5b7f316440415c7f4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie46f4a357a2f4fbe87c10ff118d9a34d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6036a7082bf04c138376afbc99b33671_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">hum:TermLoanAndCommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31961d11bba447c88c3178990212f2be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">hum:TermLoanAndCommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i02980ff246d1468a8e06860f6caca51d_I20210427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hum:KindredAtHomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice7f37fee78e4e338fbc8d1d06f7ae0e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd18e11d3c604b7da08f0fffe4565217_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9423060dcf3c49fabea691f0ed0b95eb_I20210427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ddafd8649e14ac7acac5c6ccd24d75f_I20210427"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e890b4b6701420b99a2fd9eb4ec7e41_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6cabb5822a048bd9df34c65a2029e22_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff8e2116ff51438a81ec082998730629_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i176fb35f957e441dbdcafceaebb04e6d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38aeda789d4a488e891a8aa87e9fa1ec_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice2ed9f6fb0c49ae9a1285ff2740d4e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3403a6c0905646bcbd8ae9d599d80f52_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i041054aa105846e8ab6457532786e0e7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia18bd7b4631c4221ae708ae77650b442_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2900bedd1cd9421e97eb2d64e4d1be5a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1473eaa5ef804e48ae190d791e55e701_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib63312bf4c4342bca36791b5e65e4bc3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieecc262ea3ca466c845eebf21b8c3520_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2124fe581b3f4e0ca125473df9d56093_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87973cc0bdc9461d9b56ed906827e2d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3739da0aa72d4c86b46499cbdae6ff38_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e8a8f01d8ca4f3a9f406c722b7ef5ed_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b64fefe292a43728aaf7bdfbede5152_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i300136ad24984a21be5bc1960dfedd31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i695c6177b9d34b308e88de94acfdfd75_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:RiskCorridorSettlementsMedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2499aa5c390a4ceab2772d3ab384250f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CmsSubsidiesOrDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf67c76176744e759331c39da83016b0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:RiskCorridorSettlementsMedicarePartDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id943835508f94dd6b4417c2cbf63f67d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CmsSubsidiesOrDiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19bf3378b91a427c9bd2f7c3566e26e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0c89853f8934b0cacaa85cfc6f9e825_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf28824348bc4dbfb4309ec50071a077_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hum:BuildingsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d4af6d0f5b84d3788f8727616c7344d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hum:BuildingsAndLeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0fdc098cf1b4a1692f37a4e684bcd29_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i066e82ee7851473e9db8d8cb4482f183_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4f43a97ffb845e68f044d5213898ca7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf6cc9bbe7804ebdada6913578e3ff0c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf9a2488b89e4d7385e1a72bd47d1cad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e5599c238174c3cb192e88685bcfea4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0db23ec2c8844ec19dd3156f925907d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i302e4dad57a14cdba91bf0b5047fed31_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i579d987c48294cf28cfd69d68d722ed7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83b359b7705141b5b92b56cd339b7eda_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86624d4911c84d1a9f17caac59321ed0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:CertificateOfNeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1d2e4631e134d44a429a68436144159_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:CertificateOfNeedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i352d3685fa15496082cf261060f9e998_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4996f726e98845bb84a13c49d761508d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a73edc57e734d3e99b59268d52d843f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i596d5af4874645ad9e06d1eeedc6d071_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ba75b2fe59340d18dee27ba36caa465_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8a6332bc1f446caa2303215ecd07bab_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fc197775115474f9bce928cb7b416e1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10ff00041a32480583c1b1682d015810_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91f583da577445c788bbe9d989064307_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14b2c5f58ee9471fb1efd368a5aec87d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i361ad41756ff4adf9c60e7e103ece2a3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0b1cd6334db4784afa7ba96eaebbccd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a9de5765b6b4f35884275a81dcd973c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0773d411ab7f4a27a5bd3070a458b15c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fc949bd76c94ac0acb9625d55ca5689_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>hum:claim</xbrli:measure></xbrli:unit><xbrli:context id="if00d8760e6f64b3b890040f421a1920e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2cd99d5331f347e4b92782b89a82aeb2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcf95e3840d049aab6f62e08d9ee6525_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07a30ac3b99249dcab52ec26094b0a75_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd981807e06146b9a8b7168780fa31e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1c0825aa8d04ce187bd5863fbc3d91f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88c075a77c0b427e841063ff79561d21_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib173a9a9bf26418d85e8c702ffd7b911_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2d89ea7a0994fdc830560ce43d6ccf3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99fded64e274478ab73f5733933c5a78_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A065PercentSeniorNotesDueAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd6ab2d56c9c482ab6bb5a898cdae46b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A065PercentSeniorNotesDueAugust2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8db13c66deb74bf2857e79213be4b395_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.15PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0dfdeedfdae442b6bb69fbd7a0e139f1_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.15PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7f278945eb146999d7aa678fa21f058_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A2.90PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0356912bdf2b4aabaeaff5e2ca21abc6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A2.90PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59f9c510abc04bad91d14e68c501cf01_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i773c7af03af34a47b324353282df0bf3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5276601cfe0b4fac93dc9dddd8c95bea_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.85PercentSeniorNotesDueOctober2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i509fa063896747ef909206a07e142390_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.85PercentSeniorNotesDueOctober2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36e388eca8694a32b6e8c72020b4c015_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A450PercentSeniorNotesDueApril2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibeb90e7ae11f495f937a25c066d3754b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A450PercentSeniorNotesDueApril2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8368074918ac49a18d7b9cd1a553e8ab_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A135PercentSeniorNotesDueFebruary2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id965da0f6c5b41cb887887c891386017_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A135PercentSeniorNotesDueFebruary2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie10cec06f87647a3a1fa3fa523fe76b1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueMarch2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied2ca976e98543e08e6ba87196523dfe_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueMarch2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i232b89f9079741ccae985c3171fc7335_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A575PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i853adef442584550b2d101e6ecef03e3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A575PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1b454e6cf714a3fa01d153c13807f69_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A370PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1af71980b56546dd9dfa3f27ecfb67a5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A370PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb98a6499094af98d17a8f638209725_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A313PercentSeniorNotesDueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia0ce78565c94456ab9c3991a4e4e4b5a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A313PercentSeniorNotesDueAugust2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i708adb6138b2495a89218e1aa2f9c270_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A488PercentSeniorNotesDueApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ca72929b8994051a4a074df8437680d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A488PercentSeniorNotesDueApril2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if64cdf61ab1842c79002bf0f3aa124c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A215PercentSeniorNotesDueFebruary2032Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57de736a34744fdea94f1c8fdd485269_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A215PercentSeniorNotesDueFebruary2032Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic096f056f036465dba708996f2f7a90c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A588PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0e1c1afc93c410d8219b30b59c4221f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A588PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A8.15PercentSeniorNotesDueJune2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i102f918dc90d487f9be67b46e5ad7593_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A8.15PercentSeniorNotesDueJune2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i62a760cb5c98497ab0e8bb6f03c6e29b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A463PercentSeniorNotesDueDecember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i853fb2ba319a40ae809f5f370473eb91_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A463PercentSeniorNotesDueDecember2042Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if5c6d742cb8343b8a723dafa1d57d5ad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.95PercentSeniorNotesDueOctober2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50436e89d2dc4ae6aeff04066d91f1e4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.95PercentSeniorNotesDueOctober2044Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i667465604c864997be52308f84abe858_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.80PercentSeniorNotesDueMarch2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83b3d29f254448849e71cacdfe49dd10_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.80PercentSeniorNotesDueMarch2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10bb54eaa9364a17b55f021b93ed865f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueAugust2049Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5297e4cf2a114648b8e3b858f90ec33b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueAugust2049Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81c11504dac94900b47f3adec13f2eac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:TermLoanDueOctober2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dbea7f466654367bb2ffab6a0f398ae_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:TermLoanDueOctober2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6401b4f44735434682c78028a5989e89_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc85f1f2648a47f78a97ded8aed480aa_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d2e5c35e8664d878870c2ac31cb5a7f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d642b46f9f947e1908279e62e1137c4_D20221201-20221201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.15PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-01</xbrli:startDate><xbrli:endDate>2022-12-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5f7b09cb2a44027b3040bd2bed6bdea_D20221215-20221215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A2.90PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-15</xbrli:startDate><xbrli:endDate>2022-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d8c3540308f450bb7239d10b7acc3b7_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5570PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63948e729cd5446e9ecb1103f8d97342_I20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5875PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b66643fcfdc4bc3aac6fe89fd6d2c8e_D20221101-20221130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-01</xbrli:startDate><xbrli:endDate>2022-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59c282fc7fc24fdfb266342670c5aa0e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A370PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6147469181034d3693ebd758a56db336_D20220301-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A370PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic09be7d135374636bb90d8a931991af6_I20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbb32b683c6d4c9389fc542d8b6ffe93_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbcdabf72f5c4bbfbf380741c218ce61_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58d6462307654072a27dd04f0987456f_D20210501-20210531"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-01</xbrli:startDate><xbrli:endDate>2021-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f8d88b80b864d978dcce7b20445315e_D20210801-20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-08-01</xbrli:startDate><xbrli:endDate>2021-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9699973b24d84dcaae4ebcf77e8bddfd_I20210831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hum:KindredAtHomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i112e4e9b6e9743f192f0c261f2174fb6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i387aa55175c54a05a686b101571c25cf_I20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:October2021TermLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d7e0a7171cf41f39322708915887790_D20211029-20211029"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:GentivaTermLoanDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-29</xbrli:startDate><xbrli:endDate>2021-10-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb7e7be2c134f1a9b7ce6ca2f0f913d_I20220816"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:October2021TermLoanAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4f21019238942898fb706ac9e7a0d38_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie41025c3734b426daf406df47fee29ea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba715c5c2419471eaade517586321b41_D20220601-20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa91146be05e483b86453c991c407783_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60d5d66074474c979c41340bd209ed02_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2901fdf8be043b3b4ce7d10615715e0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6aba1e961d1473e9cf526f0a1e804dc_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd10b85dc8cd490b8688147f8bfb596e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hum:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1321063cfc7c48c188ce65d238c95fd0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i158dd71369834c93b0a4333493fb0b28_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a26405ed8ae484ba52bfc3819cacf40_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hum:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfe28b2f52e240d0be900bf3683893a3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hum:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i146462488f28499dbcb4a352e9f0c578_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5740b2f51a534ecb852d304efddc5ba4_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2e4d343c10f4aa9ad919a757b1244b8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ec6325dd17e4a189e564e299a71923b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42f921861ba949c0aa1605c0c528cd9d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69a245a8dbe941efbcc60ad56f792d25_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id81d6fd6825341bd9dfae06ccdae8e2e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i927e6ff7d6e14022a0d65ca7195d8616_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i052c3330b4c2409992bdda8401167a8b_I20220210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e33a39278e94aba940321c53fbe7f78_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9061d9c9dbc8401d8cc25502ab63cf20_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i114dcf8181f5421f9df917dc4561297f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8e5bc41112049779d5fbc3865a6beb0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia611810824824c4998cefac84618de1b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ba6401654ae40689698616e02215fee_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib289b93fe6734476ab8f5d0c5798ec39_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2011PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f20dc8ac0564bccbfa9a003167f23df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2019PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabaf7ad5365e4602a729a73898dd2781_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2011PlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibed54bbe914a4277a816a361d2be8669_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2011PlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i000c50d1006145feb954575f49af33a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2019PlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4357b2b8b1914d969c619a19a67d1b47_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2019PlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida62d357008f4ed0bc3246cc32b3771c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c29ece986e14d5fbc1af74aef0f594b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5e4929afcc240d981441f4b646c3c65_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd04deeb98f941698ee17f88f8a23fbf_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i992f903cecc5400f81dfb547116cb415_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60f1ff28ff564a1ebbe436416a7471f0_D20221001-20221031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-01</xbrli:startDate><xbrli:endDate>2022-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i002fe084afec40a3b3544bd5ca40dff0_D20230201-20230216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0179480f2bae4075beb28f01cc367fc2_I20201222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba989f1957d14bd5ad09090a3705faec_I20190730"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-07-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa1f29c11f64ee4a23c6d619014a6bb_I20201223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic232bc3e290f4655953c1352a27704bc_I20201223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:CitibankNAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19f92caa5fd741989e66515605b91004_I20201223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:JPMorganChaseBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c75a59f8572479c926935996bad608e_D20201223-20201223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-23</xbrli:startDate><xbrli:endDate>2020-12-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53cd41e672c644b48afcbba07fd3e06f_D20201223-20201223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:CitibankNAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-23</xbrli:startDate><xbrli:endDate>2020-12-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0334069ef954f71908cae7a3e991ead_D20201223-20201223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:JPMorganChaseBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-23</xbrli:startDate><xbrli:endDate>2020-12-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0baee71e7f548278d68833140520ee3_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8fb3265c7324998bfb3a80ce36e5b0b_D20210504-20210504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:CitibankNAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-04</xbrli:startDate><xbrli:endDate>2021-05-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i350835a15d964c85bd84001ed39b4e0c_D20210505-20210505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:JPMorganChaseBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-05</xbrli:startDate><xbrli:endDate>2021-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70684713b18a4b98947fa4e3302512a4_D20201222-20210505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-22</xbrli:startDate><xbrli:endDate>2021-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73e1a9fbd6384960a77b548a06888967_D20210505-20210505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-05-05</xbrli:startDate><xbrli:endDate>2021-05-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i495ee173617d40c9a28f5030f6631472_I20210218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-02-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0b96effe20c452e850f5e6c15c8f8d3_I20220111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dd45b09421342e6818a93611f04d810_I20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4aebd9fa2ef54f84820765f00217687b_I20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibed82a92406149c48f61066e76a21f70_I20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:WellsFargoBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia10d21e8a157411e9877dc680a3ee356_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i568119642532418a8e54da51e855e96f_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:WellsFargoBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefa207bd427f4a95a03f48bf711b1dba_D20220329-20220329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-29</xbrli:startDate><xbrli:endDate>2022-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75ef00cf639a4623b3a5e417b7ffdf72_D20220330-20220330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:WellsFargoBankMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-30</xbrli:startDate><xbrli:endDate>2022-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice757c7c8d4a460d95726e2ca454481e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a532821749a4aa2adc6f2de7319e3f3_D20220329-20220330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-29</xbrli:startDate><xbrli:endDate>2022-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61359de4c6d40babbbcf4cb9a67c753_I20221102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73fcbac85e68448ba128e118ba423e97_I20221103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:GoldmanSachsCoLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0a147a615a34ceebed3a230fbb94d7f_I20221104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-11-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b2588f5c36147e39712fb70b96204b3_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5162c0c768943718eac311366829953_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i703e9357eeda40b8bac63abad7404e77_D20220112-20220112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:GoldmanSachsCoLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-12</xbrli:startDate><xbrli:endDate>2022-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54e117a2b2cb4096bee16f6734d08b94_D20221102-20221102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-11-02</xbrli:startDate><xbrli:endDate>2022-11-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8cf37da4ca144f09a6227316724ff0d9_D20221215-20221215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:GoldmanSachsCoLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-15</xbrli:startDate><xbrli:endDate>2022-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica8cb453a4214470aeb06e98f2e6defe_D20221216-20221216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-16</xbrli:startDate><xbrli:endDate>2022-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a8cc08368eb4c8087ba95516ebd17f6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i428ce4f261d54aa99e91df6496710161_D20221215-20221216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-15</xbrli:startDate><xbrli:endDate>2022-12-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i546d29dd98934753aadeaaaf3c309757_I20230215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79ef21e520e24d9b86c34779aacb9bcb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:February2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7cbb214573c842ca8b6e875c6ff4063d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:February2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf5c867675b14eb099507bc46b1d3c8b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:February2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6da3e5a26834dcc9735b2892ca0ecb0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:February2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab11132473e41d4b78b5223d9404132_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:July2019ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4f711d960cc4da69eb94de28d19a3f3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:July2019ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib058f69043374be79aeeb4ef7b5fc2dd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:July2019ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e57aa821d834ff2a62e2f0f968132d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:July2019ShareRepurchaseAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2911e9195ca74da59efd95c2f2a079cb_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d38c03d6b794fda984bd56ecc795514_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b418f12cccb453c9cf39ecc9a2f0251_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12de401f78254a06a054b3031bb6db2c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie135078db20f4355a53c7fdca9bb2dc3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61a07b55e80d459dac04cd0e5bf2f6bd_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="state"><xbrli:measure>hum:state</xbrli:measure></xbrli:unit><xbrli:unit id="beneficiary"><xbrli:measure>hum:beneficiary</xbrli:measure></xbrli:unit><xbrli:unit id="option_period"><xbrli:measure>hum:option_period</xbrli:measure></xbrli:unit><xbrli:context id="i659f9236e99f47089bc96dac2b1eec1d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FederalGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i183a5acc1cbc41339a7e84c20d8eae47_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FederalGovernmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad99ca704571480ba83888a5d38aa019_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic19eb7627fb348218e3375f5c66974a7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d672fa23f814425b4471c1e5dc74b0f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if874def50df84ee38965dd2ff7e20dc8_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6acea9d1a84d4feba6bb5ed5ce9a2413_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03a322c8d9d443e19ed5ba572d9572d3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fc365aeef164ccba60189ae8e4be0c6_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i678e6634c1f641da9467a8467bb0d1fa_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia600b949e2564d9499a7f90413acb269_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3a1e7fbd9b740abb48da6c37c8669a5_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba60622cbea46a4bea4ee9980cf49d0_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5c59ec6e1b641aba95c635ef9ee9353_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77000571fe484454b7cece9a261ff0d7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a704e86f4b24c3aaa85d60048410091_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b96d1b5772846aab2514b027450d532_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851654ab87514d19bb07259c3e31ff6b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88dbb625a14f473eb0ce08c9d6aff7e3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a97e0cfebe44b6ca9f74bebc9aae41f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i321b22b5a8d64b4fa443b551c3f5ef42_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifac46bf8882f4afd8d1dff2e3d3664d3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d9b0e5592fc42a6b5a50cddd44bac9b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c5f8b05d172420aa7d6e508a7c3261a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ed102b89a1848bf8a260145b47bc56e_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i917edca86d004c958b32aa4199b5ea4b_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32da3ea918f84f139a1ac455b07ebfda_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cdfd66eeb7d4c938de2f60123537f11_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47d0ebf962574d2da49de809c4eb19ba_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03027c1fdaa8418fb517496371138dbe_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6b045942f9d4e858da50fb74642864c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5328222283c41c587cc828204de2027_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i897a9529650a4bb884a93b8cf59bd75a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7458a4e3b4284a1e924e76cd284a045d_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i596d1ad9ab314614a3930efbc769fbf3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d8bdf2106784156b1b8947924736d88_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i590c72b5416448abb074967e44ff6ab1_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic7d56895373540d987a4fcd85111df8f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01479ee240324dfda2f8366c4adb14e7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9e4c5dc89ec4b73a775d2b544b21d0a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id179fa09e1214e46a546b7c140286685_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4ff990b381946d494741a1374b90aed_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7df369d93b09472ba0bced59c36b413f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id67dea91f3604bd78d2f964c679d21b3_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i796b3722619946a2866e39b5e61a9380_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4ec4db66fd64bc8bbf344f75b65d318_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52e79522cd64489888fa93b49c2e6243_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i299d79234a514ee99ef71046de2df3ef_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib51fd316c79f41bebb6fc344f6a46fea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89314fb76bc24433859a3e2ed527bbee_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27b8edba666c462dac30cab44012936f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i604d726215884cf397df3162b2320a54_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8388adc860dd445ba3de97b7ffe95782_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadf23257f8df4815a1982e9a75f47ead_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49240990811a4ffbb3f2a0dc683eee48_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i951e931c21c249828781deed9eee8a91_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47a95cc29f594641874afe2ad127832b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0fc07acc77f4488bb515bb553edc0192_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86a8d4d2792c484998a2be6ef7a5f7be_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47c70b5427044960a0e01b33a278221e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e4b19efa9e444958b038a59e21c75c4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0fccf5c68e841ac97cab4f30966690c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14fe41ab9d67459db2ad797f32f05552_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4687e7689164bdb8320ac4f06953159_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if321fc68ab164282ba4bc0726aa93b10_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4e8f651980b4cd48bca93f3614c15b2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if787c02ff9d64d0e86eb8be9f9c46de6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f643826c3e2422b89a1571806de6508_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacbb558c49be43379c68e6c711fbdf86_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb33cf4ae55b44f2a3f18566f90accbf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5312c3184550451f928932ad398d9016_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b44c1e415cb45b98e81cc9a0453f32e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03cda4dc42e842a09d1fdc9b3ceef45f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23dd140b009549a8ae4aa3a8fae36f29_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba55647075e043b2b181dba0f49b1e76_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8547008a36864217a82b790897092dc0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dc3f58523444595909416938e01f4b3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia427ffdd9dff49bf85f8ee91a5835796_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide89fb74b6854034944d82f12a08655f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0654ac32fb3f48b58e198b661a0db5c2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib05710ff212440dfaeea8f28f8a00d3f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7142e963e6ee4d9c8c2e655388f8918f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie513cbe1edfa4c8dacc68ed1e879643b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad139752acf7480db3dd52727e06ef78_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic676151b15dd4c80a0f1e58f9d321c46_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i059d3ba987f746dca463069e8b556721_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35acacb165204dcd9adc612f30611f25_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if39c9d28566e49fb94ca604dad0f7413_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6eaa0a4a53de41adbac051ef9fae2992_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e964222588640aaa4fc9517b9915eb7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icae43fd407c4414b943b92f92c1a164a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i361c2054214544b3a52b1c8f570d1486_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i298fcaa6f9554c64bd5f075426eeb27d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb67851ec4dc4e8d82168000c4595810_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98770db22e0b4594a796eee0640b15a3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d182410af6d45d1810973f77992c508_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4d69af6e550428ca1462f8259d169c1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib40497970a7d49a3a88ba998a48f7805_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f7a2cf3d405471395d39b0680066ce9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bd3273e77284e40b2171ed9f574fe18_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56bb0fd352744b9b9971c20e238c2186_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8955c114fdc3489daa2dee4a9140f585_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf9f80bbf5a6434ea08491bd367d4e20_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i138d886578ea47c5bdfc107eafd19fdf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id95534e4967c4794a2bec00ba0a1892d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02af1f31fe144885b9fc028cec9cc8b7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a6507afa1e242dcb28f8c57ad781f71_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3908bb51774249158321c4ed8ca6ac40_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b2d04219b8943159debcd053092fe5b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bad957ce43349d9871780e049801c78_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04343d7d31a84ac79e44e3b54ac8536d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee9aefc250a24fa2b78e41b534370e5b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48e8960d40aa4748b405ee8aac3326b7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c79c3029f1c466b82ea3f885f7dbd83_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9711652ed43c412f9b92e3193a318e66_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44030fa27c974660bded54de8fb11a50_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaec631922eab4df1b6048c710078b4c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8f743f1a22644caac1e859fb29a7aa1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ded12f91baa4171b745a570b579f67a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2c8cfea28c541b7b645922d44fbf2f4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3e7d86e1bea4d3f962cf462f8b5c6cc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f092984c5164c6d84492225b149eaa2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i948d525c3b334e34b62da49d9c7482fc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d8e5a12ecf549238eedf1a87c7d1e88_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i325ae4c732a24279a4460fdb5f2ce1b8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25389e35fd5c4d46b3ce2e270d42eaa0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d2420a864954324be79ba29b455d706_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i128c3bbb84cb4ebfa37efdd581ba4fb6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54776761815d43f0b22c0e07b84bbe14_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63dbef0b32684c9c8234fd4ad305f9d5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17ef1ab00ada45a291c117cd6de96bcd_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea836c2c260040cc9a90acfff66f58e4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58027b9122014dee871db47b91819791_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabd8c18c4f8548ff9a23c8f591e89113_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dfbff48771b4638b79a2300493d8877_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hum:LongDurationInsuranceProductsAxis">hum:CoinsuranceAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4523ccf1b56c43b9960b083342924008_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:ReinsuranceRecoverableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ReinsurerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i704efe02ea3f46fdadbf3661e8fb4018_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:ReinsuranceRecoverableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ReinsurerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4eaa3ef983134ea9b906d1bd180d672d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hum:ProtectiveLifeInsuranceCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c4d94cfc4be468a97bde38608cbc8a6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hum:AllOthersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="reinsurer"><xbrli:measure>hum:reinsurer</xbrli:measure></xbrli:unit><xbrli:context id="ibda24e1355ca41dcad5d202558a258c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idca4a73570f341c190a700bcb5fc200a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b37d40697eb42ba8f7d32eb522463dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i349fa291d8d14aaa9e2386bb9b8b283a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMzAw_35433c32-303e-4b67-a029-4f990eceff08">10-K</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6MWRiM2VhZjJjMDJiNGFjOGIyYzQzZmRlZmM0YzU0MmYvdGFibGVyYW5nZToxZGIzZWFmMmMwMmI0YWM4YjJjNDNmZGVmYzRjNTQyZl8wLTAtMS0xLTE0MDY0NQ_15dcab74-0ab5-4d30-8ac9-18ac902ca0d3">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18xMTY_e4464931-fb55-4ab6-a5ac-b399d8710131"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18xMTY_48ae4768-1892-4c24-aec4-72113ade5226">December&#160;31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.706%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6MmJmY2Q1NzRlY2YyNDRmMWJkMGIxY2Q3NzU3NjhmNDUvdGFibGVyYW5nZToyYmZjZDU3NGVjZjI0NGYxYmQwYjFjZDc3NTc2OGY0NV8wLTAtMS0xLTE0MDY0NQ_f297161f-c112-4faf-9203-c7d9157eee72">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)&#160;OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _____ to _____</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjkx_a74ade95-9653-4844-afff-e813eadf6e28">1-5975</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg3_b51c471d-1b80-4e34-8cbd-5ddf2d183773">HUMANA INC.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:45.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6OGEyYzJjZGQ5MDRkNGQ1MWJmMWY0NWE0MjRmZGYyN2YvdGFibGVyYW5nZTo4YTJjMmNkZDkwNGQ0ZDUxYmYxZjQ1YTQyNGZkZjI3Zl8wLTAtMS0xLTE0MDY0NQ_8a83fd24-5673-4765-882e-859d28d3be68">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6OGEyYzJjZGQ5MDRkNGQ1MWJmMWY0NWE0MjRmZGYyN2YvdGFibGVyYW5nZTo4YTJjMmNkZDkwNGQ0ZDUxYmYxZjQ1YTQyNGZkZjI3Zl8wLTItMS0xLTE0MDY0NQ_62a3d0e1-4e85-4d2b-a97e-70720be3edeb">61-0647538</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation of organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk1_5584475c-1c91-47d4-97ed-e77dc903e9ed">500 West Main Street</ix:nonNumeric>, <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg2_03e89c46-1bc8-45bc-a5dd-21b8db8d310c">Louisville</ix:nonNumeric>, <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk0_f8f2e0e9-28e2-4ef7-9bef-d9ab60c5c27a">Kentucky</ix:nonNumeric>  <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk2_fc3698a5-bbb6-4756-befa-8c0590268529">40202</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Address of principal executive offices, and zip code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant&#8217;s telephone number, including area code: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg4_a4260959-1731-48bd-a356-92846c755fa7">502</ix:nonNumeric>) <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjky_74ed549a-2c91-4a2d-8795-f85bf9488786">580-1000</ix:nonNumeric> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.290%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.206%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Trading Symbol</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline">Name of exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NjcxYzlkZmM2OGQyNDZmMWE2YzE0ZWNjOWY3OGFiZDIvdGFibGVyYW5nZTo2NzFjOWRmYzY4ZDI0NmYxYTZjMTRlY2M5Zjc4YWJkMl8xLTAtMS0xLTE0MDY0NQ_06424555-5a5c-4db4-82eb-98661cfdd5a3">Common stock, $0.16 2/3 par value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NjcxYzlkZmM2OGQyNDZmMWE2YzE0ZWNjOWY3OGFiZDIvdGFibGVyYW5nZTo2NzFjOWRmYzY4ZDI0NmYxYTZjMTRlY2M5Zjc4YWJkMl8xLTEtMS0xLTE0MDY0NQ_09ad9df0-f18b-46b3-85ba-2223fca6fbde">HUM</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NjcxYzlkZmM2OGQyNDZmMWE2YzE0ZWNjOWY3OGFiZDIvdGFibGVyYW5nZTo2NzFjOWRmYzY4ZDI0NmYxYTZjMTRlY2M5Zjc4YWJkMl8xLTItMS0xLTE0MDY0NQ_e164336f-7067-4fdc-b037-949625a6cb34">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act:  None</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjkz_4121cf4c-b790-4d5e-b4d0-73b570fb5f40">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk3_0e165626-49f3-4aed-819e-ea4bb75a5122">No</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.  <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg1_04d6c5d2-d290-4cf6-9b71-5c1597ff8615">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744; </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg5_d1c74f74-0a50-45f5-a1ed-9869d84d49bc">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744; </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.199%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.201%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NTg1YTRhMWFmYWE5NDU3NGE3NzQ5YWE4NmY2N2YzYzkvdGFibGVyYW5nZTo1ODVhNGExYWZhYTk0NTc0YTc3NDlhYTg2ZjY3ZjNjOV8wLTAtMS0xLTE0MDY0NQ_8c7c04ab-d6c7-468d-b7bc-45521eb5c1d1">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NTg1YTRhMWFmYWE5NDU3NGE3NzQ5YWE4NmY2N2YzYzkvdGFibGVyYW5nZTo1ODVhNGExYWZhYTk0NTc0YTc3NDlhYTg2ZjY3ZjNjOV8xLTQtMS0xLTE0MDY0NQ_4eef8be4-1d93-413f-86b4-d908205e3ecc">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NTg1YTRhMWFmYWE5NDU3NGE3NzQ5YWE4NmY2N2YzYzkvdGFibGVyYW5nZTo1ODVhNGExYWZhYTk0NTc0YTc3NDlhYTg2ZjY3ZjNjOV8yLTQtMS0xLTE0MDY0NQ_a17a5ffa-da74-4818-8542-d56ce44fd4d8">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjkw_d18ebee3-aef0-4178-af30-0dd00c969ad3">&#9745;</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk4_698f0e0d-f1c0-41d4-8085-47891f893a25">&#9744;</ix:nonNumeric>  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9745;</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of voting stock held by non-affiliates of the Registrant as of June&#160;30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="iac825e81fd674052afb8ee0b15e037c5_I20220630" decimals="0" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18yNzAw_32964d77-f31d-45cc-8fe1-cee6f764a9fa">59,158,438,222</ix:nonFraction> calculated using the average price on June&#160;30, 2022 of $468.33 per share.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of shares outstanding of the Registrant&#8217;s Common Stock as of January&#160;31, 2023 was <ix:nonFraction unitRef="shares" contextRef="i197c35ec7c824ce1bc66227545a36037_I20230131" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18yODQw_d36f0b6e-ad41-408d-a468-307d9f91813d">124,974,862</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk5_c02dab48-32fd-4dcb-9021-b76066a493ce" escape="true">Parts II and III incorporate herein by reference portions of the Registrant&#8217;s Definitive Proxy Statement to be filed pursuant to Regulation 14A with respect to the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</ix:nonNumeric>  </span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_7"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HUMANA INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO ANNUAL REPORT ON FORM 10-K</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the Year Ended December&#160;31, 2022 </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:72.340%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Business</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_19">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Risk Factors</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_70">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Unresolved Staff Comments</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_73">35</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Properties</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_76">35</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Legal Proceedings</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_79">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Mine Safety Disclosures</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_82">36</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Market for the Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_88">37</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Reserved</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_91">40</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_97">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;7A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Quantitative and Qualitative Disclosures about Market Risk</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_118">72</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;8.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Financial Statements and Supplementary Data</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_121">74</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_208">130</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Controls and Procedures</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_211">130</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;9B.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Other Information</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_214">131</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 9C.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_217">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_217">131</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part III</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;10.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Directors, Executive Officers and Corporate Governance</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_223">132</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;11.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Executive Compensation</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_226">133</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;12.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_229">133</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;13.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Certain Relationships and Related Transactions, and Director Independence</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_232">134</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;14.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Principal Accounting Fees and Services</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_235">134</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part IV</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;15.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibits, Financial Statement Schedule</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_241">135</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;16.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_286">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_286">147</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Signatures and Certifications</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i10e87e90a96248dfbd5b204f2b8c4b03_289">148</a></span></div></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_10"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Some of the statements under &#8220;Business,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; and elsewhere in this report may contain forward-looking statements which reflect our current views with respect to future events and financial performance. These forward-looking statements are made within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934, or the Exchange Act. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and we are including this statement for purposes of complying with these safe harbor provisions. We have based these forward-looking statements on our current expectations and projections about future events, trends and uncertainties. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions, including the information discussed under the section entitled &#8220;Risk Factors&#8221; in this report. In making these statements, we are not undertaking to address or update them in future filings or communications regarding our business or results. Our business is highly complicated, regulated and competitive with many different factors affecting results.</span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_13"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1. BUSINESS </span></div><div><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_19"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> General</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Headquartered in Louisville, Kentucky, Humana Inc. and its subsidiaries, referred to throughout this document as &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;Company&#8221; or &#8220;Humana,&#8221; is a leading health and well-being company committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well&#8208;being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools, such as in&#8208;home care, behavioral health, pharmacy services, data analytics and wellness solutions, combine to produce a simplified experience that makes health care easier to navigate and more effective. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2022, we had approximately 17 million members in our medical benefit plans, as well as approximately 5&#160;million members in our specialty products. During 2022, 82% of our total premiums and services revenue were derived from contracts with the federal government, including 14% derived from our individual Medicare Advantage contracts in Florida with the Centers for Medicare and Medicaid Services, or CMS, under which we provide health insurance coverage to approximately 771,900 members as of December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc. was organized as a Delaware corporation in 1964. Our principal executive offices are located at 500 West Main Street, Louisville, Kentucky 40202, the telephone number at that address is (502)&#160;580-1000, and our website address is www.humana.com. We have made available free of charge through the Investor Relations section of our web site our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements, and, if applicable, amendments to those reports filed or furnished pursuant to Section&#160;13(a) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K, or 2022 Form 10-K, contains both historical and forward-looking information. See Item&#160;1A. &#8211; Risk Factors in this 2022 Form 10-K for a description of a number of factors that may adversely affect our results or business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_22"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2022, we realigned our businesses into two distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period segment financial information has been recast to conform to the 2022 presentation. For a recast of prior period segment financial information, refer to Note 18 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our  two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources. For additional information on our business segments and segment financial information, refer to Note 18 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_25"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Products</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our medical and specialty insurance products allow members to access health care services primarily through our networks of health care providers with whom we have contracted. These products may vary in the degree to which members have coverage. Health maintenance organizations, or HMOs, include comprehensive managed care benefits generally through a participating network of physicians, hospitals, and other providers. Preferred provider organizations, or PPOs, provide members the freedom to choose any health care provider. However, PPOs generally require the member to pay a greater portion of the provider&#8217;s fee in the event the member chooses not to use a provider participating in the PPO&#8217;s network. Point of Service, or POS, plans combine the advantages of HMO plans with the flexibility of PPO plans. In general, POS plans allow members to choose, at the time medical services are needed, to seek care from a provider within the plan&#8217;s network or outside the network. In addition, we offer services to our health plan members as well as to third parties that promote health and wellness, including pharmacy, provider services, and home solutions, as well as services and capabilities to advance population health. At the core of our strategy is our integrated care delivery model, which unites quality care, high member engagement, and sophisticated data analytics. Three core elements of the model are to improve the consumer experience by simplifying the interaction with us, engaging members in clinical programs, and offering assistance to providers in transitioning from a fee-for-service, or FFS, to a value-based arrangement. Our approach to primary, physician-directed care for our members aims to provide quality care that is consistent, integrated, cost-effective, and member-focused. The model is designed to improve health outcomes and affordability for individuals and for the health system as a whole, while offering our members a simple, seamless healthcare experience. The discussion that follows describes the products offered by each of our segments.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_28"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Insurance Segment Products</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment is comprised of products serving Medicare and state-based contract beneficiaries sold on a retail basis to individuals including medical and supplemental benefit plans. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision and life insurance benefits, as well as administrative services only, or ASO.  In addition, our Insurance segment includes our military services business as well as the operations of our PBM business. These products are described in the discussion that follows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our premiums and services revenue for the Insurance segment by product for the year ended December&#160;31, 2022:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:56.203%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.448%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance Segment<br/>Premiums and<br/>Services&#160;Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of<br/>Consolidated<br/>Premiums and<br/>Services&#160;Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fully-insured</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,712&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums and services revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,562&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have participated in the Medicare program for private health plans for over 30 years and have established a national presence, offering at least one type of Medicare plan in all 50 states. We have a geographically diverse membership base that we believe provides us with greater ability to expand our network of PPO and HMO providers. We employ strategies including health assessments and clinical guidance programs such as lifestyle and fitness programs for seniors to guide Medicare beneficiaries in making cost-effective decisions with respect to their health care. We believe these strategies result in cost savings that occur from making positive behavior changes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare is a federal program that provides persons age 65 and over and some disabled persons under the age of 65 certain hospital and medical insurance benefits. CMS, an agency of the United States Department of Health and Human Services, administers the Medicare program. Hospitalization benefits are provided under Part A, without the payment of any premium, for up to 90 days per incident of illness plus a lifetime reserve aggregating 60 days. Eligible beneficiaries are required to pay an annually adjusted premium to the federal government to be eligible for physician care and other services under Part B. Beneficiaries eligible for Part A and Part B coverage under traditional fee-for-service Medicare are still required to pay out-of-pocket deductibles and coinsurance. Throughout this document this program is referred to as Medicare FFS. As an alternative to Medicare FFS, in geographic areas where a managed care organization has contracted with CMS pursuant to the Medicare Advantage program, Medicare beneficiaries may choose to receive benefits from a Medicare Advantage organization under Medicare Part C. Pursuant to Medicare Part C, Medicare Advantage organizations contract with CMS to offer Medicare Advantage plans to provide benefits at least comparable to those offered under Medicare FFS. Our Medicare </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advantage, or MA, plans are discussed in the following sections. Prescription drug benefits are provided under Part D.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Individual Medicare Advantage Products</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We contract with CMS under the Medicare Advantage program to provide a comprehensive array of health insurance benefits, including wellness programs, chronic care management, and care coordination, to Medicare eligible persons under HMO, PPO, Private Fee-For-Service, or PFFS, and Special Needs Plans, including Dual Eligible Special Needs, or D-SNP, plans in exchange for contractual payments received from CMS, usually a fixed payment per member per month. With each of these products, the beneficiary receives benefits in excess of Medicare FFS, typically including reduced cost sharing, enhanced prescription drug benefits, care coordination, data analysis techniques to help identify member needs, complex case management, tools to guide members in their health care decisions, care management programs, wellness and prevention programs and, in some instances, a reduced monthly Part B premium. Most Medicare Advantage plans offer the prescription drug benefit under Part D as part of the basic plan, subject to cost sharing and other limitations. Accordingly, all of the provisions of the Medicare Part D program described in connection with our stand-alone prescription drug plans in the following section also are applicable to most of our Medicare Advantage plans. Medicare Advantage plans may charge beneficiaries monthly premiums and other copayments for Medicare-covered services or for certain extra benefits. Generally, Medicare-eligible individuals enroll in one of our plan choices between October&#160;15 and December&#160;7 for coverage that begins on the following January&#160;1.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare HMO and PPO plans, which cover Medicare-eligible individuals residing in certain counties, may eliminate or reduce coinsurance or the level of deductibles on many other medical services while seeking care from participating in-network providers or in emergency situations. Except in emergency situations or as specified by the plan, most HMO plans provide no out-of-network benefits. PPO plans carry an out-of network benefit that is subject to higher member cost-sharing. In some cases, these beneficiaries are required to pay a monthly premium to the HMO or PPO plan in addition to the monthly Part B premium they are required to pay the Medicare program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our Medicare PFFS plans are network-based products with in and out of network benefits due to a requirement that Medicare Advantage organizations establish adequate provider networks, except in geographic areas that CMS determines have fewer than two network-based Medicare Advantage plans. In these areas, we offer Medicare PFFS plans that have no preferred network. Individuals in these plans pay us a monthly premium to receive typical Medicare Advantage benefits along with the freedom to choose any health care provider that accepts individuals at rates equivalent to Medicare FFS payment rates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage, or MA, plans according to health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997 (BBA) and the Benefits Improvement and Protection Act of 2000 (BIPA), generally pays more where a plan's membership has higher expected costs. Under this model, rates paid to MA plans are based on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a "national average risk profile." That baseline payment amount is adjusted to account for certain demographic characteristics and health status of our enrolled members. Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data, collected from providers, to calculate the health status-related risk-adjusted premium payment to MA plans, which CMS further adjusts for coding pattern differences between the health plans and the government fee-for-service (FFS) program. We generally rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our health status-adjusted payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model. For additional information, refer to Note 17 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" and Part I, Item 1A, "Risk Factors" of this Form 10-K.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we provided health insurance coverage under CMS contracts to approximately 4,565,600 individual Medicare Advantage members, including approximately 771,900 members in Florida. These Florida contracts accounted for premiums revenue of approximately $13.2 billion, which represented approximately 20% of our individual Medicare Advantage premiums revenue, or 14% of our consolidated premiums and services revenue for the year ended December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our individual Medicare Advantage products covered under Medicare Advantage contracts with CMS are renewed generally for a calendar year term unless CMS notifies us of its decision not to renew by May&#160;1 of the calendar year in which the contract would end, or we notify CMS of our decision not to renew by the first Monday in June of the calendar year in which the contract would end. All material contracts between Humana and CMS relating to our Medicare Advantage products have been renewed for 2023, and all of our product offerings filed with CMS for 2023 have been approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Individual Medicare Stand-Alone Prescription Drug Products</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer stand-alone prescription drug plans, or PDPs, under Medicare Part D, including a PDP offering co-branded with Wal-Mart Stores, Inc., or the Humana-Walmart plan. Generally, Medicare-eligible individuals enroll in one of our plan choices between October&#160;15 and December&#160;7 for coverage that begins on the following January&#160;1. Our stand-alone PDP offerings consist of plans offering basic coverage with benefits mandated by Congress, as well as plans providing enhanced coverage with varying degrees of out-of-pocket costs for premiums, deductibles, and co-insurance. Our revenues from CMS and the beneficiary are determined from our PDP bids submitted annually to CMS. These revenues also reflect the health status of the beneficiary and risk sharing provisions as more fully described in Note 2 to the audited Consolidated Financial Statements included in Item&#160;8. &#8211; Financial Statements and Supplementary Data, titled &#8220;Medicare Part D.&#8221; Our stand-alone PDP contracts with CMS are renewed generally for a calendar year term unless CMS notifies us of its decision not to renew by May&#160;1 of the calendar year in which the contract would end, or we notify CMS of our decision not to renew by the first Monday in June of the calendar year in which the contract would end. All material contracts between Humana and CMS relating to our Medicare stand-alone PDP products have been renewed for 2023, and all of our product offerings filed with CMS for 2023 have been approved.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have administered CMS&#8217;s Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program since 2010. This program allows individuals who receive Medicare&#8217;s low-income subsidy to also receive immediate prescription drug coverage at the point of sale if they are not already enrolled in a Medicare Part D plan. CMS temporarily enrolls newly identified individuals with both Medicare and Medicaid into the LI-NET prescription drug plan program, and subsequently transitions each member into a Medicare Part D plan that may or may not be a Humana Medicare plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Group Medicare Advantage and Medicare Stand-Alone PDP</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer products that enable employers that provide post-retirement health care benefits to replace Medicare wrap or Medicare supplement products with Medicare Advantage or stand-alone PDPs from Humana. These products are primarily offered as PPO plans on the same Medicare platform as individual Medicare Advantage plans. These plans offer the same types of benefits and services available to members in our individual Medicare plans discussed previously, however, group Medicare Advantage plans typically have richer benefit offerings than individual Medicare Advantage plans, including prescription drug coverage in the gap, for instance, due to the desire of many customers to closely match their pre-retirement benefit structure.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Supplement</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also offer Medicare supplement products that help pay the medical expenses that Medicare FFS does not cover, such as copayments, coinsurance and deductibles.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State-based Medicaid Contracts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our state-based contracts, we serve members enrolled in Medicaid, a program funded by both the federal and state governments and administered by states to care for their most vulnerable populations. Within federal guidelines, states determine whom to cover, but general categories for traditional Medicaid programs include: children and parents receiving assistance through Temporary Assistance to Needy Families (TANF); Aged, Blind, and Disabled (ABD) individuals; and Medicaid Expansion adults. Through Medicaid Managed Long-Term Support Services (MLTSS) programs, states offer programs to deliver support services to people who receive home and community or institution-based services for long-term care. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have contracts in multiple states to serve Medicaid-eligible members, including Florida, Kentucky, Louisiana, Ohio, South Carolina and Wisconsin. The Louisiana contract was effective January 1, 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also serve members who qualify for both Medicaid and Medicare, referred to as "dual eligible", through our Medicaid, Medicare Advantage, and stand-alone prescription drug plans. As the dual eligible population represents a disproportionate share of costs, Humana is participating in varied integration models designed to improve health outcomes and reduce avoidable costs. These programs largely operate separately from traditional Medicaid programs. We currently serve dual eligible members under CMS&#8217;s dual eligible demonstration program in Illinois.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our individual Medicare Advantage products, we also offer Dual-Eligible Special Needs Plans (D-SNP). In connection with offering a D-SNP in a particular state, we are required to enter into a special coordinating contract with the applicable state Medicaid agency. To meet federal requirements that took effect in 2021, states have begun to implement new D-SNP requirements to strengthen Medicaid-Medicare integration requirements for D-SNPs. Some states are also moving to support the dual eligible population by linking D-SNP participation to enrollment in a plan that also participates in a state-based Medicaid program to coordinate and integrate both Medicare and Medicaid benefits.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Group Commercial Coverage </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial products sold to employer groups include a broad spectrum of major medical benefits with multiple in-network coinsurance levels and annual deductible choices that employers of all sizes can offer to their employees on either a fully-insured, through HMO, PPO, or POS plans, or self-funded basis. Our plans integrate clinical programs, plan designs, communication tools, and spending accounts. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ASO products are offered to small group and large group employers who self-insure their employee health plans. We receive fees to provide administrative services which generally include the processing of claims, offering access to our provider networks and clinical programs, and responding to customer service inquiries from members of self-funded employers. These products may include all of the same benefit and product design characteristics of our fully-insured HMO, PPO, or POS products described previously. Under ASO contracts, self-funded employers generally retain the risk of financing the costs of health benefits, with large group customers retaining a greater share and small group customers a smaller share of the cost of health benefits.&#160; All small group ASO customers and many large group ASO customers purchase stop loss insurance coverage from us to cover catastrophic claims or to limit aggregate annual costs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employers can customize their offerings with optional benefits such as dental, vision, and life products. We also offer optional benefits such as dental and vision to individuals.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Military Services</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our TRICARE contracts with the United States Department of Defense, or DoD, we provide administrative services to arrange health care services for the dependents of active duty military personnel and for retired military personnel and their dependents. We have participated in the TRICARE program since 1996 under contracts with the DoD. Under our contracts, we provide administrative services while the federal government retains all of the risk of the cost of health benefits. Accordingly, we account for revenues under the current contract net of estimated health care costs similar to an administrative services fee only agreement. </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2018, we began to deliver services under the T2017 East Region contract. The T2017 East Region contract comprises 32 states and approximately 6 million TRICARE beneficiaries. The T2017 East Region contract, which was originally set to expire on December 31, 2022, was subsequently extended by the DoD and is currently scheduled to expire on December 31, 2023, unless further extended.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we were awarded the next generation of TRICARE Managed Care Support Contracts, or T-5, for the TRICARE East Region by the Defense Health Agency of the DoD. The contract is expected to go into effect in 2024. Until then the T2017 contract remains in place. Under the terms of the award, our service area covers approximately 4.6&#160;million beneficiaries in a region consisting of 24 states and Washington, D.C. The length of the contract is one base year with eight annual option periods, which, if all options are exercised, would result in a total contract length of nine years. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_34"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our CenterWell Segment Products</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The products offered by our CenterWell segment are key to our integrated care delivery model. This segment includes our pharmacy, provider services, and home solutions operations. The CenterWell segment also includes our strategic partnerships with Welsh, Carson, Anderson &amp; Stowe, or WCAS, to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs. For information on our intersegment revenues, refer to Note 18 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our services revenue for the CenterWell segment by line of business for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:55.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.606%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.608%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell<br/>Segment<br/>Services Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent of<br/>Consolidated<br/>Premiums&#160;and<br/>Services&#160;Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">n/a</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External services revenue:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external services revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:49.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n/a &#8211; not applicable</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pharmacy business includes the operations of CenterWell Pharmacy (our mail-order pharmacy business), CenterWell Specialty Pharmacy, and other retail pharmacies located within CenterWell Primary Care clinics for brand, generic, specialty drugs, over the counter medications and supplies, and hospice pharmacy drugs.&#160;</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provider Services</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate full-service, value-based senior focused primary care centers in a number of states, including Georgia, Florida, Kansas, Louisiana, Missouri, Nevada, North Carolina, South Carolina, Texas, Arizona and </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kentucky staffed by primary care providers and medical specialists with a primary focus on the senior population under our Primary Care Organization, or PCO. PCO operates these clinics primarily under the Conviva Care Centers and CenterWell Senior Primary Care brands. Our primary care subsidiaries operate our medical center business through both employed physicians and care providers, and through third party management service organizations with whom we contract to arrange for and manage certain clinical services. PCO currently operates 235 primary care clinics and employs approximately 670 primary care providers. PCO serves approximately 247,900 patients, primarily under risk sharing arrangements with Humana Medicare Advantage health plans, third party Medicare Advantage health plans and CMS administered risk sharing arrangements for Medicare FFS.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;PCO also operates a Medical Services Organization, or MSO, through Conviva that coordinates medical care for Medicare Advantage beneficiaries in Florida and Texas. This MSO provides resources in care coordination, financial risk management, clinical integration and patient engagement that help physicians improve the patient experience as well as care outcomes. Conviva&#8217;s MSO collaborates with physicians, medical groups and integrated delivery systems to successfully transition to value-based care by engaging, partnering and offering practical services and solutions.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our Primary Care Organization entered into a strategic partnership with Welsh, Carson, Anderson &amp; Stowe, or WCAS, to accelerate the expansion of our primary care model. In May 2022, we established a second strategic partnership with WCAS to develop additional centers between 2023 and 2025. As of December 31, 2022, there were 50 primary care clinics operating under the partnership and we intend to open approximately 100 additional primary care clinics in future periods under the existing arrangements. For additional information, refer to Note 4 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Home Solutions </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CenterWell Home Health</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are actively involved in the care management of our customers with the greatest needs via in-home care. On August 17, 2021, we fully acquired Kindred at Home, or KAH, the nation&#8217;s largest home health and hospice provider with locations in 40 states, providing extensive geographic coverage with approximately 65% overlap with our individual Medicare Advantage membership. Our home solutions geographic scale and clinical breadth provides the opportunity to offer care beyond our health plan members. We have fully-integrated the home health operations, now branded CenterWell Home Health, allowing us to accelerate clinical innovation and the development and roll out of a value-based operating model at scale, more closely aligning incentives to focus on improving patient outcomes and reducing the total cost of care. This is critical to deploying a value-based, advanced home health model at scale that makes it easier for patients and providers to benefit from our full continuum of home-based capabilities, leveraging the best channel to deliver the right care needed at the right time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onehome</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Onehome serves as the convener for the value-based model meeting the needs of health plans by serving their members through a full-risk model for integrated home-based services. Onehome manages a full range of post-acute patient needs, integrating and coordinating with physicians, hospitals and health plans for the provision of home health and infusion services as well as the distribution of durable medical equipment, or DME, at patients&#8217; homes. Onehome served 15% of our MA members with our value-based model as of December 31, 2022. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hospice</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospice care is an important offering in the full continuum of care we offer patients, and we have been successful in delivering the desired patient experience and outcomes through partnership models, including through participation in the CMS hospice Value-Based Insurance Design, or VBID, model. As such, on August&#160;11, 2022, we completed the sale of a 60% i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest in Humana&#8217;s Kindred at Home Hospice subsidiary, or KAH Hospice, to Clayton, Dubilier &amp; Rice, or CD&amp;R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon closing, KAH Hospice was restructured into a new stand-alone company. We continue to own a 40% minority ownership in hospice operations. For additional information on the </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sale of KAH Hospice, refer to Note 3 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_37"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Membership</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total medical membership (in thousands) at December&#160;31, 2022, by market and product:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.557%"><tr><td style="width:1.0%"></td><td style="width:19.225%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.867%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.872%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Individual<br/>Medicare<br/>Advantage</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Group<br/>Medicare<br/>Advantage</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Medicare<br/>stand-<br/>alone&#160;PDP</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Medicare Supplement</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">State-<br/>based<br/>contracts and Other</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Fully-<br/>insured<br/>commercial<br/>Group</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">ASO</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Military services</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Percent<br/>of&#160;Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">771.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">835.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,927.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Kentucky</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">112.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">75.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">169.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">172.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">145.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">759.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">366.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">239.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">78.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">758.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">California</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">103.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">401.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">528.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Georgia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">521.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">North Carolina</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">217.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">115.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">503.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ohio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">176.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">381.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Tennessee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">184.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">369.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Illinois</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">157.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">126.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">357.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Missouri/Kansas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">109.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">324.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Louisiana</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">211.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">50.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">321.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Wisconsin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">69.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">266.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indiana</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">122.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">252.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Virginia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">140.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">251.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">New York</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">107.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">248.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michigan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">236.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Alabama</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">86.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">231.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">South Carolina</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">228.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Pennsylvania</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">213.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Arizona</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">118.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">70.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">213.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Military&#160;services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,959.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,959.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.90&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Others</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">867.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">80.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,098.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,226.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Totals</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4,565.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">565.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,551.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">313.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,137.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">556.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">430.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,959.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17,079.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_40"></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provider Arrangements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide our members with access to health care services through our networks of health care providers whom we employ or with whom we have contracted, including hospitals and other independent facilities such as outpatient surgery centers, primary care providers, specialist physicians, dentists, and providers of ancillary health care services and facilities. These ancillary services and facilities include laboratories, ambulance services, medical equipment services, home health agencies, mental health providers, rehabilitation facilities, nursing homes, optical services, and pharmacies. Our membership base and the ability to influence where our members seek care generally enable us to obtain contractual discounts with providers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a variety of techniques to provide access to effective and efficient use of health care services for our members. These techniques include the coordination of care for our members, product and benefit designs, hospital inpatient management systems, the use of sophisticated analytics, and enrolling members into various care management programs. The focal point for health care services in many of our HMO networks is the primary care provider who, under contract with us, provides services to our members, and may control utilization of appropriate services by directing or approving hospitalization and referrals to specialists and other providers. Some physicians may have arrangements under which they can earn bonuses when certain target goals relating to the provision of quality patient care are met. We have available care management programs related to complex chronic conditions </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such as congestive heart failure and coronary artery disease. We also have programs for prenatal and premature infant care, asthma related illness, end stage renal disease, diabetes, cancer, and certain other conditions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically contract with hospitals on either (1)&#160;a per diem rate, which is an all-inclusive rate per day, (2)&#160;a case rate for diagnosis-related groups (DRG), which is an all-inclusive rate per admission, or (3)&#160;a discounted charge for inpatient hospital services. Outpatient hospital services generally are contracted at a flat rate by type of service, ambulatory payment classifications, or APCs, or at a discounted charge. APCs are similar to flat rates except multiple services and procedures may be aggregated into one fixed payment. These contracts are often multi-year agreements, with rates that are adjusted for inflation annually based on the consumer price index, other nationally recognized inflation indexes, or specific negotiations with the provider. Outpatient surgery centers and other ancillary providers typically are contracted at flat rates per service provided or are reimbursed based upon a nationally recognized fee schedule such as the Medicare allowable fee schedule.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contracts with physicians typically are renewed automatically each year, unless either party gives written notice, generally ranging from 90 to 120 days, to the other party of its intent to terminate the arrangement. Most of the physicians in our PPO networks and some of our physicians in our HMO networks are reimbursed based upon a fixed fee schedule, which typically provides for reimbursement based upon a percentage of the standard Medicare allowable fee schedule.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of our contracts with hospitals and physicians may also vary between Medicare and commercial business. A significant portion of our Medicare network contracts, including those with both hospitals and physicians, are tied to Medicare reimbursement levels and methodologies.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_43"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capitation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer providers a continuum of opportunities to increase the integration of care and offer assistance to providers in transitioning from a fee-for-service to a value-based arrangement. These include performance bonuses, shared savings and shared risk relationships. For some of our medical membership, we share risk with providers under capitation contracts where physicians and hospitals accept varying levels of financial risk for a defined set of membership, primarily HMO membership. Under the typical capitation arrangement, we prepay these providers a monthly fixed-fee per member, known as a capitation (per capita) payment, to cover all or a defined portion of the benefits provided to the capitated member.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe these value-based arrangements represent a key element of our integrated care delivery model at the core of our strategy. Our health plan subsidiaries may enter into these value-based arrangements with third party providers or our owned provider subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, approximately 1,850,500 members, or 10.8% of our medical membership, were covered under shared risk value-based arrangements, which provide all member benefits, including 1,563,700 individual Medicare Advantage members, or 34.2% of our total individual Medicare Advantage membership. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physicians under capitation arrangements typically have stop loss coverage so that a physician&#8217;s financial risk for any single member is limited to a maximum amount on an annual basis. We typically process all claims and measure the financial performance of our capitated providers and require guarantees in certain instances.&#160;However, we delegated claim processing functions under capitation arrangements covering approximately 250,900 HMO members, including 246,100 individual Medicare Advantage members, or 15.7% of the 1,563,700 individual Medicare Advantage members covered under value-based contracts at December&#160;31, 2022, with the provider assuming substantially all the risk of coordinating the members&#8217; health care benefits.&#160;Capitation expense under delegated arrangements for which we have a limited view of the underlying claims experience was approximately $3.0 billion, or 3.9% of total benefits expense, for the year ended December&#160;31, 2022. We remain financially responsible for health care services to our members in the event our providers fail to provide such services.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_46"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Accreditation Assessment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accreditation assessment program consists of several internal programs, including those that credential providers and those designed to meet the audit standards of federal and state agencies as well as external accreditation standards. We also offer quality and outcome measurement and improvement programs such as the Health Care Effectiveness Data and Information Set, or HEDIS, which is used by employers, government purchasers and the National Committee for Quality Assurance (NCQA) to evaluate health plans based on various criteria, including effectiveness of care and member satisfaction.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Providers participating in our networks must satisfy specific criteria, including licensing, patient access, office standards, after-hours coverage, and other factors. Most participating hospitals also meet accreditation criteria established by CMS and/or The Joint Commission.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recredentialing of participating providers occurs every three years, unless otherwise required by state or federal regulations. Recredentialing of participating providers includes verification of their medical licenses, review of their malpractice liability claims histories, review of their board certifications, if applicable, and review of applicable quality information. A committee composed of a peer group of providers reviews the applications of providers being considered for credentialing and recredentialing.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain accreditation for certain of our health plans and/or departments from NCQA, the Accreditation Association for Ambulatory Health Care (AAAHC), and/or URAC. Certain commercial businesses, such as those impacted by a third-party labor agreement or those where a request is made by the employer, may require or prefer accredited health plans.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NCQA reviews our compliance based on standards for quality improvement, population health management, credentialing, utilization management, network management, and member experience. We have achieved and maintained NCQA accreditation in many of our commercial, Medicare and Medicaid markets for HMO, POS, and PPO products, and our wellness program, Go365. Humana&#8217;s pharmacy organization is accredited by URAC.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_49"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use various methods to market our products, including television, radio, the Internet, telemarketing, and direct mailings.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we employed approximately 1,400 sales representatives, as well as approximately 1,900 telemarketing representatives who assisted in the marketing of Medicare products, including Medicare Advantage and PDP, and specialty products in our Insurance segment, including making appointments for sales representatives with prospective members. We have a marketing arrangement with Wal-Mart Stores, Inc., or Wal-Mart, for our individual Medicare stand-alone PDP offering. We also sell group Medicare Advantage products through large employers. In addition, we market our Medicare and individual specialty products through licensed independent brokers and agents. For our Medicare products, commissions paid to employed sales representatives and independent brokers and agents are based on a per unit commission structure, regulated in structure and amount by CMS. For our individual specialty products, we generally pay brokers a commission based on premiums, with commissions varying by market and premium volume. In addition to a commission based directly on premium volume for sales to particular customers, we also have programs that pay brokers and agents based on other metrics. These include commission bonuses based on sales that attain certain levels or involve particular products. We also pay additional commissions based on aggregate volumes of sales involving multiple customers.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our Insurance segment, individuals may become members of our commercial HMOs and PPOs through their employers or other groups, which typically offer employees or members a selection of health insurance products, pay for all or part of the premiums, and make payroll deductions for any premiums payable by the employees. We attempt to become an employer&#8217;s or group&#8217;s exclusive source of health insurance benefits by offering a variety of HMO, PPO, and specialty products that provide cost-effective quality health care coverage consistent with the needs and expectations of their employees or members. We use licensed independent brokers, independent agents, digital insurance agencies, and employees to sell our group products. Many of our larger employer group customers are </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represented by insurance brokers and consultants who assist these groups in the design and purchase of health care products. We pay brokers and agents using the same commission structure described above for our specialty products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_52"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Underwriting</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 2014, the Patient Protection and Affordability Care Act and The Health Care and Education Reconciliation Act of 2010, which we collectively refer to as the Health Care Reform Law, requires certain group health plans to guarantee issuance and renew coverage without pre-existing condition exclusions or health-status rating adjustments. Accordingly, certain group health plans are not subject to underwriting. Further, underwriting techniques are not employed in connection with our individual Medicare, military services, or Medicaid products because government regulations require us to accept all eligible applicants regardless of their health or medical history.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_55"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health benefits industry is highly competitive. Our competitors vary by local market and include other managed care companies, national insurance companies, and other HMOs and PPOs. Many of our competitors have a larger membership base and/or greater financial resources than our health plans in the markets in which we compete. Our ability to sell our products and to retain customers may be influenced by such factors as those described in Item&#160;1A. &#8211; Risk Factors in this 2022 Form 10-K.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_58"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diverse legislative and regulatory initiatives at both the federal and state levels continue to affect aspects of the nation&#8217;s health care system, including the Health Care Reform Law at the federal level and laws in certain states limiting the entry of new providers or services though a certificate of need, or CON, process. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management works proactively to ensure compliance with all governmental laws and regulations affecting our business. We are unable to predict how existing federal or state laws and regulations may be changed or interpreted, what additional laws or regulations affecting our businesses may be enacted or proposed, when and which of the proposed laws will be adopted or what effect any such new laws and regulations will have on our results of operations, financial position, or cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of certain material current activities in the federal and state legislative areas, see Item&#160;1A. &#8211; Risk Factors in this 2022 Form 10-K.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_61"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Other Services</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Captive Insurance Company</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We bear general business risks associated with operating our Company such as professional and general liability, employee workers&#8217; compensation, cybersecurity, and officer and director errors and omissions risks. Professional and general liability risks may include, for example, medical malpractice claims and disputes with members regarding benefit coverage. We retain certain of these risks through our wholly-owned, captive insurance subsidiary. We reduce exposure to these risks by insuring levels of coverage for losses in excess of our retained limits with a number of third-party insurance companies. We remain liable in the event these insurance companies are unable to pay their portion of the losses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Centralized Intercompany Services</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide centralized intercompany services to each of our health plans and to our business segments from our headquarters and service centers. These services include management information systems, product development and administration, finance, human resources, accounting, law, public relations, marketing, insurance, purchasing, risk management, internal audit, actuarial, underwriting, claims processing, billing/enrollment, and customer service. </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through intercompany service agreements approved, if required, by state regulatory authorities, Humana Inc., our parent company, charges a services fee for reimbursement of certain centralized services provided to its subsidiaries to the extent that Humana Inc. is the service provider.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_64"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital Management </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our associates are essential to our success in delivering on our core strategy, and creating positive healthcare experiences for our members. We are committed to recruiting, developing, and retaining strong, diverse teams, actively promoting a culture of inclusion and diversity. As of December 31, 2022, we had approximately 67,100 associates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Culture</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our members&#8217; experience is linked to our associates&#8217; experience and that engaged, productive associates are the key to building a healthy company and a caring environment where our associates go above and beyond for our members, driving innovation, and offering fulfilling experiences that incentivizes them to stay with us over the long-term. We provide opportunities for our associates to add to their personal well-being experiences that go beyond health to enhance their individual need for purpose, belonging and security. We regularly measure our success and opportunities to advance engagement through methods like a third-party administered Associate Experience Survey and continuous listening campaigns. Continuous listening involves our proactive solicitation, analysis and response to associate feedback. Pulse surveys are sent to associates throughout the year to get feedback on how we&#8217;re doing, allowing us to assess our approach to work and act when needed. We believe this helps to strengthen our culture and support associate engagement. We also provide survey results to our entire associate population and encourage leaders to use the information to create open, honest action plans with their teams to build upon and further deepen our collective engagement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our culture is further strengthened by optimizing the well-being and effectiveness of our workforce. Through alternative work styles, we help associates work more productively, communicate more easily and collaborate more freely. Alternate work styles enable associates to work from a job-appropriate location of their choice for all or some portion of their work schedule and to create a work schedule that better fits the diverse demands of today&#8217;s work environment. When managed effectively, alternative work styles can enhance a company&#8217;s employment brand, foster the development and effective delivery of innovative and diverse business solutions, right-size a company&#8217;s energy-consumption footprint, and increase associate engagement and well-being. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar to many companies, we experienced lower engagement and higher turnover in 2022 and 2021 than in prior years. Our associate voluntary turnover rate, or VTR, for 2022 was 17.0%, up from 15.1% in 2021. However, associate engagement and well-being rates remained higher than average, despite challenges posed by the Great Resignation, COVID-19 and workforce optimization efforts to fulfill our commitment to execute on our value creation initiative to allow for increased investment in our Medicare Advantage benefits and healthcare services capabilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Inclusion and Diversity </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Office of Inclusion &amp; Diversity, or I&amp;D Office, efforts are led by our Chief Inclusion and Diversity Officer, who reports directly to the Chief Administrative Officer. The I&amp;D Office connects to business groups across the enterprise to cultivate a diverse and inclusive culture that is representative of the communities we serve. By prioritizing I&amp;D across our business, we enable associates to bring their whole selves to work, while also driving the innovation and insights needed to better serve our diverse members and communities. We strive to accelerate our culture of inclusion to build deep relationships and create simple, personalized experiences for all of our stakeholders.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To help integrate inclusion and diversity into the fabric of the organization from the top down, the Executive Inclusion &amp; Diversity Council is led by our President and CEO, with top priorities consisting of (i) leading and informing the strategy to drive the hiring, development, promotion and retention of our full diverse workforce; (ii) creating and maintaining an inclusive culture; (iii) reviewing our supply base and spend for diversification </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opportunities; and (iv) improving transparency and accountability to sustain outcomes. We are committed to having balanced diversity at all levels and have developed a pathway for diverse talent within our recruiting initiatives. We&#8217;ve also incorporated balanced interview panels into our interview process, through which we strategically engage a broad spectrum of interviewers that bring greater diversity and perspective. This proven best practice strengthens the candidate experience and hiring of diverse talent, ensuring we get the right talent for any given role, and minimizes the potential for personal blind spots when evaluating candidates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inclusion and diversity objectives also aim to build an awareness of biases and beliefs, identify differences and similarities of our multi-generational workforce and enable associates to leverage differences to drive innovation and create value. We are committed to growing our associates&#8217; inclusion skills and diversity knowledge and provide a variety of associate training programs and workshop opportunities in areas of unconscious bias, disability awareness, cultural competency, racial equity, and social justice, among others. It is also our fundamental belief that every person has the right to a safe workplace. This includes having freedom of gender identity and expression, which we have included within our non-discrimination and anti-harassment policies. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our associates&#8217; vast experiences and perceptions, unique characteristics, backgrounds and beliefs, drive the groundbreaking, strategic thinking that gives our Company its competitive edge in a diverse marketplace. Our approach fosters innovative thinking and creativity, expands insights and generates better business outcomes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pay and Benefits Philosophy, Compensation and Financial Security</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe all of our associates have the right to receive a fair living wage and we are committed to maintaining a pay and benefits philosophy that is market-based and recognizes an associate&#8217;s contributions so that we can attract and retain an engaged, talented team. Our Company&#8217;s pay and benefits structure is designed to motivate, incentivize and reward our associates - at all levels of the organization - for their skill development, demonstration of our values and performance. While our programs vary by location, associate type and business, they generally include:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Financial</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Health</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Life</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Competitive Base Pay</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Medical, Dental and Vision Benefits</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Paid Time Off, Paid Holidays, Paid Volunteer Time Off and Jury Duty Pay</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Associate Incentive Plan (Annual Bonus)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Supplemental Health Benefits</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Adoption Assistance</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Supplemental Pay (Including Overtime)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Long-term Care Insurance</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Paid Parental Leave Program (6 weeks)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Recognition Pay and Service Awards</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Wellness and Rewards Program</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Paid Caregiver Time Off Program (2 weeks)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">401(k) Retirement Savings Plan with Company Match Program</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Health Plan Incentives</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Employee Assistance Program</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Life Insurance</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On-site Health and Fitness Centers</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Associate Discount Programs and Services</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Short- and Long-Term Disability Insurance</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On-site Health Screenings and Vaccinations</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Helping Hands Program</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Tuition Assistance Program</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Transit Services</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Talent Development and Growth Opportunities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We champion the individual goals and development of our associates, and provide a number of programs and resources to support their efforts. We provide opportunities for our associates to earn professional certifications through continued education programs and to participate in instructor-led and online courses designed to strengthen soft and hard-skills and enhance leadership development. Our Career Cultivation team sponsors workshops and events to promote associate accountability within their personal and professional growth as part of overall career development. Our associates are also encouraged to participate in mentoring programs with people of various backgrounds and cultures. We view mentoring as an essential development tool for sharing skills and knowledge so we can all succeed. Our commitment to mentoring feeds the successful future of our Company. Additionally, we utilize development programs to enhance talent within our organizations through targeted internal initiatives, where we aim to upskill and reskill existing associates for opportunities in new career pathways. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information related to our human capital can be found by referencing our Definitive Proxy Statement of the Annual Meeting of Stockholders scheduled to be held on April 20, 2023 appearing under the caption "Human Capital Management." </span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_67"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information About Our Executive Officers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Set forth below are names and ages of all of our current executive officers as of February&#160;1, 2023, their positions, and the date first elected as an executive officer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:22.854%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.507%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.028%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.051%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">First<br/>Elected<br/>Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruce D. Broussard</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer, Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/11</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vishal Agrawal, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Strategy and Corporate Development Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/18</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Andrew C. Agwunobi, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment President, Home Solutions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Samir M. Deshpande</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Information Officer </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">07/17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Susan M. Diamond </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">07/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John-Paul W. Felter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Accounting Officer and Controller</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">08/22</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">William K. Fleming, PharmD</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment President, Pharmacy Solutions &amp; Chief Corporate Affairs Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">03/17</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Timothy S. Huval</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Administrative Officer</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/12</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">George Renaudin II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President, Medicare &amp; Medicaid</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Susan D. Schick</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment President, Group and Military Business</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">09/21</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph C. Ventura </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Legal Officer </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">02/19</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td></tr></table></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Mr. Broussard currently serves as Director, President and Chief Executive Officer (Principal Executive Officer), having held these positions since January 1, 2013. Mr. Broussard was elected President upon joining the Company in December 2011 and served in that capacity through December 2012. Prior to joining the Company, Mr.&#160;Broussard was Chief Executive Officer of McKesson Specialty/US Oncology, Inc. US Oncology was purchased by McKesson in December 2010. At US Oncology, Mr. Broussard served in a number of senior executive roles, including Chief Financial Officer, Chief Executive Officer, and Chairman of the Board.</span></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Dr. Agrawal currently serves as Chief Strategy and Corporate Development Officer, having joined the Company in December 2018.&#160; Prior to joining the Company, Dr. Agrawal was Senior Advisor for The Carlyle Group L.P., having held that position from October 2017 to December 2018.&#160; Previously, Dr. Agrawal was President and Chief Growth Officer of Ciox Health, the largest health information exchange and release of information services organization in the U.S. from December of 2015 to October 2018.&#160; Prior to joining Ciox Health, Dr. Agrawal served as President of Harris Healthcare Solutions from January 2013 to December 2015. </span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Dr. Agwunobi currently serves as Segment President, Home Solutions, having joined Humana in February 2022. Prior to joining the Company, Dr. Agwunobi served as Interim President of the University of Connecticut (UConn) from May 2021 until February 2022, and the Chief Executive Officer and Executive Vice President for Health Affairs for UConn Health from 2014 to February 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Mr. Deshpande currently serves as Chief Information Officer, having been elected to this position in July 2021, from his prior role as Chief Technology and Risk Officer.  Before joining the Company in July 2017, Mr. Deshpande spent 17 years at Capital One in key leadership positions, most recently as Business Chief Risk Officer for the U.S. and international card business. He previously served as the Business Chief Risk Officer and Head of Enterprise Services for the Financial Services Division, responsible for Business Risk, Data Science, Data Quality, Process Excellence and Project Management. He also led marketing and </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">analysis for the Home Loans, Auto Finance, and Credit Card businesses, with responsibilities for business strategy, credit, product and marketing.</span></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Ms. Diamond currently serves as Chief Financial Officer, having been elected to this position in June 2021, from her prior role as Segment President, Home Business. Ms. Diamond joined the Company in June 2004 and has spent the majority of her career in various leadership roles in the Medicare and Home businesses, with a particular passion and emphasis on growth and consumer segmentation strategies for the Company&#8217;s individual Medicare Advantage and Stand Alone Part D offerings. Ms. Diamond also served for two and a half years as the Enterprise Vice President of Finance, where she was responsible for enterprise planning and forecasting, trend analytics and had responsibility for each of the Company&#8217;s line of business CFOs and controllers. </span></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Mr. Felter currently serves as Senior Vice President, Chief Accounting Officer and Controller, having been elected to this position in August 2022. Before joining the Company, Mr. Felter served as Senior Director - Investment Finance for OneAmerica Financial Partners, Inc. from May 2022 until June 2022.  Prior to OneAmerica, Mr. Felter spent nearly 11 years as a Senior Manager at Ernst &amp; Young LLP where he oversaw large audit engagements for public and private entities with a concentration in the health insurance sector.  </span></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Dr. Fleming currently serves as Segment President, Pharmacy Solutions and Chief Corporate Affairs Officer, having been elected to this position in July 2021, from his prior role as Segment President, Clinical and Pharmacy Solutions. Prior to that, Dr. Fleming held positions of Segment President, Healthcare Services as well as President of the Company&#8217;s pharmacy business.  Dr. Fleming joined the Company in 1994.</span></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Mr. Huval currently serves as Chief Administrative Officer, having been elected to this position in July 2019, from his previous role as Chief Human Resources Officer. Prior to joining the Company, Mr. Huval spent 10 years at Bank of America in multiple senior-level roles, including Human Resources executive and Chief Information Officer for Global Wealth &amp; Investment Management, as well as Human Resources executive for both Global Treasury Services and Technology &amp; Global Operations.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Mr. Renaudin currently services as President, Medicare &amp; Medicaid, having been elected to this position in February 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">He joined the Company in April 2004 and since then has held various leadership roles of increasing responsibility, most recently holding the position of President, Medicare.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.34pt">Ms. Schick currently serves as Segment President, Group and Military Business, having been elected to this position in September 2021.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Schick joined the Company in February 2020 in the role of Senior Vice President, Employer Group.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before she joined the Company, Ms. Schick spent 16 years in a range of senior-level leadership roles at United Healthcare in its Medicaid and Commercial businesses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.34pt">Mr. Ventura currently serves as Chief Legal Officer. He joined the Company in January 2009 and since then has held various positions of increasing responsibility in the Company's Law Department, including most recently, Senior Vice President, Associate General Counsel &amp; Corporate Secretary from July 2017 until February 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive officers are elected annually by our Board of Directors and serve until their successors are elected or until resignation or removal. There are no family relationships among any of our executive officers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_70"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A.  RISK FACTORS</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not design and price our products properly and competitively, if the premiums we charge are insufficient to cover the cost of health care services delivered to our members, if we are unable to implement clinical initiatives to provide a better health care experience for our members, lower costs and appropriately document the risk profile of our members, or if our estimates of benefits expense are inadequate, our profitability may be materially adversely affected. We estimate the costs of our benefits expense payments, and design and price our products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends.  Accordingly, our reserves may be insufficient.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a substantial portion of our revenues to pay the costs of health care services delivered to our members, including claims payments, capitation payments to providers (predetermined amounts paid to cover services), estimates of future payments to hospitals and others for medical care provided to our members, and various other costs. Generally, premiums in the health care business are fixed for one-year periods. Accordingly, costs we incur in excess of our benefit cost projections generally are not recovered in the contract year through higher premiums. We estimate the costs of our future benefit claims and other expenses using actuarial methods and assumptions based upon claim payment patterns, medical inflation, historical developments, including claim inventory levels and claim receipt patterns, and other relevant factors. We also record benefits payable for future payments. We continually review estimates of future payments relating to benefit claims costs for services incurred in the current and prior periods and make necessary adjustments to our reserves, including premium deficiency reserves where appropriate. However, these estimates involve extensive judgment, and have considerable inherent variability that is sensitive to claim payment patterns and medical cost trends. Many factors may and often do cause actual health care costs to exceed what was estimated and used to set our premiums. These factors may include:</span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased use of medical facilities and services, and the increased cost of such services;</span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased use or cost of prescription drugs, including specialty prescription drugs;</span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the introduction of new or costly treatments, prescription drugs, or new technologies; </span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our membership mix;</span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variances in actual versus estimated levels of cost associated with new products, benefits or lines of business, product changes or benefit level changes;</span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the demographic characteristics of an account or market;</span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes or reductions of our utilization management functions such as preauthorization of services, concurrent review or requirements for physician referrals; </span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our purchase discounts or pharmacy volume rebates received from drug manufacturers and wholesalers, which are generally passed on to clients in the form of steeper price discounts;</span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">catastrophes, including acts of terrorism, public health emergencies, epidemics or pandemics (such as the spread of COVID-19 or natural disasters (such as hurricanes and earthquakes) which could occur more frequently or with more intense effects as a result of the impact of global climate change; </span></div><div style="margin-bottom:3pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">medical cost inflation; and</span></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">government mandated benefits, member eligibility criteria, or other legislative, judicial, or regulatory changes.</span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Key to our operational strategy is the implementation of clinical initiatives that we believe provide a better health care experience for our members, lower the cost of healthcare services delivered to our members, and appropriately document the risk profile of our members. Our profitability and competitiveness depend in large part </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on our ability to appropriately manage health care costs through, among other things, the application of medical management programs such as our chronic care management program. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we proactively attempt to effectively manage our operating expenses, increases or decreases in staff-related expenses, any costs associated with exiting products, additional investment in new products (including our opportunities in the Medicare programs, state-based contracts, and expansion of clinical capabilities as part of our integrated care delivery model), investments in health and well-being product offerings, acquisitions, new taxes and assessments, inflation,and implementation of regulatory requirements may increase our operating expenses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to adequately price our products or estimate sufficient benefits payable or effectively manage our operating expenses, may result in a material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in a highly competitive industry. Some of our competitors are more established in the health care industry in terms of a larger market share and have greater financial resources than we do in some markets. In addition, other companies may enter our markets in the future, including emerging competitors in the Medicare program or competitors in the delivery of health care services. We believe that barriers to entry in our markets are not substantial, so the addition of new competitors can occur relatively easily, and customers enjoy significant flexibility in moving between competitors through the Medicare Annual Enrollment Period. In addition, contracts for the sale of group commercial products are generally bid upon or renewed annually. While health plans compete on the basis of many factors, including service and the quality and depth of provider networks, we expect that price will continue to be a significant basis of competition. In addition to the challenge of controlling health care costs, we face intense competitive pressure to contain premium prices. Factors such as business consolidations, strategic alliances, legislative reform, and marketing practices create pressure to contain premium price increases, despite being faced with increasing medical and administrative costs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The policies and decisions of the federal and state governments regarding the Medicare Advantage and Prescription Drug Plans, military and Medicaid programs in which we participate have a substantial impact on our profitability. These governmental policies and decisions, which we cannot predict with certainty, directly shape the premiums or other revenues to us under the programs, the eligibility and enrollment of our members, the services we provide to our members, and our administrative, health care services, and other costs associated with these programs. Legislative or regulatory actions, such as changes to the programs in which we participate, those resulting in a reduction in premium payments to us, an increase in our cost of administrative and health care services, or additional fees, taxes or assessments, may have a material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium increases, introduction of new product designs, and our relationships with our providers in various markets, among other issues, could also affect our membership levels. Other actions that could affect membership levels include our possible exit from or entrance into Medicare or commercial markets, or the termination of a large contract. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not compete effectively in our markets, if we set rates too high or too low in highly competitive markets to keep or increase our market share, if membership does not increase as we expect, if membership declines, or if we lose membership with favorable medical cost experience while retaining or increasing membership with unfavorable medical cost experience, our results of operations, financial position, and cash flows may be materially adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to effectively implement our operational and strategic initiatives, including our Medicare initiatives, which are of particular importance given the concentration of our revenues in these products, our state-based contracts strategy, the growth of our CenterWell businesses, and our integrated care delivery model, our business may be materially adversely affected. In addition, there can be no assurances that we will be successful in maintaining or improving our Star ratings in future years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future performance depends in large part upon our ability to execute our strategy, including opportunities created by the expansion of our Medicare programs, our strategy with respect to state-based contracts, including </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">those covering members dually eligible for the Medicare and Medicaid programs, the growth of our pharmacy, provider services, and home solutions businesses, and the successful implementation of our integrated care delivery model. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made substantial investments in the Medicare program to enhance our ability to participate in these programs. The growth of our Medicare products is an important part of our business strategy, and the attendant concentration of revenues intensifies the risks to us inherent in Medicare products. Any failure to achieve this growth may have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The achievement of star ratings of 4-star or higher qualifies Medicare Advantage plans for premium bonuses. Our Medicare Advantage plans' operating results may be significantly affected by their star ratings. Despite our operational efforts to improve our star ratings, there can be no assurances that we will be successful in maintaining or improving our star ratings in future years. In addition, audits of our performance for past or future periods may result in downgrades to our star ratings. Accordingly, our plans may not be eligible for full level quality bonuses, which could adversely affect the benefits such plans can offer, reduce membership and/or reduce profit margins.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to properly maintain the integrity of our data, to strategically maintain existing or implement new information systems, or to protect our proprietary rights to our systems, our business may be materially adversely affected. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business depends significantly on effective information systems and the integrity and timeliness of the data we use to run our business. Our business strategy involves providing members and providers with easy to use products that leverage our information to meet their needs. Our ability to adequately price our products and services, provide effective and efficient service to our customers, and to timely and accurately report our financial results depends significantly on the integrity of the data in our information systems. These systems require an ongoing commitment of significant resources to maintain, protect, and enhance existing systems and develop and integrate new systems to keep pace with continuing changes in information processing technology, evolving industry and regulatory standards, and changing customer preferences, and even with such resources there is no assurance that we will be able to do so. If the information we rely upon to run our businesses was found to be inaccurate or unreliable or if we fail to improve service levels or maintain effectively our information systems and data integrity, we could have operational disruptions, problems in determining medical cost estimates and establishing appropriate pricing, customer and health care provider disputes, regulatory or other legal problems, difficulty preventing and detecting fraud, have increases in operating expenses, loss of existing customers, difficulty in attracting new customers, or other adverse consequences, each of which may result in a material adverse effect on our results of operations, financial position, and cash flows. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on independent third parties for significant portions of our systems-related support, equipment, facilities, and certain data, including data center operations, data network, voice communication services and pharmacy data processing. This dependence makes our operations vulnerable to such third parties' failure to perform adequately under the contract, due to internal or external factors. A change in service providers could result in a decline in service quality and effectiveness or less favorable contract terms which may adversely affect our operating results. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our agreements with customers and service providers, confidentiality agreements with employees, and our trade secrets and copyrights to protect our proprietary rights. These legal protections and precautions may not prevent misappropriation of our proprietary information. The misappropriation of our proprietary information could hinder our ability to market and sell products and services and may result in a material adverse effect on our results of operations, financial position and cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we, and the third-party service providers on whom we rely, are unable to defend our information technology security systems against cybersecurity attacks or prevent other privacy or data security incidents that result in security breaches that disrupt our operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, we could be exposed to significant regulatory fines or penalties, liability or reputational damage, or experience a material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we process, store and transmit large amounts of data, and rely on third-party service providers to do the same, including sensitive personal information as well as proprietary or confidential information relating to our business or a third-party. We have been, and will likely continue to be, regular targets of attempted cybersecurity attacks and other security threats and may be subject to breaches of our information technology security systems. Although the impact of such attacks has not been material to our operations or results of operations, financial position, or cash flow through December 31, 2022, we can provide no assurance that we will be able to detect, prevent, or contain the effects of such cybersecurity attacks or other information security risks or threats in the future. A cybersecurity attack may penetrate our layered security controls and misappropriate or compromise sensitive personal information or proprietary or confidential information or that of third-parties, create system disruptions, cause shutdowns, or deploy viruses, worms, and other malicious software programs that attack our systems. A cybersecurity attack that bypasses our IT security systems, or the security of third-party service providers, could materially affect us due to the theft, destruction, loss, misappropriation or release of confidential data or intellectual property, operational or business delays resulting from the disruption of our IT systems, or negative publicity resulting in reputation or brand damage with our members, customers, providers, and other stakeholders.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs to detect, prevent, eliminate or address cybersecurity threats and vulnerabilities before or after an incident could be substantial. Our remediation efforts may not be successful and could result in interruptions, delays, or cessation of service, and loss of existing or potential members.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, breaches of our security measures or the security measures of third-party service providers, and the unauthorized dissemination of sensitive personal information or proprietary or confidential information about us or our members or other third-parties, could expose our associates' or members&#8217; private information and result in the risk of financial or medical identity theft, or expose us or other third-parties to a risk of loss or misuse of this information, result in significant regulatory fines or penalties, litigation and potential liability for us, damage our brand and reputation, or otherwise harm our business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are involved in various legal actions and governmental and internal investigations, any of which, if resolved unfavorably to us, could result in substantial monetary damages or changes in our business practices. Increased litigation and negative publicity could increase our cost of doing business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are or may become a party to a variety of legal actions that affect our business, including breach of contract actions, employment compensation and other labor and employment practice suits, employee benefit claims, stockholder suits and other securities laws claims, intellectual and other property claims, and tort claims.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because of the nature of the health care business, we are subject to a variety of legal actions relating to our business operations, including the design, management, and offering of products and services. These include and could include in the future: claims relating to the methodologies for calculating premiums; claims relating to the denial of health care benefit payments; claims relating to the denial or rescission of insurance coverage; challenges to the use of some software products used in administering claims; claims relating to our administration of our Medicare Part D offerings; medical malpractice actions brought against our employed providers or affiliated physician-owned professional groups, based on our medical necessity decisions or brought against us on the theory that we are liable for a third-party providers' alleged malpractice; claims arising from any adverse medical consequences resulting from our recommendations about the appropriateness of providers&#8217; proposed medical treatment plans for patients; allegations of anti-competitive and unfair business activities; provider disputes over compensation or non-acceptance or termination of provider contracts; disputes related to ASO business, including actions alleging claim administration errors; false claims litigation, such as qui tam lawsuits, brought by individuals who seek to sue on behalf of the government, alleging that we, as a government contractor, submitted false claims to the government or retained overpayments from the government, among other allegations, resulting from coding and review practices under the Medicare risk-adjustment model; claims related to the failure to disclose some business practices; claims relating to customer audits and contract performance; claims relating to dispensing of drugs associated with our in-house dispensing pharmacies; and professional liability claims arising out of the delivery of healthcare and related services to the public.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, substantial non-economic or punitive damages as well as treble damages under the federal False Claims Act, Racketeer Influenced and Corrupt Organizations Act and other statutes may be sought. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we currently have insurance coverage for some of these potential liabilities, other potential liabilities may not be covered by insurance, insurers may dispute coverage, or the amount of our insurance may not be enough to cover the damages awarded. In addition, some types of damages, like punitive damages, may not be covered by insurance. In some jurisdictions, coverage of punitive damages is prohibited. Insurance coverage for all or some forms of liability may become unavailable or prohibitively expensive in the future.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health benefits industry continues to receive significant negative publicity reflecting the public perception of the industry. This publicity and perception have been accompanied by increased litigation, including some large jury awards, legislative activity, regulation, and governmental review of industry practices. These factors may materially adversely affect our ability to market our products or services, may require us to change our products or services or otherwise change our business practices, may increase the regulatory burdens under which we operate, and may require us to pay large judgments or fines. Any combination of these factors could further increase our cost of doing business and adversely affect our results of operations, financial position, and cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See "Legal Proceedings and Certain Regulatory Matters" in Note 17 to the audited Consolidated Financial Statements included in Item 8. - Financial Statements and Supplementary Data. We cannot predict the outcome of these matters with certainty.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As a government contractor, we are exposed to risks that may materially adversely affect our business or our willingness or ability to participate in government health care programs.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A significant portion of our revenues relates to federal and state government health care coverage programs, including the Medicare, military, and Medicaid programs. These programs accounted for approximately 88% of our total premiums and services revenue for the year ended December 31, 2022. These programs involve various risks, as described further below.</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">At December 31, 2022, under our contracts with CMS we provided health insurance coverage to approximately 771,900 individual Medicare Advantage members in Florida. These contracts accounted for approximately 14% of our total premiums and services revenue for the year ended December 31, 2022. The loss of these and other CMS contracts (which are generally renewed annually) or significant changes in the Medicare Advantage and Prescription Drug Plan programs as a result of legislative or regulatory action, including changes to the Part D prescription drug benefit design or reductions in premium payments to us or increases in member benefits or changes to member eligibility criteria without corresponding increases in premium payments to us, may have a material adverse effect on our results of operations, financial position, and cash flows. </span></div><div style="padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our military services business, which accounted for approximately 1% of our total premiums and services revenue for the year ended December 31, 2022, primarily consisted of the TRICARE T2017 East Region contract.  The T2017 East Region contract is a consolidation of the former T3 North and South Regions, comprising 32 states and approximately six million TRICARE beneficiaries, under which delivery of health care services commenced on January 1, 2018. On December 23, 2022, the Department of Defense (&#8220;DoD&#8221;) exercised its option to extend the T2017 East Region contract, adding Option Periods 6 &amp; 7, and exercised Option Period 6 which extends the T2017 East Region contract through December 31, 2023. On December 22, 2022, we were notified by the DoD that we were awarded the new contract for the TRICARE East Region, with delivery of health care services expected to commence in 2024. The next generation East Region contract awards may be subject to protests by unsuccessful bidders before the U.S. Court of Federal Claims. The loss of the current T2017 East Region contract or an overturn of the award of the new East Region contract to us, should either occur, may have a material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage, or MA, plans according to health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997 (BBA) and the Benefits Improvement and Protection Act of 2000 (BIPA), generally pays more where a plan's membership has higher expected costs. Under this model, rates paid to MA plans are based on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a "national average risk profile." That baseline payment amount is adjusted to account for certain demographic characteristics and health status of our enrolled members. Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data, collected from providers, to calculate the health status-related risk-adjusted premium payment to MA plans, which CMS further adjusts for coding pattern differences between the health plans and the government fee-for-service (FFS) program. We generally rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our health status-adjusted payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS and the Office of the Inspector General of Health and Human Services, or HHS-OIG, perform audits of various companies&#8217; risk adjustment diagnosis data submissions. We refer to these audits as Risk-Adjustment Data Validation Audits, or RADV audits. RADV audits review medical records in an attempt to validate provider medical record documentation and coding practices that influence the calculation of health status-related premium payments to MA plans.  </span></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS released an MA contract-level RADV methodology that would extrapolate the results of each CMS RADV audit sample to the audited MA contract&#8217;s entire health status-related risk adjusted premium amount for the year under audit.  In doing so, CMS recognized &#8220;that the documentation standard used in RADV audits to determine a contract&#8217;s payment error (medical records) is different from the documentation standard used to develop the Part C risk-adjustment model (FFS claims).&#8221;  To correct for this difference, CMS stated that it would apply a &#8220;Fee-for-Service Adjuster (FFS Adjuster)&#8221; as &#8220;an offset to the preliminary recovery amount.&#8221;  This adjuster would be &#8220;calculated by CMS based on a RADV-like review of records submitted to support FFS claims data.&#8221;  CMS stated that this methodology would apply to audits beginning with PY 2011.  Humana relied on CMS&#8217;s 2012 guidance in submitting MA bids to CMS.  Humana also launched a &#8220;Self-Audits&#8221; program in 2013 that applied CMS&#8217;s 2012 RADV audit methodology and included an estimated FFS Adjuster.  Humana completed Self-Audits for PYs 2011-2016 and reported results to CMS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, however, CMS issued a proposed rule announcing possible changes to the RADV audit methodology, including elimination of the FFS Adjuster.  CMS proposed applying its revised methodology, including extrapolated recoveries without application of a FFS Adjuster, to RADV audits dating back to PY 2011.  On January 30, 2023, CMS published a final rule related to the RADV audit methodology (Final RADV Rule).  The Final RADV Rule confirmed CMS&#8217;s decision to eliminate the FFS Adjuster. The Final RADV Rule states CMS&#8217;s intention to extrapolate results from CMS and HHS-OIG RADV audits beginning with PY 2018, rather than PY 2011 as proposed.  However, CMS&#8217;s Final RADV Rule does not adopt a specific sampling, extrapolation or audit methodology.  CMS instead stated its general plan to rely on &#8220;any statistically valid method . . . that is determined to be well-suited to a particular audit.&#8221;</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana is considering its legal options with respect to CMS&#8217;s changed position on the FFS Adjuster and seeking clarity regarding our compliance obligations in light of the Final RADV Rule. We believe that the Final RADV Rule fails to address adequately the statutory requirement of actuarial equivalence. Further, Humana&#8217;s actuarially certified bids through PY 2023 preserved Humana&#8217;s position that CMS </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">should apply an FFS Adjuster in any RADV audit that CMS intends to extrapolate. We expect CMS to apply the Final RADV Rule, including the first application of extrapolated audit results to determine audit settlements without a FFS Adjuster, to CMS and HHS-OIG RADV audits conducted for PY 2018 and subsequent years.  The Final RADV  Rule, including the lack of a FFS Adjuster, and any related regulatory, industry or company reactions, could have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="margin-bottom:9pt;padding-left:45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as part of our internal compliance efforts, we routinely perform ordinary course reviews of our internal business processes related to, among other things, our risk coding and data submissions in connection with the risk adjustment model. These reviews may also result in the identification of errors and the submission of corrections to CMS that may, either individually or in the aggregate, be material. As such, the result of these reviews may have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we explore our legal options and compliance obligations, we remain committed to working alongside CMS to promote the integrity of the MA program as well as affordability and cost certainty for our members.  It is critical that MA plans are paid accurately and that payment model principles, including the application of a FFS Adjuster, are in accordance with the requirements of the Social Security Act, which, if not implemented correctly could have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="padding-left:45pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our CMS contracts which cover members&#8217; prescription drugs under Medicare Part D contain provisions for risk sharing and certain payments for prescription drug costs for which we are not at risk. These provisions, certain of which are described below, affect our ultimate payments from CMS.</span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The premiums from CMS are subject to risk corridor provisions which compare costs targeted in our annual bids to actual prescription drug costs, limited to actual costs that would have been incurred under the standard coverage as defined by CMS. Variances exceeding certain thresholds may result in CMS making additional payments to us or require us to refund to CMS a portion of the premiums we received (known as a &#8220;risk corridor&#8221;). We estimate and recognize an adjustment to premiums revenue related to the risk corridor payment settlement based upon pharmacy claims experience. The estimate of the settlement associated with these risk corridor provisions requires us to consider factors that may not be certain, including member eligibility differences with CMS. </span></div><div style="margin-bottom:6pt;padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance and low-income cost subsidies represent payments from CMS in connection with the Medicare Part D program for which we assume no risk. Reinsurance subsidies represent payments for CMS&#8217;s portion of claims costs which exceed the member&#8217;s out-of-pocket threshold, or the catastrophic coverage level. Low-income cost subsidies represent payments from CMS for all or a portion of the deductible, the coinsurance and co-payment amounts above the out-of-pocket threshold for low-income beneficiaries. Monthly prospective payments from CMS for reinsurance and low-income cost subsidies are based on assumptions submitted with our annual bid. A reconciliation and settlement of CMS&#8217;s prospective subsidies against actual prescription drug costs we paid is made after the end of the applicable year. </span></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlement of the reinsurance and low-income cost subsidies as well as the risk corridor payment is based on a reconciliation made approximately 9 months after the close of each calendar year. This reconciliation process requires us to submit claims data necessary for CMS to administer the program. Our claims data may not pass CMS&#8217;s claims edit processes due to various reasons, including discrepancies in eligibility or classification of low-income members. To the extent our data does not pass CMS&#8217;s claim edit processes, we may bear the risk for all or a portion of the claim which otherwise may have been subject to the risk corridor provision or payment which we would have otherwise received as a low-income subsidy or reinsurance claim. In addition, in the event the settlement represents an amount CMS owes us, there is a negative impact on our cash flows and financial condition as a result of financing CMS&#8217;s share of the risk. The opposite is true in the event the settlement represents an amount we owe CMS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, legislative or regulatory changes to how actual prescription drug costs are </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:45pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reported or calculated or other changes to the Part D prescription drug benefit design may lower reinsurance or low-income cost subsidies paid by CMS and may have a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="padding-left:45pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are subject to various other governmental audits and investigations. Under state laws, our HMOs and health insurance companies are audited by state departments of insurance for financial and contractual compliance. Our HMOs are audited for compliance with health services by state departments of health. Audits and investigations, including audits of risk adjustment data, are also conducted by state attorneys general, CMS, HHS-OIG, the Office of Personnel Management, the Department of Justice, the Department of Labor, and the Defense Contract Audit Agency. All of these activities could result in the loss of licensure or temporary or permanent exclusion from participating in various government health care programs (such as Medicare and Medicaid), including a limitation on our ability to market or sell products, the imposition of fines, penalties and other civil and criminal sanctions, or changes in our business practices. The outcome of any current or future governmental or internal investigations cannot be accurately predicted, nor can we predict any resulting penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities. Nevertheless, it is reasonably possible that any such outcome of litigation, penalties, fines or other sanctions could be substantial, and the outcome of these matters may have a material adverse effect on our results of operations, financial position, and cash flows. Certain of these matters could also affect our reputation. In addition, disclosure of any adverse investigation or audit results or sanctions could negatively affect our industry or our reputation in various markets and make it more difficult for us to sell our products and services.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase our cost of doing business and may have a material adverse effect on our results of operations, or cash flows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">New Laws or Regulations, or Future Legislative, Judicial or Regulatory Changes</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are and will continue to be regularly subject to new laws and regulations, changes to existing laws and regulations, and judicial determinations that impact the interpretation and applicability of those laws and regulations. The Patient Protection and Affordable Care Act and The Health Care and Education Reconciliation Act of 2010 (which we collectively refer to as the Health Care Reform Law), the Families First Coronavirus Response Act (the &#8220;Families First Act&#8221;), the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;), and the Inflation Reduction Act of 2022 (the &#8220;Inflation Reduction Act&#8221;), and related regulations, are examples of laws which have enacted significant reforms to various aspects of the U.S. health insurance industry, including among others, mandated coverage requirements, mandated benefits and guarantee issuance associated with commercial medical insurance, rebates to policyholders based on minimum benefit ratios, adjustments to Medicare Advantage premiums, the establishment of federally facilitated or state-based exchanges coupled with programs designed to spread risk among insurers, the introduction of plan designs based on set actuarial values, and changes to the Part D prescription drug benefit design.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that these laws and regulations, as well as other current or future legislative, judicial or regulatory changes (including further legislative or regulatory action taken in response to COVID-19), including restrictions on our ability to manage our provider network or otherwise operate our business, or restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage business profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, increases in member benefits or changes to member eligibility criteria without corresponding increases in premium payments to us, increases in regulation of our prescription drug benefit businesses, or changes to the Part D prescription drug benefit design may have a material adverse effect on our results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting our ability to expand into new markets, increasing our medical and operating costs, further lowering our Medicare payment rates and increasing </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our expenses associated with assessments); our financial position (including our ability to maintain the value of our goodwill); and our cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, potential legislative changes or judicial determinations, including activities to repeal or replace these laws and regulations, including the Health Care Reform Law or declare all or certain portions of these laws and regulations unconstitutional or contrary to law, create uncertainty for our business, and we cannot predict when, or in what form, such legislative changes or judicial determinations may occur.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurance Portability and Accountability Act (HIPAA) and the Health Information Technology for Economic and Clinical Health Act (HITECH Act)</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The use of individually identifiable health data by our business is regulated at federal and state levels. These laws and rules are changed frequently by legislation or administrative interpretation. Various state laws address the use and maintenance of individually identifiable health data. Most are derived from the privacy provisions in the federal Gramm-Leach-Bliley Act and the Health Insurance Portability and Accountability Act, or HIPAA. HIPAA includes administrative provisions directed at simplifying electronic data interchange through standardizing transactions, establishing uniform health care provider, payer, and employer identifiers, and seeking protections for the confidentiality and security of patient data. The rules do not provide for complete federal preemption of state laws, but rather preempt all inconsistent state laws unless the state law is more stringent. These regulations set standards for the security of electronic health information, including requirements that insurers provide customers with notice regarding how their non-public personal information is used, including an opportunity to "opt out" of certain disclosures. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HITECH Act, one part of the American Recovery and Reinvestment Act of 2009, significantly broadened and strengthened the scope of the privacy and security regulations of HIPAA and imposes additional limits on the use and disclosure of protected health information, or PHI. Among other requirements, the HITECH Act and HIPAA requires us and other covered entities to report any unauthorized release or use of or access to PHI to any impacted individuals and to HHS in those instances where the unauthorized activity poses a significant risk of financial, reputational or other harm to the individuals, and to notify the media in any states where 500 or more people are impacted by any unauthorized release or use of or access to PHI, requires business associates to comply with certain provisions of the HIPAA privacy and security rule, and grants enforcement authority to state attorneys general in addition to the HHS Office of Civil Rights. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there are numerous federal and state laws and regulations addressing patient and consumer privacy concerns, including unauthorized access or theft of personal information. State statutes and regulations vary from state to state and could impose additional penalties. Violations of HIPAA or applicable federal or state laws or regulations could subject us to significant criminal or civil penalties, including significant monetary penalties. Compliance with HIPAA and other privacy regulations requires significant systems enhancements, training and administrative effort. HIPAA can also expose us to additional liability for violations by our business associates (e.g., entities that provide services to health plans and providers).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Practice of Medicine and Other Laws </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a corporate entity, Humana Inc. is not licensed to practice medicine. Many states in which we operate through our subsidiaries limit the practice of medicine to licensed individuals or professional organizations comprised of licensed individuals, and business corporations generally may not exercise control over the medical decisions of physicians. Statutes and regulations relating to the practice of medicine, fee-splitting between physicians and referral sources, and similar issues vary widely from state to state. Under management agreements between certain of our subsidiaries and affiliated physician-owned professional groups, these groups retain sole responsibility for all medical decisions, as well as for hiring and managing physicians and other licensed healthcare providers, developing operating policies and procedures, implementing professional standards and controls, and maintaining malpractice insurance. We believe that our health services operations comply with applicable state statutes regarding corporate practice of medicine, fee-splitting, and similar issues. However, any enforcement actions by governmental officials alleging non-compliance with these statutes, which could subject us to penalties or </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">restructuring or reorganization of our business, may result in a material adverse effect on our results of operations, financial position, or cash flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-Kickback, Physician Self-Referral, and Other Fraud and Abuse Laws </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various federal and state healthcare fraud and abuse laws including the federal False Claims Act (the &#8220;False Claims Act&#8221;), the federal anti-kickback statute (the &#8220;Anti-Kickback Statute&#8221;), the federal &#8220;Stark Law,&#8221; and related state laws. Potential sanctions for violating these laws include recoupment or reduction of government reimbursement amounts, civil penalties, treble damages, and exclusion from participating in the Medicare and Medicaid programs or other government healthcare programs. The False Claims Act prohibits knowingly submitting, conspiring to submit, or causing to be submitted, false claims, records, or statements to the federal government, or intentionally failing to return overpayments, in connection with reimbursement by federal government programs.  The Anti-Kickback Statute prohibits the offer, payment, solicitation, or receipt of any form of remuneration to induce, or in return for, the referral of business under Medicare or other governmental health program.  The Stark Law prohibits physicians from referring Medicare or Medicaid beneficiaries for certain services to any entity with which the physician, or an immediate family member of the physician, has a financial relationship, unless the financial relationship fits within a permissible exception.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many states also have enacted laws similar in scope and purpose to the Anti-Kickback Statute and, in more limited instances, the Stark Law, that are not limited to services for which Medicare or Medicaid payment is made. In addition, most states have statutes, regulations, or professional codes that restrict a physician from accepting various kinds of remuneration in exchange for making referrals. These laws vary from state to state and have seldom been interpreted by the courts or regulatory agencies. In states that have enacted these statutes, we believe that regulatory authorities and state courts interpreting these statutes may regard federal law under the Anti-Kickback Statute and the Stark Law as persuasive. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our operations comply with the Anti-Kickback Statute, the Stark Law, and similar federal or state laws addressing fraud and abuse. These laws are subject to modification and changes in interpretation, and are enforced by authorities vested with broad discretion. We continually monitor developments in this area. If these laws are interpreted in a manner contrary to our interpretation or are reinterpreted or amended, or if new legislation is enacted with respect to healthcare fraud and abuse, illegal remuneration, or similar issues, we may be required to restructure our affected operations to maintain compliance with applicable law. There can be no assurances that any such restructuring will be possible or, if possible, would not have a material adverse effect on our results of operations, financial position, or cash flows.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Regulation of our Products and Services</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Laws in each of the states (and Puerto Rico) in which we operate our HMOs, PPOs and other health insurance-related services regulate our operations including: capital adequacy and other licensing requirements, policy language describing benefits, mandated benefits and processes, entry, withdrawal or re-entry into a state or market, rate increases, delivery systems, utilization review procedures, quality assurance, complaint systems, enrollment requirements, claim payments, marketing, and advertising. The HMO, PPO, and other health insurance-related products we offer are sold under licenses issued by the applicable insurance regulators.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our licensed insurance subsidiaries are also subject to regulation under state insurance holding company and Puerto Rico regulations. These regulations generally require, among other things, prior approval and/or notice of new products, rates, benefit changes, and certain material transactions, including dividend payments, purchases or sales of assets, intercompany agreements, and the filing of various financial and operational reports.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our healthcare services businesses require a Certificate of Need, or CON, to operate in certain states. These states restrict the entry of new providers or services and the expansion of existing providers or services in their state through a CON process, which is periodically evaluated and updated as required by applicable state law. To the extent that we require a CON or other similar approvals to expand our operations, our expansion could be adversely affected by our inability to obtain the necessary approval. To the extent laws in these CON states change, </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including the elimination of the CON requirement, the intangible value associated with these CONs may be impaired.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure by us to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on our results of operations, financial position, and cash flows. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our business strategy, we frequently engage in discussions with third parties regarding possible investments, acquisitions, divestitures, strategic alliances, joint ventures, and outsourcing transactions and often enter into agreements relating to such transactions in order to further our business objectives. In order to pursue our acquisition strategy successfully, we must identify suitable candidates for and successfully complete transactions, some of which may be large and complex, and manage post-closing issues such as the integration of acquired companies or employees. Integration and other risks can be more pronounced for larger and more complicated transactions, transactions outside of our core business space, or if multiple transactions are pursued simultaneously. The failure to successfully integrate acquired entities and businesses or failure to produce results consistent with the financial model used in the analysis of our transactions may cause asset write-offs, restructuring costs or other expenses and may have a material adverse effect on our results of operations, financial position, and cash flows. If we fail to identify and complete successfully transactions that further our strategic objectives, we may be required to expend resources to develop products and technology internally. In addition, from time to time, we evaluate alternatives for our businesses that do not meet our strategic, growth or profitability objectives, and we may divest or wind down such businesses. There can be no assurance that we will be able to complete any such divestiture on terms favorable to us, and the divestiture of certain businesses could result, individually or in the aggregate, in the recognition of material losses and a material adverse effect on our results of operations.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to develop and maintain satisfactory relationships with the providers of care to our members, our business may be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ or contract with physicians, hospitals and other providers to deliver health care to our members. Our products encourage or require our customers to use these contracted providers. A key component of our integrated care delivery strategy is to increase the number of providers who share medical cost risk with us or have financial incentives to deliver quality medical services in a cost-effective manner.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In any particular market, providers could refuse to contract with us, demand higher payments, or take other actions that could result in higher health care costs for us, less desirable products for customers and members or difficulty meeting regulatory or accreditation requirements. In some markets, some providers, particularly hospitals, physician specialty groups, physician/hospital organizations, or multi-specialty physician groups, may have significant market positions and negotiating power. In addition, physician or practice management companies, which aggregate physician practices for administrative efficiency and marketing leverage, may compete directly with us. If these providers refuse to contract with us, use their market position to negotiate unfavorable contracts with us or place us at a competitive disadvantage, or do not enter into contracts with us that encourage the delivery of quality medical services in a cost-effective manner, our ability to market products or to be profitable in those areas may be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some situations, we have contracts with individual or groups of primary care providers for an actuarially determined, fixed fee per month to provide a basket of required medical services to our members. This type of contract is referred to as a &#8220;capitation&#8221; contract. The inability of providers to properly manage costs under these capitation arrangements can result in the financial instability of these providers and the termination of their relationship with us. In addition, payment or other disputes between a primary care provider and specialists with whom the primary care provider contracts can result in a disruption in the provision of services to our members or a reduction in the services available to our members. The financial instability or failure of a primary care provider to pay other providers for services rendered could lead those other providers to demand payment from us even though we have made our regular fixed payments to the primary provider. There can be no assurance that providers with whom we contract will properly manage the costs of services, maintain financial solvency or avoid disputes with other providers. Any of these events may have a material adverse effect on the provision of services to our members and our results of operations, financial position, and cash flows.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our healthcare services businesses depends on our ability, and the ability of our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affiliated physician-owned professional groups </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and management services organizations, to recruit, hire, acquire, contract with, and retain physicians, nurses and other medical professionals who are experienced in providing care services to older adults.  The market to acquire or manage physician practices, and to employ or contract with individual physicians, nurses and other medical professionals is, and is expected to remain, highly competitive, and the performance of our healthcare services businesses may be adversely impacted if we, and our </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affiliated physician-owned professional groups </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and management services organizations, are unable to attract, maintain satisfactory relationships with, and retain physicians, nurses and other medical professionals, or if these businesses are unable to retain patients following the departure of a physician, nurses or other medical professional. In addition, our healthcare services businesses contract with competitors of our health benefits businesses, and these businesses could suffer if they are unable to maintain relationships with these companies, or fail to adequately price their contracts with these third-party payers.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to our success, and our failure to do so could adversely affect our businesses, operating results and/or future performance.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our ability to attract, develop and retain qualified employees and executives, including those with diverse backgrounds, experiences and skill sets, to operate and expand our business. We face intense competition for qualified employees, and there can be no assurance that we will be able to attract and retain such employees or that such competition among potential employers will not result in increasing salaries.  In addition, while we have development and succession plans in place for our key employees and executives, these plans do not guarantee the services of our key employees and executives will continue to be available to us. If we are unable to attract, develop, retain and effectively manage the development and succession plans for key employees and executives, our business, results of operations and future performance could be adversely affected.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our pharmacy business is highly competitive and subjects us to regulations and distribution and supply chain risks in addition to those we face with our core health benefits businesses.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our in-house dispensing pharmacy business competes with locally owned drugstores, retail drugstore chains, supermarkets, discount retailers, membership clubs, internet companies and other mail-order and long-term care pharmacies. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our pharmacy business also subjects us to extensive federal, state, and local regulation. The practice of pharmacy is generally regulated at the state level by state boards of pharmacy. Many of the states where we deliver pharmaceuticals, including controlled substances, have laws and regulations that require out-of-state mail-order pharmacies to register with that state&#8217;s board of pharmacy. Federal agencies further regulate our pharmacy operations, requiring registration with the U.S. Drug Enforcement Administration and individual state controlled substance authorities in order to dispense controlled substances. In addition, the FDA inspects facilities in connection with procedures to effect recalls of prescription drugs. The Federal Trade Commission also has requirements for mail-order sellers of goods. The U.S. Postal Service, or USPS, has statutory authority to restrict the transmission of drugs and medicines through the mail to a degree that may have an adverse effect on our mail-order operations. The USPS historically has exercised this statutory authority only with respect to controlled substances. If the USPS restricts our ability to deliver drugs through the mail, alternative means of delivery could be significantly more expensive. The U.S. Department of Transportation has regulatory authority to impose restrictions on drugs inserted in the stream of commerce. These regulations generally do not apply to the USPS and its operations. In addition, we are subject to CMS rules regarding the administration of our PDP plans and intercompany pricing between our PDP plans and our pharmacy business.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to risks inherent in the packaging and distribution of pharmaceuticals and other health care products, including the application of state laws and regulations related to the operation of internet and mail-order pharmacies, violations of which could expose us to civil and criminal penalties, and manufacturing, distribution or other supply chain disruptions (including disruptions that occur as a result of catastrophes, including acts of </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">terrorism, public health emergencies, epidemics or pandemics (such as the spread of COVID-19), or natural disasters (such as hurricanes and earthquakes) which could occur more frequently or with more intense effects as a result of the impacts of global climate change), each of which could impact the availability or cost of supplying of such products.</span></div><div><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in the prescription drug industry pricing benchmarks may adversely affect our financial performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts in the prescription drug industry generally use certain published benchmarks to establish pricing for prescription drugs. These benchmarks include average wholesale price, which is referred to as &#8220;AWP,&#8221; average selling price, which is referred to as &#8220;ASP,&#8221; and wholesale acquisition cost. It is uncertain whether payors, pharmacy providers, pharmacy benefit managers, or PBMs, and others in the prescription drug industry will continue to utilize AWP as it has previously been calculated, or whether other pricing benchmarks will be adopted for establishing prices within the industry. Legislation may lead to changes in the pricing for Medicare and Medicaid programs. Regulators have conducted investigations into the use of AWP for federal program payment, and whether the use of AWP has inflated drug expenditures by the Medicare and Medicaid programs. Federal and state proposals have sought to change the basis for calculating payment of certain drugs by the Medicare and Medicaid programs. Adoption of ASP in lieu of AWP as the measure for determining payment by Medicare or Medicaid programs for the drugs sold in our in-house dispensing pharmacy business may reduce the revenues and gross margins of this business which may result in a material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to obtain funds from certain of our licensed subsidiaries is restricted by state insurance regulations.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we operate as a holding company, we are dependent upon dividends and administrative expense reimbursements from our subsidiaries to fund the obligations of Humana Inc., our parent company. Certain of our insurance subsidiaries operate in states that regulate the payment of dividends, loans, administrative expense reimbursements or other cash transfers to Humana Inc., and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid to Humana Inc. by these insurance subsidiaries, without prior approval by state regulatory authorities, or ordinary dividends, is limited based on the entity's level of statutory income and statutory capital and surplus. In most states, prior notification is provided before paying a dividend even if approval is not required. Actual dividends paid may vary due to consideration of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix. Dividends from our non-insurance companies such as in our CenterWell segment are generally not restricted by Departments of Insurance. In the event that we are unable to provide sufficient capital to fund the obligations of Humana Inc., our results of operations, financial position, and cash flows may be materially adversely affected.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Downgrades in our debt ratings, should they occur, may adversely affect our business, results of operations, and financial condition.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Claims paying ability, financial strength, and debt ratings by recognized rating organizations are an increasingly important factor in establishing the competitive position of insurance companies. Ratings information is broadly disseminated and generally used throughout the industry. Historically, rating agencies take action to lower ratings due to, among other things, perceived concerns about liquidity or solvency, the competitive environment in the insurance industry, the inherent uncertainty in determining reserves for future claims, the outcome of pending litigation and regulatory investigations, and possible changes in the methodology or criteria applied by the rating agencies. Each of the rating agencies reviews its ratings periodically and there can be no assurance that current ratings will be maintained in the future. Our ratings reflect each rating agency&#8217;s opinion of our financial strength, operating performance, and ability to meet our debt obligations or obligations to policyholders, but are not evaluations directed toward the protection of investors in our common stock and should not be relied upon as such. </span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that certain of our customers place importance on our claims paying ability, financial strength, and debt ratings, and we may lose customers and compete less successfully if our ratings were to be downgraded. In addition, our credit ratings impact our ability to obtain future borrowings and investment capital on favorable terms. If our credit ratings were to be lowered, our cost of borrowing likely would increase, our sales and earnings could decrease, and our results of operations, financial position, and cash flows may be materially adversely affected.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The securities and credit markets may experience volatility and disruption, which may adversely affect our business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ongoing volatility or disruption in the securities and credit markets could impact our investment portfolio. We evaluate our investment securities for impairment on a quarterly basis. This review is subjective and requires a high degree of judgment. For the purpose of determining gross realized gains and losses, the cost of investment securities sold is based upon specific identification. For debt securities held, we recognize an impairment loss in income when the fair value of the debt security is less than the carrying value and we have the intent to sell the debt security or it is more likely than not that we will be required to sell the debt security before recovery of our amortized cost basis, or if a credit loss has occurred. When we do not intend to sell or are not required to sell a security in an unrealized loss position, potential credit related impairments are considered using a variety of factors, including the extent to which the fair value has been less than cost, adverse conditions specifically related to the industry, geographic area or financial condition of the issuer or underlying collateral of a security; payment structure of the security; changes in credit rating of the security by the rating agencies; the volatility of the fair value changes; and changes in fair value of the security after the balance sheet date. For debt securities, we take into account expectations of relevant market and economic data. We continuously review our investment portfolios and there is a continuing risk that declines in fair value may occur and additional material realized losses from sales or credit related impairments may be recorded in future periods.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash balances, investment securities, operating cash flows, and funds available under our credit agreement or from other public or private financing sources, taken together, provide adequate resources to fund ongoing operating and regulatory requirements, acquisitions, future expansion opportunities, and capital expenditures for at least the next twelve months, as well as to refinance or repay debt, and repurchase shares. However, continuing adverse securities and credit market conditions may significantly affect the availability of credit. While there is no assurance in the current economic environment, including the heightened uncertainty created by the COVID-19 pandemic, we have no reason to believe the lenders participating in our credit agreement will not be willing and able to provide financing in accordance with the terms of the agreement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our access to additional credit will depend on a variety of factors such as market conditions, the general availability of credit, both to the overall market and our industry, our credit ratings and debt capacity, as well as the possibility that customers or lenders could develop a negative perception of our long or short-term financial prospects. Similarly, our access to funds could be limited if regulatory authorities or rating agencies were to take negative actions against us. If a combination of these factors were to occur, we may not be able to successfully obtain additional financing on favorable terms or at all. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The spread of, and response to, COVID-19 underscores certain risks we face, including those discussed above, and the ongoing, heightened uncertainty created by the pandemic precludes any prediction as to the ultimate adverse impact to us of COVID-19.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 underscores certain risks we face, including those discussed above.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the COVID-19 pandemic continues, the premiums we charge may prove to be insufficient to cover the cost of health care services delivered to our members, each of which could be impacted by many factors, including the impacts that we have experienced, and may continue to experience, to our revenues due to limitations on our ability to implement clinical initiatives to manage health care costs and chronic conditions of our members, and appropriately document their risk profiles, as a result of our members being unable or unwilling to see their providers due to actions taken to mitigate the spread of COVID-19; increased costs that may result from higher utilization rates of medical facilities and services and other increases in associated hospital and pharmaceutical costs; and shifts in our premium and medical claims cost trends to reflect the demographic impact of higher mortality during the COVID-19 pandemic. In addition, we are offering, </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and have been mandated by legislative and regulatory action (including the Families First Act and CARES Act) to provide, certain expanded benefit coverage to our members, such as waiving, or reimbursing, certain costs for COVID-19 testing, vaccinations and treatment. These measures taken by us, or governmental action, to respond to the ongoing impact of COVID-19 (including further expansion or modification of the services delivered to our members, the adoption or modification of regulatory requirements associated with those services and the costs and challenges associated with ensuring timely compliance with such requirements), and the potential for widespread testing, treatments and the distribution and administration of COVID-19 vaccines, could adversely impact our profitability.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The spread and impact of COVID-19 and additional variants, or actions taken to mitigate this spread, could have material and adverse effects on our ability to operate effectively, including as a result of the complete or partial closure of facilities or labor shortages. Disruptions in public and private infrastructure, including communications, availability of in-person sales and marketing channels, financial services and supply chains, could materially and adversely disrupt our normal business operations. A significant subset of our and our third party providers&#8217; employee populations are in a remote work environment in an effort to mitigate the spread of COVID-19, which may exacerbate certain risks to our business, including an increased demand for information technology resources, increased risk of phishing and other cybersecurity attacks, and increased risk of unauthorized dissemination of sensitive personal, or proprietary and/or confidential information. The continued COVID-19 pandemic has severely impacted global economic activity, including the businesses of some of our commercial customers, and caused significant volatility and negative pressure in the financial markets. In addition to disrupting our operations, these developments may adversely affect the timing of commercial customer premium collections and corresponding claim payments, the value of our investment portfolio, or future liquidity needs.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ongoing, heightened uncertainty created by the pandemic precludes any prediction as to the ultimate adverse impact to us of COVID-19. We are continuing to monitor the spread of COVID-19, changes to our benefit coverages, and the ongoing costs and business impacts of dealing with COVID-19, including the potential costs and impacts associated with lifting, or reimposing, restrictions on movement and economic activity, the timing and degree in resumption of demand for deferred healthcare services, the pace of administration of COVID-19 vaccines and the effectiveness of those vaccines, and related risks. The magnitude and duration of the pandemic remains uncertain, and its ultimate impact on our business, results of operations, financial position, and cash flows could be material.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_73"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;1B. UNRESOLVED STAFF COMMENTS</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_76"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;2. PROPERTIES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive office is located in the Humana Building, 500 West Main Street, Louisville, Kentucky 40202. In addition to the headquarters in Louisville, Kentucky, we maintain other principal operating facilities used for customer service, enrollment, and/or claims processing and certain other corporate functions in Louisville, Kentucky; Green Bay, Wisconsin; Tampa, Florida; Cincinnati, Ohio; San Antonio, Texas; San Juan, Puerto Rico; Atlanta, Georgia; Mooresville, North Carolina and Austin, Texas.</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We owned or leased numerous medical centers and administrative offices at December 31, 2022. The medical centers we operate are primarily located in Florida and Texas, including full-service, multi-specialty medical centers staffed by primary care providers and medical specialists. Of these medical centers, approximately 289 of these facilities are leased or subleased to our contracted providers to operate.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_79"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;3. LEGAL PROCEEDINGS</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to a variety of legal actions in the ordinary course of business, certain of which may be styled as class-action lawsuits. Among other matters, this litigation may include employment matters, claims of medical malpractice, bad faith, nonacceptance or termination of providers, anticompetitive practices, improper rate setting, provider contract rate disputes, qui tam litigation brought by individuals seeking to sue on behalf of the government, failure to disclose network discounts and various other provider arrangements, general contractual matters, intellectual property matters, and challenges to subrogation practices. For a discussion of our material legal actions, including those not in the ordinary course of business, see &#8220;Legal Proceedings and Certain Regulatory Matters&#8221; in Note 17 to the audited Consolidated Financial Statements included in Item&#160;8. &#8211; Financial Statements and Supplementary Data. We cannot predict the outcome of these suits with certainty.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_82"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;4. MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_85"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_88"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;5. MARKET FOR THE REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock trades on the New York Stock Exchange under the symbol HUM. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Holders of our Capital Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;31, 2023, there were 1,707 holders of record of our common stock and 634,739 beneficial holders of our common stock.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of dividend payments, excluding dividend equivalent rights, in 2021 and 2022, under our Board approved quarterly cash dividend policy:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.250%"><tr><td style="width:1.0%"></td><td style="width:23.160%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.160%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.160%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Record<br/>Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment<br/>Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021 payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/29/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.6250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$81</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/30/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.7000</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$90</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/30/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.7000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$90</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/29/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.7000</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$90</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022 payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12/31/2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1/28/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.7000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$90</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4/29/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.7875</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6/30/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7/29/2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.7875</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9/30/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10/28/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.7875</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$100</span></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, the Board declared a cash dividend of $0.7875 per share payable on January&#160;27, 2023 to stockholders of record on December 31, 2021 for an aggregate amount of $98 million. In February 2023, the Board declared a cash dividend of $0.8850 per share payable on April&#160;28, 2023 to stockholders of record on March&#160;31, 2023. Declaration and payment of future quarterly dividends is at the discretion of our Board and may be adjusted as business needs or market conditions change.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Total Return Performance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following graph compares our total return to stockholders with the returns of the Standard&#160;&amp; Poor&#8217;s Composite 500 Index (&#8220;S&amp;P 500&#8221;) and the Dow Jones US Select Health Care Providers Index (&#8220;Peer Group&#8221;) for the five years ended December&#160;31, 2022. The graph assumes an investment of $100 in each of our common stock, the S&amp;P 500, and the Peer Group on December&#160;31, 2017, and that dividends were reinvested when paid.</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:24.75pt"><img src="hum-20221231_g1.jpg" alt="hum-20221231_g1.jpg" style="height:337px;margin-bottom:5pt;vertical-align:text-bottom;width:573px"/></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:27.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.314%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.321%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2017</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2018</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HUM</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">S&amp;P 500</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peer Group</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The stock price performance included in this graph is not necessarily indicative of future stock price performance.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides information about purchases by us during the three months ended December&#160;31, 2022 of equity securities that are registered by us pursuant to Section&#160;12 of the Exchange Act:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:24.986%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.774%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.774%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.774%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.777%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number<br/>of Shares<br/>Purchased (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average<br/>Price&#160;Paid<br/>per Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>as&#160;Part&#160;of&#160;Publicly<br/>Announced Plans<br/>or&#160;Programs&#160;(1)(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollar Value of<br/>Shares&#160;that&#160;May<br/>Yet&#160;Be&#160;Purchased<br/>Under the Plans<br/>or Programs (1) (2) (3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.02&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,518,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,150,000,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000,000,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872,600&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">534.02&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,872,600&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On November&#160;2, 2022, we entered into separate accelerated stock repurchase agreements, the November 2022 ASR Agreements, with Goldman Sachs &amp; Co. LLC, or Goldman Sachs, and Mizuho Markets Americas LLC, or Mizuho, to repurchase $1&#160;billion of our common stock as part of the $3&#160;billion repurchase program authorized by the Board of Directors on February&#160;18, 2021. In accordance with the November 2022 ASR Agreements, we made a payment of $1&#160;billion ($500&#160;million to Goldman Sachs on November 3, 2022 and $500&#160;million to Mizuho on November 4, 2022) and received an initial delivery of 1.5&#160;million shares of our common stock (0.760&#160;million shares each from Goldman Sachs and Mizuho). In November 2022, we recorded the payments to Goldman Sachs and Mizuho as a reduction to stockholders&#8217; equity, consisting of an $850&#160;million increase in treasury stock, which reflects the value of the initial 1.5&#160;million shares received upon initial settlement, and a $150&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Goldman Sachs and Mizuho pending final settlement of the November 2022 ASR Agreements. Upon final settlement of the November 2022 ASR Agreements with Goldman Sachs and Mizuho on December&#160;15, 2022 and December&#160;16, 2022, respectively, we received an additional 0.177&#160;million shares and 0.177&#160;million shares, respectively, as determined by the average daily volume weighted-averages share price of our common stock during the terms of the agreements, less a discount, of $534.16 and $533.87, respectively, bringing the total shares received under the November 2022 ASR Agreements to 1.8&#160;million. In addition, upon settlement we reclassified the $150&#160;million value of stock initially held back by Goldman Sachs and Mizuho from capital in excess of par value to treasury stock. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Excludes 0.2 million shares repurchased in connection with employee stock plans.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On February&#160;15, 2023, the Board of Directors replaced the previous share repurchase authorization of up to $3&#160;billion (of which approximately $1&#160;billion remained unused) with a new authorization for repurchases of up to $3&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February&#160;15, 2026.</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_91"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;6. [Reserved]</span></div><div><span><br/></span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_97"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS </span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_100"></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">For discussion of 2020 items and year-over-year comparisons between 2021 and 2020 that are not included in this 2022 10-K and were not impacted by our segment realignment, refer to "Item 7. &#8211; Management Discussion and Analysis of Financial Condition and Results of Operations" found in our Form 10-K for the year ended December 31, 2021, that was filed with the Securities and Exchange Commission on February 17, 2022.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Overview</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc., headquartered in Louisville, Kentucky, is a leading health and well-being company committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well&#8208;being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools, such as in&#8208;home care, behavioral health, pharmacy services, data analytics and wellness solutions, combine to produce a simplified experience that makes health care easier to navigate and more effective.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The health benefits industry relies on two key statistics to measure performance. The benefit ratio, which is computed by taking total benefits expense as a percentage of premiums revenue, represents a statistic used to measure underwriting profitability. The operating cost ratio, which is computed by taking total operating costs, excluding depreciation and amortization, as a percentage of total revenue less investment income, represents a statistic used to measure administrative spending efficiency.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sale of Hospice and Personal Care Divisions</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 11, 2022, we completed</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the sale of a 60% i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest in Humana&#8217;s Kindred at Home Hospice subsidiary, or KAH Hospice, to Clayton, Dubilier &amp; Rice, or CD&amp;R, for cash proceeds of approximately $2.7&#160;billion, net of cash disposed, including debt repayments from KAH Hospice to Humana of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.9&#160;billion. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale we recognized a pre-tax gain, net of transaction costs, of $237&#160;million which is reported as a gain on sale of KAH Hospice in the accompanying consolidated statements of income for the year ended December 31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kindred at Home Acquisition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2021, we acquired the remaining 60% interest in Kindred at Home, or KAH, the nation&#8217;s largest home health and hospice provider, from TPG Capital and Welsh, Carson, Anderson &amp; Stowe, two private equity funds, for an enterprise value of $8.2 billion, which includes our equity value of $2.4 billion associated with our 40% minority ownership interest. The remeasurement to fair value of our previously held 40% equity method investment with a carrying value of approximately $1.3 billion, resulted in a $1.1 billion gain recognized in "Other (income) expense, net". KAH has locations in 40 states, providing extensive geographic coverage with approximately 65% overlap with our individual Medicare Advantage membership. We paid the approximate $5.8 billion transaction price (net of our existing equity stake) through a combination of debt financing, the assumption of existing KAH indebtedness and parent company cash.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:103%">COVID-19</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The emergence and spread of the novel coronavirus, or COVID-19, beginning in the first quarter of 2020 has impacted our business. During periods of increased incidences of COVID-19, a reduction in non-COVID-19 hospital admissions for non-emergent and elective medical care have resulted in lower overall healthcare system utilization. At the same time, COVID-19 treatment and testing costs increased utilization. During 2022, we experienced lower overall utilization of the healthcare system than anticipated, as the reduction in COVID-19 utilization following the increased incidence associated with the Omicron variant outpaced the increase in non-COVID-19 utilization. The </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant disruption in utilization during 2020 also impacted our ability to implement clinical initiatives to manage health care costs and chronic conditions of our members, and appropriately document their risk profiles, and, as such, significantly affected our 2021 revenue under the risk adjustment payment model for Medicare Advantage plans. Finally, changes in utilization patterns and actions taken in 2020 and 2021 as a result of the COVID-19 pandemic, including the suspension of certain financial recovery programs for a period of time and shifting the timing of claim payments and provider capitation surplus payments, impacted our claim reserve development and operating cash flows for 2020 and 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Creation Initiatives </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473&#160;million included within operating costs in the consolidated statement of income for the year ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Segments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2022, we realigned our businesses into two distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period segment financial information has been recast to conform to the 2022 presentation. For a recast of prior period segment financial information, refer to Note 18 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our  two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources. For segment financial information, refer to Note 18 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as our contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only, or ASO. In addition, our Insurance segment includes our military services business, primarily our T-2017 East Region contract, as well as the operations of our PBM business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CenterWell segment includes our pharmacy, provider services, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs. </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of each segment are measured by income before income taxes and equity in net (losses) earnings from equity method investments, or segment earnings. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider, and home services, to our Insurance segment customers. Intersegment sales and expenses are recorded at fair value and eliminated in consolidation. Members served by our segments often use the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at a corporate level. These corporate amounts are reported separately from our reportable segments and are included with intersegment eliminations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 disrupted the pattern of our quarterly earnings and operating cash flows largely due to the temporary deferral of non-essential care which resulted in reductions in non-COVID-19 hospital admissions and lower overall healthcare system utilization during higher levels of COVID-19 hospital admissions. At the same time, during periods of increased incidences of COVID-19, COVID-19 treatment and testing costs increase. Similar impacts and seasonal disruptions from either higher or lower utilization are expected to persist as we respond to and recover from the COVID-19 global health crisis.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of the product offerings of our Insurance segment is Medicare stand-alone prescription drug plans, or PDP, under the Medicare Part D program. Our quarterly Insurance segment earnings and operating cash flows are impacted by the Medicare Part D benefit design and changes in the composition of our membership. The Medicare Part D benefit design results in coverage that varies as a member&#8217;s cumulative out-of-pocket costs pass through successive stages of a member&#8217;s plan period, which begins annually on January 1 for renewals. These plan designs generally result in us sharing a greater portion of the responsibility for total prescription drug costs in the early stages and less in the latter stages. As a result, the PDP benefit ratio generally decreases as the year progresses. In addition, the number of low income senior members as well as year-over-year changes in the mix of membership in our standalone PDP products affects the quarterly benefit ratio pattern. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment also experiences seasonality in the fully-insured product offering. The effect on the Insurance's segment benefit ratio is opposite of the Medicare stand-alone PDP impact, with the benefit ratio increasing as fully-insured members progress through their annual deductible and maximum out-of-pocket expenses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Insurance segment also experiences seasonality in the operating cost ratio as a result of costs incurred in the second half of the year associated with the Medicare marketing season. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Highlights </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our strategy offers our members affordable health care combined with a positive consumer experience in growing markets. At the core of this strategy is our integrated care delivery model, which unites quality care, high member engagement, and sophisticated data analytics. Our approach to primary, physician-directed care for our members aims to provide quality care that is consistent, integrated, cost-effective, and member-focused, provided by both employed physicians and physicians with network contract arrangements. The model is designed to improve health outcomes and affordability for individuals and for the health system as a whole, while offering our members a simple, seamless healthcare experience. We believe this strategy is positioning us for long-term growth in both membership and earnings. We offer providers a continuum of opportunities to increase the integration of care and offer assistance to providers in transitioning from a fee-for-service to a value-based arrangement. These include performance bonuses, shared savings and shared risk relationships. At December&#160;31, 2022, approximately 3,175,500 members, or 70%, of our individual Medicare Advantage members were in value-based relationships under our integrated care delivery model, as compared to 3,009,600 members, or 68%, at December&#160;31, 2021. </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On February 1, 2023, Centers for Medicare &amp; Medicaid Services, or CMS, issued its preliminary 2024 Medicare Advantage and Part D payment rates and proposed policy changes, collectively, the Advance Notice. CMS has invited public comment on the Advance Notice before publishing final rates on or before April 3, 2023, or the Final Notice. In the Advance Notice, CMS estimates Medicare Advantage plans across the sector will, on average, experience a 2.27% decrease in benchmark funding based on proposals included therein. As indicated by CMS, its estimate excludes the impact of fee-for-service county rebasing/re-pricing since the related impact is dependent upon finalization of certain data, which will be available with the publication of the Final Notice. Further the benchmark decrease excludes MA risk score trend as individual plans&#8217; experience will vary. Based on the company&#8217;s preliminary analysis using the same factors CMS included in its estimate, the components of which are detailed on CMS&#8217;s website, we anticipate the proposals in the Advance Notice would result, on average, in a change relatively in line with CMS&#8217; estimate, with the exception of Humana's Medicare Star Ratings for bonus year 2024, which led the company&#8217;s peers, as well as the Risk Model Revision and Normalization Adjustment, which the company continues to analyze. With respect to the Risk Model Revision and Normalization adjustment, CMS provided detail to the company indicating an average impact to Humana relatively in line with the average negative 3.12% industry impact. The company continues to analyze the Advance Notice, including CMS&#8217; estimate of the Humana specific impact related to the Risk Model Revision and Normalization adjustment, which is likely to have a more negative impact on individual plans and specific membership cohorts with greater risk score trend, and will be drawing upon its program expertise to provide CMS formal commentary on the impact of the Advance Notice and the related impact on Medicare beneficiaries&#8217; quality of care and service to its members through the Medicare Advantage program.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net income was $2.8 billion, or $22.08 per diluted common share, and $2.9 billion, or $22.67 per diluted common share, in  2022 and 2021, respectively. This comparison was significantly impacted by the gain on KAH equity method investment recognized in August 2021, put/call valuation adjustments associated with non-consolidating minority interest investments, transaction and integration costs, the change in the fair value of publicly-traded equity securities, charges associated with productivity initiatives related to previously disclosed $1 billion value creation plan, and the net gain on the sale of KAH Hospice. The impact of these adjustments to our consolidated income before income taxes and equity in net (losses) earnings and diluted earnings per common share was as follows for the 2022 and 2021 periods:</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.241%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated income before income taxes and equity in net (losses) earnings:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on Kindred at Home equity method investment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,129)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of KAH Hospice</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges associated with productivity initiatives related to the previously disclosed $1 billion value creation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put/call valuation adjustments associated with our non consolidating minority interest investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of publicly-traded equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">341&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per common share:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on Kindred at Home equity method investment</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.73)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of KAH Hospice</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.86)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charges associated with productivity initiatives related to the previously disclosed $1 billion value creation plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Put/call valuation adjustments associated with our non consolidating minority interest investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.53&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction and integration costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in the fair value of publicly-traded equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax impact of all transactions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.52)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.93)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.67&#160;</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.42)</span></td><td style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are and will continue to be regularly subject to new laws and regulations, changes to existing laws and regulations, and judicial determinations that impact the interpretation and applicability of those laws and regulations. The Health Care Reform Law, the Families First Act, the CARES Act, and the Inflation Reduction Act, and related regulations, are examples of laws which have</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enacted significant reforms to various aspects of the U.S. health insurance industry, including, among others, mandated coverage requirements, mandated benefits and guarantee issuance associated with commercial medical insurance, rebates to policyholders based on minimum benefit ratios, adjustments to Medicare Advantage premiums, the establishment of federally facilitated or state-based exchanges coupled with programs designed to spread risk among insurers, and the introduction of plan designs based on set actuarial values, and changes to the Part D prescription drug benefit design</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that these laws and regulations, as well as other current or future legislative, judicial or regulatory changes (including further legislative or regulatory action taken in response to COVID-19) including restrictions on our ability to manage our provider network or otherwise operate our business, or restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, increases in member benefits or changes to member eligibility criteria without corresponding increases in premium payments to us, or increases in regulation of our prescription drug benefit businesses, in the aggregate may have a material adverse effect on our results of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting our ability to expand into new markets, increasing our medical and operating costs, further lowering our Medicare payment rates and increasing our expenses associated with assessments); our financial position (including our ability to maintain the value of our goodwill); and our cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend for the discussion of our financial condition and results of operations that follows to assist in the understanding of our financial statements and related changes in certain key items in those financial statements from year to year, including the primary factors that accounted for those changes. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider services, and home solutions, to our Insurance segment customers and are described in Note 18 to the audited Consolidated Financial Statements included in Item 8. &#8211;  Financial Statements and Supplementary Data in this 2022 Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_103"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of Results of Operations for 2022 and 2021 </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain financial data on a consolidated basis and for our segments was as follows for the years ended December&#160;31, 2022 and 2021:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except per<br/>common share results)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,712&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,712&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,890&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CenterWell</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,776&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,721&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,806&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of KAH Hospice</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net (losses) earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,568&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net (losses) earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.08&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.67&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.59)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">Represents total benefits expense as a percentage of premiums revenue.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">Represents total operating costs, excluding depreciation and amortization, as a percentage of total revenues less investment income.</span></div><div style="text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums Revenue</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Consolidated premiums revenue increased $7.9 billion, or 9.9%, from $79.8 billion in the 2021 period to $87.7 billion in the 2022 period primarily due to individual Medicare Advantage and state-based contracts membership growth and higher per member individual Medicare Advantage and commercial fully-insured medical premiums, partially offset by declining year-over-year membership associated with the group commercial medical products and the phase-out of COVID-19 sequestration relief in the 2022 period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated services revenue increased $1.7 billion, or 56.3%, from $3.1 billion in the 2021 period to $4.8 billion in the 2022 period primarily due to the impact of our home solutions revenues which reflect the acquisition of the remaining 60% interest in KAH during August 2021 partially offset by the divestiture of the 60% ownership interest in KAH Hospice during August 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Income</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income increased $195 million, or 104.3%, from $187 million in the 2021 period to $382 million in the 2022 period p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rimarily due to lower mark to market losses on our publicly traded equity securities during the 2022 period compared to the 2021 period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Benefits Expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated benefits expense increased $6.5 billion, or 9.4%, from $69.2 billion in the 2021 period to $75.7 billion in the 2022 period. The consolidated benefit ratio decreased 40 basis points from 86.7% in the 2021 period to 86.3% in the 2022 period primarily due to higher per member individual Medicare Advantage premiums and lower inpatient utilization associated with the individual Medicare Advantage business. These factors were partially offset by lower favorable prior-period medical claims reserve development. Further, the 2022 period ratio reflects a shift in line of business mix, with continued growth in certain government programs, which carry a higher benefits expense ratio, combined with a decline in Medicare stand-alone PDP, which has a lower benefits expense ratio. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated benefits expense included $415 million of favorable prior-period medical claims reserve development in the 2022 period and $825 million of favorable prior-period medical claims reserve development in the 2021 period. Prior-period medical claims reserve development decreased the consolidated benefit ratio by approximately 50 basis points in the 2022 period and decreased the consolidated benefit ratio by approximately 100 basis points in the 2021 period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segments incur both direct and shared indirect operating costs. We allocate the indirect costs shared by the segments primarily as a function of revenues. As a result, the profitability of each segment is interdependent.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated operating costs increased $2.6 billion, or 25.2%, from $10.1 billion in the 2021 period to $12.7 billion in the 2022 period. The consolidated operating cost ratio increased 150 basis points from 12.2% in the 2021 period to 13.7% in the 2022 period. The ratio increase was primarily due to the impact of the consolidation of KAH operations, which have a significantly higher operating cost ratio than our historical consolidated operating cost ratio, the  net  impact  of  charges  associated  with  initiatives  undertaken  associated  with  our value creation initiatives, as well as the impact of higher marketing spend in 2022 to support individual Medicare Advantage growth. These increases were partially offset by scale efficiencies associated with growth in individual Medicare Advantage membership.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and Amortization</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization increased $113 million, or 19.0%, from $596 million in the 2021 period to $709 million in the 2022 period primarily due to capital expenditures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $75 million, or 23.0%, from $326 million in the 2021 period to $401 million in the 2022 period primarily due to higher average borrowings outstanding partially offset by lower interest rates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate during 2022 was 21.4% compared to the effective tax rate of 14.2% in 2021. The year-over-year increase in the effective income tax rates is primarily due to the impact of the August 2021 acquisition of the remaining 60% interest in KAH. In that period, we recognized a $1.1 billion mark-to-market gain related to our previously held 40% investment in KAH. This unrealized gain was not taxable, thereby reducing the effective income tax rate for the 2021 period. The increase is partially offset by the August 2022 disposition of our 60% interest in KAH Hospice, which resulted in an increase to our tax basis in both the shares sold and the shares retained, thereby reducing the effective income tax rate for the 2022 period. For a complete reconciliation of the federal statutory rate to the effective tax rate, refer to Note 12 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K. </span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Segment</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Members</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565,600&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,409,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,551,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,606,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,682,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,575,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,300)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.5)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(118,300)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(136,600)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,200&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,959,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,100)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medical Membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,079,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,067,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Specialty Membership</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,194,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,294,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99,500)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:45.041%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums and Services Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,591&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,177&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fully-insured</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,476&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(526)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,267&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,712&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,890&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums and services revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,562&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:4pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance segment income from operations increased $0.6 billion, or 25.3%, from $2.4 billion in the 2021 period to $3.0 billion in the 2022 period primarily due to the same factors impacting the segment's lower benefit ratio offset by the same factors impacting the segment's higher operating cost ratio as more fully described below.</span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enrollment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual Medicare Advantage membership increased </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156,500</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> members, or 3.5%, from 4,409,100 members as of December&#160;31, 2021 to 4,565,600 members as of December&#160;31, 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to membership additions associated with the 2022 Annual Election Period, or AEP. The year-over-year growth was further impacted by continued enrollment resulting from special elections, age-ins, and Dual Eligible Special Need Plans, or D-SNP, membership. I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ndividual Medicare Advantage membership includes 668,900 D-SNP members as of December&#160;31, 2022, a net increase of 92,800 members, or 16.1%, from 576,100 members as of December&#160;31, 2021. </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the full year 2023, we anticipate a net membership growth in our individual Medicare Advantage offerings of at least 625,000 members. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Group Medicare Advantage membership increased 4,500 members, or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.8%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, from 560,600 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to 565,100 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> reflectin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">g smaller account sales and organic growth in concurrent accounts with no large accounts won or lost for the period.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the full year 2023, </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we anticipate a net membership decline in our group Medicare Advantage offerings of approximately 60,000 members.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are stand-alone PDP membership decreased 54,900 members, or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, from 3,606,200 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to 3,551,300 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to continued intensified competition for Medicare stand-alone PDP offerings. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the full year 2023, we anticipate a</span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> net membership decline in our Medicare stand-alone PDP offerings of approximately 800,000 members. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid and other </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">membership increased 197,200 members, or 21.0%, from 940,100 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to 1,137,300 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 31, 2022 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reflecting the suspension of state eligibility redetermination efforts due to the currently enacted public health emergency, or PHE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the full year 2023, we anticipate a net membership growth in our state-based contracts of approximately </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25,000 to 100,000</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> members.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial fully-insured medical membership decreased 118,300 members, or 17.5%, from 674,600 members as of December&#160;31, 2021 to 556,300 members as of December&#160;31, 2022  reflecting the impact of pricing discipline to address COVID-19 and improve profitability.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASO commercial medical membership decreased 65,400 members, or 13.2%, from 495,500 members as of December&#160;31, 2021 to 430,100 members as of December&#160;31, 2022 reflecting continued intensified competition for small group accounts, partially offset by strong retention among large group accounts. For the full year 2023, we anticipate a net membership decline in our group commercial medical offerings, which includes fully-insured and ASO, of approximately 300,000 members.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Military services membership decreased 89,100 members, or 1.5%, from 6,049,000 members as of December&#160;31, 2021 to 5,959,900 members as of December&#160;31, 2022. Membership includes military service members, retirees, and their families to whom we are providing healthcare services under the current TRICARE East Region contract.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specialty membership decreased 99,500 members, or 1.9%, from 5,294,300 members as of December&#160;31, 2021 to 5,194,800 members as of December&#160;31, 2022 primarily due to the loss of dental and vision groups cross-sold with medical, as reflected in the loss of group fully-insured commercial medical membership above. In addition, current membership reflects the economic impact of the COVID-19 pandemic.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance segment premiums revenue increased $7.9 billion, or 9.9%, from $79.8 billion in the 2021 period to $87.7 billion in the 2022 period primarily due to individual Medicare Advantage and state-based contracts membership growth and higher per member individual Medicare Advantage and commercial fully-insured medical premiums, partially offset by declining year-over-year membership associated with the group commercial medical products and the phase-out of COVID-19 sequestration relief in the 2022 period.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance segment services revenue decreased $3 million, or 0.4%, from $853 million in the 2021 period to $850 million in the 2022 period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Benefits expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment benefit ratio decreased 60 basis points from 87.2% in the 2021 period to 86.6% in the 2022 period primarily due to higher per member individual Medicare Advantage premiums and lower inpatient utilization associated with the individual Medicare Advantage business. These factors were partially offset by lower favorable prior-period medical claims reserve development. Further, the 2022 period ratio reflects a shift in line of business mix, with continued growth in certain government programs, which carry a higher benefits expense ratio, combined with a decline in Medicare stand-alone PDP, which has a lower benefits expense ratio.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment benefits expense included $415 million of favorable prior-period medical claims reserve development in the 2022 period and $825 million of favorable prior-period medical claims reserve development in the 2021 period. Prior-period medical claims reserve development decreased the Insurance's segment benefit ratio by approximately 50 basis points in the 2022 period and decreased the Insurance's segment benefit ratio by approximately 100 basis points in the 2021 period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment operating cost ratio increased 10 basis points from 10.3% in the 2021 period to 10.4% in the 2022 period primarily due to strategic investments to position the segment for long-term success, including the impact of higher marketing spend in the 2022 period to support individual Medicare Advantage growth. These factors were partially offset by scale efficiencies associated with growth in the individual Medicare Advantage membership. </span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CenterWell Segment</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,724&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,521&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services and intersegment revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,299&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,054&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell segment income from operations increased $353 million, or 37.6%, from $938 million in the 2021 period to $1.3 billion in the 2022 period primarily due primarily due to the same factors impacting the increase in services revenue and intersegment revenues as well as the same factors impacting the segment's lower operating cost ratio in the 2022 period as more fully described below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell segment services revenue increased $1.7 billion, or 78.3%, from $2.2 billion in the 2021 period to $3.9 billion in the 2022 period primarily due to the impact of our home solutions revenues which reflect the acquisition of the remaining 60% interest in KAH during August 2021 partially offset by the divestiture of the 60% ownership interest in KAH Hospice during August 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intersegment revenues</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell segment intersegment revenues increased $1.5&#160;billion, or 12.8%, from $11.9&#160;billion in the 2021 period to $13.4&#160;billion in the 2022 period primarily due to individual Medicare Advantage membership growth, combined with the impact of greater mail-order pharmacy penetration for Medicare Advantage members, which lead to higher pharmacy revenues, as well as higher revenues associated with growth in our provider business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CenterWell segment operating cost ratio decreased 80 basis points from 92.3% in the 2021 period to 91.5% in the 2022 period primarily represents the consolidation of KAH operations for the entire 2022 period compared to the partial 2021 period due to timing of the previously disclosed transaction. The KAH operations have a lower operating cost ratio than other businesses within the segment. The year-over-year favorability was further impacted by our pharmacy operations partially offset by investments in KAH to abate the pressures of the current nursing labor environment as well as the divestiture of the 60% interest in KAH Hospice during August 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_1099511630209"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of Results of Operations for 2021 and 2020 </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain financial data on a consolidated basis and for our segments reflect our segment realignment and are recast as follows for the years ended December&#160;31, 2021 and 2020:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidated</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except per<br/>common share results)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,238&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(602)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CenterWell</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(967)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 61.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,064&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,909&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,571&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,916&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,169&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,747&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,838)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">635&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,246)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(822)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,934&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(433)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.67&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.31&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.64)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.4)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio (a)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio (b)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:20.41pt">Represents total benefits expense as a percentage of premiums revenue.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">Represents total operating costs, excluding depreciation and amortization, as a percentage of total revenues less investment income.</span></div><div style="text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums Revenue</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-13.5pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Consolidated premiums increased $5.6 billion, or 7.6%, from $74.2 billion in the 2020 period to $79.8 billion in the 2021 period primarily due to higher premium revenues from Medicare Advantage and state-based contracts membership growth, higher per member Medicare Advantage premiums as a result of the improving CMS benchmark rate for 2021, net of Medicare Risk Adjustment (MRA) headwinds resulting from COVID-19 related utilization disruption in 2020, as well as the additional quarter impact of Medicare sequestration relief in 2021 that was not enacted until the second quarter of 2020. These increases were partially offset by declining stand-alone PDP, group commercial medical, and group Medicare Advantage membership, as well as the 2020 impact of the receipt of commercial risk corridor receivables previously written off.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated services revenue increased $1.2 billion, or 68.3%, from $1.8 billion in the 2020 period to $3.1 billion in the 2021 period primarily due to higher home solutions revenues associated with consolidation of Kindred at Home earnings.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investment Income</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment income decreased $967 million, or 83.8%, from $1.2 billion in the 2020 period to $187 million in the 2021 period p</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">rimarily due to a</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> significant decrease in </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the fair value of our publicly-traded equity securities  investments. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Benefits Expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated benefits expense increased $7.6 billion, or 12.3%, from $61.6 billion in the 2020 period to $69.2 billion in the 2021 period. The consolidated benefit ratio increased 360 basis points from 83.1% in the 2020 period to 86.7% in the 2021 period. These increases reflect the termination in 2021 of the non-deductible health insurance industry fee which, along with a portion of the related tax benefit, was contemplated in the pricing and benefit design of our products, and COVID-19 impacts, including the impact of the deferral of non-essential care, net of meaningful COVID-19 treatment and testing costs, our pandemic relief efforts in 2020, as well as 2021 MRA headwinds resulting from this COVID-19 related utilization disruption in 2020. The year over year increase further reflects the 2020 impact of the receipt of commercial risk corridor receivables that were previously written off, and the 2021 impact a</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ssociated with the competitive nature of the group Medicare Advantage business, particularly in large group accounts that were recently procured, as well as in the stand-alone PDP business. These factors were partially offset by higher favorable prior-period medical claims reserve development in 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The higher favorable prior-period medical claims reserve development was primarily attributable to the reversal of actions taken in 2020, including the suspension of certain financial recovery programs for a period of time impacting our claim payment patterns. The suspension during 2020 was intended to provide financial and administrative relief for providers facing unprecedented strain as a result of the COVID-19 pandemic. The favorable prior-period medical claims reserve development decreased the consolidated benefit ratio by approximately 100 basis points in the 2021 period versus approximately 40 basis points in the 2020 period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our segments incur both direct and shared indirect operating costs. We allocate the indirect costs shared by the segments primarily as a function of revenues. As a result, the profitability of each segment is interdependent.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated operating costs increased $0.07 billion, or 0.7%, from $10.05 billion in the 2020 period to $10.12 billion in the 2021 period. The consolidated operating cost ratio decreased 100 basis points from 13.2% in the 2020 period to 12.2% in the 2021 period. The ratio decrease was primarily due to the termination of the non-deductible health insurance industry fee in 2021, as well as lower COVID-19 related administrative costs in 2021 compared to 2020. Administrative costs in 2020 included costs associated with personal protective equipment, member response efforts, and the build-out of infrastructure necessary to support employees working remotely. The decrease was </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">further impacted by scale efficiencies associated with growth in our individual Medicare Advantage membership, operating cost efficiencies in 2021 from previously implemented productivity initiatives, as well as the impact of a $200 million contribution to the Humana Foundation in the first half of 2020 to support communities served by the Company, particularly those with social and health disparities. These factors were partially offset by the consolidation of Kindred at Home operations as the business has a significantly higher operating cost ratio than our historical consolidated operating cost ratio, continued strategic and technology modernization investments made to position us for long-term success, transaction and integration costs associated with the Kindred at Home transaction, as well as the 2020 impact of the receipt of the commercial risk corridor receivables that were previously written off. The non-deductible health insurance industry fee impacted the operating cost ratio by 160 basis points in the 2020 period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and Amortization</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization increased $107 million, or 21.9%, from $489 million in the 2020 period to $596 million in the 2021 period primarily due to capital expenditures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased $43 million, or 15.2%, from $283 million in the 2020 period to $326 million in the 2021 period from borrowings to fund the KAH acquisition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate during 2021 was 14.2% compared to the effective tax rate of 28.0% in 2020. The change was primarily due to the non-taxable gain we recognized on our previously held Kindred at Home equity method investment from our acquisition of the remaining ownership interest in the business in August 2021 and the termination of the non-deductible health insurance industry fee in 2021.   </span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insurance Segment</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Members</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Membership:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,409,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,962,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">446,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">613,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,600)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,606,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,866,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(260,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,575,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,442,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,300&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331,900&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,700)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">674,600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">777,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102,800)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006,500&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">940,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">772,400&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,700&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,998,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,400)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medical Membership</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,067,000&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,831,600&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,400&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Specialty Membership</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,294,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,310,300&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,000)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:45.041%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.767%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Premiums and Services Revenue:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,654&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,697&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(819)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(371)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,980&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,213&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,767&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare Supplement</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">688&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial fully-insured</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total fully-insured</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,449&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(447)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,109&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">886&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,584&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,238&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums and services revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,397&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(708)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefit ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:1pt;margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance segment income from operations decreased $0.7 billion, or 22.7%, from $3.1 billion in the 2020 period to $2.4 billion in the 2021 period primarily due to the same factors impacting the segment's higher benefit ratio offset by the same factors impacting the segment's lower operating cost ratio as more fully described below.</span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Enrollment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual Medicare Advantage membership increased </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">446,400</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> members, or 11.3%, from 3,962,700 members as of December&#160;31, 2020 to 4,409,100 members as of December&#160;31, 2021 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to membership additions associated with the previous Annual Election Period, or AEP, and Open Election Period, or OEP, for Medicare beneficiaries. The membership growth was further impacted by continued enrollment resulting from special elections, age-ins, and Dual Eligible Special Need Plans, or D-SNP, members. The OEP sales period, which ran from January 1 to March 31, 2021 added approximately 36,000 members compared to the 2020 OEP that added approximately 30,000 members. I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ndividual Medicare Advantage membership includes 576,100 D-SNP members as of December&#160;31, 2021, a net increase of 170,000 members, or 42%, from 406,100 members as of December&#160;31, 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Group Medicare Advantage membership decreased 52,600 members, or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.6%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, from 613,200 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to 560,600 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> primarily due to the net loss of certain large accounts in January 2021, partially offset by continued growth in small group accounts.</span><span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medic</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are stand-alone PDP membership decreased 260,500 members, or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7%</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, from 3,866,700 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to 3,606,200 members as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily due to anticipated declines as a result of the Walmart Value plan no longer being the low cost leader in 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicaid and other membership increased 167,700 members, or 21.7%, from 772,400 members as of December&#160;31, 2020 to 940,100 members as of December 31, 2021 primarily reflecting additional enrollment as a result of the suspension of state eligibility redetermination efforts due to the currently-enacted Public Health Emergency, as well as our acquisition of the remaining 50% ownership interest in Wisconsin health care company iCare. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial fully-insured medical membership decreased 102,800 members, or 13.2%, from 777,400 members as of December&#160;31, 2020 to 674,600 members as of December&#160;31, 2021 reflecting lower small group quoting activity and sales attributable to depressed economic activity from the COVID-19 pandemic, partially offset by higher retention of existing customers, particularly in larger groups. The portion of commercial fully-insured medical membership in small group accounts was approximately 50% at December&#160;31, 2021 and 54% at December&#160;31, 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ASO commercial medical membership decreased 9,400 members, or 1.9%, from 504,900 members as of December&#160;31, 2020 to 495,500 members as of December&#160;31, 2021. S</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">mall group membership comprised </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43% </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of ASO commercial medical membership at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2021</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 45% at </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The membership change reflects intensified competition for small group accounts, partially offset by strong retention among large group accounts.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Military services membership increased 50,300 members, or 0.8%, from 5,998,700 members as of December&#160;31, 2020 to 6,049,000 members as of December&#160;31, 2021. Membership includes military service members, retirees, and their families to whom we are providing healthcare services under the current TRICARE East Region contract. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specialty membership decreased 16,000 members, or 0.3%, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from 5,310,300</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> members as of December&#160;31, 2020 to 5,294,300 members as of December&#160;31, 2021 primarily due to the loss of dental and vision groups cross-sold with medical, as reflected in the loss of commercial fully-insured medical membership described above. The decrease also reflects the impact of the economic downturn driven by the COVID-19 pandemic.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance segment premiums increased $6.2 billion, or 8.5%, from $73.6 billion in the 2020 period to $79.8 billion in the 2021 period primarily due to higher premium revenues from Medicare Advantage and state-based contracts membership growth, higher per member Medicare Advantage premiums as a result of the improving CMS benchmark rate for 2021, net of Medicare Risk Adjustment (MRA) headwinds resulting from COVID-19 related </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">utilization disruption in 2020, as well as the additional quarter impact of Medicare sequestration relief in 2021 that was not enacted until the second quarter of 2020. These increases were partially offset by declining Medicare stand-alone PDP, commercial fully insured, and group Medicare Advantage membership.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Insurance segment services revenue increased $40 million, or 4.9%, from $813 million in the 2020 period to $853 million in the 2021 period primarily due to higher TRICARE services revenue partially offset by lower ASO membership described previously.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Benefits expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment benefit ratio increased 310 basis points from 84.1% in the 2020 period to 87.2% in the 2021 period. This increase reflects the termination in 2021 of the non-deductible health insurance industry fee which, along with a portion of the related tax benefit, was contemplated in the pricing and benefit design of our products, and COVID-19 impacts, including the impact of the deferral of non-essential care, net of meaningful COVID-19 treatment and testing costs, our pandemic relief efforts in 2020, as well as 2021 MRA headwinds resulting from this COVID-19 related utilization disruption in 2020. The year over year increase further reflects the 2021 impact associated with the competitive nature of the group Medicare Advantage business, particularly in large group accounts that were recently procured, as well as in the stand-alone PDP business. These factors were partially offset by higher favorable prior-period medical claims reserve development in 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment benefits expense included $825 million of favorable prior-period medical claims reserve development in the 2021 period and $313 million of favorable prior-period medical claims reserve development in the 2021 period. Prior-period medical claims reserve development decreased the Insurance's segment benefit ratio by approximately 100 basis points in the 2021 period and decreased the Insurance's segment benefit ratio by approximately 40 basis points in the 2020 period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The higher favorable prior-period medical claims reserve development was primarily attributable to the reversal of actions taken in 2020, including the suspension of certain financial recovery programs for a period of time impacting our claim payment patterns. The suspension during 2020 was intended to provide financial and administrative relief for providers facing unprecedented strain as a result of the COVID-19 pandemic. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment operating cost ratio decreased 200 basis points from 12.3% in the 2020 period to 10.3% in the 2022 period primarily due to the termination of the non-deductible health insurance industry fee in 2021, lower COVID-19 related administrative costs, as previously discussed, scale efficiencies associated with growth in our individual Medicare Advantage membership, as well as operating cost efficiencies driven by previously implemented productivity initiatives. These improvements were partially offset by continued strategic investments made in 2021 to position us for long-term success. The non-deductible health insurance industry fee impacted the operating cost ratio by 160 basis points in the 2020 period.</span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CenterWell Segment</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.291%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.880%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">989.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,096&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intersegment revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,852&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,377&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services and intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,054&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,477&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income from operations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cost ratio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income from operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell segment income from operations increased $314 million, or 50.3%, from $624 million in the 2020 period to $938 million in the 2021 period primarily due to consolidation of Kindred at Home earnings, individual Medicare Advantage and state-based contracts membership growth leading to higher pharmacy revenues, higher revenues associated with growth in our provider business, as well as the factors that drove the segment declining operating cost ratio as more fully described below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell segment services revenue increased $1.2 billion, or 119.8%, from $1.0 billion in the 2020 period to $2.2 billion in the 2021 period primarily due to consolidation of Kindred at Home earnings. The 2021 period further reflects higher revenue from growth in the number of primary care clinics serving third party payors, and additional pharmacy revenues associated with the acquisition of Enclara which was closed during the first quarter of 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intersegment revenues</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell segment intersegment revenues increased $1.4&#160;billion, or 13.1%, from $10.5&#160;billion in the 2020 period to $11.9&#160;billion in the 2021 period primarily due to individual Medicare Advantage and state-based contracts membership growth, as well as higher revenues associated with our provider business. These increases were partially offset by the loss of intersegment revenues associated with the decline in stand-alone PDP and group Medicare Advantage membership as previously discussed. </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CenterWell segment operating cost ratio decreased 100 basis points from 93.3% in the 2020 period to 92.3% in the 2021 period primarily due to consolidation of Kindred at Home operations which have a lower operating cost ratio than other businesses within the segment, the 2020 impact associated with COVID-19 administrative related costs, including expenses associated with additional safety measures taken for our pharmacy, provider, and home solutions teams who continued to provide services to members throughout the crisis, as well as operational improvements in our provider services business, largely related to Conviva, along with operating cost efficiencies driven by previously implemented productivity initiatives in 2021. The decrease further reflects the impact of additional investments in the segment's provider business during 2020 related to marketing and AEP initiatives. These decreases were partially offset by increased administrative costs in the pharmacy operations as a result of incremental spend to accelerate growth within the business, increased utilization levels in our provider business in 2021 compared to levels in 2020 amid the COVID-19 pandemic, as well as increased pharmacy labor-related overtime costs due to weather disruptions occurring in the first quarter of 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_106"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our primary sources of cash have included receipts of premiums, services revenue, and investment and other income, as well as proceeds from the sale or maturity of our investment securities, and borrowings. Our primary uses of cash historically have included disbursements for claims payments, operating costs, interest on borrowings, taxes, purchases of investment securities, acquisitions, capital expenditures, repayments on borrowings, dividends, and share repurchases. Because premiums generally are collected in advance of claim payments by a period of up to several months, our business normally should produce positive cash flows during periods of increasing premiums and enrollment. Conversely, cash flows would be negatively impacted during periods of decreasing premiums and enrollment. From period to period, our cash flows may also be affected by the timing of working capital items including premiums receivable, benefits payable, and other receivables and payables. Our cash flows are impacted by the timing of payments to and receipts from CMS associated with Medicare Part D subsidies for which we do not assume risk. The use of cash flows may be limited by regulatory requirements of state departments of insurance (or comparable state regulators) which require, among other items, that our regulated subsidiaries maintain minimum levels of capital and seek approval before paying dividends from the subsidiaries to the parent. Our use of cash flows derived from our non-insurance subsidiaries, such as in our CenterWell segment, is generally not restricted by state departments of insurance (or comparable state regulators).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on our liquidity risk, please refer to Item&#160;1A. &#8211; Risk Factors in this 2022 Form 10-K.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents increased to $5.1&#160;billion at December&#160;31, 2022 from $3.4 billion at December&#160;31, 2021. The change in cash and cash equivalents for the years ended December&#160;31, 2022, 2021 and 2020 is summarized as follows:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:52.672%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.827%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,006)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,556)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,065)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,914)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,955)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase (decrease) in cash and cash equivalents</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,279)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">619&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow from Operating Activities</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flows provided by operations of $4.6&#160;billion in the 2022 period increased $2.3&#160;billion from cash flows provided by operations of $2.3&#160;billion in the 2021 period primarily due to higher earnings in 2022, exclusive of the gain on the sale of KAH Hospice recognized in the 2022 period and the gain on the KAH equity method investment recognized in the 2021 period, combined with positive working capital impacts in 2022, and the 2021 period impact associated with the pay down of claims inventory and capitation for provider surplus amounts earned in 2020 and additional provider support.</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most significant drivers of changes in our working capital are typically the timing of payments of benefits expense and receipts for premiums. Benefits expense includes claim payments, capitation payments, pharmacy costs net of rebates, allocations of certain centralized expenses and various other costs incurred to provide health insurance coverage to members, as well as estimates of future payments to hospitals and others for medical care and other supplemental benefits provided on or prior to the balance sheet date. For additional information regarding our benefits payable and benefits expense recognition, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The detail of total net receivables was as follows at December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:58.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.505%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(196)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Military services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,814&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(140)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">676&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation to cash flow statement:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in receivables from disposition (acquisition) of business</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in receivables per cash flow statement resulting in </span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">cash used by operations</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The changes in Medicare receivables for both the 2022 period and the 2021 period reflect individual Medicare Advantage membership growth and the typical pattern caused by the timing of accruals and related collections associated with the CMS risk-adjustment model. The decrease in Commercial and other receivables and the allowance for doubtful accounts for 2022 primarily relates to the KAH Hospice disposition. The increase in Commercial and other receivables in 2021 primarily relates to the Kindred at Home acquisition.</span></div><div style="margin-top:4pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow from Investing Activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, we acquired various businesses totaling to approximately $337 million, net of cash received.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2021, we acquired Kindred at Home and other primary care businesses for cash consideration of approximately $4.2 billion, net of cash received. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2020, we acquired Enclara Healthcare, a hospice, pharmacy and benefit provider,  for cash consideration of approximately $709&#160;million, net of cash received.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we completed the sale of a 60% i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest in Humana&#8217;s Kindred at Home Hospice subsidiary, or KAH Hospice, to Clayton, Dubilier &amp; Rice, or CD&amp;R, for cash proceeds of approximately $2.7&#160;billion, net of cash disposed, including debt repayments from KAH Hospice to Humana of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.9&#160;billion. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale, we recognized a pre-tax gain, net of transaction costs, of $237&#160;million which is reported as a gain on sale of KAH Hospice in the accompanying consolidated statement of income for the year ended December 31, 2022.  </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ongoing capital expenditures primarily relate to our information technology initiatives, support of services in our provider services operations including medical and administrative facility improvements necessary for activities such as the provision of care to members, claims processing, billing and collections, wellness solutions, care coordination, regulatory compliance and customer service. Total capital expenditures, excluding acquisitions, were $1.1 billion, $1.3 billion and $964 million in the 2022, 2021 and 2020 periods, respectively. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net purchases of investment securities were $2.3 billion, $1.1 billion, $1.4 billion in the 2022, 2021 and 2020 periods, respectively. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flow from Financing Activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financing cash flows are significantly impacted by the timing of claims payments and the related receipts from CMS associated with Medicare Part D claim subsidies for which we do not assume risk. Monthly prospective payments from CMS for reinsurance and low-income cost subsidies are based on assumptions submitted with our annual bid. Settlement of the reinsurance and low-income cost subsidies is based on a reconciliation made approximately 9 months after the close of each calendar year. Receipts from CMS associated with Medicare Part D claim subsidies for which we do not assume risk were higher than claim payments by $2 billion in the 2022 period and claim payments were higher than receipts from CMS associated with Medicare Part D claim subsidies for which we do not assume risk by $261 million and $938 million in the 2021 and 2020 periods, respectively. Our net payable from CMS for subsidies and brand name prescription drug discounts was $540 million at December 31, 2022 compared to a net receivable of $1.4 billion at December 31, 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our administrative services only TRICARE contract, reimbursements from the federal government exceeded health care costs payments for which we do not assume risk by $25 million in the 2022 period and health care costs payments for which we do not assume risk exceeded reimbursements from the federal government by $45 million and $1 million in the 2021 and 2020 periods, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we repaid $600 million aggregate principal amount of our 3.150% senior notes due on their maturity date of December 1, 2022 and $400 million aggregate principal amount of our 2.900% senior notes due on their maturity date of December 15, 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, we issued $500&#160;million of 5.750% unsecured senior notes due March 1, 2028 and $750&#160;million of 5.875% unsecured senior notes due March 1, 2033. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $1.2&#160;billion. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we issued $750&#160;million of 3.700% unsecured senior notes due March 23, 2029. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $744&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we issued $1.5&#160;billion of 0.650% unsecured senior notes due August 3, 2023, $750&#160;million of 1.350% unsecured senior notes due February 3, 2027 and $750&#160;million of 2.150% unsecured senior notes due February 3, 2032. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $2,984&#160;million. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2020, we repaid $400&#160;million aggregate principal amount of our 2.500% senior notes due on their maturity date of December 15, 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we issued $600 million of 4.500% senior notes due April 1, 2025 and $500 million of 4.875% senior notes due April 1, 2030. Our net proceeds, reduced for the underwriters' discounts and commissions and offering expenses paid, were $1,088 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we repaid the $2.0&#160;billion October 2021 Term Loan Agreement without a prepayment penalty due.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, we entered into a $2.0&#160;billion term loan agreement and applied the proceeds to finance the repayment in full of the outstanding assumed Kindred at Home debt.  </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2021, we borrowed $500&#160;million under the delayed draw term loan agreement, which was used, in combination with other debt financing, to fund the approximate $5.8&#160;billion transaction price of Kindred at Home. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, we drew $1&#160;billion on the existing term loan commitment at the time, which was repaid in November 2020. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into a commercial paper program in October 2014. Net repayments from issuance of commercial paper were $376&#160;million in 2022 and the maximum principal amount outstanding at any one time during 2022 was $1.5 billion. Net proceeds from the issuance of commercial paper were $352&#160;million in 2021 and the maximum principal amount outstanding at any one time during 2021 was $1.2&#160;billion. Net proceeds from issuance of commercial paper were $295&#160;million in 2020 and the maximum principal amount outstanding at any one time during 2020 was $600 million.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      We repurchased common shares for $2.10 billion, $79&#160;million and $1.82&#160;billion in 2022, 2021 and 2020, respectively, under share repurchase plans authorized by the Board of Directors and in connection with employee stock plans. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We paid dividends to stockholders of $392&#160;million in 2022, $354&#160;million in 2021, and $323&#160;million in 2020.</span></div><div style="margin-top:1pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remainder of the cash used in or provided by financing activities in 2022, 2021, and 2020 primarily resulted from debt issuance costs, proceeds from stock option exercises and the change in book overdraft.</span></div><div style="margin-top:1pt;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_109"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Sources and Uses of Liquidity</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of dividends to stockholders, please refer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of stock repurchases, please refer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of our debt, including our senior notes, term loans, credit agreement and commercial paper program, please refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity Requirements</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash balances, investment securities, operating cash flows, and funds available under our credit agreement and our commercial paper program or from other public or private financing sources, taken together, provide adequate resources to fund ongoing operating and regulatory requirements, acquisitions, future expansion opportunities, and capital expenditures for at least the next twelve months, as well as to refinance or repay debt, and repurchase shares.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adverse changes in our credit rating may increase the rate of interest we pay and may impact the amount of credit available to us in the future. Our investment-grade credit rating at December&#160;31, 2022 was BBB+ according to Standard&#160;&amp; Poor&#8217;s Rating Services, or S&amp;P, and Baa3 according to Moody&#8217;s Investors Services, Inc., or Moody&#8217;s. A downgrade by S&amp;P to BB+ or by Moody&#8217;s to Ba1 triggers an interest rate increase of 25 basis points with respect to $250 million of our senior notes. Successive one notch downgrades increase the interest rate an additional 25 basis points, or annual interest expense by $1 million, up to a maximum 100 basis points, or annual interest expense by $3 million.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we operate as a holding company in a highly regulated industry. Humana Inc., our parent company, is dependent upon dividends and administrative expense reimbursements from our subsidiaries, most of which are subject to regulatory restrictions. We continue to maintain significant levels of aggregate excess statutory capital and surplus in our state-regulated operating subsidiaries. Cash, cash equivalents, and short-term investments at the parent company decreased to $0.9 billion at December&#160;31, 2022 from $1.3 billion at December&#160;31, 2021. This decrease primarily reflects common stock repurchases, repayment of the October 2021 Term Loan Agreement, repayment of maturing senior notes, capital expenditures, repayment of borrowings under the commercial paper program, capital contributions to certain subsidiaries, cash dividends to shareholders and acquisitions, partially offset by net proceeds from the senior notes, proceeds from the sale of investment securities, dividends from insurance subsidiaries, and cash from certain non-insurance subsidiaries within our CenterWell segment. Our use of operating cash derived from our non-insurance subsidiaries, such as our CenterWell segment, is generally not restricted by regulators. Our regulated insurance subsidiaries paid dividends to our parent company of $1.3 billion in 2022, $1.6 billion in 2021, and $1.3 billion in 2020. Subsidiary capital requirements from significant premium growth has impacted the amount of regulated subsidiary dividends over the last two years. Refer to our parent company financial statements and accompanying notes in Schedule I - Parent Company Financial Information. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of ordinary dividends that may be paid to our parent company in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1.8 billion, in the aggregate. Actual dividends paid may vary due to consideration of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix.</span></div><div style="margin-top:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of our regulatory requirements, including aggregate statutory capital and surplus as well as dividends paid from the subsidiaries to our parent, please refer to Note 16 to the to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-top:14pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, we were not involved in any special purpose entity, or SPE, transactions. For a detailed discussion of off-balance sheet arrangements, please refer to Note 17 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Indemnifications</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of our guarantees and indemnifications, please refer to Note 17 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Contracts</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a detailed discussion of our government contracts, including our Medicare, Military, and Medicaid and state-based contracts, please refer to Note 17  to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_115"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements and accompanying notes, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements and accompanying notes requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We continuously evaluate our estimates and those critical accounting policies primarily related to benefits expense and revenue recognition as well as accounting for impairments related to our investment securities, goodwill, indefinite-lived and long-lived assets. These estimates are based on knowledge of current events and anticipated future events and, accordingly, actual results ultimately may differ from those estimates. We believe the following critical accounting policies involve the most significant judgments and estimates used in the preparation of our consolidated financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefits Expense Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits expense is recognized in the period in which services are provided and includes an estimate of the cost of services which have been incurred but not yet reported, or IBNR. Our reserving practice is to consistently recognize the actuarial best point estimate within a level of confidence required by actuarial standards. For further discussion of our reserving methodology, including our use of completion and claims per member per month trend factors to estimate IBNR, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completion and claims per member per month trend factors are the most significant factors impacting the IBNR estimate. The portion of IBNR estimated using completion factors for claims incurred prior to the most recent two months is generally less variable than the portion of IBNR estimated using trend factors. The following table illustrates the sensitivity of these factors assuming moderately adverse experience and the estimated potential impact on our operating results caused by reasonably likely changes in these factors based on December&#160;31, 2022 data:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:464.25pt"><tr><td style="width:1.0pt"></td><td style="width:111.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:111.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:111.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:1.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:111.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Completion Factor (a):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Claims Trend Factor (b):</span></td></tr><tr style="height:20pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Factor<br/>Change (c)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease in<br/>Benefits Payable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Factor<br/>Change (c)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease&#160;in<br/>Benefits Payable</span></td></tr><tr style="height:12pt"><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$588</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$479</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$522</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$445</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.70%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$457</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$411</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.60%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$392</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$376</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$326</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$342</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.40%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$261</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$308</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.30%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$196</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$274</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$131</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$239</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$65</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$205</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.05%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$33</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$171</span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.03%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.00%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$137</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Reflects estimated potential changes in benefits payable at December&#160;31, 2022 caused by changes in completion factors for incurred months prior to the most recent two months.</span></div><div style="margin-bottom:3pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Reflects estimated potential changes in benefits payable at December&#160;31, 2022 caused by changes in annualized claims trend used for the estimation of per member per month incurred claims for the most recent two months.</span></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The factor change indicated represents the percentage point change.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a historical perspective regarding the accrual and payment of our benefits payable. Components of the total incurred claims for each year include amounts accrued for current year estimated benefits expense as well as adjustments to prior year estimated accruals. Refer to Note 11 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for information about incurred and paid claims development as of December&#160;31, 2022, net of reinsurance, as well as cumulative claim frequency and the total of IBNR included within the net incurred claims amounts.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:7pt;text-align:center;text-indent:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:56.456%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.404%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.404%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at January&#160;1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at January 1, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,690&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,628&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,428)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,715)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,095)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,421)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reinsurance recoverable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December&#160;31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,264&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in estimate for incurred claims related to prior years attributable to our key assumptions. As previously described, our key assumptions consist of trend and completion factors estimated using an assumption of moderately adverse conditions. The amounts below represent the difference between our original estimates and the actual benefits expense ultimately incurred as determined from subsequent claim payments.</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.355%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.358%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Favorable Development by Changes in Key Assumptions</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Factor<br/>Change&#160;(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Factor<br/>Change&#160;(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Factor<br/>Change&#160;(a)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trend factors</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(167)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completion factors</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(464)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">The factor change indicated represents the percentage point change.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously discussed, our reserving practice is to consistently recognize the actuarial best estimate of our ultimate liability for claims. Actuarial standards require the use of assumptions based on moderately adverse experience, which generally results in favorable reserve development, or reserves that are considered redundant. We experienced favorable medical claims reserve development related to prior fiscal years of $415 million in 2022, $825 million in 2021, and $313 million in 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The favorable medical claims reserve development for 2022, 2021, and 2020 primarily reflects the consistent application of trend and completion factors estimated using an assumption of moderately adverse conditions. In addition, the higher prior year favorable development for the year ended December 31, 2021 was primarily attributable to the reversal of actions taken in 2020, including the suspension of certain financial recovery programs for a period of time impacting our claim payment patterns. The suspension during 2020 was intended to provide financial and administrative relief for providers facing unprecedented strain as a result of the COVID-19 pandemic. Our favorable development for each of the years presented above is discussed further in Note 11 to the audited Consolidated Financial Statements included in Item&#160;8. &#8211; Financial Statements and Supplementary Data.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continually adjust our historical trend and completion factor experience with our knowledge of recent events that may impact current trends and completion factors when establishing our reserves. Because our reserving practice is to consistently recognize the actuarial best point estimate using an assumption of moderately adverse </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">conditions as required by actuarial standards, there is a reasonable possibility that variances between actual trend and completion factors and those assumed in our December&#160;31, 2022 estimates would fall towards the middle of the ranges previously presented in our sensitivity table. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally establish one-year commercial membership contracts with employer groups, subject to cancellation by the employer group on 30-day written notice. Our Medicare contracts with CMS renew annually. Our military services contracts with the federal government and certain contracts with various state Medicaid programs generally are multi-year contracts subject to annual renewal provisions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive monthly premiums from the federal government and various states according to government specified payment rates and various contractual terms. We bill and collect premiums from employer groups and members in our Medicare and other individual products monthly.  Changes in premium revenues resulting from the periodic changes in risk-adjustment scores derived from medical diagnoses for our membership are estimated by projecting the ultimate annual premium and recognized ratably during the year with adjustments each period to reflect changes in the ultimate premium. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums revenue is estimated by multiplying the membership covered under the various contracts by the contractual rates. Premiums revenue is recognized as income in the period members are entitled to receive services, and is net of estimated uncollectible amounts, retroactive membership adjustments, and adjustments to recognize rebates under the minimum benefit ratios required under the Health Care Reform Law. We estimate policyholder rebates by projecting calendar year minimum benefit ratios for the small group and large group markets, as defined by the Health Care Reform Law using a methodology prescribed by HHS, separately by state and legal entity. Medicare Advantage products are also subject to minimum benefit ratio requirements under the Health Care Reform Law. Estimated calendar year rebates recognized ratably during the year are revised each period to reflect current experience. Retroactive membership adjustments result from enrollment changes not yet processed, or not yet reported by an employer group or the government. We routinely monitor the collectability of specific accounts, the aging of receivables, historical retroactivity trends, estimated rebates, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. Premiums received prior to the service period are recorded as unearned revenues.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Risk-Adjustment Provisions </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage, or MA, plans according to health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997 (BBA) and the Benefits Improvement and Protection Act of 2000 (BIPA), generally pays more where a plan's membership has higher expected costs. Under this model, rates paid to MA plans are based on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a "national average risk profile." That baseline payment amount is adjusted to account for certain demographic characteristics and health status of our enrolled members. Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data, collected from providers, to calculate the health status-related risk-adjusted premium payment to MA plans, which CMS further adjusts for coding pattern differences between the health plans and the government fee-for-service (FFS) program. We generally rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our health status-adjusted payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model. For additional information, refer to Note 17 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" and Part I, Item 1A, "Risk Factors" of this Form 10-K.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities totaled $14.3 billion, or 33% of total assets at December&#160;31, 2022, and $14.0 billion, or 31% of total assets at December&#160;31, 2021. The investment portfolio was primarily comprised of debt securities, detailed below, at December&#160;31, 2022 and December 31, 2021. The fair value of investment securities were as follows at December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:40.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.565%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.893%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage<br/>of Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage<br/>of Total</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,497&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96.6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,261&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,972&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 96% of our debt securities were investment-grade quality, with a weighted average credit rating of AA- by S&amp;P at December&#160;31, 2022. Most of the debt securities that were below investment-grade were rated BB-, the higher end of the below investment-grade rating scale. Tax-exempt municipal securities were diversified among general obligation bonds of states and local municipalities in the United States as well as special revenue bonds issued by municipalities to finance specific public works projects such as utilities, water and sewer, transportation, or education. Our general obligation bonds are diversified across the United States with no individual </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">state exceeding 1% of our total debt securities. Our investment policy limits investments in a single issuer and requires diversification among various asset types. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross unrealized losses and fair values aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position were as follows at December&#160;31, 2022:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:35.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.738%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.606%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.745%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or more</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr style="height:15pt"><td colspan="36" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,419&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,431)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,381&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on January 1, 2020, we adopted the new current expected credit losses, or CECL, model which retained many similarities from the previous other-than-temporary impairment model except eliminating from consideration in the impairment analysis the length of time over which the fair value had been less than cost. Also, under the CECL model, expected losses on available for sale debt securities are recognized through an allowance for credit losses rather than as reductions in the amortized cost of the securities. For debt securities whose fair value is less than their amortized cost which we do not intend to sell or are not required to sell, we evaluate the expected cash flows to be received as compared to amortized cost and determine if an expected credit loss has occurred. In the event of an expected credit loss, only the amount of the impairment associated with the expected credit loss is recognized in income with the remainder, if any, of the loss recognized in other comprehensive income.  To the extent we have the intent to sell the debt security or it is more likely than not we will be required to sell the debt security before recovery of our amortized cost basis, we recognize an impairment loss in income in an amount equal to the full difference between the amortized cost basis and the fair value.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential expected credit loss impairment is considered using a variety of factors, including the extent to which the fair value has been less than cost; adverse conditions specifically related to the industry, geographic area or financial condition of the issuer or underlying collateral of a debt security; changes in the quality of the debt security's credit enhancement; payment structure of the debt security; changes in credit rating of the debt security by the rating agencies; failure of the issuer to make scheduled principal or interest payments on the debt security and changes in prepayment speeds. For debt securities, we take into account expectations of relevant market and economic data. For example, with respect to mortgage and asset-backed securities, such data includes underlying loan level data and structural features such as seniority and other forms of credit enhancements. We estimate the amount of the expected credit loss component of a debt security as the difference between the amortized cost and the present value of the expected cash flows of the security. The present value is determined using the best estimate of future cash flows discounted at the implicit interest rate at the date of purchase. The expected credit loss cannot exceed the full difference between the amortized cost basis and the fair value. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks inherent in assessing the impairment of an investment include the risk that market factors may differ from our expectations, facts and circumstances factored into our assessment may change with the passage of time, or </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we may decide to subsequently sell the investment. The determination of whether a decline in the value of an investment is related to a credit event requires us to exercise significant diligence and judgment. The discovery of new information and the passage of time can significantly change these judgments. The status of the general economic environment and significant changes in the national securities markets influence the determination of fair value and the assessment of investment impairment. There is a continuing risk that declines in fair value may occur and additional material realized losses from sales or expected credit loss impairments may be recorded in future periods.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All issuers of debt securities we own that were trading at an unrealized loss at December&#160;31, 2022 remain current on all contractual payments. After taking into account these and other factors previously described, we believe these unrealized losses primarily were caused by an increase in market interest rates in the current markets since the time the debt securities were purchased. At December&#160;31, 2022, we did not intend to sell any debt securities with an unrealized loss position in accumulated other comprehensive income, and it is not likely that we will be required to sell these debt securities before recovery of their amortized cost basis. Additionally, we did not record any material credit allowances for debt securities that were in an unrealized loss position at December&#160;31, 2022,  2021 or 2020.</span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Indefinite-lived and Long-lived Assets</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, goodwill, indefinite-lived and other long-lived assets represented 33% of total assets and 92% of total stockholders&#8217; equity, compared to 38% and 104%, respectively, at December&#160;31, 2021. The decrease in goodwill, indefinite-lived and other long-lived assets is primarily attributable to our August 2022 sale of KAH Hospice.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For goodwill, we are required to test at least annually for impairment at a level of reporting referred to as the reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. A reporting unit either is our operating segments or one level below the operating segments, referred to as a component, which comprise our reportable segments. A component is considered a reporting unit if the component constitutes a business for which discrete financial information is available that is regularly reviewed by management. We are required to aggregate the components of an operating segment into one reporting unit if they have similar economic characteristics. Goodwill is assigned to the reporting unit that is expected to benefit from a specific acquisition. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform a quantitative assessment to review goodwill for impairment to determine both the existence and amount of goodwill impairment, if any. Our strategy, long-range business plan, and annual planning process support our goodwill impairment tests. These tests are performed, at a minimum, annually in the fourth quarter, and are based on an evaluation of future discounted cash flows. We rely on this discounted cash flow analysis to determine fair value. However outcomes from the discounted cash flow analysis are compared to other market approach valuation methodologies for reasonableness. We use discount rates that correspond to a market-based weighted-average cost of capital and terminal growth rates that correspond to long-term growth prospects, consistent with the long-term inflation rate. Key assumptions in our cash flow projections, including changes in membership, premium yields, medical and operating cost trends, and certain government contract extensions, are consistent with those utilized in our long-range business plan and annual planning process. If these assumptions differ from actual, including the impact of the Health Care Reform Law or changes in government reimbursement rates, the estimates underlying our goodwill impairment tests could be adversely affected. The fair value of our reporting units with significant goodwill exceeded carrying amounts by a substantial margin. However, unfavorable changes in key assumptions or combinations of assumptions including a significant increase in the discount rate, decrease in the long-term growth rate or substantial reduction in our underlying cash flow assumptions, including revenue growth rates, medical and operating cost trends, and projected operating income could have a significant negative impact on the estimated fair value of our home solutions and provider reporting units, which accounted for $4.3&#160;billion and $1.1&#160;billion of goodwill, respectively. Impairment tests completed for 2022, 2021, and 2020 did not result in an impairment loss.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite-lived intangible assets relate to Certificate of Needs (CON) and Medicare licenses acquired in connection with our August 2021 KAH acquisition with a carrying value of $1.4&#160;billion at December&#160;31, 2022. Like </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goodwill, we are required to test at least annually for impairment and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. These tests are performed, at a minimum, annually in the fourth quarter. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized. Fair values of indefinite-lived intangible assets are determined based on the income approach. Impairment tests completed for 2022 did not result in a material impairment loss. These charges reflect the amount by which the carrying value exceeded its estimated fair value. Impairment tests completed for 2021 did not result in an impairment loss. The fair values of the assets were measured using Level 3 inputs, such as projected revenues and operating cash flows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets consist of property and equipment and other definite-lived intangible assets. These assets are depreciated or amortized over their estimated useful life, and are subject to impairment reviews. We periodically review long-lived assets whenever adverse events or changes in circumstances indicate the carrying value of the asset may not be recoverable. In assessing recoverability, we must make assumptions regarding estimated future cash flows and other factors to determine if an impairment loss may exist, and, if so, estimate fair value. We also must estimate and make assumptions regarding the useful life we assign to our long-lived assets. If these estimates or their related assumptions change in the future, we may be required to record impairment losses or change the useful life, including accelerating depreciation or amortization for these assets. Other than the $248&#160;million of asset impairment charges as a result of our value creation initiatives as described in Footnote 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K, there were no other impairment losses in the last three years.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our earnings and financial position are exposed to financial market risk, including those resulting from changes in interest rates.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The level of our pretax earnings is subject to market risk due to changes in interest rates and the resulting impact on investment income and interest expense.  In the past we have, and in the future we may enter into interest rate swap agreements depending on market conditions and other factors. Under the revolving credit agreements, at our option, we can borrow on either a competitive advance basis or a revolving credit basis. The revolving credit portion bears interest at either LIBOR plus a spread or the base rate plus a spread. The competitive advance portion of any borrowings will bear interest at market rates prevailing at the time of borrowing on either a fixed rate or a floating rate based on LIBOR, at our option. The revolving credit agreements provide for the transition from LIBOR and do not require amendment in connection with such transition. There were no borrowings outstanding under our credit agreements at December&#160;31, 2022 or December&#160;31, 2021.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk also represents a market risk factor affecting our consolidated financial position due to our significant investment portfolio, consisting primarily of fixed maturity securities of investment-grade quality with a weighted average S&amp;P credit rating of AA- at December&#160;31, 2022. Our net unrealized position decreased $1.7 billion from a net unrealized gain position of $57 million at December&#160;31, 2021 to a net unrealized loss position of $1.7 billion at December&#160;31, 2022. At December&#160;31, 2022, we had gross unrealized losses of $1.7 billion on our investment portfolio primarily due to an increase in market interest rates since the time the securities were purchased.  We did not record any material credit allowances for debt securities that were in an unrealized loss position during 2022 and 2021. While we believe that these impairments will be recovered and we currently do not have the intent to sell such securities, given the current market conditions and the significant judgments involved, there is a continuing risk that future declines in fair value may occur and material realized losses from sales or credit loss impairments may be recorded in future periods.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duration is the time-weighted average of the present value of the bond portfolio&#8217;s cash flow. Duration is indicative of the relationship between changes in fair value and changes in interest rates, providing a general indication of the sensitivity of the fair values of our fixed maturity securities to changes in interest rates. However, actual fair values may differ significantly from estimates based on duration. The average duration of our investment portfolio, including cash and cash equivalents, was approximately 3.2 years as of December&#160;31, 2022 and 3.6 years </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as of December&#160;31, 2021. Based on the duration including cash equivalents, a 1% increase in interest rates would generally decrease the December&#160;31, 2022 fair value of our securities by approximately $603 million.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also evaluated the impact on our investment income and interest expense resulting from a hypothetical change in interest rates of 100, 200, and 300 basis points over the next twelve-month period, as reflected in the following table. The evaluation was based on our investment portfolio and our outstanding indebtedness at December&#160;31, 2022 and 2021. Our investment portfolio consists of cash, cash equivalents, and investment securities. The modeling technique used to calculate the pro forma net change in pretax earnings considered the cash flows related to fixed income investments and debt, which are subject to interest rate changes during a prospective twelve-month period. This evaluation measures parallel shifts in interest rates and may not account for certain unpredictable events that may affect interest income, including unexpected changes of cash flows into and out of the portfolio, changes in the asset allocation, including shifts between taxable and tax-exempt securities, spread changes specific to various investment categories and the mix of short-term versus long-term debt. In the past ten years, changes in 10 year US treasury rates during the year have not exceeded 300 basis points, have changed between 200 and 300 basis points once, have changed between 100 and 200 basis points four times, and have changed by less than 100 basis points five times.</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.105%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.278%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease) in<br/>pretax&#160;earnings&#160;given&#160;an<br/>interest&#160;rate&#160;decrease&#160;of<br/>X basis points</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Increase (decrease) in<br/>pretax earnings given an<br/>interest rate increase of<br/>X basis points</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(300)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(200)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(100)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">100</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">200</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">300</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(184)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">281&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(220)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(147)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (a)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (b)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pretax</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:4pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">As of December&#160;31, 2022, none of our investments had interest rates below 1%. As of December&#160;31, 2021, some of our investments had interest rates below 1% , so the assumed hypothetical change in pretax earnings does not reflect the full 1% point reduction.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The interest rate under our senior notes, which represent 90% of total debt, is fixed, unaffected by changes in interest rates. We had $500&#160;million and $2.5&#160;billion of variable rate term loans at December&#160;31, 2022 and December&#160;31, 2021, respectively, used to fund the August 2021 KAH acquisition. There were no borrowings outstanding under the credit agreement at December&#160;31, 2022 or December&#160;31, 2021. There was $595 million and $955 million outstanding under our commercial paper program at December&#160;31, 2022 and 2021, respectively.  As of December&#160;31, 2022, our interest rate under our commercial paper program was not less than 1%. As of December&#160;31, 2021, our interest rate under our commercial paper program was less than 1% so the assumed hypothetical change in pretax earnings does not reflect the full 1% point reduction.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_121"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_124"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.932%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except<br/>share amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzUtMS0xLTEtMTQwNjQ1_843fe5ae-0130-4b5a-83e1-59af8e10d248">5,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzUtMy0xLTEtMTQwNjQ1_ffa4cceb-9ed0-471e-ba49-e269b21a3931">3,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzYtMS0xLTEtMTQwNjQ1_09240dd0-462e-4ef4-b15e-e623850150cf">13,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzYtMy0xLTEtMTQwNjQ1_46ea9b98-bee6-44a8-8c2b-3b61e45bde9e">13,192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables, net of allowances of $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzctMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246Yzk2MjA3NGU1OWJmNDQxMGI2ZGVjOGZjMmQ1NjM2MDJfNjI_4908f67a-6394-4e2b-992e-9971c552102a">70</ix:nonFraction> in 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzctMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246Yzk2MjA3NGU1OWJmNDQxMGI2ZGVjOGZjMmQ1NjM2MDJfNzc_dbd330fb-e909-438a-8c17-7334fbc2865a">83</ix:nonFraction> in 2021</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzctMS0xLTEtMTQwNjQ1_9dbab0e9-d2dc-468b-9726-e54d7cb69b89">1,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzctMy0xLTEtMTQwNjQ1_df9fe458-a8c7-4dd1-a3d5-7110b41c7bf8">1,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzgtMS0xLTEtMTQwNjQ1_7ce67bc3-9f80-4bfe-9180-9a0fa68b29b3">5,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzgtMy0xLTEtMTQwNjQ1_1d84631d-79a7-4780-8d82-13684e599fda">6,493</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzktMS0xLTEtMTQwNjQ1_556ff9d4-f1df-4e8b-ba0f-4acebf85a831">26,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzktMy0xLTEtMTQwNjQ1_f585ca51-b100-4b3f-a23c-050bb846c3bd">24,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEwLTEtMS0xLTE0MDY0NQ_7ee82557-747f-4c86-9a91-fe84a68d5bfb">3,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEwLTMtMS0xLTE0MDY0NQ_81c0a4af-e494-4251-94fe-62c1baca84f4">3,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzExLTEtMS0xLTE0MDY0NQ_fdf0390c-a6fd-4767-af8d-428bb1fa4a7b">380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzExLTMtMS0xLTE0MDY0NQ_f12aff4e-2115-4edd-997b-ce5126385fa9">780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEyLTEtMS0xLTE0MDY0NQ_f27c5f77-bd69-426c-be98-76bfbfcf5983">9,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEyLTMtMS0xLTE0MDY0NQ_ffcc0ba4-dbc6-4149-b152-de61a713d4fc">11,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEzLTEtMS0xLTE0MDY0NQ_49584df2-9ecc-4334-904a-b6ca88aaf4af">749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEzLTMtMS0xLTE0MDY0NQ_d689404f-4f0f-4fee-88a7-19f2600b86cc">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE0LTEtMS0xLTE0MDY0NQ_f8c155ec-4ee2-462d-b795-3824d1ccff1e">3,380</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE0LTMtMS0xLTE0MDY0NQ_d330c48e-3ae5-469d-a69b-90c0b135108f">4,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE1LTEtMS0xLTE0MDY0NQ_3b6b2680-90f5-48da-9001-57404c8b026c">43,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE1LTMtMS0xLTE0MDY0NQ_fd8ee2da-72df-4766-b157-4b67c994b11a">44,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE4LTEtMS0xLTE0MDY0NQ_3cd44d89-7c32-47ba-82ad-77d7361d92d8">9,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE4LTMtMS0xLTE0MDY0NQ_257ee850-7e81-4154-9a4a-7be74859cae7">8,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE5LTEtMS0xLTE0MDY0NQ_6ba82b24-c3c8-4b82-91e7-77ad3aed2f96">5,238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE5LTMtMS0xLTE0MDY0NQ_e1b68b7b-a878-4251-b107-79ce3c60b7a5">4,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book overdraft</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="hum:BookOverdraftLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIwLTEtMS0xLTE0MDY0NQ_b44e5107-902d-43b7-b052-1d26579089fc">298</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="hum:BookOverdraftLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIwLTMtMS0xLTE0MDY0NQ_989482b9-f9d3-4dc9-9518-2d2e77539991">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIxLTEtMS0xLTE0MDY0NQ_b17bfd1e-856a-4d4c-944c-3ef0d621b255">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIxLTMtMS0xLTE0MDY0NQ_32ffc258-7ed4-4280-bfe9-42e825d4579a">254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIyLTEtMS0xLTE0MDY0NQ_920c9b54-b531-4a88-a9f7-64b03b4f23a1">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIyLTMtMS0xLTE0MDY0NQ_279c4455-0e06-4a23-91bb-33373045c67b">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIzLTEtMS0xLTE0MDY0NQ_1498e970-a4cd-48c1-aea7-2c6cb77c2d34">17,178</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIzLTMtMS0xLTE0MDY0NQ_810f9c1a-b214-4d39-8e76-397f73442a1b">15,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI0LTEtMS0xLTE0MDY0NQ_f40feb56-9ad0-4931-b476-4dbb01d0d213">9,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI0LTMtMS0xLTE0MDY0NQ_db0dc1ce-5f1f-4617-93f7-5668671bfd18">10,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI1LTEtMS0xLTE0MDY0NQ_fbed6209-07c5-4559-af07-8e5b2f6050f2">1,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI1LTMtMS0xLTE0MDY0NQ_efcc9c59-d8d5-4a57-abdd-e6cd9bc54373">2,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI2LTEtMS0xLTE0MDY0NQ_98ec4de0-fdaf-4b33-8264-a968e0fd79dc">27,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI2LTMtMS0xLTE0MDY0NQ_2b9f4be1-9c33-4050-89f1-f3be21f5929c">28,255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 17)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI3LTEtMS0xLTE0MDY0NQ_a5982aed-fcf8-4341-94ff-e8331805abde"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI3LTMtMS0xLTE0MDY0NQ_6604b55a-225d-4111-a056-d3713b84d3fc"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders' Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzIx_3d4a8f9f-175d-41b3-b0ae-9e28daadf2e9"><ix:nonFraction unitRef="usdPerShare" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzIx_91693683-12d2-4791-be7e-5be861923ed2">1</ix:nonFraction></ix:nonFraction> par; <ix:nonFraction unitRef="shares" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzI5_28e3ada6-510b-42c8-a620-992be93c9c39"><ix:nonFraction unitRef="shares" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzI5_88ae8b21-61a8-4f10-9205-ff33279acd94">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzUx_c190c4db-ec25-481d-927c-42d290c96e84"><ix:nonFraction unitRef="shares" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzUx_e32fbe8d-d9bf-4222-8982-b3100f25512e">none</ix:nonFraction></ix:nonFraction> issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTEtMS0xLTE0MDY0NQ_0919ab0c-42c8-4274-9950-8fac5d88a77d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTMtMS0xLTE0MDY0NQ_06a7b5ad-8c1b-440f-823c-c174fef32e06">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.16 2/3 par; <ix:nonFraction unitRef="shares" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQ2YjdhMzY4NzRkMjQwOGRhZTE0N2JhNDQzMjVhMTVlXzMz_98702ca4-1762-4a1b-b161-98fbc3636bae"><ix:nonFraction unitRef="shares" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQ2YjdhMzY4NzRkMjQwOGRhZTE0N2JhNDQzMjVhMTVlXzMz_9eb26840-d527-4637-a1d0-332c97e99d35">300,000,000</ix:nonFraction></ix:nonFraction> shares authorized; </span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQ2YjdhMzY4NzRkMjQwOGRhZTE0N2JhNDQzMjVhMTVlXzYw_acc8fc17-4718-44bc-9b7e-6456bc56bf1e">198,666,598</ix:nonFraction> shares issued at December 31, 2022 and <ix:nonFraction unitRef="shares" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQ2YjdhMzY4NzRkMjQwOGRhZTE0N2JhNDQzMjVhMTVlXzEwOTk1MTE2Mjc4OTk_0d445bf6-282d-47a8-92b1-abb6d601180b">198,648,742</ix:nonFraction> shares issued at December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTEtMS0xLTE0MDY0NQ_761a324d-e152-454f-85f2-1dde2bbd8138">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTMtMS0xLTE0MDY0NQ_ff392d93-fd09-4c93-8a96-c2d9c466adac">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMxLTEtMS0xLTE0MDY0NQ_307dc93f-7ce4-4773-a4b4-3539bb33697b">3,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMxLTMtMS0xLTE0MDY0NQ_d7d5f28c-3c96-4a55-9441-a53040da60ff">3,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMyLTEtMS0xLTE0MDY0NQ_83849948-e4a2-4255-a74a-b295f1817b87">25,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMyLTMtMS0xLTE0MDY0NQ_f5e21153-8ea3-446d-b703-22f5804c76ca">23,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMzLTEtMS0xLTE0MDY0NQ_3b060dbc-dc0e-4fde-a30c-2c7ea50194b5">1,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMzLTMtMS0xLTE0MDY0NQ_0c2b69f5-fe24-452c-afe6-586262538938">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjdkZGJmM2IyYzkzODRiYzE4OTc5NjVlZTBhOTg1NWM1XzI5_626c5750-be95-4761-a8fa-b9d93f178f21">73,691,955</ix:nonFraction> shares at December 31, 2022</span></div><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;and <ix:nonFraction unitRef="shares" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjdkZGJmM2IyYzkzODRiYzE4OTc5NjVlZTBhOTg1NWM1XzY5_73e225c9-e3a2-4a36-85e3-56ec8037666d">69,846,758</ix:nonFraction> shares at December 31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM0LTEtMS0xLTE0MDY0NQ_b19e98c7-c4a5-4017-9d4d-6fc7afd09385">12,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM0LTMtMS0xLTE0MDY0NQ_c7527511-6c8f-4566-812a-6fe049b7792c">10,163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM1LTEtMS0xLTE3MzkwMQ_62ff0382-24e0-4b69-9a07-5fbc66665366">15,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM1LTMtMS0xLTE3MzkwMQ_f20ae844-398b-42f1-bbad-1d7c474ded21">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM1LTEtMS0xLTE0MDY0NQ_c669b207-e756-44aa-abf1-3c79473b38ed">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM1LTMtMS0xLTE0MDY0NQ_466ac0b2-e5ec-4cb7-902d-280c7a1e2144">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM2LTEtMS0xLTE0MDY0NQ_813ea8cb-2a7a-4a11-87e8-e7fb27a51786">15,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM2LTMtMS0xLTE0MDY0NQ_76819915-58c9-4aaf-89be-7118f02ace7d">16,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM3LTEtMS0xLTE0MDY0NQ_b2befb2f-2a2c-4617-bb3e-cbb3ffd58d84">43,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM3LTMtMS0xLTE0MDY0NQ_b2540f7c-c533-47de-8126-d965b17e74e2">44,358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_130"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:48.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.951%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions, except per share results)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzQtMS0xLTEtMTQwNjQ1_b388f011-6e0b-475a-be36-dcbfa024b10f">87,712</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzQtMy0xLTEtMTQwNjQ1_ce38699d-dd32-42c6-b3a8-7645e70b07e3">79,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzQtNS0xLTEtMTQwNjQ1_42f10aa6-e469-4cfc-80c7-ae9f92a62fd3">74,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMC0xLTEtMTQwNjQ1_256dbbe4-e72d-43cb-856f-f86c3ab31032"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMC0xLTEtMTQwNjQ1_63a0ed7e-2224-43f9-9b9a-e3b0d3ae6fad"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMC0xLTEtMTQwNjQ1_e463531f-2ae3-4151-ab6a-b78870f1c964">Services</span></span></span></span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMS0xLTEtMTQwNjQ1_ac77f2ba-e094-4c3b-943c-98ad83dd570b">4,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMy0xLTEtMTQwNjQ1_91b5d893-5d0a-4d5e-91be-04660d7b6e3c">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtNS0xLTEtMTQwNjQ1_9d9ca5fe-da99-4f3d-a9d8-00d2fcf5c5aa">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzYtMS0xLTEtMTQwNjQ1_96042c9c-256e-494f-9d18-b1c92abbf7bf">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzYtMy0xLTEtMTQwNjQ1_fd0dbfaa-b74a-4a74-8f0d-230445250c98">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzYtNS0xLTEtMTQwNjQ1_0e454f22-5af5-4b6c-bfb3-79267f58201c">1,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzctMS0xLTEtMTQwNjQ1_12e96cb6-b62a-466c-9be9-774e1c1996d4">92,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzctMy0xLTEtMTQwNjQ1_321fec25-c193-48b9-bfd3-525a0a60fec7">83,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzctNS0xLTEtMTQwNjQ1_21919683-71b5-43ac-8863-fec285d464d1">77,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzktMS0xLTEtMTQwNjQ1_60cfa511-303c-4ca5-aa5c-de08cad135b6">75,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzktMy0xLTEtMTQwNjQ1_a4e6bb82-75d5-44f4-b285-77a515af73be">69,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzktNS0xLTEtMTQwNjQ1_ff36e8d1-af44-4608-8c57-3992e99ab57b">61,628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEwLTEtMS0xLTE0MDY0NQ_eb2ca466-3481-46fd-979a-75b305a0cec4">12,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEwLTMtMS0xLTE0MDY0NQ_bd12f18e-4203-41bc-81f8-87de3af0e558">10,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEwLTUtMS0xLTE0MDY0NQ_d94ad9e7-f5c3-49cb-bd19-1cdde00ce40a">10,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEyLTEtMS0xLTE0MDY0NQ_161b7afa-e177-474c-820a-8b9b38e653c2">709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEyLTMtMS0xLTE0MDY0NQ_9a6139c2-149a-425b-816b-1e31503d2e8e">596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEyLTUtMS0xLTE0MDY0NQ_c7af2e60-e8f7-4a14-98ed-7cfebf490be3">489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEzLTEtMS0xLTE0MDY0NQ_da27a3a7-d1bc-4974-964e-db9826e7dd38">89,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEzLTMtMS0xLTE0MDY0NQ_1791ad02-259f-41df-83ac-102444926707">79,916</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEzLTUtMS0xLTE0MDY0NQ_00ac2cb8-0d5b-4fa9-83be-fbd24d58c976">72,169</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE0LTEtMS0xLTE0MDY0NQ_c12e1cbb-0cc3-4b85-be3f-e91fae90450c">3,800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE0LTMtMS0xLTE0MDY0NQ_b3d2a708-1255-47d3-9b2b-016de2a47f52">3,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE0LTUtMS0xLTE0MDY0NQ_0a4af452-1c45-4532-b76f-992e8bb0243a">4,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of KAH Hospice</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE1LTEtMS0xLTE0MDY0NQ_2bf49c51-755d-46c7-86fa-6985c22b1e87">237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE1LTMtMS0xLTE0MDY0NQ_792549d5-3188-4b4e-9ec4-def84d50d91f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE1LTUtMS0xLTE0MDY0NQ_342a3c80-492d-4b06-82d2-d027f40ab895">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE2LTEtMS0xLTE0MDY0NQ_f2001727-6ffa-4b3e-9e07-5fe933cb5ca1">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE2LTMtMS0xLTE0MDY0NQ_ba1778ff-ca4c-4496-ad05-7d994aea9911">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE2LTUtMS0xLTE0MDY0NQ_e76fb949-8af9-465a-bb6f-516f3d5aa8ce">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense (income), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE3LTEtMS0xLTE0MDY0NQ_207c0ad3-063d-4553-8616-dccb7fc115fb">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE3LTMtMS0xLTE0MDY0NQ_88129307-1c38-4f37-aa7a-a1604f26f77c">532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE3LTUtMS0xLTE0MDY0NQ_dd9946b1-d834-4bb3-977d-fb9056c56dee">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net (losses) earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE4LTEtMS0xLTE0MDY0NQ_fb2ac635-0cc1-440c-8c25-626d24192bbd">3,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE4LTMtMS0xLTE0MDY0NQ_d4d2b546-33e3-4c17-b212-6876dbb78f7c">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE4LTUtMS0xLTE0MDY0NQ_53cba1ce-5221-4be6-9deb-261a5b56316b">4,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE5LTEtMS0xLTE0MDY0NQ_e21fe71f-cdd3-4d4f-ba53-3045bdca66a2">762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE5LTMtMS0xLTE0MDY0NQ_d5d70d5e-23cb-45a0-ad6e-32ae28949772">485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE5LTUtMS0xLTE0MDY0NQ_95822749-b3bc-4f16-b59e-3129dd633dc5">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net (losses) earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIwLTEtMS0xLTE0MDY0NQ_dcf2aa77-b82f-478f-8fb2-674b2cb927f3">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIwLTMtMS0xLTE0MDY0NQ_c300fd65-aaed-42a4-8fa3-3fa049bd7653">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIwLTUtMS0xLTE0MDY0NQ_eb26f460-6394-4be4-bdad-fa68fccd75b4">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIxLTEtMS0xLTE0MDY0NQ_d164e76f-d61a-435b-a89e-843502648f61">2,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIxLTMtMS0xLTE0MDY0NQ_12037c26-9da6-48b7-856c-80274a74e827">2,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIxLTUtMS0xLTE0MDY0NQ_3ec8dcca-558d-46b3-a506-8471b894a948">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss (income) attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIyLTEtMS0xLTE0MDY0NQ_786104eb-da9e-40c5-828f-ccda4ee9a180">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIyLTMtMS0xLTE0MDY0NQ_06ec0ec5-05b7-4f4e-8ade-a6e056aa8757">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIyLTUtMS0xLTE0MDY0NQ_69f906c8-1d16-4927-af36-763fb5c46664">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Humana</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIzLTEtMS0xLTE0MDY0NQ_5c93cfef-f26d-4353-894d-b3be47d4397f">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIzLTMtMS0xLTE0MDY0NQ_33c76633-2afc-43a1-919d-6b2787b74693">2,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIzLTUtMS0xLTE0MDY0NQ_2892dc23-1cc9-4cff-a43b-b0af04cb72f0">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI0LTEtMS0xLTE0MDY0NQ_926e0682-92f4-4497-b58e-eb08439d96e8">22.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI0LTMtMS0xLTE0MDY0NQ_0f373657-c846-49a3-bf77-cbbaf4cb0f64">22.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI0LTUtMS0xLTE0MDY0NQ_44954585-4660-4703-bbe9-8571e7a16846">25.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI1LTEtMS0xLTE0MDY0NQ_0ae93125-a6b3-4e22-b822-3636446e238a">22.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI1LTMtMS0xLTE0MDY0NQ_1bc6a62e-1670-4dc5-82a4-800668f5acd8">22.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI1LTUtMS0xLTE0MDY0NQ_dff9a4ec-f523-4e51-8df2-d050bd820254">25.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_133"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:54.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.025%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.025%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Humana</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzMtMS0xLTEtMTQwNjQ1_5c93cfef-f26d-4353-894d-b3be47d4397f">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzMtMy0xLTEtMTQwNjQ1_33c76633-2afc-43a1-919d-6b2787b74693">2,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzMtNS0xLTEtMTQwNjQ1_2892dc23-1cc9-4cff-a43b-b0af04cb72f0">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in gross unrealized investment (losses) gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzUtMS0xLTEtMTQwNjQ1_8cc0286d-fed8-4c87-b553-2d34d028cafb">1,819</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzUtMy0xLTEtMTQwNjQ1_a64e52ed-e266-4321-b969-41f5c7d84463">356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzUtNS0xLTEtMTQwNjQ1_63b23004-6112-4515-a7ac-90b6d4dace86">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzYtMS0xLTEtMTQwNjQ1_a819f708-505b-4252-92da-024aaab6491d">418</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzYtMy0xLTEtMTQwNjQ1_5fa8793b-8bdd-4417-a908-e28315515128">81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzYtNS0xLTEtMTQwNjQ1_438b9b64-c993-4219-9702-44f852c46219">89</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total change in unrealized investment  <br/>&#160;&#160;&#160;&#160;(losses) gains, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzctMS0xLTEtMTQwNjQ1_e6fa904a-d18c-4bb5-a3ed-7aedf6f5cb26">1,401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzctMy0xLTEtMTQwNjQ1_4c4cabdf-3fba-4c19-832e-e5aa4db08268">275</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzctNS0xLTEtMTQwNjQ1_45f1ac0d-f517-4d91-885e-c7259a774c63">304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification adjustment for net realized <br/>&#160;losses (gains) included in investment income </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzgtMS0xLTEtMTQwNjQ1_1f419d12-4efc-442f-964d-96f6302ca731">72</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzgtMy0xLTEtMTQwNjQ1_dbbe74fa-9129-433a-b8cf-06a602803dbd">103</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzgtNS0xLTEtMTQwNjQ1_4ee59957-0f09-4ac2-8a92-477a69e197dd">90</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzktMS0xLTEtMTQwNjQ1_2db2d40e-b411-479e-bafa-9b2679c6ed86">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzktMy0xLTEtMTQwNjQ1_25c35de7-982c-4eca-b867-d29d7d10a7bb">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzktNS0xLTEtMTQwNjQ1_48caa0f2-ed84-4423-aa4f-0927f147c657">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassification adjustment, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEwLTEtMS0xLTE0MDY0NQ_f89e27a7-1cf0-4d04-8ca1-3d8ceac6e8d6">55</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEwLTMtMS0xLTE0MDY0NQ_07049988-23f3-4ef3-a0d2-975d4e3b475e">80</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEwLTUtMS0xLTE0MDY0NQ_51c06ee4-c1ec-434a-a620-c7273c43bbea">70</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzExLTEtMS0xLTE0MDY0NQ_084ce757-eb0d-45bd-af2b-1931e97c8032">1,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzExLTMtMS0xLTE0MDY0NQ_363df253-61e0-472a-a4dd-ad0f6c649655">355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzExLTUtMS0xLTE0MDY0NQ_37e8f711-1f93-4d41-aca0-b5ef8dc02eda">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to equity method<br/>&#160;&#160;investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEyLTEtMS0xLTE0MDY0NQ_14e12ebd-9316-489d-a9d8-e487f2738109">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEyLTMtMS0xLTE0MDY0NQ_bbef3812-9d6f-42e4-a7e6-8b6a10a081e5">6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEyLTUtMS0xLTE0MDY0NQ_e9982e42-c324-4241-821d-e346ff393eee">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Humana</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEzLTEtMS0xLTE0MDY0NQ_de6f4248-7d02-4086-b355-193eaace6d3b">1,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEzLTMtMS0xLTE0MDY0NQ_404842b5-1b49-4ce0-a851-f8accfc4dc80">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEzLTUtMS0xLTE0MDY0NQ_e90b1d8d-81b6-4cb4-baa7-aa621abda531">3,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_136"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.528%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.015%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.050%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.050%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.249%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.050%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.317%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.094%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Capital&#160;In<br/>Excess&#160;of<br/>Par Value</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Total Stockholders'<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Noncontrolling Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Total<br/>Equity</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Issued<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.25pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="51" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, share amounts in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28bf61673f944bc1ac5aa3fe90724e55_I20191231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMS0xLTEtMTQwNjQ1_1d389c92-7dd9-44ae-bf9e-4020d6072cb4">198,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28bf61673f944bc1ac5aa3fe90724e55_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMy0xLTEtMTQwNjQ1_42d1e44d-2a11-4e6f-9826-e75722f3d350">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae3316eaa1ab4c63b284379afe39c1c3_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtNS0xLTEtMTQwNjQ1_4a1e8eed-56be-44cf-bade-7222c9f7f90b">2,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e3e965bd7f546cb8bdfffae17fa5c03_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtNy0xLTEtMTQwNjQ1_bd190a5f-0081-496e-8c7e-5c13d4a0d4cf">17,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99ec67bd37c741fcae4bda5f42e6b771_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtOS0xLTEtMTQwNjQ1_7f2471a2-9770-456a-a6e7-5e43da80248a">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d04f982d8e74a8d8291aa9c72da676e_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMTEtMS0xLTE0MDY0NQ_213519b5-acb9-4a65-b9ad-948defbfc92e">8,455</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389e820acaed4f94986088bd4c6ee7e8_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMTMtMS0xLTE3MzkwNA_e32fc967-2eb8-4f87-933a-86b3c1acea02">12,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd1f8bbcda74c90a7dfd0297a038626_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMTMtMS0xLTE0MDY0NQ_adf2b67a-6598-4578-814c-46acc6b63012">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMTUtMS0xLTE0MDY0NQ_13fc954e-a065-4afe-8067-fdb387b9f124">12,037</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7285850bb8c54632823083969a16a30b_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzQtNy0xLTEtMTQwNjQ1_5c41b5ba-b77f-4def-b755-6963e262d1e7">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzQtMTMtMS0xLTE3MzkwNg_50d92ce6-c212-45f5-bbae-2fb40db9c77f">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzQtMTUtMS0xLTE0MDY0NQ_da87de99-5bbc-4e0c-8405-cbcfcf4f7f46">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impact of adopting accounting standard</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae0e22f86a6949a8a48e01671ed1c284_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtNy0xLTEtMTU0ODkx_6b4cd521-3f01-4556-a829-bd6e9d669ec8">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7781da092ad41ee8990573fd28577bd_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtMTMtMS0xLTE3MzkwNg_add633a4-16d3-420a-ab25-e75267d0bd1b">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id7f017f098bd40b1a9bdb0c3ec9f1caa_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtMTUtMS0xLTE1NDg5MQ_896ac0fa-7ddb-4e77-affb-31a72eff860b">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbcbb10618b845c1add87e9d45a78991_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtOS0xLTEtMTQwNjQ1_73a58fab-e498-4588-8c6e-668d9cdca334">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktMTMtMS0xLTE3MzkwNg_0626e276-0eee-445f-bf7d-e3de17571dbc">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtMTUtMS0xLTE0MDY0NQ_502f8de2-bdcd-4552-b37d-c911296ecb12">235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzYtNS0xLTEtMTQwNjQ1_89535761-edcb-43d3-84ef-1334ade066c9">263</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fe1870a9b49406daaf2ba671fa7e631_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzYtMTEtMS0xLTE0MDY0NQ_ad3ce80a-3832-4ed5-9448-4a5f4f6ac8db">1,557</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEwLTEzLTEtMS0xNzM5MDY_a0fc0875-90d2-4bad-907a-a713279648fd">1,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzYtMTUtMS0xLTE0MDY0NQ_5ba4f163-467d-4f47-a624-37bf620fc6ff">1,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends and dividend <br/>&#160;&#160;&#160;equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7285850bb8c54632823083969a16a30b_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzctNy0xLTEtMTQwNjQ1_a4b838f9-767f-43ef-b812-4518c1a0e94f">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTEzLTEtMS0xNzM5MDY_17c151df-17ca-453d-8fa2-82b82010c7b0">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzctMTUtMS0xLTE0MDY0NQ_32526ee5-1978-418b-b271-82cb41f32c5a">331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzgtNS0xLTEtMTQwNjQ1_73ddf348-27c4-44ee-aa0e-b8b029a79cc0">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEyLTEzLTEtMS0xNzM5MDY_db986eec-55be-4b97-b697-8db713b6c69f">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzgtMTUtMS0xLTE0MDY0NQ_9488da68-7be9-412e-8d74-83afb4719244">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted stock unit vesting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibe78b6c543d6497ba9c3f17b26297551_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktMS0xLTEtMTQwNjQ1_da181f93-3cc8-4074-8f53-45448dcb14ee">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktNS0xLTEtMTQwNjQ1_270ec9db-7f75-479b-8b71-65244d88625b">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe1870a9b49406daaf2ba671fa7e631_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktMTEtMS0xLTE0MDY0NQ_3604990f-8d24-4d31-8a61-15c48315a1de">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktMTUtMS0xLTE0MDY0NQ_a627c39d-c74b-4626-81b9-85d636ec88cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option exercises</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEwLTUtMS0xLTE0MDY0NQ_814529a9-e0ed-4a7a-af52-01256490ed35">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fe1870a9b49406daaf2ba671fa7e631_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEwLTExLTEtMS0xNDA2NDU_703221ae-bb3f-49da-88dd-72ecad160d77">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE0LTEzLTEtMS0xNzM5MDY_bf965939-f6ff-487b-9520-f1e0e7252048">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEwLTE1LTEtMS0xNDA2NDU_9edaef22-0cf6-4907-9b0a-6eb9b2b9e01f">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i47316da3a3ca4462a4861e765c936186_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTEtMS0xLTE0MDY0NQ_ccf9c539-7dfd-4332-af68-251fd4ec1370">198,649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47316da3a3ca4462a4861e765c936186_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTMtMS0xLTE0MDY0NQ_485cc721-1b39-4ca7-b6ad-ca523a608ff4">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fe62d64db7e4bf4972bf02ec4c90535_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTUtMS0xLTE0MDY0NQ_137a72e5-8ab8-4c98-9bde-f16e50d8941b">2,705</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i65031e9551cb4c5e98bf719298231efb_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTctMS0xLTE0MDY0NQ_cae865a4-6b4e-46ef-9618-dd9bb4ff7fc0">20,517</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36906efe5bd14a959e87de9672f63b52_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTktMS0xLTE0MDY0NQ_37ffc3c1-d84b-4464-8c94-9a7ea227a5f5">391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i06d4dc5e79574b798135918a523c5afb_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTExLTEtMS0xNDA2NDU_dc5354fa-dcf2-4d3c-a8c2-eb816f093bcd">9,918</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90fb72011b3b41c089fdc685a8b914a1_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE1LTEzLTEtMS0xNzM5MDQ_886b09fd-15d2-49ca-be3a-706443e01acc">13,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52688808256645f9b0b3dadea8649a92_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTEzLTEtMS0xNDA2NDU_067df4b4-2b10-4e16-96d5-866e774ebb44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTE1LTEtMS0xNDA2NDU_43e36563-5481-42af-9306-7dbd284d886b">13,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i518fee92d21348d4bac22ba846904d99_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEyLTctMS0xLTE0MDY0NQ_4e42c1ad-5c64-4ff1-9745-e97fcafb8e88">2,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE2LTEzLTEtMS0xNzM5MDY_b06f0f38-91f0-420c-b24c-1e3e8f02cb29">2,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc29f8ee3dbf4eca981b29f3496e9b8f_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE2LTEzLTEtMS0xNTQ5MzY_f5b71f9d-9884-4068-ab5b-0a83f2302a86">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEyLTE1LTEtMS0xNDA2NDU_11bd4b5e-4f11-410c-8ce4-40523c05be1f">2,934</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc29f8ee3dbf4eca981b29f3496e9b8f_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE5LTEzLTEtMS0xNTQ5MzY_db1bead5-e1f9-4830-b87f-2778315d0a49">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEzLTE1LTEtMS0xNDA2NDU_17b18b57-5f62-4312-ac5d-fd568c8c57b2">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib31d3b30f3a84c83be93331f0c89a3b9_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE0LTktMS0xLTE0MDY0NQ_472e0df4-1e47-4bd5-84fb-f9e1aa962955">349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTEzLTEtMS0xNzM5MDY_62735154-ba40-49be-ba2e-3964fa9d4b0b">349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE0LTE1LTEtMS0xNDA2NDU_bbbd926b-d1f2-4cb5-b91f-aa7dc2b0a1e5">349</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE1LTUtMS0xLTE0MDY0NQ_ec25602c-c20c-4b47-95bd-1d87c438eb2a">262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3e2a44f0beb4bac9ff346a4269524b9_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE1LTExLTEtMS0xNDA2NDU_a0405374-eacb-4482-9e3e-ed4b79f3038c">341</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIxLTEzLTEtMS0xNzM5MDY_db831a43-6eb4-43fe-8480-21a132441204">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE1LTE1LTEtMS0xNDA2NDU_b6a7993c-0748-4562-ad05-4f385bc44c96">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends and dividend <br/>&#160;&#160;&#160;equivalents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i518fee92d21348d4bac22ba846904d99_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE2LTctMS0xLTE0MDY0NQ_501c2fbd-7685-4f91-b8ad-5aa859404695">364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIyLTEzLTEtMS0xNzM5MDY_28a33182-1967-4557-8fe2-e38a821c7563">364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE2LTE1LTEtMS0xNDA2NDU_81308298-4be3-45e3-b937-7e2f4462ec19">364</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE3LTUtMS0xLTE0MDY0NQ_66f1c07d-824e-4659-ac47-4deaee8e0e21">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIzLTEzLTEtMS0xNzM5MDY_1cc8a187-5e00-4985-9b93-402034063f39">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE3LTE1LTEtMS0xNDA2NDU_a5850db2-c145-4b5c-86ff-0cf52758f565">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted stock unit vesting</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE4LTUtMS0xLTE0MDY0NQ_6b8c7bfd-9ce2-4554-9755-ae0ab6a4e5e0">81</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e2a44f0beb4bac9ff346a4269524b9_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE4LTExLTEtMS0xNDA2NDU_cea7bb3f-1f67-4b52-a637-6043e9a4f55f">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI0LTEzLTEtMS0xNzM5MDY_6a074ace-c22e-4f75-944f-413ff62917b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE4LTE1LTEtMS0xNDA2NDU_b8e07b20-449f-4d42-ba0c-27bd62ad7890">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option exercises</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE5LTUtMS0xLTE0MDY0NQ_71f77a41-8eb7-4273-b808-d8c2f05cd4aa">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e2a44f0beb4bac9ff346a4269524b9_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE5LTExLTEtMS0xNDA2NDU_d4b5f64e-23fa-4117-b354-2c2af5457c2b">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI1LTEzLTEtMS0xNzM5MDY_320e12c5-59b3-4142-b9a2-e111052cd186">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE5LTE1LTEtMS0xNDA2NDU_3414e365-6579-4abb-8e2f-5d7b5628b75c">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7f3f59a5f394d4faae0211463973ead_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTEtMS0xLTE0MDY0NQ_ef653d61-e205-4266-b381-6fe9c8ed0919">198,649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f3f59a5f394d4faae0211463973ead_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTMtMS0xLTE0MDY0NQ_ba6c1ddc-b44a-437b-a13e-27bd1659be43">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53ef7bd107114170bc009542db1e7bcc_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTUtMS0xLTE0MDY0NQ_60c93a11-e9f2-4c44-b16f-d3206c08705e">3,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c643278b48c4671a48980681e36ec67_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTctMS0xLTE0MDY0NQ_125c2254-e32a-4bac-854d-0815a6911142">23,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35f272177b134f6b8a1b91bc0c09280b_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTktMS0xLTE0MDY0NQ_16cef099-1caf-48ac-a16c-93fd102c04f3">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaae6442e790a4944978a3019753b8334_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTExLTEtMS0xNDA2NDU_abefcd86-298c-41e1-97db-19a6232f5a17">10,163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i287579c2615947bd90df9271fb6c17d1_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI2LTEzLTEtMS0xNzM5MDQ_b5ef4492-a69a-42f0-b891-5685faa00cda">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57dca7a5679246a790f3f371e95e7dd7_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTEzLTEtMS0xNDA2NDU_30adb7ad-5fd6-4c79-9026-1ec91c8496db">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTE1LTEtMS0xNDA2NDU_43f01de0-cafe-46d3-bfc5-a74ccf4ebff8">16,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9143bd79088c45919a393886eedf2fed_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIxLTctMS0xLTE0MDY0NQ_8fb9c0d6-4adf-4b34-8f7c-1f7d0f506718">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI3LTEzLTEtMS0xNzM5MDY_d8ef900f-b997-48bb-a5b5-b4271e4b4144">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIxLTEzLTEtMS0xNDA2NDU_589a7bb6-bc62-48aa-9506-3900fb7bf863">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIxLTE1LTEtMS0xNDA2NDU_9229904d-df04-4a3d-9a12-ead2bdec3664">2,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distribution to noncontrolling interest holders, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231" decimals="-6" sign="-" name="hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIyLTEzLTEtMS0xNDA2NDU_bff408bf-4bfb-4fb6-a8f0-1ec0bce8d61c">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIyLTE1LTEtMS0xNDA2NDU_43f69734-4ebe-4d31-9d90-abe47a6f1dbf">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Sale of KAH Hospice</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTEzLTEtMS0xNTQ5NDQ_4bc0e557-162a-426c-a0f0-d77bcbcb208b">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTE1LTEtMS0xNTQ5NDQ_f6dfb517-9be5-4313-860e-4d295f9de220">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMwLTEzLTEtMS0xNTQ5NDQ_a59f460c-9fa8-415f-bc29-d7ef844b1b06">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMwLTE1LTEtMS0xNTQ5NDQ_503c3dfa-d795-4366-94f1-0f6fb18d42f7">52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i42f85c8b4a084c0bbd1a7804fa2fb617_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIzLTktMS0xLTE0MDY0NQ_b8140bd9-ecd5-4831-92d5-22b0f0351f3b">1,346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMxLTEzLTEtMS0xNzM5MDY_e8a8ad97-979b-4c14-9586-b18357c10a1e">1,346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIzLTE1LTEtMS0xNDA2NDU_514fd623-317f-47bb-8635-67eb79b5c14a">1,346</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52d2b054f3fb47ad90e22fc446758bc3_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI0LTExLTEtMS0xNDA2NDU_d7bbef27-3483-4dc2-8dba-c2dcd1eddad1">2,096</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMyLTEzLTEtMS0xNzM5MDY_e52eaefc-4399-493b-93c9-5f00885526fd">2,096</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI0LTE1LTEtMS0xNDA2NDU_0bcebfd6-5c02-4c97-beda-1c1a2af54de6">2,096</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends and dividend <br/>&#160;&#160;&#160;equivalents</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9143bd79088c45919a393886eedf2fed_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI1LTctMS0xLTE0MDY0NQ_a00119cf-be8d-41eb-a7f3-8c594c3b7dda">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMzLTEzLTEtMS0xNzM5MDY_9bdf6c73-0d6c-44ff-aae1-89bfbed6d2a8">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI1LTE1LTEtMS0xNDA2NDU_e6b0f230-fa88-4096-b6cc-910f79ceaeb2">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a0a21d7c6d4429b8a0de15cd71eb93f_D20220101-20221231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI2LTUtMS0xLTE0MDY0NQ_07b336a7-c79d-4714-aed8-711626fc890f">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzM0LTEzLTEtMS0xNzM5MDY_2e26a434-cd2e-4cde-a78f-b48763a0396a">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI2LTE1LTEtMS0xNDA2NDU_38274fbb-1dc9-46ec-9ea0-e888be822691">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restricted stock unit vesting</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if9a733dd9abd4513bb45837c142b7106_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzM1LTEtMS0xLTE1NDk0NA_06ff9e33-13b8-4c41-bf13-a19e679bb927">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a0a21d7c6d4429b8a0de15cd71eb93f_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI3LTUtMS0xLTE0MDY0NQ_33fa4fd4-d4eb-457b-a2de-193068f89cbf">78</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d2b054f3fb47ad90e22fc446758bc3_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI3LTExLTEtMS0xNDA2NDU_517e88e9-913c-46c9-b22e-4ad22533bfa4">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI3LTE1LTEtMS0xNDA2NDU_e06fb4f1-49a0-451a-860a-7b6e1cbd734d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option exercises</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a0a21d7c6d4429b8a0de15cd71eb93f_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI4LTUtMS0xLTE0MDY0NQ_e1b66e13-a343-461c-9f63-0c1c9c4aafb0">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d2b054f3fb47ad90e22fc446758bc3_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI4LTExLTEtMS0xNDA2NDU_e4664285-0a0f-448f-b2f0-57f37bef6db0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzM2LTEzLTEtMS0xNzM5MDY_c90736ac-3d5d-4062-aa2a-4b6e63789013">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI4LTE1LTEtMS0xNDA2NDU_3e26563c-b427-4952-b0a2-43c16c6f889b">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balances, December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i28901f9b5d9648d3bcdd517445a5b77e_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTEtMS0xLTE0MDY0NQ_435a5a98-4de6-4ab3-9418-f130f69752a2">198,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28901f9b5d9648d3bcdd517445a5b77e_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTMtMS0xLTE0MDY0NQ_e7a8f8ea-f6f6-4e3e-91e6-2c576a3a6670">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a3b5852afb54656981769e75c1661ed_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTUtMS0xLTE0MDY0NQ_1c262258-bfa5-4417-806e-8df0c3e40a4a">3,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8521cad256a441f09269040aa936b3c2_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTctMS0xLTE0MDY0NQ_06ed2863-a31b-4546-9784-cdf6a5385261">25,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iff654d59997d4f00bf56601509888261_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTktMS0xLTE0MDY0NQ_d1ec5093-7969-48d2-a018-a5dcd80e5f5e">1,304</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i04f20e9ecbc842eb84ec33df7c1e03ac_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTExLTEtMS0xNDA2NDU_710c5f29-152b-4689-bc3c-f9349c0be7a5">12,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7cc33f8e79b44da9048bfcf1f0d1520_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzM3LTEzLTEtMS0xNzM5MDQ_bf4f2c7b-cc1f-45d4-b0c6-eb9c80227840">15,311</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc3e3d48014423a92047239f09e25bd_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTEzLTEtMS0xNDA2NDU_b74a982c-e457-426a-bdfc-f45dbbbcce80">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTE1LTEtMS0xNDA2NDU_73e4581c-b928-4252-a804-ea72c643135a">15,370</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.&#160;&#160;&#160;&#160;</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_139"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOW</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQtMS0xLTEtMTQwNjQ1_93ec6ba9-732e-49c8-8a29-8ac175a629ab">2,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQtMy0xLTEtMTQwNjQ1_a8771b64-1423-4ef5-885b-1f15d7ac34a3">2,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQtNS0xLTEtMTQwNjQ1_a24eb484-2fc7-426b-8d00-7c49c54ada62">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on sale of KAH Hospice</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzYtMS0xLTEtMTQwNjQ1_ffe16040-2149-45d0-9697-5a3129094fc5">237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzYtMy0xLTEtMTQwNjQ1_61eaba0e-7b53-465e-a8ef-6f212c5d281a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzYtNS0xLTEtMTQwNjQ1_b8763cf0-3ed4-43b4-9f86-78945a7a33f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss (gain) on investment securities, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzctMS0xLTEtMTQwNjQ1_849b18ba-abf6-426b-8955-88f07877c463">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzctMy0xLTEtMTQwNjQ1_f8c6a218-6c94-4a5d-ac09-59d93ade5770">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzctNS0xLTEtMTQwNjQ1_27721ab2-3ddf-403a-baaa-bb0d28fa5b68">838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on Kindred at Home equity method investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzgtMS0xLTEtMTQwNjQ1_0038c57c-ceb2-4252-999a-2984484052fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzgtMy0xLTEtMTQwNjQ1_0885adda-1f87-4844-b076-37e5e4265691">1,129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzgtNS0xLTEtMTQwNjQ1_7ad1c2fa-650e-4321-a7cb-04f6671d83e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity in net losses (earnings)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzktMS0xLTEtMTQwNjQ1_b9b6fcfb-aeca-483c-a6b2-be781f08771a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzktMy0xLTEtMTQwNjQ1_b78b1fc3-854c-44fa-95bb-7923716ee982">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzktNS0xLTEtMTQwNjQ1_cb514168-7a36-4e1c-ae16-30a8cb039bfb">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEwLTEtMS0xLTE0MDY0NQ_94d1c860-6e3f-41d0-8291-16874b32c702">216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEwLTMtMS0xLTE0MDY0NQ_17653d5c-6510-4fa0-94b4-1879639b4a01">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEwLTUtMS0xLTE0MDY0NQ_f9687e34-0315-4182-8877-db6a2b097c0b">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzExLTEtMS0xLTE0MDY0NQ_b77b9752-b245-4f33-a3a8-7b631a0eddec">749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzExLTMtMS0xLTE0MDY0NQ_89c71e00-f960-4b4f-b23b-5d10967a3980">640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzExLTUtMS0xLTE0MDY0NQ_b244d263-c9bf-47c4-a39c-25e4586990ca">528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEyLTEtMS0xLTE0MDY0NQ_2cac1c26-c9df-4ff7-8b3c-6b613904398b">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEyLTMtMS0xLTE0MDY0NQ_595de132-ac02-4cf0-bfef-5b23c0e1a96b">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEyLTUtMS0xLTE0MDY0NQ_9f34f73c-c4a5-45c1-a211-ef26bfb31c80">88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:TangibleAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTEtMS0xLTE0NjQzNA_09e58d72-dced-4fa2-bbb1-7fa8a953e716">248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTMtMS0xLTE0NjQzNA_684a76be-6c12-4bbd-bf32-1683b6575195">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTUtMS0xLTE0NjQzNA_a0fd992d-6997-4337-b854-1d2dfb190239">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Benefit) provision for deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTEtMS0xLTE0MDY0NQ_57e49d61-1173-455a-85a4-4e825e3ade92">100</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTMtMS0xLTE0MDY0NQ_9ef27153-fc2f-4575-99c3-8f4d69f4e449">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTUtMS0xLTE0MDY0NQ_c9166a7c-457e-4958-b95a-a4f909dc0ea4">195</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, net of effect of businesses acquired and dispositions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE1LTEtMS0xLTE0MDY0NQ_a2b1adeb-a4f1-49e4-b077-71240f712cb5">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE1LTMtMS0xLTE0MDY0NQ_ad2de764-1dba-4b5b-b9ab-81ce7115f2b2">280</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE1LTUtMS0xLTE0MDY0NQ_0c93e83a-062d-4e81-be03-ab5d11ac40f6">85</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE2LTEtMS0xLTE0MDY0NQ_2d8af3f6-5cd2-40e9-ac37-2157c025f59d">463</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE2LTMtMS0xLTE0MDY0NQ_c9d81e3d-9ad2-472f-a51b-16c67ebf8b2b">491</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE2LTUtMS0xLTE0MDY0NQ_3843bc19-e76c-49a1-a976-07df2b52f724">581</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE3LTEtMS0xLTE0MDY0NQ_5a0140b3-1758-4a56-916a-c93d9db37973">975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE3LTMtMS0xLTE0MDY0NQ_4c7c6028-9a4d-43af-852c-5496237ce165">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE3LTUtMS0xLTE0MDY0NQ_7fb15747-8bda-46a6-b695-fea0792c5333">2,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE4LTEtMS0xLTE0MDY0NQ_f58ba61f-06a9-46de-926c-766505b5b1e5">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE4LTMtMS0xLTE0MDY0NQ_43bdfb53-6c9f-4d27-bf8d-835d39540cbc">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE4LTUtMS0xLTE0MDY0NQ_79b422fd-82bc-46e3-9192-2e6920f8c373">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE5LTEtMS0xLTE0MDY0NQ_4145c1d9-c1c3-4ca4-9219-4ffe8a8c0657">32</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE5LTMtMS0xLTE0MDY0NQ_0850750e-1041-4091-b5bd-2deb13803e44">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE5LTUtMS0xLTE0MDY0NQ_be21cca6-47b2-4758-b7f7-9c9fb12625dc">71</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIwLTEtMS0xLTE0MDY0NQ_6b7b1320-8697-427c-ac82-219d53fc71da">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIwLTMtMS0xLTE0MDY0NQ_ed36bb85-6d3b-4cf9-8be5-62db430b45fa">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIwLTUtMS0xLTE0MDY0NQ_c5dd3a46-341c-41d1-bf28-03fca15a3d87">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIxLTEtMS0xLTE0MDY0NQ_23aafb7c-e889-4859-9c22-8e0ced93cb5e">4,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIxLTMtMS0xLTE0MDY0NQ_6044c6df-f9d9-4d82-a9dc-3af90500c655">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIxLTUtMS0xLTE0MDY0NQ_168e6218-f1e7-4d68-bbc3-5146055a8bc2">5,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of KAH Hospice, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI0LTEtMS0xLTE0MDY0NQ_02603e3e-0827-4732-856c-969fab06de5a">2,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI0LTMtMS0xLTE0MDY0NQ_afcbd236-89c6-4898-982e-0dcc8d797763">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI0LTUtMS0xLTE0MDY0NQ_c7f7e31a-7386-445b-972f-5ab8db15cb9e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquisitions, net of cash and cash equivalents acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTEtMS0xLTE0NjQ0NA_d8b684b4-212f-4270-83cd-8b87e0af9da8">337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTMtMS0xLTE0NjQ0NA_470b506f-ab3f-4822-8cc2-cbab09c83887">4,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTUtMS0xLTE0NjQ0NA_044c6b26-c050-4fab-8a7f-2d7645994571">709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI1LTEtMS0xLTE0MDY0NQ_3bc66ee6-cea7-4f93-ad37-b9a49f4762b4">1,120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI1LTMtMS0xLTE0MDY0NQ_5b413e19-d4bc-486c-8d8d-4d895e2a9d3e">1,316</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI1LTUtMS0xLTE0MDY0NQ_9d0f0953-848f-4c77-8410-b0ff97ae9176">964</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTEtMS0xLTE0MDY0NQ_d5e79914-743c-4491-b8b2-8fcec4572879">6,049</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTMtMS0xLTE0MDY0NQ_9053bc71-0ccb-4ed5-9e1e-0590fc4f2874">7,197</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTUtMS0xLTE0MDY0NQ_b363adeb-047d-4c6d-8a6a-86b95d45d696">9,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from maturities of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI3LTEtMS0xLTE0MDY0NQ_44f99c76-0942-4fdd-a52b-42c35cc6a3d3">1,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI3LTMtMS0xLTE0MDY0NQ_7c6eea45-faba-4ac3-ad3e-35c315999b1f">2,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI3LTUtMS0xLTE0MDY0NQ_dbba739c-cacb-4486-a148-fc43a5670160">4,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sales of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI4LTEtMS0xLTE0MDY0NQ_1130433f-964f-4d6e-83e8-f196634d1652">2,434</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI4LTMtMS0xLTE0MDY0NQ_f95e9541-4890-443f-ba8e-86fb2c78805f">3,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI4LTUtMS0xLTE0MDY0NQ_ca53c8db-663d-4bfd-adc5-69bf20d7d97b">2,747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI5LTEtMS0xLTE0MDY0NQ_20946dc0-1502-4a61-ad91-a36c5a1c5b06">1,006</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI5LTMtMS0xLTE0MDY0NQ_5292662c-0f86-457d-a9b0-4d862a651f38">6,556</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI5LTUtMS0xLTE0MDY0NQ_88dc5e52-c913-4291-9275-860de0e5b9fa">3,065</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Receipts (withdrawals) from contract deposits, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="hum:PaymentsForProceedsFromContractDeposits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMxLTEtMS0xLTE0MDY0NQ_b6e657df-49da-4838-8263-08dd4227b8c7">1,993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:PaymentsForProceedsFromContractDeposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMxLTMtMS0xLTE0MDY0NQ_4c3eabb7-de67-4395-b011-fb41ba2b1409">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:PaymentsForProceedsFromContractDeposits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMxLTUtMS0xLTE0MDY0NQ_c3fe09c0-fa82-4cfc-bdb5-ca4f4c0eb918">939</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMyLTEtMS0xLTE0MDY0NQ_2510890d-5dbe-4cfe-9931-483756fc8db6">1,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMyLTMtMS0xLTE0MDY0NQ_b69f8894-0c4d-4dcb-8798-5b427fa6a659">2,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMyLTUtMS0xLTE0MDY0NQ_afcc88e1-7dfd-4512-9c22-bd0ab83b8219">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMzLTEtMS0xLTE0MDY0NQ_449bc028-52b6-48f7-92f7-f080477ca2f7">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMzLTMtMS0xLTE0MDY0NQ_d8715c67-e5fb-4188-945e-5f9578316b54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMzLTUtMS0xLTE0MDY0NQ_2ed0d4c5-0cc7-4c58-8157-e0a0b18bda12">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Repayments) proceeds from issuance of commercial paper, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM0LTEtMS0xLTE0MDY0NQ_e47eda72-c323-4038-b338-a5ef2ad247ba">376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM0LTMtMS0xLTE0MDY0NQ_1555511f-70f8-448e-90ca-1daf3acc0e05">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM0LTUtMS0xLTE0MDY0NQ_03dd11d2-4bc3-4305-93c9-e37eeefac022">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM1LTEtMS0xLTE0MDY0NQ_1c50942d-15de-4fba-a10a-3b70f175c17b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM1LTMtMS0xLTE0MDY0NQ_150978ea-9861-4463-9154-d1bb4ccb8a72">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM1LTUtMS0xLTE0MDY0NQ_af690694-fc15-4d0a-87ee-2ad8d511849a">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM2LTEtMS0xLTE0MDY0NQ_8950bbcb-b664-4a86-ab93-16d0e08f7532">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM2LTMtMS0xLTE0MDY0NQ_72e8ff59-bd1c-47b9-9c0e-3ec53c5eaae2">2,078</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM2LTUtMS0xLTE0MDY0NQ_3d732164-03ac-4c72-8be9-c8cad29a349f">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Debt issue costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM3LTEtMS0xLTE0MDY0NQ_1028a237-d1ac-40d2-9e63-11b1011537cb">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM3LTMtMS0xLTE0MDY0NQ_4a8fb0ab-ad4d-4fa6-a7de-4f09614c20e8">31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM3LTUtMS0xLTE0MDY0NQ_d877d80f-21ab-41da-8926-f67312424d32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM4LTEtMS0xLTE0MDY0NQ_db6198b9-0dfa-4d15-9699-eef45bcaad26">2,096</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM4LTMtMS0xLTE0MDY0NQ_b484d14d-f626-4530-aee0-3243c21ba5ca">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM4LTUtMS0xLTE0MDY0NQ_c883edbc-f6f4-4ee7-a6f0-30ae785f1a9c">1,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM5LTEtMS0xLTE0MDY0NQ_1c9e401f-0051-466b-b898-3bcc7a8b9692">392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM5LTMtMS0xLTE0MDY0NQ_eb019a37-617e-4306-8faf-49d5c3a94cd2">354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM5LTUtMS0xLTE0MDY0NQ_561cbb14-5213-4bf9-b852-9e10c5f4b312">323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in book overdraft</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInBookOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQwLTEtMS0xLTE0MDY0NQ_dd151491-fde3-4dda-8d6b-b86d224c17ad">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncreaseDecreaseInBookOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQwLTMtMS0xLTE0MDY0NQ_59e4f463-5260-49ae-8c21-c7686ac57153">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInBookOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQwLTUtMS0xLTE0MDY0NQ_8f90a710-b9f3-4368-995a-75fa74c1233f">95</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQxLTEtMS0xLTE0MDY0NQ_90af5352-de76-40d2-ba49-8073618f55e9">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQxLTMtMS0xLTE0MDY0NQ_682f6c4a-2ff5-4ce2-8fdc-d1640af05a2a">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQxLTUtMS0xLTE0MDY0NQ_f6e930d3-2ca8-4da1-a1d3-721a8af8b0d4">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQyLTEtMS0xLTE0MDY0NQ_cf866aa1-e4fe-4362-8a69-5982553f984c">1,914</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQyLTMtMS0xLTE0MDY0NQ_2fda49a6-d6d3-4cdc-830f-c729ccae580f">3,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQyLTUtMS0xLTE0MDY0NQ_ad81d62f-eb68-4b6e-8564-7516d370fe92">1,955</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQzLTEtMS0xLTE0MDY0NQ_4181a926-96e5-4e14-8f0c-5a0a9621af78">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQzLTMtMS0xLTE0MDY0NQ_5491da10-faba-43ef-b2ce-2ddd6722d765">1,279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQzLTUtMS0xLTE0MDY0NQ_65c056ed-485c-4f46-a97a-1d8f50bfc44c">619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ0LTEtMS0xLTE0MDY0NQ_e51589e9-72a3-4105-9329-d6c4badf1239">3,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ0LTMtMS0xLTE0MDY0NQ_d96e9616-d3a6-44d6-94a0-b624746d061e">4,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ0LTUtMS0xLTE0MDY0NQ_22da40ac-2bcd-414c-b0d5-a3937ab44b16">4,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ1LTEtMS0xLTE0MDY0NQ_6921972c-bd02-4ebe-831d-933b5dc4e46c">5,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ1LTMtMS0xLTE0MDY0NQ_88a6a65c-2d31-4f2c-9125-59f1d477ab5d">3,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ1LTUtMS0xLTE0MDY0NQ_da5e4040-758a-41f0-bf6d-10a2db8defe3">4,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOW&#8212;(Continued)</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:62.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.636%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzMtMS0xLTEtMTQwNjQ1_51e23dd0-f0ac-42b8-9759-966fb01f26ba">354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzMtMy0xLTEtMTQwNjQ1_48eba089-a277-425f-bcf5-08ea390bf24b">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:InterestPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzMtNS0xLTEtMTQwNjQ1_2255a9d2-d5e0-4620-bd5b-5f5121c86de8">258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income tax payments, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzQtMS0xLTEtMTQwNjQ1_c246bc1a-21a1-4a05-81b3-f1351a26c0cc">758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzQtMy0xLTEtMTQwNjQ1_05246d52-b404-4224-befd-473429195004">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzQtNS0xLTEtMTQwNjQ1_9d50d5a2-a268-421a-bfc1-f7df461d9479">1,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Details of businesses acquired in purchase transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Fair value of assets acquired, net of cash acquired</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzYtMS0xLTEtMTQwNjQ1_342582d3-b2b3-48c3-bd63-2eef4129489f">460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzYtMy0xLTEtMTQwNjQ1_4a18ecbc-1b65-4bfe-8c93-b882990d3f6d">9,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzYtNS0xLTEtMTQwNjQ1_24290ea1-e92a-40ab-b3c1-05c517bbc6f0">819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Fair value of liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzctMS0xLTEtMTQwNjQ1_7beebb54-c45e-4304-a4db-ed7b585b4303">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:LiabilitiesAssumed1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzctMy0xLTEtMTQwNjQ1_65ccbcb1-d204-40b0-b2fc-3580f1ce915a">3,235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzctNS0xLTEtMTQwNjQ1_7609a3c9-8a8f-4cc3-9c00-5210998a8f15">110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Noncontrolling interests acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzgtMS0xLTEtMTQwNjQ1_ab071f60-84eb-4c0f-ab2b-d87c04a089a1">53</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzgtMy0xLTEtMTQwNjQ1_fb541667-2b7b-424c-bac9-b60cd36b9a25">22</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzgtNS0xLTEtMTQwNjQ1_3eb2a009-e4cf-4900-97b4-e7006d348a14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Less: Remeasured existing Kindred at Home equity method investment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzktMS0xLTEtMTQwNjQ1_3dd39881-dd5a-4c0a-ae5d-866dc453bb7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzktMy0xLTEtMTQwNjQ1_e7ba51b3-7cdc-42db-b5ef-acb83f4627cb">2,360</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzktNS0xLTEtMTQwNjQ1_0ea39e13-969c-46fb-807b-a87962eaa399">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid for acquired businesses, net of cash acquired</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzEwLTEtMS0xLTE0MDY0NQ_ed40aea1-c275-4f99-9999-a3f452a95268">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzEwLTMtMS0xLTE0MDY0NQ_975e90cb-4bda-40ae-854c-6829b5e19b82">4,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzEwLTUtMS0xLTE0MDY0NQ_0d8be365-f37e-4f73-b29f-e1e3243b793d">709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of the consolidated financial statements.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_142"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_145"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;<ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDUvZnJhZzplNmVjMmJkOWRkMDE0NjY3YmViYzZmMjUxOTVkYmFkNS90ZXh0cmVnaW9uOmU2ZWMyYmQ5ZGQwMTQ2NjdiZWJjNmYyNTE5NWRiYWQ1XzY4MQ_f9d91198-83d3-491d-bf1e-464ebc2cf392" continuedAt="iabe0b06341364301a1253d21d22fa4bd" escape="true">REPORTING ENTITY</ix:nonNumeric></span></div><ix:continuation id="iabe0b06341364301a1253d21d22fa4bd"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc., headquartered in Louisville, Kentucky, is a leading health and well-being company committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well&#8208;being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools, such as in&#8208;home care, behavioral health, pharmacy services, data analytics and wellness solutions, combine to produce a simplified experience that makes health care easier to navigate and more effective. References throughout these notes to consolidated financial statements to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; and &#8220;Humana,&#8221; mean Humana Inc. and its subsidiaries. We derived approximately <ix:nonFraction unitRef="number" contextRef="ie3ecfbb6c22b417ebc6482a6408f9cdb_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDUvZnJhZzplNmVjMmJkOWRkMDE0NjY3YmViYzZmMjUxOTVkYmFkNS90ZXh0cmVnaW9uOmU2ZWMyYmQ5ZGQwMTQ2NjdiZWJjNmYyNTE5NWRiYWQ1XzI4Mw_67944d94-d75a-4a09-b142-90d21a332476">82</ix:nonFraction>% of our total premiums and services revenue from contracts with the federal government in 2022, including <ix:nonFraction unitRef="number" contextRef="i9069595e8b1946288939814801ab0b92_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDUvZnJhZzplNmVjMmJkOWRkMDE0NjY3YmViYzZmMjUxOTVkYmFkNS90ZXh0cmVnaW9uOmU2ZWMyYmQ5ZGQwMTQ2NjdiZWJjNmYyNTE5NWRiYWQ1XzM4OQ_9bdd8b8a-f6a9-4eab-aa2f-d84441f544ed">14</ix:nonFraction>% related to our federal government contracts with the Centers for Medicare and Medicaid Services, or CMS, to provide health insurance coverage for individual Medicare Advantage members in Florida. CMS is the federal government&#8217;s agency responsible for administering the Medicare program.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Segment Realignment </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2022, we realigned our businesses into <ix:nonFraction unitRef="segment" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDUvZnJhZzplNmVjMmJkOWRkMDE0NjY3YmViYzZmMjUxOTVkYmFkNS90ZXh0cmVnaW9uOmU2ZWMyYmQ5ZGQwMTQ2NjdiZWJjNmYyNTE5NWRiYWQ1XzEwOTk1MTE2MzM4MTE_fc569758-264f-4c5c-84e6-dab652519dda">two</ix:nonFraction> distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period segment financial information has been recast to conform to the 2022 presentation. For a recast of prior period segment financial information, refer to Note 18 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_148"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;<ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzU5_86c71d64-e894-4634-89b0-62aec5a20a17" continuedAt="ia79ddf00a8b749d385a7f7779c82bd74" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="ia79ddf00a8b749d385a7f7779c82bd74" continuedAt="i42cec67cf9514fe3b2d87fe65515d4dd"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzE5_2929aaa2-4a3c-4d79-b038-b67d2b930e42" continuedAt="ie79bb48bf3fa4946a51fed34d306ad54" escape="true"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Our consolidated financial statements include the accounts of Humana Inc. and subsidiaries that the Company controls, including variable interest entities associated with medical practices for which we are the primary beneficiary. We do not own many of our medical practices but instead enter into exclusive management agreements with the affiliated Professional Associations, or P.A.s, that operate these medical practices. Based upon the provisions of these agreements, these affiliated P.A.s are variable interest entities and we are the primary beneficiary, and accordingly we consolidate the affiliated P.A.s. All significant intercompany balances and transactions have been eliminated.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based </span></div></ix:nonNumeric></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i42cec67cf9514fe3b2d87fe65515d4dd" continuedAt="i4a86b3f64cef43ce99e3ce543a964e8d"><ix:continuation id="ie79bb48bf3fa4946a51fed34d306ad54"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Creation Initiatives</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $<ix:nonFraction unitRef="usd" contextRef="icb9c2813455d48969d1c9c193176fa13_D20220101-20221231" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ5NDc4MDIzOTAzMzg_e56eed4c-1707-4185-b6f5-4cdfc441be93">473</ix:nonFraction>&#160;million included within operating costs in the consolidated statement of income for the year ended December 31, 2022. These charges primarily relate to $<ix:nonFraction unitRef="usd" contextRef="icb9c2813455d48969d1c9c193176fa13_D20220101-20221231" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzEwOTk1MTE2OTU3Nzk_5ab5b6d8-1f4e-4c2d-abe9-56938e983e45">248</ix:nonFraction>&#160;million in asset impairments, including software and abandonment, and $<ix:nonFraction unitRef="usd" contextRef="icb9c2813455d48969d1c9c193176fa13_D20220101-20221231" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ5NDc4MDIzOTA0ODg_565661b0-78bd-4b13-9705-42a09224bea3">116</ix:nonFraction>&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments.</span></div></ix:continuation><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The emergence and spread of the novel coronavirus, or COVID-19, beginning in the first quarter of 2020 has impacted our business. During periods of increased incidences of COVID-19, a reduction in non-COVID-19 hospital admissions for non-emergent and elective medical care have resulted in lower overall healthcare system utilization. At the same time, COVID-19 treatment and testing costs increased utilization. During 2022, we experienced lower overall utilization of the healthcare system than anticipated, as the reduction in COVID-19 utilization following the increased incidence associated with the Omicron variant outpaced the increase in non-COVID-19 utilization. The significant disruption in utilization during 2020 also impacted our ability to implement clinical initiatives to manage health care costs and chronic conditions of our members, and appropriately document their risk profiles, and, as such, significantly affected our 2021 revenue under the risk adjustment payment model for Medicare Advantage plans. Finally, changes in utilization patterns and actions taken in 2020 and 2021 as a result of the COVID-19 pandemic, including the suspension of certain financial recovery programs for a period of time and shifting the timing of claim payments and provider capitation surplus payments, impacted our claim reserve development and operating cash flows for 2020 and 2021.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:HealthCareReformPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1ODA0_0941f7e1-4d98-4461-af77-a90f2e90b7e0" continuedAt="iad1e550938e04adb9459b075f6b86645" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act and The Health Care and Education Reconciliation Act of 2010 (which we collectively refer to as the Health Care Reform Law) enacted significant reforms to various aspects of the U.S. health insurance industry. Certain of these reforms became effective January 1, 2014, including an annual insurance industry premium-based fee. The Continuing Resolution bill, H.R. 195, enacted on January 22, 2018, included a one year suspension in 2019 of the health insurance industry fee, but the fee resumed in calendar year 2020. The Further Consolidated Appropriations Act, 2020, enacted on December 20, 2019, permanently repealed the health insurance industry fee beginning in calendar year 2021. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iad1e550938e04adb9459b075f6b86645">The annual premium-based fee on health insurers was not deductible for tax purposes. We estimated a liability for the health insurance industry fee and recorded it in full once qualifying insurance coverage was provided in the applicable calendar year in which the fee was payable with a corresponding deferred cost that was amortized ratably to expense over the same calendar year. We recorded the liability for the health insurance industry fee in trade accounts payable and accrued expenses and recorded the deferred cost in other current assets in our consolidated financial statements. We paid the health insurance industry fee in September or October of each year.</ix:continuation> We paid the federal government $<ix:nonFraction unitRef="usd" contextRef="i3a4c2fcb56be4c3697d752d81e29b9d4_D20200101-20201231" decimals="-7" name="hum:PaymentOfAnnualHealthInsuranceIndustryFee" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQzNDI_7a30de11-2283-46c0-886b-cb2f8c7b3509">1.18</ix:nonFraction> billion for the annual health insurance industry fee attributed to calendar year 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2017, we filed suit against the United States of America in the United States Court of Federal Claims, on behalf of our health plans seeking recovery from the federal government of approximately $<ix:nonFraction unitRef="usd" contextRef="ic581aed5cfed42a7a2f64bd4ed501897_I20171102" decimals="-6" name="hum:GainContingencyRecoverySought" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ2MzU_d1178b40-e137-4cdd-a6ad-0296c27f2833">611</ix:nonFraction>&#160;million in payments under the risk corridor premium stabilization program established under Health Care Reform, for years 2014, 2015 and 2016. On April 27, 2020, the U.S. Supreme Court ruled that the government is obligated to pay the losses under this risk corridor program and that Congress did not implicitly repeal the obligation under its appropriations riders. In September 2020, we received a $<ix:nonFraction unitRef="usd" contextRef="i72beb26dbcd64e57a53b102d2216d4e3_D20200901-20200930" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzUwMzA_44e7f70c-8ca1-4d5d-93a0-44a27939f84d">609</ix:nonFraction>&#160;million payment from the U.S Government pursuant </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i4a86b3f64cef43ce99e3ce543a964e8d" continuedAt="ie04740e8607b4187933facf3f75da190"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the judgement issued by the Court of Federal Claims on July 7, 2020. The $<ix:nonFraction unitRef="usd" contextRef="ia736406081164b128479b1d1f0573b44_D20200101-20201231" decimals="-6" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzUxNTA_18ac6d19-3951-481f-be48-0f817dd94010">609</ix:nonFraction>&#160;million payment received from the U.S Government and approximately $<ix:nonFraction unitRef="usd" contextRef="ia736406081164b128479b1d1f0573b44_D20200101-20201231" decimals="-6" name="us-gaap:LitigationSettlementExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzUyMTI_a50940cf-b5f7-4ac2-92bd-4af5d765c7fc">31</ix:nonFraction>&#160;million in related fees and expenses are reflected in Premiums revenue and Operating costs, respectively, in our consolidated statements of income for the year ended December 31, 2020 and reported in the Corporate segment.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzEy_8419713f-9434-40ad-b654-9319f5853404" escape="true"><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash, time deposits, money market funds, commercial paper, other money market instruments, and certain U.S. Government securities with an original maturity of three months or less. Carrying value approximates fair value due to the short-term maturity of the investments.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:InvestmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzQz_45096bba-fd1c-49b6-8c0c-5642947071c9" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities, which consist of debt and equity securities, are stated at fair value. Our debt securities have been categorized as available for sale. Debt securities available for current operations, as well as our equity securities, are classified as current assets, and debt securities available to fund our professional and other self-insurance liability requirements, as well as restricted statutory deposits, are classified as long-term assets. For the purpose of determining realized gross gains and losses for debt securities sold, that are included as a component of investment income in the consolidated statements of income, the cost of investment securities sold is based upon specific identification. Unrealized holding gains and losses for debt securities, net of applicable deferred taxes, are included in other comprehensive income or loss as a component of stockholders&#8217; equity until realized from a sale or an expected credit loss is recognized. For the purpose of determining gross gains and losses for equity securities, changes in fair value at the reporting date are included as a component of investment income in the consolidated statements of income.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on January 1, 2020, we adopted the new current expected credit losses, or CECL, model which retained many similarities from the previous other-than-temporary impairment model except eliminating from consideration in the impairment analysis the length of time over which the fair value had been less than cost. Also, under the CECL model, expected losses on available for sale debt securities are recognized through an allowance for credit losses rather than as reductions in the amortized cost of the securities. For debt securities whose fair value is less than their amortized cost which we do not intend to sell or are not required to sell, we evaluate the expected cash flows to be received as compared to amortized cost and determine if an expected credit loss has occurred. In the event of an expected credit loss, only the amount of the impairment associated with the expected credit loss is recognized in income with the remainder, if any, of the loss recognized in other comprehensive income.  To the extent we have the intent to sell the debt security or it is more likely than not we will be required to sell the debt security before recovery of our amortized cost basis, we recognize an impairment loss in income in an amount equal to the full difference between the amortized cost basis and the fair value.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential expected credit loss impairment is considered using a variety of factors, including the extent to which the fair value has been less than cost; adverse conditions specifically related to the industry, geographic area or financial condition of the issuer or underlying collateral of a debt security; changes in the quality of the debt security's credit enhancement; payment structure of the debt security; changes in credit rating of the debt security by the rating agencies; failure of the issuer to make scheduled principal or interest payments on the debt security and changes in prepayment speeds. For debt securities, we take into account expectations of relevant market and economic data. For example, with respect to mortgage and asset-backed securities, such data includes underlying loan level data and structural features such as seniority and other forms of credit enhancements. We estimate the amount of the expected credit loss component of a debt security as the difference between the amortized cost and the present value of the expected cash flows of the security. The present value is determined using the best estimate of future cash flows discounted at the implicit interest rate at the date of purchase. The expected credit loss cannot exceed the full difference between the amortized cost basis and the fair value.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables and Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally establish <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:CommercialMembershipContractTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzU0OTc1NTg4ODc3Ng_6a6976a4-8085-4bd6-9291-d31fb67f1c99">one-year</ix:nonNumeric> commercial membership contracts with employer groups, subject to cancellation by the employer group on <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzk5NzI_c2fbb6c4-4621-4ac6-9dc9-9b384f23cfbe">30</ix:nonNumeric>-day written notice. Our Medicare contracts with CMS renew annually. </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="ie04740e8607b4187933facf3f75da190" continuedAt="i34abc2ce0cc54b93adb97b709cb46e57"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our military services contracts with the federal government and certain contracts with various state Medicaid programs generally are multi-year contracts subject to annual renewal provisions.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:InsurancePremiumsRevenueRecognitionPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzA4_cc23a6ee-17c1-412c-bfe7-21c11ef19576" continuedAt="i9e94c63c0a4c4a40829c49982a93a110" escape="true"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive monthly premiums from the federal government and various states according to government specified payment rates and various contractual terms. We bill and collect premium from employer groups and members in our Medicare and other individual products monthly.  Changes in premium revenues resulting from the periodic changes in risk-adjustment scores derived from medical diagnoses for our membership are estimated by projecting the ultimate annual premium and are recognized ratably during the year, with adjustments each period to reflect changes in the ultimate premium. Receivables or payables are classified as current or long-term in our consolidated balance sheet based on the timing of the expected settlement. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums revenue is estimated by multiplying the membership covered under the various contracts by the contractual rates. Premiums revenue is recognized as income in the period members are entitled to receive services and is net of estimated uncollectible amounts, retroactive membership adjustments, and adjustments to recognize rebates under the minimum benefit ratios required under the Health Care Reform Law. We estimate policyholder rebates by projecting calendar year minimum benefit ratios for the small group and large group markets, as defined by the Health Care Reform Law using a methodology prescribed by Health and Human Services, or HHS, separately by state and legal entity. Medicare Advantage and Medicaid products are also subject to minimum benefit ratio requirements. Estimated calendar year rebates recognized ratably during the year are revised each period to reflect current experience. Retroactive membership adjustments result from enrollment changes not yet processed, or not yet reported by an employer group or the government. We routinely monitor the collectability of specific accounts, the aging of receivables, historical retroactivity trends, estimated rebates, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. Premiums received prior to the service period are recorded as unearned revenues.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Part D</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with CMS. The payments we receive monthly from CMS and members, which are determined from our annual bid, represent amounts for providing prescription drug insurance coverage. We recognize premiums revenue for providing this insurance coverage ratably over the term of our annual contract. Our CMS payment is subject to risk sharing through the Medicare Part D risk corridor provisions. In addition, receipts for reinsurance and low-income cost subsidies as well as receipts for certain discounts on brand name prescription drugs in the coverage gap represent payments for prescription drug costs for which we are not at risk.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk corridor provisions compare costs targeted in our bids to actual prescription drug costs, limited to actual costs that would have been incurred under the standard coverage as defined by CMS. Variances exceeding certain thresholds may result in CMS making additional payments to us or require us to refund to CMS a portion of the premiums we received. As risk corridor provisions are considered in our overall annual bid process, we estimate and recognize an adjustment to premiums revenue related to these provisions based upon pharmacy claims experience. We record a receivable or payable at the contract level and classify the amount as current or long-term in our consolidated balance sheets based on the timing of expected settlement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance and low-income cost subsidies represent funding from CMS in connection with the Medicare Part D program for which we assume no risk. Reinsurance subsidies represent funding from CMS for its portion of prescription drug costs which exceed the member&#8217;s out-of-pocket threshold, or the catastrophic coverage level. Low-income cost subsidies represent funding from CMS for all or a portion of the deductible, the coinsurance and co-payment amounts above the out-of-pocket threshold for low-income beneficiaries. Monthly prospective payments from CMS for reinsurance and low-income cost subsidies are based on assumptions submitted with our annual bid. A reconciliation and related settlement of CMS&#8217;s prospective subsidies against actual prescription drug costs we paid is made after the end of the year. The Health Care Reform Law mandates consumer discounts of <ix:nonFraction unitRef="number" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="INF" name="hum:ConsumerDiscountsOnBrandNamePrescriptionDrugs" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE0NzM2_6390a0e7-9d4e-4a26-9e19-091b7f10d403">50</ix:nonFraction>% on brand name prescription drugs for Part D plan participants in the coverage gap. These discounts are funded by CMS and pharmaceutical manufacturers while we administer the application of these funds. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njc0_146aee57-dcc7-4739-81d7-6581b98c4f04" continuedAt="i42c8b09b824b44949e7c50865a5e53eb" escape="true">We account for these subsidies </ix:nonNumeric></span></div></ix:nonNumeric></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i34abc2ce0cc54b93adb97b709cb46e57" continuedAt="ie588262f2e644324a492d0d12f2ea34e"><ix:continuation id="i9e94c63c0a4c4a40829c49982a93a110"><ix:continuation id="i42c8b09b824b44949e7c50865a5e53eb" continuedAt="ic89f57ea24164e48b5baa830fe02026d"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and discounts as a deposit in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits, net in our consolidated statements of cash flows. </span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"></td><td style="width:56.896%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.472%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part D subsidy/discount payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:SubsidyAndDiscountPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzItMS0xLTEtMTQwNjQ1_ea0809a1-e667-4d63-ac56-2cd88f9274ef">16,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:SubsidyAndDiscountPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzItMy0xLTEtMTQwNjQ1_57f01452-05e8-4b8b-9268-aa713bfa7c34">14,889</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:SubsidyAndDiscountPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzItNS0xLTEtMTQwNjQ1_993a9342-4cb9-4239-83f1-7525a25f01ff">13,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part D subsidy/discount reimbursements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:SubsidyAndDiscountReimbursements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzMtMS0xLTEtMTQwNjQ1_e8919289-ed61-46dc-8cce-0c45b6604de3">18,498</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:SubsidyAndDiscountReimbursements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzMtMy0xLTEtMTQwNjQ1_9a4d2119-c6c2-4612-97af-c116daa6341a">14,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:SubsidyAndDiscountReimbursements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzMtNS0xLTEtMTQwNjQ1_461ec9e1-ed4d-4059-93c5-d8330c90f71a">12,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reimbursements (payments)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="hum:SubsidyAndDiscountPaymentsInExcessOfReimbursements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzQtMS0xLTEtMTQwNjQ1_87d4aa7e-19dc-4123-9fb5-6320ddb5272e">1,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:SubsidyAndDiscountPaymentsInExcessOfReimbursements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzQtMy0xLTEtMTQwNjQ1_8282da20-76f2-4fe8-954b-9c5517515025">261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:SubsidyAndDiscountPaymentsInExcessOfReimbursements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzQtNS0xLTEtMTQwNjQ1_249adc80-48dd-4b71-976d-81a3f4b91199">938</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not recognize premiums revenue or benefit expenses for these subsidies or discounts. Receipt and payment activity is accumulated at the contract level and recorded in our consolidated balance sheets in other current assets or trade accounts payable and accrued expenses depending on the contract balance at the end of the reporting period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlement of the reinsurance and low-income cost subsidies as well as the risk corridor payment is based on a reconciliation made approximately <ix:nonNumeric contextRef="i98b5cd0e14da45a2a65ccbb7b999b126_D20220101-20221231" name="hum:SubsidyAndDiscountsSettlementPeriodAfterClose" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE1NjU0_1a7025c2-0785-4f43-935e-fbfcb3fa141f">9</ix:nonNumeric> months after the close of each calendar year. Settlement with CMS for brand name prescription drug discounts is based on a reconciliation made approximately <ix:nonNumeric contextRef="id0a1f1c3b72a40b3b4bdbf0a7f076fe1_D20220101-20221231" name="hum:SubsidyAndDiscountsSettlementPeriodAfterClose" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE1ODE0_dabafcb3-3223-4fe1-92a6-f1e5054873f0">14</ix:nonNumeric> to <ix:nonNumeric contextRef="ie78f1bb938b8481f8841f9c8c53b4b44_D20220101-20221231" name="hum:SubsidyAndDiscountsSettlementPeriodAfterClose" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE1ODIw_1e1af58d-5a8a-4287-a891-7bf34a8f11ba">18</ix:nonNumeric> months after the close of each calendar year. We continue to revise our estimates with respect to the risk corridor provisions based on subsequent period pharmacy claims data. See Note 7 for detail regarding amounts recorded to our consolidated balance sheets related to the risk corridor settlement and subsidies from CMS with respect to the Medicare Part D program.</span></div></ix:continuation><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njc3_8dee89a8-cf1f-4cb2-a678-7e8ff8adab82" continuedAt="iebddb5fb9ddf4594954cb52adcd534d0" escape="true"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services Revenue</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient services revenue </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient services include services related to pharmacy, provider services, and home solutions services, such as home health and other services and capabilities to promote wellness and advance population health. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our pharmacy business, external pharmacy revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through our CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Services revenues related to product revenues from dispensing prescriptions are recorded when the prescription or product is shipped.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provider services business recognizes revenues for certain value-based arrangements. Under these value-based arrangements, we enter into agreements with health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our patients. In exchange, we receive a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our patients. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our home solutions businesses, revenues include net patient services revenue recorded based upon established billing rates, net of contractual allowances, discounts, or other implicit price concessions, and are recognized as performance obligations are satisfied, which is in the period services are rendered.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the&#160;year ended December&#160;31, 2022, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price), was not material. Further, revenue expected to be recognized in any future year related to remaining performance obligations is not material.</span></div></ix:nonNumeric></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="ie588262f2e644324a492d0d12f2ea34e" continuedAt="i7ed3bb94d6dd4259a050fc30065def18"><ix:continuation id="iebddb5fb9ddf4594954cb52adcd534d0"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Administrative services fees </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Administrative services fees cover the processing of claims, offering access to our provider networks and clinical programs, and responding to customer service inquiries from members of self-funded groups. Revenues from providing administration services, also known as administrative services only, or ASO, are recognized in the period services are performed and are net of estimated uncollectible amounts. ASO fees are estimated by multiplying the membership covered under the various contracts by the contractual rates. Under ASO contracts, self-funded employers retain the risk of financing substantially all of the cost of health benefits. However, many ASO customers purchase stop loss insurance coverage from us to cover catastrophic claims or to limit aggregate annual costs. Accordingly, we have recorded premiums revenue and benefits expense related to these stop loss insurance contracts. We routinely monitor the collectability of specific accounts, the aging of receivables, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. ASO fees received prior to the service period are recorded as unearned revenues.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under our TRICARE contracts with the Department of Defense (DoD) we provide administrative services, including offering access to our provider networks and clinical programs, claim processing, customer service, enrollment, and other services, while the federal government retains all of the risk of the cost of health benefits. We account for revenues under our contracts net of estimated health care costs similar to an administrative services fee only agreement. Our contracts include fixed administrative services fees and incentive fees and penalties. Administrative services fees are recognized as services are performed.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our TRICARE members are served by both in-network and out-of-network providers in accordance with our contracts. We pay health care costs related to these services to the providers and are subsequently reimbursed by the DoD for such payments. <ix:continuation id="ic89f57ea24164e48b5baa830fe02026d" continuedAt="if448b44e0acd453fa6386b2d9118c24e">We account for the payments of the federal government&#8217;s claims and the related reimbursements under deposit accounting in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits,net in our consolidated statements of cash flows.  </ix:continuation></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><ix:continuation id="if448b44e0acd453fa6386b2d9118c24e"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:56.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.448%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.448%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:HealthCareCostPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzItMS0xLTEtMTQwNjQ1_0f1bbaf8-0ecb-48a2-b282-ffe716c7c9c9">7,110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:HealthCareCostPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzItMy0xLTEtMTQwNjQ1_2dab1383-e870-464d-b5e7-6f5e8c6b42c6">6,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:HealthCareCostPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzItNS0xLTEtMTQwNjQ1_80338290-a4e1-41a4-92d2-d73e00996931">6,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost reimbursements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:HealthCareCostReimbursements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzMtMS0xLTEtMTQwNjQ1_b0d73e95-9b9b-44d6-8d8b-4e28ee604e17">7,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:HealthCareCostReimbursements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzMtMy0xLTEtMTQwNjQ1_e90af891-cbcd-4729-b959-ba71eb088953">6,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:HealthCareCostReimbursements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzMtNS0xLTEtMTQwNjQ1_16387a74-3b3f-4841-a48d-ccfdde82d57b">6,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reimbursements (payments)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="hum:HealthCareCostPaymentsAndReimbursementsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzQtMS0xLTEtMTQwNjQ1_390f31ba-3a91-4df7-8e5e-c83dfea8b21d">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:HealthCareCostPaymentsAndReimbursementsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzQtMy0xLTEtMTQwNjQ1_02c0fc5f-037f-4872-8186-bd6af0b2e3c5">45</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:HealthCareCostPaymentsAndReimbursementsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzQtNS0xLTEtMTQwNjQ1_880e8bc4-bc02-4387-9d29-e3a5757cbb0a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzIx_b972feb5-46b5-433e-83a2-ac51435e631a" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables, including premium receivables, patient services revenue receivables, and ASO fee receivables, are shown net of allowances for estimated uncollectible accounts, retroactive membership adjustments, and contractual allowances.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At&#160;December&#160;31, 2022 and 2021, accounts receivable related to services were $<ix:nonFraction unitRef="usd" contextRef="iea3fc08d0e0f43fe959d292fad010549_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE5OTE4_dde0769c-e976-4599-8bd5-55cd6c588d4f">291</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2987740b0cdb40188339b7acd6a0181b_I20211231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE5OTI1_937a10a9-b38f-4e4b-a17b-853cb2a2a080">475</ix:nonFraction> million, respectively. For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the consolidated balance sheet at&#160;December&#160;31, 2022 and 2021.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:OtherCurrentAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzMx_7bca4149-472c-4f4f-806d-baecb44cac2d" continuedAt="i9e064181388946038c1a5bd780e87e12" escape="true">Other Current Assets</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9e064181388946038c1a5bd780e87e12">Other current assets include amounts associated with Medicare Part D as discussed above and in Note 7, rebates due from pharmaceutical manufacturers and other amounts due within one year.  We accrue pharmaceutical rebates as they are earned based on contractual terms and usage of the product.</ix:continuation>  The balance of pharmaceutical rebates receivable was $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-8" name="hum:AccruedPharmaceuticalRebatesCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIwNTMz_1a6d164d-4892-4479-a6eb-647523216362"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-8" name="hum:AccruedPharmaceuticalRebatesCurrent" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIwNTMz_51d0d341-372c-4d9d-b4d3-7b312284798a">2.0</ix:nonFraction></ix:nonFraction> billion at December&#160;31, 2022 and 2021.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i7ed3bb94d6dd4259a050fc30065def18" continuedAt="i932a17fd766d4baea866ec4f73486af2"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:AcquisitionCostsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njk5_df384ad2-1662-472e-8a85-07747fcc6932" escape="true"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policy acquisition costs are those costs that relate directly to the successful acquisition of new and renewal insurance policies. Such costs include commissions, costs of policy issuance and underwriting, and other costs we incur to acquire new business or renew existing business. We expense policy acquisition costs related to our employer-group prepaid health services policies as incurred. These short-duration employer-group prepaid health services policies typically have a <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxMDc4_7f190590-3fe7-49ab-8f77-0c195759ddfa">1</ix:nonNumeric>-year term and may be canceled upon <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxMTE2_a429f53a-a59b-4759-be36-89b38f5b2036">30</ix:nonNumeric> days notice by the employer group.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzYx_c1b58500-ee16-4677-8ce2-818686c912cc" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is recorded at cost. Gains and losses on sales or disposals of property and equipment are included in operating costs in our consolidated income statements. Certain costs related to the development or purchase of internal-use software are capitalized. Depreciation is computed using the straight-line method over estimated useful lives ranging from <ix:nonNumeric contextRef="id079b2db40e84b14a641fb9b1eb51da6_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTA2_2d9c2163-164e-4b7c-8e1a-ee29cf1ef631">3</ix:nonNumeric> to <ix:nonNumeric contextRef="iaaab669d71af421191ca3584d7396347_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTEy_83e20e48-e9dc-4ac8-8bee-386d102cedc2">10</ix:nonNumeric> years for equipment, <ix:nonNumeric contextRef="i60d881bff54b49609993a08aa88212dd_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTM2_206d08f5-67be-4bea-aa76-160399f645fe">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i05e6d98d428a4d49940ae089d750047d_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTQy_c0bed5cb-027c-44bb-aefe-2ec592501ef9">5</ix:nonNumeric> years for computer software, and <ix:nonNumeric contextRef="i864645f1e72a4441a86287765a3dae2b_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTc4_cc26ce59-6ffd-4f18-baac-d86a5feafec6">10</ix:nonNumeric> to <ix:nonNumeric contextRef="i44ae02ca45e24424b2e1bd6d8003c7bb_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTg0_d0a01556-c5d1-427d-9179-7feafb75550e">20</ix:nonNumeric> years for buildings. Improvements to leased facilities are depreciated over the shorter of the remaining lease term or the anticipated life of the improvement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review long-lived assets, including property and equipment and other definite-lived intangible assets, for impairment whenever adverse events or changes in circumstances indicate the carrying value of the asset may not be recoverable. Losses are recognized for a long-lived asset to be held and used in our operations when the undiscounted future cash flows expected to result from the use of the asset are less than its carrying value. We recognize an impairment loss based on the excess of the carrying value over the fair value of the asset. A long-lived asset held for sale is reported at the lower of the carrying amount or fair value less costs to sell. Depreciation expense is not recognized on assets held for sale. Losses are recognized for a long-lived asset to be abandoned when the asset ceases to be used. In addition, we periodically review the estimated lives of all long-lived assets for reasonableness.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzUy_c904d8db-5755-4aa2-a2cc-3ddee02df6e0" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the equity method of accounting for equity investments in companies where we are able to exercise significant influence, but not control, over operating and financial policies of the investee. Judgment regarding the level of influence over each equity method investment includes considering key factors such as our ownership interest, representation on the board of directors, organizational structure, participation in policy-making decisions and material intra-entity transactions.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by our share of equity in income or losses after the date of acquisition as well as capital contributions to and distributions from these companies. Our proportionate share of the net income or loss of these companies is included in consolidated net income.  Investment amounts in excess of our share of an investee&#8217;s net assets are amortized over the life of the related asset creating the excess. Excess goodwill is not amortized. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by us when reviewing an equity method investment for impairment include the length of time (duration) and the extent (severity) to which the fair value of the equity method investment has been less than carrying value, the investee&#8217;s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than-temporary is recognized in the period identified.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional detail regarding our equity method investments is included in Note 4.</span></div><div style="text-indent:18pt"><span><br/></span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzE0_fb98743b-e45a-4730-973e-0b754c7a7a84" continuedAt="i671218d102394e079d163343d5289a92" escape="true"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the unamortized excess of cost over the fair value of the net tangible and other intangible assets acquired. We are required to test at least annually for impairment at a level of reporting referred to as the </span></div></ix:nonNumeric></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i932a17fd766d4baea866ec4f73486af2" continuedAt="i7290ece457744e3e8a39b6799fee7f6f"><ix:continuation id="i671218d102394e079d163343d5289a92"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. A reporting unit either is our operating segments or one level below the operating segments, referred to as a component, which comprise our reportable segments. A component is considered a reporting unit if the component constitutes a business for which discrete financial information is available that is regularly reviewed by management. We aggregate the components of an operating segment into one reporting unit if they have similar economic characteristics. Goodwill is assigned to the reporting units that are expected to benefit from the specific synergies of the business combination.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform a quantitative assessment to review goodwill for impairment to determine both the existence and amount of goodwill impairment, if any. Impairment tests are performed, at a minimum, in the fourth quarter of each year supported by our long-range business plan and annual planning process. We rely on an evaluation of future discounted cash flows to determine fair value of our reporting units. The fair value of our reporting units with significant goodwill exceeded carrying amounts. However, unfavorable changes in key assumptions or combinations of assumptions including a significant increase in the discount rate, decrease in the long-term growth rate or substantial reduction in our underlying cash flow assumptions, including revenue growth rates, medical and operating cost trends, and projected operating income could have a significant negative impact on the estimated fair value of our home solutions and provider reporting units, which accounted for $<ix:nonFraction unitRef="usd" contextRef="ieab9cc19ff1c48b3834f6647ccd0c104_I20221231" decimals="-8" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NDgw_22614c68-3ad3-47fe-9b38-8877567c0fac">4.3</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i95a27ca7ed954826900c752a38aa4c67_I20221231" decimals="-8" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NDg3_e0bd15db-185a-4595-bd07-5dfbf4399d30">1.1</ix:nonFraction>&#160;billion of goodwill, respectively. Impairment tests completed for 2022, 2021, and 2020 did <ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NTY3_322dfa71-fc7e-45f2-940a-34169a0f4b19"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NTY3_64a6ce7f-cd93-4da5-91e6-45ac85481f0b"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NTY3_dd8b7b55-acbe-41a2-87a2-eb79e83aad8f">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t result in an impairment loss. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with indefinite lives relate to Certificate of Needs (CON) and Medicare licenses acquired as part of our acquisition of Kindred at Home, or KAH, and are included within other long-term assets in the consolidated balance sheet at December&#160;31, 2022 and December&#160;31, 2021. See Note 3 for further information. We are required to annually compare the fair values of other indefinite-lived intangible assets to their carrying amounts. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized. Fair values of indefinite-lived intangible assets are determined based on the income approach. Impairment tests completed for 2022 did not result in a material impairment loss. These charges reflect the amount by which the carrying value exceeded its estimated fair value. Impairment tests completed for 2021 did not result in an impairment loss. The fair values of the assets were measured using Level 3 inputs, such as projected revenues and operating cash flows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible assets primarily relate to acquired customer contracts/relationships and are included with other long-term assets in the consolidated balance sheets. Definite-lived intangible assets are amortized over the useful life generally using the straight-line method. We review definite-lived intangible assets for impairment under our long-lived asset policy.</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njgw_74c7fd3a-25b2-453e-a260-d3546785f79a" continuedAt="i8b880a31013942feac4a74042f30facc" escape="true"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefits Payable and Benefits Expense Recognition</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits expense includes claim payments, capitation payments, pharmacy costs net of rebates, allocations of certain centralized expenses and various other costs incurred to provide health insurance coverage to members, as well as estimates of future payments to hospitals and others for medical care and other supplemental benefits provided on or prior to the balance sheet date. Capitation payments represent monthly contractual fees disbursed to primary care and other providers who are responsible for providing medical care to members. Pharmacy costs represent payments for members&#8217; prescription drug benefits, net of rebates from drug manufacturers. Receivables for such pharmacy rebates are included in other current assets in our consolidated balance sheets. Other supplemental benefits include dental, vision, and other supplemental health products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the costs of our benefits expense payments using actuarial methods and assumptions based upon claim payment patterns, medical cost inflation, historical developments such as claim inventory levels and claim receipt patterns, and other relevant factors, and record benefit reserves for future payments. We continually review estimates of future payments relating to claims costs for services incurred in the current and prior periods and make necessary adjustments to our reserves.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i7290ece457744e3e8a39b6799fee7f6f" continuedAt="i73d9aa25dd49479da446ed7f931d3c06"><ix:continuation id="i8b880a31013942feac4a74042f30facc" continuedAt="i86f7e524a4ef48a1ac973893ea0089b1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits expense is recognized in the period in which services are provided and includes an estimate of the cost of services which have been incurred but not yet reported, or IBNR. Our reserving practice is to consistently recognize the actuarial best point estimate within a level of confidence required by actuarial standards. Actuarial standards of practice generally require a level of confidence such that the liabilities established for IBNR have a greater probability of being adequate versus being insufficient, or such that the liabilities established for IBNR are sufficient to cover obligations under an assumption of moderately adverse conditions. Adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of the estimate. Therefore, in many situations, the claim amounts ultimately settled will be less than the estimate that satisfies the actuarial standards of practice.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop our estimate for IBNR using actuarial methodologies and assumptions, primarily based upon historical claim experience. Depending on the period for which incurred claims are estimated, we apply a different method in determining our estimate. For periods prior to the most recent two months, a completion factor method uses historical paid claims patterns to estimate the percentage of claims incurred during a given period that have historically been adjudicated as of the reporting period. Changes in claim inventory levels and known changes in claim payment processes are taken into account in these estimates. For the most recent two months, the incurred claims are estimated primarily from a trend analysis based upon per member per month claims trends developed from our historical experience in the preceding months, adjusted for known changes in estimates of hospital admissions, recent hospital and drug utilization data, provider contracting changes, changes in benefit levels, changes in member cost sharing, changes in medical management processes, product mix, and workday seasonality.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completion factor method is used for the months of incurred claims prior to the most recent two months because the historical percentage of claims processed for those months is at a level sufficient to produce a consistently reliable result. Conversely, for the most recent two months of incurred claims, the volume of claims processed historically is not at a level sufficient to produce a reliable result, which therefore requires us to examine historical trend patterns as the primary method of evaluation. Changes in claim processes, including recoveries of overpayments, receipt cycle times, claim inventory levels, outsourcing, system conversions, and processing disruptions due to weather or other events affect views regarding the reasonable choice of completion factors. Claim payments to providers for services rendered are often net of overpayment recoveries for claims paid previously, as contractually allowed. Claim overpayment recoveries can result from many different factors, including retroactive enrollment activity, audits of provider billings, and/or payment errors. Changes in patterns of claim overpayment recoveries can be unpredictable and result in completion factor volatility, as they often impact older dates of service. The receipt cycle time measures the average length of time between when a medical claim was initially incurred and when the claim form was received. Increases in electronic claim submissions from providers decrease the receipt cycle time. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claim may be more (less) complete than originally estimated using our completion factors, which may result in reserves that are higher (lower) than required.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical cost trends potentially are more volatile than other segments of the economy. The drivers of medical cost trends include increases in the utilization of hospital facilities, physician services, new higher priced technologies and medical procedures, and new prescription drugs and therapies, as well as the inflationary effect on the cost per unit of each of these expense components. Other external factors such as government-mandated benefits or other regulatory changes, the tort liability system, increases in medical services capacity, direct to consumer advertising for prescription drugs and medical services, an aging population, lifestyle changes including diet and smoking, catastrophes, public health emergencies, epidemics and pandemics (such as the spread of COVID-19) also may impact medical cost trends. Internal factors such as system conversions, claims processing cycle times, changes in medical management practices and changes in provider contracts also may impact our ability to accurately predict estimates of historical completion factors or medical cost trends. All of these factors are considered in estimating IBNR and in estimating the per member per month claims trend for purposes of determining the reserve for the most recent two months. Additionally, we continually prepare and review follow-up studies to assess the reasonableness of the estimates generated by our process and methods over time. The results of these studies are also considered in determining the reserve for the most recent two months. Each of these factors requires significant judgment by management.</span></div></ix:continuation></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i73d9aa25dd49479da446ed7f931d3c06" continuedAt="i44c9571970054bdc82ee4b0d6a62edf1"><ix:continuation id="i86f7e524a4ef48a1ac973893ea0089b1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reassess the profitability of our contracts for providing insurance coverage to our members when current operating results or forecasts indicate probable future losses. We establish a premium deficiency reserve in current operations to the extent that the sum of expected future costs, claim adjustment expenses, and maintenance costs exceeds related future premiums under contracts without consideration of investment income. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with our method of acquiring, servicing, and measuring the profitability of such contracts. Losses recognized as a premium deficiency result in a beneficial effect in subsequent periods as operating losses under these contracts are charged to the liability previously established. Because the majority of our member contracts renew annually, we would not record a material premium deficiency reserve, except when unanticipated adverse events or changes in circumstances indicate otherwise.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our benefits payable are adequate to cover future claims payments required. However, such estimates are based on knowledge of current events and anticipated future events. Therefore, the actual liability could differ materially from the amounts provided.</span></div></ix:continuation><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njky_a8e49135-b779-40b1-bb99-3a4c0c23f9c7" escape="true"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future policy benefits payable</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits payable includes liabilities for long-duration insurance policies primarily related to certain blocks of insurance assumed in acquisitions, primarily life and annuities in run-off status, and are included in our consolidated balance sheet within other long-term liabilities. Most of these policies are subject to reinsurance as detailed in Note 19.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:BookOverdraftPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzU3_4dbc6414-8fac-4454-84ec-628598919d9d" escape="true"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Book Overdraft</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our cash management system, checks issued but not yet presented to banks that would result in negative bank balances when presented are classified as a current liability in the consolidated balance sheets. Changes in book overdrafts from period to period are reported in the consolidated statement of cash flows as a financing activity.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzM1_94bb9113-2c5a-4860-a38e-d79f2053a92a" escape="true"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize an asset or liability for the deferred tax consequences of temporary differences between the tax bases of assets or liabilities and their reported amounts in the consolidated financial statements. These temporary differences will result in taxable or deductible amounts in future years when the reported amounts of the assets or liabilities are recovered or settled. We also recognize the future tax benefits such as net operating and capital loss carryforwards as deferred tax assets. A valuation allowance is provided against these deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. Future years&#8217; tax expense may be increased or decreased by adjustments to the valuation allowance or to the estimated accrual for income taxes. Deferred tax assets and deferred tax liabilities are further adjusted for changes in the enacted tax rates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record tax benefits when it is more likely than not that the tax return position taken with respect to a particular transaction will be sustained. A liability, if recorded, is not considered resolved until the statute of limitations for the relevant taxing authority to examine and challenge the tax position has expired, or the tax position is ultimately settled through examination, negotiation, or litigation. We classify interest and penalties associated with uncertain tax positions in our provision for income taxes.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:NoncontrollingInterestsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzQ1_b6861f7c-1d66-474a-8c5a-e5035d1fa654" continuedAt="i87c42d1058874d99850933eb0c4c6d65" escape="true"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned affiliates that we control. Accordingly, we record noncontrolling interests in the earnings and equity of such entities. We record adjustments to noncontrolling interests for the allocable portion of income or loss to which the noncontrolling interest holders are entitled based upon their portion of the subsidiaries they own. Distributions to holders of noncontrolling interests are adjusted to the respective noncontrolling interest holders&#8217; balances. Noncontrolling interests, which relate to the minority ownership held by third party investors in certain of our businesses within our Insurance and CenterWell segments, are reported below net income under the heading &#8220;Net </span></div></ix:nonNumeric></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i44c9571970054bdc82ee4b0d6a62edf1" continuedAt="ibf04558608684af099ba287fe0450deb"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i87c42d1058874d99850933eb0c4c6d65">income attributable to noncontrolling interests&#8221; in the consolidated statements of income and presented as a component of equity in the consolidated balance sheets.</ix:continuation></span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzY4_76f7bc2b-60c2-4db1-a605-cf9a1e96f901" continuedAt="i104d991984e44e528df2371acb4feb68" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i104d991984e44e528df2371acb4feb68">We generally recognize stock-based compensation expense, as determined on the date of grant at fair value, on a straight-line basis over the period during which an employee is required to provide service in exchange for the award (the vesting period). In addition, for awards with both time and performance-based conditions, we generally recognize compensation expense on a straight line basis over the vesting period when it is probable that the performance condition will be achieved. We estimate expected forfeitures and recognize compensation expense only for those awards which are expected to vest. We estimate the grant-date fair value of stock options using the Black-Scholes option-pricing model.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Additional detail regarding our stock-based compensation plans is included in Note 14.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Nzcy_aa909cd9-d294-4419-8731-98b76e2fdacd" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute basic earnings per common share on the basis of the weighted-average number of unrestricted common shares outstanding. Diluted earnings per common share is computed on the basis of the weighted-average number of unrestricted common shares outstanding plus the dilutive effect of outstanding employee stock options and restricted shares, or units, using the treasury stock method.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional detail regarding earnings per common share is included in Note 15.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Nzky_4185a05a-5501-42dd-a516-1abaef139330" continuedAt="ia811738d67634d55ad7cb6eec80df4e4" escape="true"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value are categorized into a fair value hierarchy based on whether the inputs to valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our own assumptions about the assumptions market participants would use. The fair value hierarchy includes three levels of inputs that may be used to measure fair value as described below.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8211; Quoted prices in active markets for identical assets or liabilities. Level 1 assets and liabilities include securities that are traded in an active exchange market.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8211; Observable inputs other than Level 1 prices such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments as well as debt securities whose value is determined using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8211; Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes assets and liabilities whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting our own assumptions about the assumptions market participants would use as well as those requiring significant management judgment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of actively traded debt and equity securities are based on quoted market prices. Fair value of other debt securities are based on quoted market prices of identical or similar securities or based on observable inputs like interest rates generally using a market valuation approach, or, less frequently, an income valuation approach and are generally classified as Level 2. Fair value of privately held investment grade debt securities are estimated using a variety of valuation methodologies, including both market and income approaches, where an observable quoted market does not exist and are generally classified as Level 3. For privately-held investment grade debt securities, such methodologies include reviewing the value ascribed to the most recent financing, comparing the security with </span></div></ix:nonNumeric></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="ibf04558608684af099ba287fe0450deb"><ix:continuation id="ia811738d67634d55ad7cb6eec80df4e4"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities of publicly-traded companies in similar lines of business with similar credit characteristics, and reviewing the underlying financial performance including estimating discounted cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain at least one price for each security from a third party pricing service. These prices are generally derived from recently reported trades for identical or similar securities, including adjustments through the reporting date based upon observable market information. When quoted prices are not available, the third party pricing service may use quoted market prices of comparable securities or discounted cash flow analysis, incorporating inputs that are currently observable in the markets for similar securities. Inputs that are often used in the valuation methodologies include benchmark yields, reported trades, credit spreads, broker quotes, default rates, and prepayment speeds. We are responsible for the determination of fair value and as such we perform analysis on the prices received from the third party pricing service to determine whether the prices are reasonable estimates of fair value. Our analysis includes a review of monthly price fluctuations as well as a quarterly comparison of the prices received from the pricing service to prices reported by our third party investment adviser. In addition, on a quarterly basis we examine the underlying inputs and assumptions for a sample of individual securities across asset classes, credit rating levels, and various durations.</span></div></ix:continuation><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Nzk3_a6f50b24-c3af-4ec5-8510-a469b1d18a29" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Pronouncements Effective in Future Periods</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#8212;Insurance (Topic 944): Effective Date and Early Application (&#8220;ASU 2020-11&#8221;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#8212;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#8220;ASU 2018-12&#8221;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare supplement product which represent less than <ix:nonFraction unitRef="number" contextRef="i19ce21448fc64f32b2239d5bd098448e_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ5NDc4MDIzODE1MDY_2ae47c25-0d9e-4420-834a-de61bb16b256">1</ix:nonFraction>% of consolidated premiums and services revenue, is effective for us beginning with annual and interim periods in 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position and cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_151"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;<ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzM1NDU_9f65faeb-5464-48ba-bacf-cff95f9e8314" continuedAt="i9934727b9e2449e1be47cd028d4c4b01" escape="true">ACQUISITIONS AND DIVESTITURES</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i9934727b9e2449e1be47cd028d4c4b01" continuedAt="i51e0a1a7953e4e9c9f2d72fa9806277b">&#160;&#160;&#160;&#160;</ix:continuation></span></div><ix:continuation id="i51e0a1a7953e4e9c9f2d72fa9806277b" continuedAt="idfec1b1519774bf19a8cb0f837cbbbcd"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;11, 2022, we completed the sale of a <ix:nonFraction unitRef="number" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="2" name="hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcwOTk_c756b1d8-c781-41eb-8bd2-2b9120596953">60</ix:nonFraction>% i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest in Humana&#8217;s Kindred at Home Hospice subsidiary, or KAH Hospice, to Clayton, Dubilier &amp; Rice, or CD&amp;R, for cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-8" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcxMTQ_4f820175-8e78-4cd2-89c9-3adee45482d3">2.7</ix:nonFraction>&#160;billion, net of cash disposed, including debt repayments from KAH Hospice to Humana of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ib2a53b141d0e477195c76cb94f076fd4_D20220811-20220811" decimals="-8" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcxMzM_39c98a3a-9d3c-4f1b-966b-4efc01a5483f">1.9</ix:nonFraction>&#160;billion. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale, we recognized a pre-tax gain, net of transaction costs, of $<ix:nonFraction unitRef="usd" contextRef="i94ffd24e1fbd46079ca060beb77c46db_D20220811-20220811" decimals="-6" name="us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcxNTE_237d02d7-3e0a-48a1-82fc-f16fcd6d62d5">237</ix:nonFraction>&#160;million which is reported as a gain on sale of KAH Hospice in the accompanying consolidated statement of income for the year ended December 31, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we classified KAH Hospice as held-for-sale and aggregated KAH Hospice&#8217;s assets and liabilities separately on the balance sheet. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzM1NTE_aedc3816-53ca-4990-be16-dc90e0041212" continuedAt="i652a96fd89ba4c73835e512bd79fff62" escape="true">The assets, liabilities and noncontrolling interest disposed of on August 11, 2022 were as follows:</ix:nonNumeric></span></div><div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:18pt"><ix:continuation id="i652a96fd89ba4c73835e512bd79fff62" continuedAt="i53e1a8ecc79a4731818223d6d547732c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:77.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.928%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzMtMS0xLTEtMTQwNjQ1_fbe24630-bf0b-4d33-95d4-7f23b6d04587">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Receivables, net of allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzQtMS0xLTEtMTQwNjQ1_b654f778-329c-4895-ab14-4fb8c60757a4">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzUtMS0xLTEtMTQwNjQ1_af981fd3-2f8c-40e1-b1f1-bc9cf67e87bf">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzYtMS0xLTEtMTQwNjQ1_2cb5aae3-6f71-4891-b2f5-f45bb39390b2">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzctMS0xLTEtMTQwNjQ1_85ab34fa-534e-42c6-8658-019f780445ea">2,331</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzgtMS0xLTEtMTQwNjQ1_b3b8b7f3-19f0-4ef4-b6cb-8ce03167ee0c">960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzktMS0xLTEtMTQwNjQ1_016fc087-96de-4b55-a6f7-18ccaae19faf">3,622</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trade accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzEyLTEtMS0xLTE0MDY0NQ_c4d60101-c890-45c7-8135-8b0acdff5773">245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzEzLTEtMS0xLTE0MDY0NQ_61d573a1-70ee-4138-b76a-c517ca24c2dd">285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzE0LTEtMS0xLTE0MDY0NQ_5248c77c-5256-495b-96b8-56f1a4b11731">530</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Noncontrolling interest</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="-6" name="hum:DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzE1LTEtMS0xLTE0MDY0NQ_71384338-876b-47e2-8b5b-0a379ee64ce5">11</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets included $<ix:nonFraction unitRef="usd" contextRef="i82bf2d71677045cb89ab8202ad71abfb_I20220811" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcxNjk_70074dce-92d1-4fd3-b9c4-c68e871a8022">866</ix:nonFraction>&#160;million identifiable intangibles consisting of Medicare licenses and CON. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the sale of a <ix:nonFraction unitRef="number" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="2" name="hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzE2NDkyNjc0NTE0MDk_28c3a965-7ef2-432e-b6de-425d0bd2dac8">60</ix:nonFraction>% interest in KAH Hospice on August 11, 2022, as discussed above, KAH Hospice revenues and pretax earnings through the date of sale for the year ended December 31, 2022, were $<ix:nonFraction unitRef="usd" contextRef="i52e9445cef15459ca1a4443266fda6db_D20220101-20221231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc1ODk_daba424c-47e3-4dd1-aeeb-199682d9de08">958</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i52e9445cef15459ca1a4443266fda6db_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2MDg_3c26d981-9e32-477d-941b-0b9755c05a18">150</ix:nonFraction>&#160;million, respectively. KAH Hospice revenues and pretax earnings for the year ended December 31, 2021, were $<ix:nonFraction unitRef="usd" contextRef="i794c5dbf39734709be53637e3659df79_D20210101-20211231" decimals="-6" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDgzODA_dde182d1-4a0e-4bb3-a1bd-8ddc6551b56e">582</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i794c5dbf39734709be53637e3659df79_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDgzOTk_c5feacc0-ddf1-4328-adad-cff653dad633">113</ix:nonFraction>&#160;million, respectively. </span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="idfec1b1519774bf19a8cb0f837cbbbcd"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2021, we acquired the remaining <ix:nonFraction unitRef="number" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="2" name="hum:BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2MTk_374435a9-fae6-4fc2-9f2f-fa3906460b84">60</ix:nonFraction>% interest in Kindred at Home, or KAH, the nation&#8217;s largest home health and hospice provider, from TPG Capital, or TPG, and Welsh, Carson, Anderson &amp; Stowe, or WCAS, two private equity funds, for an enterprise value of $<ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-8" name="hum:BusinessCombinationTotalEnterpriseValueOfAcquiree" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2Nzg_8d8b4f03-e7f0-4403-8d6e-2c37ad44e81f">8.2</ix:nonFraction>&#160;billion, which included our equity value of $<ix:nonFraction unitRef="usd" contextRef="i5fe4d9a70fd54514aadcf5bc01daa43c_D20210817-20210817" decimals="-8" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2NDE_2224fb3f-b470-4ab1-976b-d9d0cce942b0">2.4</ix:nonFraction>&#160;billion associated with our <ix:nonFraction unitRef="number" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2MjU_72a1d562-addf-41ff-8b82-7c445b0ef3b5">40</ix:nonFraction>% minority ownership interest. The remeasurement to fair value of our previously held <ix:nonFraction unitRef="number" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgyMzY1MA_85ddb747-8877-4396-b12b-6945ef976a28">40</ix:nonFraction>% equity method investment with a carrying value of approximately $<ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-8" name="us-gaap:EquityMethodInvestments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDgxNDc_17a5fabd-c5f5-4cc1-a38c-a325a65de6ab">1.3</ix:nonFraction>&#160;billion, resulted in a $<ix:nonFraction unitRef="usd" contextRef="i5fe4d9a70fd54514aadcf5bc01daa43c_D20210817-20210817" decimals="-8" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDgxNjE_9b5d40d2-12be-40ab-8772-c263de3f6401">1.1</ix:nonFraction>&#160;billion gain recognized in "Other (income) expense, net". We paid the approximate $<ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-8" name="hum:BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2NjA_25928038-7ced-46fa-92a8-db9a68b1b7a1">5.8</ix:nonFraction>&#160;billion transaction price (net of our existing equity stake) through a combination of debt financing, the assumption of existing KAH indebtedness and parent company cash. <ix:continuation id="i53e1a8ecc79a4731818223d6d547732c" continuedAt="i7a736685d55b4a4da792c05ae0fdb05a">The final fair values of KAH&#8217;s assets acquired and liabilities assumed at the date of the acquisition are summarized as follows: </ix:continuation></span></div><div style="text-align:center;text-indent:18pt"><ix:continuation id="i7a736685d55b4a4da792c05ae0fdb05a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:77.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzItMS0xLTEtMTcxMDYx_691f8dc2-76a4-437b-94bd-b406aec15bce">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzMtMS0xLTEtMTcxMDYx_2f662173-7164-48c9-92a6-0261e080822d">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzQtMS0xLTEtMTcxMDYx_24908e55-a679-486b-806c-dd144a2a266e">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzUtMS0xLTEtMTcxMDYx_d2c110f3-c3f3-43bb-b59d-14f8843b7d86">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzYtMS0xLTEtMTcxMDYx_aea30be0-61ec-470f-8556-038f06cb0fbe">5,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzctMS0xLTEtMTcxMDYx_a46f6d5f-7c8e-4554-a590-e9a546b93fe8">2,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzgtMS0xLTEtMTcxMDYx_336fc025-0a31-4f98-8734-fc68fe18d613">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzktMS0xLTEtMTcxMDYx_a30952ac-5578-4252-98fd-31a155bb06da">9,049</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzEwLTEtMS0xLTE3MTA2MQ_b9f7db20-5c07-4f27-8abe-69add61d5ea4">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzExLTEtMS0xLTE3MTA2MQ_c84c20c1-a423-4124-91a8-f462e9000621">2,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzEyLTEtMS0xLTE3MTA2MQ_fd19ef82-e4fc-4b12-804f-6915267cdbe1">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzEzLTEtMS0xLTE3MTA2MQ_79a77574-6605-4cb5-91c6-d165fda9bc21">2,857</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzE0LTEtMS0xLTE3MTA2MQ_8f8971f8-4907-4e1f-b5eb-9b7cf3ee7460">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"><ix:nonFraction unitRef="usd" contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzE1LTEtMS0xLTE3MTA2MQ_2cb7ea0b-6ded-42c6-913f-9134787b8dfc">6,170</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021, and 2020 we acquired other health and wellness related businesses which other than the impacts to goodwill, individually or in the aggregate, have not had a material impact on our results of operations, financial condition, or cash flows.  The results of operations and financial condition of these businesses have been included in our consolidated statements of income and consolidated balance sheets from the respective acquisition dates. Acquisition-related costs recognized in each of 2022, 2021 and 2020 were not material to our results of operations. For asset acquisitions the goodwill acquired is partially amortizable as deductible expenses for tax purposes. The pro forma financial information assuming the acquisitions had occurred as of the beginning of the calendar year prior to the year of acquisition, as well as the revenues and earnings generated during the year of acquisition, were not material for disclosure purposes.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_154"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzE1MTU_3b4b9e21-b8a4-421e-96dc-651104192bfb" continuedAt="ia4bed4849ebf4daa8a1c75c585196830" escape="true">EQUITY METHOD INVESTMENT</ix:nonNumeric></span></div><ix:continuation id="ia4bed4849ebf4daa8a1c75c585196830"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to our acquisition of KAH in August 2021, we accounted for our <ix:nonFraction unitRef="number" contextRef="i6e64b83f1ebc4e4c9cef19a100effeb3_I20210731" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzEwMg_ab48440f-0152-4f45-9248-97b34c19c814">40</ix:nonFraction>%&#160;investment in KAH using the equity method of accounting. Our share of income or loss was reported as equity in net (losses) earnings in our consolidated statements of income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We completed the sale of a <ix:nonFraction unitRef="number" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="2" name="hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzYwNDczMTM5NTUxNzc_25014b72-24e6-4175-bc76-f24cbcb284c3">60</ix:nonFraction>% interest in KAH Hospice on August 11, 2022 and account for our <ix:nonFraction unitRef="number" contextRef="i48a47654fd0f48f7903a22655de0905d_I20220811" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzYwNDczMTM5NTUxNzI_73ad91f0-2f9f-402f-bc80-4cf71f9f6d0e">40</ix:nonFraction>% minority ownership in hospice operations using the equity method of accounting. This investment was reflected in equity method investments in our December&#160;31, 2022 consolidated balance sheet, with our share of income or loss reported as equity in net (losses) earnings in our consolidated statements of income.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzE1MTY_712977a2-5ddb-4d7e-8615-34a1edefb634" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized balance sheet at December&#160;31, 2022 and statement of income for the period beginning August 11, 2022 through December&#160;31, 2022 of KAH Hospice were as follows:</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:77.195%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.605%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance sheet</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzMtMS0xLTEtMTQwNjQ1_d73d8de9-7209-40e4-a7fa-bf0915205e9d">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231" decimals="-6" name="us-gaap:AssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzQtMS0xLTEtMTQwNjQ1_cc85f1b8-329a-47bd-b0a8-89b4f8bfa793">3,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzUtMS0xLTEtMTQwNjQ1_99fac544-a3dc-4a76-b1d0-1ecea647595f">269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231" decimals="-6" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzYtMS0xLTEtMTQwNjQ1_3e356bf8-9e3d-4fa2-8113-91c939fee29d">2,219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzctMS0xLTEtMTQwNjQ1_246e2098-1c93-4ecd-aeab-3e62a281fe8d">1,386</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:76.516%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.284%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statements of income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">August 11, 2022 through December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9f8031ffe444ed9b9343359a58376a4_D20220811-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTo3OGEyYWIxMTVmY2Y0MjExOTg4NjdkZWNhOTUzMjFlNC90YWJsZXJhbmdlOjc4YTJhYjExNWZjZjQyMTE5ODg2N2RlY2E5NTMyMWU0XzMtMS0xLTEtMTQwNjQ1_b5588568-fdf2-4dc8-be47-b7f62427118e">654</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9f8031ffe444ed9b9343359a58376a4_D20220811-20221231" decimals="-6" name="hum:Expenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTo3OGEyYWIxMTVmY2Y0MjExOTg4NjdkZWNhOTUzMjFlNC90YWJsZXJhbmdlOjc4YTJhYjExNWZjZjQyMTE5ODg2N2RlY2E5NTMyMWU0XzQtMS0xLTEtMTQwNjQ1_9865694a-aaba-4fc4-9dfc-6c86d166fcd5">652</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9f8031ffe444ed9b9343359a58376a4_D20220811-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTo3OGEyYWIxMTVmY2Y0MjExOTg4NjdkZWNhOTUzMjFlNC90YWJsZXJhbmdlOjc4YTJhYjExNWZjZjQyMTE5ODg2N2RlY2E5NTMyMWU0XzUtMS0xLTEtMTQwNjQ1_54798a56-4469-45f8-a6e1-cb39d6adbcf1">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other insignificant equity method investments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our Primary Care Organization entered into a strategic partnership with Welsh, Carson, Anderson &amp; Stowe, or WCAS, to accelerate the expansion of our primary care model. In May 2022, we established a second strategic partnership with WCAS to develop additional centers between 2023 and 2025. As of December 31, 2022, there were <ix:nonFraction unitRef="primary_care_center" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="hum:StrategicPartnershipAgreementNumberOfPrimaryCareCenters" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzE1MTg_691497a8-ff91-485b-bd65-b892d37dd60b">50</ix:nonFraction> primary care clinics operating under the partnership and we intend to open approximately <ix:nonFraction unitRef="primary_care_center" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-2" name="hum:StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzU0OTc1NTgxNjgzMw_b46c2f01-2a32-4bbb-8193-63c16f3f1ca2">100</ix:nonFraction> additional primary clinics in future periods under the existing arrangements. In addition, the agreements include a series of put and call options through which WCAS may require us to purchase their interest in the entity, and through which we may acquire WCAS&#8217;s interest, over the next <ix:nonNumeric contextRef="i0243358af036489b9db890af0f19a8da_D20220101-20221231" name="hum:StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzExMzk_901c4b2e-3c55-472c-a111-bffab5466546">3</ix:nonNumeric> to <ix:nonNumeric contextRef="i0243358af036489b9db890af0f19a8da_D20220101-20221231" name="hum:StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzExNDU_5c1e9d1a-1b33-4efd-b535-375747df5f29">10</ix:nonNumeric> years. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have several individually immaterial equity method investments, including our strategic partnership with WCAS as described above, included within equity method investments in our consolidated balance sheets as of December&#160;31, 2022 and 2021 with our share of income or loss reported as equity in net (losses) earnings in our consolidated statements of income for the years ended December&#160;31, 2022, 2021 and 2020.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_157"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NjM_5609063f-ddd2-40ce-89ba-364e8e726ae7" continuedAt="i7f0ce85ffddb4e64897f8002373c5ed1" escape="true">INVESTMENT SECURITIES</ix:nonNumeric></span></div><ix:continuation id="i7f0ce85ffddb4e64897f8002373c5ed1" continuedAt="i9a2835e6edad4b5497ab081a0a830154"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NzQ_6d0f3ead-ff20-4257-9cc9-e509182b6a31" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities classified as current and long-term were as follows at December&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.682%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.646%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzQtMS0xLTEtMTQwNjQ1_c9ab489f-781f-4927-8572-6d84075e0bbd">1,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzQtMy0xLTEtMTQwNjQ1_d4f39191-7a09-4c9c-9cf2-c7c60579e6d5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzQtNS0xLTEtMTQwNjQ1_0b4fdadb-0ecd-4c7a-a4df-77e85621af91">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzQtNy0xLTEtMTQwNjQ1_5406f91f-af31-40ed-b5d9-0ce48c3ff85a">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzUtMS0xLTEtMTQwNjQ1_ffebd72f-956d-4583-8fff-be2c6b31a25e">3,697</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzUtMy0xLTEtMTQwNjQ1_fba65c13-9021-4a97-bce2-b231b509dc10">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzUtNS0xLTEtMTQwNjQ1_83ae9a47-cccd-4e3d-adff-432bc17472f7">471</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzUtNy0xLTEtMTQwNjQ1_ca3efaed-999d-4508-9331-d153cd9ff8c2">3,230</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzYtMS0xLTEtMTQwNjQ1_1c0f013f-e728-467c-babf-b199fa1e954b">765</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzYtMy0xLTEtMTQwNjQ1_2f784d7b-74cd-47a0-bc79-5736642ca676">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzYtNS0xLTEtMTQwNjQ1_4960d612-8e3c-4753-8a44-5cf277053073">37</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzYtNy0xLTEtMTQwNjQ1_11c23e40-45f2-4d0d-8a79-fc867f3478a4">728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzgtMS0xLTEtMTQwNjQ1_6613a384-7eea-4308-8eb4-26ee138c734b">477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzgtMy0xLTEtMTQwNjQ1_9833cfc2-af85-4497-8532-f484dc3e3f6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzgtNS0xLTEtMTQwNjQ1_7db52900-ed42-405c-8d9b-766ae4f44e37">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzgtNy0xLTEtMTQwNjQ1_389ba8eb-151d-4656-b7d3-822959fb833d">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzktMS0xLTEtMTQwNjQ1_9f644d14-e1de-4136-b4b0-de482ec75f95">1,554</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzktMy0xLTEtMTQwNjQ1_a6f2c8f1-8693-4215-962f-e272fc35cdd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzktNS0xLTEtMTQwNjQ1_2f8f8cd0-9e37-4d20-bc22-d73698b7145d">155</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzktNy0xLTEtMTQwNjQ1_7c98ee82-5ba5-4657-b200-4093ef8c6798">1,399</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEwLTEtMS0xLTE0MDY0NQ_ad16fa5e-1bd2-4fc8-b6d7-bcadd88dfd9f">1,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEwLTMtMS0xLTE0MDY0NQ_847fe47b-5715-4407-8f0f-c8fbeec40908">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEwLTUtMS0xLTE0MDY0NQ_e89ea7c8-4188-4c2e-a1f8-2f78c0d8da91">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEwLTctMS0xLTE0MDY0NQ_d222b815-71bf-46d1-a917-ee4d72eabdfd">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzExLTEtMS0xLTE0MDY0NQ_384a7252-e101-42b7-b2d7-4b2d6a153122">6,551</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzExLTMtMS0xLTE0MDY0NQ_4545accb-cf0e-4e2c-945a-d1b2ba58a128">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzExLTUtMS0xLTE0MDY0NQ_26cef62c-96b3-4c55-bb6e-c7fcbba43461">828</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzExLTctMS0xLTE0MDY0NQ_daec43a4-de5d-4252-97fb-156e8d15b815">5,726</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEyLTEtMS0xLTE0MDY0NQ_34097d16-d634-4d32-b496-188cece81072">15,946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEyLTMtMS0xLTE0MDY0NQ_c67e49d8-b2dd-4aae-8215-17fbc8400f74">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEyLTUtMS0xLTE0MDY0NQ_466e7414-f7c3-4f40-9082-475520f2550e">1,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEyLTctMS0xLTE0MDY0NQ_7a00fe7f-7db7-4095-ad06-70a9eacd3b41">14,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEzLTctMS0xLTE0MDY0NQ_a6bd8984-38c8-47ac-9b06-3694cca067d0">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE0LTctMS0xLTE0MDY0NQ_64e3d230-d6a0-42bf-8b81-1ead1f0fd048">14,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE4LTEtMS0xLTE0MDY0NQ_3976eefd-c046-4d41-b915-535cceb28ba0">611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE4LTMtMS0xLTE0MDY0NQ_98d6ae3d-f6b4-4c55-a271-0c2a011aa51b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE4LTUtMS0xLTE0MDY0NQ_a2cdeecd-54ec-419f-9fe5-927efcda9562">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE4LTctMS0xLTE0MDY0NQ_5c8586c9-b85e-4429-8b4d-ca1340163d46">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE5LTEtMS0xLTE0MDY0NQ_6de8e300-33e8-42f3-be1a-6e02d9e8ef39">3,265</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE5LTMtMS0xLTE0MDY0NQ_4d4969e1-540e-4e12-afcf-3dc38806a118">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE5LTUtMS0xLTE0MDY0NQ_ffcbfd06-a5a2-4b13-bdbc-ca12aa41db01">69</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE5LTctMS0xLTE0MDY0NQ_b8d3d80e-1bb7-4cbd-9174-ede30dc8f55a">3,229</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIwLTEtMS0xLTE0MDY0NQ_533945fe-1642-455e-9462-5236d749aff6">810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIwLTMtMS0xLTE0MDY0NQ_140afe13-0761-4f70-9b5e-5ceba45310a5">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIwLTUtMS0xLTE0MDY0NQ_8482038e-ad37-436a-81c5-b842f5b8dbb5">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIwLTctMS0xLTE0MDY0NQ_061197bc-4786-4bea-ad6f-f6306c9ed510">841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIyLTEtMS0xLTE0MDY0NQ_2b654f6f-ce18-403e-b966-7eb4d35ee44d">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIyLTMtMS0xLTE0MDY0NQ_900e2b12-2fc9-4416-b11a-35f730a611c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIyLTUtMS0xLTE0MDY0NQ_dc9a48e0-de0b-40ed-849a-2d660b30389a">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIyLTctMS0xLTE0MDY0NQ_b345a574-30de-45c7-b041-c68275ac2968">367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIzLTEtMS0xLTE0MDY0NQ_4eb2c3e3-4c8c-45d4-86ea-bc4b1cc2c90d">1,394</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIzLTMtMS0xLTE0MDY0NQ_65e81f61-6d2f-4bcd-bec3-6f8ce2dd3ecf">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIzLTUtMS0xLTE0MDY0NQ_fc8bc481-e4b6-465c-a9e6-c1a428fd5ed7">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIzLTctMS0xLTE0MDY0NQ_82e8530c-9bc1-497d-8425-97d6a6149c16">1,410</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI0LTEtMS0xLTE0MDY0NQ_3f1a15db-3053-40bb-9031-4e0bf4307fa1">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI0LTMtMS0xLTE0MDY0NQ_8ced1b86-4922-4a7e-a3b6-13df161b0373">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI0LTUtMS0xLTE0MDY0NQ_adaa990d-09ad-4f00-9a5e-653372c99c13">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI0LTctMS0xLTE0MDY0NQ_58c96d0a-beb1-4201-8dd1-d9a074a73dd2">1,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI1LTEtMS0xLTE0MDY0NQ_48386707-99a9-44cd-b43a-c95c7006c8ea">5,641</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI1LTMtMS0xLTE0MDY0NQ_d0afd6b0-26f0-40bb-83e2-0d53a91842a2">118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI1LTUtMS0xLTE0MDY0NQ_bc8cf12f-9e82-4578-a67c-f8e6c8bf41c2">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI1LTctMS0xLTE0MDY0NQ_b3c5f50e-f59f-47e7-843c-25eb9999fdf7">5,700</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI2LTEtMS0xLTE0MDY0NQ_0cff8a83-f67f-47cc-91a4-b8ef5b6e9538">13,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI2LTMtMS0xLTE0MDY0NQ_2660407b-5414-4879-b3fa-66c352835256">218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI2LTUtMS0xLTE0MDY0NQ_eddf0c38-71e6-4770-a5bf-626ff10827af">161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI2LTctMS0xLTE0MDY0NQ_1334c2c9-7a5e-4da5-b2e9-4a555b279dcc">13,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI3LTctMS0xLTE0MDY0NQ_c1ce9645-2567-4af5-868f-daad5f65ff58">475</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:Investments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI4LTctMS0xLTE0MDY0NQ_073b9db9-a885-4a13-a701-5089a87bbab6">13,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i9a2835e6edad4b5497ab081a0a830154" continuedAt="iaa636e8bd1ba4ee4b26a3ef343bc6e64"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we purchased certain corporate debt securities of KAH Hospice subsequent to the sale. The book value and fair value are $<ix:nonFraction unitRef="usd" contextRef="ief49b2992b1d4ac9b764f4b88eede797_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzQ5NDc4MDIzMjgxMjY_16608549-c888-4dbc-a5a6-bebf5fed4973">280</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ief49b2992b1d4ac9b764f4b88eede797_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzQ5NDc4MDIzMjgxMzg_b606114a-feff-4fd8-9e5a-923b38506a64">278</ix:nonFraction>&#160;million, respectively, at December&#160;31, 2022.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NDk_415b5630-45f5-4b9d-858f-dab692dfa3b1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross unrealized losses and fair values aggregated by investment category and length of time that individual debt securities have been in a continuous unrealized loss position were as follows at December&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:37.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.519%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;months</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or more</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr style="height:15pt"><td colspan="36" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtMS0xLTEtMTQwNjQ1_a87095d4-6e0f-4298-af80-f1b49e91fbbd">512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtMy0xLTEtMTQwNjQ1_e1ae9589-8c9e-47e7-abd2-18107d3858ac">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtNS0xLTEtMTQwNjQ1_17054f42-81ed-4a99-b1da-55d9ca47c8d4">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtNy0xLTEtMTQwNjQ1_a4e068a0-d0fc-475b-92ea-aa26ab9b5bc6">50</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtOS0xLTEtMTQwNjQ1_c0964066-0859-413c-83b6-06e04f08ddc3">909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtMTEtMS0xLTE0MDY0NQ_19108de6-0908-4db1-9bbe-fdcee443a1c9">55</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctMS0xLTEtMTQwNjQ1_c3ec1d22-a062-442a-aa2f-cf87952e73b7">1,231</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctMy0xLTEtMTQwNjQ1_d588e035-3422-4f71-9c40-08f80f85e1d4">104</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctNS0xLTEtMTQwNjQ1_e0120f1a-53bd-444e-bbce-e6975cfd74ac">1,683</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctNy0xLTEtMTQwNjQ1_66714f7b-4de7-4ad7-827f-d8a891226f78">367</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctOS0xLTEtMTQwNjQ1_a0ea1852-369d-4f49-ab57-3d4d2fd09262">2,914</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctMTEtMS0xLTE0MDY0NQ_f7829647-c188-4465-a5e8-d62214241c3a">471</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtMS0xLTEtMTQwNjQ1_e038e8a5-949f-4598-ba27-eadd076f8693">64</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtMy0xLTEtMTQwNjQ1_1b5e8352-ce1f-4afe-a6a0-421f83b164e5">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtNS0xLTEtMTQwNjQ1_55047f71-c8d9-4312-847e-adaa860f1a03">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtNy0xLTEtMTQwNjQ1_6426e09b-92a4-4d1e-8323-334c0826988e">36</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtOS0xLTEtMTQwNjQ1_f0045dcb-abf6-4527-8aa6-f6931294c519">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0c91010e34245c3976100a5e9202503_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtMTEtMS0xLTE0MDY0NQ_fc5d144f-d18c-4a57-984f-84ff4d788a77">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTEtMS0xLTE0MDY0NQ_50fd2c76-3b2e-4995-829d-0202f70ffc4f">124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTMtMS0xLTE0MDY0NQ_93bd87b8-c0cf-4b66-b950-e2f8c2d7a735">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTUtMS0xLTE0MDY0NQ_72cd2574-4c2e-48ca-a168-691f41b4e5c7">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTctMS0xLTE0MDY0NQ_02f126ac-4fad-4490-8d11-c6563dc6ecdb">60</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTktMS0xLTE0MDY0NQ_9a3d7fa7-013d-4299-997f-d2e74b524ad2">398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTExLTEtMS0xNDA2NDU_750f1e98-64fb-4a76-978a-da15145fa813">76</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTEtMS0xLTE0MDY0NQ_b4b6b198-30ee-4171-bd6f-62be77f3f472">243</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTMtMS0xLTE0MDY0NQ_0ff65881-5081-4b39-b2ac-20b311a1abc1">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTUtMS0xLTE0MDY0NQ_05d67e04-4157-4a27-bf3b-38a9df8cb035">1,157</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTctMS0xLTE0MDY0NQ_123e3ead-8c54-4d21-9573-ddc453aa5288">142</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTktMS0xLTE0MDY0NQ_17e01de7-8778-4073-b30c-c6f1224f60a3">1,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTExLTEtMS0xNDA2NDU_589a4705-8f0d-419d-88f5-fe743cfd5606">155</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTEtMS0xLTE0MDY0NQ_720563a4-ff4a-4624-ae3d-ff8f56a255f3">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTMtMS0xLTE0MDY0NQ_4ed708df-ed16-4dab-9cf5-6da690a56878">32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTUtMS0xLTE0MDY0NQ_8de8a8d5-fd23-4e49-8ccd-4e539e658537">1,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTctMS0xLTE0MDY0NQ_a90ab2be-fbfd-4b72-9d41-c06d525fdbf1">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTktMS0xLTE0MDY0NQ_d4b4e42c-9e1f-4847-9e05-e703274ba77b">1,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i11cd665f1547467c8350d08512260dd4_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTExLTEtMS0xNDA2NDU_538ba83b-f9fe-472e-a7c5-21214827b349">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTEtMS0xLTE0MDY0NQ_b6707394-8794-4f7c-a809-e97ae2ddb0cf">1,625</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTMtMS0xLTE0MDY0NQ_312d0bbb-7198-4f6d-bc3b-7d046b385466">98</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTUtMS0xLTE0MDY0NQ_5fa2f02c-1ad3-4f3a-8d6f-94b1be649c93">3,825</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTctMS0xLTE0MDY0NQ_a92eed41-bb7b-427d-88f3-9577766973d4">730</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTktMS0xLTE0MDY0NQ_0f08d9f9-965b-43e8-815a-6b9066189612">5,450</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTExLTEtMS0xNDA2NDU_aa7d1157-c650-4c59-b012-460afafd2a37">828</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTEtMS0xLTE0MDY0NQ_75f46767-dd05-4816-9f29-aaa1f06a879a">4,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTMtMS0xLTE0MDY0NQ_c237b567-c7a6-4cb5-807c-46492c97a759">270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTUtMS0xLTE0MDY0NQ_59094af3-b211-429f-aa18-50cfbed8125c">8,962</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTctMS0xLTE0MDY0NQ_6dbcfc2a-7129-44af-9ad9-4f31e0db9b0b">1,431</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTktMS0xLTE0MDY0NQ_8caf9b3b-fed8-4ed9-ada8-19a96d18583e">13,381</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTExLTEtMS0xNDA2NDU_5f19c42a-97e4-4ec8-b504-dc0bcad11e50">1,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTEtMS0xLTE0MDY0NQ_7899e82b-9cc6-4b69-b200-c5de1a2b3d3c">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTMtMS0xLTE0MDY0NQ_9c5b7a6d-fcab-4688-9825-b56e8cfbcfbd">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTUtMS0xLTE0MDY0NQ_dd7bc15f-ee1d-4c26-b026-2dd00901544b">355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTctMS0xLTE0MDY0NQ_b863e612-9410-4256-84d3-93e69342f274">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTktMS0xLTE0MDY0NQ_2b1ac615-e0b5-4f5a-baae-beb31e2615ba">556</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTExLTEtMS0xNDA2NDU_be3d5367-28c5-427c-b646-56ec927f9820">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTEtMS0xLTE0MDY0NQ_b2204c4d-5ca0-4113-9fc7-53d78d00ce20">2,082</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTMtMS0xLTE0MDY0NQ_6152099c-a922-44f0-a002-05107c5ebd7c">49</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTUtMS0xLTE0MDY0NQ_b2f64951-955f-4f2f-a61d-675636fe0d09">556</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTctMS0xLTE0MDY0NQ_d900543f-b03e-4a65-964c-3e2c8c7488d6">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTktMS0xLTE0MDY0NQ_c40dd92b-11aa-48ed-aecf-b502b8f92fb1">2,638</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i126217602c624f2ebda161c66e36c104_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTExLTEtMS0xNDA2NDU_ce997ae4-46d2-4c40-8cf6-81a98a820389">69</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTEtMS0xLTE0MDY0NQ_d6ec8af4-facd-4c6b-8905-2bf4e06dbd39">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTMtMS0xLTE0MDY0NQ_f4eb559c-1b90-4002-a2d4-5784225605cd">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTUtMS0xLTE0MDY0NQ_b9be14ea-b2ab-4247-8d4f-6b854e449195">34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTctMS0xLTE0MDY0NQ_67f6aae3-13cc-4197-a9d2-bc3a38089709">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTktMS0xLTE0MDY0NQ_d0aa870d-a972-4153-a6a6-f13dd2e2390c">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16730b092e6c42b38643174820335d57_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTExLTEtMS0xNDA2NDU_41c7fdaf-86f0-45db-9211-c8af5099caf7">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTEtMS0xLTE0MDY0NQ_bd0c165f-50a2-4125-bedd-0468be80f26a">358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTMtMS0xLTE0MDY0NQ_55759c9c-015e-434e-933b-c872dee4595a">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTUtMS0xLTE0MDY0NQ_e4c2fa77-626f-434d-9310-ab4641e75f82">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTctMS0xLTE0MDY0NQ_05aa07a1-3882-4e20-9e9b-87002fea171a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTktMS0xLTE0MDY0NQ_a898ef93-4ae9-486f-9e3b-6fbe72c7fa63">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTExLTEtMS0xNDA2NDU_6f6bde2e-875c-4879-a150-8cd2eaee63bb">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTEtMS0xLTE0MDY0NQ_0f826b9c-4dee-44d0-b38e-ad37392a0130">295</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTMtMS0xLTE0MDY0NQ_213ede8e-3b6c-43c3-97c0-c5442e26e0be">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTUtMS0xLTE0MDY0NQ_e1ef4f64-af8e-4e12-9efe-fceb577ac85d">400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTctMS0xLTE0MDY0NQ_1737928b-1b8e-4ee0-8804-cdbe8f6047ed">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTktMS0xLTE0MDY0NQ_02e42a91-c6fc-446f-99ba-70fd9b64e9d8">695</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTExLTEtMS0xNDA2NDU_9482feb6-0787-4cc1-933c-df7eaa7c68b6">11</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTEtMS0xLTE0MDY0NQ_54c4444a-f97e-4021-ada3-d8818945a28d">530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTMtMS0xLTE0MDY0NQ_9d8608e1-396f-441d-adee-6b46ca0621a2">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTUtMS0xLTE0MDY0NQ_e324f996-20c5-4c1d-9ceb-227c616e25bf">425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTctMS0xLTE0MDY0NQ_d4fad434-61ea-410c-852c-567ffe0c3798">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTktMS0xLTE0MDY0NQ_7cd95409-0c33-42e3-ae8a-499c83b875fe">955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia1df5272756d4e92b091873e633f3429_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTExLTEtMS0xNDA2NDU_3f609aff-29d4-4be0-b124-98fad26f07cd">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTEtMS0xLTE0MDY0NQ_0e98c390-4b3d-49a9-905e-4d37444e83d7">1,456</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTMtMS0xLTE0MDY0NQ_11136c0e-89a8-4228-85ea-ea6d45211e86">28</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTUtMS0xLTE0MDY0NQ_5c118a76-a79c-46dc-8dfc-00547a878075">769</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTctMS0xLTE0MDY0NQ_8fa917f8-32df-4e17-8b3c-32a538276fe2">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTktMS0xLTE0MDY0NQ_b5947b0c-b465-4527-8e76-748c240a33f6">2,225</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i58cabae69b214817826771be532892eb_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTExLTEtMS0xNDA2NDU_50772802-7ca0-4aae-8215-b053e9bb6f70">59</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTEtMS0xLTE0MDY0NQ_f0f2a964-6e9d-42c7-8de7-85e072356922">4,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTMtMS0xLTE0MDY0NQ_66de0f7d-a20e-40d8-9296-236fa49d0aa5">94</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTUtMS0xLTE0MDY0NQ_8c78fd36-258e-4b29-977c-2ac3468f537a">2,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTctMS0xLTE0MDY0NQ_2eeb8270-dd92-48f3-99d8-95d566f591c4">67</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTktMS0xLTE0MDY0NQ_94e35c33-ca38-40d6-b844-fa394c79a006">7,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTExLTEtMS0xNDA2NDU_d0b6e0aa-7e88-4d8a-aef1-d5a903d1b5db">161</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately <ix:nonFraction unitRef="number" contextRef="i35b2694e329a46c09a0bc95ee97db01c_I20221231" decimals="2" name="hum:PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzM3MQ_ede6fd32-57b3-4dd7-a316-0031f8095a71">96</ix:nonFraction>% of our debt securities were investment-grade quality, with a weighted average credit rating of AA- by S&amp;P at December&#160;31, 2022. Most of the debt securities that were below investment-grade were rated BB-, the higher end of the below investment-grade rating scale. Tax-exempt municipal securities were diversified among general obligation bonds of states and local municipalities in the United States as well as special revenue bonds issued by municipalities to finance specific public works projects such as utilities, water and sewer, transportation, or education. Our general obligation bonds are diversified across the United States with no individual state exceeding <ix:nonFraction unitRef="number" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="2" name="hum:MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzEwMjg_19212b6c-cfbc-4afe-adab-badbb41bfcf7">1</ix:nonFraction>% of our total debt securities. Our investment policy limits investments in a single issuer and requires diversification among various asset types. &#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unrealized loss from all debt securities was generated from approximately <ix:nonFraction unitRef="position" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="0" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzEyNTc_277b8f14-6c65-4eb5-91ab-226699519947">1,625</ix:nonFraction> positions out of a total of approximately <ix:nonFraction unitRef="position" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="0" name="hum:DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzEzMDI_522886f4-c0bc-40a1-96d2-28be3a59ac95">1,710</ix:nonFraction> positions at December&#160;31, 2022. All issuers of debt securities we own that were trading at an </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="iaa636e8bd1ba4ee4b26a3ef343bc6e64"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unrealized loss at December&#160;31, 2022 remain current on all contractual payments. After taking into account these and other factors previously described, we believe these unrealized losses primarily were caused by an increase in market interest rates in the current markets since the time the debt securities were purchased. At December&#160;31, 2022, we did not intend to sell any debt securities with an unrealized loss position in accumulated other comprehensive income, and it is not likely that we will be required to sell these debt securities before recovery of their amortized cost basis. Additionally, we did not record any material credit allowances for debt securities that were in an unrealized loss position at December&#160;31, 2022, 2021 or 2020.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfRealizedGainLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NDU_b2e41b16-50b9-4590-a247-e77793ebe251" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The detail of realized gains (losses) related to investment securities and included within investment income was as follows for the years ended December&#160;31, 2022, 2021, and 2020:</span></div><div style="margin-bottom:7pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:57.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.226%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on investment securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:DebtAndEquitySecuritiesRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzItMS0xLTEtMTQwNjQ1_c6c578cb-6e94-441e-a16f-362e02591abe">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:DebtAndEquitySecuritiesRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzItMy0xLTEtMTQwNjQ1_7831f913-fca7-4e44-82ae-7256429acde7">219</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:DebtAndEquitySecuritiesRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzItNS0xLTEtMTQwNjQ1_8946481f-bef6-4421-a5f9-97f6d7cbbabf">110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:DebtAndEquitySecuritiesRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzMtMS0xLTEtMTQwNjQ1_025872cb-af49-4d79-a453-4524a3c3e20f">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:DebtAndEquitySecuritiesRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzMtMy0xLTEtMTQwNjQ1_d6597982-2a7f-45b5-81c8-203019ed44a1">8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:DebtAndEquitySecuritiesRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzMtNS0xLTEtMTQwNjQ1_87c0ee6d-77f5-4024-8a36-9b2c97ee7166">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzQtMS0xLTEtMTQwNjQ1_d9a01837-4894-4ede-b1a7-6f8641e0236e">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzQtMy0xLTEtMTQwNjQ1_70713921-b3b1-4440-a90e-eae55642f9f4">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzQtNS0xLTEtMTQwNjQ1_a82af024-6a9f-4bc9-8b72-a149b184f92d">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzUtMS0xLTEtMTQwNjQ1_8425c71b-a092-4e89-ac44-4126f5de3def">174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzUtMy0xLTEtMTQwNjQ1_ffc517b2-d261-47eb-989c-7dc20540b6d4">364</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzUtNS0xLTEtMTQwNjQ1_765215e6-614a-44cd-9ecf-0a7f4f3b0be4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net recognized (losses) gains on investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzYtMS0xLTEtMTQwNjQ1_9b248c4e-9a67-49f6-9273-d3bd176ce1c1">205</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzYtMy0xLTEtMTQwNjQ1_f0aba05d-2e64-4909-bcd3-f3a8617c828a">130</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:DebtAndEquitySecuritiesGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzYtNS0xLTEtMTQwNjQ1_406a809a-52d8-4708-b225-08636ee967a6">838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:GainLossOnInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NTg_de05a94f-38a2-46aa-940e-8e451445f3ce" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses related to equity securities for the years ended December&#160;31, 2022, 2021 and 2020 was as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.515%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.517%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains recognized on equity securities during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzItMS0xLTEtMTQwNjQ1_c44b9e47-7d97-45a4-a09a-7849b654f053">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzItMy0xLTEtMTQwNjQ1_c37b9a2e-c362-4399-8926-27636974581e">341</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzItNS0xLTEtMTQ0ODI4_c7e78c1d-06ce-4eec-bdb4-92861a2d6994">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net losses recognized on equity securities sold during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzMtMS0xLTEtMTQwNjQ1_0ce21a7c-429e-4d4e-a9fb-83dedd295c7e">105</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzMtMy0xLTEtMTQwNjQ1_169e9d93-a8b2-4cc8-8ef6-1ee6dea66f78">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzMtNS0xLTEtMTQ0ODQ1_f11a7346-980f-45f2-a56b-435043b4662c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains recognized on equity securities still held at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzQtMS0xLTEtMTQwNjQ1_b3191ba5-72f2-43f8-9886-b524df1492d6">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzQtMy0xLTEtMTQwNjQ1_6da658e5-0599-489e-bee7-b8c0d34af206">328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzQtNS0xLTEtMTQ0ODI4_5dddad67-a50c-4f36-a805-58264465b23a">746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All purchases of and proceeds from investment securities for the year ended December&#160;31, 2020 relate to debt securities.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4Njk_593495fb-5a73-44eb-8963-a6c30fc5e9ac" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of debt securities available for sale at December&#160;31, 2022, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:75.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.995%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzItMS0xLTEtMTQwNjQ1_0ae2a072-3501-4869-a924-c54831ac3453">529</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzItMy0xLTEtMTQwNjQ1_0f30d429-0392-43ca-8dd0-71b6516c22a8">525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzMtMS0xLTEtMTQwNjQ1_245f41cf-4506-44cd-9a8a-fb106204e5ef">3,399</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzMtMy0xLTEtMTQwNjQ1_a0176a16-e895-4bdb-9771-dc64ec75ecb8">3,210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzQtMS0xLTEtMTQwNjQ1_46dd4f1c-7585-44c1-b54a-28a1187a0bd8">3,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzQtMy0xLTEtMTQwNjQ1_d96bd015-d047-4c4a-824b-977298cac772">2,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzUtMS0xLTEtMTQwNjQ1_d87649ab-2864-48ee-b7ba-75d814c24e05">1,250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzUtMy0xLTEtMTQwNjQ1_e2015669-33a9-4398-ab25-6bf9836097ed">994</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage and asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzYtMS0xLTEtMTQwNjQ1_ef58cac7-eb83-4b6d-b858-51a3da79454d">7,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzYtMy0xLTEtMTQwNjQ1_b085ee09-3dc3-46ec-8d58-1f921b2b0042">6,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzctMS0xLTEtMTQwNjQ1_9bb7be10-def5-4a2b-975a-55d6add7d5a9">15,946</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzctMy0xLTEtMTQwNjQ1_1948ead9-f918-4f3b-8b73-2e07ec2e893a">14,254</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_160"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzUyOTA_e6bf9faa-176e-4503-be4a-73025acd5657" continuedAt="i38beb88c5c484727bd39e08ff6343bb8" escape="true">FAIR VALUE</ix:nonNumeric></span></div><ix:continuation id="i38beb88c5c484727bd39e08ff6343bb8" continuedAt="ibbcec290f9174b609f9d1af000d1876b"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Assets</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzUyODg_2c6b3055-c485-4886-9c0c-639ab9973588" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our fair value measurements at December&#160;31, 2022 and 2021, respectively, for financial assets measured at fair value on a recurring basis:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:45.127%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.741%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72dad613204f368ff4a26fd335a8af_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzQtMS0xLTEtMTQwNjQ1_07507c15-a69b-42b8-aaae-2f08fe48eddb">4,832</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19ce7d0320634c71911eb129b62cdd75_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzQtMy0xLTEtMTQwNjQ1_d2706967-379c-421d-a4f4-b26a70e2ef66">4,832</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1d051e2a57c4934876ddc48b5f49744_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzQtNS0xLTEtMTQwNjQ1_ab13b149-dfb8-48a6-8891-655220d69640">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzQtNy0xLTEtMTQwNjQ1_5f59671a-a7c1-4dfa-ad10-6fc5b648086d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4600bbd96e654f4bb87bb99cc75e8721_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzctMS0xLTEtMTQwNjQ1_cf4f29de-9b0f-4707-b8f6-5bfa6434155b">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id37e3970a9a245bf992b7f2bf10aaf9d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzctMy0xLTEtMTQwNjQ1_464817d6-52a5-46e7-9d2a-4d3351e89130">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e412987c124923843c11133670979d_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzctNS0xLTEtMTQwNjQ1_64a9cce1-6117-4fbd-88f7-e3218cf67841">1,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d065eb8ec814e6fb943f186f38242fb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzctNy0xLTEtMTQwNjQ1_f93cae21-92ad-4293-9089-1deb8bf27bb6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a05fc957d0846f4b011a965962086b6_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzgtMS0xLTEtMTQwNjQ1_cb261eeb-e323-45cf-8bd4-449ba5260f65">3,230</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i568af216307e4b179878b2da53d4122b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzgtMy0xLTEtMTQwNjQ1_bdd71961-19ae-4216-9596-e2c207202878">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i185a7e76a1d24172bb01a134f7adc9c0_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzgtNS0xLTEtMTQwNjQ1_fd176b4d-d5c2-4af3-adec-8e5707104e34">3,230</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa6ce38b809041c9968dfc78a7b6929e_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzgtNy0xLTEtMTQwNjQ1_4774ec90-7c46-417a-836f-850dee1897c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i100f7d2a885e4239994500a96187a154_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzktMS0xLTEtMTQwNjQ1_ac2cda32-7f00-46aa-a744-e1cf86ce277e">728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663f713df5004ce691b805cccc0c3c41_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzktMy0xLTEtMTQwNjQ1_6b3671f1-b9d7-4902-b4aa-58c1bdde66cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35d173bcc08f401d8448c3429d521e73_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzktNS0xLTEtMTQwNjQ1_53f2cef4-a9e4-434e-99f3-b342ee41ea84">728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa5a405115aa4a9e80c1d4170818b435_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzktNy0xLTEtMTQwNjQ1_a39d66e9-dcdb-46c4-994c-4ba0d792737a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6fbd362be394a77a0bae5d4e503c621_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzExLTEtMS0xLTE0MDY0NQ_48fc596e-1df0-43a4-9ee1-fd6f24e7b7e6">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf95ac00e96b4da2b61537caecf2a63f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzExLTMtMS0xLTE0MDY0NQ_ff91d424-acf3-490b-af18-35be2f822dfb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01fe7de4b48b4757bdba67c3c30223dc_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzExLTUtMS0xLTE0MDY0NQ_600027d0-2b0f-47cb-b996-297cf4fa64f1">401</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7892d0ce35f4c4d809ca56ec7b8ed92_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzExLTctMS0xLTE0MDY0NQ_a45aa17e-ea5f-4471-bd4b-f50b7171a860">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6016170130d84d3f9c5fe6be1493ed7b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEyLTEtMS0xLTE0MDY0NQ_0526e4d2-270f-4de4-ba5b-86e3227c735b">1,399</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf26e22bb6694373b3ec116c8848c087_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEyLTMtMS0xLTE0MDY0NQ_2bfdcdc6-c587-4af1-bb04-6efb39a473a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f2d76839dc425e9923d094887a6852_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEyLTUtMS0xLTE0MDY0NQ_f4a38848-d8fe-4cbe-b42d-b0e99feb3758">1,399</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia42d9264fe60436397893746d07f5344_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEyLTctMS0xLTE0MDY0NQ_20b480e0-fa82-4605-921f-d521e1775f7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10a317cf3f8749508994c7c0895c690c_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEzLTEtMS0xLTE0MDY0NQ_37c0d55a-26ac-4b41-a992-2cfed7e7cc99">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ffca985b624437598892a6a46f6e67f_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEzLTMtMS0xLTE0MDY0NQ_40710f3b-d8c7-4357-8221-817671a04b6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0951e2e238645f2ae9ad57771d70f73_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEzLTUtMS0xLTE0MDY0NQ_903df4c6-ac38-4ffc-a542-00736950d7ff">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2617a33f07e4ea1ae164ff1bd350258_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEzLTctMS0xLTE0MDY0NQ_52b65acc-0999-4c26-b6cc-561695bc27ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f87bad1dca649f6acab6b67b66ef008_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE0LTEtMS0xLTE0MDY0NQ_8058db0f-3fff-4f8f-8679-76d17900980a">5,726</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb5c00bb1f8b464b98779dcffeb0bc99_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE0LTMtMS0xLTE0MDY0NQ_007d1720-54b0-4682-8dcd-fcd19eb2bf3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i099d522bfaf0457cbb3b97f0e040976b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE0LTUtMS0xLTE0MDY0NQ_4b55bab2-9e86-4fe5-8970-ca65254dfb84">5,625</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf1e6a604f94423babd31a467494b284_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE0LTctMS0xLTE0MDY0NQ_07ce1ccb-105f-4109-a4f0-8142713aa300">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72dad613204f368ff4a26fd335a8af_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE1LTEtMS0xLTE0MDY0NQ_d4d217c7-b414-48a0-aea6-c2b32fa667a3">14,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19ce7d0320634c71911eb129b62cdd75_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE1LTMtMS0xLTE0MDY0NQ_47a00a61-1096-47ac-911c-2a96a323cefb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1d051e2a57c4934876ddc48b5f49744_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE1LTUtMS0xLTE0MDY0NQ_65dadaf2-0902-49be-96ab-8c76d7d8d22e">14,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE1LTctMS0xLTE0MDY0NQ_247d2e94-9900-46db-a901-d0f4d7f3ab4e">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72dad613204f368ff4a26fd335a8af_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE2LTEtMS0xLTE0MDY0NQ_6860cb09-5f8f-4d75-bc48-0ab7d15bef17">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19ce7d0320634c71911eb129b62cdd75_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE2LTMtMS0xLTE0MDY0NQ_6d406203-72fb-4902-8a58-0c964cd2543c">7</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1d051e2a57c4934876ddc48b5f49744_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE2LTUtMS0xLTE0MDY0NQ_2ebddc24-06e7-4577-a58e-806b2a865bf0">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE2LTctMS0xLTE0MDY0NQ_b254d1fe-b9a3-4c51-bf76-bb795a193222">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb72dad613204f368ff4a26fd335a8af_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE3LTEtMS0xLTE0MDY0NQ_4be27326-6e1a-4ba3-9961-816c2466e40f">19,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19ce7d0320634c71911eb129b62cdd75_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE3LTMtMS0xLTE0MDY0NQ_44b9ca31-f8bf-4e95-a62a-19b930de04bb">4,839</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1d051e2a57c4934876ddc48b5f49744_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE3LTUtMS0xLTE0MDY0NQ_a4beb6b7-0972-4728-96b8-0961b96de09f">14,153</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE3LTctMS0xLTE0MDY0NQ_ce20dfeb-10be-4020-bf35-e3f40352c921">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1173c14adecf46f78881e3a27f37aec1_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIwLTEtMS0xLTE0MDY0NQ_ec891db5-b397-42bc-8ffe-176c3f86a584">3,322</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d65e744f83e4ad98d0958df7c78c34a_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIwLTMtMS0xLTE0MDY0NQ_755d8fea-5b44-4a69-8a30-46a35d561697">3,322</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3faa3637d1e54906a31aad04f195a8ed_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIwLTUtMS0xLTE0MDY0NQ_5ed136d0-9e84-4f6d-bc67-70260e5eeb34">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14db3e8f943f46e786c81127e5ea0564_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIwLTctMS0xLTE0MDY0NQ_0ae62154-4f9e-4c0b-81ea-eb9a406a80b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie60cdd956a6640969d47e0833e86ba9f_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIzLTEtMS0xLTE0MDY0NQ_563a92e6-28f0-46c2-a264-5d622ddc0587">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib385aa21fe4c4616838ee0d0ca6d2cba_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIzLTMtMS0xLTE0MDY0NQ_546ec494-221a-44f7-929a-53e475c9ac80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0146b48a0e5489eaa956daf6df2d528_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIzLTUtMS0xLTE0MDY0NQ_3c45830a-154b-4260-b698-0f7d24e56348">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6fc8277fc204250b7480ed77aecc8e5_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIzLTctMS0xLTE0MDY0NQ_b1081b4d-0b18-4c15-a66c-0c45715bbb00">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa72a9d84a68409eac53fed976508820_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI0LTEtMS0xLTE0MDY0NQ_da574a7e-dd6d-4150-87d0-fabaafe56b22">3,229</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia64dce68a9ab4a58acdbb1db7d67bb70_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI0LTMtMS0xLTE0MDY0NQ_9dbe08ce-0962-41cc-86cb-aaebdc09d0a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5acccdd82ff846ff8ef892b418bb1485_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI0LTUtMS0xLTE0MDY0NQ_6d7dcf87-59f6-47ac-a33e-9b4ec4810d27">3,229</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i081e21499a8c458baa615ff77f0ac1cd_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI0LTctMS0xLTE0MDY0NQ_b2c65e8e-9cf9-4f36-b3fd-a6d6fb545987">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20264b95ebc04dcabbb626a171f3e744_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI1LTEtMS0xLTE0MDY0NQ_9992cd8d-5721-42eb-aefe-31e84329571c">841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3fa38cc574124cecb80a041e6b188e3d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI1LTMtMS0xLTE0MDY0NQ_825cdeb1-93fe-49e5-b592-dbb0485a0997">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7d7ed7bd6f64ee0acfeb9cbb1fae2f9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI1LTUtMS0xLTE0MDY0NQ_d0fd09da-3e5c-451c-ac2b-237d4b4e06a5">841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cfec53bb2494f19a47c713e3227de97_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI1LTctMS0xLTE0MDY0NQ_c3041ca2-0035-4544-b3ae-63ddf58060c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2235b6260df49a1a6c11eed924939df_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI3LTEtMS0xLTE0MDY0NQ_e1415d95-c6f8-4ce2-b6b1-fd4d68ed101d">367</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f54148e6d2c499a806b66f7dca47359_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI3LTMtMS0xLTE0MDY0NQ_c1295e78-13e3-48d9-9c69-9ad4070c80e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0fb95db0bf242dbab96b217510a895a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI3LTUtMS0xLTE0MDY0NQ_9a928292-1837-41e0-ab3c-9e075b89c42c">367</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3c7b37cedae462f862afaec00b4bc46_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI3LTctMS0xLTE0MDY0NQ_5036d916-a2ef-4aa9-a8c3-a0fece898362">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cf29001a702470bacacce5139c387a6_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI4LTEtMS0xLTE0MDY0NQ_9a0e3bdd-fe44-442f-bcc2-54b0dfbb3007">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3338f1806f36453abbd7a52e1b0790e9_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI4LTMtMS0xLTE0MDY0NQ_d3dff2fe-b3ea-47a3-b6c3-de55d061b64e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e0593849c444ccbbeb42e1512fa4a1_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI4LTUtMS0xLTE0MDY0NQ_baa23cad-62ab-430d-b00b-7ce5c7f6eefd">1,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fb42a9cbf7b4e7cba7da4a133439c55_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI4LTctMS0xLTE0MDY0NQ_55adcdd5-ab51-472d-9e2d-98b54fe7db0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85753dd3a8f54f9fb0d831cf7c5c43f2_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI5LTEtMS0xLTE0MDY0NQ_084e7837-7dc2-4a6e-bf3c-56767e89cf0b">1,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bea5d25f6cd43a8a70162eca920c430_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI5LTMtMS0xLTE0MDY0NQ_e7cf02f4-ac9c-4677-90fd-4d8041bb927e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb0684f421e64ce79522d2eb9a6a8413_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI5LTUtMS0xLTE0MDY0NQ_864a7c1f-897c-4220-9db3-7c110cd67475">1,348</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i642f883149c04810939d034bfa0a52ed_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI5LTctMS0xLTE0MDY0NQ_df728430-6441-4d63-bf1e-80767dbdb341">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f49ba358e744656a0580c671549df4d_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMwLTEtMS0xLTE0MDY0NQ_d94fef9b-46e1-4bc1-b50d-fc5b7300822d">5,700</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78acbd1a53b04291b66fdbb04a15ae30_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMwLTMtMS0xLTE0MDY0NQ_09d481fb-690c-418b-b77d-17a72ea3fe95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie39ae48296ce4b29aa8bbe2041ed8eb4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMwLTUtMS0xLTE0MDY0NQ_7ec7a92d-d714-4274-89e0-81344f390fb9">5,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae1d525c8d394981a6e5be40d156b6c4_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMwLTctMS0xLTE0MDY0NQ_5a3b64ec-d401-41c2-8213-5ab212a5f250">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1173c14adecf46f78881e3a27f37aec1_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMxLTEtMS0xLTE0MDY0NQ_cb316bb6-9ba1-4eea-a93a-d160e3cd648a">13,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d65e744f83e4ad98d0958df7c78c34a_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMxLTMtMS0xLTE0MDY0NQ_7f3b3a7e-bb4c-49ab-92dc-085a5a2e6576">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3faa3637d1e54906a31aad04f195a8ed_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMxLTUtMS0xLTE0MDY0NQ_a20f0776-b30d-4b57-afc7-d9d81294d219">13,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14db3e8f943f46e786c81127e5ea0564_I20211231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMxLTctMS0xLTE0MDY0NQ_1df1731b-fc68-454e-807f-9c7bcbd61d90">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1173c14adecf46f78881e3a27f37aec1_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMyLTEtMS0xLTE0MDY0NQ_b5888cc1-59cb-4923-a143-be476c959e1d">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d65e744f83e4ad98d0958df7c78c34a_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMyLTMtMS0xLTE0MDY0NQ_0dd3404b-0d6f-424a-8110-52b87031faf4">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3faa3637d1e54906a31aad04f195a8ed_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMyLTUtMS0xLTE0MDY0NQ_95b3433a-e9c1-40a3-8713-5c6e5837113d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14db3e8f943f46e786c81127e5ea0564_I20211231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMyLTctMS0xLTE0MDY0NQ_64f1578c-60a5-423e-ad61-38500b601bbd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1173c14adecf46f78881e3a27f37aec1_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMzLTEtMS0xLTE0MDY0NQ_0e33dd88-aa1e-490e-813f-eee1084649a7">17,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d65e744f83e4ad98d0958df7c78c34a_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMzLTMtMS0xLTE0MDY0NQ_fd09280f-50bc-44d6-8dce-7e9ce8d4f502">3,797</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3faa3637d1e54906a31aad04f195a8ed_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMzLTUtMS0xLTE0MDY0NQ_a4310d67-0bae-4fe1-86bd-73d1055dd19d">13,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14db3e8f943f46e786c81127e5ea0564_I20211231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMzLTctMS0xLTE0MDY0NQ_b9a4d77f-5b8f-4a77-8d13-46194b3419f1">68</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="ibbcec290f9174b609f9d1af000d1876b" continuedAt="i500cb302c63d47edb3c16e9a77010551"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Level 3 assets had fair values of $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzIwNTY_d5114175-fc72-415f-a318-275ddb928b74">101</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i212f1e342411493daed02b16d1a256c7_D20220101-20221231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzIxMjE_6c6009f4-499b-44c8-a2c8-a1f92abbc38a">0.5</ix:nonFraction>% of total invested assets, and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzIwNjQ_43e2bda9-4623-490e-a647-19fae5213e84">68</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i9c27e561235648b8b13b0b1006fe90ec_D20210101-20211231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzIxODY_16fbdff3-d598-4bcb-bd54-d6f44c7cda72">0.4</ix:nonFraction>% of total invested assets, at December&#160;31, 2022 and 2021, respectively. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzUyOTM_87d5036c-24c2-4800-8e21-0b19bcbd9803" continuedAt="i3e48b1f87f7a4582925e04f7e5b767fb" escape="true">During the years ended December&#160;31, 2022 and 2021, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center;text-indent:11.25pt"><ix:continuation id="i3e48b1f87f7a4582925e04f7e5b767fb"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:54.277%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.211%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.212%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Private<br/>Placements</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance at January&#160;1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzQtMS0xLTEtMTQ0OTUz_ca657329-fddf-4778-b21a-bfb56c0b1570">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzQtMS0xLTEtMTQwNjQ1_79b086ba-a1ef-4ad7-bac1-a092c72bb9e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gains or losses:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzYtMS0xLTEtMTQ0OTUz_6eb9ac51-2910-4c38-8edf-b7f8b0262586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzYtMS0xLTEtMTQwNjQ1_fecc56ce-96da-4516-af0c-21f1f8c585dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized in other comprehensive&#160;income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzctMS0xLTEtMTQ0OTUz_858bbc17-fc44-4ff6-96cb-a1d340db5de3">14</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzctMS0xLTEtMTQwNjQ1_fedcb7c7-5b47-460d-abf4-e80af3c0c6e4">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzgtMS0xLTEtMTQ0OTUz_c7c7d0b9-8ab9-4855-82f1-1a618d0f5d09">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzgtMS0xLTEtMTQwNjQ1_6d0dac51-44cd-4ded-8e46-39b5563fc47b">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzktMS0xLTEtMTQ0OTUz_017256d1-c24e-4955-8e78-0fd7cb05036b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzktMS0xLTEtMTQwNjQ1_8a16d893-49c9-4d01-96aa-e8348f51c3f6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzEwLTEtMS0xLTE0NDk1Mw_7071edaa-42bd-4035-9dd0-f521b7b53915">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzEwLTEtMS0xLTE0MDY0NQ_afb50ecf-5270-4a34-91e1-4715c2bd3a75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzExLTEtMS0xLTE0NDk1Mw_d5114175-fc72-415f-a318-275ddb928b74">101</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzExLTEtMS0xLTE0MDY0NQ_43e2bda9-4623-490e-a647-19fae5213e84">68</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Liabilities</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt is recorded at carrying value in our consolidated balance sheets. The carrying value of our senior notes debt outstanding, net of unamortized debt issuance costs, was $<ix:nonFraction unitRef="usd" contextRef="i7d2d71ecd0c84d618d11b24ea25820ea_I20221231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzEyODY_f409e9a8-6c71-41f6-aeec-8af1d9908b88">10.0</ix:nonFraction>&#160;billion at December&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i57df0c8d81b2453f8a238e040f1b0da0_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzY1Mw_2df5c46a-896b-430c-8e6c-580704f1c04b">9.0</ix:nonFraction> billion at December&#160;31, 2021. The fair value of our senior note debt was $<ix:nonFraction unitRef="usd" contextRef="i4e44bcbe607149f5b7f316440415c7f4_I20221231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzcwNg_135b8a93-6363-45f7-83e5-b7f81d23eef9">9.4</ix:nonFraction> billion at December&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ie46f4a357a2f4fbe87c10ff118d9a34d_I20211231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzcxOQ_58cee6c1-1f1e-472e-8b88-4217daeead5e">10.0</ix:nonFraction> billion at December&#160;31, 2021. The fair value of our senior note debt is determined based on Level 2 inputs, including quoted market prices for the same or similar debt, or if no quoted market prices are available, on the current prices estimated to be available to us for debt with similar terms and remaining maturities. Carrying value approximates fair value for our term loans and commercial paper borrowings. The term loan and commercial paper borrowings&#160;were $<ix:nonFraction unitRef="usd" contextRef="i6036a7082bf04c138376afbc99b33671_I20221231" decimals="-8" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzEyOTM_d9483c4e-90b1-4648-8524-4cd4aee4c400">1.1</ix:nonFraction>&#160;billion at December&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="i31961d11bba447c88c3178990212f2be_I20211231" decimals="-8" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzEyMTE_f813a6f3-0e44-4477-b3a2-d49da21ae989">3.5</ix:nonFraction> billion  at  December&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Put and Call Options Measured at Fair Value</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our put and call options associated with our equity method investments are measured at fair value each period using a Monte Carlo simulation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective April 27, 2021, with the signing of the definitive agreement to acquire the remaining <ix:nonFraction unitRef="number" contextRef="i02980ff246d1468a8e06860f6caca51d_I20210427" decimals="2" name="hum:DefinitiveAgreementEquityInterestToBeAcquiredPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE1MDc_7852f5f7-f3f7-4f74-b84f-0d4ae290af49">60</ix:nonFraction>% interest of KAH, the respective put and call options were terminated. As such, the $<ix:nonFraction unitRef="usd" contextRef="ice7f37fee78e4e338fbc8d1d06f7ae0e_I20210331" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE1OTM_f0d00e55-d636-4063-85f6-7a3be11da400">63</ix:nonFraction>&#160;million put and $<ix:nonFraction unitRef="usd" contextRef="icd18e11d3c604b7da08f0fffe4565217_I20210331" decimals="-6" name="hum:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2MDQ_8abc158b-f6fd-41c1-85b0-bcde6c156c1c">440</ix:nonFraction>&#160;million call fair values as of the first quarter of 2021 were reduced to <ix:nonFraction unitRef="usd" contextRef="i9423060dcf3c49fabea691f0ed0b95eb_I20210427" decimals="INF" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2NzI_ce6b9fb5-8482-47d9-8b8b-0fe438bc54b3"><ix:nonFraction unitRef="usd" contextRef="i8ddafd8649e14ac7acac5c6ccd24d75f_I20210427" decimals="INF" name="hum:FinancialAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2NzI_dd624781-63a4-43b0-81ba-a584f5f47516">zero</ix:nonFraction></ix:nonFraction>, resulting in $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:LossOnTerminationOfDerivatives" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2ODk_d22b9a0a-357f-406f-8dd1-2a0cfa40b3b3">377</ix:nonFraction>&#160;million in other expense (income),net in our consolidated statements of income for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The put and call options fair values associated with our Primary Care Organization strategic partnership with WCAS, which are exercisable at a fixed revenue exit multiple and provide a minimum return on WCAS' investment if exercised, are measured at fair value each reporting period using a Monte Carlo simulation. The put and call options fair values, derived from the Monte Carlo simulation, were $<ix:nonFraction unitRef="usd" contextRef="i7e890b4b6701420b99a2fd9eb4ec7e41_I20221231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzMxNTM_7d4e6167-bff7-41b0-aeef-0807b5692f2f">267</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia6cabb5822a048bd9df34c65a2029e22_I20221231" decimals="-6" name="hum:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzMxNjA_346f6ffd-5b79-4d2c-b7ab-d9100abeb1f6">10</ix:nonFraction> million, respectively, at December&#160;31, 2022. The put and call options fair values, derived from the Monte Carlo simulation, were $<ix:nonFraction unitRef="usd" contextRef="iff8e2116ff51438a81ec082998730629_I20211231" decimals="-6" name="us-gaap:FinancialLiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzMyNjk_99623f21-e2fa-4892-9528-3ade1a2892cb">202</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i176fb35f957e441dbdcafceaebb04e6d_I20211231" decimals="-6" name="hum:FinancialAssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzMyNzY_28afb19f-96f4-4438-b0f9-b372ab9cb932">13</ix:nonFraction> million, respectively, at December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant unobservable inputs utilized in these Level 3 fair value measurements (and selected values) include the enterprise value, annualized volatility and credit spread. Enterprise value was derived from a discounted cash flow model, which utilized significant unobservable inputs for long-term revenue, to measure underlying cash flows, weighted average cost of capital and long term growth rate. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzUyNzk_16be20cb-922e-4a35-bb40-72066ea86089" continuedAt="i278adb45efae44ebbcddc99971c9d418" escape="true">The table below presents the assumptions used for December&#160;31, 2022 and 2021, respectively: </ix:nonNumeric></span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i500cb302c63d47edb3c16e9a77010551"><ix:continuation id="i278adb45efae44ebbcddc99971c9d418"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:59.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.837%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i38aeda789d4a488e891a8aa87e9fa1ec_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzEtMS0xLTEtMTQ2MzUwL3RleHRyZWdpb246NzI1YTg2MWFhNWJkNGJmMjhiZmJkZTNiMWFjOTU1NTBfMTA5OTUxMTYyNzc4MA_46ca7835-3916-488d-af0a-8b229fdbcf00">16.7</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ice2ed9f6fb0c49ae9a1285ff2740d4e4_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzEtMS0xLTEtMTQ2MzUwL3RleHRyZWdpb246NzI1YTg2MWFhNWJkNGJmMjhiZmJkZTNiMWFjOTU1NTBfMTA5OTUxMTYyNzc4Ng_28980446-9825-4d42-93f1-481096dea7a0">20.8</ix:nonFraction>%</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3403a6c0905646bcbd8ae9d599d80f52_I20211231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzEtMS0xLTEtMTQwNjQ1_22ddbcb8-e98e-4cbe-915d-d53294b5a93e">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit spread</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i041054aa105846e8ab6457532786e0e7_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzItMS0xLTEtMTQ2MzUwL3RleHRyZWdpb246MzFjNzQ4Y2RjM2FmNDIzNzg3ODhlNDQyZWI1OGFjNjZfMTA5OTUxMTYyNzc4MA_c46a75e4-55ef-48e7-92d0-b7e3115eff94">1.3</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="ia18bd7b4631c4221ae708ae77650b442_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzItMS0xLTEtMTQ2MzUwL3RleHRyZWdpb246MzFjNzQ4Y2RjM2FmNDIzNzg3ODhlNDQyZWI1OGFjNjZfMTA5OTUxMTYyNzc4Ng_bc142a26-f9c2-49e3-9359-dfb84f353cb4">1.5</ix:nonFraction>%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2900bedd1cd9421e97eb2d64e4d1be5a_I20211231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzItMS0xLTEtMTQwNjQ1_e87b837c-0191-438d-9073-ac7004a3fc15">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue exit multiple</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1473eaa5ef804e48ae190d791e55e701_I20221231" decimals="1" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzMtMS0xLTEtMTU1ODY5L3RleHRyZWdpb246NTkzZGM4ZTUyNjA3NDdhYTkzYjgzY2QxNDNhZjkwYTZfMTA5OTUxMTYyNzc4MA_ee4d1824-fadd-447d-854f-8d154d76eff5">1.5</ix:nonFraction>x - <ix:nonFraction unitRef="number" contextRef="ib63312bf4c4342bca36791b5e65e4bc3_I20221231" decimals="1" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzMtMS0xLTEtMTU1ODY5L3RleHRyZWdpb246NTkzZGM4ZTUyNjA3NDdhYTkzYjgzY2QxNDNhZjkwYTZfMTA5OTUxMTYyNzc4OA_8756899a-6890-49f0-ad6f-ebf7b2d2a6ed">2.5</ix:nonFraction>x </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ieecc262ea3ca466c845eebf21b8c3520_I20211231" decimals="1" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzMtMS0xLTEtMTQwNjQ1L3RleHRyZWdpb246MmIyZjFlYmI1NzM4NDU3NThjOGQ4NDViY2VmNGRkYTRfMTA5OTUxMTYyNzc5MA_45b60768-83a2-449e-97cc-a5f1541fe85a">1.5</ix:nonFraction>x - <ix:nonFraction unitRef="number" contextRef="i2124fe581b3f4e0ca125473df9d56093_I20211231" decimals="1" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzMtMS0xLTEtMTQwNjQ1L3RleHRyZWdpb246MmIyZjFlYmI1NzM4NDU3NThjOGQ4NDViY2VmNGRkYTRfMTA5OTUxMTYyNzc5Mw_7b247333-aaa9-4a6a-9c92-c9ef351d8ca3">2.5</ix:nonFraction>x</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of capital</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87973cc0bdc9461d9b56ed906827e2d6_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzQtMS0xLTEtMTQ2MzUyL3RleHRyZWdpb246YWYyNjdlZjA1NDg0NDZmOTgxNWZkNjU3M2UyMWE3ZmFfNA_ee900d36-675a-4d99-a6fb-586a93e3c965">11.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i3739da0aa72d4c86b46499cbdae6ff38_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzQtMS0xLTEtMTQ2MzUyL3RleHRyZWdpb246YWYyNjdlZjA1NDg0NDZmOTgxNWZkNjU3M2UyMWE3ZmFfOQ_d299d3ad-877d-4e04-a315-939d6490f5cc">12.5</ix:nonFraction>%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1e8a8f01d8ca4f3a9f406c722b7ef5ed_I20211231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzQtMS0xLTEtMTQwNjQ1_8947c56a-95ef-4672-8e16-6ed0aac86cf4">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term growth rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b64fefe292a43728aaf7bdfbede5152_I20221231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzUtMS0xLTEtMTQ2MzUy_0fe4a677-ff83-4085-9474-acca6637b0fe">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i300136ad24984a21be5bc1960dfedd31_I20211231" decimals="3" name="us-gaap:DerivativeAssetLiabilityNetMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzUtMS0xLTEtMTQwNjQ1_9c477c53-c310-4c32-9d81-da02cf5320df">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for annualized volatility, credit spread and weighted average cost of capital reflect the lowest and highest values where they differ significantly across the series of put and call options due to their expected exercise dates.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are measured at fair value on a non-recurring basis subject to fair value adjustment only in certain circumstances.  As disclosed in Note 3, &#8220;Acquisitions&#8221;, we completed our acquisition of KAH during the third quarter of 2021. The net assets acquired and resulting goodwill and other intangible assets were recorded at fair value primarily using Level 3 inputs.  The net tangible assets including receivables and accrued liabilities were recorded at their carrying value which approximated their fair value due to their short term nature. The fair value of goodwill and other intangible assets were internally estimated based on the income approach.  The income approach estimates fair value based on the present value of cash flow that the assets could be expected to generate in the future. We developed internal estimates for expected cash flows in the present value calculation using inputs and significant assumptions that include historical revenues and earnings, long-term growth rate, discount rate, contributory asset charges and future tax rates, among others.  The excess purchase price over the fair value of assets and liabilities acquired is recorded as goodwill.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in Note 3, we completed the sale of a <ix:nonFraction unitRef="number" contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811" decimals="2" name="hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2NDkyNjc0NDg5OTY_3774dfe9-0f79-46c0-98c6-0f1a5c4b7663">60</ix:nonFraction>% interest in KAH Hospice on August 11, 2022. The carrying value of the assets and liabilities of KAH Hospice disposed approximates fair value. The amount of goodwill included in the carrying value is based on the relative fair value of KAH Hospice as compared to the total fair value of our home solutions reporting unit included within the CenterWell segment.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the assets acquired and liabilities assumed in the KAH and other acquisitions in Note 3, there were no other material assets or liabilities measured at fair value on a recurring or nonrecurring basis during 2022, 2021, or 2020.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_163"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:MedicarePartDDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90ZXh0cmVnaW9uOmFmOWIyNDY3NTY5ODQ3ZTQ5ZTg0MDdlNTNhMjkwNWVjXzU4MQ_a05df16a-6b7a-4e97-9fb2-79e8ce2d99f6" continuedAt="ib20e148f7a5a442d923b3262847a2946" escape="true">MEDICARE PART D</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib20e148f7a5a442d923b3262847a2946" continuedAt="i3d6c9cf77caa4842968186c1be46e827">We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with CMS. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90ZXh0cmVnaW9uOmFmOWIyNDY3NTY5ODQ3ZTQ5ZTg0MDdlNTNhMjkwNWVjXzU2OA_fa2688d8-7083-43d0-8f51-2e803702f099" continuedAt="ibf798df8db414c199b8668b57c85bb20" escape="true">The accompanying consolidated balance sheets include the following amounts associated with Medicare Part D as of December&#160;31, 2022 and 2021. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to </ix:nonNumeric></ix:continuation></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i3d6c9cf77caa4842968186c1be46e827"><ix:continuation id="ibf798df8db414c199b8668b57c85bb20"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:52.672%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.658%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzMtMi0xLTEtMTQwNjQ1_7467888d-6f51-4beb-8ae6-4fb7e8eb7a8e">240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzMtNC0xLTEtMTQwNjQ1_eb5a62c5-ddd1-48fb-bfd1-5e595d2541ce">696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf67c76176744e759331c39da83016b0_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzMtNi0xLTEtMTQwNjQ1_4cdc0fff-b8ad-4f90-8d92-f8fd27ed0d57">363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzMtOC0xLTEtMTQwNjQ1_adb39efd-cf6f-408a-a2eb-b173cbfdc045">1,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzQtMi0xLTEtMTQwNjQ1_22d29fb5-d451-4d68-9e0d-44c186f0e43b">166</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzQtNC0xLTEtMTQwNjQ1_3e725a3e-7ab7-418f-993c-b5d91e72b71e">1,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf67c76176744e759331c39da83016b0_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzQtNi0xLTEtMTQwNjQ1_7689a7df-fcc5-468a-ac2a-93081f632921">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231" decimals="-6" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzQtOC0xLTEtMTQwNjQ1_23155dd5-9994-48e4-82a2-ac774b7d8622">466</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current asset (liability)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231" decimals="-6" name="hum:NetCurrentLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzUtMi0xLTEtMTQwNjQ1_97eff864-a1f8-4cc0-8e9b-05c20d67f45f">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231" decimals="-6" sign="-" name="hum:NetCurrentLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzUtNC0xLTEtMTQwNjQ1_828276ba-29b0-480a-a1a9-0456dbf38969">540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf67c76176744e759331c39da83016b0_I20211231" decimals="-6" name="hum:NetCurrentLiabilityAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzUtNi0xLTEtMTQwNjQ1_bd7e21b1-11d4-4cd1-8e01-b8ea440d55ec">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231" decimals="-6" name="hum:NetCurrentLiabilityAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzUtOC0xLTEtMTQwNjQ1_2c145c0d-9af2-4262-a743-b943231e2635">1,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzYtMi0xLTEtMTQwNjQ1_9e35edea-174e-4698-ba37-5e50677dbd16">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzYtNC0xLTEtMTQwNjQ1_79ccb31e-0c90-4a62-8ec1-b4563063d4f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf67c76176744e759331c39da83016b0_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzYtNi0xLTEtMTQwNjQ1_e4d9bd59-6970-470d-bf59-23b7880eedec">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzYtOC0xLTEtMTQwNjQ1_418f1448-e8ab-4301-b7f2-c88247db91eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzctMi0xLTEtMTQwNjQ1_829c0eeb-3b7b-48a6-9c81-12c7ccfb1d05">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzctNC0xLTEtMTQwNjQ1_e8b9361b-4ac9-491a-ac09-5f42b4e313ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf67c76176744e759331c39da83016b0_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzctNi0xLTEtMTQwNjQ1_cf081b82-4257-4511-a52b-65a81aad5b50">194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzctOC0xLTEtMTQwNjQ1_35edcf54-3035-4f09-96b6-1a738bcaa294">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net long-term liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231" decimals="-6" sign="-" name="hum:NetNoncurrentAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzgtMi0xLTEtMTQwNjQ1_692a5bbf-cdd6-46c7-96ba-e86a959bad18">59</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231" decimals="-6" name="hum:NetNoncurrentAssetLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzgtNC0xLTEtMTQwNjQ1_34aa81bf-953c-4b6e-976d-d8f09e25ff70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf67c76176744e759331c39da83016b0_I20211231" decimals="-6" sign="-" name="hum:NetNoncurrentAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzgtNi0xLTEtMTQwNjQ1_2746cb06-b6e8-4b10-be53-222d690b2f97">189</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231" decimals="-6" name="hum:NetNoncurrentAssetLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzgtOC0xLTEtMTQwNjQ1_c53c26f9-7a11-40d1-b2df-170ba60fa368">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net asset (liability)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231" decimals="-6" name="hum:NetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzktMi0xLTEtMTQwNjQ1_f77baae5-98de-4f9e-b034-69d8b0aeb800">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231" decimals="-6" sign="-" name="hum:NetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzktNC0xLTEtMTQwNjQ1_b7286ef5-85d1-40c1-83cd-55480eb50b50">540</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf67c76176744e759331c39da83016b0_I20211231" decimals="-6" name="hum:NetAssetLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzktNi0xLTEtMTQwNjQ1_e19d08f0-6d35-4b48-83d9-b9773f022265">106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231" decimals="-6" name="hum:NetAssetLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzktOC0xLTEtMTQwNjQ1_d5f38a34-00fc-4af4-8d1b-0c470cb8db85">1,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_166"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzI5Mw_576dff45-544b-4a4b-bd71-5a07ebbd030d" continuedAt="ifd20d5ea295c41f887096780433090ec" escape="true">PROPERTY AND EQUIPMENT, NET</ix:nonNumeric></span></div><ix:continuation id="ifd20d5ea295c41f887096780433090ec"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzMwMw_2be20318-c02d-46c1-8ef2-fbf6e686b3a6" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment was comprised of the following at December&#160;31, 2022 and 2021. </span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:75.786%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.656%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19bf3378b91a427c9bd2f7c3566e26e4_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzItMi0xLTEtMTQwNjQ1_25e0f996-8250-4503-a616-e7bffba4dfdb">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0c89853f8934b0cacaa85cfc6f9e825_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzItNC0xLTEtMTQwNjQ1_68c87b8b-2c1d-4327-80e9-770fc3e1e599">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf28824348bc4dbfb4309ec50071a077_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzMtMi0xLTEtMTQwNjQ1_033c2799-88f2-4e60-b74e-4b73fd464d47">1,143</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d4af6d0f5b84d3788f8727616c7344d_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzMtNC0xLTEtMTQwNjQ1_eda71047-90fb-40b9-ae9a-26a699b7ff3a">1,126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0fdc098cf1b4a1692f37a4e684bcd29_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzQtMi0xLTEtMTQwNjQ1_5f4a106e-5e90-4d75-bff7-e113cd6dc9dd">1,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i066e82ee7851473e9db8d8cb4482f183_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzQtNC0xLTEtMTQwNjQ1_d653cc29-fb29-4081-9370-a1844a801f86">1,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4f43a97ffb845e68f044d5213898ca7_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzUtMi0xLTEtMTQwNjQ1_60d4068d-fef6-40c4-9efb-e4136d292695">3,951</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf6cc9bbe7804ebdada6913578e3ff0c_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzUtNC0xLTEtMTQwNjQ1_25e68973-8990-4887-ba4e-e0fc4bc3382c">3,656</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzYtMi0xLTEtMTQwNjQ1_7e5cfc7e-8aba-487d-b19f-0a794f5d5dc3">6,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzYtNC0xLTEtMTQwNjQ1_3b86fbae-1979-494f-8447-19f403e23166">5,947</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzctMi0xLTEtMTQwNjQ1_aba8aefc-a6dd-4822-a593-191ff182a423">3,136</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzctNC0xLTEtMTQwNjQ1_337fd606-dc0f-4c9c-8f5c-44b5e3e34986">2,874</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzgtMi0xLTEtMTQwNjQ1_be7e6dad-95dd-462c-896f-f0c9f6e47db6">3,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzgtNC0xLTEtMTQwNjQ1_e1766e27-6af1-4783-b3d0-848033606306">3,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzEzMg_fdc19c1b-726c-42fb-ad6f-da9bdf320d86">749</ix:nonFraction>&#160;million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzE0Mg_1aad8eba-11f9-4747-9175-c84d556fbc5e">640</ix:nonFraction> million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzE1Ng_a1d0a851-64ba-4dfc-b43d-b93a0915e18a">528</ix:nonFraction> million in 2020, including amortization expense for capitalized internally developed and purchased software of $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzI2MA_03740c11-a825-4eec-95f0-9ac5879e1b59">525</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzI3MA_d2394b85-70c4-427a-8ced-c28b5142de3c">443</ix:nonFraction> million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzI4NA_2cbe6396-fc91-4e2a-957b-dbbc70faa430">351</ix:nonFraction> million in 2020.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_169"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 9. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzYwNQ_5a1fe5e0-36b7-4033-95eb-3b77d13e14e6" continuedAt="i55ef3739774a4d54aa6ee476e81d993d" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="i55ef3739774a4d54aa6ee476e81d993d" continuedAt="i1e11a7f7373e4d79a2407bdf5409d3b6"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of goodwill for our reportable segments has been retrospectively adjusted to conform to the 2022 business segment realignment as discussed in Note 1. There was no impairment. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzU5NQ_3d7f69db-7d60-482a-a972-a1d7dbf60433" continuedAt="ie8d6647ae1a241b98a98f8b4ceddd6d1" escape="true">Changes in the carrying amount of goodwill for our reportable segments for the years ended December&#160;31, 2022 and 2021 were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:1pt;text-align:center"><ix:continuation id="ie8d6647ae1a241b98a98f8b4ceddd6d1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:53.635%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.189%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9a2488b89e4d7385e1a72bd47d1cad_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzItMi0xLTEtMTQwNjQ1_3fc04a1f-954c-4f52-8376-0a51b76c0cb2">1,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e5599c238174c3cb192e88685bcfea4_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzItNC0xLTEtMTQwNjQ1_35a8a267-6723-4c22-a03c-73a4381fdc43">2,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzItMTAtMS0xLTE0MDY0NQ_3fce161b-19f5-4882-8fc5-65a7b0142a3f">4,447</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzMtMi0xLTEtMTQwNjQ1_0d4497d0-67f2-4a4f-95aa-151960df046e">398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzMtNC0xLTEtMTQwNjQ1_110980ff-3ea7-482e-9ca6-a55892a91a48">6,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzMtMTAtMS0xLTE0MDY0NQ_1ac50638-2f27-4554-af38-837c0ab01edc">6,645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0db23ec2c8844ec19dd3156f925907d3_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzYtMi0xLTEtMTQwNjQ1_de7904d2-97ff-4d6b-a6bb-5120caf3ecb6">2,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i302e4dad57a14cdba91bf0b5047fed31_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzYtNC0xLTEtMTQwNjQ1_7d2933aa-862c-43f2-b6a8-ccf3c27f969c">8,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzYtMTAtMS0xLTE0MDY0NQ_858e19a3-19ff-4975-bb7a-8c3dbbede44a">11,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzctMi0xLTEtMTQwNjQ1_f5ad19e7-fcba-4a04-b66b-31f0ef91d186">182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzctNC0xLTEtMTQwNjQ1_95b94809-7ab1-4abb-9234-1c615813d86e">199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzctMTAtMS0xLTE0MDY0NQ_cd508f7f-336b-4fcb-bdec-5e7aa8a20f18">381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dispositions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzgtMi0xLTEtMTQwNjQ1_b434ccba-623a-42e7-bdea-00dd8e583e37">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzgtNC0xLTEtMTQwNjQ1_40bc0562-67b3-478b-a90c-4201b22d69b1">2,331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzgtMTAtMS0xLTE0MDY0NQ_416c629f-629e-4e2c-a44e-c1c4f7a0b503">2,331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i579d987c48294cf28cfd69d68d722ed7_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzEwLTItMS0xLTE0MDY0NQ_3081ed07-e694-41df-8d67-231352859bd9">2,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b359b7705141b5b92b56cd339b7eda_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzEwLTQtMS0xLTE0MDY0NQ_ee0145fa-3d92-4151-9523-a8132ef88ffc">6,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzEwLTEwLTEtMS0xNDA2NDU_4ce99881-ba0f-4051-be00-005c0e0e1ab3">9,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i1e11a7f7373e4d79a2407bdf5409d3b6"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzU5MA_537820f5-953b-4dc0-bd7d-5871ce3d7142" escape="true"><div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our other intangible assets included in other long-term assets in the accompanying consolidated balance sheets at December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.791%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.592%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.957%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.116%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86624d4911c84d1a9f17caac59321ed0_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzQtNC0xLTEtMTQwNjQ1_7f084c10-c4a8-482e-8abb-a08a8d31140b">1,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86624d4911c84d1a9f17caac59321ed0_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzQtOC0xLTEtMTQwNjQ1_e590ecfd-45ae-465e-ad24-0fc27f954095">1,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2e4631e134d44a429a68436144159_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzQtMTAtMS0xLTE0MDY0NQ_6d8075bf-52d3-43c7-a40d-11b937bbbafa">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2e4631e134d44a429a68436144159_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzQtMTQtMS0xLTE0MDY0NQ_2baea689-f889-41db-b31c-a6b9bd89b96d">1,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i352d3685fa15496082cf261060f9e998_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzUtNC0xLTEtMTQwNjQ1_2d98f554-8c74-4c51-ba8c-fa29d3f0b499">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i352d3685fa15496082cf261060f9e998_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzUtOC0xLTEtMTQwNjQ1_7e067726-49f2-421b-8399-9fd6639b6dba">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4996f726e98845bb84a13c49d761508d_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzUtMTAtMS0xLTE0MDY0NQ_b9f73b49-5a5e-49b5-976d-17c9a69184da">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4996f726e98845bb84a13c49d761508d_I20211231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzUtMTQtMS0xLTE0MDY0NQ_491b81ce-406f-4879-bdf3-fd59ff057ef5">522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a73edc57e734d3e99b59268d52d843f_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtMi0xLTEtMTQwNjQ1_61342444-3b6d-4d00-9ad9-b091c60a0218">9.3</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596d5af4874645ad9e06d1eeedc6d071_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtNC0xLTEtMTQwNjQ1_00bc6f05-0da8-4efd-9bc7-28072f501f02">929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596d5af4874645ad9e06d1eeedc6d071_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtNi0xLTEtMTQwNjQ1_c7b870d8-b99e-4820-b563-174b45f6d3d3">673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596d5af4874645ad9e06d1eeedc6d071_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtOC0xLTEtMTQwNjQ1_56c5ea14-06f4-4fc9-98a4-5832d4d64882">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba75b2fe59340d18dee27ba36caa465_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtMTAtMS0xLTE0MDY0NQ_1f6714a0-622d-435a-8d8c-ea951e2d5f59">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba75b2fe59340d18dee27ba36caa465_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtMTItMS0xLTE0MDY0NQ_c23a64ee-ccfe-4b4f-b2ba-b21c53a36734">620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ba75b2fe59340d18dee27ba36caa465_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtMTQtMS0xLTE0MDY0NQ_a6cb4358-a8ca-4774-a166-bc5507dba2fd">263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie8a6332bc1f446caa2303215ecd07bab_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctMi0xLTEtMTQwNjQ1_0afeb575-fa48-4e6d-a89a-c0f1a1114490">6.7</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc197775115474f9bce928cb7b416e1_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctNC0xLTEtMTQwNjQ1_309a541b-d5fc-4365-81d5-3adafa091d97">142</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc197775115474f9bce928cb7b416e1_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctNi0xLTEtMTQwNjQ1_0345cbe2-3417-45c2-ac13-a506a873a6bc">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fc197775115474f9bce928cb7b416e1_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctOC0xLTEtMTQwNjQ1_ea0cb410-2781-4325-909f-349e06f8c947">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ff00041a32480583c1b1682d015810_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctMTAtMS0xLTE0MDY0NQ_4f17dd3c-cd2f-4edd-9fd6-5d18a9ab2b76">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ff00041a32480583c1b1682d015810_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctMTItMS0xLTE0MDY0NQ_cac40060-13a6-4abc-b47f-d406c85c2d2f">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10ff00041a32480583c1b1682d015810_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctMTQtMS0xLTE0MDY0NQ_2731393c-85a1-4f42-8f16-81a83f13f540">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i91f583da577445c788bbe9d989064307_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtMi0xLTEtMTQwNjQ1_ba6c6b5a-105f-46e5-8701-b87d8cd81490">11.6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b2c5f58ee9471fb1efd368a5aec87d_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtNC0xLTEtMTQwNjQ1_53c99234-7613-4e9a-be26-293d67880ce0">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b2c5f58ee9471fb1efd368a5aec87d_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtNi0xLTEtMTQwNjQ1_2523abfd-85c3-406a-b7d0-7880f6f6d580">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14b2c5f58ee9471fb1efd368a5aec87d_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtOC0xLTEtMTQwNjQ1_87e1514b-856f-4e93-9246-06c94c273f3f">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i361ad41756ff4adf9c60e7e103ece2a3_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtMTAtMS0xLTE0MDY0NQ_a775ffcd-81eb-4088-a3c2-cfacaaa6d818">72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i361ad41756ff4adf9c60e7e103ece2a3_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtMTItMS0xLTE0MDY0NQ_1849908f-e8df-4131-b340-03dce5480bce">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i361ad41756ff4adf9c60e7e103ece2a3_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtMTQtMS0xLTE0MDY0NQ_459b9896-d72a-46b0-ae35-a7400f0ec6e1">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetes and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie0b1cd6334db4784afa7ba96eaebbccd_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktMi0xLTEtMTQwNjQ1_56a38750-a74b-4ac4-9241-b1c7976ab662">8.4</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9de5765b6b4f35884275a81dcd973c_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktNC0xLTEtMTQwNjQ1_4f76e855-ce63-4219-bb06-01cf70ad9058">86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9de5765b6b4f35884275a81dcd973c_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktNi0xLTEtMTQwNjQ1_587b6668-3e5e-4204-a500-2449434cfc53">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a9de5765b6b4f35884275a81dcd973c_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktOC0xLTEtMTQwNjQ1_df43e055-19bb-4aaf-a417-ede13d35d23a">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0773d411ab7f4a27a5bd3070a458b15c_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktMTAtMS0xLTE0MDY0NQ_b227bddd-0642-46a5-ae3b-0f83fb901c80">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0773d411ab7f4a27a5bd3070a458b15c_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktMTItMS0xLTE0MDY0NQ_96d8bb46-b966-473e-a67a-d013f838f2bf">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0773d411ab7f4a27a5bd3070a458b15c_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktMTQtMS0xLTE0MDY0NQ_b150a0af-70a6-4dea-aa63-847e04364fdf">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTItMS0xLTE0MDY0NQ_19630259-f862-4f40-9a02-f33b15c0e73c">9.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTQtMS0xLTE0MDY0NQ_c0b0ca1b-7104-4e8b-9947-69f0f9dc4103">2,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTYtMS0xLTE0MDY0NQ_d3c9a04c-c93f-467a-afb4-39c4502140e9">883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTgtMS0xLTE0MDY0NQ_c41fe778-c370-42d6-ba14-11e89d231430">1,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTEwLTEtMS0xNDA2NDU_f02668a7-ada6-4514-b5bc-b7dd7f099793">3,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTEyLTEtMS0xNDA2NDU_4ce06d2f-2773-4b32-8a26-bf80527bc52f">804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTE0LTEtMS0xNDA2NDU_fa2f947e-21b9-4047-be4e-d5cf90a26dfb">2,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for other intangible assets was approximately $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzQyNw_b5148758-f2a2-4642-bf05-b23955ab7060">81</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzU0OTc1NTgxMzk0OTU_ca4807f8-7724-4f2a-bf10-4dbe03f7bcba">65</ix:nonFraction>&#160;million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzU0OTc1NTgxMzk1MDI_3fe3d176-5383-4db0-b151-12c929e9ce09">88</ix:nonFraction>&#160;million in 2020. </span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzYwMQ_86cec1dd-e836-4743-ba9e-9cbe2786f23b" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our estimate of amortization expense for each of the five next succeeding fiscal years: </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:81.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.614%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzEtMS0xLTEtMTQwNjQ1_e1a2cacc-da4b-426b-afe6-fca50be3f6c0">63</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzItMS0xLTEtMTQwNjQ1_565a1ce9-244e-442f-95a6-7de77b6ff930">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzMtMS0xLTEtMTQwNjQ1_b777523f-4e43-414f-8926-63321e229d4a">53</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzQtMS0xLTEtMTQwNjQ1_84b53a61-f747-47c3-8da9-f9c9c7d3b710">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzUtMS0xLTEtMTQwNjQ1_8c21a54a-3cc7-41ea-9d13-881027b83bf3">31</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_172"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTM_984b515e-65dd-4abd-9ae4-10b7ff4d947c" continuedAt="i750e7da0b33f48e28468dbb903d065d0" escape="true">LEASES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i750e7da0b33f48e28468dbb903d065d0" continuedAt="ief576955ebfc493d9e47eff2b53ea0e1"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if a contract contains a lease by evaluating the nature and substance of the agreement. We lease facilities, computer hardware, and other furniture and equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For new lease agreements, we combine lease and nonlease components for all of our asset classes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When portions of the lease payments are not fixed or depend on an index or rate, we consider those payments to be variable in nature. Our variable lease payments include, but are not limited to, common area maintenance, taxes and insurance which are not dependent upon an index or rate. Variable lease payments are recorded in the period in which the obligation for the payment is incurred. Most leases include options to renew, with renewal terms that can extend the lease term. The exercise of lease renewal options is at our sole discretion. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets included within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_aa3c46cd-ae1d-4dbb-b466-6a345a4c4ee1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_fb3c77fb-1c01-43eb-9b8e-b8c8b202045a">other long-term assets</span></span> in our consolidated balance sheets were $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE0NzY_a21e6e7f-d04d-4a90-b470-840b913a602c">515</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE0ODM_6144f2cd-7aee-495f-88aa-f7200a041be0">678</ix:nonFraction> million at December&#160;31, 2022 and December&#160;31, 2021, respectively. Operating lease liabilities included within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_0f510c82-dcff-42e3-bbab-71fc1ed8e909"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_f7698f80-d9e2-4b51-aa84-637d028779f0">trade accounts payable and accrued expenses</span></span> in our consolidated balance sheets were $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE2MDc_1fdd68d5-3aa1-409c-9256-64ea2e9a42e0">152</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE2MTQ_73333e8e-c6cd-42ab-b50a-0c73bb1eaa5b">185</ix:nonFraction> million at December&#160;31, 2022 and December&#160;31, 2021, respectively. Additionally, operating lease liabilities included within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_bc2d9dd9-e2c4-4f69-a280-01a78070d904"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_e06b9087-2af6-4553-b278-719cfd049d22">other long-term liabilities</span></span> in our consolidated balance sheets were $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE3MzY_661ee99a-5368-4e42-817e-104668b4401a">456</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE3NDM_345e6f6d-3685-4aaa-8d60-6919a6b35ef7">546</ix:nonFraction> million at </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="ief576955ebfc493d9e47eff2b53ea0e1"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022 and December&#160;31, 2021, respectively. The classification of our operating lease liabilities is based on the remaining lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, total fixed operating lease costs, excluding short-term lease costs, were $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE5NzE_95cb9b8c-6220-4990-ae5d-4a7f7cfa6704">183</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE5Nzg_fcb9bb3b-16c0-441d-8ee2-3fdccfbad5fe">159</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzQ5NDc4MDIzMjgyMDk_73fe4641-d4e7-44be-8103-3b595f160cf4">141</ix:nonFraction> million, respectively, and are included within operating costs in our consolidated statements of income. Short-term lease costs were not material for the years ended December&#160;31, 2022, 2021 and 2020. In addition, for the years ended December&#160;31, 2022, 2021 and 2020, total variable operating lease costs were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzIyMzY_abff7cc7-b851-48ad-9326-de013e4c2b6b">101</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzIyNDM_eb310957-5a5f-4f83-b0a4-bfb3380fa7ea">94</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzQ5NDc4MDIzMjgyNzA_e2259570-3452-43eb-bae3-9a4092aba9fe">92</ix:nonFraction> million, respectively, and are included within operating costs in our consolidated statements of income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sublease facilities or partial facilities to third party tenants for space not used in our operations. For the years ended December&#160;31, 2022, 2021 and 2020, sublease rental income was</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI1MDg_0531748e-e32f-4dc4-85c1-2413eaa00835">52</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI1MTU_3f55d725-af9b-46bc-ae2f-a42c66056718">43</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzQ5NDc4MDIzMjgzMDg_44bf3b54-f2c9-4c5d-8dcf-b7df0502d4de">36</ix:nonFraction> million, respectively, and is included within operating costs in our consolidated statements of income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term is <ix:nonNumeric contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI2NTk_73882f7f-8053-4f7b-99f9-48f26d634122"><ix:nonNumeric contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI2NTk_a5ba6c20-5ad6-4715-b487-be3dbaa17582">5.4</ix:nonNumeric></ix:nonNumeric> years with a weighted average discount rate of <ix:nonFraction unitRef="number" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI3MTA_49a708ac-7fa5-4eb6-b3be-0cb03636050b"><ix:nonFraction unitRef="number" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI3MTA_fa0c9af6-65e7-4a14-b96f-2ae0fafaccc5">3.2</ix:nonFraction></ix:nonFraction>% at December&#160;31, 2022 and December&#160;31, 2021. For the years ended December&#160;31, 2022, 2021 and 2020, cash paid for amounts included in the measurement of lease liabilities included within our operating cash flows was $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI4OTQ_a2ac308f-8d65-48ad-aaff-629ca4e38ff9">191</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI5MDE_7e024584-810f-4942-8cff-3776230d8400">165</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzQ5NDc4MDIzMjgzNTE_d130a489-c7c2-4a86-8bc1-e5f88d312490">146</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTI_d1edff0e-6d69-47a0-b13e-35d84a098e00" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:80.601%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity of&#160;Lease&#160;Liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzItMi0xLTEtMTQwNjQ1_1386f5f0-f870-4ab2-914c-6709e09f8653">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzMtMi0xLTEtMTQwNjQ1_d68ae360-6322-4c89-94f4-302bff2f02fd">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzQtMi0xLTEtMTQwNjQ1_d701fcfc-daf6-4a67-b60f-aa720f690f67">114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzUtMi0xLTEtMTQwNjQ1_542a960b-4ab8-43ef-b152-50c69068ceb6">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzYtMi0xLTEtMTQwNjQ1_b3230c69-9683-4f02-a732-72a06b54e67a">49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzctMi0xLTEtMTQwNjQ1_8c780d8b-5fa3-4e21-be7d-d13369304fca">116</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzgtMi0xLTEtMTQwNjQ1_1727372e-c9e2-4edd-acbf-a5507f8c646c">663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzktMi0xLTEtMTQwNjQ1_97a9abd9-202d-4b8f-90a7-a088c68a58aa">55</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzEwLTItMS0xLTE0MDY0NQ_385f5eef-8728-455b-b7c4-80eafdf140f5">608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of our leases do not provide an implicit rate, we use our incremental borrowing rate, as adjusted for collateralized borrowings, based on the information available at date of adoption or commencement date in determining the present value of lease payments.</span></div></ix:continuation><div style="margin-bottom:10pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_175"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:InsuranceDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzM3NTc_03bd27ba-6a1a-45b8-8f3c-5cda3eaf56af" continuedAt="ice95fa1281c84551b48a41941b9c4698" escape="true">BENEFITS PAYABLE</ix:nonNumeric></span></div><ix:continuation id="ice95fa1281c84551b48a41941b9c4698" continuedAt="i6b6e2d1e1ff540cab3d39c2ca2053acd"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzM3ODE_4a1c5d8e-becb-4e26-b396-75f23297d211" escape="true"><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:54.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at January&#160;1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzItMi0xLTEtMTQwNjQ1_d500f505-be80-4195-8da7-6176e6d7b71e">8,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzItNC0xLTEtMTQwNjQ1_d0e5f8b9-c671-44fc-98ca-5c8002572cc5">8,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzItNi0xLTEtMTQwNjQ1_db38861a-4eab-4036-b1c0-e0384739d004">6,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzQtMi0xLTEtMTQwNjQ1_c3735661-b9c3-4497-8b57-b256c9026f77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzQtNC0xLTEtMTQwNjQ1_b32d4dd7-870b-440b-a0d9-c381db791b70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231" decimals="-6" name="us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzQtNi0xLTEtMTQwNjQ1_49f418b6-5c48-4796-8fc6-e42e5bf70359">68</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at January 1, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzUtMi0xLTEtMTQwNjQ1_39fa5e1b-154a-41f1-8653-4b309720ad7f">8,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzUtNC0xLTEtMTQwNjQ1_5f6f26b1-8b3a-4e4e-b1e2-7acd82bf9e83">8,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzUtNi0xLTEtMTQwNjQ1_bb55a45a-3c61-4c8b-95da-7069cd6d4cd3">5,936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzYtMi0xLTEtMTQwNjQ1_13500f77-57fd-4f16-a581-e1b2a41b4af9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzYtNC0xLTEtMTQwNjQ1_f8ad0219-9ca6-4b07-ae0c-39b838aa9ae0">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzYtNi0xLTEtMTQwNjQ1_dd198f04-8b07-4b24-b6b8-2ebc6f9c3db4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzgtMi0xLTEtMTQwNjQ1_4bb1ce6a-0113-481c-8c5a-bee1a0ac8e87">76,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzgtNC0xLTEtMTQwNjQ1_f71ec1d4-9e5c-4309-b29e-297602dd21ab">70,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzgtNi0xLTEtMTQwNjQ1_a0b0e9af-87ce-47cc-ade9-5f204ccdf75d">61,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzktMi0xLTEtMTQwNjQ1_82ed9917-4d63-41eb-a5dc-ebaf5d7dca1e">415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzktNC0xLTEtMTQwNjQ1_e22015df-b924-45e1-9a1b-06c87f5f5a84">825</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzktNi0xLTEtMTQwNjQ1_5bdf5d22-8ef6-466c-8fc3-50db9c77cf4b">313</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEwLTItMS0xLTE0MDY0NQ_dbbf509d-a6e9-4b8f-8d89-85b725857759">75,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEwLTQtMS0xLTE0MDY0NQ_d31a0a6d-643a-4308-87f7-f14e45a8aba3">69,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEwLTYtMS0xLTE0MDY0NQ_9854d830-cf76-466e-bccf-471a6d54c1e0">61,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEyLTItMS0xLTE0MDY0NQ_24b5eb16-4271-4dcf-ac7e-ad89ab21faae">67,287</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEyLTQtMS0xLTE0MDY0NQ_7736375d-c472-496a-956f-64df4dc1e7c6">62,149</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEyLTYtMS0xLTE0MDY0NQ_9fff3f4d-1974-4865-954d-c0ba5decb5d8">54,003</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEzLTItMS0xLTE0MDY0NQ_8d01244a-fa5b-466d-8c33-14c6a126d24a">7,428</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEzLTQtMS0xLTE0MDY0NQ_9dd10f23-cf6e-4735-a14b-f7682d3f8f2a">6,946</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEzLTYtMS0xLTE0MDY0NQ_d2580672-c453-4cda-99cd-bf2962f8dd70">5,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE0LTItMS0xLTE0MDY0NQ_cf2a70f2-e98c-4fb0-81f2-7239bc02ebf9">74,715</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE0LTQtMS0xLTE0MDY0NQ_dd48f819-6b45-423d-97a6-28986363ed70">69,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForLossesAndLossAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE0LTYtMS0xLTE0MDY0NQ_fed5f177-8373-4443-8e1a-ceb928b58742">59,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December&#160;31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE3LTItMS0xLTE0MDY0NQ_ee16b459-6eca-4e31-9cea-fd1751b5b842">9,264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE3LTQtMS0xLTE0MDY0NQ_e306eeec-0a31-45d7-8710-418eb71ac7be">8,289</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231" decimals="-6" name="us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE3LTYtMS0xLTE0MDY0NQ_5484d668-bd9e-4ff4-b09d-a03777e50b9f">8,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total estimate of benefits payable for claims incurred but not reported, or IBNR, is included within the net </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incurred claims amounts. At December&#160;31, 2022, benefits payable included IBNR of approximately $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-8" name="us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzU0OTc1NTgxNDUwMTE_460551b3-6808-4f8a-966c-f13f2721f08b">5.7</ix:nonFraction>&#160;billion, primarily associated with claims incurred in 2022. The cumulative number of reported claims as of December&#160;31, 2022 was approximately <ix:nonFraction unitRef="claim" contextRef="i8fc949bd76c94ac0acb9625d55ca5689_I20221231" decimals="-5" name="hum:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzU0OTc1NTgxNDUwMzk_aa8c6bdd-79b8-4f93-97b9-e62048af3de6">173.5</ix:nonFraction>&#160;million for claims incurred in 2022, <ix:nonFraction unitRef="claim" contextRef="if00d8760e6f64b3b890040f421a1920e_I20221231" decimals="-5" name="hum:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzU0OTc1NTgxNDUwNTg_a61aa5d7-3863-4fa2-9fb7-45366b010d92">173.3</ix:nonFraction>&#160;million for claims incurred in 2021, and <ix:nonFraction unitRef="claim" contextRef="i2cd99d5331f347e4b92782b89a82aeb2_I20221231" decimals="-5" name="hum:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzU0OTc1NTgxNDUwODA_2a09a8e9-a225-4c0b-816b-606b4e8eeb21">149.8</ix:nonFraction>&#160;million for claims incurred in 2020.</span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Amounts incurred related to prior years vary from previously estimated liabilities as the claims ultimately are settled. Negative amounts reported for incurred related to prior years result from claims being ultimately settled for amounts less than originally estimated (favorable development).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously discussed, our reserving practice is to consistently recognize the actuarial best estimate of our ultimate liability for claims. Actuarial standards require the use of assumptions based on moderately adverse experience, which generally results in favorable reserve development, or reserves that are considered redundant. We experienced favorable medical claims reserve development related to prior fiscal years of $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1Xzg3MA_109194e5-b87d-4210-a748-9c3b2f79d48d">415</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1Xzg4MA_043f8c81-8329-4c45-9a2e-323d1327215e">825</ix:nonFraction> million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1Xzg5NA_9ff7af4b-8c9c-4f45-ac80-8f44ed33b006">313</ix:nonFraction> million in 2020.</span></div><div style="margin-bottom:12pt;margin-top:4pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical claims reserve development for 2022, 2021, and 2020 primarily reflects the consistent application of trend and completion factors estimated using an assumption of moderately adverse conditions. In addition, the higher prior year favorable development for the year ended December 31, 2021 was primarily attributable to the reversal of actions taken in 2020, including the suspension of certain financial recovery programs for a period of time impacting our claim payment patterns. The suspension during 2020 was intended to provide financial and administrative relief for providers facing unprecedented strain as a result of the COVID-19 pandemic.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incurred and Paid Claims Development</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion provides information about incurred and paid claims development as of December&#160;31, 2022, net of reinsurance, as well as cumulative claim frequency and the total of IBNR included within the net incurred claims amounts. The information about incurred and paid claims development for the years ended December 31, 2021 and 2020 is presented as supplementary information.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i6b6e2d1e1ff540cab3d39c2ca2053acd"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims frequency is measured as medical fee-for-service claims for each service encounter with a unique provider identification number. Our claims frequency measure includes claims covered by deductibles as well as claims under capitated arrangements. Claim counts may vary based on product mix and the percentage of delegated capitation arrangements.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzM3NDc_ebfeb68e-9ea5-42b4-9d0c-7da2f12d43b9" continuedAt="i671d84c976fb4a2ab7e2f6db29d68625" escape="true">The following tables provide information about incurred and paid claims development as of December&#160;31, 2022, net of reinsurance.</ix:nonNumeric></span></div><ix:continuation id="i671d84c976fb4a2ab7e2f6db29d68625"><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:54.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.890%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, Net of Reinsurance</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Claims Incurred Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf95e3840d049aab6f62e08d9ee6525_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzQtMi0xLTEtMTQwNjQ1_5d467392-00cb-4f06-87a8-b6c4ca7cb54b">61,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a30ac3b99249dcab52ec26094b0a75_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzQtNC0xLTEtMTQwNjQ1_974a6126-848d-4cb4-8d66-6edf8f9531ac">61,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd99d5331f347e4b92782b89a82aeb2_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzQtNi0xLTEtMTQwNjQ1_e55bed4c-9e42-4b44-b020-17d005e67198">61,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd981807e06146b9a8b7168780fa31e5_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzUtNC0xLTEtMTQwNjQ1_d88aa218-e152-499b-96ad-1b2c2f10a9a5">70,066</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00d8760e6f64b3b890040f421a1920e_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzUtNi0xLTEtMTQwNjQ1_8724db81-88b5-48e0-b3b0-1454e1905cfe">69,698</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc949bd76c94ac0acb9625d55ca5689_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzYtNi0xLTEtMTQwNjQ1_aa398fbd-e9e7-4388-9fac-4a53d3605319">76,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzctNi0xLTEtMTQwNjQ1_fd434f1d-740d-49f1-9e42-2104ef4a3ec8">207,027</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:53.883%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.891%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims, Net of Reinsurance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Claims Incurred Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcf95e3840d049aab6f62e08d9ee6525_I20201231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzQtMi0xLTEtMTQwNjQ1_ed5415b2-5076-4df5-9309-b22d59daa42e">54,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a30ac3b99249dcab52ec26094b0a75_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzQtNC0xLTEtMTQwNjQ1_a7220879-4fb8-447e-836f-f566b7ddce41">60,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cd99d5331f347e4b92782b89a82aeb2_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzQtNi0xLTEtMTQwNjQ1_03227288-b8a5-4603-8340-1b97c6f8e7e4">61,224</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd981807e06146b9a8b7168780fa31e5_I20211231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzUtNC0xLTEtMTQwNjQ1_3ab4ee4b-9d83-4e01-9ab4-bd9ac4f391c7">62,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if00d8760e6f64b3b890040f421a1920e_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzUtNi0xLTEtMTQwNjQ1_1c89b646-8288-448a-9772-423632bb6ec6">69,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8fc949bd76c94ac0acb9625d55ca5689_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzYtNi0xLTEtMTQwNjQ1_e865e637-090f-4b92-9e28-fa6b7181afda">67,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzctNi0xLTEtMTQwNjQ1_fd1c8ac1-754f-4c38-ab79-5b3c85493312">197,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All outstanding benefit liabilities before 2020, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzktNi0xLTEtMTQwNjQ1_7c7c2955-f5ef-432f-ad2b-28ac0253aa7a">9,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our benefits payable and benefits expense recognition, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in this Form 10-K.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_178"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzI0NTE_a3fcbd6b-e869-464e-b881-0e481444208f" continuedAt="ib5fb3f5fa49b477fb0bc9304bbf921e4" escape="true">INCOME TAXES </ix:nonNumeric></span></div><ix:continuation id="ib5fb3f5fa49b477fb0bc9304bbf921e4" continuedAt="i5fde25eaa5a840b08d49e26efac1771b"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzI0NTI_cb60e049-dcce-4187-9576-44ef4db0b31f" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:55.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current provision:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzMtMS0xLTEtMTQwNjQ1_0a9f3397-f8ee-4ed5-aa8d-fd15b3b8d18e">755</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzMtMy0xLTEtMTQwNjQ1_dfcd7250-cf46-4ef0-827b-6e75c89f2ab4">466</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzMtNS0xLTEtMTQwNjQ1_cfc65274-d7a0-45b0-a995-7833018a8ced">1,019</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States and Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzQtMS0xLTEtMTQwNjQ1_f9018cfa-1203-454e-a3c6-5650dc055f3c">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzQtMy0xLTEtMTQwNjQ1_c0f47d79-3ab1-4c1a-b43c-7bc4297c01d0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzQtNS0xLTEtMTQwNjQ1_10008244-831b-4584-98c8-71a80792eb81">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzUtMS0xLTEtMTQwNjQ1_f704a483-60ad-4ca5-8f08-2f7cf71957d3">862</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzUtMy0xLTEtMTQwNjQ1_6ed9ffa6-a0a0-4b99-ab99-f6958bbc9a10">470</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzUtNS0xLTEtMTQwNjQ1_e0032272-b822-4590-b2dd-df85cbc0601d">1,112</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzYtMS0xLTEtMTQwNjQ1_dfef530c-920e-415d-a39d-eff998b3c29f">100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzYtMy0xLTEtMTQwNjQ1_be803b7e-3d9f-46f1-ac81-7eab4699959f">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzYtNS0xLTEtMTQwNjQ1_ced396ae-345a-421e-b34f-ff0b3155a704">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzctMS0xLTEtMTQwNjQ1_dc0a12a4-44e8-4363-b879-d9edd79830a6">762</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzctMy0xLTEtMTQwNjQ1_2ffddf78-3a86-4b98-9bac-f880a3118a89">485</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzctNS0xLTEtMTQwNjQ1_4d57cfc3-6c41-44cf-b5ab-c8ad47cf0333">1,307</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzI0NTk_76a362f6-b289-4132-9239-6e7ef9578068" escape="true"><div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was different from the amount computed using the federal statutory rate for the years ended December&#160;31, 2022, 2021 and 2020 due to the following:</span></div><div style="margin-bottom:7pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:55.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision at federal statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzItMS0xLTEtMTQwNjQ1_ef3bc1e9-a6e1-4731-9eac-dc68d9ae7031">750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzItMy0xLTEtMTQwNjQ1_73035aa1-9ce4-4d79-8bb5-4be5905b1132">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzItNS0xLTEtMTQwNjQ1_62c9e5c8-8dbd-4a2e-9a31-f37f7b2466d4">982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, net of federal benefit, and Puerto Rico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzMtMS0xLTEtMTQwNjQ1_44366329-de4d-4a35-8463-5a5e084687a9">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzMtMy0xLTEtMTQwNjQ1_3b3775bb-acb3-465e-a9fa-76f0c774748b">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzMtNS0xLTEtMTQwNjQ1_68d59346-c15d-49b6-8087-71112e24235c">63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax exempt investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzQtMS0xLTEtMTQwNjQ1_43b031d4-e9d5-4df6-a408-4da225f151e3">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzQtMy0xLTEtMTQwNjQ1_adf0b53e-864e-41a5-b19f-29e4a68f6a9e">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxExemptIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzQtNS0xLTEtMTQwNjQ1_f206510c-677f-4068-87d6-d5226f19e12b">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzUtMS0xLTEtMTQwNjQ1_50e4422f-6564-49cf-9843-b7df75de1b41">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzUtMy0xLTEtMTQwNjQ1_d89fa7b4-4132-41ff-b7f3-8d92f0301e81">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzUtNS0xLTEtMTQwNjQ1_f71865fe-b1f7-4dab-98a4-59eca11e932f">19</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-taxable KAH gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:EffectiveIncomeTaxReconciliationNonTaxableKAHGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzYtMS0xLTEtMTQwNjQ1_ad5c7492-876c-4710-b8d8-7cd9a455511c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:EffectiveIncomeTaxReconciliationNonTaxableKAHGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzYtMy0xLTEtMTQwNjQ1_38eb439f-3e0f-4e9e-b1d8-dd96de17cd28">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:EffectiveIncomeTaxReconciliationNonTaxableKAHGain" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzYtNS0xLTEtMTQwNjQ1_70ce610d-b517-4440-a04c-1d7cf68a4d80">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect from sale of KAH Hospice</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctMS0xLTEtMTYzNTI2_3c1ab9a3-e6c4-4bd3-8a08-e592fc9f3fd3">72</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctMy0xLTEtMTYzNTI2_9282ae09-ba08-4c2d-bc9b-8d83d6d5a3b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxReconciliationDispositionOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctNS0xLTEtMTYzNTI2_5dd2b480-c13c-4b7a-a0f7-2d856a6809a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance industry fee </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctMS0xLTEtMTQwNjQ1_211fdc01-b949-45de-8cab-82563490a514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctMy0xLTEtMTQwNjQ1_d9c0cce7-8b74-498d-9424-ba01e14f8240">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctNS0xLTEtMTQwNjQ1_65d5c9ac-956f-4c30-9b43-cdd3d7c97ecf">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzktMS0xLTEtMTQwNjQ1_53cf661c-bee0-4ba4-ab15-6be8ace92c0e">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzktMy0xLTEtMTQwNjQ1_25e07f19-3124-4e93-844b-7b48abe81024">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzktNS0xLTEtMTQwNjQ1_b0103df8-9331-41ad-b3c8-d218341e8b1c">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzEwLTEtMS0xLTE0MDY0NQ_4990eb07-8049-4a7a-8840-af138576cd5d">762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzEwLTMtMS0xLTE0MDY0NQ_d028324b-b706-4259-9460-21d88e5741a0">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzEwLTUtMS0xLTE0MDY0NQ_e24eed02-9d6e-408a-8cba-02f6ebb00e84">1,307</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax balances reflect the impact of temporary differences between the tax bases of assets or liabilities and their reported amounts in our consolidated financial statements, and are stated at enacted tax rates expected to be in effect when the reported amounts are actually recovered or settled. </span></div></ix:continuation><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i5fde25eaa5a840b08d49e26efac1771b" continuedAt="i46aca8b0e8fb4f29b67afdc79441e6f9"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzI0NTA_4e71a5c5-94bf-474f-8655-4bd7b0bd4620" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal components of our net deferred tax balances at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:70.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.866%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets&#160;(Liabilities)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzMtMS0xLTEtMTQwNjQ1_1b05af84-0cca-4b5b-8464-fe50ced68613">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzMtMy0xLTEtMTQwNjQ1_3278dea6-8064-4811-a571-a56a4ac2c3d1">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and other accrued expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzQtMS0xLTEtMTQwNjQ1_29d1dd7b-281d-4fdd-be08-d70f18a0708e">158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzQtMy0xLTEtMTQwNjQ1_84fa56ac-1f0b-443e-b14d-a486528ece04">186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzUtMS0xLTEtMTQwNjQ1_ca473702-2820-48c4-9d59-a19cbc9d4ae0">103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzUtMy0xLTEtMTQwNjQ1_2bc61cdd-b7d5-46f7-b5fb-c9b4f40555e4">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="hum:DeferredTaxAssetsDeferredPolicyAcquisitionCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzYtMS0xLTEtMTQwNjQ1_40addb6e-10bd-4d3c-8fed-3de3118efdf0">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="hum:DeferredTaxAssetsDeferredPolicyAcquisitionCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzYtMy0xLTEtMTQwNjQ1_4d8d23b6-568b-439e-bd13-958accb38a76">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jobs tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="hum:DeferredTaxAssetJobsTaxCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzctMS0xLTEtMTQwNjQ1_0ae6c4c5-8573-4261-97a2-76acffca640f">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="hum:DeferredTaxAssetJobsTaxCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzctMy0xLTEtMTQwNjQ1_a3fcb727-cf07-4768-bc20-4cd3ea8afd42">33</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzgtMS0xLTEtMTQwNjQ1_fa4b04dd-e958-49fa-94de-60a4609564f5">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzgtMy0xLTEtMTQwNjQ1_d00494f5-55ea-439d-9d7a-f9a016309e09">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzktMS0xLTEtMTQwNjQ1_9e7f3cc2-eacf-413e-85ca-962f15d4e0c2">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzktMy0xLTEtMTQwNjQ1_58f4ee56-8460-4489-b186-c6159a29a498">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzExLTEtMS0xLTE0MDY0NQ_9c666066-28e2-4b06-9131-176d38f1cb05">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzExLTMtMS0xLTE0MDY0NQ_593f8a38-1715-4f5b-b4c3-d05dcf330340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzEzLTEtMS0xLTE0MDY0NQ_33f24f0d-46ea-42a3-be20-9515bd91ddd7">908</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzEzLTMtMS0xLTE0MDY0NQ_e34ef57d-fd0d-41cb-8c20-078e354fdc4f">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE0LTEtMS0xLTE0MDY0NQ_898568b5-8cbb-491c-9ec7-83f688dec02c">57</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE0LTMtMS0xLTE0MDY0NQ_690afe48-6b3a-4a5e-bf8e-2d58acf0c72c">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE1LTEtMS0xLTE0MDY0NQ_a570f573-fa26-4deb-a534-6139bf081fd4">851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE1LTMtMS0xLTE0MDY0NQ_9b85e58a-f1fb-4514-bfb9-70415cbc6951">578</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciable property and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="hum:DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE2LTEtMS0xLTE0MDY0NQ_ca5be8ae-c6da-4ae7-9616-c7bb115818b0">740</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="hum:DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE2LTMtMS0xLTE0MDY0NQ_dca07567-8f6d-4780-bd95-84a62874ece9">1,072</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE3LTEtMS0xLTE0MDY0NQ_824bbc8b-deb2-4c52-b978-3fdb8cdae7f9">132</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE3LTMtMS0xLTE0MDY0NQ_291cefab-4d86-4a08-94a0-c127d7303075">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE4LTEtMS0xLTE0MDY0NQ_27bffcef-0878-4555-8349-04419d1e3d22">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE4LTMtMS0xLTE0MDY0NQ_0f81b005-b6d3-487e-9599-1001f8f0df78">98</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE5LTEtMS0xLTE0MDY0NQ_0147bffe-f08c-43cb-a852-931f5aac4616">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE5LTMtMS0xLTE0MDY0NQ_59ba2523-46b5-49af-991a-2f339908205c">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzIwLTEtMS0xLTE0MDY0NQ_8078a919-40a7-436a-9003-cf5e39c347f3">878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzIwLTMtMS0xLTE0MDY0NQ_ad54bde7-e9ac-4d00-983d-860495322885">1,276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzIxLTEtMS0xLTE0MDY0NQ_f55af46b-9fbf-4f1d-a573-80671ae64c7d">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzIxLTMtMS0xLTE0MDY0NQ_826a620f-8642-46b9-b7e2-f72dfe68765d">698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All deferred tax liabilities and assets are classified as noncurrent in our consolidated balance sheets as other long-term liabilities at December 31, 2022  and 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had approximately $<ix:nonFraction unitRef="usd" contextRef="ia1c0825aa8d04ce187bd5863fbc3d91f_I20221231" decimals="-6" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzkyNQ_044b5c9e-363a-4058-8371-ad403d03b9ec">68</ix:nonFraction> million of federal net operating losses and approximately $<ix:nonFraction unitRef="usd" contextRef="i88c075a77c0b427e841063ff79561d21_I20221231" decimals="-8" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzk3OA_8bba5b51-8a3f-47c9-9597-cf18043ab6ef">1.6</ix:nonFraction> billion of state and Puerto Rico net operating losses to carry forward. A portion of these loss carryforwards, if not used to offset future taxable income, will expire from 2031 through 2038. The balance of the net operating loss carryforwards has no expiration date. Due to limitations and uncertainty regarding our ability to use some of the loss carryforwards and certain other deferred tax assets, a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzEzOTY_b07352b9-787b-423f-8c86-bbe29ab0b6e6">57</ix:nonFraction> million was established. For the remainder of the net operating loss carryforwards and other cumulative temporary differences, based on our historical record of producing taxable income and profitability, we have concluded that future operating income will be sufficient to recover these deferred tax assets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the United States and Puerto Rico.&#160;The U.S. Internal Revenue Service, or IRS, has completed its examinations of our consolidated income tax returns for 2020 and prior years. Our 2021 tax return is in the post-filing review period under the Compliance Assurance Process, or CAP. Our 2022 tax return is under advance review by the IRS under CAP. With a few exceptions, which are immaterial in the aggregate, we are no longer subject to state, local and foreign tax examinations for years before 2019.&#160;We are not aware of any material adjustments that may be proposed as a result of any ongoing or future examinations. We do not have material uncertain tax positions reflected in our consolidated balance sheets.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i46aca8b0e8fb4f29b67afdc79441e6f9">On August 16, 2022, the Inflation Reduction Act was signed into law. The Inflation Reduction Act includes various tax provisions, which are effective for the tax years beginning on or after January 1, 2023. There was no material impact on our consolidated financial statements at December 31, 2022.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_181"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzgxMjA_980954fc-66c7-4090-a6da-fd1405010758" continuedAt="idfde39235f8e449ab390829d1ac2fdb2" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="idfde39235f8e449ab390829d1ac2fdb2" continuedAt="i6c9ad5d8e42d4ea8a6d67e12ab338171"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzgxMTM_2f63ca4e-eb0a-42f6-be83-f2a9e52b90f4" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of debt outstanding was as follows at December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:61.981%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.877%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib173a9a9bf26418d85e8c702ffd7b911_I20221231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzMtMS0xLTEtMTQwNjQ1_9620f421-28a2-456d-b090-6a01cb5bfcc5">595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d89ea7a0994fdc830560ce43d6ccf3_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzMtMy0xLTEtMTQwNjQ1_de2280ec-0a29-4098-a7fe-fc4bc9927087">955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i99fded64e274478ab73f5733933c5a78_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMC0xLTEtMTUwMzE5L3RleHRyZWdpb246MWNlNDFjNmE2OTZmNGM3ZTkyODg3MjQyMjc4MjgwZTRfODc5NjA5MzAyMjIzOA_7161dffa-b778-4624-bbd5-0ea6339d1406">1,500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i99fded64e274478ab73f5733933c5a78_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMC0xLTEtMTUwMzE5L3RleHRyZWdpb246MWNlNDFjNmE2OTZmNGM3ZTkyODg3MjQyMjc4MjgwZTRfODc5NjA5MzAyMjI0OA_261393ef-164d-4b9f-9b16-5326f501db27">0.65</ix:nonFraction>% due August 3, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fded64e274478ab73f5733933c5a78_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMS0xLTEtMTQ4NDI1_0cef5c68-66fb-4c47-8c16-0c3c2d22a273">1,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6ab2d56c9c482ab6bb5a898cdae46b_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMy0xLTEtMTQ4NDI1_6676e611-72f3-4888-813f-6d9c5a03fc19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8db13c66deb74bf2857e79213be4b395_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246NTU2YTAyOTk3YWJlNDVmNjg1NTM2NzA4OWI2OGYwNmZfNA_8ee764b4-84d5-4eb0-a55d-a0c5abb51a26">600</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="i8db13c66deb74bf2857e79213be4b395_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246NTU2YTAyOTk3YWJlNDVmNjg1NTM2NzA4OWI2OGYwNmZfOA_b9370ff1-0807-4799-ae95-eccbfec29fd8">3.15</ix:nonFraction>% due December&#160;1, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8db13c66deb74bf2857e79213be4b395_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMS0xLTEtMTQwNjQ1_eae86b62-56f2-4232-8a38-a644d0774836">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0dfdeedfdae442b6bb69fbd7a0e139f1_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMy0xLTEtMTQwNjQ1_5b9863dc-05b6-4731-9c4a-681051aea1da">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic7f278945eb146999d7aa678fa21f058_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzYtMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246YjUwMmY1MDk1NTI4NDRjMTkyZDM2ZDQ3MGZhNzU5NWZfNA_67c7944f-d3c6-428f-9f2b-019ae2e1fa23">400</ix:nonFraction> million, <ix:nonFraction unitRef="number" contextRef="ic7f278945eb146999d7aa678fa21f058_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzYtMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246YjUwMmY1MDk1NTI4NDRjMTkyZDM2ZDQ3MGZhNzU5NWZfOA_935577c1-1a74-48a7-9474-4065d82aac4a">2.90</ix:nonFraction>% due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic7f278945eb146999d7aa678fa21f058_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzYtMS0xLTEtMTQwNjQ1_51320699-1cdf-4aa6-bf73-1ebe85df3ea6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0356912bdf2b4aabaeaff5e2ca21abc6_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzYtMy0xLTEtMTQwNjQ1_4a2be26d-3a44-485b-9808-5e3fbf4ab653">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59f9c510abc04bad91d14e68c501cf01_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzctMS0xLTEtMTQwNjQ1_e8a54fde-1e02-4062-a883-13c87b3514b1">1,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i773c7af03af34a47b324353282df0bf3_I20211231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzctMy0xLTEtMTQwNjQ1_6152bf68-6e25-4517-afcf-12be5e1559d3">998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzgtMS0xLTEtMTQwNjQ1_c4adb641-3bd1-4330-8e59-6fa83483d8e6">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzgtMy0xLTEtMTQwNjQ1_db250834-db9c-4f64-a59f-5287bb579658">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i99fded64e274478ab73f5733933c5a78_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEyLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjQyYzJiOWM3MmM0MDQwYmVhMGM3MGViODYxYzQ3Mjk1Xzg3OTYwOTMwMjIyNjI_ac6505d5-e3ce-4835-a4f2-72bf34f6e108">1,500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i99fded64e274478ab73f5733933c5a78_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEyLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjQyYzJiOWM3MmM0MDQwYmVhMGM3MGViODYxYzQ3Mjk1Xzg3OTYwOTMwMjIyNzA_c78bee87-d4d8-4c34-9852-886ca31441bf">0.65</ix:nonFraction>% due August 3, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99fded64e274478ab73f5733933c5a78_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEyLTEtMS0xLTE0MDY0NQ_37f883a4-1382-4be9-ba07-053ab30fbede">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd6ab2d56c9c482ab6bb5a898cdae46b_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEyLTMtMS0xLTE0MDY0NQ_522e60f0-3e05-4ad3-bffb-7ba7cdb46a68">1,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i5276601cfe0b4fac93dc9dddd8c95bea_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEzLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmU2NWExODZhZGE4NzRjMDlhMDAwOGRkZWE2MDIxZDMxXzg3OTYwOTMwMjIyNjM_5b3f0d93-21c5-4605-b024-1f8bf5c97db1">600</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i5276601cfe0b4fac93dc9dddd8c95bea_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEzLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmU2NWExODZhZGE4NzRjMDlhMDAwOGRkZWE2MDIxZDMxXzg3OTYwOTMwMjIyNzI_f1e86320-2bbb-4c59-bdea-cc3d370059c1">3.85</ix:nonFraction>% due October 1, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5276601cfe0b4fac93dc9dddd8c95bea_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEzLTEtMS0xLTE0MDY0NQ_edb3846a-718a-4a6b-88a6-9daa157cb92d">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i509fa063896747ef909206a07e142390_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEzLTMtMS0xLTE0MDY0NQ_5717a14e-c9da-433a-847f-4ef51b5e7a6f">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i36e388eca8694a32b6e8c72020b4c015_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmE2MjgzYzg4M2EwNjRkMmRiM2RlNTI2MzRlNmYyYjFlXzg3OTYwOTMwMjIyNTM_4f870c68-48a2-4088-a64c-365e17dac782">600</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i36e388eca8694a32b6e8c72020b4c015_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmE2MjgzYzg4M2EwNjRkMmRiM2RlNTI2MzRlNmYyYjFlXzg3OTYwOTMwMjIyNjE_3a7c6913-8a2f-46b1-926a-47087f6382b4">4.50</ix:nonFraction>% due April 1, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36e388eca8694a32b6e8c72020b4c015_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE0LTEtMS0xLTE0MDY0NQ_5502831a-2331-46d6-83ea-1ee76b9d4195">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibeb90e7ae11f495f937a25c066d3754b_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE0LTMtMS0xLTE0MDY0NQ_981a1560-64e2-4cdf-8069-f693ac7b3a1f">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i8368074918ac49a18d7b9cd1a553e8ab_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjYxOTU1NTgzMmU0NzQ2YTQ5Y2ZmYWVkYTgwZjEzNDEzXzg3OTYwOTMwMjIyNjU_b25f2e48-eb4b-4d3d-ba51-69cdcd482b47">750</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="i8368074918ac49a18d7b9cd1a553e8ab_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjYxOTU1NTgzMmU0NzQ2YTQ5Y2ZmYWVkYTgwZjEzNDEzXzg3OTYwOTMwMjIyNzQ_1d700543-0d35-41d2-a1cb-282aabdba3ba">1.35</ix:nonFraction>% due February 3, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8368074918ac49a18d7b9cd1a553e8ab_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE1LTEtMS0xLTE0MDY0NQ_8b0eb939-8e2d-4e06-abba-e57a2b23a00b">745</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id965da0f6c5b41cb887887c891386017_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE1LTMtMS0xLTE0MDY0NQ_a5c75149-4f3e-417d-aa2c-0c277d40083d">742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie10cec06f87647a3a1fa3fa523fe76b1_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE2LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjkwOTdjOThiMGI0MDQ3ZWE4YjAyYmRjOTFlMWVkMGFkXzg3OTYwOTMwMjIyNjI_64db7430-0657-4e17-a427-42c97b1584f5">600</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ie10cec06f87647a3a1fa3fa523fe76b1_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE2LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjkwOTdjOThiMGI0MDQ3ZWE4YjAyYmRjOTFlMWVkMGFkXzg3OTYwOTMwMjIyNzA_fb32164a-ce06-4b35-9b3e-51f30f751fb9">3.95</ix:nonFraction>% due March 15, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie10cec06f87647a3a1fa3fa523fe76b1_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE2LTEtMS0xLTE0MDY0NQ_8da1b3ae-07a2-41ac-87e5-934d8706b58a">597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied2ca976e98543e08e6ba87196523dfe_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE2LTMtMS0xLTE0MDY0NQ_538a4a47-7178-48f1-985a-6bef1462a292">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i232b89f9079741ccae985c3171fc7335_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTAtMS0xLTE2MTI0MC90ZXh0cmVnaW9uOjc1NWRiMzBmZDQ2ZDQ0ZjNhYzNhNzY4NGRkZTQyMTM3Xzg3OTYwOTMwMjIyMTI_535f56f3-eb0b-483b-b617-ce7dd9f85e21">500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i232b89f9079741ccae985c3171fc7335_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTAtMS0xLTE2MTI0MC90ZXh0cmVnaW9uOjc1NWRiMzBmZDQ2ZDQ0ZjNhYzNhNzY4NGRkZTQyMTM3Xzg3OTYwOTMwMjIyMTc_5eda8237-755c-49ee-b4f4-08ce9f7201ba">5.75</ix:nonFraction>% due March 1, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i232b89f9079741ccae985c3171fc7335_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTEtMS0xLTE2MTIyMQ_8bf587b7-6ad9-4e9c-8a7c-c74e14576774">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i853adef442584550b2d101e6ecef03e3_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTMtMS0xLTE2MTIyMQ_7fac8935-465f-431f-bb29-803e2f8b1fe8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic1b454e6cf714a3fa01d153c13807f69_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE3LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmM3ZWUyOGQ2Yjk5MzRlZDA5YjM5NWUzYjM0YTNmYjMzXzg3OTYwOTMwMjIyNjM_01ae9f05-a133-4284-a2a5-aa777b499e92">750</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ic1b454e6cf714a3fa01d153c13807f69_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE3LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmM3ZWUyOGQ2Yjk5MzRlZDA5YjM5NWUzYjM0YTNmYjMzXzg3OTYwOTMwMjIyNzI_8b3074f1-4dad-4a82-bdad-fa810c2079bd">3.70</ix:nonFraction>% due March 23, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1b454e6cf714a3fa01d153c13807f69_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE3LTEtMS0xLTE0MDY0NQ_29ad515f-651b-4373-bf2a-d636fd0d1681">743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1af71980b56546dd9dfa3f27ecfb67a5_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE3LTMtMS0xLTE0MDY0NQ_f564e8d4-9f69-4531-913c-dfd3df9519f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i6eb98a6499094af98d17a8f638209725_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmNlNGQ0MmE3ZTJlYTQ3MjViMjk5OTMyNzMzM2VmY2U4Xzg3OTYwOTMwMjIyNjQ_6f62e7a5-1789-485a-b3dd-aad60d836971">500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i6eb98a6499094af98d17a8f638209725_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmNlNGQ0MmE3ZTJlYTQ3MjViMjk5OTMyNzMzM2VmY2U4Xzg3OTYwOTMwMjIyNzM_7e6d78a6-55b1-40f2-8cb1-7d5ee0b1e8a1">3.13</ix:nonFraction>% due August 15, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb98a6499094af98d17a8f638209725_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTEtMS0xLTE0MDY0NQ_75e58238-d8e5-44c5-badf-25437e346d29">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia0ce78565c94456ab9c3991a4e4e4b5a_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTMtMS0xLTE0MDY0NQ_8c29434f-ccf4-4a84-b4dc-09add83411bb">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i708adb6138b2495a89218e1aa2f9c270_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjZlZTFmN2Q5MTZkNjRkMzZiZWQ0NTFhYjU5NDdjZTllXzg3OTYwOTMwMjIyNjI_4d09569a-f73a-4f33-83bc-6879cf708062">500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i708adb6138b2495a89218e1aa2f9c270_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjZlZTFmN2Q5MTZkNjRkMzZiZWQ0NTFhYjU5NDdjZTllXzg3OTYwOTMwMjIyNzI_d1a589c3-12c4-4701-99b8-c33e714d8b57">4.88</ix:nonFraction>% due April 1, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i708adb6138b2495a89218e1aa2f9c270_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE5LTEtMS0xLTE0MDY0NQ_f35e0702-2e0c-4242-8825-5b583d62e629">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ca72929b8994051a4a074df8437680d_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE5LTMtMS0xLTE0MDY0NQ_6985ef22-2f2f-4f36-80b4-f9fcfff89c8e">495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if64cdf61ab1842c79002bf0f3aa124c0_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjU4MzgwZjJjYmJmODQ0M2Q5MDYyZGYzNTZjOGFiNTVhXzg3OTYwOTMwMjIyNjQ_be9e3485-5a19-494a-9ce9-8cb7e2fe76f9">750</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="if64cdf61ab1842c79002bf0f3aa124c0_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjU4MzgwZjJjYmJmODQ0M2Q5MDYyZGYzNTZjOGFiNTVhXzg3OTYwOTMwMjIyNzI_0f291ce4-6005-4494-8b25-a211a156d09b">2.15</ix:nonFraction>% due February 3, 2032</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if64cdf61ab1842c79002bf0f3aa124c0_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIwLTEtMS0xLTE0MDY0NQ_f90c6652-5c09-470c-a47b-70e169df47c7">743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57de736a34744fdea94f1c8fdd485269_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIwLTMtMS0xLTE0MDY0NQ_752ab823-cdbc-46b0-9b3c-22f597081cdd">741</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ic096f056f036465dba708996f2f7a90c_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTAtMS0xLTE2MTI1Mi90ZXh0cmVnaW9uOjU2ZmNhZGQ1OTQ4MjRmZjZhYTgyY2NmNDk3NWExOTQwXzg3OTYwOTMwMjIyMTI_4e04b4aa-92ef-4b01-9b23-9e8ac9e4903a">750</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="ic096f056f036465dba708996f2f7a90c_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTAtMS0xLTE2MTI1Mi90ZXh0cmVnaW9uOjU2ZmNhZGQ1OTQ4MjRmZjZhYTgyY2NmNDk3NWExOTQwXzg3OTYwOTMwMjIyMTc_28cc4b14-d8e1-4e3b-94cb-e802d5c87bcd">5.88</ix:nonFraction>% due March 1, 2033</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic096f056f036465dba708996f2f7a90c_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTEtMS0xLTE2MTIyOQ_db35fefe-15f8-4b69-953e-a7086f899f54">739</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0e1c1afc93c410d8219b30b59c4221f_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTMtMS0xLTE2MTIyOQ_34f2fadc-1641-4c8f-8d92-9d6cc21d752f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg0ZGJlNDIyNTAwMzRmNmJiYzgyNTVmMDRiNDcxYzIyXzg3OTYwOTMwMjIyNjE_dfa33fb8-140d-4350-b529-5d8fbeace9de">250</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg0ZGJlNDIyNTAwMzRmNmJiYzgyNTVmMDRiNDcxYzIyXzg3OTYwOTMwMjIyNjk_6ff83a82-e963-4b91-b4f0-c41f993b9a8e">8.15</ix:nonFraction>% due June&#160;15, 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIxLTEtMS0xLTE0MDY0NQ_18b9f556-5dc1-472f-98eb-017bb6d11dd8">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i102f918dc90d487f9be67b46e5ad7593_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIxLTMtMS0xLTE0MDY0NQ_7d19c040-6c3d-428d-9d22-79556f01c77d">261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i62a760cb5c98497ab0e8bb6f03c6e29b_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIyLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmRlNDdhNTcxYjAzYjQyNWE5ZWE3YmE3MDI4OGQyZTRhXzg3OTYwOTMwMjIyNjU_25aa9332-5c64-4cbf-b34c-cd64084c3613">400</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i62a760cb5c98497ab0e8bb6f03c6e29b_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIyLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmRlNDdhNTcxYjAzYjQyNWE5ZWE3YmE3MDI4OGQyZTRhXzg3OTYwOTMwMjIyNzQ_dfc4ff05-5299-40b1-892e-bc9f5bfe201a">4.63</ix:nonFraction>% due December&#160;1, 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i62a760cb5c98497ab0e8bb6f03c6e29b_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIyLTEtMS0xLTE0MDY0NQ_c6ed099a-0afd-4d7d-851a-595cfd62f9ee">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i853fb2ba319a40ae809f5f370473eb91_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIyLTMtMS0xLTE0MDY0NQ_a7f74952-6253-4858-8a96-309d17300f56">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if5c6d742cb8343b8a723dafa1d57d5ad_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQwMmVlNWJhYTFlYzQxMGQ5MWQwMGUzZmFjZDZjOTUzXzg3OTYwOTMwMjIyNjM_b646dadf-2925-4b0f-b089-498eb5f3d51d">750</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="if5c6d742cb8343b8a723dafa1d57d5ad_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQwMmVlNWJhYTFlYzQxMGQ5MWQwMGUzZmFjZDZjOTUzXzg3OTYwOTMwMjIyNzI_c19cd4b0-6fd6-4c70-9655-ef1b6997fbac">4.95</ix:nonFraction>% due October 1, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5c6d742cb8343b8a723dafa1d57d5ad_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTEtMS0xLTE0MDY0NQ_c27e1631-8569-47a8-a847-8c91de510f4f">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50436e89d2dc4ae6aeff04066d91f1e4_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTMtMS0xLTE0MDY0NQ_b76684dc-733d-48b2-8377-be012fa42f36">740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i667465604c864997be52308f84abe858_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjZhZWQwMmQ0YWZkMTQwNmM4OTdmZjQwYWViN2E2OTdhXzg3OTYwOTMwMjIyNjI_ed680253-03c9-42f9-a958-e0f624af812d">400</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i667465604c864997be52308f84abe858_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjZhZWQwMmQ0YWZkMTQwNmM4OTdmZjQwYWViN2E2OTdhXzg3OTYwOTMwMjIyNzA_cd1b88b0-2603-4908-8243-f1255e6b2400">4.80</ix:nonFraction>% due March 15, 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i667465604c864997be52308f84abe858_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI0LTEtMS0xLTE0MDY0NQ_8d33f8ed-2c7a-4371-a484-0ad1a7d045e8">396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83b3d29f254448849e71cacdfe49dd10_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI0LTMtMS0xLTE0MDY0NQ_23361167-65d0-47dc-b695-ec61e69a08e9">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="i10bb54eaa9364a17b55f021b93ed865f_I20221231" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjY1ZjQ0MTc4Mjk0YzRjODRhODZjZGYwZDgxNzZjY2UwXzg3OTYwOTMwMjIyNjM_72bd1a27-d175-4f2c-9187-aba5a9730328">500</ix:nonFraction>&#160;million, <ix:nonFraction unitRef="number" contextRef="i10bb54eaa9364a17b55f021b93ed865f_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjY1ZjQ0MTc4Mjk0YzRjODRhODZjZGYwZDgxNzZjY2UwXzg3OTYwOTMwMjIyNzE_a825887c-b779-4603-8830-af21baecffea">3.95</ix:nonFraction>% due August 15, 2049</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10bb54eaa9364a17b55f021b93ed865f_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI1LTEtMS0xLTE0MDY0NQ_08b63675-cbf1-428a-b430-d487b95dba64">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5297e4cf2a114648b8e3b858f90ec33b_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI1LTMtMS0xLTE0MDY0NQ_0d2b2332-14de-4036-887a-7d2424a0b2a3">493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, due October 29, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81c11504dac94900b47f3adec13f2eac_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI4LTEtMS0xLTE0MDY0NQ_efd7a3f5-0698-4b59-b00b-8e1c70d32277">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dbea7f466654367bb2ffab6a0f398ae_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI4LTMtMS0xLTE0MDY0NQ_eabfa6ae-2cb2-43fe-a4de-cd47a882fc3c">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delayed draw term loan, due May 28, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6401b4f44735434682c78028a5989e89_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI5LTEtMS0xLTE0MDY0NQ_18ab8d12-8a0d-4a69-8351-baa59aac8586">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc85f1f2648a47f78a97ded8aed480aa_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI5LTMtMS0xLTE0MDY0NQ_b0d4e5cc-8834-4cb5-8808-929ae06b16f8">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzMwLTEtMS0xLTE0MDY0NQ_0bbe3457-3779-475e-8758-22d77f14d18b">9,034</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzMwLTMtMS0xLTE0MDY0NQ_da446fb5-3d9d-499a-80cd-f353879b11ad">10,541</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i6c9ad5d8e42d4ea8a6d67e12ab338171" continuedAt="ib96a7961727e4260a06e54a61888f52c"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzgxMTU_6070d5f6-706b-418c-ad5c-47ae05a3ebda" escape="true"><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the short-term and long-term debt for the years ending December 31, are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"></td><td style="width:79.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.094%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzEtMS0xLTEtMTQwNjQ1_9f34d201-2dc5-4acc-ba81-0111e95afee1">2,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzItMS0xLTEtMTQwNjQ1_2b486c2d-6f0a-437f-a259-85703b546457">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzMtMS0xLTEtMTQwNjQ1_6528978a-c436-4d8f-9ded-5bc347b6fdc4">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzQtMS0xLTEtMTQwNjQ1_1ea1ecea-1d66-4a53-8e3d-803cc9559b44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzUtMS0xLTEtMTQwNjQ1_3c019d26-2a1e-4e7c-b9ca-16b64a48d90d">1,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzYtMS0xLTEtMTQwNjQ1_903f6cad-a285-4be1-b57a-9f04775a15c8">6,050</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior notes, which are unsecured, may be redeemed at our option at any time at <ix:nonFraction unitRef="number" contextRef="i8d2e5c35e8664d878870c2ac31cb5a7f_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NDk4Nzc_fc8d7410-c84a-42ee-a236-17008bf5d5f0">100</ix:nonFraction>% of the principal amount plus accrued interest and a specified make-whole amount. The <ix:nonFraction unitRef="number" contextRef="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NDk4ODM_8727c5a8-bdd1-4c2a-95d7-28958d2fb0ec">8.15</ix:nonFraction>% senior notes are subject to an interest rate adjustment if the debt ratings assigned to the notes are downgraded (or subsequently upgraded). In addition, our senior notes contain a change of control provision that may require us to purchase the notes under certain circumstances. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we repaid $<ix:nonFraction unitRef="usd" contextRef="i3d642b46f9f947e1908279e62e1137c4_D20221201-20221201" decimals="-6" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzU0OTc1NTgxNzEwMDE_5c1f4f08-16e3-4066-93cf-eb892500589a">600</ix:nonFraction>&#160;million aggregate principal amount of our <ix:nonFraction unitRef="number" contextRef="i8db13c66deb74bf2857e79213be4b395_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzU0OTc1NTgxNzEwMTU_dc41aafc-de05-4a84-a523-16a945290043">3.150</ix:nonFraction>% senior notes due on their maturity date of December 1, 2022 and $<ix:nonFraction unitRef="usd" contextRef="id5f7b09cb2a44027b3040bd2bed6bdea_D20221215-20221215" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzU0OTc1NTgxNzEwMzE_966c2e73-8a39-4194-9313-c5a2c2ed7dd6">400</ix:nonFraction> million aggregate principal amount of our <ix:nonFraction unitRef="number" contextRef="ic7f278945eb146999d7aa678fa21f058_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzU0OTc1NTgxNzEwMjM_a25a5023-c272-49c1-aa2c-983d918e4162">2.900</ix:nonFraction>% senior notes due on their maturity date of December 15, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, we issued $<ix:nonFraction unitRef="usd" contextRef="i9d8c3540308f450bb7239d10b7acc3b7_I20221130" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NjAyOTI_91d6d807-63b7-4ed4-9a04-74465bc62201">500</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i9d8c3540308f450bb7239d10b7acc3b7_I20221130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTQwNTc_971b6c83-1f89-479e-8c97-dc023e22429c">5.750</ix:nonFraction>% unsecured senior notes due March 1, 2028 and $<ix:nonFraction unitRef="usd" contextRef="i63948e729cd5446e9ecb1103f8d97342_I20221130" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NjAzMzg_f65077a8-2f99-449f-b8f8-9da951c39745">750</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i63948e729cd5446e9ecb1103f8d97342_I20221130" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NjAzMTQ_fcb1d09b-1d1c-4eaa-aeb5-53ab116600d0">5.875</ix:nonFraction>% unsecured senior notes due March 1, 2033. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $<ix:nonFraction unitRef="usd" contextRef="i0b66643fcfdc4bc3aac6fe89fd6d2c8e_D20221101-20221130" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NjAzMjI_e7be1a28-7769-4ff3-b1f0-244202b21dd2">1.2</ix:nonFraction>&#160;billion. We used the net proceeds for general corporate purposes, which included the repayment of existing indebtedness.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we issued $<ix:nonFraction unitRef="usd" contextRef="i59c282fc7fc24fdfb266342670c5aa0e_I20220331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE5MTA_df3b4cb4-c402-405d-ac1e-5c9307bce2a4">750</ix:nonFraction>&#160;million of <ix:nonFraction unitRef="number" contextRef="i59c282fc7fc24fdfb266342670c5aa0e_I20220331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE5MzE_cafd9078-fd85-4cd1-9e54-37122b81c2fe">3.700</ix:nonFraction>% unsecured senior notes due March 23, 2029. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $<ix:nonFraction unitRef="usd" contextRef="i6147469181034d3693ebd758a56db336_D20220301-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE5NTI_0e9369c5-6d96-47b9-bc1c-605a05c86106">744</ix:nonFraction>&#160;million. We used the net proceeds for general corporate purposes, which included the repayment of existing indebtedness, including borrowings under our commercial paper program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delayed Draw Term Loan Credit Agreement</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into a $<ix:nonFraction unitRef="usd" contextRef="ic09be7d135374636bb90d8a931991af6_I20210531" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDYxMzc_ed4dd03c-e448-435c-aef7-f00b8c3ada52">500</ix:nonFraction>&#160;million unsecured delayed draw term loan credit agreement. Under the term loan credit agreement, loans bear interest at either LIBOR plus a spread or the base rate plus a spread. The loans under the term loan credit agreement mature on the third anniversary of the funding date. The LIBOR spread, currently <ix:nonFraction unitRef="number" contextRef="ibbb32b683c6d4c9389fc542d8b6ffe93_D20210501-20210531" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDYxNTU_25a63fd3-d4fb-4900-9125-28b673b5439c">125</ix:nonFraction> basis points, varies depending on our credit ratings ranging from <ix:nonFraction unitRef="number" contextRef="idbcdabf72f5c4bbfbf380741c218ce61_D20210501-20210531" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDYxNjY_084c6516-3013-486d-b4c9-57efda847503">100.0</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i58d6462307654072a27dd04f0987456f_D20210501-20210531" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDYxNzk_436d5fe8-a0e0-4f16-925c-165a53fd8dca">162.5</ix:nonFraction> basis points. The term loan credit agreement provides for the transition from LIBOR and does not require amendment in connection with such transition.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2021, we borrowed $<ix:nonFraction unitRef="usd" contextRef="i1f8d88b80b864d978dcce7b20445315e_D20210801-20210831" decimals="-6" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTM5ODU_19dfbac6-6b54-422c-b2f4-1a6487fffc97">500</ix:nonFraction>&#160;million under the delayed draw term loan agreement, which was used, in combination with other debt financing, to fund the approximate $<ix:nonFraction unitRef="usd" contextRef="i9699973b24d84dcaae4ebcf77e8bddfd_I20210831" decimals="-8" name="hum:BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTM5OTk_deb005bf-23d9-43ca-92e6-0f4d8210ec06">5.8</ix:nonFraction>&#160;billion transaction price of Kindred at Home. The term loan credit agreement contains customary restrictive covenants and a financial covenant regarding maximum debt to capitalization of <ix:nonFraction unitRef="number" contextRef="i112e4e9b6e9743f192f0c261f2174fb6_I20221231" decimals="INF" name="hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTQwMTM_5024d7ea-4a48-40a3-ba25-ef5b694e95f6">60</ix:nonFraction>%, as well as customary events of default. We are in compliance with this financial covenant, with actual debt to capitalization of <ix:nonFraction unitRef="number" contextRef="i112e4e9b6e9743f192f0c261f2174fb6_I20221231" decimals="3" name="hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTQwMjM_02b9efce-c59d-4782-8edb-7571e01effb7">42.0</ix:nonFraction>% as measured in accordance with the term loan credit agreement as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have other customary relationships, including financial advisory and banking, with some parties to the term loan agreement.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="ib96a7961727e4260a06e54a61888f52c" continuedAt="icce3cf61363f47bcb33e6501acc848ba"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2021 Term Loan Agreement</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 29, 2021, we entered into a $<ix:nonFraction unitRef="usd" contextRef="i387aa55175c54a05a686b101571c25cf_I20211029" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTE2NDc_38808cd0-67eb-43aa-9444-cd5441835b21">2.0</ix:nonFraction>&#160;billion term loan credit agreement, which we refer to as the October 2021 Term Loan Agreement, with certain lending banks and other financial institutions. Proceeds of the October 2021 Term Loan Agreement were applied to finance the repayment in full of the outstanding KAH debt of $<ix:nonFraction unitRef="usd" contextRef="i9d7e0a7171cf41f39322708915887790_D20211029-20211029" decimals="-8" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTIyMDA_8d02affd-af9f-4585-825b-fb106331cd70">1.9</ix:nonFraction>&#160;billion.</span></div><div style="text-align:justify;text-indent:24.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> repaid the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="iacb7e7be2c134f1a9b7ce6ca2f0f913d_I20220816" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDY5MDA_8f950101-33d7-4b46-919d-e35892648b73">2.0</ix:nonFraction>&#160;billion October 2021 Term Loan Agreement without a prepayment penalty due.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Revolving Credit Agreements</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we entered into a <ix:nonNumeric contextRef="ia4f21019238942898fb706ac9e7a0d38_D20210601-20210630" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkxNjg_949cc38c-6a6a-441e-a32c-e5b4a3c715ea">5</ix:nonNumeric>-year, $<ix:nonFraction unitRef="usd" contextRef="ie41025c3734b426daf406df47fee29ea_I20210630" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkxODQ_298741d9-a363-4468-8707-315bf8510433">2.5</ix:nonFraction>&#160;billion unsecured revolving credit agreement. Under the <ix:nonNumeric contextRef="ia4f21019238942898fb706ac9e7a0d38_D20210601-20210630" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDg1OTM_2bbd5c54-547b-4e1a-a76b-912c38716d17">5</ix:nonNumeric>-year revolving credit agreement, at our option, we can borrow on either a competitive advance basis or a revolving credit basis. The revolving credit portion bears interest at either LIBOR plus a spread or the base rate plus a spread. The competitive advance portion of any borrowings will bear interest at market rates prevailing at the time of borrowing on either a fixed rate or a floating rate based on LIBOR, at our option. The revolving credit agreement provides for the transition from LIBOR and does not require amendment in connection with such transition.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we entered into a <ix:nonNumeric contextRef="iba715c5c2419471eaade517586321b41_D20220601-20220630" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4MjA_af6292a4-dd17-4148-88eb-7a002838aad4">364</ix:nonNumeric>-day $<ix:nonFraction unitRef="usd" contextRef="ifa91146be05e483b86453c991c407783_I20220630" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4Mzg_6b84ab96-68e1-419b-b905-8f3efbf1c39e">1.5</ix:nonFraction>&#160;billion unsecured revolving credit agreement (replacing the <ix:nonNumeric contextRef="i60d5d66074474c979c41340bd209ed02_D20210601-20210630" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4NTY_41fc25b8-9388-499b-949d-bc169d0ea5f0">364</ix:nonNumeric>-day $<ix:nonFraction unitRef="usd" contextRef="ia2901fdf8be043b3b4ce7d10615715e0_I20210630" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4NzQ_c7ddcd6d-f337-472a-87b8-704b6b0b61b7">1.5</ix:nonFraction>&#160;billion unsecured revolving credit agreement entered in June 2021, which expired in accordance with its terms). Under the <ix:nonNumeric contextRef="iba715c5c2419471eaade517586321b41_D20220601-20220630" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4OTI_b23b3125-e4c8-4bd5-8385-051870315a9e">364</ix:nonNumeric>-day revolving credit agreement, at our option, we can borrow on either a competitive advance basis or a revolving credit basis. The revolving credit portion bears interest at Term SOFR or the base rate plus a spread. The competitive advance portion of any borrowings will bear interest at market rates prevailing at the time of borrowing on either a fixed rate or a floating rate based Term SOFR, at our option.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LIBOR spread, currently <ix:nonFraction unitRef="number" contextRef="id6aba1e961d1473e9cf526f0a1e804dc_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyMDc_484b80a9-841a-414e-b8b6-dbf65f80bcc5">110.0</ix:nonFraction> basis points under the <ix:nonNumeric contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDY5Njk_4880cd37-acbc-4657-b04b-ae0d99c4e977">5</ix:nonNumeric>-year revolving credit agreements and the SOFR spread, currently <ix:nonFraction unitRef="number" contextRef="ifd10b85dc8cd490b8688147f8bfb596e_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyMjk_59a1d204-522f-4da9-b71d-e9c1c0acf91d">115.0</ix:nonFraction> basis points under the <ix:nonNumeric contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyMTg_d2f86968-5627-4b11-b530-d1c2daa67a6d">364</ix:nonNumeric>-day revolving credit agreement, varies depending on our credit ratings ranging from <ix:nonFraction unitRef="number" contextRef="i1321063cfc7c48c188ce65d238c95fd0_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyNDE_1e17dbc0-44e7-4a5e-b897-6de37f36a119">91.0</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i158dd71369834c93b0a4333493fb0b28_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyNTM_365a7fe1-21f1-42c7-9a8e-3e6fb0a1660e">140.0</ix:nonFraction> basis points under the <ix:nonNumeric contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyNjI_0df26871-0d74-4817-9804-eed287c4436c">5</ix:nonNumeric>-year revolving credit agreement and from <ix:nonFraction unitRef="number" contextRef="i6a26405ed8ae484ba52bfc3819cacf40_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyNzA_d5971ee1-aa01-438a-8f8e-3f6e6341f747">94.0</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="ibfe28b2f52e240d0be900bf3683893a3_D20220101-20221231" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyODI_ca6ad3e8-16fd-47c2-b711-de6d5c6b1d2e">135.0</ix:nonFraction> basis points under the <ix:nonNumeric contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyOTM_a61add41-6a22-4153-ac94-24e81c9ba958">364</ix:nonNumeric>-day revolving credit agreement. We also pay an annual facility fee regardless of utilization. This facility fee, currently <ix:nonFraction unitRef="number" contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMDM_baa6a0c7-efa5-4441-8aeb-25e45f3714f5">15.0</ix:nonFraction> basis points, under the <ix:nonNumeric contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMTE_c25ffc9d-71d9-4edc-b1a0-04f92db044ba">5</ix:nonNumeric>-year revolving credit agreement and <ix:nonFraction unitRef="number" contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMTk_898953a8-18af-45bd-b09b-acb4783dab2f">10.0</ix:nonFraction> basis points under the <ix:nonNumeric contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMjk_54313f1a-2358-4dad-89a7-4764c9003137">364</ix:nonNumeric>-day revolving agreement, varies depending on our credit ratings ranging from <ix:nonFraction unitRef="number" contextRef="i146462488f28499dbcb4a352e9f0c578_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMzg_8fb296b6-481b-4c8e-a71e-bb50ff269017">9.0</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i5740b2f51a534ecb852d304efddc5ba4_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzNDg_8adbcccd-dbc8-4720-900c-34e9aad54378">22.5</ix:nonFraction> basis points under the <ix:nonNumeric contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDc2MDI_d29e58af-16b2-42cb-a1c3-e20603bea7a4">5</ix:nonNumeric>-year revolving credit agreement and from <ix:nonFraction unitRef="number" contextRef="ia2e4d343c10f4aa9ad919a757b1244b8_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzNTg_ea848873-d905-46fd-8fd4-0c20067f4bec">6.0</ix:nonFraction> to <ix:nonFraction unitRef="number" contextRef="i4ec6325dd17e4a189e564e299a71923b_D20220101-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-4" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzNjg_6e501260-09e9-43a2-8bf8-5ee344148ab8">15.0</ix:nonFraction> basis points under the <ix:nonNumeric contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzNzg_3bece305-2d35-44d3-847c-e54ea426e9d4">364</ix:nonNumeric>-day revolving credit agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the revolving credit agreements include standard provisions related to conditions of borrowing which could limit our ability to borrow additional funds. In addition, the credit agreements contain customary restrictive covenants and a financial covenant regarding maximum debt to capitalization of <ix:nonFraction unitRef="number" contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231" decimals="INF" name="hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzODc_4327d3c9-6ef9-4fe3-ad6d-d0aab1e3deef">60</ix:nonFraction>%, as well as customary events of default. We are in compliance with this financial covenant, with actual debt to capitalization of <ix:nonFraction unitRef="number" contextRef="i112e4e9b6e9743f192f0c261f2174fb6_I20221231" decimals="3" name="hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzOTQ_02b9efce-c59d-4782-8edb-7571e01effb7">42.0</ix:nonFraction>% as measured in accordance with the revolving credit agreements as of December&#160;31, 2022. Upon our agreement with one or more financial institutions, we may expand the aggregate commitments under the revolving credit agreements by up to $<ix:nonFraction unitRef="usd" contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231" decimals="-6" name="hum:LineOfCreditFacilityUncommittedIncrementalCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDk0MTQ_50a9d862-fec9-4a12-a4ea-e3651d885ad0">750</ix:nonFraction>&#160;million in the aggregate, to a maximum of $<ix:nonFraction unitRef="usd" contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231" decimals="INF" name="hum:LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDk0NDI_94c814e5-e7b7-49cb-97c3-763deda0de3c">4.75</ix:nonFraction>&#160;billion, across the <ix:nonNumeric contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDk0NTk_f2881a6f-78a8-4337-9836-5116183149e1">5</ix:nonNumeric>-year and <ix:nonNumeric contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDk0NjY_ab063656-8cd8-4e1a-9f50-7231f163cda3">364</ix:nonNumeric>-day revolving credit agreements. </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="icce3cf61363f47bcb33e6501acc848ba"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had <ix:nonFraction unitRef="usd" contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231" decimals="INF" name="us-gaap:LinesOfCreditCurrent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzNjM_def09ef3-72fe-42e4-a9fb-ec013d526ac9">no</ix:nonFraction> borrowings and approximately $<ix:nonFraction unitRef="usd" contextRef="i69a245a8dbe941efbcc60ad56f792d25_I20221231" decimals="-6" name="us-gaap:LinesOfCreditCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzMDE_82cbdaea-327d-41fd-a975-a393f74e7302">45</ix:nonFraction>&#160;million of letters of credit outstanding under the revolving credit agreements, including those of KAH. Accordingly, as of December&#160;31, 2022, we had $<ix:nonFraction unitRef="usd" contextRef="id81d6fd6825341bd9dfae06ccdae8e2e_I20221231" decimals="-8" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzMTQ_5f719171-1595-4ed5-a1e1-0e6ef09704ce">2.4</ix:nonFraction>&#160;billion of remaining borrowing capacity under the <ix:nonNumeric contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzODg_b951aaab-68e3-45e2-84be-82f8203d231b">5-year</ix:nonNumeric> revolving credit agreement and $<ix:nonFraction unitRef="usd" contextRef="i927e6ff7d6e14022a0d65ca7195d8616_I20221231" decimals="-8" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzMjg_f0247186-7ca7-4658-bb11-694f2e7ffb9d">1.5</ix:nonFraction>&#160;billion of remaining borrowing capacity under the <ix:nonNumeric contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzODc_b3af6bc0-a642-46f7-afe6-ff3b67fbfee2">364-day</ix:nonNumeric> revolving credit agreement (which excludes the uncommitted $<ix:nonFraction unitRef="usd" contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231" decimals="INF" name="hum:LineOfCreditFacilityUncommittedIncrementalCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzNDI_834172ae-343e-4b45-9a77-e4f36852decf">750</ix:nonFraction>&#160;million of incremental loan facilities), none of which would be restricted by our financial covenant compliance requirement. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have other customary relationships, including financial advisory and banking, with some parties to the revolving credit agreements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     Under our commercial paper program we may issue short-term, unsecured commercial paper notes privately placed on a discount basis through certain broker dealers at any time. On February 10, 2022, we increased the size of our commercial paper program to permit the issuance of commercial paper notes in an aggregate principal amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="i052c3330b4c2409992bdda8401167a8b_I20220210" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzczMjM_5f1a7ebb-a763-481d-846d-38dd466c7c3a">4</ix:nonFraction>&#160;billion compared to the prior amount not to exceed $<ix:nonFraction unitRef="usd" contextRef="ia2d89ea7a0994fdc830560ce43d6ccf3_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDIyNTE_a4e911a3-ce7d-43ec-8c7f-be8765e179c9">2</ix:nonFraction>&#160;billion. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. The maximum principal amount outstanding at any one time during the year ended&#160;December&#160;31, 2022&#160;was $<ix:nonFraction unitRef="usd" contextRef="i4e33a39278e94aba940321c53fbe7f78_D20220101-20221231" decimals="-6" name="us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzc2NDY_1f2e6bd6-3ba9-4261-84aa-139542c8035e">1,450</ix:nonFraction> million, with $<ix:nonFraction unitRef="usd" contextRef="ib173a9a9bf26418d85e8c702ffd7b911_I20221231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzc2NTU_9620f421-28a2-456d-b090-6a01cb5bfcc5">595</ix:nonFraction> million outstanding at December&#160;31, 2022 compared to $<ix:nonFraction unitRef="usd" contextRef="ia2d89ea7a0994fdc830560ce43d6ccf3_I20211231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzc2ODg_7ad7841e-06c8-437f-b880-b3badb53a825">955</ix:nonFraction> million outstanding at December 31, 2021. The outstanding commercial paper at December&#160;31, 2022 had a weighted average annual interest rate of <ix:nonFraction unitRef="number" contextRef="ib173a9a9bf26418d85e8c702ffd7b911_I20221231" decimals="4" name="us-gaap:ShortTermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzc4MDk_ba55a201-00b5-458a-b25b-ddd90a272238">4.92</ix:nonFraction>%.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Short-term Borrowings</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a member, through one subsidiary, of the Federal Home Loan Bank of Cincinnati, or FHLB. As a member we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. As of December&#160;31, 2022 and December&#160;31, 2021, we had <ix:nonFraction unitRef="usd" contextRef="i9061d9c9dbc8401d8cc25502ab63cf20_I20211231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTMzMDY_73db6775-550e-47ab-8c40-e73f9102659e"><ix:nonFraction unitRef="usd" contextRef="i114dcf8181f5421f9df917dc4561297f_I20221231" decimals="INF" name="us-gaap:ShortTermBorrowings" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTMzMDY_a06b286b-b01d-44a7-a820-54010cddae6f">no</ix:nonFraction></ix:nonFraction> outstanding short-term FHLB borrowings</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_184"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNjA_ffa2b542-47c2-4356-a01b-06abf5159204" continuedAt="if4af3dc8a8c144caa6569e9c512a17d0" escape="true">EMPLOYEE BENEFIT PLANS</ix:nonNumeric></span></div><ix:continuation id="if4af3dc8a8c144caa6569e9c512a17d0" continuedAt="i6143598138dc4cd5bffeed9fe05f1363"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Savings Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have defined contribution retirement savings plans covering eligible employees which include matching contributions based on the amount of our employees&#8217; contributions to the plans. The cost of these plans amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzI5MA_1bb2c33a-a09f-4bc7-8378-bf4ae73ea520">286</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMwMA_a9abb732-f656-4b63-9bcf-f7f9ec813f62">259</ix:nonFraction> million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxNA_5a95a1a1-6d61-4135-b87c-caa34534d5fa">236</ix:nonFraction> million in 2020. The Company&#8217;s cash match is invested pursuant to the participant&#8217;s contribution direction. Based on the closing price of our common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="hum:CompanyCommonStockClosingSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ2NQ_922703b7-dd54-4d54-a2e9-61523c0e3178">512.19</ix:nonFraction> on December&#160;31, 2022, approximately <ix:nonFraction unitRef="number" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="2" name="hum:DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzUwMg_89b70963-766f-4903-9780-4a39bc6e8713">11</ix:nonFraction>% of the retirement and savings plan&#8217;s assets were invested in our common stock, or approximately <ix:nonFraction unitRef="shares" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-5" name="hum:DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzYwMQ_d3bcf008-16ed-4484-a789-5e93ead11ac3">1.4</ix:nonFraction> million shares, representing approximately <ix:nonFraction unitRef="number" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="3" name="hum:DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzYzOQ_6e84b1dd-1f68-47e4-8b88-4fd3fe1c24c8">1.1</ix:nonFraction>% of the shares outstanding as of December&#160;31, 2022. At December&#160;31, 2022, approximately <ix:nonFraction unitRef="shares" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-5" name="hum:DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcyNQ_9c9bed2b-9d3c-4d39-b384-d93a48c2a58b">5.8</ix:nonFraction> million shares of our common stock were reserved for issuance under our defined contribution retirement savings plans.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have plans under which options to purchase our common stock and restricted stock units have been granted to executive officers, directors and key employees. Awards generally require both a change in control and termination of employment within <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzExMTE_380c78a9-8d1f-4046-acc8-d6ca8e63a167">2</ix:nonNumeric> years of the date of the change in control to accelerate the vesting, including those granted to retirement-eligible participants. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and vesting schedules for stock-based awards vary by type of grant. Generally, the awards vest upon time-based conditions. We have also granted awards to certain employees that vest upon a combination of time and performance-based conditions. The stock awards of retirement-eligible participants are generally earned ratably over the service period for each tranche. Accordingly, upon retirement the earned portion of the current tranche will continue to vest on the originally scheduled vest date and any remaining unearned portion of the award will be forfeited. Our equity award program includes a retirement provision that generally treats employees with a combination of age and years of services with the Company totaling <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzE5Nzg_8829ac99-0aa7-40e5-a7b0-13f7f62c0e41">65</ix:nonNumeric> or greater, with a minimum required age of </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i6143598138dc4cd5bffeed9fe05f1363" continuedAt="i20b23e404fb24d01843349eaf3c5ae7c"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzIwMjQ_2b44d5ec-cc2a-424c-b8b2-4c9047a33339">55</ix:nonNumeric> and a minimum requirement of <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzIwNTY_603076ac-9089-4d92-98f0-e8cc73bb0748">5</ix:nonNumeric> years of service, as retirement-eligible. Upon exercise, stock-based compensation awards are settled with authorized but unissued company stock or treasury stock. </span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNTI_b4a45f6f-c25a-476d-8df2-ac34d5fe2b2a" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation expense that has been charged against income for these plans was as follows for the years ended December 31, 2022, 2021, and 2020:</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:55.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense by type:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzMtMS0xLTEtMTQwNjQ1_79e2ed4e-c6ba-4720-9418-a569c8e794ea">207</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8e5bc41112049779d5fbc3865a6beb0_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzMtMy0xLTEtMTQwNjQ1_48daa978-c344-4ff6-9d49-37ad9d570d2a">171</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia611810824824c4998cefac84618de1b_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzMtNS0xLTEtMTQwNjQ1_cbef87ff-8fe6-4cf2-8af7-76d17bed309d">171</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzQtMS0xLTEtMTQwNjQ1_0f7a540f-971f-40dd-b83c-031d78de0922">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzQtMy0xLTEtMTQwNjQ1_07cf2ee6-54eb-4443-b5ef-1b5d5e59320c">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzQtNS0xLTEtMTQwNjQ1_849b30d3-c0e7-4550-a9a2-2ae087e5bdbc">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzUtMS0xLTEtMTQwNjQ1_22cc4300-7311-4b18-b71f-9a340a035040">216</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzUtMy0xLTEtMTQwNjQ1_3007698e-eb23-46de-8d9d-1f662117b27f">180</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzUtNS0xLTEtMTQwNjQ1_faaf5cd0-de5d-4f5c-ab6f-e235d89c1154">181</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzYtMS0xLTEtMTQwNjQ1_059beb62-d3eb-4254-9cf4-113e2815c17c">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzYtMy0xLTEtMTQwNjQ1_e82bc799-e91f-4b28-a276-8a0b0582ab75">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzYtNS0xLTEtMTQwNjQ1_04ca5b23-8f02-4c2e-b37d-184ba91a1fbc">29</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzctMS0xLTEtMTQwNjQ1_939dfb89-b14e-428a-8b27-6a609ca2f08b">188</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzctMy0xLTEtMTQwNjQ1_1bb26a21-e7e8-41f6-b145-3b889a54bbc9">165</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzctNS0xLTEtMTQwNjQ1_4773e122-e01e-40a0-8f90-e31f2fa39da3">152</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax benefit recognized in our consolidated financial statements is based on the amount of compensation expense recorded for book purposes, subject to limitations on the deductibility of annual compensation in excess of $500,000 per employee as mandated by the Health Care Reform Law. The actual tax benefit realized in our tax return is based on the intrinsic value, or the excess of the market value over the exercise or purchase price, of stock options exercised and restricted stock vested during the period, subject to limitations on the deductibility of annual compensation in excess of $500,000 per employee as mandated by the Health Care Reform Law. The actual tax benefit realized for the deductions taken on our tax returns from option exercises and restricted stock vesting totaled $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxNDE_4b64ba93-0d62-4b8c-89b1-02eeabee13af">31</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxNTE_0a297826-2dab-4862-bf93-f7d259d77e4b">28</ix:nonFraction>&#160;million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxNjU_89c4730d-3e46-4dd0-a441-107044b19484">32</ix:nonFraction> million in 2020. There was <ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxODU_1396e9a7-5000-4552-b6bb-0a9f6863ea9f"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxODU_806300f3-49b1-4890-94dd-7a5ea8b636fc"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="INF" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxODU_b0379c8a-24f8-4274-bc31-8278efa9db3b">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> capitalized stock-based compensation expense during these years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="ib289b93fe6734476ab8f5d0c5798ec39_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMyODQ_16b1ee9e-64c0-43c9-97b9-c2073d74201f">11.0</ix:nonFraction> million shares reserved for stock award plans under the Humana Inc. 2011 Stock Incentive Plan, or 2011 Plan, and <ix:nonFraction unitRef="shares" contextRef="i6f20dc8ac0564bccbfa9a003167f23df_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMzOTI_091ae8d0-f7c1-45be-a30d-79d640559af6">15.3</ix:nonFraction> million shares reserved for stock award plans under the Humana Inc. 2019 Stock Incentive Plan, or 2019 Plan. These reserved shares included giving effect to, under the 2011 Plan, <ix:nonFraction unitRef="shares" contextRef="iabaf7ad5365e4602a729a73898dd2781_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzM1NjY_49ed8694-fc1b-4fad-9299-bfe58a7cfb95">3.3</ix:nonFraction> million shares of common stock available for future grants assuming all stock options were granted or <ix:nonFraction unitRef="shares" contextRef="ibed54bbe914a4277a816a361d2be8669_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzM2NjM_30991d3e-3a68-4c00-8295-8610fdbd513f">1.4</ix:nonFraction> million shares available for future grants assuming all restricted stock were granted.&#160;These reserved shares included giving effect to, under the 2019 Plan, <ix:nonFraction unitRef="shares" contextRef="i000c50d1006145feb954575f49af33a2_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzM4MTU_cffe98fa-0ae2-4b7f-bc79-90c97adda509">11.2</ix:nonFraction> million shares of common stock available for future grants assuming all stock options were granted or <ix:nonFraction unitRef="shares" contextRef="i4357b2b8b1914d969c619a19a67d1b47_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzM5MTI_2674ce41-b990-4141-8629-7de0319f86bc">3.4</ix:nonFraction> million shares available for future grants assuming all restricted stock were granted. Shares may be issued from authorized but unissued company stock or treasury stock.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i20b23e404fb24d01843349eaf3c5ae7c" continuedAt="ie9c7a411c6f54419808b99cfb6fdb755"><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock is granted with a fair value equal to the market price of our common stock on the date of grant and generally vests in equal annual tranches over a <ix:nonNumeric contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczMzQ_fed267de-1e4b-4ff3-8160-70a22d133954">three year</ix:nonNumeric> period from the date of grant. Certain of our restricted stock grants also include performance-based conditions generally associated with return on invested capital and strategic membership growth. Restricted stock units have forfeitable dividend equivalent rights equal to the dividend paid on common stock. The weighted-average grant date fair value of our restricted stock was $<ix:nonFraction unitRef="usdPerShare" contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ2NDc_63b7280e-e6dc-45fd-a619-e78598c89ae5">430.06</ix:nonFraction> in 2022, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie8e5bc41112049779d5fbc3865a6beb0_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ2NTc_9bb4ccdd-6908-4cee-a935-84f86eb258ae">381.34</ix:nonFraction> in 2021, and $<ix:nonFraction unitRef="usdPerShare" contextRef="ia611810824824c4998cefac84618de1b_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ2NzE_77e425c8-6d7e-45df-805e-522fc9c4f274">354.66</ix:nonFraction> in 2020. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNDM_1ca03717-c38f-4546-8750-2332eaa4f43b" continuedAt="i1dc4c11bb3a84d0a853518c10e8d5a27" escape="true">Activity for our restricted stock was as follows for the year ended December&#160;31, 2022:</ix:nonNumeric></span></div><div style="margin-bottom:7pt;text-align:center"><ix:continuation id="i1dc4c11bb3a84d0a853518c10e8d5a27"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:70.121%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.887%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.889%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida62d357008f4ed0bc3246cc32b3771c_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzItMS0xLTEtMTQwNjQ1_51b92849-523a-4b12-ae1d-19eaf7468cdf">873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ida62d357008f4ed0bc3246cc32b3771c_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzItMy0xLTEtMTQwNjQ1_d6355772-0009-4d41-9ba6-383331f3f133">380.55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzMtMS0xLTEtMTQwNjQ1_ed25fe14-ecf2-4034-a126-e0732f8ee5df">492</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzMtMy0xLTEtMTQwNjQ1_30b7e07e-b83b-49e2-8979-213cecad1cca">430.06</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzQtMS0xLTEtMTQwNjQ1_4316d528-1825-4e96-9c28-3d9cc1aa91ee">449</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzQtMy0xLTEtMTQwNjQ1_c14bdb31-54c9-4e9a-b67e-2b868009f5bc">342.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzUtMS0xLTEtMTQwNjQ1_8113c6f1-e155-4b10-a40b-5394c01c3c64">103</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzUtMy0xLTEtMTQwNjQ1_05b0654c-5cd9-4985-b6b4-268126f31ec2">292.28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5c29ece986e14d5fbc1af74aef0f594b_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzYtMS0xLTEtMTQwNjQ1_9eb1c32f-5800-42c9-a445-204dcd21f75b">813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5c29ece986e14d5fbc1af74aef0f594b_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzYtMy0xLTEtMTQwNjQ1_6c30b399-0612-418c-af4a-a67b6bdf3ca0">429.22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately <ix:nonFraction unitRef="number" contextRef="i5c29ece986e14d5fbc1af74aef0f594b_I20221231" decimals="2" name="hum:ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ3ODI_2001eaad-6f54-446f-86f1-2dedc503b813">36</ix:nonFraction>% of the nonvested restricted stock at December 31, 2022 included performance-based conditions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of shares vested was $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ5MTM_a00411ae-6632-4e36-855e-5d00de74dfab">244</ix:nonFraction> million during 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ5Mjc_697c4548-5818-40f1-ba06-41b46e402acc">236</ix:nonFraction> million during 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ5NDU_b095a66e-e77f-46ee-8230-1e868fa39cfe">191</ix:nonFraction> million during 2020. Total compensation expense not yet recognized related to nonvested restricted stock was $<ix:nonFraction unitRef="usd" contextRef="i5c29ece986e14d5fbc1af74aef0f594b_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzUwNDc_cb8a345a-cdae-4d34-b982-5f778a704bff">202</ix:nonFraction> million at December&#160;31, 2022. We expect to recognize this compensation expense over a weighted-average period of approximately <ix:nonNumeric contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzUxNjc_67d896af-22dd-4db1-b25d-604969f53c43">1.7</ix:nonNumeric> years. There are no other contractual terms covering restricted stock once vested.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted with an exercise price equal to the fair market value of the underlying common stock on the date of grant. Our stock plans, as approved by the Board of Directors and stockholders, define fair market value as the average of the highest and lowest stock prices reported on the composite tape by the New York Stock Exchange on a given date. Exercise provisions vary, but most options vest in whole or in part <ix:nonNumeric contextRef="ic5e4929afcc240d981441f4b646c3c65_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzU2OTM_6d7c6caa-74ed-4c91-8136-f23552cfd27d">1</ix:nonNumeric> to <ix:nonNumeric contextRef="ibd04deeb98f941698ee17f88f8a23fbf_D20220101-20221231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzU2OTk_ae75abd7-8a88-472d-a152-64492130e04a">3</ix:nonNumeric> years after grant and expire <ix:nonNumeric contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzU3MzE_b040752a-522b-4779-a60d-43397dc002b8">7</ix:nonNumeric> years after grant.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value of each option granted during 2022, 2021, and 2020 is provided below. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNDE_d87f8e43-766f-47c3-8ec0-9fb22f5dfbe1" continuedAt="i110b44d045c0440f8512f6bbb68a76c3" escape="true">The fair value was estimated on the date of grant using the Black-Scholes pricing model with the weighted-average assumptions indicated below:</ix:nonNumeric></span></div><div style="margin-bottom:7pt;text-align:center"><ix:continuation id="i110b44d045c0440f8512f6bbb68a76c3"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:55.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.868%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value at grant date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzEtMS0xLTEtMTQwNjQ1_f66dad43-dafd-423e-9316-b8539e168fae">113.35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzEtMy0xLTEtMTQwNjQ1_9200c256-797a-44b1-99e9-fd8d6e763d37">92.21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzEtNS0xLTEtMTQwNjQ1_53097b46-08ba-437b-b8c1-65c01fc3b702">69.73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzItMS0xLTEtMTQwNjQ1_2d0d9abd-aeb3-41bb-a61d-85feb38a81a4">3.6</ix:nonNumeric> years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzItMy0xLTEtMTQwNjQ1_8bdb515b-ca94-447e-a3ad-6f595c47b0e9">3.7</ix:nonNumeric> years</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzItNS0xLTEtMTQwNjQ1_be3ea3cf-dfec-47e7-9163-6a9c5d0eb82c">4.0</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzMtMS0xLTEtMTQwNjQ1_2ba9c4f7-ca35-4de3-ac80-96a6fb31c6e3">36.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzMtMy0xLTEtMTQwNjQ1_58784b55-673a-40dc-b056-18dec656b12d">33.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzMtNS0xLTEtMTQwNjQ1_e53e780a-a1e5-4a02-9587-d715c80bbfa8">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate at grant date</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzQtMS0xLTEtMTQwNjQ1_b25c1ab4-9417-4f4c-b7b7-4332e274cff1">1.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzQtMy0xLTEtMTQwNjQ1_f7eb08a3-4763-4a8b-8f86-af0b0fa9487b">0.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzQtNS0xLTEtMTQwNjQ1_6bfd6879-9fe9-47a8-9209-58399ba858e1">1.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzUtMS0xLTEtMTQwNjQ1_8ddc38a0-c3ee-4c2d-8621-bfd44721fdea">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzUtMy0xLTEtMTQwNjQ1_a5ce95a7-2802-4e2f-b426-312725af6035">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzUtNS0xLTEtMTQwNjQ1_bf4ad104-fc9c-4a2a-9a99-d7fe66b28c88">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate the expected term for our employee stock options based on historical employee exercise behavior and base the risk-free interest rate on a traded zero-coupon U.S. Treasury bond with a term substantially equal to the option&#8217;s expected term.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="ie9c7a411c6f54419808b99cfb6fdb755"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The volatility used to value employee stock options is based on historical volatility. We calculate historical volatility using a simple-average calculation methodology based on daily price intervals as measured over the expected term of the option.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNTk_22384d44-6c9a-4808-a030-73f320ad2df5" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for our option plans was as follows for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:70.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.866%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160; Under<br/>Option</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzItMS0xLTEtMTQwNjQ1_1bb04f8e-a4ec-464b-b318-aa26082a35ec">310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzItMy0xLTEtMTQwNjQ1_afe25419-34b6-4fd4-bcfe-1a6921fe989d">339.08</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzMtMS0xLTEtMTQwNjQ1_fbeda628-c8e4-49cd-9957-a7e3fe8cc8f7">65</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzMtMy0xLTEtMTQwNjQ1_eecece81-af6a-4397-8bf6-e1146b9ceb09">425.32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzQtMS0xLTEtMTQwNjQ1_03752eac-1869-44e4-b362-5f9b5745d407">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzQtMy0xLTEtMTQwNjQ1_f6afa59d-3483-4f60-a8a9-23d38c219fc2">319.27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzUtMS0xLTEtMTQwNjQ1_e5dce04f-42ef-49b7-8d58-92d602db109b">8</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzUtMy0xLTEtMTQwNjQ1_44c222f9-b3d1-4812-853a-9f58e0939fd1">370.26</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzYtMS0xLTEtMTQwNjQ1_90f9d808-84b9-4810-9db1-93fab5dbb5f3">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzYtMy0xLTEtMTQwNjQ1_3c755f3f-f87d-4049-93dc-08603c4f334c">381.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at December&#160;31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzctMS0xLTEtMTQwNjQ1_722b2e51-8719-4f7d-a89f-7a598d66b6fe">48</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzctMy0xLTEtMTQwNjQ1_d4406839-e158-4baa-95c3-2d6a059057cf">345.90</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of  December&#160;31, 2022, outstanding stock options, substantially all of which are expected to vest, had an aggregate intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY3MTU_9a46b00d-dbdd-4107-93bd-275532caf9e0">26</ix:nonFraction> million, and a weighted-average remaining contractual term of <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY3NzI_ab469a92-d1f1-4203-ab20-3db5ac45eb05">4.9</ix:nonNumeric> years. As of December&#160;31, 2022, exercisable stock options had an aggregate intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY4NjE_52ead9c4-9faa-4ec8-91be-24b45a22d2e3">8</ix:nonFraction> million, and a weighted-average remaining contractual term of <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY5MTg_abd32609-5d8a-4bf9-81b3-c88928b811bc">4.1</ix:nonNumeric> years. The total intrinsic value of stock options exercised during 2022 was $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY5ODk_4dc819d7-595d-46a3-b97d-51abbb5bf3d1">32</ix:nonFraction> million, compared with $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcwMDc_500275be-5720-422a-9be7-b870ff15fcc5">18</ix:nonFraction> million during 2021 and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcwMjQ_23f049b0-a398-44c8-adb0-ac4a39fd5ad0">51</ix:nonFraction> million during 2020. Cash received from stock option exercises totaled $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcwODg_4997e985-bfd6-4ab9-beba-a21adf04aeea">51</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcwOTg_b395dbd6-459b-4b16-ab7c-bfbcd5b49780">30</ix:nonFraction> million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcxMTI_b41a7b6d-5d32-4ee0-8c46-03a4c858a7d2">61</ix:nonFraction> million in 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total compensation expense not yet recognized related to nonvested options was $<ix:nonFraction unitRef="usd" contextRef="i992f903cecc5400f81dfb547116cb415_I20221231" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcyMDE_ceb30c32-c657-46da-8d13-a9d156fa65e5">7</ix:nonFraction> million at December&#160;31, 2022. We expect to recognize this compensation expense over a weighted-average period of approximately <ix:nonNumeric contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczMjE_7e332a8f-6c23-4025-be94-43937c6a4509">1.7</ix:nonNumeric> years.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_187"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;<ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90ZXh0cmVnaW9uOjE3MTQ0Y2MyM2U1ODQzODNhNGQ1MjNmZGZkNjIxOTk5XzIwNg_cdbcd068-2c51-4367-a7d9-8e6c4a6a5782" continuedAt="ic692f02b59394b088cc5a82324d7f927" escape="true">EARNINGS PER COMMON SHARE COMPUTATION</ix:nonNumeric></span></div><ix:continuation id="ic692f02b59394b088cc5a82324d7f927"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90ZXh0cmVnaW9uOjE3MTQ0Y2MyM2U1ODQzODNhNGQ1MjNmZGZkNjIxOTk5XzE5Ng_417d2bda-8632-4e49-b3d6-83ba9782778d" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Detail supporting the computation of basic and diluted earnings per common share was as follows for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except&#160;per<br/>common share results, number&#160;of<br/>shares/options in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income available for common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzItMS0xLTEtMTQwNjQ1_5c93cfef-f26d-4353-894d-b3be47d4397f">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzItMy0xLTEtMTQwNjQ1_33c76633-2afc-43a1-919d-6b2787b74693">2,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzItNS0xLTEtMTQwNjQ1_2892dc23-1cc9-4cff-a43b-b0af04cb72f0">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average outstanding shares of common stock used to <br/>&#160;&#160;&#160;&#160;compute basic earnings per common share</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzMtMS0xLTEtMTQwNjQ1_b051d1a8-4f52-441d-a06a-8e8a23be012b">126,419</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzMtMy0xLTEtMTQwNjQ1_6fb58185-e8dc-4b9f-84f0-38969181b425">128,688</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzMtNS0xLTEtMTQwNjQ1_eebd22f7-2185-469e-877c-7f3728ba7ce7">132,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzUtMS0xLTEtMTQwNjQ1_3cd45c0f-d430-474e-9f3b-61a0d2a0c65f">50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzUtMy0xLTEtMTQwNjQ1_04e19936-cc1f-445d-96b9-51b144fddd09">64</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzUtNS0xLTEtMTQwNjQ1_8b7ea799-da63-4142-ab7f-cd1da3c4a818">92</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzYtMS0xLTEtMTQwNjQ1_8a568fee-4c6f-4821-90fd-5affaa26ca16">625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie8e5bc41112049779d5fbc3865a6beb0_D20210101-20211231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzYtMy0xLTEtMTQwNjQ1_dcf1c091-d3fb-45b0-87d3-450b571c80a1">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia611810824824c4998cefac84618de1b_D20200101-20201231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzYtNS0xLTEtMTQwNjQ1_56311fde-40e0-4b05-9869-7ec65057abda">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted earnings per&#160;common share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzctMS0xLTEtMTQwNjQ1_2e853f10-ebde-4515-b9ef-2dfc5142ac95">127,094</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzctMy0xLTEtMTQwNjQ1_b3726b17-9584-46cd-ab99-9c5105381ac9">129,396</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzctNS0xLTEtMTQwNjQ1_2c0bc5a9-b51f-4181-b2af-b864ddfa37c8">133,012</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzgtMS0xLTEtMTQwNjQ1_926e0682-92f4-4497-b58e-eb08439d96e8">22.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzgtMy0xLTEtMTQwNjQ1_0f373657-c846-49a3-bf77-cbbaf4cb0f64">22.79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzgtNS0xLTEtMTQwNjQ1_44954585-4660-4703-bbe9-8571e7a16846">25.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzktMS0xLTEtMTQwNjQ1_0ae93125-a6b3-4e22-b822-3636446e238a">22.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzktMy0xLTEtMTQwNjQ1_1bc6a62e-1670-4dc5-82a4-800668f5acd8">22.67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzktNS0xLTEtMTQwNjQ1_dff9a4ec-f523-4e51-8df2-d050bd820254">25.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of antidilutive stock options and restricted stock&#160;awards <br/>&#160;&#160;&#160;&#160;excluded from computation</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzEwLTEtMS0xLTE0MDY0NQ_71b6c153-ec16-4007-8c2f-efb81c4ed94d">205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzEwLTMtMS0xLTE0MDY0NQ_b41465dc-edcf-478b-91a4-cc9953cbb543">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzEwLTUtMS0xLTE0MDY0NQ_75f87674-cb74-45ce-8f07-7a5accd9ca8e">238</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_190"></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNTc1_c0d988b9-00f2-47ad-bc61-c7b499ffebd4" continuedAt="ie922a8202fc14e52b75b0d837b65432f" escape="true">STOCKHOLDERS&#8217; EQUITY</ix:nonNumeric></span></div><ix:continuation id="ie922a8202fc14e52b75b0d837b65432f" continuedAt="ib9cbcc388b9c4cc3940ce289c655c0ce"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="hum:ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNjA3_b2c9f77a-3ee1-40b7-b915-86ad68bd763f" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of dividend payments, excluding dividend equivalent rights, in 2020, 2021, and 2022, under our Board approved quarterly cash dividend policy:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:64.117%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.486%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.487%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzItMi0xLTEtMTQwNjQ1_41641260-0026-4a8d-a415-6f8395eda656">2.43</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzItNC0xLTEtMTQwNjQ1_d77ca2f9-3e08-461c-bfa0-75826b924c1b">322</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzMtMi0xLTEtMTQwNjQ1_7ec9aed2-bd1b-4bc9-a09d-5c60f5a89543">2.73</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzMtNC0xLTEtMTQwNjQ1_1282f9ed-56a6-4513-94ba-741a2d9b50d9">351</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzQtMi0xLTEtMTQwNjQ1_be9e3752-b9c3-4bad-b069-98d3a7d67379">3.06</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:Dividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzQtNC0xLTEtMTQwNjQ1_93c7168d-2fb2-4110-a68c-6aa5b785011d">390</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, the Board declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i60f1ff28ff564a1ebbe436416a7471f0_D20221001-20221031" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzI3MA_c43c8bd5-2751-44f1-ab37-0d82fb4362cf">0.79</ix:nonFraction> per share payable on January&#160;27, 2023 to stockholders of record on December&#160;30, 2022 for an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzM3MQ_bc1460a7-1d7d-437e-80b9-89286d0ca934">98</ix:nonFraction> million. In February 2023, the Board declared a cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i002fe084afec40a3b3544bd5ca40dff0_D20230201-20230216" decimals="4" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzQzMQ_b66dea91-e638-4c12-9a9f-2770f54e646b">0.8850</ix:nonFraction> per share payable on April&#160;28, 2023 to stockholders of record on March&#160;31, 2023. Declaration and payment of future quarterly dividends is at the discretion of our Board and may be adjusted as business needs or market conditions change.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors may authorize the purchase of our common shares. Under our share repurchase authorization, shares may have been purchased from time to time at prevailing prices in the open market, by block purchases, through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or in privately-negotiated transactions (including pursuant to accelerated share repurchase agreements with investment banks), subject to certain regulatory restrictions on volume, pricing, and timing. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2020, we entered into separate accelerated stock repurchase agreements, ("the December 2020 ASR Agreements"), with Citibank, N.A., or Citi, and JPMorgan Chase Bank, or JPM, to repurchase $<ix:nonFraction unitRef="usd" contextRef="i0179480f2bae4075beb28f01cc367fc2_I20201222" decimals="INF" name="hum:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTM5NDE_c81c2541-1725-4c2c-b679-ed5f0964b1b1">1.75</ix:nonFraction>&#160;billion of our common stock as part of the $<ix:nonFraction unitRef="usd" contextRef="iba989f1957d14bd5ad09090a3705faec_I20190730" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTM5NTY_d57acdbe-45b1-459a-8670-411b8d6e72ad">3</ix:nonFraction>&#160;billion repurchase program authorized by the Board of Directors on July 30, 2019. On December 23, 2020, in accordance with the December 2020 ASR Agreements, we made a payment of $<ix:nonFraction unitRef="usd" contextRef="iafa1f29c11f64ee4a23c6d619014a6bb_I20201223" decimals="-7" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwMDI_ba45b9e8-4b5c-4bae-a502-f31cd016e77d">1.75</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="ic232bc3e290f4655953c1352a27704bc_I20201223" decimals="-6" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwMTc_009fe088-9fe4-4054-a459-913e3ec67dcd">875</ix:nonFraction>&#160;million to Citi and $<ix:nonFraction unitRef="usd" contextRef="i19f92caa5fd741989e66515605b91004_I20201223" decimals="-6" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwMzE_98b384aa-e165-4fe2-9dcc-a426dd8e35cc">875</ix:nonFraction>&#160;million to JPM) and received an initial delivery of <ix:nonFraction unitRef="shares" contextRef="i3c75a59f8572479c926935996bad608e_D20201223-20201223" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwNDU_50a90a94-2187-42e1-ba74-bf2a2272c676">3.8</ix:nonFraction>&#160;million shares of our common stock (<ix:nonFraction unitRef="shares" contextRef="i53cd41e672c644b48afcbba07fd3e06f_D20201223-20201223" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwNTg_45973b06-5eed-45e5-a031-56f440d20012"><ix:nonFraction unitRef="shares" contextRef="ia0334069ef954f71908cae7a3e991ead_D20201223-20201223" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwNTg_98e70f3b-5c21-45e1-b902-81ae0b305169">1.9</ix:nonFraction></ix:nonFraction>&#160;million shares each from Citi and JPM). We recorded the payments to Citi and JPM as a reduction to stockholders&#8217; equity, consisting of an $<ix:nonFraction unitRef="usd" contextRef="ia0baee71e7f548278d68833140520ee3_D20201201-20201231" decimals="-8" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwNzE_6e3a3fed-da97-4702-9a22-540aa61ca032">1.5</ix:nonFraction>&#160;billion increase in treasury stock, which reflects the value of the initial <ix:nonFraction unitRef="shares" contextRef="i3c75a59f8572479c926935996bad608e_D20201223-20201223" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwODU_a9dc432d-3b16-4dd8-a663-f1e281715d57">3.8</ix:nonFraction>&#160;million shares received upon initial settlement, and a $<ix:nonFraction unitRef="usd" contextRef="i3c75a59f8572479c926935996bad608e_D20201223-20201223" decimals="-5" name="hum:TreasuryStockDecreaseInCapitalInExcessOfParValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5NjY_a694d9b4-c991-4cb5-bf01-3fe635556df4">262.5</ix:nonFraction>&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Citi and JPM pending final settlement of the December 2020 ASR Agreements. Upon final settlement of the December 2020 ASR agreements with Citi and JPM on May 4, 2021 and May 5, 2021, respectively, we received an additional <ix:nonFraction unitRef="shares" contextRef="id8fb3265c7324998bfb3a80ce36e5b0b_D20210504-20210504" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxMzI_c1f3c6a1-641d-4051-a067-119c2b935bef">0.3</ix:nonFraction>&#160;million shares and <ix:nonFraction unitRef="shares" contextRef="i350835a15d964c85bd84001ed39b4e0c_D20210505-20210505" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxNDU_37919bb3-bbd3-4229-970c-e28133f83f7b">0.3</ix:nonFraction>&#160;million shares, respectively, as determined by the average daily volume weighted-averages share price of our common stock during the term of the agreement, less a discount, of $<ix:nonFraction unitRef="usdPerShare" contextRef="id8fb3265c7324998bfb3a80ce36e5b0b_D20210504-20210504" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxNTg_4187f3dc-a399-4e54-ad09-ad66ae99095f">400.07</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i350835a15d964c85bd84001ed39b4e0c_D20210505-20210505" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxNjc_5d64ebc3-b167-46ce-9c1e-8c2174501ddd">401.49</ix:nonFraction>, respectively, bringing the total shares received under the December 2020 ASR agreements to <ix:nonFraction unitRef="shares" contextRef="i70684713b18a4b98947fa4e3302512a4_D20201222-20210505" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxNzY_43416f23-08bd-4c79-834d-af3ca0e08503">4.4</ix:nonFraction>&#160;million. In addition, upon settlement we reclassified the $<ix:nonFraction unitRef="usd" contextRef="i73e1a9fbd6384960a77b548a06888967_D20210505-20210505" decimals="-5" name="hum:CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5ODk_625c3c3e-c8c1-49ff-b7fb-c1362c3bac3f">262.5</ix:nonFraction>&#160;million value of stock initially held back by Citi and JPM from capital in excess of par value to treasury stock.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2021, the Board of Directors replaced the previous share repurchase authorization of up to $<ix:nonFraction unitRef="usd" contextRef="i495ee173617d40c9a28f5030f6631472_I20210218" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQyMTY_6b077fff-5a85-41bc-bbac-ecc8d265af44">3</ix:nonFraction>&#160;billion (of which approximately $<ix:nonFraction unitRef="usd" contextRef="i495ee173617d40c9a28f5030f6631472_I20210218" decimals="-9" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTU2OTQ_22d760bc-6ed9-4c09-8f76-9826f1980e73">1</ix:nonFraction>&#160;billion remained unused) with a new authorization for repurchases of up to $<ix:nonFraction unitRef="usd" contextRef="i495ee173617d40c9a28f5030f6631472_I20210218" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQyMjg_46a2e430-c6ff-45bb-aded-b1cdd7b50124">3</ix:nonFraction>&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 18, 2024.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2022, we entered into separate accelerated stock repurchase agreements, the January 2022 ASR Agreements, with Mizuho Markets Americas LLC, or Mizuho, and Wells Fargo Bank, or Wells Fargo, to repurchase $<ix:nonFraction unitRef="usd" contextRef="id0b96effe20c452e850f5e6c15c8f8d3_I20220111" decimals="-9" name="hum:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQyNjA_ea90e373-bcc6-4926-adc9-7966636bb408">1</ix:nonFraction>&#160;billion of our common stock as part of the $<ix:nonFraction unitRef="usd" contextRef="i495ee173617d40c9a28f5030f6631472_I20210218" decimals="-9" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQyNzI_a48c4e41-116f-42b5-868e-847a2ecdfd81">3</ix:nonFraction>&#160;billion repurchase program authorized by the Board of Directors on February 18, 2021. On January 12, 2022, in accordance with the January 2022 ASR Agreements, we made a </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="ib9cbcc388b9c4cc3940ce289c655c0ce" continuedAt="iaacf8d6e880f44c683491688aff3581f"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment of $<ix:nonFraction unitRef="usd" contextRef="i9dd45b09421342e6818a93611f04d810_I20220112" decimals="-9" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzMjE_bad0f6b4-daee-4084-a97d-1c40cadd7686">1</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="i4aebd9fa2ef54f84820765f00217687b_I20220112" decimals="-6" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzMzM_34872fd9-24db-44f3-9c53-a2c1b7a25887">500</ix:nonFraction>&#160;million to Mizuho and $<ix:nonFraction unitRef="usd" contextRef="ibed82a92406149c48f61066e76a21f70_I20220112" decimals="-6" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5MjA_91610a0f-9383-4286-a6fb-70f57cb7ff7d">500</ix:nonFraction>&#160;million to Wells Fargo) and received an initial delivery of <ix:nonFraction unitRef="shares" contextRef="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5NDY_5c091fbb-8bba-499b-ab64-9e64d2a0b4c4">2.2</ix:nonFraction>&#160;million shares of our common stock (<ix:nonFraction unitRef="shares" contextRef="ia10d21e8a157411e9877dc680a3ee356_D20220112-20220112" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzNTM_3469a6b4-f3e0-41ca-8324-80f7e93d3dc3"><ix:nonFraction unitRef="shares" contextRef="i568119642532418a8e54da51e855e96f_D20220112-20220112" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzNTM_d8f53307-82d6-49cd-b5b7-52662d25c67f">1.08</ix:nonFraction></ix:nonFraction>&#160;million shares each from Mizuho and Wells Fargo). We recorded the payments to Mizuho and Wells Fargo as a reduction to stockholders&#8217; equity, consisting of an $<ix:nonFraction unitRef="usd" contextRef="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzNjc_c68d8b76-be2d-448c-ad99-047df59d430d">850</ix:nonFraction>&#160;million increase in treasury stock, which reflects the value of the initial <ix:nonFraction unitRef="shares" contextRef="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzODE_8f9d01be-87ee-4295-b6c9-700377ff1248">2.2</ix:nonFraction>&#160;million shares received upon initial settlement, and a $<ix:nonFraction unitRef="usd" contextRef="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112" decimals="-6" name="hum:TreasuryStockDecreaseInCapitalInExcessOfParValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzOTQ_f7072ed8-2685-4698-a45d-f8c186cec7cb">150</ix:nonFraction>&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Mizuho and Wells Fargo pending final settlement of the January 2022 ASR Agreements. Upon final settlement of the January 2022 ASR Agreements with Mizuho and Wells Fargo on March 29, 2022 and March 30, 2022, respectively, we received an additional <ix:nonFraction unitRef="shares" contextRef="iefa207bd427f4a95a03f48bf711b1dba_D20220329-20220329" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0NDA_14921a9f-6616-4a5c-86a0-37d176ffee1e">0.1</ix:nonFraction>&#160;million shares and <ix:nonFraction unitRef="shares" contextRef="i75ef00cf639a4623b3a5e417b7ffdf72_D20220330-20220330" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5MDI_b48a29ac-4714-4166-a9d0-bbfb1473b718">0.1</ix:nonFraction>&#160;million shares, respectively, as determined by the average daily volume weighted-averages share price of our common stock during the term of the agreement, less a discount, of $<ix:nonFraction unitRef="usdPerShare" contextRef="iefa207bd427f4a95a03f48bf711b1dba_D20220329-20220329" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0NTQ_856e7a0f-d5fa-4efb-ad7b-79abb64a61d1">410.96</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i75ef00cf639a4623b3a5e417b7ffdf72_D20220330-20220330" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0NjM_23c135ec-a7ec-4a8b-905b-a62ce4f066ec">411.66</ix:nonFraction>, respectively, bringing the total shares received under the January 2022 ASR Agreements to <ix:nonFraction unitRef="shares" contextRef="ice757c7c8d4a460d95726e2ca454481e_D20220101-20221231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0NzI_552b926f-cf7d-492d-9285-785d323854ab">2.4</ix:nonFraction>&#160;million. In addition, upon settlement we reclassified the $<ix:nonFraction unitRef="usd" contextRef="i4a532821749a4aa2adc6f2de7319e3f3_D20220329-20220330" decimals="-6" name="hum:CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0ODU_0bf07f4a-edc8-417d-a6b9-f9aeaddaeb4a">150</ix:nonFraction>&#160;million value of stock initially held back by Mizuho and Wells Fargo from capital in excess of par value to treasury stock. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2022, we entered into separate accelerated stock repurchase agreements, the November 2022 ASR Agreements, with Goldman Sachs &amp; Co. LLC, or Goldman Sachs, and Mizuho Markets Americas LLC, or Mizuho, to repurchase $<ix:nonFraction unitRef="usd" contextRef="id61359de4c6d40babbbcf4cb9a67c753_I20221102" decimals="-9" name="hum:AcceleratedShareRepurchasesAgreementAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ4MTg_cd2fdf5b-a691-4ed6-9e46-6941bd0e5695">1</ix:nonFraction>&#160;billion of our common stock as part of the $<ix:nonFraction unitRef="usd" contextRef="i495ee173617d40c9a28f5030f6631472_I20210218" decimals="-9" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5MzQ_78b848d0-0f76-4501-bf65-6681656a225f">3</ix:nonFraction>&#160;billion repurchase program authorized by the Board of Directors on February 18, 2021. In accordance with the November 2022 ASR Agreements, we made a payment of $<ix:nonFraction unitRef="usd" contextRef="id61359de4c6d40babbbcf4cb9a67c753_I20221102" decimals="-9" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ4Njc_617d72fa-83e3-4607-8408-afcaa751ed8d">1</ix:nonFraction>&#160;billion ($<ix:nonFraction unitRef="usd" contextRef="i73fcbac85e68448ba128e118ba423e97_I20221103" decimals="-6" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ4Nzk_bf188663-0711-4cb9-a671-b251f501554b">500</ix:nonFraction>&#160;million to Goldman Sachs on November 3, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ie0a147a615a34ceebed3a230fbb94d7f_I20221104" decimals="-6" sign="-" name="us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ4OTM_a3b2f7e7-a5c3-4d20-92ad-37fffa78a7e0">500</ix:nonFraction>&#160;million to Mizuho on November 4, 2022) and received an initial delivery of <ix:nonFraction unitRef="shares" contextRef="i4b2588f5c36147e39712fb70b96204b3_D20220112-20220112" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5MDc_8fabfe13-daf9-44dd-bdac-93084c3748ee">1.5</ix:nonFraction>&#160;million shares of our common stock (<ix:nonFraction unitRef="shares" contextRef="ia5162c0c768943718eac311366829953_D20220112-20220112" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5MjA_18287d78-db26-41e9-8a1e-37cf4778e41b"><ix:nonFraction unitRef="shares" contextRef="i703e9357eeda40b8bac63abad7404e77_D20220112-20220112" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5MjA_e4da41a3-de51-464f-8bbf-11db9e0ff0d7">0.760</ix:nonFraction></ix:nonFraction>&#160;million shares each from Goldman Sachs and Mizuho). We recorded the payments to Goldman Sachs and Mizuho as a reduction to stockholders&#8217; equity, consisting of an $<ix:nonFraction unitRef="usd" contextRef="i54e117a2b2cb4096bee16f6734d08b94_D20221102-20221102" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5MzU_483e2ec5-03bb-44f0-a78a-33722b70ca9b">850</ix:nonFraction>&#160;million increase in treasury stock, which reflects the value of the initial <ix:nonFraction unitRef="shares" contextRef="i54e117a2b2cb4096bee16f6734d08b94_D20221102-20221102" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5NDk_6f2edbbd-f922-4561-b2a4-116f915dc8b8">1.5</ix:nonFraction>&#160;million shares received upon initial settlement, and a $<ix:nonFraction unitRef="usd" contextRef="i54e117a2b2cb4096bee16f6734d08b94_D20221102-20221102" decimals="-6" name="hum:TreasuryStockDecreaseInCapitalInExcessOfParValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5NjI_3a4ae674-a0e1-4ea8-a64a-5c2bfaf0ef2c">150</ix:nonFraction>&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Goldman Sachs and Mizuho pending final settlement of the November 2022 ASR Agreements. Upon final settlement of the November 2022 ASR Agreements with Goldman Sachs and Mizuho on December 15, 2022 and December 16, 2022, respectively, we received an additional <ix:nonFraction unitRef="shares" contextRef="i8cf37da4ca144f09a6227316724ff0d9_D20221215-20221215" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwMTQ_02a94708-029c-40a2-9f4a-50635265d841">0.177</ix:nonFraction>&#160;million shares and <ix:nonFraction unitRef="shares" contextRef="ica8cb453a4214470aeb06e98f2e6defe_D20221216-20221216" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwMjk_41618ea8-83d3-4f88-b3bf-a66a6cef2603">0.177</ix:nonFraction>&#160;million shares, respectively,  as determined by the average daily volume weighted-averages share price of our common stock during the term of the agreement, less a discount, of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8cf37da4ca144f09a6227316724ff0d9_D20221215-20221215" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwNDQ_165df361-08d3-4c11-ac63-6b3e97fcce37">534.16</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ica8cb453a4214470aeb06e98f2e6defe_D20221216-20221216" decimals="2" name="us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwNTM_ae90f11d-eba2-41d9-a76c-7af3d2190352">533.87</ix:nonFraction>, respectively, bringing the total shares received under the November 2022 ASR Agreements to <ix:nonFraction unitRef="shares" contextRef="i1a8cc08368eb4c8087ba95516ebd17f6_D20220101-20221231" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwNjI_24b8793c-8d7e-45ea-ac76-d118e4e4e775">1.8</ix:nonFraction>&#160;million. In addition, upon settlement we reclassified the $<ix:nonFraction unitRef="usd" contextRef="i428ce4f261d54aa99e91df6496710161_D20221215-20221216" decimals="-6" name="hum:CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwNzU_e5fe681b-f461-4acf-ae52-51be59a0b233">150</ix:nonFraction>&#160;million value of stock initially held back by Goldman Sachs and Mizuho from capital in excess of par value to treasury stock. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2023, the Board of Directors replaced the previous share repurchase authorization of up to $<ix:nonFraction unitRef="usd" contextRef="i546d29dd98934753aadeaaaf3c309757_I20230215" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTY5MzY_235b8e1a-3b6f-41c4-9c04-406d942f9b23">3</ix:nonFraction>&#160;billion (of which approximately $<ix:nonFraction unitRef="usd" contextRef="i546d29dd98934753aadeaaaf3c309757_I20230215" decimals="-9" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTY5NDg_17a94256-ae92-4049-9ef9-14bcb58416a9">1</ix:nonFraction>&#160;billion remained unused) with a new authorization for repurchases of up to $<ix:nonFraction unitRef="usd" contextRef="i546d29dd98934753aadeaaaf3c309757_I20230215" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTY5NjA_e08f113d-1eee-4ade-aec3-cc5ec7fb929d">3</ix:nonFraction>&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 15, 2026.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfTreasuryStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNjA2_7883ef71-d1d9-4068-89b4-11d17cb10fc9" escape="true"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding shares acquired in connection with employee stock plans, share repurchases were as follows during the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:38.546%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.296%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.123%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.129%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Authorization Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Not to Exceed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79ef21e520e24d9b86c34779aacb9bcb_I20221231" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtMi0xLTEtMTQwNjQ1_95e591eb-cb22-4c8d-8d9b-4db5d10c5031">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7cbb214573c842ca8b6e875c6ff4063d_D20220101-20221231" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtNC0xLTEtMTQwNjQ1_9b79d7d4-face-48dd-894e-b1fe26cd472e">4.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cbb214573c842ca8b6e875c6ff4063d_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtNi0xLTEtMTQwNjQ1_9577ecb0-1d05-4783-83f3-8ed2e0667eda">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icf5c867675b14eb099507bc46b1d3c8b_D20210101-20211231" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtOC0xLTEtMTQwNjQ1_9f7645c4-c32e-470d-b83a-a945356733a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf5c867675b14eb099507bc46b1d3c8b_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtMTAtMS0xLTE0MDY0NQ_f0fe4da9-70ff-409c-8a00-2ad85d9e01c9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if6da3e5a26834dcc9735b2892ca0ecb0_D20200101-20201231" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtMTItMS0xLTE0MDY0NQ_614528f9-4e13-46d0-b068-e0a6a77bdc33">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6da3e5a26834dcc9735b2892ca0ecb0_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtMTQtMS0xLTE0MDY0NQ_c44fcb0b-3749-4468-b46c-fe4eb5e21fc6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idab11132473e41d4b78b5223d9404132_I20221231" decimals="INF" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtMi0xLTEtMTQwNjQ1_43074841-5338-4d8b-a086-b031c75c7789">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4f711d960cc4da69eb94de28d19a3f3_D20220101-20221231" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtNC0xLTEtMTQwNjQ1_442eee0f-5df8-4e62-bf75-0340c2ee1f4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f711d960cc4da69eb94de28d19a3f3_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtNi0xLTEtMTQwNjQ1_c8146e34-20ff-4a9c-8f34-de04ef80c6f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib058f69043374be79aeeb4ef7b5fc2dd_D20210101-20211231" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtOC0xLTEtMTQwNjQ1_2016852b-cb09-437e-8f0b-e8489cf2142c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib058f69043374be79aeeb4ef7b5fc2dd_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtMTAtMS0xLTE0MDY0NQ_4de5d294-842b-4d6e-b69a-ef35d2032973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5e57aa821d834ff2a62e2f0f968132d0_D20200101-20201231" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtMTItMS0xLTE0MDY0NQ_5f176995-d17a-425f-b1e7-183370194388">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e57aa821d834ff2a62e2f0f968132d0_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtMTQtMS0xLTE0MDY0NQ_70c25da3-9601-4fe9-8b0c-2578d8e5f39c">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2911e9195ca74da59efd95c2f2a079cb_D20220101-20221231" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtNC0xLTEtMTQwNjQ1_2bdf7655-5fbb-48ba-8d19-f2f3063089c3">4.30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2911e9195ca74da59efd95c2f2a079cb_D20220101-20221231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtNi0xLTEtMTQwNjQ1_debedc1e-8fbd-4000-aab8-4e39e2eb1fb9">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d38c03d6b794fda984bd56ecc795514_D20210101-20211231" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtOC0xLTEtMTQwNjQ1_6a96e0e0-273e-4676-824e-0ba40072c97b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d38c03d6b794fda984bd56ecc795514_D20210101-20211231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtMTAtMS0xLTE0MDY0NQ_ec0d3ac5-f413-47b2-9a0a-dd9c6a65f506">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b418f12cccb453c9cf39ecc9a2f0251_D20200101-20201231" decimals="-4" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtMTItMS0xLTE0MDY0NQ_c74f22df-9b40-450c-b294-4a360e4b8670">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b418f12cccb453c9cf39ecc9a2f0251_D20200101-20201231" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtMTQtMS0xLTE0MDY0NQ_2f1afd38-2d78-4888-a0c5-2a29a47ecc0b">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with employee stock plans, we acquired <ix:nonFraction unitRef="shares" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-5" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg2NzA_8bd4eb72-8a74-4023-835c-5e0e30eefdd9">0.2</ix:nonFraction> million common shares for $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg2OTE_fed5d658-aaa8-412f-92a3-9cb5dc834f3a">96</ix:nonFraction> million in 2022, <ix:nonFraction unitRef="shares" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-5" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3MDE_ce426644-a5dc-4421-b44d-f8d30d98857a">0.2</ix:nonFraction> million common shares for $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3MjI_e081612b-5f34-4b28-87f8-d7d6230cd2f3">79</ix:nonFraction> million in 2021, and <ix:nonFraction unitRef="shares" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-5" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3MzY_8da82279-883d-40cd-8723-45b41d1b9ecb">0.2</ix:nonFraction> million common shares for $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3NTc_9ba7fc41-6c2f-4adc-914b-fe7128f62b61">70</ix:nonFraction> million in 2020.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="iaacf8d6e880f44c683491688aff3581f"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our stockholders' equity, refer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2021 Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our subsidiaries operate in states that regulate the payment of dividends, loans, or other cash transfers to Humana Inc., our parent company, and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid to Humana Inc. by these subsidiaries, without prior approval by state regulatory authorities, or ordinary dividends, is limited based on the entity&#8217;s level of statutory income and statutory capit</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">al and surplus. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an extraordinary dividend requiring prior regulatory approval. In most states, prior notification is provided before paying a dividend even if approval is not required. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although minimum required levels of equity are largely based on premium volume, product mix, and the quality of assets held, minimum requirements vary significantly at the state level. Our state regulated insurance subsidiaries had aggregate statutory capital and surplus of approximately $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzk5NDg_cf8245e0-ecb7-4ce3-80ad-c751dbb0961a">11.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzk5NTU_bbaa1b2f-0532-498e-82fd-4d5418d67a86">9.6</ix:nonFraction> billion as of December&#160;31, 2022 and 2021, respectively, which exceeded aggregate minimum regulatory requirements of </span><span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwMDYz_688407f5-9157-4ba4-b942-c4da1764ad84">8.4</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwMDcw_cf44b787-27f1-4bb8-8d91-97855df20d02">7.6</ix:nonFraction> billion, respectively.  The amount of ordinary dividends that may be paid to our parent company in 2023 is approximately $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwMTg0_a676963a-ec90-4015-9a1c-678762ec02b6">1.8</ix:nonFraction> billion in the aggregate. The amount, timing and mix of ordinary and extraordinary dividend payments will vary due to state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory requirements, the level of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix. Actual dividends that were paid to our parent company were approximately  $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-8" name="hum:DividendsToParentWithoutPriorStateRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNTUx_5aa5f86c-b9ac-47e3-bc96-3c3059ee272c">1.3</ix:nonFraction> billion in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-8" name="hum:DividendsToParentWithoutPriorStateRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNTU5_50ff6e63-31bc-4ec8-a709-9c9140025b81">1.6</ix:nonFraction> billion in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-8" name="hum:DividendsToParentWithoutPriorStateRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNTY3_e0defaa9-f4f0-4f02-a286-a3d5e7d4d229">1.3</ix:nonFraction> billion in 2020.</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_193"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;<ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzIwMTc2_0cf83e52-6c8f-4d1d-bc2f-1272a66e6655" continuedAt="i69687ee698dd411d870d0c016532e3e2" escape="true">COMMITMENTS, GUARANTEES AND CONTINGENCIES</ix:nonNumeric></span></div><ix:continuation id="i69687ee698dd411d870d0c016532e3e2" continuedAt="ie8336cd557d24c1dbc985876c73173b6"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">     Purchase Obligations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreements to purchase services, primarily information technology related services, or to make improvements to real estate, in each case that are enforceable and legally binding on us and that specify all significant terms, including: fixed or minimum levels of service to be purchased; fixed, minimum or variable price provisions; and the appropriate timing of the transaction. We have purchase obligation commitments of $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzUwNw_b93e1f7e-35fc-4d49-bc1a-92d161d910b4">687</ix:nonFraction> million in 2023, $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzUxNw_a475b92b-8819-4fce-b0e9-6675b01906db">451</ix:nonFraction> million in 2024, $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzUyNw_41d5da39-80bc-4786-8d69-821b55f21b80">288</ix:nonFraction> million in 2025, $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzUzNw_6aad2661-fd60-44fd-9d24-5e0214539be5">236</ix:nonFraction> million in 2026, and $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU1MQ_119f1d88-709c-4762-9c60-b51d87f7256e">153</ix:nonFraction> million in 2027. Purchase obligations exclude agreements that are cancellable without penalty.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our ongoing business, we do not participate or knowingly seek to participate in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, or SPEs, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of December&#160;31, 2022, we were not involved in any SPE transactions.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Indemnifications</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through indemnity agreements approved by the state regulatory authorities, certain of our regulated subsidiaries generally are guaranteed by Humana Inc., our parent company, in the event of insolvency for (1)&#160;member coverage for which premium payment has been made prior to insolvency; (2)&#160;benefits for members then hospitalized until discharged; and (3)&#160;payment to providers for services rendered prior to insolvency. Our parent also has guaranteed the obligations of certain of our non-regulated subsidiaries and funding to maintain required statutory capital levels of certain regulated subsidiaries.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="ie8336cd557d24c1dbc985876c73173b6" continuedAt="i225b93fb48f14fd18b1e0384926be016"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we enter into contractual arrangements under which we may agree to indemnify a third party to such arrangement from any losses incurred relating to the services they perform on behalf of us, or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. Such indemnification obligations may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Contracts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare products, which accounted for approximately <ix:nonFraction unitRef="number" contextRef="i12de401f78254a06a054b3031bb6db2c_D20220101-20221231" decimals="2" name="hum:PercentageOfTotalPremiumAndServicesRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzI0NDI_94172f0c-002c-4a3f-aa1f-9ee0f28ccfce">81</ix:nonFraction>% of our total premiums and services revenue for the year ended December&#160;31, 2022, primarily consisted of products covered under the Medicare Advantage and Medicare Part D Prescription Drug Plan contracts with the federal government. These contracts are renewed generally for a calendar year term unless CMS notifies us of its decision not to renew by May 1 of the calendar year in which the contract would end, or we notify CMS of our decision not to renew by the first Monday in June of the calendar year in which the contract would end. All material contracts between Humana and CMS relating to our Medicare products have been renewed for 2023, and all of our product offerings filed with CMS for 2023 have been approved.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage, or MA, plans according to health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997 (BBA) and the Benefits Improvement and Protection Act of 2000 (BIPA), generally pays more where a plan's membership has higher expected costs. Under this model, rates paid to MA plans are based on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a "national average risk profile." That baseline payment amount is adjusted to account for certain demographic characteristics and health status of our enrolled members. Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data, collected from providers, to calculate the health status-related risk-adjusted premium payment to MA plans, which CMS further adjusts for coding pattern differences between the health plans and the government fee-for-service (FFS) program. We generally rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our health status-adjusted payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS and the Office of the Inspector General of Health and Human Services, or HHS-OIG, perform audits of various companies&#8217; risk adjustment diagnosis data submissions. We refer to these audits as Risk-Adjustment Data Validation Audits, or RADV audits. RADV audits review medical records in an attempt to validate provider medical record documentation and coding practices that influence the calculation of health status-related premium payments to MA plans.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS released an MA contract-level RADV methodology that would extrapolate the results of each CMS RADV audit sample to the audited MA contract&#8217;s entire health status-related risk adjusted premium amount for the year under audit.  In doing so, CMS recognized &#8220;that the documentation standard used in RADV audits to determine a contract&#8217;s payment error (medical records) is different from the documentation standard used to develop the Part C risk-adjustment model (FFS claims).&#8221;  To correct for this difference, CMS stated that it would apply a &#8220;Fee-for-Service Adjuster (FFS Adjuster)&#8221; as &#8220;an offset to the preliminary recovery amount.&#8221;  This adjuster would be &#8220;calculated by CMS based on a RADV-like review of records submitted to support FFS claims data.&#8221;  CMS stated that this methodology would apply to audits beginning with PY 2011.  Humana relied on CMS&#8217;s 2012 guidance in submitting MA bids to CMS.  Humana also launched a &#8220;Self-Audits&#8221; program in 2013 that applied CMS&#8217;s 2012 RADV audit methodology and included an estimated FFS Adjuster.  Humana completed Self-Audits for PYs 2011-2016 and reported results to CMS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i225b93fb48f14fd18b1e0384926be016" continuedAt="i40b8a908b35540239114f777317359a4"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, however, CMS issued a proposed rule announcing possible changes to the RADV audit methodology, including elimination of the FFS Adjuster.  CMS proposed applying its revised methodology, including extrapolated recoveries without application of a FFS Adjuster, to RADV audits dating back to PY 2011.  On January 30, 2023, CMS published a final rule related to the RADV audit methodology (Final RADV Rule).  The Final RADV Rule confirmed CMS&#8217;s decision to eliminate the FFS Adjuster. The Final RADV Rule states CMS&#8217;s intention to extrapolate results from CMS and HHS-OIG RADV audits beginning with PY 2018, rather than PY 2011 as proposed.  However, CMS&#8217;s Final RADV Rule does not adopt a specific sampling, extrapolation or audit methodology.  CMS instead stated its general plan to rely on &#8220;any statistically valid method . . . that is determined to be well-suited to a particular audit.&#8221;  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana is considering its legal options with respect to CMS&#8217;s changed position on the FFS Adjuster and seeking clarity regarding our compliance obligations in light of the Final RADV Rule. We believe that the Final RADV Rule fails to address adequately the statutory requirement of actuarial equivalence. Further, Humana&#8217;s actuarially certified bids through PY 2023 preserved Humana&#8217;s position that CMS should apply an FFS Adjuster in any RADV audit that CMS intends to extrapolate. We expect CMS to apply the Final RADV Rule, including the first application of extrapolated audit results to determine audit settlements without a FFS Adjuster, to CMS and HHS-OIG RADV audits conducted for PY 2018 and subsequent years.  The Final RADV  Rule, including the lack of a FFS Adjuster, and any related regulatory, industry or company reactions, could have a material adverse effect on our results of operations, financial position, or cash flows.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as part of our internal compliance efforts, we routinely perform ordinary course reviews of our internal business processes related to, among other things, our risk coding and data submissions in connection with the risk adjustment model. These reviews may also result in the identification of errors and the submission of corrections to CMS that may, either individually or in the aggregate, be material. As such, the result of these reviews may have a material adverse effect on our results of operations, financial position, or cash flows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we explore our legal options and compliance obligations, we remain committed to working alongside CMS to promote the integrity of the MA program as well as affordability and cost certainty for our members.  It is critical that MA plans are paid accurately and that payment model principles, including the application of a FFS Adjuster, are in accordance with the requirements of the Social Security Act, which, if not implemented correctly could have a material adverse effect on our results of operations, financial position, or cash flows. </span></div><div style="margin-bottom:9pt;margin-top:4.5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our state-based Medicaid business accounted for approximately <ix:nonFraction unitRef="number" contextRef="ie135078db20f4355a53c7fdca9bb2dc3_D20220101-20221231" decimals="2" name="hum:PercentageOfTotalPremiumAndServicesRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzEwOTQ5_2fd4643e-ba57-437b-9131-23b58e9e749b">6</ix:nonFraction>% of our total premiums and services revenue for the year ended December 31, 2022 primarily serving members enrolled in Medicaid, and in certain circumstances members who qualify for both Medicaid and Medicare, under contracts with various states. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     Our military services business, which accounted for approximately <ix:nonFraction unitRef="number" contextRef="i61a07b55e80d459dac04cd0e5bf2f6bd_D20220101-20221231" decimals="2" name="hum:PercentageOfTotalPremiumAndServicesRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzExMjcw_1fd7f182-d39f-46d1-a565-3dac57c59018">1</ix:nonFraction>% of our total premiums and services revenue for the year ended December 31, 2022, primarily consisted of the TRICARE T2017 East Region contract. The T2017 East Region contract comprises <ix:nonFraction unitRef="state" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="hum:NumberOfStatesComprisingTRICAREBeneficiaries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzExNDMy_f968d057-9539-4dd3-83f3-0f91d753d514">32</ix:nonFraction> states and approximately <ix:nonFraction unitRef="beneficiary" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:NumberOfTRICAREBeneficiaries" format="ixt-sec:numwordsen" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzExNDYw_d1ec625e-e3e2-45b0-b276-587b1d2c9199">six million</ix:nonFraction> TRICARE beneficiaries, under which delivery of health care services commenced on January 1, 2018. The T2017 East Region contract, which was originally set to expire on December 31, 2022, was subsequently extended by the DoD and is currently scheduled to expire on December 31, 2023, unless further extended. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we were awarded the next generation of TRICARE Managed Care Support Contracts, or T-5, for the TRICARE East Region by the Defense Health Agency of the DoD. The contract is expected to go into effect in 2024. Until then the T2017 contract remains in place. Under the terms of the award, our service area covers approximately <ix:nonFraction unitRef="beneficiary" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="INF" name="hum:NumberOfTRICAREManagedCareSupportContractBeneficiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzkzNDU4NDg4NjExOTI_1bc2471d-196d-4b70-883a-455565ed5203">4.6</ix:nonFraction>&#160;million beneficiaries in a region consisting of <ix:nonFraction unitRef="state" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="hum:NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzkzNDU4NDg4NjEyMDU_6b3f7383-e24e-4c81-a153-90cbd2d6dd8d">24</ix:nonFraction>  states and Washington, D.C. The length of the contract is <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMyOA_c266142d-523a-4672-8755-4dc23319d78b">one</span> base year with <ix:nonFraction unitRef="option_period" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="INF" name="hum:TRICAREManagedCareSupportContractNumberOfOptionPeriods" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDgwNA_1e544ea2-1ac3-482d-a16c-165b8b27d3b1">eight</ix:nonFraction>  annual option periods, which, if all options are exercised, would result in a total contract length of  <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMzOA_961b1df7-1bbf-49b4-94e1-c81bd4087591">nine</span> years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of any of the contracts above or significant changes in these programs as a result of legislative or regulatory action, including reductions in premium payments to us, regulatory restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, or increases in member benefits or </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i40b8a908b35540239114f777317359a4" continuedAt="i5756af540264438f88abec73e76e9146"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">member eligibility criteria without corresponding increases in premium payments to us, may have a material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings and Certain Regulatory Matters</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the Civil Division of the United States Department of Justice provided us with an information request in December 2014, concerning our Medicare Part C risk adjustment practices. The request relates to our oversight and submission of risk adjustment data generated by providers in our Medicare Advantage network, as well as to our business and compliance practices related to risk adjustment data generated by our providers and by us, including medical record reviews conducted as part of our data and payment accuracy compliance efforts, the use of health and well-being assessments, and our fraud detection efforts. We believe that this request for information is in connection with a wider review of Medicare Risk Adjustment generally that includes a number of Medicare Advantage plans, providers and vendors. We cooperated with the Department of Justice, and we have not heard from the Department of Justice on this matter since 2020. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, on January 19, 2016, an individual filed a qui tam suit captioned United States of America ex rel. Steven Scott v. Humana, Inc., in United States District Court, Central District of California, Western Division. The complaint alleges certain civil violations by us in connection with the actuarial equivalence of the plan benefits under Humana&#8217;s Basic PDP plan, a prescription drug plan offered by us under Medicare Part D. The action seeks damages and penalties on behalf of the United States under the False Claims Act. The court ordered the qui tam action unsealed on September 13, 2017, so that the relator could proceed, following notice from the U.S. Government that it was not intervening at that time. On January 29, 2018, the suit was transferred to the United States District Court, Western District of Kentucky, Louisville Division. We have substantially completed discovery with the relator who has pursued the matter on behalf of the United States following its unsealing. On March 31, 2022, the Court denied the parties' Motions for Summary Judgement. We take seriously our obligations to comply with applicable CMS requirements and actuarial standards of practice, and continue to vigorously defend against these allegations.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Lawsuits and Regulatory Matters</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our current and past business practices are subject to review or other investigations by various state insurance and health care regulatory authorities and other state and federal regulatory authorities. These authorities regularly scrutinize the business practices of health insurance, health care delivery and benefits companies. These reviews focus on numerous facets of our business, including claims payment practices, statutory capital requirements, provider contracting, risk adjustment, competitive practices, commission payments, privacy issues, utilization management practices, pharmacy benefits, access to care, sales practices, and provision of care by our healthcare services businesses, among others. Some of these reviews have historically resulted in fines imposed on us and some have required changes to some of our practices. We continue to be subject to these reviews, which could result in additional fines or other sanctions being imposed on us or additional changes in some of our practices.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also are involved in various other lawsuits that arise, for the most part, in the ordinary course of our business operations, certain of which may be styled as class-action lawsuits. Among other matters, this litigation may include employment matters, claims of medical malpractice, bad faith, nonacceptance or termination of providers, anticompetitive practices, improper rate setting, provider contract rate and payment disputes, including disputes over reimbursement rates required by statute, disputes arising from competitive procurement process, general contractual matters, intellectual property matters, and challenges to subrogation practices. Under state guaranty assessment laws, including those related to state cooperative failures in the industry, we may be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of insolvent insurance companies that write the same line or lines of business as we do.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a government contractor, we may also be subject to false claims litigation, such as qui tam lawsuits brought by individuals who seek to sue on behalf of the government, alleging that the government contractor submitted false claims to the government or related overpayments from the government, including, among other allegations, those resulting from coding and review practices under the Medicare risk adjustment model. Qui tam litigation is filed </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i5756af540264438f88abec73e76e9146"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under seal to allow the government an opportunity to investigate and to decide if it wishes to intervene and assume control of the litigation. If the government does not intervene, the individual may continue to prosecute the action on his or her own, on behalf of the government. We also are subject to other allegations of nonperformance of contractual obligations to providers, members, and others, including failure to properly pay claims, improper policy terminations, challenges to our implementation of the Medicare Part D prescription drug program and other litigation.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the claims asserted against us are subject to insurance coverage. Personal injury claims, claims for extra contractual damages, care delivery malpractice, and claims arising from medical benefit denials are covered by insurance from our wholly owned captive insurance subsidiary and excess carriers, except to the extent that claimants seek punitive damages, which may not be covered by insurance in certain states in which insurance coverage for punitive damages is not permitted. In addition, insurance coverage for all or certain forms of liability has become increasingly costly and may become unavailable or prohibitively expensive in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record accruals for the contingencies discussed in the sections above to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because of the inherently unpredictable nature of legal proceedings, which also may be exacerbated by various factors, including: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties (including where it is uncertain how liability, if any, will be shared among multiple defendants); or (vii) there is a wide range of potential outcomes.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting judgments, penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities or as a result of actions by third parties. Nevertheless, it is reasonably possible that any such outcome of litigation, judgments, penalties, fines or other sanctions could be substantial, and the outcome of these matters may have a material adverse effect on our results of operations, financial position, and cash flows, and may also affect our reputation.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_196"></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;<ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzY1MTc_b1eb74ae-ba94-4df5-916c-88874f01612e" continuedAt="i8f6be8af83a54527a9259f3a7f1491c1" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i8f6be8af83a54527a9259f3a7f1491c1" continuedAt="i049a88e39bd54920bd2d47520f980aa5"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2022, we realigned our businesses into <ix:nonFraction unitRef="segment" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzU0OTc1NTgxNjYyOTk_fc569758-264f-4c5c-84e6-dab652519dda">two</ix:nonFraction> distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period segment financial information has been recast to conform to the 2022 presentation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our  <ix:nonFraction unitRef="segment" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzU3_25b4f256-0104-416e-b4b4-c67c4ff0a698">two</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as our contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health </span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><ix:continuation id="i049a88e39bd54920bd2d47520f980aa5" continuedAt="i24861342a2d14a46938b594468a041ce"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only, or ASO. In addition, our Insurance segment includes our military services business, primarily our T-2017 East Region contract, as well as the operations of our PBM business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CenterWell segment includes our pharmacy, provider services, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CenterWell intersegment revenues primarily relate to the operations of CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our CenterWell intersegment revenues includes revenues earned by certain owned providers (CenterWell Senior Primary Care) derived from certain value-based arrangements with our health plans. Under these value-based arrangements, our owned providers enter into agreements with our health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our members. In exchange, the owned provider receives a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our members. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present our consolidated results of operations from the perspective of the health plans. As a result, the cost of providing benefits to our members, whether provided via a third party provider or internally through a stand-alone subsidiary, is classified as benefits expense and excludes the portion of the cost for which the health plans do not bear responsibility, including member co-share amounts and government subsidies of $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-8" name="hum:GovernmentAndHealthPlanMemberSubsidiesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzQ2OTk_ebcab375-9e29-405c-b32f-972b560c325f">19.7</ix:nonFraction> billion in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-8" name="hum:GovernmentAndHealthPlanMemberSubsidiesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzQ3MDk_3694c94e-36da-40a6-9ce2-28f25f925296">18.1</ix:nonFraction> billion in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-8" name="hum:GovernmentAndHealthPlanMemberSubsidiesAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzQ3MjM_5ad3ff4d-2de8-47ce-b1f4-764823e72c29">16.5</ix:nonFraction> billion in 2020. In addition, depreciation and amortization expense associated with certain businesses delivering benefits to our members, primarily associated with our provider services and pharmacy operations, are included with benefits expense. The amount of this expense was $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:DepreciationAndAmortizationClassifiedAsBenefitExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzUwMzA_51870bb0-6100-45de-8ef2-fceca2c34075">122</ix:nonFraction>&#160;million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:DepreciationAndAmortizationClassifiedAsBenefitExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzUwNDA_db42ff17-7211-4ef3-b6b5-d5bfce68f494">108</ix:nonFraction>&#160;million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:DepreciationAndAmortizationClassifiedAsBenefitExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzUwNTQ_a7a6adb6-7ee4-4757-85e7-30a8aabb2444">127</ix:nonFraction>&#160;million in 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than those described previously, the accounting policies of each segment are the same and are described in Note 2. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider, and home services, to our Insurance segment customers. Intersegment sales and expenses are recorded at fair value and eliminated in consolidation. Members served by our segments often use the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at a corporate level. These corporate amounts are reported separately from our reportable segments and are included with intersegment eliminations in the tables presenting segment results below. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium and services revenues derived from our contracts with the federal government, as a percentage of our total premium and services revenues, were approximately <ix:nonFraction unitRef="number" contextRef="ie3ecfbb6c22b417ebc6482a6408f9cdb_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzEwOTk1MTE2NzM5Nzg_67944d94-d75a-4a09-b142-90d21a332476">82</ix:nonFraction>% for 2022, <ix:nonFraction unitRef="number" contextRef="i659f9236e99f47089bc96dac2b1eec1d_D20210101-20211231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzY0NjY_6b215b84-4afd-4147-9add-bcb6f6a0279c">83</ix:nonFraction>% for 2021 and <ix:nonFraction unitRef="number" contextRef="i183a5acc1cbc41339a7e84c20d8eae47_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzY0ODA_45ee111a-655d-4db9-baad-94850314799f">83</ix:nonFraction>% for 2020.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="text-align:center"><ix:continuation id="i24861342a2d14a46938b594468a041ce" continuedAt="i81113e7a38ab4d9ca8a5238da82df29f"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzY1MTk_4051388a-8f0c-41e4-a3a1-07d724e12a5e" continuedAt="i580112d630d845a3ab23646c5e463007" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.861%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad99ca704571480ba83888a5d38aa019_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzUtMS0xLTEtMTQwNjQ1_74eca7e2-16c3-4f5f-a847-fd5c0c20b966">65,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic19eb7627fb348218e3375f5c66974a7_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzUtNS0xLTEtMTQwNjQ1_40263cbb-8419-4b26-8016-1f279e80f77d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d672fa23f814425b4471c1e5dc74b0f_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzUtOS0xLTEtMTQwNjQ1_d7dc205d-f5c9-4222-a898-04b1522ff3b7">65,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if874def50df84ee38965dd2ff7e20dc8_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzYtMS0xLTEtMTQwNjQ1_ebbfbaef-3edd-4356-a690-2d6f6ff1665c">7,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6acea9d1a84d4feba6bb5ed5ce9a2413_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzYtNS0xLTEtMTQwNjQ1_cd0689c0-786b-4944-80ed-8169f01afd07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03a322c8d9d443e19ed5ba572d9572d3_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzYtOS0xLTEtMTQwNjQ1_dcf03d05-8baa-40b1-b144-f38ba4a3ce48">7,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fc365aeef164ccba60189ae8e4be0c6_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzctMS0xLTEtMTQwNjQ1_a3c5af4a-b22f-427a-aa60-1996bf96eb52">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i678e6634c1f641da9467a8467bb0d1fa_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzctNS0xLTEtMTQwNjQ1_cf5c9aad-16cd-4a2e-a93d-0b6e952c5d95">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia600b949e2564d9499a7f90413acb269_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzctOS0xLTEtMTQwNjQ1_c601278b-263f-48fe-994f-0988397c01cc">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3a1e7fbd9b740abb48da6c37c8669a5_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzgtMS0xLTEtMTQwNjQ1_996cf9bc-1676-457e-9a81-1b043eb460c2">75,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba60622cbea46a4bea4ee9980cf49d0_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzgtNS0xLTEtMTQwNjQ1_f2fcf192-20ef-45d9-94c5-44987805ce8b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12de401f78254a06a054b3031bb6db2c_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzgtOS0xLTEtMTQwNjQ1_39a23540-75c7-478e-8958-e3dd2853fa4d">75,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5c59ec6e1b641aba95c635ef9ee9353_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzktMS0xLTEtMTQwNjQ1_53cf4340-b960-4629-a1a6-6bfdb8351174">4,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77000571fe484454b7cece9a261ff0d7_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzktNS0xLTEtMTQwNjQ1_83153cf4-249a-4745-b6c2-77da0d63d8ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a704e86f4b24c3aaa85d60048410091_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzktOS0xLTEtMTQwNjQ1_2434e0a6-668c-4a83-9a0f-11bb7be280fc">4,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b96d1b5772846aab2514b027450d532_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEwLTEtMS0xLTE0MDY0NQ_f9ce0c25-d3fd-4eac-b030-0e9bb55cea1c">1,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i851654ab87514d19bb07259c3e31ff6b_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEwLTUtMS0xLTE0MDY0NQ_7280a361-4679-4f7d-9d37-90e17a99f77b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88dbb625a14f473eb0ce08c9d6aff7e3_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEwLTktMS0xLTE0MDY0NQ_d4c29e88-2636-4808-8359-2481af8d782e">1,703</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a97e0cfebe44b6ca9f74bebc9aae41f_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzExLTEtMS0xLTE0MDY0NQ_14b16b7f-8be9-4ab6-9f81-8f10472b96c2">6,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i321b22b5a8d64b4fa443b551c3f5ef42_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzExLTUtMS0xLTE0MDY0NQ_29273261-43bc-413c-a416-09a0c9dd50cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifac46bf8882f4afd8d1dff2e3d3664d3_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzExLTktMS0xLTE0MDY0NQ_15bcffdd-94f8-4593-8329-6e15213974a5">6,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEyLTEtMS0xLTE0MDY0NQ_984fdb11-174e-424d-a09e-39b506174730">87,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEyLTUtMS0xLTE0MDY0NQ_251589f6-8f23-4983-bf74-54acfc90d3c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEyLTktMS0xLTE0MDY0NQ_fc9898e6-dbed-4211-a985-0d38f3e89e95">87,712</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d9b0e5592fc42a6b5a50cddd44bac9b_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE0LTEtMS0xLTE0MDY0NQ_020f54cf-e680-4b3b-8f63-dab7bd211c02">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c5f8b05d172420aa7d6e508a7c3261a_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE0LTUtMS0xLTE0MDY0NQ_973f6f86-213a-4db1-88ed-ea65f2ddacc8">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed102b89a1848bf8a260145b47bc56e_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE0LTktMS0xLTE0MDY0NQ_b770e669-5357-4f72-aa8f-74f0e52b835b">2,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i917edca86d004c958b32aa4199b5ea4b_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE1LTEtMS0xLTE0MDY0NQ_1a16d3aa-0abb-43fc-970b-958b2b3ecf36">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32da3ea918f84f139a1ac455b07ebfda_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE1LTUtMS0xLTE0MDY0NQ_5707247a-b55b-4659-9003-fa27e490f7d5">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cdfd66eeb7d4c938de2f60123537f11_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE1LTktMS0xLTE0MDY0NQ_86a5769d-f167-42cc-bb21-71f78aee4df5">568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47d0ebf962574d2da49de809c4eb19ba_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE2LTEtMS0xLTE0MDY0NQ_d7090c78-f891-4105-9616-fcb3452b51b9">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03027c1fdaa8418fb517496371138dbe_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE2LTUtMS0xLTE0MDY0NQ_5ffc562d-62fd-48ff-8cae-f638effc6202">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6b045942f9d4e858da50fb74642864c_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE2LTktMS0xLTE0MDY0NQ_b8248278-b6af-40a2-b09e-ec7ae44ba54b">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5328222283c41c587cc828204de2027_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE3LTEtMS0xLTE0MDY0NQ_34298cab-62c6-4bd3-888e-9e52e19fdc3c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i897a9529650a4bb884a93b8cf59bd75a_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE3LTUtMS0xLTE0MDY0NQ_f8e629a2-e1b6-48df-96c5-fa9f295421eb">1,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7458a4e3b4284a1e924e76cd284a045d_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE3LTktMS0xLTE0MDY0NQ_8ff6e1c0-52de-4557-920e-0d014f20b2b5">1,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE4LTEtMS0xLTE0MDY0NQ_ca098cd3-c64f-45c3-88a8-0c9070cbebd0">850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE4LTUtMS0xLTE0MDY0NQ_977fd7e9-554e-4d6a-81bc-0592fbf92002">3,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE4LTktMS0xLTE0MDY0NQ_5afc4107-d939-4262-87aa-bed908291f1f">4,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE5LTEtMS0xLTE0MDY0NQ_6a3d8114-c2e9-4b90-9d91-16445cea52f0">88,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE5LTUtMS0xLTE0MDY0NQ_84ab6157-96dc-49e1-bf77-b819f6f6b814">3,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i596d1ad9ab314614a3930efbc769fbf3_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE5LTktMS0xLTE0MDY0NQ_a43cac57-6849-4db1-8335-37f7b33e1c6e">92,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d8bdf2106784156b1b8947924736d88_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIxLTEtMS0xLTE0MDY0NQ_dfa60fea-1ba5-4831-aee3-0e8ee3c3e6f2">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i590c72b5416448abb074967e44ff6ab1_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIxLTUtMS0xLTE0MDY0NQ_56ed3823-f231-431d-ae18-4a64466f8410">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic7d56895373540d987a4fcd85111df8f_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIxLTctMS0xLTE0MDY0NQ_17007449-8b00-4519-824b-1815e9749c8a">3,588</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01479ee240324dfda2f8366c4adb14e7_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIyLTEtMS0xLTE0MDY0NQ_b7128917-d347-4da2-b1a4-47c4b3187f51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e4c5dc89ec4b73a775d2b544b21d0a_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIyLTUtMS0xLTE0MDY0NQ_a21256bc-1d55-46ee-b69a-d20661082e4a">9,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id179fa09e1214e46a546b7c140286685_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIyLTctMS0xLTE0MDY0NQ_43d123db-7e79-4c93-b798-2e1fa9555560">9,841</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4ff990b381946d494741a1374b90aed_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIzLTEtMS0xLTE0MDY0NQ_77e1ec3d-3fe3-4d06-bb12-d938bbfeeb68">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7df369d93b09472ba0bced59c36b413f_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIzLTUtMS0xLTE0MDY0NQ_eddf82c7-f71b-49c1-bb36-ee653701a6b1">13,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id67dea91f3604bd78d2f964c679d21b3_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIzLTctMS0xLTE0MDY0NQ_23fba745-6122-4480-9666-90eb99af4aba">13,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI0LTEtMS0xLTE0MDY0NQ_0726fd81-28eb-4e32-9de5-17238f21868b">223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI0LTUtMS0xLTE0MDY0NQ_4337b6a0-9ecd-4314-9b68-2138e3d4bf78">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI0LTctMS0xLTE0MDY0NQ_85d80427-0307-4144-a601-14fa7efa669d">151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI0LTktMS0xLTE0MDY0NQ_f7dd8094-eecb-4d5f-b7db-0748fcd52f05">382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI1LTEtMS0xLTE0MDY0NQ_1e327f50-8395-45eb-82b0-708d1a5f2a58">88,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI1LTUtMS0xLTE0MDY0NQ_337b00ce-96fd-470d-a62f-9e9b0d06edf9">17,307</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI1LTctMS0xLTE0MDY0NQ_075a45b7-d25d-4a28-b69a-98f24431c7f3">13,278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI1LTktMS0xLTE0MDY0NQ_0febf608-5c58-42d4-ab41-1535e0771a39">92,870</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI3LTEtMS0xLTE0MDY0NQ_18741451-86b9-424c-958e-65f9510ef838">75,934</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI3LTUtMS0xLTE0MDY0NQ_980d0ac4-8d81-4628-a838-c2e2980cf2b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI3LTctMS0xLTE0MDY0NQ_ef829dd2-2b2c-4daa-8c93-e067552f82e2">244</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI3LTktMS0xLTE0MDY0NQ_00bc2f23-9d4c-4e59-84ad-0f6c4fe8c1de">75,690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI4LTEtMS0xLTE0MDY0NQ_f1730ac5-23b7-4bc6-a2cc-d5dd295deedc">9,251</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI4LTUtMS0xLTE0MDY0NQ_14ea1c36-ef4d-441e-9b02-0a0a223322f0">15,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI4LTctMS0xLTE0MDY0NQ_cb74f8e0-f325-4f7e-bfcd-26a913e1f4d1">12,415</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI4LTktMS0xLTE0MDY0NQ_ec53629b-1b19-4c3c-be52-f42a4dd76cee">12,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI5LTEtMS0xLTE0MDY0NQ_1a4d58a3-39cb-4782-86ef-2a5cfb6231b9">634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI5LTUtMS0xLTE0MDY0NQ_816d6d53-5c75-40d4-97ec-94c6ff7c354c">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI5LTctMS0xLTE0MDY0NQ_b2125269-6e44-4812-9dd8-86ef5a530ca8">106</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI5LTktMS0xLTE0MDY0NQ_7df7b35c-cdc4-4b3d-b5ca-493f308a85d5">709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMwLTEtMS0xLTE0MDY0NQ_48bc57e3-7fe2-48d6-9414-c6c3e8614c21">85,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMwLTUtMS0xLTE0MDY0NQ_9e732bb7-8c51-46d1-a68f-c58e634996f1">16,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMwLTctMS0xLTE0MDY0NQ_cf28850c-a6f5-4d9a-98cf-373d54742e47">12,765</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMwLTktMS0xLTE0MDY0NQ_e33848bd-5b88-4072-ac01-a87fe161789a">89,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMxLTEtMS0xLTE0MDY0NQ_df710018-9637-4579-b0f1-81081333fd80">3,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMxLTUtMS0xLTE0MDY0NQ_6a9a6aad-a96c-4441-9c1f-be38c0f7c7da">1,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMxLTctMS0xLTE0MDY0NQ_e35ec0e9-82ae-4a91-b04b-dd8c7b710ee4">513</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMxLTktMS0xLTE0MDY0NQ_dfdcd071-0e41-4052-b300-86d2f1bb7611">3,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of KAH Hospice</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMyLTEtMS0xLTE0MDY0NQ_f423764c-a182-45c0-9aea-df33a21d7c0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMyLTUtMS0xLTE0MDY0NQ_e052215f-3834-4371-bf59-5dcfaa644ec2">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMyLTctMS0xLTE0MDY0NQ_93a4bd2d-334a-4f48-a9a4-42e25f6d4214">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:GainLossOnSaleOfBusiness" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMyLTktMS0xLTE0MDY0NQ_b286c0bf-2798-4f77-947c-f02166536d18">237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMzLTEtMS0xLTE0MDY0NQ_9b87541c-1fd0-468e-a318-3d67a4cdab9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMzLTUtMS0xLTE0MDY0NQ_0c9b9ede-033c-4485-9433-65b1093421de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMzLTctMS0xLTE0MDY0NQ_6db97075-7fc1-4f71-bf31-2de1267cbe60">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMzLTktMS0xLTE0MDY0NQ_ee2b287c-c2d7-4f1a-8811-db386bcd28ca">401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM0LTEtMS0xLTE0MDY0NQ_2718274b-f452-404e-acb9-3213bb30c4ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM0LTUtMS0xLTE0MDY0NQ_9e8e35b0-cd0c-4b96-8173-3f271b2f1a07">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM0LTctMS0xLTE0MDY0NQ_3deb0589-85a6-4561-ad6b-f4bc14d6c00b">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM0LTktMS0xLTE0MDY0NQ_cfa107e2-598a-4cd3-bc33-73dc1876db68">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM1LTEtMS0xLTE0MDY0NQ_0a1fdf2f-fa9b-43d1-9f0f-672d5dcf7cb5">3,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM1LTUtMS0xLTE0MDY0NQ_9f9f1aef-381a-4b47-8725-8f6bccf8ba91">1,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM1LTctMS0xLTE0MDY0NQ_e15b2f78-50af-4dbf-b4fc-780a398e10de">982</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM1LTktMS0xLTE0MDY0NQ_0946a33c-eea4-4023-af04-2b78c2084ee3">3,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM2LTEtMS0xLTE0MDY0NQ_30ce42bc-39af-4601-b141-0b868eb02b30">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM2LTUtMS0xLTE0MDY0NQ_cc5ce03a-762d-4c1e-ad3e-cff6e901a345">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM2LTctMS0xLTE0MDY0NQ_0fa8e98c-4e5f-4254-bb1f-c7716de6e718">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM2LTktMS0xLTE0MDY0NQ_9b3f526f-f836-44e0-b9ba-a370a138dbd8">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM3LTEtMS0xLTE0MDY0NQ_47dcdefc-db48-44ec-bb64-c623225f0c08">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM3LTUtMS0xLTE0MDY0NQ_dc022e07-ee82-4ef1-a99c-ee776fecc80e">1,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM3LTctMS0xLTE0MDY0NQ_3a4f9721-b43b-46cc-b228-caae0220a5b6">982</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM3LTktMS0xLTE0MDY0NQ_35cccd34-2cd7-4b01-9f5e-17c4539dc682">3,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" sign="-" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM4LTEtMS0xLTE0MDY0NQ_81dd7f66-71d6-469d-9ff9-41d2065a03b5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM4LTUtMS0xLTE0MDY0NQ_175f8d4f-858a-496a-9db9-9475bdc79f15">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM4LTctMS0xLTE0MDY0NQ_3baccf4f-0af9-4a53-aca9-e791b959ac4f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" sign="-" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM4LTktMS0xLTE0MDY0NQ_e9571609-9363-40a3-9021-8a54e00de8a8">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss) attributable to Humana</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM5LTEtMS0xLTE0MDY0NQ_62b791c7-20b7-471d-9042-181cfd3b02b1">3,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM5LTUtMS0xLTE0MDY0NQ_95fe5f6b-0e2f-4c07-bfd8-849fa5811804">1,505</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231" decimals="-6" sign="-" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM5LTctMS0xLTE0MDY0NQ_dde96292-6f1f-4165-9cab-ff88ce7dc4fd">982</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM5LTktMS0xLTE0MDY0NQ_6fd072bc-5c85-4bec-815b-d4f88b66c1c3">3,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:1pt;text-align:center"><ix:continuation id="i81113e7a38ab4d9ca8a5238da82df29f" continuedAt="i4cf729f540df47f5abe5d7069e3dccf8"><ix:continuation id="i580112d630d845a3ab23646c5e463007" continuedAt="i591f43f0b4e94a1ea92609c901dbb10a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i796b3722619946a2866e39b5e61a9380_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzUtMS0xLTEtMTQwNjQ1_f12dd765-8574-4e25-a64e-fe4aabc8f019">58,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ec4db66fd64bc8bbf344f75b65d318_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzUtNS0xLTEtMTQwNjQ1_1f2f39c6-b546-44e8-8d61-ef7e914890fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e79522cd64489888fa93b49c2e6243_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzUtOS0xLTEtMTQwNjQ1_cb45021d-7dd5-4098-ae34-80daf2b07239">58,654</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i299d79234a514ee99ef71046de2df3ef_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzYtMS0xLTEtMTQwNjQ1_7f896f44-fa8b-4080-8942-62effa37cbe7">6,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib51fd316c79f41bebb6fc344f6a46fea_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzYtNS0xLTEtMTQwNjQ1_d42e1820-572a-40f4-901e-b553edf5cd59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89314fb76bc24433859a3e2ed527bbee_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzYtOS0xLTEtMTQwNjQ1_85258342-8035-4618-90b2-348fab802b9b">6,955</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27b8edba666c462dac30cab44012936f_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzctMS0xLTEtMTQwNjQ1_201cff07-1546-462c-bb10-ae73784b4f9c">2,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i604d726215884cf397df3162b2320a54_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzctNS0xLTEtMTQwNjQ1_04ed3541-48e0-472b-bda3-dcfeed2ab424">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8388adc860dd445ba3de97b7ffe95782_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzctOS0xLTEtMTQwNjQ1_128d0bae-eb2f-45a0-957f-e801490dda2b">2,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadf23257f8df4815a1982e9a75f47ead_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzgtMS0xLTEtMTQwNjQ1_6aa7c60e-7052-4e9f-9640-e97637569856">67,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49240990811a4ffbb3f2a0dc683eee48_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzgtNS0xLTEtMTQwNjQ1_9c2f1bf3-ee03-45c5-8d11-347badb1c245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i951e931c21c249828781deed9eee8a91_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzgtOS0xLTEtMTQwNjQ1_aee23504-b2c5-4c38-9428-369d54c5d537">67,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47a95cc29f594641874afe2ad127832b_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzktMS0xLTEtMTQwNjQ1_0f94d5bb-d114-4541-aa16-05f8166e0200">5,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0fc07acc77f4488bb515bb553edc0192_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzktNS0xLTEtMTQwNjQ1_017cd2e4-0662-48b7-928d-2f2d69110c7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86a8d4d2792c484998a2be6ef7a5f7be_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzktOS0xLTEtMTQwNjQ1_c6f1ebac-44e1-4b63-9218-c0bd31303019">5,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47c70b5427044960a0e01b33a278221e_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEwLTEtMS0xLTE0MDY0NQ_530a6eb0-dc14-4fa6-9ed0-d414fb993f1f">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e4b19efa9e444958b038a59e21c75c4_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEwLTUtMS0xLTE0MDY0NQ_69a081fc-a762-4e7c-8d1e-fc8a4da1c367">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0fccf5c68e841ac97cab4f30966690c_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEwLTktMS0xLTE0MDY0NQ_7dfb5d35-1813-4389-99b0-570802315ca0">1,731</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14fe41ab9d67459db2ad797f32f05552_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzExLTEtMS0xLTE0MDY0NQ_64fa11ae-c2b9-487d-b91f-69168a14bd71">5,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4687e7689164bdb8320ac4f06953159_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzExLTUtMS0xLTE0MDY0NQ_92f6edd2-1d24-4821-9991-402832e5ef54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if321fc68ab164282ba4bc0726aa93b10_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzExLTktMS0xLTE0MDY0NQ_6af57fd8-6070-45a1-a91b-bd906a3c72c0">5,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEyLTEtMS0xLTE0MDY0NQ_d4ab1379-f123-4258-ba04-f37e5cc5712e">79,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEyLTUtMS0xLTE0MDY0NQ_c1880fe4-6044-4e61-a44f-8bffbf3fe918">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEyLTktMS0xLTE0MDY0NQ_c2b70e12-9804-484b-b2e3-33c31ad0163b">79,822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e8f651980b4cd48bca93f3614c15b2_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE0LTEtMS0xLTE0MDY0NQ_e8909991-62d7-4f9a-bcbd-8a47c2b3d8db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if787c02ff9d64d0e86eb8be9f9c46de6_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE0LTUtMS0xLTE0MDY0NQ_9e1152c8-9371-406f-9435-f41c4cd6d604">1,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f643826c3e2422b89a1571806de6508_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE0LTktMS0xLTE0MDY0NQ_a36a4fbe-f4a7-4eba-b1a8-348f1d0322c6">1,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacbb558c49be43379c68e6c711fbdf86_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE1LTEtMS0xLTE0MDY0NQ_6ed21b50-17bc-470e-ba87-6ec49376a77a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb33cf4ae55b44f2a3f18566f90accbf_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE1LTUtMS0xLTE0MDY0NQ_834b63b3-a018-436b-81e0-06742c39fcd3">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5312c3184550451f928932ad398d9016_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE1LTktMS0xLTE0MDY0NQ_a4efae49-db55-41a8-ba8e-0554cff99a84">413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b44c1e415cb45b98e81cc9a0453f32e_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE2LTEtMS0xLTE0MDY0NQ_464552e8-126b-433f-8eab-756a906c6c0c">853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03cda4dc42e842a09d1fdc9b3ceef45f_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE2LTUtMS0xLTE0MDY0NQ_5fa99de1-b247-4043-acde-7195383e2eff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23dd140b009549a8ae4aa3a8fae36f29_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE2LTktMS0xLTE0MDY0NQ_a0f556e4-0f1c-4234-a4c7-f7d601d99817">853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba55647075e043b2b181dba0f49b1e76_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE3LTEtMS0xLTE0MDY0NQ_8e7514b6-1762-4615-a1c8-c5238886d4cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8547008a36864217a82b790897092dc0_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE3LTUtMS0xLTE0MDY0NQ_477f5f95-1c98-48b4-8200-4cd948c11520">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dc3f58523444595909416938e01f4b3_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE3LTktMS0xLTE0MDY0NQ_91f08440-49a8-48ff-bd30-2a09987eb5d9">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE4LTEtMS0xLTE0MDY0NQ_fe6e3585-b873-48f4-b1da-800c352b3beb">853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE4LTUtMS0xLTE0MDY0NQ_d9d1230e-6598-498c-8753-ed0794727815">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE4LTktMS0xLTE0MDY0NQ_4ffff93a-8040-4d45-b36a-fb394f37ae9a">3,055</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE5LTEtMS0xLTE0MDY0NQ_43724273-09c0-46f6-8388-8fe403cc8b07">80,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE5LTUtMS0xLTE0MDY0NQ_d4940e45-9c78-4091-968d-4134bb297e17">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia427ffdd9dff49bf85f8ee91a5835796_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE5LTktMS0xLTE0MDY0NQ_943357c3-28c7-4105-ad64-41640e0ab286">82,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide89fb74b6854034944d82f12a08655f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIxLTEtMS0xLTE0MDY0NQ_1c66b7ba-8e59-43f9-8dc4-c86a8fc42b91">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0654ac32fb3f48b58e198b661a0db5c2_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIxLTUtMS0xLTE0MDY0NQ_3f5d2999-6472-4a6a-9ff6-89701af0a8dc">2,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib05710ff212440dfaeea8f28f8a00d3f_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIxLTctMS0xLTE0MDY0NQ_bfb01b6a-f6bd-4604-83c8-6f995b428d8a">2,869</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7142e963e6ee4d9c8c2e655388f8918f_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIyLTEtMS0xLTE0MDY0NQ_2253ab46-90b7-498c-833d-a6c939070a32">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie513cbe1edfa4c8dacc68ed1e879643b_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIyLTUtMS0xLTE0MDY0NQ_23b44933-b654-4fc0-a84c-b381c79fd5a2">9,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad139752acf7480db3dd52727e06ef78_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIyLTctMS0xLTE0MDY0NQ_a08e7378-572f-470d-9c56-1f6ac08a0403">9,024</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic676151b15dd4c80a0f1e58f9d321c46_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIzLTEtMS0xLTE0MDY0NQ_e1d8327a-5a27-429a-ab20-d33e8808e1b8">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i059d3ba987f746dca463069e8b556721_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIzLTUtMS0xLTE0MDY0NQ_e83db29e-6771-452b-9ace-2f8e9d7f7e17">11,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35acacb165204dcd9adc612f30611f25_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIzLTctMS0xLTE0MDY0NQ_de917726-0a33-443b-b78f-f00ad3888d19">11,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI0LTEtMS0xLTE0MDY0NQ_8ec72b46-51ab-4e4a-9d32-c29d96e65389">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI0LTUtMS0xLTE0MDY0NQ_18acf8fe-6b43-4baf-bc7f-5dfff18a332a">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI0LTctMS0xLTE0MDY0NQ_6ca5dc33-3782-4e9f-903e-0f217a77216e">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI0LTktMS0xLTE0MDY0NQ_7fed566f-5f58-4c37-8a50-be87063e3b88">187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI1LTEtMS0xLTE0MDY0NQ_08d7b7f2-0f68-4d2a-8766-36ea3e8e95b0">80,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI1LTUtMS0xLTE0MDY0NQ_9484dc2b-9e2a-43e5-9d6a-52c5a952701f">14,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI1LTctMS0xLTE0MDY0NQ_e95f4a29-3179-434e-b287-ee40a461ff07">11,924</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI1LTktMS0xLTE0MDY0NQ_9993c9c9-87d2-4f56-9516-ad4ee471e8dc">83,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI3LTEtMS0xLTE0MDY0NQ_1295e938-fdb7-427f-85c8-8758188fdaeb">69,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI3LTUtMS0xLTE0MDY0NQ_ac10a249-63d5-4903-b2dd-1aa66a29ace3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI3LTctMS0xLTE0MDY0NQ_37751f83-03ba-4b0a-a675-1d4befa421cc">440</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI3LTktMS0xLTE0MDY0NQ_a8bf6fab-4e17-4ba4-b3a7-edb0c5bbcbec">69,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI4LTEtMS0xLTE0MDY0NQ_974e9e80-3779-453a-9b1b-5ed52bfed6e3">8,340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI4LTUtMS0xLTE0MDY0NQ_21af9404-35e4-4b22-aac5-d6fcef976bbd">12,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI4LTctMS0xLTE0MDY0NQ_20ec4d9f-d96a-4631-a402-e57972d3d9d3">11,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI4LTktMS0xLTE0MDY0NQ_2527ce51-93a8-4f36-9513-3ec6ae7900af">10,121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI5LTEtMS0xLTE0MDY0NQ_92e1665c-f584-4c70-90e2-b83bd8138e07">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI5LTUtMS0xLTE0MDY0NQ_b2d0c169-a21a-4123-a5db-0203a17499d2">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" sign="-" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI5LTctMS0xLTE0MDY0NQ_5bca9581-c7a5-4b68-b11e-353561cb66af">95</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI5LTktMS0xLTE0MDY0NQ_1ba7aa90-0ece-43e3-b5fe-bd7b2bde7c28">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMwLTEtMS0xLTE0MDY0NQ_7fefce11-32f2-455e-b799-319772dda450">78,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMwLTUtMS0xLTE0MDY0NQ_f1c6ff8a-0a2a-498c-ad87-1b8378432d48">13,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMwLTctMS0xLTE0MDY0NQ_279d1066-ad93-4353-a884-ff9bc6f16c79">11,722</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMwLTktMS0xLTE0MDY0NQ_0fbfbc90-43fa-4aaa-90ce-dd9c5f8d0fa8">79,916</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMxLTEtMS0xLTE0MDY0NQ_24783320-9dab-49d1-a739-3a05de3e3a03">2,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMxLTUtMS0xLTE0MDY0NQ_6da67ccb-ffb2-4237-96df-71117d8b4f71">938</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMxLTctMS0xLTE0MDY0NQ_7aa2db8a-5de1-42f1-bb4e-5253a953e1cd">202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMxLTktMS0xLTE0MDY0NQ_dbacbfb1-cdd6-438c-9d82-8a2e06fab915">3,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMzLTEtMS0xLTE0MDY0NQ_ad3a4438-2b59-4c83-a9ce-24cbf36f53db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMzLTUtMS0xLTE0MDY0NQ_9b3d38dd-a39d-45c0-9a35-2dfba0ca37f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMzLTctMS0xLTE0MDY0NQ_19093591-b95a-448d-a98a-f6fc16dcceca">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMzLTktMS0xLTE0MDY0NQ_d4c6d52a-45ec-4433-ba9f-7f22d5889d3d">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM0LTEtMS0xLTE0MDY0NQ_ffa62b56-1c3c-4d87-a06a-5c5e8f2acfd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM0LTUtMS0xLTE0MDY0NQ_fb793466-f664-4db1-bb66-574ff7a5b583">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM0LTctMS0xLTE0MDY0NQ_f1ddf373-e761-406a-9f36-134bc972d649">532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM0LTktMS0xLTE0MDY0NQ_fb853e8e-9426-438d-b28e-f11590e9d410">532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM1LTEtMS0xLTE0MDY0NQ_cf2a1c8e-7b12-4135-990d-3fd3a2b44e77">2,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM1LTUtMS0xLTE0MDY0NQ_242eeea1-bebd-4a63-becc-75dd49a2f06a">938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM1LTctMS0xLTE0MDY0NQ_a56dcf88-78ee-444e-9e0c-d26f5cd9d85c">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM1LTktMS0xLTE0MDY0NQ_e7fab6fc-b9f5-4be8-aeb1-c1e98457c64c">3,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM2LTEtMS0xLTE0MDY0NQ_9cb5209b-bcc0-457b-b404-a867f2a6daf5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM2LTUtMS0xLTE0MDY0NQ_db92f229-8830-426c-99c3-0ebe9f00a867">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM2LTctMS0xLTE0MDY0NQ_ddc4ebf6-121d-43c5-b196-98556c9ecf63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM2LTktMS0xLTE0MDY0NQ_6654ae79-082e-426e-8156-d363e6006ce8">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM3LTEtMS0xLTE0MDY0NQ_97093619-be10-4f91-bf87-f097c933b4a8">2,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM3LTUtMS0xLTE0MDY0NQ_3320243d-b949-4126-8fc0-9e39e11c88b5">1,003</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM3LTctMS0xLTE0MDY0NQ_0aceab51-ff95-4b3c-8d38-b3fa67d5c7e2">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM3LTktMS0xLTE0MDY0NQ_1295c1b9-8c78-4a28-90e1-08750f18227d">3,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM4LTEtMS0xLTE0MDY0NQ_2aedaf94-9f04-4293-84b0-c2a88f4e19eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM4LTUtMS0xLTE0MDY0NQ_621a73f8-4e25-454b-af7a-47ad9858a5f3">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM4LTctMS0xLTE0MDY0NQ_05a52b4f-8234-4f97-b299-46918f06706b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM4LTktMS0xLTE0MDY0NQ_73643982-6f7a-4de4-bda0-6a9476269335">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings attributable to Humana</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM5LTEtMS0xLTE0MDY0NQ_0fa7fd9b-c611-4742-b7b8-c6319d661715">2,412</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM5LTUtMS0xLTE0MDY0NQ_9dcb0122-2a0b-42b2-aee0-ca1ea2aebf36">1,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM5LTctMS0xLTE0MDY0NQ_3cf3a267-ea71-4cf5-a7c8-c1da77881e08">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM5LTktMS0xLTE0MDY0NQ_f6cf482d-416f-4d33-b1fc-ea0006b321d8">3,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></ix:continuation></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:1pt;text-align:center"><ix:continuation id="i4cf729f540df47f5abe5d7069e3dccf8"><ix:continuation id="i591f43f0b4e94a1ea92609c901dbb10a"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if39c9d28566e49fb94ca604dad0f7413_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzUtMS0xLTEtMTQwNjQ1_c4b0b7e3-8ff7-4677-be31-37b699350ade">51,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eaa0a4a53de41adbac051ef9fae2992_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzUtNS0xLTEtMTQwNjQ1_5b050db5-8912-431c-abb3-c102b4d5d12f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e964222588640aaa4fc9517b9915eb7_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzUtOS0xLTEtMTQwNjQ1_1e778e77-27b1-4c05-b471-21e5b7a165ec">51,697</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icae43fd407c4414b943b92f92c1a164a_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzYtMS0xLTEtMTQwNjQ1_b718d310-a073-4bbf-a56a-9b7f594d4c55">7,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i361c2054214544b3a52b1c8f570d1486_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzYtNS0xLTEtMTQwNjQ1_8c683d86-423e-4ea8-967a-db71c5f06178">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i298fcaa6f9554c64bd5f075426eeb27d_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzYtOS0xLTEtMTQwNjQ1_bd38b0ce-9f01-4a5f-85c1-bec108420cce">7,774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb67851ec4dc4e8d82168000c4595810_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzctMS0xLTEtMTQwNjQ1_6636fca6-12b7-48a5-a7c6-d24df200940a">2,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98770db22e0b4594a796eee0640b15a3_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzctNS0xLTEtMTQwNjQ1_ec9edb35-a421-40b9-bcba-4f151e54a752">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3d182410af6d45d1810973f77992c508_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzctOS0xLTEtMTQwNjQ1_ccd64de3-80d2-49e7-8d4b-c4f428efef18">2,742</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4d69af6e550428ca1462f8259d169c1_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzgtMS0xLTEtMTQwNjQ1_5bd2c6cd-ce1e-41a8-a81e-d788c8ace827">62,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib40497970a7d49a3a88ba998a48f7805_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzgtNS0xLTEtMTQwNjQ1_0f69c957-840a-4bd0-ba47-44f98761b0c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f7a2cf3d405471395d39b0680066ce9_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzgtOS0xLTEtMTQwNjQ1_1786c0b3-c64d-442e-a1cf-189f8e7a4b12">62,213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd3273e77284e40b2171ed9f574fe18_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzktMS0xLTEtMTQwNjQ1_8119468e-63b5-43b1-b8b6-5baad0514e92">5,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56bb0fd352744b9b9971c20e238c2186_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzktNS0xLTEtMTQwNjQ1_54ce77cc-dcef-4e11-9dfb-fe9f30f18f83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8955c114fdc3489daa2dee4a9140f585_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzktNy0xLTEtMTQwNjQ1_ca4891b7-a814-4d03-bab3-48d4ead71215">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf9f80bbf5a6434ea08491bd367d4e20_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzktOS0xLTEtMTQwNjQ1_a2b4d908-9bac-4415-863f-5572eea02c03">6,051</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i138d886578ea47c5bdfc107eafd19fdf_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEwLTEtMS0xLTE0MDY0NQ_b18dc69d-855c-4680-a476-15c6c2c3ee1e">1,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id95534e4967c4794a2bec00ba0a1892d_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEwLTUtMS0xLTE0MDY0NQ_b99ae95a-c1ba-4e78-8536-0f34ab07ae61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i02af1f31fe144885b9fc028cec9cc8b7_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEwLTktMS0xLTE0MDY0NQ_a9acb20a-279f-469d-85d9-164dd861b111">1,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6507afa1e242dcb28f8c57ad781f71_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzExLTEtMS0xLTE0MDY0NQ_f0da7180-a271-4ae8-a170-bea608a7548d">4,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3908bb51774249158321c4ed8ca6ac40_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzExLTUtMS0xLTE0MDY0NQ_a3614041-2119-479c-b1f8-b840da9c397b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b2d04219b8943159debcd053092fe5b_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzExLTktMS0xLTE0MDY0NQ_a39babc3-479e-4fc1-8f45-f382cb4c87cc">4,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEyLTEtMS0xLTE0MDY0NQ_6990a654-1302-47b3-93d8-2a5614765640">73,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEyLTUtMS0xLTE0MDY0NQ_92637ab1-5132-433d-bbdc-1e1f1e9f88a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEyLTctMS0xLTE0MDY0NQ_7e54e722-0308-4503-b2aa-7f36d3157b99">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PremiumsEarnedNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEyLTktMS0xLTE0MDY0NQ_adcb9d3a-0634-4785-9431-9c48bfc6c75c">74,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04343d7d31a84ac79e44e3b54ac8536d_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE0LTEtMS0xLTE0MDY0NQ_c894d97b-1bfe-4735-9664-cf95d2308957">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee9aefc250a24fa2b78e41b534370e5b_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE0LTUtMS0xLTE0MDY0NQ_d3890ad6-3004-4a98-98de-df1de271eb1a">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48e8960d40aa4748b405ee8aac3326b7_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE0LTktMS0xLTE0MDY0NQ_221c5630-7659-443d-9324-2d29c24451d3">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c79c3029f1c466b82ea3f885f7dbd83_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE1LTEtMS0xLTE0MDY0NQ_ec1964e7-1f81-4f83-b0a8-e22ba22a73dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9711652ed43c412f9b92e3193a318e66_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE1LTUtMS0xLTE0MDY0NQ_5a64ce9d-b4a1-4934-aa0d-9a98644ad579">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44030fa27c974660bded54de8fb11a50_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE1LTktMS0xLTE0MDY0NQ_d75da88f-d4ff-4439-bc14-9de3c089a646">328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaec631922eab4df1b6048c710078b4c7_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE2LTEtMS0xLTE0MDY0NQ_e2a21df0-e780-4c54-8087-34fe02e34c76">813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f743f1a22644caac1e859fb29a7aa1_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE2LTUtMS0xLTE0MDY0NQ_341669f1-d087-4677-9bce-58e01aaa47dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ded12f91baa4171b745a570b579f67a_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE2LTktMS0xLTE0MDY0NQ_a72b4eb2-9a1e-49f1-8d3e-a0da9dfd71ec">813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id2c8cfea28c541b7b645922d44fbf2f4_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE3LTEtMS0xLTE0MDY0NQ_bb464fef-d939-4b6b-803a-805ef43fd9e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3e7d86e1bea4d3f962cf462f8b5c6cc_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE3LTUtMS0xLTE0MDY0NQ_f8e11089-9448-443c-ad12-c057e94773af">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f092984c5164c6d84492225b149eaa2_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE3LTktMS0xLTE0MDY0NQ_f3f15248-5a0a-4d63-b6d9-e8e84197dcd0">567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE4LTEtMS0xLTE0MDY0NQ_9aa1e144-5a6b-473f-bd11-a3bc87f8b111">813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE4LTUtMS0xLTE0MDY0NQ_3fd4a9e8-93b0-411e-a6c9-1db620156abf">1,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE4LTktMS0xLTE0MDY0NQ_c3a8d4a7-9bec-45dd-8c13-1b252c957c10">1,815</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE5LTEtMS0xLTE0MDY0NQ_edc158c4-860f-465d-8792-b55d052a65dc">74,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE5LTUtMS0xLTE0MDY0NQ_f756c7d8-84be-44ff-b4c6-a9fc96f1bc1f">1,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8955c114fdc3489daa2dee4a9140f585_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE5LTctMS0xLTE0MDY0NQ_06e178f9-797b-4e76-a6ec-aef39d9e3c1b">602</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i948d525c3b334e34b62da49d9c7482fc_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE5LTktMS0xLTE0MDY0NQ_fa3717f0-afcc-4d96-a6db-c0a8ef626bd6">76,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d8e5a12ecf549238eedf1a87c7d1e88_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIxLTEtMS0xLTE0MDY0NQ_29a28887-486c-467f-b0ce-873236bae096">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i325ae4c732a24279a4460fdb5f2ce1b8_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIxLTUtMS0xLTE0MDY0NQ_d35f9799-b785-4e2d-9ae5-6eab4ee23fdd">2,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i25389e35fd5c4d46b3ce2e270d42eaa0_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIxLTctMS0xLTE0MDY0NQ_1fb62f70-1ebc-4eb9-95b7-6648f842d78c">2,576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d2420a864954324be79ba29b455d706_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIyLTEtMS0xLTE0MDY0NQ_4c414858-02a4-44da-aea9-d0f5fe44f7e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i128c3bbb84cb4ebfa37efdd581ba4fb6_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIyLTUtMS0xLTE0MDY0NQ_3ecb01f4-8537-4634-a3fb-ed8f415f6b22">7,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i54776761815d43f0b22c0e07b84bbe14_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIyLTctMS0xLTE0MDY0NQ_9d8d2b19-825e-4cea-b027-51a7ecefbca3">7,928</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63dbef0b32684c9c8234fd4ad305f9d5_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIzLTEtMS0xLTE0MDY0NQ_56bf0280-a469-4ccb-b88a-c1b6bf6eae9d">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17ef1ab00ada45a291c117cd6de96bcd_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIzLTUtMS0xLTE0MDY0NQ_d0078175-6758-4101-b23e-0a3240f8a7b3">10,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iea836c2c260040cc9a90acfff66f58e4_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIzLTctMS0xLTE0MDY0NQ_19b046fd-74f2-4894-ac73-f9e73106370a">10,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58027b9122014dee871db47b91819791_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI0LTEtMS0xLTE0MDY0NQ_3fe7c912-41d6-4967-bea3-7b9c53a7f90b">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd8c18c4f8548ff9a23c8f591e89113_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI0LTUtMS0xLTE0MDY0NQ_c9814023-fb8b-4e37-9240-e19685517862">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI0LTctMS0xLTE0MDY0NQ_95b947ce-2064-46d5-8686-31ee7c10e586">970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:InvestmentIncomeInterestAndDividend" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI0LTktMS0xLTE0MDY0NQ_0d0117e5-c0ce-436a-b245-01509afd0c4d">1,154</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58027b9122014dee871db47b91819791_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI1LTEtMS0xLTE0MDY0NQ_907b8848-cfe3-4d3b-a2c4-907e3640601d">74,597</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd8c18c4f8548ff9a23c8f591e89113_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI1LTUtMS0xLTE0MDY0NQ_2ef5d13a-5fc3-4880-946c-0dd7c76188c9">11,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI1LTctMS0xLTE0MDY0NQ_cdeee210-484a-4b74-8447-0d49c67154fb">8,932</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI1LTktMS0xLTE0MDY0NQ_9c0e7c03-9ee5-411a-a335-f46b21dc31da">77,155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI3LTEtMS0xLTE0MDY0NQ_97336520-13c7-494d-a1dd-1118bf2bf804">61,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI3LTUtMS0xLTE0MDY0NQ_3575416d-9148-4631-ab1e-f83b03a78de8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI3LTctMS0xLTE0MDY0NQ_73b48fd0-525b-4a48-b207-9f3716da11cf">281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI3LTktMS0xLTE0MDY0NQ_030418cd-ce41-4116-ac00-ce05d878d5c8">61,628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI4LTEtMS0xLTE0MDY0NQ_812ee6a8-ff6c-4665-87f4-ad8e77430be7">9,129</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI4LTUtMS0xLTE0MDY0NQ_83a05164-ccc0-456a-938d-ace1e68e5eb6">10,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI4LTctMS0xLTE0MDY0NQ_a1186585-5a37-415c-aaeb-10e50ddbd86c">9,783</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI4LTktMS0xLTE0MDY0NQ_156cdef6-8e54-49c2-b2ba-594350b534c3">10,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI5LTEtMS0xLTE0MDY0NQ_cb14070d-9d38-4dca-8daa-8a4224a93dbe">439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI5LTUtMS0xLTE0MDY0NQ_4eb966fa-0e2e-4809-8456-1643e7674a8d">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" sign="-" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI5LTctMS0xLTE0MDY0NQ_77ffe0ed-633c-45d9-87e2-55d02ac0f05e">110</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="hum:DepreciationAndAmortizationIncomeStatement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI5LTktMS0xLTE0MDY0NQ_49870b37-2e58-45c1-bf32-565f49f4ebe2">489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58027b9122014dee871db47b91819791_D20200101-20201231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMwLTEtMS0xLTE0MDY0NQ_de4112b7-1648-4ae7-9c01-86d238e258f2">71,477</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabd8c18c4f8548ff9a23c8f591e89113_D20200101-20201231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMwLTUtMS0xLTE0MDY0NQ_55e383fd-08a9-469d-bd8c-8fbd736f17f6">10,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMwLTctMS0xLTE0MDY0NQ_d2f2250b-eb8c-4dea-914e-219897b65390">10,174</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:BenefitsLossesAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMwLTktMS0xLTE0MDY0NQ_0f6e20be-8e0d-4103-b5f5-75da6eaf8053">72,169</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMxLTEtMS0xLTE0MDY0NQ_a66cf6c9-469c-4557-8ade-61dd78a3f0ac">3,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMxLTUtMS0xLTE0MDY0NQ_2d25e02b-8330-4ce9-a0b6-6d10cae27cf6">624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMxLTctMS0xLTE0MDY0NQ_2f8f6666-f46e-4c69-97a6-4b4d0c8b4ce8">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMxLTktMS0xLTE0MDY0NQ_74ba20c0-0991-47a7-9cb1-97a9b3ece66a">4,986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMzLTEtMS0xLTE0MDY0NQ_db058e89-45a4-4a3b-aaf8-9f91fe2e19e7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMzLTUtMS0xLTE0MDY0NQ_535c928d-046c-481a-98a6-d80971fc6336">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMzLTctMS0xLTE0MDY0NQ_3e4ebf0f-86e5-4428-8f78-985c6daf5c72">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMzLTktMS0xLTE0MDY0NQ_2e4689cc-9399-49f4-a39b-10cac299833e">283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM0LTEtMS0xLTE0MDY0NQ_f88e84c6-eed0-4210-9378-b378451e8d92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM0LTUtMS0xLTE0MDY0NQ_84df5ad5-1f26-4d58-ae6f-6ec12d55f147">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM0LTctMS0xLTE0MDY0NQ_43bc4519-48ac-47ca-9bb9-6ae5f516c8f3">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM0LTktMS0xLTE0MDY0NQ_7961c3ce-8df1-404b-83ec-0732abf64dff">103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM1LTEtMS0xLTE0MDY0NQ_9a4ab787-8641-4395-b744-61bf1e205200">3,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM1LTUtMS0xLTE0MDY0NQ_2b6d594d-953a-48b9-8975-88609972e54e">624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM1LTctMS0xLTE0MDY0NQ_241f7b93-9ea2-4bac-b064-960d9b94bde2">856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM1LTktMS0xLTE0MDY0NQ_8f0eea77-3185-46fc-9aaa-339bb002f16d">4,600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM2LTEtMS0xLTE0MDY0NQ_4f21ded6-327c-422f-bd7f-2df77155b614">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM2LTUtMS0xLTE0MDY0NQ_0beb47d8-9209-4674-bd9e-56a6ab2e0423">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM2LTctMS0xLTE0MDY0NQ_9f45c4c0-fe20-4d6d-b123-08d9dd9391a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM2LTktMS0xLTE0MDY0NQ_aceae095-72cf-4706-a0f7-07a7d21bba5b">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM3LTEtMS0xLTE0MDY0NQ_708edf75-add2-4a02-a5f2-6415c8a75166">3,120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM3LTUtMS0xLTE0MDY0NQ_e332ef9f-13cd-4d95-9532-8e9254e93151">698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM3LTctMS0xLTE0MDY0NQ_aa356f48-cb4e-49bb-9c84-cbfcb6a60d0b">856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM3LTktMS0xLTE0MDY0NQ_e304ea31-3690-415a-8efe-87574237402e">4,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_199"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:3pt;text-align:center;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS&#8212;(Continued)</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;<ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:ReinsuranceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzI2MjE_f9b79a2e-d7b4-43f9-94dc-526fd7b7e6b9" continuedAt="i3d76ec8b19d84cee83b520d6768d845e" escape="true">REINSURANCE </ix:nonNumeric></span></div><ix:continuation id="i3d76ec8b19d84cee83b520d6768d845e"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain blocks of insurance assumed in acquisitions, primarily life and annuities in run-off status are subject to reinsurance where some or all of the underwriting risk related to these policies has been ceded to a third party. In addition, a large portion of our reinsurance takes the form of 100% coinsurance agreements where, in addition to all of the underwriting risk, all administrative responsibilities, including premium collections and claim payment, have also been ceded to a third party. We acquired these policies and related reinsurance agreements with the purchase of stock of companies in which the policies were originally written. We acquired these companies for business reasons unrelated to these particular policies, including the companies&#8217; other products and licenses necessary to fulfill strategic plans. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reinsurance agreement between two entities transfers the underwriting risk of policyholder liabilities to a reinsurer while the primary insurer retains the contractual relationship with the ultimate insured. As such, these reinsurance agreements do not completely relieve us of our potential liability to the ultimate insured. However, given the transfer of underwriting risk, our potential liability is limited to the credit exposure which exists should the reinsurer be unable to meet its obligations assumed under these reinsurance agreements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables represent the portion of future policy benefits payable and benefits payable that are covered by reinsurance. Reinsurance recoverables, included in other current and long-term assets, were $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE2MTU_1f9d3df6-9883-4d19-9654-f087445efee3">181</ix:nonFraction> million at December&#160;31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE2NDE_333f0c09-d523-4271-acf1-90f2c3c8efd9">188</ix:nonFraction> million at December&#160;31, 2021. The amount of these reinsurance recoverables resulting from <ix:nonFraction unitRef="number" contextRef="i0dfbff48771b4638b79a2300493d8877_D20220101-20221231" decimals="INF" name="hum:PercentageOfCoinsuranceAgreement" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE3MjQ_0a961f50-2056-4651-abba-faa1f82c1a0d">100</ix:nonFraction>% coinsurance agreements was approximately $<ix:nonFraction unitRef="usd" contextRef="i4523ccf1b56c43b9960b083342924008_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE3Njg_e50fd5d0-e9f6-438f-9ade-02c6a3a8595d">181</ix:nonFraction> million at December&#160;31, 2022 and approximately $<ix:nonFraction unitRef="usd" contextRef="i704efe02ea3f46fdadbf3661e8fb4018_I20211231" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE4MDg_5ca5abe9-5fc9-4a3a-b822-8579609c4451">188</ix:nonFraction> million at December&#160;31, 2021. Premiums ceded were $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:CededPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE4NTE_d14f5053-249e-4839-82d3-4eac4670600c">5</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:CededPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE4NjE_8e0031b2-7400-4342-bb29-3a32e1cb1b32">6</ix:nonFraction> million in 2021 and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:CededPremiumsWritten" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE4NzQ_07383c23-2080-4eee-b5c8-f4f3d131966f">29</ix:nonFraction> million in 2020. Benefits ceded were $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE5MDQ_b99f938b-4593-4b19-9720-9666162ed64a">2</ix:nonFraction> million in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE5MTQ_5f902740-5635-4261-a3a6-ee471e337ebc">2</ix:nonFraction> million in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-6" name="us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE5Mjg_74bec75f-b66d-463d-a4ca-ceb22b0521c8">7</ix:nonFraction> million in 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the financial condition of our reinsurers on a regular basis. Protective Life Insurance Company with $<ix:nonFraction unitRef="usd" contextRef="i4eaa3ef983134ea9b906d1bd180d672d_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzIzMDY_f921050e-51db-4ab1-a963-eb6b7ff74a35">165</ix:nonFraction> million in reinsurance recoverables is well-known and well-established with a AM Best rating of A+ at December&#160;31, 2022. The remaining reinsurance recoverables of $<ix:nonFraction unitRef="usd" contextRef="i0c4d94cfc4be468a97bde38608cbc8a6_I20221231" decimals="-6" name="us-gaap:ReinsuranceRecoverables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzI0NjI_d5f85d51-b634-47fa-b7e3-ffc36d59e382">16</ix:nonFraction> million are divided between <ix:nonFraction unitRef="reinsurer" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="INF" name="hum:NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzI0ODU_c17572cc-b8ed-43f8-8590-0432f8721524">10</ix:nonFraction> other reinsurers, with $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-6" name="hum:AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzI1MTE_5d105261-9d92-4d9d-ad4b-ba20ab5af385">1</ix:nonFraction> million subject to funds withheld accounts or other financial guarantees supporting the repayment of these amounts.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_202"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Board of Directors and Stockholders of Humana Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinions on the Financial Statements and Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Humana Inc. and its subsidiaries (the &#8220;Company&#8221;) as of December 31, 2022 and 2021, and the related consolidated statements of income, of comprehensive income, of stockholders&#8217; equity and of cash flow for each of the three years in the period ended December 31, 2022, including the related notes and financial statement schedule listed in the index appearing under Item 15(a)(2) (collectively referred to as the &#8220;consolidated financial statements&#8221;). We also have audited the Company's internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2022 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2022, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management&#8217;s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company&#8217;s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Critical Audit Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Valuation of Incurred but not yet Reported Benefits Payable</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Notes 2 and 11 to the consolidated financial statements, the Company&#8217;s incurred but not yet reported benefits payable (IBNR) was $5.7 billion as of December 31, 2022. Management develops its estimate for IBNR using actuarial methodologies and assumptions, primarily based upon historical claim experience. Actuarial standards of practice generally require a level of confidence such that the liabilities established for IBNR have a greater probability of being adequate versus being insufficient, or such that the liabilities established for IBNR are sufficient to cover obligations under an assumption of moderately adverse conditions. As described by management, for the periods prior to the most recent two months, a completion factor method uses historical paid claims patterns to estimate the percentage of claims incurred during a given period that have historically been adjudicated as of the reporting period. Changes in claim inventory levels and known changes in claim payment processes are taken into account in these estimates. For the most recent two months, the incurred claims are estimated primarily from a trend analysis based upon per member per month claims trends developed from historical experience in the preceding months, adjusted for known changes in estimates of hospital admissions, recent hospital and drug utilization data, provider contracting changes, changes in benefit levels, changes in member cost sharing, changes in medical management processes, product mix and workday seasonality.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal considerations for our determination that performing procedures relating to the valuation of IBNR is a critical audit matter are the significant judgment by management when developing the estimate of IBNR, which in turn led to a high degree of auditor judgment, subjectivity and effort in performing procedures and evaluating the actuarial methodologies and significant assumptions related to completion factors, per member per month claims trends, and the potential for moderately adverse conditions. Also, the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to the valuation of IBNR, including controls over the actuarial methodologies and development of significant assumptions related to completion factors, per member per month claims trends, and the potential for moderately adverse conditions. These procedures also included, among others, the involvement of professionals with </span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specialized skill and knowledge to assist in developing an independent estimate of IBNR. This independent estimate includes a range of reasonable outcomes, including outcomes under moderately adverse conditions, which are compared to management&#8217;s estimate of IBNR. Developing the independent estimate involved developing independent completion factors and per member per month claims trends assumptions using management&#8217;s data, testing the completeness and accuracy of data provided by management, and evaluating the reasonableness of management&#8217;s assumptions. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill Impairment Assessments &#8211; Provider and Home Solutions Reporting Units</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Notes 2 and 9 to the consolidated financial statements, the Company&#8217;s consolidated goodwill balance was $9.1 billion as of December 31, 2022, and the goodwill associated with the Provider and Home Solutions Reporting Units was $1.1 billion and $4.3 billion, respectively. Management conducts an impairment test in the fourth quarter of each year and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. Management relies on an evaluation of future discounted cash flows analysis to determine fair value and uses discount rates that correspond to a market-based weighted-average cost of capital, and terminal growth rates that correspond to long-term growth prospects, consistent with the long-term inflation rate. Key assumptions in management&#8217;s cash flow projections, including revenue growth rates, medical and operating cost trends, and projected operating income, are supported with management&#8217;s long-range business plan and annual planning process.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal considerations for our determination that performing procedures relating to the goodwill impairment assessments of the Provider and Home Solutions reporting units is a critical audit matter are the significant judgment by management when determining the fair value of the reporting units, which in turn led to a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management&#8217;s significant assumptions related to the revenue and terminal growth rates, projected operating income, and the discount rates. Also, the audit effort involved the use of professionals with specialized skill and knowledge.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management&#8217;s goodwill impairment assessments, including controls over the significant assumptions used in the valuation of the Provider and Home Solutions reporting units. These procedures also included, among others, testing management's process for determining the fair value estimate of the reporting units; evaluating the appropriateness of the discounted cash flows analysis; testing the completeness and accuracy of underlying data used in the analysis; and evaluating the reasonableness of the significant assumptions used by management related to the revenue and terminal growth rates, projected operating income, and the discount rates. Evaluating management&#8217;s assumptions related to revenue and terminal growth rates and projected operating income involved considering the past performance of the reporting units and whether the assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in the evaluation of the appropriateness of the Company&#8217;s discounted cash flows analysis and the reasonableness of the significant assumptions related to the terminal growth rates and the discount rates. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yMDIvZnJhZzpmYmI3ZTkyOTY1Yjk0NjhlODJkM2FiYjNmZDBjYWI3OC90ZXh0cmVnaW9uOmZiYjdlOTI5NjViOTQ2OGU4MmQzYWJiM2ZkMGNhYjc4XzE2MzI5_096ab417-93b6-46e0-a085-2276b60deff4">PricewaterhouseCoopers LLP</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yMDIvZnJhZzpmYmI3ZTkyOTY1Yjk0NjhlODJkM2FiYjNmZDBjYWI3OC90ZXh0cmVnaW9uOmZiYjdlOTI5NjViOTQ2OGU4MmQzYWJiM2ZkMGNhYjc4XzE2MzI4_b2805068-af18-47e9-bade-fb256346d7c9">Louisville, Kentucky</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 16, 2023</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 1968.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_208"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_211"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9A. CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Responsibility for Financial Statements and Other Information</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are responsible for the preparation and integrity of the consolidated financial statements appearing in our Annual Report. The consolidated financial statements were prepared in conformity with accounting principles generally accepted in the United States and include amounts based on our estimates and judgments. All other financial information in this report has been presented on a basis consistent with the information included in the financial statements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our control environment is the foundation for our system of internal control over financial reporting and is embodied in our Code of Ethics and Business Conduct, which we currently refer to as the Humana Inc. Ethics Every Day. It sets the tone of our organization and includes factors such as integrity and ethical values. Our internal control over financial reporting is supported by formal policies and procedures which are reviewed, modified and improved as changes occur in business conditions and operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee of the Board of Directors, which is composed solely of independent outside directors, meets periodically with members of management, the internal auditors and our independent registered public accounting firm to review and discuss internal controls over financial reporting and accounting and financial reporting matters. Our independent registered public accounting firm and internal auditors report to the Audit Committee and accordingly have full and free access to the Audit Committee at any time.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established disclosure controls and procedures to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to members of senior management and the Board of Directors.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our evaluation as of December&#160;31, 2022, we as the principal executive officer, the principal financial officer and the principal accounting officer of the Company have concluded that the Company&#8217;s disclosure controls and procedures (as defined in the Securities Exchange Act of 1934) are effective to ensure that the information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported as specified in Securities and Exchange Commission rules and forms.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are responsible for establishing and maintaining effective internal control over financial reporting as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934. The Company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (i)&#160;pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii)&#160;provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii)&#160;provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assessed the effectiveness of the Company&#8217;s internal control over financial reporting as of December&#160;31, 2022. In making this assessment, we used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO)&#160;in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8211; Integrated Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (2013). Based on our assessment, we determined that, as of December&#160;31, 2022, the Company&#8217;s internal control over financial reporting was effective based on those criteria.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effectiveness of our internal control over financial reporting as of December&#160;31, 2022 has been audited by PricewaterhouseCoopers LLP, our independent registered public accounting firm, who also audited the Company&#8217;s consolidated financial statements included in our Annual Report on Form 10-K, as stated in their report which appears on pages 127-129.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes in the Company&#8217;s internal control over financial reporting during the quarter ended December&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_214"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9B. OTHER INFORMATION</span></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_217"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_220"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_223"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;10</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Directors</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is herein incorporated by reference from our Definitive Proxy Statement for the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023 appearing under the caption &#8220;Proposal One: Election of Directors&#8221; in such Definitive Proxy Statement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Officers of the Registrant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A list of our executive officers and biographical information appears in Part I, Item 1 of this Form 10-K.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code of Conduct for Chief Executive Officer and Senior Financial Officers</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Conduct for the Chief Executive Officer and Senior Financial Officers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> violations of which should be reported to the Audit Committee. The code may be viewed through the Investor Relations section of our web site at www.humana.com. Any amendment to or waiver of the application of the Code of Conduct for the Chief Executive Officer and Senior Financial Officers will be promptly disclosed through the Investor Relations section of our web site at www.humana.com.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code of Business Conduct and Ethics</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since 1995, we have operated under an omnibus Code of Ethics and Business Conduct, currently known as the Humana Inc. Ethics Every Day (the &#8220;Code&#8221;). All employees and directors are required to annually affirm in writing their acceptance of the Code. The Code was adopted by our Board of Directors in June 2014, replacing a previous iteration, known as the Humana Inc. Principles of Business Ethics, as the document to comply with the New York Stock Exchange Corporate Governance Standard 303A.10. The Code is available on the Investor Relations section of our web site at www.humana.com, and any waiver of the application of the Code with respect to directors or executive officers must be made by the Board of Directors and will be promptly disclosed on our web site at www.humana.com.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Governance Items</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made available free of charge on or through the Investor Relations section of our web site at www.humana.com our annual reports on Form 10-K, quarterly reports on Form 10-Q, proxy statements, and all of our other reports, and, if applicable, amendments to those reports filed or furnished pursuant to Section&#160;13(a) of the Exchange Act, as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Also available on the Investor Relations section of our Internet web site at www.humana.com is information about our corporate governance, including:</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a determination of independence for each member of our Board of Directors;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the name, membership, role, and charter of each of the various committees of our Board of Directors;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the name(s) of the directors designated as a financial expert under rules and regulations promulgated by the SEC;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the responsibility of the Company&#8217;s Lead Independent Director, if applicable, to convene, set the agenda for, and lead executive sessions of the non-management directors, pursuant to our Corporate Governance Guidelines;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the pre-approval process of non-audit services provided by our independent accountants;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our By-laws and Certificate of Incorporation;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Majority Vote policy, pursuant to our By-laws;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Related Persons Transaction Policy;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the process by which interested parties can communicate with directors;</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the process by which stockholders can make director nominations (pursuant to our By-laws);</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Corporate Governance Guidelines;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Policy Regarding Transactions in Company Securities, Inside Information and Confidentiality;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock Ownership Guidelines for directors and for executive officers;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Humana Inc. Ethics Every Day and any waivers thereto; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Code of Conduct for the Chief Executive Officer and Senior Financial Officers and any waivers thereto.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information about these items can be found in, and is incorporated by reference to, our Definitive Proxy Statement for the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Changes to the Procedures by which Security Holders May Recommend Nominees to the Registrant&#8217;s Board of Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee Financial Expert</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is herein incorporated by reference from our Definitive Proxy Statement for the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023 appearing under the caption &#8220;Corporate Governance &#8211; Audit Committee&#8221; of such Definitive Proxy Statement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee Composition and Independence</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is herein incorporated by reference from our Definitive Proxy Statement for the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023 appearing under the caption &#8220;Corporate Governance &#8211; Committee Membership and Attendance&#8221; of such Definitive Proxy Statement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_226"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;11. EXECUTIVE COMPENSATION</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information required by this Item is incorporated herein by reference from our Definitive Proxy Statement for the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_229"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity compensation plan information</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain plans under which options to purchase our common stock and awards of restricted stock may be made to officers, directors, and key employees. Stock options are granted with an exercise price equal to the fair market value of the underlying common stock on the date of grant. Our stock plans, as approved by the Board of Directors and stockholders, define fair market value as the average of the highest and lowest stock prices reported on the composite tape by the New York Stock Exchange on a given date. Exercise provisions vary, but most options vest in whole or in part 1 to 3 years after grant and expire up to 7 years after grant.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning stock option awards and the number of securities remaining available for future issuance under our equity compensation plans in effect as of December&#160;31, 2022 follows:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.124%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.489%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.198%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Plan category</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(a)<br/>Number&#160;of&#160; securities<br/>to be issued upon<br/>exercise&#160;of&#160;outstanding<br/>options, warrants<br/>and rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(b)<br/>Weighted-average<br/>exercise price of<br/>outstanding<br/>options, warrants<br/>and rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(c)<br/>Number&#160;of&#160; securities<br/>remaining&#160;available&#160;for<br/>future issuance under<br/>equity&#160;compensation&#160;<br/>plans<br/>(excluding securities<br/>reflected in column(a))</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans approved by <br/>&#160;&#160;&#160;&#160;security holders (1)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,472</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,541,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)(3)(4)&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation plans not approved <br/>&#160;&#160;&#160;&#160;by security holders</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,472&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.366&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,541,660&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The above table does not include awards of shares of restricted stock or restricted stock units. For information concerning these awards, see Note 14.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Humana Inc. 2011 Stock Incentive Plan was approved by stockholders at the Annual Meeting held on April&#160;21, 2011. On July&#160;5, 2011, 18.5&#160;million shares were registered with the Securities and Exchange Commission on Form S-8.</span></div><div style="padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Humana Inc. Amended and Restated Stock Incentive Plan was approved by stockholders at the Annual Meeting held on April 18, 2019. On May 1, 2019, 16&#160;million shares were registered with the Securities and Exchange Commission on Form S-8.</span></div><div style="margin-bottom:9pt;padding-left:31.5pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Of the number listed above, 4,798,324 (1,445,966 from the 2011 Plan and 3,352,358 from the Amended and Restated Plan) can be issued as restricted stock at December&#160;31, 2022 (giving effect to the provision that one restricted share is equivalent to 2.29 stock options in the 2011 Plan and 3.35 stock options in the Amended and Restated Plan).</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information under the captions &#8220;Stock Ownership Information - Security Ownership of Certain Beneficial Owners of Company Common Stock&#8221; and &#8220;Stock Ownership Information - Security Ownership of Directors and Executive Officers&#8221; in our Definitive Proxy Statement for the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023, is herein incorporated by reference.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_232"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is herein incorporated by reference from our Definitive Proxy Statement for the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023 appearing under the captions &#8220;Certain Transactions with Management and Others&#8221; and &#8220;Corporate Governance &#8211; Director Independence&#8221; of such Definitive Proxy Statement.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_235"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;14. PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is herein incorporated by reference from our Definitive Proxy Statement for the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023 appearing under the caption &#8220;Audit Committee Report&#8221; of such Definitive Proxy Statement.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_238"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_241"></div><div style="-sec-extract:summary;margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;15. EXHIBITS, FINANCIAL STATEMENT SCHEDULE</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:9.975%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.506%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.643%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.322%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The financial statements, Report of Independent Registered Public Accounting Firm (PCAOB ID <ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDEvZnJhZzo1ZjdjZTNmNDYzYjI0YWY4YmE0YjIzN2RiNWMyOTU4OC90YWJsZTplN2FlYWU4MjE0NTM0Y2ZjODZhNjBjOWNkOTQ3MjdkYi90YWJsZXJhbmdlOmU3YWVhZTgyMTQ1MzRjZmM4NmE2MGM5Y2Q5NDcyN2RiXzAtMi0xLTEtMTQwNjQ1L3RleHRyZWdpb246OTc4ZmVlYTg4Zjk4NDU3ZWE1N2FjODA5NDNkNzViZmVfOTY_480ebf3e-8e36-467b-bd04-f905cacbcbe4">238</ix:nonNumeric>), financial statement schedule and exhibits set forth below are filed as part of this report.</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Statements &#8211; The response to this portion of Item&#160;15 is submitted as Item&#160;8 of Part II of this report.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="24" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The following Consolidated Financial Statement Schedule is included herein:</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Schedule I</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Parent Company Condensed Financial Information at December 31, 2022 and 2021 and for the years ended December 31, 2022, 2021 and 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules have been omitted because they are not applicable.</span></div><div style="padding-left:31.5pt;text-indent:-31.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.84pt">Exhibits:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3(a)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restated Certificate of Incorporation of Humana Inc. filed with the Secretary of State of Delaware on November 9, 1989, as restated to incorporate the amendment of January 9, 1992, and the correction of March 23, 1992 (incorporated herein by reference to Exhibit 4(i) to Humana Inc.&#8217;s Post-Effective Amendment No.1 to the Registration Statement on Form S-8 (Reg. No.&#160;33-49305) filed February 2, 1994).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000004907122000083/exhibit3bhumanaincamendeda.htm">(b)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc. Amended and Restated By-laws, effective as of December 8, 2022 (incorporated herein by reference to Exhibit 3(b) to Humana Inc.&#8217;s Current Report on Form 8-K filed on December 8, 2022).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312503073141/dex41.htm">4(a)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of August 5, 2003, by and between Humana Inc. and The Bank of New York, as trustee (incorporated herein by reference to Exhibit 4.1 to Humana Inc.'s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003, File No. 001-05975). </span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312508128893/dex43.htm">(b)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourth Supplemental Indenture, dated as of June 5, 2008, by and between Humana Inc. and The Bank of New York Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit&#160;4.3 to Humana Inc.&#8217;s Current Report on Form 8-K filed on June 5, 2008).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000089534506000406/ex4_2.txt">(c)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture, dated as of March 30, 2006, by and between Humana Inc. and The Bank of New York Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Humana Inc.&#8217;s Registration Statement on Form S-3 filed on March 31, 2006, Req. No. 333-132878).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">There are no instruments defining the rights of holders with respect to long-term debt in excess of 10 percent of the total assets of Humana Inc. on a consolidated basis. Other long-term indebtedness of Humana Inc. is described herein in Note 13 to Consolidated Financial Statements. Humana Inc. agrees to furnish copies of all such instruments defining the rights of the holders of such indebtedness not otherwise filed as an Exhibit to this Annual Report on Form 10-K to the Commission upon request.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312512496959/d451705dex43.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312512496959/d451705dex43.htm">e</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312512496959/d451705dex43.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sixth Supplemental Indenture, dated as of December 10, 2012, by and between Humana Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.3 to Humana Inc.&#8217;s Current Report on Form 8-K filed on December 10, 2012).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312514347186/d792515dex44.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312514347186/d792515dex44.htm">f</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312514347186/d792515dex44.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eighth Supplemental Indenture, dated as of September 19, 2014, by and between Humana Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.4 to Humana Inc.&#8217;s Current Report on Form 8-K filed on September 19, 2014).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312514347186/d792515dex46.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312514347186/d792515dex46.htm">g</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312514347186/d792515dex46.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ninth Supplemental Indenture, dated as of September 19, 2014, by and between Humana Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.6 to Humana Inc.&#8217;s Current Report on Form 8-K filed on September 19, 2014).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312517085551/d335535dex42.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312517085551/d335535dex42.htm">h</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312517085551/d335535dex42.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenth Supplemental Indenture, dated March 16, 2017, between Humana Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Humana Inc.&#8217;s Current Report on Form 8-K filed on March 16, 2017).</span></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312517085551/d335535dex44.htm">(i)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eleventh Supplemental Indenture, dated March 16, 2017, between Humana Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.4 to Humana Inc.&#8217;s Current Report on Form 8-K filed on March 16, 2017).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312519222527/d793619dex42.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312519222527/d793619dex42.htm">j</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312519222527/d793619dex42.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fourteenth Supplemental Indenture, dated August 15, 2019, between Humana Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Humana Inc.&#8217;s Current Report on Form 8-K filed on August 15, 2019). </span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312519222527/d793619dex44.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312519222527/d793619dex44.htm">k</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312519222527/d793619dex44.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fifteenth Supplemental Indenture, dated August 15, 2019, between Humana Inc. and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.4 to Humana Inc.&#8217;s Current Report on Form 8-K filed on August 15, 2019). </span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907120000071/form8kex4x2linked.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907120000071/form8kex4x2linked.htm">l</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907120000071/form8kex4x2linked.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sixteenth Supplemental Indenture, dated March 26, 2020, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Humana Inc.&#8217;s Current Report on Form 8-K, filed March 27, 2020).</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907120000071/form8kex4x3linked.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907120000071/form8kex4x3linked.htm">m</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907120000071/form8kex4x3linked.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Seventeenth Supplemental Indenture, dated March 26, 2020, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.3 to Humana Inc.&#8217;s Current Report on Form 8-K, filed March 27, 2020).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521235039/d161015dex42.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521235039/d161015dex42.htm">n</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521235039/d161015dex42.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Eighteenth Supplemental Indenture, dated August 3, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Humana Inc.&#8217;s Current Report on Form 8-K filed on August 3, 2021).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521235039/d161015dex44.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521235039/d161015dex44.htm">o</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521235039/d161015dex44.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Nineteenth Supplemental Indenture, dated August 3, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.4 to Humana Inc.&#8217;s Current Report on Form 8-K filed on August 3, 2021).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521235039/d161015dex46.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521235039/d161015dex46.htm">p</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521235039/d161015dex46.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Twentieth Supplemental Indenture, dated August 3, 2021, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.6 to Humana Inc.&#8217;s Current Report on Form 8-K filed on August 3, 2021).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000119312522082811/d335183dex42.htm">(q)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Twenty-First Supplemental Indenture, dated March 23, 2022, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Humana Inc.&#8217;s Current Report on Form 8-K filed on March 23, 2022).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000119312522291138/d383861dex42.htm">(r)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Twenty-Second Supplemental Indenture, dated November 22, 2022, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.2 to Humana Inc.&#8217;s Current Report on Form 8-K filed on November 22, 2022).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000119312522291138/d383861dex44.htm">(s)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Twenty-Third Supplemental Indenture, dated November 22, 2022, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee (incorporated herein by reference to Exhibit 4.4 to Humana Inc.&#8217;s Current Report on Form 8-K filed on November 22, 2022).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907120000032/hum-20191231x10kxex4o.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907120000032/hum-20191231x10kxex4o.htm">t</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907120000032/hum-20191231x10kxex4o.htm">)</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Description of Securities (incorporated herein by reference to Exhibit 4(o) to Humana Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2019).</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907116000117/hum-20151231x10kxex10b.htm">(a)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Company&#8217;s Restricted Stock Unit Agreement and Agreement not to Compete or Solicit under the 2011 Stock Incentive Plan (without retirement provisions) (incorporated herein by reference to Exhibit 10(b) to Humana Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2015).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10bexecutiveaip.htm">(b)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc. Executive Incentive Compensation Plan, as amended and restated January 1, 2020 (incorporated herein by reference to Exhibit 10(b) to Humana Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2020).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trust under Humana Inc. Deferred Compensation Plans (incorporated herein by reference to Exhibit 10(p) to Humana Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 1999, File No. 001-05975).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312513069911/d446200dex10m.htm">(d)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Humana Inc. Deferred Compensation Plan for Non-Employee Directors (as amended on October 18, 2012) (incorporated herein by reference to Exhibit 10(m) to Humana Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2012).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum2018123110kex10f.htm">(e)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc. Executive Severance Policy, effective as of March 1, 2019 (incorporated herein by reference to Exhibit 10(f) to Humana Inc.&#8217;s Annual Report on Form 10-K filed on February 21, 2019).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907111000014/exhibit4-1.htm">(f)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc. Deferred Compensation Plan (incorporated herein by reference to Exhibit 4.1 to the Company&#8217;s Registration Statement on Form S-8 (Reg. No. 333-171616), filed on January 7, 2011).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312511039288/dex10p.htm">(g)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Retirement Equalization Plan, as amended and restated as of January 1, 2011 (incorporated herein by reference to Exhibit 10(p) to Humana Inc.&#8217;s Annual Report on Form 10-K filed on February 18, 2011).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(h)*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Letter agreement with Humana Inc. officers concerning health insurance availability (incorporated herein by reference to Exhibit 10(mm) to Humana Inc.&#8217;s Annual Report on Form&#160;10-K for the fiscal year ended December&#160;31, 1994, File No. 001-05975).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312504188013/dex10a.htm">(i)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Long-Term Disability Program (incorporated herein by reference to Exhibit 10(a) to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2004).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(j)*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnity Agreement (incorporated herein by reference to Appendix B to Humana Inc.&#8217;s Proxy Statement with respect to the Annual Meeting of Stockholders held on January 8, 1987).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312513069911/d446200dex10v.htm">(k)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summary of the Company&#8217;s Financial Planning Program for our executive officers (incorporated herein by reference to Exhibit 10(v) to Humana&#8217;s Inc.&#8217;s Annual Report on Form 10-K filed on February 22, 2013).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521182941/d211636dex101.htm">(l)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Five-Year $2.5 Billion Amended and Restated Credit Agreement, dated as of June 4, 2021, among Humana Inc., and JPMorgan Chase Bank, N.A. as Agent and as CAF Loan Agent, Bank of America, N.A. and Goldman Sachs Bank USA as Syndication Agents, Citibank, N.A., PNC Capital Markets LLC, National Association, U.S. Bank, National Association and Wells Fargo Securities, LLC, as Documentation Agents, and JPMorgan Chase Bank, N.A., BofA Securities, Inc., Goldman Sachs Bank USA, Citibank, N.A., PNC Capital Markets LLC, U.S. Bank, National Association and Wells Fargo Securities, LLC, as Joint-Lead Arrangers and Joint Bookrunners (incorporated herein by reference to Exhibit 10 to Humana Inc.&#8217;s Current Report on Form 8-K filed on June 4, 2021).</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000119312522167326/d272127dex101.htm">(m)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364-Day $1.5 Billion Revolving Credit Agreement, dated as of June 3, 2022, among Humana Inc., and JPMorgan Chase Bank, N.A. as Agent and as CAF Loan Agent, Bank of America, N.A. as Syndication Agent, Citibank, N.A., Goldman Sachs Bank USA, PNC Capital Markets LLC, U.S. Bank National Association and Wells Fargo Securities, LLC, as Documentation Agents, and JPMorgan Chase Bank, N.A., BofA Securities, Inc., Goldman Sachs Bank USA, Citibank, N.A., PNC Capital Markets LLC, U.S. Bank National Association and Wells Fargo Securities, LLC, as Joint-Lead Arrangers and Joint Bookrunners (incorporated herein by reference to Exhibit 10.1 to Humana Inc.&#8217;s Current Report on Form 8-K filed on June 3, 2022).</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521182941/d211636dex103.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521182941/d211636dex103.htm">n</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000119312521182941/d211636dex103.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500 Million Delayed Draw Term Loan Credit Agreement, dated as of May 28, 2021, among Humana Inc., and JPMorgan Chase Bank, N.A. as Agent, Bank of America, N.A. and Goldman Sachs Bank USA as Syndication Agents, Citibank, N.A., PNC Capital Markets LLC, U.S. Bank, National Association and Wells Fargo Securities, LLC, as Documentation Agents, and Goldman Sachs Bank USA, BofA Securities, Inc., JPMorgan Chase Bank, N.A., Citibank, N.A., PNC Capital Markets LLC, U.S. Bank, National Association and Wells Fargo Securities, LLC, as Joint-Lead Arrangers and Joint Bookrunners (incorporated herein by reference to Exhibit 10 to Humana Inc.&#8217;s Current Report on Form 8-K filed on June 4, 2021).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex101.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex101.htm">o</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex101.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of CMS Coordinated Care Plan Agreement (incorporated herein by reference to Exhibit 10.1 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, File No. 001-05975).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex102.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex102.htm">p</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex102.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of CMS Private Fee for Service Agreement (incorporated herein by reference to Exhibit 10.2 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, File No. 001-05975).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex103.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex103.htm">q</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex103.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum to Agreement Providing for the Operation of a Medicare Voluntary Prescription Drug Plan (incorporated herein by reference to Exhibit 10.3 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, File No. 001-05975).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex104.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex104.htm">r</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex104.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum to Agreement Providing for the Operation of an Employer/Union-only Group Medicare Advantage Prescription Drug Plan (incorporated herein by reference to Exhibit 10.4 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, File No. 001-05975).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex105.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex105.htm">s</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex105.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum to Agreement Providing for the Operation of an Employer/Union-only Group Medicare Advantage-Only Plan (incorporated herein by reference to Exhibit 10.5 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, File No. 001-05975).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex106.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex106.htm">t</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312505218181/dex106.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Addendum to Agreement Providing for the Operation of a Medicare Advantage Regional Coordinated Care Plan (incorporated herein by reference to Exhibit 10.6 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2005, File No. 001-05975).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312506045135/dex10nn.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312506045135/dex10nn.htm">u</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312506045135/dex10nn.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Explanatory Note regarding Medicare Prescription Drug Plan Contracts between Humana and CMS (incorporated herein by reference to Exhibit 10(nn) to Humana Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2005, File No. 001-05975).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312511057037/ddef14a.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312511057037/ddef14a.htm">v</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312511057037/ddef14a.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc. 2011 Stock Incentive Plan (incorporated herein by reference to Appendix A to Humana Inc.&#8217;s Proxy Statement with respect to the Annual Meeting of Stockholders held on April 21, 2011).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907114000053/humana8-k02282014ex10.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907114000053/humana8-k02282014ex10.htm">w</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907114000053/humana8-k02282014ex10.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Employment Agreement, dated as of February 27, 2014, by and between Humana Inc. and Bruce D. Broussard (incorporated herein by reference to Exhibit 10.1 to Humana Inc.&#8217;s current report on Form 8-K filed on February 28, 2014).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312515249229/d41670dex101.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312515249229/d41670dex101.htm">x</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312515249229/d41670dex101.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to the Amended and Restated Employment Agreement between Humana Inc. and Bruce D. Broussard, dated July 2, 2015 (incorporated herein by reference to Exhibit 10.1 to Humana Inc.&#8217;s current report on Form 8-K filed on July 9, 2015).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312518253067/d603469dex101.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312518253067/d603469dex101.htm">y</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312518253067/d603469dex101.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 2, dated as of August 16, 2018, to the Amended and Restated Employment Agreement between Humana Inc. and Bruce D. Broussard, dated as of February 27, 2014 (incorporated herein by reference to Exhibit 10.1 to Humana Inc.s Current Report on Form 8-K, filed on August 20, 2018).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10aa.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10aa.htm">z</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10aa.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc. Change in Control Policy, effective March 1, 2019 (incorporated herein by reference to Exhibit 10(aa) to Humana Inc.&#8217;s Annual Report on Form 10-K filed on February 21, 2019).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907114000121/humana8-k10062014ex10.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907114000121/humana8-k10062014ex10.htm">aa</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907114000121/humana8-k10062014ex10.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Commercial Paper Dealer Agreement between Humana Inc., as Issuer, and the Dealer party thereto (incorporated herein by reference to Exhibit 10.1 to Humana Inc.&#8217;s current report on Form 8-K filed on October 7, 2014).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907116000117/hum-20151231x10kxex10jj.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907116000117/hum-20151231x10kxex10jj.htm">bb</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907116000117/hum-20151231x10kxex10jj.htm">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Company's Stock Option Agreement under the 2011 Stock Incentive Plan (Incentive Stock Options) (incorporated herein by reference to Exhibit 10(jj) to Humana Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2015).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907116000117/hum-20151231x10kxex10kk.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907116000117/hum-20151231x10kxex10kk.htm">cc</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907116000117/hum-20151231x10kxex10kk.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Company's Stock Option Agreement under the 2011 Stock Incentive Plan (Non-Qualified Stock Options with Non-Compete/Non-Solicit) (incorporated herein by reference to Exhibit 10(kk) to Humana Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2015).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10gg.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10gg.htm">dd</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10gg.htm">)*</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Company's Restricted Stock Unit Agreement with Performance Vesting and Agreement not to Compete or Solicit under the 2011 Stock Incentive Plan (incorporated herein by reference to Exhibit 10(gg) to Humana Inc.&#8217;s Annual Report on Form 10-K filed on February 21, 2019).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10hh.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10hh.htm">ee</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10hh.htm">)*</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Company&#8217;s Incentive Stock Option Agreement and Agreement not to Compete or Solicit under the 2011 Stock Incentive Plan (incorporated herein by reference to Exhibit 10(hh) to Humana Inc.&#8217;s Annual Report on Form 10-K filed on February 21, 2019).</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10ii.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10ii.htm">ff</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10ii.htm">)*</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Company&#8217;s Stock Option Agreement and Agreement not to Compete or Solicit under the 2011 Stock Incentive Plan (Non-Qualified Stock Options) (incorporated herein by reference to Exhibit 10(ii) to Humana Inc.&#8217;s Annual Report on Form 10-K filed on February 21, 2019).</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10jj.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10jj.htm">gg</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000023/hum-20181231x10kxex10jj.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Humana Inc. Compensation Recoupment Policy, effective February 21, 2019 (incorporated herein by reference to Exhibit 10(jj) to Humana Inc.&#8217;s Annual Report on Form 10-K filed on February 21, 2019).</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312519064676/d662496ddef14a.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312519064676/d662496ddef14a.htm">hh</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312519064676/d662496ddef14a.htm">)*</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Humana Inc. Stock Incentive Plan (incorporated herein by reference to Appendix A to Humana Inc.&#8217;s Proxy Statement with respect to the Annual Meeting of Stockholders held on April 18, 2019).</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000061/hum20190331ex105.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000061/hum20190331ex105.htm">ii)</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000061/hum20190331ex105.htm">*</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Company&#8217;s Incentive Stock Option Agreement and Agreement not to Compete or Solicit under the Amended and Restated Humana Inc. Stock Incentive Plan (incorporated herein by reference to Exhibit 10.5 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019).</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000061/hum20190331ex106.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000061/hum20190331ex106.htm">jj</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000004907119000061/hum20190331ex106.htm">)*</a></span></div><div><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Company&#8217;s Stock Option Agreement and Agreement not to Compete or Solicit under the Amended and Restated Humana Inc. Stock Incentive Plan (Non-Qualified Stock Options) (incorporated herein by reference to Exhibit 10.6 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019).</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10nn-annualnq3yr33.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10nn-annualnq3yr33.htm">kk</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10nn-annualnq3yr33.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Company&#8217;s Stock Option Agreement and Agreement not to Compete or Solicit under the Amended and Restated Humana Inc. Stock Incentive Plan (Non-Qualified Stock Options) (incorporated herein by reference to Exhibit 10(nn) to Humana Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020).</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10oo-annualiso3yr33.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10oo-annualiso3yr33.htm">ll</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10oo-annualiso3yr33.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Company&#8217;s Incentive Stock Option Agreement and Agreement not to Compete or Solicit under the Amended and Restated Humana Inc. Stock Incentive Plan (incorporated herein by reference to Exhibit 10(oo) to Humana Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020).</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10pp-annualpsu100at3yr.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10pp-annualpsu100at3yr.htm">mm</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10pp-annualpsu100at3yr.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Company&#8217;s Restricted Stock Unit Agreement with Performance Vesting and Agreement not to Compete or Solicit under the Amended and Restated Humana Inc. Stock Incentive Plan (incorporated herein by reference to Exhibit 10(pp) to Humana Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020).</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10qq-newhirersu3yr33.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10qq-newhirersu3yr33.htm">nn</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10qq-newhirersu3yr33.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Company&#8217;s Restricted Stock Unit Agreement and Agreement not to Compete or Solicit under the Amended and Restated Humana Inc. Stock Incentive Plan (without retirement provisions) (incorporated herein by reference to Exhibit 10(qq) to Humana Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020).</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10rr-annualrsu3yr33.htm">(</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10rr-annualrsu3yr33.htm">oo</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0000049071/000004907121000039/ex10rr-annualrsu3yr33.htm">)*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Form of Company&#8217;s Restricted Stock Unit Agreement and Agreement not to Compete or Solicit under the Amended and Restated Humana Inc. Stock Incentive Plan (with retirement provisions) (incorporated herein by reference to Exhibit 10(rr) to Humana Inc.&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020).</span></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/49071/000119312504035443/dex14.htm">14</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Code of Conduct for Chief Executive Officer &amp; Senior Financial Officers (incorporated herein by reference to Exhibit 14 to Humana Inc.&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2003).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-20221231x10kxex21.htm">21 &#8224;</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">List of subsidiaries.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-20221231x10kxex23.htm">23 &#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent of PricewaterhouseCoopers LLP.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-20221231x10kxex311.htm">31.1 &#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CEO certification pursuant to Rule 13a-14(a)/15d-14(a).</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-20221231x10kxex312.htm">31.2 &#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CFO certification pursuant to Rule 13a-14(a)/15d-14(a).</span></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.484%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="hum-20221231x10kxex32.htm">32 &#8224;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes &#8211; Oxley Act of 2002.</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101&#160;&#160;&#160;&#160;The following materials from Humana Inc.'s Annual Report on Form 10-K formatted in iXBRL (Inline Extensible Business Reporting Language): (i)&#160;the Consolidated Balance Sheets at December&#160;31, 2022 and 2021; (ii)&#160;the Consolidated Statements of Income for the&#160;years ended December&#160;31, 2022, 2021 and 2020; (iii)&#160;the Consolidated Statements of Comprehensive Income for the years ended December&#160;31, 2022, 2021 and 2020; (iv)&#160;the Consolidated Statements of Stockholders&#8217; Equity as of December&#160;31, 2022, 2021, and 2020; (v)&#160;the Consolidated Statements of Cash Flows for the years ended December&#160;31, 2022, 2021 and 2020; and (vi)&#160;Notes to Consolidated Financial Statements. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104 &#160;&#160;&#160;&#160;Cover Page Interactive Data File formatted in Inline XBRL and contained in Exhibit 101.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*Exhibits 10(a) through and including 10(k), and Exhibits 10(v) through and including 10(z), as well as Exhibits 10(bb) through and including Exhibit 10(oo) are compensatory plans or management contracts.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Pursuant to Rule 24b-2 of the Exchange Act, confidential portions of this exhibit have been omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;Submitted electronically with this report.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_244"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><ix:nonNumeric contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" name="us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90ZXh0cmVnaW9uOmY4OTQ0OTBkZmJlNTQyNDM4MjVhYzY1NDg1ODk1ZmY0XzE2Mg_12ddfb22-90cb-45c8-b912-43aac8319613" continuedAt="i572570cdf2924f04948bfc4a83801158" escape="true"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED BALANCE SHEETS</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"></td><td style="width:63.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.341%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.344%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions,&#160;except&#160;share<br/>amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzUtMS0xLTEtMTQwNjQ1_5b262c98-953d-4e6e-ae73-f6be2d44be78">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzUtMy0xLTEtMTQwNjQ1_f1fe4370-0b0b-4391-babd-958a3cd1982c">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzYtMS0xLTEtMTQwNjQ1_febbb318-22bb-48a2-b420-d85637d631fe">320</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:ShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzYtMy0xLTEtMTQwNjQ1_eb6a7c79-1813-4d00-9a51-109ba1661534">428</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Receivable from operating subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:AccountsReceivableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzctMS0xLTEtMTQwNjQ1_144ecc2d-786a-4a54-86f1-714391dab068">1,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:AccountsReceivableRelatedPartiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzctMy0xLTEtMTQwNjQ1_ad2b23e7-78f7-4c38-98bc-057d3d348384">1,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzgtMS0xLTEtMTQwNjQ1_e07c9c01-be74-4345-9554-36ca13788197">577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:OtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzgtMy0xLTEtMTQwNjQ1_eb763bc7-04e2-4c1c-a388-964a25d75db9">545</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzktMS0xLTEtMTQwNjQ1_8853a3bc-8536-47ba-9dbe-88de73037daf">3,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzktMy0xLTEtMTQwNjQ1_ec74b5e2-f293-4752-9228-f1424d46c654">3,195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzEwLTEtMS0xLTE0MDY0NQ_51a1e2b2-1d6c-4af7-bc6f-67c7903bc82e">2,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzEwLTMtMS0xLTE0MDY0NQ_8dc03b2a-78cc-4f5d-aafd-1e68891db2ee">2,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="hum:InvestmentInRelatedPartiesAndSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzExLTEtMS0xLTE0MDY0NQ_b446667a-13c9-4230-8c45-0e167dfa93b3">27,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="hum:InvestmentInRelatedPartiesAndSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzExLTMtMS0xLTE0MDY0NQ_a9071c1a-d9ba-4d63-9a0e-97034bfce699">26,885</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzEzLTEtMS0xLTE0MDY0NQ_e4d5e8ca-15ef-4248-8086-64b9f663f70e">282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzEzLTMtMS0xLTE0MDY0NQ_93d7d932-cffe-4835-aec2-2b2698ad922b">666</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE1LTEtMS0xLTE0MDY0NQ_56a6ccdb-d4d5-4832-9073-5088f7a5f878">33,898</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE1LTMtMS0xLTE0MDY0NQ_27881596-5049-424f-8a28-df259252d9b2">32,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payable to operating subsidiaries</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE2LTEtMS0xLTE3NTY1Ng_8d90cea3-95e7-4cf2-881b-c184051ba1ae">5,421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE2LTMtMS0xLTE3NTY1Ng_f1d77058-b9dd-44ee-8791-5598ee213d5f">2,056</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE5LTEtMS0xLTE3MTcwNg_4d6cd5be-c407-475d-a5af-204d6ac8ca65">2,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE5LTMtMS0xLTE3MTcwNg_7b6a717b-6efb-4440-946f-4439e30cc6ac">1,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable to operating subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE5LTEtMS0xLTE0MDY0NQ_df71a8a5-071b-4fbc-ace1-7a8f9f62858f">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:NotesPayableRelatedPartiesClassifiedCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE5LTMtMS0xLTE0MDY0NQ_8ee57cc2-a8e3-42e2-be28-4371d90f9607">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book overdraft</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="hum:BookOverdraftLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIwLTEtMS0xLTE0MDY0NQ_28ebb3e1-f0cd-4fb6-822a-18edc9c9144b">73</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="hum:BookOverdraftLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIwLTMtMS0xLTE0MDY0NQ_50cc621b-5463-4a7c-98d8-a721c4d0028e">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIyLTEtMS0xLTE0MDY0NQ_658f2ec1-515e-4b51-90aa-8bf0a7bc7885">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIyLTMtMS0xLTE0MDY0NQ_5a613cc9-9c77-4308-a9f0-f5707edb2412">1,460</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIzLTEtMS0xLTE0MDY0NQ_f52a643c-f6fa-4102-956a-aabd76a9a42f">9,047</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIzLTMtMS0xLTE0MDY0NQ_7365ca2b-fdb6-467e-9c20-d2de4228bb39">5,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI0LTEtMS0xLTE0MDY0NQ_0e6fe73d-0609-4e13-a184-0a9fcacd708e">9,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI0LTMtMS0xLTE0MDY0NQ_b0a3de5d-a3e4-422b-a22a-568ba12c60fd">10,541</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI2LTEtMS0xLTE0MDY0NQ_a669fcca-21a3-4da3-beba-f9ed8e7bfa04">506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI2LTMtMS0xLTE0MDY0NQ_882056b6-6fb2-4ee1-9770-4b10f67b562d">775</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI3LTEtMS0xLTE0MDY0NQ_b19f6e5b-5fff-4229-9280-c612aaef3871">18,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI3LTMtMS0xLTE0MDY0NQ_059797f8-ac4c-4c87-ba74-eee8e88c43f3">16,889</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI4LTEtMS0xLTE0MDY0NQ_341a7b99-2ae8-4cf5-b46d-4f42a14a5688"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI4LTMtMS0xLTE0MDY0NQ_68da47d9-463b-46cc-a79c-e20eaa705fbb"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzIx_6bcbc69b-6e4f-4f27-8a7e-3d248cc4b4d8"><ix:nonFraction unitRef="usdPerShare" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzIx_bd8c4e5d-8453-48a8-b25f-0ad1b0f3fe7d">1</ix:nonFraction></ix:nonFraction> par; <ix:nonFraction unitRef="shares" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzI5_0db3eec5-c854-494e-afb9-14ead976b03d"><ix:nonFraction unitRef="shares" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzI5_b9cdb11e-cd47-4a44-82be-2d282bd1222f">10,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzUx_2889d2f5-39bf-4fe7-b2d8-c808f5bc6fb1"><ix:nonFraction unitRef="shares" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzUx_d074a8ee-7d52-44df-8976-42ea084533d3">none</ix:nonFraction></ix:nonFraction> issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTEtMS0xLTE0MDY0NQ_03946bc2-42ad-4cf4-85b0-e80697937d49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTMtMS0xLTE0MDY0NQ_55175791-01d9-4654-b952-0aa38def4e23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.16 2/3 par; <ix:nonFraction unitRef="shares" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjhkYzJhNTgzOTA2NjRhODc5Y2NhZWY2NTIwYTNjMjA5XzU0OTc1NTgxMzkyMDQ_088f7df5-159b-436a-8def-4e0bac45f6d3"><ix:nonFraction unitRef="shares" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjhkYzJhNTgzOTA2NjRhODc5Y2NhZWY2NTIwYTNjMjA5XzU0OTc1NTgxMzkyMDQ_9d388732-4c1e-46c8-bbea-94af22908e5f">300,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjhkYzJhNTgzOTA2NjRhODc5Y2NhZWY2NTIwYTNjMjA5XzU0OTc1NTgxMzkyMDg_27f87900-a686-41f1-a1de-22efe0eb1fc7">198,666,598</ix:nonFraction> shares issued at December&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjhkYzJhNTgzOTA2NjRhODc5Y2NhZWY2NTIwYTNjMjA5XzU0OTc1NTgxMzkyMTI_79c0ebc6-d19c-4804-bf8c-7320697f0687">198,648,742</ix:nonFraction> shares issued at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTEtMS0xLTE0MDY0NQ_283f8f05-6505-4284-bc0d-1e24e478f680">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTMtMS0xLTE0MDY0NQ_dd2d013d-4fe2-4cd7-800e-89bdfc9c972e">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMyLTEtMS0xLTE0MDY0NQ_e11d4146-4952-4559-b2f4-41c9de2f3852">3,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMyLTMtMS0xLTE0MDY0NQ_8cc9a70f-6b2b-4975-9c9d-9460f4976f24">3,082</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMzLTEtMS0xLTE0MDY0NQ_22c1b5cf-967c-4ada-88c9-c7716d3ae2a3">25,492</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMzLTMtMS0xLTE0MDY0NQ_741add33-4d62-47d7-b501-3a50fe1ea6ec">23,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM0LTEtMS0xLTE0MDY0NQ_b5eb7cce-cc26-41fe-a1c4-09d69bd84a1f">1,304</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM0LTMtMS0xLTE0MDY0NQ_5ba9d9c2-2596-4a32-8d0d-1b79e912c1b9">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjc0OTgxNWVhNzhkYjRmOGFiMTZlMGExZTQ0NzgzMTAwXzU0OTc1NTgxMzkwNjk_8123fa45-a2a8-4ee8-b599-36727a1ac52b">73,691,955</ix:nonFraction> shares at December&#160;31, 2022 and <ix:nonFraction unitRef="shares" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjc0OTgxNWVhNzhkYjRmOGFiMTZlMGExZTQ0NzgzMTAwXzU0OTc1NTgxMzkwNzM_20b8be45-b03b-42a3-b58a-30f57efb2f99">69,846,758</ix:nonFraction> shares at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM1LTEtMS0xLTE0MDY0NQ_3a357fed-4c3a-4d8f-a615-19852158d89f">12,156</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM1LTMtMS0xLTE0MDY0NQ_1d9ef124-4fe5-442d-a110-07cff7120bb7">10,163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM2LTEtMS0xLTE0MDY0NQ_844a4ebb-b996-4fbe-b887-74a7f5b427cd">15,311</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM2LTMtMS0xLTE0MDY0NQ_5f9277cb-7c2b-44be-838d-2db201bd6b24">16,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM3LTEtMS0xLTE0MDY0NQ_a7f02b03-1dc5-48a5-8a3e-18c342a0bfff">33,898</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM3LTMtMS0xLTE0MDY0NQ_0c1f8feb-7a5c-4f59-b6b0-805e64807eab">32,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the parent company financial statements.</span></div></ix:nonNumeric><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">141</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_250"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><ix:continuation id="i572570cdf2924f04948bfc4a83801158" continuedAt="i17a95c352ef343858eb798d1a6702b8d"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED STATEMENTS OF INCOME</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:58.224%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.922%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.922%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.603%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.926%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees charged to operating subsidiaries</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="hum:ManagementFeesChargedToOperatingSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzQtMS0xLTEtMTQwNjQ1_e894524e-ec8f-4c80-b5c7-8ca42a5dd8d0">1,554</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="hum:ManagementFeesChargedToOperatingSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzQtMy0xLTEtMTQwNjQ1_09c5d748-b28b-4699-aa44-2ff5735059e7">1,633</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="hum:ManagementFeesChargedToOperatingSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzQtNS0xLTEtMTQwNjQ1_1f92bbd8-5d65-4bf7-b399-3d91ff18b93d">2,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other (loss) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="hum:InvestmentAndOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzUtMS0xLTEtMTQwNjQ1_a5b23ed3-c33b-424b-9056-562c53e92dd5">88</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" sign="-" name="hum:InvestmentAndOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzUtMy0xLTEtMTQwNjQ1_d874f24d-2cb7-4b78-92e4-a4774082f837">266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="hum:InvestmentAndOtherIncomeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzUtNS0xLTEtMTQwNjQ1_faeb5fb2-63e5-4c01-b22a-084225002518">763</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzYtMS0xLTEtMTQwNjQ1_5aa28a70-98f4-41fb-bfa9-58714b0f12f2">1,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzYtMy0xLTEtMTQwNjQ1_bf61902a-1fa8-40c8-b4ca-0d6258888c9d">1,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzYtNS0xLTEtMTQwNjQ1_08814786-d368-4b7d-a162-1d60df859c1b">2,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Operating costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzgtMS0xLTEtMTQwNjQ1_47b4cf9e-7aee-4cce-9c30-1ffe19dd8d3e">1,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzgtMy0xLTEtMTQwNjQ1_4205d753-1fda-4004-be56-b919b41278c9">1,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzgtNS0xLTEtMTQwNjQ1_02e512b6-33cd-4ccd-8961-796421b89c86">2,204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzktMS0xLTEtMTQwNjQ1_5d7e7c36-bf16-4c73-9d8b-45178c1cbecd">581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzktMy0xLTEtMTQwNjQ1_e9dcdf53-34f5-4be3-af44-0a52ad4769f8">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzktNS0xLTEtMTQwNjQ1_34a6c80d-1a4c-4aa1-8c83-e7649c7135f9">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEwLTEtMS0xLTE0MDY0NQ_2638ea25-dbd3-45e2-83b9-f9466c8b2ae5">400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEwLTMtMS0xLTE0MDY0NQ_59aa6dce-84cf-49b4-95dd-69cb7c5fd8df">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEwLTUtMS0xLTE0MDY0NQ_1b9e630a-2b3b-4c92-b6ce-07fbfbbdc58a">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzExLTEtMS0xLTE0MDY0NQ_970ffb6c-e247-461d-bf8d-dc0208491cbe">2,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzExLTMtMS0xLTE0MDY0NQ_a6dd6ff7-63be-4d8e-ac5f-c1daf4b7e7b1">2,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzExLTUtMS0xLTE0MDY0NQ_1e2902b5-05ad-4466-80b7-d2c6f471781c">2,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEyLTEtMS0xLTE0MDY0NQ_1b1f7ebb-33d1-4efd-90b1-f0408d90d8ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEyLTMtMS0xLTE0MDY0NQ_42dfa957-55c2-4266-a708-5080708c0b90">672</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEyLTUtMS0xLTE0MDY0NQ_17d9efd4-7402-4440-a382-c921e806391e">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before income taxes and equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="hum:IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEzLTEtMS0xLTE0MDY0NQ_9d298bc7-d541-4a09-bc1f-8411aaff4dfb">1,215</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" sign="-" name="hum:IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEzLTMtMS0xLTE0MDY0NQ_5b704d82-d071-413c-8626-3b07d4ffd2ae">166</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="hum:IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEzLTUtMS0xLTE0MDY0NQ_c171822f-cbda-4f11-b3af-70864ea4a9c7">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Benefit) provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE0LTEtMS0xLTE0MDY0NQ_58503522-0111-485c-86e0-b24dbb5ef4d4">266</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE0LTMtMS0xLTE0MDY0NQ_4195ae81-c07a-47c2-8ce5-759e5f8730c4">259</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE0LTUtMS0xLTE0MDY0NQ_dba1d1cd-2c78-4596-b00e-9e746825d4ba">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="hum:IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE1LTEtMS0xLTE0MDY0NQ_4d765d93-77d1-45a9-95a2-404347ddce0f">949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="hum:IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE1LTMtMS0xLTE0MDY0NQ_7800b41e-1928-4819-a1b1-7ddd51f22a47">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="hum:IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE1LTUtMS0xLTE0MDY0NQ_a66978d3-0c61-4298-9d9a-c6f6b7e2bb27">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="hum:EquityInNetEarningsOfSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE2LTEtMS0xLTE0MDY0NQ_cc6fca0d-e1ec-4f7e-bcdd-af033085eb88">3,751</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="hum:EquityInNetEarningsOfSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE2LTMtMS0xLTE0MDY0NQ_a77a4607-0a67-4b00-9026-5c2185bbee90">2,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="hum:EquityInNetEarningsOfSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE2LTUtMS0xLTE0MDY0NQ_c40442ac-9886-4da7-b0f9-c8301aea9079">3,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings of equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE3LTEtMS0xLTE0MDY0NQ_435b5dd3-3637-402f-b31f-e65ee0cc671c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE3LTMtMS0xLTE0MDY0NQ_af19637a-1dc4-4ef3-b1ed-a2788ec19cd5">79</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE3LTUtMS0xLTE0MDY0NQ_b51e8a64-468d-41c6-9ac5-5cd03f463748">81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE4LTEtMS0xLTE0MDY0NQ_ed2eb982-c2df-48a3-80e4-d0ebd486fc75">2,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE4LTMtMS0xLTE0MDY0NQ_ed02403b-8050-42ed-bb7f-a9389fe0561b">2,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE4LTUtMS0xLTE0MDY0NQ_3c070c2c-cea4-4641-8563-b75c1b671e88">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the parent company financial statements.</span></div></ix:continuation><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">142</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_253"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><ix:continuation id="i17a95c352ef343858eb798d1a6702b8d" continuedAt="i9ac271d088614971b79402a7be4b9cc5"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:54.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.025%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.025%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Humana</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzMtMS0xLTEtMTQwNjQ1_b08db89e-4ec3-43d6-9c1c-9c2add215b85">2,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzMtMy0xLTEtMTQwNjQ1_7ac485ab-9f3c-4810-a050-42b28bd81541">2,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzMtNS0xLTEtMTQwNjQ1_d076f6e9-73bf-4d48-aa41-85009af4dc8f">3,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in gross unrealized investment (losses) gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzUtMS0xLTEtMTQwNjQ1_3e5e52cd-6f28-4f45-a85b-4c466498b926">1,819</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzUtMy0xLTEtMTQwNjQ1_6ad891c4-4f62-4c00-8446-4aeef9b7115b">356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzUtNS0xLTEtMTQwNjQ1_75b22510-c5df-4d1f-9081-d2f6c1c2c515">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzYtMS0xLTEtMTQwNjQ1_299f7691-48e5-429d-99cc-7f62cfa76ec2">418</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzYtMy0xLTEtMTQwNjQ1_ca3f3c3a-b819-46e6-9feb-53112d5cf638">81</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzYtNS0xLTEtMTQwNjQ1_4b1aaa13-ade6-43e8-8583-a56469164e34">89</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total change in unrealized investment  <br/>&#160;&#160;&#160;&#160;(losses) gains, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzctMS0xLTEtMTQwNjQ1_d95b42a7-802b-4733-9295-98c7ffbe709a">1,401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzctMy0xLTEtMTQwNjQ1_89865be8-66b3-431e-9ec2-c49906306b89">275</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzctNS0xLTEtMTQwNjQ1_5fae215b-0288-46e0-a5b8-43a9490af0e1">304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification adjustment for net realized <br/>&#160;losses (gains) included in investment income </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzgtMS0xLTEtMTQwNjQ1_a4fc1f95-d469-402c-b796-a9de7c01558f">72</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzgtMy0xLTEtMTQwNjQ1_2d6a0474-6cbd-45a2-9964-b7d8bf8b7a7d">103</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzgtNS0xLTEtMTQwNjQ1_7f320a87-a846-43ee-9f4c-c1e717ec398b">90</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzktMS0xLTEtMTQwNjQ1_8313f8cc-2bb2-4659-92ea-a2d13b9871b5">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzktMy0xLTEtMTQwNjQ1_de9d7ef0-2c51-4509-8a04-f96fcab5fd16">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzktNS0xLTEtMTQwNjQ1_0818c1d5-6f86-4606-ab6b-d28b2a07b9a6">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassification adjustment, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEwLTEtMS0xLTE0MDY0NQ_37593e9a-fb6c-4032-b243-32dae0c5c14d">55</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEwLTMtMS0xLTE0MDY0NQ_64c6a59c-3d74-488f-bc7f-f4b3c70b2ecb">80</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEwLTUtMS0xLTE0MDY0NQ_e713e4b8-607b-43b5-b597-5538a34e5b7f">70</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzExLTEtMS0xLTE0MDY0NQ_3f826aea-42ab-4132-a5f9-cbb8cbfda4af">1,346</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzExLTMtMS0xLTE0MDY0NQ_18918261-9daa-4ea6-bcd6-5247320cf17f">355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzExLTUtMS0xLTE0MDY0NQ_0dc7c19c-76bf-4c03-ad4c-173d2492670d">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to equity method<br/>&#160;&#160;investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEyLTEtMS0xLTE0MDY0NQ_ca698079-b187-4303-a7e1-429234d92d6c">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEyLTMtMS0xLTE0MDY0NQ_b5af0b1c-10e1-4692-a6c6-cb33d7ab173e">6</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEyLTUtMS0xLTE0MDY0NQ_f0f7c5ee-1818-43d6-91b0-0adb58185a62">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Humana</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEzLTEtMS0xLTE0MDY0NQ_2e4c29fb-3006-4044-a376-abe36d6a3b09">1,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEzLTMtMS0xLTE0MDY0NQ_5c740ba0-1064-4503-b045-2c1b117c5c8d">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEzLTUtMS0xLTE0MDY0NQ_018d6933-3f01-457a-9d1a-e402d3395c0c">3,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the parent company financial statements.</span></div></ix:continuation><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_256"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><ix:continuation id="i9ac271d088614971b79402a7be4b9cc5" continuedAt="i27f9d27623cc4a139b527925cd6884a2"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:52.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.667%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.602%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzMtMS0xLTEtMTQwNjQ1_71663964-5b37-4a6e-a16b-d14cb0383036">4,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzMtMy0xLTEtMTQwNjQ1_0c36f674-5590-408a-9108-9618aec3866c">2,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzMtNS0xLTEtMTQwNjQ1_a624af5f-bcd3-4f81-b08c-ff7393597e41">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzUtMS0xLTEtMTQwNjQ1_ed3f63c5-5977-46d7-bdbd-5741320f76c8">337</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzUtMy0xLTEtMTQwNjQ1_ff7df8e1-bda7-45f9-ad2a-54416c8b6b3f">4,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzUtNS0xLTEtMTQwNjQ1_58cc2269-6161-490d-bda6-2f22cff0b9a9">709</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to operating subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="hum:CapitalContributionsToOperatingSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzYtMS0xLTEtMTQwNjQ1_9b85c849-d496-4ebc-bf9e-3e491cfb4d24">484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="hum:CapitalContributionsToOperatingSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzYtMy0xLTEtMTQwNjQ1_902a0473-ca8f-4b84-b8db-6e44efc57763">2,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="hum:CapitalContributionsToOperatingSubsidiaries" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzYtNS0xLTEtMTQwNjQ1_9043c35e-2fb3-44c4-80ec-8ab647a3cbd7">538</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Purchases of property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctMS0xLTEtMTc2MTU0_39908432-8100-4549-a0e6-852c5984e142">931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctMy0xLTEtMTc2MTU0_4dfcc67a-f095-452c-ad16-e29252ca8d3d">958</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctNS0xLTEtMTc2MTU0_edf5027d-5aea-402e-bd9d-841016e03daf">785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctMS0xLTEtMTQwNjQ1_23272414-eaa0-43a3-8286-dce2c42a83b9">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctMy0xLTEtMTQwNjQ1_64d1eabe-a5bc-44db-a303-76775925199e">200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctNS0xLTEtMTQwNjQ1_9327ee7a-6153-44d5-b8b4-b62f4ff46bc7">460</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzgtMS0xLTEtMTQwNjQ1_e73989e1-a600-4b24-aa4c-e52b9abbbc49">468</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzgtMy0xLTEtMTQwNjQ1_a0aaf801-ca42-4164-888f-e3c3f59a160c">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzgtNS0xLTEtMTQwNjQ1_8074c064-f1f9-457b-b8db-ef65aa0364cf">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzktMS0xLTEtMTQwNjQ1_8d48df9b-10f0-44c3-9674-9fdf85dbba6b">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzktMy0xLTEtMTQwNjQ1_0e93c2f3-2929-48a1-bd5e-1aa7d2e5a69e">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzktNS0xLTEtMTQwNjQ1_521761d4-4ece-48b6-bf47-6668299d8136">411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzExLTEtMS0xLTE0MDY0NQ_fd234925-fc67-4024-8877-1d7b1e7a5569">1,317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzExLTMtMS0xLTE0MDY0NQ_51717bad-570a-4d65-ab5f-46daf52e988d">7,732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzExLTUtMS0xLTE0MDY0NQ_de500e4c-e1c3-4028-838e-c2ba2a843036">2,068</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzEzLTEtMS0xLTE0MDY0NQ_e273ba59-838d-4f9a-bb32-a37591c336f8">1,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzEzLTMtMS0xLTE0MDY0NQ_4ef87e34-b905-4db3-8072-34a9f6f00a10">2,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzEzLTUtMS0xLTE0MDY0NQ_387ed9c9-c012-4344-8965-c3534b62075b">1,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Repayments of senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE0LTEtMS0xLTE0MDY0NQ_ec437b2c-ae6b-42da-a443-cfd3c194682f">1,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE0LTMtMS0xLTE0MDY0NQ_4e8201cb-756e-4fca-bdc2-00e253fa0388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfSeniorDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE0LTUtMS0xLTE0MDY0NQ_67d06ca7-e16d-41d9-931f-3cf8b37ab99c">400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Repayments) proceeds from issuance of commercial paper, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE1LTEtMS0xLTE0MDY0NQ_23fdfbdc-db8d-45f8-85c4-b34d81ee49c1">376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE1LTMtMS0xLTE0MDY0NQ_16700d39-c670-4774-b855-aeee5b9effa9">352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfCommercialPaper" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE1LTUtMS0xLTE0MDY0NQ_ca1d424f-417f-4d81-a264-1347d7e77ff8">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Proceeds from issuance of term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromNotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE2LTEtMS0xLTE0MDY0NQ_b9771bc3-1874-423b-81ea-1ad60ba9fe3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE2LTMtMS0xLTE0MDY0NQ_343ee092-d440-4ab8-85ff-703e10c4bf93">2,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:ProceedsFromNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE2LTUtMS0xLTE0MDY0NQ_66359d4f-6b68-473e-b93b-7d353f44413a">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE3LTEtMS0xLTE0MDY0NQ_cab935c4-42a0-42ac-a064-55c5db015c5c">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE3LTMtMS0xLTE0MDY0NQ_f522ff8d-6984-4154-becc-f6084951ddb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:RepaymentsOfNotesPayable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE3LTUtMS0xLTE0MDY0NQ_617816e7-7e30-4479-bb0a-6c11f603ef21">1,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Change in book overdraft</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:IncreaseDecreaseInBookOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE4LTEtMS0xLTE0MDY0NQ_ef68e6ab-f78f-40e2-8c51-913d80f3201b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInBookOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE4LTMtMS0xLTE0MDY0NQ_3e747f93-97ac-465b-8425-b0e9de2fea33">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:IncreaseDecreaseInBookOverdrafts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE4LTUtMS0xLTE0MDY0NQ_296955f4-b148-48dc-9c43-5232b0495c74">80</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Common stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE5LTEtMS0xLTE0MDY0NQ_f9bbb7b6-fc7e-4f52-ae61-70f229cb19ae">2,096</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE5LTMtMS0xLTE0MDY0NQ_74f26196-cdff-4a79-95a1-62ff0fd634db">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE5LTUtMS0xLTE0MDY0NQ_0d7b7be5-f9c1-40fb-9487-38e8c470a161">1,820</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIwLTEtMS0xLTE0MDY0NQ_989f069a-78e1-40ff-a916-04aeac2edde5">392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIwLTMtMS0xLTE0MDY0NQ_67401460-aff3-412b-81af-721ad8a5ee7f">354</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="us-gaap:PaymentsOfDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIwLTUtMS0xLTE0MDY0NQ_cf4ce4fe-fb3e-417b-b368-2471e06fad64">323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock option exercises and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" name="hum:ProceedsFromStockOptionsExercisedAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIxLTEtMS0xLTE0MDY0NQ_b71f3724-1672-4241-8f3f-71633950532c">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="hum:ProceedsFromStockOptionsExercisedAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIxLTMtMS0xLTE0MDY0NQ_8e280396-f46f-42e7-a609-8c9c4d382d51">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" name="hum:ProceedsFromStockOptionsExercisedAndOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIxLTUtMS0xLTE0MDY0NQ_8b7fa102-1cf6-4637-805d-0b900f6a7377">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIyLTEtMS0xLTE0MDY0NQ_4425b7f1-6703-4db0-8fe3-6256ae775e91">3,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIyLTMtMS0xLTE0MDY0NQ_96d60130-1814-4c0a-831b-2fc95774b89d">5,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIyLTUtMS0xLTE0MDY0NQ_cce79fd5-2281-4106-9c2d-9b82ed84b670">1,033</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIzLTEtMS0xLTE0MDY0NQ_8eefa904-47da-4fca-a033-d27e8bd8edf8">292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIzLTMtMS0xLTE0MDY0NQ_bd3a2afc-7909-440b-9ad8-ce54868becd5">470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIzLTUtMS0xLTE0MDY0NQ_279fb1ce-3d11-4e07-8557-1112f7251fb3">570</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI0LTEtMS0xLTE0MDY0NQ_8a05c3bc-eea7-42e0-b464-ce182616c30c">906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b37d40697eb42ba8f7d32eb522463dc_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI0LTMtMS0xLTE0MDY0NQ_614671b5-83e8-453d-8a96-3a928788401c">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i349fa291d8d14aaa9e2386bb9b8b283a_I20191231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI0LTUtMS0xLTE0MDY0NQ_e21cecf8-e0dd-4714-bbad-1381e476c97e">1,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI1LTEtMS0xLTE0MDY0NQ_96f7e581-d184-4e33-b71c-8ed4c339592c">614</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI1LTMtMS0xLTE0MDY0NQ_2540955a-4caa-4108-838f-028edce15443">906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b37d40697eb42ba8f7d32eb522463dc_I20201231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI1LTUtMS0xLTE0MDY0NQ_465be648-1a15-408d-9d9b-61a9800f71f2">436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the parent company financial statements.</span></div></ix:continuation><div><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">144</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_259"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><ix:continuation id="i27f9d27623cc4a139b527925cd6884a2" continuedAt="i3581f26ff1c44fc59e083fea5440c3f7"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED FINANCIAL STATEMENTS</span></div></ix:continuation><div><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_262"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;<ix:continuation id="i3581f26ff1c44fc59e083fea5440c3f7" continuedAt="if95efed65b7a4b81ac13630a2abad4ee">BASIS OF PRESENTATION</ix:continuation></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if95efed65b7a4b81ac13630a2abad4ee" continuedAt="i73253c092e9d42e5b0dbbd1e94929fdf">Parent company financial information has been derived from our consolidated financial statements and excludes the accounts of all operating subsidiaries. This information should be read in conjunction with our consolidated financial statements.</ix:continuation></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_265"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 2.&#160;<ix:continuation id="i73253c092e9d42e5b0dbbd1e94929fdf" continuedAt="idabe97519a4a4ec2bb9bee327198db28">TRANSACTIONS WITH SUBSIDIARIES</ix:continuation></span></div><ix:continuation id="idabe97519a4a4ec2bb9bee327198db28" continuedAt="icba415b7058647c1a7abbc27e8d02d33"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Services Fee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through intercompany service agreements approved, if required, by state regulatory authorities, Humana Inc., our parent company, charges a services fee for reimbursement of certain centralized services provided to its subsidiaries including information systems, disbursement, investment and cash administration, marketing, legal, finance, and medical and executive management oversight.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends received from subsidiaries and included as a component of net cash provided by operating activities were $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-8" name="hum:DividendsToParentWithoutPriorStateRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjUvZnJhZzo1ZDVhMDk0YjhlMzA0MzY0YjYzMTM0OTA0ODFjOTBkNS90ZXh0cmVnaW9uOjVkNWEwOTRiOGUzMDQzNjRiNjMxMzQ5MDQ4MWM5MGQ1XzU3NA_5aa5f86c-b9ac-47e3-bc96-3c3059ee272c">1.3</ix:nonFraction> billion in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-8" name="hum:DividendsToParentWithoutPriorStateRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjUvZnJhZzo1ZDVhMDk0YjhlMzA0MzY0YjYzMTM0OTA0ODFjOTBkNS90ZXh0cmVnaW9uOjVkNWEwOTRiOGUzMDQzNjRiNjMxMzQ5MDQ4MWM5MGQ1XzU4NA_50ff6e63-31bc-4ec8-a709-9c9140025b81">1.6</ix:nonFraction> billion in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-8" name="hum:DividendsToParentWithoutPriorStateRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjUvZnJhZzo1ZDVhMDk0YjhlMzA0MzY0YjYzMTM0OTA0ODFjOTBkNS90ZXh0cmVnaW9uOjVkNWEwOTRiOGUzMDQzNjRiNjMxMzQ5MDQ4MWM5MGQ1XzU5OA_e0defaa9-f4f0-4f02-a286-a3d5e7d4d229">1.3</ix:nonFraction> billion in 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantee</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through indemnity agreements approved by state regulatory authorities, certain of our regulated subsidiaries generally are guaranteed by our parent company in the event of insolvency for: (1) member coverage for which premium payment has been made prior to insolvency; (2) benefits for members then hospitalized until discharged; and (3)&#160;payment to providers for services rendered prior to insolvency. Our parent has also guaranteed the obligations of our military services subsidiaries and funding to maintain required statutory capital levels of certain other regulated subsidiaries.</span></div></ix:continuation><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_268"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">  3.&#160;<ix:continuation id="icba415b7058647c1a7abbc27e8d02d33" continuedAt="i62460b96324e43afb64077ee0d950cdf">REGULATORY REQUIREMENTS</ix:continuation></span></div><ix:continuation id="i62460b96324e43afb64077ee0d950cdf" continuedAt="ia2a0f17553224fd588e63ae2b5a2acc2"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our subsidiaries operate in states that regulate the payment of dividends, loans, or other cash transfers to Humana Inc., our parent company, and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid to Humana Inc. by these subsidiaries, without prior approval by state regulatory authorities, or ordinary dividends, is limited based on the entity&#8217;s level of statutory income and statutory capit</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">al and surplus. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an extraordinary dividend requiring prior regulatory approval. In most states, prior notification is provided before paying a dividend even if approval is not required.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although minimum required levels of equity are largely based on premium volume, product mix, and the quality of assets held, minimum requirements vary significantly at the state level. Our state regulated insurance subsidiaries had aggregate statutory capital and surplus of approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzQx_cf8245e0-ecb7-4ce3-80ad-c751dbb0961a">11.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzQ4_bbaa1b2f-0532-498e-82fd-4d5418d67a86">9.6</ix:nonFraction> billion as of December&#160;31, 2022 and 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively, which exceeded aggregate minimum regulatory requirements of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzg0_688407f5-9157-4ba4-b942-c4da1764ad84">8.4</ix:nonFraction> billion</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $<ix:nonFraction unitRef="usd" contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzkx_cf44b787-27f1-4bb8-8d91-97855df20d02">7.6</ix:nonFraction> billion, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of ordinary dividends that may be paid to our parent company in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231" decimals="-8" name="us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzExOA_a676963a-ec90-4015-9a1c-678762ec02b6">1.8</ix:nonFraction> billion </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the aggregate. The amount, timing and mix of ordinary and extraordinary dividend payments will vary due to state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory requirements, the level of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix. Actual dividends that were paid to our parent company were approximately  $<ix:nonFraction unitRef="usd" contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231" decimals="-8" name="hum:DividendsToParentWithoutPriorStateRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzEyOQ_5aa5f86c-b9ac-47e3-bc96-3c3059ee272c">1.3</ix:nonFraction> billion in 2022, $<ix:nonFraction unitRef="usd" contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231" decimals="-8" name="hum:DividendsToParentWithoutPriorStateRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzEzNw_50ff6e63-31bc-4ec8-a709-9c9140025b81">1.6</ix:nonFraction> billion in 2021, and $<ix:nonFraction unitRef="usd" contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231" decimals="-8" name="hum:DividendsToParentWithoutPriorStateRegulatoryApproval" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzE0NQ_e0defaa9-f4f0-4f02-a286-a3d5e7d4d229">1.3</ix:nonFraction> billion in 2020.</span></div></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED FINANCIAL STATEMENTS&#8212;(Continued)</span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia2a0f17553224fd588e63ae2b5a2acc2" continuedAt="i8bbaf06dd0a145b3bb9512dc8a1b2b0b">Our use of operating cash flows derived from our non-insurance subsidiaries, such as in our Healthcare Services segment, is generally not restricted by state departments of insurance (or comparable state regulators).</ix:continuation></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_271"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;<ix:continuation id="i8bbaf06dd0a145b3bb9512dc8a1b2b0b" continuedAt="i44a6564f97e5495abeb0ae73e8655bcb">ACQUISITIONS</ix:continuation></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i44a6564f97e5495abeb0ae73e8655bcb" continuedAt="i782330ce55574e999996980e7686c598">Refer to Note 3 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of certain acquisitions. During 2022, 2021 and 2020, we funded certain non-regulated subsidiary acquisitions with contributions from Humana Inc., our parent company, included in capital contributions in the condensed statement of cash flows.</ix:continuation>  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_274"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;<ix:continuation id="i782330ce55574e999996980e7686c598" continuedAt="i47c5b6cd10414b4ba4aa7ec887bfe6c9">INCOME TAXES</ix:continuation></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i47c5b6cd10414b4ba4aa7ec887bfe6c9" continuedAt="if5fe7edc68d648b596463275ae89992a">Refer to Note 12 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of income taxes.</ix:continuation></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_277"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;<ix:continuation id="if5fe7edc68d648b596463275ae89992a" continuedAt="i4ef807f860d742c6a5cebe7ac836c516">DEBT</ix:continuation></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i4ef807f860d742c6a5cebe7ac836c516" continuedAt="ie91aa07f6aaa42f88b33708451818472">Refer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of debt.</ix:continuation></span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_280"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;<ix:continuation id="ie91aa07f6aaa42f88b33708451818472" continuedAt="i3c92a304782c45f8b7a1c718ec67fe7f">STOCKHOLDERS' EQUITY</ix:continuation></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3c92a304782c45f8b7a1c718ec67fe7f">Refer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of stockholders&#8217; equity, including stock repurchases and stockholder dividends.</ix:continuation></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_286"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM&#160;16. FORM 10-K SUMMARY</span></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147</span></div></div></div><div id="i10e87e90a96248dfbd5b204f2b8c4b03_289"></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Sections 13 or 15(d) of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.580%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.780%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">UMANA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;SUSAN M. DIAMOND</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Susan M. Diamond</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Chief Financial Officer<br/>&#160;(Principal Financial Officer)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Company and in the capacities and on the date indicated.</span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:94.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:1pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:31.066%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.068%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;SUSAN M. DIAMOND</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Susan M. Diamond</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JOHN-PAUL W. FELTER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Accounting Officer and Controller (Principal Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:17pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">John-Paul W. Felter</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;BRUCE D. BROUSSARD</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer, <br/>Director (Principal Executive Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Bruce D. Broussard</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;KURT J. HILZINGER</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Kurt J. Hilzinger</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;RAQUEL C. BONO, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Raquel C. Bono, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;FRANK A. D&#8217;AMELIO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Frank A. D&#8217;Amelio</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;DAVID T. FEINBERG, M.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">David T. Feinberg, M.D.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;WAYNE A. I. FREDERICK, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Wayne A. I. Frederick, M.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JOHN W. GARRATT</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">John W. Garratt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;DAVID A. JONES, JR.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">David A. Jones, Jr.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;KAREN W. KATZ</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Karen W. Katz</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;MARCY S. KLEVORN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Marcy S. Klevorn</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;WILLIAM&#160;J. MCDONALD</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">William J. McDonald</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JORGE S. MESQUITA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Jorge S. Mesquita</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;JAMES J. O&#8217;BRIEN</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">James J. O&#8217;Brien</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;BRAD D. SMITH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Brad D. Smith</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>2
<FILENAME>hum-20221231x10kxex21.htm
<DESCRIPTION>EX-21
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i60b7dd89303942a385601e1f01bcdd84_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 21</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HUMANA INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUBSIDIARY LIST</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ALABAMA</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mid-South Home Health Agency, LLC</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARIZONA</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premier Home Health Agency, LLC</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARKANSAS</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Regional Health Plan, Inc.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CALIFORNIA</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asian American Home Care, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana EAP and Work-Life Services of California, Inc. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Health Plan of California, Inc. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Healthcare at Home, LLC</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">COLORADO</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alpine Home Health Care, LLC</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DELAWARE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Access Home Health of Florida, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amazing Home Health Holdings, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">American Homecare Management Corp.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDO 1, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CDO 2, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Care Solutions, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Certified Healthcare Corp.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Health Services (Certified), Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Health Services (USA) LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Health Services Holding Corp.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Health Services, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Pharmacy, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CompBenefits Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CompBenefits Direct, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conviva Care Solutions, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conviva Care Solutions II, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conviva Group Holdings, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conviva Health Management, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conviva Health MSO of Texas, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conviva Medical Center Management, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eagle NY Rx, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eagle Rx Holdco, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eagle Rx, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Echo Primary Care Holdings, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Edge Health MSO, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emphesys, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enclara Pharmacia, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FPG Acquisition Corp.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FPG Acquisition Holdings Corp.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FPG Holding Company, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Go365, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harden Healthcare Holdings, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harden Home Health, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Health Value Management, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthfield Operating Group, LLC</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthfield, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HHS Healthcare Corp.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hospice Pharmacy Solutions, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HP Solutions Holdings, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HUM Provider Holdings, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana at Home, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Digital Health and Analytics Platform Services, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Direct Contracting Entity, Inc. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Government Business, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Innovation Enterprises, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana WellWorks LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HumanaDental, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integracare Holdings, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integracare Intermediate Holdings, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KAH Development 10, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KAH Development 12, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KAH Development 14, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KAH Development 4, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kentucky Homecare Holdings, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kentucky Homecare Parent Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kindred Hospice Missouri, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kindred Hospice Services, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KND Development 50, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mid-South Home Health, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">North Region Providers, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Home Medical Equipment NC, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Home Medical Equipment VA, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Infusion Pharmacy NC, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Infusion Pharmacy TX, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Infusion Pharmacy VA, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBM Holding Company</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PBM Plus Mail Service Pharmacy, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PF Development 10, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PF Development 15, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PF Development 16, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PF Development 21, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PF Development 5, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PF Development 7, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PF Development 9, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pharaoh JV, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PHH Acquisition Corp.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PHHC Acquisition Corp.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Primary Care Holdings II, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prime West JV Holdings, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Professional Healthcare, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regency Home Office, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SHC Holding, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transcend Population Health Management II, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voyager Home Health, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voyager Hospicecare, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DOMINICAN REPUBLIC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trueshore S.R. I.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">FLORIDA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accredited Home Health of Broward, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advanced Oncology Services, Inc.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amazing Home Health Care, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amicus Medical Center LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amicus Medical Group, Inc. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amicus Medical Services Organization, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Hope Holdings, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Hope Home Health Agency, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care Partners Home Care, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CarePlus Health Plans, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Accountable Care, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Senior Primary Care (FL), Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CompBenefits Company</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Complex Clinical Management, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conviva Physician Group, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conviva Specialty, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elite Health Medical Centers, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Elite Health Primary Care, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enhanz DCE, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FPG Senior Services, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Homecare Holdings, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HUM-e-FL, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana At Home 1, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Dental Company</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Health Insurance Company of Florida, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Medical Plan, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Med. Tech. Services of South Florida, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Med-Tech Services of Dade, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Med-Tech Services of Palm Beach, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">METCARE of Florida, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Metropolitan Health Networks, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Naples Health Care Specialists, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nursing Solutions, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the Way Home Care, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Home Health Holdings, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Home Medical Equipment, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Homecare Solutions, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Homecare Systems, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Infusion Pharmacy, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Nursing Care, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One TPA Systems, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SeniorBridge Family Companies (FL), Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SeniorBridge-Florida, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Home Care, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">South Florida Cardiology Associates, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trueshore BPO, LLC</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GEORGIA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital Care Resources of South Carolina, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital Care Resources, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital Health Management Group, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chattahoochee Valley Home Care Services, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chattahoochee Valley Home Health, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CHMG Acquisition LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CHMG of Atlanta, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CHMG of Griffin, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthfield Home Health, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthfield of Southwest Georgia, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthfield of Statesboro, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthfield of Tennessee, LLC</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Employers Health Plan of Georgia, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kindred at Home Foundation, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mid-South Home Health of Gadsden, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Care Home Health of Louisburg, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Care Home Health of North Carolina, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Care Home Health of South Carolina, LLC</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ILLINOIS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CompBenefits Dental, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dental Care Plus Management, Corp.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Benefit Plan of Illinois, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Healthcare Research, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">INDIANA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SeniorBridge Family Companies (IN), Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">IOWA</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Hawkeye Health Services, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">KENTUCKY</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">516-526 West Main Street Condominium Council of Co-Owners, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CHA HMO, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Active Outlook, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Health Plan, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Insurance Company of Kentucky</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana MarketPOINT, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Pharmacy Solutions, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Real Estate Company</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humco, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dental Concern, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LOUISIANA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Health Benefit Plan of Louisiana, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Synergy Home Care-Acadiana Region, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Synergy Home Care-Capitol Region, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Synergy Home Care-Central Region, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Synergy Home Care-Northeastern Region, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Synergy Home Care-Northshore Region, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Synergy Home Care-Northwestern Region, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Synergy Home Care-Southeastern Region, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Synergy, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">MICHIGAN</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Medical Plan of Michigan, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prime Accountable Care West, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prime West Management, LLC</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">MISSISSIPPI</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Gilbert's Home Health Agency, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Home Health Care Affiliates of Central Mississippi, L.L.C.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Home Health Care Affiliates of Mississippi, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Home Health Care Affiliates, Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Van Winkle Home Health Care, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">MISSOURI</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Missouri Home Care of Rolla, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The American Heartland Hospice Corp.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NEVADA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nevada Independent Physicians, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Southern Nevada Home Health Care, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NEW YORK</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alexander Infusion, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CenterWell Services of New York, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harris, Rothenberg International Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Health Company of New York, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Insurance Company of New York</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New York Healthcare Services, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SeniorBridge Family Companies (NY), Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">QC-Medi New York, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality Care - USA, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OHIO</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovative Financial Group Holdings, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Innovative Financial Partners, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Planning of America LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Rees Financial</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Lead Store LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Versa Management LLC</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OHIO</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Health Plan of Ohio, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hummingbird Coaching Systems LLC</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PENNSYLVANIA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Medical Plan of Pennsylvania, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PUERTO RICO</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Health Plans of Puerto Rico, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Insurance of Puerto Rico, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Management Services of Puerto Rico, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana MarketPOINT of Puerto Rico, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SOUTH CAROLINA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Benefit Plan of South Carolina, Inc. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TENNESSEE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cariten Health Plan Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PHP Companies, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred Health Partnership, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TEXAS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aberdeen Holdings, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Able Home Healthcare, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BWB Sunbelt Home Health Services, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California Hospice, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CompBenefits Insurance Company</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corpus Christi Home Care, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DentiCare, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emphesys Insurance Company</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Focus Care Health Resources, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GBA Holding, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GBA West, LLC</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Georgia Hospice, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harden Clinical Services, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harden HC Texas Holdco, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harden Healthcare, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Harden Hospice, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Home Health of Rural Texas, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Horizon Health Care Services, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana At Home (Dallas), Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana At Home (Houston), Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana At Home (San Antonio), Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana At Home (TLC), Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Benefit Plan of Texas, Inc. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Health Plan of Texas, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integracare Home Health Services, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integracare of Albany, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integracare of Athens-Home Health, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integracare of Olney Home Health, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integracare of Texas, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integracare of West Texas-Home Health, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Integracare of Wichita Falls, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lighthouse Hospice - Metroplex, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lighthouse Hospice Management, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lighthouse Hospice-San Antonio, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Home Health Holdings CCTX, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One Home Medical Equipment TX, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outreach Health Services of North Texas, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROHC, L.L.C.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Texas Dental Plans, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vernon Home Health Care Agency, LLC</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voyager Acquisition, L.P.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">UTAH</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Home Health Services, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Medical Plan of Utah, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">VERMONT</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Managed Care Indemnity, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WASHINGTON</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arcadian Health Plan, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WEST VIRGINIA</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">First Home Health, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nursing Care-Home Health Agency, Inc.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WISCONSIN</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CareNetwork, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GuidantRx, Inc.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Insurance Company</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Wisconsin Health Organization Insurance Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HumanaDental Insurance Company</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Independent Care Health Plan</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>3
<FILENAME>hum-20221231x10kxex23.htm
<DESCRIPTION>EX-23
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7073725742ba4ad4a2062ebac6ec331a_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">We hereby consent to the incorporation by reference in the Registration Statements on Form</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">S-3 (No. 333-254041)</font><font style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and Form S-8 (Nos. 033-49305, 333-04435, 333-57095, 333-86801, 333-41408, 333-86280, 333-105622, 333-134887, 333-162747, 333-171616, 333-175350, 333-231154, and 033-264543) of Humana Inc. of our report dated February&#160;16, 2023 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.</font></div><div style="text-indent:18pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; PricewaterhouseCoopers LLP </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Louisville, Kentucky </font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;16, 2023 </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>hum-20221231x10kxex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i03a5a7f4061d490d8ef03d36a86309f9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">I, Bruce D. Broussard, principal executive officer of Humana Inc., certify that&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.           I have reviewed this annual report on Form 10-K of Humana Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2.           Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3.           Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">4.           The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a)&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b)&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">c)&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">d) &#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5.           The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">a)&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-indent:36pt"><font><br></font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">b)&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:40.5pt"><font><br></font></div><div style="padding-left:40.5pt"><font><br></font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:10.613%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.703%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.091%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.093%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; BRUCE D. BROUSSARD</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruce D. Broussard<br>Principal Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>hum-20221231x10kxex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i961724baa5f44fa99e77c7afa0c74587_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO SECTION 302 OF SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Susan M. Diamond, principal financial officer of Humana Inc., certify that&#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. &#160;&#160;&#160;&#160;I have reviewed this annual report on Form 10-K of Humana Inc.&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)&#160;&#160;&#160;&#160; Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)&#160;&#160;&#160;&#160; Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) &#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) &#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. &#160;&#160;&#160;&#160;The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) &#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) &#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="margin-bottom:9pt;padding-left:36pt"><font><br></font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.706%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.155%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.652%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 16, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; SUSAN M. DIAMOND</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Susan M. Diamond<br>Principal Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>6
<FILENAME>hum-20221231x10kxex32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5ac8c732c2624547b6df3334df272102_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of Humana Inc. (the &#8220;Company&#8221;) on Form 10-K for the period ended December&#160;31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of the undersigned hereby certifies, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, in his capacity as an officer of Humana Inc., that&#58;</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) The Report fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.335%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; BRUCE D. BROUSSARD</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruce D. Broussard<br>President and Chief Executive Officer (Principal Executive Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> February&#160;16, 2023 </font></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:57.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.335%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; SUSAN M. DIAMOND</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Susan M. Diamond<br>Chief Financial Officer (Principal Financial Officer)</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> February&#160;16, 2023 </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A signed original of this written statement required by Section&#160;906 has been provided to Humana Inc. and will be retained by Humana Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>hum-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:be062877-2225-41e8-b603-0f500ed981f8,g:73ed13b8-2607-407e-984b-2bfb1b06116c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hum="http://www.humana.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.humana.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.humana.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.humana.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFINCOME" roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOW" roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REPORTINGENTITY" roleURI="http://www.humana.com/role/REPORTINGENTITY">
        <link:definition>0000009 - Disclosure - REPORTING ENTITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURES" roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES">
        <link:definition>0000011 - Disclosure - ACQUISITIONS AND DIVESTITURES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYMETHODINVESTMENT" roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENT">
        <link:definition>0000012 - Disclosure - EQUITY METHOD INVESTMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIES" roleURI="http://www.humana.com/role/INVESTMENTSECURITIES">
        <link:definition>0000013 - Disclosure - INVESTMENT SECURITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUE" roleURI="http://www.humana.com/role/FAIRVALUE">
        <link:definition>0000014 - Disclosure - FAIR VALUE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICAREPARTD" roleURI="http://www.humana.com/role/MEDICAREPARTD">
        <link:definition>0000015 - Disclosure - MEDICARE PART D</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNET" roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNET">
        <link:definition>0000016 - Disclosure - PROPERTY AND EQUIPMENT, NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETS" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS">
        <link:definition>0000017 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://www.humana.com/role/LEASES">
        <link:definition>0000018 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITSPAYABLE" roleURI="http://www.humana.com/role/BENEFITSPAYABLE">
        <link:definition>0000019 - Disclosure - BENEFITS PAYABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://www.humana.com/role/INCOMETAXES">
        <link:definition>0000020 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://www.humana.com/role/DEBT">
        <link:definition>0000021 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANS" roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANS">
        <link:definition>0000022 - Disclosure - EMPLOYEE BENEFIT PLANS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERCOMMONSHARECOMPUTATION" roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION">
        <link:definition>0000023 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITY">
        <link:definition>0000024 - Disclosure - STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSGUARANTEESANDCONTINGENCIES" roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES">
        <link:definition>0000025 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://www.humana.com/role/SEGMENTINFORMATION">
        <link:definition>0000026 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REINSURANCE" roleURI="http://www.humana.com/role/REINSURANCE">
        <link:definition>0000027 - Disclosure - REINSURANCE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION" roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION">
        <link:definition>0000028 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>0000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>0000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESTables" roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESTables">
        <link:definition>0000031 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYMETHODINVESTMENTTables" roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENTTables">
        <link:definition>0000032 - Disclosure - EQUITY METHOD INVESTMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESTables" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESTables">
        <link:definition>0000033 - Disclosure - INVESTMENT SECURITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUETables" roleURI="http://www.humana.com/role/FAIRVALUETables">
        <link:definition>0000034 - Disclosure - FAIR VALUE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICAREPARTDTables" roleURI="http://www.humana.com/role/MEDICAREPARTDTables">
        <link:definition>0000035 - Disclosure - MEDICARE PART D (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNETTables" roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETTables">
        <link:definition>0000036 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSTables" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables">
        <link:definition>0000037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://www.humana.com/role/LEASESTables">
        <link:definition>0000038 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITSPAYABLETables" roleURI="http://www.humana.com/role/BENEFITSPAYABLETables">
        <link:definition>0000039 - Disclosure - BENEFITS PAYABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://www.humana.com/role/INCOMETAXESTables">
        <link:definition>0000040 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://www.humana.com/role/DEBTTables">
        <link:definition>0000041 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSTables" roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSTables">
        <link:definition>0000042 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERCOMMONSHARECOMPUTATIONTables" roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables">
        <link:definition>0000043 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYTables" roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYTables">
        <link:definition>0000044 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://www.humana.com/role/SEGMENTINFORMATIONTables">
        <link:definition>0000045 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REPORTINGENTITYDetails" roleURI="http://www.humana.com/role/REPORTINGENTITYDetails">
        <link:definition>0000046 - Disclosure - REPORTING ENTITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>0000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails_1" roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails_1">
        <link:definition>0000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails" roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails">
        <link:definition>0000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Part D Subsidy/Discount Payments, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails" roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails">
        <link:definition>0000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Health Care Cost Payments, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESNarrativeDetails" roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails">
        <link:definition>0000050 - Disclosure - ACQUISITIONS AND DIVESTITURES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails" roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails">
        <link:definition>0000051 - Disclosure - ACQUISITIONS AND DIVESTITURES - Assets, Liabilities And Noncontrolling Interest Disposed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails" roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails">
        <link:definition>0000052 - Disclosure - ACQUISITIONS AND DIVESTITURES - Preliminary Fair Value on Date of Acquisition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYMETHODINVESTMENTNarrativeDetails" roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails">
        <link:definition>0000053 - Disclosure - EQUITY METHOD INVESTMENT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails" roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails">
        <link:definition>0000054 - Disclosure - EQUITY METHOD INVESTMENT - Summarized Balance Sheets and Statements of Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails">
        <link:definition>0000055 - Disclosure - INVESTMENT SECURITIES - Classified as Current and Long-Term (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails">
        <link:definition>0000056 - Disclosure - INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESNarrativeDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails">
        <link:definition>0000057 - Disclosure - INVESTMENT SECURITIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails">
        <link:definition>0000058 - Disclosure - INVESTMENT SECURITIES - Realized Gains (Losses) Included Within Investment Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails">
        <link:definition>0000059 - Disclosure - INVESTMENT SECURITIES - Gains (Losses) on Equity Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" roleURI="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails">
        <link:definition>0000060 - Disclosure - INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" roleURI="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails">
        <link:definition>0000061 - Disclosure - FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUENarrativeDetails" roleURI="http://www.humana.com/role/FAIRVALUENarrativeDetails">
        <link:definition>0000062 - Disclosure - FAIR VALUE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUESignificantUnobservableInputsLevel3Details" roleURI="http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details">
        <link:definition>0000063 - Disclosure - FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" roleURI="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails">
        <link:definition>0000064 - Disclosure - FAIR VALUE - Put and Call Options Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MEDICAREPARTDDetails" roleURI="http://www.humana.com/role/MEDICAREPARTDDetails">
        <link:definition>0000065 - Disclosure - MEDICARE PART D (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails" roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails">
        <link:definition>0000066 - Disclosure - PROPERTY AND EQUIPMENT, NET - Property and Equipment Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNETNarrativeDetails" roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails">
        <link:definition>0000067 - Disclosure - PROPERTY AND EQUIPMENT, NET - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails">
        <link:definition>0000068 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill by Reportable Segments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails">
        <link:definition>0000069 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Details of Intangible Assets Included in Other Long-Term Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails">
        <link:definition>0000070 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails" roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails">
        <link:definition>0000071 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Estimate of Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://www.humana.com/role/LEASESNarrativeDetails">
        <link:definition>0000072 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESMaturityofLeaseLiabilitiesDetails" roleURI="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails">
        <link:definition>0000073 - Disclosure - LEASES - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESMaturityofLeaseLiabilitiesDetails_1" roleURI="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1">
        <link:definition>0000073 - Disclosure - LEASES - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITSPAYABLEActivityinBenefitsPayableDetails" roleURI="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails">
        <link:definition>0000074 - Disclosure - BENEFITS PAYABLE - Activity in Benefits Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITSPAYABLENarrativeDetails" roleURI="http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails">
        <link:definition>0000075 - Disclosure - BENEFITS PAYABLE - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails" roleURI="http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails">
        <link:definition>0000076 - Disclosure - BENEFITS PAYABLE - Incurred and Paid Claims Development (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESProvisionforIncomeTaxesDetails" roleURI="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails">
        <link:definition>0000077 - Disclosure - INCOME TAXES - Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESProvisionforIncomeTaxesReconciliationDetails" roleURI="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails">
        <link:definition>0000078 - Disclosure - INCOME TAXES - Provision for Income Taxes Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails" roleURI="http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails">
        <link:definition>0000079 - Disclosure - INCOME TAXES - Principal Components of Net Deferred Tax Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://www.humana.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>0000080 - Disclosure - INCOME TAXES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTDebtOutstandingDetails" roleURI="http://www.humana.com/role/DEBTDebtOutstandingDetails">
        <link:definition>0000081 - Disclosure - DEBT - Debt Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTMaturitiesofDebtDetails" roleURI="http://www.humana.com/role/DEBTMaturitiesofDebtDetails">
        <link:definition>0000082 - Disclosure - DEBT - Maturities of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSeniorNotesDetails" roleURI="http://www.humana.com/role/DEBTSeniorNotesDetails">
        <link:definition>0000083 - Disclosure - DEBT - Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTDelayedDrawTermLoanCreditAgreementDetails" roleURI="http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails">
        <link:definition>0000084 - Disclosure - DEBT - Delayed Draw Term Loan Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTOctober2021TermLoanAgreementDetails" roleURI="http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails">
        <link:definition>0000085 - Disclosure - DEBT - October 2021 Term Loan Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTRevolvingCreditAgreementsDetails" roleURI="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails">
        <link:definition>0000086 - Disclosure - DEBT - Revolving Credit Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTCommercialPaperandOtherShorttermBorrowingsDetails" roleURI="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails">
        <link:definition>0000087 - Disclosure - DEBT - Commercial Paper and Other Short-term Borrowings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSNarrativeDetails" roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails">
        <link:definition>0000088 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails" roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails">
        <link:definition>0000089 - Disclosure - EMPLOYEE BENEFIT PLANS - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails" roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails">
        <link:definition>0000090 - Disclosure - EMPLOYEE BENEFIT PLANS - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails" roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails">
        <link:definition>0000091 - Disclosure - EMPLOYEE BENEFIT PLANS - Weighted-Average Fair Value Assumptions for Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EMPLOYEEBENEFITPLANSOptionPlansActivityDetails" roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails">
        <link:definition>0000092 - Disclosure - EMPLOYEE BENEFIT PLANS - Option Plans Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERCOMMONSHARECOMPUTATIONDetails" roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails">
        <link:definition>0000093 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYDividendPaymentsDetails" roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYDividendPaymentsDetails">
        <link:definition>0000094 - Disclosure - STOCKHOLDERS' EQUITY - Dividend Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>0000095 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYShareRepurchasesDetails" roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails">
        <link:definition>0000096 - Disclosure - STOCKHOLDERS' EQUITY - Share Repurchases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails">
        <link:definition>0000097 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONNarrativeDetails" roleURI="http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails">
        <link:definition>0000098 - Disclosure - SEGMENT INFORMATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONSegmentResultsDetails" roleURI="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails">
        <link:definition>0000099 - Disclosure - SEGMENT INFORMATION - Segment Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REINSURANCEDetails" roleURI="http://www.humana.com/role/REINSURANCEDetails">
        <link:definition>0000100 - Disclosure - REINSURANCE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails" roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails">
        <link:definition>0000101 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails" roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails">
        <link:definition>0000102 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets Share Data) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails" roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails">
        <link:definition>0000103 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails" roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails">
        <link:definition>0000104 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Comprehensive Income) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails" roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails">
        <link:definition>0000105 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Cash Flows) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails" roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails">
        <link:definition>0000106 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Notes to Condensed Financial Statements) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hum_A575PercentSeniorNotesDueMarch2028Member" abstract="true" name="A575PercentSeniorNotesDueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock" abstract="false" name="BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer" abstract="false" name="AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" abstract="false" name="LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened" abstract="false" name="StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_A463PercentSeniorNotesDueDecember2042Member" abstract="true" name="A463PercentSeniorNotesDueDecember2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TRICAREManagedCareSupportContractBaseTerm" abstract="false" name="TRICAREManagedCareSupportContractBaseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_NetAssetLiability" abstract="false" name="NetAssetLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock" abstract="false" name="BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" abstract="true" name="FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hum_SignificantAccountingPoliciesTable" abstract="true" name="SignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="hum_A3.85PercentSeniorNotesDueOctober2024Member" abstract="true" name="A3.85PercentSeniorNotesDueOctober2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" abstract="false" name="MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock" abstract="false" name="ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_RevolvingCreditAgreementJune2021FiveYearMember" abstract="true" name="RevolvingCreditAgreementJune2021FiveYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_BuildingsAndLeaseholdImprovementsMember" abstract="true" name="BuildingsAndLeaseholdImprovementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_BookOverdraftPolicyPolicyTextBlock" abstract="false" name="BookOverdraftPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_TRICAREManagedCareSupportContractTermWithOptionExercises" abstract="false" name="TRICAREManagedCareSupportContractTermWithOptionExercises" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_A588PercentSeniorNotesDueMarch2033Member" abstract="true" name="A588PercentSeniorNotesDueMarch2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram" abstract="false" name="CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_A3.95PercentSeniorNotesDueAugust2049Member" abstract="true" name="A3.95PercentSeniorNotesDueAugust2049Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" abstract="false" name="DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_HealthCareCostPayments" abstract="false" name="HealthCareCostPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_ValueCreationInitiativesMember" abstract="true" name="ValueCreationInitiativesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TreasuryStockDecreaseInCapitalInExcessOfParValue" abstract="false" name="TreasuryStockDecreaseInCapitalInExcessOfParValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_December2020AcceleratedShareRepurchaseAgreementMember" abstract="true" name="December2020AcceleratedShareRepurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_RegulatoryMattersDomain" abstract="true" name="RegulatoryMattersDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CitibankNAMember" abstract="true" name="CitibankNAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares" abstract="false" name="DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hum_AcceleratedShareRepurchasesAgreementAmount" abstract="false" name="AcceleratedShareRepurchasesAgreementAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A065PercentSeniorNotesDueAugust2023Member" abstract="true" name="A065PercentSeniorNotesDueAugust2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_October2021TermLoanAgreementMember" abstract="true" name="October2021TermLoanAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MedicareAdvantageMember" abstract="true" name="MedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CmsSubsidiesOrDiscountsMember" abstract="true" name="CmsSubsidiesOrDiscountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A8.15PercentSeniorNotesDueJune2038Member" abstract="true" name="A8.15PercentSeniorNotesDueJune2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DelayedDrawTermLoanMay2024Member" abstract="true" name="DelayedDrawTermLoanMay2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NetCurrentLiabilityAsset" abstract="false" name="NetCurrentLiabilityAsset" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_RevenueExitMultipleMember" abstract="true" name="RevenueExitMultipleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_WelshCarsonAndersonAndStoweMember" abstract="true" name="WelshCarsonAndersonAndStoweMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DelayedDrawTermLoanMay2021Member" abstract="true" name="DelayedDrawTermLoanMay2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" abstract="false" name="BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_GovernmentAndHealthPlanMemberSubsidiesAmount" abstract="false" name="GovernmentAndHealthPlanMemberSubsidiesAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A370PercentSeniorNotesDueMarch2029Member" abstract="true" name="A370PercentSeniorNotesDueMarch2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MizuhoMarketsAmericasLLCMember" abstract="true" name="MizuhoMarketsAmericasLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_PaymentOfAnnualHealthInsuranceIndustryFee" abstract="false" name="PaymentOfAnnualHealthInsuranceIndustryFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage" abstract="false" name="DefinitiveAgreementEquityInterestToBeAcquiredPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" abstract="false" name="DebtInstrumentCovenantDebtToCapitalizationPercentageActual" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements" abstract="false" name="SubsidyAndDiscountPaymentsInExcessOfReimbursements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_DeferredTaxAssetJobsTaxCredit" abstract="false" name="DeferredTaxAssetJobsTaxCredit" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_NoncompetesAndOtherMember" abstract="true" name="NoncompetesAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_ProtectiveLifeInsuranceCompanyMember" abstract="true" name="ProtectiveLifeInsuranceCompanyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" abstract="false" name="NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_DebtAndEquitySecuritiesRealizedLoss" abstract="false" name="DebtAndEquitySecuritiesRealizedLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_MedicarePartDDisclosureTextBlock" abstract="false" name="MedicarePartDDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" abstract="false" name="IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" abstract="false" name="DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" abstract="false" name="NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_ASOAndOtherMember" abstract="true" name="ASOAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_FederalGovernmentMember" abstract="true" name="FederalGovernmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A313PercentSeniorNotesDueAugust2029Member" abstract="true" name="A313PercentSeniorNotesDueAugust2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_Expenses" abstract="false" name="Expenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" abstract="false" name="FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance" abstract="false" name="DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hum_SubsidyAndDiscountReimbursements" abstract="false" name="SubsidyAndDiscountReimbursements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_TermLoanAndCommercialPaperMember" abstract="true" name="TermLoanAndCommercialPaperMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_SpecialtyMember" abstract="true" name="SpecialtyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A3.15PercentSeniorNotesDueDecember2022Member" abstract="true" name="A3.15PercentSeniorNotesDueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" abstract="false" name="NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_JPMorganChaseBankMember" abstract="true" name="JPMorganChaseBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TermLoanDueOctober2023Member" abstract="true" name="TermLoanDueOctober2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MedicareStandAlonePrescriptionDrugPlanMember" abstract="true" name="MedicareStandAlonePrescriptionDrugPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A135PercentSeniorNotesDueFebruary2027Member" abstract="true" name="A135PercentSeniorNotesDueFebruary2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A5570PercentSeniorNotesDueMarch2028Member" abstract="true" name="A5570PercentSeniorNotesDueMarch2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CoinsuranceAgreementMember" abstract="true" name="CoinsuranceAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_HealthCareReformPolicyTextBlock" abstract="false" name="HealthCareReformPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" abstract="false" name="EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A2.90PercentSeniorNotesDueDecember2022Member" abstract="true" name="A2.90PercentSeniorNotesDueDecember2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance" abstract="false" name="NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram" abstract="false" name="MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_CenterWellSegmentMember" abstract="true" name="CenterWellSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_AcquisitionCostsPolicyPolicyTextBlock" abstract="false" name="AcquisitionCostsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_SubsidyAndDiscountPayments" abstract="false" name="SubsidyAndDiscountPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram" abstract="false" name="MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_SubsidyAndDiscountsSettlementPeriodAfterClose" abstract="false" name="SubsidyAndDiscountsSettlementPeriodAfterClose" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_InsuranceSegmentMember" abstract="true" name="InsuranceSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_USRiskCorridorPremiumStabilizationProgramMember" abstract="true" name="USRiskCorridorPremiumStabilizationProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_AccruedPharmaceuticalRebatesCurrent" abstract="false" name="AccruedPharmaceuticalRebatesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" abstract="false" name="PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_February2021ShareRepurchaseAuthorizationMember" abstract="true" name="February2021ShareRepurchaseAuthorizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_RiskCorridorSettlementsMedicarePartDMember" abstract="true" name="RiskCorridorSettlementsMedicarePartDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CertificateOfNeedMember" abstract="true" name="CertificateOfNeedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_FairValueRiskMember" abstract="true" name="FairValueRiskMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_LineOfCreditFacilityUncommittedIncrementalCapacity" abstract="false" name="LineOfCreditFacilityUncommittedIncrementalCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_WellsFargoBankMember" abstract="true" name="WellsFargoBankMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" abstract="false" name="NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" abstract="false" name="TRICAREManagedCareSupportContractNumberOfOptionPeriods" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_ProceedsFromStockOptionsExercisedAndOther" abstract="false" name="ProceedsFromStockOptionsExercisedAndOther" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain" abstract="false" name="EffectiveIncomeTaxReconciliationNonTaxableKAHGain" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_MedicaidAndOtherMember" abstract="true" name="MedicaidAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NoncontrollingInterestsPolicyTextBlock" abstract="false" name="NoncontrollingInterestsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" abstract="false" name="CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A4.95PercentSeniorNotesDueOctober2044Member" abstract="true" name="A4.95PercentSeniorNotesDueOctober2044Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_BusinessCombinationTotalEnterpriseValueOfAcquiree" abstract="false" name="BusinessCombinationTotalEnterpriseValueOfAcquiree" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs" abstract="false" name="ConsumerDiscountsOnBrandNamePrescriptionDrugs" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_AllOthersMember" abstract="true" name="AllOthersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A2011PlanMember" abstract="true" name="A2011PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies" abstract="false" name="TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_LongDurationInsuranceProductsAxis" abstract="true" name="LongDurationInsuranceProductsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost" abstract="false" name="DeferredTaxAssetsDeferredPolicyAcquisitionCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_LossOnTerminationOfDerivatives" abstract="false" name="LossOnTerminationOfDerivatives" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" abstract="false" name="ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_July2019ShareRepurchaseAuthorizationMember" abstract="true" name="July2019ShareRepurchaseAuthorizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock" abstract="false" name="DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" abstract="false" name="DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_PercentageOfTotalPremiumAndServicesRevenues" abstract="false" name="PercentageOfTotalPremiumAndServicesRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_SecuredOvernightFinancingRateSOFRMember" abstract="true" name="SecuredOvernightFinancingRateSOFRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A2019PlanMember" abstract="true" name="A2019PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember" abstract="true" name="KindredAtHomeHospiceAndPersonalCareDivisionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_OtherCurrentAssetsPolicyTextBlock" abstract="false" name="OtherCurrentAssetsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_InvestmentAndOtherIncomeNet" abstract="false" name="InvestmentAndOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_RegulatoryMattersAxis" abstract="true" name="RegulatoryMattersAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hum_NetNoncurrentAssetLiability" abstract="false" name="NetNoncurrentAssetLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_HomeSolutionsMember" abstract="true" name="HomeSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" abstract="false" name="IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_MedicareSupplementProductMember" abstract="true" name="MedicareSupplementProductMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MilitaryServiceMember" abstract="true" name="MilitaryServiceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A5875PercentSeniorNotesDueMarch2033Member" abstract="true" name="A5875PercentSeniorNotesDueMarch2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CorporateAndEliminationsMember" abstract="true" name="CorporateAndEliminationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MedicaidMember" abstract="true" name="MedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_January2022AcceleratedShareRepurchaseAgreementMember" abstract="true" name="January2022AcceleratedShareRepurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions" abstract="false" name="ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_PharmacyMember" abstract="true" name="PharmacyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding" abstract="false" name="DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum" abstract="false" name="StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_LongDurationInsuranceProductsDomain" abstract="true" name="LongDurationInsuranceProductsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_PercentageOfCoinsuranceAgreement" abstract="false" name="PercentageOfCoinsuranceAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_DepreciationAndAmortizationIncomeStatement" abstract="false" name="DepreciationAndAmortizationIncomeStatement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A450PercentSeniorNotesDueApril2025Member" abstract="true" name="A450PercentSeniorNotesDueApril2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_November2022AcceleratedShareRepurchaseProgramMember" abstract="true" name="November2022AcceleratedShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A3.95PercentSeniorNotesDueMarch2027Member" abstract="true" name="A3.95PercentSeniorNotesDueMarch2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member" abstract="true" name="A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_ReinsuranceTable" abstract="true" name="ReinsuranceTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="hum_DebtAndEquitySecuritiesRealizedGain" abstract="false" name="DebtAndEquitySecuritiesRealizedGain" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_NumberOfStatesComprisingTRICAREBeneficiaries" abstract="false" name="NumberOfStatesComprisingTRICAREBeneficiaries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_GentivaTermLoanDue2025Member" abstract="true" name="GentivaTermLoanDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A4.80PercentSeniorNotesDueMarch2047Member" abstract="true" name="A4.80PercentSeniorNotesDueMarch2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_InvestmentInRelatedPartiesAndSubsidiaries" abstract="false" name="InvestmentInRelatedPartiesAndSubsidiaries" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_A488PercentSeniorNotesDueApril2030Member" abstract="true" name="A488PercentSeniorNotesDueApril2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" abstract="false" name="DepreciationAndAmortizationClassifiedAsBenefitExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_KindredAtHomeMember" abstract="true" name="KindredAtHomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" abstract="false" name="ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_CommercialMembershipContractTerm" abstract="false" name="CommercialMembershipContractTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember" abstract="true" name="FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CapitalContributionsToOperatingSubsidiaries" abstract="false" name="CapitalContributionsToOperatingSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock" abstract="false" name="ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_PaymentsForProceedsFromContractDeposits" abstract="false" name="PaymentsForProceedsFromContractDeposits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum" abstract="false" name="StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock" abstract="false" name="DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_NumberOfTRICAREBeneficiaries" abstract="false" name="NumberOfTRICAREBeneficiaries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember" abstract="true" name="ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_GroupMedicareAdvantageMember" abstract="true" name="GroupMedicareAdvantageMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_HealthCareCostReimbursements" abstract="false" name="HealthCareCostReimbursements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_DividendsToParentWithoutPriorStateRegulatoryApproval" abstract="false" name="DividendsToParentWithoutPriorStateRegulatoryApproval" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" abstract="false" name="NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_GainContingencyRecoverySought" abstract="false" name="GainContingencyRecoverySought" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_FullyInsuredMember" abstract="true" name="FullyInsuredMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_CompanyCommonStockClosingSharePrice" abstract="false" name="CompanyCommonStockClosingSharePrice" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hum_HomeSolutionsReportingUnitMember" abstract="true" name="HomeSolutionsReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_ProviderMember" abstract="true" name="ProviderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_EquityInNetEarningsOfSubsidiaries" abstract="false" name="EquityInNetEarningsOfSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_RevolvingCreditAgreementJune2021OneYearMember" abstract="true" name="RevolvingCreditAgreementJune2021OneYearMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock" abstract="false" name="FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="hum_BookOverdraftLiability" abstract="false" name="BookOverdraftLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_ProviderReportingUnitMember" abstract="true" name="ProviderReportingUnitMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" abstract="false" name="NumberOfTRICAREManagedCareSupportContractBeneficiaries" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_MedicareLicensesAndCertificatesOfNeedMember" abstract="true" name="MedicareLicensesAndCertificatesOfNeedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage" abstract="false" name="BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" abstract="false" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_HealthCareCostPaymentsAndReimbursementsNet" abstract="false" name="HealthCareCostPaymentsAndReimbursementsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_HealthCareReformMember" abstract="true" name="HealthCareReformMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_A215PercentSeniorNotesDueFebruary2032Member" abstract="true" name="A215PercentSeniorNotesDueFebruary2032Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_FinancialAssetsFairValueDisclosure" abstract="false" name="FinancialAssetsFairValueDisclosure" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" abstract="false" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hum_GoldmanSachsCoLLCMember" abstract="true" name="GoldmanSachsCoLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hum_SignificantAccountingPoliciesLineItems" abstract="true" name="SignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" abstract="false" name="ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters" abstract="false" name="StrategicPartnershipAgreementNumberOfPrimaryCareCenters" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hum_ManagementFeesChargedToOperatingSubsidiaries" abstract="false" name="ManagementFeesChargedToOperatingSubsidiaries" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>hum-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:be062877-2225-41e8-b603-0f500ed981f8,g:73ed13b8-2607-407e-984b-2bfb1b06116c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b9b1c74c-e966-40f9-81b0-403304d3ef5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cd7d2823-f28e-4781-86a5-1b9b4480e5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b9b1c74c-e966-40f9-81b0-403304d3ef5f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_cd7d2823-f28e-4781-86a5-1b9b4480e5fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3d23528f-46f7-48b8-a635-0c73afa60e4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b9b1c74c-e966-40f9-81b0-403304d3ef5f" xlink:to="loc_us-gaap_ShortTermInvestments_3d23528f-46f7-48b8-a635-0c73afa60e4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_bb631bc1-42bf-4e02-83e1-5374c90addcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b9b1c74c-e966-40f9-81b0-403304d3ef5f" xlink:to="loc_us-gaap_ReceivablesNetCurrent_bb631bc1-42bf-4e02-83e1-5374c90addcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_e7fed261-e491-4f21-b1cd-8a4feff8f821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_b9b1c74c-e966-40f9-81b0-403304d3ef5f" xlink:to="loc_us-gaap_OtherAssetsCurrent_e7fed261-e491-4f21-b1cd-8a4feff8f821" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a241b614-bd5b-48ee-8ba7-d7b9a282823b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_19810260-0551-422b-ae19-0c83d7e6d079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a241b614-bd5b-48ee-8ba7-d7b9a282823b" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_19810260-0551-422b-ae19-0c83d7e6d079" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_89a09114-9e37-4be7-83ab-3a9ce40f1266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a241b614-bd5b-48ee-8ba7-d7b9a282823b" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_89a09114-9e37-4be7-83ab-3a9ce40f1266" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftLiability_efa06624-bd4b-4198-9fc4-4e15a78d4633" xlink:href="hum-20221231.xsd#hum_BookOverdraftLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a241b614-bd5b-48ee-8ba7-d7b9a282823b" xlink:to="loc_hum_BookOverdraftLiability_efa06624-bd4b-4198-9fc4-4e15a78d4633" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ffda4064-a946-4c80-9ea2-fb4ddf3222c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a241b614-bd5b-48ee-8ba7-d7b9a282823b" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ffda4064-a946-4c80-9ea2-fb4ddf3222c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_cab9fc49-400e-4382-ba0c-5ceb59f535e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_a241b614-bd5b-48ee-8ba7-d7b9a282823b" xlink:to="loc_us-gaap_DebtCurrent_cab9fc49-400e-4382-ba0c-5ceb59f535e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_14bd0cb1-7204-4b58-a77f-cfed66393595" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ce9be635-c188-430e-bf6b-e0874842675b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14bd0cb1-7204-4b58-a77f-cfed66393595" xlink:to="loc_us-gaap_AssetsCurrent_ce9be635-c188-430e-bf6b-e0874842675b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ddef98b0-e075-4b1b-b432-68415b9ba9ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14bd0cb1-7204-4b58-a77f-cfed66393595" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ddef98b0-e075-4b1b-b432-68415b9ba9ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_850b7e74-4b78-4638-bfd0-c708582e9018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14bd0cb1-7204-4b58-a77f-cfed66393595" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_850b7e74-4b78-4638-bfd0-c708582e9018" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_40c53748-3874-4f64-8e67-bfc95b85ae64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14bd0cb1-7204-4b58-a77f-cfed66393595" xlink:to="loc_us-gaap_Goodwill_40c53748-3874-4f64-8e67-bfc95b85ae64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_b041aa9c-8422-41ad-9987-737e33799cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14bd0cb1-7204-4b58-a77f-cfed66393595" xlink:to="loc_us-gaap_EquityMethodInvestments_b041aa9c-8422-41ad-9987-737e33799cec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_d6553915-f3ef-4103-9471-147607514f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_14bd0cb1-7204-4b58-a77f-cfed66393595" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_d6553915-f3ef-4103-9471-147607514f2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_93ca7589-e0ac-4117-9e77-2638113646db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_dec4f53a-e349-4339-9190-965c7d4856cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_93ca7589-e0ac-4117-9e77-2638113646db" xlink:to="loc_us-gaap_TreasuryStockCommonValue_dec4f53a-e349-4339-9190-965c7d4856cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_75be02dc-9e77-4592-a27e-ba309cf4d4e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_93ca7589-e0ac-4117-9e77-2638113646db" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_75be02dc-9e77-4592-a27e-ba309cf4d4e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_d2ae59e5-b567-4fc5-baee-1064aa7dd3b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_93ca7589-e0ac-4117-9e77-2638113646db" xlink:to="loc_us-gaap_CommonStockValue_d2ae59e5-b567-4fc5-baee-1064aa7dd3b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_004e1074-9eab-432f-8877-32b65111dbf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_93ca7589-e0ac-4117-9e77-2638113646db" xlink:to="loc_us-gaap_PreferredStockValue_004e1074-9eab-432f-8877-32b65111dbf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4676d823-3ca8-40e2-b395-7e2cdf1a7494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_93ca7589-e0ac-4117-9e77-2638113646db" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_4676d823-3ca8-40e2-b395-7e2cdf1a7494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18551108-fee3-483e-9cb1-2eaa41f4d8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_93ca7589-e0ac-4117-9e77-2638113646db" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18551108-fee3-483e-9cb1-2eaa41f4d8b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cca36253-7f8d-4696-a554-fe7f8ef2f1c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7b0c04e5-26ab-471b-82a8-7beeec50cb04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cca36253-7f8d-4696-a554-fe7f8ef2f1c4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7b0c04e5-26ab-471b-82a8-7beeec50cb04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_84fdfd7f-e4bb-4d69-868c-c822944bd34f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cca36253-7f8d-4696-a554-fe7f8ef2f1c4" xlink:to="loc_us-gaap_CommonStockValue_84fdfd7f-e4bb-4d69-868c-c822944bd34f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c3d0fd9-df94-4258-91a4-600315135604" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cca36253-7f8d-4696-a554-fe7f8ef2f1c4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_3c3d0fd9-df94-4258-91a4-600315135604" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_2d3cd13c-151a-4c90-9717-7dd97b1406f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cca36253-7f8d-4696-a554-fe7f8ef2f1c4" xlink:to="loc_us-gaap_MinorityInterest_2d3cd13c-151a-4c90-9717-7dd97b1406f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_95b9c934-dfa7-4c19-a802-9c08f8509ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cca36253-7f8d-4696-a554-fe7f8ef2f1c4" xlink:to="loc_us-gaap_TreasuryStockCommonValue_95b9c934-dfa7-4c19-a802-9c08f8509ec9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d5267b68-b3c5-4e80-8dcf-c82a2e29587a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cca36253-7f8d-4696-a554-fe7f8ef2f1c4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d5267b68-b3c5-4e80-8dcf-c82a2e29587a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f9c34c42-e606-4f8a-8ff4-43574108f810" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cca36253-7f8d-4696-a554-fe7f8ef2f1c4" xlink:to="loc_us-gaap_PreferredStockValue_f9c34c42-e606-4f8a-8ff4-43574108f810" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_2701740a-f6cf-4a89-9106-218a36f9dce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_9e3ae0f1-925a-4ec4-91c4-3fda691f3b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2701740a-f6cf-4a89-9106-218a36f9dce5" xlink:to="loc_us-gaap_LiabilitiesCurrent_9e3ae0f1-925a-4ec4-91c4-3fda691f3b2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5e6c5739-d906-4176-9452-4df78bec7a99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2701740a-f6cf-4a89-9106-218a36f9dce5" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5e6c5739-d906-4176-9452-4df78bec7a99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_500aa72e-0f27-4055-849a-35a591a340ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_2701740a-f6cf-4a89-9106-218a36f9dce5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_500aa72e-0f27-4055-849a-35a591a340ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_cda5b050-632d-478a-b40c-0bee0c914215" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_55502e1c-a059-4eda-a65b-8228d12a8156" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cda5b050-632d-478a-b40c-0bee0c914215" xlink:to="loc_us-gaap_CommitmentsAndContingencies_55502e1c-a059-4eda-a65b-8228d12a8156" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_49a4105e-a314-4d70-a32a-da6345632669" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cda5b050-632d-478a-b40c-0bee0c914215" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_49a4105e-a314-4d70-a32a-da6345632669" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_fd6cbd04-37aa-4aff-a544-574f3bbb521c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_cda5b050-632d-478a-b40c-0bee0c914215" xlink:to="loc_us-gaap_Liabilities_fd6cbd04-37aa-4aff-a544-574f3bbb521c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6de2c238-910c-47e0-8351-ddb76e6ea045" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_16c78015-ada5-4c4e-bc4c-8ddb631f5275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6de2c238-910c-47e0-8351-ddb76e6ea045" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_16c78015-ada5-4c4e-bc4c-8ddb631f5275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_53b62225-7cb7-42cc-a35a-17232f3cc8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6de2c238-910c-47e0-8351-ddb76e6ea045" xlink:to="loc_us-gaap_InterestExpense_53b62225-7cb7-42cc-a35a-17232f3cc8d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2f3ab433-c342-4839-9c64-de6689a73b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6de2c238-910c-47e0-8351-ddb76e6ea045" xlink:to="loc_us-gaap_OperatingIncomeLoss_2f3ab433-c342-4839-9c64-de6689a73b7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_674abd7b-edd6-4c63-8852-492b20af8abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_6de2c238-910c-47e0-8351-ddb76e6ea045" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_674abd7b-edd6-4c63-8852-492b20af8abf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6231cf34-e9bf-42e1-b15b-5a3c3aa5050b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5cdb68fc-097c-43f5-bd11-30efc053eb8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6231cf34-e9bf-42e1-b15b-5a3c3aa5050b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5cdb68fc-097c-43f5-bd11-30efc053eb8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a8607cad-d3fc-4c83-abb0-e6b26ac1b258" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6231cf34-e9bf-42e1-b15b-5a3c3aa5050b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a8607cad-d3fc-4c83-abb0-e6b26ac1b258" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_36d6f5f9-11e9-45e0-ae0e-ae2ffba3b8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_6231cf34-e9bf-42e1-b15b-5a3c3aa5050b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_36d6f5f9-11e9-45e0-ae0e-ae2ffba3b8d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_5d67945c-13b4-4bc9-b79f-ba99f870b931" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_57d3acfa-6b25-4f70-99e9-359fec9f0517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_5d67945c-13b4-4bc9-b79f-ba99f870b931" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_57d3acfa-6b25-4f70-99e9-359fec9f0517" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6d7806ee-66b3-47d8-8524-67cbbf5a2bc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_5d67945c-13b4-4bc9-b79f-ba99f870b931" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_6d7806ee-66b3-47d8-8524-67cbbf5a2bc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement_dc3952d4-b1b0-4459-9e03-93a13f33e4dd" xlink:href="hum-20221231.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses_5d67945c-13b4-4bc9-b79f-ba99f870b931" xlink:to="loc_hum_DepreciationAndAmortizationIncomeStatement_dc3952d4-b1b0-4459-9e03-93a13f33e4dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cdbabe69-c4a4-4d72-b030-dfd179aaa500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_08db497d-a7f4-41d6-bf9c-33b089058056" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_cdbabe69-c4a4-4d72-b030-dfd179aaa500" xlink:to="loc_us-gaap_PremiumsEarnedNet_08db497d-a7f4-41d6-bf9c-33b089058056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d69c25a1-18dc-4315-ac9f-672973310573" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_cdbabe69-c4a4-4d72-b030-dfd179aaa500" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_d69c25a1-18dc-4315-ac9f-672973310573" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_b6d1a8a2-3b40-4086-8f5b-773a53d6a3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_cdbabe69-c4a4-4d72-b030-dfd179aaa500" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_b6d1a8a2-3b40-4086-8f5b-773a53d6a3cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ab032774-3d02-4679-981c-ad2fd045c2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_80fe5fe0-484d-4afc-9c84-961bc6164188" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ab032774-3d02-4679-981c-ad2fd045c2d3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_80fe5fe0-484d-4afc-9c84-961bc6164188" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a4d133df-ba94-4535-bf62-a9e76fd6269b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_ab032774-3d02-4679-981c-ad2fd045c2d3" xlink:to="loc_us-gaap_ProfitLoss_a4d133df-ba94-4535-bf62-a9e76fd6269b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_76732d5d-71e1-429e-b9e4-fc8d68465585" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7b874cea-70ab-42fc-9dbc-0398b9296894" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_76732d5d-71e1-429e-b9e4-fc8d68465585" xlink:to="loc_us-gaap_Revenues_7b874cea-70ab-42fc-9dbc-0398b9296894" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_d0e4b4e6-098e-42d6-b4c7-3c1254bcd929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_76732d5d-71e1-429e-b9e4-fc8d68465585" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_d0e4b4e6-098e-42d6-b4c7-3c1254bcd929" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_83f79a2c-cfd6-4f1b-9b4c-25e8c83e38f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_cb61e35c-fb6d-431a-af04-f77c6a6dae0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_83f79a2c-cfd6-4f1b-9b4c-25e8c83e38f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_cb61e35c-fb6d-431a-af04-f77c6a6dae0d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_26ed8895-bb15-416c-8a05-f8c602b4c154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_83f79a2c-cfd6-4f1b-9b4c-25e8c83e38f0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_26ed8895-bb15-416c-8a05-f8c602b4c154" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_526c3146-7038-42fd-aca3-77e6f3169a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_26cbe186-836a-431b-8642-e2e58c4a5702" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_526c3146-7038-42fd-aca3-77e6f3169a44" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_26cbe186-836a-431b-8642-e2e58c4a5702" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_16a39127-e44c-4729-b255-c2af611ee7df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_526c3146-7038-42fd-aca3-77e6f3169a44" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_16a39127-e44c-4729-b255-c2af611ee7df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ae9c648e-2b7c-466c-bfbf-365abc5b3d50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2b6ea8e7-7f5a-413c-a904-4b8f02dc0275" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ae9c648e-2b7c-466c-bfbf-365abc5b3d50" xlink:to="loc_us-gaap_NetIncomeLoss_2b6ea8e7-7f5a-413c-a904-4b8f02dc0275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_82cd9b65-63f3-46c6-be51-617ddb96f478" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ae9c648e-2b7c-466c-bfbf-365abc5b3d50" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_82cd9b65-63f3-46c6-be51-617ddb96f478" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_71ec6989-fc8f-4473-98e8-01cfa675565d" xlink:href="hum-20221231.xsd#hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ae9c648e-2b7c-466c-bfbf-365abc5b3d50" xlink:to="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_71ec6989-fc8f-4473-98e8-01cfa675565d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c60a2317-c30d-452a-bc24-d3a948355432" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3280bf8f-0b86-4b69-9fe9-e05a82b3e1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c60a2317-c30d-452a-bc24-d3a948355432" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3280bf8f-0b86-4b69-9fe9-e05a82b3e1b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_047257d3-f80e-480e-a52f-3954532b0aaf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c60a2317-c30d-452a-bc24-d3a948355432" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_047257d3-f80e-480e-a52f-3954532b0aaf" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOW"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ebaffda0-fd3c-49e6-9530-1656fd15763d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e2029b-82c8-46c2-963a-1ee6c2a17f13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ebaffda0-fd3c-49e6-9530-1656fd15763d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_83e2029b-82c8-46c2-963a-1ee6c2a17f13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8e4f695a-a9a1-4ffb-be64-99b86bf99bea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ebaffda0-fd3c-49e6-9530-1656fd15763d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8e4f695a-a9a1-4ffb-be64-99b86bf99bea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_759058ff-52dc-42d7-968b-48c6908273e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ebaffda0-fd3c-49e6-9530-1656fd15763d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_759058ff-52dc-42d7-968b-48c6908273e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_6eea5727-40b3-40f3-a303-1d326659d9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_6eea5727-40b3-40f3-a303-1d326659d9cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_2f440f21-4b60-4665-ab8c-745288af487c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_2f440f21-4b60-4665-ab8c-745288af487c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_92227c5b-de31-48c9-b5af-fa8165bbf9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_92227c5b-de31-48c9-b5af-fa8165bbf9d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_61e7f6dc-30f2-45bf-8d90-6e07cbde51e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_61e7f6dc-30f2-45bf-8d90-6e07cbde51e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_43a0321b-ef60-459c-8284-e9d493c45110" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_43a0321b-ef60-459c-8284-e9d493c45110" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_06708c12-0fb6-4d42-bfe3-bddfcfc271f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_ShareBasedCompensation_06708c12-0fb6-4d42-bfe3-bddfcfc271f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_4ea018b8-99ce-48a5-9de5-7e8e353a441f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_4ea018b8-99ce-48a5-9de5-7e8e353a441f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6072a54a-b855-4b0e-bde4-67dd4c8c2062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_6072a54a-b855-4b0e-bde4-67dd4c8c2062" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_2b63c76a-cf7e-46ec-8e04-975f621dfa96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_Depreciation_2b63c76a-cf7e-46ec-8e04-975f621dfa96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_36f77e83-c6a1-4972-8b10-dd95385497bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_AdjustmentForAmortization_36f77e83-c6a1-4972-8b10-dd95385497bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_c7b46f7e-24fa-4020-805a-c9fc93a5c5db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_c7b46f7e-24fa-4020-805a-c9fc93a5c5db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5fc9d2e7-c230-427a-a0aa-d0189ab6d36a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_ProfitLoss_5fc9d2e7-c230-427a-a0aa-d0189ab6d36a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4154df86-1023-41c5-9ac2-c669dbab5977" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4154df86-1023-41c5-9ac2-c669dbab5977" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cdba22a0-d5f3-4a9d-a519-b015c2487457" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_cdba22a0-d5f3-4a9d-a519-b015c2487457" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_30e9d9f2-495e-43f9-b93d-a7d78a2deb03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_30e9d9f2-495e-43f9-b93d-a7d78a2deb03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_3a1608fe-ccb1-4a1f-84f6-88eb86a5207c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f78aa6c0-d6e6-4044-ac95-7b056ca90a9c" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_3a1608fe-ccb1-4a1f-84f6-88eb86a5207c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_e30616c5-9f92-4330-98a2-1558a70d4603" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_PaymentsOfDividends_e30616c5-9f92-4330-98a2-1558a70d4603" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_5a27b9bd-05f6-4aee-98fc-f6f996912d52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_5a27b9bd-05f6-4aee-98fc-f6f996912d52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentsForProceedsFromContractDeposits_c3b5ab76-21fb-4e2d-9ed0-22f423541742" xlink:href="hum-20221231.xsd#hum_PaymentsForProceedsFromContractDeposits"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_hum_PaymentsForProceedsFromContractDeposits_c3b5ab76-21fb-4e2d-9ed0-22f423541742" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5a474bc1-3a50-43eb-bfdd-90b5f9c539b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_5a474bc1-3a50-43eb-bfdd-90b5f9c539b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_13de2a88-660b-41be-aa66-eba835a1a392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_13de2a88-660b-41be-aa66-eba835a1a392" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_35fd4284-9fa1-43e1-8bea-5024bf6b573d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_35fd4284-9fa1-43e1-8bea-5024bf6b573d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_9a74466f-af29-43f4-83e1-e47c75b402a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_9a74466f-af29-43f4-83e1-e47c75b402a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_25469e25-fa5d-40f4-9b59-d08ea84cf0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInBookOverdrafts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_25469e25-fa5d-40f4-9b59-d08ea84cf0b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_e0e8316d-d462-4e0d-aca4-85fb16181db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_e0e8316d-d462-4e0d-aca4-85fb16181db9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_5d42343f-98ab-4c40-819a-ac5c6289b6ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_5d42343f-98ab-4c40-819a-ac5c6289b6ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_abefa58f-1d37-42d9-ac8f-ff2215cc8277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_804d5ec8-0a60-441e-9cb4-c37cbe083637" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_abefa58f-1d37-42d9-ac8f-ff2215cc8277" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b32e927-3826-431c-9e43-2993ef79c6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_42049ed1-ae7b-435b-9a5f-13392e2a2d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b32e927-3826-431c-9e43-2993ef79c6fe" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_42049ed1-ae7b-435b-9a5f-13392e2a2d6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1f8af1d5-7257-4843-94b0-aa3763034763" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b32e927-3826-431c-9e43-2993ef79c6fe" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_1f8af1d5-7257-4843-94b0-aa3763034763" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2c675599-c76e-4700-b94c-56b41c8ab3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b32e927-3826-431c-9e43-2993ef79c6fe" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_2c675599-c76e-4700-b94c-56b41c8ab3d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2a024baf-e89f-46ff-8ff7-faa7340374cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b32e927-3826-431c-9e43-2993ef79c6fe" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2a024baf-e89f-46ff-8ff7-faa7340374cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_defd4852-6748-4f00-b9b6-ebd356478df8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b32e927-3826-431c-9e43-2993ef79c6fe" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_defd4852-6748-4f00-b9b6-ebd356478df8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CapitalContributionsToOperatingSubsidiaries_a37034a1-19a8-4371-8af5-76268ce100b6" xlink:href="hum-20221231.xsd#hum_CapitalContributionsToOperatingSubsidiaries"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b32e927-3826-431c-9e43-2993ef79c6fe" xlink:to="loc_hum_CapitalContributionsToOperatingSubsidiaries_a37034a1-19a8-4371-8af5-76268ce100b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_358366e2-7a74-4223-bb3c-3c4ca24bbd65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8b32e927-3826-431c-9e43-2993ef79c6fe" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_358366e2-7a74-4223-bb3c-3c4ca24bbd65" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements_850e2cec-b568-4ebe-af94-1e2f8f1e5c12" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountPayments_d5504d3d-4947-453a-9513-660e6d1cc932" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountPayments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements_850e2cec-b568-4ebe-af94-1e2f8f1e5c12" xlink:to="loc_hum_SubsidyAndDiscountPayments_d5504d3d-4947-453a-9513-660e6d1cc932" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountReimbursements_73292985-8afe-412e-b6d9-9e936df98d14" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountReimbursements"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements_850e2cec-b568-4ebe-af94-1e2f8f1e5c12" xlink:to="loc_hum_SubsidyAndDiscountReimbursements_73292985-8afe-412e-b6d9-9e936df98d14" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareCostPaymentsAndReimbursementsNet_78768709-ea85-46fc-b515-0b37906bf15d" xlink:href="hum-20221231.xsd#hum_HealthCareCostPaymentsAndReimbursementsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareCostPayments_9ba5a679-bce8-440a-86f2-94fc591cfb92" xlink:href="hum-20221231.xsd#hum_HealthCareCostPayments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_HealthCareCostPaymentsAndReimbursementsNet_78768709-ea85-46fc-b515-0b37906bf15d" xlink:to="loc_hum_HealthCareCostPayments_9ba5a679-bce8-440a-86f2-94fc591cfb92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareCostReimbursements_ee9d253d-da76-4dc3-852a-0785e18939b4" xlink:href="hum-20221231.xsd#hum_HealthCareCostReimbursements"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_HealthCareCostPaymentsAndReimbursementsNet_78768709-ea85-46fc-b515-0b37906bf15d" xlink:to="loc_hum_HealthCareCostReimbursements_ee9d253d-da76-4dc3-852a-0785e18939b4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_eaf04fa6-0d66-4bdb-85fa-e78631577f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_e3548733-b7a8-4aa2-b258-094345cff984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_eaf04fa6-0d66-4bdb-85fa-e78631577f3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_e3548733-b7a8-4aa2-b258-094345cff984" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_445e2a80-609b-4fa2-905b-f475a268911b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_eaf04fa6-0d66-4bdb-85fa-e78631577f3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_445e2a80-609b-4fa2-905b-f475a268911b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_3c6af4a4-6cf9-4ad5-a631-e4f7db747cec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_eaf04fa6-0d66-4bdb-85fa-e78631577f3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_3c6af4a4-6cf9-4ad5-a631-e4f7db747cec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_f52123fa-230c-461f-a032-71167af22341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_eaf04fa6-0d66-4bdb-85fa-e78631577f3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_f52123fa-230c-461f-a032-71167af22341" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_1f6cdc49-faad-426a-997a-42bf30cf0219" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_eaf04fa6-0d66-4bdb-85fa-e78631577f3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_1f6cdc49-faad-426a-997a-42bf30cf0219" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_6e583c35-3e7e-470b-be58-e4a87067eed4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_eaf04fa6-0d66-4bdb-85fa-e78631577f3f" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_6e583c35-3e7e-470b-be58-e4a87067eed4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_53b6ebc0-f454-4175-bcff-487394712fc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_0e90dcd5-67de-42d7-9c2f-f8de0e166613" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_53b6ebc0-f454-4175-bcff-487394712fc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_0e90dcd5-67de-42d7-9c2f-f8de0e166613" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_84b4d753-38ff-4c81-92ee-817c4aea3921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_53b6ebc0-f454-4175-bcff-487394712fc7" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_84b4d753-38ff-4c81-92ee-817c4aea3921" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2bc34731-d27c-4cd3-8069-f3c8342c30ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_bb9f4075-6137-4637-8358-c8a701037768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2bc34731-d27c-4cd3-8069-f3c8342c30ea" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_bb9f4075-6137-4637-8358-c8a701037768" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_02af9680-ab88-4b84-b9df-a8bc964214db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2bc34731-d27c-4cd3-8069-f3c8342c30ea" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_02af9680-ab88-4b84-b9df-a8bc964214db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_844262b6-6d26-45a4-83de-9e3205a27fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_2bc34731-d27c-4cd3-8069-f3c8342c30ea" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_844262b6-6d26-45a4-83de-9e3205a27fa7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_ff1cfe2b-63d2-4a3f-bf1d-eed792b4f496" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_36c8889b-deba-45c0-b3bf-feb4c7b7856e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_ff1cfe2b-63d2-4a3f-bf1d-eed792b4f496" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_36c8889b-deba-45c0-b3bf-feb4c7b7856e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_1de9c99f-e7e2-4a38-94be-8bf047edb0e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_ff1cfe2b-63d2-4a3f-bf1d-eed792b4f496" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_1de9c99f-e7e2-4a38-94be-8bf047edb0e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_3844110e-8845-4df8-b0fa-b35b94d31cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_ff1cfe2b-63d2-4a3f-bf1d-eed792b4f496" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_3844110e-8845-4df8-b0fa-b35b94d31cbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02481aed-094d-4097-a6ed-facfbd41795e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_9f3c6ef3-2d6c-4177-b44d-322d913aad7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02481aed-094d-4097-a6ed-facfbd41795e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_9f3c6ef3-2d6c-4177-b44d-322d913aad7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_98659f26-1d72-4fde-83e6-805a4dc976d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02481aed-094d-4097-a6ed-facfbd41795e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_98659f26-1d72-4fde-83e6-805a4dc976d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_dbac2702-8c29-4047-ac78-0fe4c4087991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02481aed-094d-4097-a6ed-facfbd41795e" xlink:to="loc_us-gaap_Goodwill_dbac2702-8c29-4047-ac78-0fe4c4087991" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_9d435b9d-c3b4-4b51-acb4-72151bbf14af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02481aed-094d-4097-a6ed-facfbd41795e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_9d435b9d-c3b4-4b51-acb4-72151bbf14af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_16bf04a3-86d1-4224-b0e1-78054bda2ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02481aed-094d-4097-a6ed-facfbd41795e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_16bf04a3-86d1-4224-b0e1-78054bda2ef5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d6453570-cff1-4cc2-a774-2acce3bd6ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02481aed-094d-4097-a6ed-facfbd41795e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_d6453570-cff1-4cc2-a774-2acce3bd6ab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_80c46699-ae4b-4a14-977c-a4bae83aa7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_02481aed-094d-4097-a6ed-facfbd41795e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_80c46699-ae4b-4a14-977c-a4bae83aa7db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_d737b77e-b3c2-4f5d-abb3-fecd7b40f5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3961cd20-4bc0-4ad3-a94e-a26d76176a52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_d737b77e-b3c2-4f5d-abb3-fecd7b40f5ca" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_3961cd20-4bc0-4ad3-a94e-a26d76176a52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_bfe87dd2-a067-45a9-87bf-f59381933979" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Investments_d737b77e-b3c2-4f5d-abb3-fecd7b40f5ca" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_bfe87dd2-a067-45a9-87bf-f59381933979" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7b8d2aaa-1b36-4f3a-970f-a0a583d0ea83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4c80c9ff-615d-4d29-82a1-6adc303d3ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7b8d2aaa-1b36-4f3a-970f-a0a583d0ea83" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_4c80c9ff-615d-4d29-82a1-6adc303d3ae4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4fdc3242-e8c6-422b-95e3-6e5fbb59c5f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7b8d2aaa-1b36-4f3a-970f-a0a583d0ea83" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4fdc3242-e8c6-422b-95e3-6e5fbb59c5f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a28e67f0-7b58-4cd4-b1e8-3bddcd4f41c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_7b8d2aaa-1b36-4f3a-970f-a0a583d0ea83" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a28e67f0-7b58-4cd4-b1e8-3bddcd4f41c7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_07d428ba-c3bd-49e3-afe0-a3de213e7a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a54d966a-26f5-4274-9031-f06a356382d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_07d428ba-c3bd-49e3-afe0-a3de213e7a4b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_a54d966a-26f5-4274-9031-f06a356382d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_a1440586-3320-4a79-a56e-1b0e515bcfb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_07d428ba-c3bd-49e3-afe0-a3de213e7a4b" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_a1440586-3320-4a79-a56e-1b0e515bcfb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_389e749b-291a-4858-bdbf-dfd412bbf3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_79e2dfc4-83af-443f-b66a-44338631cb7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_389e749b-291a-4858-bdbf-dfd412bbf3cf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_79e2dfc4-83af-443f-b66a-44338631cb7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_70b40e8b-5d4d-4695-981c-c2cd2b479fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_389e749b-291a-4858-bdbf-dfd412bbf3cf" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_70b40e8b-5d4d-4695-981c-c2cd2b479fbc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_eb828d6c-e76c-4086-8d4a-fc023136e981" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtAndEquitySecuritiesRealizedGain_48156aaf-f9a5-4331-955e-11c225b81fa8" xlink:href="hum-20221231.xsd#hum_DebtAndEquitySecuritiesRealizedGain"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_eb828d6c-e76c-4086-8d4a-fc023136e981" xlink:to="loc_hum_DebtAndEquitySecuritiesRealizedGain_48156aaf-f9a5-4331-955e-11c225b81fa8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtAndEquitySecuritiesRealizedLoss_3c56d18e-edff-4930-9168-b7a8e8e1de4b" xlink:href="hum-20221231.xsd#hum_DebtAndEquitySecuritiesRealizedLoss"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_eb828d6c-e76c-4086-8d4a-fc023136e981" xlink:to="loc_hum_DebtAndEquitySecuritiesRealizedLoss_3c56d18e-edff-4930-9168-b7a8e8e1de4b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_459ec12f-469d-426d-933d-1c30edacd2f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_eb828d6c-e76c-4086-8d4a-fc023136e981" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_459ec12f-469d-426d-933d-1c30edacd2f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_6ef5a352-46a9-4fd5-b7d9-c3cb143a3de8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_eb828d6c-e76c-4086-8d4a-fc023136e981" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_6ef5a352-46a9-4fd5-b7d9-c3cb143a3de8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_c32a48bf-07bc-4fd0-9c97-c54f504eae3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_5caf11ec-0e00-4959-a342-9fb5bf225bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss_c32a48bf-07bc-4fd0-9c97-c54f504eae3b" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_5caf11ec-0e00-4959-a342-9fb5bf225bdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_9596935c-2eff-40d3-b141-93329c6f07dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss_c32a48bf-07bc-4fd0-9c97-c54f504eae3b" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_9596935c-2eff-40d3-b141-93329c6f07dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a911fd5f-2ec8-46f6-bf49-f3e2f722729d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5389a22e-4888-4d10-b0ec-c49014687569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a911fd5f-2ec8-46f6-bf49-f3e2f722729d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_5389a22e-4888-4d10-b0ec-c49014687569" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cd20631c-cf90-4b2e-a368-456fd36e8ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a911fd5f-2ec8-46f6-bf49-f3e2f722729d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_cd20631c-cf90-4b2e-a368-456fd36e8ccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_62efc263-f6ea-45cf-8131-4cfb820cae01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a911fd5f-2ec8-46f6-bf49-f3e2f722729d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_62efc263-f6ea-45cf-8131-4cfb820cae01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_675e030c-7e92-4f6a-8dcc-cd441fea8a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a911fd5f-2ec8-46f6-bf49-f3e2f722729d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_675e030c-7e92-4f6a-8dcc-cd441fea8a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_afa2e621-a569-452f-8266-dac291ea30ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a911fd5f-2ec8-46f6-bf49-f3e2f722729d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_afa2e621-a569-452f-8266-dac291ea30ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2865e787-01a1-441e-9cd5-2a6974ddc47c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5ee73ebb-06a5-4725-a2ae-00d1bd18a70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2865e787-01a1-441e-9cd5-2a6974ddc47c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_5ee73ebb-06a5-4725-a2ae-00d1bd18a70e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_e874cfb0-dcb5-4056-9042-372f81017e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2865e787-01a1-441e-9cd5-2a6974ddc47c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_e874cfb0-dcb5-4056-9042-372f81017e2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_f84c83d0-2742-470e-bda0-64e9df1c500c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2865e787-01a1-441e-9cd5-2a6974ddc47c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_f84c83d0-2742-470e-bda0-64e9df1c500c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_9376a649-378a-4d61-8edf-682630822e1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2865e787-01a1-441e-9cd5-2a6974ddc47c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_9376a649-378a-4d61-8edf-682630822e1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_674fd957-1a5b-46c0-b5dc-3d86aa7ef8a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_2865e787-01a1-441e-9cd5-2a6974ddc47c" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_674fd957-1a5b-46c0-b5dc-3d86aa7ef8a6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e8ccd2cc-5c32-4469-9d3f-183a12051fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7308b3f3-6b9b-466a-a392-e1d3e3b9599d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_e8ccd2cc-5c32-4469-9d3f-183a12051fdf" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_7308b3f3-6b9b-466a-a392-e1d3e3b9599d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d2cbec30-75e8-4aa0-b052-932e664a9f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_e8ccd2cc-5c32-4469-9d3f-183a12051fdf" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d2cbec30-75e8-4aa0-b052-932e664a9f5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_e9cefa7c-6872-426a-ba30-f62430ede8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_e8ccd2cc-5c32-4469-9d3f-183a12051fdf" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_e9cefa7c-6872-426a-ba30-f62430ede8e5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#MEDICAREPARTDDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset_86a6453a-c0eb-4528-8204-597814f9d60a" xlink:href="hum-20221231.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b5572cc0-8aa0-4651-9605-0daecf66d68a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetCurrentLiabilityAsset_86a6453a-c0eb-4528-8204-597814f9d60a" xlink:to="loc_us-gaap_OtherAssetsCurrent_b5572cc0-8aa0-4651-9605-0daecf66d68a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_42ab913c-1488-4145-8e91-f562bfd995c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetCurrentLiabilityAsset_86a6453a-c0eb-4528-8204-597814f9d60a" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_42ab913c-1488-4145-8e91-f562bfd995c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetAssetLiability_348101b2-417a-4c21-8b0b-dcfcaf5cfc41" xlink:href="hum-20221231.xsd#hum_NetAssetLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset_39976e48-679f-4d7f-b096-4c8584cd120e" xlink:href="hum-20221231.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetAssetLiability_348101b2-417a-4c21-8b0b-dcfcaf5cfc41" xlink:to="loc_hum_NetCurrentLiabilityAsset_39976e48-679f-4d7f-b096-4c8584cd120e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability_f4873b01-6f50-433d-902f-4e06d06391a1" xlink:href="hum-20221231.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetAssetLiability_348101b2-417a-4c21-8b0b-dcfcaf5cfc41" xlink:to="loc_hum_NetNoncurrentAssetLiability_f4873b01-6f50-433d-902f-4e06d06391a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability_573608bd-3178-4694-922d-1a63645453eb" xlink:href="hum-20221231.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_9a81b916-b1e4-4f20-9604-7f473ba5820a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetNoncurrentAssetLiability_573608bd-3178-4694-922d-1a63645453eb" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_9a81b916-b1e4-4f20-9604-7f473ba5820a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_049ee4e6-94a9-46cd-8a8c-b33bd3f377f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_NetNoncurrentAssetLiability_573608bd-3178-4694-922d-1a63645453eb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_049ee4e6-94a9-46cd-8a8c-b33bd3f377f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4a3e3bc9-17f7-4ce6-82e9-54a41df81711" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_241000ae-4263-4a2f-adac-6a21ec91a4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4a3e3bc9-17f7-4ce6-82e9-54a41df81711" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_241000ae-4263-4a2f-adac-6a21ec91a4b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_39700e67-cf0a-422a-8918-5dc0cfdc8034" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_4a3e3bc9-17f7-4ce6-82e9-54a41df81711" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_39700e67-cf0a-422a-8918-5dc0cfdc8034" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_17e660e3-ed1e-4fda-9b29-6f176b8ab593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3043fec6-eff1-4b57-807d-8495d64d55d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_17e660e3-ed1e-4fda-9b29-6f176b8ab593" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_3043fec6-eff1-4b57-807d-8495d64d55d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_060243b6-740c-4b40-bcd0-564c25e34e50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_17e660e3-ed1e-4fda-9b29-6f176b8ab593" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_060243b6-740c-4b40-bcd0-564c25e34e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cecac661-14ac-403a-9b8a-b85c89a56471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dd139d94-3557-4c16-94dc-3ca09c40e83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cecac661-14ac-403a-9b8a-b85c89a56471" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_dd139d94-3557-4c16-94dc-3ca09c40e83f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_07523188-86a0-4658-be6b-a7cb81f54ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cecac661-14ac-403a-9b8a-b85c89a56471" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_07523188-86a0-4658-be6b-a7cb81f54ef0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_39b3cf0f-9d20-42ec-8a5e-1dd6d59c16d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_58ffd636-6bf6-4a73-8340-76b2d6eed8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_39b3cf0f-9d20-42ec-8a5e-1dd6d59c16d9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_58ffd636-6bf6-4a73-8340-76b2d6eed8d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_59b6d7f0-c2af-4596-adbd-7a2242a8286c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_39b3cf0f-9d20-42ec-8a5e-1dd6d59c16d9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_59b6d7f0-c2af-4596-adbd-7a2242a8286c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#LEASESMaturityofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_357700ee-2a0f-4502-8a1d-82aca6d1beec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2aa10149-e98a-481d-a6ea-53b3e5adc994" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_357700ee-2a0f-4502-8a1d-82aca6d1beec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_2aa10149-e98a-481d-a6ea-53b3e5adc994" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_65cd3b3f-aa05-40ef-877a-e3c1889b2001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_357700ee-2a0f-4502-8a1d-82aca6d1beec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_65cd3b3f-aa05-40ef-877a-e3c1889b2001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3411f54d-d3a0-4e40-8e83-3e8ffb97e428" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_357700ee-2a0f-4502-8a1d-82aca6d1beec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_3411f54d-d3a0-4e40-8e83-3e8ffb97e428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_625b1be4-2f5c-46f5-9ddc-c572f87bf68d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_357700ee-2a0f-4502-8a1d-82aca6d1beec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_625b1be4-2f5c-46f5-9ddc-c572f87bf68d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_aadf5d32-d170-40c2-9fa0-0f53912ffe7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_357700ee-2a0f-4502-8a1d-82aca6d1beec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_aadf5d32-d170-40c2-9fa0-0f53912ffe7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_375d00be-603c-4be3-9dfb-c1c76c070905" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_357700ee-2a0f-4502-8a1d-82aca6d1beec" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_375d00be-603c-4be3-9dfb-c1c76c070905" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="hum-20221231.xsd#LEASESMaturityofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e9839ed1-8d77-4533-ae82-1a0076864eac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9d80b121-7cec-42c0-abae-ea3e72eef621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e9839ed1-8d77-4533-ae82-1a0076864eac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9d80b121-7cec-42c0-abae-ea3e72eef621" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_89242517-abc0-407d-a202-78d2b54de7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e9839ed1-8d77-4533-ae82-1a0076864eac" xlink:to="loc_us-gaap_OperatingLeaseLiability_89242517-abc0-407d-a202-78d2b54de7d1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#BENEFITSPAYABLEActivityinBenefitsPayableDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_ece5027b-69ed-4740-907e-db80b0e8b2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_f4155863-eb9f-47d4-8c99-2c3745314a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_ece5027b-69ed-4740-907e-db80b0e8b2d4" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_f4155863-eb9f-47d4-8c99-2c3745314a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_98776ee8-b9e4-4f3d-976b-91c1deac6b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_ece5027b-69ed-4740-907e-db80b0e8b2d4" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_98776ee8-b9e4-4f3d-976b-91c1deac6b7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8f2c3bbc-42c6-4ff7-a09f-622fdfc913da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_a7d4d737-16fc-4c12-bc05-bc32b4b88db2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8f2c3bbc-42c6-4ff7-a09f-622fdfc913da" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_a7d4d737-16fc-4c12-bc05-bc32b4b88db2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_21a754fe-4a24-49e2-9e2b-95ca29a9aca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_8f2c3bbc-42c6-4ff7-a09f-622fdfc913da" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_21a754fe-4a24-49e2-9e2b-95ca29a9aca5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f59388ce-cac5-4b4f-b5f4-d41bebb4e992" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_7fd71a65-ea02-49bb-8732-f4a6d1f951b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f59388ce-cac5-4b4f-b5f4-d41bebb4e992" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_7fd71a65-ea02-49bb-8732-f4a6d1f951b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_9375d8c8-580c-42cb-91de-1b8e03a9d290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_f59388ce-cac5-4b4f-b5f4-d41bebb4e992" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_9375d8c8-580c-42cb-91de-1b8e03a9d290" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXESProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f88b6527-523a-423b-b0b9-e3e63c9cc29c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fc96f604-5854-42d1-987e-0adb617fb0da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f88b6527-523a-423b-b0b9-e3e63c9cc29c" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_fc96f604-5854-42d1-987e-0adb617fb0da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4b4ff156-3a1a-4551-9429-c168eaaca003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f88b6527-523a-423b-b0b9-e3e63c9cc29c" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4b4ff156-3a1a-4551-9429-c168eaaca003" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a379c7f6-b9f8-45ed-a53f-a9d9bf209a58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3f9f4ac-90bb-43e3-818c-5291da211c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a379c7f6-b9f8-45ed-a53f-a9d9bf209a58" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e3f9f4ac-90bb-43e3-818c-5291da211c5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4ab0092b-8fcb-4712-b907-772319b7b373" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_a379c7f6-b9f8-45ed-a53f-a9d9bf209a58" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4ab0092b-8fcb-4712-b907-772319b7b373" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_64bdeb6b-4636-493a-8077-4b65da489de7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_57a43add-39ec-4bad-9ea9-1590e7f80567" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_64bdeb6b-4636-493a-8077-4b65da489de7" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_57a43add-39ec-4bad-9ea9-1590e7f80567" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_dae740c6-43f8-483d-be84-1dd044660d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_64bdeb6b-4636-493a-8077-4b65da489de7" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_dae740c6-43f8-483d-be84-1dd044660d65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain_bf057b08-0894-4c9d-b8b8-783d7efd3645" xlink:href="hum-20221231.xsd#hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_64bdeb6b-4636-493a-8077-4b65da489de7" xlink:to="loc_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain_bf057b08-0894-4c9d-b8b8-783d7efd3645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_50caf0ca-96b7-4d71-893b-4a3e9ba8cf35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_64bdeb6b-4636-493a-8077-4b65da489de7" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_50caf0ca-96b7-4d71-893b-4a3e9ba8cf35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount_2f0a9931-ac67-415d-911a-7d51d48c29b3" xlink:href="hum-20221231.xsd#hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_64bdeb6b-4636-493a-8077-4b65da489de7" xlink:to="loc_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount_2f0a9931-ac67-415d-911a-7d51d48c29b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_8799fb89-e6e2-49f4-a554-efc6f24b4774" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_64bdeb6b-4636-493a-8077-4b65da489de7" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_8799fb89-e6e2-49f4-a554-efc6f24b4774" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f8bcf576-37ab-40b4-93e3-4bbe4046d0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_64bdeb6b-4636-493a-8077-4b65da489de7" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f8bcf576-37ab-40b4-93e3-4bbe4046d0d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_c064d4b3-ea85-4890-acfa-4519884df72b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_64bdeb6b-4636-493a-8077-4b65da489de7" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_c064d4b3-ea85-4890-acfa-4519884df72b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_a0bd17ff-0acb-45ae-b4f5-f6e53a40c475" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_ccbae6a5-bb55-4d90-8f8f-6111863dcdec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a0bd17ff-0acb-45ae-b4f5-f6e53a40c475" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_ccbae6a5-bb55-4d90-8f8f-6111863dcdec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_d308ab02-8b40-45dd-9ca8-c76c40edb96a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a0bd17ff-0acb-45ae-b4f5-f6e53a40c475" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_d308ab02-8b40-45dd-9ca8-c76c40edb96a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a0502237-1180-49fc-8638-d46d40602466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a0bd17ff-0acb-45ae-b4f5-f6e53a40c475" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a0502237-1180-49fc-8638-d46d40602466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_d19f0743-6a0a-4b4b-96b5-4c2192dbc773" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a0bd17ff-0acb-45ae-b4f5-f6e53a40c475" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_d19f0743-6a0a-4b4b-96b5-4c2192dbc773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost_5c20f763-54a5-4e2d-802b-d3f2184ee37e" xlink:href="hum-20221231.xsd#hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a0bd17ff-0acb-45ae-b4f5-f6e53a40c475" xlink:to="loc_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost_5c20f763-54a5-4e2d-802b-d3f2184ee37e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DeferredTaxAssetJobsTaxCredit_1ae6265f-f812-49f7-b7ca-f8a5e682a24a" xlink:href="hum-20221231.xsd#hum_DeferredTaxAssetJobsTaxCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a0bd17ff-0acb-45ae-b4f5-f6e53a40c475" xlink:to="loc_hum_DeferredTaxAssetJobsTaxCredit_1ae6265f-f812-49f7-b7ca-f8a5e682a24a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_e009593d-5bb7-4db5-a0ab-5146710e4476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a0bd17ff-0acb-45ae-b4f5-f6e53a40c475" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_e009593d-5bb7-4db5-a0ab-5146710e4476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_9a9446e0-c390-41bc-9114-10532515f0b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_a0bd17ff-0acb-45ae-b4f5-f6e53a40c475" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_9a9446e0-c390-41bc-9114-10532515f0b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_fcc61b74-907e-4983-b06a-fd725c9cf9df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_3ca8c372-05b7-4475-aee9-e56eead949e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_fcc61b74-907e-4983-b06a-fd725c9cf9df" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_3ca8c372-05b7-4475-aee9-e56eead949e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_677f01b0-3f18-477d-a4b3-0e5459fc75c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_fcc61b74-907e-4983-b06a-fd725c9cf9df" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_677f01b0-3f18-477d-a4b3-0e5459fc75c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_92f6d10d-4b76-4de9-8a95-1e5f42e37a2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets_5ab15e2f-79c1-4841-a0c7-03240042af20" xlink:href="hum-20221231.xsd#hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_92f6d10d-4b76-4de9-8a95-1e5f42e37a2e" xlink:to="loc_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets_5ab15e2f-79c1-4841-a0c7-03240042af20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_8038f8e6-8127-4eb2-8035-a3ef2f0b91b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_92f6d10d-4b76-4de9-8a95-1e5f42e37a2e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_8038f8e6-8127-4eb2-8035-a3ef2f0b91b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_d39bb695-4834-4932-8ecb-2e651eeb93fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_92f6d10d-4b76-4de9-8a95-1e5f42e37a2e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_d39bb695-4834-4932-8ecb-2e651eeb93fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_92547360-ef86-4ee5-a735-c31526ac65eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_92f6d10d-4b76-4de9-8a95-1e5f42e37a2e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_92547360-ef86-4ee5-a735-c31526ac65eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e982c801-58a5-4f5f-a514-8fa7d5cea6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f5d52d34-fd06-4ff8-8210-54fa0e1fcd72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e982c801-58a5-4f5f-a514-8fa7d5cea6d7" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_f5d52d34-fd06-4ff8-8210-54fa0e1fcd72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d00e44b-50e4-4b5a-b4d3-fc456d2d737e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e982c801-58a5-4f5f-a514-8fa7d5cea6d7" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0d00e44b-50e4-4b5a-b4d3-fc456d2d737e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTDebtOutstandingDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_3f871a3f-1c29-40b6-98c3-13b697fc7855" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_47cbfe17-9672-4183-9c17-5f0113e3a1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_3f871a3f-1c29-40b6-98c3-13b697fc7855" xlink:to="loc_us-gaap_ShortTermBorrowings_47cbfe17-9672-4183-9c17-5f0113e3a1eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_48f31765-6705-4f47-862f-6e27a7e14714" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtCurrent_3f871a3f-1c29-40b6-98c3-13b697fc7855" xlink:to="loc_us-gaap_LongTermDebtCurrent_48f31765-6705-4f47-862f-6e27a7e14714" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_77f86a38-88cd-49dd-8cfd-cc6daa176990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_df73d8e6-0140-4707-9142-efd625fc6d06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_77f86a38-88cd-49dd-8cfd-cc6daa176990" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_df73d8e6-0140-4707-9142-efd625fc6d06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_5be3d378-801d-4ecc-b349-9494f19c9db3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_77f86a38-88cd-49dd-8cfd-cc6daa176990" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_5be3d378-801d-4ecc-b349-9494f19c9db3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EARNINGSPERCOMMONSHARECOMPUTATIONDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1ad3870-813d-4422-af51-0b7668794e43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d90a06cc-509d-438c-a218-d57ffecad184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1ad3870-813d-4422-af51-0b7668794e43" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d90a06cc-509d-438c-a218-d57ffecad184" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4fcb64d6-0dae-45e3-9a5e-c2270cb48ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c1ad3870-813d-4422-af51-0b7668794e43" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4fcb64d6-0dae-45e3-9a5e-c2270cb48ac5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SEGMENTINFORMATIONSegmentResultsDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_5bfb1317-d695-4e64-aebd-67aafbef3cd6" xlink:href="hum-20221231.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_1afdd29f-8c25-4e69-aa53-4d67d4ec2bf5" xlink:href="hum-20221231.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_5bfb1317-d695-4e64-aebd-67aafbef3cd6" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_1afdd29f-8c25-4e69-aa53-4d67d4ec2bf5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db9c8f58-eec8-4221-873f-672c97976be2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_5bfb1317-d695-4e64-aebd-67aafbef3cd6" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_db9c8f58-eec8-4221-873f-672c97976be2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a776683-a335-4c0f-9e0e-7e66a9e01858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3c5bbd57-3e90-4d6d-b5eb-5341c856ff82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a776683-a335-4c0f-9e0e-7e66a9e01858" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3c5bbd57-3e90-4d6d-b5eb-5341c856ff82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e3bfeac5-0b0b-48c7-8c9b-33057f996ec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_0a776683-a335-4c0f-9e0e-7e66a9e01858" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e3bfeac5-0b0b-48c7-8c9b-33057f996ec2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_e6da6924-3cc8-4f55-826d-cdbd931e92c7" xlink:href="hum-20221231.xsd#hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5345256f-3470-41a7-9f4e-aa93204c0a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_e6da6924-3cc8-4f55-826d-cdbd931e92c7" xlink:to="loc_us-gaap_CostsAndExpenses_5345256f-3470-41a7-9f4e-aa93204c0a4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_3fdf41c6-83f6-459d-b682-c0d8802428af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_e6da6924-3cc8-4f55-826d-cdbd931e92c7" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_3fdf41c6-83f6-459d-b682-c0d8802428af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_41a9876a-3a0d-4647-b4d9-1b504c540ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_e6da6924-3cc8-4f55-826d-cdbd931e92c7" xlink:to="loc_us-gaap_Revenues_41a9876a-3a0d-4647-b4d9-1b504c540ff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ffbdf3a4-cf65-4194-8b4a-5adf63a1451b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_11f57f02-88fb-4ec8-aeb9-77b9a62f5ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ffbdf3a4-cf65-4194-8b4a-5adf63a1451b" xlink:to="loc_us-gaap_InterestExpense_11f57f02-88fb-4ec8-aeb9-77b9a62f5ebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a6fe8be3-4b30-40c0-8bbf-62238c672655" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ffbdf3a4-cf65-4194-8b4a-5adf63a1451b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a6fe8be3-4b30-40c0-8bbf-62238c672655" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_8b3e92e8-5318-417b-8b12-3597fd0a8fc5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_ffbdf3a4-cf65-4194-8b4a-5adf63a1451b" xlink:to="loc_us-gaap_Depreciation_8b3e92e8-5318-417b-8b12-3597fd0a8fc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_634e226d-5f5b-4d69-9b87-8d6b90e4534a" xlink:href="hum-20221231.xsd#hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_09f88acb-39c2-4324-a379-49d74f9fadc0" xlink:href="hum-20221231.xsd#hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_634e226d-5f5b-4d69-9b87-8d6b90e4534a" xlink:to="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_09f88acb-39c2-4324-a379-49d74f9fadc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_4f448b7f-ae5c-43ed-871f-ac2374e8c5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_634e226d-5f5b-4d69-9b87-8d6b90e4534a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_4f448b7f-ae5c-43ed-871f-ac2374e8c5cf" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>hum-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:be062877-2225-41e8-b603-0f500ed981f8,g:73ed13b8-2607-407e-984b-2bfb1b06116c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i0354c63c836540a0a8a1884b27074f5c_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8b452279-d524-465c-8743-8ee7dde8e946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8b452279-d524-465c-8743-8ee7dde8e946" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e239b1f4-eccc-4a15-bc75-8ec162805782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e239b1f4-eccc-4a15-bc75-8ec162805782" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c9e6cc25-6000-4a19-bbe6-8a5f6c629c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c9e6cc25-6000-4a19-bbe6-8a5f6c629c54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4c8e879a-8106-417d-bac5-9383e905f405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_ProfitLoss_4c8e879a-8106-417d-bac5-9383e905f405" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_094cae45-b432-4a1c-a271-b8b12bbb82cd" xlink:href="hum-20221231.xsd#hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_094cae45-b432-4a1c-a271-b8b12bbb82cd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_8f7a3922-e8be-4b38-b5df-d61f9c880e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_8f7a3922-e8be-4b38-b5df-d61f9c880e36" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8b78fb0c-efc2-4ee3-ac70-3d44fe9b46d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8b78fb0c-efc2-4ee3-ac70-3d44fe9b46d9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b00eb97e-0e70-4e43-9dfb-dfa060e4f97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b00eb97e-0e70-4e43-9dfb-dfa060e4f97f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4ed11dce-c91b-4671-a3e5-71fef193c7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4ed11dce-c91b-4671-a3e5-71fef193c7ec" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e65411cb-5671-4bca-80cf-4ff5f069eb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_DividendsCommonStockCash_e65411cb-5671-4bca-80cf-4ff5f069eb91" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_13c867b8-6a62-413a-9874-e5e6301ba3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_13c867b8-6a62-413a-9874-e5e6301ba3cf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_70ba407b-ab2a-4939-b60d-f8bca8148c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_70ba407b-ab2a-4939-b60d-f8bca8148c3c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_940c5ade-2c31-4af8-89b9-a1463709042a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_940c5ade-2c31-4af8-89b9-a1463709042a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d4b5a0d7-2f68-411c-8189-3c9c386deab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d4b5a0d7-2f68-411c-8189-3c9c386deab8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d09ff3b1-677c-4fe8-a04f-6ce06376aec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_caeba131-0dcd-421b-82e3-9ca347c2d6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c025d7ff-fb47-4f25-ae23-b360e855a9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8b452279-d524-465c-8743-8ee7dde8e946" xlink:to="loc_us-gaap_StatementTable_c025d7ff-fb47-4f25-ae23-b360e855a9c6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_43013972-2ff6-4174-929b-24afab3b76cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c025d7ff-fb47-4f25-ae23-b360e855a9c6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_43013972-2ff6-4174-929b-24afab3b76cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_43013972-2ff6-4174-929b-24afab3b76cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_43013972-2ff6-4174-929b-24afab3b76cc" xlink:to="loc_us-gaap_EquityComponentDomain_43013972-2ff6-4174-929b-24afab3b76cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5879079e-583f-40e4-beb9-3200e47533db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_43013972-2ff6-4174-929b-24afab3b76cc" xlink:to="loc_us-gaap_EquityComponentDomain_5879079e-583f-40e4-beb9-3200e47533db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5879079e-583f-40e4-beb9-3200e47533db" xlink:to="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bdb94838-3086-4696-9e83-27f17bf0415a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_CommonStockMember_bdb94838-3086-4696-9e83-27f17bf0415a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_60bb0536-ace5-4ebe-b3c1-cd700ad20676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_60bb0536-ace5-4ebe-b3c1-cd700ad20676" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9fcfe6e3-a55d-4ded-b76c-08959c3121c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_RetainedEarningsMember_9fcfe6e3-a55d-4ded-b76c-08959c3121c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_339cfdf6-fb27-4386-8dd2-323e892bf6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_339cfdf6-fb27-4386-8dd2-323e892bf6e6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_3920641e-0cf3-4122-88ef-d7f493128d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_TreasuryStockMember_3920641e-0cf3-4122-88ef-d7f493128d40" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ff0e5ede-3378-4469-a3ae-4617f0a070a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5879079e-583f-40e4-beb9-3200e47533db" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ff0e5ede-3378-4469-a3ae-4617f0a070a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cf5f4474-94ca-4c20-9ace-351c03256b53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c025d7ff-fb47-4f25-ae23-b360e855a9c6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cf5f4474-94ca-4c20-9ace-351c03256b53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cf5f4474-94ca-4c20-9ace-351c03256b53_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cf5f4474-94ca-4c20-9ace-351c03256b53" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cf5f4474-94ca-4c20-9ace-351c03256b53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d2bdd07e-84c6-44f4-8bcb-40da22d5b96d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cf5f4474-94ca-4c20-9ace-351c03256b53" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d2bdd07e-84c6-44f4-8bcb-40da22d5b96d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3302fc3c-9b35-459e-9ecf-28b57e43e2b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d2bdd07e-84c6-44f4-8bcb-40da22d5b96d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3302fc3c-9b35-459e-9ecf-28b57e43e2b9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/REPORTINGENTITYDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#REPORTINGENTITYDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/REPORTINGENTITYDetails" xlink:type="extended" id="i796e7197603645a2990c91d5325f5630_REPORTINGENTITYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c938d5d5-5733-446c-b833-bacacd8d410b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_a49d68d3-7655-4df7-bcad-140a1e558317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c938d5d5-5733-446c-b833-bacacd8d410b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_a49d68d3-7655-4df7-bcad-140a1e558317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2712f761-c440-439a-bc4a-08942d2798fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c938d5d5-5733-446c-b833-bacacd8d410b" xlink:to="loc_us-gaap_NumberOfReportableSegments_2712f761-c440-439a-bc4a-08942d2798fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c938d5d5-5733-446c-b833-bacacd8d410b" xlink:to="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aa0ee214-6678-4a49-9695-7cec3019bc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aa0ee214-6678-4a49-9695-7cec3019bc73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_aa0ee214-6678-4a49-9695-7cec3019bc73_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aa0ee214-6678-4a49-9695-7cec3019bc73" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_aa0ee214-6678-4a49-9695-7cec3019bc73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3c42105-02ad-40ab-a933-c9269534cf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aa0ee214-6678-4a49-9695-7cec3019bc73" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3c42105-02ad-40ab-a933-c9269534cf5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueProductLineMember_c96ed367-7600-4115-8e86-a05a554b885a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3c42105-02ad-40ab-a933-c9269534cf5d" xlink:to="loc_us-gaap_SalesRevenueProductLineMember_c96ed367-7600-4115-8e86-a05a554b885a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_9b31608e-648e-48ab-af3e-5234d1be7622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_9b31608e-648e-48ab-af3e-5234d1be7622" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9b31608e-648e-48ab-af3e-5234d1be7622_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_9b31608e-648e-48ab-af3e-5234d1be7622" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9b31608e-648e-48ab-af3e-5234d1be7622_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f1229662-8c8f-419c-986a-368cac5e54be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_9b31608e-648e-48ab-af3e-5234d1be7622" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f1229662-8c8f-419c-986a-368cac5e54be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractsConcentrationRiskMember_c06881ff-60f7-4774-9037-ddc5982be8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractsConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f1229662-8c8f-419c-986a-368cac5e54be" xlink:to="loc_us-gaap_GovernmentContractsConcentrationRiskMember_c06881ff-60f7-4774-9037-ddc5982be8d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_156f03bb-54f2-4a1b-9f1d-0bf0e7b57b04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:to="loc_srt_MajorCustomersAxis_156f03bb-54f2-4a1b-9f1d-0bf0e7b57b04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_156f03bb-54f2-4a1b-9f1d-0bf0e7b57b04_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_156f03bb-54f2-4a1b-9f1d-0bf0e7b57b04" xlink:to="loc_srt_NameOfMajorCustomerDomain_156f03bb-54f2-4a1b-9f1d-0bf0e7b57b04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_83183af1-fc7f-48f7-aa79-1ae8678bf639" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_156f03bb-54f2-4a1b-9f1d-0bf0e7b57b04" xlink:to="loc_srt_NameOfMajorCustomerDomain_83183af1-fc7f-48f7-aa79-1ae8678bf639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FederalGovernmentMember_8e1e2538-8f5b-448c-a3b2-8171a3a73e13" xlink:href="hum-20221231.xsd#hum_FederalGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_83183af1-fc7f-48f7-aa79-1ae8678bf639" xlink:to="loc_hum_FederalGovernmentMember_8e1e2538-8f5b-448c-a3b2-8171a3a73e13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember_cdbb8368-7822-4624-be7c-44d07be94830" xlink:href="hum-20221231.xsd#hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_83183af1-fc7f-48f7-aa79-1ae8678bf639" xlink:to="loc_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember_cdbb8368-7822-4624-be7c-44d07be94830" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended" id="i9f452f188ee547bb80024f4cf9b67e4d_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:href="hum-20221231.xsd#hum_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_428ae0ef-6884-40f5-bf82-81f4b2719048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_428ae0ef-6884-40f5-bf82-81f4b2719048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_632d97bc-f6ae-418b-9b09-6b4705d5c384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_632d97bc-f6ae-418b-9b09-6b4705d5c384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_b0464f48-cbe4-4ed3-b923-6b157320bbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_SeveranceCosts1_b0464f48-cbe4-4ed3-b923-6b157320bbcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentOfAnnualHealthInsuranceIndustryFee_57336965-05ac-4859-a261-7aca3a75cd4d" xlink:href="hum-20221231.xsd#hum_PaymentOfAnnualHealthInsuranceIndustryFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_PaymentOfAnnualHealthInsuranceIndustryFee_57336965-05ac-4859-a261-7aca3a75cd4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GainContingencyRecoverySought_08568dc7-faa7-425f-9268-2009afe18cb6" xlink:href="hum-20221231.xsd#hum_GainContingencyRecoverySought"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_GainContingencyRecoverySought_08568dc7-faa7-425f-9268-2009afe18cb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29749ed2-9725-4caf-a9b3-4379decc4caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29749ed2-9725-4caf-a9b3-4379decc4caa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_f9b257e4-317e-4b5d-8570-4073afda33d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_LitigationSettlementExpense_f9b257e4-317e-4b5d-8570-4073afda33d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialMembershipContractTerm_b25bdc46-99ac-4112-837e-1c22a61db5b3" xlink:href="hum-20221231.xsd#hum_CommercialMembershipContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_CommercialMembershipContractTerm_b25bdc46-99ac-4112-837e-1c22a61db5b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies_38f3ff91-28a8-4fff-b7cc-4756241cef81" xlink:href="hum-20221231.xsd#hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies_38f3ff91-28a8-4fff-b7cc-4756241cef81" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs_71d4d332-466a-4cf7-b1fb-be822ee8f888" xlink:href="hum-20221231.xsd#hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs_71d4d332-466a-4cf7-b1fb-be822ee8f888" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountsSettlementPeriodAfterClose_788564ca-d2b5-459b-92b1-5c8459dc4514" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountsSettlementPeriodAfterClose"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_SubsidyAndDiscountsSettlementPeriodAfterClose_788564ca-d2b5-459b-92b1-5c8459dc4514" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_12618c1f-33bd-46ea-8dee-06c98238094b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_12618c1f-33bd-46ea-8dee-06c98238094b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AccruedPharmaceuticalRebatesCurrent_23827665-8f73-4d8f-abfd-fc4e73d36202" xlink:href="hum-20221231.xsd#hum_AccruedPharmaceuticalRebatesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_AccruedPharmaceuticalRebatesCurrent_23827665-8f73-4d8f-abfd-fc4e73d36202" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies_ec9ac40e-ccc5-4e42-9ad6-ea265a946f63" xlink:href="hum-20221231.xsd#hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies_ec9ac40e-ccc5-4e42-9ad6-ea265a946f63" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_267726b6-0b82-429e-b776-f30366833c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_267726b6-0b82-429e-b776-f30366833c51" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_342d20e0-0747-4958-af2e-6d092195c057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_Goodwill_342d20e0-0747-4958-af2e-6d092195c057" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_737effde-88fd-489d-b068-a8096f0587f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_737effde-88fd-489d-b068-a8096f0587f3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f609d1fe-268e-4bd9-a492-dc128b47784b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f609d1fe-268e-4bd9-a492-dc128b47784b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:href="hum-20221231.xsd#hum_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersDomain_5172cee3-653f-48b3-a346-8419d09885bf_default" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:to="loc_hum_RegulatoryMattersDomain_5172cee3-653f-48b3-a346-8419d09885bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersDomain_02ae566f-2c5b-499d-9557-2818e172b59c" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:to="loc_hum_RegulatoryMattersDomain_02ae566f-2c5b-499d-9557-2818e172b59c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareReformMember_c39043fa-f83d-4795-af31-5778ed7274ea" xlink:href="hum-20221231.xsd#hum_HealthCareReformMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_RegulatoryMattersDomain_02ae566f-2c5b-499d-9557-2818e172b59c" xlink:to="loc_hum_HealthCareReformMember_c39043fa-f83d-4795-af31-5778ed7274ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_417cd8cc-3743-48e7-99e1-7becfe986490_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:to="loc_srt_LitigationCaseTypeDomain_417cd8cc-3743-48e7-99e1-7becfe986490_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_54866801-e0ed-403b-a045-a1db25c2c315" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:to="loc_srt_LitigationCaseTypeDomain_54866801-e0ed-403b-a045-a1db25c2c315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_USRiskCorridorPremiumStabilizationProgramMember_5cdc8c17-9bfc-44ba-8469-1225b846f2b6" xlink:href="hum-20221231.xsd#hum_USRiskCorridorPremiumStabilizationProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_54866801-e0ed-403b-a045-a1db25c2c315" xlink:to="loc_hum_USRiskCorridorPremiumStabilizationProgramMember_5cdc8c17-9bfc-44ba-8469-1225b846f2b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_83572281-e199-4b6c-b911-a67fc6cc90f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ReinsuranceContractAxis_83572281-e199-4b6c-b911-a67fc6cc90f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4462e84e-52ff-4860-a239-0b6904b1ece9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:to="loc_srt_ProductsAndServicesDomain_4462e84e-52ff-4860-a239-0b6904b1ece9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:to="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_3e361085-b2fa-4e34-93d5-cad8730d68be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:to="loc_us-gaap_ServiceMember_3e361085-b2fa-4e34-93d5-cad8730d68be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareSupplementProductMember_bf588731-58fc-4317-ac69-cfe12a621afa" xlink:href="hum-20221231.xsd#hum_MedicareSupplementProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:to="loc_hum_MedicareSupplementProductMember_bf588731-58fc-4317-ac69-cfe12a621afa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f1a1209-c3ab-47c8-8d30-89eb79d7d155_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f1a1209-c3ab-47c8-8d30-89eb79d7d155_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_59a913ff-09ec-4702-9ded-64c3b61d3336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:to="loc_us-gaap_EquipmentMember_59a913ff-09ec-4702-9ded-64c3b61d3336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e521085-70b1-4f6c-a695-1c5df31a3b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e521085-70b1-4f6c-a695-1c5df31a3b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_8d6b7475-1ecd-446f-8637-14f7eceae93b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:to="loc_us-gaap_BuildingMember_8d6b7475-1ecd-446f-8637-14f7eceae93b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_cda0b153-fdef-4a2d-83a4-183fe8281f87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:to="loc_us-gaap_ReportingUnitDomain_cda0b153-fdef-4a2d-83a4-183fe8281f87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:to="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsReportingUnitMember_1cc42ec6-d9b1-4dc6-b019-7aaaaf392313" xlink:href="hum-20221231.xsd#hum_HomeSolutionsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:to="loc_hum_HomeSolutionsReportingUnitMember_1cc42ec6-d9b1-4dc6-b019-7aaaaf392313" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderReportingUnitMember_5796b3b3-0716-456a-8d43-16a38a3e2927" xlink:href="hum-20221231.xsd#hum_ProviderReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:to="loc_hum_ProviderReportingUnitMember_5796b3b3-0716-456a-8d43-16a38a3e2927" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bbbd0a67-e467-41ce-98e4-fbd574e4224e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:to="loc_srt_RangeMember_bbbd0a67-e467-41ce-98e4-fbd574e4224e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:to="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_36b23e49-c22a-4950-bab1-f7a701f2fa97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:to="loc_srt_MinimumMember_36b23e49-c22a-4950-bab1-f7a701f2fa97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_037833ee-8747-442a-b9b1-d1e0840a0899" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:to="loc_srt_MaximumMember_037833ee-8747-442a-b9b1-d1e0840a0899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed42dffa-bda5-4791-b5f7-6ac7382d8b79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed42dffa-bda5-4791-b5f7-6ac7382d8b79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c0aa3c77-e418-4dd0-8f04-54df28cf3730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c0aa3c77-e418-4dd0-8f04-54df28cf3730" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_1c565c66-c2eb-454b-b2a0-f14f25fe37b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c0aa3c77-e418-4dd0-8f04-54df28cf3730" xlink:to="loc_us-gaap_SalesRevenueNetMember_1c565c66-c2eb-454b-b2a0-f14f25fe37b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_17e8aa46-d621-48d2-bed6-5bdf9252bc3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_17e8aa46-d621-48d2-bed6-5bdf9252bc3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_61270b67-8a4d-4c93-bb7f-8ebb3254a861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_61270b67-8a4d-4c93-bb7f-8ebb3254a861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_7dd1d854-0eb4-48e9-9397-5885119ac38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_61270b67-8a4d-4c93-bb7f-8ebb3254a861" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_7dd1d854-0eb4-48e9-9397-5885119ac38c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_52a515c3-ae85-4890-b37f-2d6373264134_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:to="loc_us-gaap_RestructuringPlanDomain_52a515c3-ae85-4890-b37f-2d6373264134_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_727433fb-032a-46ee-9d5f-377ba9bdd2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:to="loc_us-gaap_RestructuringPlanDomain_727433fb-032a-46ee-9d5f-377ba9bdd2c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ValueCreationInitiativesMember_0c231722-6b65-49d4-9922-cf7c71bc7e58" xlink:href="hum-20221231.xsd#hum_ValueCreationInitiativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_727433fb-032a-46ee-9d5f-377ba9bdd2c0" xlink:to="loc_hum_ValueCreationInitiativesMember_0c231722-6b65-49d4-9922-cf7c71bc7e58" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails_1" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails_1"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails_1" xlink:type="extended" id="i604bceb29d0945eaa4a7a55e02d88313_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:href="hum-20221231.xsd#hum_SignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_428ae0ef-6884-40f5-bf82-81f4b2719048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_428ae0ef-6884-40f5-bf82-81f4b2719048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_632d97bc-f6ae-418b-9b09-6b4705d5c384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_632d97bc-f6ae-418b-9b09-6b4705d5c384" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_b0464f48-cbe4-4ed3-b923-6b157320bbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_SeveranceCosts1_b0464f48-cbe4-4ed3-b923-6b157320bbcb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentOfAnnualHealthInsuranceIndustryFee_57336965-05ac-4859-a261-7aca3a75cd4d" xlink:href="hum-20221231.xsd#hum_PaymentOfAnnualHealthInsuranceIndustryFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_PaymentOfAnnualHealthInsuranceIndustryFee_57336965-05ac-4859-a261-7aca3a75cd4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GainContingencyRecoverySought_08568dc7-faa7-425f-9268-2009afe18cb6" xlink:href="hum-20221231.xsd#hum_GainContingencyRecoverySought"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_GainContingencyRecoverySought_08568dc7-faa7-425f-9268-2009afe18cb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29749ed2-9725-4caf-a9b3-4379decc4caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29749ed2-9725-4caf-a9b3-4379decc4caa" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_f9b257e4-317e-4b5d-8570-4073afda33d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_LitigationSettlementExpense_f9b257e4-317e-4b5d-8570-4073afda33d2" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialMembershipContractTerm_b25bdc46-99ac-4112-837e-1c22a61db5b3" xlink:href="hum-20221231.xsd#hum_CommercialMembershipContractTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_CommercialMembershipContractTerm_b25bdc46-99ac-4112-837e-1c22a61db5b3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies_38f3ff91-28a8-4fff-b7cc-4756241cef81" xlink:href="hum-20221231.xsd#hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies_38f3ff91-28a8-4fff-b7cc-4756241cef81" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs_71d4d332-466a-4cf7-b1fb-be822ee8f888" xlink:href="hum-20221231.xsd#hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs_71d4d332-466a-4cf7-b1fb-be822ee8f888" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountsSettlementPeriodAfterClose_788564ca-d2b5-459b-92b1-5c8459dc4514" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountsSettlementPeriodAfterClose"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_SubsidyAndDiscountsSettlementPeriodAfterClose_788564ca-d2b5-459b-92b1-5c8459dc4514" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_12618c1f-33bd-46ea-8dee-06c98238094b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_12618c1f-33bd-46ea-8dee-06c98238094b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AccruedPharmaceuticalRebatesCurrent_23827665-8f73-4d8f-abfd-fc4e73d36202" xlink:href="hum-20221231.xsd#hum_AccruedPharmaceuticalRebatesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_AccruedPharmaceuticalRebatesCurrent_23827665-8f73-4d8f-abfd-fc4e73d36202" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies_ec9ac40e-ccc5-4e42-9ad6-ea265a946f63" xlink:href="hum-20221231.xsd#hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies_ec9ac40e-ccc5-4e42-9ad6-ea265a946f63" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_267726b6-0b82-429e-b776-f30366833c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_267726b6-0b82-429e-b776-f30366833c51" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_342d20e0-0747-4958-af2e-6d092195c057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_Goodwill_342d20e0-0747-4958-af2e-6d092195c057" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_737effde-88fd-489d-b068-a8096f0587f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_737effde-88fd-489d-b068-a8096f0587f3" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f609d1fe-268e-4bd9-a492-dc128b47784b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f609d1fe-268e-4bd9-a492-dc128b47784b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:href="hum-20221231.xsd#hum_SignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersDomain_5172cee3-653f-48b3-a346-8419d09885bf_default" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:to="loc_hum_RegulatoryMattersDomain_5172cee3-653f-48b3-a346-8419d09885bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersDomain_02ae566f-2c5b-499d-9557-2818e172b59c" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:to="loc_hum_RegulatoryMattersDomain_02ae566f-2c5b-499d-9557-2818e172b59c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareReformMember_c39043fa-f83d-4795-af31-5778ed7274ea" xlink:href="hum-20221231.xsd#hum_HealthCareReformMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_RegulatoryMattersDomain_02ae566f-2c5b-499d-9557-2818e172b59c" xlink:to="loc_hum_HealthCareReformMember_c39043fa-f83d-4795-af31-5778ed7274ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_417cd8cc-3743-48e7-99e1-7becfe986490_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:to="loc_srt_LitigationCaseTypeDomain_417cd8cc-3743-48e7-99e1-7becfe986490_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_54866801-e0ed-403b-a045-a1db25c2c315" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:to="loc_srt_LitigationCaseTypeDomain_54866801-e0ed-403b-a045-a1db25c2c315" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_USRiskCorridorPremiumStabilizationProgramMember_5cdc8c17-9bfc-44ba-8469-1225b846f2b6" xlink:href="hum-20221231.xsd#hum_USRiskCorridorPremiumStabilizationProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_54866801-e0ed-403b-a045-a1db25c2c315" xlink:to="loc_hum_USRiskCorridorPremiumStabilizationProgramMember_5cdc8c17-9bfc-44ba-8469-1225b846f2b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4462e84e-52ff-4860-a239-0b6904b1ece9_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:to="loc_srt_ProductsAndServicesDomain_4462e84e-52ff-4860-a239-0b6904b1ece9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:to="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_3e361085-b2fa-4e34-93d5-cad8730d68be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:to="loc_us-gaap_ServiceMember_3e361085-b2fa-4e34-93d5-cad8730d68be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareSupplementProductMember_bf588731-58fc-4317-ac69-cfe12a621afa" xlink:href="hum-20221231.xsd#hum_MedicareSupplementProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:to="loc_hum_MedicareSupplementProductMember_bf588731-58fc-4317-ac69-cfe12a621afa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f1a1209-c3ab-47c8-8d30-89eb79d7d155_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f1a1209-c3ab-47c8-8d30-89eb79d7d155_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_59a913ff-09ec-4702-9ded-64c3b61d3336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:to="loc_us-gaap_EquipmentMember_59a913ff-09ec-4702-9ded-64c3b61d3336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e521085-70b1-4f6c-a695-1c5df31a3b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e521085-70b1-4f6c-a695-1c5df31a3b08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_8d6b7475-1ecd-446f-8637-14f7eceae93b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:to="loc_us-gaap_BuildingMember_8d6b7475-1ecd-446f-8637-14f7eceae93b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_cda0b153-fdef-4a2d-83a4-183fe8281f87_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:to="loc_us-gaap_ReportingUnitDomain_cda0b153-fdef-4a2d-83a4-183fe8281f87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:to="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsReportingUnitMember_1cc42ec6-d9b1-4dc6-b019-7aaaaf392313" xlink:href="hum-20221231.xsd#hum_HomeSolutionsReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:to="loc_hum_HomeSolutionsReportingUnitMember_1cc42ec6-d9b1-4dc6-b019-7aaaaf392313" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderReportingUnitMember_5796b3b3-0716-456a-8d43-16a38a3e2927" xlink:href="hum-20221231.xsd#hum_ProviderReportingUnitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:to="loc_hum_ProviderReportingUnitMember_5796b3b3-0716-456a-8d43-16a38a3e2927" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bbbd0a67-e467-41ce-98e4-fbd574e4224e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:to="loc_srt_RangeMember_bbbd0a67-e467-41ce-98e4-fbd574e4224e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:to="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_36b23e49-c22a-4950-bab1-f7a701f2fa97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:to="loc_srt_MinimumMember_36b23e49-c22a-4950-bab1-f7a701f2fa97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_037833ee-8747-442a-b9b1-d1e0840a0899" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:to="loc_srt_MaximumMember_037833ee-8747-442a-b9b1-d1e0840a0899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed42dffa-bda5-4791-b5f7-6ac7382d8b79_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_ed42dffa-bda5-4791-b5f7-6ac7382d8b79_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c0aa3c77-e418-4dd0-8f04-54df28cf3730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c0aa3c77-e418-4dd0-8f04-54df28cf3730" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_1c565c66-c2eb-454b-b2a0-f14f25fe37b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c0aa3c77-e418-4dd0-8f04-54df28cf3730" xlink:to="loc_us-gaap_SalesRevenueNetMember_1c565c66-c2eb-454b-b2a0-f14f25fe37b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_17e8aa46-d621-48d2-bed6-5bdf9252bc3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_17e8aa46-d621-48d2-bed6-5bdf9252bc3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_61270b67-8a4d-4c93-bb7f-8ebb3254a861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_61270b67-8a4d-4c93-bb7f-8ebb3254a861" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_7dd1d854-0eb4-48e9-9397-5885119ac38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_61270b67-8a4d-4c93-bb7f-8ebb3254a861" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_7dd1d854-0eb4-48e9-9397-5885119ac38c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_52a515c3-ae85-4890-b37f-2d6373264134_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:to="loc_us-gaap_RestructuringPlanDomain_52a515c3-ae85-4890-b37f-2d6373264134_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_727433fb-032a-46ee-9d5f-377ba9bdd2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:to="loc_us-gaap_RestructuringPlanDomain_727433fb-032a-46ee-9d5f-377ba9bdd2c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ValueCreationInitiativesMember_0c231722-6b65-49d4-9922-cf7c71bc7e58" xlink:href="hum-20221231.xsd#hum_ValueCreationInitiativesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_727433fb-032a-46ee-9d5f-377ba9bdd2c0" xlink:to="loc_hum_ValueCreationInitiativesMember_0c231722-6b65-49d4-9922-cf7c71bc7e58" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails" xlink:type="extended" id="i8fbfc6731f74475ba5c19aa742fa2513_ACQUISITIONSANDDIVESTITURESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_29571adb-600c-44ce-b8a2-cea626e302fc" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_29571adb-600c-44ce-b8a2-cea626e302fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ce8b9b55-ece8-4c3c-8490-1beb8206e451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ce8b9b55-ece8-4c3c-8490-1beb8206e451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_2e374e7f-e55d-4ab7-ae04-5f0f7638c5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_RepaymentsOfDebt_2e374e7f-e55d-4ab7-ae04-5f0f7638c5b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_71d9cb91-34e6-4410-ad57-ab5092338ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_71d9cb91-34e6-4410-ad57-ab5092338ddd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_a063ef94-076c-4e80-b953-2015e386d86f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_a063ef94-076c-4e80-b953-2015e386d86f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_86323b79-4ddc-4fe6-a88f-f1d95048e09e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_86323b79-4ddc-4fe6-a88f-f1d95048e09e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_4ec1eb20-2263-4c79-8cb4-7b9d9070a970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_4ec1eb20-2263-4c79-8cb4-7b9d9070a970" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage_54c6b530-99d3-4d1e-8d87-ede103a3ae13" xlink:href="hum-20221231.xsd#hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage_54c6b530-99d3-4d1e-8d87-ede103a3ae13" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree_f9a3ada0-eac8-4f12-9c96-56c222c927b6" xlink:href="hum-20221231.xsd#hum_BusinessCombinationTotalEnterpriseValueOfAcquiree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree_f9a3ada0-eac8-4f12-9c96-56c222c927b6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_e93bd5cd-27ca-4a92-aa0c-680ef7f18dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_e93bd5cd-27ca-4a92-aa0c-680ef7f18dc6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_30169009-9d61-453a-b38a-0c380a8024ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_30169009-9d61-453a-b38a-0c380a8024ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_c7a39601-bf0b-4843-9356-ec9c8a6ec374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_EquityMethodInvestments_c7a39601-bf0b-4843-9356-ec9c8a6ec374" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_506f5a0b-3d93-4de8-a009-b48eaa842952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_506f5a0b-3d93-4de8-a009-b48eaa842952" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_658fd29e-df23-48a1-b5c0-f9a6763e3680" xlink:href="hum-20221231.xsd#hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_658fd29e-df23-48a1-b5c0-f9a6763e3680" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5f9ceba4-fb38-40c0-899e-92f2a07ef719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5f9ceba4-fb38-40c0-899e-92f2a07ef719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5f9ceba4-fb38-40c0-899e-92f2a07ef719_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5f9ceba4-fb38-40c0-899e-92f2a07ef719" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5f9ceba4-fb38-40c0-899e-92f2a07ef719_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5899aae3-5898-4f5f-900d-3c4a8fb9621a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5f9ceba4-fb38-40c0-899e-92f2a07ef719" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5899aae3-5898-4f5f-900d-3c4a8fb9621a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2caa754d-936e-46e8-9216-d6bf1f9236e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5899aae3-5898-4f5f-900d-3c4a8fb9621a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2caa754d-936e-46e8-9216-d6bf1f9236e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8840808e-02d1-4869-ae24-9193e6f389cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8840808e-02d1-4869-ae24-9193e6f389cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8840808e-02d1-4869-ae24-9193e6f389cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8840808e-02d1-4869-ae24-9193e6f389cc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8840808e-02d1-4869-ae24-9193e6f389cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f9d31b9-43f2-4956-beca-e838c8ba7c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8840808e-02d1-4869-ae24-9193e6f389cc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f9d31b9-43f2-4956-beca-e838c8ba7c8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_013dbc29-a679-4b43-a218-ca1416565850" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f9d31b9-43f2-4956-beca-e838c8ba7c8a" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_013dbc29-a679-4b43-a218-ca1416565850" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_118d3b0e-1604-4867-b7ed-f8780ebaa92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_118d3b0e-1604-4867-b7ed-f8780ebaa92c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_118d3b0e-1604-4867-b7ed-f8780ebaa92c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_118d3b0e-1604-4867-b7ed-f8780ebaa92c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_118d3b0e-1604-4867-b7ed-f8780ebaa92c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d20d2a60-577d-4b07-bc41-19c347680a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_118d3b0e-1604-4867-b7ed-f8780ebaa92c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d20d2a60-577d-4b07-bc41-19c347680a73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_095a6c9a-75c6-4b21-b798-d9788f3ba915" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d20d2a60-577d-4b07-bc41-19c347680a73" xlink:to="loc_hum_KindredAtHomeMember_095a6c9a-75c6-4b21-b798-d9788f3ba915" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6946d361-9a83-46dc-9b9d-5a9efa933323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_DebtInstrumentAxis_6946d361-9a83-46dc-9b9d-5a9efa933323" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_6946d361-9a83-46dc-9b9d-5a9efa933323_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_6946d361-9a83-46dc-9b9d-5a9efa933323" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_6946d361-9a83-46dc-9b9d-5a9efa933323_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc3a687b-1457-4f80-b2ab-68a5399cf832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_6946d361-9a83-46dc-9b9d-5a9efa933323" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc3a687b-1457-4f80-b2ab-68a5399cf832" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanDueOctober2023Member_f373aeff-05fd-4e7f-ae90-7b76f6e02b75" xlink:href="hum-20221231.xsd#hum_TermLoanDueOctober2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc3a687b-1457-4f80-b2ab-68a5399cf832" xlink:to="loc_hum_TermLoanDueOctober2023Member_f373aeff-05fd-4e7f-ae90-7b76f6e02b75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d826c109-27dc-4aa2-af58-f71a0ebc2261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d826c109-27dc-4aa2-af58-f71a0ebc2261" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d826c109-27dc-4aa2-af58-f71a0ebc2261_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d826c109-27dc-4aa2-af58-f71a0ebc2261" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d826c109-27dc-4aa2-af58-f71a0ebc2261_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9008f5ba-d653-412d-9fb7-e8e8674fbd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d826c109-27dc-4aa2-af58-f71a0ebc2261" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9008f5ba-d653-412d-9fb7-e8e8674fbd15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_057e5dcd-7c35-44f8-8eb8-9171dd504d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9008f5ba-d653-412d-9fb7-e8e8674fbd15" xlink:to="loc_us-gaap_LoansPayableMember_057e5dcd-7c35-44f8-8eb8-9171dd504d77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f5a305c-dbe3-42f9-aa92-14f35a623cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f5a305c-dbe3-42f9-aa92-14f35a623cae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f5a305c-dbe3-42f9-aa92-14f35a623cae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f5a305c-dbe3-42f9-aa92-14f35a623cae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f5a305c-dbe3-42f9-aa92-14f35a623cae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_45587db9-94a1-430a-a981-4151c6e35679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f5a305c-dbe3-42f9-aa92-14f35a623cae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_45587db9-94a1-430a-a981-4151c6e35679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareLicensesAndCertificatesOfNeedMember_8697ebf2-069a-4263-b659-f0c42af187dd" xlink:href="hum-20221231.xsd#hum_MedicareLicensesAndCertificatesOfNeedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_45587db9-94a1-430a-a981-4151c6e35679" xlink:to="loc_hum_MedicareLicensesAndCertificatesOfNeedMember_8697ebf2-069a-4263-b659-f0c42af187dd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails" xlink:type="extended" id="i6abada3185484447a6a5f0d72f51d44b_ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_113ad605-7c5b-4d92-a502-6b7a14ee66f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_113ad605-7c5b-4d92-a502-6b7a14ee66f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_08bf4969-42ae-42ca-be55-5d06497bded5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_08bf4969-42ae-42ca-be55-5d06497bded5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_54780005-b7d5-4d28-8dba-586dccefc17c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_54780005-b7d5-4d28-8dba-586dccefc17c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_cdc80189-112f-4899-a696-a58073bd9713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_cdc80189-112f-4899-a696-a58073bd9713" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_a0d5f5a8-2a6f-4819-bb04-bdac286a1bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_a0d5f5a8-2a6f-4819-bb04-bdac286a1bd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_cc53f92b-6070-468a-bc63-15b8e51e373c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_cc53f92b-6070-468a-bc63-15b8e51e373c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_01482c44-fb2e-481a-9e45-c21ea72a8883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_01482c44-fb2e-481a-9e45-c21ea72a8883" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_0273ffd2-93c1-4a38-9f4c-bffff85528a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_0273ffd2-93c1-4a38-9f4c-bffff85528a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_dc8886da-4c69-4b86-9730-636bcfb77506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_dc8886da-4c69-4b86-9730-636bcfb77506" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_53319f74-6a63-42f6-a1b8-d2dab4a1a1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_53319f74-6a63-42f6-a1b8-d2dab4a1a1cb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_03aff303-9b61-49da-af75-ab4a4d01c791" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_03aff303-9b61-49da-af75-ab4a4d01c791" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66e75839-84ac-478b-bcf9-a79b256c37c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66e75839-84ac-478b-bcf9-a79b256c37c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_60aa0a61-015c-4388-918a-3989849ab1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66e75839-84ac-478b-bcf9-a79b256c37c1" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_60aa0a61-015c-4388-918a-3989849ab1af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_60aa0a61-015c-4388-918a-3989849ab1af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_60aa0a61-015c-4388-918a-3989849ab1af" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_60aa0a61-015c-4388-918a-3989849ab1af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e2983602-505b-4134-bd0a-d170870f7a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_60aa0a61-015c-4388-918a-3989849ab1af" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e2983602-505b-4134-bd0a-d170870f7a18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8233f2ab-fe27-4cf0-927d-ae3cf0649b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e2983602-505b-4134-bd0a-d170870f7a18" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8233f2ab-fe27-4cf0-927d-ae3cf0649b17" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b39f5208-8732-4c01-89bd-07a6da6e7400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66e75839-84ac-478b-bcf9-a79b256c37c1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b39f5208-8732-4c01-89bd-07a6da6e7400" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b39f5208-8732-4c01-89bd-07a6da6e7400_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b39f5208-8732-4c01-89bd-07a6da6e7400" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b39f5208-8732-4c01-89bd-07a6da6e7400_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7fd2174b-5f13-45ed-a49e-7171c855e634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b39f5208-8732-4c01-89bd-07a6da6e7400" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7fd2174b-5f13-45ed-a49e-7171c855e634" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_b3ea70a0-49e5-4f3f-97d1-cc15d78ff92f" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7fd2174b-5f13-45ed-a49e-7171c855e634" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_b3ea70a0-49e5-4f3f-97d1-cc15d78ff92f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails" xlink:type="extended" id="i7e0559f39e8847749db2d064b542a4f7_ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_02862329-00b6-4cee-bb3f-ead9adc6238c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_02862329-00b6-4cee-bb3f-ead9adc6238c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ad66cf46-a9ca-4c56-a540-f10cef1b9c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ad66cf46-a9ca-4c56-a540-f10cef1b9c0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_1abc8ce4-9d54-4911-8a20-6495f41ca9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_1abc8ce4-9d54-4911-8a20-6495f41ca9e3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2483d1db-238a-4db0-84e2-5a043858ff87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2483d1db-238a-4db0-84e2-5a043858ff87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_60e7354b-ac8b-4b4b-8457-0949d8f74880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_Goodwill_60e7354b-ac8b-4b4b-8457-0949d8f74880" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d32071bd-3da9-4314-98fe-cfcb6ddd4506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d32071bd-3da9-4314-98fe-cfcb6ddd4506" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bba104ba-9567-495c-8319-18bfae5fc174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bba104ba-9567-495c-8319-18bfae5fc174" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_0a1fec92-548f-4117-b25e-4f8b41d27ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_0a1fec92-548f-4117-b25e-4f8b41d27ff3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0617b97c-97b7-4505-beca-776198dbae4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0617b97c-97b7-4505-beca-776198dbae4d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_744fc90e-afdf-48f6-808b-67dbe3249929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_744fc90e-afdf-48f6-808b-67dbe3249929" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_17d57622-24e5-4db0-a8be-2bf8382e4b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_17d57622-24e5-4db0-a8be-2bf8382e4b6e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b3dd9fd4-5451-4ef3-9289-9690b15d85e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b3dd9fd4-5451-4ef3-9289-9690b15d85e2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_a5f6fa68-e110-4125-bb8c-e768f208d637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_a5f6fa68-e110-4125-bb8c-e768f208d637" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_d5eab0e6-bd02-4806-8f95-827f50455ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_d5eab0e6-bd02-4806-8f95-827f50455ba8" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fd23d7d-3729-4d6e-9240-e61b4c66600a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fd23d7d-3729-4d6e-9240-e61b4c66600a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5a65cb68-514d-45ce-9527-0afeb1f97401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fd23d7d-3729-4d6e-9240-e61b4c66600a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5a65cb68-514d-45ce-9527-0afeb1f97401" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a65cb68-514d-45ce-9527-0afeb1f97401_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5a65cb68-514d-45ce-9527-0afeb1f97401" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5a65cb68-514d-45ce-9527-0afeb1f97401_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c374fa01-eebf-4111-8952-57a828fa501d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5a65cb68-514d-45ce-9527-0afeb1f97401" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c374fa01-eebf-4111-8952-57a828fa501d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_60bbddd0-b4eb-46d9-a232-8db2bd7a238a" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c374fa01-eebf-4111-8952-57a828fa501d" xlink:to="loc_hum_KindredAtHomeMember_60bbddd0-b4eb-46d9-a232-8db2bd7a238a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EQUITYMETHODINVESTMENTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails" xlink:type="extended" id="ie7c01652b8f84f738573867ef19e1b39_EQUITYMETHODINVESTMENTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_39e1897f-138e-44f0-901b-893c4af9569a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_39e1897f-138e-44f0-901b-893c4af9569a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_5f9a74c7-7765-41e9-99d6-72933d55396e" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_5f9a74c7-7765-41e9-99d6-72933d55396e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters_2aa981f5-99c4-42a4-9fcd-10e445cfd164" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters_2aa981f5-99c4-42a4-9fcd-10e445cfd164" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened_b14f899c-1f2b-4f75-a92e-c4cba53a619d" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened_b14f899c-1f2b-4f75-a92e-c4cba53a619d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum_8e23482b-9b7a-4946-91b6-0ee12026ee99" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum_8e23482b-9b7a-4946-91b6-0ee12026ee99" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum_0dac08e4-28b5-4278-a76e-04c07492be41" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum_0dac08e4-28b5-4278-a76e-04c07492be41" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d884a459-4a84-4e49-bc75-4510335216da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d884a459-4a84-4e49-bc75-4510335216da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_d884a459-4a84-4e49-bc75-4510335216da_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d884a459-4a84-4e49-bc75-4510335216da" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_d884a459-4a84-4e49-bc75-4510335216da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7f2032b9-ce41-46af-a09f-86a50fb50198" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d884a459-4a84-4e49-bc75-4510335216da" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7f2032b9-ce41-46af-a09f-86a50fb50198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_b5ce3315-9f34-4593-8ca3-9c9f62c94166" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7f2032b9-ce41-46af-a09f-86a50fb50198" xlink:to="loc_hum_KindredAtHomeMember_b5ce3315-9f34-4593-8ca3-9c9f62c94166" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_36f88b59-cb97-4d0a-94c9-fa8536f2389a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:to="loc_srt_CounterpartyNameAxis_36f88b59-cb97-4d0a-94c9-fa8536f2389a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_36f88b59-cb97-4d0a-94c9-fa8536f2389a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_36f88b59-cb97-4d0a-94c9-fa8536f2389a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_36f88b59-cb97-4d0a-94c9-fa8536f2389a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7a8b8a30-9de5-4e09-91f3-df37ae3a5874" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_36f88b59-cb97-4d0a-94c9-fa8536f2389a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7a8b8a30-9de5-4e09-91f3-df37ae3a5874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_WelshCarsonAndersonAndStoweMember_9ef3378e-5549-4eed-93cc-ffaca84373ff" xlink:href="hum-20221231.xsd#hum_WelshCarsonAndersonAndStoweMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7a8b8a30-9de5-4e09-91f3-df37ae3a5874" xlink:to="loc_hum_WelshCarsonAndersonAndStoweMember_9ef3378e-5549-4eed-93cc-ffaca84373ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b227e77f-decf-4856-8468-41daf983a158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b227e77f-decf-4856-8468-41daf983a158" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b227e77f-decf-4856-8468-41daf983a158_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b227e77f-decf-4856-8468-41daf983a158" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b227e77f-decf-4856-8468-41daf983a158_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_810211e7-aaf7-43d6-b7fb-44b431089928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b227e77f-decf-4856-8468-41daf983a158" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_810211e7-aaf7-43d6-b7fb-44b431089928" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_77d2b697-4536-460b-9817-2fb3486062bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_810211e7-aaf7-43d6-b7fb-44b431089928" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_77d2b697-4536-460b-9817-2fb3486062bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_585c2a70-400d-4a55-b50f-f0e3db7e683c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_585c2a70-400d-4a55-b50f-f0e3db7e683c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_585c2a70-400d-4a55-b50f-f0e3db7e683c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_585c2a70-400d-4a55-b50f-f0e3db7e683c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_585c2a70-400d-4a55-b50f-f0e3db7e683c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_be08c0f5-cdd3-4f72-8d7d-78ef4fff254c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_585c2a70-400d-4a55-b50f-f0e3db7e683c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_be08c0f5-cdd3-4f72-8d7d-78ef4fff254c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_54c0d207-1407-4685-b2a4-08ba03d2b525" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_be08c0f5-cdd3-4f72-8d7d-78ef4fff254c" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_54c0d207-1407-4685-b2a4-08ba03d2b525" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails" xlink:type="extended" id="ibb790197071f45bfa2f96a32fd8228be_EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7fd07357-50b2-4919-9950-1b5a89751243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7fd07357-50b2-4919-9950-1b5a89751243" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_88195495-f8f9-4836-b778-ec525349d427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_AssetsCurrent_88195495-f8f9-4836-b778-ec525349d427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_3957e1a8-a4d2-4278-8a4a-21c3c288ed2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_AssetsNoncurrent_3957e1a8-a4d2-4278-8a4a-21c3c288ed2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ed32f9d3-be5e-46df-bfb7-6bb775c44ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_LiabilitiesCurrent_ed32f9d3-be5e-46df-bfb7-6bb775c44ff9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_9307a5ec-bd6f-4efd-b4ca-512615acfa8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_9307a5ec-bd6f-4efd-b4ca-512615acfa8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6cbc9cf1-6dc0-4f5b-9872-a2f21d6b4ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_StockholdersEquity_6cbc9cf1-6dc0-4f5b-9872-a2f21d6b4ad1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementRelatedDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7fd07357-50b2-4919-9950-1b5a89751243" xlink:to="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_973acd62-2ff9-4089-b3fd-9cea457ea1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:to="loc_us-gaap_Revenues_973acd62-2ff9-4089-b3fd-9cea457ea1bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_Expenses_ddeac072-e8e8-4c91-9ee3-20b7004c77f9" xlink:href="hum-20221231.xsd#hum_Expenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:to="loc_hum_Expenses_ddeac072-e8e8-4c91-9ee3-20b7004c77f9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c1713ba7-ea88-45e3-b37e-9ac8637cca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:to="loc_us-gaap_NetIncomeLoss_c1713ba7-ea88-45e3-b37e-9ac8637cca9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_099b821a-6df4-4bfb-a1a6-a1dde2c03838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7fd07357-50b2-4919-9950-1b5a89751243" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_099b821a-6df4-4bfb-a1a6-a1dde2c03838" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f58ae83e-f559-4cd0-926e-64d58c5dd382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_099b821a-6df4-4bfb-a1a6-a1dde2c03838" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f58ae83e-f559-4cd0-926e-64d58c5dd382" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_f58ae83e-f559-4cd0-926e-64d58c5dd382_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f58ae83e-f559-4cd0-926e-64d58c5dd382" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_f58ae83e-f559-4cd0-926e-64d58c5dd382_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_a68012e2-dfa5-4722-b196-0933919b6033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f58ae83e-f559-4cd0-926e-64d58c5dd382" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_a68012e2-dfa5-4722-b196-0933919b6033" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_b12168ad-6ecd-4434-bc10-4827148bb015" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_a68012e2-dfa5-4722-b196-0933919b6033" xlink:to="loc_hum_KindredAtHomeMember_b12168ad-6ecd-4434-bc10-4827148bb015" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails" xlink:type="extended" id="i172cb65b473649009eb557806535d382_INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a5c7c12-70a5-4d9a-b160-dc0ca9bd6a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a5c7c12-70a5-4d9a-b160-dc0ca9bd6a1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e223f7b5-e7c2-457a-a66c-160619dd3023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e223f7b5-e7c2-457a-a66c-160619dd3023" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c5806edc-fdc8-4abf-a38d-330c96ec949f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c5806edc-fdc8-4abf-a38d-330c96ec949f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0371683a-79cb-4d06-bc1d-0341dcc1208a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0371683a-79cb-4d06-bc1d-0341dcc1208a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_f1cd38b6-66a6-4630-9eff-a8dc3f78dac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_f1cd38b6-66a6-4630-9eff-a8dc3f78dac6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4f9e85f6-63a7-4ec3-bae6-7ef18198cded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:to="loc_us-gaap_Investments_4f9e85f6-63a7-4ec3-bae6-7ef18198cded" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bcd0f79-d577-47e7-ae11-063056bfa111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bcd0f79-d577-47e7-ae11-063056bfa111" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4ed638a5-e0c4-43db-bc64-a34d469cc179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bcd0f79-d577-47e7-ae11-063056bfa111" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4ed638a5-e0c4-43db-bc64-a34d469cc179" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ed638a5-e0c4-43db-bc64-a34d469cc179_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4ed638a5-e0c4-43db-bc64-a34d469cc179" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4ed638a5-e0c4-43db-bc64-a34d469cc179_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4ed638a5-e0c4-43db-bc64-a34d469cc179" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_63a894e4-45af-44c1-8c34-651ddbb50ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_63a894e4-45af-44c1-8c34-651ddbb50ebf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_84bf08bf-623a-4c88-a0f1-06abcd935cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_84bf08bf-623a-4c88-a0f1-06abcd935cf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_ee89b4e2-0d47-418e-aa19-63cd9080b2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_ee89b4e2-0d47-418e-aa19-63cd9080b2fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_8cee230d-3946-4db3-9677-626255dc2ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_8cee230d-3946-4db3-9677-626255dc2ba6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d07cf4b9-5da5-477c-bcbf-88484d608da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d07cf4b9-5da5-477c-bcbf-88484d608da5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_fb5d975c-56ab-410e-88f6-dd5c3b6a35c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_fb5d975c-56ab-410e-88f6-dd5c3b6a35c2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bdf9738c-f653-46b2-a658-b1492135be7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bdf9738c-f653-46b2-a658-b1492135be7b" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="extended" id="i4900e3f5365447b3b387f088b456cd38_INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_6b2293a3-f877-49b7-b1cf-9743d97d69cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_6b2293a3-f877-49b7-b1cf-9743d97d69cd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_612d48c3-b606-45cd-96a5-93011303a8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_612d48c3-b606-45cd-96a5-93011303a8d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_06962852-138b-4ea0-8227-031d4095493d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_06962852-138b-4ea0-8227-031d4095493d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c47fbb5b-f812-465e-845b-fb751618397e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c47fbb5b-f812-465e-845b-fb751618397e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_6b2293a3-f877-49b7-b1cf-9743d97d69cd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_2636e1cb-4bc4-4e35-bfaa-3580e5a72b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_2636e1cb-4bc4-4e35-bfaa-3580e5a72b96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_abf198e8-aa7e-468e-b363-7d13d728b3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_abf198e8-aa7e-468e-b363-7d13d728b3aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_59882d57-8dc7-4040-a5e6-e775d9417d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_59882d57-8dc7-4040-a5e6-e775d9417d2d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_b14ccf05-493f-47aa-8209-d708e3e58ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_6b2293a3-f877-49b7-b1cf-9743d97d69cd" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_b14ccf05-493f-47aa-8209-d708e3e58ae3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1d091bbe-02c8-4855-9dd6-41422938a16b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_b14ccf05-493f-47aa-8209-d708e3e58ae3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1d091bbe-02c8-4855-9dd6-41422938a16b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1d091bbe-02c8-4855-9dd6-41422938a16b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1d091bbe-02c8-4855-9dd6-41422938a16b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1d091bbe-02c8-4855-9dd6-41422938a16b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1d091bbe-02c8-4855-9dd6-41422938a16b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_7de46032-d82e-4805-8d68-652b395e4d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_7de46032-d82e-4805-8d68-652b395e4d7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_aea5f379-08f9-4910-b234-5a714e4294cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_aea5f379-08f9-4910-b234-5a714e4294cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_790753cf-7ca5-47ed-9b4a-982c0aa505e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_790753cf-7ca5-47ed-9b4a-982c0aa505e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6754ee48-1d0b-4235-ad1c-16203e251ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6754ee48-1d0b-4235-ad1c-16203e251ef9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_9e032664-2b1e-4ecf-a840-69cf7f147ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_9e032664-2b1e-4ecf-a840-69cf7f147ff9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f19de214-1cb9-42fb-a2af-ceae0285faf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f19de214-1cb9-42fb-a2af-ceae0285faf4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dfc111e2-b8bd-43a5-a58a-135a614d83ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dfc111e2-b8bd-43a5-a58a-135a614d83ca" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails" xlink:type="extended" id="i7aa47200f2744d089503a2a7e0284d91_INVESTMENTSECURITIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c0fe64f1-211a-486a-ab19-689564dc12e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c0fe64f1-211a-486a-ab19-689564dc12e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34af7ac9-3789-4e38-be07-996ab4b4c8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34af7ac9-3789-4e38-be07-996ab4b4c8a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_ca316ad9-7ca5-4ab6-887c-3878c4ddea3a" xlink:href="hum-20221231.xsd#hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_ca316ad9-7ca5-4ab6-887c-3878c4ddea3a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_8488585f-6455-4262-b744-37044d63bc5c" xlink:href="hum-20221231.xsd#hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_8488585f-6455-4262-b744-37044d63bc5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0a44c785-3b0b-4c7a-b465-13401b5ab898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0a44c785-3b0b-4c7a-b465-13401b5ab898" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_c9cc4f3f-7a9a-48b9-a58a-e8aea0a0269f" xlink:href="hum-20221231.xsd#hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_c9cc4f3f-7a9a-48b9-a58a-e8aea0a0269f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c75473dd-d50c-493f-bc42-d4d206cc8eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c75473dd-d50c-493f-bc42-d4d206cc8eb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_c75473dd-d50c-493f-bc42-d4d206cc8eb1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c75473dd-d50c-493f-bc42-d4d206cc8eb1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_c75473dd-d50c-493f-bc42-d4d206cc8eb1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a77ff797-f9bf-48cf-a83b-de175a1968a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c75473dd-d50c-493f-bc42-d4d206cc8eb1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a77ff797-f9bf-48cf-a83b-de175a1968a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_79073f0f-1488-43ad-9213-6bd7d1a67427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a77ff797-f9bf-48cf-a83b-de175a1968a4" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_79073f0f-1488-43ad-9213-6bd7d1a67427" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c1ba868c-c944-445f-acb2-d3484b779940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c1ba868c-c944-445f-acb2-d3484b779940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1ba868c-c944-445f-acb2-d3484b779940_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c1ba868c-c944-445f-acb2-d3484b779940" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c1ba868c-c944-445f-acb2-d3484b779940_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_99810810-0996-4b05-b4ac-dbf2a0c01f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c1ba868c-c944-445f-acb2-d3484b779940" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_99810810-0996-4b05-b4ac-dbf2a0c01f9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_214c0a65-a778-428e-b381-07db65cf265c" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_99810810-0996-4b05-b4ac-dbf2a0c01f9a" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_214c0a65-a778-428e-b381-07db65cf265c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis_add3cdf8-e8cd-4cb7-8ac6-ab67019813ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:to="loc_srt_CreditRatingStandardPoorsAxis_add3cdf8-e8cd-4cb7-8ac6-ab67019813ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_add3cdf8-e8cd-4cb7-8ac6-ab67019813ff_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_add3cdf8-e8cd-4cb7-8ac6-ab67019813ff" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_add3cdf8-e8cd-4cb7-8ac6-ab67019813ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_210f90ee-acde-4b27-804d-5e0b85d01c56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_add3cdf8-e8cd-4cb7-8ac6-ab67019813ff" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_210f90ee-acde-4b27-804d-5e0b85d01c56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAAMinusRatingMember_d6636f7b-ffcf-4658-a738-5502b7447e1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAAMinusRatingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_210f90ee-acde-4b27-804d-5e0b85d01c56" xlink:to="loc_srt_StandardPoorsAAMinusRatingMember_d6636f7b-ffcf-4658-a738-5502b7447e1d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="extended" id="i4a716ea939634b9287aa7da03f91e856_FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e5342848-e5fc-4fcb-b14b-19b32fd747a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e5342848-e5fc-4fcb-b14b-19b32fd747a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6fd2608b-0e70-4d73-8888-38e66163137a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6fd2608b-0e70-4d73-8888-38e66163137a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ad5ed97d-3196-4e30-b9fd-acb9733bfe5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ad5ed97d-3196-4e30-b9fd-acb9733bfe5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f43f268e-49bf-4e63-b435-bd49e084f4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_f43f268e-49bf-4e63-b435-bd49e084f4d6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f0fadd38-91af-41b2-b684-71c4c0a13c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f0fadd38-91af-41b2-b684-71c4c0a13c06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f0fadd38-91af-41b2-b684-71c4c0a13c06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f0fadd38-91af-41b2-b684-71c4c0a13c06" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f0fadd38-91af-41b2-b684-71c4c0a13c06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb0730ea-687b-451a-8036-afeed9fa28c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f0fadd38-91af-41b2-b684-71c4c0a13c06" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb0730ea-687b-451a-8036-afeed9fa28c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a6288ed7-a5b3-4a41-8e4c-bc8d667c8822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb0730ea-687b-451a-8036-afeed9fa28c5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a6288ed7-a5b3-4a41-8e4c-bc8d667c8822" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ff5dec6-2d67-48e2-bdc4-9f5e0e2a306a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ff5dec6-2d67-48e2-bdc4-9f5e0e2a306a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ff5dec6-2d67-48e2-bdc4-9f5e0e2a306a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ff5dec6-2d67-48e2-bdc4-9f5e0e2a306a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_5ff5dec6-2d67-48e2-bdc4-9f5e0e2a306a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ff5dec6-2d67-48e2-bdc4-9f5e0e2a306a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b0965982-902d-44ff-beb8-377bab3b5d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b0965982-902d-44ff-beb8-377bab3b5d30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_00f0203a-3837-4332-ad34-55dcad28bd23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_00f0203a-3837-4332-ad34-55dcad28bd23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4387b52b-fdfc-4b11-a5bd-b9f439738cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4387b52b-fdfc-4b11-a5bd-b9f439738cb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7811d9c8-ded4-48ff-9011-72a737b5b2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7811d9c8-ded4-48ff-9011-72a737b5b2ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7811d9c8-ded4-48ff-9011-72a737b5b2ed_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7811d9c8-ded4-48ff-9011-72a737b5b2ed" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7811d9c8-ded4-48ff-9011-72a737b5b2ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7811d9c8-ded4-48ff-9011-72a737b5b2ed" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_28b78a79-d470-4d48-a416-ceb2d483c73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_28b78a79-d470-4d48-a416-ceb2d483c73b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_e49e3032-6405-4649-b74a-ad1ecd57b16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_e49e3032-6405-4649-b74a-ad1ecd57b16c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_5436e1de-9bb6-48aa-98dc-7bf77c36c542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_5436e1de-9bb6-48aa-98dc-7bf77c36c542" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_fbf338ed-bca6-416d-a725-aea880ce967a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_fbf338ed-bca6-416d-a725-aea880ce967a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_4455857f-a30a-4714-951f-5a7fb5315268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_4455857f-a30a-4714-951f-5a7fb5315268" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_747103cf-d15e-4acf-8857-814afbf2e808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_747103cf-d15e-4acf-8857-814afbf2e808" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_cb8ccb57-6a07-433c-8ef6-ba530fb7cf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_cb8ccb57-6a07-433c-8ef6-ba530fb7cf42" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUENarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/FAIRVALUENarrativeDetails" xlink:type="extended" id="i0b9dd92d01eb4cc69be0355551d754a0_FAIRVALUENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_cb9d33b0-315e-456b-a614-8b4db716e1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_cb9d33b0-315e-456b-a614-8b4db716e1b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_6d714bd4-26f5-4035-93ab-1ca94a00b139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_6d714bd4-26f5-4035-93ab-1ca94a00b139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_878fb76e-f2b7-4618-a7be-c30be3398b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_878fb76e-f2b7-4618-a7be-c30be3398b57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f2c1c50c-7a04-48cb-a033-cf3179c4f0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_ShortTermBorrowings_f2c1c50c-7a04-48cb-a033-cf3179c4f0ca" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage_08cf4d08-59ba-421b-8451-f207ffe896d2" xlink:href="hum-20221231.xsd#hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage_08cf4d08-59ba-421b-8451-f207ffe896d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_ce04d943-8f57-4af5-aa0e-2363d50274b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_ce04d943-8f57-4af5-aa0e-2363d50274b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FinancialAssetsFairValueDisclosure_c40e2fcf-0a60-42ea-b659-30006342b65f" xlink:href="hum-20221231.xsd#hum_FinancialAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_hum_FinancialAssetsFairValueDisclosure_c40e2fcf-0a60-42ea-b659-30006342b65f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LossOnTerminationOfDerivatives_e9523f09-843f-4790-873e-318a6bd04cca" xlink:href="hum-20221231.xsd#hum_LossOnTerminationOfDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_hum_LossOnTerminationOfDerivatives_e9523f09-843f-4790-873e-318a6bd04cca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_20281894-4044-4098-970f-0d13468826a3" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_20281894-4044-4098-970f-0d13468826a3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1d356023-8910-4319-af06-e0c79837ec2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1d356023-8910-4319-af06-e0c79837ec2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d356023-8910-4319-af06-e0c79837ec2e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1d356023-8910-4319-af06-e0c79837ec2e" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_1d356023-8910-4319-af06-e0c79837ec2e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e07877d5-8eb5-486a-9133-b59277c7d4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1d356023-8910-4319-af06-e0c79837ec2e" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e07877d5-8eb5-486a-9133-b59277c7d4c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363d60b0-953c-4ede-8923-09e4ba242095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e07877d5-8eb5-486a-9133-b59277c7d4c7" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363d60b0-953c-4ede-8923-09e4ba242095" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_38d9d7d6-7a85-4e71-9cd6-7e7fbbd37cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363d60b0-953c-4ede-8923-09e4ba242095" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_38d9d7d6-7a85-4e71-9cd6-7e7fbbd37cd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7a49d5ce-5c9f-4b7a-b751-0df6475c0cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363d60b0-953c-4ede-8923-09e4ba242095" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7a49d5ce-5c9f-4b7a-b751-0df6475c0cb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_21a431dc-e9c1-4b6d-af21-b90affd50b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_21a431dc-e9c1-4b6d-af21-b90affd50b16" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_21a431dc-e9c1-4b6d-af21-b90affd50b16_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_21a431dc-e9c1-4b6d-af21-b90affd50b16" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_21a431dc-e9c1-4b6d-af21-b90affd50b16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3997545a-10c4-40ef-94a5-bf4e58e0647b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_21a431dc-e9c1-4b6d-af21-b90affd50b16" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3997545a-10c4-40ef-94a5-bf4e58e0647b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanAndCommercialPaperMember_c99b3834-1998-44b6-876f-18c0fee7dbab" xlink:href="hum-20221231.xsd#hum_TermLoanAndCommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_3997545a-10c4-40ef-94a5-bf4e58e0647b" xlink:to="loc_hum_TermLoanAndCommercialPaperMember_c99b3834-1998-44b6-876f-18c0fee7dbab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_87ec1799-4d1c-48c3-8b35-6d73ca5fbcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_87ec1799-4d1c-48c3-8b35-6d73ca5fbcdf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87ec1799-4d1c-48c3-8b35-6d73ca5fbcdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_87ec1799-4d1c-48c3-8b35-6d73ca5fbcdf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_87ec1799-4d1c-48c3-8b35-6d73ca5fbcdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811fbb6d-cc72-4f0b-acca-23eec07c3875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_87ec1799-4d1c-48c3-8b35-6d73ca5fbcdf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811fbb6d-cc72-4f0b-acca-23eec07c3875" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_8b79f007-f0cd-4844-85ac-62636d1a7c3f" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811fbb6d-cc72-4f0b-acca-23eec07c3875" xlink:to="loc_hum_KindredAtHomeMember_8b79f007-f0cd-4844-85ac-62636d1a7c3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2fdfa97c-2450-436a-98fe-cad8c4aa3508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2fdfa97c-2450-436a-98fe-cad8c4aa3508" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_2fdfa97c-2450-436a-98fe-cad8c4aa3508_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2fdfa97c-2450-436a-98fe-cad8c4aa3508" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_2fdfa97c-2450-436a-98fe-cad8c4aa3508_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c630bf21-33ef-4c4b-928b-6203a656e06b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2fdfa97c-2450-436a-98fe-cad8c4aa3508" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c630bf21-33ef-4c4b-928b-6203a656e06b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_98ac9fb4-5fc2-4b2c-9197-f58e5a98df26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c630bf21-33ef-4c4b-928b-6203a656e06b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_98ac9fb4-5fc2-4b2c-9197-f58e5a98df26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_3afd7de1-95c2-4a99-ac92-b8c2a5b84a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c630bf21-33ef-4c4b-928b-6203a656e06b" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_3afd7de1-95c2-4a99-ac92-b8c2a5b84a65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_12440b8e-dbf9-47d8-b8f6-2e790349e4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_12440b8e-dbf9-47d8-b8f6-2e790349e4e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_12440b8e-dbf9-47d8-b8f6-2e790349e4e1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_12440b8e-dbf9-47d8-b8f6-2e790349e4e1" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_12440b8e-dbf9-47d8-b8f6-2e790349e4e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_261b88f5-3e0d-4b1b-993b-6c287918bd84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_12440b8e-dbf9-47d8-b8f6-2e790349e4e1" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_261b88f5-3e0d-4b1b-993b-6c287918bd84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_1bee5eab-da5f-4d2d-836c-86ede7470da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PutOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_261b88f5-3e0d-4b1b-993b-6c287918bd84" xlink:to="loc_us-gaap_PutOptionMember_1bee5eab-da5f-4d2d-836c-86ede7470da9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_223524a5-3a95-437e-836f-90967e4d7867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_261b88f5-3e0d-4b1b-993b-6c287918bd84" xlink:to="loc_us-gaap_CallOptionMember_223524a5-3a95-437e-836f-90967e4d7867" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_3df5fe4e-bbca-4316-91ed-21e9361ca052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_3df5fe4e-bbca-4316-91ed-21e9361ca052" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3df5fe4e-bbca-4316-91ed-21e9361ca052_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3df5fe4e-bbca-4316-91ed-21e9361ca052" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3df5fe4e-bbca-4316-91ed-21e9361ca052_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6766fff2-c278-4161-9bd3-c767e7cdc234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3df5fe4e-bbca-4316-91ed-21e9361ca052" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6766fff2-c278-4161-9bd3-c767e7cdc234" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueRiskMember_37aa23a5-d70d-41a1-acf7-0374f252bbfd" xlink:href="hum-20221231.xsd#hum_FairValueRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6766fff2-c278-4161-9bd3-c767e7cdc234" xlink:to="loc_hum_FairValueRiskMember_37aa23a5-d70d-41a1-acf7-0374f252bbfd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4046e2d-1f70-4a5e-a1a2-80da42acf86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4046e2d-1f70-4a5e-a1a2-80da42acf86e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e4046e2d-1f70-4a5e-a1a2-80da42acf86e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4046e2d-1f70-4a5e-a1a2-80da42acf86e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e4046e2d-1f70-4a5e-a1a2-80da42acf86e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cffd708c-7f03-4a39-b2ce-7737648bf6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4046e2d-1f70-4a5e-a1a2-80da42acf86e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cffd708c-7f03-4a39-b2ce-7737648bf6b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_53d35f7e-91a2-40f0-a010-09647a234c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cffd708c-7f03-4a39-b2ce-7737648bf6b9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_53d35f7e-91a2-40f0-a010-09647a234c5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3efeedd3-dbe7-4edb-b390-ce6ac959f336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3efeedd3-dbe7-4edb-b390-ce6ac959f336" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3efeedd3-dbe7-4edb-b390-ce6ac959f336_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3efeedd3-dbe7-4edb-b390-ce6ac959f336" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3efeedd3-dbe7-4edb-b390-ce6ac959f336_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e2d15d-347d-42f1-bdfd-eed86f160227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3efeedd3-dbe7-4edb-b390-ce6ac959f336" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e2d15d-347d-42f1-bdfd-eed86f160227" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_395599ae-cb0a-4275-955f-bf0b9ff466f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e2d15d-347d-42f1-bdfd-eed86f160227" xlink:to="loc_us-gaap_InvestmentsMember_395599ae-cb0a-4275-955f-bf0b9ff466f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5a0f447a-1691-471c-a166-fec6b2e50e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5a0f447a-1691-471c-a166-fec6b2e50e76" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5a0f447a-1691-471c-a166-fec6b2e50e76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5a0f447a-1691-471c-a166-fec6b2e50e76" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5a0f447a-1691-471c-a166-fec6b2e50e76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2fb440ca-2884-44c0-9a9d-2349461dc5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5a0f447a-1691-471c-a166-fec6b2e50e76" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2fb440ca-2884-44c0-9a9d-2349461dc5b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_845dbd3c-e21f-4475-ba04-aa36322dff61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2fb440ca-2884-44c0-9a9d-2349461dc5b4" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_845dbd3c-e21f-4475-ba04-aa36322dff61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbec45cb-b556-4e84-aa3f-a566dd540f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbec45cb-b556-4e84-aa3f-a566dd540f40" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bbec45cb-b556-4e84-aa3f-a566dd540f40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbec45cb-b556-4e84-aa3f-a566dd540f40" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_bbec45cb-b556-4e84-aa3f-a566dd540f40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_85a751c0-a288-4032-b85e-572be954abc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbec45cb-b556-4e84-aa3f-a566dd540f40" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_85a751c0-a288-4032-b85e-572be954abc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_ff2b3098-dbeb-4cab-b7c9-60ba6f721f52" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_85a751c0-a288-4032-b85e-572be954abc3" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_ff2b3098-dbeb-4cab-b7c9-60ba6f721f52" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" xlink:type="extended" id="iea9423f99f4f45938448372ce1386ab7_FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85e0863e-e59d-4d06-b6a3-3ec872a3d1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_dafc4efe-7a0a-420c-9e3e-b117a3da62ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetLiabilityNetMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85e0863e-e59d-4d06-b6a3-3ec872a3d1e4" xlink:to="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_dafc4efe-7a0a-420c-9e3e-b117a3da62ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85e0863e-e59d-4d06-b6a3-3ec872a3d1e4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_150cd5c1-1735-456d-b9ce-c41ddd004ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_150cd5c1-1735-456d-b9ce-c41ddd004ce2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_150cd5c1-1735-456d-b9ce-c41ddd004ce2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_150cd5c1-1735-456d-b9ce-c41ddd004ce2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_150cd5c1-1735-456d-b9ce-c41ddd004ce2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24c38102-045c-48bf-9391-0c64019ff283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_150cd5c1-1735-456d-b9ce-c41ddd004ce2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24c38102-045c-48bf-9391-0c64019ff283" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionOnSecuritiesMember_55cd4ae9-7831-487a-b286-0cc4007cdc41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionOnSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24c38102-045c-48bf-9391-0c64019ff283" xlink:to="loc_us-gaap_OptionOnSecuritiesMember_55cd4ae9-7831-487a-b286-0cc4007cdc41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_023d6e00-edb2-477c-b367-479fb1d6be50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_023d6e00-edb2-477c-b367-479fb1d6be50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_023d6e00-edb2-477c-b367-479fb1d6be50_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_023d6e00-edb2-477c-b367-479fb1d6be50" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_023d6e00-edb2-477c-b367-479fb1d6be50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f37fe2b-3a4b-49ae-b779-20464d24a13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_023d6e00-edb2-477c-b367-479fb1d6be50" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f37fe2b-3a4b-49ae-b779-20464d24a13f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_749e002b-5ca3-4353-9cbf-23f481e9ca58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f37fe2b-3a4b-49ae-b779-20464d24a13f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_749e002b-5ca3-4353-9cbf-23f481e9ca58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_78b8d0ea-a675-4268-b53a-837afccd05a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_78b8d0ea-a675-4268-b53a-837afccd05a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_78b8d0ea-a675-4268-b53a-837afccd05a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_78b8d0ea-a675-4268-b53a-837afccd05a1" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_78b8d0ea-a675-4268-b53a-837afccd05a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_78b8d0ea-a675-4268-b53a-837afccd05a1" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputOptionVolatilityMember_2785f5f7-96be-4620-aef5-318d53b2f1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputOptionVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_us-gaap_MeasurementInputOptionVolatilityMember_2785f5f7-96be-4620-aef5-318d53b2f1b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditSpreadOptionMember_51fe40c3-995f-4b34-835e-e61fa31c869d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditSpreadOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_us-gaap_CreditSpreadOptionMember_51fe40c3-995f-4b34-835e-e61fa31c869d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevenueExitMultipleMember_64cd10f2-1a35-4d02-bf70-4684e758841a" xlink:href="hum-20221231.xsd#hum_RevenueExitMultipleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_hum_RevenueExitMultipleMember_64cd10f2-1a35-4d02-bf70-4684e758841a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b121f4a9-009e-40e9-a611-e08e1c8195b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b121f4a9-009e-40e9-a611-e08e1c8195b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_2f76fdcb-cf33-4b59-9c2e-9c5f1dd2c8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_2f76fdcb-cf33-4b59-9c2e-9c5f1dd2c8d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c7834236-3eab-4906-9a3e-5c9f64b1de73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:to="loc_srt_RangeAxis_c7834236-3eab-4906-9a3e-5c9f64b1de73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7834236-3eab-4906-9a3e-5c9f64b1de73_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c7834236-3eab-4906-9a3e-5c9f64b1de73" xlink:to="loc_srt_RangeMember_c7834236-3eab-4906-9a3e-5c9f64b1de73_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0e9e0f36-7e10-4a2d-b321-96733e7ff03a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c7834236-3eab-4906-9a3e-5c9f64b1de73" xlink:to="loc_srt_RangeMember_0e9e0f36-7e10-4a2d-b321-96733e7ff03a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7fabbffa-c433-45b3-b30e-130b160a09da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0e9e0f36-7e10-4a2d-b321-96733e7ff03a" xlink:to="loc_srt_MinimumMember_7fabbffa-c433-45b3-b30e-130b160a09da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d78d82a6-425e-4c49-b0fc-ec7839e67f41" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_0e9e0f36-7e10-4a2d-b321-96733e7ff03a" xlink:to="loc_srt_MaximumMember_d78d82a6-425e-4c49-b0fc-ec7839e67f41" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#MEDICAREPARTDDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="extended" id="ia384a15d7ac042b2904fc38edf201a66_MEDICAREPARTDDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d4b6069b-f273-4329-9380-f7bae4eb1169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_us-gaap_OtherAssetsCurrent_d4b6069b-f273-4329-9380-f7bae4eb1169" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_209cf23b-ca24-45b6-8262-1b7209393313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_209cf23b-ca24-45b6-8262-1b7209393313" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset_099f02f2-01ad-4768-8552-dbff4b04ef4a" xlink:href="hum-20221231.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_hum_NetCurrentLiabilityAsset_099f02f2-01ad-4768-8552-dbff4b04ef4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_18b00505-4eb4-4504-bc64-710066205284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_18b00505-4eb4-4504-bc64-710066205284" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_64998640-477d-4868-8126-60541a33adb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_64998640-477d-4868-8126-60541a33adb1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability_dfe8f20c-09b3-4689-a5e8-dc3199098c01" xlink:href="hum-20221231.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_hum_NetNoncurrentAssetLiability_dfe8f20c-09b3-4689-a5e8-dc3199098c01" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetAssetLiability_5fa6ae5c-93b8-4ec5-aa3e-00996b3f2a81" xlink:href="hum-20221231.xsd#hum_NetAssetLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_hum_NetAssetLiability_5fa6ae5c-93b8-4ec5-aa3e-00996b3f2a81" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9010009b-cd35-4568-9c0e-a671269e6dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9010009b-cd35-4568-9c0e-a671269e6dee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9b7c7a13-9c77-44e8-bf05-1fa0c265adf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9010009b-cd35-4568-9c0e-a671269e6dee" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9b7c7a13-9c77-44e8-bf05-1fa0c265adf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9b7c7a13-9c77-44e8-bf05-1fa0c265adf1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9b7c7a13-9c77-44e8-bf05-1fa0c265adf1" xlink:to="loc_us-gaap_SegmentDomain_9b7c7a13-9c77-44e8-bf05-1fa0c265adf1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c34e1c7f-6795-4d29-9a57-a4f45bb0cda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9b7c7a13-9c77-44e8-bf05-1fa0c265adf1" xlink:to="loc_us-gaap_SegmentDomain_c34e1c7f-6795-4d29-9a57-a4f45bb0cda2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RiskCorridorSettlementsMedicarePartDMember_32318f9e-d1af-4504-b2bf-a1fcafbb8782" xlink:href="hum-20221231.xsd#hum_RiskCorridorSettlementsMedicarePartDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c34e1c7f-6795-4d29-9a57-a4f45bb0cda2" xlink:to="loc_hum_RiskCorridorSettlementsMedicarePartDMember_32318f9e-d1af-4504-b2bf-a1fcafbb8782" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CmsSubsidiesOrDiscountsMember_21c57cd5-381d-43bc-a901-abf3804c88b1" xlink:href="hum-20221231.xsd#hum_CmsSubsidiesOrDiscountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c34e1c7f-6795-4d29-9a57-a4f45bb0cda2" xlink:to="loc_hum_CmsSubsidiesOrDiscountsMember_21c57cd5-381d-43bc-a901-abf3804c88b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails" xlink:type="extended" id="i5a75c9d28a6b48879fb376d90ea02842_PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_00d9b94e-3732-4720-925f-beb110d185f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_00d9b94e-3732-4720-925f-beb110d185f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f5871069-682b-4778-a416-c68dcb6c0b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f5871069-682b-4778-a416-c68dcb6c0b09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f7653a49-b55f-430e-966c-d72d3c97a976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f7653a49-b55f-430e-966c-d72d3c97a976" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8dbf55c4-b471-49a9-a25b-eed4484fbb83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8dbf55c4-b471-49a9-a25b-eed4484fbb83" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10718070-3d47-487f-b020-54b12883372a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8dbf55c4-b471-49a9-a25b-eed4484fbb83" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10718070-3d47-487f-b020-54b12883372a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_10718070-3d47-487f-b020-54b12883372a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10718070-3d47-487f-b020-54b12883372a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_10718070-3d47-487f-b020-54b12883372a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10718070-3d47-487f-b020-54b12883372a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_5fee54c9-e512-4ac9-ba03-6d3063450e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:to="loc_us-gaap_LandMember_5fee54c9-e512-4ac9-ba03-6d3063450e9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BuildingsAndLeaseholdImprovementsMember_c418514b-d755-4589-b7eb-f995d684ee47" xlink:href="hum-20221231.xsd#hum_BuildingsAndLeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:to="loc_hum_BuildingsAndLeaseholdImprovementsMember_c418514b-d755-4589-b7eb-f995d684ee47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a6a18469-f1a5-4eea-88d7-7fa5ee05c154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a6a18469-f1a5-4eea-88d7-7fa5ee05c154" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_29d39618-382e-41ba-ace4-0a1e8eb2bccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:to="loc_us-gaap_ComputerEquipmentMember_29d39618-382e-41ba-ace4-0a1e8eb2bccb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails" xlink:type="extended" id="ic348fa02afea457e991994d592d409a6_GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3dc5aa80-6cc1-49a8-b8b9-45aef3b83f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_3dc5aa80-6cc1-49a8-b8b9-45aef3b83f9b" xlink:to="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_754b7659-ffc3-4a8f-9a55-b2701f3f4bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:to="loc_us-gaap_Goodwill_754b7659-ffc3-4a8f-9a55-b2701f3f4bb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a28902bf-63b3-4607-849c-898820172012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a28902bf-63b3-4607-849c-898820172012" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_348dddeb-4d1e-44ae-a4bd-060a4f7adbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_348dddeb-4d1e-44ae-a4bd-060a4f7adbe2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4200e569-06bb-471e-bdd8-bdca04074058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8e8d2f2c-1138-4892-8a67-8e70363b0de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_3dc5aa80-6cc1-49a8-b8b9-45aef3b83f9b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8e8d2f2c-1138-4892-8a67-8e70363b0de0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9be2544b-20dd-4a25-827d-859808564a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8e8d2f2c-1138-4892-8a67-8e70363b0de0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9be2544b-20dd-4a25-827d-859808564a06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9be2544b-20dd-4a25-827d-859808564a06_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9be2544b-20dd-4a25-827d-859808564a06" xlink:to="loc_us-gaap_SegmentDomain_9be2544b-20dd-4a25-827d-859808564a06_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4b24c693-2eb7-44ad-991d-b702f3e32faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9be2544b-20dd-4a25-827d-859808564a06" xlink:to="loc_us-gaap_SegmentDomain_4b24c693-2eb7-44ad-991d-b702f3e32faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember_ff2ad99d-eb1a-4dd1-930b-b28d2e9999e2" xlink:href="hum-20221231.xsd#hum_InsuranceSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4b24c693-2eb7-44ad-991d-b702f3e32faa" xlink:to="loc_hum_InsuranceSegmentMember_ff2ad99d-eb1a-4dd1-930b-b28d2e9999e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember_fc59f30d-0a1b-42e1-82f7-5e0ba562bc46" xlink:href="hum-20221231.xsd#hum_CenterWellSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_4b24c693-2eb7-44ad-991d-b702f3e32faa" xlink:to="loc_hum_CenterWellSegmentMember_fc59f30d-0a1b-42e1-82f7-5e0ba562bc46" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails" xlink:type="extended" id="i5c2c4678b33a4e029939a814ea8078dc_GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b519f135-21e3-48cb-b5e1-8b5e01d8734b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b519f135-21e3-48cb-b5e1-8b5e01d8734b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_59ffee39-832d-44f6-911d-f54b8c42fc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_59ffee39-832d-44f6-911d-f54b8c42fc2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_dc15de90-cd9d-44ed-955c-17e406997700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_dc15de90-cd9d-44ed-955c-17e406997700" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3afbf594-d8a8-4542-b088-b9736f26df7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3afbf594-d8a8-4542-b088-b9736f26df7d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6ec39b6a-dae7-4890-923e-77bfebeea9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6ec39b6a-dae7-4890-923e-77bfebeea9a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_caa1fe65-9738-4c3c-9c7d-8571be5823c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_caa1fe65-9738-4c3c-9c7d-8571be5823c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_952c1f96-ee51-4cc9-8a6d-7b9417fadc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_952c1f96-ee51-4cc9-8a6d-7b9417fadc5e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5c2ebc05-719a-469f-9bdd-fb979a93e668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5c2ebc05-719a-469f-9bdd-fb979a93e668" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e20aadad-f1b1-47df-b801-128497067dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b519f135-21e3-48cb-b5e1-8b5e01d8734b" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e20aadad-f1b1-47df-b801-128497067dce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3077f7c5-8940-439b-bfc1-7a3e635c1926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e20aadad-f1b1-47df-b801-128497067dce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3077f7c5-8940-439b-bfc1-7a3e635c1926" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3077f7c5-8940-439b-bfc1-7a3e635c1926_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3077f7c5-8940-439b-bfc1-7a3e635c1926" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3077f7c5-8940-439b-bfc1-7a3e635c1926_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3077f7c5-8940-439b-bfc1-7a3e635c1926" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CertificateOfNeedMember_d2ae5070-032d-469d-97e6-93ecde0ad231" xlink:href="hum-20221231.xsd#hum_CertificateOfNeedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_hum_CertificateOfNeedMember_d2ae5070-032d-469d-97e6-93ecde0ad231" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_e6845403-6a88-4326-b995-dbea88f99975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_us-gaap_LicensingAgreementsMember_e6845403-6a88-4326-b995-dbea88f99975" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_ac3c7fd3-5936-4c5f-a560-1a09576a5500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_us-gaap_CustomerContractsMember_ac3c7fd3-5936-4c5f-a560-1a09576a5500" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1442759d-f5b7-4403-a9b5-db5728876ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_us-gaap_TradeNamesMember_1442759d-f5b7-4403-a9b5-db5728876ced" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_557ae4ec-900c-4876-9467-926a7a21a238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_us-gaap_ContractualRightsMember_557ae4ec-900c-4876-9467-926a7a21a238" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncompetesAndOtherMember_6aa0bffd-548d-4f54-8d8d-fa6b1f5c0870" xlink:href="hum-20221231.xsd#hum_NoncompetesAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_hum_NoncompetesAndOtherMember_6aa0bffd-548d-4f54-8d8d-fa6b1f5c0870" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#BENEFITSPAYABLENarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails" xlink:type="extended" id="i892d1bd9f4d04b13b4c79a7608c2e88c_BENEFITSPAYABLENarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_20682187-bd93-4a49-b7a9-63376183c0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_20682187-bd93-4a49-b7a9-63376183c0ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported_d4510be9-9b47-4256-86f7-0c7b9c474f32" xlink:href="hum-20221231.xsd#hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:to="loc_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported_d4510be9-9b47-4256-86f7-0c7b9c474f32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears_894253b4-67aa-4040-9ad7-8a3c21e2c24d" xlink:href="hum-20221231.xsd#hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:to="loc_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears_894253b4-67aa-4040-9ad7-8a3c21e2c24d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_e4baf9de-0f36-4ebd-a073-9d153bbfee74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_e4baf9de-0f36-4ebd-a073-9d153bbfee74" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_52d89e58-3840-42cb-9cc2-9bff18ebf9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_e4baf9de-0f36-4ebd-a073-9d153bbfee74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_52d89e58-3840-42cb-9cc2-9bff18ebf9cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_52d89e58-3840-42cb-9cc2-9bff18ebf9cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_52d89e58-3840-42cb-9cc2-9bff18ebf9cb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_52d89e58-3840-42cb-9cc2-9bff18ebf9cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_52d89e58-3840-42cb-9cc2-9bff18ebf9cb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_945b472e-20f2-4fca-aced-07a74d461b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_945b472e-20f2-4fca-aced-07a74d461b59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_f132485d-a160-4fc5-b5d5-2d9d03772517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_f132485d-a160-4fc5-b5d5-2d9d03772517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_6ed9f558-7d78-4f7e-96b9-835d3b824207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_6ed9f558-7d78-4f7e-96b9-835d3b824207" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails" xlink:type="extended" id="if2257da8a60043919ed1494babf3740b_BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_dacf1821-12ee-4dc6-bded-e5ea4c1dc148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_dacf1821-12ee-4dc6-bded-e5ea4c1dc148" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c1cc7e6f-f5a4-4654-ae2e-40310ae137e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c1cc7e6f-f5a4-4654-ae2e-40310ae137e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c12981e8-3da0-41da-a051-57f8095b76bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c12981e8-3da0-41da-a051-57f8095b76bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_3891fe5a-f994-4e79-a6b8-150f3f7f3e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_3891fe5a-f994-4e79-a6b8-150f3f7f3e33" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_c3cbb834-765a-4899-abb5-ad8d5880250d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_3891fe5a-f994-4e79-a6b8-150f3f7f3e33" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_c3cbb834-765a-4899-abb5-ad8d5880250d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_c3cbb834-765a-4899-abb5-ad8d5880250d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_c3cbb834-765a-4899-abb5-ad8d5880250d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_c3cbb834-765a-4899-abb5-ad8d5880250d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_c3cbb834-765a-4899-abb5-ad8d5880250d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1a45c660-5c7a-4a7d-ab98-bc23f36852a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1a45c660-5c7a-4a7d-ab98-bc23f36852a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_63cb79c1-34c9-4ecb-a365-0cd68316cf8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_63cb79c1-34c9-4ecb-a365-0cd68316cf8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_bc59e3ca-e4cf-46f3-87db-6055b8e71404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_bc59e3ca-e4cf-46f3-87db-6055b8e71404" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended" id="i042982d417484ca89a50e30c403cfa35_INCOMETAXESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_8724547e-5852-4868-b21b-16b07b12baa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_6370dce5-d2b3-4219-ad2a-07a1cbb1a7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_8724547e-5852-4868-b21b-16b07b12baa7" xlink:to="loc_us-gaap_OperatingLossCarryforwards_6370dce5-d2b3-4219-ad2a-07a1cbb1a7ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8776990b-bb28-4c34-8777-43c0260fdc94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_8724547e-5852-4868-b21b-16b07b12baa7" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8776990b-bb28-4c34-8777-43c0260fdc94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_3be081c4-af55-403a-86b7-9eb3081586ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_8724547e-5852-4868-b21b-16b07b12baa7" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_3be081c4-af55-403a-86b7-9eb3081586ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b74dec7d-1a5a-4e66-9b88-8b971f25f9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_3be081c4-af55-403a-86b7-9eb3081586ec" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b74dec7d-1a5a-4e66-9b88-8b971f25f9f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_b74dec7d-1a5a-4e66-9b88-8b971f25f9f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b74dec7d-1a5a-4e66-9b88-8b971f25f9f6" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_b74dec7d-1a5a-4e66-9b88-8b971f25f9f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_144389fc-0c38-46c3-be86-69d4ed107391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b74dec7d-1a5a-4e66-9b88-8b971f25f9f6" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_144389fc-0c38-46c3-be86-69d4ed107391" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_4ad849be-a263-4af2-9ab4-dd0ee1def463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_144389fc-0c38-46c3-be86-69d4ed107391" xlink:to="loc_us-gaap_DomesticCountryMember_4ad849be-a263-4af2-9ab4-dd0ee1def463" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_5ab4fb32-133c-47d9-b367-802c46bb5421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_144389fc-0c38-46c3-be86-69d4ed107391" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_5ab4fb32-133c-47d9-b367-802c46bb5421" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTDebtOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="extended" id="if2f4c6f682124b5fb07b31b133a5e5dd_DEBTDebtOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2d7eb83f-6c3e-4664-94ab-e609c2546858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2d7eb83f-6c3e-4664-94ab-e609c2546858" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_17ef1cb1-8685-4267-9028-2770c59a115d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_17ef1cb1-8685-4267-9028-2770c59a115d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_a361f3be-c870-4af5-a994-12c43ff1bfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_ShortTermBorrowings_a361f3be-c870-4af5-a994-12c43ff1bfb8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_16724973-161e-4b51-8464-3edb387ad8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_LongTermDebtCurrent_16724973-161e-4b51-8464-3edb387ad8c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2b00cedc-b749-49c1-b982-15f4fd379b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_DebtCurrent_2b00cedc-b749-49c1-b982-15f4fd379b66" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_01adc5af-9bd0-41ad-81bd-d6a01b887b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_01adc5af-9bd0-41ad-81bd-d6a01b887b2e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_d867a14b-bcb6-4bff-b50d-92c955a2492d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_d867a14b-bcb6-4bff-b50d-92c955a2492d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_d867a14b-bcb6-4bff-b50d-92c955a2492d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_d867a14b-bcb6-4bff-b50d-92c955a2492d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_d867a14b-bcb6-4bff-b50d-92c955a2492d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_d8bc777f-94b6-4cfc-93ca-d1013046318c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_d867a14b-bcb6-4bff-b50d-92c955a2492d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_d8bc777f-94b6-4cfc-93ca-d1013046318c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9f9e7dae-d5bb-42b5-b741-247be163a160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d8bc777f-94b6-4cfc-93ca-d1013046318c" xlink:to="loc_us-gaap_CommercialPaperMember_9f9e7dae-d5bb-42b5-b741-247be163a160" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_26e13074-982b-4ebd-b7f6-f39d32a25022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_26e13074-982b-4ebd-b7f6-f39d32a25022" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_26e13074-982b-4ebd-b7f6-f39d32a25022_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_26e13074-982b-4ebd-b7f6-f39d32a25022" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_26e13074-982b-4ebd-b7f6-f39d32a25022_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f07bda8e-2222-4a99-a8a9-0e6af0701acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_26e13074-982b-4ebd-b7f6-f39d32a25022" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f07bda8e-2222-4a99-a8a9-0e6af0701acc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2169ced6-a91c-4ba7-af62-ada7018f3685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f07bda8e-2222-4a99-a8a9-0e6af0701acc" xlink:to="loc_us-gaap_SeniorNotesMember_2169ced6-a91c-4ba7-af62-ada7018f3685" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_c72fb18a-7231-4d78-a299-4c72fdffb99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f07bda8e-2222-4a99-a8a9-0e6af0701acc" xlink:to="loc_us-gaap_LoansPayableMember_c72fb18a-7231-4d78-a299-4c72fdffb99d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8a2d14bf-32c3-4fd9-9cf5-399f075c8240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:to="loc_us-gaap_DebtInstrumentAxis_8a2d14bf-32c3-4fd9-9cf5-399f075c8240" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8a2d14bf-32c3-4fd9-9cf5-399f075c8240_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8a2d14bf-32c3-4fd9-9cf5-399f075c8240" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8a2d14bf-32c3-4fd9-9cf5-399f075c8240_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8a2d14bf-32c3-4fd9-9cf5-399f075c8240" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A065PercentSeniorNotesDueAugust2023Member_e18c9632-4d54-4360-8142-3dd391e89d9a" xlink:href="hum-20221231.xsd#hum_A065PercentSeniorNotesDueAugust2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A065PercentSeniorNotesDueAugust2023Member_e18c9632-4d54-4360-8142-3dd391e89d9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member_3b5f87d7-e43f-48b0-a474-82f2b1d351f4" xlink:href="hum-20221231.xsd#hum_A3.15PercentSeniorNotesDueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member_3b5f87d7-e43f-48b0-a474-82f2b1d351f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member_52da77f0-a5f2-41f6-96e3-7624aa2bc738" xlink:href="hum-20221231.xsd#hum_A2.90PercentSeniorNotesDueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member_52da77f0-a5f2-41f6-96e3-7624aa2bc738" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_a07ae106-c1d2-48f1-9226-12547711b8ab" xlink:href="hum-20221231.xsd#hum_A3.85PercentSeniorNotesDueOctober2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_a07ae106-c1d2-48f1-9226-12547711b8ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A450PercentSeniorNotesDueApril2025Member_d6c21f0d-f9a2-4628-807e-f990afdf2be9" xlink:href="hum-20221231.xsd#hum_A450PercentSeniorNotesDueApril2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A450PercentSeniorNotesDueApril2025Member_d6c21f0d-f9a2-4628-807e-f990afdf2be9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A135PercentSeniorNotesDueFebruary2027Member_f9e7449c-4e78-4b87-88af-3799332ac3a9" xlink:href="hum-20221231.xsd#hum_A135PercentSeniorNotesDueFebruary2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A135PercentSeniorNotesDueFebruary2027Member_f9e7449c-4e78-4b87-88af-3799332ac3a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member_ffbbeeaa-9353-4514-901d-472ea50833aa" xlink:href="hum-20221231.xsd#hum_A3.95PercentSeniorNotesDueMarch2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member_ffbbeeaa-9353-4514-901d-472ea50833aa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A575PercentSeniorNotesDueMarch2028Member_69787142-8caf-44b8-857f-8088d65266af" xlink:href="hum-20221231.xsd#hum_A575PercentSeniorNotesDueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A575PercentSeniorNotesDueMarch2028Member_69787142-8caf-44b8-857f-8088d65266af" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A370PercentSeniorNotesDueMarch2029Member_aa708b9e-7e32-4c2a-bd12-8f584f750dd5" xlink:href="hum-20221231.xsd#hum_A370PercentSeniorNotesDueMarch2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A370PercentSeniorNotesDueMarch2029Member_aa708b9e-7e32-4c2a-bd12-8f584f750dd5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A313PercentSeniorNotesDueAugust2029Member_3690ab5d-ce28-41b2-9c66-6ff062d4413b" xlink:href="hum-20221231.xsd#hum_A313PercentSeniorNotesDueAugust2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A313PercentSeniorNotesDueAugust2029Member_3690ab5d-ce28-41b2-9c66-6ff062d4413b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A488PercentSeniorNotesDueApril2030Member_5c5773d2-da96-4af1-8dd0-8c9509077932" xlink:href="hum-20221231.xsd#hum_A488PercentSeniorNotesDueApril2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A488PercentSeniorNotesDueApril2030Member_5c5773d2-da96-4af1-8dd0-8c9509077932" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A215PercentSeniorNotesDueFebruary2032Member_884f8bde-36ac-4987-9fa7-217f6f62c9ba" xlink:href="hum-20221231.xsd#hum_A215PercentSeniorNotesDueFebruary2032Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A215PercentSeniorNotesDueFebruary2032Member_884f8bde-36ac-4987-9fa7-217f6f62c9ba" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A588PercentSeniorNotesDueMarch2033Member_60c67792-4660-491d-aafa-27b68ce46386" xlink:href="hum-20221231.xsd#hum_A588PercentSeniorNotesDueMarch2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A588PercentSeniorNotesDueMarch2033Member_60c67792-4660-491d-aafa-27b68ce46386" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_d86f0e22-3adb-45ee-ad9c-ad0967caf9b7" xlink:href="hum-20221231.xsd#hum_A8.15PercentSeniorNotesDueJune2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_d86f0e22-3adb-45ee-ad9c-ad0967caf9b7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A463PercentSeniorNotesDueDecember2042Member_36698d42-182a-402b-bb6d-6293ceb2d60a" xlink:href="hum-20221231.xsd#hum_A463PercentSeniorNotesDueDecember2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A463PercentSeniorNotesDueDecember2042Member_36698d42-182a-402b-bb6d-6293ceb2d60a" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member_3bb7e96a-9e6a-40a0-9108-2e2f0fe12622" xlink:href="hum-20221231.xsd#hum_A4.95PercentSeniorNotesDueOctober2044Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member_3bb7e96a-9e6a-40a0-9108-2e2f0fe12622" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member_4054186b-db7d-49d0-8e2a-33d5b04a1453" xlink:href="hum-20221231.xsd#hum_A4.80PercentSeniorNotesDueMarch2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member_4054186b-db7d-49d0-8e2a-33d5b04a1453" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.95PercentSeniorNotesDueAugust2049Member_9cd5ec8b-c5ba-4130-bb3c-a9bc1e068f83" xlink:href="hum-20221231.xsd#hum_A3.95PercentSeniorNotesDueAugust2049Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A3.95PercentSeniorNotesDueAugust2049Member_9cd5ec8b-c5ba-4130-bb3c-a9bc1e068f83" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanDueOctober2023Member_f6efb20c-1192-4e98-8baa-eb6c33a709ed" xlink:href="hum-20221231.xsd#hum_TermLoanDueOctober2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_TermLoanDueOctober2023Member_f6efb20c-1192-4e98-8baa-eb6c33a709ed" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMay2024Member_f79d5878-2e97-47e6-990a-3af5c75704ce" xlink:href="hum-20221231.xsd#hum_DelayedDrawTermLoanMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_DelayedDrawTermLoanMay2024Member_f79d5878-2e97-47e6-990a-3af5c75704ce" xlink:type="arc" order="19"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTSeniorNotesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTSeniorNotesDetails" xlink:type="extended" id="icef0660d6e6949d3b663cc4bc7a1a128_DEBTSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_65710a5b-f83a-4226-84a2-be188e6f6984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_65710a5b-f83a-4226-84a2-be188e6f6984" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_de0803c7-8b37-444c-9a80-2fd8454b82b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_de0803c7-8b37-444c-9a80-2fd8454b82b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_f535d0bf-6838-475f-acc4-5d3ab95e82bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_RepaymentsOfDebt_f535d0bf-6838-475f-acc4-5d3ab95e82bd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_31e7db75-81d3-436b-8c6b-d0eec82d525d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_31e7db75-81d3-436b-8c6b-d0eec82d525d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_7f57a164-f44b-4c94-961a-c146f5dd6cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_7f57a164-f44b-4c94-961a-c146f5dd6cfc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_219be70e-7dcc-49ae-8a01-6666c4f816af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_DebtInstrumentTable_219be70e-7dcc-49ae-8a01-6666c4f816af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_445ad34b-f5ce-46fe-aeb3-3cdec5b80fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_219be70e-7dcc-49ae-8a01-6666c4f816af" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_445ad34b-f5ce-46fe-aeb3-3cdec5b80fef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_445ad34b-f5ce-46fe-aeb3-3cdec5b80fef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_445ad34b-f5ce-46fe-aeb3-3cdec5b80fef" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_445ad34b-f5ce-46fe-aeb3-3cdec5b80fef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a16edf07-5004-4de7-a2e0-9fb7a54f89a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_445ad34b-f5ce-46fe-aeb3-3cdec5b80fef" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a16edf07-5004-4de7-a2e0-9fb7a54f89a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3919db2e-c57f-40fa-b10b-43c497802105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a16edf07-5004-4de7-a2e0-9fb7a54f89a5" xlink:to="loc_us-gaap_SeniorNotesMember_3919db2e-c57f-40fa-b10b-43c497802105" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_932fc710-f44d-4a4b-9f14-329983b6ec4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_219be70e-7dcc-49ae-8a01-6666c4f816af" xlink:to="loc_us-gaap_DebtInstrumentAxis_932fc710-f44d-4a4b-9f14-329983b6ec4c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_932fc710-f44d-4a4b-9f14-329983b6ec4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_932fc710-f44d-4a4b-9f14-329983b6ec4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_932fc710-f44d-4a4b-9f14-329983b6ec4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_932fc710-f44d-4a4b-9f14-329983b6ec4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_dc1fe710-0f83-4dfe-abb4-97df64de0ed7" xlink:href="hum-20221231.xsd#hum_A8.15PercentSeniorNotesDueJune2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_dc1fe710-0f83-4dfe-abb4-97df64de0ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_21adbf43-3bab-4463-b1b7-3a9b6d775790" xlink:href="hum-20221231.xsd#hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_21adbf43-3bab-4463-b1b7-3a9b6d775790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5570PercentSeniorNotesDueMarch2028Member_d242d813-a67b-4f84-9fb7-27e53b8a6224" xlink:href="hum-20221231.xsd#hum_A5570PercentSeniorNotesDueMarch2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_21adbf43-3bab-4463-b1b7-3a9b6d775790" xlink:to="loc_hum_A5570PercentSeniorNotesDueMarch2028Member_d242d813-a67b-4f84-9fb7-27e53b8a6224" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5875PercentSeniorNotesDueMarch2033Member_f7c43dad-6f8e-4d7d-b870-e5477ccf3666" xlink:href="hum-20221231.xsd#hum_A5875PercentSeniorNotesDueMarch2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_21adbf43-3bab-4463-b1b7-3a9b6d775790" xlink:to="loc_hum_A5875PercentSeniorNotesDueMarch2033Member_f7c43dad-6f8e-4d7d-b870-e5477ccf3666" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A370PercentSeniorNotesDueMarch2029Member_bbb5c8cb-1040-4f61-8e83-1bbe60225ddf" xlink:href="hum-20221231.xsd#hum_A370PercentSeniorNotesDueMarch2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A370PercentSeniorNotesDueMarch2029Member_bbb5c8cb-1040-4f61-8e83-1bbe60225ddf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member_459c940b-73ea-4529-a62f-6beddb361230" xlink:href="hum-20221231.xsd#hum_A3.15PercentSeniorNotesDueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member_459c940b-73ea-4529-a62f-6beddb361230" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member_fb898675-59ec-4857-853a-03a864077c41" xlink:href="hum-20221231.xsd#hum_A2.90PercentSeniorNotesDueDecember2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member_fb898675-59ec-4857-853a-03a864077c41" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTDelayedDrawTermLoanCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails" xlink:type="extended" id="i21aa6674fd8e4922a667b88d06686f2b_DEBTDelayedDrawTermLoanCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_659fc56e-4277-4950-8a16-0fbc9c28fcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_659fc56e-4277-4950-8a16-0fbc9c28fcf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d4786975-ac59-42de-bd92-373730dbbb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d4786975-ac59-42de-bd92-373730dbbb6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_e0cb1d17-cf7f-4eb0-a8f2-ddd44ad9f85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_e0cb1d17-cf7f-4eb0-a8f2-ddd44ad9f85f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_c5b1902b-c3b9-481e-9de9-6fd2f9c1aea4" xlink:href="hum-20221231.xsd#hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_c5b1902b-c3b9-481e-9de9-6fd2f9c1aea4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_8fcb4f7c-0f59-4195-b8ad-a15ee7967aa9" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_8fcb4f7c-0f59-4195-b8ad-a15ee7967aa9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_a86df8b3-4423-4f2b-9b8c-2d1f8e8cfd81" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_a86df8b3-4423-4f2b-9b8c-2d1f8e8cfd81" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a54a6215-b493-4d5f-a0b8-b18b8263c7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_us-gaap_DebtInstrumentAxis_a54a6215-b493-4d5f-a0b8-b18b8263c7ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a54a6215-b493-4d5f-a0b8-b18b8263c7ee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a54a6215-b493-4d5f-a0b8-b18b8263c7ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a54a6215-b493-4d5f-a0b8-b18b8263c7ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_243064eb-febc-411e-ac48-70aa0fe09f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a54a6215-b493-4d5f-a0b8-b18b8263c7ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_243064eb-febc-411e-ac48-70aa0fe09f03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMay2021Member_babd881b-1540-4b5b-96f7-3edfef81ee77" xlink:href="hum-20221231.xsd#hum_DelayedDrawTermLoanMay2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_243064eb-febc-411e-ac48-70aa0fe09f03" xlink:to="loc_hum_DelayedDrawTermLoanMay2021Member_babd881b-1540-4b5b-96f7-3edfef81ee77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5dee0d1a-5536-4a50-a577-838e976b75de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5dee0d1a-5536-4a50-a577-838e976b75de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_5dee0d1a-5536-4a50-a577-838e976b75de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5dee0d1a-5536-4a50-a577-838e976b75de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_5dee0d1a-5536-4a50-a577-838e976b75de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_416a26b5-a0e3-4f76-a9a5-1158dd714eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5dee0d1a-5536-4a50-a577-838e976b75de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_416a26b5-a0e3-4f76-a9a5-1158dd714eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b2cfa88f-c196-4286-9fa7-baa7ba48e5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_416a26b5-a0e3-4f76-a9a5-1158dd714eb3" xlink:to="loc_us-gaap_LoansPayableMember_b2cfa88f-c196-4286-9fa7-baa7ba48e5fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e139eedc-5503-4d42-8775-428aedfb6fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_us-gaap_VariableRateAxis_e139eedc-5503-4d42-8775-428aedfb6fb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_e139eedc-5503-4d42-8775-428aedfb6fb0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_e139eedc-5503-4d42-8775-428aedfb6fb0" xlink:to="loc_us-gaap_VariableRateDomain_e139eedc-5503-4d42-8775-428aedfb6fb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1b21b665-7233-45cb-915e-3d467f510dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_e139eedc-5503-4d42-8775-428aedfb6fb0" xlink:to="loc_us-gaap_VariableRateDomain_1b21b665-7233-45cb-915e-3d467f510dd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_b42548c0-b805-4d6c-a316-4ccc41d24346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_1b21b665-7233-45cb-915e-3d467f510dd7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_b42548c0-b805-4d6c-a316-4ccc41d24346" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f61d7aa-0b59-4335-94fa-b6c5ffbee829" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_srt_RangeAxis_6f61d7aa-0b59-4335-94fa-b6c5ffbee829" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6f61d7aa-0b59-4335-94fa-b6c5ffbee829_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6f61d7aa-0b59-4335-94fa-b6c5ffbee829" xlink:to="loc_srt_RangeMember_6f61d7aa-0b59-4335-94fa-b6c5ffbee829_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_473a8ccd-c987-478c-8977-ba652994c406" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6f61d7aa-0b59-4335-94fa-b6c5ffbee829" xlink:to="loc_srt_RangeMember_473a8ccd-c987-478c-8977-ba652994c406" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_70092311-9516-462c-b25d-375f0e070a87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_473a8ccd-c987-478c-8977-ba652994c406" xlink:to="loc_srt_MinimumMember_70092311-9516-462c-b25d-375f0e070a87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5a13e570-ec73-47ab-8ff0-847b54ae3071" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_473a8ccd-c987-478c-8977-ba652994c406" xlink:to="loc_srt_MaximumMember_5a13e570-ec73-47ab-8ff0-847b54ae3071" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8a50da0d-034e-4bb8-9999-aa510f419f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8a50da0d-034e-4bb8-9999-aa510f419f90" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8a50da0d-034e-4bb8-9999-aa510f419f90_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8a50da0d-034e-4bb8-9999-aa510f419f90" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_8a50da0d-034e-4bb8-9999-aa510f419f90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31ad6b09-0104-4e8c-bdc8-195124bc170d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8a50da0d-034e-4bb8-9999-aa510f419f90" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31ad6b09-0104-4e8c-bdc8-195124bc170d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_b6f8e93d-2c50-47a3-b55e-2d1c04871461" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31ad6b09-0104-4e8c-bdc8-195124bc170d" xlink:to="loc_hum_KindredAtHomeMember_b6f8e93d-2c50-47a3-b55e-2d1c04871461" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTOctober2021TermLoanAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails" xlink:type="extended" id="i27687844bf274df9a24447daade62663_DEBTOctober2021TermLoanAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_deefd730-7b14-4c29-b352-47ddf4b24350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cc26e9e4-a105-4243-b67d-80e993409d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deefd730-7b14-4c29-b352-47ddf4b24350" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cc26e9e4-a105-4243-b67d-80e993409d0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_b1488d0f-57b5-4285-acfd-959388bdd8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deefd730-7b14-4c29-b352-47ddf4b24350" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_b1488d0f-57b5-4285-acfd-959388bdd8f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_883e0598-9380-48ea-89eb-7c825e98f4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deefd730-7b14-4c29-b352-47ddf4b24350" xlink:to="loc_us-gaap_DebtInstrumentTable_883e0598-9380-48ea-89eb-7c825e98f4db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_db5a4d74-0de9-4d0c-ac8f-c927c8477e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_883e0598-9380-48ea-89eb-7c825e98f4db" xlink:to="loc_us-gaap_DebtInstrumentAxis_db5a4d74-0de9-4d0c-ac8f-c927c8477e09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_db5a4d74-0de9-4d0c-ac8f-c927c8477e09_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_db5a4d74-0de9-4d0c-ac8f-c927c8477e09" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_db5a4d74-0de9-4d0c-ac8f-c927c8477e09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a56970fa-ff5a-4b31-b09b-d37f8b85cdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_db5a4d74-0de9-4d0c-ac8f-c927c8477e09" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a56970fa-ff5a-4b31-b09b-d37f8b85cdcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_October2021TermLoanAgreementMember_96e4bb8a-c9d0-4ecd-860b-5e36abb1b0e1" xlink:href="hum-20221231.xsd#hum_October2021TermLoanAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a56970fa-ff5a-4b31-b09b-d37f8b85cdcd" xlink:to="loc_hum_October2021TermLoanAgreementMember_96e4bb8a-c9d0-4ecd-860b-5e36abb1b0e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GentivaTermLoanDue2025Member_a982deb6-afbe-43e6-b177-98f279da1810" xlink:href="hum-20221231.xsd#hum_GentivaTermLoanDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a56970fa-ff5a-4b31-b09b-d37f8b85cdcd" xlink:to="loc_hum_GentivaTermLoanDue2025Member_a982deb6-afbe-43e6-b177-98f279da1810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7e422bb4-37a9-418a-8d3c-41e26aa2c174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_883e0598-9380-48ea-89eb-7c825e98f4db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7e422bb4-37a9-418a-8d3c-41e26aa2c174" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7e422bb4-37a9-418a-8d3c-41e26aa2c174_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7e422bb4-37a9-418a-8d3c-41e26aa2c174" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7e422bb4-37a9-418a-8d3c-41e26aa2c174_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_100aad5e-43a2-494d-bc4b-ea28aaaa45ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7e422bb4-37a9-418a-8d3c-41e26aa2c174" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_100aad5e-43a2-494d-bc4b-ea28aaaa45ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_cee4a700-d5d7-41c1-8c48-3b2995b34bac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_100aad5e-43a2-494d-bc4b-ea28aaaa45ee" xlink:to="loc_us-gaap_LoansPayableMember_cee4a700-d5d7-41c1-8c48-3b2995b34bac" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTRevolvingCreditAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails" xlink:type="extended" id="ifa5e25e2c9ba435e9c2deffa4f17972d_DEBTRevolvingCreditAgreementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ac0c11c4-9552-411c-88b7-8097a464a5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_DebtInstrumentTerm_ac0c11c4-9552-411c-88b7-8097a464a5ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_39ad993b-f076-46c8-b670-26a5e0a47f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_39ad993b-f076-46c8-b670-26a5e0a47f82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a8755773-4d52-4678-8ef4-4a50cdee6d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a8755773-4d52-4678-8ef4-4a50cdee6d0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6aa44cc0-931d-4548-81f3-716db3f5662a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6aa44cc0-931d-4548-81f3-716db3f5662a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_4667663a-4803-41d5-b7e0-c2d0280acef9" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_4667663a-4803-41d5-b7e0-c2d0280acef9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_0323abf2-29d1-4337-96a9-81c890a1e78f" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_0323abf2-29d1-4337-96a9-81c890a1e78f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_a5572fe8-de9f-4e35-9c32-6dd87c4928ba" xlink:href="hum-20221231.xsd#hum_LineOfCreditFacilityUncommittedIncrementalCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_a5572fe8-de9f-4e35-9c32-6dd87c4928ba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity_bc684916-11fb-4b91-b311-74344022a103" xlink:href="hum-20221231.xsd#hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity_bc684916-11fb-4b91-b311-74344022a103" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_0b2fd77d-c322-4401-8806-d072b26a3405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_LinesOfCreditCurrent_0b2fd77d-c322-4401-8806-d072b26a3405" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_62c2d379-70e8-4e8f-be05-3955a5b26581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_62c2d379-70e8-4e8f-be05-3955a5b26581" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b39bf071-eaa6-447a-864b-5436ab482e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_us-gaap_CreditFacilityAxis_b39bf071-eaa6-447a-864b-5436ab482e6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b39bf071-eaa6-447a-864b-5436ab482e6b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b39bf071-eaa6-447a-864b-5436ab482e6b" xlink:to="loc_us-gaap_CreditFacilityDomain_b39bf071-eaa6-447a-864b-5436ab482e6b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5df74197-198b-4ee4-9393-c3a52eaa9fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b39bf071-eaa6-447a-864b-5436ab482e6b" xlink:to="loc_us-gaap_CreditFacilityDomain_5df74197-198b-4ee4-9393-c3a52eaa9fce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4595482f-fe97-489e-9d0e-c26a98707114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5df74197-198b-4ee4-9393-c3a52eaa9fce" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4595482f-fe97-489e-9d0e-c26a98707114" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_fcbc99d6-5ae6-4d64-92bf-0406f968cf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5df74197-198b-4ee4-9393-c3a52eaa9fce" xlink:to="loc_us-gaap_LetterOfCreditMember_fcbc99d6-5ae6-4d64-92bf-0406f968cf4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e22508cc-085b-409f-9253-4418d01abc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_us-gaap_DebtInstrumentAxis_e22508cc-085b-409f-9253-4418d01abc7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e22508cc-085b-409f-9253-4418d01abc7a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e22508cc-085b-409f-9253-4418d01abc7a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e22508cc-085b-409f-9253-4418d01abc7a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ca7e321c-4d94-4a44-912d-a65fb4bbe7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e22508cc-085b-409f-9253-4418d01abc7a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ca7e321c-4d94-4a44-912d-a65fb4bbe7db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember_c74d90bd-0bac-4e25-a5ca-3bdf9c78b1d4" xlink:href="hum-20221231.xsd#hum_RevolvingCreditAgreementJune2021FiveYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ca7e321c-4d94-4a44-912d-a65fb4bbe7db" xlink:to="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember_c74d90bd-0bac-4e25-a5ca-3bdf9c78b1d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021OneYearMember_e76d58c5-5429-4542-9721-966822fa4735" xlink:href="hum-20221231.xsd#hum_RevolvingCreditAgreementJune2021OneYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ca7e321c-4d94-4a44-912d-a65fb4bbe7db" xlink:to="loc_hum_RevolvingCreditAgreementJune2021OneYearMember_e76d58c5-5429-4542-9721-966822fa4735" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d8979ba1-437d-4336-8cc3-3083b8a4881a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d8979ba1-437d-4336-8cc3-3083b8a4881a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d8979ba1-437d-4336-8cc3-3083b8a4881a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d8979ba1-437d-4336-8cc3-3083b8a4881a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d8979ba1-437d-4336-8cc3-3083b8a4881a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dee73535-bf37-44ed-8b42-f0ae445bd3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d8979ba1-437d-4336-8cc3-3083b8a4881a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dee73535-bf37-44ed-8b42-f0ae445bd3d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_84a0c465-ed13-461c-8f20-2208edb4ab70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dee73535-bf37-44ed-8b42-f0ae445bd3d3" xlink:to="loc_us-gaap_LoansPayableMember_84a0c465-ed13-461c-8f20-2208edb4ab70" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_503abe09-42de-4386-b513-50453198f75b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_us-gaap_VariableRateAxis_503abe09-42de-4386-b513-50453198f75b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_503abe09-42de-4386-b513-50453198f75b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_503abe09-42de-4386-b513-50453198f75b" xlink:to="loc_us-gaap_VariableRateDomain_503abe09-42de-4386-b513-50453198f75b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f3083220-b721-457e-a13c-d96712b989d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_503abe09-42de-4386-b513-50453198f75b" xlink:to="loc_us-gaap_VariableRateDomain_f3083220-b721-457e-a13c-d96712b989d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cd015a3f-5391-47ae-9f81-a8a0f027cc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_f3083220-b721-457e-a13c-d96712b989d0" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cd015a3f-5391-47ae-9f81-a8a0f027cc0a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SecuredOvernightFinancingRateSOFRMember_528fd75f-3e62-4ed7-8a67-0312ac6c0ee5" xlink:href="hum-20221231.xsd#hum_SecuredOvernightFinancingRateSOFRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_f3083220-b721-457e-a13c-d96712b989d0" xlink:to="loc_hum_SecuredOvernightFinancingRateSOFRMember_528fd75f-3e62-4ed7-8a67-0312ac6c0ee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b20a3f82-7fb7-473a-9dc1-e16299daa4ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_srt_RangeAxis_b20a3f82-7fb7-473a-9dc1-e16299daa4ab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b20a3f82-7fb7-473a-9dc1-e16299daa4ab_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b20a3f82-7fb7-473a-9dc1-e16299daa4ab" xlink:to="loc_srt_RangeMember_b20a3f82-7fb7-473a-9dc1-e16299daa4ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e1c600fb-3de0-4520-95d0-2b568bffcd93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b20a3f82-7fb7-473a-9dc1-e16299daa4ab" xlink:to="loc_srt_RangeMember_e1c600fb-3de0-4520-95d0-2b568bffcd93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_00af9d8e-b3fb-4e08-9f77-808cbaf9cbc1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e1c600fb-3de0-4520-95d0-2b568bffcd93" xlink:to="loc_srt_MinimumMember_00af9d8e-b3fb-4e08-9f77-808cbaf9cbc1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_df4542da-f920-4ce2-bc98-a1d577a71039" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e1c600fb-3de0-4520-95d0-2b568bffcd93" xlink:to="loc_srt_MaximumMember_df4542da-f920-4ce2-bc98-a1d577a71039" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTCommercialPaperandOtherShorttermBorrowingsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails" xlink:type="extended" id="i722bf492799d4b8eaa749bc66a6ebcb3_DEBTCommercialPaperandOtherShorttermBorrowingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_488f5e1b-acb3-47f7-9093-a944a4b8d89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_488f5e1b-acb3-47f7-9093-a944a4b8d89a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_ce165d72-5189-4a60-89f7-c6fc8961dd8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:to="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_ce165d72-5189-4a60-89f7-c6fc8961dd8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_49cd27fe-b36e-48cd-b685-4ae707a0e134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:to="loc_us-gaap_ShortTermBorrowings_49cd27fe-b36e-48cd-b685-4ae707a0e134" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_786238c5-c0e9-49b3-ac72-7859a5edb5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_786238c5-c0e9-49b3-ac72-7859a5edb5c0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_9751b2f9-8789-4200-bad7-0de8b306d511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_9751b2f9-8789-4200-bad7-0de8b306d511" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_0dbe7990-9bf1-4ea0-abe2-80190b3e5768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_9751b2f9-8789-4200-bad7-0de8b306d511" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_0dbe7990-9bf1-4ea0-abe2-80190b3e5768" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_0dbe7990-9bf1-4ea0-abe2-80190b3e5768_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_0dbe7990-9bf1-4ea0-abe2-80190b3e5768" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_0dbe7990-9bf1-4ea0-abe2-80190b3e5768_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_cc35b1be-108a-4703-b4c0-1744ab81164b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_0dbe7990-9bf1-4ea0-abe2-80190b3e5768" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_cc35b1be-108a-4703-b4c0-1744ab81164b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8fd635c5-e13b-427e-a409-1d29b252811d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_cc35b1be-108a-4703-b4c0-1744ab81164b" xlink:to="loc_us-gaap_CommercialPaperMember_8fd635c5-e13b-427e-a409-1d29b252811d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_c962bf99-28af-4a5e-80f8-d7635457f046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_cc35b1be-108a-4703-b4c0-1744ab81164b" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_c962bf99-28af-4a5e-80f8-d7635457f046" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="extended" id="i8aca5a9cefab4c64ab52f44a02991ff4_EMPLOYEEBENEFITPLANSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_a8b39ad3-9be3-4d81-9a74-d2c622a35097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_a8b39ad3-9be3-4d81-9a74-d2c622a35097" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CompanyCommonStockClosingSharePrice_982d9a77-092d-42ad-b288-ed1caac67bee" xlink:href="hum-20221231.xsd#hum_CompanyCommonStockClosingSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_CompanyCommonStockClosingSharePrice_982d9a77-092d-42ad-b288-ed1caac67bee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock_b1845507-f7d3-41c8-9271-68af6ea5a86b" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock_b1845507-f7d3-41c8-9271-68af6ea5a86b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares_f7124ac6-92c9-4c7f-8d81-e02195b935db" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares_f7124ac6-92c9-4c7f-8d81-e02195b935db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding_7f8a3b85-8870-4162-99cb-2b92e87d90b6" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding_7f8a3b85-8870-4162-99cb-2b92e87d90b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance_c99053da-f982-4de0-9a24-1433f8598b28" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance_c99053da-f982-4de0-9a24-1433f8598b28" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod_fe0c433e-8d8c-42f3-a5d6-dc1c919219d5" xlink:href="hum-20221231.xsd#hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod_fe0c433e-8d8c-42f3-a5d6-dc1c919219d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram_7ba04509-d50c-495c-a1bb-2f64084483fa" xlink:href="hum-20221231.xsd#hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram_7ba04509-d50c-495c-a1bb-2f64084483fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram_c5788945-3dc1-434b-9dc7-e254f09d4a38" xlink:href="hum-20221231.xsd#hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram_c5788945-3dc1-434b-9dc7-e254f09d4a38" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram_46500058-2b17-48fb-8c68-98a8c4710126" xlink:href="hum-20221231.xsd#hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram_46500058-2b17-48fb-8c68-98a8c4710126" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting_2a9c9163-2e30-4742-ba93-24e4c83ed7b2" xlink:href="hum-20221231.xsd#hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting_2a9c9163-2e30-4742-ba93-24e4c83ed7b2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_b79a5ec1-c897-4ac8-acbd-69d3362dac4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_b79a5ec1-c897-4ac8-acbd-69d3362dac4e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_da3fc799-4268-4496-9c5e-65082d19e789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_da3fc799-4268-4496-9c5e-65082d19e789" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_155cb150-6b1f-4f9c-8a94-dee4def864ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_155cb150-6b1f-4f9c-8a94-dee4def864ea" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_17a7f333-3b59-4946-95be-5fe5579be113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_17a7f333-3b59-4946-95be-5fe5579be113" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8824a86d-6c67-49d7-8716-620cd08cc3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8824a86d-6c67-49d7-8716-620cd08cc3c3" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions_2ccf7402-dcbd-4d31-ad98-26fe36f6b615" xlink:href="hum-20221231.xsd#hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions_2ccf7402-dcbd-4d31-ad98-26fe36f6b615" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_354cd51f-8f39-4a22-a178-476dc4bb2ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_354cd51f-8f39-4a22-a178-476dc4bb2ad1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ae1e00d3-7e12-467f-85c0-d382aafeeaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ae1e00d3-7e12-467f-85c0-d382aafeeaf4" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b3ac000e-feee-4afc-bc68-b1f34297160d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b3ac000e-feee-4afc-bc68-b1f34297160d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_16385cde-6cfc-494a-b1aa-25b0be6893ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_16385cde-6cfc-494a-b1aa-25b0be6893ee" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a436fbcc-af98-4a09-8a62-f9cb9fb99080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a436fbcc-af98-4a09-8a62-f9cb9fb99080" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_9b65facf-ff2d-427c-a412-4a6404e00185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_9b65facf-ff2d-427c-a412-4a6404e00185" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_3ae33756-a9dd-40ac-bb8f-c8632ff2e97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_3ae33756-a9dd-40ac-bb8f-c8632ff2e97f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1a8ce31e-222e-4f9f-b974-19ac0fa9863a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1a8ce31e-222e-4f9f-b974-19ac0fa9863a" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_db660b9c-89f8-49fe-ae1c-b41c3e175e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_db660b9c-89f8-49fe-ae1c-b41c3e175e0d" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_122a71de-56b8-4d9c-921a-5ed9c5e55cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_122a71de-56b8-4d9c-921a-5ed9c5e55cab" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e0c7fb2f-d6dd-4ae6-916c-74844bdeb62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:to="loc_us-gaap_PlanNameAxis_e0c7fb2f-d6dd-4ae6-916c-74844bdeb62a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e0c7fb2f-d6dd-4ae6-916c-74844bdeb62a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_e0c7fb2f-d6dd-4ae6-916c-74844bdeb62a" xlink:to="loc_us-gaap_PlanNameDomain_e0c7fb2f-d6dd-4ae6-916c-74844bdeb62a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_280062f1-7bc6-423e-bc71-496ee3a11f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_e0c7fb2f-d6dd-4ae6-916c-74844bdeb62a" xlink:to="loc_us-gaap_PlanNameDomain_280062f1-7bc6-423e-bc71-496ee3a11f53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2011PlanMember_ad8487a7-69f8-4146-8a5e-abf85ccd1326" xlink:href="hum-20221231.xsd#hum_A2011PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_280062f1-7bc6-423e-bc71-496ee3a11f53" xlink:to="loc_hum_A2011PlanMember_ad8487a7-69f8-4146-8a5e-abf85ccd1326" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2019PlanMember_82a0b772-ca46-4dd0-8caa-26a13cc20b48" xlink:href="hum-20221231.xsd#hum_A2019PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_280062f1-7bc6-423e-bc71-496ee3a11f53" xlink:to="loc_hum_A2019PlanMember_82a0b772-ca46-4dd0-8caa-26a13cc20b48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9aa8a6f7-b5dd-4e50-bdda-80c141dc715c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:to="loc_us-gaap_AwardTypeAxis_9aa8a6f7-b5dd-4e50-bdda-80c141dc715c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9aa8a6f7-b5dd-4e50-bdda-80c141dc715c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9aa8a6f7-b5dd-4e50-bdda-80c141dc715c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9aa8a6f7-b5dd-4e50-bdda-80c141dc715c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc4abd1c-3a24-46c1-a84c-b7c27c760003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9aa8a6f7-b5dd-4e50-bdda-80c141dc715c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc4abd1c-3a24-46c1-a84c-b7c27c760003" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6a3fdf6d-9fb3-4a5f-a7e3-2a51774de1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc4abd1c-3a24-46c1-a84c-b7c27c760003" xlink:to="loc_us-gaap_RestrictedStockMember_6a3fdf6d-9fb3-4a5f-a7e3-2a51774de1d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7151b48f-5cd0-411a-8588-eb2942113af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc4abd1c-3a24-46c1-a84c-b7c27c760003" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7151b48f-5cd0-411a-8588-eb2942113af9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc65f2b1-7484-4ba2-bfe2-36d3e3a58c8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:to="loc_srt_RangeAxis_cc65f2b1-7484-4ba2-bfe2-36d3e3a58c8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc65f2b1-7484-4ba2-bfe2-36d3e3a58c8f_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cc65f2b1-7484-4ba2-bfe2-36d3e3a58c8f" xlink:to="loc_srt_RangeMember_cc65f2b1-7484-4ba2-bfe2-36d3e3a58c8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1cd8586c-2630-4a9c-9442-2176484cbb73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cc65f2b1-7484-4ba2-bfe2-36d3e3a58c8f" xlink:to="loc_srt_RangeMember_1cd8586c-2630-4a9c-9442-2176484cbb73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2f6217dc-104a-4915-9272-53028065062a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1cd8586c-2630-4a9c-9442-2176484cbb73" xlink:to="loc_srt_MinimumMember_2f6217dc-104a-4915-9272-53028065062a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3c6b50c8-3273-4e3b-8252-da241e1894cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_1cd8586c-2630-4a9c-9442-2176484cbb73" xlink:to="loc_srt_MaximumMember_3c6b50c8-3273-4e3b-8252-da241e1894cb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="extended" id="i7417462e7b16406b9f7bb33598504f96_EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4cecded5-73a4-4bd5-934a-97eb2dc52ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4cecded5-73a4-4bd5-934a-97eb2dc52ab5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b33b9d4b-e6a2-4cc1-b20d-6cdf008f4a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b33b9d4b-e6a2-4cc1-b20d-6cdf008f4a48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_affe3c18-64d3-4b2f-a858-b5afd1342405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_affe3c18-64d3-4b2f-a858-b5afd1342405" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a92b8fd6-128f-429b-9cf3-65c201d084dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a92b8fd6-128f-429b-9cf3-65c201d084dc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_db3737d7-4aed-4014-b337-b64522c64750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a92b8fd6-128f-429b-9cf3-65c201d084dc" xlink:to="loc_us-gaap_AwardTypeAxis_db3737d7-4aed-4014-b337-b64522c64750" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_db3737d7-4aed-4014-b337-b64522c64750_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_db3737d7-4aed-4014-b337-b64522c64750" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_db3737d7-4aed-4014-b337-b64522c64750_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f781590-2eb3-4a1f-ab3f-f7f2a5febe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_db3737d7-4aed-4014-b337-b64522c64750" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f781590-2eb3-4a1f-ab3f-f7f2a5febe9f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e03e47c4-b4d2-4829-b4ff-d8b9d0fd1784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f781590-2eb3-4a1f-ab3f-f7f2a5febe9f" xlink:to="loc_us-gaap_RestrictedStockMember_e03e47c4-b4d2-4829-b4ff-d8b9d0fd1784" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_abacb7f0-ceb2-401e-9aba-8dc77e01b434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f781590-2eb3-4a1f-ab3f-f7f2a5febe9f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_abacb7f0-ceb2-401e-9aba-8dc77e01b434" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails" xlink:type="extended" id="i91a89606ff32461889190b60e1b9391b_EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b8338a7-6f05-44b9-83ad-8d133bf6f18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b8338a7-6f05-44b9-83ad-8d133bf6f18c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eae0ca17-46e5-42c1-ba8c-922d5a390dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eae0ca17-46e5-42c1-ba8c-922d5a390dea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad68cdaa-06d2-445c-8cb3-12ccc5c1b46f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad68cdaa-06d2-445c-8cb3-12ccc5c1b46f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a372362d-4d31-4038-83e1-baca5e1416b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a372362d-4d31-4038-83e1-baca5e1416b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_08cd3d86-e9dc-4f7e-99a1-5a78f0aa5ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_08cd3d86-e9dc-4f7e-99a1-5a78f0aa5ed0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7a7fb197-13aa-4101-8ab3-14238fe1d74c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b8338a7-6f05-44b9-83ad-8d133bf6f18c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ce85bb7b-66a4-4f21-be4c-7c94db9b4b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ce85bb7b-66a4-4f21-be4c-7c94db9b4b49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a731866a-9545-4fb5-8e8b-1e1c87cf1396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a731866a-9545-4fb5-8e8b-1e1c87cf1396" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_70e9cfb8-e8ac-4b3e-8ebf-10fbad0de7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_70e9cfb8-e8ac-4b3e-8ebf-10fbad0de7fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35be403a-b605-429f-b3bb-6b0b844d2228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35be403a-b605-429f-b3bb-6b0b844d2228" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eea30c00-4bca-49e2-805d-8e59e9b15c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d5d54f7-58f6-4630-ad2a-c1726c6149b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b8338a7-6f05-44b9-83ad-8d133bf6f18c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d5d54f7-58f6-4630-ad2a-c1726c6149b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_99bc10da-1348-4d42-a283-37004ee73ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d5d54f7-58f6-4630-ad2a-c1726c6149b6" xlink:to="loc_us-gaap_AwardTypeAxis_99bc10da-1348-4d42-a283-37004ee73ac9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99bc10da-1348-4d42-a283-37004ee73ac9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_99bc10da-1348-4d42-a283-37004ee73ac9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_99bc10da-1348-4d42-a283-37004ee73ac9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f170625e-627f-4488-aa2c-ad49e836cbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_99bc10da-1348-4d42-a283-37004ee73ac9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f170625e-627f-4488-aa2c-ad49e836cbd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_86301934-e9f3-4f6d-94c0-a45014f8e306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f170625e-627f-4488-aa2c-ad49e836cbd5" xlink:to="loc_us-gaap_RestrictedStockMember_86301934-e9f3-4f6d-94c0-a45014f8e306" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails" xlink:type="extended" id="ia1b891edfdbb4f1eb3516d8c39581174_EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15ebb1c6-ebe3-4792-bef7-173ef1f47106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15ebb1c6-ebe3-4792-bef7-173ef1f47106" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4f8adb8f-addd-4ad3-a6b3-1c6996e90d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4f8adb8f-addd-4ad3-a6b3-1c6996e90d2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b6a5433a-fcca-4d17-b3b9-2eb6228c3935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b6a5433a-fcca-4d17-b3b9-2eb6228c3935" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_52cd0a74-535b-45ff-b936-b934afcc5bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_52cd0a74-535b-45ff-b936-b934afcc5bae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_87d1720a-d2ac-436a-9bb5-ae3faa74b270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_87d1720a-d2ac-436a-9bb5-ae3faa74b270" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1eb4a-9f5a-49f8-9649-faf6de054887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1eb4a-9f5a-49f8-9649-faf6de054887" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_23ea0f87-8095-4b01-85a3-8fbdcbff7f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1eb4a-9f5a-49f8-9649-faf6de054887" xlink:to="loc_us-gaap_AwardTypeAxis_23ea0f87-8095-4b01-85a3-8fbdcbff7f1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23ea0f87-8095-4b01-85a3-8fbdcbff7f1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_23ea0f87-8095-4b01-85a3-8fbdcbff7f1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_23ea0f87-8095-4b01-85a3-8fbdcbff7f1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_952440c3-6e4f-4dba-8ae8-25ecf43494e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_23ea0f87-8095-4b01-85a3-8fbdcbff7f1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_952440c3-6e4f-4dba-8ae8-25ecf43494e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a788d0cd-d61b-43ef-b926-51028fa78d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_952440c3-6e4f-4dba-8ae8-25ecf43494e2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a788d0cd-d61b-43ef-b926-51028fa78d98" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EARNINGSPERCOMMONSHARECOMPUTATIONDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="extended" id="icec63bc1517b4e61bbe9147778973c6e_EARNINGSPERCOMMONSHARECOMPUTATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54df474f-1952-4102-a8a6-34823271ee6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_NetIncomeLoss_54df474f-1952-4102-a8a6-34823271ee6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_67fe945b-de7b-4d1c-983b-8410135bdf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_67fe945b-de7b-4d1c-983b-8410135bdf2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_80210c68-7d41-4698-a428-234510187ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_80210c68-7d41-4698-a428-234510187ba2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8de3ba91-d42a-45d6-b277-3e841139afd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8de3ba91-d42a-45d6-b277-3e841139afd4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2b7a2adc-b476-42c9-a640-86342d4dd909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_EarningsPerShareBasic_2b7a2adc-b476-42c9-a640-86342d4dd909" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_da22f705-42d5-439d-9704-8d8db50a244b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_EarningsPerShareDiluted_da22f705-42d5-439d-9704-8d8db50a244b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7b67e434-cf69-4a6f-8b19-2f4bbe57256d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7b67e434-cf69-4a6f-8b19-2f4bbe57256d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_935ba2dd-a10a-4fb8-85fc-8cb8916edca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_935ba2dd-a10a-4fb8-85fc-8cb8916edca6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_def46108-ed8b-4ece-b97d-6bd928179d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_935ba2dd-a10a-4fb8-85fc-8cb8916edca6" xlink:to="loc_us-gaap_AwardTypeAxis_def46108-ed8b-4ece-b97d-6bd928179d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_def46108-ed8b-4ece-b97d-6bd928179d8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_def46108-ed8b-4ece-b97d-6bd928179d8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_def46108-ed8b-4ece-b97d-6bd928179d8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_725cc0f5-4810-4264-a032-301894668d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_def46108-ed8b-4ece-b97d-6bd928179d8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_725cc0f5-4810-4264-a032-301894668d5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8c963865-0905-43ef-a593-ed6c46ce4a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_725cc0f5-4810-4264-a032-301894668d5f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8c963865-0905-43ef-a593-ed6c46ce4a48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fe07d65e-d18f-4766-8edb-7e712b1ae2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_725cc0f5-4810-4264-a032-301894668d5f" xlink:to="loc_us-gaap_RestrictedStockMember_fe07d65e-d18f-4766-8edb-7e712b1ae2ed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended" id="i4df1a15044b84245900ef83cb464d8f9_STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_eb004713-d137-44af-b9e1-39261bb1cc89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_eb004713-d137-44af-b9e1-39261bb1cc89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_298396d0-782e-4c64-a364-307ed0c3118a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_298396d0-782e-4c64-a364-307ed0c3118a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AcceleratedShareRepurchasesAgreementAmount_c6dd7964-ea80-4d48-92ec-0c01bbae93ca" xlink:href="hum-20221231.xsd#hum_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_AcceleratedShareRepurchasesAgreementAmount_c6dd7964-ea80-4d48-92ec-0c01bbae93ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be561f08-c8c5-4379-8f5b-a40257a142e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be561f08-c8c5-4379-8f5b-a40257a142e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8166ff6a-824b-40c0-8a51-5ebdf6a82647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8166ff6a-824b-40c0-8a51-5ebdf6a82647" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_5303648e-9bb4-4068-b579-586a40290eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_5303648e-9bb4-4068-b579-586a40290eab" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3a2ff5d7-90e9-46ce-91d9-467c2243f4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3a2ff5d7-90e9-46ce-91d9-467c2243f4ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue_22a4aa3c-1c0c-42a6-8c71-3259dd274734" xlink:href="hum-20221231.xsd#hum_TreasuryStockDecreaseInCapitalInExcessOfParValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue_22a4aa3c-1c0c-42a6-8c71-3259dd274734" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_d6df0c8c-7f27-43fc-8f96-7c03be9cb8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_d6df0c8c-7f27-43fc-8f96-7c03be9cb8e1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue_8b07790a-67f8-4152-a262-93e42f18aeaa" xlink:href="hum-20221231.xsd#hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue_8b07790a-67f8-4152-a262-93e42f18aeaa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f9fdb6d0-680f-49c3-ab99-6722a060976b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f9fdb6d0-680f-49c3-ab99-6722a060976b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_444cb48a-d770-47cb-8d3d-1c6144f2c055" xlink:href="hum-20221231.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_444cb48a-d770-47cb-8d3d-1c6144f2c055" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_87104348-c659-4782-ad5e-186bce37653f" xlink:href="hum-20221231.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_87104348-c659-4782-ad5e-186bce37653f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_a0322663-bb57-44bb-8337-edf551f20f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_a0322663-bb57-44bb-8337-edf551f20f4a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_708188f0-7254-4995-b9b1-9ee371d39abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_708188f0-7254-4995-b9b1-9ee371d39abf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_ec257b3e-725b-4408-b612-cefb39e7dcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_ec257b3e-725b-4408-b612-cefb39e7dcd0" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_15caca71-193d-4d06-a07e-10c52d43dccc" xlink:href="hum-20221231.xsd#hum_DividendsToParentWithoutPriorStateRegulatoryApproval"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_15caca71-193d-4d06-a07e-10c52d43dccc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_88cedf39-e796-4ea2-b87d-7de55c2f1196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_88cedf39-e796-4ea2-b87d-7de55c2f1196" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_88cedf39-e796-4ea2-b87d-7de55c2f1196_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_88cedf39-e796-4ea2-b87d-7de55c2f1196" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_88cedf39-e796-4ea2-b87d-7de55c2f1196_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_88cedf39-e796-4ea2-b87d-7de55c2f1196" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_December2020AcceleratedShareRepurchaseAgreementMember_bda5a140-28b8-47a5-a024-c3eac88c5b3c" xlink:href="hum-20221231.xsd#hum_December2020AcceleratedShareRepurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:to="loc_hum_December2020AcceleratedShareRepurchaseAgreementMember_bda5a140-28b8-47a5-a024-c3eac88c5b3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_January2022AcceleratedShareRepurchaseAgreementMember_1f8cfa1e-2731-4846-8b3f-0dfa2f5eeb50" xlink:href="hum-20221231.xsd#hum_January2022AcceleratedShareRepurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:to="loc_hum_January2022AcceleratedShareRepurchaseAgreementMember_1f8cfa1e-2731-4846-8b3f-0dfa2f5eeb50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_November2022AcceleratedShareRepurchaseProgramMember_c309f5d1-7640-4e45-842d-bc29e87b50f3" xlink:href="hum-20221231.xsd#hum_November2022AcceleratedShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:to="loc_hum_November2022AcceleratedShareRepurchaseProgramMember_c309f5d1-7640-4e45-842d-bc29e87b50f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f1cd6311-7b2f-4533-9c8b-9b4d92d8e876" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:to="loc_srt_CounterpartyNameAxis_f1cd6311-7b2f-4533-9c8b-9b4d92d8e876" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f1cd6311-7b2f-4533-9c8b-9b4d92d8e876_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_f1cd6311-7b2f-4533-9c8b-9b4d92d8e876" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_f1cd6311-7b2f-4533-9c8b-9b4d92d8e876_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_f1cd6311-7b2f-4533-9c8b-9b4d92d8e876" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CitibankNAMember_46cdea42-0a75-40c6-a044-acc1fb0cb8e5" xlink:href="hum-20221231.xsd#hum_CitibankNAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_CitibankNAMember_46cdea42-0a75-40c6-a044-acc1fb0cb8e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_JPMorganChaseBankMember_6053374e-9bab-442d-9790-57864809509b" xlink:href="hum-20221231.xsd#hum_JPMorganChaseBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_JPMorganChaseBankMember_6053374e-9bab-442d-9790-57864809509b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MizuhoMarketsAmericasLLCMember_ee29f90b-e6b7-4193-a328-539a04f9636a" xlink:href="hum-20221231.xsd#hum_MizuhoMarketsAmericasLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_MizuhoMarketsAmericasLLCMember_ee29f90b-e6b7-4193-a328-539a04f9636a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_WellsFargoBankMember_46bc4871-94c2-4c10-82f6-f5a5a6066e70" xlink:href="hum-20221231.xsd#hum_WellsFargoBankMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_WellsFargoBankMember_46bc4871-94c2-4c10-82f6-f5a5a6066e70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GoldmanSachsCoLLCMember_3e0b646b-1331-446e-94af-7772e4c24509" xlink:href="hum-20221231.xsd#hum_GoldmanSachsCoLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_GoldmanSachsCoLLCMember_3e0b646b-1331-446e-94af-7772e4c24509" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_35eeb310-54c1-4d2a-8cfc-eb5688bda1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_35eeb310-54c1-4d2a-8cfc-eb5688bda1cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_35eeb310-54c1-4d2a-8cfc-eb5688bda1cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_35eeb310-54c1-4d2a-8cfc-eb5688bda1cd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_35eeb310-54c1-4d2a-8cfc-eb5688bda1cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_83f3f659-57d5-4331-bf24-e1497c309838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_35eeb310-54c1-4d2a-8cfc-eb5688bda1cd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_83f3f659-57d5-4331-bf24-e1497c309838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_cdd47cf7-d81c-48fa-92a5-b99d4db21faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_83f3f659-57d5-4331-bf24-e1497c309838" xlink:to="loc_us-gaap_SubsequentEventMember_cdd47cf7-d81c-48fa-92a5-b99d4db21faa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#STOCKHOLDERSEQUITYShareRepurchasesDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails" xlink:type="extended" id="i78e86a7f006b4b4e8bcb6774fb875824_STOCKHOLDERSEQUITYShareRepurchasesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a41dfb1f-11e9-4b38-97d8-72b036bb219e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a41dfb1f-11e9-4b38-97d8-72b036bb219e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_25f88aba-c81b-44b9-9520-3f5ca55c2206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_25f88aba-c81b-44b9-9520-3f5ca55c2206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ec146105-6db6-4122-83c4-7160c623ea6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ec146105-6db6-4122-83c4-7160c623ea6b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_368cd11e-b72a-45a1-a46c-46442c4ec03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_368cd11e-b72a-45a1-a46c-46442c4ec03f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_2cee4513-099b-45ca-ad66-1fe2f72132db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_368cd11e-b72a-45a1-a46c-46442c4ec03f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_2cee4513-099b-45ca-ad66-1fe2f72132db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_2cee4513-099b-45ca-ad66-1fe2f72132db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2cee4513-099b-45ca-ad66-1fe2f72132db" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_2cee4513-099b-45ca-ad66-1fe2f72132db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_70ca9cca-1e0e-4483-beb8-d3a750caa078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2cee4513-099b-45ca-ad66-1fe2f72132db" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_70ca9cca-1e0e-4483-beb8-d3a750caa078" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_43ac30b9-012a-4de0-a924-c3de8533fad7" xlink:href="hum-20221231.xsd#hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_70ca9cca-1e0e-4483-beb8-d3a750caa078" xlink:to="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_43ac30b9-012a-4de0-a924-c3de8533fad7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_February2021ShareRepurchaseAuthorizationMember_67865035-b81c-4e19-b664-53c36e823f8e" xlink:href="hum-20221231.xsd#hum_February2021ShareRepurchaseAuthorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_43ac30b9-012a-4de0-a924-c3de8533fad7" xlink:to="loc_hum_February2021ShareRepurchaseAuthorizationMember_67865035-b81c-4e19-b664-53c36e823f8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_July2019ShareRepurchaseAuthorizationMember_8723dd44-fca3-4855-85aa-608b2450354d" xlink:href="hum-20221231.xsd#hum_July2019ShareRepurchaseAuthorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_43ac30b9-012a-4de0-a924-c3de8533fad7" xlink:to="loc_hum_July2019ShareRepurchaseAuthorizationMember_8723dd44-fca3-4855-85aa-608b2450354d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" xlink:type="extended" id="i8a34acb559f0402a80ffc3f088fc79b2_COMMITMENTSGUARANTEESANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_f610ee3d-1f20-4749-a36a-96d69eba25cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_f610ee3d-1f20-4749-a36a-96d69eba25cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_34fe8e8e-0bd3-4a0d-b73b-4608f4d585a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_34fe8e8e-0bd3-4a0d-b73b-4608f4d585a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_839ab15f-e14f-49a7-bce1-529a92870473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_839ab15f-e14f-49a7-bce1-529a92870473" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_a8dbdfaf-1933-4764-8fb0-087d3758ca70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_a8dbdfaf-1933-4764-8fb0-087d3758ca70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_55554935-8c6a-4575-9ec5-ff10661aa7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_55554935-8c6a-4575-9ec5-ff10661aa7a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalPremiumAndServicesRevenues_ce4e37b6-1ac4-49a3-8ef3-a9e7d5ddd612" xlink:href="hum-20221231.xsd#hum_PercentageOfTotalPremiumAndServicesRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_PercentageOfTotalPremiumAndServicesRevenues_ce4e37b6-1ac4-49a3-8ef3-a9e7d5ddd612" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries_67105370-9cde-496d-b5fc-14d34762b0d0" xlink:href="hum-20221231.xsd#hum_NumberOfStatesComprisingTRICAREBeneficiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries_67105370-9cde-496d-b5fc-14d34762b0d0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREBeneficiaries_02a68d43-8f66-4e2d-8ea7-dbbb8eb99a8e" xlink:href="hum-20221231.xsd#hum_NumberOfTRICAREBeneficiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_NumberOfTRICAREBeneficiaries_02a68d43-8f66-4e2d-8ea7-dbbb8eb99a8e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_a315c66a-5914-499f-b1cd-ba9bd82a77f5" xlink:href="hum-20221231.xsd#hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_a315c66a-5914-499f-b1cd-ba9bd82a77f5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_5dcb7a5a-0ba5-4bf7-a664-c6a8fd31f18b" xlink:href="hum-20221231.xsd#hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_5dcb7a5a-0ba5-4bf7-a664-c6a8fd31f18b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractBaseTerm_253bf68d-a5a3-418c-a9a1-ea19fd32686b" xlink:href="hum-20221231.xsd#hum_TRICAREManagedCareSupportContractBaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_TRICAREManagedCareSupportContractBaseTerm_253bf68d-a5a3-418c-a9a1-ea19fd32686b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_14c88642-0cf1-4ac5-8d3a-85c01e3e9f34" xlink:href="hum-20221231.xsd#hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_14c88642-0cf1-4ac5-8d3a-85c01e3e9f34" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_d2d0b6a8-04a1-4d5c-890f-77697625248c" xlink:href="hum-20221231.xsd#hum_TRICAREManagedCareSupportContractTermWithOptionExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_d2d0b6a8-04a1-4d5c-890f-77697625248c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_abb53bfe-c3db-4650-8eac-b4cb37d509e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_LossContingenciesTable_abb53bfe-c3db-4650-8eac-b4cb37d509e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_da4071e8-fd03-4aa4-84ac-94afcc78a5f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_abb53bfe-c3db-4650-8eac-b4cb37d509e8" xlink:to="loc_srt_MajorCustomersAxis_da4071e8-fd03-4aa4-84ac-94afcc78a5f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_da4071e8-fd03-4aa4-84ac-94afcc78a5f2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_da4071e8-fd03-4aa4-84ac-94afcc78a5f2" xlink:to="loc_srt_NameOfMajorCustomerDomain_da4071e8-fd03-4aa4-84ac-94afcc78a5f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_da4071e8-fd03-4aa4-84ac-94afcc78a5f2" xlink:to="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember_c9cdc4aa-abc7-4c5c-9872-751511a911bc" xlink:href="hum-20221231.xsd#hum_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:to="loc_hum_MedicareMember_c9cdc4aa-abc7-4c5c-9872-751511a911bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidMember_75f6dec4-f7d1-4f9c-bff8-eff6c62321f9" xlink:href="hum-20221231.xsd#hum_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:to="loc_hum_MedicaidMember_75f6dec4-f7d1-4f9c-bff8-eff6c62321f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MilitaryServiceMember_31e76276-aaad-43ec-ae5b-655d12b6149f" xlink:href="hum-20221231.xsd#hum_MilitaryServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:to="loc_hum_MilitaryServiceMember_31e76276-aaad-43ec-ae5b-655d12b6149f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SEGMENTINFORMATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails" xlink:type="extended" id="i61003893a8e54700ad9e5ad640fc0c10_SEGMENTINFORMATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_177bc530-8648-487d-97ec-2898d31cdab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:to="loc_us-gaap_NumberOfReportableSegments_177bc530-8648-487d-97ec-2898d31cdab5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_68c994f7-ca02-4dfd-9ccf-d606d5031550" xlink:href="hum-20221231.xsd#hum_GovernmentAndHealthPlanMemberSubsidiesAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:to="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_68c994f7-ca02-4dfd-9ccf-d606d5031550" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_af1457fe-1705-48cb-8fd6-cddb8a040619" xlink:href="hum-20221231.xsd#hum_DepreciationAndAmortizationClassifiedAsBenefitExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:to="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_af1457fe-1705-48cb-8fd6-cddb8a040619" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_62ed5d78-cffe-4783-9d00-9d6097a62d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_62ed5d78-cffe-4783-9d00-9d6097a62d7b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_8a412c69-6733-4a26-91d0-52cef3c36dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_8a412c69-6733-4a26-91d0-52cef3c36dd5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_8a412c69-6733-4a26-91d0-52cef3c36dd5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8a412c69-6733-4a26-91d0-52cef3c36dd5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_8a412c69-6733-4a26-91d0-52cef3c36dd5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f992ac3f-16a3-4f1d-87af-ce03182c783d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8a412c69-6733-4a26-91d0-52cef3c36dd5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f992ac3f-16a3-4f1d-87af-ce03182c783d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractsConcentrationRiskMember_e9be776c-3d15-4b39-abf7-7a41fdc6207d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractsConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f992ac3f-16a3-4f1d-87af-ce03182c783d" xlink:to="loc_us-gaap_GovernmentContractsConcentrationRiskMember_e9be776c-3d15-4b39-abf7-7a41fdc6207d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e736f700-2744-4100-9640-2c158ce44380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e736f700-2744-4100-9640-2c158ce44380" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e736f700-2744-4100-9640-2c158ce44380_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e736f700-2744-4100-9640-2c158ce44380" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e736f700-2744-4100-9640-2c158ce44380_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8f4d5b6b-b974-4985-8a4b-9e313dd03643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e736f700-2744-4100-9640-2c158ce44380" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8f4d5b6b-b974-4985-8a4b-9e313dd03643" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueProductLineMember_7ab7e329-0554-46e1-950e-9617f7322d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueProductLineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8f4d5b6b-b974-4985-8a4b-9e313dd03643" xlink:to="loc_us-gaap_SalesRevenueProductLineMember_7ab7e329-0554-46e1-950e-9617f7322d49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_466d97cd-d218-4d59-a4ef-2d51368a280a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:to="loc_srt_MajorCustomersAxis_466d97cd-d218-4d59-a4ef-2d51368a280a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_466d97cd-d218-4d59-a4ef-2d51368a280a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_466d97cd-d218-4d59-a4ef-2d51368a280a" xlink:to="loc_srt_NameOfMajorCustomerDomain_466d97cd-d218-4d59-a4ef-2d51368a280a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e73ffb82-9839-4011-b538-1c8603619ef7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_466d97cd-d218-4d59-a4ef-2d51368a280a" xlink:to="loc_srt_NameOfMajorCustomerDomain_e73ffb82-9839-4011-b538-1c8603619ef7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FederalGovernmentMember_43550140-4570-44e5-9600-44b62a6c0991" xlink:href="hum-20221231.xsd#hum_FederalGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e73ffb82-9839-4011-b538-1c8603619ef7" xlink:to="loc_hum_FederalGovernmentMember_43550140-4570-44e5-9600-44b62a6c0991" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SEGMENTINFORMATIONSegmentResultsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="extended" id="i935b4a25e5cf4d179f360e494891105a_SEGMENTINFORMATIONSegmentResultsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_3a0eaddb-1859-43b3-bc4c-f03f4b3a7ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_PremiumsEarnedNet_3a0eaddb-1859-43b3-bc4c-f03f4b3a7ea3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_394b83f4-0d1e-4f47-9c17-43a64b363208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_394b83f4-0d1e-4f47-9c17-43a64b363208" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_90725eb1-0172-43cc-afce-2a037c8a391f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_Revenues_90725eb1-0172-43cc-afce-2a037c8a391f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_1fec3a0a-43a0-44f5-97bb-27698387d9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_1fec3a0a-43a0-44f5-97bb-27698387d9ac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_bb729c26-414f-43af-b587-dc4bc66e7bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_bb729c26-414f-43af-b587-dc4bc66e7bb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2fc3a199-7ce2-4740-a0b0-1f4695e02b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2fc3a199-7ce2-4740-a0b0-1f4695e02b69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement_f412ab57-99e9-49a2-a038-065d6805432f" xlink:href="hum-20221231.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_hum_DepreciationAndAmortizationIncomeStatement_f412ab57-99e9-49a2-a038-065d6805432f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_400c18e9-fb5a-4776-b6bc-10700f1b9409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_400c18e9-fb5a-4776-b6bc-10700f1b9409" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e0fdb9e3-ce86-4ed9-95fa-16806dcbed98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_OperatingIncomeLoss_e0fdb9e3-ce86-4ed9-95fa-16806dcbed98" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_e338fd41-c42c-4f70-b08e-490ec37d23fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_e338fd41-c42c-4f70-b08e-490ec37d23fb" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c83a31c1-fb0d-42ca-beaa-524d7e439e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_InterestExpense_c83a31c1-fb0d-42ca-beaa-524d7e439e19" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_968b5fd4-f568-4d57-82b7-b32dbd15437b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_968b5fd4-f568-4d57-82b7-b32dbd15437b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_04d8e8a0-2942-48ec-9931-43adcc27b956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_04d8e8a0-2942-48ec-9931-43adcc27b956" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c987435b-8d25-4b2a-8ee3-dd89add11e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c987435b-8d25-4b2a-8ee3-dd89add11e39" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82248c55-5aa8-48e1-b041-8f55a8adbbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82248c55-5aa8-48e1-b041-8f55a8adbbe5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_92d5a320-ff16-4056-b99e-ae62d1e642c4" xlink:href="hum-20221231.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_92d5a320-ff16-4056-b99e-ae62d1e642c4" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_4951eb24-9b31-4ad3-b784-31519733923f" xlink:href="hum-20221231.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_4951eb24-9b31-4ad3-b784-31519733923f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_81ebe554-85cd-4a3f-9ac5-b27ee904f709" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:to="loc_srt_ConsolidationItemsAxis_81ebe554-85cd-4a3f-9ac5-b27ee904f709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_81ebe554-85cd-4a3f-9ac5-b27ee904f709_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_81ebe554-85cd-4a3f-9ac5-b27ee904f709" xlink:to="loc_srt_ConsolidationItemsDomain_81ebe554-85cd-4a3f-9ac5-b27ee904f709_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_81ebe554-85cd-4a3f-9ac5-b27ee904f709" xlink:to="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_4817afbf-2537-4fca-9f26-c75350cddfba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:to="loc_us-gaap_OperatingSegmentsMember_4817afbf-2537-4fca-9f26-c75350cddfba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CorporateAndEliminationsMember_2b85677c-77a5-4049-9623-cb3bab8179ed" xlink:href="hum-20221231.xsd#hum_CorporateAndEliminationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:to="loc_hum_CorporateAndEliminationsMember_2b85677c-77a5-4049-9623-cb3bab8179ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_a99a89c1-f0dc-43ce-8067-900e97e0e4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:to="loc_us-gaap_IntersegmentEliminationMember_a99a89c1-f0dc-43ce-8067-900e97e0e4fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_97facb81-9f4c-4c82-bfcf-b8107119fbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_97facb81-9f4c-4c82-bfcf-b8107119fbda" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_97facb81-9f4c-4c82-bfcf-b8107119fbda_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_97facb81-9f4c-4c82-bfcf-b8107119fbda" xlink:to="loc_us-gaap_SegmentDomain_97facb81-9f4c-4c82-bfcf-b8107119fbda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d17bdb3-e2c2-4e10-97c1-ceacd20f88db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_97facb81-9f4c-4c82-bfcf-b8107119fbda" xlink:to="loc_us-gaap_SegmentDomain_0d17bdb3-e2c2-4e10-97c1-ceacd20f88db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember_83517b0c-0072-4d20-983b-06b2dfce672e" xlink:href="hum-20221231.xsd#hum_InsuranceSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d17bdb3-e2c2-4e10-97c1-ceacd20f88db" xlink:to="loc_hum_InsuranceSegmentMember_83517b0c-0072-4d20-983b-06b2dfce672e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember_cf54e971-97bb-4b93-8a92-2a35f17b5a88" xlink:href="hum-20221231.xsd#hum_CenterWellSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0d17bdb3-e2c2-4e10-97c1-ceacd20f88db" xlink:to="loc_hum_CenterWellSegmentMember_cf54e971-97bb-4b93-8a92-2a35f17b5a88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_bbf4a88d-ab7e-4824-9426-b8b1bd7ee519" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:to="loc_srt_MajorCustomersAxis_bbf4a88d-ab7e-4824-9426-b8b1bd7ee519" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_bbf4a88d-ab7e-4824-9426-b8b1bd7ee519_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_bbf4a88d-ab7e-4824-9426-b8b1bd7ee519" xlink:to="loc_srt_NameOfMajorCustomerDomain_bbf4a88d-ab7e-4824-9426-b8b1bd7ee519_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_bbf4a88d-ab7e-4824-9426-b8b1bd7ee519" xlink:to="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareAdvantageMember_cc37e4da-f7b0-4a06-96d1-d3060b3fa452" xlink:href="hum-20221231.xsd#hum_MedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_MedicareAdvantageMember_cc37e4da-f7b0-4a06-96d1-d3060b3fa452" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GroupMedicareAdvantageMember_f9364f13-c261-4fcf-b9bb-27c4a783d288" xlink:href="hum-20221231.xsd#hum_GroupMedicareAdvantageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_GroupMedicareAdvantageMember_f9364f13-c261-4fcf-b9bb-27c4a783d288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember_f75a0372-3583-47fb-bf83-2348eaa354ff" xlink:href="hum-20221231.xsd#hum_MedicareStandAlonePrescriptionDrugPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember_f75a0372-3583-47fb-bf83-2348eaa354ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember_7640f16d-6869-419e-ad77-9c339f149e01" xlink:href="hum-20221231.xsd#hum_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_MedicareMember_7640f16d-6869-419e-ad77-9c339f149e01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FullyInsuredMember_0e8e5a42-0016-4517-9f56-60bdb0a1740c" xlink:href="hum-20221231.xsd#hum_FullyInsuredMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_FullyInsuredMember_0e8e5a42-0016-4517-9f56-60bdb0a1740c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SpecialtyMember_210f5e48-1766-4050-9753-e0fff11e7788" xlink:href="hum-20221231.xsd#hum_SpecialtyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_SpecialtyMember_210f5e48-1766-4050-9753-e0fff11e7788" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidAndOtherMember_b9c07b97-d3c2-4639-9683-3a472ebe1d68" xlink:href="hum-20221231.xsd#hum_MedicaidAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_MedicaidAndOtherMember_b9c07b97-d3c2-4639-9683-3a472ebe1d68" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsMember_2695be3e-d988-49a1-9420-6fd75fb6403f" xlink:href="hum-20221231.xsd#hum_HomeSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_HomeSolutionsMember_2695be3e-d988-49a1-9420-6fd75fb6403f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderMember_292db3aa-743e-4f2a-8854-3679d03cc8aa" xlink:href="hum-20221231.xsd#hum_ProviderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_ProviderMember_292db3aa-743e-4f2a-8854-3679d03cc8aa" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ASOAndOtherMember_62b3cde9-cb3d-45de-a860-735568c98111" xlink:href="hum-20221231.xsd#hum_ASOAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_ASOAndOtherMember_62b3cde9-cb3d-45de-a860-735568c98111" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PharmacyMember_4d58735f-7eca-4eb3-9f14-534278a9b0b0" xlink:href="hum-20221231.xsd#hum_PharmacyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_PharmacyMember_4d58735f-7eca-4eb3-9f14-534278a9b0b0" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5fe31d14-e526-4490-af26-7827b2e2fff5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:to="loc_srt_ProductOrServiceAxis_5fe31d14-e526-4490-af26-7827b2e2fff5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5fe31d14-e526-4490-af26-7827b2e2fff5_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5fe31d14-e526-4490-af26-7827b2e2fff5" xlink:to="loc_srt_ProductsAndServicesDomain_5fe31d14-e526-4490-af26-7827b2e2fff5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_be4dc748-3625-4629-9da1-846283969196" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5fe31d14-e526-4490-af26-7827b2e2fff5" xlink:to="loc_srt_ProductsAndServicesDomain_be4dc748-3625-4629-9da1-846283969196" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_bae88f09-d5e7-414e-ad9c-62f6e957fc40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_be4dc748-3625-4629-9da1-846283969196" xlink:to="loc_us-gaap_ServiceMember_bae88f09-d5e7-414e-ad9c-62f6e957fc40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_584489ee-06b6-4d43-a721-aa3b2cbf3328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_be4dc748-3625-4629-9da1-846283969196" xlink:to="loc_us-gaap_ProductMember_584489ee-06b6-4d43-a721-aa3b2cbf3328" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/REINSURANCEDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#REINSURANCEDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/REINSURANCEDetails" xlink:type="extended" id="ida399e5399094df89285c16f9092718b_REINSURANCEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_d892b7a0-cc57-4d3f-8cab-81471a67aad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_us-gaap_ReinsuranceRecoverables_d892b7a0-cc57-4d3f-8cab-81471a67aad0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfCoinsuranceAgreement_03c5d3ae-e49a-4307-8de7-454c5edd2f5b" xlink:href="hum-20221231.xsd#hum_PercentageOfCoinsuranceAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_hum_PercentageOfCoinsuranceAgreement_03c5d3ae-e49a-4307-8de7-454c5edd2f5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsWritten_157cb390-b49c-47c9-8800-a801e643a162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsWritten"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_us-gaap_CededPremiumsWritten_157cb390-b49c-47c9-8800-a801e643a162" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_a00c6c8e-ccbe-4339-8a57-f59c2f91dc52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_a00c6c8e-ccbe-4339-8a57-f59c2f91dc52" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance_4c972f9c-8f0a-4187-9dbc-8f38d9d31521" xlink:href="hum-20221231.xsd#hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance_4c972f9c-8f0a-4187-9dbc-8f38d9d31521" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer_eb36825f-015b-4f4a-b8ff-5f7da18d2542" xlink:href="hum-20221231.xsd#hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer_eb36825f-015b-4f4a-b8ff-5f7da18d2542" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:href="hum-20221231.xsd#hum_ReinsuranceTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78af9072-c05f-4a18-8344-65cc078aa091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78af9072-c05f-4a18-8344-65cc078aa091" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_78af9072-c05f-4a18-8344-65cc078aa091_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78af9072-c05f-4a18-8344-65cc078aa091" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_78af9072-c05f-4a18-8344-65cc078aa091_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54c3f9a5-a70a-4e0e-b5a6-10acefe4cd91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78af9072-c05f-4a18-8344-65cc078aa091" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54c3f9a5-a70a-4e0e-b5a6-10acefe4cd91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableMember_83ad90d8-c180-453e-9e67-71001e9b0414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54c3f9a5-a70a-4e0e-b5a6-10acefe4cd91" xlink:to="loc_us-gaap_ReinsuranceRecoverableMember_83ad90d8-c180-453e-9e67-71001e9b0414" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_52148fc4-6296-4454-b9cc-e59285f1f758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_52148fc4-6296-4454-b9cc-e59285f1f758" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_52148fc4-6296-4454-b9cc-e59285f1f758_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_52148fc4-6296-4454-b9cc-e59285f1f758" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_52148fc4-6296-4454-b9cc-e59285f1f758_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9e44a867-d2e7-4fd7-89a1-06849e46a256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_52148fc4-6296-4454-b9cc-e59285f1f758" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9e44a867-d2e7-4fd7-89a1-06849e46a256" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurerConcentrationRiskMember_7b403937-974a-46de-88ef-1d58e844e6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9e44a867-d2e7-4fd7-89a1-06849e46a256" xlink:to="loc_us-gaap_ReinsurerConcentrationRiskMember_7b403937-974a-46de-88ef-1d58e844e6fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LongDurationInsuranceProductsAxis_163f0de6-553c-4545-9980-b4f9d99672cc" xlink:href="hum-20221231.xsd#hum_LongDurationInsuranceProductsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:to="loc_hum_LongDurationInsuranceProductsAxis_163f0de6-553c-4545-9980-b4f9d99672cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LongDurationInsuranceProductsDomain_163f0de6-553c-4545-9980-b4f9d99672cc_default" xlink:href="hum-20221231.xsd#hum_LongDurationInsuranceProductsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hum_LongDurationInsuranceProductsAxis_163f0de6-553c-4545-9980-b4f9d99672cc" xlink:to="loc_hum_LongDurationInsuranceProductsDomain_163f0de6-553c-4545-9980-b4f9d99672cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LongDurationInsuranceProductsDomain_e8b14a8d-fb29-44d9-b506-779eb2c22341" xlink:href="hum-20221231.xsd#hum_LongDurationInsuranceProductsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hum_LongDurationInsuranceProductsAxis_163f0de6-553c-4545-9980-b4f9d99672cc" xlink:to="loc_hum_LongDurationInsuranceProductsDomain_e8b14a8d-fb29-44d9-b506-779eb2c22341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CoinsuranceAgreementMember_c52e8a9b-964b-46e2-9328-518460996730" xlink:href="hum-20221231.xsd#hum_CoinsuranceAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hum_LongDurationInsuranceProductsDomain_e8b14a8d-fb29-44d9-b506-779eb2c22341" xlink:to="loc_hum_CoinsuranceAgreementMember_c52e8a9b-964b-46e2-9328-518460996730" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a4e7bddd-dde2-4403-b82a-c9cb217ebd1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:to="loc_srt_ProductOrServiceAxis_a4e7bddd-dde2-4403-b82a-c9cb217ebd1a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a4e7bddd-dde2-4403-b82a-c9cb217ebd1a_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a4e7bddd-dde2-4403-b82a-c9cb217ebd1a" xlink:to="loc_srt_ProductsAndServicesDomain_a4e7bddd-dde2-4403-b82a-c9cb217ebd1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4e39ac1e-1af5-4697-89da-292166261e69" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a4e7bddd-dde2-4403-b82a-c9cb217ebd1a" xlink:to="loc_srt_ProductsAndServicesDomain_4e39ac1e-1af5-4697-89da-292166261e69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProtectiveLifeInsuranceCompanyMember_22dda5d9-1ee8-4014-9351-7236d26896fd" xlink:href="hum-20221231.xsd#hum_ProtectiveLifeInsuranceCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4e39ac1e-1af5-4697-89da-292166261e69" xlink:to="loc_hum_ProtectiveLifeInsuranceCompanyMember_22dda5d9-1ee8-4014-9351-7236d26896fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AllOthersMember_41ad9785-e44a-4333-a0c3-3d2ee47114b1" xlink:href="hum-20221231.xsd#hum_AllOthersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_4e39ac1e-1af5-4697-89da-292166261e69" xlink:to="loc_hum_AllOthersMember_41ad9785-e44a-4333-a0c3-3d2ee47114b1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails" xlink:type="extended" id="i0c4e09fe7c5742528acb10d6878d74ec_SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_28abe6dd-dc98-44f2-9da5-828346a27814" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_28abe6dd-dc98-44f2-9da5-828346a27814" xlink:to="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97cae472-41df-42b9-8eee-80873abb9ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97cae472-41df-42b9-8eee-80873abb9ee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_7f669a31-87e6-46e7-9f78-3df7ab110882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_ShortTermInvestments_7f669a31-87e6-46e7-9f78-3df7ab110882" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent_7faf7d45-8965-4d2d-8d83-549b939b1091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent_7faf7d45-8965-4d2d-8d83-549b939b1091" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b450c043-062f-4758-8f4b-0234a4447c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_OtherAssetsCurrent_b450c043-062f-4758-8f4b-0234a4447c83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f022cd68-a4e9-40f1-80da-d3bde22640e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_AssetsCurrent_f022cd68-a4e9-40f1-80da-d3bde22640e2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d9ac059e-e42e-4c93-897c-f0386980d819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d9ac059e-e42e-4c93-897c-f0386980d819" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InvestmentInRelatedPartiesAndSubsidiaries_eb409b8f-3fda-420d-9fef-5bf18d881ea2" xlink:href="hum-20221231.xsd#hum_InvestmentInRelatedPartiesAndSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_hum_InvestmentInRelatedPartiesAndSubsidiaries_eb409b8f-3fda-420d-9fef-5bf18d881ea2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1b9c40fc-41a1-47e2-983a-a6752f4e804b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1b9c40fc-41a1-47e2-983a-a6752f4e804b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a418f5f9-91f9-4339-ac81-03a2004720d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_us-gaap_Assets_a418f5f9-91f9-4339-ac81-03a2004720d0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_28abe6dd-dc98-44f2-9da5-828346a27814" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_bd0f8c09-7bc9-4eeb-ab5d-379538dd66da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_bd0f8c09-7bc9-4eeb-ab5d-379538dd66da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d97b15d4-504e-41ac-95c4-c9933b851f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_DebtCurrent_d97b15d4-504e-41ac-95c4-c9933b851f9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_7506258d-b28e-4c23-8ff1-4a57fde7af9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_7506258d-b28e-4c23-8ff1-4a57fde7af9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftLiability_9f5425c9-f2b8-43c3-9aec-89ca3e7fdbe4" xlink:href="hum-20221231.xsd#hum_BookOverdraftLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_hum_BookOverdraftLiability_9f5425c9-f2b8-43c3-9aec-89ca3e7fdbe4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d7d543b5-0d03-490c-9434-1bf5d72fca76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d7d543b5-0d03-490c-9434-1bf5d72fca76" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_13a24593-e01a-49f9-80be-86c89f5e6fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_LiabilitiesCurrent_13a24593-e01a-49f9-80be-86c89f5e6fcc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a416fe03-971a-4272-9d5f-1b182602107a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a416fe03-971a-4272-9d5f-1b182602107a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d16dc9e2-564a-432a-9336-a3db5622e010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d16dc9e2-564a-432a-9336-a3db5622e010" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dba18ba1-6870-4f6e-9913-400c5d359b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_Liabilities_dba18ba1-6870-4f6e-9913-400c5d359b43" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c2638d4f-437d-4ec1-8938-f7ac74766226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c2638d4f-437d-4ec1-8938-f7ac74766226" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_eb9b3199-3aea-44cc-94ab-edf551fdc448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_PreferredStockValue_eb9b3199-3aea-44cc-94ab-edf551fdc448" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_282757b4-1392-4a41-aa13-551a65e038e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_CommonStockValue_282757b4-1392-4a41-aa13-551a65e038e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3ba55266-860e-4e89-b244-85ce11f9f3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3ba55266-860e-4e89-b244-85ce11f9f3a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_64418c3d-db7b-42b8-bea5-73d250525ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_64418c3d-db7b-42b8-bea5-73d250525ee2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_71e5494a-8e94-4323-9820-3abd1fe03a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_71e5494a-8e94-4323-9820-3abd1fe03a44" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_7df2611c-365c-4de0-bb24-c23f497b1d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_TreasuryStockCommonValue_7df2611c-365c-4de0-bb24-c23f497b1d41" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_faada2f9-b74c-4310-928c-0e69644cd284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_StockholdersEquity_faada2f9-b74c-4310-928c-0e69644cd284" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_71dbd9bb-3e2d-4096-aa29-456c103b5207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_71dbd9bb-3e2d-4096-aa29-456c103b5207" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_73044ba8-f4a2-4810-b826-14d62d70f8db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_28abe6dd-dc98-44f2-9da5-828346a27814" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_73044ba8-f4a2-4810-b826-14d62d70f8db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_7a0fef0c-4afa-4d6a-ae91-cb6289b666c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_73044ba8-f4a2-4810-b826-14d62d70f8db" xlink:to="loc_srt_ConsolidatedEntitiesAxis_7a0fef0c-4afa-4d6a-ae91-cb6289b666c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_7a0fef0c-4afa-4d6a-ae91-cb6289b666c1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_7a0fef0c-4afa-4d6a-ae91-cb6289b666c1" xlink:to="loc_srt_ConsolidatedEntitiesDomain_7a0fef0c-4afa-4d6a-ae91-cb6289b666c1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_afc301da-b016-4f25-b0f5-a936092b250f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_7a0fef0c-4afa-4d6a-ae91-cb6289b666c1" xlink:to="loc_srt_ConsolidatedEntitiesDomain_afc301da-b016-4f25-b0f5-a936092b250f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_10528698-2b98-4bd1-887b-4c8f0d5b1d73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_afc301da-b016-4f25-b0f5-a936092b250f" xlink:to="loc_srt_ParentCompanyMember_10528698-2b98-4bd1-887b-4c8f0d5b1d73" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails" xlink:type="extended" id="ife068af64d6f42fe9827a2a6f3013459_SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e1d6939d-4546-45f0-b9a1-6cf87ec26e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e1d6939d-4546-45f0-b9a1-6cf87ec26e7a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b13d469e-4835-4314-af1b-da5e78ce4767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b13d469e-4835-4314-af1b-da5e78ce4767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_33413aba-b451-4aa3-8046-2e79b551021e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_PreferredStockSharesIssued_33413aba-b451-4aa3-8046-2e79b551021e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_29a02692-5666-4280-82b6-694145dde4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_29a02692-5666-4280-82b6-694145dde4e7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9f29355d-7510-4496-b607-3f4698c724a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9f29355d-7510-4496-b607-3f4698c724a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_abc19f65-55dc-4786-813f-00001d7d17e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_CommonStockSharesIssued_abc19f65-55dc-4786-813f-00001d7d17e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_871be45c-0516-4851-965f-053ecc3f35ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_TreasuryStockCommonShares_871be45c-0516-4851-965f-053ecc3f35ab" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_57cfddb1-c8c6-47a4-8c8e-62097a7f9cdc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_57cfddb1-c8c6-47a4-8c8e-62097a7f9cdc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d3ef47ca-b46b-425c-876a-112dec3df96e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_57cfddb1-c8c6-47a4-8c8e-62097a7f9cdc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d3ef47ca-b46b-425c-876a-112dec3df96e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_d3ef47ca-b46b-425c-876a-112dec3df96e_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d3ef47ca-b46b-425c-876a-112dec3df96e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_d3ef47ca-b46b-425c-876a-112dec3df96e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_766418d6-7fdb-4f93-a87f-8f8eea905226" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d3ef47ca-b46b-425c-876a-112dec3df96e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_766418d6-7fdb-4f93-a87f-8f8eea905226" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_0df7013a-9286-47bd-b0b1-3628d7efa1b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_766418d6-7fdb-4f93-a87f-8f8eea905226" xlink:to="loc_srt_ParentCompanyMember_0df7013a-9286-47bd-b0b1-3628d7efa1b2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails" xlink:type="extended" id="ifa40317b74ae4c0bb56ad857c06b198e_SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ManagementFeesChargedToOperatingSubsidiaries_41ce7192-501d-4818-a8b0-9594a42651e5" xlink:href="hum-20221231.xsd#hum_ManagementFeesChargedToOperatingSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:to="loc_hum_ManagementFeesChargedToOperatingSubsidiaries_41ce7192-501d-4818-a8b0-9594a42651e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InvestmentAndOtherIncomeNet_ada15007-ff8a-4843-9ff6-d76f33458be0" xlink:href="hum-20221231.xsd#hum_InvestmentAndOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:to="loc_hum_InvestmentAndOtherIncomeNet_ada15007-ff8a-4843-9ff6-d76f33458be0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_40bb91e5-32f0-46e2-a021-7c19ab066081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:to="loc_us-gaap_Revenues_40bb91e5-32f0-46e2-a021-7c19ab066081" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_695891c0-b14b-4ccd-8aad-3b8cc75bf00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_695891c0-b14b-4ccd-8aad-3b8cc75bf00f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d2541420-fa52-4fb7-9d77-7ec9f4e5a6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:to="loc_us-gaap_Depreciation_d2541420-fa52-4fb7-9d77-7ec9f4e5a6cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2e136c13-a973-4374-a069-70abd5889cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:to="loc_us-gaap_InterestExpense_2e136c13-a973-4374-a069-70abd5889cfc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9624fdca-ac11-4578-9220-90daf87030af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:to="loc_us-gaap_CostsAndExpenses_9624fdca-ac11-4578-9220-90daf87030af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_18e3743a-f7c0-4e23-b52f-2dda1b4ff222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_18e3743a-f7c0-4e23-b52f-2dda1b4ff222" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_7a85ed72-97c8-44e9-b348-1d547e1ef1f4" xlink:href="hum-20221231.xsd#hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_7a85ed72-97c8-44e9-b348-1d547e1ef1f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_52e57589-9b2c-42bf-81cb-455eb634d83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_52e57589-9b2c-42bf-81cb-455eb634d83f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_93ba4c0b-f483-4cee-b55d-c496430fda81" xlink:href="hum-20221231.xsd#hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_93ba4c0b-f483-4cee-b55d-c496430fda81" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EquityInNetEarningsOfSubsidiaries_a35b5d83-7091-4479-882a-2618b1a2a8cb" xlink:href="hum-20221231.xsd#hum_EquityInNetEarningsOfSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_hum_EquityInNetEarningsOfSubsidiaries_a35b5d83-7091-4479-882a-2618b1a2a8cb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_783e2269-fb1c-49a0-9b18-47f44c049cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_783e2269-fb1c-49a0-9b18-47f44c049cea" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f9a38658-c014-424a-ad22-3d6f2ff14bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_ProfitLoss_f9a38658-c014-424a-ad22-3d6f2ff14bec" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_ca01b424-318f-43bf-881d-dbee2f05e291" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_ca01b424-318f-43bf-881d-dbee2f05e291" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1b1b80bb-c9fe-486a-b7b6-6fdd67816bcb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_ca01b424-318f-43bf-881d-dbee2f05e291" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1b1b80bb-c9fe-486a-b7b6-6fdd67816bcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_1b1b80bb-c9fe-486a-b7b6-6fdd67816bcb_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1b1b80bb-c9fe-486a-b7b6-6fdd67816bcb" xlink:to="loc_srt_ConsolidatedEntitiesDomain_1b1b80bb-c9fe-486a-b7b6-6fdd67816bcb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_659e5bc2-7494-4cf0-8593-ec5a7a198490" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1b1b80bb-c9fe-486a-b7b6-6fdd67816bcb" xlink:to="loc_srt_ConsolidatedEntitiesDomain_659e5bc2-7494-4cf0-8593-ec5a7a198490" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_6374c6ef-3d85-46ff-8cac-39d2bd95cbe4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_659e5bc2-7494-4cf0-8593-ec5a7a198490" xlink:to="loc_srt_ParentCompanyMember_6374c6ef-3d85-46ff-8cac-39d2bd95cbe4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails" xlink:type="extended" id="ib833944e870c4a2b8594b1dae16922ec_SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c67658b7-87c2-4337-8675-b60519b47d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:to="loc_us-gaap_NetIncomeLoss_c67658b7-87c2-4337-8675-b60519b47d1c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_160638cd-b460-4d71-b267-ad2623b6147f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_160638cd-b460-4d71-b267-ad2623b6147f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_7f072a6e-2e9b-4e1a-878e-1df39525cc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_7f072a6e-2e9b-4e1a-878e-1df39525cc4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4629a6a2-dbdb-4a7c-8841-14174c2d2e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4629a6a2-dbdb-4a7c-8841-14174c2d2e10" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_df0596bd-667b-4b12-9dd8-bd600fcdb9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_df0596bd-667b-4b12-9dd8-bd600fcdb9cb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_b0b908a1-d83a-41a9-a430-5e47a59a5e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_b0b908a1-d83a-41a9-a430-5e47a59a5e64" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_0956f03c-018d-415b-8e69-a1005c5d0aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_0956f03c-018d-415b-8e69-a1005c5d0aba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ecb53763-57c6-45b2-b1a4-427f033eb3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ecb53763-57c6-45b2-b1a4-427f033eb3ff" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_1cd04ac5-9ca5-4af3-bf3c-163acbf45612" xlink:href="hum-20221231.xsd#hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:to="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_1cd04ac5-9ca5-4af3-bf3c-163acbf45612" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0c079e0d-fcdc-4fbc-ae7f-b682091727e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0c079e0d-fcdc-4fbc-ae7f-b682091727e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a5fb2686-7911-4f1f-be44-69f2244b811f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a5fb2686-7911-4f1f-be44-69f2244b811f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_69868bdf-34bd-4dd3-a83f-5e5b25c3e7ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a5fb2686-7911-4f1f-be44-69f2244b811f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_69868bdf-34bd-4dd3-a83f-5e5b25c3e7ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_69868bdf-34bd-4dd3-a83f-5e5b25c3e7ca_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69868bdf-34bd-4dd3-a83f-5e5b25c3e7ca" xlink:to="loc_srt_ConsolidatedEntitiesDomain_69868bdf-34bd-4dd3-a83f-5e5b25c3e7ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e54a937b-dc6c-48d8-949b-c25fdbfde00e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69868bdf-34bd-4dd3-a83f-5e5b25c3e7ca" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e54a937b-dc6c-48d8-949b-c25fdbfde00e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d33c9e39-1706-4be5-a065-dd5c07aa7cda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e54a937b-dc6c-48d8-949b-c25fdbfde00e" xlink:to="loc_srt_ParentCompanyMember_d33c9e39-1706-4be5-a065-dd5c07aa7cda" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails" xlink:type="extended" id="id55b31fb8c864c938dabce249d63aa45_SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_89a9b303-2e1f-44a2-a79a-19d1c65017bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_89a9b303-2e1f-44a2-a79a-19d1c65017bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_adc53b8e-f734-4204-9272-b6ee58d9164c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_adc53b8e-f734-4204-9272-b6ee58d9164c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CapitalContributionsToOperatingSubsidiaries_bfbe3aab-9db2-4a5b-8057-6c600ec5e690" xlink:href="hum-20221231.xsd#hum_CapitalContributionsToOperatingSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_hum_CapitalContributionsToOperatingSubsidiaries_bfbe3aab-9db2-4a5b-8057-6c600ec5e690" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_4cd69ba7-5218-41cb-9938-b86b25869b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_4cd69ba7-5218-41cb-9938-b86b25869b19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_345ae31c-c026-4820-9ccf-78c842259ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_345ae31c-c026-4820-9ccf-78c842259ea2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_63390be6-41b2-459e-8541-415073159fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_63390be6-41b2-459e-8541-415073159fef" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_56d6deed-d49e-4f2e-a14a-59d733a4f1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_56d6deed-d49e-4f2e-a14a-59d733a4f1e5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_091f741e-158b-4635-8e2f-15c921ec51a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_091f741e-158b-4635-8e2f-15c921ec51a0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_a1dc77ec-5c80-46ce-9529-c9c1c71a9d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_a1dc77ec-5c80-46ce-9529-c9c1c71a9d3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d2af4f20-1b64-4eec-90f7-50d9b6e76437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d2af4f20-1b64-4eec-90f7-50d9b6e76437" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_f9bf1156-7f8d-4e1e-b6fb-df83f947c859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_f9bf1156-7f8d-4e1e-b6fb-df83f947c859" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_1ac7da92-5ec7-46cf-a9dd-77988410b730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_1ac7da92-5ec7-46cf-a9dd-77988410b730" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_3926a7b2-c4ce-4416-8b24-77ceb6419706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_3926a7b2-c4ce-4416-8b24-77ceb6419706" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_8a6ff655-a8f7-4f9d-82c0-426fc56f56ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_8a6ff655-a8f7-4f9d-82c0-426fc56f56ad" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_a8a6e484-a3db-423f-8623-aa48e139ddc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInBookOverdrafts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_a8a6e484-a3db-423f-8623-aa48e139ddc1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_716009be-0d83-4911-82b8-3e6f6427873c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_716009be-0d83-4911-82b8-3e6f6427873c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_bef1dcc2-d838-4b16-a8f4-77598566dd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_PaymentsOfDividends_bef1dcc2-d838-4b16-a8f4-77598566dd5d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProceedsFromStockOptionsExercisedAndOther_62c2198f-d27e-4f12-81e2-5f72ed4b60bf" xlink:href="hum-20221231.xsd#hum_ProceedsFromStockOptionsExercisedAndOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_hum_ProceedsFromStockOptionsExercisedAndOther_62c2198f-d27e-4f12-81e2-5f72ed4b60bf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ddcfb39a-1064-4d25-a72f-ad72a32ed7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ddcfb39a-1064-4d25-a72f-ad72a32ed7bf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_17f62d34-a969-4513-865e-ad1eadbabc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_17f62d34-a969-4513-865e-ad1eadbabc4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_737cbb4e-6806-49b4-a9dc-19845d2c8e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_737cbb4e-6806-49b4-a9dc-19845d2c8e33" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6cf4eede-8019-461b-b5b9-fb637947ad10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f8418e94-8414-4188-8c02-a7c35b4760e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f8418e94-8414-4188-8c02-a7c35b4760e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9affdf6a-7bf9-4e99-a3c5-48b485492e4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f8418e94-8414-4188-8c02-a7c35b4760e7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9affdf6a-7bf9-4e99-a3c5-48b485492e4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9affdf6a-7bf9-4e99-a3c5-48b485492e4c_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9affdf6a-7bf9-4e99-a3c5-48b485492e4c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9affdf6a-7bf9-4e99-a3c5-48b485492e4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3ce1a933-ee79-43f7-bdb6-31eb43a96c02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9affdf6a-7bf9-4e99-a3c5-48b485492e4c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3ce1a933-ee79-43f7-bdb6-31eb43a96c02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_6732c39d-4367-4387-9303-0422ea37f6c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3ce1a933-ee79-43f7-bdb6-31eb43a96c02" xlink:to="loc_srt_ParentCompanyMember_6732c39d-4367-4387-9303-0422ea37f6c3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>hum-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:be062877-2225-41e8-b603-0f500ed981f8,g:73ed13b8-2607-407e-984b-2bfb1b06116c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_c6b6fa67-6a35-4eb4-85e5-a0406de8e010_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligations in 2024</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A3.15PercentSeniorNotesDueDecember2022Member_6ae186f7-540e-40e7-8caf-08e22f8b60c7_terseLabel_en-US" xlink:label="lab_hum_A3.15PercentSeniorNotesDueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$600 million, 3.15% due December&#160;1, 2022</link:label>
    <link:label id="lab_hum_A3.15PercentSeniorNotesDueDecember2022Member_label_en-US" xlink:label="lab_hum_A3.15PercentSeniorNotesDueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.15 Percent Senior Notes Due December 2022 [Member]</link:label>
    <link:label id="lab_hum_A3.15PercentSeniorNotesDueDecember2022Member_documentation_en-US" xlink:label="lab_hum_A3.15PercentSeniorNotesDueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.15 Percent Senior Notes Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member" xlink:href="hum-20221231.xsd#hum_A3.15PercentSeniorNotesDueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member" xlink:to="lab_hum_A3.15PercentSeniorNotesDueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_35cbc71d-68ba-48e6-9d06-b174c898241c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements_58bb29a5-8e61-4fd8-8c69-b8fd1d9284fb_negatedTotalLabel_en-US" xlink:label="lab_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net reimbursements (payments)</link:label>
    <link:label id="lab_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements_label_en-US" xlink:label="lab_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidy And Discount Payments In Excess Of Reimbursements</link:label>
    <link:label id="lab_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements_documentation_en-US" xlink:label="lab_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidy And Discount Payments In Excess Of Reimbursements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements" xlink:to="lab_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod_70ed4bdb-f994-491e-9ea7-b5ba61615095_terseLabel_en-US" xlink:label="lab_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated vesting, termination of employment period</link:label>
    <link:label id="lab_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod_label_en-US" xlink:label="lab_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Termination Of Employment Period</link:label>
    <link:label id="lab_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod_documentation_en-US" xlink:label="lab_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Termination Of Employment Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod" xlink:href="hum-20221231.xsd#hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod" xlink:to="lab_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ReinsuranceTable_1dabbf44-a944-49d6-ac9a-ed10d360e327_terseLabel_en-US" xlink:label="lab_hum_ReinsuranceTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Table]</link:label>
    <link:label id="lab_hum_ReinsuranceTable_label_en-US" xlink:label="lab_hum_ReinsuranceTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Table]</link:label>
    <link:label id="lab_hum_ReinsuranceTable_documentation_en-US" xlink:label="lab_hum_ReinsuranceTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ReinsuranceTable" xlink:href="hum-20221231.xsd#hum_ReinsuranceTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ReinsuranceTable" xlink:to="lab_hum_ReinsuranceTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_56caabb6-f8eb-4934-83a3-fb8dcaafed8b_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_1c4bb570-3eec-4c6d-9aef-079bf06b783a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_643c8723-ce97-41e4-b191-cd09c78233f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity in Benefits Payable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ProtectiveLifeInsuranceCompanyMember_e95090b6-2edd-40a5-b956-c23585128dca_verboseLabel_en-US" xlink:label="lab_hum_ProtectiveLifeInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Protective Life Insurance Company</link:label>
    <link:label id="lab_hum_ProtectiveLifeInsuranceCompanyMember_label_en-US" xlink:label="lab_hum_ProtectiveLifeInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Protective Life Insurance Company [Member]</link:label>
    <link:label id="lab_hum_ProtectiveLifeInsuranceCompanyMember_documentation_en-US" xlink:label="lab_hum_ProtectiveLifeInsuranceCompanyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Protective Life Insurance Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProtectiveLifeInsuranceCompanyMember" xlink:href="hum-20221231.xsd#hum_ProtectiveLifeInsuranceCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ProtectiveLifeInsuranceCompanyMember" xlink:to="lab_hum_ProtectiveLifeInsuranceCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_fd0b70c0-83a0-4bf6-9947-1f3e0ed8e5a8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_a92b1603-365d-45c7-92e6-e50d312b5cbf_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_6d634b17-df84-40ef-81cc-dc8294aa4a54_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TermLoanDueOctober2023Member_bc5ce360-5e54-4d7e-82dc-5141d8c10df0_terseLabel_en-US" xlink:label="lab_hum_TermLoanDueOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term loan, due October 29, 2023</link:label>
    <link:label id="lab_hum_TermLoanDueOctober2023Member_label_en-US" xlink:label="lab_hum_TermLoanDueOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due October 2023 [Member]</link:label>
    <link:label id="lab_hum_TermLoanDueOctober2023Member_documentation_en-US" xlink:label="lab_hum_TermLoanDueOctober2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan Due October 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanDueOctober2023Member" xlink:href="hum-20221231.xsd#hum_TermLoanDueOctober2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TermLoanDueOctober2023Member" xlink:to="lab_hum_TermLoanDueOctober2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_88f08fbb-0f90-4e1a-90a4-a4aca1c88731_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt outstanding</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember_e6e61150-549f-4d08-9426-8fb344f97cf1_terseLabel_en-US" xlink:label="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare stand-alone PDP</link:label>
    <link:label id="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember_label_en-US" xlink:label="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Stand Alone Prescription Drug Plan [Member]</link:label>
    <link:label id="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember_documentation_en-US" xlink:label="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Stand Alone Prescription Drug Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:href="hum-20221231.xsd#hum_MedicareStandAlonePrescriptionDrugPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:to="lab_hum_MedicareStandAlonePrescriptionDrugPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A3.95PercentSeniorNotesDueAugust2049Member_ecf06511-5757-4a43-b16a-ada93f275a92_terseLabel_en-US" xlink:label="lab_hum_A3.95PercentSeniorNotesDueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500&#160;million, 3.95% due August 15, 2049</link:label>
    <link:label id="lab_hum_A3.95PercentSeniorNotesDueAugust2049Member_label_en-US" xlink:label="lab_hum_A3.95PercentSeniorNotesDueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A 3.95 Percent Senior Notes Due August 2049 [Member]</link:label>
    <link:label id="lab_hum_A3.95PercentSeniorNotesDueAugust2049Member_documentation_en-US" xlink:label="lab_hum_A3.95PercentSeniorNotesDueAugust2049Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A 3.95 Percent Senior Notes Due August 2049 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.95PercentSeniorNotesDueAugust2049Member" xlink:href="hum-20221231.xsd#hum_A3.95PercentSeniorNotesDueAugust2049Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A3.95PercentSeniorNotesDueAugust2049Member" xlink:to="lab_hum_A3.95PercentSeniorNotesDueAugust2049Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_1a75bc49-ba55-43b6-ae4e-3ac416d80cb7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_98afd25e-efd9-468e-a336-d3bb488ca97c_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits payable</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_8e7ae3c7-1157-4a33-9af9-12bd454bbfed_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances, beginning of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_6b0b6632-65a4-4b54-bd83-1ddb75b4c321_periodEndLabel_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances, end of period</link:label>
    <link:label id="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_88abe9b2-a2f3-4821-a802-12bf1f9206df_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_9ce251a3-9ac2-4b53-9079-48fc9f489995_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_4b068d4d-d649-4132-acb7-add887da2d2b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_de06b00b-ea38-4689-8a0b-9f41bf9f5705_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_77713b88-19a5-43da-9c22-d24ab90b0a4a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis points spread on variable rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_94f53bb6-6d6e-4cf7-a3af-9ea2463d5540_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_964715a8-7d3b-4e62-af01-c54961b9ad83_verboseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e17111ff-25f8-4827-8d1c-4c7e5a070845_negatedLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock_ff985157-e02f-4ad2-a701-ca5acc206be1_terseLabel_en-US" xlink:label="lab_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Details of Dividend Payments</link:label>
    <link:label id="lab_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock_label_en-US" xlink:label="lab_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Dividends Declared And Paid Table [Table Text Block]</link:label>
    <link:label id="lab_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock_documentation_en-US" xlink:label="lab_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular disclosure of all or some of the information related to dividends declared and paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock" xlink:href="hum-20221231.xsd#hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock" xlink:to="lab_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_b3aad7bc-a108-4fe5-86ad-f2d41e8f86db_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9291c23d-cee8-46f7-bf3c-a702d89e0adc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate (percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_8dc7509b-2179-4d79-9e42-2b16a29991ac_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock_58eb6ce3-da8c-4c06-be8c-059a9928d6a1_terseLabel_en-US" xlink:label="lab_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits Payable and Benefits Expense Recognition</link:label>
    <link:label id="lab_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock_label_en-US" xlink:label="lab_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits Payable And Benefit Expense Recognition Policy [Policy Text Block]</link:label>
    <link:label id="lab_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes the entity's accounting policies, methodologies, and assumptions for estimating its liability as of the balance sheet date for the cost of settling reported and unreported claims.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock" xlink:href="hum-20221231.xsd#hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock" xlink:to="lab_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_2c1046a6-1f75-4e99-9fff-3467cdcb7ec8_terseLabel_en-US" xlink:label="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Member co-share amounts and government subsidies</link:label>
    <link:label id="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_label_en-US" xlink:label="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government And Health Plan Member Subsidies Amount</link:label>
    <link:label id="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_documentation_en-US" xlink:label="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of member co-share amounts and government subsidies that are excluded from benefits expense because the health plans do not bear responsibility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:href="hum-20221231.xsd#hum_GovernmentAndHealthPlanMemberSubsidiesAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:to="lab_hum_GovernmentAndHealthPlanMemberSubsidiesAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_63de6f2f-3b7b-4fd5-b9a4-adae9310ecbc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital in excess of par value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_SpecialtyMember_baf0d28d-a0b7-4af4-9510-2491762f6635_terseLabel_en-US" xlink:label="lab_hum_SpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty</link:label>
    <link:label id="lab_hum_SpecialtyMember_label_en-US" xlink:label="lab_hum_SpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty [Member]</link:label>
    <link:label id="lab_hum_SpecialtyMember_documentation_en-US" xlink:label="lab_hum_SpecialtyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SpecialtyMember" xlink:href="hum-20221231.xsd#hum_SpecialtyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_SpecialtyMember" xlink:to="lab_hum_SpecialtyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_e6e6cfa3-94bd-42c4-92fb-072357720438_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States and Puerto Rico</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_February2021ShareRepurchaseAuthorizationMember_4eb93ebc-9d84-4140-a6df-2ac391b20bb5_terseLabel_en-US" xlink:label="lab_hum_February2021ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Authorization</link:label>
    <link:label id="lab_hum_February2021ShareRepurchaseAuthorizationMember_label_en-US" xlink:label="lab_hum_February2021ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Share Repurchase Authorization [Member]</link:label>
    <link:label id="lab_hum_February2021ShareRepurchaseAuthorizationMember_documentation_en-US" xlink:label="lab_hum_February2021ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">February 2021 Share Repurchase Authorization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_February2021ShareRepurchaseAuthorizationMember" xlink:href="hum-20221231.xsd#hum_February2021ShareRepurchaseAuthorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_February2021ShareRepurchaseAuthorizationMember" xlink:to="lab_hum_February2021ShareRepurchaseAuthorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8c066505-5fbd-4ac1-8b0b-b63aa7350f6e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_f4425b84-5df1-49aa-bf64-e9cccd92da24_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_af580f85-8bdd-4c3a-966a-af07345ca22b_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_08410e5f-6a40-4c5e-98bc-c724fd16a32f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of antidilutive stock options and restricted stock&#160;awards excluded from computation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FederalGovernmentMember_de2e8752-5a53-4d41-bbdf-0144f4817937_terseLabel_en-US" xlink:label="lab_hum_FederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal government contracts</link:label>
    <link:label id="lab_hum_FederalGovernmentMember_label_en-US" xlink:label="lab_hum_FederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Government [Member]</link:label>
    <link:label id="lab_hum_FederalGovernmentMember_documentation_en-US" xlink:label="lab_hum_FederalGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FederalGovernmentMember" xlink:href="hum-20221231.xsd#hum_FederalGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FederalGovernmentMember" xlink:to="lab_hum_FederalGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_f8d54d15-bb2f-47fe-89c3-8d9686b66657_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total reclassification adjustment, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_73d5896a-1d78-4d62-ac9f-ce1c475f216f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturity of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_9f7cdfad-4fab-4e67-8c70-20ea314a93a8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_f4dc328d-5aef-442a-8a71-c7dcf1e1f03d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_28e9f988-bbe2-4f7f-9d51-b06328e5d01b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ProviderMember_818c3e7d-2aa2-4a89-9954-4be6dd416677_terseLabel_en-US" xlink:label="lab_hum_ProviderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider</link:label>
    <link:label id="lab_hum_ProviderMember_label_en-US" xlink:label="lab_hum_ProviderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider [Member]</link:label>
    <link:label id="lab_hum_ProviderMember_documentation_en-US" xlink:label="lab_hum_ProviderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderMember" xlink:href="hum-20221231.xsd#hum_ProviderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ProviderMember" xlink:to="lab_hum_ProviderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_02cb9008-16c7-4281-9a84-52f2f1739fff_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_84170ada-b9ce-44fc-81c8-bdc73b969c1c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average cost of capital</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_c359dc7c-18f1-4ea6-8544-bb377ff74b68_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain_6d5719b3-52b3-4d9f-99ee-607a21533b04_negatedTerseLabel_en-US" xlink:label="lab_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-taxable KAH gain</link:label>
    <link:label id="lab_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain_label_en-US" xlink:label="lab_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Non-Taxable KAH Gain</link:label>
    <link:label id="lab_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain_documentation_en-US" xlink:label="lab_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Non-Taxable KAH Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain" xlink:href="hum-20221231.xsd#hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain" xlink:to="lab_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_b0b1a989-12f0-4035-9c9a-9333b1a95758_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PaymentsForProceedsFromContractDeposits_85bc819d-a35c-4f73-b508-9605e79d363a_negatedTerseLabel_en-US" xlink:label="lab_hum_PaymentsForProceedsFromContractDeposits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receipts (withdrawals) from contract deposits, net</link:label>
    <link:label id="lab_hum_PaymentsForProceedsFromContractDeposits_label_en-US" xlink:label="lab_hum_PaymentsForProceedsFromContractDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Contract Deposits</link:label>
    <link:label id="lab_hum_PaymentsForProceedsFromContractDeposits_documentation_en-US" xlink:label="lab_hum_PaymentsForProceedsFromContractDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Contract Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentsForProceedsFromContractDeposits" xlink:href="hum-20221231.xsd#hum_PaymentsForProceedsFromContractDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PaymentsForProceedsFromContractDeposits" xlink:to="lab_hum_PaymentsForProceedsFromContractDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2232f6ee-1afc-4912-baa2-2a46cdd1663a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_253ad42d-0ef3-4dc4-8a61-06859bd3652f_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9371a5c2-c895-45a5-92a3-c1015eafdfba_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_36e77868-43ee-4575-a22d-c21f2428381b_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_41251735-4ee0-4398-8404-14bc121ff66c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities current, balance sheet line item</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_f448a241-773c-47de-939f-21c760a277b6_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosures:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_dba94e03-b3e8-465f-aff8-b1a377bda597_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_ba5bd27e-31c7-4c16-86cd-7feabb05dcf8_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_9c640513-eb9e-4ad8-a08d-917acd1c64d8_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_e772df87-c333-49a6-9cbc-5200287db795_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears_90526b6e-eb59-4af4-b6be-fddf31e91cc0_terseLabel_en-US" xlink:label="lab_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Favorable&#160;medical&#160;claims&#160;reserve development related to prior fiscal years</link:label>
    <link:label id="lab_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears_label_en-US" xlink:label="lab_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Favorable Medical Claims Reserve Development Related To Prior Fiscal Years</link:label>
    <link:label id="lab_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears_documentation_en-US" xlink:label="lab_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Favorable medical claims reserve development related to prior fiscal years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" xlink:href="hum-20221231.xsd#hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" xlink:to="lab_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_4d024445-1858-4b9c-b0ac-71db8a8335d9_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average annual interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_ShortTermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member_88025288-5fe9-4428-a4ac-717534b545f8_terseLabel_en-US" xlink:label="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$600&#160;million, 3.85% due October 1, 2024</link:label>
    <link:label id="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member_label_en-US" xlink:label="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.85 Percent Senior Notes Due October 2024 [Member]</link:label>
    <link:label id="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member_documentation_en-US" xlink:label="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.85 Percent Senior Notes Due October 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:href="hum-20221231.xsd#hum_A3.85PercentSeniorNotesDueOctober2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:to="lab_hum_A3.85PercentSeniorNotesDueOctober2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_980e88f0-14ad-4050-b3ba-3f7f0fcf8425_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss):</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_cfc8fe5e-a87a-4d6b-a5e1-58e5aba04752_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term of outstanding options (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverables_5ab368d6-dce7-4e67-b675-3ea127dd711e_verboseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverables_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Including Reinsurance Premium Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverables" xlink:to="lab_us-gaap_ReinsuranceRecoverables" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A370PercentSeniorNotesDueMarch2029Member_d9886410-5a40-4f0d-86c0-57fa4a4895c8_terseLabel_en-US" xlink:label="lab_hum_A370PercentSeniorNotesDueMarch2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750&#160;million, 3.70% due March 23, 2029</link:label>
    <link:label id="lab_hum_A370PercentSeniorNotesDueMarch2029Member_label_en-US" xlink:label="lab_hum_A370PercentSeniorNotesDueMarch2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70 Percent Senior Notes Due March 2029 [Member]</link:label>
    <link:label id="lab_hum_A370PercentSeniorNotesDueMarch2029Member_documentation_en-US" xlink:label="lab_hum_A370PercentSeniorNotesDueMarch2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70 Percent Senior Notes Due March 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A370PercentSeniorNotesDueMarch2029Member" xlink:href="hum-20221231.xsd#hum_A370PercentSeniorNotesDueMarch2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A370PercentSeniorNotesDueMarch2029Member" xlink:to="lab_hum_A370PercentSeniorNotesDueMarch2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MilitaryServiceMember_7da3c8a5-91e8-4f29-a222-1233c0928f13_terseLabel_en-US" xlink:label="lab_hum_MilitaryServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Military services</link:label>
    <link:label id="lab_hum_MilitaryServiceMember_label_en-US" xlink:label="lab_hum_MilitaryServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Military Service [Member]</link:label>
    <link:label id="lab_hum_MilitaryServiceMember_documentation_en-US" xlink:label="lab_hum_MilitaryServiceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Military Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MilitaryServiceMember" xlink:href="hum-20221231.xsd#hum_MilitaryServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MilitaryServiceMember" xlink:to="lab_hum_MilitaryServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_8e126cfc-8d8c-4718-83a6-782627304d9f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_13c394a2-25af-417e-929f-aad7b0771cef_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities included within trade accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_89b1eca0-4b56-4722-b97d-b4cd99ac0408_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_95de8406-2d7d-4b81-8b84-4d83f8e49ce3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_EquityInNetEarningsOfSubsidiaries_24573124-2128-44e1-88f8-88fa85a70262_terseLabel_en-US" xlink:label="lab_hum_EquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net earnings of subsidiaries</link:label>
    <link:label id="lab_hum_EquityInNetEarningsOfSubsidiaries_label_en-US" xlink:label="lab_hum_EquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity In Net Earnings Of Subsidiaries</link:label>
    <link:label id="lab_hum_EquityInNetEarningsOfSubsidiaries_documentation_en-US" xlink:label="lab_hum_EquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net earnings of subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EquityInNetEarningsOfSubsidiaries" xlink:href="hum-20221231.xsd#hum_EquityInNetEarningsOfSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_EquityInNetEarningsOfSubsidiaries" xlink:to="lab_hum_EquityInNetEarningsOfSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_06a60304-c9b7-4f91-9651-e7218c10f021_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_3dfcfb22-5f6b-48f9-8f40-c8becb9ada13_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_3c7e4e90-9390-412c-8cbe-3cd82a42ea4f_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RegulatoryMattersAxis_faa60f8c-e178-47bc-83a3-849d01988a0b_terseLabel_en-US" xlink:label="lab_hum_RegulatoryMattersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Matters [Axis]</link:label>
    <link:label id="lab_hum_RegulatoryMattersAxis_label_en-US" xlink:label="lab_hum_RegulatoryMattersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Matters [Axis]</link:label>
    <link:label id="lab_hum_RegulatoryMattersAxis_documentation_en-US" xlink:label="lab_hum_RegulatoryMattersAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Matters [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersAxis" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RegulatoryMattersAxis" xlink:to="lab_hum_RegulatoryMattersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_f94f68c0-174f-48c6-b164-e684a9e9be05_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_c65d6807-9618-43ca-ac32-93c6ccba9f0a_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_00832ace-2668-4e39-9cd0-9b2ffc9cb517_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicareLicensesAndCertificatesOfNeedMember_d8bc620d-17f4-48b0-ab81-e115f10fb4b1_terseLabel_en-US" xlink:label="lab_hum_MedicareLicensesAndCertificatesOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Licenses And Certificates Of Need</link:label>
    <link:label id="lab_hum_MedicareLicensesAndCertificatesOfNeedMember_label_en-US" xlink:label="lab_hum_MedicareLicensesAndCertificatesOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Licenses And Certificates Of Need [Member]</link:label>
    <link:label id="lab_hum_MedicareLicensesAndCertificatesOfNeedMember_documentation_en-US" xlink:label="lab_hum_MedicareLicensesAndCertificatesOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Licenses And Certificates Of Need [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareLicensesAndCertificatesOfNeedMember" xlink:href="hum-20221231.xsd#hum_MedicareLicensesAndCertificatesOfNeedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicareLicensesAndCertificatesOfNeedMember" xlink:to="lab_hum_MedicareLicensesAndCertificatesOfNeedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7a55465-3d46-4b09-814f-3248be903a1e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0944fa33-be97-4a43-bb40-72dce284ede8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8b57e04c-d8e8-487a-b65e-c4cbff0634d2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_2da3393a-3f64-43b6-adda-18387b6b42bc_totalLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits payable, net of reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_336c3000-de06-47b7-9f67-ad3328dec1fb_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_7b1b7175-3634-4dd4-a3ec-afef4074073e_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_57b8c1b7-b0cf-4d05-834f-ff9b75dd8ce4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount_854663d4-105c-4785-ab0e-10f1ecef537f_terseLabel_en-US" xlink:label="lab_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health insurance industry fee</link:label>
    <link:label id="lab_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount_label_en-US" xlink:label="lab_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Health Insurer Fee, Amount</link:label>
    <link:label id="lab_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount_documentation_en-US" xlink:label="lab_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Health Insurer Fee, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" xlink:href="hum-20221231.xsd#hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" xlink:to="lab_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_9e1b5e0f-01fe-4134-90ee-0a763e56ba92_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_53492193-9771-4df0-a499-72dc92d17c81_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_a7cca711-6b25-4e21-9911-0834a1ece2af_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pretax earnings</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Individually Significant Component Disposed of or Held-for-sale, Excluding Discontinued Operations, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:to="lab_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_20c4119f-1f16-400e-8afc-1cfc749d690c_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_7813c846-ebb0-4242-a974-13990be092ac_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_64d00ba9-ba95-4cb8-87c3-45872abefe02_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets estimated useful life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_92735bb8-027a-41b8-acc4-e2d552a42b9e_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_70818716-e4c1-4b3b-a91a-35a75b3c6054_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0af7035d-34bd-4b6a-ac0e-bff6bb2931a8_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_79f3ed7d-fd5b-4b5e-bdaf-4295763c198c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_93cf7a5e-6682-4e30-8150-d817dac4c067_terseLabel_en-US" xlink:label="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gains or losses:</link:label>
    <link:label id="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_label_en-US" xlink:label="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) [Abstract]</link:label>
    <link:label id="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_documentation_en-US" xlink:label="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:href="hum-20221231.xsd#hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:to="lab_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_bf856e42-c8fc-40fc-a9bc-8c589ba985fb_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Benefit) provision for deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_e4f0ecec-3fa5-497f-b3f6-a172cc730178_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred (benefit) expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_92d4092a-7394-4577-b706-4a751de5cddb_terseLabel_en-US" xlink:label="lab_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to equity method investments</link:label>
    <link:label id="lab_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_d835bc51-dab8-4c10-8193-4044f5eb2cae_verboseLabel_en-US" xlink:label="lab_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to equity method investments</link:label>
    <link:label id="lab_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_label_en-US" xlink:label="lab_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable To Equity Method Investments</link:label>
    <link:label id="lab_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_documentation_en-US" xlink:label="lab_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable To Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" xlink:href="hum-20221231.xsd#hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" xlink:to="lab_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_a2657fcd-f0f6-41ae-b246-3a7d5aac933f_terseLabel_en-US" xlink:label="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of TRICARE Managed Care Support Contract beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_label_en-US" xlink:label="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of TRICARE Managed Care Support Contract Beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_documentation_en-US" xlink:label="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of TRICARE Managed Care Support Contract Beneficiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:href="hum-20221231.xsd#hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:to="lab_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_Expenses_fc58cdd4-a7fb-44eb-a506-9c5144791c9e_terseLabel_en-US" xlink:label="lab_hum_Expenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_hum_Expenses_label_en-US" xlink:label="lab_hum_Expenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_hum_Expenses_documentation_en-US" xlink:label="lab_hum_Expenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_Expenses" xlink:href="hum-20221231.xsd#hum_Expenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_Expenses" xlink:to="lab_hum_Expenses" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A2.90PercentSeniorNotesDueDecember2022Member_5e9b44f9-83ba-496c-8c90-08b5efd0a999_terseLabel_en-US" xlink:label="lab_hum_A2.90PercentSeniorNotesDueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$400 million, 2.90% due December 15, 2022</link:label>
    <link:label id="lab_hum_A2.90PercentSeniorNotesDueDecember2022Member_label_en-US" xlink:label="lab_hum_A2.90PercentSeniorNotesDueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.90 Percent Senior Notes Due December 2022 [Member]</link:label>
    <link:label id="lab_hum_A2.90PercentSeniorNotesDueDecember2022Member_documentation_en-US" xlink:label="lab_hum_A2.90PercentSeniorNotesDueDecember2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.90 Percent Senior Notes Due December 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member" xlink:href="hum-20221231.xsd#hum_A2.90PercentSeniorNotesDueDecember2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member" xlink:to="lab_hum_A2.90PercentSeniorNotesDueDecember2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_ee9cc990-0a22-49de-943d-c2b5c4b82354_terseLabel_en-US" xlink:label="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest to be sold</link:label>
    <link:label id="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_label_en-US" xlink:label="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Equity Interest Sold</link:label>
    <link:label id="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_documentation_en-US" xlink:label="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Equity Interest Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:to="lab_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome_d87a2ee0-cbe0-4658-9a8d-3a91471d3df9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax exempt investment income</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxExemptIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_200a0024-f01e-4e64-9548-445ce735c373_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Realized in earnings</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_99675f92-de26-44cc-91f6-2bcfab1f7299_terseLabel_en-US" xlink:label="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization classified as benefit expense</link:label>
    <link:label id="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_label_en-US" xlink:label="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Classified As Benefit Expense</link:label>
    <link:label id="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_documentation_en-US" xlink:label="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense that has been reclassified to be included with benefit expenses. The reclassification is the result of depreciation and amortization expense associated primarily from the delivery of pharmacy services by our wholly-owned pharmacy business included in our Healthcare Services segment.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:href="hum-20221231.xsd#hum_DepreciationAndAmortizationClassifiedAsBenefitExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:to="lab_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_04f8a332-0973-4476-85b5-5aaf9dc4e380_terseLabel_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt to capitalization percentage, maximum</link:label>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_label_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum</link:label>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_documentation_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:to="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PutOptionMember_5103fbf6-85ea-4d98-8cba-91fee3a90e65_terseLabel_en-US" xlink:label="lab_us-gaap_PutOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put option</link:label>
    <link:label id="lab_us-gaap_PutOptionMember_label_en-US" xlink:label="lab_us-gaap_PutOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PutOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PutOptionMember" xlink:to="lab_us-gaap_PutOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_701d090a-85ce-4f38-b27d-4b0c6b44d7ca_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_d023ccfb-14c4-4f33-b70f-9cc9e8a6096b_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total paid</link:label>
    <link:label id="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:to="lab_us-gaap_PaymentsForLossesAndLossAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened_5f6a2073-3d9f-4fcf-8717-7bd43b6287f2_terseLabel_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional primary care centers expected to be opened in strategic partnership</link:label>
    <link:label id="lab_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened_label_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Partnership Agreement, Number Of Additional Primary Care Centers Expected To Be Opened</link:label>
    <link:label id="lab_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened_documentation_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Partnership Agreement, Number Of Additional Primary Care Centers Expected To Be Opened</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened" xlink:to="lab_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_be3a2e2b-b97c-4ca1-a1b6-4060b1d8d5b9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_4dd6ba30-624b-4eb6-abe6-480ff872d843_terseLabel_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances</link:label>
    <link:label id="lab_us-gaap_FederalHomeLoanBankAdvancesMember_label_en-US" xlink:label="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Home Loan Bank Advances [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:to="lab_us-gaap_FederalHomeLoanBankAdvancesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_45df0a71-9817-4a14-b7d9-57d1ca428ee4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in gross unrealized investment (losses) gains</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_a6eab51d-cc41-4b2f-921f-de04e0ab6aa2_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, current maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_3906e199-9601-47d5-82ef-384ed281c37a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_dfa99d45-cd6b-414d-bd9f-7bed02900dfc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_e258524a-a210-4c4c-b700-10c873bccc3b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease costs</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_52da325f-f2db-4218-bdc3-3b3d7f3d94ae_terseLabel_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares acquired in connection with employee stock plans, amount</link:label>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_label_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases Related To Employee Stock Based Compensation Awards Value</link:label>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_documentation_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:href="hum-20221231.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:to="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_5b1c5325-3c34-43c3-860c-2d9fe4a96dc5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of KAH Hospice</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_f2998a42-278c-45a1-862e-e47fc8450ac8_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_b0af94fb-bf36-444a-a6d6-4355f0e05820_terseLabel_en-US" xlink:label="lab_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.570 Percent Senior Notes Due March 2028 And 5.875 Percent Senior Notes Due March 2033</link:label>
    <link:label id="lab_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_label_en-US" xlink:label="lab_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.570 Percent Senior Notes Due March 2028 And 5.875 Percent Senior Notes Due March 2033 [Member]</link:label>
    <link:label id="lab_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_documentation_en-US" xlink:label="lab_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.570 Percent Senior Notes Due March 2028 And 5.875 Percent Senior Notes Due March 2033</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member" xlink:href="hum-20221231.xsd#hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member" xlink:to="lab_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_d5d6886d-177f-4229-9b45-65ef602f8cbd_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_AllOthersMember_1b87444b-f476-42c0-95f8-27cd65468fa5_verboseLabel_en-US" xlink:label="lab_hum_AllOthersMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All others</link:label>
    <link:label id="lab_hum_AllOthersMember_label_en-US" xlink:label="lab_hum_AllOthersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Others [Member]</link:label>
    <link:label id="lab_hum_AllOthersMember_documentation_en-US" xlink:label="lab_hum_AllOthersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Others</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AllOthersMember" xlink:href="hum-20221231.xsd#hum_AllOthersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_AllOthersMember" xlink:to="lab_hum_AllOthersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_0dd28a8b-a4e4-4998-ab9d-0063ea57e1e5_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_76dd93a5-d965-4f9b-90fb-74dcd313058c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_02a3e5bc-a6b4-4950-b6fc-1aae86459b20_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7e305e17-2f7f-47bd-83f6-149226a619f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted-Average Fair Value Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_d6ce1295-6e50-407c-a3e9-69f947cc0aba_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_71ef27b9-79c3-43ff-88fb-37aeb0e949ec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Income Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_9d3a9a83-ca7d-4b2c-9726-ca028886706e_terseLabel_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential</link:label>
    <link:label id="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Residential Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_ResidentialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_8229c8ea-58ea-4b55-aef7-ca5c4ea2c7b3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation expense recognition over a weighted-average period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_998cebad-c99b-42c6-ba84-57a1c4020226_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_361d7f51-a44b-4d81-b0b7-ce30f4e9509d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payable to operating subsidiaries</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_22410b1e-93b5-4c24-b655-1e9245fefa54_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term of exercisable options (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_8fca5286-4589-44ef-905c-0e20a251a762_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_559977a7-3c56-4165-acdc-d92d69027db7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets Included in Other Long-Term Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_196392f5-06b6-43db-90d0-f36a0d357d37_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_9ecf6e8b-72fe-4ae8-9247-8cb28821e028_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_3ffa3685-dee4-4368-be30-c31a537f8418_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred Claims, Net of Reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_AuditInformationAbstract_label_en-US" xlink:label="lab_hum_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_hum_AuditInformationAbstract_documentation_en-US" xlink:label="lab_hum_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AuditInformationAbstract" xlink:href="hum-20221231.xsd#hum_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_AuditInformationAbstract" xlink:to="lab_hum_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ProceedsFromStockOptionsExercisedAndOther_36f5fa58-2f42-4367-8f1a-e3aa7da073c5_verboseLabel_en-US" xlink:label="lab_hum_ProceedsFromStockOptionsExercisedAndOther" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_hum_ProceedsFromStockOptionsExercisedAndOther_label_en-US" xlink:label="lab_hum_ProceedsFromStockOptionsExercisedAndOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Stock Options Exercised And Other</link:label>
    <link:label id="lab_hum_ProceedsFromStockOptionsExercisedAndOther_documentation_en-US" xlink:label="lab_hum_ProceedsFromStockOptionsExercisedAndOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Stock Options Exercised And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProceedsFromStockOptionsExercisedAndOther" xlink:href="hum-20221231.xsd#hum_ProceedsFromStockOptionsExercisedAndOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ProceedsFromStockOptionsExercisedAndOther" xlink:to="lab_hum_ProceedsFromStockOptionsExercisedAndOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_4ab218df-33f8-45fd-9706-7da860563395_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage and asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_eed17a9b-ab30-402c-939e-2694c5726308_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A450PercentSeniorNotesDueApril2025Member_360eb4d7-a807-4316-9402-1c54025c7212_terseLabel_en-US" xlink:label="lab_hum_A450PercentSeniorNotesDueApril2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$600&#160;million, 4.50% due April 1, 2025</link:label>
    <link:label id="lab_hum_A450PercentSeniorNotesDueApril2025Member_label_en-US" xlink:label="lab_hum_A450PercentSeniorNotesDueApril2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Senior Notes Due April 2025 [Member]</link:label>
    <link:label id="lab_hum_A450PercentSeniorNotesDueApril2025Member_documentation_en-US" xlink:label="lab_hum_A450PercentSeniorNotesDueApril2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50 Percent Senior Notes Due April 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A450PercentSeniorNotesDueApril2025Member" xlink:href="hum-20221231.xsd#hum_A450PercentSeniorNotesDueApril2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A450PercentSeniorNotesDueApril2025Member" xlink:to="lab_hum_A450PercentSeniorNotesDueApril2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9bdb03d9-fd9d-4c09-b007-c02ed0d70f69_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_dbf03ed0-e196-4190-b06b-8976331a23ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9a43ce56-45d2-4c8c-9411-014827fc28bc_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b26c4a3e-e97b-46de-b8b6-967d8499efca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_76969f70-58b4-4689-ba66-360ba770a6bb_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_USRiskCorridorPremiumStabilizationProgramMember_106c1543-09b9-485a-acc2-720e3eb02acb_terseLabel_en-US" xlink:label="lab_hum_USRiskCorridorPremiumStabilizationProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Risk Corridor Premium Stabilization Program</link:label>
    <link:label id="lab_hum_USRiskCorridorPremiumStabilizationProgramMember_label_en-US" xlink:label="lab_hum_USRiskCorridorPremiumStabilizationProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Risk Corridor Premium Stabilization Program [Member]</link:label>
    <link:label id="lab_hum_USRiskCorridorPremiumStabilizationProgramMember_documentation_en-US" xlink:label="lab_hum_USRiskCorridorPremiumStabilizationProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Risk Corridor Premium Stabilization Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_USRiskCorridorPremiumStabilizationProgramMember" xlink:href="hum-20221231.xsd#hum_USRiskCorridorPremiumStabilizationProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_USRiskCorridorPremiumStabilizationProgramMember" xlink:to="lab_hum_USRiskCorridorPremiumStabilizationProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_d379bbac-4a35-4923-be20-c8bb4886673c_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_9370c15a-1d67-47ba-b006-279677b9298e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_86e6dc75-f72b-4b99-863a-a80d93788814_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenues</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Unearned Premiums Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7035ab4f-49ba-4e94-9363-d04502558c8e_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_2dde5e85-4f56-4b06-9263-29e7dbe08376_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9de7901b-c1ac-4060-a889-52896e632b49_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible executive compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_c134eb98-28b9-4a29-8ebe-cd43e6a7aada_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c8685adb-6462-4f99-ae7e-dbed01580ea8_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_2ecbb236-2fc9-4a1d-b60f-eb247252db22_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_72d59b14-7dfc-4a3a-a630-49e0adc16261_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_c68ca3a6-5422-455a-bbc0-393f4e8d46e8_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3e0404fc-8b48-4c7c-9d3b-9db5448369df_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_LossOnTerminationOfDerivatives_cb8e2d68-b187-49cc-82f9-420f0c298ec2_terseLabel_en-US" xlink:label="lab_hum_LossOnTerminationOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination of put and call options</link:label>
    <link:label id="lab_hum_LossOnTerminationOfDerivatives_label_en-US" xlink:label="lab_hum_LossOnTerminationOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss On Termination Of Derivatives</link:label>
    <link:label id="lab_hum_LossOnTerminationOfDerivatives_documentation_en-US" xlink:label="lab_hum_LossOnTerminationOfDerivatives" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss On Termination Of Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LossOnTerminationOfDerivatives" xlink:href="hum-20221231.xsd#hum_LossOnTerminationOfDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_LossOnTerminationOfDerivatives" xlink:to="lab_hum_LossOnTerminationOfDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_4d2a1ac4-aa4f-4cc6-9b7d-3abfa059466a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_December2020AcceleratedShareRepurchaseAgreementMember_4ec50832-2b9d-47bd-b98e-ccc92c7d3fdb_terseLabel_en-US" xlink:label="lab_hum_December2020AcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2020 ASR</link:label>
    <link:label id="lab_hum_December2020AcceleratedShareRepurchaseAgreementMember_label_en-US" xlink:label="lab_hum_December2020AcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2020 Accelerated Share Repurchase Agreement [Member]</link:label>
    <link:label id="lab_hum_December2020AcceleratedShareRepurchaseAgreementMember_documentation_en-US" xlink:label="lab_hum_December2020AcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 2020 Accelerated Share Repurchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_December2020AcceleratedShareRepurchaseAgreementMember" xlink:href="hum-20221231.xsd#hum_December2020AcceleratedShareRepurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_December2020AcceleratedShareRepurchaseAgreementMember" xlink:to="lab_hum_December2020AcceleratedShareRepurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_fe339a28-a08e-43aa-a320-5b1f76607d66_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_abd0b6df-0e4a-46ea-9dac-40cac39b55b8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_6c9839b5-8972-444e-803d-b60a01aa1ad4_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-tax gain, net of transaction costs</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:to="lab_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum_cefd973e-77e1-435c-a98b-913198701d6b_terseLabel_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time frame for put and call option activity per partnership agreement, maximum</link:label>
    <link:label id="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum_label_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Maximum</link:label>
    <link:label id="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum_documentation_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum" xlink:to="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_a12562f4-818a-4684-a95c-fc11353828d1_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_e6c6c947-2a72-428b-ad1a-88110e6a5460_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Paid Claims, Net of Reinsurance</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_a50bb99e-fd32-4d1b-a26b-cedfe8647899_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_HealthCareCostPayments_9a0d2727-9dcf-4641-a1dd-27cce6bee365_negatedTerseLabel_en-US" xlink:label="lab_hum_HealthCareCostPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care cost payments</link:label>
    <link:label id="lab_hum_HealthCareCostPayments_label_en-US" xlink:label="lab_hum_HealthCareCostPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Payments</link:label>
    <link:label id="lab_hum_HealthCareCostPayments_documentation_en-US" xlink:label="lab_hum_HealthCareCostPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care cost payments associated with the TRICARE South Region contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareCostPayments" xlink:href="hum-20221231.xsd#hum_HealthCareCostPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_HealthCareCostPayments" xlink:to="lab_hum_HealthCareCostPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_50ee111a-e12a-45c4-9685-8593ef07a08e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_595f3a40-9b9d-4a50-ad4d-dab183b89d4c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_22cdf3df-8d42-4710-bb05-a4082830b7d4_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_4ec65427-43be-4360-b4aa-6f71203fda7f_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other intangible assets, cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_95f75f42-b000-489c-aeb1-44eecc536d9d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost, Rolling Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_6a80953b-189a-4a3e-b1c5-8329e8d53c85_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_386d26d7-76b8-4931-9f0e-5b90ce4d54e0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_a88a70fe-02f8-4ba2-a46e-8a756d08cd08_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance_62ee80e8-9359-45ca-8099-0bdac37e80fc_terseLabel_en-US" xlink:label="lab_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reinsurers comprising other reinsurance recoverables balance</link:label>
    <link:label id="lab_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance_label_en-US" xlink:label="lab_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Reinsurers Comprising Other Reinsurance Recoverables Balance</link:label>
    <link:label id="lab_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance_documentation_en-US" xlink:label="lab_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reinsurers comprising other reinsurance recoverables balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance" xlink:href="hum-20221231.xsd#hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance" xlink:to="lab_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_d4572d3f-f8bb-4e09-bd22-72906780aacb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceDisclosureTextBlock_70852acf-4fe5-436c-bdab-be8925121bce_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BENEFITS PAYABLE</link:label>
    <link:label id="lab_us-gaap_InsuranceDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceDisclosureTextBlock" xlink:to="lab_us-gaap_InsuranceDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DelayedDrawTermLoanMay2024Member_b5d86a7b-9679-45b0-89f8-4c25083156d1_terseLabel_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMay2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed draw term loan, due May 28, 2024</link:label>
    <link:label id="lab_hum_DelayedDrawTermLoanMay2024Member_label_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMay2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan May 2024 [Member]</link:label>
    <link:label id="lab_hum_DelayedDrawTermLoanMay2024Member_documentation_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMay2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan May 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMay2024Member" xlink:href="hum-20221231.xsd#hum_DelayedDrawTermLoanMay2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DelayedDrawTermLoanMay2024Member" xlink:to="lab_hum_DelayedDrawTermLoanMay2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_855e23a9-e5db-47f0-9327-1afd52907514_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_AcquisitionCostsPolicyPolicyTextBlock_eb49c4e2-48e0-41ee-b57a-7b9e17cb56e3_terseLabel_en-US" xlink:label="lab_hum_AcquisitionCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policy Acquisition Costs</link:label>
    <link:label id="lab_hum_AcquisitionCostsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_hum_AcquisitionCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Costs Policy [Policy Text Block]</link:label>
    <link:label id="lab_hum_AcquisitionCostsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_hum_AcquisitionCostsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Describes an insurance entity's accounting policy for deferred policy acquisition costs, including the nature and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AcquisitionCostsPolicyPolicyTextBlock" xlink:href="hum-20221231.xsd#hum_AcquisitionCostsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_AcquisitionCostsPolicyPolicyTextBlock" xlink:to="lab_hum_AcquisitionCostsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_6a9fb24e-698b-425e-8b12-f694758116ef_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_dc368e40-71db-40d2-98db-481ea6a84cfb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost_1e40683d-b20d-43ba-b5fc-b5e38db938b4_terseLabel_en-US" xlink:label="lab_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred acquisition costs</link:label>
    <link:label id="lab_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost_label_en-US" xlink:label="lab_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Deferred Policy Acquisition Cost</link:label>
    <link:label id="lab_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost_documentation_en-US" xlink:label="lab_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of deferred tax balance as it relates to deferred acquisition costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost" xlink:href="hum-20221231.xsd#hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost" xlink:to="lab_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_b5f21c23-f6a7-4dab-83a2-574e6ef3aa63_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d6f79540-b8e6-4bc1-959e-92302aa281f0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effect of businesses acquired and dispositions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_0cdb564b-856b-4ff5-a27e-320d0f41b192_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_442c069e-6fb3-4128-9feb-c02eac345af3_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive (loss) income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NetNoncurrentAssetLiability_9e064083-460f-400f-ab26-c1f8b5bd9a28_totalLabel_en-US" xlink:label="lab_hum_NetNoncurrentAssetLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net long-term liability</link:label>
    <link:label id="lab_hum_NetNoncurrentAssetLiability_label_en-US" xlink:label="lab_hum_NetNoncurrentAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Noncurrent Asset (Liability)</link:label>
    <link:label id="lab_hum_NetNoncurrentAssetLiability_documentation_en-US" xlink:label="lab_hum_NetNoncurrentAssetLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Noncurrent Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability" xlink:href="hum-20221231.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NetNoncurrentAssetLiability" xlink:to="lab_hum_NetNoncurrentAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_e3b25611-9795-4e50-b00f-8c952f9eec04_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d39c9d36-20e8-4641-9d71-ec3f22dee02a_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_5a4d049f-9992-4d36-b3ba-0db68d3fbad3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_40aadf70-47fa-422f-8e7e-d2fa83150923_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net of allowances of $70 in 2022 and $83 in 2021</link:label>
    <link:label id="lab_us-gaap_ReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_ReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesNetCurrent" xlink:to="lab_us-gaap_ReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_628ddd4f-4208-4fa9-b6c7-7ba843844d18_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PercentageOfCoinsuranceAgreement_944f5ebc-2afb-4e54-834a-06fd0f852750_terseLabel_en-US" xlink:label="lab_hum_PercentageOfCoinsuranceAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of coinsurance agreement</link:label>
    <link:label id="lab_hum_PercentageOfCoinsuranceAgreement_label_en-US" xlink:label="lab_hum_PercentageOfCoinsuranceAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Coinsurance Agreement</link:label>
    <link:label id="lab_hum_PercentageOfCoinsuranceAgreement_documentation_en-US" xlink:label="lab_hum_PercentageOfCoinsuranceAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Coinsurance Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfCoinsuranceAgreement" xlink:href="hum-20221231.xsd#hum_PercentageOfCoinsuranceAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PercentageOfCoinsuranceAgreement" xlink:to="lab_hum_PercentageOfCoinsuranceAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_3a7f8596-3b7f-4b44-b210-27aef22d1685_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_e330b01e-ffd6-4538-b8ba-f8955ace1602_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase payment</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Settlement (Payment) or Receipt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_66d959bf-c3e7-4763-8236-47c72e2cef64_terseLabel_en-US" xlink:label="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states comprising TRICARE Managed Care Support Contract beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_label_en-US" xlink:label="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_documentation_en-US" xlink:label="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:href="hum-20221231.xsd#hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:to="lab_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_c2031238-f5ea-435a-a4a1-8c1f07c903fb_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net losses recognized on equity securities sold during the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e42b10f2-d522-4898-9599-f1e5350bd6e6_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_11b36570-6e86-4091-abf4-a928c6e2e4b2_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CommercialMembershipContractTerm_f3b19bde-8623-4241-af5b-5c663874b47f_terseLabel_en-US" xlink:label="lab_hum_CommercialMembershipContractTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health services term</link:label>
    <link:label id="lab_hum_CommercialMembershipContractTerm_label_en-US" xlink:label="lab_hum_CommercialMembershipContractTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Membership Contract Term</link:label>
    <link:label id="lab_hum_CommercialMembershipContractTerm_documentation_en-US" xlink:label="lab_hum_CommercialMembershipContractTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Membership Contract Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialMembershipContractTerm" xlink:href="hum-20221231.xsd#hum_CommercialMembershipContractTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CommercialMembershipContractTerm" xlink:to="lab_hum_CommercialMembershipContractTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_3097841f-d0ac-404a-8e56-54b23b904ab3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0c6b990f-6910-4fcf-ba03-7b9e5829e5ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_67605549-bc86-4865-b96c-0510b4864ac1_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_68ab4f4e-c1bc-4f04-90da-de62dc21edc6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less&#160;than&#160;12&#160;months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_96114315-abfa-4703-9480-49fef46ec62e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of income taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_1330f8c1-9185-4e50-8ee0-b2566c583537_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_25543c76-0223-4578-a2b9-1b5d450eb841_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_548f23a9-1407-4cdb-b0da-129c4989f91a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_17cc06c4-870f-48e0-930b-1f89ee69eb95_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9375f9d0-811e-4812-8e09-92931b9081e3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration to be received</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_f1996cc4-cb17-4601-815a-47fada9837fa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NoncontrollingInterestsPolicyTextBlock_5a5a4ffa-cb9d-461c-9bee-c407cd084599_terseLabel_en-US" xlink:label="lab_hum_NoncontrollingInterestsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_hum_NoncontrollingInterestsPolicyTextBlock_label_en-US" xlink:label="lab_hum_NoncontrollingInterestsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests [Policy Text Block]</link:label>
    <link:label id="lab_hum_NoncontrollingInterestsPolicyTextBlock_documentation_en-US" xlink:label="lab_hum_NoncontrollingInterestsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncontrollingInterestsPolicyTextBlock" xlink:href="hum-20221231.xsd#hum_NoncontrollingInterestsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NoncontrollingInterestsPolicyTextBlock" xlink:to="lab_hum_NoncontrollingInterestsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_605b7887-df1d-405c-8a94-fd7c3a0df846_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductMember_f8b4819b-254f-4472-8c59-b561424497cf_terseLabel_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_us-gaap_ProductMember_label_en-US" xlink:label="lab_us-gaap_ProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductMember" xlink:to="lab_us-gaap_ProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_578efe6d-8cf0-4d0d-85cf-0527329e074d_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current provision</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_30fd4376-68fd-4667-b84a-099f91a95375_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CmsSubsidiesOrDiscountsMember_0a35c436-c68e-45f5-8f9e-d487b0d9427b_terseLabel_en-US" xlink:label="lab_hum_CmsSubsidiesOrDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS Subsidies/ Discounts</link:label>
    <link:label id="lab_hum_CmsSubsidiesOrDiscountsMember_label_en-US" xlink:label="lab_hum_CmsSubsidiesOrDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cms Subsidies Or Discounts [Member]</link:label>
    <link:label id="lab_hum_CmsSubsidiesOrDiscountsMember_documentation_en-US" xlink:label="lab_hum_CmsSubsidiesOrDiscountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS Subsidies Or Discounts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CmsSubsidiesOrDiscountsMember" xlink:href="hum-20221231.xsd#hum_CmsSubsidiesOrDiscountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CmsSubsidiesOrDiscountsMember" xlink:to="lab_hum_CmsSubsidiesOrDiscountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_86baf4ef-833b-49de-9226-9328032fbb61_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_4e83b784-f463-4742-8f8f-b221d1419ba7_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_383bbceb-afa1-409e-b515-a63603a2df5b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_GoldmanSachsCoLLCMember_1ea5b4de-5778-47f4-b828-0ab365aef976_terseLabel_en-US" xlink:label="lab_hum_GoldmanSachsCoLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goldman Sachs</link:label>
    <link:label id="lab_hum_GoldmanSachsCoLLCMember_label_en-US" xlink:label="lab_hum_GoldmanSachsCoLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goldman Sachs &amp; Co. LLC [Member]</link:label>
    <link:label id="lab_hum_GoldmanSachsCoLLCMember_documentation_en-US" xlink:label="lab_hum_GoldmanSachsCoLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goldman Sachs &amp; Co. LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GoldmanSachsCoLLCMember" xlink:href="hum-20221231.xsd#hum_GoldmanSachsCoLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_GoldmanSachsCoLLCMember" xlink:to="lab_hum_GoldmanSachsCoLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputOptionVolatilityMember_becfbd87-f0cd-4c4c-bfa1-6b0c2d0294ba_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputOptionVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annualized volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputOptionVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputOptionVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Option Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputOptionVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputOptionVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputOptionVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputOptionVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_a8a1456f-9c9a-48f7-8294-9f296aa92563_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_1864cec2-c034-49a4-b03b-175a886324d2_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_6a94e56c-b72b-4bf0-aefb-41c63bcf0b7a_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_3b3ccabc-2a88-42ad-a8af-f5f012f5407e_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance sheet</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c34734b8-2248-4409-933d-4a827d60b537_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock_496234f0-a26e-49b8-b0a8-aeb2b28a7f2e_terseLabel_en-US" xlink:label="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets invested in Company common stock (percent)</link:label>
    <link:label id="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock_label_en-US" xlink:label="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Plan Assets Invested In Company Common Stock</link:label>
    <link:label id="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock_documentation_en-US" xlink:label="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Plan Assets Invested In Company Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock" xlink:to="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4ef9d991-cdbd-4244-9b9b-8df7d39320e1_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_500db825-1a6e-4170-b8dd-51a14272ba4e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_90d2e7e7-32a5-40a9-bb8d-7f705852465f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Benefit) provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A463PercentSeniorNotesDueDecember2042Member_a9ae7785-f9d6-4157-ba24-11b1ca178ba5_terseLabel_en-US" xlink:label="lab_hum_A463PercentSeniorNotesDueDecember2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$400&#160;million, 4.63% due December&#160;1, 2042</link:label>
    <link:label id="lab_hum_A463PercentSeniorNotesDueDecember2042Member_label_en-US" xlink:label="lab_hum_A463PercentSeniorNotesDueDecember2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.63 Percent Senior Notes Due December 2042 [Member]</link:label>
    <link:label id="lab_hum_A463PercentSeniorNotesDueDecember2042Member_documentation_en-US" xlink:label="lab_hum_A463PercentSeniorNotesDueDecember2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.625 Percent Senior Notes Due December 2042 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A463PercentSeniorNotesDueDecember2042Member" xlink:href="hum-20221231.xsd#hum_A463PercentSeniorNotesDueDecember2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A463PercentSeniorNotesDueDecember2042Member" xlink:to="lab_hum_A463PercentSeniorNotesDueDecember2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GovernmentContractsConcentrationRiskMember_30505be9-af70-4a48-9646-d455301bc239_terseLabel_en-US" xlink:label="lab_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government contracts concentration risk</link:label>
    <link:label id="lab_us-gaap_GovernmentContractsConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Contracts Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractsConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:to="lab_us-gaap_GovernmentContractsConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_d9678282-e5d0-4ef7-a7a9-74b753273a66_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5b9dd339-be6c-47e7-a9ba-c6619d5b4fe2_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances on net operating loss carryforwards related to prior acquisitions</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_54d31a20-d518-4bd7-9cf9-3ed2912e1c58_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_b51836ef-594b-4c53-8ab6-00b77d417ef5_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_928d8590-bade-4e00-8678-1fd224f38feb_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Gain (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_99cdebad-9d64-48d7-b6e1-59c18ee53dde_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross losses on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_3c883289-afca-4d3c-b636-9da79047d4b8_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_af4ab2c8-d141-475b-9674-d4844ac8f315_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_05cc685a-9a03-46dc-ac16-8ffb63b4a75f_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue_b045030a-e1d9-4e68-9d94-02e14b1ec401_terseLabel_en-US" xlink:label="lab_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from capital in excess of par value to treasury stock</link:label>
    <link:label id="lab_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue_label_en-US" xlink:label="lab_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Reclassified From Capital In Excess Of Par Value To Treasury Stock Upon Repurchase, Value</link:label>
    <link:label id="lab_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue_documentation_en-US" xlink:label="lab_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Reclassified From Capital In Excess Of Par Value To Treasury Stock Upon Repurchase, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" xlink:href="hum-20221231.xsd#hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" xlink:to="lab_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_680cb4ec-6cf3-49e0-99a4-9ea832b304c2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_9cd76686-26e0-47b3-865c-8b4251c910ae_negatedLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Investments_f25d4104-91c1-45f6-8c5f-200da7232d7b_totalLabel_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total investment securities</link:label>
    <link:label id="lab_us-gaap_Investments_label_en-US" xlink:label="lab_us-gaap_Investments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Investments" xlink:to="lab_us-gaap_Investments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_e6ad769c-678c-4fa9-8f73-7d3867cd4815_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at December 31, 2022 and 198,648,742 shares issued at December 31, 2021</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_0b707ac0-ddab-4910-b83c-be7c112068a2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_4d36b1b4-7993-4cc1-86d2-d031b8dcd3da_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_3fbd326f-d21a-42e5-b01a-f01e40a1bdac_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_0a3bc0cf-b1a7-42f4-aca1-cba25228b013_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock unit vesting (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_81f535d0-69c9-4514-b8d7-a7395dd53084_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_79f6ce08-9231-47f9-9a0a-8c2c421b68ea_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_31377699-9322-412f-88f6-dadbbc0a25c9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_ce2023de-7bc0-41ff-af4d-c91d9f35bdcd_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock options exercised</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_a037c695-a6f5-4bec-98a6-9526d422321a_terseLabel_en-US" xlink:label="lab_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excluding Employee Stock Plans and ASR</link:label>
    <link:label id="lab_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_label_en-US" xlink:label="lab_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excluding Employee Stock Plans And Accelerated Share Repurchase Agreement [Member]</link:label>
    <link:label id="lab_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_documentation_en-US" xlink:label="lab_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excluding Employee Stock Plans And Accelerated Share Repurchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember" xlink:href="hum-20221231.xsd#hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember" xlink:to="lab_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_4928008f-adda-4a2b-978c-33c726866154_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInBookOverdrafts_009c655c-732b-4208-9911-35f0aeec61f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in book overdraft</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInBookOverdrafts_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Book Overdrafts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInBookOverdrafts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:to="lab_us-gaap_IncreaseDecreaseInBookOverdrafts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_a1a770f1-d620-4a02-8051-c4b288311939_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenues</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_4d87e5ad-9ca2-4eb9-8847-e27beb7280e2_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gross Unrealized Losses and Fair Value of Securities</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:to="lab_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_d20bcbd0-d1c7-49c6-9904-d19d299c4922_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FinancialAssetsFairValueDisclosure_2b589a8d-c46a-4868-996b-39b07fdabf39_terseLabel_en-US" xlink:label="lab_hum_FinancialAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial asset</link:label>
    <link:label id="lab_hum_FinancialAssetsFairValueDisclosure_label_en-US" xlink:label="lab_hum_FinancialAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets, Fair Value Disclosure</link:label>
    <link:label id="lab_hum_FinancialAssetsFairValueDisclosure_documentation_en-US" xlink:label="lab_hum_FinancialAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FinancialAssetsFairValueDisclosure" xlink:href="hum-20221231.xsd#hum_FinancialAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FinancialAssetsFairValueDisclosure" xlink:to="lab_hum_FinancialAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PercentageOfTotalPremiumAndServicesRevenues_4526fe97-5fdb-4e0e-81ee-d80b8a39b01f_terseLabel_en-US" xlink:label="lab_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of premiums and services revenue</link:label>
    <link:label id="lab_hum_PercentageOfTotalPremiumAndServicesRevenues_label_en-US" xlink:label="lab_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Premium And Services Revenues</link:label>
    <link:label id="lab_hum_PercentageOfTotalPremiumAndServicesRevenues_documentation_en-US" xlink:label="lab_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Premium And Services Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:href="hum-20221231.xsd#hum_PercentageOfTotalPremiumAndServicesRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:to="lab_hum_PercentageOfTotalPremiumAndServicesRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_a0c7c690-ddfe-4d17-b768-1114e1766cd6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities in unrealized loss position, number of positions</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_35237c60-28a2-4f20-98c6-4f29cb8e606a_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_6f4dcd44-01ef-4863-a701-b49bdd769a04_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_87e6dc33-95b7-43c0-82ae-a65ee06572ac_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractBaseTerm_cb66d3cf-7eb7-4bed-9b08-f384b363c6c7_terseLabel_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract base term</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractBaseTerm_label_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Base Term</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractBaseTerm_documentation_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Base Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:href="hum-20221231.xsd#hum_TRICAREManagedCareSupportContractBaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:to="lab_hum_TRICAREManagedCareSupportContractBaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram_372bbb51-7ccc-4ef6-aff0-9296df111d09_terseLabel_en-US" xlink:label="lab_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum number of years of service for retirement eligibility as related to our equity award program</link:label>
    <link:label id="lab_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram_label_en-US" xlink:label="lab_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Number Of Years Of Service For Retirement Eligibility As Related To Our Equity Award Program</link:label>
    <link:label id="lab_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram_documentation_en-US" xlink:label="lab_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum number of years of service for retirement eligibility as related to our equity award program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:href="hum-20221231.xsd#hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:to="lab_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_5aaee649-77da-4e90-adad-af4fb9a509b8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fixed operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_da74a29f-8cfa-44e2-a41d-5129ecf6076e_terseLabel_en-US" xlink:label="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum individual state general bond obligation as a percentage of total debt securities (percent)</link:label>
    <link:label id="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_label_en-US" xlink:label="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities</link:label>
    <link:label id="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_documentation_en-US" xlink:label="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:href="hum-20221231.xsd#hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:to="lab_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1181976d-cc9a-452c-a9d6-4af15a6a73f5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_SubsidyAndDiscountReimbursements_ab8090f1-b119-455c-a1d0-b0fca6d53f8a_terseLabel_en-US" xlink:label="lab_hum_SubsidyAndDiscountReimbursements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Part D subsidy/discount reimbursements</link:label>
    <link:label id="lab_hum_SubsidyAndDiscountReimbursements_label_en-US" xlink:label="lab_hum_SubsidyAndDiscountReimbursements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidy And Discount Reimbursements</link:label>
    <link:label id="lab_hum_SubsidyAndDiscountReimbursements_documentation_en-US" xlink:label="lab_hum_SubsidyAndDiscountReimbursements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidy And Discount Reimbursements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountReimbursements" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountReimbursements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_SubsidyAndDiscountReimbursements" xlink:to="lab_hum_SubsidyAndDiscountReimbursements" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets_5adaf24b-19a3-43e4-a5b3-7911671acd56_negatedLabel_en-US" xlink:label="lab_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciable property and intangible assets</link:label>
    <link:label id="lab_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets_label_en-US" xlink:label="lab_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities Depreciable Property And Intangible Assets</link:label>
    <link:label id="lab_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets_documentation_en-US" xlink:label="lab_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion of deferred tax balance as it relates to depreciable property and intangible assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" xlink:href="hum-20221231.xsd#hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" xlink:to="lab_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_1238f85e-ddec-4f2c-93c7-121170c130d9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_99a7f39b-7a3a-4db4-854e-1eeddf51c16f_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS AND DIVESTITURES</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_0f390349-c44b-423b-9087-5240ce895ddd_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0f18fded-5da5-4ef0-b4ec-6dfad56dc624_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9c170d0a-c218-40e5-92bd-ac7267f7c2df_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_607055b2-383c-49fe-9468-42d261e9df89_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_957ce2ce-206c-46cd-9c17-455d6a70371e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsurerConcentrationRiskMember_1358be93-5f41-4da1-b581-2f0f2461e1fa_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsurerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurer concentration risk</link:label>
    <link:label id="lab_us-gaap_ReinsurerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ReinsurerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsurerConcentrationRiskMember" xlink:to="lab_us-gaap_ReinsurerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_9e407da4-3f2c-4e52-b21d-59c5d77df759_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock_64d2f89d-5b5b-4768-9cfe-35269790a175_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Realized Gains (Losses) Related to Investment Securities Included Within Investment Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Realized Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRealizedGainLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRealizedGainLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting_2bee7340-1ebf-4324-b652-068123ca3160_terseLabel_en-US" xlink:label="lab_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual realized tax benefit on tax returns from option exercises and restricted stock vesting</link:label>
    <link:label id="lab_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting_label_en-US" xlink:label="lab_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options And Restricted Stock Vesting</link:label>
    <link:label id="lab_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting_documentation_en-US" xlink:label="lab_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of the aggregate tax benefit realized from the exercise of stock options and vesting of restricted stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" xlink:href="hum-20221231.xsd#hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" xlink:to="lab_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum_6ae0f693-0647-442d-b5d7-50d97cfd613f_terseLabel_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time frame for put and call option activity per partnership agreement, minimum</link:label>
    <link:label id="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum_label_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Minimum</link:label>
    <link:label id="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum_documentation_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum" xlink:to="lab_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_a3239b9e-2aa0-476e-96d4-6fd8ea4d25b3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Paid related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_6513f036-022b-456d-b81e-5d3b37a83c31_terseLabel_en-US" xlink:label="lab_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kindred at Home, Hospice and Personal Care Divisions</link:label>
    <link:label id="lab_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_label_en-US" xlink:label="lab_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kindred At Home, Hospice And Personal Care Divisions [Member]</link:label>
    <link:label id="lab_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_documentation_en-US" xlink:label="lab_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kindred At Home, Hospice And Personal Care Divisions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember" xlink:to="lab_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_d320ca21-92f4-47ec-b858-ae42da2a6436_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of senior notes, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Senior Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_7254ecd9-194c-4bfa-a78d-3128b17a8a3d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_HomeSolutionsMember_b8a0d22b-b639-4c2a-88e6-754de6be9ca6_terseLabel_en-US" xlink:label="lab_hum_HomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home solutions</link:label>
    <link:label id="lab_hum_HomeSolutionsMember_label_en-US" xlink:label="lab_hum_HomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Solutions [Member]</link:label>
    <link:label id="lab_hum_HomeSolutionsMember_documentation_en-US" xlink:label="lab_hum_HomeSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsMember" xlink:href="hum-20221231.xsd#hum_HomeSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_HomeSolutionsMember" xlink:to="lab_hum_HomeSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_0c86ce56-afb7-447f-b0be-2a00c351fc58_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_dd073c05-4006-40d4-9adb-95c5872d64be_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Health Care Insurance Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_OtherCurrentAssetsPolicyTextBlock_b14eb605-8dfe-407a-b192-41d92085c7bd_terseLabel_en-US" xlink:label="lab_hum_OtherCurrentAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_hum_OtherCurrentAssetsPolicyTextBlock_label_en-US" xlink:label="lab_hum_OtherCurrentAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Policy Text Block]</link:label>
    <link:label id="lab_hum_OtherCurrentAssetsPolicyTextBlock_documentation_en-US" xlink:label="lab_hum_OtherCurrentAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_OtherCurrentAssetsPolicyTextBlock" xlink:href="hum-20221231.xsd#hum_OtherCurrentAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_OtherCurrentAssetsPolicyTextBlock" xlink:to="lab_hum_OtherCurrentAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_34009fa7-a8fd-40d2-b65a-c4965e1f9b2f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_3cd10c8f-b321-4f79-84ba-18a9c54566c6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cash payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_867e3b1a-76ca-4128-a2d0-3d11d4825b7a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e39aa69f-a15b-4b34-9c72-737725e8f1bf_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_e1eb10ee-95e3-4fd8-a589-69c07af7383b_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate statutory capital and surplus in our state regulated insurance subsidiaries</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus, Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_67399301-5292-443c-a8b0-4106bb35d84d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_31a863e4-5d89-4d78-bc58-206c7d5afee4_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_ebba236a-770e-4740-933d-552b41481a82_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option exercises</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_GainContingencyRecoverySought_f3b8371e-e138-417a-9482-67c807234186_terseLabel_en-US" xlink:label="lab_hum_GainContingencyRecoverySought" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation recoveries sought</link:label>
    <link:label id="lab_hum_GainContingencyRecoverySought_label_en-US" xlink:label="lab_hum_GainContingencyRecoverySought" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Recovery Sought</link:label>
    <link:label id="lab_hum_GainContingencyRecoverySought_documentation_en-US" xlink:label="lab_hum_GainContingencyRecoverySought" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain Contingency, Recovery Sought</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GainContingencyRecoverySought" xlink:href="hum-20221231.xsd#hum_GainContingencyRecoverySought"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_GainContingencyRecoverySought" xlink:to="lab_hum_GainContingencyRecoverySought" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_f9ab9060-e511-4380-bcc5-c9df3901e083_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average daily volume weighted-average share price of common stock during term of agreement (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Final Price Paid Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_a4b0555c-0791-48f2-ad2a-dc054b6f6c59_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d2259f3c-599e-4d3f-b321-278ad09e6664_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_bbb91538-ad34-436d-a984-a35826999ba4_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_ba7b9b79-01bb-4a03-8525-086228512097_terseLabel_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION</link:label>
    <link:label id="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information of Parent Company Only Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:to="lab_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_GentivaTermLoanDue2025Member_5e6e81f0-b357-43fe-9c3c-7de5341863bc_terseLabel_en-US" xlink:label="lab_hum_GentivaTermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gentiva Term Loan Due 2025</link:label>
    <link:label id="lab_hum_GentivaTermLoanDue2025Member_label_en-US" xlink:label="lab_hum_GentivaTermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gentiva Term Loan Due 2025 [Member]</link:label>
    <link:label id="lab_hum_GentivaTermLoanDue2025Member_documentation_en-US" xlink:label="lab_hum_GentivaTermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gentiva Term Loan Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GentivaTermLoanDue2025Member" xlink:href="hum-20221231.xsd#hum_GentivaTermLoanDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_GentivaTermLoanDue2025Member" xlink:to="lab_hum_GentivaTermLoanDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4b138deb-8cd8-4b20-8530-c0ed3bd1bf17_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_89818914-29da-468a-871a-50bb6222f83f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_3893e37c-76ce-4cb7-9d00-9ed617060569_totalLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (losses) gains recognized on equity securities during the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_6558a33e-03a6-4db0-b69e-a63e356688e3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unearned revenues</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_5d82b4d6-6e16-4fbc-aba3-60aadbf27dfd_totalLabel_en-US" xlink:label="lab_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income before income taxes and equity in net earnings of subsidiaries</link:label>
    <link:label id="lab_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_label_en-US" xlink:label="lab_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Before Income Taxes And Equity In Net Earnings Of Subsidiaries</link:label>
    <link:label id="lab_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_documentation_en-US" xlink:label="lab_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) Before Income Taxes And Equity In Net Earnings Of Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" xlink:href="hum-20221231.xsd#hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" xlink:to="lab_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_d13167a4-87e6-42c2-a1a2-c55fcfc969cb_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU asset, balance sheet line item</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_364d53aa-955f-45dd-888c-162fa20b9a9c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_InvestmentInRelatedPartiesAndSubsidiaries_15ff7e70-0457-4cb0-8222-4a4d7764d3a9_terseLabel_en-US" xlink:label="lab_hum_InvestmentInRelatedPartiesAndSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in subsidiaries</link:label>
    <link:label id="lab_hum_InvestmentInRelatedPartiesAndSubsidiaries_label_en-US" xlink:label="lab_hum_InvestmentInRelatedPartiesAndSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment In Related Parties And Subsidiaries</link:label>
    <link:label id="lab_hum_InvestmentInRelatedPartiesAndSubsidiaries_documentation_en-US" xlink:label="lab_hum_InvestmentInRelatedPartiesAndSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in related parties and subsidiaries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InvestmentInRelatedPartiesAndSubsidiaries" xlink:href="hum-20221231.xsd#hum_InvestmentInRelatedPartiesAndSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_InvestmentInRelatedPartiesAndSubsidiaries" xlink:to="lab_hum_InvestmentInRelatedPartiesAndSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_fef9d0da-a2ab-4a13-8c57-81a3ae40e0c0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f5aebe69-eb95-4a2b-88db-18927f84acf6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_LongDurationInsuranceProductsDomain_30b31c52-cfd8-4f55-8816-c3033f11540b_terseLabel_en-US" xlink:label="lab_hum_LongDurationInsuranceProductsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Duration Insurance Products [Domain]</link:label>
    <link:label id="lab_hum_LongDurationInsuranceProductsDomain_label_en-US" xlink:label="lab_hum_LongDurationInsuranceProductsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Duration Insurance Products [Domain]</link:label>
    <link:label id="lab_hum_LongDurationInsuranceProductsDomain_documentation_en-US" xlink:label="lab_hum_LongDurationInsuranceProductsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Duration Insurance Products [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LongDurationInsuranceProductsDomain" xlink:href="hum-20221231.xsd#hum_LongDurationInsuranceProductsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_LongDurationInsuranceProductsDomain" xlink:to="lab_hum_LongDurationInsuranceProductsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A2011PlanMember_9b7a2490-48cc-4f23-88fb-2a395d7c7559_terseLabel_en-US" xlink:label="lab_hum_A2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Plan</link:label>
    <link:label id="lab_hum_A2011PlanMember_label_en-US" xlink:label="lab_hum_A2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Plan [Member]</link:label>
    <link:label id="lab_hum_A2011PlanMember_documentation_en-US" xlink:label="lab_hum_A2011PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2011 Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2011PlanMember" xlink:href="hum-20221231.xsd#hum_A2011PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A2011PlanMember" xlink:to="lab_hum_A2011PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_16e310a0-2fc5-4ae1-b902-4b0d8907155f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_05ac0585-33bf-4759-9c08-e520f771c71c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investment securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_HealthCareCostPaymentsAndReimbursementsNet_4f628316-e8cc-4010-b94f-cdf1ea93954a_negatedTotalLabel_en-US" xlink:label="lab_hum_HealthCareCostPaymentsAndReimbursementsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net reimbursements (payments)</link:label>
    <link:label id="lab_hum_HealthCareCostPaymentsAndReimbursementsNet_label_en-US" xlink:label="lab_hum_HealthCareCostPaymentsAndReimbursementsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Payments And Reimbursements, Net</link:label>
    <link:label id="lab_hum_HealthCareCostPaymentsAndReimbursementsNet_documentation_en-US" xlink:label="lab_hum_HealthCareCostPaymentsAndReimbursementsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The difference between health care cost payments and reimbursements related to the TRICARE South Region contract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareCostPaymentsAndReimbursementsNet" xlink:href="hum-20221231.xsd#hum_HealthCareCostPaymentsAndReimbursementsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_HealthCareCostPaymentsAndReimbursementsNet" xlink:to="lab_hum_HealthCareCostPaymentsAndReimbursementsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FullyInsuredMember_21b57db1-8f91-4c8b-9b15-d318223a8919_terseLabel_en-US" xlink:label="lab_hum_FullyInsuredMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fully-insured</link:label>
    <link:label id="lab_hum_FullyInsuredMember_label_en-US" xlink:label="lab_hum_FullyInsuredMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fully Insured [Member]</link:label>
    <link:label id="lab_hum_FullyInsuredMember_documentation_en-US" xlink:label="lab_hum_FullyInsuredMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fully Insured [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FullyInsuredMember" xlink:href="hum-20221231.xsd#hum_FullyInsuredMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FullyInsuredMember" xlink:to="lab_hum_FullyInsuredMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_82cf223f-b766-4a70-b3e4-153283a2a371_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage and asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1b3aecd5-7be0-4c5e-bcb1-d0c296e267ed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax benefit recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_14579678-187c-42db-abe7-871add0aae63_terseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease rental income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_9c9eb6f8-b4fb-4309-9477-c6245ba5909c_terseLabel_en-US" xlink:label="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum amount outstanding during period</link:label>
    <link:label id="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_label_en-US" xlink:label="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Maximum Amount Outstanding During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:to="lab_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_218b1493-cc53-45dc-b136-b143988204db_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_17e14f7b-9739-4c82-bbd4-97a1fda44079_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt outstanding</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_cf032ed0-7a6e-4146-8d49-5b3b3a36cecb_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_23448c31-034c-4a9f-912b-f6db02de9071_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_SecuredOvernightFinancingRateSOFRMember_4ebd0ecd-b967-43e6-8437-683db64feeed_terseLabel_en-US" xlink:label="lab_hum_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SOFR</link:label>
    <link:label id="lab_hum_SecuredOvernightFinancingRateSOFRMember_label_en-US" xlink:label="lab_hum_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) [Member]</link:label>
    <link:label id="lab_hum_SecuredOvernightFinancingRateSOFRMember_documentation_en-US" xlink:label="lab_hum_SecuredOvernightFinancingRateSOFRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SecuredOvernightFinancingRateSOFRMember" xlink:href="hum-20221231.xsd#hum_SecuredOvernightFinancingRateSOFRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_SecuredOvernightFinancingRateSOFRMember" xlink:to="lab_hum_SecuredOvernightFinancingRateSOFRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_a8497809-466e-4afd-97fe-36756712f2d1_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_6c720430-4dd8-4e7d-801c-4ae8ca3a0b04_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A313PercentSeniorNotesDueAugust2029Member_2762cec3-7c4d-4927-a536-3345947179e1_terseLabel_en-US" xlink:label="lab_hum_A313PercentSeniorNotesDueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500&#160;million, 3.13% due August 15, 2029</link:label>
    <link:label id="lab_hum_A313PercentSeniorNotesDueAugust2029Member_label_en-US" xlink:label="lab_hum_A313PercentSeniorNotesDueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13 Percent Senior Notes Due August 2029 [Member]</link:label>
    <link:label id="lab_hum_A313PercentSeniorNotesDueAugust2029Member_documentation_en-US" xlink:label="lab_hum_A313PercentSeniorNotesDueAugust2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.13 Percent Senior Notes Due August 2029</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A313PercentSeniorNotesDueAugust2029Member" xlink:href="hum-20221231.xsd#hum_A313PercentSeniorNotesDueAugust2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A313PercentSeniorNotesDueAugust2029Member" xlink:to="lab_hum_A313PercentSeniorNotesDueAugust2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_a15d7d81-4525-4961-8498-71ceadc5ed45_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfTreasuryStockTable_label_en-US" xlink:label="lab_us-gaap_ClassOfTreasuryStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable" xlink:to="lab_us-gaap_ClassOfTreasuryStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_6ae0f300-b80f-4ffb-8bdd-9e4521f6b86b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfTRICAREBeneficiaries_177b28a8-6b14-4ac7-be6a-f17fffc8988a_terseLabel_en-US" xlink:label="lab_hum_NumberOfTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of TRICARE beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfTRICAREBeneficiaries_label_en-US" xlink:label="lab_hum_NumberOfTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of TRICARE Beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfTRICAREBeneficiaries_documentation_en-US" xlink:label="lab_hum_NumberOfTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of TRICARE Beneficiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREBeneficiaries" xlink:href="hum-20221231.xsd#hum_NumberOfTRICAREBeneficiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfTRICAREBeneficiaries" xlink:to="lab_hum_NumberOfTRICAREBeneficiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_079b3e4a-550f-46f2-909b-6fbf59713993_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less&#160;than&#160;12&#160;months</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member_02d7ec6d-dd26-455a-8d49-618919f764d2_terseLabel_en-US" xlink:label="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$400&#160;million, 4.80% due March 15, 2047</link:label>
    <link:label id="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member_label_en-US" xlink:label="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.80 Percent Senior Notes Due March 2047 [Member]</link:label>
    <link:label id="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member_documentation_en-US" xlink:label="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.80 Percent Senior Notes Due March 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:href="hum-20221231.xsd#hum_A4.80PercentSeniorNotesDueMarch2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:to="lab_hum_A4.80PercentSeniorNotesDueMarch2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TermLoanAndCommercialPaperMember_c1f9ac8c-00be-4b55-86e3-a3353a541486_terseLabel_en-US" xlink:label="lab_hum_TermLoanAndCommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan And Commercial Paper</link:label>
    <link:label id="lab_hum_TermLoanAndCommercialPaperMember_label_en-US" xlink:label="lab_hum_TermLoanAndCommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan And Commercial Paper [Member]</link:label>
    <link:label id="lab_hum_TermLoanAndCommercialPaperMember_documentation_en-US" xlink:label="lab_hum_TermLoanAndCommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan And Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanAndCommercialPaperMember" xlink:href="hum-20221231.xsd#hum_TermLoanAndCommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TermLoanAndCommercialPaperMember" xlink:to="lab_hum_TermLoanAndCommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_9c74425b-d325-4242-a210-4ffbce232b02_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NoncompetesAndOtherMember_2e05b0db-4ad7-45ec-b536-0002f370ba3a_terseLabel_en-US" xlink:label="lab_hum_NoncompetesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetes and other</link:label>
    <link:label id="lab_hum_NoncompetesAndOtherMember_label_en-US" xlink:label="lab_hum_NoncompetesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetes And Other [Member]</link:label>
    <link:label id="lab_hum_NoncompetesAndOtherMember_documentation_en-US" xlink:label="lab_hum_NoncompetesAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompetes and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncompetesAndOtherMember" xlink:href="hum-20221231.xsd#hum_NoncompetesAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NoncompetesAndOtherMember" xlink:to="lab_hum_NoncompetesAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_61e742d6-5c8c-45e7-80be-0252d4108965_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Nonconsolidated Investee [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:to="lab_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_a3169c7e-093d-4f6f-ad91-e4dc5f685c3f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 months or more</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_00ab3bd8-052f-45cd-b110-48f51d6fe9f3_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d1661862-0ce0-42da-ae78-635d99a4eaff_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a98e2a-c2d6-481d-bea1-e784f214a013_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_0d5615ae-828f-4bd3-800c-1be10ccfa58d_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ddee5c50-5fda-4fc8-b964-56a3407209e6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_2ef09b60-fdd6-4887-a701-8008c4a6b44f_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_f0640ff5-7194-4fe1-a3ae-16c969cb6a7d_terseLabel_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract term with exercises</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_label_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Term With Option Exercises</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_documentation_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Term With Option Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:href="hum-20221231.xsd#hum_TRICAREManagedCareSupportContractTermWithOptionExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:to="lab_hum_TRICAREManagedCareSupportContractTermWithOptionExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_d5c0518c-37fc-4c4c-8777-a46bc4668ab8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider contracts</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_2ba47538-9d94-45cd-b279-2c26f3bc7c69_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CreditRatingStandardPoorsAxis_7de9b86b-839b-4fd1-b60d-a757f440fbd7_terseLabel_en-US" xlink:label="lab_srt_CreditRatingStandardPoorsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Standard &amp; Poor's [Axis]</link:label>
    <link:label id="lab_srt_CreditRatingStandardPoorsAxis_label_en-US" xlink:label="lab_srt_CreditRatingStandardPoorsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Rating, Standard &amp; Poor's [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CreditRatingStandardPoorsAxis" xlink:to="lab_srt_CreditRatingStandardPoorsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PaymentOfAnnualHealthInsuranceIndustryFee_ebe4f784-4f9a-48e9-a5cb-febc5b73453c_terseLabel_en-US" xlink:label="lab_hum_PaymentOfAnnualHealthInsuranceIndustryFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of annual health insurance industry fee</link:label>
    <link:label id="lab_hum_PaymentOfAnnualHealthInsuranceIndustryFee_label_en-US" xlink:label="lab_hum_PaymentOfAnnualHealthInsuranceIndustryFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Annual Health Insurance Industry Fee</link:label>
    <link:label id="lab_hum_PaymentOfAnnualHealthInsuranceIndustryFee_documentation_en-US" xlink:label="lab_hum_PaymentOfAnnualHealthInsuranceIndustryFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment Of Annual Health Insurance Industry Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentOfAnnualHealthInsuranceIndustryFee" xlink:href="hum-20221231.xsd#hum_PaymentOfAnnualHealthInsuranceIndustryFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PaymentOfAnnualHealthInsuranceIndustryFee" xlink:to="lab_hum_PaymentOfAnnualHealthInsuranceIndustryFee" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage_f2ae0065-52b6-4cda-9ff4-5887971bcd8f_terseLabel_en-US" xlink:label="lab_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest to be acquired per agreement (percent)</link:label>
    <link:label id="lab_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage_label_en-US" xlink:label="lab_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreement, Equity Interest To Be Acquired, Percentage</link:label>
    <link:label id="lab_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage_documentation_en-US" xlink:label="lab_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Definitive Agreement, Equity Interest To Be Acquired, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage" xlink:href="hum-20221231.xsd#hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage" xlink:to="lab_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_SignificantAccountingPoliciesLineItems_3ce6abf5-6034-4280-97c2-71aad4161824_terseLabel_en-US" xlink:label="lab_hum_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_hum_SignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_hum_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_hum_SignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_hum_SignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SignificantAccountingPoliciesLineItems" xlink:href="hum-20221231.xsd#hum_SignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems" xlink:to="lab_hum_SignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueProductLineMember_cbb14341-df0e-4b6b-946d-67b4e5fce4d1_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueProductLineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums and services revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueProductLineMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueProductLineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueProductLineMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueProductLineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueProductLineMember" xlink:to="lab_us-gaap_SalesRevenueProductLineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_41825ae2-bb1e-43c0-83e8-a1979c68924d_terseLabel_en-US" xlink:label="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution to noncontrolling interest holders, net</link:label>
    <link:label id="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders</link:label>
    <link:label id="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:href="hum-20221231.xsd#hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:to="lab_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1596b1ab-7353-478d-8fb1-659a7307a7a2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average outstanding shares of common stock used to compute basic earnings per common share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_d515a002-3190-4931-a77b-4d55ab0ddbe8_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_label_en-US" xlink:label="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Year Claims and Claims Adjustment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:to="lab_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_d3e2711c-f542-4273-a074-a141c3ceb738_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable intangibles</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_11b3e361-5966-43d7-9790-b0e374551046_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investment ownership (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue_dd02bf85-88d0-4838-9830-fd57e36dd5df_terseLabel_en-US" xlink:label="lab_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in capital in excess of par value</link:label>
    <link:label id="lab_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue_label_en-US" xlink:label="lab_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Decrease In Capital In Excess Of Par Value</link:label>
    <link:label id="lab_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue_documentation_en-US" xlink:label="lab_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Decrease In Capital In Excess Of Par Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue" xlink:href="hum-20221231.xsd#hum_TreasuryStockDecreaseInCapitalInExcessOfParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue" xlink:to="lab_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_665e27d4-0d6a-48a8-8fde-79777dd7475f_negatedTerseLabel_en-US" xlink:label="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Noncontrolling interests acquired</link:label>
    <link:label id="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_label_en-US" xlink:label="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash Acquisition Noncontrolling Interest Acquired</link:label>
    <link:label id="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_documentation_en-US" xlink:label="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash Acquisition Noncontrolling Interest Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:href="hum-20221231.xsd#hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:to="lab_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_4cdb6cec-dd68-45d7-bf6f-02edda7d4073_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (gain) on investment securities, net</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_e1d9d2f4-68f1-4fc5-bea0-a444350f9d49_totalLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net recognized (losses) gains on investment securities</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Equity Securities, Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A8.15PercentSeniorNotesDueJune2038Member_aec8b4d7-7543-4f56-b183-c8e917631c84_terseLabel_en-US" xlink:label="lab_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$250&#160;million, 8.15% due June&#160;15, 2038</link:label>
    <link:label id="lab_hum_A8.15PercentSeniorNotesDueJune2038Member_label_en-US" xlink:label="lab_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">8.15 Percent Senior Notes Due June 2038 [Member]</link:label>
    <link:label id="lab_hum_A8.15PercentSeniorNotesDueJune2038Member_documentation_en-US" xlink:label="lab_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">8.15 Percent Senior Notes Due June 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:href="hum-20221231.xsd#hum_A8.15PercentSeniorNotesDueJune2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:to="lab_hum_A8.15PercentSeniorNotesDueJune2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_64b1367f-f962-49fd-b866-90d08e3952f5_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $1 par; 10,000,000 shares authorized; none issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_8c0625b9-aeb5-49c3-8062-0d5623513491_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_a516a545-455e-4d2b-b978-743b15cd4bee_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_252fb64e-45dd-4ba6-939a-c7107eca04cb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_cd9061ec-52b3-4e10-8f54-a33ca6e3ffd6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Value of Debt Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_43d07783-ccf3-4d07-ad7c-2bc5203e54cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_4beee7f4-85ab-4273-886a-b345f9caf3e0_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_27e04e9e-9a7c-4d71-8ca1-730ca02ca3ec_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized in other comprehensive&#160;income</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtCurrent_0d5bbb4a-eb20-45b2-b22e-f1b5e859aca5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_00eb63c3-b156-4e22-8ced-82ea7ba1ba06_totalLabel_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total short-term debt</link:label>
    <link:label id="lab_us-gaap_DebtCurrent_label_en-US" xlink:label="lab_us-gaap_DebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtCurrent" xlink:to="lab_us-gaap_DebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4e43d65c-2f02-419e-9cf6-4fc1f5eeb807_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_4cf3db6f-9a2c-4305-9e8f-edcc9743d901_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a5e5029e-e0e4-43ff-a60e-773f9605d729_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unobservable Inputs (Level 3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_6453e4a9-bc31-4860-9a5f-cf4965af13a9_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3 fair value measurement</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrent_d5a54752-c2fc-4e7b-b806-e2583d84902f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrent" xlink:to="lab_us-gaap_AssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CapitalContributionsToOperatingSubsidiaries_5e628acc-1563-4c01-9996-c5e5102479af_negatedLabel_en-US" xlink:label="lab_hum_CapitalContributionsToOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to operating subsidiaries</link:label>
    <link:label id="lab_hum_CapitalContributionsToOperatingSubsidiaries_label_en-US" xlink:label="lab_hum_CapitalContributionsToOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Contributions To Operating Subsidiaries</link:label>
    <link:label id="lab_hum_CapitalContributionsToOperatingSubsidiaries_documentation_en-US" xlink:label="lab_hum_CapitalContributionsToOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions to operating subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CapitalContributionsToOperatingSubsidiaries" xlink:href="hum-20221231.xsd#hum_CapitalContributionsToOperatingSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CapitalContributionsToOperatingSubsidiaries" xlink:to="lab_hum_CapitalContributionsToOperatingSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_92b2001b-8c7c-47c4-a555-dd68d4f3315e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in net (losses) earnings</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_d938980c-aa35-4910-9214-40f406f1a6f8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term investment securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_a9a68fe2-4ce7-4933-8fb4-2da248fea04e_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of notes payable to operating subsidiaries</link:label>
    <link:label id="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:to="lab_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RegulatoryMattersDomain_b56bbf45-30bd-4d4b-8cbd-8680a9903971_terseLabel_en-US" xlink:label="lab_hum_RegulatoryMattersDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Matters [Domain]</link:label>
    <link:label id="lab_hum_RegulatoryMattersDomain_label_en-US" xlink:label="lab_hum_RegulatoryMattersDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Matters [Domain]</link:label>
    <link:label id="lab_hum_RegulatoryMattersDomain_documentation_en-US" xlink:label="lab_hum_RegulatoryMattersDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Regulatory Matters [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersDomain" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RegulatoryMattersDomain" xlink:to="lab_hum_RegulatoryMattersDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_b9c62999-9462-4dcd-8ce4-dfa568e2db41_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_8747c897-30fd-4da5-8495-12bb921540f6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_1296b991-521a-4d08-bfe8-36030d859647_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies_fc05b5e0-84f2-4bf0-b1fc-aed8e856bc20_terseLabel_en-US" xlink:label="lab_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of days notice for employer group to cancel short-duration prepaid health services policies</link:label>
    <link:label id="lab_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies_label_en-US" xlink:label="lab_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days Notice For Employer Group To Cancel Short Duration Prepaid Health Services Policies</link:label>
    <link:label id="lab_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies_documentation_en-US" xlink:label="lab_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Days Notice For Employer Group To Cancel Short Duration Prepaid Health Services Policies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" xlink:href="hum-20221231.xsd#hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" xlink:to="lab_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_e49006a1-8ee2-41cf-b823-59b18fd0bd94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions</link:label>
    <link:label id="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_label_en-US" xlink:label="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Written off Related to Sale of Business Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:to="lab_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_2aced0d3-35fa-4294-b2df-3856b655126a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument term (in years)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_32cee22b-a892-47f7-9425-c3604ed3de55_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Components of Net Deferred Tax Balances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_235b4ffa-7e71-4c23-9817-47bc0dd35ee7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_b3ced19a-56ec-43c4-95a8-02fefdca715a_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_d850b6cf-7ab9-400a-8081-9445e7393d71_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of employee stock options and restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_8281deba-01cd-4123-bba3-6f847af7f8ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a8e27f42-c934-496c-ada1-f7a7194eaef6_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerContractsMember_94edcc68-a280-48e5-9417-5c3f94229c49_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer contracts/relationships</link:label>
    <link:label id="lab_us-gaap_CustomerContractsMember_label_en-US" xlink:label="lab_us-gaap_CustomerContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerContractsMember" xlink:to="lab_us-gaap_CustomerContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_3d3cf9d5-f4c3-475a-a99d-4cb78782fcc6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_41364e9a-5b79-4ecb-9f57-09a551af9c9d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash and cash equivalents acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1f2bf6f8-0c0a-41d8-869c-4866fe4699d9_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquired businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_a912b840-0d21-4592-93f2-166d19057455_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Observable Inputs (Level 2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_cbe801a6-312a-4aea-b4ea-378912b68660_terseLabel_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits</link:label>
    <link:label id="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_label_en-US" xlink:label="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Net, Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:to="lab_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4076bbef-a248-4f1b-b7dc-64a5c2f7541a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c7ad2eaf-f6f4-4c7e-8484-4ca4481b0f6a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_a3e5c983-e6ee-4d6b-95c5-a0a9a8a5d812_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock_4dc18a0d-9faa-45a5-b021-9a5253fc0412_terseLabel_en-US" xlink:label="lab_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future policy benefits payable</link:label>
    <link:label id="lab_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock_label_en-US" xlink:label="lab_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Policy And Benefits Payable Policy [Policy Text Block]</link:label>
    <link:label id="lab_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of policies associated with the accounting treatment of future policy benefits payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock" xlink:href="hum-20221231.xsd#hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock" xlink:to="lab_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_c640afd7-3891-4e5d-94eb-7b00a76bf3f1_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_b22b0dea-3287-42db-816f-5aa5c0580315_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_fbd63c95-951f-469b-8df1-25111b085484_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_e97b7b5c-f732-4429-a908-5262a598c65b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_16a70cf5-69c4-4927-867f-d1928d7ae5d1_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_08dbb370-7348-4737-b3b8-72117fee94c8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligations in 2026</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_3fd43202-f4fa-40ec-8b98-347286f09825_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_271ce0ac-35a2-4d93-9385-4ec71ae66c00_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_63a8ba58-d8c1-4829-b36f-5ff3568201ed_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_7b1a9ad9-03b0-4d97-85e6-2959f124135e_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_9caf9667-6114-45cd-a471-3cb8d36348c4_periodStartLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balances, beginning of period, net</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtAndEquitySecuritiesRealizedLoss_fd9feb3f-190a-464a-8d96-d766aa17df6c_negatedTerseLabel_en-US" xlink:label="lab_hum_DebtAndEquitySecuritiesRealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross losses on investment securities</link:label>
    <link:label id="lab_hum_DebtAndEquitySecuritiesRealizedLoss_label_en-US" xlink:label="lab_hum_DebtAndEquitySecuritiesRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities, Realized Loss</link:label>
    <link:label id="lab_hum_DebtAndEquitySecuritiesRealizedLoss_documentation_en-US" xlink:label="lab_hum_DebtAndEquitySecuritiesRealizedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities, Realized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtAndEquitySecuritiesRealizedLoss" xlink:href="hum-20221231.xsd#hum_DebtAndEquitySecuritiesRealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtAndEquitySecuritiesRealizedLoss" xlink:to="lab_hum_DebtAndEquitySecuritiesRealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_c0e2bb0c-feef-4b4c-a341-dab8cfa6f5ab_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_7badde37-a54e-4324-9c72-c5708b754169_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized (losses) gains recognized on equity securities still held at the end of the period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:to="lab_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_43abc9be-ad36-4e7b-aa53-3eb962746dab_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, net of allowances</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_b4f4b01a-4158-44cd-959d-e01ed5fe7a19_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REINSURANCE</link:label>
    <link:label id="lab_us-gaap_ReinsuranceTextBlock_label_en-US" xlink:label="lab_us-gaap_ReinsuranceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceTextBlock" xlink:to="lab_us-gaap_ReinsuranceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_4b339d2e-2d95-4738-b433-1384903bbf64_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_cdb14fe6-1332-464e-9ce3-a764dfb55a55_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BookOverdraftPolicyPolicyTextBlock_76844e27-4290-4282-9367-83155bac3101_terseLabel_en-US" xlink:label="lab_hum_BookOverdraftPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book Overdraft</link:label>
    <link:label id="lab_hum_BookOverdraftPolicyPolicyTextBlock_label_en-US" xlink:label="lab_hum_BookOverdraftPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book Overdraft Policy [Policy Text Block]</link:label>
    <link:label id="lab_hum_BookOverdraftPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_hum_BookOverdraftPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of policies associated with the accounting treatment of book overdraft</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftPolicyPolicyTextBlock" xlink:href="hum-20221231.xsd#hum_BookOverdraftPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BookOverdraftPolicyPolicyTextBlock" xlink:to="lab_hum_BookOverdraftPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_69dee74c-44fb-4a9e-b9ab-e0cb340145a9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_86c0d37b-a747-4744-85cb-88b75fad9fe2_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_bcbb6df5-2ea9-4e64-b724-53ac8faef1f1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total incurred</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_d94b6d84-4dc3-48f8-967a-d60b6077753a_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d0c66ef8-56f9-4cad-8bb1-8c66d85f1e31_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total change in unrealized investment (losses) gains, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CertificateOfNeedMember_5161f381-e825-48c9-b080-10f1b3aea819_terseLabel_en-US" xlink:label="lab_hum_CertificateOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of need</link:label>
    <link:label id="lab_hum_CertificateOfNeedMember_label_en-US" xlink:label="lab_hum_CertificateOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificate Of Need [Member]</link:label>
    <link:label id="lab_hum_CertificateOfNeedMember_documentation_en-US" xlink:label="lab_hum_CertificateOfNeedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificate Of Need</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CertificateOfNeedMember" xlink:href="hum-20221231.xsd#hum_CertificateOfNeedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CertificateOfNeedMember" xlink:to="lab_hum_CertificateOfNeedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_b7ccfa93-eaf9-4ece-92e5-f4af7924c94b_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_HomeSolutionsReportingUnitMember_d48923b7-d58c-4f5b-b2d3-d62934d0a508_terseLabel_en-US" xlink:label="lab_hum_HomeSolutionsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Solutions Reporting Unit</link:label>
    <link:label id="lab_hum_HomeSolutionsReportingUnitMember_label_en-US" xlink:label="lab_hum_HomeSolutionsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Solutions Reporting Unit [Member]</link:label>
    <link:label id="lab_hum_HomeSolutionsReportingUnitMember_documentation_en-US" xlink:label="lab_hum_HomeSolutionsReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Solutions Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsReportingUnitMember" xlink:href="hum-20221231.xsd#hum_HomeSolutionsReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_HomeSolutionsReportingUnitMember" xlink:to="lab_hum_HomeSolutionsReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f921f7fd-2d91-4da8-ac42-905e968dd048_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NetAssetLiability_4ce4e5be-a2fa-4cf6-b359-7b0ac848ec2c_totalLabel_en-US" xlink:label="lab_hum_NetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net asset (liability)</link:label>
    <link:label id="lab_hum_NetAssetLiability_label_en-US" xlink:label="lab_hum_NetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Asset (Liability)</link:label>
    <link:label id="lab_hum_NetAssetLiability_documentation_en-US" xlink:label="lab_hum_NetAssetLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Asset (Liability)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetAssetLiability" xlink:href="hum-20221231.xsd#hum_NetAssetLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NetAssetLiability" xlink:to="lab_hum_NetAssetLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_b591ef42-1388-4e6c-a6bc-445ed567f225_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_879bd5a6-8292-4e46-bbb5-5ae91ec8e1ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock shares reserved for stock award plans (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_aa822117-fcfc-4ef4-a43f-854b9ed73ea4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_a37e85a6-88b9-4f70-b0b9-0259c74e7475_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits payable</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_2c0989e6-96be-4209-87a9-d2cdab67a75d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceContractAxis_1d3d2e15-4c3c-4220-90d7-4e5f198156f0_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceContractAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Policy, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ReinsuranceContractAxis_label_en-US" xlink:label="lab_us-gaap_ReinsuranceContractAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Contract [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceContractAxis" xlink:to="lab_us-gaap_ReinsuranceContractAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_42cfb102-9bbc-4c07-8ace-1b2b6fb5930f_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related legal fees and expenses</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_f68a6f1f-5be0-440c-ad2a-01695226f249_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Income Taxes Using Federal Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_757b263d-3d83-4c3d-b6c5-d0df66496cfb_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_6fd4f80e-9e5a-4276-84b1-a5ad6d31bb52_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States, net of federal benefit, and Puerto Rico</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_893cedbf-5681-4e3a-ac17-0cfa94947d72_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_2cf1ee99-8c01-44ba-858e-5b540f511e8a_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NetCurrentLiabilityAsset_7edf48af-871a-4be0-8dc2-83ea85e677ba_totalLabel_en-US" xlink:label="lab_hum_NetCurrentLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current asset (liability)</link:label>
    <link:label id="lab_hum_NetCurrentLiabilityAsset_label_en-US" xlink:label="lab_hum_NetCurrentLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Current (Liability) Asset</link:label>
    <link:label id="lab_hum_NetCurrentLiabilityAsset_documentation_en-US" xlink:label="lab_hum_NetCurrentLiabilityAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net current (liability) asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset" xlink:href="hum-20221231.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NetCurrentLiabilityAsset" xlink:to="lab_hum_NetCurrentLiabilityAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicaidMember_e6014f48-100e-43c6-843b-64a30608f3c0_terseLabel_en-US" xlink:label="lab_hum_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_hum_MedicaidMember_label_en-US" xlink:label="lab_hum_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:label id="lab_hum_MedicaidMember_documentation_en-US" xlink:label="lab_hum_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidMember" xlink:href="hum-20221231.xsd#hum_MedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicaidMember" xlink:to="lab_hum_MedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_ffacb3f3-9f2d-41ce-becd-4b52662279e0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5837070-208a-45b7-8e86-7056859540dd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_876db148-c542-49bb-b046-ad2449e8b873_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RevenueExitMultipleMember_a2624535-6d36-4c51-9269-bc0c170943dd_terseLabel_en-US" xlink:label="lab_hum_RevenueExitMultipleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue exit multiple</link:label>
    <link:label id="lab_hum_RevenueExitMultipleMember_label_en-US" xlink:label="lab_hum_RevenueExitMultipleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Exit Multiple [Member]</link:label>
    <link:label id="lab_hum_RevenueExitMultipleMember_documentation_en-US" xlink:label="lab_hum_RevenueExitMultipleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Exit Multiple</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevenueExitMultipleMember" xlink:href="hum-20221231.xsd#hum_RevenueExitMultipleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RevenueExitMultipleMember" xlink:to="lab_hum_RevenueExitMultipleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_WelshCarsonAndersonAndStoweMember_ca47f04f-a2cb-4057-8ba3-604f836ac171_terseLabel_en-US" xlink:label="lab_hum_WelshCarsonAndersonAndStoweMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">WCAS</link:label>
    <link:label id="lab_hum_WelshCarsonAndersonAndStoweMember_label_en-US" xlink:label="lab_hum_WelshCarsonAndersonAndStoweMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Welsh Carson Anderson And Stowe [Member]</link:label>
    <link:label id="lab_hum_WelshCarsonAndersonAndStoweMember_documentation_en-US" xlink:label="lab_hum_WelshCarsonAndersonAndStoweMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Welsh Carson Anderson And Stowe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_WelshCarsonAndersonAndStoweMember" xlink:href="hum-20221231.xsd#hum_WelshCarsonAndersonAndStoweMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_WelshCarsonAndersonAndStoweMember" xlink:to="lab_hum_WelshCarsonAndersonAndStoweMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_010744ee-e088-4af8-8995-319b7733119b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_634eb08a-59d6-481f-bcc5-d4ae2b1dd518_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_6f7828e4-29f2-4de6-87b3-1e3a26dfa34d_terseLabel_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit, outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LinesOfCreditCurrent_label_en-US" xlink:label="lab_us-gaap_LinesOfCreditCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LinesOfCreditCurrent" xlink:to="lab_us-gaap_LinesOfCreditCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_1da8d721-51d8-43e6-a3eb-fb4267e0b722_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:to="lab_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_0abc8747-fff0-496c-952c-d34360233240_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_65da59ab-9951-4945-be31-fa524befd530_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of financial liability</link:label>
    <link:label id="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_FinancialLiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_620b6351-df99-43fe-95f8-a42dea309705_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_9d5470f3-a429-4ce7-bc05-e73a06f95c8f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_cea0d93a-af50-4e69-9535-c103f463138a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_95d4fabb-3540-4985-bdf7-698de8df0af0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average fair value at grant date (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_bb412c3f-9955-4bb5-b64c-1ea59c1cb632_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_171803e6-f3a1-4f16-8cae-eed5b1c12860_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of senior notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfSeniorDebt" xlink:to="lab_us-gaap_RepaymentsOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicaidAndOtherMember_349d7535-2fec-48dc-828c-6e6bba65b6c0_terseLabel_en-US" xlink:label="lab_hum_MedicaidAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and other</link:label>
    <link:label id="lab_hum_MedicaidAndOtherMember_label_en-US" xlink:label="lab_hum_MedicaidAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid And Other [Member]</link:label>
    <link:label id="lab_hum_MedicaidAndOtherMember_documentation_en-US" xlink:label="lab_hum_MedicaidAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidAndOtherMember" xlink:href="hum-20221231.xsd#hum_MedicaidAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicaidAndOtherMember" xlink:to="lab_hum_MedicaidAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_01f1bd5b-81b2-42da-b9fa-e3025dca1bf2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_993d2439-caf3-4ff8-b8d5-aa7932d4eaa2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_435a096c-e48a-43be-beff-ebf803f5f8c9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net (losses) earnings</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_195b00b3-b64c-41f9-a79a-704b0a050a9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in net losses (earnings)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram_a4fc3ee7-c045-48a6-bcb1-0621e0a200df_terseLabel_en-US" xlink:label="lab_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum age required for retirement eligibility as related to our equity award program</link:label>
    <link:label id="lab_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram_label_en-US" xlink:label="lab_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Age Required For Retirement Eligibility As Related To Our Equity Award Program</link:label>
    <link:label id="lab_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram_documentation_en-US" xlink:label="lab_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum age required for retirement eligibility as related to our equity award program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:href="hum-20221231.xsd#hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:to="lab_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6205eb95-dba0-453e-b1cf-95ce46512837_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_92d758b9-a2d2-4b00-bc7a-91be771e0a02_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_80e26ebf-71d1-4ec6-b85c-734903d012d9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance_044b6b83-fcae-45df-8738-6a589864afa6_terseLabel_en-US" xlink:label="lab_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares of common stock reserved for issuance under defined contribution retirement savings plan (in shares)</link:label>
    <link:label id="lab_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance_label_en-US" xlink:label="lab_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Number Of Shares Of Common Stock Reserved For Issuance</link:label>
    <link:label id="lab_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance_documentation_en-US" xlink:label="lab_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Number Of Shares Of Common Stock Reserved For Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance" xlink:to="lab_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_820f4a24-baee-454f-a746-b6dac2b96236_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e7f1da91-c133-44be-8cf3-a24a313658c5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Computation of Basic and Diluted Earnings Per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_de641c6b-db75-431a-a2f3-9285de76b948_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_c66eac1a-3416-40c2-902a-31a4191b0518_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_44f59d13-945f-403b-9975-afb76bce084d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_53ba7d23-fc30-4251-b0c7-7b2d74092fe3_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_e5fa60aa-f6e3-4b3a-8fd3-7b09079da7d0_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_d55e4744-ef3c-4432-a0a5-4023b7541851_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableMember_ab089c4f-d42d-4d39-bb79-498c27f4587a_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableMember_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable Including Reinsurance Premium Paid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableMember" xlink:to="lab_us-gaap_ReinsuranceRecoverableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_369331e4-5c0c-4682-af76-d63d10325394_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_1b5d7895-6d4c-48a4-936c-7e2627bed2ec_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset (Liability) Net, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetLiabilityNetMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:to="lab_us-gaap_DerivativeAssetLiabilityNetMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0c2e22f3-322e-4262-a5d4-6ec88d920d30_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_933e550a-74b6-49dd-b5be-073ac644000c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_7e146fd4-48c4-452c-b563-f0695b23a605_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_d3575d94-b45c-437f-a43a-a87d4e31972b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_24127b69-5bd4-43d2-ba25-7b42eb3f6cab_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies_397f5883-9439-45b6-aeff-30271d06a684_terseLabel_en-US" xlink:label="lab_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Typical term (in years) of short-duration employer-group prepaid health services policies</link:label>
    <link:label id="lab_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies_label_en-US" xlink:label="lab_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Typical Term In Years Of Short Duration Employer Group Prepaid Health Services Policies</link:label>
    <link:label id="lab_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies_documentation_en-US" xlink:label="lab_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Typical Term (In Years) Of Short-Duration Employer-Group Prepaid Health Services Policies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies" xlink:href="hum-20221231.xsd#hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies" xlink:to="lab_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_July2019ShareRepurchaseAuthorizationMember_37541848-904b-45e5-8607-fd06af561f3c_terseLabel_en-US" xlink:label="lab_hum_July2019ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Authorization</link:label>
    <link:label id="lab_hum_July2019ShareRepurchaseAuthorizationMember_label_en-US" xlink:label="lab_hum_July2019ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Authorization [Member]</link:label>
    <link:label id="lab_hum_July2019ShareRepurchaseAuthorizationMember_documentation_en-US" xlink:label="lab_hum_July2019ShareRepurchaseAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">July 2019 Share Repurchase Authorization [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_July2019ShareRepurchaseAuthorizationMember" xlink:href="hum-20221231.xsd#hum_July2019ShareRepurchaseAuthorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_July2019ShareRepurchaseAuthorizationMember" xlink:to="lab_hum_July2019ShareRepurchaseAuthorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_8ec67573-d44b-4537-9d6e-ca89803d5460_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_f51b85df-18e5-437f-a4b0-2e8ec0e9b8e8_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_4840f343-d3e9-4e3f-9a52-e42cbe9681cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember_e765fd67-2ac7-4666-9a44-6726b2cc5047_terseLabel_en-US" xlink:label="lab_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CMS, coverage for individual Medicare Advantage members in Florida</link:label>
    <link:label id="lab_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember_label_en-US" xlink:label="lab_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Government, Centers For Medicare And Medicaid Services, Florida Medicare Advantage [Member]</link:label>
    <link:label id="lab_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember_documentation_en-US" xlink:label="lab_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Government, Centers For Medicare And Medicaid Services, Florida Medicare Advantage [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember" xlink:href="hum-20221231.xsd#hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember" xlink:to="lab_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A135PercentSeniorNotesDueFebruary2027Member_0127f4c7-a466-4d0c-bb83-ff45b04ae6c4_terseLabel_en-US" xlink:label="lab_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750&#160;million 1.35% due February 3, 2027</link:label>
    <link:label id="lab_hum_A135PercentSeniorNotesDueFebruary2027Member_label_en-US" xlink:label="lab_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.35 Percent Senior Notes Due February 2027 [Member]</link:label>
    <link:label id="lab_hum_A135PercentSeniorNotesDueFebruary2027Member_documentation_en-US" xlink:label="lab_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.35 Percent Senior Notes Due February 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:href="hum-20221231.xsd#hum_A135PercentSeniorNotesDueFebruary2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:to="lab_hum_A135PercentSeniorNotesDueFebruary2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_e40e514e-f3e7-4f38-b0ac-9667dd8426fe_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityEquityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_4b3a9f87-9a55-4d93-a7eb-7b6d3b0cf905_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_4b87befb-064f-4fb6-bc31-000244b7c345_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_62e9987d-b8df-4983-832a-d657c4cf69d2_negatedTerseLabel_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (income) loss attributable to noncontrolling interests</link:label>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Attributable To Noncontrolling Interest</link:label>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_documentation_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Attributable To Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:href="hum-20221231.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:to="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_d6a12542-bcc6-4d4d-92fb-f0883fe4c252_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_4afc10e6-859a-4998-b74a-58f6c774a351_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in treasury stock from share repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_38e8fef0-5f2f-4b2c-be20-c2746ab1c656_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of repurchases</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_35ff0644-aae0-4b5a-b533-a6281bd27e64_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Humana</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_b58bd74a-9003-421d-bec5-66e3af4e6aba_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Humana</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_25bab949-3b02-4b41-9ce2-7a53b96cb261_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income available for common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_LongDurationInsuranceProductsAxis_3d0a3332-453b-4066-8e72-5646834ee881_terseLabel_en-US" xlink:label="lab_hum_LongDurationInsuranceProductsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Duration Insurance Products [Axis]</link:label>
    <link:label id="lab_hum_LongDurationInsuranceProductsAxis_label_en-US" xlink:label="lab_hum_LongDurationInsuranceProductsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Duration Insurance Products [Axis]</link:label>
    <link:label id="lab_hum_LongDurationInsuranceProductsAxis_documentation_en-US" xlink:label="lab_hum_LongDurationInsuranceProductsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Duration Insurance Products [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LongDurationInsuranceProductsAxis" xlink:href="hum-20221231.xsd#hum_LongDurationInsuranceProductsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_LongDurationInsuranceProductsAxis" xlink:to="lab_hum_LongDurationInsuranceProductsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_932ad426-44f1-4460-9ef0-26dd736219a0_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_381d3a9c-3f5f-4ef9-b961-bd33d892c5f1_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_c915aa89-ba8c-4bf6-ad02-064dcfe95610_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_550beab3-bdea-4261-99fc-a23dd1bed89e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A065PercentSeniorNotesDueAugust2023Member_729f48ce-c267-4e2f-9d39-e4a39e6ff0c2_terseLabel_en-US" xlink:label="lab_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1,500&#160;million, 0.65% due August 3, 2023</link:label>
    <link:label id="lab_hum_A065PercentSeniorNotesDueAugust2023Member_label_en-US" xlink:label="lab_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.65 Percent Senior Notes Due August 2023 [Member]</link:label>
    <link:label id="lab_hum_A065PercentSeniorNotesDueAugust2023Member_documentation_en-US" xlink:label="lab_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.65 Percent Senior Notes Due August 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:href="hum-20221231.xsd#hum_A065PercentSeniorNotesDueAugust2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:to="lab_hum_A065PercentSeniorNotesDueAugust2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_1dee7d9d-05b0-4e46-8afe-4b5fbb3ff801_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption price, percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_db8f25d0-8f7c-4b53-ac61-087327ed8347_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_801875ff-b67c-4121-b22d-fb9eeb3a91a3_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total invested assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_49c144c8-5d85-4dbd-a461-b7f41ef508ef_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_401bada8-9764-4954-a5b1-437a8f172a44_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_5c369aca-7324-4ac0-8583-617063bc16f0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_7fb954e7-5552-4f94-a2b0-4dc3127567dc_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense for capitalized internally developed and purchased software</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_dcdfeb9e-622a-4168-8cd1-aabbcd470acc_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minority ownership prior to acquisition (percent)</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_e12fcaeb-2b5d-4ea8-9f79-95cb3a87e2ab_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost, 73,691,955 shares at December 31, 2022 and 69,846,758 shares at December 31, 2021</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_bc88cef4-d149-40d5-acfe-429bcfc63426_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_69ed8b86-45e0-4176-838a-25cd1f68f4a5_totalLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense, net of tax</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e8685223-ecc0-4df2-a682-0170b702457f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangible assets:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_November2022AcceleratedShareRepurchaseProgramMember_fc753a6b-f262-4e14-94f9-d52dbf40164f_terseLabel_en-US" xlink:label="lab_hum_November2022AcceleratedShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2022 ASR</link:label>
    <link:label id="lab_hum_November2022AcceleratedShareRepurchaseProgramMember_label_en-US" xlink:label="lab_hum_November2022AcceleratedShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2022 Accelerated Share Repurchase Program [Member]</link:label>
    <link:label id="lab_hum_November2022AcceleratedShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_hum_November2022AcceleratedShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">November 2022 Accelerated Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_November2022AcceleratedShareRepurchaseProgramMember" xlink:href="hum-20221231.xsd#hum_November2022AcceleratedShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_November2022AcceleratedShareRepurchaseProgramMember" xlink:to="lab_hum_November2022AcceleratedShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_86c016ec-64f5-4c7f-a6f7-f022e12dc6bf_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total IBNR</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_2b0ec6ff-a521-4cd7-8d6d-09012d3ea5e0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_27b7a2f6-e572-4e6f-812b-ee9c354428b3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_d4bf0848-e482-4044-ab18-ba6717a66811_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices in Active Markets (Level 1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_806bbab3-920a-4ef6-a265-551ba0fc97ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported_1dcc7685-3cf3-4161-89a6-6ba770efd81f_terseLabel_en-US" xlink:label="lab_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative number of reported claims</link:label>
    <link:label id="lab_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported_label_en-US" xlink:label="lab_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Cumulative Number Of Claims, Reported</link:label>
    <link:label id="lab_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported_documentation_en-US" xlink:label="lab_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability For Unpaid Claims And Claims Adjustment Expense, Cumulative Number Of Claims, Reported</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" xlink:href="hum-20221231.xsd#hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" xlink:to="lab_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtAndEquitySecuritiesRealizedGain_91938b09-c8ef-4d20-8671-09a4b7fb1923_terseLabel_en-US" xlink:label="lab_hum_DebtAndEquitySecuritiesRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross gains on investment securities</link:label>
    <link:label id="lab_hum_DebtAndEquitySecuritiesRealizedGain_label_en-US" xlink:label="lab_hum_DebtAndEquitySecuritiesRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities, Realized Gain</link:label>
    <link:label id="lab_hum_DebtAndEquitySecuritiesRealizedGain_documentation_en-US" xlink:label="lab_hum_DebtAndEquitySecuritiesRealizedGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt And Equity Securities, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtAndEquitySecuritiesRealizedGain" xlink:href="hum-20221231.xsd#hum_DebtAndEquitySecuritiesRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtAndEquitySecuritiesRealizedGain" xlink:to="lab_hum_DebtAndEquitySecuritiesRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_706ac1d6-36b1-4d7a-81a8-957935eb430d_terseLabel_en-US" xlink:label="lab_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction amount, net of existing equity stake</link:label>
    <link:label id="lab_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_label_en-US" xlink:label="lab_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Per Agreement, Net Of Existing Equity Interest</link:label>
    <link:label id="lab_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_documentation_en-US" xlink:label="lab_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Per Agreement, Net Of Existing Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" xlink:href="hum-20221231.xsd#hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" xlink:to="lab_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_InvestmentAndOtherIncomeNet_88c06b5a-4aca-4f3f-ae44-443c160ad2d4_terseLabel_en-US" xlink:label="lab_hum_InvestmentAndOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other (loss) income, net</link:label>
    <link:label id="lab_hum_InvestmentAndOtherIncomeNet_label_en-US" xlink:label="lab_hum_InvestmentAndOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment And Other Income Net</link:label>
    <link:label id="lab_hum_InvestmentAndOtherIncomeNet_documentation_en-US" xlink:label="lab_hum_InvestmentAndOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment and other income, net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InvestmentAndOtherIncomeNet" xlink:href="hum-20221231.xsd#hum_InvestmentAndOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_InvestmentAndOtherIncomeNet" xlink:to="lab_hum_InvestmentAndOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b618e9ff-36bd-4a09-b3df-e68ba81d8435_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_bfde1710-e360-4d6f-918f-268c7b5f36d9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_cf35b889-3380-4304-8169-c24d4d261938_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-backed securities</link:label>
    <link:label id="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_label_en-US" xlink:label="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:to="lab_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_a09f5bd3-e8a4-404a-a88a-de9cfe9a4c01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock Awards Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_4d6fcb7d-4787-4c3c-b537-956153a65ecf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax effect from sale of KAH Hospice</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Disposition of Business, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:to="lab_us-gaap_IncomeTaxReconciliationDispositionOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_5e2dca81-98c4-4765-bd06-eaf2501ddfae_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Incurred and Paid Claims Development</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Claims Development [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares_d2ccc7f6-a62e-4291-8486-46197e31d22b_terseLabel_en-US" xlink:label="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan assets invested in Company common stock (in shares)</link:label>
    <link:label id="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares_label_en-US" xlink:label="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Plan Assets Invested In Company Common Stock, Shares</link:label>
    <link:label id="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares_documentation_en-US" xlink:label="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Plan Assets Invested In Company Common Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares" xlink:to="lab_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a81735db-ddb1-4dce-a76b-5b732beb6d57_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_018e1767-6c4f-4032-bc17-7dfed296aabc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_SignificantAccountingPoliciesTable_682ca848-95ef-4b6c-9d4c-64ffc1e0acc6_terseLabel_en-US" xlink:label="lab_hum_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_hum_SignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_hum_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_hum_SignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_hum_SignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SignificantAccountingPoliciesTable" xlink:href="hum-20221231.xsd#hum_SignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_SignificantAccountingPoliciesTable" xlink:to="lab_hum_SignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_9a79a378-b0fd-4f69-9e2e-d075b885a5ed_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_ca29516d-c640-4828-bdf5-fa81806aa89c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_d7457ac3-3713-4309-a2d5-92a032c14b7b_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior years</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_c70838a0-d69f-4631-8d89-dd3c432e3ef9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and impairment charge</link:label>
    <link:label id="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_RestructuringCostsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_887c3433-4c8b-4d34-bbee-3b72e0b495be_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_242d31d2-b846-462d-9d50-49fe8fa5548a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_6777dbe5-b37f-428b-9ac3-2a400355466c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_376a8aee-1ede-4f57-be0d-d5266b26ba81_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_9dd56662-105e-48e8-859c-53ac96530787_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_e288d531-90fc-4bf0-bf2b-3d27a7c0c668_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_060130e2-6544-4433-8816-926f5563ee84_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_04b9437a-dfc7-446f-8071-03d3ef227980_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_7d47366f-7a54-4cbc-9b61-dd86d81c1c8b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1f62f640-6a1a-4f17-ae3a-3978398f55f9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedPartiesCurrent_e2827123-e1d0-475c-a031-b46f69a98b69_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable from operating subsidiaries</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:to="lab_us-gaap_AccountsReceivableRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_a6da23ea-3b8d-4ea7-9bb9-51c23c246f47_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_6e356f72-e014-4b62-b2e3-2f95498f7363_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_00df0a77-57dd-489a-8821-cb7b68860f31_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities noncurrent, balance sheet line item</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_dd8a18dc-388a-4f59-94a3-daa51fb4ca65_terseLabel_en-US" xlink:label="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities, number of positions</link:label>
    <link:label id="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_label_en-US" xlink:label="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Securities, Available-For-Sale, Securities, Number Of Positions</link:label>
    <link:label id="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_documentation_en-US" xlink:label="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Securities, Number of Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:href="hum-20221231.xsd#hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:to="lab_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_HealthCareReformMember_ad77fc11-e536-491e-b84e-27172d14a359_terseLabel_en-US" xlink:label="lab_hum_HealthCareReformMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Reform</link:label>
    <link:label id="lab_hum_HealthCareReformMember_label_en-US" xlink:label="lab_hum_HealthCareReformMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Reform [Member]</link:label>
    <link:label id="lab_hum_HealthCareReformMember_documentation_en-US" xlink:label="lab_hum_HealthCareReformMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Reform [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareReformMember" xlink:href="hum-20221231.xsd#hum_HealthCareReformMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_HealthCareReformMember" xlink:to="lab_hum_HealthCareReformMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_51b61058-4658-40e6-8ed1-df80ac812fa2_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_9b40167d-a4e9-4ac7-8abb-badb96905301_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_1957f021-d8e3-47cd-911e-7c4de6e516d3_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_fce22499-078f-4919-b30f-a8bfa5a4b4ef_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_91230ea1-2de7-4aa5-b7dd-ac907e36e80d_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_January2022AcceleratedShareRepurchaseAgreementMember_6cb8dd2c-5879-4c63-af99-72055f67ef01_terseLabel_en-US" xlink:label="lab_hum_January2022AcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2022 ASR</link:label>
    <link:label id="lab_hum_January2022AcceleratedShareRepurchaseAgreementMember_label_en-US" xlink:label="lab_hum_January2022AcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2022 Accelerated Share Repurchase Agreement [Member]</link:label>
    <link:label id="lab_hum_January2022AcceleratedShareRepurchaseAgreementMember_documentation_en-US" xlink:label="lab_hum_January2022AcceleratedShareRepurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">January 2022 Accelerated Share Repurchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_January2022AcceleratedShareRepurchaseAgreementMember" xlink:href="hum-20221231.xsd#hum_January2022AcceleratedShareRepurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_January2022AcceleratedShareRepurchaseAgreementMember" xlink:to="lab_hum_January2022AcceleratedShareRepurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_0246d8b4-f559-4fba-9e79-4b563e913606_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock_eb31b2c6-1fac-47c2-a985-d0869e4403f9_terseLabel_en-US" xlink:label="lab_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Health Care Cost Payments and Reimbursements</link:label>
    <link:label id="lab_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock_label_en-US" xlink:label="lab_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Health Care Cost Payments and Reimbursements [Table Text Block]</link:label>
    <link:label id="lab_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock_documentation_en-US" xlink:label="lab_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Health Care Cost Payments and Reimbursements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock" xlink:href="hum-20221231.xsd#hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock" xlink:to="lab_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_f1f199b0-389e-4bd6-85c0-67718fc79311_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_0ff0574d-1c9d-435b-81dd-1007264ea84b_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment received upon judgement</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_e9d4bfa8-554e-49c1-a54b-7da40c978255_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2a774b30-e933-40be-941f-306fb82516bd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_d1cac8a0-76c4-41b4-9492-f2d6cb921537_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_4d69c011-adf9-4a03-a5e4-65145a78e15a_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase authorization</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_d3783c46-8b04-4a65-955b-03d1a2e2160c_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_88a5ca6e-24af-45f7-97b4-eb010f922d3a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment earnings</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_d51c986d-ee60-4dfa-81c5-a44b807d5525_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CorporateAndEliminationsMember_dec7f257-bf89-4312-b8d4-914ef0aa8b9f_terseLabel_en-US" xlink:label="lab_hum_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Eliminations/ Corporate</link:label>
    <link:label id="lab_hum_CorporateAndEliminationsMember_label_en-US" xlink:label="lab_hum_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Eliminations [Member]</link:label>
    <link:label id="lab_hum_CorporateAndEliminationsMember_documentation_en-US" xlink:label="lab_hum_CorporateAndEliminationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate And Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CorporateAndEliminationsMember" xlink:href="hum-20221231.xsd#hum_CorporateAndEliminationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CorporateAndEliminationsMember" xlink:to="lab_hum_CorporateAndEliminationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_551ee463-c623-4f09-8b87-5d2da3135657_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_a1aef0ea-d0a4-45ca-87fb-95aadcdd14b9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS PER COMMON SHARE COMPUTATION</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_642cd1f3-fef7-4045-967c-5002866bff62_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_b7aaa176-e225-40a6-9070-cc0a9f1eb80b_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Reinsurance recoverables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_48d9ec01-8bbc-4210-a8ab-e2b92f36f8b7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance recoverable</link:label>
    <link:label id="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_label_en-US" xlink:label="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverable for Unpaid Claims and Claims Adjustments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:to="lab_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_f18d4e20-3e91-4771-ab03-592c74ee07e8_verboseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_facc470b-d320-498f-9b82-6b43c6228cc3_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposed of by sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_3e9e4067-53d0-41c7-bbde-268f79107ff9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_24ebe212-6249-4761-9557-cbbd574ffd83_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_1b201874-26e5-44df-994b-20be9e1fb5ee_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_7fca76f5-b3b7-4c7d-8c8d-3c7d22a8e794_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock unit vesting</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_f827c522-4a92-4561-86b5-658742a9ac9b_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits ceded</link:label>
    <link:label id="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_label_en-US" xlink:label="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Policyholder Benefits and Claims Incurred, Ceded</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:to="lab_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A588PercentSeniorNotesDueMarch2033Member_1ada79ee-5b54-4b92-8b01-a4dc03fddf69_terseLabel_en-US" xlink:label="lab_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750&#160;million, 5.88% due March 1, 2033</link:label>
    <link:label id="lab_hum_A588PercentSeniorNotesDueMarch2033Member_label_en-US" xlink:label="lab_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.88 Percent Senior Notes Due March 2033 [Member]</link:label>
    <link:label id="lab_hum_A588PercentSeniorNotesDueMarch2033Member_documentation_en-US" xlink:label="lab_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.88 Percent Senior Notes Due March 2033</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:href="hum-20221231.xsd#hum_A588PercentSeniorNotesDueMarch2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:to="lab_hum_A588PercentSeniorNotesDueMarch2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_5cce019b-2538-4fdd-9766-110ff7b37f84_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer software</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer_28519d01-b42e-4f9b-a5e1-c346da71446c_terseLabel_en-US" xlink:label="lab_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and securities in trusts held by certain reinsurers</link:label>
    <link:label id="lab_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer_label_en-US" xlink:label="lab_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Held In Cash And Securities In Trust At Least Equal To Recoverable From Reinsurer</link:label>
    <link:label id="lab_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer_documentation_en-US" xlink:label="lab_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount held in cash and securities in trust, at least equal to the recoverable from the reinsurer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer" xlink:href="hum-20221231.xsd#hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer" xlink:to="lab_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_50571927-2842-4969-9584-2c2c2f701b11_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_58a30686-dded-4dbe-8b3b-46a7daca7cb9_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_067d85b0-a8fc-416b-8f92-2adc0af20ba9_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsuranceAbstract_d283c465-f107-4527-a9db-c488f15f8d82_terseLabel_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:label id="lab_us-gaap_InsuranceAbstract_label_en-US" xlink:label="lab_us-gaap_InsuranceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsuranceAbstract" xlink:to="lab_us-gaap_InsuranceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree_0629269d-435d-45c2-9dd0-6a3b883d0586_terseLabel_en-US" xlink:label="lab_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Enterprise value of acquiree including existing equity value</link:label>
    <link:label id="lab_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree_label_en-US" xlink:label="lab_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Total Enterprise Value Of Acquiree</link:label>
    <link:label id="lab_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree_documentation_en-US" xlink:label="lab_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Total Enterprise Value Of Acquiree</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree" xlink:href="hum-20221231.xsd#hum_BusinessCombinationTotalEnterpriseValueOfAcquiree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree" xlink:to="lab_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InsurancePremiumsRevenueRecognitionPolicy_3d5a3efb-8ce6-4dea-b950-2560b6d04277_terseLabel_en-US" xlink:label="lab_us-gaap_InsurancePremiumsRevenueRecognitionPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Revenue</link:label>
    <link:label id="lab_us-gaap_InsurancePremiumsRevenueRecognitionPolicy_label_en-US" xlink:label="lab_us-gaap_InsurancePremiumsRevenueRecognitionPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Premiums Revenue Recognition, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsurancePremiumsRevenueRecognitionPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsurancePremiumsRevenueRecognitionPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InsurancePremiumsRevenueRecognitionPolicy" xlink:to="lab_us-gaap_InsurancePremiumsRevenueRecognitionPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_2dd51ae8-4993-446b-867c-aad44fada87c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Claims Incurred Year</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member_e0598cf2-2600-42af-9533-a3d42fbf05a4_terseLabel_en-US" xlink:label="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$600&#160;million, 3.95% due March 15, 2027</link:label>
    <link:label id="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member_label_en-US" xlink:label="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95 Percent Senior Notes Due March 2027 [Member]</link:label>
    <link:label id="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member_documentation_en-US" xlink:label="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.95 Percent Senior Notes Due March 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:href="hum-20221231.xsd#hum_A3.95PercentSeniorNotesDueMarch2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:to="lab_hum_A3.95PercentSeniorNotesDueMarch2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_e580c101-4491-4b1e-b0a0-8fdad97573a6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_4e605253-d752-46e5-bb4a-e97f3348ac9a_terseLabel_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual debt to capitalization percentage</link:label>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_label_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual</link:label>
    <link:label id="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_documentation_en-US" xlink:label="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:to="lab_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_63b08ddd-8009-4790-a00c-a7be71d8251a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of KAH Hospice</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Deconsolidation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:to="lab_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_85950284-51ff-4d75-813c-af1f1bda98e4_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_7d1d7cf5-862f-420e-ab1b-4dae2aa6f55a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_85987139-6113-451f-8ce2-fed4698e0b54_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate minimum regulatory requirements of statutory capital and surplus</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Capital and Surplus Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_0fe9d4d7-7f0d-4add-a6d1-687e3722cc94_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_363e5477-2d3b-41dc-89d0-7f335b8eb302_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_5e8e3548-d426-4a12-9c6f-9edc236b7003_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries_545afcb5-5c1e-4024-a35a-fab136842179_terseLabel_en-US" xlink:label="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states comprising TRICARE beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries_label_en-US" xlink:label="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of States Comprising TRICARE Beneficiaries</link:label>
    <link:label id="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries_documentation_en-US" xlink:label="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of States Comprising TRICARE Beneficiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:href="hum-20221231.xsd#hum_NumberOfStatesComprisingTRICAREBeneficiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:to="lab_hum_NumberOfStatesComprisingTRICAREBeneficiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A575PercentSeniorNotesDueMarch2028Member_c9b65ddc-77e4-4c85-9a4f-ef51ecb57160_terseLabel_en-US" xlink:label="lab_hum_A575PercentSeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500&#160;million, 5.75% due March 1, 2028</link:label>
    <link:label id="lab_hum_A575PercentSeniorNotesDueMarch2028Member_label_en-US" xlink:label="lab_hum_A575PercentSeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75 Percent Senior Notes Due March 2028 [Member]</link:label>
    <link:label id="lab_hum_A575PercentSeniorNotesDueMarch2028Member_documentation_en-US" xlink:label="lab_hum_A575PercentSeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.75 Percent Senior Notes Due March 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A575PercentSeniorNotesDueMarch2028Member" xlink:href="hum-20221231.xsd#hum_A575PercentSeniorNotesDueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A575PercentSeniorNotesDueMarch2028Member" xlink:to="lab_hum_A575PercentSeniorNotesDueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_8d275953-ffb2-4e0f-8261-93582594f777_terseLabel_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClaimsDevelopmentLineItems_label_en-US" xlink:label="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Claims Development [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems" xlink:to="lab_us-gaap_ClaimsDevelopmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d6d3348a-f5d2-44e9-8cb8-a5df831bcc17_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_7193cd5d-3c46-45f3-8cdc-ba9d5eaaab73_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_855f29e7-0270-44e0-a1fe-6aef4d3584af_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating losses to carryforward related to prior acquisitions</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_721a05cf-6e8c-454b-8785-ff429ab42a01_terseLabel_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares acquired in connection with employee stock plans (in shares)</link:label>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_label_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchases Related To Employee Stock Based Compensation Awards Shares</link:label>
    <link:label id="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_documentation_en-US" xlink:label="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:href="hum-20221231.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:to="lab_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_4350bc07-242c-4f73-89e4-8b2729cd70fe_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_3df8f53b-47fc-4e71-8a58-f065b675d446_terseLabel_en-US" xlink:label="lab_hum_DividendsToParentWithoutPriorStateRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Actual dividends paid to parent company</link:label>
    <link:label id="lab_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_label_en-US" xlink:label="lab_hum_DividendsToParentWithoutPriorStateRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends To Parent Without Prior State Regulatory Approval</link:label>
    <link:label id="lab_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_documentation_en-US" xlink:label="lab_hum_DividendsToParentWithoutPriorStateRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of dividends paid to our parent company without prior approval by state regulatory authorities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DividendsToParentWithoutPriorStateRegulatoryApproval" xlink:href="hum-20221231.xsd#hum_DividendsToParentWithoutPriorStateRegulatoryApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DividendsToParentWithoutPriorStateRegulatoryApproval" xlink:to="lab_hum_DividendsToParentWithoutPriorStateRegulatoryApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_18d87593-3888-4c8b-bff7-59d6e683ef59_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CitibankNAMember_8b98c882-63fe-40b6-a67b-509075b42d6d_terseLabel_en-US" xlink:label="lab_hum_CitibankNAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citi</link:label>
    <link:label id="lab_hum_CitibankNAMember_label_en-US" xlink:label="lab_hum_CitibankNAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank NA [Member]</link:label>
    <link:label id="lab_hum_CitibankNAMember_documentation_en-US" xlink:label="lab_hum_CitibankNAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Citibank NA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CitibankNAMember" xlink:href="hum-20221231.xsd#hum_CitibankNAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CitibankNAMember" xlink:to="lab_hum_CitibankNAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_5216b1de-280c-4f6c-b5a1-40e4b283ab1e_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A488PercentSeniorNotesDueApril2030Member_b2ee2287-a9bd-4c33-b66d-d62d194dd32d_terseLabel_en-US" xlink:label="lab_hum_A488PercentSeniorNotesDueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$500&#160;million, 4.88% due April 1, 2030</link:label>
    <link:label id="lab_hum_A488PercentSeniorNotesDueApril2030Member_label_en-US" xlink:label="lab_hum_A488PercentSeniorNotesDueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88 Percent Senior Notes Due April 2030 [Member]</link:label>
    <link:label id="lab_hum_A488PercentSeniorNotesDueApril2030Member_documentation_en-US" xlink:label="lab_hum_A488PercentSeniorNotesDueApril2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.88 Percent Senior Notes Due April 2030</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A488PercentSeniorNotesDueApril2030Member" xlink:href="hum-20221231.xsd#hum_A488PercentSeniorNotesDueApril2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A488PercentSeniorNotesDueApril2030Member" xlink:to="lab_hum_A488PercentSeniorNotesDueApril2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ExternalCreditRatingStandardPoorsMember_d82248aa-3c24-4201-a079-669c9577e4e4_terseLabel_en-US" xlink:label="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating, Standard &amp; Poor's [Domain]</link:label>
    <link:label id="lab_srt_ExternalCreditRatingStandardPoorsMember_label_en-US" xlink:label="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">External Credit Rating, Standard &amp; Poor's [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember" xlink:to="lab_srt_ExternalCreditRatingStandardPoorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_38c2767c-e0e0-45ea-a6d1-9de26434081b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ParentCompanyMember_50fab2b6-a1a7-46bb-ad51-199b6895ed24_terseLabel_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company</link:label>
    <link:label id="lab_srt_ParentCompanyMember_label_en-US" xlink:label="lab_srt_ParentCompanyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent Company [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ParentCompanyMember" xlink:to="lab_srt_ParentCompanyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_af366e2a-6f63-443e-8a17-25831f22bdfb_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StandardPoorsAAMinusRatingMember_230fccc5-404d-412f-bfdc-bc1f2a3cb07d_terseLabel_en-US" xlink:label="lab_srt_StandardPoorsAAMinusRatingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard &amp; Poor's, AA- Rating</link:label>
    <link:label id="lab_srt_StandardPoorsAAMinusRatingMember_label_en-US" xlink:label="lab_srt_StandardPoorsAAMinusRatingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard &amp; Poor's, AA- Rating [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAAMinusRatingMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAAMinusRatingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StandardPoorsAAMinusRatingMember" xlink:to="lab_srt_StandardPoorsAAMinusRatingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_a58a762e-e871-4928-af3e-1d9277b7faa4_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_8c8a1b04-ebda-4db8-8462-bd8d147bce57_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_a23b5786-66b4-4ece-ba07-ebc92cb5eb45_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTMENT SECURITIES</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_9d3d606e-0a6a-4e58-b4d4-d70bd53be9a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">12 months or more</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_c4c99aa4-aca8-4657-ba22-bdbc38b6e495_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense for other intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_b76e5e27-8ade-4fb6-b55e-402139e4516c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Changes in Carrying Amount of Goodwill By Reportable Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_2f7cd98b-87f2-4adb-9f59-7d2cb7a0a4c0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest payments</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_46e0f6a3-9252-4331-b5f6-3933efc00827_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_00f07c3a-7b06-4d6f-a230-9bf9c1c62fdb_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_73e45b02-daf4-4617-ae35-8cbc2eb73aa6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Repayments) proceeds from issuance of commercial paper, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Commercial Paper</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfCommercialPaper" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_a69b78f7-6e5d-4287-b9ae-c5daed7c976c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_9e8a4327-9468-430a-bb2f-897252957fb7_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_bdf6ab22-afa9-47fd-8834-119a7292dd38_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_38344f0a-9c7f-4fcb-a952-0f67628a846c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_e34cbbe6-0bde-4a54-b982-1acb94ff3860_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0a59861e-b747-4336-83e5-6210b1a68304_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsMember_c1d741d5-e8d2-410a-98d9-86f805c0a968_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsMember_label_en-US" xlink:label="lab_us-gaap_InvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsMember" xlink:to="lab_us-gaap_InvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_e51e7f1d-2feb-4b48-8f91-e60d234a66b6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BookOverdraftLiability_c39f86e2-b696-4b6a-b0d7-56f50f2e13ab_terseLabel_en-US" xlink:label="lab_hum_BookOverdraftLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book overdraft</link:label>
    <link:label id="lab_hum_BookOverdraftLiability_label_en-US" xlink:label="lab_hum_BookOverdraftLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book Overdraft Liability</link:label>
    <link:label id="lab_hum_BookOverdraftLiability_documentation_en-US" xlink:label="lab_hum_BookOverdraftLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book Overdraft Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftLiability" xlink:href="hum-20221231.xsd#hum_BookOverdraftLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BookOverdraftLiability" xlink:to="lab_hum_BookOverdraftLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_e4beaa64-09f4-49ef-97fc-7c146255f506_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DelayedDrawTermLoanMay2021Member_635f9baf-856b-476d-a992-c92d84b37be1_terseLabel_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMay2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan May 2021</link:label>
    <link:label id="lab_hum_DelayedDrawTermLoanMay2021Member_label_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMay2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan May 2021 [Member]</link:label>
    <link:label id="lab_hum_DelayedDrawTermLoanMay2021Member_documentation_en-US" xlink:label="lab_hum_DelayedDrawTermLoanMay2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Delayed Draw Term Loan May 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMay2021Member" xlink:href="hum-20221231.xsd#hum_DelayedDrawTermLoanMay2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DelayedDrawTermLoanMay2021Member" xlink:to="lab_hum_DelayedDrawTermLoanMay2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_ab3e66a2-3026-413d-8a99-cedd9e7b172d_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial</link:label>
    <link:label id="lab_us-gaap_CommercialMortgageBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Mortgage-Backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:to="lab_us-gaap_CommercialMortgageBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_08724587-1d53-4c60-a85e-6c0f670fb3ed_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_6542bb0c-273a-457b-899d-2ae937d4ee5a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_84df4cfe-ca33-42ea-a8ba-6b29b8ce2bb8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_275048b0-9a0d-4b91-9862-a38736237d5c_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Claims Incurred Year</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_683aec97-dd93-4e2e-9c62-98ded46f2d0c_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_a1e5cd5a-02e8-486e-8a8c-2f15d6f6881a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_ef20880a-9b95-4d04-86af-f4801b421244_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_941ef324-9f64-453d-8def-c6659ba0cd96_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_dee62294-b2ee-4917-b044-15b5c8165c0e_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_92ab9116-097b-4bb8-8253-df623991430b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_1c10c913-4c92-422c-b20f-257e4a5c5a1c_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends and dividend equivalents</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_KindredAtHomeMember_d6b58a15-1cec-4fdb-947a-be36c32666db_verboseLabel_en-US" xlink:label="lab_hum_KindredAtHomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KAH</link:label>
    <link:label id="lab_hum_KindredAtHomeMember_d3c6ee13-9354-4f4c-83e5-0847e0ebe0fe_terseLabel_en-US" xlink:label="lab_hum_KindredAtHomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kindred at Home</link:label>
    <link:label id="lab_hum_KindredAtHomeMember_label_en-US" xlink:label="lab_hum_KindredAtHomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kindred At Home [Member]</link:label>
    <link:label id="lab_hum_KindredAtHomeMember_documentation_en-US" xlink:label="lab_hum_KindredAtHomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Kindred At Home [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_KindredAtHomeMember" xlink:to="lab_hum_KindredAtHomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_a263a2d9-f981-4f51-8f9f-60c0b313421c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_2a06b7fb-bbd0-4ab8-80a1-bf484adbc77b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_efff169a-501f-4a15-9d3b-b0cd24115de2_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_f8b7de97-e6f5-429e-99b2-04120e3aaaad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future grants assuming all stock options or restricted stock are granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_9621814a-f4cb-475a-92ce-bf6d542f0f1b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_32f5c364-f5c7-431c-8c23-50f97471c4c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_757e5ad0-710f-4258-9670-4adcba678c2b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on Kindred at Home equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems_81d1e81c-9166-46be-a46f-fcdb7904e840_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Line Items]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Credit Quality Indicator [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:to="lab_us-gaap_FinancingReceivableRecordedInvestmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_340cd2a1-2695-4220-b225-630905bf99d3_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_5ca07a29-7b53-40ff-a907-54fd2c8a8d94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters_6ac01cc9-f377-42d9-8baf-ff616888d1c3_terseLabel_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of primary care centers in strategic partnership</link:label>
    <link:label id="lab_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters_label_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Partnership Agreement, Number Of Primary Care Centers</link:label>
    <link:label id="lab_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters_documentation_en-US" xlink:label="lab_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Strategic Partnership Agreement, Number Of Primary Care Centers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters" xlink:to="lab_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_0e1ace76-2d5c-4e60-893b-828213f8b982_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities included within other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NontaxableMunicipalNotesMember_c1f9036e-260f-46a4-808b-5d8938a3d5ba_verboseLabel_en-US" xlink:label="lab_us-gaap_NontaxableMunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax-exempt municipal securities</link:label>
    <link:label id="lab_us-gaap_NontaxableMunicipalNotesMember_label_en-US" xlink:label="lab_us-gaap_NontaxableMunicipalNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nontaxable Municipal Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NontaxableMunicipalNotesMember" xlink:to="lab_us-gaap_NontaxableMunicipalNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_019cc990-e81f-43a5-8a67-eebd7a638046_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share Repurchases</link:label>
    <link:label id="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Treasury Stock [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfTreasuryStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_7d063764-40e0-4dcd-a60f-0af3c52b3ea0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assumptions Used For Inputs In Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_e0e2c156-323c-4239-8c8a-d1d9d4f5226b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee retirement and savings plan cost</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_c4f1f29f-75a8-4e08-9fed-526370c1f69e_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_cc7d34c8-411c-454c-9071-83794e573801_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares received (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_2db2a426-e2fb-409c-a0ad-1ca49f1c54d3_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGain_20ead2a6-4076-4c31-91f1-a363fee82dba_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross gains on equity securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNiRealizedGain_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI, Realized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:to="lab_us-gaap_EquitySecuritiesFvNiRealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7ae8500d-298d-415b-b925-a7f49eaeeca6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_HealthCareCostReimbursements_f00674c2-15e2-4dea-93de-f7a78cb27452_terseLabel_en-US" xlink:label="lab_hum_HealthCareCostReimbursements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health care cost reimbursements</link:label>
    <link:label id="lab_hum_HealthCareCostReimbursements_label_en-US" xlink:label="lab_hum_HealthCareCostReimbursements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Cost Reimbursements</link:label>
    <link:label id="lab_hum_HealthCareCostReimbursements_documentation_en-US" xlink:label="lab_hum_HealthCareCostReimbursements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reimbursements for health care cost payments associated with the TRICARE South Region contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareCostReimbursements" xlink:href="hum-20221231.xsd#hum_HealthCareCostReimbursements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_HealthCareCostReimbursements" xlink:to="lab_hum_HealthCareCostReimbursements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_e133e558-6423-44fd-912b-68597281f819_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_1ed9d186-439b-48b4-9932-49e158ed068e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_bbce534e-256a-4d42-911c-47712b821ba8_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_8b04bf72-d935-4973-b952-ba9c704b79cf_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Treasury and agency obligations</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3c93b79e-6b43-42f1-85e1-262b02b4a384_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock_4ead6722-07a3-4f55-b89d-8c318ce70d8a_terseLabel_en-US" xlink:label="lab_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EMPLOYEE BENEFIT PLANS</link:label>
    <link:label id="lab_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock_label_en-US" xlink:label="lab_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Compensation Related Costs Share Based Payments And Compensation And Retirement Disclosure [Text Block]</link:label>
    <link:label id="lab_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock_documentation_en-US" xlink:label="lab_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure Of Compensation Related Costs Share Based Payments And Compensation And Retirement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock" xlink:href="hum-20221231.xsd#hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock" xlink:to="lab_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_f41e2dfe-487a-4fbe-9458-c872942f4987_terseLabel_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_label_en-US" xlink:label="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contracts, Accident Year [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:to="lab_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_a4dbcfd2-9d31-4303-82dd-b0fa11a617af_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a825f8d5-a053-485d-93d7-4c35385c7460_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_cdb5d567-77a6-4b67-b00c-289d1d35eea7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_fd52e18a-9e75-4e76-a386-fad4552d6890_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested restricted stock, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_a2e11cf5-7c0f-4a7c-91a3-b3f4bcace456_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceLineItems_384ee84b-7c2d-490b-9f3a-d90aa2ebc367_terseLabel_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Reinsurance [Line Items]</link:label>
    <link:label id="lab_us-gaap_EffectsOfReinsuranceLineItems_label_en-US" xlink:label="lab_us-gaap_EffectsOfReinsuranceLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effects of Reinsurance [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems" xlink:to="lab_us-gaap_EffectsOfReinsuranceLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_5e54d135-a2a3-4b76-bef9-66d33a4ba275_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_5b9322c2-3b9b-4d1e-a372-0c8fa1a320ad_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_5497a0bd-44fd-47a4-8286-079fe914bdb1_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DeferredTaxAssetJobsTaxCredit_525bee01-0b40-45ba-af31-5be22afcb6e6_terseLabel_en-US" xlink:label="lab_hum_DeferredTaxAssetJobsTaxCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Jobs tax credits</link:label>
    <link:label id="lab_hum_DeferredTaxAssetJobsTaxCredit_label_en-US" xlink:label="lab_hum_DeferredTaxAssetJobsTaxCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Jobs Tax Credit</link:label>
    <link:label id="lab_hum_DeferredTaxAssetJobsTaxCredit_documentation_en-US" xlink:label="lab_hum_DeferredTaxAssetJobsTaxCredit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Jobs Tax Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DeferredTaxAssetJobsTaxCredit" xlink:href="hum-20221231.xsd#hum_DeferredTaxAssetJobsTaxCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DeferredTaxAssetJobsTaxCredit" xlink:to="lab_hum_DeferredTaxAssetJobsTaxCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_0e84736e-4d54-4b6c-865a-74be1cace3f2_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets included within other long-term assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7e8bf7d1-39f3-494a-9ca1-6dcd2d8b5de1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a54c97aa-fe8e-4c01-8680-de083192e01a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_FairValueRiskMember_bcd71656-add5-4dec-86a3-557bbac217cd_terseLabel_en-US" xlink:label="lab_hum_FairValueRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Risk</link:label>
    <link:label id="lab_hum_FairValueRiskMember_label_en-US" xlink:label="lab_hum_FairValueRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Risk [Member]</link:label>
    <link:label id="lab_hum_FairValueRiskMember_documentation_en-US" xlink:label="lab_hum_FairValueRiskMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Risk</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueRiskMember" xlink:href="hum-20221231.xsd#hum_FairValueRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_FairValueRiskMember" xlink:to="lab_hum_FairValueRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_5ed473fb-744d-454e-80fd-a7ea7cbf4e47_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_68808496-cbe1-4438-8245-ebb994346a81_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustment for net realized losses (gains) included in investment income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_03c44506-0384-430c-9d2b-0b79b124e7a4_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_53f2b7a9-979c-4d0a-b5d5-c389111c4c24_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4e87affb-f5bb-4606-adb6-8857cb38d96e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Activity for Option Plans</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_4ad983cb-552a-4dc4-ab97-e21172a1906c_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_41b29c39-09e0-4346-a189-fc806854f4b4_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_dea63cd2-ad5a-4c1f-9390-af0eec43ad8d_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Puerto Rico</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_b8f8a30a-c0e5-4cf0-bbfb-1e809df6a1dc_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Services</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A215PercentSeniorNotesDueFebruary2032Member_a500e145-55b4-4709-a2d8-292181b77ad6_terseLabel_en-US" xlink:label="lab_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750&#160;million, 2.15% due February 3, 2032</link:label>
    <link:label id="lab_hum_A215PercentSeniorNotesDueFebruary2032Member_label_en-US" xlink:label="lab_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.15 Percent Senior Notes Due February 2032 [Member]</link:label>
    <link:label id="lab_hum_A215PercentSeniorNotesDueFebruary2032Member_documentation_en-US" xlink:label="lab_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.15 Percent Senior Notes Due February 2032</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:href="hum-20221231.xsd#hum_A215PercentSeniorNotesDueFebruary2032Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:to="lab_hum_A215PercentSeniorNotesDueFebruary2032Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_7315fc82-f8bd-4e2f-870c-f4c022b2e142_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6441244b-b5eb-4934-9097-238cbac5d429_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND OTHER INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions_2b3a7246-cfc5-4fe2-a932-3cbb821d44cb_terseLabel_en-US" xlink:label="lab_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of restricted stock with performance-based conditions</link:label>
    <link:label id="lab_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions_label_en-US" xlink:label="lab_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation By Share Based Payment Award, Equity Instruments Other Than Options, Percent Of Stock With Performance Based Conditions</link:label>
    <link:label id="lab_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions_documentation_en-US" xlink:label="lab_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation By Share Based Payment Award, Equity Instruments Other Than Options, Percent Of Stock With Performance Based Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions" xlink:href="hum-20221231.xsd#hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions" xlink:to="lab_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_630bf0d6-bef6-4a08-a82b-1d5b0b7b5c46_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_b447384e-9bae-43cd-8354-74b19f46a46b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_119169cf-2cb2-47a2-98a6-d5655a404bd5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5ce2c3cf-50cd-4e02-8400-a7d2cbd62f7c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital&#160;In Excess&#160;of Par Value</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_04c7a89b-059d-46a4-bcfb-aadce08e3912_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_969ab2c8-ee0e-4b75-8664-b9d82675eda3_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2754052d-6ade-4b5d-8161-7f7e6079a0c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intrinsic value of stock options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicareAdvantageMember_412f82e8-5c4b-45b1-a0f7-b50b38f5319f_terseLabel_en-US" xlink:label="lab_hum_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual Medicare Advantage</link:label>
    <link:label id="lab_hum_MedicareAdvantageMember_label_en-US" xlink:label="lab_hum_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage [Member]</link:label>
    <link:label id="lab_hum_MedicareAdvantageMember_documentation_en-US" xlink:label="lab_hum_MedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Advantage [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareAdvantageMember" xlink:href="hum-20221231.xsd#hum_MedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicareAdvantageMember" xlink:to="lab_hum_MedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_52a544f8-65c4-49bd-af48-aba454d79672_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b12e03ca-8cf5-48cc-be11-ef92eac1c22c_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares used to compute diluted earnings per&#160;common share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021OneYearMember_e5560363-00c4-475a-9c03-0ba38df83740_terseLabel_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 One Year</link:label>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021OneYearMember_label_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 One Year [Member]</link:label>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021OneYearMember_documentation_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 One Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:href="hum-20221231.xsd#hum_RevolvingCreditAgreementJune2021OneYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:to="lab_hum_RevolvingCreditAgreementJune2021OneYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2613cf8a-fb08-455d-b3ad-7eb32a558407_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected option life (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CompanyCommonStockClosingSharePrice_2dff8a2a-a35e-4773-977a-70e48ab5ab07_terseLabel_en-US" xlink:label="lab_hum_CompanyCommonStockClosingSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company common stock closing price (in dollars per share)</link:label>
    <link:label id="lab_hum_CompanyCommonStockClosingSharePrice_label_en-US" xlink:label="lab_hum_CompanyCommonStockClosingSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Common Stock, Closing Share Price</link:label>
    <link:label id="lab_hum_CompanyCommonStockClosingSharePrice_documentation_en-US" xlink:label="lab_hum_CompanyCommonStockClosingSharePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Common Stock, Closing Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CompanyCommonStockClosingSharePrice" xlink:href="hum-20221231.xsd#hum_CompanyCommonStockClosingSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CompanyCommonStockClosingSharePrice" xlink:to="lab_hum_CompanyCommonStockClosingSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_dbe67c26-d055-4702-b266-8282ac293eb2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_a4a3da9c-6694-4c68-88b2-3c626da44d5d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investment Securities Classified as Current and Long-Term</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_d486ff41-6346-44ea-93b9-d28f35ade5e7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_06da239b-a38e-487c-b7e9-274de197bb53_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_e6b81fba-2fb4-4dd3-bba9-3fd752921006_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_051e9127-1ddb-40d6-9e95-d51d13abc71c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term growth rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Long-Term Revenue Growth Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:to="lab_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_bf3644f3-9b18-41d0-9609-b92f382f4fa9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_688f7e4c-a5f0-4915-8347-e22663830b20_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bde7beea-f016-4eea-b580-919fbf23145c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_66b20306-2518-4e09-bcd0-607f56e5d259_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_f0efc72c-57a9-4044-9b4f-179a3eff2ca6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_f8169bc3-82f7-4e79-b3e8-2c54dda4d9c4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of stock options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_bccd9194-b6f2-48ca-b825-3981d7fadf61_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_62e4c64c-a0f3-406b-851f-72535898aa43_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_aa227eeb-18f3-4214-b67e-341d2e37aab2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_968cd7bb-d410-4cfc-823a-49fd3952c8e3_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ASOAndOtherMember_e784e751-5ebf-421b-900b-1c8432f53aae_terseLabel_en-US" xlink:label="lab_hum_ASOAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASO and other</link:label>
    <link:label id="lab_hum_ASOAndOtherMember_label_en-US" xlink:label="lab_hum_ASOAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A S O And Other [Member]</link:label>
    <link:label id="lab_hum_ASOAndOtherMember_documentation_en-US" xlink:label="lab_hum_ASOAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASO and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ASOAndOtherMember" xlink:href="hum-20221231.xsd#hum_ASOAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ASOAndOtherMember" xlink:to="lab_hum_ASOAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_76a5b95d-e482-485a-b7ed-249f0d247eaa_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_933450c2-ad9e-47a5-ae70-44328c6b4e31_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (income) attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_957fbfd9-466e-4e2d-b5db-57973c9b28aa_terseLabel_en-US" xlink:label="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of debt securities considered to be of investment-grade (percent)</link:label>
    <link:label id="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_label_en-US" xlink:label="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Debt Securities, Investment Grade Quality</link:label>
    <link:label id="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_documentation_en-US" xlink:label="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Total Debt Securities, Investment Grade Quality</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:href="hum-20221231.xsd#hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:to="lab_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_bf8623b7-a12f-4fdd-b527-75f11bd4a016_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS, GUARANTEES AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_2847f22e-3843-4ef3-8e2a-1108c6869b91_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c0928ee3-ddc6-411e-b564-9e42bf7771d2_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_1039815f-fb14-42bc-9a9a-cb2c306ba7ac_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_ce8e2457-f7c4-453d-8288-b2bd73a22f9e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity method investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs_4fc7ef14-b2c2-4930-a477-ab0ddc429303_terseLabel_en-US" xlink:label="lab_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer discounts on brand name prescription drugs</link:label>
    <link:label id="lab_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs_label_en-US" xlink:label="lab_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Discounts On Brand Name Prescription Drugs</link:label>
    <link:label id="lab_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs_documentation_en-US" xlink:label="lab_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning in 2011, the Health Reform Legislation mandates consumer discounts of 50% on brand name prescription drugs for Part D plan participants in the coverage gap. These discounts are funded by CMS and pharmaceutical manufacturers while we administer the application of these funds.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs" xlink:href="hum-20221231.xsd#hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs" xlink:to="lab_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_193e3c5b-1f77-4eae-ae73-4c7bb6bd6f5d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_0eb9be5c-1b7d-42f4-bb7a-2b2c12bad6b7_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b091cfb5-a715-455b-9b28-b9a577036eaf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MizuhoMarketsAmericasLLCMember_90a6be03-2c06-4783-a34a-c0a82dd3400a_terseLabel_en-US" xlink:label="lab_hum_MizuhoMarketsAmericasLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mizuho Markets Americas LLC</link:label>
    <link:label id="lab_hum_MizuhoMarketsAmericasLLCMember_label_en-US" xlink:label="lab_hum_MizuhoMarketsAmericasLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mizuho Markets Americas LLC [Member]</link:label>
    <link:label id="lab_hum_MizuhoMarketsAmericasLLCMember_documentation_en-US" xlink:label="lab_hum_MizuhoMarketsAmericasLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mizuho Markets Americas LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MizuhoMarketsAmericasLLCMember" xlink:href="hum-20221231.xsd#hum_MizuhoMarketsAmericasLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MizuhoMarketsAmericasLLCMember" xlink:to="lab_hum_MizuhoMarketsAmericasLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_96e894bd-f1d8-4549-a6dc-d4dfc19e5929_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_60f31d92-63ea-443b-9168-8175418778ac_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_32feb26d-123d-4a72-bcb3-9e341209721f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and other accrued expense</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionOnSecuritiesMember_b72baafd-c0d4-4eed-87bd-24c7bf791da4_terseLabel_en-US" xlink:label="lab_us-gaap_OptionOnSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options</link:label>
    <link:label id="lab_us-gaap_OptionOnSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_OptionOnSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Option on Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionOnSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionOnSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionOnSecuritiesMember" xlink:to="lab_us-gaap_OptionOnSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_7f7b6c47-5624-49f8-9c78-1980f142a51c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentPolicyTextBlock" xlink:to="lab_us-gaap_InvestmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_8d5486c5-d685-4ab6-b4d4-d726569abca8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Existing equity value</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_dbbd423d-a889-4451-9177-45b9e7e4f30d_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Humana</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_d09710bd-3e84-4c9e-9a7e-0f280dbb1dc9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Claims Incurred Year</link:label>
    <link:label id="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_label_en-US" xlink:label="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-Duration Insurance Contract, Accident Year 2020 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:to="lab_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_50fcc27b-c17e-4753-86b5-d11a54ac6432_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_0ae823b4-5aa6-4e86-8279-4c7aa65b624e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, By Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_6f242646-a8c8-4e9a-b734-7d0572df7eaf_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for abandonment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_400dd37a-5284-4ba4-b468-c29e9e4b6eef_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_dcc4fca2-60fb-4a00-af28-7ff3df005227_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_6b77f560-ca50-41fa-bd97-0e6ecd4a9d87_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_fec52407-4b78-4968-be39-20da9e036780_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:label id="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_label_en-US" xlink:label="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Financial Information Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:to="lab_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_8fb7a20d-0f46-497d-8332-33c92e42ba04_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtByMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract" xlink:to="lab_us-gaap_LongTermDebtByMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_665921af-b5f8-4637-9d72-3af0968496c0_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of property and equipment</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BuildingsAndLeaseholdImprovementsMember_c9207735-fdf5-4fb7-9849-1c7207028472_terseLabel_en-US" xlink:label="lab_hum_BuildingsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and leasehold improvements</link:label>
    <link:label id="lab_hum_BuildingsAndLeaseholdImprovementsMember_label_en-US" xlink:label="lab_hum_BuildingsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings And Leasehold Improvements [Member]</link:label>
    <link:label id="lab_hum_BuildingsAndLeaseholdImprovementsMember_documentation_en-US" xlink:label="lab_hum_BuildingsAndLeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings And Leasehold Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BuildingsAndLeaseholdImprovementsMember" xlink:href="hum-20221231.xsd#hum_BuildingsAndLeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BuildingsAndLeaseholdImprovementsMember" xlink:to="lab_hum_BuildingsAndLeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_7cd53fad-bdc2-4e80-a1fc-a7de2131eafb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_82100748-84a2-4a0a-9681-ccbbf416e50d_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_b22c0dea-246e-438c-ac9a-af35d020028a_terseLabel_en-US" xlink:label="lab_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_label_en-US" xlink:label="lab_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Noncontrolling interest</link:label>
    <link:label id="lab_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_documentation_en-US" xlink:label="lab_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Noncontrolling interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest" xlink:to="lab_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_6de2442d-545a-42f8-91a6-d67dc26684f9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_155f65de-8e4c-43b7-a203-646ea945b329_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_aaac9fd2-d35f-4a06-912c-d3b3faea7409_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_AccruedPharmaceuticalRebatesCurrent_83a130d9-e5cc-4d01-8467-6fa91b25176c_terseLabel_en-US" xlink:label="lab_hum_AccruedPharmaceuticalRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical rebates</link:label>
    <link:label id="lab_hum_AccruedPharmaceuticalRebatesCurrent_label_en-US" xlink:label="lab_hum_AccruedPharmaceuticalRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Pharmaceutical Rebates, Current</link:label>
    <link:label id="lab_hum_AccruedPharmaceuticalRebatesCurrent_documentation_en-US" xlink:label="lab_hum_AccruedPharmaceuticalRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Pharmaceutical Rebates, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AccruedPharmaceuticalRebatesCurrent" xlink:href="hum-20221231.xsd#hum_AccruedPharmaceuticalRebatesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_AccruedPharmaceuticalRebatesCurrent" xlink:to="lab_hum_AccruedPharmaceuticalRebatesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_SubsidyAndDiscountPayments_9a40547d-b3bc-400a-821a-444320e77e42_negatedTerseLabel_en-US" xlink:label="lab_hum_SubsidyAndDiscountPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Part D subsidy/discount payments</link:label>
    <link:label id="lab_hum_SubsidyAndDiscountPayments_label_en-US" xlink:label="lab_hum_SubsidyAndDiscountPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidy And Discount Payments</link:label>
    <link:label id="lab_hum_SubsidyAndDiscountPayments_documentation_en-US" xlink:label="lab_hum_SubsidyAndDiscountPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidy And Discount Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountPayments" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_SubsidyAndDiscountPayments" xlink:to="lab_hum_SubsidyAndDiscountPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_1f53b7a7-ed8f-4baa-9452-a50baf14d39e_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_df698722-630f-4b4a-a622-73ba584b2d6e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_e9c9571d-ede2-4e01-ac31-5c61b4b5142f_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram_da146fe9-1664-42e1-8439-240abf8abf36_terseLabel_en-US" xlink:label="lab_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combination of age and years necessary for retirement provision as related to our equity award program</link:label>
    <link:label id="lab_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram_label_en-US" xlink:label="lab_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combination Of Age And Years Necessary For Retirement Provision As Related To Our Equity Award Program</link:label>
    <link:label id="lab_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram_documentation_en-US" xlink:label="lab_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Combination of age and years necessary for retirement provision as related to our equity award program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram" xlink:href="hum-20221231.xsd#hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram" xlink:to="lab_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_55312968-2e22-4f67-b740-a3efa2727164_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimate of Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_5d5ab983-f8ab-41e5-b8b6-3396b96c3183_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligations in 2023</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Dividends_545f9d16-1a33-4cf1-82fd-31de31469b90_terseLabel_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amount</link:label>
    <link:label id="lab_us-gaap_Dividends_label_en-US" xlink:label="lab_us-gaap_Dividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Dividends" xlink:to="lab_us-gaap_Dividends" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_October2021TermLoanAgreementMember_265cfa24-9089-4487-a513-440e16dc5118_terseLabel_en-US" xlink:label="lab_hum_October2021TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2021 Term Loan Agreement</link:label>
    <link:label id="lab_hum_October2021TermLoanAgreementMember_label_en-US" xlink:label="lab_hum_October2021TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2021 Term Loan Agreement [Member]</link:label>
    <link:label id="lab_hum_October2021TermLoanAgreementMember_documentation_en-US" xlink:label="lab_hum_October2021TermLoanAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">October 2021 Term Loan Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_October2021TermLoanAgreementMember" xlink:href="hum-20221231.xsd#hum_October2021TermLoanAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_October2021TermLoanAgreementMember" xlink:to="lab_hum_October2021TermLoanAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_7b1a8cf6-f926-42f6-bc83-3d874bbf5993_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e9242828-4734-4e7f-b319-786e65d9a293_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense (income), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_dbc1a156-03ce-4433-8a99-7b71d4b04326_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_JPMorganChaseBankMember_0b5e4576-efa4-445b-b1fd-2872c970e2d3_terseLabel_en-US" xlink:label="lab_hum_JPMorganChaseBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JPM</link:label>
    <link:label id="lab_hum_JPMorganChaseBankMember_label_en-US" xlink:label="lab_hum_JPMorganChaseBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JPMorgan Chase Bank [Member]</link:label>
    <link:label id="lab_hum_JPMorganChaseBankMember_documentation_en-US" xlink:label="lab_hum_JPMorganChaseBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">JPMorgan Chase Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_JPMorganChaseBankMember" xlink:href="hum-20221231.xsd#hum_JPMorganChaseBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_JPMorganChaseBankMember" xlink:to="lab_hum_JPMorganChaseBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4aee556c-1bdf-4e52-b5b0-ec31b46cde51_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicarePartDDisclosureTextBlock_3d1b812d-ddef-4713-9c5a-572c54ec27ab_terseLabel_en-US" xlink:label="lab_hum_MedicarePartDDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MEDICARE PART D</link:label>
    <link:label id="lab_hum_MedicarePartDDisclosureTextBlock_label_en-US" xlink:label="lab_hum_MedicarePartDDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Part D Disclosure [Text Block]</link:label>
    <link:label id="lab_hum_MedicarePartDDisclosureTextBlock_documentation_en-US" xlink:label="lab_hum_MedicarePartDDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance sheet amounts associated with Medicare Part D.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicarePartDDisclosureTextBlock" xlink:href="hum-20221231.xsd#hum_MedicarePartDDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicarePartDDisclosureTextBlock" xlink:to="lab_hum_MedicarePartDDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_f63b106b-e78d-4a96-a4ee-aa9fd3c75b23_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_99cfd1be-b055-4757-b36b-26a8c87548aa_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_213ebb50-fd0e-42c1-a625-97c5bf102093_totalLabel_en-US" xlink:label="lab_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Loss) income before equity in net earnings of subsidiaries</link:label>
    <link:label id="lab_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_label_en-US" xlink:label="lab_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss Before Equity In Net Earnings Of Subsidiaries</link:label>
    <link:label id="lab_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_documentation_en-US" xlink:label="lab_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) before equity in net earnings of subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:href="hum-20221231.xsd#hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:to="lab_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_5ba0a8f1-d2de-49ba-9d5d-ba2e47634a71_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax payments, net</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_1da7778d-b283-4374-badb-9fd4f3b477ee_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_9524bde1-05a9-4dac-9e08-23bc6c226ac0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementRelatedDisclosuresAbstract_db1e6a98-3756-4e52-89f7-0d866f445a7d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeStatementRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_512f766e-580e-4ba9-8a71-93ff251a0f0d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividend declared (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_252cf276-0c4a-439f-85b6-5f6a14322b1a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_c384613b-a844-4a25-b82d-ae0929e79649_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_ca267f63-0528-4559-a6dc-cdb63ba59f65_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligations in 2027</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_26155a4c-c2c1-4597-9b02-d359daf44739_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_8a594440-7e9e-4b91-932d-9bfa192a5cd0_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_88d10b2b-8f7f-4f7c-a0ed-57c60db5152e_terseLabel_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums</link:label>
    <link:label id="lab_us-gaap_PremiumsEarnedNet_label_en-US" xlink:label="lab_us-gaap_PremiumsEarnedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums Earned, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PremiumsEarnedNet" xlink:to="lab_us-gaap_PremiumsEarnedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_85e7ce0d-608f-4ae7-b5a8-cc65c05366bb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total compensation expense not yet recognized related to nonvested awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_5f172773-5ae5-4de7-bebe-2b598ef118f6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment securities</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInvestments_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInvestments" xlink:to="lab_us-gaap_DeferredTaxAssetsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_ebb99f6a-3f45-4fab-856b-d3f324300850_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares&#160; Under Option</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_17cf8f4a-77ee-45c6-a28c-396653a2eb3f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT, NET</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a66ef6a1-6707-4161-9749-4296ba94fc01_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of stock options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5896623e-85da-46d9-8780-9d9e6eecbd21_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_46b89783-9d41-4a8a-8672-d77fbbbdeec1_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_23c73ea0-8563-4e2f-8656-43f72384b253_totalLabel_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment earnings (loss) attributable to Humana</link:label>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_label_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Attributable To Parent</link:label>
    <link:label id="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_documentation_en-US" xlink:label="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Attributable To Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:href="hum-20221231.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:to="lab_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_9732134d-1d8d-462b-bb1e-c57a9162da41_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_7213eb07-6e07-4119-aaf3-46baa253a3bc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity_d9ff7e27-5ca2-44b2-a82b-a46a8a67e777_terseLabel_en-US" xlink:label="lab_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity including uncommitted incremental loan facility</link:label>
    <link:label id="lab_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity_label_en-US" xlink:label="lab_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity Including Uncommitted Incremental Capacity</link:label>
    <link:label id="lab_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity_documentation_en-US" xlink:label="lab_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity under the credit facility including uncommitted incremental capacity and without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity" xlink:href="hum-20221231.xsd#hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity" xlink:to="lab_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_6388a2db-e722-41b1-bfd7-f3c664977d6c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_771dc71b-f053-4080-8172-95b5eacae155_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_eeaf8a84-8c37-4ca0-a3c1-2fa57c424c4c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_9db35bea-df3b-4c3b-b987-12871001b8de_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_5ffe3737-8857-4c8b-a147-689f10da70d3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issue costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_33f6e6cf-bda1-4536-8750-21b912b2f2d5_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_0b05dc69-e55a-4571-b645-95be1df7cefd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract_2c134d3b-0b77-40a4-b936-fe1f4b07ecf5_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of businesses acquired in purchase transactions:</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dce34211-e0d9-4441-83a0-619750590497_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_InsuranceSegmentMember_614207c4-aa0e-47f9-b27f-737c3d201f20_terseLabel_en-US" xlink:label="lab_hum_InsuranceSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance</link:label>
    <link:label id="lab_hum_InsuranceSegmentMember_label_en-US" xlink:label="lab_hum_InsuranceSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Segment [Member]</link:label>
    <link:label id="lab_hum_InsuranceSegmentMember_documentation_en-US" xlink:label="lab_hum_InsuranceSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember" xlink:href="hum-20221231.xsd#hum_InsuranceSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_InsuranceSegmentMember" xlink:to="lab_hum_InsuranceSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_20307e79-ed2f-455a-a40d-319b1928d85c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_3391b1a9-f1dd-4911-8b6b-9c231d2d7148_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_ccf938d2-4d2a-43fd-9c81-330d4890d142_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Book value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b7493a54-69be-47cc-80de-620246fdc7e7_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditSpreadOptionMember_b24368f0-7ae4-452c-a8f2-c76c7277a5ab_terseLabel_en-US" xlink:label="lab_us-gaap_CreditSpreadOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit spread</link:label>
    <link:label id="lab_us-gaap_CreditSpreadOptionMember_label_en-US" xlink:label="lab_us-gaap_CreditSpreadOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Spread Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditSpreadOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditSpreadOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditSpreadOptionMember" xlink:to="lab_us-gaap_CreditSpreadOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_SubsidyAndDiscountsSettlementPeriodAfterClose_cd2491c2-d000-4ab3-b80a-c31211cdf185_terseLabel_en-US" xlink:label="lab_hum_SubsidyAndDiscountsSettlementPeriodAfterClose" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlement period after close</link:label>
    <link:label id="lab_hum_SubsidyAndDiscountsSettlementPeriodAfterClose_label_en-US" xlink:label="lab_hum_SubsidyAndDiscountsSettlementPeriodAfterClose" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidy And Discounts, Settlement Period After Close</link:label>
    <link:label id="lab_hum_SubsidyAndDiscountsSettlementPeriodAfterClose_documentation_en-US" xlink:label="lab_hum_SubsidyAndDiscountsSettlementPeriodAfterClose" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidy And Discounts, Settlement Period After Close</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountsSettlementPeriodAfterClose" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountsSettlementPeriodAfterClose"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_SubsidyAndDiscountsSettlementPeriodAfterClose" xlink:to="lab_hum_SubsidyAndDiscountsSettlementPeriodAfterClose" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_4e36a43c-8f2b-4db1-bfbb-6a338a354807_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_186ab0f0-dd28-4741-be7d-fa0c264f8e7c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Contractual Maturities of Debt Securities Available for Sale</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_b79a7d90-6afb-4c2d-8dab-a034fda9c77a_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_7ebb53a9-d4cc-4661-87c1-a2ae478762cf_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REPORTING ENTITY</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_cc04c46c-d4d3-47fa-8414-06281951086d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RiskCorridorSettlementsMedicarePartDMember_8bbc9816-286c-436e-a83c-c9c4e747a651_terseLabel_en-US" xlink:label="lab_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Corridor Settlement</link:label>
    <link:label id="lab_hum_RiskCorridorSettlementsMedicarePartDMember_label_en-US" xlink:label="lab_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Corridor Settlements Medicare Part D [Member]</link:label>
    <link:label id="lab_hum_RiskCorridorSettlementsMedicarePartDMember_documentation_en-US" xlink:label="lab_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk Corridor Settlements - Medicare Part D [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:href="hum-20221231.xsd#hum_RiskCorridorSettlementsMedicarePartDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:to="lab_hum_RiskCorridorSettlementsMedicarePartDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicareMember_772e2a38-dd7e-4a06-bfd1-2ab6540ebc3d_verboseLabel_en-US" xlink:label="lab_hum_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_hum_MedicareMember_ad4551eb-551e-46d3-9bfc-dcb78af048f8_terseLabel_en-US" xlink:label="lab_hum_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Medicare</link:label>
    <link:label id="lab_hum_MedicareMember_label_en-US" xlink:label="lab_hum_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_hum_MedicareMember_documentation_en-US" xlink:label="lab_hum_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember" xlink:href="hum-20221231.xsd#hum_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicareMember" xlink:to="lab_hum_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_d0e8e96e-7fe3-4e2d-b227-fdf0f718e354_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_17ce6431-ced3-4cf2-aaa6-262b410fcadd_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_5a575d1a-f513-4ba4-a46c-110c229dd177_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 17)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_99a3afe1-9e42-4cb7-9ab6-dda9ac454478_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e6acfbe8-175c-44c5-a256-6894af9e51bd_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_661d7d20-0a05-496e-abbf-35cc2d3721c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_HealthCareReformPolicyTextBlock_9b13f0a7-88b4-4d5f-beae-c84ba9eb11b0_terseLabel_en-US" xlink:label="lab_hum_HealthCareReformPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Reform</link:label>
    <link:label id="lab_hum_HealthCareReformPolicyTextBlock_label_en-US" xlink:label="lab_hum_HealthCareReformPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Reform [Policy Text Block]</link:label>
    <link:label id="lab_hum_HealthCareReformPolicyTextBlock_documentation_en-US" xlink:label="lab_hum_HealthCareReformPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care Reform</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareReformPolicyTextBlock" xlink:href="hum-20221231.xsd#hum_HealthCareReformPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_HealthCareReformPolicyTextBlock" xlink:to="lab_hum_HealthCareReformPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e90bf414-019f-401a-8699-072300f0789d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_9f04d97d-255f-4741-ac52-8bd7193598b0_terseLabel_en-US" xlink:label="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uncommitted incremental loan facility</link:label>
    <link:label id="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_label_en-US" xlink:label="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Uncommitted Incremental Capacity</link:label>
    <link:label id="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_documentation_en-US" xlink:label="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Uncommitted Incremental Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:href="hum-20221231.xsd#hum_LineOfCreditFacilityUncommittedIncrementalCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:to="lab_hum_LineOfCreditFacilityUncommittedIncrementalCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_7299bb7c-101d-436a-bcf0-1866157a3f5a_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities Amortized Cost to Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CoinsuranceAgreementMember_3bc1bd27-30e0-4dd4-b380-1942e9b8ac15_terseLabel_en-US" xlink:label="lab_hum_CoinsuranceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">100% coinsurance agreements</link:label>
    <link:label id="lab_hum_CoinsuranceAgreementMember_label_en-US" xlink:label="lab_hum_CoinsuranceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coinsurance Agreement [Member]</link:label>
    <link:label id="lab_hum_CoinsuranceAgreementMember_documentation_en-US" xlink:label="lab_hum_CoinsuranceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Coinsurance Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CoinsuranceAgreementMember" xlink:href="hum-20221231.xsd#hum_CoinsuranceAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CoinsuranceAgreementMember" xlink:to="lab_hum_CoinsuranceAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_341f3f0e-5eee-45d1-8da7-530ac4312f5b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_5e6a1b2a-260b-4418-af17-812dbf694575_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_11990797-1b3c-40c8-8a77-f110a9926797_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_806d2757-ea75-4b7e-bac1-77aaf4787bd2_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ProviderReportingUnitMember_b1edf6d3-b491-43d2-b42b-48799a45be26_terseLabel_en-US" xlink:label="lab_hum_ProviderReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider reporting unit</link:label>
    <link:label id="lab_hum_ProviderReportingUnitMember_label_en-US" xlink:label="lab_hum_ProviderReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Reporting Unit [Member]</link:label>
    <link:label id="lab_hum_ProviderReportingUnitMember_documentation_en-US" xlink:label="lab_hum_ProviderReportingUnitMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provider Reporting Unit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderReportingUnitMember" xlink:href="hum-20221231.xsd#hum_ProviderReportingUnitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ProviderReportingUnitMember" xlink:to="lab_hum_ProviderReportingUnitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_c9bc0647-80e0-4fb4-b600-d00fc4629b16_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CallOptionMember_e651db00-8ea3-4dfc-ad19-9c3857e05af6_terseLabel_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call option</link:label>
    <link:label id="lab_us-gaap_CallOptionMember_label_en-US" xlink:label="lab_us-gaap_CallOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Call Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CallOptionMember" xlink:to="lab_us-gaap_CallOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_d92c9560-187f-4de5-8158-060d60fcd1f6_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incurred related to:</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ValueCreationInitiativesMember_cf10128a-bbf3-40ef-b8ee-1154fd6bc5fc_terseLabel_en-US" xlink:label="lab_hum_ValueCreationInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Creation Initiatives</link:label>
    <link:label id="lab_hum_ValueCreationInitiativesMember_label_en-US" xlink:label="lab_hum_ValueCreationInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Creation Initiatives [Member]</link:label>
    <link:label id="lab_hum_ValueCreationInitiativesMember_documentation_en-US" xlink:label="lab_hum_ValueCreationInitiativesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value Creation Initiatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ValueCreationInitiativesMember" xlink:href="hum-20221231.xsd#hum_ValueCreationInitiativesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ValueCreationInitiativesMember" xlink:to="lab_hum_ValueCreationInitiativesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_495951a5-9b63-446c-96e2-a20ee0d5dac6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate at grant date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_a87ec3fd-833c-417a-92c6-05bcbdaa9f97_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_80b474bf-27e3-429d-bb54-80478ac603e3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_8fa14c05-e92e-4e00-8d1e-ef54bfc51f1a_negatedLabel_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current year</link:label>
    <link:label id="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_label_en-US" xlink:label="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:to="lab_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_e9a418aa-9bd9-4e3f-80e7-282fee36318c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_fa03528b-6c1b-4d9d-87aa-41001a391719_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_a7c9ad22-a63b-441c-8944-e8efeab864f4_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A5570PercentSeniorNotesDueMarch2028Member_b1240131-6691-4fb2-9d49-7a81f167f2d1_terseLabel_en-US" xlink:label="lab_hum_A5570PercentSeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.570 Percent Senior Notes Due March 2028</link:label>
    <link:label id="lab_hum_A5570PercentSeniorNotesDueMarch2028Member_label_en-US" xlink:label="lab_hum_A5570PercentSeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.570 Percent Senior Notes Due March 2028 [Member]</link:label>
    <link:label id="lab_hum_A5570PercentSeniorNotesDueMarch2028Member_documentation_en-US" xlink:label="lab_hum_A5570PercentSeniorNotesDueMarch2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.570 Percent Senior Notes Due March 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5570PercentSeniorNotesDueMarch2028Member" xlink:href="hum-20221231.xsd#hum_A5570PercentSeniorNotesDueMarch2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A5570PercentSeniorNotesDueMarch2028Member" xlink:to="lab_hum_A5570PercentSeniorNotesDueMarch2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_777cdd5d-0bbf-4cbb-93fc-178e6b6b24e3_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_0f352e3b-46b0-4ee5-a7f5-64caf3bf079b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_7205eec2-e7c0-4e65-81c8-bee09ba84d4c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0080cb5f-7dd3-489b-8811-acf2af479411_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_GroupMedicareAdvantageMember_ed7ada94-a92d-4a11-8e87-73a9caf3c411_terseLabel_en-US" xlink:label="lab_hum_GroupMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Medicare Advantage</link:label>
    <link:label id="lab_hum_GroupMedicareAdvantageMember_label_en-US" xlink:label="lab_hum_GroupMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Medicare Advantage [Member]</link:label>
    <link:label id="lab_hum_GroupMedicareAdvantageMember_documentation_en-US" xlink:label="lab_hum_GroupMedicareAdvantageMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Group Medicare Advantage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GroupMedicareAdvantageMember" xlink:href="hum-20221231.xsd#hum_GroupMedicareAdvantageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_GroupMedicareAdvantageMember" xlink:to="lab_hum_GroupMedicareAdvantageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_aca7b104-fb81-4b75-9cfe-1a2828b6b5d4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b8de9f72-b9e0-409f-9ed4-c34ce6c948de_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_WellsFargoBankMember_41cb270a-aa6f-453d-b3a4-b1458779ef42_terseLabel_en-US" xlink:label="lab_hum_WellsFargoBankMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wells Fargo Bank</link:label>
    <link:label id="lab_hum_WellsFargoBankMember_label_en-US" xlink:label="lab_hum_WellsFargoBankMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wells Fargo Bank [Member]</link:label>
    <link:label id="lab_hum_WellsFargoBankMember_documentation_en-US" xlink:label="lab_hum_WellsFargoBankMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wells Fargo Bank</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_WellsFargoBankMember" xlink:href="hum-20221231.xsd#hum_WellsFargoBankMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_WellsFargoBankMember" xlink:to="lab_hum_WellsFargoBankMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_f274784c-cc03-40e6-ab94-9b6f3db65beb_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember_d240b1de-5150-4baa-add5-840a5bf24bdb_terseLabel_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 Five Year</link:label>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember_label_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 Five Year [Member]</link:label>
    <link:label id="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember_documentation_en-US" xlink:label="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Agreement June 2021 Five Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:href="hum-20221231.xsd#hum_RevolvingCreditAgreementJune2021FiveYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:to="lab_hum_RevolvingCreditAgreementJune2021FiveYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3509dc43-ad3b-4181-9b16-5741d64e9838_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_a412f04d-02b6-4eb5-91c1-4f8ad704238d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_2868774a-4fd0-4700-98ab-0f3729baa93a_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_c3cc0c02-e0fd-4dea-b26d-ca3a02be2fe3_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DepreciationAndAmortizationIncomeStatement_4eee9a17-a33c-4f13-9dec-6ac6f595e8ac_terseLabel_en-US" xlink:label="lab_hum_DepreciationAndAmortizationIncomeStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_hum_DepreciationAndAmortizationIncomeStatement_label_en-US" xlink:label="lab_hum_DepreciationAndAmortizationIncomeStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization Income Statement</link:label>
    <link:label id="lab_hum_DepreciationAndAmortizationIncomeStatement_documentation_en-US" xlink:label="lab_hum_DepreciationAndAmortizationIncomeStatement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense excluding depreciation and amortization primarily from the delivery of pharmacy services by our wholly-owned pharmacy business (included in our Healthcare Services segment) which has been reclassified to benefit expenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement" xlink:href="hum-20221231.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DepreciationAndAmortizationIncomeStatement" xlink:to="lab_hum_DepreciationAndAmortizationIncomeStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_8a22c12e-66a4-4c2a-a900-20466c5c7d4c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax assets, net of valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_ManagementFeesChargedToOperatingSubsidiaries_f29df9c2-d179-42a2-acdc-8957afdbe7ec_terseLabel_en-US" xlink:label="lab_hum_ManagementFeesChargedToOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fees charged to operating subsidiaries</link:label>
    <link:label id="lab_hum_ManagementFeesChargedToOperatingSubsidiaries_label_en-US" xlink:label="lab_hum_ManagementFeesChargedToOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Fees Charged To Operating Subsidiaries</link:label>
    <link:label id="lab_hum_ManagementFeesChargedToOperatingSubsidiaries_documentation_en-US" xlink:label="lab_hum_ManagementFeesChargedToOperatingSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Through intercompany service agreements approved, if required, by state regulatory authorities, Humana Inc., our parent company, charges a management fee for reimbursement of certain centralized services provided to its subsidiaries, including information systems, disbursement, investment and cash administration, marketing, legal, finance, and medical and executive management oversight</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ManagementFeesChargedToOperatingSubsidiaries" xlink:href="hum-20221231.xsd#hum_ManagementFeesChargedToOperatingSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_ManagementFeesChargedToOperatingSubsidiaries" xlink:to="lab_hum_ManagementFeesChargedToOperatingSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock_b6a2f0fc-1dca-4416-8592-36b57024704e_terseLabel_en-US" xlink:label="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Balance Sheet Amounts Associated With Medicare Part D</link:label>
    <link:label id="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock_label_en-US" xlink:label="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Account Associated With Medicare Part D [Table Text Block]</link:label>
    <link:label id="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock_documentation_en-US" xlink:label="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Account Associated With Medicare Part D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock" xlink:href="hum-20221231.xsd#hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock" xlink:to="lab_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_83b9ceba-e78b-4613-a73f-dd1e8bdfe773_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member_f2c8e266-6ba6-4cb0-9516-207ff69d2ec3_terseLabel_en-US" xlink:label="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$750&#160;million, 4.95% due October 1, 2044</link:label>
    <link:label id="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member_label_en-US" xlink:label="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95 Percent Senior Notes Due October 2044 [Member]</link:label>
    <link:label id="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member_documentation_en-US" xlink:label="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95 Percent Senior Notes Due October 2044 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:href="hum-20221231.xsd#hum_A4.95PercentSeniorNotesDueOctober2044Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:to="lab_hum_A4.95PercentSeniorNotesDueOctober2044Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_941cf5c6-af7e-49a4-abb4-903afa79c08d_verboseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_17c01390-9420-4249-a3ba-f43d9d028f32_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility fee (percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_e0258a64-b411-4cce-be0b-e8afc9c27cec_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_d2185c27-58a4-4cd1-9e16-b1d7e2b9cc26_terseLabel_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_EquityClassOfTreasuryStockLineItems_label_en-US" xlink:label="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Class of Treasury Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:to="lab_us-gaap_EquityClassOfTreasuryStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_ba0aba89-38df-49a1-b766-fc06a270f11f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8d279503-58ae-45bd-b93e-e2951b306800_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturity of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_97582709-6bed-4bfe-99e6-861ebedbc9f3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpenses_48220e16-50eb-4777-a3b7-80dfc40e33de_totalLabel_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_BenefitsLossesAndExpenses_label_en-US" xlink:label="lab_us-gaap_BenefitsLossesAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Benefits, Losses and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BenefitsLossesAndExpenses" xlink:to="lab_us-gaap_BenefitsLossesAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_97053f08-c5e6-4fd8-a262-0ad3d9290c83_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_25a98d15-a27b-4fff-ad4a-2d50100e0c37_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_fbcca739-18cc-42f8-af02-ebca912e2a88_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CededPremiumsWritten_b33cc728-0c7f-4af3-a61d-70174858f3bd_terseLabel_en-US" xlink:label="lab_us-gaap_CededPremiumsWritten" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premiums ceded</link:label>
    <link:label id="lab_us-gaap_CededPremiumsWritten_label_en-US" xlink:label="lab_us-gaap_CededPremiumsWritten" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ceded Premiums Written</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsWritten" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsWritten"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CededPremiumsWritten" xlink:to="lab_us-gaap_CededPremiumsWritten" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_5f012081-141c-44dd-addd-4ba5c922f07a_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_a3d6190c-b0ca-4f6d-9e16-49606e8c55d4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_ce5685ac-7d2e-456e-ad76-720ff184ff11_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names and technology</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_61364d7d-6804-4cb6-8f0e-a9d8cbffcaec_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsPolicy_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsPolicy" xlink:to="lab_us-gaap_EquityMethodInvestmentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_PharmacyMember_fa6395a9-183a-479d-938e-3bd093489c63_terseLabel_en-US" xlink:label="lab_hum_PharmacyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:label id="lab_hum_PharmacyMember_label_en-US" xlink:label="lab_hum_PharmacyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy [Member]</link:label>
    <link:label id="lab_hum_PharmacyMember_documentation_en-US" xlink:label="lab_hum_PharmacyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PharmacyMember" xlink:href="hum-20221231.xsd#hum_PharmacyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_PharmacyMember" xlink:to="lab_hum_PharmacyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_a57c69ba-55cd-4c3a-aa8c-8a62db85d78b_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_ae206c08-1d80-4ae9-8d36-d4ce354d66e8_terseLabel_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ordinary dividends that may be paid to parent company</link:label>
    <link:label id="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_label_en-US" xlink:label="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:to="lab_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_761ea34a-467a-4c69-8d79-7e794574c5a6_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_5854df1b-9b63-4b4d-8373-cff3bf19ef48_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_aab02faa-9695-476e-a64c-20f0ac8e6616_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase obligations in 2025</link:label>
    <link:label id="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_label_en-US" xlink:label="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:to="lab_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_11da9d44-b263-494a-bbdf-09a7afbcf53f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term assets</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentAssetsMember" xlink:to="lab_us-gaap_OtherNoncurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_CenterWellSegmentMember_408cf863-ef7c-423d-bd59-5f01f4499a24_terseLabel_en-US" xlink:label="lab_hum_CenterWellSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CenterWell</link:label>
    <link:label id="lab_hum_CenterWellSegmentMember_label_en-US" xlink:label="lab_hum_CenterWellSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CenterWell Segment [Member]</link:label>
    <link:label id="lab_hum_CenterWellSegmentMember_documentation_en-US" xlink:label="lab_hum_CenterWellSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CenterWell Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember" xlink:href="hum-20221231.xsd#hum_CenterWellSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_CenterWellSegmentMember" xlink:to="lab_hum_CenterWellSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_c3aa303b-c34d-4cc8-b086-7bfbaf562b52_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred income tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_997a2153-57ed-4710-a175-7a8ff6421f80_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from term loan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromNotesPayable" xlink:to="lab_us-gaap_ProceedsFromNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_MedicareSupplementProductMember_6f695cdc-5eb3-4b4e-9496-a0c7523aa177_terseLabel_en-US" xlink:label="lab_hum_MedicareSupplementProductMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement Product</link:label>
    <link:label id="lab_hum_MedicareSupplementProductMember_label_en-US" xlink:label="lab_hum_MedicareSupplementProductMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement Product [Member]</link:label>
    <link:label id="lab_hum_MedicareSupplementProductMember_documentation_en-US" xlink:label="lab_hum_MedicareSupplementProductMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare Supplement Product</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareSupplementProductMember" xlink:href="hum-20221231.xsd#hum_MedicareSupplementProductMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_MedicareSupplementProductMember" xlink:to="lab_hum_MedicareSupplementProductMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_4b02974a-5f17-42cc-8c29-40034c8e7b52_verboseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ed9960b8-98ae-4152-b884-fc6271e4d8cd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_dc3c0444-d32c-4d21-979b-876d10680749_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_cf8c4cdf-621d-4394-87f0-57de1747e5ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant-Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_5c026cfc-f600-4415-b496-a5db276abd5f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_fc5c8819-3e16-499d-a5b3-9fdf3f64d20c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_255e3cf1-ad47-4c5b-a2c6-6fe1d562e7a8_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_AcceleratedShareRepurchasesAgreementAmount_4912e1db-beab-49d7-b005-f72145aeabe9_terseLabel_en-US" xlink:label="lab_hum_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement amount</link:label>
    <link:label id="lab_hum_AcceleratedShareRepurchasesAgreementAmount_label_en-US" xlink:label="lab_hum_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Agreement Amount</link:label>
    <link:label id="lab_hum_AcceleratedShareRepurchasesAgreementAmount_documentation_en-US" xlink:label="lab_hum_AcceleratedShareRepurchasesAgreementAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Agreement Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AcceleratedShareRepurchasesAgreementAmount" xlink:href="hum-20221231.xsd#hum_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_AcceleratedShareRepurchasesAgreementAmount" xlink:to="lab_hum_AcceleratedShareRepurchasesAgreementAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a5f66a01-edf9-4bd2-a204-a71a67230007_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_710a9b0d-e7df-454b-b7cb-296b3f79b06d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_95c5c756-cc10-409b-adec-7b2d9e72d829_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance at January&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_de15f000-6e69-46ea-98ad-2129fdd588fc_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December&#160;31</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A2019PlanMember_a58befe6-b2e3-40d6-8d41-0a5df215f3af_terseLabel_en-US" xlink:label="lab_hum_A2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019 Plan</link:label>
    <link:label id="lab_hum_A2019PlanMember_label_en-US" xlink:label="lab_hum_A2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A2019 Plan [Member]</link:label>
    <link:label id="lab_hum_A2019PlanMember_documentation_en-US" xlink:label="lab_hum_A2019PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">A2019 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2019PlanMember" xlink:href="hum-20221231.xsd#hum_A2019PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A2019PlanMember" xlink:to="lab_hum_A2019PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_fa4a46eb-a94b-4587-81de-2263731c94d7_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax provision at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1551711d-dece-4425-b78d-1997a9bacf46_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of investment securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a92976ba-9a4c-4b53-967e-3cef9f671b81_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_24dc0cc7-882f-4cf5-a152-13a85254bec2_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_0ff204d1-33c3-4bcf-ac63-f8bef8a00f08_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Equity Securities</link:label>
    <link:label id="lab_us-gaap_GainLossOnInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Securities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnInvestmentsTextBlock" xlink:to="lab_us-gaap_GainLossOnInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_A5875PercentSeniorNotesDueMarch2033Member_b16b1c30-c9b6-4507-a9b4-1b48d34cffe6_terseLabel_en-US" xlink:label="lab_hum_A5875PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.875 Percent Senior Notes Due March 2033</link:label>
    <link:label id="lab_hum_A5875PercentSeniorNotesDueMarch2033Member_label_en-US" xlink:label="lab_hum_A5875PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.875 Percent Senior Notes Due March 2033 [Member]</link:label>
    <link:label id="lab_hum_A5875PercentSeniorNotesDueMarch2033Member_documentation_en-US" xlink:label="lab_hum_A5875PercentSeniorNotesDueMarch2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.875 Percent Senior Notes Due March 2033</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5875PercentSeniorNotesDueMarch2033Member" xlink:href="hum-20221231.xsd#hum_A5875PercentSeniorNotesDueMarch2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_A5875PercentSeniorNotesDueMarch2033Member" xlink:to="lab_hum_A5875PercentSeniorNotesDueMarch2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_0b6c62c4-2edc-4c36-a588-8c7b00b29358_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EQUITY METHOD INVESTMENT</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_7eedb97c-9930-4e97-937f-e9144f669a46_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment_90bdaf43-ee2a-494d-bbf4-b9b54b1b7b56_negatedTerseLabel_en-US" xlink:label="lab_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Remeasured existing Kindred at Home equity method investment</link:label>
    <link:label id="lab_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment_label_en-US" xlink:label="lab_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash Acquisition Remeasurement Of Equity Investment</link:label>
    <link:label id="lab_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment_documentation_en-US" xlink:label="lab_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Or Part Noncash Acquisition Remeasurement Of Equity Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" xlink:href="hum-20221231.xsd#hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" xlink:to="lab_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_fdf12ec3-5658-41c5-9816-bc26e0c9a1b7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of KAH Hospice, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses, Net of Cash Divested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_327d42a2-c29b-4e88-a735-1acc7845c1fb_terseLabel_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual option periods</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_label_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Number Of Option Periods</link:label>
    <link:label id="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_documentation_en-US" xlink:label="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRICARE Managed Care Support Contract, Number Of Option Periods</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:href="hum-20221231.xsd#hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:to="lab_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding_56ad5504-8884-46ce-bb96-d2b6cd388d8a_terseLabel_en-US" xlink:label="lab_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock plan assets as percentage of shares outstanding</link:label>
    <link:label id="lab_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding_label_en-US" xlink:label="lab_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Shares Of Common Stock In Plan As Percentage Of Shares Outstanding</link:label>
    <link:label id="lab_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding_documentation_en-US" xlink:label="lab_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Shares Of Common Stock In Plan As Percentage Of Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding" xlink:to="lab_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage_44556580-5aa7-42ea-940e-ff9984c703d3_terseLabel_en-US" xlink:label="lab_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining ownership percentage acquired</link:label>
    <link:label id="lab_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage_label_en-US" xlink:label="lab_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Subsequent Acquisition, Percentage</link:label>
    <link:label id="lab_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage_documentation_en-US" xlink:label="lab_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Subsequent Acquisition, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage" xlink:href="hum-20221231.xsd#hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage" xlink:to="lab_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HealthCareMember_label_en-US" xlink:label="lab_us-gaap_HealthCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HealthCareMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HealthCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HealthCareMember" xlink:to="lab_us-gaap_HealthCareMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>hum-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:be062877-2225-41e8-b603-0f500ed981f8,g:73ed13b8-2607-407e-984b-2bfb1b06116c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.humana.com/role/Cover" xlink:type="simple" xlink:href="hum-20221231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_f426c140-a31a-4a68-82bc-23fda80488b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_DocumentType_f426c140-a31a-4a68-82bc-23fda80488b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_dfd685c9-2590-4466-88d5-71901d2473f8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_DocumentAnnualReport_dfd685c9-2590-4466-88d5-71901d2473f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3ff61fb5-53f1-41bc-86e2-c0d001e64116" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_DocumentPeriodEndDate_3ff61fb5-53f1-41bc-86e2-c0d001e64116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_c22f3d95-d844-46fc-9bd5-c904a88c1320" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_CurrentFiscalYearEndDate_c22f3d95-d844-46fc-9bd5-c904a88c1320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_027f4d9e-b556-4b07-b079-2760944fb018" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_DocumentTransitionReport_027f4d9e-b556-4b07-b079-2760944fb018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_e80190df-e6a6-47ba-8693-21a0fc25d0ef" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityFileNumber_e80190df-e6a6-47ba-8693-21a0fc25d0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_92cbd1ca-9e4d-484e-a15a-74968d96ee90" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityRegistrantName_92cbd1ca-9e4d-484e-a15a-74968d96ee90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_04c228dc-1a5e-415c-acb8-f9819772457b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityIncorporationStateCountryCode_04c228dc-1a5e-415c-acb8-f9819772457b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_29c7924a-7b53-4090-a298-aaa4a17bb81f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityTaxIdentificationNumber_29c7924a-7b53-4090-a298-aaa4a17bb81f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e02ccc22-4450-42eb-a660-17b371bb6bf1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityAddressAddressLine1_e02ccc22-4450-42eb-a660-17b371bb6bf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_2eb2651e-2fb8-44de-b855-5152a5b2f876" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityAddressCityOrTown_2eb2651e-2fb8-44de-b855-5152a5b2f876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5204ac26-e51e-4aae-8ffa-aa1a91bcd2b6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityAddressStateOrProvince_5204ac26-e51e-4aae-8ffa-aa1a91bcd2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_4a8fd4d5-9a04-4160-815f-051b6216c95a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityAddressPostalZipCode_4a8fd4d5-9a04-4160-815f-051b6216c95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e6aecfec-01d3-4e5d-a009-956777f31e78" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_CityAreaCode_e6aecfec-01d3-4e5d-a009-956777f31e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_14f79d41-a629-4830-8492-1f7274c0def6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_LocalPhoneNumber_14f79d41-a629-4830-8492-1f7274c0def6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_16d40435-3eac-4f53-b3c7-f1b51ded0b55" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_Security12bTitle_16d40435-3eac-4f53-b3c7-f1b51ded0b55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_1b47cc95-63a8-49cf-8ed7-fa8ff827aa9f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_TradingSymbol_1b47cc95-63a8-49cf-8ed7-fa8ff827aa9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_620452ec-b122-4050-8a08-e2372442f6d2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_SecurityExchangeName_620452ec-b122-4050-8a08-e2372442f6d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_61e84ef2-081f-43ae-ae06-f4bd9eb6fa95" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_61e84ef2-081f-43ae-ae06-f4bd9eb6fa95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_4fb1d9fc-9d0c-4c61-a6f7-c7371fd52142" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityVoluntaryFilers_4fb1d9fc-9d0c-4c61-a6f7-c7371fd52142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_dc78f3f0-1c3a-4544-9b6c-87c266720d3d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityCurrentReportingStatus_dc78f3f0-1c3a-4544-9b6c-87c266720d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f0a2bbb2-72dd-4000-aa24-5a7c87763462" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityInteractiveDataCurrent_f0a2bbb2-72dd-4000-aa24-5a7c87763462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_56039e82-cd4c-4520-80f7-14b129b9234a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityFilerCategory_56039e82-cd4c-4520-80f7-14b129b9234a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_11228199-bc73-44f9-84ac-7340c0f0ec48" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntitySmallBusiness_11228199-bc73-44f9-84ac-7340c0f0ec48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_14c851ea-2e93-43f5-9daf-b6215a275a83" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityEmergingGrowthCompany_14c851ea-2e93-43f5-9daf-b6215a275a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_b430427b-3ba8-4bc3-a237-786eeb7782db" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_IcfrAuditorAttestationFlag_b430427b-3ba8-4bc3-a237-786eeb7782db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_085c44be-71e4-41a3-909c-18dea3f1f1da" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityShellCompany_085c44be-71e4-41a3-909c-18dea3f1f1da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_58c37802-2947-4211-b70a-08fbb7eb6a95" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityPublicFloat_58c37802-2947-4211-b70a-08fbb7eb6a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b3959840-13b0-4a6a-ac3e-a50b7b6fa4b8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b3959840-13b0-4a6a-ac3e-a50b7b6fa4b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_5256f351-fe9f-479d-8703-e8d8507e82d9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_5256f351-fe9f-479d-8703-e8d8507e82d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2674e3d2-b0d9-45af-9120-3508d461e0a9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_EntityCentralIndexKey_2674e3d2-b0d9-45af-9120-3508d461e0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_23ce068e-4e64-437c-9a2b-3cb278307e19" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_DocumentFiscalYearFocus_23ce068e-4e64-437c-9a2b-3cb278307e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_04f99a32-7be8-4540-b669-648d41384276" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_DocumentFiscalPeriodFocus_04f99a32-7be8-4540-b669-648d41384276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4cc621f8-09a4-45fc-8dbe-fe9409ab449b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4d50a825-f66a-4391-91a0-b52096575bc7" xlink:to="loc_dei_AmendmentFlag_4cc621f8-09a4-45fc-8dbe-fe9409ab449b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/AuditInformation" xlink:type="simple" xlink:href="hum-20221231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hum_AuditInformationAbstract_56eee5e8-0727-4411-b016-631ad2a3852a" xlink:href="hum-20221231.xsd#hum_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_459aec6c-1439-442b-8c76-c0d2ce807b38" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_AuditInformationAbstract_56eee5e8-0727-4411-b016-631ad2a3852a" xlink:to="loc_dei_AuditorName_459aec6c-1439-442b-8c76-c0d2ce807b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_b3d7bdb1-37d9-4e92-afcf-a955fe96b607" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_AuditInformationAbstract_56eee5e8-0727-4411-b016-631ad2a3852a" xlink:to="loc_dei_AuditorLocation_b3d7bdb1-37d9-4e92-afcf-a955fe96b607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_586e5681-a408-4b6a-8f6b-226c944a7b04" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_AuditInformationAbstract_56eee5e8-0727-4411-b016-631ad2a3852a" xlink:to="loc_dei_AuditorFirmId_586e5681-a408-4b6a-8f6b-226c944a7b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_6d07088d-c722-4474-9228-092cdacfef23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_9d333aac-b8a7-42f2-a687-7dfd6f91d5bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6d07088d-c722-4474-9228-092cdacfef23" xlink:to="loc_us-gaap_AssetsAbstract_9d333aac-b8a7-42f2-a687-7dfd6f91d5bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4009a6f8-d3c0-4171-8708-7526627bd091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d333aac-b8a7-42f2-a687-7dfd6f91d5bb" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4009a6f8-d3c0-4171-8708-7526627bd091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_44cdbea7-2e02-4e7e-b7d3-84481c77020f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4009a6f8-d3c0-4171-8708-7526627bd091" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_44cdbea7-2e02-4e7e-b7d3-84481c77020f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9f3cb087-7011-461d-a515-ac6f9abc5411" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4009a6f8-d3c0-4171-8708-7526627bd091" xlink:to="loc_us-gaap_ShortTermInvestments_9f3cb087-7011-461d-a515-ac6f9abc5411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_988fab63-69d2-4670-ab5f-44a9b1bc545a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4009a6f8-d3c0-4171-8708-7526627bd091" xlink:to="loc_us-gaap_ReceivablesNetCurrent_988fab63-69d2-4670-ab5f-44a9b1bc545a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_1f691ce3-14db-41cc-862d-37d2640815a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4009a6f8-d3c0-4171-8708-7526627bd091" xlink:to="loc_us-gaap_OtherAssetsCurrent_1f691ce3-14db-41cc-862d-37d2640815a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_65db4be6-9858-4156-8701-355d7f347ccd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4009a6f8-d3c0-4171-8708-7526627bd091" xlink:to="loc_us-gaap_AssetsCurrent_65db4be6-9858-4156-8701-355d7f347ccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6164ae48-8217-4709-9d98-6c90b3111f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d333aac-b8a7-42f2-a687-7dfd6f91d5bb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6164ae48-8217-4709-9d98-6c90b3111f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_8308ab86-7170-4ea9-bc88-133fb2762f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d333aac-b8a7-42f2-a687-7dfd6f91d5bb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_8308ab86-7170-4ea9-bc88-133fb2762f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5071597d-f70f-414e-b604-0ec1e8686b5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d333aac-b8a7-42f2-a687-7dfd6f91d5bb" xlink:to="loc_us-gaap_Goodwill_5071597d-f70f-414e-b604-0ec1e8686b5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_7bd715f2-6959-4424-9fc3-df3cd3e48d92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d333aac-b8a7-42f2-a687-7dfd6f91d5bb" xlink:to="loc_us-gaap_EquityMethodInvestments_7bd715f2-6959-4424-9fc3-df3cd3e48d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_2a44fac5-5109-4375-804e-a10bf883c3f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d333aac-b8a7-42f2-a687-7dfd6f91d5bb" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_2a44fac5-5109-4375-804e-a10bf883c3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9fa7788f-8f07-4f57-ae67-68f9589cd1e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_9d333aac-b8a7-42f2-a687-7dfd6f91d5bb" xlink:to="loc_us-gaap_Assets_9fa7788f-8f07-4f57-ae67-68f9589cd1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d9ea2fa0-f631-41fe-8d86-029e77b5bb42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_6d07088d-c722-4474-9228-092cdacfef23" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d9ea2fa0-f631-41fe-8d86-029e77b5bb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_c0eb56dd-44a4-4c50-8039-3c6cf7c8c078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d9ea2fa0-f631-41fe-8d86-029e77b5bb42" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_c0eb56dd-44a4-4c50-8039-3c6cf7c8c078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_92621dae-fb44-44c1-add1-086d124ea8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0eb56dd-44a4-4c50-8039-3c6cf7c8c078" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_92621dae-fb44-44c1-add1-086d124ea8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_abf3afd9-162d-42d1-b653-635328841538" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0eb56dd-44a4-4c50-8039-3c6cf7c8c078" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_abf3afd9-162d-42d1-b653-635328841538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftLiability_c7b5a4aa-3bb8-48ee-b1f7-3eb84afa93eb" xlink:href="hum-20221231.xsd#hum_BookOverdraftLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0eb56dd-44a4-4c50-8039-3c6cf7c8c078" xlink:to="loc_hum_BookOverdraftLiability_c7b5a4aa-3bb8-48ee-b1f7-3eb84afa93eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0d0f9ccd-5cb1-4b43-beda-332eadfd19be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0eb56dd-44a4-4c50-8039-3c6cf7c8c078" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_0d0f9ccd-5cb1-4b43-beda-332eadfd19be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_e67d9f2c-4a7e-422e-9153-9c26aa6c0dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0eb56dd-44a4-4c50-8039-3c6cf7c8c078" xlink:to="loc_us-gaap_DebtCurrent_e67d9f2c-4a7e-422e-9153-9c26aa6c0dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_69a036fd-9c64-4b37-8ed2-cb8f300c1cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_c0eb56dd-44a4-4c50-8039-3c6cf7c8c078" xlink:to="loc_us-gaap_LiabilitiesCurrent_69a036fd-9c64-4b37-8ed2-cb8f300c1cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6e39b4c1-3a05-4dce-8881-252534454af6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d9ea2fa0-f631-41fe-8d86-029e77b5bb42" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6e39b4c1-3a05-4dce-8881-252534454af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_82b4d85f-7c78-49bf-856f-cbbd4e393d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d9ea2fa0-f631-41fe-8d86-029e77b5bb42" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_82b4d85f-7c78-49bf-856f-cbbd4e393d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a1d891fa-e91b-4e8c-b2e7-a39ae396244a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d9ea2fa0-f631-41fe-8d86-029e77b5bb42" xlink:to="loc_us-gaap_Liabilities_a1d891fa-e91b-4e8c-b2e7-a39ae396244a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_3ee48843-5b69-435e-b76d-d33006880685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d9ea2fa0-f631-41fe-8d86-029e77b5bb42" xlink:to="loc_us-gaap_CommitmentsAndContingencies_3ee48843-5b69-435e-b76d-d33006880685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d9ea2fa0-f631-41fe-8d86-029e77b5bb42" xlink:to="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_85b05f0c-ce2e-45e6-9ac8-4f9763dd272e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:to="loc_us-gaap_PreferredStockValue_85b05f0c-ce2e-45e6-9ac8-4f9763dd272e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_393a63ce-9f13-4d0c-a7eb-35092c488a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:to="loc_us-gaap_CommonStockValue_393a63ce-9f13-4d0c-a7eb-35092c488a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_70aa4d7d-0415-4e78-bd1e-e97adf9f40ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_70aa4d7d-0415-4e78-bd1e-e97adf9f40ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f6fc78a5-b064-438f-a12d-c73f9b45351d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_f6fc78a5-b064-438f-a12d-c73f9b45351d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16d853c0-1b55-49e6-94c5-46c5197fd5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_16d853c0-1b55-49e6-94c5-46c5197fd5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_08bf2b1d-d858-40e9-a953-29f9941ea05f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:to="loc_us-gaap_TreasuryStockCommonValue_08bf2b1d-d858-40e9-a953-29f9941ea05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_50863899-fe73-4398-8170-b6a7fb07746b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:to="loc_us-gaap_StockholdersEquity_50863899-fe73-4398-8170-b6a7fb07746b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_d37d5d4d-5fa7-4500-a5db-5b1c1232ce51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:to="loc_us-gaap_MinorityInterest_d37d5d4d-5fa7-4500-a5db-5b1c1232ce51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_efc90b16-375d-4887-a2a2-4d3ff14a9b80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_0c434797-f113-4a5b-a8a4-f7858705712d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_efc90b16-375d-4887-a2a2-4d3ff14a9b80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_34c46aeb-0094-4cb5-a505-62d8eb846807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d9ea2fa0-f631-41fe-8d86-029e77b5bb42" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_34c46aeb-0094-4cb5-a505-62d8eb846807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_804e695f-030f-488f-9815-3753f4dfa014" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7b88ecdb-1a32-4932-b957-cf2eb3fcf4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_804e695f-030f-488f-9815-3753f4dfa014" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_7b88ecdb-1a32-4932-b957-cf2eb3fcf4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4554da5f-dae4-497d-830e-3fa7d407c696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_804e695f-030f-488f-9815-3753f4dfa014" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4554da5f-dae4-497d-830e-3fa7d407c696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ab183e7e-8b71-45f8-bf2d-668177b8c901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_804e695f-030f-488f-9815-3753f4dfa014" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ab183e7e-8b71-45f8-bf2d-668177b8c901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_c3a1f485-7e9e-41bb-ba39-1dcfd51c5359" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_804e695f-030f-488f-9815-3753f4dfa014" xlink:to="loc_us-gaap_PreferredStockSharesIssued_c3a1f485-7e9e-41bb-ba39-1dcfd51c5359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0db8f265-4e55-46d6-9d4f-fef10ee72db9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_804e695f-030f-488f-9815-3753f4dfa014" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0db8f265-4e55-46d6-9d4f-fef10ee72db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b30824ad-5641-4989-9215-a08b5189b63c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_804e695f-030f-488f-9815-3753f4dfa014" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b30824ad-5641-4989-9215-a08b5189b63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_828b7369-ff81-4ccb-b407-e773ed5649a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_804e695f-030f-488f-9815-3753f4dfa014" xlink:to="loc_us-gaap_CommonStockSharesIssued_828b7369-ff81-4ccb-b407-e773ed5649a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_11856d33-7bfc-4ffb-8f6c-15a79924e236" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_804e695f-030f-488f-9815-3753f4dfa014" xlink:to="loc_us-gaap_TreasuryStockCommonShares_11856d33-7bfc-4ffb-8f6c-15a79924e236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_9e5f6534-dc00-4a92-b7d5-5d1ceea931f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList_9e5f6534-dc00-4a92-b7d5-5d1ceea931f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_782b9cbb-2234-4b75-9fa2-2894af1315c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_RevenuesAbstract_782b9cbb-2234-4b75-9fa2-2894af1315c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_cc0dd0e0-04ed-4bce-ba1e-790b6fc8fd02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_782b9cbb-2234-4b75-9fa2-2894af1315c4" xlink:to="loc_us-gaap_PremiumsEarnedNet_cc0dd0e0-04ed-4bce-ba1e-790b6fc8fd02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3b6db9d2-8957-4c33-9b7b-ba76c60386cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_782b9cbb-2234-4b75-9fa2-2894af1315c4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_3b6db9d2-8957-4c33-9b7b-ba76c60386cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_99bb9bf7-5fd3-4513-8afa-9e1f627b88ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_782b9cbb-2234-4b75-9fa2-2894af1315c4" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_99bb9bf7-5fd3-4513-8afa-9e1f627b88ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_dd9c0c31-7201-4194-95ad-858a3c307380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_782b9cbb-2234-4b75-9fa2-2894af1315c4" xlink:to="loc_us-gaap_Revenues_dd9c0c31-7201-4194-95ad-858a3c307380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_430dfea8-feac-4760-b979-2fb59bbb50f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_OperatingExpensesAbstract_430dfea8-feac-4760-b979-2fb59bbb50f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_4774aea8-6e6b-4ea2-b0f2-629fc555d686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_430dfea8-feac-4760-b979-2fb59bbb50f0" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_4774aea8-6e6b-4ea2-b0f2-629fc555d686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4e6d3ca1-8d01-4665-ad78-c4821f5e74c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_430dfea8-feac-4760-b979-2fb59bbb50f0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4e6d3ca1-8d01-4665-ad78-c4821f5e74c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement_acaeff44-1d3f-4580-80de-49e648aa4791" xlink:href="hum-20221231.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_430dfea8-feac-4760-b979-2fb59bbb50f0" xlink:to="loc_hum_DepreciationAndAmortizationIncomeStatement_acaeff44-1d3f-4580-80de-49e648aa4791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_42a27763-1bfa-4177-ae72-2c6a328f497e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_430dfea8-feac-4760-b979-2fb59bbb50f0" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_42a27763-1bfa-4177-ae72-2c6a328f497e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_baf6430b-b45d-42b1-bd15-81d4da3e492c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_OperatingIncomeLoss_baf6430b-b45d-42b1-bd15-81d4da3e492c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_1d7f8cfd-3536-475c-82f1-b1dfabc264c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_1d7f8cfd-3536-475c-82f1-b1dfabc264c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_957c36bc-89c7-4ed4-b996-7bbfde81d09f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_InterestExpense_957c36bc-89c7-4ed4-b996-7bbfde81d09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1c61864a-5d18-48c0-be11-c8943c093112" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1c61864a-5d18-48c0-be11-c8943c093112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7a72b929-2227-4b99-9f43-ad724f24af01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7a72b929-2227-4b99-9f43-ad724f24af01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_00c266a3-a95a-4f98-b177-30a2e8863fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_00c266a3-a95a-4f98-b177-30a2e8863fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c24bc20c-950b-46c1-a873-03e515bc8f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c24bc20c-950b-46c1-a873-03e515bc8f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_62e06215-9368-496d-b38a-95170b671db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_ProfitLoss_62e06215-9368-496d-b38a-95170b671db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_12b39463-cad0-413c-9471-1efef5aa95e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_12b39463-cad0-413c-9471-1efef5aa95e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3162ad34-9d39-4335-bbe7-543ea08a555c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_NetIncomeLoss_3162ad34-9d39-4335-bbe7-543ea08a555c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2fabd9a4-889e-41e3-b6cc-56ddd873a8db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_EarningsPerShareBasic_2fabd9a4-889e-41e3-b6cc-56ddd873a8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_74215fc2-75c4-4a50-9b43-8723b5bb2e56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_9f4b154f-411f-4c78-b692-97f47263dcae" xlink:to="loc_us-gaap_EarningsPerShareDiluted_74215fc2-75c4-4a50-9b43-8723b5bb2e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d98c995-6011-4b38-99b3-3cf9c40d032b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ae48008e-2df9-458b-aeb3-ac7b47678f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d98c995-6011-4b38-99b3-3cf9c40d032b" xlink:to="loc_us-gaap_NetIncomeLoss_ae48008e-2df9-458b-aeb3-ac7b47678f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_09f15d29-43f7-4daf-9a42-f80b481d838f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d98c995-6011-4b38-99b3-3cf9c40d032b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_09f15d29-43f7-4daf-9a42-f80b481d838f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_22e93b10-d790-4d5f-9b25-3b727e60de1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_09f15d29-43f7-4daf-9a42-f80b481d838f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_22e93b10-d790-4d5f-9b25-3b727e60de1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_630a1a68-672f-4242-b076-291a2b7a32d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_09f15d29-43f7-4daf-9a42-f80b481d838f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_630a1a68-672f-4242-b076-291a2b7a32d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_eff5bf6c-3a04-40b5-b8d1-65d6fedb1f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_09f15d29-43f7-4daf-9a42-f80b481d838f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_eff5bf6c-3a04-40b5-b8d1-65d6fedb1f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_3028ea7f-b770-413e-b808-287d02a855f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_09f15d29-43f7-4daf-9a42-f80b481d838f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_3028ea7f-b770-413e-b808-287d02a855f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c29da1a8-0f95-4df2-a711-20bf571677a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_09f15d29-43f7-4daf-9a42-f80b481d838f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_c29da1a8-0f95-4df2-a711-20bf571677a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_50ab4adc-0255-401b-8953-2e6866ed8552" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_09f15d29-43f7-4daf-9a42-f80b481d838f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_50ab4adc-0255-401b-8953-2e6866ed8552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_39c1a841-ba31-4fed-a83c-c28ef7fdde7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_09f15d29-43f7-4daf-9a42-f80b481d838f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_39c1a841-ba31-4fed-a83c-c28ef7fdde7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_e3fa9e23-1bae-4350-bce6-a4233255a2d1" xlink:href="hum-20221231.xsd#hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d98c995-6011-4b38-99b3-3cf9c40d032b" xlink:to="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_e3fa9e23-1bae-4350-bce6-a4233255a2d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_2986d66c-f8a5-44fc-9b6b-32e0576af452" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1d98c995-6011-4b38-99b3-3cf9c40d032b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_2986d66c-f8a5-44fc-9b6b-32e0576af452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_a31c16d6-e90e-440d-a514-17510529721d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c025d7ff-fb47-4f25-ae23-b360e855a9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_a31c16d6-e90e-440d-a514-17510529721d" xlink:to="loc_us-gaap_StatementTable_c025d7ff-fb47-4f25-ae23-b360e855a9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_43013972-2ff6-4174-929b-24afab3b76cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c025d7ff-fb47-4f25-ae23-b360e855a9c6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_43013972-2ff6-4174-929b-24afab3b76cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5879079e-583f-40e4-beb9-3200e47533db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_43013972-2ff6-4174-929b-24afab3b76cc" xlink:to="loc_us-gaap_EquityComponentDomain_5879079e-583f-40e4-beb9-3200e47533db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5879079e-583f-40e4-beb9-3200e47533db" xlink:to="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_bdb94838-3086-4696-9e83-27f17bf0415a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_CommonStockMember_bdb94838-3086-4696-9e83-27f17bf0415a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_60bb0536-ace5-4ebe-b3c1-cd700ad20676" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_60bb0536-ace5-4ebe-b3c1-cd700ad20676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_9fcfe6e3-a55d-4ded-b76c-08959c3121c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_RetainedEarningsMember_9fcfe6e3-a55d-4ded-b76c-08959c3121c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_339cfdf6-fb27-4386-8dd2-323e892bf6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_339cfdf6-fb27-4386-8dd2-323e892bf6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_3920641e-0cf3-4122-88ef-d7f493128d40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_12695913-42ee-4e8e-85d8-edd6fe4689dc" xlink:to="loc_us-gaap_TreasuryStockMember_3920641e-0cf3-4122-88ef-d7f493128d40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_ff0e5ede-3378-4469-a3ae-4617f0a070a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5879079e-583f-40e4-beb9-3200e47533db" xlink:to="loc_us-gaap_NoncontrollingInterestMember_ff0e5ede-3378-4469-a3ae-4617f0a070a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cf5f4474-94ca-4c20-9ace-351c03256b53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c025d7ff-fb47-4f25-ae23-b360e855a9c6" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cf5f4474-94ca-4c20-9ace-351c03256b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d2bdd07e-84c6-44f4-8bcb-40da22d5b96d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cf5f4474-94ca-4c20-9ace-351c03256b53" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d2bdd07e-84c6-44f4-8bcb-40da22d5b96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3302fc3c-9b35-459e-9ecf-28b57e43e2b9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d2bdd07e-84c6-44f4-8bcb-40da22d5b96d" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_3302fc3c-9b35-459e-9ecf-28b57e43e2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8b452279-d524-465c-8743-8ee7dde8e946" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c025d7ff-fb47-4f25-ae23-b360e855a9c6" xlink:to="loc_us-gaap_StatementLineItems_8b452279-d524-465c-8743-8ee7dde8e946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8b452279-d524-465c-8743-8ee7dde8e946" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e239b1f4-eccc-4a15-bc75-8ec162805782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e239b1f4-eccc-4a15-bc75-8ec162805782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c9e6cc25-6000-4a19-bbe6-8a5f6c629c54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_c9e6cc25-6000-4a19-bbe6-8a5f6c629c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4c8e879a-8106-417d-bac5-9383e905f405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_ProfitLoss_4c8e879a-8106-417d-bac5-9383e905f405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_094cae45-b432-4a1c-a271-b8b12bbb82cd" xlink:href="hum-20221231.xsd#hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders_094cae45-b432-4a1c-a271-b8b12bbb82cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_8f7a3922-e8be-4b38-b5df-d61f9c880e36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation_8f7a3922-e8be-4b38-b5df-d61f9c880e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8b78fb0c-efc2-4ee3-ac70-3d44fe9b46d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8b78fb0c-efc2-4ee3-ac70-3d44fe9b46d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b00eb97e-0e70-4e43-9dfb-dfa060e4f97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b00eb97e-0e70-4e43-9dfb-dfa060e4f97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4ed11dce-c91b-4671-a3e5-71fef193c7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_4ed11dce-c91b-4671-a3e5-71fef193c7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_e65411cb-5671-4bca-80cf-4ff5f069eb91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_DividendsCommonStockCash_e65411cb-5671-4bca-80cf-4ff5f069eb91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_13c867b8-6a62-413a-9874-e5e6301ba3cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_13c867b8-6a62-413a-9874-e5e6301ba3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_70ba407b-ab2a-4939-b60d-f8bca8148c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_70ba407b-ab2a-4939-b60d-f8bca8148c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_940c5ade-2c31-4af8-89b9-a1463709042a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross_940c5ade-2c31-4af8-89b9-a1463709042a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d4b5a0d7-2f68-411c-8189-3c9c386deab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d4b5a0d7-2f68-411c-8189-3c9c386deab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d09ff3b1-677c-4fe8-a04f-6ce06376aec6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d09ff3b1-677c-4fe8-a04f-6ce06376aec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_caeba131-0dcd-421b-82e3-9ca347c2d6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3ba1dc82-d58a-4ef6-b5b2-3e5ee1e2666f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_caeba131-0dcd-421b-82e3-9ca347c2d6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="simple" xlink:href="hum-20221231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOW"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ee49b474-cb0b-4e5e-b794-0560eb66bb75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_de42e0cf-37a0-42ac-9622-c7934d3990c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee49b474-cb0b-4e5e-b794-0560eb66bb75" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_de42e0cf-37a0-42ac-9622-c7934d3990c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8ff26ec3-7b27-4cdb-93c6-4ed92f8a1249" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_de42e0cf-37a0-42ac-9622-c7934d3990c4" xlink:to="loc_us-gaap_ProfitLoss_8ff26ec3-7b27-4cdb-93c6-4ed92f8a1249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_de42e0cf-37a0-42ac-9622-c7934d3990c4" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_bf28d223-0fd6-472c-87bc-d05f994d7631" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_bf28d223-0fd6-472c-87bc-d05f994d7631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_fb9eb85b-2144-414b-b0de-34f14f438221" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_fb9eb85b-2144-414b-b0de-34f14f438221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_924d555a-5a3e-4e1c-a3a4-a3c67080b5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_924d555a-5a3e-4e1c-a3a4-a3c67080b5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c903d662-e93d-49e8-935a-4cfbfb3201fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c903d662-e93d-49e8-935a-4cfbfb3201fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_a248fed9-d439-4ff8-a705-c6cdce8a6e08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_ShareBasedCompensation_a248fed9-d439-4ff8-a705-c6cdce8a6e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_0f48198d-9da6-43a8-ad2f-7347056279d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_Depreciation_0f48198d-9da6-43a8-ad2f-7347056279d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_097043e6-d57a-44f9-aad2-6a7d6548c227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_AdjustmentForAmortization_097043e6-d57a-44f9-aad2-6a7d6548c227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_aad3ab7e-678e-4cbd-a8da-3ad8a1713cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_aad3ab7e-678e-4cbd-a8da-3ad8a1713cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_29141a16-3b26-4e0a-998d-bc82a32de282" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_29141a16-3b26-4e0a-998d-bc82a32de282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_67b9cb3c-f19d-4867-af90-5659e4e9d998" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_67b9cb3c-f19d-4867-af90-5659e4e9d998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_a967cd4c-69f6-4da9-b79a-8d3caf291389" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_67b9cb3c-f19d-4867-af90-5659e4e9d998" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_a967cd4c-69f6-4da9-b79a-8d3caf291389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d70fb635-1b5a-462f-9f3f-38932a5b9920" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_67b9cb3c-f19d-4867-af90-5659e4e9d998" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_d70fb635-1b5a-462f-9f3f-38932a5b9920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_e5f86764-df23-4698-95a4-115e09d9413e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_67b9cb3c-f19d-4867-af90-5659e4e9d998" xlink:to="loc_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities_e5f86764-df23-4698-95a4-115e09d9413e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2c97fbcb-df39-4148-af64-3dcff85c2880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_67b9cb3c-f19d-4867-af90-5659e4e9d998" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_2c97fbcb-df39-4148-af64-3dcff85c2880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8aff3825-36cd-4d4e-bc39-d283336b33dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_67b9cb3c-f19d-4867-af90-5659e4e9d998" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_8aff3825-36cd-4d4e-bc39-d283336b33dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_5662eaec-50b3-457a-9e20-875002d8e5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_241f92e5-add1-427d-9793-178c873f3062" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_5662eaec-50b3-457a-9e20-875002d8e5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4be1837a-b3a0-4458-a3de-77a43a9159a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_de42e0cf-37a0-42ac-9622-c7934d3990c4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4be1837a-b3a0-4458-a3de-77a43a9159a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4724f7f1-3887-460c-942b-712b2b88f450" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee49b474-cb0b-4e5e-b794-0560eb66bb75" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4724f7f1-3887-460c-942b-712b2b88f450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_4ad341a8-ef99-4f6f-bfd4-37812d5a5abd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4724f7f1-3887-460c-942b-712b2b88f450" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested_4ad341a8-ef99-4f6f-bfd4-37812d5a5abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_02a54194-02f1-4d49-b02b-2e9ab02cc6db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4724f7f1-3887-460c-942b-712b2b88f450" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_02a54194-02f1-4d49-b02b-2e9ab02cc6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a01da3c4-43ea-4a8c-a0c6-6c5045e0d6a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4724f7f1-3887-460c-942b-712b2b88f450" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a01da3c4-43ea-4a8c-a0c6-6c5045e0d6a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_cd9b63a0-2c07-4ff2-b366-cfbce94e4985" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4724f7f1-3887-460c-942b-712b2b88f450" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_cd9b63a0-2c07-4ff2-b366-cfbce94e4985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_e4363cad-812f-4e16-9be8-6b68e6abad85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4724f7f1-3887-460c-942b-712b2b88f450" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_e4363cad-812f-4e16-9be8-6b68e6abad85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_849ead77-09f9-4a4e-8eb0-2ceea21a7d42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4724f7f1-3887-460c-942b-712b2b88f450" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_849ead77-09f9-4a4e-8eb0-2ceea21a7d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6e7f9b03-0d1a-4a2f-900c-d8bbcc8f3466" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4724f7f1-3887-460c-942b-712b2b88f450" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6e7f9b03-0d1a-4a2f-900c-d8bbcc8f3466" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee49b474-cb0b-4e5e-b794-0560eb66bb75" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentsForProceedsFromContractDeposits_1a8de365-01d8-4c3e-856d-96392f3bea86" xlink:href="hum-20221231.xsd#hum_PaymentsForProceedsFromContractDeposits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_hum_PaymentsForProceedsFromContractDeposits_1a8de365-01d8-4c3e-856d-96392f3bea86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_f5d6f292-d4f2-4449-869b-008cbc945f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_f5d6f292-d4f2-4449-869b-008cbc945f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_18c29458-3816-48e6-bcfb-b049f2e29724" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_18c29458-3816-48e6-bcfb-b049f2e29724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_7e80c7e5-640c-4e1e-880a-9e0cb495132e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_7e80c7e5-640c-4e1e-880a-9e0cb495132e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_8e3c8328-bbbd-41ce-98e3-dedba7f1a2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_8e3c8328-bbbd-41ce-98e3-dedba7f1a2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_ef1defbb-bc13-4d40-899c-70f09db98862" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_ef1defbb-bc13-4d40-899c-70f09db98862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d920d89b-8177-4d90-a06d-66c3a0dd8f64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d920d89b-8177-4d90-a06d-66c3a0dd8f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_10dd241a-4ac1-4e0e-839d-ea88b3e12c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_10dd241a-4ac1-4e0e-839d-ea88b3e12c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_7581b92b-6e88-411a-bfcd-333df83e8da2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_PaymentsOfDividends_7581b92b-6e88-411a-bfcd-333df83e8da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_9b5ec378-b331-44b7-9026-641261c57660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInBookOverdrafts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_9b5ec378-b331-44b7-9026-641261c57660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0726f36f-239e-4522-b751-6a3956a63b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_0726f36f-239e-4522-b751-6a3956a63b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0159597b-7a94-4429-843f-b9aeca727f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e0ef486b-aed2-4936-95b8-bc6396d1e018" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0159597b-7a94-4429-843f-b9aeca727f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0ba4f1f2-a5c4-47b8-bbe5-bee94bd42fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee49b474-cb0b-4e5e-b794-0560eb66bb75" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0ba4f1f2-a5c4-47b8-bbe5-bee94bd42fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9eb541d8-7d50-41cc-97bd-5883ace8077b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee49b474-cb0b-4e5e-b794-0560eb66bb75" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9eb541d8-7d50-41cc-97bd-5883ace8077b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_662be945-a194-4ad7-8d06-baf91468ea77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee49b474-cb0b-4e5e-b794-0560eb66bb75" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_662be945-a194-4ad7-8d06-baf91468ea77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_37b6c81a-4b6a-4a92-a900-98625268e7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ee49b474-cb0b-4e5e-b794-0560eb66bb75" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_37b6c81a-4b6a-4a92-a900-98625268e7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_2983fb6e-5e06-457d-8059-c7d683f235cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_37b6c81a-4b6a-4a92-a900-98625268e7dc" xlink:to="loc_us-gaap_InterestPaidNet_2983fb6e-5e06-457d-8059-c7d683f235cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_34ed50e1-74cc-4cca-9631-861363ed0550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_37b6c81a-4b6a-4a92-a900-98625268e7dc" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_34ed50e1-74cc-4cca-9631-861363ed0550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract_56084ba3-e3da-48aa-91ad-a7f3f12bf9bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_37b6c81a-4b6a-4a92-a900-98625268e7dc" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract_56084ba3-e3da-48aa-91ad-a7f3f12bf9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_921785a2-ee6d-4cc4-af72-abe04ffa0dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract_56084ba3-e3da-48aa-91ad-a7f3f12bf9bd" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_921785a2-ee6d-4cc4-af72-abe04ffa0dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_80a0f4f2-e4b1-4c7b-9c02-7ef9967fd703" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract_56084ba3-e3da-48aa-91ad-a7f3f12bf9bd" xlink:to="loc_us-gaap_LiabilitiesAssumed1_80a0f4f2-e4b1-4c7b-9c02-7ef9967fd703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_cd9fee03-2c2d-4ce6-a907-127805272bb2" xlink:href="hum-20221231.xsd#hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract_56084ba3-e3da-48aa-91ad-a7f3f12bf9bd" xlink:to="loc_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired_cd9fee03-2c2d-4ce6-a907-127805272bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment_b2ad713b-357e-49ea-9625-bb58e77a5afc" xlink:href="hum-20221231.xsd#hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract_56084ba3-e3da-48aa-91ad-a7f3f12bf9bd" xlink:to="loc_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment_b2ad713b-357e-49ea-9625-bb58e77a5afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_45c893ec-60e6-41c0-940f-c0dd3069870b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract_56084ba3-e3da-48aa-91ad-a7f3f12bf9bd" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_45c893ec-60e6-41c0-940f-c0dd3069870b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/REPORTINGENTITY" xlink:type="simple" xlink:href="hum-20221231.xsd#REPORTINGENTITY"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/REPORTINGENTITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e52a6bf0-1827-4680-8049-8c63ddb3c8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_42c0e3b7-2691-4335-a245-45abdb7fb593" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e52a6bf0-1827-4680-8049-8c63ddb3c8dd" xlink:to="loc_us-gaap_NatureOfOperations_42c0e3b7-2691-4335-a245-45abdb7fb593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7431d86b-144b-46dd-86bd-c6a77afcbf09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_05b0e5e4-242f-4c11-b58d-d32b7841147d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7431d86b-144b-46dd-86bd-c6a77afcbf09" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_05b0e5e4-242f-4c11-b58d-d32b7841147d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_66e05db2-c430-4beb-bba9-5f2cec429793" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_09032e8d-690b-4db8-8829-2a8785491eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_66e05db2-c430-4beb-bba9-5f2cec429793" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_09032e8d-690b-4db8-8829-2a8785491eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENT" xlink:type="simple" xlink:href="hum-20221231.xsd#EQUITYMETHODINVESTMENT"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EQUITYMETHODINVESTMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ea51acee-4b3b-4e7b-a337-587858771513" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_42b8c491-bb2d-4a5d-a18b-563d6159de7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_ea51acee-4b3b-4e7b-a337-587858771513" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_42b8c491-bb2d-4a5d-a18b-563d6159de7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIES" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_aa6d9948-7f98-4285-bb38-86cb41294788" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c031d904-85e6-4a52-bff9-6bac30925ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_aa6d9948-7f98-4285-bb38-86cb41294788" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_c031d904-85e6-4a52-bff9-6bac30925ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUE" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUE"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5f1cd03b-b837-46ac-ae8c-9cce15f88a32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_3015e7a7-1aed-43d8-b005-6b9b5450bd14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5f1cd03b-b837-46ac-ae8c-9cce15f88a32" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_3015e7a7-1aed-43d8-b005-6b9b5450bd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTD" xlink:type="simple" xlink:href="hum-20221231.xsd#MEDICAREPARTD"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/MEDICAREPARTD" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_5b0d19b2-1825-4d18-ac7b-72a7fb40c81c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicarePartDDisclosureTextBlock_fad39244-0e2c-4bb4-b394-401df9cf60ba" xlink:href="hum-20221231.xsd#hum_MedicarePartDDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_5b0d19b2-1825-4d18-ac7b-72a7fb40c81c" xlink:to="loc_hum_MedicarePartDDisclosureTextBlock_fad39244-0e2c-4bb4-b394-401df9cf60ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNET" xlink:type="simple" xlink:href="hum-20221231.xsd#PROPERTYANDEQUIPMENTNET"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/PROPERTYANDEQUIPMENTNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0876897f-4e04-4d57-95e5-1c897d076bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_569f6e40-3eac-4e4f-ba55-ba07a3ce1c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0876897f-4e04-4d57-95e5-1c897d076bc7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_569f6e40-3eac-4e4f-ba55-ba07a3ce1c17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="simple" xlink:href="hum-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_50418716-dd36-49f7-901e-e1f8bfa85c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8830f223-2c4e-4020-b114-c16117cf8782" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_50418716-dd36-49f7-901e-e1f8bfa85c3f" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_8830f223-2c4e-4020-b114-c16117cf8782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/LEASES" xlink:type="simple" xlink:href="hum-20221231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_be697ac7-5410-4075-8867-18dd142a1577" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_bd809f38-3a05-457d-86b3-ab4cc7d73338" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_be697ac7-5410-4075-8867-18dd142a1577" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_bd809f38-3a05-457d-86b3-ab4cc7d73338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLE" xlink:type="simple" xlink:href="hum-20221231.xsd#BENEFITSPAYABLE"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_d7efc0c1-0b68-4474-b89a-f5c9860725db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceDisclosureTextBlock_72a6c578-1982-4069-9610-dc506d7db77c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_d7efc0c1-0b68-4474-b89a-f5c9860725db" xlink:to="loc_us-gaap_InsuranceDisclosureTextBlock_72a6c578-1982-4069-9610-dc506d7db77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXES" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1ccf6f68-817f-4cea-9665-22f5909a81cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_9089da6d-c8c4-4d7e-98ec-f9a58fc77d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1ccf6f68-817f-4cea-9665-22f5909a81cb" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_9089da6d-c8c4-4d7e-98ec-f9a58fc77d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBT" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_26a0510c-4004-47fc-bce9-0b38e353ae51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_1cece33b-20b4-4c53-9146-83d471aeae50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_26a0510c-4004-47fc-bce9-0b38e353ae51" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_1cece33b-20b4-4c53-9146-83d471aeae50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANS" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANS"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d2060c62-ffac-4499-84b3-27bdd008aa63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock_77e086cb-803f-4979-811d-14fefe7be2ce" xlink:href="hum-20221231.xsd#hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_d2060c62-ffac-4499-84b3-27bdd008aa63" xlink:to="loc_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock_77e086cb-803f-4979-811d-14fefe7be2ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION" xlink:type="simple" xlink:href="hum-20221231.xsd#EARNINGSPERCOMMONSHARECOMPUTATION"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_20426c95-8b7d-4715-9628-f9a15d0946da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a2b4ebcf-c75a-498f-9f9c-8982697a3358" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_20426c95-8b7d-4715-9628-f9a15d0946da" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a2b4ebcf-c75a-498f-9f9c-8982697a3358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="hum-20221231.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_891d6afb-4bc7-475b-aaea-460d335bf4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_9a9d725b-1736-4c8d-8a27-167079d94880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_891d6afb-4bc7-475b-aaea-460d335bf4e4" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_9a9d725b-1736-4c8d-8a27-167079d94880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES" xlink:type="simple" xlink:href="hum-20221231.xsd#COMMITMENTSGUARANTEESANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_03a2b22b-846f-4143-a49d-54dc1d690d67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b08e384e-eb15-44c3-bcdd-31dba7fbc6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_03a2b22b-846f-4143-a49d-54dc1d690d67" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b08e384e-eb15-44c3-bcdd-31dba7fbc6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="hum-20221231.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a33b6e5d-8b91-4967-a0dd-922aa9471686" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_7cdf1b2c-7895-48f1-a672-e8d8b35b8198" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a33b6e5d-8b91-4967-a0dd-922aa9471686" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_7cdf1b2c-7895-48f1-a672-e8d8b35b8198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/REINSURANCE" xlink:type="simple" xlink:href="hum-20221231.xsd#REINSURANCE"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/REINSURANCE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_c5e758b9-b9b4-469d-8d51-23a007bad16d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceTextBlock_f66784f7-2250-44a4-b62a-d2e8764a32b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c5e758b9-b9b4-469d-8d51-23a007bad16d" xlink:to="loc_us-gaap_ReinsuranceTextBlock_f66784f7-2250-44a4-b62a-d2e8764a32b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_462d1782-380d-4bcc-a40b-d2b06d4c8d6c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_fb44e782-574a-4efe-bb26-6b01e2a52277" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_462d1782-380d-4bcc-a40b-d2b06d4c8d6c" xlink:to="loc_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock_fb44e782-574a-4efe-bb26-6b01e2a52277" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_831b4298-43c8-493d-ae4c-6b7579de0bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_831b4298-43c8-493d-ae4c-6b7579de0bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareReformPolicyTextBlock_43f34865-f02b-45e6-9357-b385c5b3b44a" xlink:href="hum-20221231.xsd#hum_HealthCareReformPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_hum_HealthCareReformPolicyTextBlock_43f34865-f02b-45e6-9357-b385c5b3b44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6e93c2cb-27c2-4fc7-bf8a-6b378c44308f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_6e93c2cb-27c2-4fc7-bf8a-6b378c44308f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentPolicyTextBlock_7c26cb02-ef68-41b3-89ad-8cb28e25762e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_InvestmentPolicyTextBlock_7c26cb02-ef68-41b3-89ad-8cb28e25762e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsurancePremiumsRevenueRecognitionPolicy_cee09cd6-9a8f-4ca2-9752-d97edddc2a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsurancePremiumsRevenueRecognitionPolicy"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_InsurancePremiumsRevenueRecognitionPolicy_cee09cd6-9a8f-4ca2-9752-d97edddc2a6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3ab94d2f-a745-4814-bf72-6cd1792820a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3ab94d2f-a745-4814-bf72-6cd1792820a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_6c59ad43-5249-476d-867d-df1632f1f5bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_6c59ad43-5249-476d-867d-df1632f1f5bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_OtherCurrentAssetsPolicyTextBlock_505dec6b-dcef-49de-9738-6230cbfe09f7" xlink:href="hum-20221231.xsd#hum_OtherCurrentAssetsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_hum_OtherCurrentAssetsPolicyTextBlock_505dec6b-dcef-49de-9738-6230cbfe09f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AcquisitionCostsPolicyPolicyTextBlock_1802ba0a-4f8a-404e-8f82-e8e80fb9eb15" xlink:href="hum-20221231.xsd#hum_AcquisitionCostsPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_hum_AcquisitionCostsPolicyPolicyTextBlock_1802ba0a-4f8a-404e-8f82-e8e80fb9eb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9559c646-eeae-47c9-9bf7-8b364444e97c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_9559c646-eeae-47c9-9bf7-8b364444e97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsPolicy_527a8fc7-c4e5-4a5c-9dbc-6751106302bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_EquityMethodInvestmentsPolicy_527a8fc7-c4e5-4a5c-9dbc-6751106302bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_b43b96cd-b28b-43bc-915f-4806d7b6647c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_b43b96cd-b28b-43bc-915f-4806d7b6647c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock_0fdfc95a-7524-48e7-92b1-be8603362fc0" xlink:href="hum-20221231.xsd#hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock_0fdfc95a-7524-48e7-92b1-be8603362fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock_b4bcb5db-3fb2-42b6-a99b-44d880e9dbc9" xlink:href="hum-20221231.xsd#hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock_b4bcb5db-3fb2-42b6-a99b-44d880e9dbc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftPolicyPolicyTextBlock_ac9984fb-73a7-4eaa-9dc8-458472bd9e4f" xlink:href="hum-20221231.xsd#hum_BookOverdraftPolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_hum_BookOverdraftPolicyPolicyTextBlock_ac9984fb-73a7-4eaa-9dc8-458472bd9e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_f7ed1577-96c3-4031-8ee8-da1abb0316f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_f7ed1577-96c3-4031-8ee8-da1abb0316f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncontrollingInterestsPolicyTextBlock_5e2391b2-4d81-4612-b686-fa0f12eac5b9" xlink:href="hum-20221231.xsd#hum_NoncontrollingInterestsPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_hum_NoncontrollingInterestsPolicyTextBlock_5e2391b2-4d81-4612-b686-fa0f12eac5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_0470dacf-879f-444f-959e-ffdcd615825f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_0470dacf-879f-444f-959e-ffdcd615825f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_753fdbd1-6e22-4392-929f-7560158c981a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_753fdbd1-6e22-4392-929f-7560158c981a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_c8e1857f-2f01-427a-9ff2-fd474a820752" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_c8e1857f-2f01-427a-9ff2-fd474a820752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3c64366a-46f9-4aee-95db-707b8a8509e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_835b9172-6dde-44bb-9b50-178c30526609" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3c64366a-46f9-4aee-95db-707b8a8509e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0af514c9-ca2e-4d5d-849a-3f0996b258c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock_76422592-131a-4e08-bc20-e10e5a5ac6d3" xlink:href="hum-20221231.xsd#hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0af514c9-ca2e-4d5d-849a-3f0996b258c7" xlink:to="loc_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock_76422592-131a-4e08-bc20-e10e5a5ac6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESTables" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURESTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f9a58d80-271a-4724-bb00-dfed7addc32a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_953c4167-b96a-4357-ac0e-fcb68bfb52ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f9a58d80-271a-4724-bb00-dfed7addc32a" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_953c4167-b96a-4357-ac0e-fcb68bfb52ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENTTables" xlink:type="simple" xlink:href="hum-20221231.xsd#EQUITYMETHODINVESTMENTTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EQUITYMETHODINVESTMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_91b2986b-e9a4-49be-91b7-2f121e22bcf2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_9beea2f9-c938-4400-a172-c70388dcaedb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_91b2986b-e9a4-49be-91b7-2f121e22bcf2" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_9beea2f9-c938-4400-a172-c70388dcaedb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESTables" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e8d3da7d-f2dc-4208-ac58-e880e67a0c99" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_0100c2ec-1dd4-4df3-8952-5473fa3a373e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e8d3da7d-f2dc-4208-ac58-e880e67a0c99" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_0100c2ec-1dd4-4df3-8952-5473fa3a373e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_8e898d85-72ba-4f9d-96b3-a3ed36219836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e8d3da7d-f2dc-4208-ac58-e880e67a0c99" xlink:to="loc_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock_8e898d85-72ba-4f9d-96b3-a3ed36219836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealizedGainLossTableTextBlock_13ee8e2d-cfbe-407a-b513-3886a853a8a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRealizedGainLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e8d3da7d-f2dc-4208-ac58-e880e67a0c99" xlink:to="loc_us-gaap_ScheduleOfRealizedGainLossTableTextBlock_13ee8e2d-cfbe-407a-b513-3886a853a8a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnInvestmentsTextBlock_d4ab35d5-70d1-4b96-91bf-d45734bfb494" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnInvestmentsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e8d3da7d-f2dc-4208-ac58-e880e67a0c99" xlink:to="loc_us-gaap_GainLossOnInvestmentsTextBlock_d4ab35d5-70d1-4b96-91bf-d45734bfb494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_b621365f-d52b-41e3-a0b2-fc6270267874" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e8d3da7d-f2dc-4208-ac58-e880e67a0c99" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_b621365f-d52b-41e3-a0b2-fc6270267874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUETables" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUETables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_cbd1d3f6-bb1c-4b66-bc4b-ac3b5924dedc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_4ecdb566-de21-4003-83df-e850ff40b184" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cbd1d3f6-bb1c-4b66-bc4b-ac3b5924dedc" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_4ecdb566-de21-4003-83df-e850ff40b184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c8b349d7-2d9b-49c0-846d-ecdcb528a19a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cbd1d3f6-bb1c-4b66-bc4b-ac3b5924dedc" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_c8b349d7-2d9b-49c0-846d-ecdcb528a19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_3e252fe7-62e8-40ce-9027-a9d018b14594" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_cbd1d3f6-bb1c-4b66-bc4b-ac3b5924dedc" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_3e252fe7-62e8-40ce-9027-a9d018b14594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTDTables" xlink:type="simple" xlink:href="hum-20221231.xsd#MEDICAREPARTDTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/MEDICAREPARTDTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_7fc4f86d-615f-4959-8912-de84bf8b6372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock_1cea3bc6-8202-4c2a-bf4e-e7b85877583b" xlink:href="hum-20221231.xsd#hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_7fc4f86d-615f-4959-8912-de84bf8b6372" xlink:to="loc_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock_1cea3bc6-8202-4c2a-bf4e-e7b85877583b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETTables" xlink:type="simple" xlink:href="hum-20221231.xsd#PROPERTYANDEQUIPMENTNETTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1a1bfde0-958e-4a08-a0e1-de1f2a345578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_cffb515f-7859-4724-922f-ae3bf52c3c93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1a1bfde0-958e-4a08-a0e1-de1f2a345578" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_cffb515f-7859-4724-922f-ae3bf52c3c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="hum-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9d2a3d8b-8bfe-442b-acbc-de88e025b8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_343ab736-88d5-4fb0-a2dd-b8506591f231" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9d2a3d8b-8bfe-442b-acbc-de88e025b8ed" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_343ab736-88d5-4fb0-a2dd-b8506591f231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_09075a44-1671-4dba-a7a3-96aebced6fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9d2a3d8b-8bfe-442b-acbc-de88e025b8ed" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_09075a44-1671-4dba-a7a3-96aebced6fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5f3c1af5-9d63-42b3-a573-490b70eab471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9d2a3d8b-8bfe-442b-acbc-de88e025b8ed" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_5f3c1af5-9d63-42b3-a573-490b70eab471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/LEASESTables" xlink:type="simple" xlink:href="hum-20221231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8cf8fc92-d2f0-4af4-afc0-a32626f1348d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_14dc9db2-d653-41f1-9b8f-e5513317bf44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8cf8fc92-d2f0-4af4-afc0-a32626f1348d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_14dc9db2-d653-41f1-9b8f-e5513317bf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLETables" xlink:type="simple" xlink:href="hum-20221231.xsd#BENEFITSPAYABLETables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_38e946e6-8508-4292-bd2e-6eefaaac0bda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_f77496a5-fad2-4077-9367-59547e3a13f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_38e946e6-8508-4292-bd2e-6eefaaac0bda" xlink:to="loc_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense_f77496a5-fad2-4077-9367-59547e3a13f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_18a02a29-c11a-4f68-b7e0-6e839d833ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_38e946e6-8508-4292-bd2e-6eefaaac0bda" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock_18a02a29-c11a-4f68-b7e0-6e839d833ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9c14b265-564f-4de5-b11a-120934a87505" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0c5d0e17-4890-41d1-b0d8-bc592bfe5442" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9c14b265-564f-4de5-b11a-120934a87505" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_0c5d0e17-4890-41d1-b0d8-bc592bfe5442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_11093f01-cf26-45f4-9884-eb6b145eb128" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9c14b265-564f-4de5-b11a-120934a87505" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_11093f01-cf26-45f4-9884-eb6b145eb128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_050b4dc2-f6c1-4816-986c-09c09886da28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9c14b265-564f-4de5-b11a-120934a87505" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_050b4dc2-f6c1-4816-986c-09c09886da28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTTables" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6452fb55-8c28-4d7a-97d1-0b3b8e48c59c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_0c201101-d005-440a-8814-e1554d2ac1c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6452fb55-8c28-4d7a-97d1-0b3b8e48c59c" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_0c201101-d005-440a-8814-e1554d2ac1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_22e3e996-af58-47c3-ba7c-b0b668fdac54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6452fb55-8c28-4d7a-97d1-0b3b8e48c59c" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_22e3e996-af58-47c3-ba7c-b0b668fdac54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_39ba91c8-e138-43a1-993e-7379caa699fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_d93f24a6-a1a4-4ab7-8d60-1fc408f3ef06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_39ba91c8-e138-43a1-993e-7379caa699fb" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_d93f24a6-a1a4-4ab7-8d60-1fc408f3ef06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_6d69112e-6012-4506-ace0-bd7dece0f4b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_39ba91c8-e138-43a1-993e-7379caa699fb" xlink:to="loc_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock_6d69112e-6012-4506-ace0-bd7dece0f4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4b0601b2-1120-4557-b99f-575d4c6f3a27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_39ba91c8-e138-43a1-993e-7379caa699fb" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_4b0601b2-1120-4557-b99f-575d4c6f3a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4b086a7c-140c-4014-a04f-63ead6bac59c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_39ba91c8-e138-43a1-993e-7379caa699fb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_4b086a7c-140c-4014-a04f-63ead6bac59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables" xlink:type="simple" xlink:href="hum-20221231.xsd#EARNINGSPERCOMMONSHARECOMPUTATIONTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_6836abb0-d12f-4ea5-a017-076680f1848b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ae38a449-9c43-40a1-8f69-e550b26bb77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_6836abb0-d12f-4ea5-a017-076680f1848b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_ae38a449-9c43-40a1-8f69-e550b26bb77d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="hum-20221231.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a31b3688-12fc-4b51-a3b1-a6a8c361e562" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock_1a953379-58c5-4697-a432-15e2c3882d27" xlink:href="hum-20221231.xsd#hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a31b3688-12fc-4b51-a3b1-a6a8c361e562" xlink:to="loc_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock_1a953379-58c5-4697-a432-15e2c3882d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_30a7a9f6-32cc-47c9-af91-6ea89ff2f6dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfTreasuryStockByClassTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a31b3688-12fc-4b51-a3b1-a6a8c361e562" xlink:to="loc_us-gaap_ScheduleOfTreasuryStockByClassTextBlock_30a7a9f6-32cc-47c9-af91-6ea89ff2f6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="hum-20221231.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fa7807a3-8c39-4690-be52-8197f19ff4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_80cec668-3cb6-4beb-af6b-9020c8abd266" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fa7807a3-8c39-4690-be52-8197f19ff4e2" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_80cec668-3cb6-4beb-af6b-9020c8abd266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/REPORTINGENTITYDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#REPORTINGENTITYDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/REPORTINGENTITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fec7092a-92d0-4b7b-a41d-8c4b30fb276a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fec7092a-92d0-4b7b-a41d-8c4b30fb276a" xlink:to="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aa0ee214-6678-4a49-9695-7cec3019bc73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aa0ee214-6678-4a49-9695-7cec3019bc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3c42105-02ad-40ab-a933-c9269534cf5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_aa0ee214-6678-4a49-9695-7cec3019bc73" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3c42105-02ad-40ab-a933-c9269534cf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueProductLineMember_c96ed367-7600-4115-8e86-a05a554b885a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_b3c42105-02ad-40ab-a933-c9269534cf5d" xlink:to="loc_us-gaap_SalesRevenueProductLineMember_c96ed367-7600-4115-8e86-a05a554b885a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_9b31608e-648e-48ab-af3e-5234d1be7622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_9b31608e-648e-48ab-af3e-5234d1be7622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f1229662-8c8f-419c-986a-368cac5e54be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_9b31608e-648e-48ab-af3e-5234d1be7622" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f1229662-8c8f-419c-986a-368cac5e54be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractsConcentrationRiskMember_c06881ff-60f7-4774-9037-ddc5982be8d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractsConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f1229662-8c8f-419c-986a-368cac5e54be" xlink:to="loc_us-gaap_GovernmentContractsConcentrationRiskMember_c06881ff-60f7-4774-9037-ddc5982be8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_156f03bb-54f2-4a1b-9f1d-0bf0e7b57b04" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:to="loc_srt_MajorCustomersAxis_156f03bb-54f2-4a1b-9f1d-0bf0e7b57b04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_83183af1-fc7f-48f7-aa79-1ae8678bf639" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_156f03bb-54f2-4a1b-9f1d-0bf0e7b57b04" xlink:to="loc_srt_NameOfMajorCustomerDomain_83183af1-fc7f-48f7-aa79-1ae8678bf639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FederalGovernmentMember_8e1e2538-8f5b-448c-a3b2-8171a3a73e13" xlink:href="hum-20221231.xsd#hum_FederalGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_83183af1-fc7f-48f7-aa79-1ae8678bf639" xlink:to="loc_hum_FederalGovernmentMember_8e1e2538-8f5b-448c-a3b2-8171a3a73e13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember_cdbb8368-7822-4624-be7c-44d07be94830" xlink:href="hum-20221231.xsd#hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_83183af1-fc7f-48f7-aa79-1ae8678bf639" xlink:to="loc_hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember_cdbb8368-7822-4624-be7c-44d07be94830" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c938d5d5-5733-446c-b833-bacacd8d410b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_343cee3d-5ba4-46b7-8077-134dbcc55680" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_c938d5d5-5733-446c-b833-bacacd8d410b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_a49d68d3-7655-4df7-bcad-140a1e558317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c938d5d5-5733-446c-b833-bacacd8d410b" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_a49d68d3-7655-4df7-bcad-140a1e558317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_2712f761-c440-439a-bc4a-08942d2798fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c938d5d5-5733-446c-b833-bacacd8d410b" xlink:to="loc_us-gaap_NumberOfReportableSegments_2712f761-c440-439a-bc4a-08942d2798fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_caa578d7-93ed-425d-9ac3-223b4f0d34e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:href="hum-20221231.xsd#hum_SignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_caa578d7-93ed-425d-9ac3-223b4f0d34e4" xlink:to="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RegulatoryMattersDomain_02ae566f-2c5b-499d-9557-2818e172b59c" xlink:href="hum-20221231.xsd#hum_RegulatoryMattersDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_RegulatoryMattersAxis_5172cee3-653f-48b3-a346-8419d09885bf" xlink:to="loc_hum_RegulatoryMattersDomain_02ae566f-2c5b-499d-9557-2818e172b59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareReformMember_c39043fa-f83d-4795-af31-5778ed7274ea" xlink:href="hum-20221231.xsd#hum_HealthCareReformMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_RegulatoryMattersDomain_02ae566f-2c5b-499d-9557-2818e172b59c" xlink:to="loc_hum_HealthCareReformMember_c39043fa-f83d-4795-af31-5778ed7274ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_54866801-e0ed-403b-a045-a1db25c2c315" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_417cd8cc-3743-48e7-99e1-7becfe986490" xlink:to="loc_srt_LitigationCaseTypeDomain_54866801-e0ed-403b-a045-a1db25c2c315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_USRiskCorridorPremiumStabilizationProgramMember_5cdc8c17-9bfc-44ba-8469-1225b846f2b6" xlink:href="hum-20221231.xsd#hum_USRiskCorridorPremiumStabilizationProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_54866801-e0ed-403b-a045-a1db25c2c315" xlink:to="loc_hum_USRiskCorridorPremiumStabilizationProgramMember_5cdc8c17-9bfc-44ba-8469-1225b846f2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceContractAxis_83572281-e199-4b6c-b911-a67fc6cc90f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceContractAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ReinsuranceContractAxis_83572281-e199-4b6c-b911-a67fc6cc90f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4462e84e-52ff-4860-a239-0b6904b1ece9" xlink:to="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_3e361085-b2fa-4e34-93d5-cad8730d68be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:to="loc_us-gaap_ServiceMember_3e361085-b2fa-4e34-93d5-cad8730d68be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareSupplementProductMember_bf588731-58fc-4317-ac69-cfe12a621afa" xlink:href="hum-20221231.xsd#hum_MedicareSupplementProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_e13583ca-fe9e-4c10-8c51-f725680c5568" xlink:to="loc_hum_MedicareSupplementProductMember_bf588731-58fc-4317-ac69-cfe12a621afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7f1a1209-c3ab-47c8-8d30-89eb79d7d155" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_59a913ff-09ec-4702-9ded-64c3b61d3336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:to="loc_us-gaap_EquipmentMember_59a913ff-09ec-4702-9ded-64c3b61d3336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e521085-70b1-4f6c-a695-1c5df31a3b08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_0e521085-70b1-4f6c-a695-1c5df31a3b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_8d6b7475-1ecd-446f-8637-14f7eceae93b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70e49aa6-4d42-4110-8d51-0da286c5a671" xlink:to="loc_us-gaap_BuildingMember_8d6b7475-1ecd-446f-8637-14f7eceae93b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_cda0b153-fdef-4a2d-83a4-183fe8281f87" xlink:to="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsReportingUnitMember_1cc42ec6-d9b1-4dc6-b019-7aaaaf392313" xlink:href="hum-20221231.xsd#hum_HomeSolutionsReportingUnitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:to="loc_hum_HomeSolutionsReportingUnitMember_1cc42ec6-d9b1-4dc6-b019-7aaaaf392313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderReportingUnitMember_5796b3b3-0716-456a-8d43-16a38a3e2927" xlink:href="hum-20221231.xsd#hum_ProviderReportingUnitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_ecc5db3c-c415-4483-aa67-6bb7b0b50a97" xlink:to="loc_hum_ProviderReportingUnitMember_5796b3b3-0716-456a-8d43-16a38a3e2927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bbbd0a67-e467-41ce-98e4-fbd574e4224e" xlink:to="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_36b23e49-c22a-4950-bab1-f7a701f2fa97" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:to="loc_srt_MinimumMember_36b23e49-c22a-4950-bab1-f7a701f2fa97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_037833ee-8747-442a-b9b1-d1e0840a0899" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_a048366e-70dd-46f8-bca6-fc275b87fb53" xlink:to="loc_srt_MaximumMember_037833ee-8747-442a-b9b1-d1e0840a0899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c0aa3c77-e418-4dd0-8f04-54df28cf3730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_ed42dffa-bda5-4791-b5f7-6ac7382d8b79" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c0aa3c77-e418-4dd0-8f04-54df28cf3730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_1c565c66-c2eb-454b-b2a0-f14f25fe37b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c0aa3c77-e418-4dd0-8f04-54df28cf3730" xlink:to="loc_us-gaap_SalesRevenueNetMember_1c565c66-c2eb-454b-b2a0-f14f25fe37b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_61270b67-8a4d-4c93-bb7f-8ebb3254a861" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_17e8aa46-d621-48d2-bed6-5bdf9252bc3b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_61270b67-8a4d-4c93-bb7f-8ebb3254a861" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_7dd1d854-0eb4-48e9-9397-5885119ac38c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_61270b67-8a4d-4c93-bb7f-8ebb3254a861" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_7dd1d854-0eb4-48e9-9397-5885119ac38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_727433fb-032a-46ee-9d5f-377ba9bdd2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_52a515c3-ae85-4890-b37f-2d6373264134" xlink:to="loc_us-gaap_RestructuringPlanDomain_727433fb-032a-46ee-9d5f-377ba9bdd2c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ValueCreationInitiativesMember_0c231722-6b65-49d4-9922-cf7c71bc7e58" xlink:href="hum-20221231.xsd#hum_ValueCreationInitiativesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_727433fb-032a-46ee-9d5f-377ba9bdd2c0" xlink:to="loc_hum_ValueCreationInitiativesMember_0c231722-6b65-49d4-9922-cf7c71bc7e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:href="hum-20221231.xsd#hum_SignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesTable_9437fb08-ea08-46d7-a448-3d98650e463f" xlink:to="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_428ae0ef-6884-40f5-bf82-81f4b2719048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAndAssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_RestructuringCostsAndAssetImpairmentCharges_428ae0ef-6884-40f5-bf82-81f4b2719048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_632d97bc-f6ae-418b-9b09-6b4705d5c384" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_632d97bc-f6ae-418b-9b09-6b4705d5c384" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_b0464f48-cbe4-4ed3-b923-6b157320bbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_SeveranceCosts1_b0464f48-cbe4-4ed3-b923-6b157320bbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PaymentOfAnnualHealthInsuranceIndustryFee_57336965-05ac-4859-a261-7aca3a75cd4d" xlink:href="hum-20221231.xsd#hum_PaymentOfAnnualHealthInsuranceIndustryFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_PaymentOfAnnualHealthInsuranceIndustryFee_57336965-05ac-4859-a261-7aca3a75cd4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GainContingencyRecoverySought_08568dc7-faa7-425f-9268-2009afe18cb6" xlink:href="hum-20221231.xsd#hum_GainContingencyRecoverySought"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_GainContingencyRecoverySought_08568dc7-faa7-425f-9268-2009afe18cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29749ed2-9725-4caf-a9b3-4379decc4caa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_29749ed2-9725-4caf-a9b3-4379decc4caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_f9b257e4-317e-4b5d-8570-4073afda33d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_LitigationSettlementExpense_f9b257e4-317e-4b5d-8570-4073afda33d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommercialMembershipContractTerm_b25bdc46-99ac-4112-837e-1c22a61db5b3" xlink:href="hum-20221231.xsd#hum_CommercialMembershipContractTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_CommercialMembershipContractTerm_b25bdc46-99ac-4112-837e-1c22a61db5b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies_38f3ff91-28a8-4fff-b7cc-4756241cef81" xlink:href="hum-20221231.xsd#hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies_38f3ff91-28a8-4fff-b7cc-4756241cef81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs_71d4d332-466a-4cf7-b1fb-be822ee8f888" xlink:href="hum-20221231.xsd#hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs_71d4d332-466a-4cf7-b1fb-be822ee8f888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountsSettlementPeriodAfterClose_788564ca-d2b5-459b-92b1-5c8459dc4514" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountsSettlementPeriodAfterClose"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_SubsidyAndDiscountsSettlementPeriodAfterClose_788564ca-d2b5-459b-92b1-5c8459dc4514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_12618c1f-33bd-46ea-8dee-06c98238094b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_12618c1f-33bd-46ea-8dee-06c98238094b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AccruedPharmaceuticalRebatesCurrent_23827665-8f73-4d8f-abfd-fc4e73d36202" xlink:href="hum-20221231.xsd#hum_AccruedPharmaceuticalRebatesCurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_AccruedPharmaceuticalRebatesCurrent_23827665-8f73-4d8f-abfd-fc4e73d36202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies_ec9ac40e-ccc5-4e42-9ad6-ea265a946f63" xlink:href="hum-20221231.xsd#hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies_ec9ac40e-ccc5-4e42-9ad6-ea265a946f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_267726b6-0b82-429e-b776-f30366833c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_267726b6-0b82-429e-b776-f30366833c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_342d20e0-0747-4958-af2e-6d092195c057" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_Goodwill_342d20e0-0747-4958-af2e-6d092195c057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_737effde-88fd-489d-b068-a8096f0587f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_737effde-88fd-489d-b068-a8096f0587f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_f609d1fe-268e-4bd9-a492-dc128b47784b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_SignificantAccountingPoliciesLineItems_5a178e41-8d70-427c-8012-bef2eb4b5abe" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_f609d1fe-268e-4bd9-a492-dc128b47784b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails_1" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails_1"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_2a0c934e-9b0b-44aa-92f8-483813ccd864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountPayments_3c515bc9-743c-483a-b95d-5ad2022878a8" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a0c934e-9b0b-44aa-92f8-483813ccd864" xlink:to="loc_hum_SubsidyAndDiscountPayments_3c515bc9-743c-483a-b95d-5ad2022878a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountReimbursements_89dee532-2e57-4d85-9fb0-0a1aa86fd5a2" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountReimbursements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a0c934e-9b0b-44aa-92f8-483813ccd864" xlink:to="loc_hum_SubsidyAndDiscountReimbursements_89dee532-2e57-4d85-9fb0-0a1aa86fd5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements_0bd189e4-652b-4288-a4b8-f978d74489fb" xlink:href="hum-20221231.xsd#hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_2a0c934e-9b0b-44aa-92f8-483813ccd864" xlink:to="loc_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements_0bd189e4-652b-4288-a4b8-f978d74489fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_20249902-80f8-48ec-b84d-4dfd2d5e6e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareCostPayments_e72db5af-69d9-4c2d-b4c0-118b2d97dcc0" xlink:href="hum-20221231.xsd#hum_HealthCareCostPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_20249902-80f8-48ec-b84d-4dfd2d5e6e19" xlink:to="loc_hum_HealthCareCostPayments_e72db5af-69d9-4c2d-b4c0-118b2d97dcc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareCostReimbursements_73fce843-df8c-4e3e-885c-61766fdefd98" xlink:href="hum-20221231.xsd#hum_HealthCareCostReimbursements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_20249902-80f8-48ec-b84d-4dfd2d5e6e19" xlink:to="loc_hum_HealthCareCostReimbursements_73fce843-df8c-4e3e-885c-61766fdefd98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HealthCareCostPaymentsAndReimbursementsNet_3c6d4955-f8a6-49bb-88a1-50e0e20cb906" xlink:href="hum-20221231.xsd#hum_HealthCareCostPaymentsAndReimbursementsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_20249902-80f8-48ec-b84d-4dfd2d5e6e19" xlink:to="loc_hum_HealthCareCostPaymentsAndReimbursementsNet_3c6d4955-f8a6-49bb-88a1-50e0e20cb906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5df2303-7bcf-4562-8d48-ce396aeb296e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_b5df2303-7bcf-4562-8d48-ce396aeb296e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5f9ceba4-fb38-40c0-899e-92f2a07ef719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5f9ceba4-fb38-40c0-899e-92f2a07ef719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_5899aae3-5898-4f5f-900d-3c4a8fb9621a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5f9ceba4-fb38-40c0-899e-92f2a07ef719" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_5899aae3-5898-4f5f-900d-3c4a8fb9621a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2caa754d-936e-46e8-9216-d6bf1f9236e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_5899aae3-5898-4f5f-900d-3c4a8fb9621a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_2caa754d-936e-46e8-9216-d6bf1f9236e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8840808e-02d1-4869-ae24-9193e6f389cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8840808e-02d1-4869-ae24-9193e6f389cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f9d31b9-43f2-4956-beca-e838c8ba7c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_8840808e-02d1-4869-ae24-9193e6f389cc" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f9d31b9-43f2-4956-beca-e838c8ba7c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_013dbc29-a679-4b43-a218-ca1416565850" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5f9d31b9-43f2-4956-beca-e838c8ba7c8a" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_013dbc29-a679-4b43-a218-ca1416565850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_118d3b0e-1604-4867-b7ed-f8780ebaa92c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_118d3b0e-1604-4867-b7ed-f8780ebaa92c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d20d2a60-577d-4b07-bc41-19c347680a73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_118d3b0e-1604-4867-b7ed-f8780ebaa92c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d20d2a60-577d-4b07-bc41-19c347680a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_095a6c9a-75c6-4b21-b798-d9788f3ba915" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d20d2a60-577d-4b07-bc41-19c347680a73" xlink:to="loc_hum_KindredAtHomeMember_095a6c9a-75c6-4b21-b798-d9788f3ba915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_6946d361-9a83-46dc-9b9d-5a9efa933323" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_DebtInstrumentAxis_6946d361-9a83-46dc-9b9d-5a9efa933323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc3a687b-1457-4f80-b2ab-68a5399cf832" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_6946d361-9a83-46dc-9b9d-5a9efa933323" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc3a687b-1457-4f80-b2ab-68a5399cf832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanDueOctober2023Member_f373aeff-05fd-4e7f-ae90-7b76f6e02b75" xlink:href="hum-20221231.xsd#hum_TermLoanDueOctober2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc3a687b-1457-4f80-b2ab-68a5399cf832" xlink:to="loc_hum_TermLoanDueOctober2023Member_f373aeff-05fd-4e7f-ae90-7b76f6e02b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d826c109-27dc-4aa2-af58-f71a0ebc2261" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d826c109-27dc-4aa2-af58-f71a0ebc2261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9008f5ba-d653-412d-9fb7-e8e8674fbd15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d826c109-27dc-4aa2-af58-f71a0ebc2261" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9008f5ba-d653-412d-9fb7-e8e8674fbd15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_057e5dcd-7c35-44f8-8eb8-9171dd504d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9008f5ba-d653-412d-9fb7-e8e8674fbd15" xlink:to="loc_us-gaap_LoansPayableMember_057e5dcd-7c35-44f8-8eb8-9171dd504d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f5a305c-dbe3-42f9-aa92-14f35a623cae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f5a305c-dbe3-42f9-aa92-14f35a623cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_45587db9-94a1-430a-a981-4151c6e35679" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f5a305c-dbe3-42f9-aa92-14f35a623cae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_45587db9-94a1-430a-a981-4151c6e35679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareLicensesAndCertificatesOfNeedMember_8697ebf2-069a-4263-b659-f0c42af187dd" xlink:href="hum-20221231.xsd#hum_MedicareLicensesAndCertificatesOfNeedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_45587db9-94a1-430a-a981-4151c6e35679" xlink:to="loc_hum_MedicareLicensesAndCertificatesOfNeedMember_8697ebf2-069a-4263-b659-f0c42af187dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_730fe710-7661-4567-9702-1e71602752cc" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_29571adb-600c-44ce-b8a2-cea626e302fc" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_29571adb-600c-44ce-b8a2-cea626e302fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ce8b9b55-ece8-4c3c-8490-1beb8206e451" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_ce8b9b55-ece8-4c3c-8490-1beb8206e451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_2e374e7f-e55d-4ab7-ae04-5f0f7638c5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_RepaymentsOfDebt_2e374e7f-e55d-4ab7-ae04-5f0f7638c5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_71d9cb91-34e6-4410-ad57-ab5092338ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_71d9cb91-34e6-4410-ad57-ab5092338ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_a063ef94-076c-4e80-b953-2015e386d86f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_a063ef94-076c-4e80-b953-2015e386d86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_86323b79-4ddc-4fe6-a88f-f1d95048e09e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax_86323b79-4ddc-4fe6-a88f-f1d95048e09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_4ec1eb20-2263-4c79-8cb4-7b9d9070a970" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue_4ec1eb20-2263-4c79-8cb4-7b9d9070a970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage_54c6b530-99d3-4d1e-8d87-ede103a3ae13" xlink:href="hum-20221231.xsd#hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage_54c6b530-99d3-4d1e-8d87-ede103a3ae13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree_f9a3ada0-eac8-4f12-9c96-56c222c927b6" xlink:href="hum-20221231.xsd#hum_BusinessCombinationTotalEnterpriseValueOfAcquiree"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree_f9a3ada0-eac8-4f12-9c96-56c222c927b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_e93bd5cd-27ca-4a92-aa0c-680ef7f18dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1_e93bd5cd-27ca-4a92-aa0c-680ef7f18dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_30169009-9d61-453a-b38a-0c380a8024ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_30169009-9d61-453a-b38a-0c380a8024ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_c7a39601-bf0b-4843-9356-ec9c8a6ec374" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_EquityMethodInvestments_c7a39601-bf0b-4843-9356-ec9c8a6ec374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_506f5a0b-3d93-4de8-a009-b48eaa842952" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_506f5a0b-3d93-4de8-a009-b48eaa842952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_658fd29e-df23-48a1-b5c0-f9a6763e3680" xlink:href="hum-20221231.xsd#hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_a92b8fc2-060c-4e61-9e02-c6f86ca038cb" xlink:to="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_658fd29e-df23-48a1-b5c0-f9a6763e3680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8b9e2f75-d07e-428d-855e-1ce09668bfd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66e75839-84ac-478b-bcf9-a79b256c37c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8b9e2f75-d07e-428d-855e-1ce09668bfd0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66e75839-84ac-478b-bcf9-a79b256c37c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_60aa0a61-015c-4388-918a-3989849ab1af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66e75839-84ac-478b-bcf9-a79b256c37c1" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_60aa0a61-015c-4388-918a-3989849ab1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_e2983602-505b-4134-bd0a-d170870f7a18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_60aa0a61-015c-4388-918a-3989849ab1af" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_e2983602-505b-4134-bd0a-d170870f7a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8233f2ab-fe27-4cf0-927d-ae3cf0649b17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_e2983602-505b-4134-bd0a-d170870f7a18" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8233f2ab-fe27-4cf0-927d-ae3cf0649b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b39f5208-8732-4c01-89bd-07a6da6e7400" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66e75839-84ac-478b-bcf9-a79b256c37c1" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b39f5208-8732-4c01-89bd-07a6da6e7400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7fd2174b-5f13-45ed-a49e-7171c855e634" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b39f5208-8732-4c01-89bd-07a6da6e7400" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7fd2174b-5f13-45ed-a49e-7171c855e634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_b3ea70a0-49e5-4f3f-97d1-cc15d78ff92f" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_7fd2174b-5f13-45ed-a49e-7171c855e634" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_b3ea70a0-49e5-4f3f-97d1-cc15d78ff92f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_66e75839-84ac-478b-bcf9-a79b256c37c1" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_113ad605-7c5b-4d92-a502-6b7a14ee66f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_113ad605-7c5b-4d92-a502-6b7a14ee66f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_08bf4969-42ae-42ca-be55-5d06497bded5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_08bf4969-42ae-42ca-be55-5d06497bded5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_54780005-b7d5-4d28-8dba-586dccefc17c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets_54780005-b7d5-4d28-8dba-586dccefc17c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_cdc80189-112f-4899-a696-a58073bd9713" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_cdc80189-112f-4899-a696-a58073bd9713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_a0d5f5a8-2a6f-4819-bb04-bdac286a1bd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_a0d5f5a8-2a6f-4819-bb04-bdac286a1bd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_cc53f92b-6070-468a-bc63-15b8e51e373c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets_cc53f92b-6070-468a-bc63-15b8e51e373c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_01482c44-fb2e-481a-9e45-c21ea72a8883" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation_01482c44-fb2e-481a-9e45-c21ea72a8883" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_0273ffd2-93c1-4a38-9f4c-bffff85528a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_0273ffd2-93c1-4a38-9f4c-bffff85528a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_dc8886da-4c69-4b86-9730-636bcfb77506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities_dc8886da-4c69-4b86-9730-636bcfb77506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_53319f74-6a63-42f6-a1b8-d2dab4a1a1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_53319f74-6a63-42f6-a1b8-d2dab4a1a1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_03aff303-9b61-49da-af75-ab4a4d01c791" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_fdfc0aac-acaf-4160-80eb-7066a89f4a50" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest_03aff303-9b61-49da-af75-ab4a4d01c791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_96cd9f01-0ce8-48c6-a72f-9ae129768789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fd23d7d-3729-4d6e-9240-e61b4c66600a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_96cd9f01-0ce8-48c6-a72f-9ae129768789" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fd23d7d-3729-4d6e-9240-e61b4c66600a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5a65cb68-514d-45ce-9527-0afeb1f97401" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fd23d7d-3729-4d6e-9240-e61b4c66600a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5a65cb68-514d-45ce-9527-0afeb1f97401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c374fa01-eebf-4111-8952-57a828fa501d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5a65cb68-514d-45ce-9527-0afeb1f97401" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c374fa01-eebf-4111-8952-57a828fa501d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_60bbddd0-b4eb-46d9-a232-8db2bd7a238a" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c374fa01-eebf-4111-8952-57a828fa501d" xlink:to="loc_hum_KindredAtHomeMember_60bbddd0-b4eb-46d9-a232-8db2bd7a238a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_3fd23d7d-3729-4d6e-9240-e61b4c66600a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_02862329-00b6-4cee-bb3f-ead9adc6238c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_02862329-00b6-4cee-bb3f-ead9adc6238c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ad66cf46-a9ca-4c56-a540-f10cef1b9c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_ad66cf46-a9ca-4c56-a540-f10cef1b9c0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_1abc8ce4-9d54-4911-8a20-6495f41ca9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_1abc8ce4-9d54-4911-8a20-6495f41ca9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2483d1db-238a-4db0-84e2-5a043858ff87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_2483d1db-238a-4db0-84e2-5a043858ff87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_60e7354b-ac8b-4b4b-8457-0949d8f74880" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_Goodwill_60e7354b-ac8b-4b4b-8457-0949d8f74880" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d32071bd-3da9-4314-98fe-cfcb6ddd4506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_d32071bd-3da9-4314-98fe-cfcb6ddd4506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bba104ba-9567-495c-8319-18bfae5fc174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_bba104ba-9567-495c-8319-18bfae5fc174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_0a1fec92-548f-4117-b25e-4f8b41d27ff3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_0a1fec92-548f-4117-b25e-4f8b41d27ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0617b97c-97b7-4505-beca-776198dbae4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_0617b97c-97b7-4505-beca-776198dbae4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_744fc90e-afdf-48f6-808b-67dbe3249929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt_744fc90e-afdf-48f6-808b-67dbe3249929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_17d57622-24e5-4db0-a8be-2bf8382e4b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther_17d57622-24e5-4db0-a8be-2bf8382e4b6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b3dd9fd4-5451-4ef3-9289-9690b15d85e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_b3dd9fd4-5451-4ef3-9289-9690b15d85e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_a5f6fa68-e110-4125-bb8c-e768f208d637" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_a5f6fa68-e110-4125-bb8c-e768f208d637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_d5eab0e6-bd02-4806-8f95-827f50455ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7cb4f0d4-f763-404f-8d10-a54fa8ac65e2" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_d5eab0e6-bd02-4806-8f95-827f50455ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EQUITYMETHODINVESTMENTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d5b1207a-166a-45ae-807b-509c7c71dc78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_d5b1207a-166a-45ae-807b-509c7c71dc78" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d884a459-4a84-4e49-bc75-4510335216da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d884a459-4a84-4e49-bc75-4510335216da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_7f2032b9-ce41-46af-a09f-86a50fb50198" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_d884a459-4a84-4e49-bc75-4510335216da" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_7f2032b9-ce41-46af-a09f-86a50fb50198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_b5ce3315-9f34-4593-8ca3-9c9f62c94166" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_7f2032b9-ce41-46af-a09f-86a50fb50198" xlink:to="loc_hum_KindredAtHomeMember_b5ce3315-9f34-4593-8ca3-9c9f62c94166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_36f88b59-cb97-4d0a-94c9-fa8536f2389a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:to="loc_srt_CounterpartyNameAxis_36f88b59-cb97-4d0a-94c9-fa8536f2389a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7a8b8a30-9de5-4e09-91f3-df37ae3a5874" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_36f88b59-cb97-4d0a-94c9-fa8536f2389a" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7a8b8a30-9de5-4e09-91f3-df37ae3a5874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_WelshCarsonAndersonAndStoweMember_9ef3378e-5549-4eed-93cc-ffaca84373ff" xlink:href="hum-20221231.xsd#hum_WelshCarsonAndersonAndStoweMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7a8b8a30-9de5-4e09-91f3-df37ae3a5874" xlink:to="loc_hum_WelshCarsonAndersonAndStoweMember_9ef3378e-5549-4eed-93cc-ffaca84373ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b227e77f-decf-4856-8468-41daf983a158" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b227e77f-decf-4856-8468-41daf983a158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_810211e7-aaf7-43d6-b7fb-44b431089928" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b227e77f-decf-4856-8468-41daf983a158" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_810211e7-aaf7-43d6-b7fb-44b431089928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_77d2b697-4536-460b-9817-2fb3486062bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_810211e7-aaf7-43d6-b7fb-44b431089928" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_77d2b697-4536-460b-9817-2fb3486062bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_585c2a70-400d-4a55-b50f-f0e3db7e683c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_585c2a70-400d-4a55-b50f-f0e3db7e683c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_be08c0f5-cdd3-4f72-8d7d-78ef4fff254c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_585c2a70-400d-4a55-b50f-f0e3db7e683c" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_be08c0f5-cdd3-4f72-8d7d-78ef4fff254c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_54c0d207-1407-4685-b2a4-08ba03d2b525" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_be08c0f5-cdd3-4f72-8d7d-78ef4fff254c" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_54c0d207-1407-4685-b2a4-08ba03d2b525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e8e26d07-4978-48c9-b761-63bb53602dda" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_39e1897f-138e-44f0-901b-893c4af9569a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_39e1897f-138e-44f0-901b-893c4af9569a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_5f9a74c7-7765-41e9-99d6-72933d55396e" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_5f9a74c7-7765-41e9-99d6-72933d55396e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters_2aa981f5-99c4-42a4-9fcd-10e445cfd164" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters_2aa981f5-99c4-42a4-9fcd-10e445cfd164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened_b14f899c-1f2b-4f75-a92e-c4cba53a619d" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened_b14f899c-1f2b-4f75-a92e-c4cba53a619d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum_8e23482b-9b7a-4946-91b6-0ee12026ee99" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum_8e23482b-9b7a-4946-91b6-0ee12026ee99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum_0dac08e4-28b5-4278-a76e-04c07492be41" xlink:href="hum-20221231.xsd#hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_a3a897c6-a30f-466d-afa1-489b72c9e546" xlink:to="loc_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum_0dac08e4-28b5-4278-a76e-04c07492be41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_7d2a08e8-9fae-4c34-a469-db69c7d214cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_099b821a-6df4-4bfb-a1a6-a1dde2c03838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_7d2a08e8-9fae-4c34-a469-db69c7d214cf" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_099b821a-6df4-4bfb-a1a6-a1dde2c03838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f58ae83e-f559-4cd0-926e-64d58c5dd382" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_099b821a-6df4-4bfb-a1a6-a1dde2c03838" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f58ae83e-f559-4cd0-926e-64d58c5dd382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_a68012e2-dfa5-4722-b196-0933919b6033" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis_f58ae83e-f559-4cd0-926e-64d58c5dd382" xlink:to="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_a68012e2-dfa5-4722-b196-0933919b6033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_b12168ad-6ecd-4434-bc10-4827148bb015" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain_a68012e2-dfa5-4722-b196-0933919b6033" xlink:to="loc_hum_KindredAtHomeMember_b12168ad-6ecd-4434-bc10-4827148bb015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7fd07357-50b2-4919-9950-1b5a89751243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_099b821a-6df4-4bfb-a1a6-a1dde2c03838" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7fd07357-50b2-4919-9950-1b5a89751243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7fd07357-50b2-4919-9950-1b5a89751243" xlink:to="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_88195495-f8f9-4836-b778-ec525349d427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_AssetsCurrent_88195495-f8f9-4836-b778-ec525349d427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrent_3957e1a8-a4d2-4278-8a4a-21c3c288ed2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_AssetsNoncurrent_3957e1a8-a4d2-4278-8a4a-21c3c288ed2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ed32f9d3-be5e-46df-bfb7-6bb775c44ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_LiabilitiesCurrent_ed32f9d3-be5e-46df-bfb7-6bb775c44ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_9307a5ec-bd6f-4efd-b4ca-512615acfa8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_9307a5ec-bd6f-4efd-b4ca-512615acfa8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6cbc9cf1-6dc0-4f5b-9872-a2f21d6b4ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_6b785a80-fc28-4ee9-942d-ec3455453d12" xlink:to="loc_us-gaap_StockholdersEquity_6cbc9cf1-6dc0-4f5b-9872-a2f21d6b4ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementRelatedDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_7fd07357-50b2-4919-9950-1b5a89751243" xlink:to="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_973acd62-2ff9-4089-b3fd-9cea457ea1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:to="loc_us-gaap_Revenues_973acd62-2ff9-4089-b3fd-9cea457ea1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_Expenses_ddeac072-e8e8-4c91-9ee3-20b7004c77f9" xlink:href="hum-20221231.xsd#hum_Expenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:to="loc_hum_Expenses_ddeac072-e8e8-4c91-9ee3-20b7004c77f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c1713ba7-ea88-45e3-b37e-9ac8637cca9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementRelatedDisclosuresAbstract_f1272154-b7eb-4add-8ddf-290a434eda4d" xlink:to="loc_us-gaap_NetIncomeLoss_c1713ba7-ea88-45e3-b37e-9ac8637cca9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9d8cf390-e6f7-4989-9cc4-cccb8f900af0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bcd0f79-d577-47e7-ae11-063056bfa111" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_9d8cf390-e6f7-4989-9cc4-cccb8f900af0" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bcd0f79-d577-47e7-ae11-063056bfa111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4ed638a5-e0c4-43db-bc64-a34d469cc179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bcd0f79-d577-47e7-ae11-063056bfa111" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4ed638a5-e0c4-43db-bc64-a34d469cc179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4ed638a5-e0c4-43db-bc64-a34d469cc179" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_63a894e4-45af-44c1-8c34-651ddbb50ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_63a894e4-45af-44c1-8c34-651ddbb50ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_84bf08bf-623a-4c88-a0f1-06abcd935cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_84bf08bf-623a-4c88-a0f1-06abcd935cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_ee89b4e2-0d47-418e-aa19-63cd9080b2fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_ee89b4e2-0d47-418e-aa19-63cd9080b2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_8cee230d-3946-4db3-9677-626255dc2ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_8cee230d-3946-4db3-9677-626255dc2ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d07cf4b9-5da5-477c-bcbf-88484d608da5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_d07cf4b9-5da5-477c-bcbf-88484d608da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_fb5d975c-56ab-410e-88f6-dd5c3b6a35c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_fb5d975c-56ab-410e-88f6-dd5c3b6a35c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_bdf9738c-f653-46b2-a658-b1492135be7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_460e044f-240d-4b21-941b-d043f80b0dd4" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_bdf9738c-f653-46b2-a658-b1492135be7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_8bcd0f79-d577-47e7-ae11-063056bfa111" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a5c7c12-70a5-4d9a-b160-dc0ca9bd6a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4a5c7c12-70a5-4d9a-b160-dc0ca9bd6a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e223f7b5-e7c2-457a-a66c-160619dd3023" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_e223f7b5-e7c2-457a-a66c-160619dd3023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c5806edc-fdc8-4abf-a38d-330c96ec949f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c5806edc-fdc8-4abf-a38d-330c96ec949f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0371683a-79cb-4d06-bc1d-0341dcc1208a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract_053a6c46-2110-4a3f-b2be-611e8fe99b79" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0371683a-79cb-4d06-bc1d-0341dcc1208a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_f1cd38b6-66a6-4630-9eff-a8dc3f78dac6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_f1cd38b6-66a6-4630-9eff-a8dc3f78dac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Investments_4f9e85f6-63a7-4ec3-bae6-7ef18198cded" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Investments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_f2c527a3-a984-4e0f-a0c7-73c1e3a766f3" xlink:to="loc_us-gaap_Investments_4f9e85f6-63a7-4ec3-bae6-7ef18198cded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_20ac8f17-4dc2-4c63-9228-a5c15a201f46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_b14ccf05-493f-47aa-8209-d708e3e58ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_20ac8f17-4dc2-4c63-9228-a5c15a201f46" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_b14ccf05-493f-47aa-8209-d708e3e58ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1d091bbe-02c8-4855-9dd6-41422938a16b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_b14ccf05-493f-47aa-8209-d708e3e58ae3" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1d091bbe-02c8-4855-9dd6-41422938a16b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1d091bbe-02c8-4855-9dd6-41422938a16b" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_7de46032-d82e-4805-8d68-652b395e4d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_7de46032-d82e-4805-8d68-652b395e4d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_aea5f379-08f9-4910-b234-5a714e4294cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_aea5f379-08f9-4910-b234-5a714e4294cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_790753cf-7ca5-47ed-9b4a-982c0aa505e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_790753cf-7ca5-47ed-9b4a-982c0aa505e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6754ee48-1d0b-4235-ad1c-16203e251ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_6754ee48-1d0b-4235-ad1c-16203e251ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_9e032664-2b1e-4ecf-a840-69cf7f147ff9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_9e032664-2b1e-4ecf-a840-69cf7f147ff9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f19de214-1cb9-42fb-a2af-ceae0285faf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f19de214-1cb9-42fb-a2af-ceae0285faf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_dfc111e2-b8bd-43a5-a58a-135a614d83ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_6fa5f75b-f23a-4a61-9865-ededf7c1bb78" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_dfc111e2-b8bd-43a5-a58a-135a614d83ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_6b2293a3-f877-49b7-b1cf-9743d97d69cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable_b14ccf05-493f-47aa-8209-d708e3e58ae3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_6b2293a3-f877-49b7-b1cf-9743d97d69cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_6b2293a3-f877-49b7-b1cf-9743d97d69cd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_612d48c3-b606-45cd-96a5-93011303a8d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_612d48c3-b606-45cd-96a5-93011303a8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_06962852-138b-4ea0-8227-031d4095493d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_06962852-138b-4ea0-8227-031d4095493d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c47fbb5b-f812-465e-845b-fb751618397e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract_e401a88d-92be-4ae4-8c25-b2b76ff94a05" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition_c47fbb5b-f812-465e-845b-fb751618397e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract_6b2293a3-f877-49b7-b1cf-9743d97d69cd" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_2636e1cb-4bc4-4e35-bfaa-3580e5a72b96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_2636e1cb-4bc4-4e35-bfaa-3580e5a72b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_abf198e8-aa7e-468e-b363-7d13d728b3aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss_abf198e8-aa7e-468e-b363-7d13d728b3aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_59882d57-8dc7-4040-a5e6-e775d9417d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract_ac98d9fe-3ee3-448e-a123-44ab8cdf057c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss_59882d57-8dc7-4040-a5e6-e775d9417d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1b10b4a4-1750-43e3-9b1f-bc7c856e553f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1b10b4a4-1750-43e3-9b1f-bc7c856e553f" xlink:to="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_c75473dd-d50c-493f-bc42-d4d206cc8eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_c75473dd-d50c-493f-bc42-d4d206cc8eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a77ff797-f9bf-48cf-a83b-de175a1968a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_c75473dd-d50c-493f-bc42-d4d206cc8eb1" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a77ff797-f9bf-48cf-a83b-de175a1968a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_79073f0f-1488-43ad-9213-6bd7d1a67427" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_a77ff797-f9bf-48cf-a83b-de175a1968a4" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_79073f0f-1488-43ad-9213-6bd7d1a67427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c1ba868c-c944-445f-acb2-d3484b779940" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c1ba868c-c944-445f-acb2-d3484b779940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_99810810-0996-4b05-b4ac-dbf2a0c01f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c1ba868c-c944-445f-acb2-d3484b779940" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_99810810-0996-4b05-b4ac-dbf2a0c01f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_214c0a65-a778-428e-b381-07db65cf265c" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_99810810-0996-4b05-b4ac-dbf2a0c01f9a" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_214c0a65-a778-428e-b381-07db65cf265c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CreditRatingStandardPoorsAxis_add3cdf8-e8cd-4cb7-8ac6-ab67019813ff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CreditRatingStandardPoorsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:to="loc_srt_CreditRatingStandardPoorsAxis_add3cdf8-e8cd-4cb7-8ac6-ab67019813ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ExternalCreditRatingStandardPoorsMember_210f90ee-acde-4b27-804d-5e0b85d01c56" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ExternalCreditRatingStandardPoorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CreditRatingStandardPoorsAxis_add3cdf8-e8cd-4cb7-8ac6-ab67019813ff" xlink:to="loc_srt_ExternalCreditRatingStandardPoorsMember_210f90ee-acde-4b27-804d-5e0b85d01c56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StandardPoorsAAMinusRatingMember_d6636f7b-ffcf-4658-a738-5502b7447e1d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StandardPoorsAAMinusRatingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ExternalCreditRatingStandardPoorsMember_210f90ee-acde-4b27-804d-5e0b85d01c56" xlink:to="loc_srt_StandardPoorsAAMinusRatingMember_d6636f7b-ffcf-4658-a738-5502b7447e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancingReceivableRecordedInvestmentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable_c2ffb924-3ee8-4893-bd2c-fb3b3033b62a" xlink:to="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c0fe64f1-211a-486a-ab19-689564dc12e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_c0fe64f1-211a-486a-ab19-689564dc12e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34af7ac9-3789-4e38-be07-996ab4b4c8a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_34af7ac9-3789-4e38-be07-996ab4b4c8a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_ca316ad9-7ca5-4ab6-887c-3878c4ddea3a" xlink:href="hum-20221231.xsd#hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality_ca316ad9-7ca5-4ab6-887c-3878c4ddea3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_8488585f-6455-4262-b744-37044d63bc5c" xlink:href="hum-20221231.xsd#hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities_8488585f-6455-4262-b744-37044d63bc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0a44c785-3b0b-4c7a-b465-13401b5ab898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions_0a44c785-3b0b-4c7a-b465-13401b5ab898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_c9cc4f3f-7a9a-48b9-a58a-e8aea0a0269f" xlink:href="hum-20221231.xsd#hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableRecordedInvestmentLineItems_be79f434-ff1d-4c50-952c-1df3cb64dce3" xlink:to="loc_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions_c9cc4f3f-7a9a-48b9-a58a-e8aea0a0269f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ba77acd5-6301-470b-beb3-2cc66ac7f07a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtAndEquitySecuritiesRealizedGain_8cdbda23-3772-43bf-911e-272646b6e793" xlink:href="hum-20221231.xsd#hum_DebtAndEquitySecuritiesRealizedGain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ba77acd5-6301-470b-beb3-2cc66ac7f07a" xlink:to="loc_hum_DebtAndEquitySecuritiesRealizedGain_8cdbda23-3772-43bf-911e-272646b6e793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtAndEquitySecuritiesRealizedLoss_bda62f91-694e-4b72-91f0-324bcb80056f" xlink:href="hum-20221231.xsd#hum_DebtAndEquitySecuritiesRealizedLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ba77acd5-6301-470b-beb3-2cc66ac7f07a" xlink:to="loc_hum_DebtAndEquitySecuritiesRealizedLoss_bda62f91-694e-4b72-91f0-324bcb80056f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_2e975c1c-9586-42d4-be58-8a92427de02b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ba77acd5-6301-470b-beb3-2cc66ac7f07a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGain_2e975c1c-9586-42d4-be58-8a92427de02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_32e23107-85a6-4e49-b0f2-bf10052c14b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ba77acd5-6301-470b-beb3-2cc66ac7f07a" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedLoss_32e23107-85a6-4e49-b0f2-bf10052c14b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_94ce395a-9623-439c-9781-c38396ac9e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtAndEquitySecuritiesGainLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ba77acd5-6301-470b-beb3-2cc66ac7f07a" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesGainLoss_94ce395a-9623-439c-9781-c38396ac9e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1f1170cd-c63b-4a44-bd08-ddda13ac8ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiGainLoss_f941895a-9f60-4e78-ba37-78a7d1a9b526" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1f1170cd-c63b-4a44-bd08-ddda13ac8ee2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiGainLoss_f941895a-9f60-4e78-ba37-78a7d1a9b526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_7fc0ca1d-b403-4d92-9574-8f7b5ea7ebd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiRealizedGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1f1170cd-c63b-4a44-bd08-ddda13ac8ee2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiRealizedGainLoss_7fc0ca1d-b403-4d92-9574-8f7b5ea7ebd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_71535bf7-58ab-4e6e-8e96-0a31f2758ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_1f1170cd-c63b-4a44-bd08-ddda13ac8ee2" xlink:to="loc_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss_71535bf7-58ab-4e6e-8e96-0a31f2758ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dd771fbe-6718-43a7-9d81-d4ef2daafae7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_8457a9ec-630e-4e0d-a55c-ecb64cecb91a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dd771fbe-6718-43a7-9d81-d4ef2daafae7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_8457a9ec-630e-4e0d-a55c-ecb64cecb91a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_57b57726-0fbc-47d6-92cf-39f1d7fe1435" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_8457a9ec-630e-4e0d-a55c-ecb64cecb91a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_57b57726-0fbc-47d6-92cf-39f1d7fe1435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_49fcd755-5658-4426-80aa-f6b1dfe77c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_8457a9ec-630e-4e0d-a55c-ecb64cecb91a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_49fcd755-5658-4426-80aa-f6b1dfe77c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_09810376-721a-4671-b9ee-2535a8c4ab5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_8457a9ec-630e-4e0d-a55c-ecb64cecb91a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_09810376-721a-4671-b9ee-2535a8c4ab5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_36056eb4-9581-4917-ad96-49f76788f938" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_8457a9ec-630e-4e0d-a55c-ecb64cecb91a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost_36056eb4-9581-4917-ad96-49f76788f938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_57cf7ab8-fa6e-432f-add7-3bd3d5137917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_8457a9ec-630e-4e0d-a55c-ecb64cecb91a" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost_57cf7ab8-fa6e-432f-add7-3bd3d5137917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_168da4ef-e038-4380-88ea-adfab38c72a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract_8457a9ec-630e-4e0d-a55c-ecb64cecb91a" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_168da4ef-e038-4380-88ea-adfab38c72a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_4dcfe103-4030-4655-bc92-0a860c7ca3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_dd771fbe-6718-43a7-9d81-d4ef2daafae7" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_4dcfe103-4030-4655-bc92-0a860c7ca3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_b57fe376-0c90-4a0b-a3b8-291d1586d4c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_4dcfe103-4030-4655-bc92-0a860c7ca3e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_b57fe376-0c90-4a0b-a3b8-291d1586d4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_9ad74e8e-47a4-42d5-bcc8-8ee8491ec7e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_4dcfe103-4030-4655-bc92-0a860c7ca3e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_9ad74e8e-47a4-42d5-bcc8-8ee8491ec7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0e4148d7-adc4-45f9-ba9f-5279a9c0562a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_4dcfe103-4030-4655-bc92-0a860c7ca3e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_0e4148d7-adc4-45f9-ba9f-5279a9c0562a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_2a8db7a8-9d27-4bc0-b588-8d59c48e051d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_4dcfe103-4030-4655-bc92-0a860c7ca3e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue_2a8db7a8-9d27-4bc0-b588-8d59c48e051d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3308e3e7-3e13-4cda-a6b1-63c2d2d83fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_4dcfe103-4030-4655-bc92-0a860c7ca3e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue_3308e3e7-3e13-4cda-a6b1-63c2d2d83fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b911e65-8cdc-4b20-a162-2ef3903b7a60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_4dcfe103-4030-4655-bc92-0a860c7ca3e0" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_5b911e65-8cdc-4b20-a162-2ef3903b7a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_68d25ee2-9d7e-4844-93fd-e2b2e98a124d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_68d25ee2-9d7e-4844-93fd-e2b2e98a124d" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f0fadd38-91af-41b2-b684-71c4c0a13c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f0fadd38-91af-41b2-b684-71c4c0a13c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb0730ea-687b-451a-8036-afeed9fa28c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_f0fadd38-91af-41b2-b684-71c4c0a13c06" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb0730ea-687b-451a-8036-afeed9fa28c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_a6288ed7-a5b3-4a41-8e4c-bc8d667c8822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_fb0730ea-687b-451a-8036-afeed9fa28c5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_a6288ed7-a5b3-4a41-8e4c-bc8d667c8822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ff5dec6-2d67-48e2-bdc4-9f5e0e2a306a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ff5dec6-2d67-48e2-bdc4-9f5e0e2a306a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_5ff5dec6-2d67-48e2-bdc4-9f5e0e2a306a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_b0965982-902d-44ff-beb8-377bab3b5d30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_b0965982-902d-44ff-beb8-377bab3b5d30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_00f0203a-3837-4332-ad34-55dcad28bd23" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_00f0203a-3837-4332-ad34-55dcad28bd23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_4387b52b-fdfc-4b11-a5bd-b9f439738cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_94384bfa-6c47-4693-b6d2-5da87e52f531" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_4387b52b-fdfc-4b11-a5bd-b9f439738cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7811d9c8-ded4-48ff-9011-72a737b5b2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7811d9c8-ded4-48ff-9011-72a737b5b2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7811d9c8-ded4-48ff-9011-72a737b5b2ed" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_28b78a79-d470-4d48-a416-ceb2d483c73b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_28b78a79-d470-4d48-a416-ceb2d483c73b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_e49e3032-6405-4649-b74a-ad1ecd57b16c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember_e49e3032-6405-4649-b74a-ad1ecd57b16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NontaxableMunicipalNotesMember_5436e1de-9bb6-48aa-98dc-7bf77c36c542" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NontaxableMunicipalNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_NontaxableMunicipalNotesMember_5436e1de-9bb6-48aa-98dc-7bf77c36c542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_fbf338ed-bca6-416d-a725-aea880ce967a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResidentialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_ResidentialMortgageBackedSecuritiesMember_fbf338ed-bca6-416d-a725-aea880ce967a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_4455857f-a30a-4714-951f-5a7fb5315268" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialMortgageBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_CommercialMortgageBackedSecuritiesMember_4455857f-a30a-4714-951f-5a7fb5315268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_747103cf-d15e-4acf-8857-814afbf2e808" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_747103cf-d15e-4acf-8857-814afbf2e808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_cb8ccb57-6a07-433c-8ef6-ba530fb7cf42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_fcecd8a8-5d54-4638-85f4-7e34ec771daa" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_cb8ccb57-6a07-433c-8ef6-ba530fb7cf42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a35e880a-f02b-4505-b712-3de9a2dc8a05" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e5342848-e5fc-4fcb-b14b-19b32fd747a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_e5342848-e5fc-4fcb-b14b-19b32fd747a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6fd2608b-0e70-4d73-8888-38e66163137a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6fd2608b-0e70-4d73-8888-38e66163137a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_ad5ed97d-3196-4e30-b9fd-acb9733bfe5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_ad5ed97d-3196-4e30-b9fd-acb9733bfe5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_f43f268e-49bf-4e63-b435-bd49e084f4d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_155b1608-6516-40f4-ad3e-c2a803a75043" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_f43f268e-49bf-4e63-b435-bd49e084f4d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUENarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_86fc743a-6781-4725-a02a-11a005a21a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_86fc743a-6781-4725-a02a-11a005a21a7a" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_1d356023-8910-4319-af06-e0c79837ec2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_1d356023-8910-4319-af06-e0c79837ec2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e07877d5-8eb5-486a-9133-b59277c7d4c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_1d356023-8910-4319-af06-e0c79837ec2e" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e07877d5-8eb5-486a-9133-b59277c7d4c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363d60b0-953c-4ede-8923-09e4ba242095" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_e07877d5-8eb5-486a-9133-b59277c7d4c7" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363d60b0-953c-4ede-8923-09e4ba242095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_38d9d7d6-7a85-4e71-9cd6-7e7fbbd37cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363d60b0-953c-4ede-8923-09e4ba242095" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_38d9d7d6-7a85-4e71-9cd6-7e7fbbd37cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7a49d5ce-5c9f-4b7a-b751-0df6475c0cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_363d60b0-953c-4ede-8923-09e4ba242095" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_7a49d5ce-5c9f-4b7a-b751-0df6475c0cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_21a431dc-e9c1-4b6d-af21-b90affd50b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_21a431dc-e9c1-4b6d-af21-b90affd50b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_3997545a-10c4-40ef-94a5-bf4e58e0647b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_21a431dc-e9c1-4b6d-af21-b90affd50b16" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_3997545a-10c4-40ef-94a5-bf4e58e0647b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanAndCommercialPaperMember_c99b3834-1998-44b6-876f-18c0fee7dbab" xlink:href="hum-20221231.xsd#hum_TermLoanAndCommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_3997545a-10c4-40ef-94a5-bf4e58e0647b" xlink:to="loc_hum_TermLoanAndCommercialPaperMember_c99b3834-1998-44b6-876f-18c0fee7dbab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_87ec1799-4d1c-48c3-8b35-6d73ca5fbcdf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_87ec1799-4d1c-48c3-8b35-6d73ca5fbcdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811fbb6d-cc72-4f0b-acca-23eec07c3875" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_87ec1799-4d1c-48c3-8b35-6d73ca5fbcdf" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811fbb6d-cc72-4f0b-acca-23eec07c3875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_8b79f007-f0cd-4844-85ac-62636d1a7c3f" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_811fbb6d-cc72-4f0b-acca-23eec07c3875" xlink:to="loc_hum_KindredAtHomeMember_8b79f007-f0cd-4844-85ac-62636d1a7c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_2fdfa97c-2450-436a-98fe-cad8c4aa3508" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_2fdfa97c-2450-436a-98fe-cad8c4aa3508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c630bf21-33ef-4c4b-928b-6203a656e06b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_2fdfa97c-2450-436a-98fe-cad8c4aa3508" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c630bf21-33ef-4c4b-928b-6203a656e06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_98ac9fb4-5fc2-4b2c-9197-f58e5a98df26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c630bf21-33ef-4c4b-928b-6203a656e06b" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_98ac9fb4-5fc2-4b2c-9197-f58e5a98df26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentAssetsMember_3afd7de1-95c2-4a99-ac92-b8c2a5b84a65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c630bf21-33ef-4c4b-928b-6203a656e06b" xlink:to="loc_us-gaap_OtherNoncurrentAssetsMember_3afd7de1-95c2-4a99-ac92-b8c2a5b84a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_12440b8e-dbf9-47d8-b8f6-2e790349e4e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityEquityAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_12440b8e-dbf9-47d8-b8f6-2e790349e4e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_261b88f5-3e0d-4b1b-993b-6c287918bd84" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityEquityAxis_12440b8e-dbf9-47d8-b8f6-2e790349e4e1" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_261b88f5-3e0d-4b1b-993b-6c287918bd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_1bee5eab-da5f-4d2d-836c-86ede7470da9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PutOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_261b88f5-3e0d-4b1b-993b-6c287918bd84" xlink:to="loc_us-gaap_PutOptionMember_1bee5eab-da5f-4d2d-836c-86ede7470da9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CallOptionMember_223524a5-3a95-437e-836f-90967e4d7867" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CallOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_261b88f5-3e0d-4b1b-993b-6c287918bd84" xlink:to="loc_us-gaap_CallOptionMember_223524a5-3a95-437e-836f-90967e4d7867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_3df5fe4e-bbca-4316-91ed-21e9361ca052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_3df5fe4e-bbca-4316-91ed-21e9361ca052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6766fff2-c278-4161-9bd3-c767e7cdc234" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3df5fe4e-bbca-4316-91ed-21e9361ca052" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6766fff2-c278-4161-9bd3-c767e7cdc234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueRiskMember_37aa23a5-d70d-41a1-acf7-0374f252bbfd" xlink:href="hum-20221231.xsd#hum_FairValueRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_6766fff2-c278-4161-9bd3-c767e7cdc234" xlink:to="loc_hum_FairValueRiskMember_37aa23a5-d70d-41a1-acf7-0374f252bbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4046e2d-1f70-4a5e-a1a2-80da42acf86e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4046e2d-1f70-4a5e-a1a2-80da42acf86e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cffd708c-7f03-4a39-b2ce-7737648bf6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_e4046e2d-1f70-4a5e-a1a2-80da42acf86e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cffd708c-7f03-4a39-b2ce-7737648bf6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_53d35f7e-91a2-40f0-a010-09647a234c5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_cffd708c-7f03-4a39-b2ce-7737648bf6b9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_53d35f7e-91a2-40f0-a010-09647a234c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3efeedd3-dbe7-4edb-b390-ce6ac959f336" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3efeedd3-dbe7-4edb-b390-ce6ac959f336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e2d15d-347d-42f1-bdfd-eed86f160227" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3efeedd3-dbe7-4edb-b390-ce6ac959f336" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e2d15d-347d-42f1-bdfd-eed86f160227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsMember_395599ae-cb0a-4275-955f-bf0b9ff466f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_45e2d15d-347d-42f1-bdfd-eed86f160227" xlink:to="loc_us-gaap_InvestmentsMember_395599ae-cb0a-4275-955f-bf0b9ff466f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_5a0f447a-1691-471c-a166-fec6b2e50e76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_5a0f447a-1691-471c-a166-fec6b2e50e76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_2fb440ca-2884-44c0-9a9d-2349461dc5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_5a0f447a-1691-471c-a166-fec6b2e50e76" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_2fb440ca-2884-44c0-9a9d-2349461dc5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_845dbd3c-e21f-4475-ba04-aa36322dff61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_2fb440ca-2884-44c0-9a9d-2349461dc5b4" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_845dbd3c-e21f-4475-ba04-aa36322dff61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbec45cb-b556-4e84-aa3f-a566dd540f40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbec45cb-b556-4e84-aa3f-a566dd540f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_85a751c0-a288-4032-b85e-572be954abc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_bbec45cb-b556-4e84-aa3f-a566dd540f40" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_85a751c0-a288-4032-b85e-572be954abc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_ff2b3098-dbeb-4cab-b7c9-60ba6f721f52" xlink:href="hum-20221231.xsd#hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_85a751c0-a288-4032-b85e-572be954abc3" xlink:to="loc_hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember_ff2b3098-dbeb-4cab-b7c9-60ba6f721f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_66b8f4db-2321-425c-abb0-fa4c0105d419" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_cb9d33b0-315e-456b-a614-8b4db716e1b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_cb9d33b0-315e-456b-a614-8b4db716e1b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_6d714bd4-26f5-4035-93ab-1ca94a00b139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_6d714bd4-26f5-4035-93ab-1ca94a00b139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_878fb76e-f2b7-4618-a7be-c30be3398b57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_DebtInstrumentFairValue_878fb76e-f2b7-4618-a7be-c30be3398b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f2c1c50c-7a04-48cb-a033-cf3179c4f0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_ShortTermBorrowings_f2c1c50c-7a04-48cb-a033-cf3179c4f0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage_08cf4d08-59ba-421b-8451-f207ffe896d2" xlink:href="hum-20221231.xsd#hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage_08cf4d08-59ba-421b-8451-f207ffe896d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_ce04d943-8f57-4af5-aa0e-2363d50274b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialLiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_us-gaap_FinancialLiabilitiesFairValueDisclosure_ce04d943-8f57-4af5-aa0e-2363d50274b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FinancialAssetsFairValueDisclosure_c40e2fcf-0a60-42ea-b659-30006342b65f" xlink:href="hum-20221231.xsd#hum_FinancialAssetsFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_hum_FinancialAssetsFairValueDisclosure_c40e2fcf-0a60-42ea-b659-30006342b65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LossOnTerminationOfDerivatives_e9523f09-843f-4790-873e-318a6bd04cca" xlink:href="hum-20221231.xsd#hum_LossOnTerminationOfDerivatives"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_hum_LossOnTerminationOfDerivatives_e9523f09-843f-4790-873e-318a6bd04cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_20281894-4044-4098-970f-0d13468826a3" xlink:href="hum-20221231.xsd#hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_8446c742-206e-421e-b386-695c094d09d2" xlink:to="loc_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold_20281894-4044-4098-970f-0d13468826a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUESignificantUnobservableInputsLevel3Details"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ecd67aef-6ec8-47c9-a3c7-bf68ecc6de8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909ce7be-07db-4d36-a012-a4ad549a03b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ecd67aef-6ec8-47c9-a3c7-bf68ecc6de8a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909ce7be-07db-4d36-a012-a4ad549a03b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_e87fc191-a305-4b05-bd6d-b3576134102a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909ce7be-07db-4d36-a012-a4ad549a03b0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_e87fc191-a305-4b05-bd6d-b3576134102a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_8c586bd4-e95a-4f1d-bb19-e5d848057410" xlink:href="hum-20221231.xsd#hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909ce7be-07db-4d36-a012-a4ad549a03b0" xlink:to="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_8c586bd4-e95a-4f1d-bb19-e5d848057410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e987cdb5-1b6e-422a-bbf9-b4544daa2c52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_8c586bd4-e95a-4f1d-bb19-e5d848057410" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_e987cdb5-1b6e-422a-bbf9-b4544daa2c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_2a9146bc-0cfb-4ff6-91e9-d2e5263af313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract_8c586bd4-e95a-4f1d-bb19-e5d848057410" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss_2a9146bc-0cfb-4ff6-91e9-d2e5263af313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_37e7fdbb-bb00-411c-b003-783dafa118d9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909ce7be-07db-4d36-a012-a4ad549a03b0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_37e7fdbb-bb00-411c-b003-783dafa118d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_f15487e8-0c5b-491e-be75-81ba1f93b780" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909ce7be-07db-4d36-a012-a4ad549a03b0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_f15487e8-0c5b-491e-be75-81ba1f93b780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_c58653aa-4781-407c-935f-ce283a5b35b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909ce7be-07db-4d36-a012-a4ad549a03b0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements_c58653aa-4781-407c-935f-ce283a5b35b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_c4b7391a-07be-4ad9-9f72-2a8b0947ed1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_909ce7be-07db-4d36-a012-a4ad549a03b0" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_c4b7391a-07be-4ad9-9f72-2a8b0947ed1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0920887f-ad00-433b-b35b-5207d889f08f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0920887f-ad00-433b-b35b-5207d889f08f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_150cd5c1-1735-456d-b9ce-c41ddd004ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:to="loc_us-gaap_FinancialInstrumentAxis_150cd5c1-1735-456d-b9ce-c41ddd004ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24c38102-045c-48bf-9391-0c64019ff283" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_150cd5c1-1735-456d-b9ce-c41ddd004ce2" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24c38102-045c-48bf-9391-0c64019ff283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionOnSecuritiesMember_55cd4ae9-7831-487a-b286-0cc4007cdc41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OptionOnSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_24c38102-045c-48bf-9391-0c64019ff283" xlink:to="loc_us-gaap_OptionOnSecuritiesMember_55cd4ae9-7831-487a-b286-0cc4007cdc41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_023d6e00-edb2-477c-b367-479fb1d6be50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_023d6e00-edb2-477c-b367-479fb1d6be50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f37fe2b-3a4b-49ae-b779-20464d24a13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_023d6e00-edb2-477c-b367-479fb1d6be50" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f37fe2b-3a4b-49ae-b779-20464d24a13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_749e002b-5ca3-4353-9cbf-23f481e9ca58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6f37fe2b-3a4b-49ae-b779-20464d24a13f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_749e002b-5ca3-4353-9cbf-23f481e9ca58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_78b8d0ea-a675-4268-b53a-837afccd05a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_78b8d0ea-a675-4268-b53a-837afccd05a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_78b8d0ea-a675-4268-b53a-837afccd05a1" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputOptionVolatilityMember_2785f5f7-96be-4620-aef5-318d53b2f1b9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputOptionVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_us-gaap_MeasurementInputOptionVolatilityMember_2785f5f7-96be-4620-aef5-318d53b2f1b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditSpreadOptionMember_51fe40c3-995f-4b34-835e-e61fa31c869d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditSpreadOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_us-gaap_CreditSpreadOptionMember_51fe40c3-995f-4b34-835e-e61fa31c869d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevenueExitMultipleMember_64cd10f2-1a35-4d02-bf70-4684e758841a" xlink:href="hum-20221231.xsd#hum_RevenueExitMultipleMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_hum_RevenueExitMultipleMember_64cd10f2-1a35-4d02-bf70-4684e758841a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_b121f4a9-009e-40e9-a611-e08e1c8195b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_b121f4a9-009e-40e9-a611-e08e1c8195b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_2f76fdcb-cf33-4b59-9c2e-9c5f1dd2c8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MeasurementInputLongTermRevenueGrowthRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_878e9ba1-194d-4160-9826-91915790d39b" xlink:to="loc_us-gaap_MeasurementInputLongTermRevenueGrowthRateMember_2f76fdcb-cf33-4b59-9c2e-9c5f1dd2c8d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c7834236-3eab-4906-9a3e-5c9f64b1de73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:to="loc_srt_RangeAxis_c7834236-3eab-4906-9a3e-5c9f64b1de73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0e9e0f36-7e10-4a2d-b321-96733e7ff03a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c7834236-3eab-4906-9a3e-5c9f64b1de73" xlink:to="loc_srt_RangeMember_0e9e0f36-7e10-4a2d-b321-96733e7ff03a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7fabbffa-c433-45b3-b30e-130b160a09da" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0e9e0f36-7e10-4a2d-b321-96733e7ff03a" xlink:to="loc_srt_MinimumMember_7fabbffa-c433-45b3-b30e-130b160a09da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d78d82a6-425e-4c49-b0fc-ec7839e67f41" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_0e9e0f36-7e10-4a2d-b321-96733e7ff03a" xlink:to="loc_srt_MaximumMember_d78d82a6-425e-4c49-b0fc-ec7839e67f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85e0863e-e59d-4d06-b6a3-3ec872a3d1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_88c2243f-b49c-4cb1-bbf0-902693bdf99e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85e0863e-e59d-4d06-b6a3-3ec872a3d1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_dafc4efe-7a0a-420c-9e3e-b117a3da62ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeAssetLiabilityNetMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_85e0863e-e59d-4d06-b6a3-3ec872a3d1e4" xlink:to="loc_us-gaap_DerivativeAssetLiabilityNetMeasurementInput_dafc4efe-7a0a-420c-9e3e-b117a3da62ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#MEDICAREPARTDDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/MEDICAREPARTDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_f4b69c5e-49e5-42fa-8364-f624c7c50e13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9010009b-cd35-4568-9c0e-a671269e6dee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_f4b69c5e-49e5-42fa-8364-f624c7c50e13" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9010009b-cd35-4568-9c0e-a671269e6dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9b7c7a13-9c77-44e8-bf05-1fa0c265adf1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9010009b-cd35-4568-9c0e-a671269e6dee" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9b7c7a13-9c77-44e8-bf05-1fa0c265adf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c34e1c7f-6795-4d29-9a57-a4f45bb0cda2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9b7c7a13-9c77-44e8-bf05-1fa0c265adf1" xlink:to="loc_us-gaap_SegmentDomain_c34e1c7f-6795-4d29-9a57-a4f45bb0cda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RiskCorridorSettlementsMedicarePartDMember_32318f9e-d1af-4504-b2bf-a1fcafbb8782" xlink:href="hum-20221231.xsd#hum_RiskCorridorSettlementsMedicarePartDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c34e1c7f-6795-4d29-9a57-a4f45bb0cda2" xlink:to="loc_hum_RiskCorridorSettlementsMedicarePartDMember_32318f9e-d1af-4504-b2bf-a1fcafbb8782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CmsSubsidiesOrDiscountsMember_21c57cd5-381d-43bc-a901-abf3804c88b1" xlink:href="hum-20221231.xsd#hum_CmsSubsidiesOrDiscountsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c34e1c7f-6795-4d29-9a57-a4f45bb0cda2" xlink:to="loc_hum_CmsSubsidiesOrDiscountsMember_21c57cd5-381d-43bc-a901-abf3804c88b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9010009b-cd35-4568-9c0e-a671269e6dee" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_d4b6069b-f273-4329-9380-f7bae4eb1169" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_us-gaap_OtherAssetsCurrent_d4b6069b-f273-4329-9380-f7bae4eb1169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_209cf23b-ca24-45b6-8262-1b7209393313" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_209cf23b-ca24-45b6-8262-1b7209393313" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetCurrentLiabilityAsset_099f02f2-01ad-4768-8552-dbff4b04ef4a" xlink:href="hum-20221231.xsd#hum_NetCurrentLiabilityAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_hum_NetCurrentLiabilityAsset_099f02f2-01ad-4768-8552-dbff4b04ef4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_18b00505-4eb4-4504-bc64-710066205284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_18b00505-4eb4-4504-bc64-710066205284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_64998640-477d-4868-8126-60541a33adb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_64998640-477d-4868-8126-60541a33adb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetNoncurrentAssetLiability_dfe8f20c-09b3-4689-a5e8-dc3199098c01" xlink:href="hum-20221231.xsd#hum_NetNoncurrentAssetLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_hum_NetNoncurrentAssetLiability_dfe8f20c-09b3-4689-a5e8-dc3199098c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NetAssetLiability_5fa6ae5c-93b8-4ec5-aa3e-00996b3f2a81" xlink:href="hum-20221231.xsd#hum_NetAssetLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b81ffa34-1a05-4616-b61d-a9e045e3bd5c" xlink:to="loc_hum_NetAssetLiability_5fa6ae5c-93b8-4ec5-aa3e-00996b3f2a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5d57fa84-df9b-4604-bf75-039eec13fb7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8dbf55c4-b471-49a9-a25b-eed4484fbb83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_5d57fa84-df9b-4604-bf75-039eec13fb7f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8dbf55c4-b471-49a9-a25b-eed4484fbb83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10718070-3d47-487f-b020-54b12883372a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8dbf55c4-b471-49a9-a25b-eed4484fbb83" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10718070-3d47-487f-b020-54b12883372a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_10718070-3d47-487f-b020-54b12883372a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_5fee54c9-e512-4ac9-ba03-6d3063450e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:to="loc_us-gaap_LandMember_5fee54c9-e512-4ac9-ba03-6d3063450e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BuildingsAndLeaseholdImprovementsMember_c418514b-d755-4589-b7eb-f995d684ee47" xlink:href="hum-20221231.xsd#hum_BuildingsAndLeaseholdImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:to="loc_hum_BuildingsAndLeaseholdImprovementsMember_c418514b-d755-4589-b7eb-f995d684ee47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a6a18469-f1a5-4eea-88d7-7fa5ee05c154" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a6a18469-f1a5-4eea-88d7-7fa5ee05c154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_29d39618-382e-41ba-ace4-0a1e8eb2bccb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_eb403f3b-2ccb-48d0-9051-feda3ffb425b" xlink:to="loc_us-gaap_ComputerEquipmentMember_29d39618-382e-41ba-ace4-0a1e8eb2bccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8dbf55c4-b471-49a9-a25b-eed4484fbb83" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_00d9b94e-3732-4720-925f-beb110d185f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_00d9b94e-3732-4720-925f-beb110d185f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f5871069-682b-4778-a416-c68dcb6c0b09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f5871069-682b-4778-a416-c68dcb6c0b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f7653a49-b55f-430e-966c-d72d3c97a976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_21eed64a-4376-46e4-b127-bfd057e7a9a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f7653a49-b55f-430e-966c-d72d3c97a976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#PROPERTYANDEQUIPMENTNETNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_322ad5ee-a5fc-45d9-a757-6ae53a8f83de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_feebe1db-a873-439b-80ac-534aa25a652d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_322ad5ee-a5fc-45d9-a757-6ae53a8f83de" xlink:to="loc_us-gaap_Depreciation_feebe1db-a873-439b-80ac-534aa25a652d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_f8695984-9cfb-4294-9809-0ac1d52242be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_322ad5ee-a5fc-45d9-a757-6ae53a8f83de" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_f8695984-9cfb-4294-9809-0ac1d52242be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_15401cf2-4247-4d9d-957c-3dd975aa44f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_8e8d2f2c-1138-4892-8a67-8e70363b0de0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_15401cf2-4247-4d9d-957c-3dd975aa44f4" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_8e8d2f2c-1138-4892-8a67-8e70363b0de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9be2544b-20dd-4a25-827d-859808564a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8e8d2f2c-1138-4892-8a67-8e70363b0de0" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9be2544b-20dd-4a25-827d-859808564a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_4b24c693-2eb7-44ad-991d-b702f3e32faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9be2544b-20dd-4a25-827d-859808564a06" xlink:to="loc_us-gaap_SegmentDomain_4b24c693-2eb7-44ad-991d-b702f3e32faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember_ff2ad99d-eb1a-4dd1-930b-b28d2e9999e2" xlink:href="hum-20221231.xsd#hum_InsuranceSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4b24c693-2eb7-44ad-991d-b702f3e32faa" xlink:to="loc_hum_InsuranceSegmentMember_ff2ad99d-eb1a-4dd1-930b-b28d2e9999e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember_fc59f30d-0a1b-42e1-82f7-5e0ba562bc46" xlink:href="hum-20221231.xsd#hum_CenterWellSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_4b24c693-2eb7-44ad-991d-b702f3e32faa" xlink:to="loc_hum_CenterWellSegmentMember_fc59f30d-0a1b-42e1-82f7-5e0ba562bc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_3dc5aa80-6cc1-49a8-b8b9-45aef3b83f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_8e8d2f2c-1138-4892-8a67-8e70363b0de0" xlink:to="loc_us-gaap_GoodwillLineItems_3dc5aa80-6cc1-49a8-b8b9-45aef3b83f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_3dc5aa80-6cc1-49a8-b8b9-45aef3b83f9b" xlink:to="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_754b7659-ffc3-4a8f-9a55-b2701f3f4bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:to="loc_us-gaap_Goodwill_754b7659-ffc3-4a8f-9a55-b2701f3f4bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_a28902bf-63b3-4607-849c-898820172012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_a28902bf-63b3-4607-849c-898820172012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_348dddeb-4d1e-44ae-a4bd-060a4f7adbe2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:to="loc_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit_348dddeb-4d1e-44ae-a4bd-060a4f7adbe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4200e569-06bb-471e-bdd8-bdca04074058" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_a5c5f6b0-97d9-4ad6-8fc2-f5dd24ca9b07" xlink:to="loc_us-gaap_Goodwill_4200e569-06bb-471e-bdd8-bdca04074058" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_70242a56-c442-4f05-ad1e-a2252483da6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e20aadad-f1b1-47df-b801-128497067dce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_70242a56-c442-4f05-ad1e-a2252483da6a" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e20aadad-f1b1-47df-b801-128497067dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3077f7c5-8940-439b-bfc1-7a3e635c1926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e20aadad-f1b1-47df-b801-128497067dce" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3077f7c5-8940-439b-bfc1-7a3e635c1926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3077f7c5-8940-439b-bfc1-7a3e635c1926" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CertificateOfNeedMember_d2ae5070-032d-469d-97e6-93ecde0ad231" xlink:href="hum-20221231.xsd#hum_CertificateOfNeedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_hum_CertificateOfNeedMember_d2ae5070-032d-469d-97e6-93ecde0ad231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_e6845403-6a88-4326-b995-dbea88f99975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_us-gaap_LicensingAgreementsMember_e6845403-6a88-4326-b995-dbea88f99975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerContractsMember_ac3c7fd3-5936-4c5f-a560-1a09576a5500" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_us-gaap_CustomerContractsMember_ac3c7fd3-5936-4c5f-a560-1a09576a5500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_1442759d-f5b7-4403-a9b5-db5728876ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_us-gaap_TradeNamesMember_1442759d-f5b7-4403-a9b5-db5728876ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_557ae4ec-900c-4876-9467-926a7a21a238" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_us-gaap_ContractualRightsMember_557ae4ec-900c-4876-9467-926a7a21a238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NoncompetesAndOtherMember_6aa0bffd-548d-4f54-8d8d-fa6b1f5c0870" xlink:href="hum-20221231.xsd#hum_NoncompetesAndOtherMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0a5a377-8739-4264-a24f-ae0b5a798403" xlink:to="loc_hum_NoncompetesAndOtherMember_6aa0bffd-548d-4f54-8d8d-fa6b1f5c0870" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b519f135-21e3-48cb-b5e1-8b5e01d8734b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_e20aadad-f1b1-47df-b801-128497067dce" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b519f135-21e3-48cb-b5e1-8b5e01d8734b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_b519f135-21e3-48cb-b5e1-8b5e01d8734b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_59ffee39-832d-44f6-911d-f54b8c42fc2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_59ffee39-832d-44f6-911d-f54b8c42fc2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_dc15de90-cd9d-44ed-955c-17e406997700" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_dc15de90-cd9d-44ed-955c-17e406997700" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3afbf594-d8a8-4542-b088-b9736f26df7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_3afbf594-d8a8-4542-b088-b9736f26df7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6ec39b6a-dae7-4890-923e-77bfebeea9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_6ec39b6a-dae7-4890-923e-77bfebeea9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_caa1fe65-9738-4c3c-9c7d-8571be5823c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_caa1fe65-9738-4c3c-9c7d-8571be5823c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_952c1f96-ee51-4cc9-8a6d-7b9417fadc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_952c1f96-ee51-4cc9-8a6d-7b9417fadc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5c2ebc05-719a-469f-9bdd-fb979a93e668" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_b45611b2-f9ad-4ff2-8b0a-8c42b7fde836" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5c2ebc05-719a-469f-9bdd-fb979a93e668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ff948496-a06a-42c6-9951-423ba700ee7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_749c2e30-2057-450f-92ee-462ae26deaeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ff948496-a06a-42c6-9951-423ba700ee7c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_749c2e30-2057-450f-92ee-462ae26deaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_53456d79-f39a-4845-8bb9-807a3e6650f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_2c94b97a-cc26-4021-b6ca-54ae2ee650d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_53456d79-f39a-4845-8bb9-807a3e6650f9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_2c94b97a-cc26-4021-b6ca-54ae2ee650d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b554506d-8421-46b9-8837-eeebfdef195e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_2c94b97a-cc26-4021-b6ca-54ae2ee650d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b554506d-8421-46b9-8837-eeebfdef195e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9cd38443-2498-42a3-92d7-b1b73eb0345d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_2c94b97a-cc26-4021-b6ca-54ae2ee650d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9cd38443-2498-42a3-92d7-b1b73eb0345d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d52f4473-7dd5-4555-8c3f-d2a39376352e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_2c94b97a-cc26-4021-b6ca-54ae2ee650d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d52f4473-7dd5-4555-8c3f-d2a39376352e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e349e9ab-45ae-4b29-8c64-1b98a792da29" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_2c94b97a-cc26-4021-b6ca-54ae2ee650d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_e349e9ab-45ae-4b29-8c64-1b98a792da29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b9eb8ae7-78d3-4ee6-a531-9d14c7072db5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract_2c94b97a-cc26-4021-b6ca-54ae2ee650d8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b9eb8ae7-78d3-4ee6-a531-9d14c7072db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_bd9f1fb2-76ea-4e71-bf3b-f0c52506a0df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList_bd9f1fb2-76ea-4e71-bf3b-f0c52506a0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f39c889-5506-4a7f-b6f6-d9db42e13d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_2f39c889-5506-4a7f-b6f6-d9db42e13d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c3e514dc-ef0f-413e-816f-7992f8be98df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_c3e514dc-ef0f-413e-816f-7992f8be98df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_08bf7571-dd5c-4204-8269-1aa511f10049" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_08bf7571-dd5c-4204-8269-1aa511f10049" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d73831e7-9b57-463e-9416-d2905182be8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d73831e7-9b57-463e-9416-d2905182be8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c4cbb1a0-2f58-4a12-8029-4fb32fa60e4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c4cbb1a0-2f58-4a12-8029-4fb32fa60e4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f160522e-c61b-48b5-ac70-5aa9f77c80bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeaseCost_f160522e-c61b-48b5-ac70-5aa9f77c80bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_1bcca105-376d-405b-9f4b-2e6b09fd47dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_VariableLeaseCost_1bcca105-376d-405b-9f4b-2e6b09fd47dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_1117020b-8a11-417b-b22f-a5ff1fd15a81" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_SubleaseIncome_1117020b-8a11-417b-b22f-a5ff1fd15a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9adeb221-fa94-4d27-b7cc-f3e9b8325b02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_9adeb221-fa94-4d27-b7cc-f3e9b8325b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_aa942ea2-63bb-4c18-bf86-c77aa81a32e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_aa942ea2-63bb-4c18-bf86-c77aa81a32e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_57365cb6-095f-4fdd-a0cd-72779cf1160c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3e3d7526-287f-48b2-b1b7-890214d47fe5" xlink:to="loc_us-gaap_OperatingLeasePayments_57365cb6-095f-4fdd-a0cd-72779cf1160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#LEASESMaturityofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e7342cdf-03fb-4c9e-801f-ff966fe78ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e7342cdf-03fb-4c9e-801f-ff966fe78ca6" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b73bc05d-4158-46d8-83ac-8f4c61f37ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_b73bc05d-4158-46d8-83ac-8f4c61f37ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_97700a73-17ed-4e56-aa4f-e3a5480ebf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_97700a73-17ed-4e56-aa4f-e3a5480ebf1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2ea0253d-0092-4452-9c40-bbe9b4d34d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2ea0253d-0092-4452-9c40-bbe9b4d34d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f058a9a6-f13d-43c4-9127-2c847f3e63d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_f058a9a6-f13d-43c4-9127-2c847f3e63d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_5c3f841d-5fcc-4da6-a3cd-5e6574b42921" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_5c3f841d-5fcc-4da6-a3cd-5e6574b42921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_95739e07-ccac-435f-a591-2bf34718b2e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_95739e07-ccac-435f-a591-2bf34718b2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9cfc22ed-f301-4b2a-8c99-e2615acd4394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9cfc22ed-f301-4b2a-8c99-e2615acd4394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fbad4479-b92e-443d-9351-68510580af2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_fbad4479-b92e-443d-9351-68510580af2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f35bcc4c-c8eb-4ae3-9c32-cc29a028bf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_d53e13f6-43be-414c-a7d4-eb6e69b46728" xlink:to="loc_us-gaap_OperatingLeaseLiability_f35bcc4c-c8eb-4ae3-9c32-cc29a028bf3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="hum-20221231.xsd#LEASESMaturityofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#BENEFITSPAYABLEActivityinBenefitsPayableDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_0e98d79d-0877-4264-9231-e83e34d3a465" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_0e98d79d-0877-4264-9231-e83e34d3a465" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_43bca3f1-4624-4ca2-9700-4821e618875a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_43bca3f1-4624-4ca2-9700-4821e618875a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_686a9705-66fe-48fc-b6d6-d83dbf4afc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_686a9705-66fe-48fc-b6d6-d83dbf4afc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_4a1fefc7-59d1-42d1-b757-01abb0d29363" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet_4a1fefc7-59d1-42d1-b757-01abb0d29363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_6fee249f-3bc3-4992-9c2f-2856b7ae410e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions_6fee249f-3bc3-4992-9c2f-2856b7ae410e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ff986e29-1d7e-4d35-a05e-09eb85d3a5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ff986e29-1d7e-4d35-a05e-09eb85d3a5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_7dc0a092-21d4-4107-98f4-fa627e661a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ff986e29-1d7e-4d35-a05e-09eb85d3a5c6" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense_7dc0a092-21d4-4107-98f4-fa627e661a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_d0321a7e-3fa6-4030-951d-d6d525ba6c59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ff986e29-1d7e-4d35-a05e-09eb85d3a5c6" xlink:to="loc_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense_d0321a7e-3fa6-4030-951d-d6d525ba6c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_fb0b2d5c-4c1d-441d-ad3c-00f094b36b24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract_ff986e29-1d7e-4d35-a05e-09eb85d3a5c6" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1_fb0b2d5c-4c1d-441d-ad3c-00f094b36b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_32023b1b-81f1-4ab3-a503-47ffd15f352d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_32023b1b-81f1-4ab3-a503-47ffd15f352d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_296e3454-e5fc-4841-9a79-2b055a2a476c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_32023b1b-81f1-4ab3-a503-47ffd15f352d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1_296e3454-e5fc-4841-9a79-2b055a2a476c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_b5d266ea-355e-4e4f-9c9e-10450ac00ff7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_32023b1b-81f1-4ab3-a503-47ffd15f352d" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1_b5d266ea-355e-4e4f-9c9e-10450ac00ff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_77187eeb-61a1-408d-b814-1a6d68440ced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForLossesAndLossAdjustmentExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract_32023b1b-81f1-4ab3-a503-47ffd15f352d" xlink:to="loc_us-gaap_PaymentsForLossesAndLossAdjustmentExpense_77187eeb-61a1-408d-b814-1a6d68440ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_86644358-9b38-48b4-89db-bc58a5316471" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:to="loc_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments_86644358-9b38-48b4-89db-bc58a5316471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9426a740-5d63-418c-8e1e-9804370dec7f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract_4b26d917-845f-4384-8c10-f6a0ec140891" xlink:to="loc_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense_9426a740-5d63-418c-8e1e-9804370dec7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#BENEFITSPAYABLENarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_55491688-3113-40bb-b07e-65a3fe146d77" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_e4baf9de-0f36-4ebd-a073-9d153bbfee74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_55491688-3113-40bb-b07e-65a3fe146d77" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_e4baf9de-0f36-4ebd-a073-9d153bbfee74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_52d89e58-3840-42cb-9cc2-9bff18ebf9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_e4baf9de-0f36-4ebd-a073-9d153bbfee74" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_52d89e58-3840-42cb-9cc2-9bff18ebf9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_52d89e58-3840-42cb-9cc2-9bff18ebf9cb" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_945b472e-20f2-4fca-aced-07a74d461b59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_945b472e-20f2-4fca-aced-07a74d461b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_f132485d-a160-4fc5-b5d5-2d9d03772517" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_f132485d-a160-4fc5-b5d5-2d9d03772517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_6ed9f558-7d78-4f7e-96b9-835d3b824207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_0d7d40e1-23fa-47a2-852e-6664f8a42a68" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_6ed9f558-7d78-4f7e-96b9-835d3b824207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_e4baf9de-0f36-4ebd-a073-9d153bbfee74" xlink:to="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_20682187-bd93-4a49-b7a9-63376183c0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:to="loc_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount_20682187-bd93-4a49-b7a9-63376183c0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported_d4510be9-9b47-4256-86f7-0c7b9c474f32" xlink:href="hum-20221231.xsd#hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:to="loc_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported_d4510be9-9b47-4256-86f7-0c7b9c474f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears_894253b4-67aa-4040-9ad7-8a3c21e2c24d" xlink:href="hum-20221231.xsd#hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_6a669cd1-fec7-4d4d-ad4a-914f9cadc68f" xlink:to="loc_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears_894253b4-67aa-4040-9ad7-8a3c21e2c24d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_c6d02773-63c2-4cee-9182-cb3dd48a3f61" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_3891fe5a-f994-4e79-a6b8-150f3f7f3e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_c6d02773-63c2-4cee-9182-cb3dd48a3f61" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_3891fe5a-f994-4e79-a6b8-150f3f7f3e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_c3cbb834-765a-4899-abb5-ad8d5880250d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_3891fe5a-f994-4e79-a6b8-150f3f7f3e33" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_c3cbb834-765a-4899-abb5-ad8d5880250d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsAccidentYearDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis_c3cbb834-765a-4899-abb5-ad8d5880250d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1a45c660-5c7a-4a7d-ab98-bc23f36852a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2020Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2020Member_1a45c660-5c7a-4a7d-ab98-bc23f36852a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_63cb79c1-34c9-4ecb-a365-0cd68316cf8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2021Member_63cb79c1-34c9-4ecb-a365-0cd68316cf8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_bc59e3ca-e4cf-46f3-87db-6055b8e71404" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortDurationInsuranceContractAccidentYear2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsAccidentYearDomain_b43a7e56-4250-4564-948e-b5afa25ff55a" xlink:to="loc_us-gaap_ShortDurationInsuranceContractAccidentYear2022Member_bc59e3ca-e4cf-46f3-87db-6055b8e71404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClaimsDevelopmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable_3891fe5a-f994-4e79-a6b8-150f3f7f3e33" xlink:to="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_dacf1821-12ee-4dc6-bded-e5ea4c1dc148" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet_dacf1821-12ee-4dc6-bded-e5ea4c1dc148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c1cc7e6f-f5a4-4654-ae2e-40310ae137e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c1cc7e6f-f5a4-4654-ae2e-40310ae137e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c12981e8-3da0-41da-a051-57f8095b76bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClaimsDevelopmentLineItems_fded6b10-63e3-48f8-8019-0500351a807d" xlink:to="loc_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet_c12981e8-3da0-41da-a051-57f8095b76bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXESProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d7e9578e-bb95-4925-9f0e-45a1fd3316aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_517b8391-adee-45f6-927d-909eb98fe9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d7e9578e-bb95-4925-9f0e-45a1fd3316aa" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_517b8391-adee-45f6-927d-909eb98fe9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_14818db3-e05c-45ef-8961-efc40c7488c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d7e9578e-bb95-4925-9f0e-45a1fd3316aa" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_14818db3-e05c-45ef-8961-efc40c7488c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f28a34b1-2408-48b2-bf55-25ccc7f4292a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d7e9578e-bb95-4925-9f0e-45a1fd3316aa" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_f28a34b1-2408-48b2-bf55-25ccc7f4292a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_325027b6-0e09-40cf-9592-034122c05e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d7e9578e-bb95-4925-9f0e-45a1fd3316aa" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_325027b6-0e09-40cf-9592-034122c05e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_757295c7-8ea3-457e-b8ed-1d247d452693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d7e9578e-bb95-4925-9f0e-45a1fd3316aa" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_757295c7-8ea3-457e-b8ed-1d247d452693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c88f5fd4-2086-4787-901b-339226b2d869" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_c88f5fd4-2086-4787-901b-339226b2d869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_97962823-5b76-430e-b330-d99dcde37dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_97962823-5b76-430e-b330-d99dcde37dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_ecebc9f3-7e8c-4b9e-aa24-362f0af85364" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationTaxExemptIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxExemptIncome_ecebc9f3-7e8c-4b9e-aa24-362f0af85364" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_eba402ba-c702-4fb4-8c22-addd8592221f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_eba402ba-c702-4fb4-8c22-addd8592221f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain_a36863d1-2d1c-492e-a449-ae3654e54a77" xlink:href="hum-20221231.xsd#hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:to="loc_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain_a36863d1-2d1c-492e-a449-ae3654e54a77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_857adf2e-fa05-400c-9108-6244cb490d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationDispositionOfBusiness"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:to="loc_us-gaap_IncomeTaxReconciliationDispositionOfBusiness_857adf2e-fa05-400c-9108-6244cb490d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount_8cb0cfaa-4aca-46bf-a972-748a103994b1" xlink:href="hum-20221231.xsd#hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:to="loc_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount_8cb0cfaa-4aca-46bf-a972-748a103994b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f56f7ca9-5938-4d82-b3db-4befe1d4fda9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_f56f7ca9-5938-4d82-b3db-4befe1d4fda9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_77688fdf-e861-47f7-9acd-5e1b9d023784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_e6f859f3-0b23-4305-bb5c-b1d4a683a345" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_77688fdf-e861-47f7-9acd-5e1b9d023784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e3dd04c6-5a7c-42d7-861f-7616d9ae75e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_e3dd04c6-5a7c-42d7-861f-7616d9ae75e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_88dcd3b1-7a1d-4eab-a1b9-9bb1d3a59bff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits_88dcd3b1-7a1d-4eab-a1b9-9bb1d3a59bff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_b3737d26-a07e-4693-bac9-ced74d277125" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits_b3737d26-a07e-4693-bac9-ced74d277125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost_5584a1b1-6e43-457e-8bab-0b1e5cc2cd61" xlink:href="hum-20221231.xsd#hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost_5584a1b1-6e43-457e-8bab-0b1e5cc2cd61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DeferredTaxAssetJobsTaxCredit_7758bf77-8ccc-4395-853f-847c13157917" xlink:href="hum-20221231.xsd#hum_DeferredTaxAssetJobsTaxCredit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_hum_DeferredTaxAssetJobsTaxCredit_7758bf77-8ccc-4395-853f-847c13157917" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_aa994557-07d7-4deb-95ea-d9c3efd3e469" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_aa994557-07d7-4deb-95ea-d9c3efd3e469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_bb4db668-74af-4f81-a31c-9338edd4f0bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve_bb4db668-74af-4f81-a31c-9338edd4f0bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInvestments_dc17fd48-204e-420c-b398-519a4fd99629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxAssetsInvestments_dc17fd48-204e-420c-b398-519a4fd99629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_13db47b4-473d-4d38-910e-65ff3b6f36b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_13db47b4-473d-4d38-910e-65ff3b6f36b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_75d951ae-b08f-4fd0-8d3c-26dc9f115e41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_75d951ae-b08f-4fd0-8d3c-26dc9f115e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_313f6320-f099-4b49-a9a5-bdef6317d40f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_313f6320-f099-4b49-a9a5-bdef6317d40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets_128c5db1-3a03-4a15-8c35-c5666442810a" xlink:href="hum-20221231.xsd#hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets_128c5db1-3a03-4a15-8c35-c5666442810a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_a52417f7-ab85-4e20-84b2-9308be4d149d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_a52417f7-ab85-4e20-84b2-9308be4d149d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesInvestments_2e3df62a-459d-4cd0-afaf-bec9b9ae5f91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesInvestments_2e3df62a-459d-4cd0-afaf-bec9b9ae5f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_e5134021-7c28-4094-b264-bfb295083d44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_e5134021-7c28-4094-b264-bfb295083d44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_cb7b4ec6-9f9a-49f6-83b2-86e80ce86b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_cb7b4ec6-9f9a-49f6-83b2-86e80ce86b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_cf40c641-7fe3-40b9-a669-7fd804addfc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4b617072-5004-4d85-91f4-2d91cc46069e" xlink:to="loc_us-gaap_DeferredTaxLiabilities_cf40c641-7fe3-40b9-a669-7fd804addfc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fe7dd4f8-f760-4e29-b48b-52b3512c9605" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_3be081c4-af55-403a-86b7-9eb3081586ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fe7dd4f8-f760-4e29-b48b-52b3512c9605" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_3be081c4-af55-403a-86b7-9eb3081586ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_b74dec7d-1a5a-4e66-9b88-8b971f25f9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_3be081c4-af55-403a-86b7-9eb3081586ec" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_b74dec7d-1a5a-4e66-9b88-8b971f25f9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_144389fc-0c38-46c3-be86-69d4ed107391" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_b74dec7d-1a5a-4e66-9b88-8b971f25f9f6" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_144389fc-0c38-46c3-be86-69d4ed107391" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_4ad849be-a263-4af2-9ab4-dd0ee1def463" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_144389fc-0c38-46c3-be86-69d4ed107391" xlink:to="loc_us-gaap_DomesticCountryMember_4ad849be-a263-4af2-9ab4-dd0ee1def463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_5ab4fb32-133c-47d9-b367-802c46bb5421" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_144389fc-0c38-46c3-be86-69d4ed107391" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_5ab4fb32-133c-47d9-b367-802c46bb5421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_8724547e-5852-4868-b21b-16b07b12baa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_3be081c4-af55-403a-86b7-9eb3081586ec" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_8724547e-5852-4868-b21b-16b07b12baa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_6370dce5-d2b3-4219-ad2a-07a1cbb1a7ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_8724547e-5852-4868-b21b-16b07b12baa7" xlink:to="loc_us-gaap_OperatingLossCarryforwards_6370dce5-d2b3-4219-ad2a-07a1cbb1a7ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8776990b-bb28-4c34-8777-43c0260fdc94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_8724547e-5852-4868-b21b-16b07b12baa7" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_8776990b-bb28-4c34-8777-43c0260fdc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTDebtOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTDebtOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d9b28b79-50df-46d0-aeb1-3915dd8221f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d9b28b79-50df-46d0-aeb1-3915dd8221f0" xlink:to="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_d867a14b-bcb6-4bff-b50d-92c955a2492d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_d867a14b-bcb6-4bff-b50d-92c955a2492d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_d8bc777f-94b6-4cfc-93ca-d1013046318c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_d867a14b-bcb6-4bff-b50d-92c955a2492d" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_d8bc777f-94b6-4cfc-93ca-d1013046318c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_9f9e7dae-d5bb-42b5-b741-247be163a160" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_d8bc777f-94b6-4cfc-93ca-d1013046318c" xlink:to="loc_us-gaap_CommercialPaperMember_9f9e7dae-d5bb-42b5-b741-247be163a160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_26e13074-982b-4ebd-b7f6-f39d32a25022" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_26e13074-982b-4ebd-b7f6-f39d32a25022" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f07bda8e-2222-4a99-a8a9-0e6af0701acc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_26e13074-982b-4ebd-b7f6-f39d32a25022" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f07bda8e-2222-4a99-a8a9-0e6af0701acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_2169ced6-a91c-4ba7-af62-ada7018f3685" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f07bda8e-2222-4a99-a8a9-0e6af0701acc" xlink:to="loc_us-gaap_SeniorNotesMember_2169ced6-a91c-4ba7-af62-ada7018f3685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_c72fb18a-7231-4d78-a299-4c72fdffb99d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f07bda8e-2222-4a99-a8a9-0e6af0701acc" xlink:to="loc_us-gaap_LoansPayableMember_c72fb18a-7231-4d78-a299-4c72fdffb99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8a2d14bf-32c3-4fd9-9cf5-399f075c8240" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:to="loc_us-gaap_DebtInstrumentAxis_8a2d14bf-32c3-4fd9-9cf5-399f075c8240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8a2d14bf-32c3-4fd9-9cf5-399f075c8240" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A065PercentSeniorNotesDueAugust2023Member_e18c9632-4d54-4360-8142-3dd391e89d9a" xlink:href="hum-20221231.xsd#hum_A065PercentSeniorNotesDueAugust2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A065PercentSeniorNotesDueAugust2023Member_e18c9632-4d54-4360-8142-3dd391e89d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member_3b5f87d7-e43f-48b0-a474-82f2b1d351f4" xlink:href="hum-20221231.xsd#hum_A3.15PercentSeniorNotesDueDecember2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member_3b5f87d7-e43f-48b0-a474-82f2b1d351f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member_52da77f0-a5f2-41f6-96e3-7624aa2bc738" xlink:href="hum-20221231.xsd#hum_A2.90PercentSeniorNotesDueDecember2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member_52da77f0-a5f2-41f6-96e3-7624aa2bc738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_a07ae106-c1d2-48f1-9226-12547711b8ab" xlink:href="hum-20221231.xsd#hum_A3.85PercentSeniorNotesDueOctober2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A3.85PercentSeniorNotesDueOctober2024Member_a07ae106-c1d2-48f1-9226-12547711b8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A450PercentSeniorNotesDueApril2025Member_d6c21f0d-f9a2-4628-807e-f990afdf2be9" xlink:href="hum-20221231.xsd#hum_A450PercentSeniorNotesDueApril2025Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A450PercentSeniorNotesDueApril2025Member_d6c21f0d-f9a2-4628-807e-f990afdf2be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A135PercentSeniorNotesDueFebruary2027Member_f9e7449c-4e78-4b87-88af-3799332ac3a9" xlink:href="hum-20221231.xsd#hum_A135PercentSeniorNotesDueFebruary2027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A135PercentSeniorNotesDueFebruary2027Member_f9e7449c-4e78-4b87-88af-3799332ac3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member_ffbbeeaa-9353-4514-901d-472ea50833aa" xlink:href="hum-20221231.xsd#hum_A3.95PercentSeniorNotesDueMarch2027Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A3.95PercentSeniorNotesDueMarch2027Member_ffbbeeaa-9353-4514-901d-472ea50833aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A575PercentSeniorNotesDueMarch2028Member_69787142-8caf-44b8-857f-8088d65266af" xlink:href="hum-20221231.xsd#hum_A575PercentSeniorNotesDueMarch2028Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A575PercentSeniorNotesDueMarch2028Member_69787142-8caf-44b8-857f-8088d65266af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A370PercentSeniorNotesDueMarch2029Member_aa708b9e-7e32-4c2a-bd12-8f584f750dd5" xlink:href="hum-20221231.xsd#hum_A370PercentSeniorNotesDueMarch2029Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A370PercentSeniorNotesDueMarch2029Member_aa708b9e-7e32-4c2a-bd12-8f584f750dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A313PercentSeniorNotesDueAugust2029Member_3690ab5d-ce28-41b2-9c66-6ff062d4413b" xlink:href="hum-20221231.xsd#hum_A313PercentSeniorNotesDueAugust2029Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A313PercentSeniorNotesDueAugust2029Member_3690ab5d-ce28-41b2-9c66-6ff062d4413b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A488PercentSeniorNotesDueApril2030Member_5c5773d2-da96-4af1-8dd0-8c9509077932" xlink:href="hum-20221231.xsd#hum_A488PercentSeniorNotesDueApril2030Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A488PercentSeniorNotesDueApril2030Member_5c5773d2-da96-4af1-8dd0-8c9509077932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A215PercentSeniorNotesDueFebruary2032Member_884f8bde-36ac-4987-9fa7-217f6f62c9ba" xlink:href="hum-20221231.xsd#hum_A215PercentSeniorNotesDueFebruary2032Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A215PercentSeniorNotesDueFebruary2032Member_884f8bde-36ac-4987-9fa7-217f6f62c9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A588PercentSeniorNotesDueMarch2033Member_60c67792-4660-491d-aafa-27b68ce46386" xlink:href="hum-20221231.xsd#hum_A588PercentSeniorNotesDueMarch2033Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A588PercentSeniorNotesDueMarch2033Member_60c67792-4660-491d-aafa-27b68ce46386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_d86f0e22-3adb-45ee-ad9c-ad0967caf9b7" xlink:href="hum-20221231.xsd#hum_A8.15PercentSeniorNotesDueJune2038Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_d86f0e22-3adb-45ee-ad9c-ad0967caf9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A463PercentSeniorNotesDueDecember2042Member_36698d42-182a-402b-bb6d-6293ceb2d60a" xlink:href="hum-20221231.xsd#hum_A463PercentSeniorNotesDueDecember2042Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A463PercentSeniorNotesDueDecember2042Member_36698d42-182a-402b-bb6d-6293ceb2d60a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member_3bb7e96a-9e6a-40a0-9108-2e2f0fe12622" xlink:href="hum-20221231.xsd#hum_A4.95PercentSeniorNotesDueOctober2044Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A4.95PercentSeniorNotesDueOctober2044Member_3bb7e96a-9e6a-40a0-9108-2e2f0fe12622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member_4054186b-db7d-49d0-8e2a-33d5b04a1453" xlink:href="hum-20221231.xsd#hum_A4.80PercentSeniorNotesDueMarch2047Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A4.80PercentSeniorNotesDueMarch2047Member_4054186b-db7d-49d0-8e2a-33d5b04a1453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.95PercentSeniorNotesDueAugust2049Member_9cd5ec8b-c5ba-4130-bb3c-a9bc1e068f83" xlink:href="hum-20221231.xsd#hum_A3.95PercentSeniorNotesDueAugust2049Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_A3.95PercentSeniorNotesDueAugust2049Member_9cd5ec8b-c5ba-4130-bb3c-a9bc1e068f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TermLoanDueOctober2023Member_f6efb20c-1192-4e98-8baa-eb6c33a709ed" xlink:href="hum-20221231.xsd#hum_TermLoanDueOctober2023Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_TermLoanDueOctober2023Member_f6efb20c-1192-4e98-8baa-eb6c33a709ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMay2024Member_f79d5878-2e97-47e6-990a-3af5c75704ce" xlink:href="hum-20221231.xsd#hum_DelayedDrawTermLoanMay2024Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_92ac9c95-6b7c-44e3-bcce-27886ed53115" xlink:to="loc_hum_DelayedDrawTermLoanMay2024Member_f79d5878-2e97-47e6-990a-3af5c75704ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9959fa53-b28f-421d-8199-9ad5a326bf67" xlink:to="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_2d7eb83f-6c3e-4664-94ab-e609c2546858" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_2d7eb83f-6c3e-4664-94ab-e609c2546858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_17ef1cb1-8685-4267-9028-2770c59a115d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_17ef1cb1-8685-4267-9028-2770c59a115d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_a361f3be-c870-4af5-a994-12c43ff1bfb8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_ShortTermBorrowings_a361f3be-c870-4af5-a994-12c43ff1bfb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_16724973-161e-4b51-8464-3edb387ad8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_LongTermDebtCurrent_16724973-161e-4b51-8464-3edb387ad8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_2b00cedc-b749-49c1-b982-15f4fd379b66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_DebtCurrent_2b00cedc-b749-49c1-b982-15f4fd379b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_01adc5af-9bd0-41ad-81bd-d6a01b887b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_bf8f966f-2864-412c-857b-1880af214531" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_01adc5af-9bd0-41ad-81bd-d6a01b887b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTMaturitiesofDebtDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTMaturitiesofDebtDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTMaturitiesofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_171f9880-7e14-46c8-ae75-7709257efe17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtByMaturityAbstract_3f715ed5-b01c-422e-ba54-2dc1b5bb9ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtByMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_171f9880-7e14-46c8-ae75-7709257efe17" xlink:to="loc_us-gaap_LongTermDebtByMaturityAbstract_3f715ed5-b01c-422e-ba54-2dc1b5bb9ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5781c5ab-cd86-45e3-974c-3a0d30a1d5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3f715ed5-b01c-422e-ba54-2dc1b5bb9ea7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_5781c5ab-cd86-45e3-974c-3a0d30a1d5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3c072c75-ad62-4c3d-88dd-a1dcda4b8c63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3f715ed5-b01c-422e-ba54-2dc1b5bb9ea7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_3c072c75-ad62-4c3d-88dd-a1dcda4b8c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5747f36b-2834-4e39-8366-25e71efd23b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3f715ed5-b01c-422e-ba54-2dc1b5bb9ea7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_5747f36b-2834-4e39-8366-25e71efd23b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_85cf2687-adab-42b5-bde0-79d7a40c4ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3f715ed5-b01c-422e-ba54-2dc1b5bb9ea7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_85cf2687-adab-42b5-bde0-79d7a40c4ffd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_8758bc86-d07b-4b14-95d8-e2818c782c86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3f715ed5-b01c-422e-ba54-2dc1b5bb9ea7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_8758bc86-d07b-4b14-95d8-e2818c782c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d2286081-d6d9-4909-aae7-00d75080fa02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtByMaturityAbstract_3f715ed5-b01c-422e-ba54-2dc1b5bb9ea7" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_d2286081-d6d9-4909-aae7-00d75080fa02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTSeniorNotesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_450d1881-4c9f-456e-838e-39cc21e5d957" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_219be70e-7dcc-49ae-8a01-6666c4f816af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_450d1881-4c9f-456e-838e-39cc21e5d957" xlink:to="loc_us-gaap_DebtInstrumentTable_219be70e-7dcc-49ae-8a01-6666c4f816af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_445ad34b-f5ce-46fe-aeb3-3cdec5b80fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_219be70e-7dcc-49ae-8a01-6666c4f816af" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_445ad34b-f5ce-46fe-aeb3-3cdec5b80fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a16edf07-5004-4de7-a2e0-9fb7a54f89a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_445ad34b-f5ce-46fe-aeb3-3cdec5b80fef" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a16edf07-5004-4de7-a2e0-9fb7a54f89a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3919db2e-c57f-40fa-b10b-43c497802105" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a16edf07-5004-4de7-a2e0-9fb7a54f89a5" xlink:to="loc_us-gaap_SeniorNotesMember_3919db2e-c57f-40fa-b10b-43c497802105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_932fc710-f44d-4a4b-9f14-329983b6ec4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_219be70e-7dcc-49ae-8a01-6666c4f816af" xlink:to="loc_us-gaap_DebtInstrumentAxis_932fc710-f44d-4a4b-9f14-329983b6ec4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_932fc710-f44d-4a4b-9f14-329983b6ec4c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_dc1fe710-0f83-4dfe-abb4-97df64de0ed7" xlink:href="hum-20221231.xsd#hum_A8.15PercentSeniorNotesDueJune2038Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A8.15PercentSeniorNotesDueJune2038Member_dc1fe710-0f83-4dfe-abb4-97df64de0ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_21adbf43-3bab-4463-b1b7-3a9b6d775790" xlink:href="hum-20221231.xsd#hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_21adbf43-3bab-4463-b1b7-3a9b6d775790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5570PercentSeniorNotesDueMarch2028Member_d242d813-a67b-4f84-9fb7-27e53b8a6224" xlink:href="hum-20221231.xsd#hum_A5570PercentSeniorNotesDueMarch2028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_21adbf43-3bab-4463-b1b7-3a9b6d775790" xlink:to="loc_hum_A5570PercentSeniorNotesDueMarch2028Member_d242d813-a67b-4f84-9fb7-27e53b8a6224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A5875PercentSeniorNotesDueMarch2033Member_f7c43dad-6f8e-4d7d-b870-e5477ccf3666" xlink:href="hum-20221231.xsd#hum_A5875PercentSeniorNotesDueMarch2033Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member_21adbf43-3bab-4463-b1b7-3a9b6d775790" xlink:to="loc_hum_A5875PercentSeniorNotesDueMarch2033Member_f7c43dad-6f8e-4d7d-b870-e5477ccf3666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A370PercentSeniorNotesDueMarch2029Member_bbb5c8cb-1040-4f61-8e83-1bbe60225ddf" xlink:href="hum-20221231.xsd#hum_A370PercentSeniorNotesDueMarch2029Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A370PercentSeniorNotesDueMarch2029Member_bbb5c8cb-1040-4f61-8e83-1bbe60225ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member_459c940b-73ea-4529-a62f-6beddb361230" xlink:href="hum-20221231.xsd#hum_A3.15PercentSeniorNotesDueDecember2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A3.15PercentSeniorNotesDueDecember2022Member_459c940b-73ea-4529-a62f-6beddb361230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member_fb898675-59ec-4857-853a-03a864077c41" xlink:href="hum-20221231.xsd#hum_A2.90PercentSeniorNotesDueDecember2022Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d4f95688-128f-48b6-9657-1791cc6716b3" xlink:to="loc_hum_A2.90PercentSeniorNotesDueDecember2022Member_fb898675-59ec-4857-853a-03a864077c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_219be70e-7dcc-49ae-8a01-6666c4f816af" xlink:to="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_65710a5b-f83a-4226-84a2-be188e6f6984" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_65710a5b-f83a-4226-84a2-be188e6f6984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_de0803c7-8b37-444c-9a80-2fd8454b82b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_de0803c7-8b37-444c-9a80-2fd8454b82b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_f535d0bf-6838-475f-acc4-5d3ab95e82bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_RepaymentsOfDebt_f535d0bf-6838-475f-acc4-5d3ab95e82bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_31e7db75-81d3-436b-8c6b-d0eec82d525d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_31e7db75-81d3-436b-8c6b-d0eec82d525d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_7f57a164-f44b-4c94-961a-c146f5dd6cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_842958c5-5bd8-4e87-8e53-6ffd938ded31" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_7f57a164-f44b-4c94-961a-c146f5dd6cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTDelayedDrawTermLoanCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_b98f9fbe-1f57-453b-9b02-3c27df89660a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_b98f9fbe-1f57-453b-9b02-3c27df89660a" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a54a6215-b493-4d5f-a0b8-b18b8263c7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_us-gaap_DebtInstrumentAxis_a54a6215-b493-4d5f-a0b8-b18b8263c7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_243064eb-febc-411e-ac48-70aa0fe09f03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a54a6215-b493-4d5f-a0b8-b18b8263c7ee" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_243064eb-febc-411e-ac48-70aa0fe09f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DelayedDrawTermLoanMay2021Member_babd881b-1540-4b5b-96f7-3edfef81ee77" xlink:href="hum-20221231.xsd#hum_DelayedDrawTermLoanMay2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_243064eb-febc-411e-ac48-70aa0fe09f03" xlink:to="loc_hum_DelayedDrawTermLoanMay2021Member_babd881b-1540-4b5b-96f7-3edfef81ee77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_5dee0d1a-5536-4a50-a577-838e976b75de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_5dee0d1a-5536-4a50-a577-838e976b75de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_416a26b5-a0e3-4f76-a9a5-1158dd714eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_5dee0d1a-5536-4a50-a577-838e976b75de" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_416a26b5-a0e3-4f76-a9a5-1158dd714eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_b2cfa88f-c196-4286-9fa7-baa7ba48e5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_416a26b5-a0e3-4f76-a9a5-1158dd714eb3" xlink:to="loc_us-gaap_LoansPayableMember_b2cfa88f-c196-4286-9fa7-baa7ba48e5fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_e139eedc-5503-4d42-8775-428aedfb6fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_us-gaap_VariableRateAxis_e139eedc-5503-4d42-8775-428aedfb6fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1b21b665-7233-45cb-915e-3d467f510dd7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_e139eedc-5503-4d42-8775-428aedfb6fb0" xlink:to="loc_us-gaap_VariableRateDomain_1b21b665-7233-45cb-915e-3d467f510dd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_b42548c0-b805-4d6c-a316-4ccc41d24346" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_1b21b665-7233-45cb-915e-3d467f510dd7" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_b42548c0-b805-4d6c-a316-4ccc41d24346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6f61d7aa-0b59-4335-94fa-b6c5ffbee829" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_srt_RangeAxis_6f61d7aa-0b59-4335-94fa-b6c5ffbee829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_473a8ccd-c987-478c-8977-ba652994c406" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6f61d7aa-0b59-4335-94fa-b6c5ffbee829" xlink:to="loc_srt_RangeMember_473a8ccd-c987-478c-8977-ba652994c406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_70092311-9516-462c-b25d-375f0e070a87" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_473a8ccd-c987-478c-8977-ba652994c406" xlink:to="loc_srt_MinimumMember_70092311-9516-462c-b25d-375f0e070a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_5a13e570-ec73-47ab-8ff0-847b54ae3071" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_473a8ccd-c987-478c-8977-ba652994c406" xlink:to="loc_srt_MaximumMember_5a13e570-ec73-47ab-8ff0-847b54ae3071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_8a50da0d-034e-4bb8-9999-aa510f419f90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_8a50da0d-034e-4bb8-9999-aa510f419f90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31ad6b09-0104-4e8c-bdc8-195124bc170d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_8a50da0d-034e-4bb8-9999-aa510f419f90" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31ad6b09-0104-4e8c-bdc8-195124bc170d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_KindredAtHomeMember_b6f8e93d-2c50-47a3-b55e-2d1c04871461" xlink:href="hum-20221231.xsd#hum_KindredAtHomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_31ad6b09-0104-4e8c-bdc8-195124bc170d" xlink:to="loc_hum_KindredAtHomeMember_b6f8e93d-2c50-47a3-b55e-2d1c04871461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_5ea89ad6-0730-48f1-bf09-763507712ea4" xlink:to="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_659fc56e-4277-4950-8a16-0fbc9c28fcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_659fc56e-4277-4950-8a16-0fbc9c28fcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d4786975-ac59-42de-bd92-373730dbbb6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_d4786975-ac59-42de-bd92-373730dbbb6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_e0cb1d17-cf7f-4eb0-a8f2-ddd44ad9f85f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_e0cb1d17-cf7f-4eb0-a8f2-ddd44ad9f85f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_c5b1902b-c3b9-481e-9de9-6fd2f9c1aea4" xlink:href="hum-20221231.xsd#hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest_c5b1902b-c3b9-481e-9de9-6fd2f9c1aea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_8fcb4f7c-0f59-4195-b8ad-a15ee7967aa9" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_8fcb4f7c-0f59-4195-b8ad-a15ee7967aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_a86df8b3-4423-4f2b-9b8c-2d1f8e8cfd81" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_291731d0-9872-44c2-ae55-8546ae907e2e" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_a86df8b3-4423-4f2b-9b8c-2d1f8e8cfd81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTOctober2021TermLoanAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_514eb59a-f9ef-48d3-abf6-da17e194ca0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_883e0598-9380-48ea-89eb-7c825e98f4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_514eb59a-f9ef-48d3-abf6-da17e194ca0d" xlink:to="loc_us-gaap_DebtInstrumentTable_883e0598-9380-48ea-89eb-7c825e98f4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_db5a4d74-0de9-4d0c-ac8f-c927c8477e09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_883e0598-9380-48ea-89eb-7c825e98f4db" xlink:to="loc_us-gaap_DebtInstrumentAxis_db5a4d74-0de9-4d0c-ac8f-c927c8477e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a56970fa-ff5a-4b31-b09b-d37f8b85cdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_db5a4d74-0de9-4d0c-ac8f-c927c8477e09" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a56970fa-ff5a-4b31-b09b-d37f8b85cdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_October2021TermLoanAgreementMember_96e4bb8a-c9d0-4ecd-860b-5e36abb1b0e1" xlink:href="hum-20221231.xsd#hum_October2021TermLoanAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a56970fa-ff5a-4b31-b09b-d37f8b85cdcd" xlink:to="loc_hum_October2021TermLoanAgreementMember_96e4bb8a-c9d0-4ecd-860b-5e36abb1b0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GentivaTermLoanDue2025Member_a982deb6-afbe-43e6-b177-98f279da1810" xlink:href="hum-20221231.xsd#hum_GentivaTermLoanDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a56970fa-ff5a-4b31-b09b-d37f8b85cdcd" xlink:to="loc_hum_GentivaTermLoanDue2025Member_a982deb6-afbe-43e6-b177-98f279da1810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7e422bb4-37a9-418a-8d3c-41e26aa2c174" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_883e0598-9380-48ea-89eb-7c825e98f4db" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7e422bb4-37a9-418a-8d3c-41e26aa2c174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_100aad5e-43a2-494d-bc4b-ea28aaaa45ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7e422bb4-37a9-418a-8d3c-41e26aa2c174" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_100aad5e-43a2-494d-bc4b-ea28aaaa45ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_cee4a700-d5d7-41c1-8c48-3b2995b34bac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_100aad5e-43a2-494d-bc4b-ea28aaaa45ee" xlink:to="loc_us-gaap_LoansPayableMember_cee4a700-d5d7-41c1-8c48-3b2995b34bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_deefd730-7b14-4c29-b352-47ddf4b24350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_883e0598-9380-48ea-89eb-7c825e98f4db" xlink:to="loc_us-gaap_DebtInstrumentLineItems_deefd730-7b14-4c29-b352-47ddf4b24350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_cc26e9e4-a105-4243-b67d-80e993409d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deefd730-7b14-4c29-b352-47ddf4b24350" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_cc26e9e4-a105-4243-b67d-80e993409d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_b1488d0f-57b5-4285-acfd-959388bdd8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_deefd730-7b14-4c29-b352-47ddf4b24350" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_b1488d0f-57b5-4285-acfd-959388bdd8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTRevolvingCreditAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5e7a4d25-2262-4d05-930b-fd9c5a5b2aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5e7a4d25-2262-4d05-930b-fd9c5a5b2aa3" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b39bf071-eaa6-447a-864b-5436ab482e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_us-gaap_CreditFacilityAxis_b39bf071-eaa6-447a-864b-5436ab482e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5df74197-198b-4ee4-9393-c3a52eaa9fce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b39bf071-eaa6-447a-864b-5436ab482e6b" xlink:to="loc_us-gaap_CreditFacilityDomain_5df74197-198b-4ee4-9393-c3a52eaa9fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_4595482f-fe97-489e-9d0e-c26a98707114" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5df74197-198b-4ee4-9393-c3a52eaa9fce" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_4595482f-fe97-489e-9d0e-c26a98707114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_fcbc99d6-5ae6-4d64-92bf-0406f968cf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5df74197-198b-4ee4-9393-c3a52eaa9fce" xlink:to="loc_us-gaap_LetterOfCreditMember_fcbc99d6-5ae6-4d64-92bf-0406f968cf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e22508cc-085b-409f-9253-4418d01abc7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_us-gaap_DebtInstrumentAxis_e22508cc-085b-409f-9253-4418d01abc7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ca7e321c-4d94-4a44-912d-a65fb4bbe7db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e22508cc-085b-409f-9253-4418d01abc7a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ca7e321c-4d94-4a44-912d-a65fb4bbe7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember_c74d90bd-0bac-4e25-a5ca-3bdf9c78b1d4" xlink:href="hum-20221231.xsd#hum_RevolvingCreditAgreementJune2021FiveYearMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ca7e321c-4d94-4a44-912d-a65fb4bbe7db" xlink:to="loc_hum_RevolvingCreditAgreementJune2021FiveYearMember_c74d90bd-0bac-4e25-a5ca-3bdf9c78b1d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_RevolvingCreditAgreementJune2021OneYearMember_e76d58c5-5429-4542-9721-966822fa4735" xlink:href="hum-20221231.xsd#hum_RevolvingCreditAgreementJune2021OneYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_ca7e321c-4d94-4a44-912d-a65fb4bbe7db" xlink:to="loc_hum_RevolvingCreditAgreementJune2021OneYearMember_e76d58c5-5429-4542-9721-966822fa4735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d8979ba1-437d-4336-8cc3-3083b8a4881a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d8979ba1-437d-4336-8cc3-3083b8a4881a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dee73535-bf37-44ed-8b42-f0ae445bd3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d8979ba1-437d-4336-8cc3-3083b8a4881a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dee73535-bf37-44ed-8b42-f0ae445bd3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_84a0c465-ed13-461c-8f20-2208edb4ab70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dee73535-bf37-44ed-8b42-f0ae445bd3d3" xlink:to="loc_us-gaap_LoansPayableMember_84a0c465-ed13-461c-8f20-2208edb4ab70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_503abe09-42de-4386-b513-50453198f75b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_us-gaap_VariableRateAxis_503abe09-42de-4386-b513-50453198f75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_f3083220-b721-457e-a13c-d96712b989d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_503abe09-42de-4386-b513-50453198f75b" xlink:to="loc_us-gaap_VariableRateDomain_f3083220-b721-457e-a13c-d96712b989d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cd015a3f-5391-47ae-9f81-a8a0f027cc0a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_f3083220-b721-457e-a13c-d96712b989d0" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_cd015a3f-5391-47ae-9f81-a8a0f027cc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SecuredOvernightFinancingRateSOFRMember_528fd75f-3e62-4ed7-8a67-0312ac6c0ee5" xlink:href="hum-20221231.xsd#hum_SecuredOvernightFinancingRateSOFRMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_f3083220-b721-457e-a13c-d96712b989d0" xlink:to="loc_hum_SecuredOvernightFinancingRateSOFRMember_528fd75f-3e62-4ed7-8a67-0312ac6c0ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b20a3f82-7fb7-473a-9dc1-e16299daa4ab" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_srt_RangeAxis_b20a3f82-7fb7-473a-9dc1-e16299daa4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e1c600fb-3de0-4520-95d0-2b568bffcd93" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b20a3f82-7fb7-473a-9dc1-e16299daa4ab" xlink:to="loc_srt_RangeMember_e1c600fb-3de0-4520-95d0-2b568bffcd93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_00af9d8e-b3fb-4e08-9f77-808cbaf9cbc1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e1c600fb-3de0-4520-95d0-2b568bffcd93" xlink:to="loc_srt_MinimumMember_00af9d8e-b3fb-4e08-9f77-808cbaf9cbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_df4542da-f920-4ce2-bc98-a1d577a71039" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e1c600fb-3de0-4520-95d0-2b568bffcd93" xlink:to="loc_srt_MaximumMember_df4542da-f920-4ce2-bc98-a1d577a71039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_4146bae0-f248-4edc-8885-2511dacbe4e9" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_ac0c11c4-9552-411c-88b7-8097a464a5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_DebtInstrumentTerm_ac0c11c4-9552-411c-88b7-8097a464a5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_39ad993b-f076-46c8-b670-26a5e0a47f82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_39ad993b-f076-46c8-b670-26a5e0a47f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a8755773-4d52-4678-8ef4-4a50cdee6d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_a8755773-4d52-4678-8ef4-4a50cdee6d0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6aa44cc0-931d-4548-81f3-716db3f5662a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_6aa44cc0-931d-4548-81f3-716db3f5662a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_4667663a-4803-41d5-b7e0-c2d0280acef9" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum_4667663a-4803-41d5-b7e0-c2d0280acef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_0323abf2-29d1-4337-96a9-81c890a1e78f" xlink:href="hum-20221231.xsd#hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual_0323abf2-29d1-4337-96a9-81c890a1e78f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_a5572fe8-de9f-4e35-9c32-6dd87c4928ba" xlink:href="hum-20221231.xsd#hum_LineOfCreditFacilityUncommittedIncrementalCapacity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_hum_LineOfCreditFacilityUncommittedIncrementalCapacity_a5572fe8-de9f-4e35-9c32-6dd87c4928ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity_bc684916-11fb-4b91-b311-74344022a103" xlink:href="hum-20221231.xsd#hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity_bc684916-11fb-4b91-b311-74344022a103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LinesOfCreditCurrent_0b2fd77d-c322-4401-8806-d072b26a3405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LinesOfCreditCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_LinesOfCreditCurrent_0b2fd77d-c322-4401-8806-d072b26a3405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_62c2d379-70e8-4e8f-be05-3955a5b26581" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_c1333329-5ed4-4c81-b5d3-48181ebfa935" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_62c2d379-70e8-4e8f-be05-3955a5b26581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#DEBTCommercialPaperandOtherShorttermBorrowingsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bd497a0d-490e-4dbd-802d-4996d1cc51bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_9751b2f9-8789-4200-bad7-0de8b306d511" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bd497a0d-490e-4dbd-802d-4996d1cc51bc" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_9751b2f9-8789-4200-bad7-0de8b306d511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_0dbe7990-9bf1-4ea0-abe2-80190b3e5768" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_9751b2f9-8789-4200-bad7-0de8b306d511" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_0dbe7990-9bf1-4ea0-abe2-80190b3e5768" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_cc35b1be-108a-4703-b4c0-1744ab81164b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_0dbe7990-9bf1-4ea0-abe2-80190b3e5768" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_cc35b1be-108a-4703-b4c0-1744ab81164b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_8fd635c5-e13b-427e-a409-1d29b252811d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_cc35b1be-108a-4703-b4c0-1744ab81164b" xlink:to="loc_us-gaap_CommercialPaperMember_8fd635c5-e13b-427e-a409-1d29b252811d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FederalHomeLoanBankAdvancesMember_c962bf99-28af-4a5e-80f8-d7635457f046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FederalHomeLoanBankAdvancesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_cc35b1be-108a-4703-b4c0-1744ab81164b" xlink:to="loc_us-gaap_FederalHomeLoanBankAdvancesMember_c962bf99-28af-4a5e-80f8-d7635457f046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_9751b2f9-8789-4200-bad7-0de8b306d511" xlink:to="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_488f5e1b-acb3-47f7-9093-a944a4b8d89a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_488f5e1b-acb3-47f7-9093-a944a4b8d89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_ce165d72-5189-4a60-89f7-c6fc8961dd8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:to="loc_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod_ce165d72-5189-4a60-89f7-c6fc8961dd8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_49cd27fe-b36e-48cd-b685-4ae707a0e134" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:to="loc_us-gaap_ShortTermBorrowings_49cd27fe-b36e-48cd-b685-4ae707a0e134" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_786238c5-c0e9-49b3-ac72-7859a5edb5c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_3586ff76-ee07-4bf6-8959-69f389b93bed" xlink:to="loc_us-gaap_ShortTermDebtWeightedAverageInterestRate_786238c5-c0e9-49b3-ac72-7859a5edb5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2468663e-7790-4c61-b67b-e5e2fc55e315" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_2468663e-7790-4c61-b67b-e5e2fc55e315" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_e0c7fb2f-d6dd-4ae6-916c-74844bdeb62a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:to="loc_us-gaap_PlanNameAxis_e0c7fb2f-d6dd-4ae6-916c-74844bdeb62a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_280062f1-7bc6-423e-bc71-496ee3a11f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_e0c7fb2f-d6dd-4ae6-916c-74844bdeb62a" xlink:to="loc_us-gaap_PlanNameDomain_280062f1-7bc6-423e-bc71-496ee3a11f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2011PlanMember_ad8487a7-69f8-4146-8a5e-abf85ccd1326" xlink:href="hum-20221231.xsd#hum_A2011PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_280062f1-7bc6-423e-bc71-496ee3a11f53" xlink:to="loc_hum_A2011PlanMember_ad8487a7-69f8-4146-8a5e-abf85ccd1326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_A2019PlanMember_82a0b772-ca46-4dd0-8caa-26a13cc20b48" xlink:href="hum-20221231.xsd#hum_A2019PlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_280062f1-7bc6-423e-bc71-496ee3a11f53" xlink:to="loc_hum_A2019PlanMember_82a0b772-ca46-4dd0-8caa-26a13cc20b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9aa8a6f7-b5dd-4e50-bdda-80c141dc715c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:to="loc_us-gaap_AwardTypeAxis_9aa8a6f7-b5dd-4e50-bdda-80c141dc715c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc4abd1c-3a24-46c1-a84c-b7c27c760003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9aa8a6f7-b5dd-4e50-bdda-80c141dc715c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc4abd1c-3a24-46c1-a84c-b7c27c760003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_6a3fdf6d-9fb3-4a5f-a7e3-2a51774de1d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc4abd1c-3a24-46c1-a84c-b7c27c760003" xlink:to="loc_us-gaap_RestrictedStockMember_6a3fdf6d-9fb3-4a5f-a7e3-2a51774de1d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_7151b48f-5cd0-411a-8588-eb2942113af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bc4abd1c-3a24-46c1-a84c-b7c27c760003" xlink:to="loc_us-gaap_EmployeeStockOptionMember_7151b48f-5cd0-411a-8588-eb2942113af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc65f2b1-7484-4ba2-bfe2-36d3e3a58c8f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:to="loc_srt_RangeAxis_cc65f2b1-7484-4ba2-bfe2-36d3e3a58c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1cd8586c-2630-4a9c-9442-2176484cbb73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cc65f2b1-7484-4ba2-bfe2-36d3e3a58c8f" xlink:to="loc_srt_RangeMember_1cd8586c-2630-4a9c-9442-2176484cbb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2f6217dc-104a-4915-9272-53028065062a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1cd8586c-2630-4a9c-9442-2176484cbb73" xlink:to="loc_srt_MinimumMember_2f6217dc-104a-4915-9272-53028065062a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3c6b50c8-3273-4e3b-8252-da241e1894cb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_1cd8586c-2630-4a9c-9442-2176484cbb73" xlink:to="loc_srt_MaximumMember_3c6b50c8-3273-4e3b-8252-da241e1894cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_cacc8cd9-3342-413c-9511-c9170ab36e2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_a8b39ad3-9be3-4d81-9a74-d2c622a35097" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_a8b39ad3-9be3-4d81-9a74-d2c622a35097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CompanyCommonStockClosingSharePrice_982d9a77-092d-42ad-b288-ed1caac67bee" xlink:href="hum-20221231.xsd#hum_CompanyCommonStockClosingSharePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_CompanyCommonStockClosingSharePrice_982d9a77-092d-42ad-b288-ed1caac67bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock_b1845507-f7d3-41c8-9271-68af6ea5a86b" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock_b1845507-f7d3-41c8-9271-68af6ea5a86b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares_f7124ac6-92c9-4c7f-8d81-e02195b935db" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares_f7124ac6-92c9-4c7f-8d81-e02195b935db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding_7f8a3b85-8870-4162-99cb-2b92e87d90b6" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding_7f8a3b85-8870-4162-99cb-2b92e87d90b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance_c99053da-f982-4de0-9a24-1433f8598b28" xlink:href="hum-20221231.xsd#hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance_c99053da-f982-4de0-9a24-1433f8598b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod_fe0c433e-8d8c-42f3-a5d6-dc1c919219d5" xlink:href="hum-20221231.xsd#hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod_fe0c433e-8d8c-42f3-a5d6-dc1c919219d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram_7ba04509-d50c-495c-a1bb-2f64084483fa" xlink:href="hum-20221231.xsd#hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram_7ba04509-d50c-495c-a1bb-2f64084483fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram_c5788945-3dc1-434b-9dc7-e254f09d4a38" xlink:href="hum-20221231.xsd#hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram_c5788945-3dc1-434b-9dc7-e254f09d4a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram_46500058-2b17-48fb-8c68-98a8c4710126" xlink:href="hum-20221231.xsd#hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram_46500058-2b17-48fb-8c68-98a8c4710126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting_2a9c9163-2e30-4742-ba93-24e4c83ed7b2" xlink:href="hum-20221231.xsd#hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting_2a9c9163-2e30-4742-ba93-24e4c83ed7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_b79a5ec1-c897-4ac8-acbd-69d3362dac4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_b79a5ec1-c897-4ac8-acbd-69d3362dac4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_da3fc799-4268-4496-9c5e-65082d19e789" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_da3fc799-4268-4496-9c5e-65082d19e789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_155cb150-6b1f-4f9c-8a94-dee4def864ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_155cb150-6b1f-4f9c-8a94-dee4def864ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_17a7f333-3b59-4946-95be-5fe5579be113" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_17a7f333-3b59-4946-95be-5fe5579be113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8824a86d-6c67-49d7-8716-620cd08cc3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_8824a86d-6c67-49d7-8716-620cd08cc3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions_2ccf7402-dcbd-4d31-ad98-26fe36f6b615" xlink:href="hum-20221231.xsd#hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions_2ccf7402-dcbd-4d31-ad98-26fe36f6b615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_354cd51f-8f39-4a22-a178-476dc4bb2ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_354cd51f-8f39-4a22-a178-476dc4bb2ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ae1e00d3-7e12-467f-85c0-d382aafeeaf4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_ae1e00d3-7e12-467f-85c0-d382aafeeaf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b3ac000e-feee-4afc-bc68-b1f34297160d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b3ac000e-feee-4afc-bc68-b1f34297160d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_16385cde-6cfc-494a-b1aa-25b0be6893ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_16385cde-6cfc-494a-b1aa-25b0be6893ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a436fbcc-af98-4a09-8a62-f9cb9fb99080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_a436fbcc-af98-4a09-8a62-f9cb9fb99080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_9b65facf-ff2d-427c-a412-4a6404e00185" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_9b65facf-ff2d-427c-a412-4a6404e00185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_3ae33756-a9dd-40ac-bb8f-c8632ff2e97f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_3ae33756-a9dd-40ac-bb8f-c8632ff2e97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1a8ce31e-222e-4f9f-b974-19ac0fa9863a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1a8ce31e-222e-4f9f-b974-19ac0fa9863a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_db660b9c-89f8-49fe-ae1c-b41c3e175e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_db660b9c-89f8-49fe-ae1c-b41c3e175e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_122a71de-56b8-4d9c-921a-5ed9c5e55cab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_cf853d3e-85f5-4645-8fc2-b3a220c67dc9" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_122a71de-56b8-4d9c-921a-5ed9c5e55cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7f347a71-998b-4c85-b182-a191ff73a97b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a92b8fd6-128f-429b-9cf3-65c201d084dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_7f347a71-998b-4c85-b182-a191ff73a97b" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a92b8fd6-128f-429b-9cf3-65c201d084dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_db3737d7-4aed-4014-b337-b64522c64750" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a92b8fd6-128f-429b-9cf3-65c201d084dc" xlink:to="loc_us-gaap_AwardTypeAxis_db3737d7-4aed-4014-b337-b64522c64750" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f781590-2eb3-4a1f-ab3f-f7f2a5febe9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_db3737d7-4aed-4014-b337-b64522c64750" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f781590-2eb3-4a1f-ab3f-f7f2a5febe9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_e03e47c4-b4d2-4829-b4ff-d8b9d0fd1784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f781590-2eb3-4a1f-ab3f-f7f2a5febe9f" xlink:to="loc_us-gaap_RestrictedStockMember_e03e47c4-b4d2-4829-b4ff-d8b9d0fd1784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_abacb7f0-ceb2-401e-9aba-8dc77e01b434" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9f781590-2eb3-4a1f-ab3f-f7f2a5febe9f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_abacb7f0-ceb2-401e-9aba-8dc77e01b434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_a92b8fd6-128f-429b-9cf3-65c201d084dc" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4cecded5-73a4-4bd5-934a-97eb2dc52ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4cecded5-73a4-4bd5-934a-97eb2dc52ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b33b9d4b-e6a2-4cc1-b20d-6cdf008f4a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_b33b9d4b-e6a2-4cc1-b20d-6cdf008f4a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_affe3c18-64d3-4b2f-a858-b5afd1342405" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_19795701-a75b-4473-9ab3-8b537b3f574b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax_affe3c18-64d3-4b2f-a858-b5afd1342405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_86fb3091-4588-4566-95c7-c2b00bca46ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d5d54f7-58f6-4630-ad2a-c1726c6149b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_86fb3091-4588-4566-95c7-c2b00bca46ac" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d5d54f7-58f6-4630-ad2a-c1726c6149b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_99bc10da-1348-4d42-a283-37004ee73ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d5d54f7-58f6-4630-ad2a-c1726c6149b6" xlink:to="loc_us-gaap_AwardTypeAxis_99bc10da-1348-4d42-a283-37004ee73ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f170625e-627f-4488-aa2c-ad49e836cbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_99bc10da-1348-4d42-a283-37004ee73ac9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f170625e-627f-4488-aa2c-ad49e836cbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_86301934-e9f3-4f6d-94c0-a45014f8e306" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f170625e-627f-4488-aa2c-ad49e836cbd5" xlink:to="loc_us-gaap_RestrictedStockMember_86301934-e9f3-4f6d-94c0-a45014f8e306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b8338a7-6f05-44b9-83ad-8d133bf6f18c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d5d54f7-58f6-4630-ad2a-c1726c6149b6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b8338a7-6f05-44b9-83ad-8d133bf6f18c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b8338a7-6f05-44b9-83ad-8d133bf6f18c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eae0ca17-46e5-42c1-ba8c-922d5a390dea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_eae0ca17-46e5-42c1-ba8c-922d5a390dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad68cdaa-06d2-445c-8cb3-12ccc5c1b46f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_ad68cdaa-06d2-445c-8cb3-12ccc5c1b46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a372362d-4d31-4038-83e1-baca5e1416b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a372362d-4d31-4038-83e1-baca5e1416b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_08cd3d86-e9dc-4f7e-99a1-5a78f0aa5ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_08cd3d86-e9dc-4f7e-99a1-5a78f0aa5ed0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7a7fb197-13aa-4101-8ab3-14238fe1d74c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_5f6458c3-daa4-4fa4-a19c-e80e926a81d2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7a7fb197-13aa-4101-8ab3-14238fe1d74c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0b8338a7-6f05-44b9-83ad-8d133bf6f18c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ce85bb7b-66a4-4f21-be4c-7c94db9b4b49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_ce85bb7b-66a4-4f21-be4c-7c94db9b4b49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a731866a-9545-4fb5-8e8b-1e1c87cf1396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a731866a-9545-4fb5-8e8b-1e1c87cf1396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_70e9cfb8-e8ac-4b3e-8ebf-10fbad0de7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_70e9cfb8-e8ac-4b3e-8ebf-10fbad0de7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35be403a-b605-429f-b3bb-6b0b844d2228" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35be403a-b605-429f-b3bb-6b0b844d2228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eea30c00-4bca-49e2-805d-8e59e9b15c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f496cda5-9092-4caa-b27d-075ac7b7137b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_eea30c00-4bca-49e2-805d-8e59e9b15c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf592d34-4ba7-4ab1-9327-70972b8b9b1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1eb4a-9f5a-49f8-9649-faf6de054887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_cf592d34-4ba7-4ab1-9327-70972b8b9b1c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1eb4a-9f5a-49f8-9649-faf6de054887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_23ea0f87-8095-4b01-85a3-8fbdcbff7f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1eb4a-9f5a-49f8-9649-faf6de054887" xlink:to="loc_us-gaap_AwardTypeAxis_23ea0f87-8095-4b01-85a3-8fbdcbff7f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_952440c3-6e4f-4dba-8ae8-25ecf43494e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_23ea0f87-8095-4b01-85a3-8fbdcbff7f1e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_952440c3-6e4f-4dba-8ae8-25ecf43494e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a788d0cd-d61b-43ef-b926-51028fa78d98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_952440c3-6e4f-4dba-8ae8-25ecf43494e2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a788d0cd-d61b-43ef-b926-51028fa78d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_03d1eb4a-9f5a-49f8-9649-faf6de054887" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15ebb1c6-ebe3-4792-bef7-173ef1f47106" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_15ebb1c6-ebe3-4792-bef7-173ef1f47106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4f8adb8f-addd-4ad3-a6b3-1c6996e90d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_4f8adb8f-addd-4ad3-a6b3-1c6996e90d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b6a5433a-fcca-4d17-b3b9-2eb6228c3935" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b6a5433a-fcca-4d17-b3b9-2eb6228c3935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_52cd0a74-535b-45ff-b936-b934afcc5bae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_52cd0a74-535b-45ff-b936-b934afcc5bae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_87d1720a-d2ac-436a-9bb5-ae3faa74b270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_49814f22-0f69-4ebb-9841-279d95e25539" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_87d1720a-d2ac-436a-9bb5-ae3faa74b270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bbb0084f-b939-4f73-82af-16296168c2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4f89df95-1c09-498b-91ce-4eb21d69172f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bbb0084f-b939-4f73-82af-16296168c2b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4f89df95-1c09-498b-91ce-4eb21d69172f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b1dac3b8-3f5d-49d5-96a6-2c473a53be5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4f89df95-1c09-498b-91ce-4eb21d69172f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_b1dac3b8-3f5d-49d5-96a6-2c473a53be5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_64e1c861-9f4d-4a84-97fc-7bffb487324c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4f89df95-1c09-498b-91ce-4eb21d69172f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_64e1c861-9f4d-4a84-97fc-7bffb487324c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d925692c-de49-4af3-a3d1-bc6224a5dc40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4f89df95-1c09-498b-91ce-4eb21d69172f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_d925692c-de49-4af3-a3d1-bc6224a5dc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1b6acb36-8309-4e50-860e-c7f8379be214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4f89df95-1c09-498b-91ce-4eb21d69172f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1b6acb36-8309-4e50-860e-c7f8379be214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_576b1fe0-121e-4f41-a00d-8982ce68276f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_4f89df95-1c09-498b-91ce-4eb21d69172f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_576b1fe0-121e-4f41-a00d-8982ce68276f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_31b3014a-dcae-4dd3-95f2-d4a4c4c6f958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bbb0084f-b939-4f73-82af-16296168c2b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_31b3014a-dcae-4dd3-95f2-d4a4c4c6f958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_22fa695a-e003-4723-ae6b-bedf89284d93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bbb0084f-b939-4f73-82af-16296168c2b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_22fa695a-e003-4723-ae6b-bedf89284d93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3e113c5a-6f3f-438f-b485-f20714a2a6d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_22fa695a-e003-4723-ae6b-bedf89284d93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3e113c5a-6f3f-438f-b485-f20714a2a6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7ca25fbf-595a-4257-8861-dd3cb1ca4801" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_22fa695a-e003-4723-ae6b-bedf89284d93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7ca25fbf-595a-4257-8861-dd3cb1ca4801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_67267cd3-f47d-4a73-97e5-c67f2d1d4bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_22fa695a-e003-4723-ae6b-bedf89284d93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_67267cd3-f47d-4a73-97e5-c67f2d1d4bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_40beaf74-de54-4c4c-9f68-7009d915b0cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_22fa695a-e003-4723-ae6b-bedf89284d93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_40beaf74-de54-4c4c-9f68-7009d915b0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8dbff576-f718-4c00-b28d-4d74d2dbde50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_22fa695a-e003-4723-ae6b-bedf89284d93" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8dbff576-f718-4c00-b28d-4d74d2dbde50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_aa5a6895-f56b-4b02-8397-37fa3c995742" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_bbb0084f-b939-4f73-82af-16296168c2b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_aa5a6895-f56b-4b02-8397-37fa3c995742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#EARNINGSPERCOMMONSHARECOMPUTATIONDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_37b35236-e301-44c2-bbea-f3fb64c43cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_935ba2dd-a10a-4fb8-85fc-8cb8916edca6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_37b35236-e301-44c2-bbea-f3fb64c43cfe" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_935ba2dd-a10a-4fb8-85fc-8cb8916edca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_def46108-ed8b-4ece-b97d-6bd928179d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_935ba2dd-a10a-4fb8-85fc-8cb8916edca6" xlink:to="loc_us-gaap_AwardTypeAxis_def46108-ed8b-4ece-b97d-6bd928179d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_725cc0f5-4810-4264-a032-301894668d5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_def46108-ed8b-4ece-b97d-6bd928179d8c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_725cc0f5-4810-4264-a032-301894668d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8c963865-0905-43ef-a593-ed6c46ce4a48" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_725cc0f5-4810-4264-a032-301894668d5f" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8c963865-0905-43ef-a593-ed6c46ce4a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_fe07d65e-d18f-4766-8edb-7e712b1ae2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_725cc0f5-4810-4264-a032-301894668d5f" xlink:to="loc_us-gaap_RestrictedStockMember_fe07d65e-d18f-4766-8edb-7e712b1ae2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_935ba2dd-a10a-4fb8-85fc-8cb8916edca6" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_54df474f-1952-4102-a8a6-34823271ee6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_NetIncomeLoss_54df474f-1952-4102-a8a6-34823271ee6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_67fe945b-de7b-4d1c-983b-8410135bdf2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_67fe945b-de7b-4d1c-983b-8410135bdf2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_80210c68-7d41-4698-a428-234510187ba2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_80210c68-7d41-4698-a428-234510187ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8de3ba91-d42a-45d6-b277-3e841139afd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8de3ba91-d42a-45d6-b277-3e841139afd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_2b7a2adc-b476-42c9-a640-86342d4dd909" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_EarningsPerShareBasic_2b7a2adc-b476-42c9-a640-86342d4dd909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_da22f705-42d5-439d-9704-8d8db50a244b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_EarningsPerShareDiluted_da22f705-42d5-439d-9704-8d8db50a244b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7b67e434-cf69-4a6f-8b19-2f4bbe57256d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_1d7099f5-a6ee-4300-bc6d-e35b13583332" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_7b67e434-cf69-4a6f-8b19-2f4bbe57256d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYDividendPaymentsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#STOCKHOLDERSEQUITYDividendPaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYDividendPaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_bb7a1b30-78c5-41a0-a8fb-dc886b7c6989" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d6742a19-a983-4c57-9673-076191a46489" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bb7a1b30-78c5-41a0-a8fb-dc886b7c6989" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d6742a19-a983-4c57-9673-076191a46489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Dividends_27a85981-8703-4919-b3dd-30e5c74fbcfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Dividends"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_bb7a1b30-78c5-41a0-a8fb-dc886b7c6989" xlink:to="loc_us-gaap_Dividends_27a85981-8703-4919-b3dd-30e5c74fbcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_4f7d3a37-cf73-41d9-bf7a-471bb0563ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_4f7d3a37-cf73-41d9-bf7a-471bb0563ba1" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_88cedf39-e796-4ea2-b87d-7de55c2f1196" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_88cedf39-e796-4ea2-b87d-7de55c2f1196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_88cedf39-e796-4ea2-b87d-7de55c2f1196" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_December2020AcceleratedShareRepurchaseAgreementMember_bda5a140-28b8-47a5-a024-c3eac88c5b3c" xlink:href="hum-20221231.xsd#hum_December2020AcceleratedShareRepurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:to="loc_hum_December2020AcceleratedShareRepurchaseAgreementMember_bda5a140-28b8-47a5-a024-c3eac88c5b3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_January2022AcceleratedShareRepurchaseAgreementMember_1f8cfa1e-2731-4846-8b3f-0dfa2f5eeb50" xlink:href="hum-20221231.xsd#hum_January2022AcceleratedShareRepurchaseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:to="loc_hum_January2022AcceleratedShareRepurchaseAgreementMember_1f8cfa1e-2731-4846-8b3f-0dfa2f5eeb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_November2022AcceleratedShareRepurchaseProgramMember_c309f5d1-7640-4e45-842d-bc29e87b50f3" xlink:href="hum-20221231.xsd#hum_November2022AcceleratedShareRepurchaseProgramMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_4f7b7b11-eb7f-4c90-9e87-7114deeac7a8" xlink:to="loc_hum_November2022AcceleratedShareRepurchaseProgramMember_c309f5d1-7640-4e45-842d-bc29e87b50f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_f1cd6311-7b2f-4533-9c8b-9b4d92d8e876" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:to="loc_srt_CounterpartyNameAxis_f1cd6311-7b2f-4533-9c8b-9b4d92d8e876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_f1cd6311-7b2f-4533-9c8b-9b4d92d8e876" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CitibankNAMember_46cdea42-0a75-40c6-a044-acc1fb0cb8e5" xlink:href="hum-20221231.xsd#hum_CitibankNAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_CitibankNAMember_46cdea42-0a75-40c6-a044-acc1fb0cb8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_JPMorganChaseBankMember_6053374e-9bab-442d-9790-57864809509b" xlink:href="hum-20221231.xsd#hum_JPMorganChaseBankMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_JPMorganChaseBankMember_6053374e-9bab-442d-9790-57864809509b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MizuhoMarketsAmericasLLCMember_ee29f90b-e6b7-4193-a328-539a04f9636a" xlink:href="hum-20221231.xsd#hum_MizuhoMarketsAmericasLLCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_MizuhoMarketsAmericasLLCMember_ee29f90b-e6b7-4193-a328-539a04f9636a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_WellsFargoBankMember_46bc4871-94c2-4c10-82f6-f5a5a6066e70" xlink:href="hum-20221231.xsd#hum_WellsFargoBankMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_WellsFargoBankMember_46bc4871-94c2-4c10-82f6-f5a5a6066e70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GoldmanSachsCoLLCMember_3e0b646b-1331-446e-94af-7772e4c24509" xlink:href="hum-20221231.xsd#hum_GoldmanSachsCoLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e832a75c-b5eb-40fe-bcfc-c7da278888ca" xlink:to="loc_hum_GoldmanSachsCoLLCMember_3e0b646b-1331-446e-94af-7772e4c24509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_35eeb310-54c1-4d2a-8cfc-eb5688bda1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_35eeb310-54c1-4d2a-8cfc-eb5688bda1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_83f3f659-57d5-4331-bf24-e1497c309838" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_35eeb310-54c1-4d2a-8cfc-eb5688bda1cd" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_83f3f659-57d5-4331-bf24-e1497c309838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_cdd47cf7-d81c-48fa-92a5-b99d4db21faa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_83f3f659-57d5-4331-bf24-e1497c309838" xlink:to="loc_us-gaap_SubsequentEventMember_cdd47cf7-d81c-48fa-92a5-b99d4db21faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_cbaa5c34-80c5-47ee-b035-838ddb695dff" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_eb004713-d137-44af-b9e1-39261bb1cc89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_eb004713-d137-44af-b9e1-39261bb1cc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_298396d0-782e-4c64-a364-307ed0c3118a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_298396d0-782e-4c64-a364-307ed0c3118a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AcceleratedShareRepurchasesAgreementAmount_c6dd7964-ea80-4d48-92ec-0c01bbae93ca" xlink:href="hum-20221231.xsd#hum_AcceleratedShareRepurchasesAgreementAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_AcceleratedShareRepurchasesAgreementAmount_c6dd7964-ea80-4d48-92ec-0c01bbae93ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be561f08-c8c5-4379-8f5b-a40257a142e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_be561f08-c8c5-4379-8f5b-a40257a142e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8166ff6a-824b-40c0-8a51-5ebdf6a82647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt_8166ff6a-824b-40c0-8a51-5ebdf6a82647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_5303648e-9bb4-4068-b579-586a40290eab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_5303648e-9bb4-4068-b579-586a40290eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3a2ff5d7-90e9-46ce-91d9-467c2243f4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3a2ff5d7-90e9-46ce-91d9-467c2243f4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue_22a4aa3c-1c0c-42a6-8c71-3259dd274734" xlink:href="hum-20221231.xsd#hum_TreasuryStockDecreaseInCapitalInExcessOfParValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue_22a4aa3c-1c0c-42a6-8c71-3259dd274734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_d6df0c8c-7f27-43fc-8f96-7c03be9cb8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare_d6df0c8c-7f27-43fc-8f96-7c03be9cb8e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue_8b07790a-67f8-4152-a262-93e42f18aeaa" xlink:href="hum-20221231.xsd#hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue_8b07790a-67f8-4152-a262-93e42f18aeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f9fdb6d0-680f-49c3-ab99-6722a060976b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_f9fdb6d0-680f-49c3-ab99-6722a060976b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_444cb48a-d770-47cb-8d3d-1c6144f2c055" xlink:href="hum-20221231.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares_444cb48a-d770-47cb-8d3d-1c6144f2c055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_87104348-c659-4782-ad5e-186bce37653f" xlink:href="hum-20221231.xsd#hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue_87104348-c659-4782-ad5e-186bce37653f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_a0322663-bb57-44bb-8337-edf551f20f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_a0322663-bb57-44bb-8337-edf551f20f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_708188f0-7254-4995-b9b1-9ee371d39abf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_708188f0-7254-4995-b9b1-9ee371d39abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_ec257b3e-725b-4408-b612-cefb39e7dcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_ec257b3e-725b-4408-b612-cefb39e7dcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_15caca71-193d-4d06-a07e-10c52d43dccc" xlink:href="hum-20221231.xsd#hum_DividendsToParentWithoutPriorStateRegulatoryApproval"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_86f0eafc-c006-45a4-ac4b-70a37855fb64" xlink:to="loc_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_15caca71-193d-4d06-a07e-10c52d43dccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#STOCKHOLDERSEQUITYShareRepurchasesDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2a1bcb0f-606a-44af-a3bd-13c2ab0fba86" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfTreasuryStockTable_368cd11e-b72a-45a1-a46c-46442c4ec03f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfTreasuryStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2a1bcb0f-606a-44af-a3bd-13c2ab0fba86" xlink:to="loc_us-gaap_ClassOfTreasuryStockTable_368cd11e-b72a-45a1-a46c-46442c4ec03f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_2cee4513-099b-45ca-ad66-1fe2f72132db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_368cd11e-b72a-45a1-a46c-46442c4ec03f" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_2cee4513-099b-45ca-ad66-1fe2f72132db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_70ca9cca-1e0e-4483-beb8-d3a750caa078" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_2cee4513-099b-45ca-ad66-1fe2f72132db" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_70ca9cca-1e0e-4483-beb8-d3a750caa078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_43ac30b9-012a-4de0-a924-c3de8533fad7" xlink:href="hum-20221231.xsd#hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_70ca9cca-1e0e-4483-beb8-d3a750caa078" xlink:to="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_43ac30b9-012a-4de0-a924-c3de8533fad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_February2021ShareRepurchaseAuthorizationMember_67865035-b81c-4e19-b664-53c36e823f8e" xlink:href="hum-20221231.xsd#hum_February2021ShareRepurchaseAuthorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_43ac30b9-012a-4de0-a924-c3de8533fad7" xlink:to="loc_hum_February2021ShareRepurchaseAuthorizationMember_67865035-b81c-4e19-b664-53c36e823f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_July2019ShareRepurchaseAuthorizationMember_8723dd44-fca3-4855-85aa-608b2450354d" xlink:href="hum-20221231.xsd#hum_July2019ShareRepurchaseAuthorizationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember_43ac30b9-012a-4de0-a924-c3de8533fad7" xlink:to="loc_hum_July2019ShareRepurchaseAuthorizationMember_8723dd44-fca3-4855-85aa-608b2450354d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityClassOfTreasuryStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfTreasuryStockTable_368cd11e-b72a-45a1-a46c-46442c4ec03f" xlink:to="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a41dfb1f-11e9-4b38-97d8-72b036bb219e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_a41dfb1f-11e9-4b38-97d8-72b036bb219e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_25f88aba-c81b-44b9-9520-3f5ca55c2206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_25f88aba-c81b-44b9-9520-3f5ca55c2206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ec146105-6db6-4122-83c4-7160c623ea6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityClassOfTreasuryStockLineItems_99507bb9-23d5-4d64-9f4a-4e97ce9e4550" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_ec146105-6db6-4122-83c4-7160c623ea6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b3b3c102-10ab-47d1-93ee-0eeb6bca5365" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_abb53bfe-c3db-4650-8eac-b4cb37d509e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_b3b3c102-10ab-47d1-93ee-0eeb6bca5365" xlink:to="loc_us-gaap_LossContingenciesTable_abb53bfe-c3db-4650-8eac-b4cb37d509e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_da4071e8-fd03-4aa4-84ac-94afcc78a5f2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_abb53bfe-c3db-4650-8eac-b4cb37d509e8" xlink:to="loc_srt_MajorCustomersAxis_da4071e8-fd03-4aa4-84ac-94afcc78a5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_da4071e8-fd03-4aa4-84ac-94afcc78a5f2" xlink:to="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember_c9cdc4aa-abc7-4c5c-9872-751511a911bc" xlink:href="hum-20221231.xsd#hum_MedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:to="loc_hum_MedicareMember_c9cdc4aa-abc7-4c5c-9872-751511a911bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidMember_75f6dec4-f7d1-4f9c-bff8-eff6c62321f9" xlink:href="hum-20221231.xsd#hum_MedicaidMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:to="loc_hum_MedicaidMember_75f6dec4-f7d1-4f9c-bff8-eff6c62321f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MilitaryServiceMember_31e76276-aaad-43ec-ae5b-655d12b6149f" xlink:href="hum-20221231.xsd#hum_MilitaryServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_d1d26724-cc43-4de3-9766-3b18a8b4fa0c" xlink:to="loc_hum_MilitaryServiceMember_31e76276-aaad-43ec-ae5b-655d12b6149f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_abb53bfe-c3db-4650-8eac-b4cb37d509e8" xlink:to="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_f610ee3d-1f20-4749-a36a-96d69eba25cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary_f610ee3d-1f20-4749-a36a-96d69eba25cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_34fe8e8e-0bd3-4a0d-b73b-4608f4d585a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary_34fe8e8e-0bd3-4a0d-b73b-4608f4d585a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_839ab15f-e14f-49a7-bce1-529a92870473" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary_839ab15f-e14f-49a7-bce1-529a92870473" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_a8dbdfaf-1933-4764-8fb0-087d3758ca70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary_a8dbdfaf-1933-4764-8fb0-087d3758ca70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_55554935-8c6a-4575-9ec5-ff10661aa7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears_55554935-8c6a-4575-9ec5-ff10661aa7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfTotalPremiumAndServicesRevenues_ce4e37b6-1ac4-49a3-8ef3-a9e7d5ddd612" xlink:href="hum-20221231.xsd#hum_PercentageOfTotalPremiumAndServicesRevenues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_PercentageOfTotalPremiumAndServicesRevenues_ce4e37b6-1ac4-49a3-8ef3-a9e7d5ddd612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries_67105370-9cde-496d-b5fc-14d34762b0d0" xlink:href="hum-20221231.xsd#hum_NumberOfStatesComprisingTRICAREBeneficiaries"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_NumberOfStatesComprisingTRICAREBeneficiaries_67105370-9cde-496d-b5fc-14d34762b0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREBeneficiaries_02a68d43-8f66-4e2d-8ea7-dbbb8eb99a8e" xlink:href="hum-20221231.xsd#hum_NumberOfTRICAREBeneficiaries"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_NumberOfTRICAREBeneficiaries_02a68d43-8f66-4e2d-8ea7-dbbb8eb99a8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_a315c66a-5914-499f-b1cd-ba9bd82a77f5" xlink:href="hum-20221231.xsd#hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries_a315c66a-5914-499f-b1cd-ba9bd82a77f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_5dcb7a5a-0ba5-4bf7-a664-c6a8fd31f18b" xlink:href="hum-20221231.xsd#hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries_5dcb7a5a-0ba5-4bf7-a664-c6a8fd31f18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractBaseTerm_253bf68d-a5a3-418c-a9a1-ea19fd32686b" xlink:href="hum-20221231.xsd#hum_TRICAREManagedCareSupportContractBaseTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_TRICAREManagedCareSupportContractBaseTerm_253bf68d-a5a3-418c-a9a1-ea19fd32686b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_14c88642-0cf1-4ac5-8d3a-85c01e3e9f34" xlink:href="hum-20221231.xsd#hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods_14c88642-0cf1-4ac5-8d3a-85c01e3e9f34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_d2d0b6a8-04a1-4d5c-890f-77697625248c" xlink:href="hum-20221231.xsd#hum_TRICAREManagedCareSupportContractTermWithOptionExercises"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_e7ff04d0-a474-4337-adbd-f6ef68f019fa" xlink:to="loc_hum_TRICAREManagedCareSupportContractTermWithOptionExercises_d2d0b6a8-04a1-4d5c-890f-77697625248c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SEGMENTINFORMATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_d68f6561-6f88-4478-8963-8621fea6e9d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_d68f6561-6f88-4478-8963-8621fea6e9d3" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_8a412c69-6733-4a26-91d0-52cef3c36dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_8a412c69-6733-4a26-91d0-52cef3c36dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f992ac3f-16a3-4f1d-87af-ce03182c783d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_8a412c69-6733-4a26-91d0-52cef3c36dd5" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f992ac3f-16a3-4f1d-87af-ce03182c783d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GovernmentContractsConcentrationRiskMember_e9be776c-3d15-4b39-abf7-7a41fdc6207d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GovernmentContractsConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f992ac3f-16a3-4f1d-87af-ce03182c783d" xlink:to="loc_us-gaap_GovernmentContractsConcentrationRiskMember_e9be776c-3d15-4b39-abf7-7a41fdc6207d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e736f700-2744-4100-9640-2c158ce44380" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e736f700-2744-4100-9640-2c158ce44380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8f4d5b6b-b974-4985-8a4b-9e313dd03643" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_e736f700-2744-4100-9640-2c158ce44380" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8f4d5b6b-b974-4985-8a4b-9e313dd03643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueProductLineMember_7ab7e329-0554-46e1-950e-9617f7322d49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueProductLineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8f4d5b6b-b974-4985-8a4b-9e313dd03643" xlink:to="loc_us-gaap_SalesRevenueProductLineMember_7ab7e329-0554-46e1-950e-9617f7322d49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_466d97cd-d218-4d59-a4ef-2d51368a280a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:to="loc_srt_MajorCustomersAxis_466d97cd-d218-4d59-a4ef-2d51368a280a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e73ffb82-9839-4011-b538-1c8603619ef7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_466d97cd-d218-4d59-a4ef-2d51368a280a" xlink:to="loc_srt_NameOfMajorCustomerDomain_e73ffb82-9839-4011-b538-1c8603619ef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FederalGovernmentMember_43550140-4570-44e5-9600-44b62a6c0991" xlink:href="hum-20221231.xsd#hum_FederalGovernmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e73ffb82-9839-4011-b538-1c8603619ef7" xlink:to="loc_hum_FederalGovernmentMember_43550140-4570-44e5-9600-44b62a6c0991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d0c15a82-7af4-4f03-8a87-5d69b851f3c3" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_177bc530-8648-487d-97ec-2898d31cdab5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:to="loc_us-gaap_NumberOfReportableSegments_177bc530-8648-487d-97ec-2898d31cdab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_68c994f7-ca02-4dfd-9ccf-d606d5031550" xlink:href="hum-20221231.xsd#hum_GovernmentAndHealthPlanMemberSubsidiesAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:to="loc_hum_GovernmentAndHealthPlanMemberSubsidiesAmount_68c994f7-ca02-4dfd-9ccf-d606d5031550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_af1457fe-1705-48cb-8fd6-cddb8a040619" xlink:href="hum-20221231.xsd#hum_DepreciationAndAmortizationClassifiedAsBenefitExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:to="loc_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense_af1457fe-1705-48cb-8fd6-cddb8a040619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_62ed5d78-cffe-4783-9d00-9d6097a62d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_385f283b-1f53-4457-a1fd-fde2ea78b583" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_62ed5d78-cffe-4783-9d00-9d6097a62d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SEGMENTINFORMATIONSegmentResultsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_7f04947c-6133-4efb-8da9-7db40e91321b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_7f04947c-6133-4efb-8da9-7db40e91321b" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_81ebe554-85cd-4a3f-9ac5-b27ee904f709" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:to="loc_srt_ConsolidationItemsAxis_81ebe554-85cd-4a3f-9ac5-b27ee904f709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_81ebe554-85cd-4a3f-9ac5-b27ee904f709" xlink:to="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_4817afbf-2537-4fca-9f26-c75350cddfba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:to="loc_us-gaap_OperatingSegmentsMember_4817afbf-2537-4fca-9f26-c75350cddfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CorporateAndEliminationsMember_2b85677c-77a5-4049-9623-cb3bab8179ed" xlink:href="hum-20221231.xsd#hum_CorporateAndEliminationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:to="loc_hum_CorporateAndEliminationsMember_2b85677c-77a5-4049-9623-cb3bab8179ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_a99a89c1-f0dc-43ce-8067-900e97e0e4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_a38786f7-702a-44db-8f03-74e3c2499dff" xlink:to="loc_us-gaap_IntersegmentEliminationMember_a99a89c1-f0dc-43ce-8067-900e97e0e4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_97facb81-9f4c-4c82-bfcf-b8107119fbda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_97facb81-9f4c-4c82-bfcf-b8107119fbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0d17bdb3-e2c2-4e10-97c1-ceacd20f88db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_97facb81-9f4c-4c82-bfcf-b8107119fbda" xlink:to="loc_us-gaap_SegmentDomain_0d17bdb3-e2c2-4e10-97c1-ceacd20f88db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InsuranceSegmentMember_83517b0c-0072-4d20-983b-06b2dfce672e" xlink:href="hum-20221231.xsd#hum_InsuranceSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d17bdb3-e2c2-4e10-97c1-ceacd20f88db" xlink:to="loc_hum_InsuranceSegmentMember_83517b0c-0072-4d20-983b-06b2dfce672e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CenterWellSegmentMember_cf54e971-97bb-4b93-8a92-2a35f17b5a88" xlink:href="hum-20221231.xsd#hum_CenterWellSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0d17bdb3-e2c2-4e10-97c1-ceacd20f88db" xlink:to="loc_hum_CenterWellSegmentMember_cf54e971-97bb-4b93-8a92-2a35f17b5a88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_bbf4a88d-ab7e-4824-9426-b8b1bd7ee519" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:to="loc_srt_MajorCustomersAxis_bbf4a88d-ab7e-4824-9426-b8b1bd7ee519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_bbf4a88d-ab7e-4824-9426-b8b1bd7ee519" xlink:to="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareAdvantageMember_cc37e4da-f7b0-4a06-96d1-d3060b3fa452" xlink:href="hum-20221231.xsd#hum_MedicareAdvantageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_MedicareAdvantageMember_cc37e4da-f7b0-4a06-96d1-d3060b3fa452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_GroupMedicareAdvantageMember_f9364f13-c261-4fcf-b9bb-27c4a783d288" xlink:href="hum-20221231.xsd#hum_GroupMedicareAdvantageMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_GroupMedicareAdvantageMember_f9364f13-c261-4fcf-b9bb-27c4a783d288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember_f75a0372-3583-47fb-bf83-2348eaa354ff" xlink:href="hum-20221231.xsd#hum_MedicareStandAlonePrescriptionDrugPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_MedicareStandAlonePrescriptionDrugPlanMember_f75a0372-3583-47fb-bf83-2348eaa354ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicareMember_7640f16d-6869-419e-ad77-9c339f149e01" xlink:href="hum-20221231.xsd#hum_MedicareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_MedicareMember_7640f16d-6869-419e-ad77-9c339f149e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_FullyInsuredMember_0e8e5a42-0016-4517-9f56-60bdb0a1740c" xlink:href="hum-20221231.xsd#hum_FullyInsuredMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_FullyInsuredMember_0e8e5a42-0016-4517-9f56-60bdb0a1740c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_SpecialtyMember_210f5e48-1766-4050-9753-e0fff11e7788" xlink:href="hum-20221231.xsd#hum_SpecialtyMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_SpecialtyMember_210f5e48-1766-4050-9753-e0fff11e7788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_MedicaidAndOtherMember_b9c07b97-d3c2-4639-9683-3a472ebe1d68" xlink:href="hum-20221231.xsd#hum_MedicaidAndOtherMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_MedicaidAndOtherMember_b9c07b97-d3c2-4639-9683-3a472ebe1d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_HomeSolutionsMember_2695be3e-d988-49a1-9420-6fd75fb6403f" xlink:href="hum-20221231.xsd#hum_HomeSolutionsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_HomeSolutionsMember_2695be3e-d988-49a1-9420-6fd75fb6403f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProviderMember_292db3aa-743e-4f2a-8854-3679d03cc8aa" xlink:href="hum-20221231.xsd#hum_ProviderMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_ProviderMember_292db3aa-743e-4f2a-8854-3679d03cc8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ASOAndOtherMember_62b3cde9-cb3d-45de-a860-735568c98111" xlink:href="hum-20221231.xsd#hum_ASOAndOtherMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_ASOAndOtherMember_62b3cde9-cb3d-45de-a860-735568c98111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PharmacyMember_4d58735f-7eca-4eb3-9f14-534278a9b0b0" xlink:href="hum-20221231.xsd#hum_PharmacyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_2a4c1cec-b5e1-4c54-bd38-8116092fd73c" xlink:to="loc_hum_PharmacyMember_4d58735f-7eca-4eb3-9f14-534278a9b0b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5fe31d14-e526-4490-af26-7827b2e2fff5" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:to="loc_srt_ProductOrServiceAxis_5fe31d14-e526-4490-af26-7827b2e2fff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_be4dc748-3625-4629-9da1-846283969196" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5fe31d14-e526-4490-af26-7827b2e2fff5" xlink:to="loc_srt_ProductsAndServicesDomain_be4dc748-3625-4629-9da1-846283969196" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_bae88f09-d5e7-414e-ad9c-62f6e957fc40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_be4dc748-3625-4629-9da1-846283969196" xlink:to="loc_us-gaap_ServiceMember_bae88f09-d5e7-414e-ad9c-62f6e957fc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductMember_584489ee-06b6-4d43-a721-aa3b2cbf3328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_be4dc748-3625-4629-9da1-846283969196" xlink:to="loc_us-gaap_ProductMember_584489ee-06b6-4d43-a721-aa3b2cbf3328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable_550e6507-1a32-4cbd-b553-55b6b24b664b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_3a0eaddb-1859-43b3-bc4c-f03f4b3a7ea3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_PremiumsEarnedNet_3a0eaddb-1859-43b3-bc4c-f03f4b3a7ea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_394b83f4-0d1e-4f47-9c17-43a64b363208" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_394b83f4-0d1e-4f47-9c17-43a64b363208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_90725eb1-0172-43cc-afce-2a037c8a391f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_Revenues_90725eb1-0172-43cc-afce-2a037c8a391f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_1fec3a0a-43a0-44f5-97bb-27698387d9ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_1fec3a0a-43a0-44f5-97bb-27698387d9ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_bb729c26-414f-43af-b587-dc4bc66e7bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare_bb729c26-414f-43af-b587-dc4bc66e7bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2fc3a199-7ce2-4740-a0b0-1f4695e02b69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_2fc3a199-7ce2-4740-a0b0-1f4695e02b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DepreciationAndAmortizationIncomeStatement_f412ab57-99e9-49a2-a038-065d6805432f" xlink:href="hum-20221231.xsd#hum_DepreciationAndAmortizationIncomeStatement"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_hum_DepreciationAndAmortizationIncomeStatement_f412ab57-99e9-49a2-a038-065d6805432f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BenefitsLossesAndExpenses_400c18e9-fb5a-4776-b6bc-10700f1b9409" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BenefitsLossesAndExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_BenefitsLossesAndExpenses_400c18e9-fb5a-4776-b6bc-10700f1b9409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e0fdb9e3-ce86-4ed9-95fa-16806dcbed98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_OperatingIncomeLoss_e0fdb9e3-ce86-4ed9-95fa-16806dcbed98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_e338fd41-c42c-4f70-b08e-490ec37d23fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_e338fd41-c42c-4f70-b08e-490ec37d23fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c83a31c1-fb0d-42ca-beaa-524d7e439e19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_InterestExpense_c83a31c1-fb0d-42ca-beaa-524d7e439e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_968b5fd4-f568-4d57-82b7-b32dbd15437b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_968b5fd4-f568-4d57-82b7-b32dbd15437b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_04d8e8a0-2942-48ec-9931-43adcc27b956" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_04d8e8a0-2942-48ec-9931-43adcc27b956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c987435b-8d25-4b2a-8ee3-dd89add11e39" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_c987435b-8d25-4b2a-8ee3-dd89add11e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82248c55-5aa8-48e1-b041-8f55a8adbbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_82248c55-5aa8-48e1-b041-8f55a8adbbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_92d5a320-ff16-4056-b99e-ae62d1e642c4" xlink:href="hum-20221231.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest_92d5a320-ff16-4056-b99e-ae62d1e642c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_4951eb24-9b31-4ad3-b784-31519733923f" xlink:href="hum-20221231.xsd#hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_edbda9a1-5f2e-4094-ae05-20ef12a6abfa" xlink:to="loc_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent_4951eb24-9b31-4ad3-b784-31519733923f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/REINSURANCEDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#REINSURANCEDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/REINSURANCEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InsuranceAbstract_cfbb3f8a-01cf-41e4-89ef-4a89e47be854" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InsuranceAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:href="hum-20221231.xsd#hum_ReinsuranceTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InsuranceAbstract_cfbb3f8a-01cf-41e4-89ef-4a89e47be854" xlink:to="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78af9072-c05f-4a18-8344-65cc078aa091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78af9072-c05f-4a18-8344-65cc078aa091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54c3f9a5-a70a-4e0e-b5a6-10acefe4cd91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_78af9072-c05f-4a18-8344-65cc078aa091" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54c3f9a5-a70a-4e0e-b5a6-10acefe4cd91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverableMember_83ad90d8-c180-453e-9e67-71001e9b0414" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_54c3f9a5-a70a-4e0e-b5a6-10acefe4cd91" xlink:to="loc_us-gaap_ReinsuranceRecoverableMember_83ad90d8-c180-453e-9e67-71001e9b0414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_52148fc4-6296-4454-b9cc-e59285f1f758" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_52148fc4-6296-4454-b9cc-e59285f1f758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9e44a867-d2e7-4fd7-89a1-06849e46a256" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_52148fc4-6296-4454-b9cc-e59285f1f758" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9e44a867-d2e7-4fd7-89a1-06849e46a256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsurerConcentrationRiskMember_7b403937-974a-46de-88ef-1d58e844e6fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsurerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9e44a867-d2e7-4fd7-89a1-06849e46a256" xlink:to="loc_us-gaap_ReinsurerConcentrationRiskMember_7b403937-974a-46de-88ef-1d58e844e6fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LongDurationInsuranceProductsAxis_163f0de6-553c-4545-9980-b4f9d99672cc" xlink:href="hum-20221231.xsd#hum_LongDurationInsuranceProductsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:to="loc_hum_LongDurationInsuranceProductsAxis_163f0de6-553c-4545-9980-b4f9d99672cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_LongDurationInsuranceProductsDomain_e8b14a8d-fb29-44d9-b506-779eb2c22341" xlink:href="hum-20221231.xsd#hum_LongDurationInsuranceProductsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_LongDurationInsuranceProductsAxis_163f0de6-553c-4545-9980-b4f9d99672cc" xlink:to="loc_hum_LongDurationInsuranceProductsDomain_e8b14a8d-fb29-44d9-b506-779eb2c22341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CoinsuranceAgreementMember_c52e8a9b-964b-46e2-9328-518460996730" xlink:href="hum-20221231.xsd#hum_CoinsuranceAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_LongDurationInsuranceProductsDomain_e8b14a8d-fb29-44d9-b506-779eb2c22341" xlink:to="loc_hum_CoinsuranceAgreementMember_c52e8a9b-964b-46e2-9328-518460996730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a4e7bddd-dde2-4403-b82a-c9cb217ebd1a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:to="loc_srt_ProductOrServiceAxis_a4e7bddd-dde2-4403-b82a-c9cb217ebd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4e39ac1e-1af5-4697-89da-292166261e69" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a4e7bddd-dde2-4403-b82a-c9cb217ebd1a" xlink:to="loc_srt_ProductsAndServicesDomain_4e39ac1e-1af5-4697-89da-292166261e69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProtectiveLifeInsuranceCompanyMember_22dda5d9-1ee8-4014-9351-7236d26896fd" xlink:href="hum-20221231.xsd#hum_ProtectiveLifeInsuranceCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4e39ac1e-1af5-4697-89da-292166261e69" xlink:to="loc_hum_ProtectiveLifeInsuranceCompanyMember_22dda5d9-1ee8-4014-9351-7236d26896fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AllOthersMember_41ad9785-e44a-4333-a0c3-3d2ee47114b1" xlink:href="hum-20221231.xsd#hum_AllOthersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_4e39ac1e-1af5-4697-89da-292166261e69" xlink:to="loc_hum_AllOthersMember_41ad9785-e44a-4333-a0c3-3d2ee47114b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectsOfReinsuranceLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hum_ReinsuranceTable_5d3c2f86-04bb-494e-994b-0e053fcb5916" xlink:to="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceRecoverables_d892b7a0-cc57-4d3f-8cab-81471a67aad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceRecoverables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_us-gaap_ReinsuranceRecoverables_d892b7a0-cc57-4d3f-8cab-81471a67aad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_PercentageOfCoinsuranceAgreement_03c5d3ae-e49a-4307-8de7-454c5edd2f5b" xlink:href="hum-20221231.xsd#hum_PercentageOfCoinsuranceAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_hum_PercentageOfCoinsuranceAgreement_03c5d3ae-e49a-4307-8de7-454c5edd2f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CededPremiumsWritten_157cb390-b49c-47c9-8800-a801e643a162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CededPremiumsWritten"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_us-gaap_CededPremiumsWritten_157cb390-b49c-47c9-8800-a801e643a162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_a00c6c8e-ccbe-4339-8a57-f59c2f91dc52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded_a00c6c8e-ccbe-4339-8a57-f59c2f91dc52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance_4c972f9c-8f0a-4187-9dbc-8f38d9d31521" xlink:href="hum-20221231.xsd#hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance_4c972f9c-8f0a-4187-9dbc-8f38d9d31521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer_eb36825f-015b-4f4a-b8ff-5f7da18d2542" xlink:href="hum-20221231.xsd#hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectsOfReinsuranceLineItems_980281e8-ef62-4fe9-8df8-fe15beb5dfad" xlink:to="loc_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer_eb36825f-015b-4f4a-b8ff-5f7da18d2542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_daa6aa5f-f631-4d55-a1b5-96be3ad46f78" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_73044ba8-f4a2-4810-b826-14d62d70f8db" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_daa6aa5f-f631-4d55-a1b5-96be3ad46f78" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_73044ba8-f4a2-4810-b826-14d62d70f8db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_7a0fef0c-4afa-4d6a-ae91-cb6289b666c1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_73044ba8-f4a2-4810-b826-14d62d70f8db" xlink:to="loc_srt_ConsolidatedEntitiesAxis_7a0fef0c-4afa-4d6a-ae91-cb6289b666c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_afc301da-b016-4f25-b0f5-a936092b250f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_7a0fef0c-4afa-4d6a-ae91-cb6289b666c1" xlink:to="loc_srt_ConsolidatedEntitiesDomain_afc301da-b016-4f25-b0f5-a936092b250f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_10528698-2b98-4bd1-887b-4c8f0d5b1d73" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_afc301da-b016-4f25-b0f5-a936092b250f" xlink:to="loc_srt_ParentCompanyMember_10528698-2b98-4bd1-887b-4c8f0d5b1d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_28abe6dd-dc98-44f2-9da5-828346a27814" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_73044ba8-f4a2-4810-b826-14d62d70f8db" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_28abe6dd-dc98-44f2-9da5-828346a27814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_28abe6dd-dc98-44f2-9da5-828346a27814" xlink:to="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97cae472-41df-42b9-8eee-80873abb9ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_97cae472-41df-42b9-8eee-80873abb9ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_7f669a31-87e6-46e7-9f78-3df7ab110882" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_ShortTermInvestments_7f669a31-87e6-46e7-9f78-3df7ab110882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent_7faf7d45-8965-4d2d-8d83-549b939b1091" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableRelatedPartiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_AccountsReceivableRelatedPartiesCurrent_7faf7d45-8965-4d2d-8d83-549b939b1091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b450c043-062f-4758-8f4b-0234a4447c83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_OtherAssetsCurrent_b450c043-062f-4758-8f4b-0234a4447c83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f022cd68-a4e9-40f1-80da-d3bde22640e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_3b582b3e-bb7f-4185-b0f2-f4b18f14d865" xlink:to="loc_us-gaap_AssetsCurrent_f022cd68-a4e9-40f1-80da-d3bde22640e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d9ac059e-e42e-4c93-897c-f0386980d819" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d9ac059e-e42e-4c93-897c-f0386980d819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InvestmentInRelatedPartiesAndSubsidiaries_eb409b8f-3fda-420d-9fef-5bf18d881ea2" xlink:href="hum-20221231.xsd#hum_InvestmentInRelatedPartiesAndSubsidiaries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_hum_InvestmentInRelatedPartiesAndSubsidiaries_eb409b8f-3fda-420d-9fef-5bf18d881ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1b9c40fc-41a1-47e2-983a-a6752f4e804b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1b9c40fc-41a1-47e2-983a-a6752f4e804b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a418f5f9-91f9-4339-ac81-03a2004720d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5df1e1e1-5930-4554-b49b-8675a6694312" xlink:to="loc_us-gaap_Assets_a418f5f9-91f9-4339-ac81-03a2004720d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_28abe6dd-dc98-44f2-9da5-828346a27814" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_bd0f8c09-7bc9-4eeb-ab5d-379538dd66da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_bd0f8c09-7bc9-4eeb-ab5d-379538dd66da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtCurrent_d97b15d4-504e-41ac-95c4-c9933b851f9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_DebtCurrent_d97b15d4-504e-41ac-95c4-c9933b851f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_7506258d-b28e-4c23-8ff1-4a57fde7af9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NotesPayableRelatedPartiesClassifiedCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent_7506258d-b28e-4c23-8ff1-4a57fde7af9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_BookOverdraftLiability_9f5425c9-f2b8-43c3-9aec-89ca3e7fdbe4" xlink:href="hum-20221231.xsd#hum_BookOverdraftLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_hum_BookOverdraftLiability_9f5425c9-f2b8-43c3-9aec-89ca3e7fdbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_d7d543b5-0d03-490c-9434-1bf5d72fca76" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_d7d543b5-0d03-490c-9434-1bf5d72fca76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_13a24593-e01a-49f9-80be-86c89f5e6fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_3748cf09-22a1-4da6-820d-9cbbb0023cfb" xlink:to="loc_us-gaap_LiabilitiesCurrent_13a24593-e01a-49f9-80be-86c89f5e6fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a416fe03-971a-4272-9d5f-1b182602107a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a416fe03-971a-4272-9d5f-1b182602107a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d16dc9e2-564a-432a-9336-a3db5622e010" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d16dc9e2-564a-432a-9336-a3db5622e010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_dba18ba1-6870-4f6e-9913-400c5d359b43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_Liabilities_dba18ba1-6870-4f6e-9913-400c5d359b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c2638d4f-437d-4ec1-8938-f7ac74766226" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c2638d4f-437d-4ec1-8938-f7ac74766226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_eb9b3199-3aea-44cc-94ab-edf551fdc448" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_PreferredStockValue_eb9b3199-3aea-44cc-94ab-edf551fdc448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_282757b4-1392-4a41-aa13-551a65e038e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_CommonStockValue_282757b4-1392-4a41-aa13-551a65e038e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3ba55266-860e-4e89-b244-85ce11f9f3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3ba55266-860e-4e89-b244-85ce11f9f3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_64418c3d-db7b-42b8-bea5-73d250525ee2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_64418c3d-db7b-42b8-bea5-73d250525ee2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_71e5494a-8e94-4323-9820-3abd1fe03a44" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_71e5494a-8e94-4323-9820-3abd1fe03a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_7df2611c-365c-4de0-bb24-c23f497b1d41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_TreasuryStockCommonValue_7df2611c-365c-4de0-bb24-c23f497b1d41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_faada2f9-b74c-4310-928c-0e69644cd284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_b22dd160-cdcf-4d0a-b5bf-7bc346574c00" xlink:to="loc_us-gaap_StockholdersEquity_faada2f9-b74c-4310-928c-0e69644cd284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_71dbd9bb-3e2d-4096-aa29-456c103b5207" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53565fb1-27ae-40c9-96f5-a2caef30bd6c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_71dbd9bb-3e2d-4096-aa29-456c103b5207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_9e1a335e-0ef1-4fe5-b28e-debcbf008c42" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_57cfddb1-c8c6-47a4-8c8e-62097a7f9cdc" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_9e1a335e-0ef1-4fe5-b28e-debcbf008c42" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_57cfddb1-c8c6-47a4-8c8e-62097a7f9cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_d3ef47ca-b46b-425c-876a-112dec3df96e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_57cfddb1-c8c6-47a4-8c8e-62097a7f9cdc" xlink:to="loc_srt_ConsolidatedEntitiesAxis_d3ef47ca-b46b-425c-876a-112dec3df96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_766418d6-7fdb-4f93-a87f-8f8eea905226" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_d3ef47ca-b46b-425c-876a-112dec3df96e" xlink:to="loc_srt_ConsolidatedEntitiesDomain_766418d6-7fdb-4f93-a87f-8f8eea905226" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_0df7013a-9286-47bd-b0b1-3628d7efa1b2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_766418d6-7fdb-4f93-a87f-8f8eea905226" xlink:to="loc_srt_ParentCompanyMember_0df7013a-9286-47bd-b0b1-3628d7efa1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_57cfddb1-c8c6-47a4-8c8e-62097a7f9cdc" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e1d6939d-4546-45f0-b9a1-6cf87ec26e7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_e1d6939d-4546-45f0-b9a1-6cf87ec26e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_b13d469e-4835-4314-af1b-da5e78ce4767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_b13d469e-4835-4314-af1b-da5e78ce4767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_33413aba-b451-4aa3-8046-2e79b551021e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_PreferredStockSharesIssued_33413aba-b451-4aa3-8046-2e79b551021e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_29a02692-5666-4280-82b6-694145dde4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_29a02692-5666-4280-82b6-694145dde4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_9f29355d-7510-4496-b607-3f4698c724a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_9f29355d-7510-4496-b607-3f4698c724a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_abc19f65-55dc-4786-813f-00001d7d17e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_CommonStockSharesIssued_abc19f65-55dc-4786-813f-00001d7d17e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_871be45c-0516-4851-965f-053ecc3f35ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4c7b8652-98fb-42eb-8038-a1be0d6dfb26" xlink:to="loc_us-gaap_TreasuryStockCommonShares_871be45c-0516-4851-965f-053ecc3f35ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_d8ce2da0-34d9-409a-9469-585aac23fa4a" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_ca01b424-318f-43bf-881d-dbee2f05e291" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_d8ce2da0-34d9-409a-9469-585aac23fa4a" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_ca01b424-318f-43bf-881d-dbee2f05e291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_1b1b80bb-c9fe-486a-b7b6-6fdd67816bcb" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_ca01b424-318f-43bf-881d-dbee2f05e291" xlink:to="loc_srt_ConsolidatedEntitiesAxis_1b1b80bb-c9fe-486a-b7b6-6fdd67816bcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_659e5bc2-7494-4cf0-8593-ec5a7a198490" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_1b1b80bb-c9fe-486a-b7b6-6fdd67816bcb" xlink:to="loc_srt_ConsolidatedEntitiesDomain_659e5bc2-7494-4cf0-8593-ec5a7a198490" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_6374c6ef-3d85-46ff-8cac-39d2bd95cbe4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_659e5bc2-7494-4cf0-8593-ec5a7a198490" xlink:to="loc_srt_ParentCompanyMember_6374c6ef-3d85-46ff-8cac-39d2bd95cbe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_ca01b424-318f-43bf-881d-dbee2f05e291" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ManagementFeesChargedToOperatingSubsidiaries_41ce7192-501d-4818-a8b0-9594a42651e5" xlink:href="hum-20221231.xsd#hum_ManagementFeesChargedToOperatingSubsidiaries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:to="loc_hum_ManagementFeesChargedToOperatingSubsidiaries_41ce7192-501d-4818-a8b0-9594a42651e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_InvestmentAndOtherIncomeNet_ada15007-ff8a-4843-9ff6-d76f33458be0" xlink:href="hum-20221231.xsd#hum_InvestmentAndOtherIncomeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:to="loc_hum_InvestmentAndOtherIncomeNet_ada15007-ff8a-4843-9ff6-d76f33458be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_40bb91e5-32f0-46e2-a021-7c19ab066081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_b35b795a-9719-4414-9c7d-44c369b0aa52" xlink:to="loc_us-gaap_Revenues_40bb91e5-32f0-46e2-a021-7c19ab066081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_695891c0-b14b-4ccd-8aad-3b8cc75bf00f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_695891c0-b14b-4ccd-8aad-3b8cc75bf00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_d2541420-fa52-4fb7-9d77-7ec9f4e5a6cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:to="loc_us-gaap_Depreciation_d2541420-fa52-4fb7-9d77-7ec9f4e5a6cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2e136c13-a973-4374-a069-70abd5889cfc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:to="loc_us-gaap_InterestExpense_2e136c13-a973-4374-a069-70abd5889cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_9624fdca-ac11-4578-9220-90daf87030af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d9d13cb4-f528-447d-972e-43de7ea7f016" xlink:to="loc_us-gaap_CostsAndExpenses_9624fdca-ac11-4578-9220-90daf87030af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_18e3743a-f7c0-4e23-b52f-2dda1b4ff222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_18e3743a-f7c0-4e23-b52f-2dda1b4ff222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_7a85ed72-97c8-44e9-b348-1d547e1ef1f4" xlink:href="hum-20221231.xsd#hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries_7a85ed72-97c8-44e9-b348-1d547e1ef1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_52e57589-9b2c-42bf-81cb-455eb634d83f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_52e57589-9b2c-42bf-81cb-455eb634d83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_93ba4c0b-f483-4cee-b55d-c496430fda81" xlink:href="hum-20221231.xsd#hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries_93ba4c0b-f483-4cee-b55d-c496430fda81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_EquityInNetEarningsOfSubsidiaries_a35b5d83-7091-4479-882a-2618b1a2a8cb" xlink:href="hum-20221231.xsd#hum_EquityInNetEarningsOfSubsidiaries"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_hum_EquityInNetEarningsOfSubsidiaries_a35b5d83-7091-4479-882a-2618b1a2a8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_783e2269-fb1c-49a0-9b18-47f44c049cea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_783e2269-fb1c-49a0-9b18-47f44c049cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f9a38658-c014-424a-ad22-3d6f2ff14bec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_fe8b835e-358c-4162-a5ff-d042e5565e03" xlink:to="loc_us-gaap_ProfitLoss_f9a38658-c014-424a-ad22-3d6f2ff14bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_9e671cfd-277f-44dd-a764-fb74e0dd3ee4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a5fb2686-7911-4f1f-be44-69f2244b811f" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_9e671cfd-277f-44dd-a764-fb74e0dd3ee4" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a5fb2686-7911-4f1f-be44-69f2244b811f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_69868bdf-34bd-4dd3-a83f-5e5b25c3e7ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a5fb2686-7911-4f1f-be44-69f2244b811f" xlink:to="loc_srt_ConsolidatedEntitiesAxis_69868bdf-34bd-4dd3-a83f-5e5b25c3e7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_e54a937b-dc6c-48d8-949b-c25fdbfde00e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_69868bdf-34bd-4dd3-a83f-5e5b25c3e7ca" xlink:to="loc_srt_ConsolidatedEntitiesDomain_e54a937b-dc6c-48d8-949b-c25fdbfde00e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_d33c9e39-1706-4be5-a065-dd5c07aa7cda" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_e54a937b-dc6c-48d8-949b-c25fdbfde00e" xlink:to="loc_srt_ParentCompanyMember_d33c9e39-1706-4be5-a065-dd5c07aa7cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_a5fb2686-7911-4f1f-be44-69f2244b811f" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c67658b7-87c2-4337-8675-b60519b47d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:to="loc_us-gaap_NetIncomeLoss_c67658b7-87c2-4337-8675-b60519b47d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_160638cd-b460-4d71-b267-ad2623b6147f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_160638cd-b460-4d71-b267-ad2623b6147f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_7f072a6e-2e9b-4e1a-878e-1df39525cc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_7f072a6e-2e9b-4e1a-878e-1df39525cc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4629a6a2-dbdb-4a7c-8841-14174c2d2e10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_4629a6a2-dbdb-4a7c-8841-14174c2d2e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_df0596bd-667b-4b12-9dd8-bd600fcdb9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax_df0596bd-667b-4b12-9dd8-bd600fcdb9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_b0b908a1-d83a-41a9-a430-5e47a59a5e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax_b0b908a1-d83a-41a9-a430-5e47a59a5e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_0956f03c-018d-415b-8e69-a1005c5d0aba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_0956f03c-018d-415b-8e69-a1005c5d0aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ecb53763-57c6-45b2-b1a4-427f033eb3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_ed4d2b30-1fff-4e20-8fa3-31c04b64c1f8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ecb53763-57c6-45b2-b1a4-427f033eb3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_1cd04ac5-9ca5-4af3-bf3c-163acbf45612" xlink:href="hum-20221231.xsd#hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:to="loc_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments_1cd04ac5-9ca5-4af3-bf3c-163acbf45612" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0c079e0d-fcdc-4fbc-ae7f-b682091727e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_32419195-bb77-4b81-859c-afd7c09ee005" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0c079e0d-fcdc-4fbc-ae7f-b682091727e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_d81c76d3-e091-4022-8a6f-0358324dd9b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f8418e94-8414-4188-8c02-a7c35b4760e7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_d81c76d3-e091-4022-8a6f-0358324dd9b6" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f8418e94-8414-4188-8c02-a7c35b4760e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_9affdf6a-7bf9-4e99-a3c5-48b485492e4c" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f8418e94-8414-4188-8c02-a7c35b4760e7" xlink:to="loc_srt_ConsolidatedEntitiesAxis_9affdf6a-7bf9-4e99-a3c5-48b485492e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_3ce1a933-ee79-43f7-bdb6-31eb43a96c02" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_9affdf6a-7bf9-4e99-a3c5-48b485492e4c" xlink:to="loc_srt_ConsolidatedEntitiesDomain_3ce1a933-ee79-43f7-bdb6-31eb43a96c02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ParentCompanyMember_6732c39d-4367-4387-9303-0422ea37f6c3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ParentCompanyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_3ce1a933-ee79-43f7-bdb6-31eb43a96c02" xlink:to="loc_srt_ParentCompanyMember_6732c39d-4367-4387-9303-0422ea37f6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_f8418e94-8414-4188-8c02-a7c35b4760e7" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_89a9b303-2e1f-44a2-a79a-19d1c65017bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_89a9b303-2e1f-44a2-a79a-19d1c65017bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_adc53b8e-f734-4204-9272-b6ee58d9164c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_adc53b8e-f734-4204-9272-b6ee58d9164c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_CapitalContributionsToOperatingSubsidiaries_bfbe3aab-9db2-4a5b-8057-6c600ec5e690" xlink:href="hum-20221231.xsd#hum_CapitalContributionsToOperatingSubsidiaries"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_hum_CapitalContributionsToOperatingSubsidiaries_bfbe3aab-9db2-4a5b-8057-6c600ec5e690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_4cd69ba7-5218-41cb-9938-b86b25869b19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_4cd69ba7-5218-41cb-9938-b86b25869b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_345ae31c-c026-4820-9ccf-78c842259ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_345ae31c-c026-4820-9ccf-78c842259ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_63390be6-41b2-459e-8541-415073159fef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_63390be6-41b2-459e-8541-415073159fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_56d6deed-d49e-4f2e-a14a-59d733a4f1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_56d6deed-d49e-4f2e-a14a-59d733a4f1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_091f741e-158b-4635-8e2f-15c921ec51a0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_42406725-66fb-425d-b1e4-332dcd2ea971" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_091f741e-158b-4635-8e2f-15c921ec51a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_a1dc77ec-5c80-46ce-9529-c9c1c71a9d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt_a1dc77ec-5c80-46ce-9529-c9c1c71a9d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d2af4f20-1b64-4eec-90f7-50d9b6e76437" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_d2af4f20-1b64-4eec-90f7-50d9b6e76437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfSeniorDebt_f9bf1156-7f8d-4e1e-b6fb-df83f947c859" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfSeniorDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_RepaymentsOfSeniorDebt_f9bf1156-7f8d-4e1e-b6fb-df83f947c859" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_1ac7da92-5ec7-46cf-a9dd-77988410b730" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfCommercialPaper"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfCommercialPaper_1ac7da92-5ec7-46cf-a9dd-77988410b730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromNotesPayable_3926a7b2-c4ce-4416-8b24-77ceb6419706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromNotesPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_ProceedsFromNotesPayable_3926a7b2-c4ce-4416-8b24-77ceb6419706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_8a6ff655-a8f7-4f9d-82c0-426fc56f56ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_8a6ff655-a8f7-4f9d-82c0-426fc56f56ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_a8a6e484-a3db-423f-8623-aa48e139ddc1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInBookOverdrafts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_IncreaseDecreaseInBookOverdrafts_a8a6e484-a3db-423f-8623-aa48e139ddc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_716009be-0d83-4911-82b8-3e6f6427873c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_716009be-0d83-4911-82b8-3e6f6427873c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_bef1dcc2-d838-4b16-a8f4-77598566dd5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_PaymentsOfDividends_bef1dcc2-d838-4b16-a8f4-77598566dd5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_ProceedsFromStockOptionsExercisedAndOther_62c2198f-d27e-4f12-81e2-5f72ed4b60bf" xlink:href="hum-20221231.xsd#hum_ProceedsFromStockOptionsExercisedAndOther"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_hum_ProceedsFromStockOptionsExercisedAndOther_62c2198f-d27e-4f12-81e2-5f72ed4b60bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ddcfb39a-1064-4d25-a72f-ad72a32ed7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d8a7ea05-c5b7-456c-aac5-e4a8fffff18b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ddcfb39a-1064-4d25-a72f-ad72a32ed7bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_17f62d34-a969-4513-865e-ad1eadbabc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_17f62d34-a969-4513-865e-ad1eadbabc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_737cbb4e-6806-49b4-a9dc-19845d2c8e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_737cbb4e-6806-49b4-a9dc-19845d2c8e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6cf4eede-8019-461b-b5b9-fb637947ad10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_a55888e7-22bc-4334-a03e-6877aa366e5e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_6cf4eede-8019-461b-b5b9-fb637947ad10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails" xlink:type="simple" xlink:href="hum-20221231.xsd#SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_546a3c3b-5566-4db6-bae0-2b5a8deed678" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_9115de38-0746-43f5-b8a7-31d005e1a920" xlink:href="hum-20221231.xsd#hum_DividendsToParentWithoutPriorStateRegulatoryApproval"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_546a3c3b-5566-4db6-bae0-2b5a8deed678" xlink:to="loc_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_9115de38-0746-43f5-b8a7-31d005e1a920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_83f0a4fc-4c44-4b11-90e8-de5bc9b15f20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_546a3c3b-5566-4db6-bae0-2b5a8deed678" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance_83f0a4fc-4c44-4b11-90e8-de5bc9b15f20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_970189a1-7a32-489c-a732-4c3e76693b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_546a3c3b-5566-4db6-bae0-2b5a8deed678" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired_970189a1-7a32-489c-a732-4c3e76693b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_f004b4c4-59b6-4a06-9508-096780ad937f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract_546a3c3b-5566-4db6-bae0-2b5a8deed678" xlink:to="loc_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval_f004b4c4-59b6-4a06-9508-096780ad937f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hum_DividendsToParentWithoutPriorStateRegulatoryApproval_cc6d119b-2337-4510-bf4b-99a4616c6e48" xlink:href="hum-20221231.xsd#hum_DividendsToParentWithoutPriorStateRegulatoryApproval"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>hum-20221231_g1.jpg
<TEXT>
begin 644 hum-20221231_g1.jpg
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M 0 "$0,1 #\ _?RBBB@ HK\]/VV/^"@7QV\=_M"?'7]C/]F?XB:3\/Y?@?\
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MB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\
M@,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_
M (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_
M .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-
M_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V**
M ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\ Z#=E_P"
MQ_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_ .@W9?\
M@,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH Q_L7C?\
MZ#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'_&C[%XW_
M .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P" Q_QK8HH
MQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H-V7_ (#'
M_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\ Z#=E_P"
MQ_QK8HH Q_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&MBB@#'^Q>-_P#H
M-V7_ (#'_&C[%XW_ .@W9?\ @,?\:V** ,?[%XW_ .@W9?\ @,?\:/L7C?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% 'A?[6'_);/@?\ ]CW+_P"DS5[I7A?[6'_);/@?
M_P!CW+_Z3-7NE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!_P#V/<O_ *3-7NE>
M%_M8?\EL^!__ &/<O_I,U>Z4 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X7^UA_R6SX'_ /8]
MR_\ I,U>Z5X7^UA_R6SX'_\ 8]R_^DS5[I0 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[/&D6.M_&KXEZ7X>BU2]^QZ1%?3_ +_4;G:6\FVA4&6XDVAF*1JS!5+$8!-
M'945S_PN^+'PS^-W@BS^)/PA\>:5XDT&_P!XM-6T:]2>%V1BCIN4G#HZLC(<
M,K*58 @BN@H **** /"_VL/^2V? _P#['N7_ -)FKW2O"_VL/^2V? __ +'N
M7_TF:O=* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **\ _;Q_X*1?LX_\$[_^%;?\- Z]]D_X6;\0+3PO
MI&V55^S>;_K;^7/2V@S'YC_P^:GK7O\ 0 4444 %%%% !1110 4444 %%%%
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M(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\
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M#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!X7^UA_R6SX'_\
M8]R_^DS5[I7A?[6'_);/@?\ ]CW+_P"DS5[I0 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P $\_VIH_V@/AQ9\K\$_C]J&-6M81_RQTS7EVG.,*D=R%AC5?XS7>_LZ_\
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M\%Z!;>+]+M?5I+JRD3"=?F"'/''-?H'10!\2_##_ (.*?^"/7Q+U3_A&[O\
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MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#PO]K#_DMGP/\
M^Q[E_P#29J]TKPO]K#_DMGP/_P"Q[E_])FKW2@ HHHH **** "BBB@ HHHH
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M6FVSW&HZGJ=VD%O:PH,M))(Y"H@ )+,0 .M?G_X^_P""QOQF_;%\9:C\ O\
M@B+\ X_BGJ%G<M9Z_P#'3Q>LUCX#\.2=&*SX$FJ2KU\N 8(*NOFKD55\,_\
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MO%'PR^T2_3^T;!,_\ ND0?\ 3TQK]_J* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /"_VL/^2V? _P#['N7_ -)F
MKW2O"_VL/^2V? __ +'N7_TF:O=* "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ***\ _X*1?\ !2+]G'_@E_\
MLXW_ .T+^T+K_P#>M_#/AFSE7[?X@O\ ;E+6W0_@7D/RQKEF[ @!_P %(O\
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MGASX5>!K$ZMXEU>5_P#5I%91'=&'_A>8QHV" Q/%?.?_  JK_@LC_P %6O\
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MO_!;7XZQWOAV.X2[T?\ 9D^%VH367A>P*G='_:=TC";5)EXR-VQ7#;)&1ME
M%_XC?\%E_BE^UCXWU']GG_@B5\!(_C#KEE<&SU[XS^)#+9> ?#,G=FN@ ^I2
M+U\JW^\"&1I0"*Z+]G'_ ((E>#9OBA9?M8_\%,_C%J'[2GQC@/FV-]XNM53P
MWX:8D-Y6E:0/W$*JP&)'4DLHD58V)K[.^'/PU^'GP?\ !.G?#7X4>!M(\->'
MM(MQ!I6AZ%IT=I:6D0Z)'%$ J#J>!U)-;= "*JHH1%  &  .E+110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'RK^V;_P
M1K_8:_;4\3I\6?$?@2^\"_$ZUD\[2_BW\+]2;0_$5I/C F-S ,7##H#.LF!T
MQUKQ#^W/^"Y__!-+Y?$NBZ=^VG\*+/\ Y?\ 1XH]%^(.F6X[M!\T&J;5P $W
M3RL"24!K]&:* /F7]BG_ (*\_L*_MWZG)X&^$WQ5;1/'MFS1ZO\ "[QW9MH_
MB33YE&7B>RG(,I3^)H3*BYP6!XKZ:KP#]M;_ ()??L._\% ],C3]IGX%:;J>
MM6:K_9'C/3"UAKFF,IRC07\!690K88(S-'D#*&OF7_A0/_!;+_@FK_I7[+GQ
MKM?VN/A;9<CX<_%S44T[QG8VX_Y9V>M >5>L .MR!V5(\\T ?HS17QU^RA_P
M6_\ V+_VC?'J_ 'XG7>N_!+XNQ,L5Y\*OC+IIT74C*> +:27$-V&(.SRW\QU
M&[RP#7V+0 45\@?M1_\ !>K_ ()/?L7?';7?V:/VE_VK/^$:\;>&OLO]MZ)_
MP@NNWGV;[1:Q74/[ZUL987W0SQ/\KG&[!PP('G__ !%'?\$*/^CYO_,9>)__
M )64 ??]%? '_$4=_P $*/\ H^;_ ,QEXG_^5E>@?LN?\%ZO^"3W[:/QVT+]
MFC]FC]JS_A)?&WB7[5_8FB?\(+KMG]I^SVLMU-^^NK&*%-L,$K_,XSMP,L0"
M ?7]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 >%_M8?\EL^!__ &/<O_I,U>Z5X7^UA_R6SX'_ /8]R_\ I,U>Z4 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 45\Z_M,_\ !6__ ()I_L?&XMOV
MA/VTO >BW]KG[1H=KK"ZAJ<>/6RLQ+<#T_U=>!'_ (+G_$KX^?Z'_P $XO\
M@E/\=OC LW%EXJ\2:7%X/\.7&>C)J&H9W#N08U."/6@#]!ZAU'4=/TBPFU35
MK^&UM;>,R7%S<2A(XD R69FP% '<U^?Q^&W_  <:_M3#/C?]H3X'?LQ:%<=+
M3P)X;E\7>((4/5)9;XK9[L<!XB,=>H%3:=_P;O\ [-/Q-OH?$/[?G[37QO\
MVC]1602O9_$CXBW4.CQ2 Y!@L+%H5A3/.PNZY]N* /2/VA?^"[7_  2A_9LU
M%O#?C#]LCPSKNO&3R8?#G@$R^(;Z6?H(?+TY)A'(3QB0I[XKS ?\%<_V_?VC
MS]F_8 _X(Q?%#4+&?B#QE\=-3M?!FGHO:=+>8R3W41[",JQ!S@<BOKG]GG]B
MG]D/]DS3AIG[,_[,_@?P,OE[))_#7AJVM;B8?]-9D022GW=F)]:]/H _/?\
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M "-?_!,7XF:]_P ]O%'PR^T2_3^T;!,_\ ND0?\ 3TQK]_J "BN(_:$_:2^
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M\IU_@9_W,W_J,:M7P!7W_P#\&N/_ "G7^!G_ ',W_J,:M0!_7[1110 4444
M%%%% !1110 4444 %%%% !1110!\K_MD?\%,;#X#>)_%_P %_@+\)=0^(OQ
M\$>$[7Q#XMM+>ZM[73/#EG<R^7:_;KB65&\Z?:[1P0K)(50NP1,,WI7[-?[6
MB?'SQOXT^$?BKX(^+OA_XS\ ?V>_B'0?%,=K)'+!?+.;6[L[JTGFANK>3[-.
M-P965HV1T1E*C\Z_^"UW['W[:O[+GQI^)'_!4C]B*6S\7>%_B#X+T[1OC_\
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MG^)C1-#]OL9,JUCIDH_%9Y@0RY\M0,EC_.10!^_W_!MU_P '(N?[!_X)Z?\
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M6N/(UM=#2ZU-<=/].N?,N3^,G7FO?:S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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MIXL,OGW'CGQL[ZYK,UP3DSBYO3(T+D]3"(P?2OJ?_A,?#'_0:@_[ZH ^!/\
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M_P"#H[_E.O\ '/\ [EG_ -1C2:^ *_LJ_:C_ ."(W_!';]M'X[:[^TO^TO\
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M:V,<>\"W8@':!GGFOH'^SM/_ .?&'_OT*\1_:P_Y+9\#_P#L>Y?_ $F:O=*
M(?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_
M +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L
M[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA
M_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?
M[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[
M]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3
M_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?
M^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.
MT_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"
MIJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^
M?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_
M0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T_
M_GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ
M* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"H]<UW1/#&C77B/Q+K-IIVGV,#3WM
M_?7"PPV\2C+.[N0J* ,DD@ 5\)_%;_@O!\,/&_CJ^^ ?_!+GX"^)_P!J3XA6
MK^3=R>!L6WA;2)#P&OM<F'V=$Z$-'O1N5WJ: /N]K#344N]G  !DDQC %?%?
M[2O_  7#_8X^%7Q"E_9Y_9C\,:Y^T3\7#N2+X>?!G31JAMG!P3>WR VUI&K<
M2$L[QX)9!7!+_P $MO\ @H#_ ,%!V&N_\%??VT)M+\'W1WM^SU\ [F;2=$:,
M\^1J6I,?M6H C >/(4,N8Y,&OM3]FG]DK]FC]CCX>Q?"S]EWX(>'? ^A1[3)
M9Z#IRQ-<N!@23R\R7$F/^6DK,Y[F@#\YOC__ ,$G?^"C/_!;/0K%_P#@J%XU
M\#? WP)IL\E_X4^%/PTT6UUO7+*Z:-D26^UFX4JKKNP\=K^ZE4 $(P##^>#_
M (*1_P#!-S]H[_@E]^T=?_L]?M"Z#_>N/#/B:SB;[!X@L-V%NK=C^ >,_-&V
M5;L3_;Y7@'_!2+_@F[^SC_P5 _9QO_V>OVA= _O7'AGQ-9Q+]O\ #]_MPEU;
MN?P#QGY9%RK=B #^0+_@FY_P3<_:._X*@_M'6'[/7[/6@_W;CQ-XFO(F^P>'
M[#=AKJX8?B$C'S2-A5[D?U\_\$XO^":?[-'_  3&_9RT_P#9[^ 'AE'(VW'B
M7Q-?P(;_ %^^VX>ZN' ^H2,?+&N%7N3)_P $W?\ @F[^SC_P2_\ V<;#]GK]
MGK0/[MQXF\37D2_;_$%_MP]U<./Q"1CY8UPJ]R??Z (?[.T__GQA_P"_0H_L
M[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ\^_:%_:Q_9D_
M9,\*GQM^TS\>_"?@73"K&&X\3Z[#:&X(ZK"CL'F;_80,Q["@#N_[.T__ )\8
M?^_0H_L[3_\ GQA_[]"OS]O?^"](_:&O)?#7_!*?]@KXK?M$7)D,47C :6?#
M/A)'SCY]4U%5Y!R=OE#<!PW>HO\ AD;_ (+H_MH_Z1^UM^WQX8_9Z\*W7,O@
M7]G32&GUAHCT276[W+V\P&<M;AD)Z#T /KK]I3]K[]C[]COPW_PEG[47QZ\%
M^!;-HR]N/$6K003W0'400$^;.W!^6-6/!XKY!F_X+A^(_P!IB5]$_P""3_\
MP3>^)OQU$C%+?Q]KFFCPGX1YXWK?Z@H>7;]XQ^6C$8 .3QZC^S7_ ,$)/^"9
M_P"S;XD_X60?@,/B)XXDD$MYX^^+NH2>)-6N9ATF+7FZ**3_ &XHXS7U]##%
M;Q+;V\2I&BA41%P% X  '04 ?G</V$?^"T/[9W^D_ML?\%#M#^"/ABZYG^'O
M[,>B&&^,9Z*^NWH,\,H'#>4KQDDD< 5Z]^R]_P $.?\ @F7^RGK7_"<^%OV;
M=/\ %GC&2437?COXE3OXAU>XG_Y[^=>EUAD./O0I'^IKZUHH @73=.50JV$
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M_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\
MSXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344
M0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_
M 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9
MVG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#
M_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_
MV=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_W
MZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG
M_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=
MI_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%
M344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 1)8V4;!X[.)6'0K& 14M%%
M !1110 4444 %%%% !1110 4444 %%%% !1110!X7^UA_P EL^!__8]R_P#I
M,U>Z5X7^UA_R6SX'_P#8]R_^DS5[I0 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 45P'[1O[5'[./[(GP]F^*O[3?QJ\.^"- AR!J
M'B'4D@$[@9\N%"=\\F.D<:LY[ U\3R?\%6?V[/\ @H#(WA[_ (([?L6W"^%;
MD[!^T+\=[>?1_#NP\>?I]@!]KU$8Y5P %9</'B@#[X^)WQ5^&/P4\$WWQ*^,
M7Q#T3PKX=TR/S-0USQ#JD5G:6R^KRRLJK[9/-?"7B+_@MO\ $?\ :OUV[^&7
M_!&']CW7?C=>0SM;7GQ8\41RZ%X%TJ0'#,;N<)+?,A!S#"$9A@HSUI?#'_@A
M#X"^)/C>Q^.__!5?]H;Q/^U#X\M)?/L]/\78LO"6CR'JMEHD!\@+R5/F[T<
M$QJ:^[?#OASP]X0T*T\+^$]!LM+TRP@6"QT[3K5((+:)1A4CC0!44#@   4
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M%J_VT_\ 1?V(O^"=.F?!'PM=?ZCXB_M.:FT-\8CU:/0K+=/%*!ROFL\9) /
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/@D&'RIK_2=*4W]RGI->2;KB?_MI(U>P444 %%%>8?M1?MI_LG_L5>"SX_\
MVJ_C_P"&/ VFLC-;'7-25)[S;U6WMUS-<N/[D2.WM0!Z?4&J:IIFB:;/K.M:
MC!9V=K"TMU=74RQQPQJ,L[,Q 50 22> !7YYG_@K?^W!^W"?['_X)#?\$]]7
MU/0;D[8/CC\>1+X>\,!#P+BUM!_IFHQ'(YCV,"#E#4^E_P#!#OX@?M4ZC;^-
M?^"Q'[<OC/XY2K*LZ?##PU._AOP59N#E4^QVC+)=E" %FD=&89WJV: .G^-O
M_!?3]D+0O'5Q\"_V,?"WBS]IGXEQ_+_PBGP5TIM1M+5LX#W>IC_18(<@AI%:
M79CYE%<C_P ,_P#_  72_P""@O\ I'[3/[16A?LE_#Z[Y?P'\&9UU;Q?/"?^
M65SK<G[JTD&>);0$<8*5]R_!+X ? []FSP+;_#+]GWX1>'/!?A^UYAT?PSH\
M-E!NQ@NRQ* SG'+MEF/))-==0!\Q?L;_ /!'C_@GY^PYJ_\ PG/PC^!MOJOC
M>63SK_XD^-[AM9\07<Y^],;RYW-"S?Q" 1J?[M?3M%% 'R!^U'_P05_X)/?M
MH_';7?VE_P!I?]E/_A)?&WB7[+_;>M_\)UKMG]I^SVL5K#^YM;Z*%-L,$2?*
M@SMR<L23Y_\ \0N/_!"C_HQG_P R;XG_ /EG7W_10!\ ?\0N/_!"C_HQG_S)
MOB?_ .6=>@?LN?\ !!7_ ()/?L7?';0OVE_V:/V4_P#A&O&WAK[5_8FM_P#"
M=:[>?9OM%K+:S?N;J^EA?=#/*GS(<;LC# $?7]% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-R=T_P #O@,9?#WA@(>3;W5V?],U&(Y/$FQ@0,.:^Q/V7OV+/V3_ -BKP6/
M'[*GP \,>!M-9%6Y&AZ:J3WFWHUQ<-F:Y<?WY7=O>@#XZ_XWY_\ !0O_ *%+
M]B_X<W@_Z9^*/'5W ?\ OFTL=R_[L\+-_$17J'[+W_!#']@?]G/QH/C1XS\'
M:O\ &+XG2NLMY\3_ (UZLWB+5I9AR)$^T#R8&4YVM'&K@'&\U]B44    P!@
M#H!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M18VW&B_#[3K>;/J9$A#L?<DFO7;>W@M8$MK6!(XXU"QQQJ J@=  .@H _/\
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MV\$^$7@N[YD^#G[-)>SFEB/_ "RO=<G#3N2/EDCC#1/D[2M 'NW[9'_!8?\
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MVL*Q6MK:PK''#&HPJ*J@!5    X %3T4 %%%% !1110 4444 %%%% !1110
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MUN89!"2Y?).X%<@#UKZE^Q>-_P#H-V7_ (#'_&O(_P!K#_DMGP/_ .Q[E_\
M29J]TH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@
M,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_
M !K8HH Q_L7C?_H-V7_@,?\ &OP-_P"#X:#6X?\ AF'^V;V&;/\ PFOE^3%M
MQ_R <Y]>U?T%5^ /_!\Y_P VN_\ <[?^X"@#\ :*** "OZQ_AO\ \&]WQH^
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M!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\
M8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B
M\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%%
M&/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\
MC1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-
M;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P
M&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8
M_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&
M[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;L
MO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+Q
MO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&_
M_0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_
M &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?
M8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q1
M0!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_
M (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
MC6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_
M\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P
M&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]
M!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&
M[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B
M\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+Q
MO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8
M_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-
M'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL
M44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8
M_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_
M (UL44 9=G:>+4ND>^U:U>(-^\1+<@D>QK4HHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** /"_VL/\ DMGP/_['N7_TF:O=*\+_ &L/^2V? _\ ['N7
M_P!)FKW2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "OX Z_O\HH _@#HK^_RB@#\ ?^#&/_FZ+_N2
M?_<_7[_444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >
M%_M8?\EL^!__ &/<O_I,U>Z5X7^UA_R6SX'_ /8]R_\ I,U>Z4 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!X7^UA_R6SX'_\ 8]R_^DS5[I7A?[6'_);/@?\ ]CW+_P"DS5[I
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'A?[6'_);/@?_P!CW+_Z3-7NE>%_M8?\EL^!_P#V
M/<O_ *3-7NE !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 >%_M8?\EL^!__ &/<O_I,U>Z5X7^U
MA_R6SX'_ /8]R_\ I,U>Z4 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\
MSXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V
M=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#S
MXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_
M ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V
M=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:
M@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_
MT&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ
M_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A
M,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@
M_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#
M'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?
M#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X
M3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?
MH4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SX
MP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_
M //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=
MI_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?
MH4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\
M^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I
M_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]
MG:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^
MJN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#
M'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3
M'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X
M3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_O
MJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'
M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0
M!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP
M_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_
M9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP
M_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@
M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M*3N^4-@B@#W>BN=\&?$G0O%?PGTGXOWKII>F:EX=@UB9KZ=56S@D@6<F1^%
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M^(_V==%\*F:W\)^#=-UG7O$(O?E@NK^XNH[:P6$1G>_E6<TSMO!17@^4^:"
M#T.BOF[]G_\ X*:_"+]H_P#;>\?_ +#7@OX:^.-+U[X<^&+76M:U7Q7X>DTN
M&X2Y=!$MO#<;;A@5D#;Y(XQV /6D_;X_X*4^$_V$=8\)^#8?V9OBY\7O$_B^
M*]N;+PG\&?!_]M:C:V=KY0EO+B(2(8X=\\:!N=S$@?=. #Z2HKX<_9F_X+?:
M+^T3^U7X._9'\0_\$X_VFOA=KOC:UU*ZT?4_BO\ #N+1;(V]C;^=<2[I;G>Z
MKNAC/EH^'N(@<;P:^XZ "BBB@ HHHH **** "BBB@ HI)'$:-(P)"@DA5)/X
M <FOG#]G/_@IG\(_VF_VTOB1^Q/X(^&WC?2M<^&&@6.IZ[J?BWP^^EQW*W9!
MA6""?%P5*,K[Y(X\AN >M 'TA17@?[:G[>%A^R7-HW@CP1^SYX]^+OQ!\1VT
M]UHW@'X<Z4MQ=+9P%%EO;N:1EBL[97D2,22-EY'"HKD-MXW_ ()U?\%;?@Y_
MP4$\9^-/@;+\*O&7PN^+'PZ9#XR^&'Q"TY;;4;2!R ES$58B:$ED!;"D&1"5
MVR1LX!]745Y[\:/CQ_PJKQW\-_AKI'A7^VM8^(OBY])MK<7WD"QM(;&YO;N_
M<['W)%';! N!OEGA3<N\&OE7]JK_ (+C:/\ LMP77Q9O_P!@WXS>)/@GI.II
M9ZS\:]%TRT&F*&E$1N[>WDF6XN+/>0JW12.*7(,32*T;. ?=E%8?A;XD>#/'
M'PUTWXO>#=7.J^'M8T.'6-*O].MI)C>64L(FBEBC13))OC96554L<@ $G%>(
M?L7_ /!2?X4?MP_''XR? _X;_#CQEH5W\%=5TW3?$%QXQT;^SI+NXNUNF'E6
M[GSD15MLYE5&;S =@') /HNBN,_:+^->@?LX? ;QA\>O$UC+=V?A'P[=ZI)8
M6[8EO6AB9TMHN#F25PL:  DLZ@ DXKS+]MO_ (*">#/^"?/[)\_[47[0WPH\
M7W:Z?I$-SK&A>!M'EU864[&)'B>[VQ01QK-,J"69HMXRRJ<%0 ?0%%<_\)_B
M!9_%CX5^&OBII^GR6EOXE\/V>JP6L[AGA2X@2948C@D!P"1QQ7SSH/\ P4ON
M_B5\'->_:H^ W[+WB?QK\)- DU KXNT_6;&"[UZUL)98KN]TNQED#7,"M#,$
M,KP/-Y1,:.&C+@'U-17,_!GXP?#K]H+X3>&_CC\(_$D6L>&/%NBV^JZ#J<*L
MHN+6>,21MM8!D.&&58!E(((!!%=-0 4444 %%%% !1110 4444 %%?-W[1O_
M  4V^$/[-_[7'PH_8S\1?#7QQ>^)/BYX@DTO0]9B\.R6^CV[11++*S7D^Q9V
M57C^6 2X+X8J017J7[37[2'@#]E/X07_ ,8OB'8ZSJ%O;30VNG:%X:TI[_5-
M9OIY!%;V-E;)\T]Q+(RJJ# '+,5168 '?T5\*? W_@N;X,\4?M9>&OV-OVL_
MV-?BO\ /%7C[>/AS<_$?3H!8>()%./LZ3PR,J7!RH$?S+N94+AGC5_K;]I#X
MVZ'^S;\ _&'QZ\1:;+?6OA+P]=:G_9MLV)K^2*,M%:Q<'][-)LB08.7D48.<
M4 =K17S!^TW_ ,%#?B3\"EC\)_"O]A3XC?&'QGINBV^H>.-#^'+V\MGX;:2(
M2?99+VY:(7-R0=R6\,;S-&4D9(UEBW]A_P $]OV_/@?_ ,%)_P!FRQ_:6^!$
M6JVEA+J%QIFL:'K]H(+_ $?48"OG6EPBLRAU#HP*L05D0\9( ![?17S=XS_X
M*;?"'PA_P4)\ _\ !.*3X:^.&\6>/K'5+VR\07GAV2RT>*&PM9YY?+GN-C73
M$P[ 84>/YP3)T!^D: "BO)OA/^U7I_Q+^#OB3XZR?#_5TT#2O%FL:3H2Z%:7
M&K7FN6UA?26'VR*VMX?,"S3PS%%4./*"2EPKG;SW_!.G_@H'\,O^"E7P%O?V
MB?A%X*\0Z%HEOXMU#0H+3Q3;QPWKO:,BO(\4;N(LEN$+%ACG!X ![U17@OCC
M]MZ:X^.OB?\ 9J_9J^">J?$WQ?X%TNTOO'266M6FFV&AFZ1I+2SEN;EOGO)H
MU,BPHC!8\-*\0>/?N_L8_MI_"']N+X7WWQ$^%L&J:9>Z!XAN_#_C/PEXBME@
MU7PUK-J^RYT^\B1W594)!RC,C*RLK$&@#UVBBB@ HHHH **** "BBB@ HHKP
MC_@H=_P4"^%?_!-S]G75_P!I#XN> O&OB#2M)A5Y;7P?X;EO"NZ6.%#-.=MO
M:H9)8UW2R*3N^4-@B@#W>BN=\&?$G0O%?PGTGXOWKII>F:EX=@UB9KZ=56S@
MD@6<F1^% 13RW3@FO@[XL_\ !P]X$^",EE\5_B5_P3\^/^E? O4-1AM;7XXW
MOA!8M.>*9]D-\;5G%PEI(2K1R.JO(K*5C+,J$ _1.BL_PGXJ\-^._"VF>-_!
MNMVVIZ1K.GPWVE:C9RAX;JVF0212HPX961E8$=017SWJ/_!1BS@^#4OQ1\+_
M +/GBOQAJFL^-=<T+X;^"_!)CO=2\46^FWDMI)J>9?)ALK,O"[F::3RUCDMS
MO9[B.)@#Z4HKY/\ V!?^"KW@C]M7XT^.OV5?''P \;?"'XN_#NUBOO$'P_\
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M\-:/XNU*.XU75)=CR7-RPA_=Q0 -!&@&YF9926P H /H*BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFJC;MTN[E^SV\EG=OO01@QO%(Q(64[3@ ^JR0!DG '4FO*O@#^W!^R=^U/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 ?)?B'_@NS_P $AO">OWWA;Q'^WQX#M-0TR\EM;^TFNY=\,T;E'1OW
M?4,"#]*J?\/^/^"-O_20GX?_ /@7-_\ &Z_#7_@B9_P2U_9/_P""I'_!1C]I
MCP%^U?I&N7FG^%=4O=0TE=#UI[)UFDU>>-BS*#N&WM7ZE_\ $(=_P1M_Z$KX
M@?\ A=S?_$4 >_\ _#_C_@C;_P!)"?A__P"!<W_QNC_A_P ?\$;?^DA/P_\
M_ N;_P"-UX!_Q"'?\$;?^A*^('_A=S?_ !%'_$(=_P $;?\ H2OB!_X7<W_Q
M% 'O_P#P_P"/^"-O_20GX?\ _@7-_P#&Z/\ A_Q_P1M_Z2$_#_\ \"YO_C=>
M ?\ $(=_P1M_Z$KX@?\ A=S?_$4?\0AW_!&W_H2OB!_X7<W_ ,10![__ ,/^
M/^"-O_20GX?_ /@7-_\ &Z/^'_'_  1M_P"DA/P__P# N;_XW7@'_$(=_P $
M;?\ H2OB!_X7<W_Q%'_$(=_P1M_Z$KX@?^%W-_\ $4 >_P#_  _X_P""-O\
MTD)^'_\ X%S?_&Z/^'_'_!&W_I(3\/\ _P "YO\ XW7@'_$(=_P1M_Z$KX@?
M^%W-_P#$4?\ $(=_P1M_Z$KX@?\ A=S?_$4 >_\ _#_C_@C;_P!)"?A__P"!
M<W_QNC_A_P ?\$;?^DA/P_\ _ N;_P"-UX!_Q"'?\$;?^A*^('_A=S?_ !%'
M_$(=_P $;?\ H2OB!_X7<W_Q% 'O_P#P_P"/^"-O_20GX?\ _@7-_P#&Z/\
MA_Q_P1M_Z2$_#_\ \"YO_C=> ?\ $(=_P1M_Z$KX@?\ A=S?_$4?\0AW_!&W
M_H2OB!_X7<W_ ,10![__ ,/^/^"-O_20GX?_ /@7-_\ &Z/^'_'_  1M_P"D
MA/P__P# N;_XW7@'_$(=_P $;?\ H2OB!_X7<W_Q%'_$(=_P1M_Z$KX@?^%W
M-_\ $4 >_P#_  _X_P""-O\ TD)^'_\ X%S?_&Z/^'_'_!&W_I(3\/\ _P "
MYO\ XW7@'_$(=_P1M_Z$KX@?^%W-_P#$4?\ $(=_P1M_Z$KX@?\ A=S?_$4
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M_&Z/^'_'_!&W_I(3\/\ _P "YO\ XW7@'_$(=_P1M_Z$KX@?^%W-_P#$4?\
M$(=_P1M_Z$KX@?\ A=S?_$4 >_\ _#_C_@C;_P!)"?A__P"!<W_QNC_A_P ?
M\$;?^DA/P_\ _ N;_P"-UX!_Q"'?\$;?^A*^('_A=S?_ !%'_$(=_P $;?\
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M('_A=S?_ !%'_$(=_P $;?\ H2OB!_X7<W_Q% 'O_P#P_P"/^"-O_20GX?\
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M@?\ A=S?_$4 >_\ _#_C_@C;_P!)"?A__P"!<W_QNC_A_P ?\$;?^DA/P_\
M_ N;_P"-UX!_Q"'?\$;?^A*^('_A=S?_ !%'_$(=_P $;?\ H2OB!_X7<W_Q
M% 'O_P#P_P"/^"-O_20GX?\ _@7-_P#&Z/\ A_Q_P1M_Z2$_#_\ \"YO_C=>
M ?\ $(=_P1M_Z$KX@?\ A=S?_$4?\0AW_!&W_H2OB!_X7<W_ ,10![__ ,/^
M/^"-O_20GX?_ /@7-_\ &Z/^'_'_  1M_P"DA/P__P# N;_XW7@'_$(=_P $
M;?\ H2OB!_X7<W_Q%'_$(=_P1M_Z$KX@?^%W-_\ $4 >_P#_  _X_P""-O\
MTD)^'_\ X%S?_&Z/^'_'_!&W_I(3\/\ _P "YO\ XW7@'_$(=_P1M_Z$KX@?
M^%W-_P#$4?\ $(=_P1M_Z$KX@?\ A=S?_$4 >_\ _#_C_@C;_P!)"?A__P"!
M<W_QNC_A_P ?\$;?^DA/P_\ _ N;_P"-UX!_Q"'?\$;?^A*^('_A=S?_ !%'
M_$(=_P $;?\ H2OB!_X7<W_Q% 'O_P#P_P"/^"-O_20GX?\ _@7-_P#&Z/\
MA_Q_P1M_Z2$_#_\ \"YO_C=> ?\ $(=_P1M_Z$KX@?\ A=S?_$4?\0AW_!&W
M_H2OB!_X7<W_ ,10![__ ,/^/^"-O_20GX?_ /@7-_\ &Z/^'_'_  1M_P"D
MA/P__P# N;_XW7@'_$(=_P $;?\ H2OB!_X7<W_Q%'_$(=_P1M_Z$KX@?^%W
M-_\ $4 >_P#_  _X_P""-O\ TD)^'_\ X%S?_&Z/^'_'_!&W_I(3\/\ _P "
MYO\ XW7@'_$(=_P1M_Z$KX@?^%W-_P#$4?\ $(=_P1M_Z$KX@?\ A=S?_$4
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M_&Z/^'_'_!&W_I(3\/\ _P "YO\ XW7@'_$(=_P1M_Z$KX@?^%W-_P#$4?\
M$(=_P1M_Z$KX@?\ A=S?_$4 >_\ _#_C_@C;_P!)"?A__P"!<W_QNC_A_P ?
M\$;?^DA/P_\ _ N;_P"-UX!_Q"'?\$;?^A*^('_A=S?_ !%'_$(=_P $;?\
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M('_A=S?_ !%'_$(=_P $;?\ H2OB!_X7<W_Q% 'O_P#P_P"/^"-O_20GX?\
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M&S1/^R@:]_Z.2@#]/J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _ '
M_@TV_P"4IG[7?_;Q_P"GR>OW^K\ ?^#3;_E*9^UW_P!O'_I\GK]_J "BBB@
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MP7XV\&>)IO#GCWPM]J,\5K?Q(C^9!(0"T+J_ ;YD9'0E@H=P#ZXHKSK]K/\
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MUS\+["ZL]&\;Z*+V&POB#-9S+(\,]NY'#-'/%+'N'#;,C@T >K4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<OCR?%?BMKC0/AWH%Q(G@'P#%<[HK"(\&YN".)KN1<;Y.BCY$PHY^.*_8?\
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M']&^(=[XS\2^)_$<_B'QUXSU"T%N^K:E,J(S)"&?R8E5%"H78Y+L3ESCA?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'X _\ !IM_RE,_:[_[>/\ T^3U^_U?R>_\$N_^"POPV_X(
M]_\ !0/]HKXD?$CX.ZYXQ@\8ZY?Z;;6VAW\,#V[Q:M/*78RC!!!Q@5^@G_$;
MS^RS_P!&/?$#_P **Q_PH _;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_]
M&/?$#_PHK'_"@#]OJ*_$'_B-Y_99_P"C'OB!_P"%%8_X4?\ $;S^RS_T8]\0
M/_"BL?\ "@#]MM6TG2M?TJYT+7=,M[VQO;=X+RSNX5DBGB=2KQNC AE9205(
M(()!KX0_8W_X-T?^">_[%'[;WB7]MGX;>%;B]OKVX$_@;PMJB+)I_@R5P?/D
MLP<EF9B?+9\F!"53LP^./^(WG]EG_HQ[X@?^%%8_X4?\1O/[+/\ T8]\0/\
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M_P#1CWQ _P#"BL?\* /V^HK\0?\ B-Y_99_Z,>^('_A16/\ A1_Q&\_LL_\
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MEG_HQ[X@?^%%8_X4?\1O/[+/_1CWQ _\**Q_PH \_P#^(&/_ *RB_P#F$_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% '"7?[+7[,=_=RW]_\ LY^
MYYYY&DFFF\(63/(Y.2S$Q9)).234?_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!
M_P ,G_LL_P#1M7P__P#"-L?_ (U1_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4
M<!_PR?\ LL_]&U?#_P#\(VQ_^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_
M  R?^RS_ -&U?#__ ,(VQ_\ C5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P
M'_#)_P"RS_T;5\/_ /PC;'_XU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\
M#)_[+/\ T;5\/_\ PC;'_P"-4?\ #)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?
M\,G_ ++/_1M7P_\ _"-L?_C5'_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,
MG_LL_P#1M7P__P#"-L?_ (U1_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4 <!_P
MR?\ LL_]&U?#_P#\(VQ_^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?
M^RS_ -&U?#__ ,(VQ_\ C5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)
M_P"RS_T;5\/_ /PC;'_XU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[
M+/\ T;5\/_\ PC;'_P"-4?\ #)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_
M ++/_1M7P_\ _"-L?_C5'_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL
M_P#1M7P__P#"-L?_ (U1_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\
MLL_]&U?#_P#\(VQ_^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_
M -&U?#__ ,(VQ_\ C5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"R
MS_T;5\/_ /PC;'_XU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\
MT;5\/_\ PC;'_P"-4?\ #)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/
M_1M7P_\ _"-L?_C5'_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1
MM7P__P#"-L?_ (U1_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]
M&U?#_P#\(VQ_^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U
M?#__ ,(VQ_\ C5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;
M5\/_ /PC;'_XU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\
M/_\ PC;'_P"-4?\ #)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7
MP_\ _"-L?_C5'_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P_
M_P#"-L?_ (U1_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#
M_P#\(VQ_^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__
M ,(VQ_\ C5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_
M /PC;'_XU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\
MPC;'_P"-4?\ #)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7P_\
M_"-L?_C5'_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P__P#"
M-L?_ (U1_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#_P#\
M(VQ_^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__ ,(V
MQ_\ C5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_ /PC
M;'_XU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\ PC;'
M_P"-4?\ #)_[+/\ T;5\/_\ PC;'_P"-5W]% ' ?\,G_ ++/_1M7P_\ _"-L
M?_C5'_#)_P"RS_T;5\/_ /PC;'_XU7?T4 <!_P ,G_LL_P#1M7P__P#"-L?_
M (U1_P ,G_LL_P#1M7P__P#"-L?_ (U7?T4 <!_PR?\ LL_]&U?#_P#\(VQ_
M^-4?\,G_ ++/_1M7P_\ _"-L?_C5=_10!P'_  R?^RS_ -&U?#__ ,(VQ_\
MC5'_  R?^RS_ -&U?#__ ,(VQ_\ C5=_10!P'_#)_P"RS_T;5\/_ /PC;'_X
MU1_PR?\ LL_]&U?#_P#\(VQ_^-5W]% ' ?\ #)_[+/\ T;5\/_\ PC;'_P"-
M5U?A#P1X+^'VC+X<\!>$-+T/3UD:1;#2-/CMH0[?>8)&H7)[G'-:E% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
@4 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337052992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-5975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HUMANA INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">61-0647538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 West Main Street<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">40202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">580-1000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.16 2/3 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HUM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 59,158,438,222<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,974,862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Parts II and III incorporate herein by reference portions of the Registrant&#8217;s Definitive Proxy Statement to be filed pursuant to Regulation 14A with respect to the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000049071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337175072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">PricewaterhouseCoopers LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Louisville, Kentucky<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">238<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337440736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 5,061<span></span>
</td>
<td class="nump">$ 3,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investment securities</a></td>
<td class="nump">13,881<span></span>
</td>
<td class="nump">13,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesNetCurrent', window );">Receivables, net of allowances of $70 in 2022 and $83 in 2021</a></td>
<td class="nump">1,674<span></span>
</td>
<td class="nump">1,814<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,567<span></span>
</td>
<td class="nump">6,493<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">26,183<span></span>
</td>
<td class="nump">24,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,221<span></span>
</td>
<td class="nump">3,073<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Long-term investment securities</a></td>
<td class="nump">380<span></span>
</td>
<td class="nump">780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">9,142<span></span>
</td>
<td class="nump">11,092<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="nump">749<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">3,380<span></span>
</td>
<td class="nump">4,379<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">43,055<span></span>
</td>
<td class="nump">44,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Benefits payable</a></td>
<td class="nump">9,264<span></span>
</td>
<td class="nump">8,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Trade accounts payable and accrued expenses</a></td>
<td class="nump">5,238<span></span>
</td>
<td class="nump">4,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BookOverdraftLiability', window );">Book overdraft</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Unearned revenues</a></td>
<td class="nump">286<span></span>
</td>
<td class="nump">254<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt</a></td>
<td class="nump">2,092<span></span>
</td>
<td class="nump">1,953<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">17,178<span></span>
</td>
<td class="nump">15,331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">9,034<span></span>
</td>
<td class="nump">10,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">1,473<span></span>
</td>
<td class="nump">2,383<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">27,685<span></span>
</td>
<td class="nump">28,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 17)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $1 par; 10,000,000 shares authorized; none issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at December 31, 2022 and 198,648,742 shares issued at December 31, 2021</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Capital in excess of par value</a></td>
<td class="nump">3,246<span></span>
</td>
<td class="nump">3,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">25,492<span></span>
</td>
<td class="nump">23,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(1,304)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 73,691,955 shares at December 31, 2022 and 69,846,758 shares at December 31, 2021</a></td>
<td class="num">(12,156)<span></span>
</td>
<td class="num">(10,163)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">15,311<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">59<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">15,370<span></span>
</td>
<td class="nump">16,103<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 43,055<span></span>
</td>
<td class="nump">$ 44,358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BookOverdraftLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Book Overdraft Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BookOverdraftLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-06(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e604059-122996<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339149840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Receivables, allowance for doubtful accounts</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par (in dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par (in dollars per share)</a></td>
<td class="nump">$ 0.1667<span></span>
</td>
<td class="nump">$ 0.1667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">198,666,598<span></span>
</td>
<td class="nump">198,648,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">73,691,955<span></span>
</td>
<td class="nump">69,846,758<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504343779936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList', window );">Services</a></td>
<td class="text">Health Care [Member]<span></span>
</td>
<td class="text">Health Care [Member]<span></span>
</td>
<td class="text">Health Care [Member]<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 87,712<span></span>
</td>
<td class="nump">$ 79,822<span></span>
</td>
<td class="nump">$ 74,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services</a></td>
<td class="nump">4,776<span></span>
</td>
<td class="nump">3,055<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment income</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">92,870<span></span>
</td>
<td class="nump">83,064<span></span>
</td>
<td class="nump">77,155<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="nump">75,690<span></span>
</td>
<td class="nump">69,199<span></span>
</td>
<td class="nump">61,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">12,671<span></span>
</td>
<td class="nump">10,121<span></span>
</td>
<td class="nump">10,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">89,070<span></span>
</td>
<td class="nump">79,916<span></span>
</td>
<td class="nump">72,169<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">3,800<span></span>
</td>
<td class="nump">3,148<span></span>
</td>
<td class="nump">4,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of KAH Hospice</a></td>
<td class="num">(237)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">68<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net (losses) earnings</a></td>
<td class="nump">3,568<span></span>
</td>
<td class="nump">3,354<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">762<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="nump">1,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net (losses) earnings</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,802<span></span>
</td>
<td class="nump">2,934<span></span>
</td>
<td class="nump">3,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss (income) attributable to noncontrolling interests</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Humana</a></td>
<td class="nump">$ 2,806<span></span>
</td>
<td class="nump">$ 2,933<span></span>
</td>
<td class="nump">$ 3,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 22.20<span></span>
</td>
<td class="nump">$ 22.79<span></span>
</td>
<td class="nump">$ 25.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 22.08<span></span>
</td>
<td class="nump">$ 22.67<span></span>
</td>
<td class="nump">$ 25.31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DepreciationAndAmortizationIncomeStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation and amortization expense excluding depreciation and amortization primarily from the delivery of pharmacy services by our wholly-owned pharmacy business (included in our Healthcare Services segment) which has been reclassified to benefit expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DepreciationAndAmortizationIncomeStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5,6,7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920602&amp;loc=SL49130690-203046-203046<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504343899600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Humana</a></td>
<td class="nump">$ 2,806<span></span>
</td>
<td class="nump">$ 2,933<span></span>
</td>
<td class="nump">$ 3,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Change in gross unrealized investment (losses) gains</a></td>
<td class="num">(1,819)<span></span>
</td>
<td class="num">(356)<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Effect of income taxes</a></td>
<td class="nump">418<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Total change in unrealized investment (losses) gains, net of tax</a></td>
<td class="num">(1,401)<span></span>
</td>
<td class="num">(275)<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Reclassification adjustment for net realized losses (gains) included in investment income</a></td>
<td class="nump">72<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax', window );">Effect of income taxes</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Total reclassification adjustment, net of tax</a></td>
<td class="nump">55<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(1,346)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments', window );">Comprehensive income attributable to equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Humana</a></td>
<td class="nump">$ 1,460<span></span>
</td>
<td class="nump">$ 2,584<span></span>
</td>
<td class="nump">$ 3,602<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Comprehensive Income (Loss), Net of Tax, Attributable To Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504338324416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Cumulative Effect, Period of Adoption, Adjustment</div></th>
<th class="th"><div>Total Stockholders' Equity</div></th>
<th class="th">
<div>Total Stockholders' Equity </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Capital&#160;In Excess&#160;of Par Value</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th">
<div>Retained Earnings </div>
<div>Cumulative Effect, Period of Adoption, Adjustment</div>
</th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Noncontrolling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 12,037<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 12,037<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 2,820<span></span>
</td>
<td class="nump">$ 17,483<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
<td class="num">$ (8,455)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">3,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,367<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(1,820)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,820)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(263)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,557)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends and dividend equivalents</a></td>
<td class="num">(331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock unit vesting (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock unit vesting</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">13,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,728<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">2,705<span></span>
</td>
<td class="nump">20,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">391<span></span>
</td>
<td class="num">(9,918)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(341)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends and dividend equivalents</a></td>
<td class="num">(364)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(364)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(364)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock unit vesting</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(81)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">16,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">3,082<span></span>
</td>
<td class="nump">23,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="num">(10,163)<span></span>
</td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,802<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,806<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders', window );">Distribution to noncontrolling interest holders, net</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation', window );">Sale of KAH Hospice</a></td>
<td class="num">(11)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Acquisition</a></td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(1,346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Common stock repurchases</a></td>
<td class="num">(2,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,096)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends and dividend equivalents</a></td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Restricted stock unit vesting (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross', window );">Restricted stock unit vesting</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 15,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,311<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33<span></span>
</td>
<td class="nump">$ 3,246<span></span>
</td>
<td class="nump">$ 25,492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,304)<span></span>
</td>
<td class="num">$ (12,156)<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate value of stock related to Restricted Stock Awards issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337190768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 2,802<span></span>
</td>
<td class="nump">$ 2,934<span></span>
</td>
<td class="nump">$ 3,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of KAH Hospice</a></td>
<td class="num">(237)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Loss (gain) on investment securities, net</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="num">(838)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on Kindred at Home equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,129)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net losses (earnings)</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="num">(74)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">216<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">749<span></span>
</td>
<td class="nump">640<span></span>
</td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="nump">96<span></span>
</td>
<td class="nump">73<span></span>
</td>
<td class="nump">88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment of property and equipment</a></td>
<td class="nump">248<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">(Benefit) provision for deferred income taxes</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effect of businesses acquired and dispositions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="num">(54)<span></span>
</td>
<td class="num">(280)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(463)<span></span>
</td>
<td class="num">(491)<span></span>
</td>
<td class="num">(581)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities', window );">Benefits payable</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">2,139<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">44<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Unearned revenues</a></td>
<td class="nump">32<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="nump">71<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other, net</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">4,587<span></span>
</td>
<td class="nump">2,262<span></span>
</td>
<td class="nump">5,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested', window );">Proceeds from sale of KAH Hospice, net</a></td>
<td class="nump">2,701<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash and cash equivalents acquired</a></td>
<td class="num">(337)<span></span>
</td>
<td class="num">(4,187)<span></span>
</td>
<td class="num">(709)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment, net</a></td>
<td class="num">(1,120)<span></span>
</td>
<td class="num">(1,316)<span></span>
</td>
<td class="num">(964)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of investment securities</a></td>
<td class="num">(6,049)<span></span>
</td>
<td class="num">(7,197)<span></span>
</td>
<td class="num">(9,125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of investment securities</a></td>
<td class="nump">1,365<span></span>
</td>
<td class="nump">2,597<span></span>
</td>
<td class="nump">4,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sales of investment securities</a></td>
<td class="nump">2,434<span></span>
</td>
<td class="nump">3,547<span></span>
</td>
<td class="nump">2,747<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,006)<span></span>
</td>
<td class="num">(6,556)<span></span>
</td>
<td class="num">(3,065)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PaymentsForProceedsFromContractDeposits', window );">Receipts (withdrawals) from contract deposits, net</a></td>
<td class="nump">1,993<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="num">(939)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes, net</a></td>
<td class="nump">1,982<span></span>
</td>
<td class="nump">2,984<span></span>
</td>
<td class="nump">1,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayment of senior notes</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">(Repayments) proceeds from issuance of commercial paper, net</a></td>
<td class="num">(376)<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of term loan</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="num">(2,078)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issue costs</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(2,096)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="num">(1,820)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(392)<span></span>
</td>
<td class="num">(354)<span></span>
</td>
<td class="num">(323)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInBookOverdrafts', window );">Change in book overdraft</a></td>
<td class="num">(28)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other, net</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(1,914)<span></span>
</td>
<td class="nump">3,015<span></span>
</td>
<td class="num">(1,955)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">1,667<span></span>
</td>
<td class="num">(1,279)<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">3,394<span></span>
</td>
<td class="nump">4,673<span></span>
</td>
<td class="nump">4,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">5,061<span></span>
</td>
<td class="nump">3,394<span></span>
</td>
<td class="nump">4,673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest payments</a></td>
<td class="nump">354<span></span>
</td>
<td class="nump">285<span></span>
</td>
<td class="nump">258<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income tax payments, net</a></td>
<td class="nump">758<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="nump">1,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract', window );"><strong>Details of businesses acquired in purchase transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired, net of cash acquired</a></td>
<td class="nump">460<span></span>
</td>
<td class="nump">9,804<span></span>
</td>
<td class="nump">819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Less: Fair value of liabilities assumed</a></td>
<td class="num">(70)<span></span>
</td>
<td class="num">(3,235)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired', window );">Less: Noncontrolling interests acquired</a></td>
<td class="num">(53)<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment', window );">Less: Remeasured existing Kindred at Home equity method investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,360)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquired businesses, net of cash acquired</a></td>
<td class="nump">$ 337<span></span>
</td>
<td class="nump">$ 4,187<span></span>
</td>
<td class="nump">$ 709<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Or Part Noncash Acquisition Noncontrolling Interest Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Or Part Noncash Acquisition Remeasurement Of Equity Investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_PaymentsForProceedsFromContractDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For (Proceeds From) Contract Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_PaymentsForProceedsFromContractDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInBookOverdrafts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash during the period due to the net increase or decrease in book overdrafts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInBookOverdrafts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126938201&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in health care insurance liability balances during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the cash inflow during the period from the sale of a component of the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504341360112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REPORTING ENTITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">REPORTING ENTITY</a></td>
<td class="text">REPORTING ENTITY<div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc., headquartered in Louisville, Kentucky, is a leading health and well-being company committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well&#8208;being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools, such as in&#8208;home care, behavioral health, pharmacy services, data analytics and wellness solutions, combine to produce a simplified experience that makes health care easier to navigate and more effective. References throughout these notes to consolidated financial statements to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;Company,&#8221; and &#8220;Humana,&#8221; mean Humana Inc. and its subsidiaries. We derived approximately 82% of our total premiums and services revenue from contracts with the federal government in 2022, including 14% related to our federal government contracts with the Centers for Medicare and Medicaid Services, or CMS, to provide health insurance coverage for individual Medicare Advantage members in Florida. CMS is the federal government&#8217;s agency responsible for administering the Medicare program.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Segment Realignment </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2022, we realigned our businesses into two distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period segment financial information has been recast to conform to the 2022 presentation. For a recast of prior period segment financial information, refer to Note 18 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI https://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504427695328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Our consolidated financial statements include the accounts of Humana Inc. and subsidiaries that the Company controls, including variable interest entities associated with medical practices for which we are the primary beneficiary. We do not own many of our medical practices but instead enter into exclusive management agreements with the affiliated Professional Associations, or P.A.s, that operate these medical practices. Based upon the provisions of these agreements, these affiliated P.A.s are variable interest entities and we are the primary beneficiary, and accordingly we consolidate the affiliated P.A.s. All significant intercompany balances and transactions have been eliminated.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Creation Initiatives</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473&#160;million included within operating costs in the consolidated statement of income for the year ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The emergence and spread of the novel coronavirus, or COVID-19, beginning in the first quarter of 2020 has impacted our business. During periods of increased incidences of COVID-19, a reduction in non-COVID-19 hospital admissions for non-emergent and elective medical care have resulted in lower overall healthcare system utilization. At the same time, COVID-19 treatment and testing costs increased utilization. During 2022, we experienced lower overall utilization of the healthcare system than anticipated, as the reduction in COVID-19 utilization following the increased incidence associated with the Omicron variant outpaced the increase in non-COVID-19 utilization. The significant disruption in utilization during 2020 also impacted our ability to implement clinical initiatives to manage health care costs and chronic conditions of our members, and appropriately document their risk profiles, and, as such, significantly affected our 2021 revenue under the risk adjustment payment model for Medicare Advantage plans. Finally, changes in utilization patterns and actions taken in 2020 and 2021 as a result of the COVID-19 pandemic, including the suspension of certain financial recovery programs for a period of time and shifting the timing of claim payments and provider capitation surplus payments, impacted our claim reserve development and operating cash flows for 2020 and 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act and The Health Care and Education Reconciliation Act of 2010 (which we collectively refer to as the Health Care Reform Law) enacted significant reforms to various aspects of the U.S. health insurance industry. Certain of these reforms became effective January 1, 2014, including an annual insurance industry premium-based fee. The Continuing Resolution bill, H.R. 195, enacted on January 22, 2018, included a one year suspension in 2019 of the health insurance industry fee, but the fee resumed in calendar year 2020. The Further Consolidated Appropriations Act, 2020, enacted on December 20, 2019, permanently repealed the health insurance industry fee beginning in calendar year 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The annual premium-based fee on health insurers was not deductible for tax purposes. We estimated a liability for the health insurance industry fee and recorded it in full once qualifying insurance coverage was provided in the applicable calendar year in which the fee was payable with a corresponding deferred cost that was amortized ratably to expense over the same calendar year. We recorded the liability for the health insurance industry fee in trade accounts payable and accrued expenses and recorded the deferred cost in other current assets in our consolidated financial statements. We paid the health insurance industry fee in September or October of each year. We paid the federal government $1.18 billion for the annual health insurance industry fee attributed to calendar year 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2017, we filed suit against the United States of America in the United States Court of Federal Claims, on behalf of our health plans seeking recovery from the federal government of approximately $611&#160;million in payments under the risk corridor premium stabilization program established under Health Care Reform, for years 2014, 2015 and 2016. On April 27, 2020, the U.S. Supreme Court ruled that the government is obligated to pay the losses under this risk corridor program and that Congress did not implicitly repeal the obligation under its appropriations riders. In September 2020, we received a $609&#160;million payment from the U.S Government pursuant </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the judgement issued by the Court of Federal Claims on July 7, 2020. The $609&#160;million payment received from the U.S Government and approximately $31&#160;million in related fees and expenses are reflected in Premiums revenue and Operating costs, respectively, in our consolidated statements of income for the year ended December 31, 2020 and reported in the Corporate segment.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash, time deposits, money market funds, commercial paper, other money market instruments, and certain U.S. Government securities with an original maturity of three months or less. Carrying value approximates fair value due to the short-term maturity of the investments.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities, which consist of debt and equity securities, are stated at fair value. Our debt securities have been categorized as available for sale. Debt securities available for current operations, as well as our equity securities, are classified as current assets, and debt securities available to fund our professional and other self-insurance liability requirements, as well as restricted statutory deposits, are classified as long-term assets. For the purpose of determining realized gross gains and losses for debt securities sold, that are included as a component of investment income in the consolidated statements of income, the cost of investment securities sold is based upon specific identification. Unrealized holding gains and losses for debt securities, net of applicable deferred taxes, are included in other comprehensive income or loss as a component of stockholders&#8217; equity until realized from a sale or an expected credit loss is recognized. For the purpose of determining gross gains and losses for equity securities, changes in fair value at the reporting date are included as a component of investment income in the consolidated statements of income.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on January 1, 2020, we adopted the new current expected credit losses, or CECL, model which retained many similarities from the previous other-than-temporary impairment model except eliminating from consideration in the impairment analysis the length of time over which the fair value had been less than cost. Also, under the CECL model, expected losses on available for sale debt securities are recognized through an allowance for credit losses rather than as reductions in the amortized cost of the securities. For debt securities whose fair value is less than their amortized cost which we do not intend to sell or are not required to sell, we evaluate the expected cash flows to be received as compared to amortized cost and determine if an expected credit loss has occurred. In the event of an expected credit loss, only the amount of the impairment associated with the expected credit loss is recognized in income with the remainder, if any, of the loss recognized in other comprehensive income.  To the extent we have the intent to sell the debt security or it is more likely than not we will be required to sell the debt security before recovery of our amortized cost basis, we recognize an impairment loss in income in an amount equal to the full difference between the amortized cost basis and the fair value.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential expected credit loss impairment is considered using a variety of factors, including the extent to which the fair value has been less than cost; adverse conditions specifically related to the industry, geographic area or financial condition of the issuer or underlying collateral of a debt security; changes in the quality of the debt security's credit enhancement; payment structure of the debt security; changes in credit rating of the debt security by the rating agencies; failure of the issuer to make scheduled principal or interest payments on the debt security and changes in prepayment speeds. For debt securities, we take into account expectations of relevant market and economic data. For example, with respect to mortgage and asset-backed securities, such data includes underlying loan level data and structural features such as seniority and other forms of credit enhancements. We estimate the amount of the expected credit loss component of a debt security as the difference between the amortized cost and the present value of the expected cash flows of the security. The present value is determined using the best estimate of future cash flows discounted at the implicit interest rate at the date of purchase. The expected credit loss cannot exceed the full difference between the amortized cost basis and the fair value.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables and Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally establish one-year commercial membership contracts with employer groups, subject to cancellation by the employer group on 30-day written notice. Our Medicare contracts with CMS renew annually. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our military services contracts with the federal government and certain contracts with various state Medicaid programs generally are multi-year contracts subject to annual renewal provisions.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive monthly premiums from the federal government and various states according to government specified payment rates and various contractual terms. We bill and collect premium from employer groups and members in our Medicare and other individual products monthly.  Changes in premium revenues resulting from the periodic changes in risk-adjustment scores derived from medical diagnoses for our membership are estimated by projecting the ultimate annual premium and are recognized ratably during the year, with adjustments each period to reflect changes in the ultimate premium. Receivables or payables are classified as current or long-term in our consolidated balance sheet based on the timing of the expected settlement. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums revenue is estimated by multiplying the membership covered under the various contracts by the contractual rates. Premiums revenue is recognized as income in the period members are entitled to receive services and is net of estimated uncollectible amounts, retroactive membership adjustments, and adjustments to recognize rebates under the minimum benefit ratios required under the Health Care Reform Law. We estimate policyholder rebates by projecting calendar year minimum benefit ratios for the small group and large group markets, as defined by the Health Care Reform Law using a methodology prescribed by Health and Human Services, or HHS, separately by state and legal entity. Medicare Advantage and Medicaid products are also subject to minimum benefit ratio requirements. Estimated calendar year rebates recognized ratably during the year are revised each period to reflect current experience. Retroactive membership adjustments result from enrollment changes not yet processed, or not yet reported by an employer group or the government. We routinely monitor the collectability of specific accounts, the aging of receivables, historical retroactivity trends, estimated rebates, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. Premiums received prior to the service period are recorded as unearned revenues.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Part D</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with CMS. The payments we receive monthly from CMS and members, which are determined from our annual bid, represent amounts for providing prescription drug insurance coverage. We recognize premiums revenue for providing this insurance coverage ratably over the term of our annual contract. Our CMS payment is subject to risk sharing through the Medicare Part D risk corridor provisions. In addition, receipts for reinsurance and low-income cost subsidies as well as receipts for certain discounts on brand name prescription drugs in the coverage gap represent payments for prescription drug costs for which we are not at risk.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk corridor provisions compare costs targeted in our bids to actual prescription drug costs, limited to actual costs that would have been incurred under the standard coverage as defined by CMS. Variances exceeding certain thresholds may result in CMS making additional payments to us or require us to refund to CMS a portion of the premiums we received. As risk corridor provisions are considered in our overall annual bid process, we estimate and recognize an adjustment to premiums revenue related to these provisions based upon pharmacy claims experience. We record a receivable or payable at the contract level and classify the amount as current or long-term in our consolidated balance sheets based on the timing of expected settlement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance and low-income cost subsidies represent funding from CMS in connection with the Medicare Part D program for which we assume no risk. Reinsurance subsidies represent funding from CMS for its portion of prescription drug costs which exceed the member&#8217;s out-of-pocket threshold, or the catastrophic coverage level. Low-income cost subsidies represent funding from CMS for all or a portion of the deductible, the coinsurance and co-payment amounts above the out-of-pocket threshold for low-income beneficiaries. Monthly prospective payments from CMS for reinsurance and low-income cost subsidies are based on assumptions submitted with our annual bid. A reconciliation and related settlement of CMS&#8217;s prospective subsidies against actual prescription drug costs we paid is made after the end of the year. The Health Care Reform Law mandates consumer discounts of 50% on brand name prescription drugs for Part D plan participants in the coverage gap. These discounts are funded by CMS and pharmaceutical manufacturers while we administer the application of these funds. We account for these subsidies </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and discounts as a deposit in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits, net in our consolidated statements of cash flows. </span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"/><td style="width:56.896%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.472%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part D subsidy/discount payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part D subsidy/discount reimbursements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reimbursements (payments)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,968&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(938)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not recognize premiums revenue or benefit expenses for these subsidies or discounts. Receipt and payment activity is accumulated at the contract level and recorded in our consolidated balance sheets in other current assets or trade accounts payable and accrued expenses depending on the contract balance at the end of the reporting period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlement of the reinsurance and low-income cost subsidies as well as the risk corridor payment is based on a reconciliation made approximately 9 months after the close of each calendar year. Settlement with CMS for brand name prescription drug discounts is based on a reconciliation made approximately 14 to 18 months after the close of each calendar year. We continue to revise our estimates with respect to the risk corridor provisions based on subsequent period pharmacy claims data. See Note 7 for detail regarding amounts recorded to our consolidated balance sheets related to the risk corridor settlement and subsidies from CMS with respect to the Medicare Part D program.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services Revenue</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient services revenue </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient services include services related to pharmacy, provider services, and home solutions services, such as home health and other services and capabilities to promote wellness and advance population health. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our pharmacy business, external pharmacy revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through our CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Services revenues related to product revenues from dispensing prescriptions are recorded when the prescription or product is shipped.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provider services business recognizes revenues for certain value-based arrangements. Under these value-based arrangements, we enter into agreements with health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our patients. In exchange, we receive a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our patients. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our home solutions businesses, revenues include net patient services revenue recorded based upon established billing rates, net of contractual allowances, discounts, or other implicit price concessions, and are recognized as performance obligations are satisfied, which is in the period services are rendered.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the&#160;year ended December&#160;31, 2022, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price), was not material. Further, revenue expected to be recognized in any future year related to remaining performance obligations is not material.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Administrative services fees </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Administrative services fees cover the processing of claims, offering access to our provider networks and clinical programs, and responding to customer service inquiries from members of self-funded groups. Revenues from providing administration services, also known as administrative services only, or ASO, are recognized in the period services are performed and are net of estimated uncollectible amounts. ASO fees are estimated by multiplying the membership covered under the various contracts by the contractual rates. Under ASO contracts, self-funded employers retain the risk of financing substantially all of the cost of health benefits. However, many ASO customers purchase stop loss insurance coverage from us to cover catastrophic claims or to limit aggregate annual costs. Accordingly, we have recorded premiums revenue and benefits expense related to these stop loss insurance contracts. We routinely monitor the collectability of specific accounts, the aging of receivables, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. ASO fees received prior to the service period are recorded as unearned revenues.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under our TRICARE contracts with the Department of Defense (DoD) we provide administrative services, including offering access to our provider networks and clinical programs, claim processing, customer service, enrollment, and other services, while the federal government retains all of the risk of the cost of health benefits. We account for revenues under our contracts net of estimated health care costs similar to an administrative services fee only agreement. Our contracts include fixed administrative services fees and incentive fees and penalties. Administrative services fees are recognized as services are performed.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our TRICARE members are served by both in-network and out-of-network providers in accordance with our contracts. We pay health care costs related to these services to the providers and are subsequently reimbursed by the DoD for such payments. We account for the payments of the federal government&#8217;s claims and the related reimbursements under deposit accounting in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits,net in our consolidated statements of cash flows.  </span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:56.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost reimbursements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reimbursements (payments)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables, including premium receivables, patient services revenue receivables, and ASO fee receivables, are shown net of allowances for estimated uncollectible accounts, retroactive membership adjustments, and contractual allowances.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At&#160;December&#160;31, 2022 and 2021, accounts receivable related to services were $291 million and $475 million, respectively. For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the consolidated balance sheet at&#160;December&#160;31, 2022 and 2021.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Current Assets</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets include amounts associated with Medicare Part D as discussed above and in Note 7, rebates due from pharmaceutical manufacturers and other amounts due within one year.  We accrue pharmaceutical rebates as they are earned based on contractual terms and usage of the product.  The balance of pharmaceutical rebates receivable was $2.0 billion at December&#160;31, 2022 and 2021.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policy acquisition costs are those costs that relate directly to the successful acquisition of new and renewal insurance policies. Such costs include commissions, costs of policy issuance and underwriting, and other costs we incur to acquire new business or renew existing business. We expense policy acquisition costs related to our employer-group prepaid health services policies as incurred. These short-duration employer-group prepaid health services policies typically have a 1-year term and may be canceled upon 30 days notice by the employer group.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is recorded at cost. Gains and losses on sales or disposals of property and equipment are included in operating costs in our consolidated income statements. Certain costs related to the development or purchase of internal-use software are capitalized. Depreciation is computed using the straight-line method over estimated useful lives ranging from 3 to 10 years for equipment, 3 to 5 years for computer software, and 10 to 20 years for buildings. Improvements to leased facilities are depreciated over the shorter of the remaining lease term or the anticipated life of the improvement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review long-lived assets, including property and equipment and other definite-lived intangible assets, for impairment whenever adverse events or changes in circumstances indicate the carrying value of the asset may not be recoverable. Losses are recognized for a long-lived asset to be held and used in our operations when the undiscounted future cash flows expected to result from the use of the asset are less than its carrying value. We recognize an impairment loss based on the excess of the carrying value over the fair value of the asset. A long-lived asset held for sale is reported at the lower of the carrying amount or fair value less costs to sell. Depreciation expense is not recognized on assets held for sale. Losses are recognized for a long-lived asset to be abandoned when the asset ceases to be used. In addition, we periodically review the estimated lives of all long-lived assets for reasonableness.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the equity method of accounting for equity investments in companies where we are able to exercise significant influence, but not control, over operating and financial policies of the investee. Judgment regarding the level of influence over each equity method investment includes considering key factors such as our ownership interest, representation on the board of directors, organizational structure, participation in policy-making decisions and material intra-entity transactions.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by our share of equity in income or losses after the date of acquisition as well as capital contributions to and distributions from these companies. Our proportionate share of the net income or loss of these companies is included in consolidated net income.  Investment amounts in excess of our share of an investee&#8217;s net assets are amortized over the life of the related asset creating the excess. Excess goodwill is not amortized. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by us when reviewing an equity method investment for impairment include the length of time (duration) and the extent (severity) to which the fair value of the equity method investment has been less than carrying value, the investee&#8217;s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than-temporary is recognized in the period identified.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional detail regarding our equity method investments is included in Note 4.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the unamortized excess of cost over the fair value of the net tangible and other intangible assets acquired. We are required to test at least annually for impairment at a level of reporting referred to as the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. A reporting unit either is our operating segments or one level below the operating segments, referred to as a component, which comprise our reportable segments. A component is considered a reporting unit if the component constitutes a business for which discrete financial information is available that is regularly reviewed by management. We aggregate the components of an operating segment into one reporting unit if they have similar economic characteristics. Goodwill is assigned to the reporting units that are expected to benefit from the specific synergies of the business combination.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform a quantitative assessment to review goodwill for impairment to determine both the existence and amount of goodwill impairment, if any. Impairment tests are performed, at a minimum, in the fourth quarter of each year supported by our long-range business plan and annual planning process. We rely on an evaluation of future discounted cash flows to determine fair value of our reporting units. The fair value of our reporting units with significant goodwill exceeded carrying amounts. However, unfavorable changes in key assumptions or combinations of assumptions including a significant increase in the discount rate, decrease in the long-term growth rate or substantial reduction in our underlying cash flow assumptions, including revenue growth rates, medical and operating cost trends, and projected operating income could have a significant negative impact on the estimated fair value of our home solutions and provider reporting units, which accounted for $4.3&#160;billion and $1.1&#160;billion of goodwill, respectively. Impairment tests completed for 2022, 2021, and 2020 did not result in an impairment loss. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with indefinite lives relate to Certificate of Needs (CON) and Medicare licenses acquired as part of our acquisition of Kindred at Home, or KAH, and are included within other long-term assets in the consolidated balance sheet at December&#160;31, 2022 and December&#160;31, 2021. See Note 3 for further information. We are required to annually compare the fair values of other indefinite-lived intangible assets to their carrying amounts. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized. Fair values of indefinite-lived intangible assets are determined based on the income approach. Impairment tests completed for 2022 did not result in a material impairment loss. These charges reflect the amount by which the carrying value exceeded its estimated fair value. Impairment tests completed for 2021 did not result in an impairment loss. The fair values of the assets were measured using Level 3 inputs, such as projected revenues and operating cash flows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible assets primarily relate to acquired customer contracts/relationships and are included with other long-term assets in the consolidated balance sheets. Definite-lived intangible assets are amortized over the useful life generally using the straight-line method. We review definite-lived intangible assets for impairment under our long-lived asset policy.</span></div><div><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefits Payable and Benefits Expense Recognition</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits expense includes claim payments, capitation payments, pharmacy costs net of rebates, allocations of certain centralized expenses and various other costs incurred to provide health insurance coverage to members, as well as estimates of future payments to hospitals and others for medical care and other supplemental benefits provided on or prior to the balance sheet date. Capitation payments represent monthly contractual fees disbursed to primary care and other providers who are responsible for providing medical care to members. Pharmacy costs represent payments for members&#8217; prescription drug benefits, net of rebates from drug manufacturers. Receivables for such pharmacy rebates are included in other current assets in our consolidated balance sheets. Other supplemental benefits include dental, vision, and other supplemental health products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the costs of our benefits expense payments using actuarial methods and assumptions based upon claim payment patterns, medical cost inflation, historical developments such as claim inventory levels and claim receipt patterns, and other relevant factors, and record benefit reserves for future payments. We continually review estimates of future payments relating to claims costs for services incurred in the current and prior periods and make necessary adjustments to our reserves.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits expense is recognized in the period in which services are provided and includes an estimate of the cost of services which have been incurred but not yet reported, or IBNR. Our reserving practice is to consistently recognize the actuarial best point estimate within a level of confidence required by actuarial standards. Actuarial standards of practice generally require a level of confidence such that the liabilities established for IBNR have a greater probability of being adequate versus being insufficient, or such that the liabilities established for IBNR are sufficient to cover obligations under an assumption of moderately adverse conditions. Adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of the estimate. Therefore, in many situations, the claim amounts ultimately settled will be less than the estimate that satisfies the actuarial standards of practice.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop our estimate for IBNR using actuarial methodologies and assumptions, primarily based upon historical claim experience. Depending on the period for which incurred claims are estimated, we apply a different method in determining our estimate. For periods prior to the most recent two months, a completion factor method uses historical paid claims patterns to estimate the percentage of claims incurred during a given period that have historically been adjudicated as of the reporting period. Changes in claim inventory levels and known changes in claim payment processes are taken into account in these estimates. For the most recent two months, the incurred claims are estimated primarily from a trend analysis based upon per member per month claims trends developed from our historical experience in the preceding months, adjusted for known changes in estimates of hospital admissions, recent hospital and drug utilization data, provider contracting changes, changes in benefit levels, changes in member cost sharing, changes in medical management processes, product mix, and workday seasonality.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completion factor method is used for the months of incurred claims prior to the most recent two months because the historical percentage of claims processed for those months is at a level sufficient to produce a consistently reliable result. Conversely, for the most recent two months of incurred claims, the volume of claims processed historically is not at a level sufficient to produce a reliable result, which therefore requires us to examine historical trend patterns as the primary method of evaluation. Changes in claim processes, including recoveries of overpayments, receipt cycle times, claim inventory levels, outsourcing, system conversions, and processing disruptions due to weather or other events affect views regarding the reasonable choice of completion factors. Claim payments to providers for services rendered are often net of overpayment recoveries for claims paid previously, as contractually allowed. Claim overpayment recoveries can result from many different factors, including retroactive enrollment activity, audits of provider billings, and/or payment errors. Changes in patterns of claim overpayment recoveries can be unpredictable and result in completion factor volatility, as they often impact older dates of service. The receipt cycle time measures the average length of time between when a medical claim was initially incurred and when the claim form was received. Increases in electronic claim submissions from providers decrease the receipt cycle time. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claim may be more (less) complete than originally estimated using our completion factors, which may result in reserves that are higher (lower) than required.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical cost trends potentially are more volatile than other segments of the economy. The drivers of medical cost trends include increases in the utilization of hospital facilities, physician services, new higher priced technologies and medical procedures, and new prescription drugs and therapies, as well as the inflationary effect on the cost per unit of each of these expense components. Other external factors such as government-mandated benefits or other regulatory changes, the tort liability system, increases in medical services capacity, direct to consumer advertising for prescription drugs and medical services, an aging population, lifestyle changes including diet and smoking, catastrophes, public health emergencies, epidemics and pandemics (such as the spread of COVID-19) also may impact medical cost trends. Internal factors such as system conversions, claims processing cycle times, changes in medical management practices and changes in provider contracts also may impact our ability to accurately predict estimates of historical completion factors or medical cost trends. All of these factors are considered in estimating IBNR and in estimating the per member per month claims trend for purposes of determining the reserve for the most recent two months. Additionally, we continually prepare and review follow-up studies to assess the reasonableness of the estimates generated by our process and methods over time. The results of these studies are also considered in determining the reserve for the most recent two months. Each of these factors requires significant judgment by management.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reassess the profitability of our contracts for providing insurance coverage to our members when current operating results or forecasts indicate probable future losses. We establish a premium deficiency reserve in current operations to the extent that the sum of expected future costs, claim adjustment expenses, and maintenance costs exceeds related future premiums under contracts without consideration of investment income. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with our method of acquiring, servicing, and measuring the profitability of such contracts. Losses recognized as a premium deficiency result in a beneficial effect in subsequent periods as operating losses under these contracts are charged to the liability previously established. Because the majority of our member contracts renew annually, we would not record a material premium deficiency reserve, except when unanticipated adverse events or changes in circumstances indicate otherwise.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our benefits payable are adequate to cover future claims payments required. However, such estimates are based on knowledge of current events and anticipated future events. Therefore, the actual liability could differ materially from the amounts provided.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future policy benefits payable</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits payable includes liabilities for long-duration insurance policies primarily related to certain blocks of insurance assumed in acquisitions, primarily life and annuities in run-off status, and are included in our consolidated balance sheet within other long-term liabilities. Most of these policies are subject to reinsurance as detailed in Note 19.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Book Overdraft</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our cash management system, checks issued but not yet presented to banks that would result in negative bank balances when presented are classified as a current liability in the consolidated balance sheets. Changes in book overdrafts from period to period are reported in the consolidated statement of cash flows as a financing activity.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize an asset or liability for the deferred tax consequences of temporary differences between the tax bases of assets or liabilities and their reported amounts in the consolidated financial statements. These temporary differences will result in taxable or deductible amounts in future years when the reported amounts of the assets or liabilities are recovered or settled. We also recognize the future tax benefits such as net operating and capital loss carryforwards as deferred tax assets. A valuation allowance is provided against these deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. Future years&#8217; tax expense may be increased or decreased by adjustments to the valuation allowance or to the estimated accrual for income taxes. Deferred tax assets and deferred tax liabilities are further adjusted for changes in the enacted tax rates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record tax benefits when it is more likely than not that the tax return position taken with respect to a particular transaction will be sustained. A liability, if recorded, is not considered resolved until the statute of limitations for the relevant taxing authority to examine and challenge the tax position has expired, or the tax position is ultimately settled through examination, negotiation, or litigation. We classify interest and penalties associated with uncertain tax positions in our provision for income taxes.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned affiliates that we control. Accordingly, we record noncontrolling interests in the earnings and equity of such entities. We record adjustments to noncontrolling interests for the allocable portion of income or loss to which the noncontrolling interest holders are entitled based upon their portion of the subsidiaries they own. Distributions to holders of noncontrolling interests are adjusted to the respective noncontrolling interest holders&#8217; balances. Noncontrolling interests, which relate to the minority ownership held by third party investors in certain of our businesses within our Insurance and CenterWell segments, are reported below net income under the heading &#8220;Net </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">income attributable to noncontrolling interests&#8221; in the consolidated statements of income and presented as a component of equity in the consolidated balance sheets.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally recognize stock-based compensation expense, as determined on the date of grant at fair value, on a straight-line basis over the period during which an employee is required to provide service in exchange for the award (the vesting period). In addition, for awards with both time and performance-based conditions, we generally recognize compensation expense on a straight line basis over the vesting period when it is probable that the performance condition will be achieved. We estimate expected forfeitures and recognize compensation expense only for those awards which are expected to vest. We estimate the grant-date fair value of stock options using the Black-Scholes option-pricing model. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Additional detail regarding our stock-based compensation plans is included in Note 14.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute basic earnings per common share on the basis of the weighted-average number of unrestricted common shares outstanding. Diluted earnings per common share is computed on the basis of the weighted-average number of unrestricted common shares outstanding plus the dilutive effect of outstanding employee stock options and restricted shares, or units, using the treasury stock method.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional detail regarding earnings per common share is included in Note 15.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value are categorized into a fair value hierarchy based on whether the inputs to valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our own assumptions about the assumptions market participants would use. The fair value hierarchy includes three levels of inputs that may be used to measure fair value as described below.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8211; Quoted prices in active markets for identical assets or liabilities. Level 1 assets and liabilities include securities that are traded in an active exchange market.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8211; Observable inputs other than Level 1 prices such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments as well as debt securities whose value is determined using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8211; Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes assets and liabilities whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting our own assumptions about the assumptions market participants would use as well as those requiring significant management judgment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of actively traded debt and equity securities are based on quoted market prices. Fair value of other debt securities are based on quoted market prices of identical or similar securities or based on observable inputs like interest rates generally using a market valuation approach, or, less frequently, an income valuation approach and are generally classified as Level 2. Fair value of privately held investment grade debt securities are estimated using a variety of valuation methodologies, including both market and income approaches, where an observable quoted market does not exist and are generally classified as Level 3. For privately-held investment grade debt securities, such methodologies include reviewing the value ascribed to the most recent financing, comparing the security with </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities of publicly-traded companies in similar lines of business with similar credit characteristics, and reviewing the underlying financial performance including estimating discounted cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain at least one price for each security from a third party pricing service. These prices are generally derived from recently reported trades for identical or similar securities, including adjustments through the reporting date based upon observable market information. When quoted prices are not available, the third party pricing service may use quoted market prices of comparable securities or discounted cash flow analysis, incorporating inputs that are currently observable in the markets for similar securities. Inputs that are often used in the valuation methodologies include benchmark yields, reported trades, credit spreads, broker quotes, default rates, and prepayment speeds. We are responsible for the determination of fair value and as such we perform analysis on the prices received from the third party pricing service to determine whether the prices are reasonable estimates of fair value. Our analysis includes a review of monthly price fluctuations as well as a quarterly comparison of the prices received from the pricing service to prices reported by our third party investment adviser. In addition, on a quarterly basis we examine the underlying inputs and assumptions for a sample of individual securities across asset classes, credit rating levels, and various durations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Pronouncements Effective in Future Periods</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#8212;Insurance (Topic 944): Effective Date and Early Application (&#8220;ASU 2020-11&#8221;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#8212;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#8220;ASU 2018-12&#8221;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare supplement product which represent less than 1% of consolidated premiums and services revenue, is effective for us beginning with annual and interim periods in 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position and cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504341081408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">ACQUISITIONS AND DIVESTITURES</a></td>
<td class="text">ACQUISITIONS AND DIVESTITURES&#160;&#160;&#160;&#160;<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;11, 2022, we completed the sale of a 60% i</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">nterest in Humana&#8217;s Kindred at Home Hospice subsidiary, or KAH Hospice, to Clayton, Dubilier &amp; Rice, or CD&amp;R, for cash proceeds of approximately $2.7&#160;billion, net of cash disposed, including debt repayments from KAH Hospice to Humana of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.9&#160;billion. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the sale, we recognized a pre-tax gain, net of transaction costs, of $237&#160;million which is reported as a gain on sale of KAH Hospice in the accompanying consolidated statement of income for the year ended December 31, 2022. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we classified KAH Hospice as held-for-sale and aggregated KAH Hospice&#8217;s assets and liabilities separately on the balance sheet. The assets, liabilities and noncontrolling interest disposed of on August 11, 2022 were as follows:</span></div><div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:77.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Receivables, net of allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">3,622</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trade accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">530</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Noncontrolling interest</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets included $866&#160;million identifiable intangibles consisting of Medicare licenses and CON. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the sale of a 60% interest in KAH Hospice on August 11, 2022, as discussed above, KAH Hospice revenues and pretax earnings through the date of sale for the year ended December 31, 2022, were $958&#160;million and $150&#160;million, respectively. KAH Hospice revenues and pretax earnings for the year ended December 31, 2021, were $582&#160;million and $113&#160;million, respectively. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 17, 2021, we acquired the remaining 60% interest in Kindred at Home, or KAH, the nation&#8217;s largest home health and hospice provider, from TPG Capital, or TPG, and Welsh, Carson, Anderson &amp; Stowe, or WCAS, two private equity funds, for an enterprise value of $8.2&#160;billion, which included our equity value of $2.4&#160;billion associated with our 40% minority ownership interest. The remeasurement to fair value of our previously held 40% equity method investment with a carrying value of approximately $1.3&#160;billion, resulted in a $1.1&#160;billion gain recognized in "Other (income) expense, net". We paid the approximate $5.8&#160;billion transaction price (net of our existing equity stake) through a combination of debt financing, the assumption of existing KAH indebtedness and parent company cash. The final fair values of KAH&#8217;s assets acquired and liabilities assumed at the date of the acquisition are summarized as follows: </span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:77.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">9,049</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2,857</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">6,170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, 2021, and 2020 we acquired other health and wellness related businesses which other than the impacts to goodwill, individually or in the aggregate, have not had a material impact on our results of operations, financial condition, or cash flows.  The results of operations and financial condition of these businesses have been included in our consolidated statements of income and consolidated balance sheets from the respective acquisition dates. Acquisition-related costs recognized in each of 2022, 2021 and 2020 were not material to our results of operations. For asset acquisitions the goodwill acquired is partially amortizable as deductible expenses for tax purposes. The pro forma financial information assuming the acquisitions had occurred as of the beginning of the calendar year prior to the year of acquisition, as well as the revenues and earnings generated during the year of acquisition, were not material for disclosure purposes.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504447423264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY METHOD INVESTMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">EQUITY METHOD INVESTMENT</a></td>
<td class="text">EQUITY METHOD INVESTMENT<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to our acquisition of KAH in August 2021, we accounted for our 40%&#160;investment in KAH using the equity method of accounting. Our share of income or loss was reported as equity in net (losses) earnings in our consolidated statements of income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We completed the sale of a 60% interest in KAH Hospice on August 11, 2022 and account for our 40% minority ownership in hospice operations using the equity method of accounting. This investment was reflected in equity method investments in our December&#160;31, 2022 consolidated balance sheet, with our share of income or loss reported as equity in net (losses) earnings in our consolidated statements of income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized balance sheet at December&#160;31, 2022 and statement of income for the period beginning August 11, 2022 through December&#160;31, 2022 of KAH Hospice were as follows:</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:77.195%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.605%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance sheet</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:76.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.284%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statements of income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">August 11, 2022 through December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other insignificant equity method investments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2020, our Primary Care Organization entered into a strategic partnership with Welsh, Carson, Anderson &amp; Stowe, or WCAS, to accelerate the expansion of our primary care model. In May 2022, we established a second strategic partnership with WCAS to develop additional centers between 2023 and 2025. As of December 31, 2022, there were 50 primary care clinics operating under the partnership and we intend to open approximately 100 additional primary clinics in future periods under the existing arrangements. In addition, the agreements include a series of put and call options through which WCAS may require us to purchase their interest in the entity, and through which we may acquire WCAS&#8217;s interest, over the next 3 to 10 years. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have several individually immaterial equity method investments, including our strategic partnership with WCAS as described above, included within equity method investments in our consolidated balance sheets as of December&#160;31, 2022 and 2021 with our share of income or loss reported as equity in net (losses) earnings in our consolidated statements of income for the years ended December&#160;31, 2022, 2021 and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI https://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339199152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">INVESTMENT SECURITIES</a></td>
<td class="text">INVESTMENT SECURITIES<div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities classified as current and long-term were as follows at December&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.646%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,551&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2022, we purchased certain corporate debt securities of KAH Hospice subsequent to the sale. The book value and fair value are $280&#160;million and $278&#160;million, respectively, at December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross unrealized losses and fair values aggregated by investment category and length of time that individual debt securities have been in a continuous unrealized loss position were as follows at December&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or more</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr style="height:15pt"><td colspan="36" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,431)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,537&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 96% of our debt securities were investment-grade quality, with a weighted average credit rating of AA- by S&amp;P at December&#160;31, 2022. Most of the debt securities that were below investment-grade were rated BB-, the higher end of the below investment-grade rating scale. Tax-exempt municipal securities were diversified among general obligation bonds of states and local municipalities in the United States as well as special revenue bonds issued by municipalities to finance specific public works projects such as utilities, water and sewer, transportation, or education. Our general obligation bonds are diversified across the United States with no individual state exceeding 1% of our total debt securities. Our investment policy limits investments in a single issuer and requires diversification among various asset types. &#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our unrealized loss from all debt securities was generated from approximately 1,625 positions out of a total of approximately 1,710 positions at December&#160;31, 2022. All issuers of debt securities we own that were trading at an </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unrealized loss at December&#160;31, 2022 remain current on all contractual payments. After taking into account these and other factors previously described, we believe these unrealized losses primarily were caused by an increase in market interest rates in the current markets since the time the debt securities were purchased. At December&#160;31, 2022, we did not intend to sell any debt securities with an unrealized loss position in accumulated other comprehensive income, and it is not likely that we will be required to sell these debt securities before recovery of their amortized cost basis. Additionally, we did not record any material credit allowances for debt securities that were in an unrealized loss position at December&#160;31, 2022, 2021 or 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The detail of realized gains (losses) related to investment securities and included within investment income was as follows for the years ended December&#160;31, 2022, 2021, and 2020:</span></div><div style="margin-bottom:7pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:57.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.222%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.222%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on investment securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net recognized (losses) gains on investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses related to equity securities for the years ended December&#160;31, 2022, 2021 and 2020 was as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.517%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains recognized on equity securities during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net losses recognized on equity securities sold during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains recognized on equity securities still held at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All purchases of and proceeds from investment securities for the year ended December&#160;31, 2020 relate to debt securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of debt securities available for sale at December&#160;31, 2022, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:75.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.995%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage and asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,946&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI https://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI https://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339159088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE</a></td>
<td class="text">FAIR VALUE<div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Assets</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our fair value measurements at December&#160;31, 2022 and 2021, respectively, for financial assets measured at fair value on a recurring basis:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:45.127%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,797&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Level 3 assets had fair values of $101 million, or 0.5% of total invested assets, and $68 million, or 0.4% of total invested assets, at December&#160;31, 2022 and 2021, respectively. During the years ended December&#160;31, 2022 and 2021, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:11.25pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:54.277%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.212%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Private<br/>Placements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance at January&#160;1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gains or losses:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized in other comprehensive&#160;income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Liabilities</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our debt is recorded at carrying value in our consolidated balance sheets. The carrying value of our senior notes debt outstanding, net of unamortized debt issuance costs, was $10.0&#160;billion at December&#160;31, 2022 and $9.0 billion at December&#160;31, 2021. The fair value of our senior note debt was $9.4 billion at December&#160;31, 2022 and $10.0 billion at December&#160;31, 2021. The fair value of our senior note debt is determined based on Level 2 inputs, including quoted market prices for the same or similar debt, or if no quoted market prices are available, on the current prices estimated to be available to us for debt with similar terms and remaining maturities. Carrying value approximates fair value for our term loans and commercial paper borrowings. The term loan and commercial paper borrowings&#160;were $1.1&#160;billion at December&#160;31, 2022 and $3.5 billion  at  December&#160;31, 2021.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Put and Call Options Measured at Fair Value</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our put and call options associated with our equity method investments are measured at fair value each period using a Monte Carlo simulation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective April 27, 2021, with the signing of the definitive agreement to acquire the remaining 60% interest of KAH, the respective put and call options were terminated. As such, the $63&#160;million put and $440&#160;million call fair values as of the first quarter of 2021 were reduced to zero, resulting in $377&#160;million in other expense (income),net in our consolidated statements of income for the year ended December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The put and call options fair values associated with our Primary Care Organization strategic partnership with WCAS, which are exercisable at a fixed revenue exit multiple and provide a minimum return on WCAS' investment if exercised, are measured at fair value each reporting period using a Monte Carlo simulation. The put and call options fair values, derived from the Monte Carlo simulation, were $267 million and $10 million, respectively, at December&#160;31, 2022. The put and call options fair values, derived from the Monte Carlo simulation, were $202 million and $13 million, respectively, at December&#160;31, 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant unobservable inputs utilized in these Level 3 fair value measurements (and selected values) include the enterprise value, annualized volatility and credit spread. Enterprise value was derived from a discounted cash flow model, which utilized significant unobservable inputs for long-term revenue, to measure underlying cash flows, weighted average cost of capital and long term growth rate. The table below presents the assumptions used for December&#160;31, 2022 and 2021, respectively: </span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:59.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.837%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7% - 20.8%</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit spread</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue exit multiple</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5x - 2.5x </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5x - 2.5x</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of capital</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5% - 12.5%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term growth rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for annualized volatility, credit spread and weighted average cost of capital reflect the lowest and highest values where they differ significantly across the series of put and call options due to their expected exercise dates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are measured at fair value on a non-recurring basis subject to fair value adjustment only in certain circumstances.  As disclosed in Note 3, &#8220;Acquisitions&#8221;, we completed our acquisition of KAH during the third quarter of 2021. The net assets acquired and resulting goodwill and other intangible assets were recorded at fair value primarily using Level 3 inputs.  The net tangible assets including receivables and accrued liabilities were recorded at their carrying value which approximated their fair value due to their short term nature. The fair value of goodwill and other intangible assets were internally estimated based on the income approach.  The income approach estimates fair value based on the present value of cash flow that the assets could be expected to generate in the future. We developed internal estimates for expected cash flows in the present value calculation using inputs and significant assumptions that include historical revenues and earnings, long-term growth rate, discount rate, contributory asset charges and future tax rates, among others.  The excess purchase price over the fair value of assets and liabilities acquired is recorded as goodwill.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As disclosed in Note 3, we completed the sale of a 60% interest in KAH Hospice on August 11, 2022. The carrying value of the assets and liabilities of KAH Hospice disposed approximates fair value. The amount of goodwill included in the carrying value is based on the relative fair value of KAH Hospice as compared to the total fair value of our home solutions reporting unit included within the CenterWell segment.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the assets acquired and liabilities assumed in the KAH and other acquisitions in Note 3, there were no other material assets or liabilities measured at fair value on a recurring or nonrecurring basis during 2022, 2021, or 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344543984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MEDICARE PART D<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_MedicarePartDDisclosureTextBlock', window );">MEDICARE PART D</a></td>
<td class="text">MEDICARE PART DWe cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with CMS. The accompanying consolidated balance sheets include the following amounts associated with Medicare Part D as of December&#160;31, 2022 and 2021. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:52.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current asset (liability)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net long-term liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net asset (liability)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_MedicarePartDDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance sheet amounts associated with Medicare Part D.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_MedicarePartDDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339160400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT, NET</a></td>
<td class="text">PROPERTY AND EQUIPMENT, NET<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment was comprised of the following at December&#160;31, 2022 and 2021. </span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:75.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.656%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,136)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,874)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $749&#160;million in 2022, $640 million in 2021, and $528 million in 2020, including amortization expense for capitalized internally developed and purchased software of $525 million in 2022, $443 million in 2021, and $351 million in 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344738112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND OTHER INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND OTHER INTANGIBLE ASSETS<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amount of goodwill for our reportable segments has been retrospectively adjusted to conform to the 2022 business segment realignment as discussed in Note 1. There was no impairment. Changes in the carrying amount of goodwill for our reportable segments for the years ended December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:53.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.189%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dispositions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our other intangible assets included in other long-term assets in the accompanying consolidated balance sheets at December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.791%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.116%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetes and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,639&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for other intangible assets was approximately $81 million in 2022, $65&#160;million in 2021, and $88&#160;million in 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our estimate of amortization expense for each of the five next succeeding fiscal years: </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:81.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI https://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504343923936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if a contract contains a lease by evaluating the nature and substance of the agreement. We lease facilities, computer hardware, and other furniture and equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For new lease agreements, we combine lease and nonlease components for all of our asset classes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When portions of the lease payments are not fixed or depend on an index or rate, we consider those payments to be variable in nature. Our variable lease payments include, but are not limited to, common area maintenance, taxes and insurance which are not dependent upon an index or rate. Variable lease payments are recorded in the period in which the obligation for the payment is incurred. Most leases include options to renew, with renewal terms that can extend the lease term. The exercise of lease renewal options is at our sole discretion. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets included within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_aa3c46cd-ae1d-4dbb-b466-6a345a4c4ee1"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_fb3c77fb-1c01-43eb-9b8e-b8c8b202045a">other long-term assets</span></span> in our consolidated balance sheets were $515 million and $678 million at December&#160;31, 2022 and December&#160;31, 2021, respectively. Operating lease liabilities included within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_0f510c82-dcff-42e3-bbab-71fc1ed8e909"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_f7698f80-d9e2-4b51-aa84-637d028779f0">trade accounts payable and accrued expenses</span></span> in our consolidated balance sheets were $152 million and $185 million at December&#160;31, 2022 and December&#160;31, 2021, respectively. Additionally, operating lease liabilities included within <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_bc2d9dd9-e2c4-4f69-a280-01a78070d904"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_e06b9087-2af6-4553-b278-719cfd049d22">other long-term liabilities</span></span> in our consolidated balance sheets were $456 million and $546 million at </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022 and December&#160;31, 2021, respectively. The classification of our operating lease liabilities is based on the remaining lease term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2022, 2021 and 2020, total fixed operating lease costs, excluding short-term lease costs, were $183 million, $159 million and $141 million, respectively, and are included within operating costs in our consolidated statements of income. Short-term lease costs were not material for the years ended December&#160;31, 2022, 2021 and 2020. In addition, for the years ended December&#160;31, 2022, 2021 and 2020, total variable operating lease costs were</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$101 million, $94 million and $92 million, respectively, and are included within operating costs in our consolidated statements of income. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sublease facilities or partial facilities to third party tenants for space not used in our operations. For the years ended December&#160;31, 2022, 2021 and 2020, sublease rental income was</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$52 million, $43 million and $36 million, respectively, and is included within operating costs in our consolidated statements of income.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average remaining lease term is 5.4 years with a weighted average discount rate of 3.2% at December&#160;31, 2022 and December&#160;31, 2021. For the years ended December&#160;31, 2022, 2021 and 2020, cash paid for amounts included in the measurement of lease liabilities included within our operating cash flows was $191 million, $165 million and $146 million, respectively.</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:80.601%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity of&#160;Lease&#160;Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As most of our leases do not provide an implicit rate, we use our incremental borrowing rate, as adjusted for collateralized borrowings, based on the information available at date of adoption or commencement date in determining the present value of lease payments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344584512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BENEFITS PAYABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceDisclosureTextBlock', window );">BENEFITS PAYABLE</a></td>
<td class="text">BENEFITS PAYABLE<div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:54.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at January&#160;1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at January 1, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,690&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,628&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,428)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,715)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,095)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,421)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December&#160;31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total estimate of benefits payable for claims incurred but not reported, or IBNR, is included within the net </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incurred claims amounts. At December&#160;31, 2022, benefits payable included IBNR of approximately $5.7&#160;billion, primarily associated with claims incurred in 2022. The cumulative number of reported claims as of December&#160;31, 2022 was approximately 173.5&#160;million for claims incurred in 2022, 173.3&#160;million for claims incurred in 2021, and 149.8&#160;million for claims incurred in 2020.</span></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Amounts incurred related to prior years vary from previously estimated liabilities as the claims ultimately are settled. Negative amounts reported for incurred related to prior years result from claims being ultimately settled for amounts less than originally estimated (favorable development).</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously discussed, our reserving practice is to consistently recognize the actuarial best estimate of our ultimate liability for claims. Actuarial standards require the use of assumptions based on moderately adverse experience, which generally results in favorable reserve development, or reserves that are considered redundant. We experienced favorable medical claims reserve development related to prior fiscal years of $415 million in 2022, $825 million in 2021, and $313 million in 2020.</span></div><div style="margin-bottom:12pt;margin-top:4pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical claims reserve development for 2022, 2021, and 2020 primarily reflects the consistent application of trend and completion factors estimated using an assumption of moderately adverse conditions. In addition, the higher prior year favorable development for the year ended December 31, 2021 was primarily attributable to the reversal of actions taken in 2020, including the suspension of certain financial recovery programs for a period of time impacting our claim payment patterns. The suspension during 2020 was intended to provide financial and administrative relief for providers facing unprecedented strain as a result of the COVID-19 pandemic.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">         </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incurred and Paid Claims Development</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion provides information about incurred and paid claims development as of December&#160;31, 2022, net of reinsurance, as well as cumulative claim frequency and the total of IBNR included within the net incurred claims amounts. The information about incurred and paid claims development for the years ended December 31, 2021 and 2020 is presented as supplementary information.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Claims frequency is measured as medical fee-for-service claims for each service encounter with a unique provider identification number. Our claims frequency measure includes claims covered by deductibles as well as claims under capitated arrangements. Claim counts may vary based on product mix and the percentage of delegated capitation arrangements.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following tables provide information about incurred and paid claims development as of December&#160;31, 2022, net of reinsurance.</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:54.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.890%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, Net of Reinsurance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Claims Incurred Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,066&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,698&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,027&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:53.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.891%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims, Net of Reinsurance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Claims Incurred Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,763&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All outstanding benefit liabilities before 2020, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,264&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our benefits payable and benefits expense recognition, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in this Form 10-K.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344696768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES <div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:55.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current provision:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States and Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was different from the amount computed using the federal statutory rate for the years ended December&#160;31, 2022, 2021 and 2020 due to the following:</span></div><div style="margin-bottom:7pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:55.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision at federal statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, net of federal benefit, and Puerto Rico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax exempt investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-taxable KAH gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect from sale of KAH Hospice</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance industry fee </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income tax balances reflect the impact of temporary differences between the tax bases of assets or liabilities and their reported amounts in our consolidated financial statements, and are stated at enacted tax rates expected to be in effect when the reported amounts are actually recovered or settled. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal components of our net deferred tax balances at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:70.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets&#160;(Liabilities)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and other accrued expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jobs tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciable property and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,072)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(878)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(698)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All deferred tax liabilities and assets are classified as noncurrent in our consolidated balance sheets as other long-term liabilities at December 31, 2022  and 2021. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had approximately $68 million of federal net operating losses and approximately $1.6 billion of state and Puerto Rico net operating losses to carry forward. A portion of these loss carryforwards, if not used to offset future taxable income, will expire from 2031 through 2038. The balance of the net operating loss carryforwards has no expiration date. Due to limitations and uncertainty regarding our ability to use some of the loss carryforwards and certain other deferred tax assets, a valuation allowance of $57 million was established. For the remainder of the net operating loss carryforwards and other cumulative temporary differences, based on our historical record of producing taxable income and profitability, we have concluded that future operating income will be sufficient to recover these deferred tax assets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file income tax returns in the United States and Puerto Rico.&#160;The U.S. Internal Revenue Service, or IRS, has completed its examinations of our consolidated income tax returns for 2020 and prior years. Our 2021 tax return is in the post-filing review period under the Compliance Assurance Process, or CAP. Our 2022 tax return is under advance review by the IRS under CAP. With a few exceptions, which are immaterial in the aggregate, we are no longer subject to state, local and foreign tax examinations for years before 2019.&#160;We are not aware of any material adjustments that may be proposed as a result of any ongoing or future examinations. We do not have material uncertain tax positions reflected in our consolidated balance sheets.</span></div>On August 16, 2022, the Inflation Reduction Act was signed into law. The Inflation Reduction Act includes various tax provisions, which are effective for the tax years beginning on or after January 1, 2023. There was no material impact on our consolidated financial statements at December 31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339090880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of debt outstanding was as follows at December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:61.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.877%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500&#160;million, 0.65% due August 3, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600 million, 3.15% due December&#160;1, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400 million, 2.90% due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500&#160;million, 0.65% due August 3, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 3.85% due October 1, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 4.50% due April 1, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million 1.35% due February 3, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 3.95% due March 15, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 5.75% due March 1, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 3.70% due March 23, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 3.13% due August 15, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 4.88% due April 1, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 2.15% due February 3, 2032</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 5.88% due March 1, 2033</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$250&#160;million, 8.15% due June&#160;15, 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400&#160;million, 4.63% due December&#160;1, 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 4.95% due October 1, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400&#160;million, 4.80% due March 15, 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 3.95% due August 15, 2049</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, due October 29, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delayed draw term loan, due May 28, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,541&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the short-term and long-term debt for the years ending December 31, are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:79.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Notes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior notes, which are unsecured, may be redeemed at our option at any time at 100% of the principal amount plus accrued interest and a specified make-whole amount. The 8.15% senior notes are subject to an interest rate adjustment if the debt ratings assigned to the notes are downgraded (or subsequently upgraded). In addition, our senior notes contain a change of control provision that may require us to purchase the notes under certain circumstances. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we repaid $600&#160;million aggregate principal amount of our 3.150% senior notes due on their maturity date of December 1, 2022 and $400 million aggregate principal amount of our 2.900% senior notes due on their maturity date of December 15, 2022.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, we issued $500&#160;million of 5.750% unsecured senior notes due March 1, 2028 and $750&#160;million of 5.875% unsecured senior notes due March 1, 2033. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $1.2&#160;billion. We used the net proceeds for general corporate purposes, which included the repayment of existing indebtedness.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we issued $750&#160;million of 3.700% unsecured senior notes due March 23, 2029. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $744&#160;million. We used the net proceeds for general corporate purposes, which included the repayment of existing indebtedness, including borrowings under our commercial paper program.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delayed Draw Term Loan Credit Agreement</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, we entered into a $500&#160;million unsecured delayed draw term loan credit agreement. Under the term loan credit agreement, loans bear interest at either LIBOR plus a spread or the base rate plus a spread. The loans under the term loan credit agreement mature on the third anniversary of the funding date. The LIBOR spread, currently 125 basis points, varies depending on our credit ratings ranging from 100.0 to 162.5 basis points. The term loan credit agreement provides for the transition from LIBOR and does not require amendment in connection with such transition.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In August 2021, we borrowed $500&#160;million under the delayed draw term loan agreement, which was used, in combination with other debt financing, to fund the approximate $5.8&#160;billion transaction price of Kindred at Home. The term loan credit agreement contains customary restrictive covenants and a financial covenant regarding maximum debt to capitalization of 60%, as well as customary events of default. We are in compliance with this financial covenant, with actual debt to capitalization of 42.0% as measured in accordance with the term loan credit agreement as of December&#160;31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have other customary relationships, including financial advisory and banking, with some parties to the term loan agreement.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">October 2021 Term Loan Agreement</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 29, 2021, we entered into a $2.0&#160;billion term loan credit agreement, which we refer to as the October 2021 Term Loan Agreement, with certain lending banks and other financial institutions. Proceeds of the October 2021 Term Loan Agreement were applied to finance the repayment in full of the outstanding KAH debt of $1.9&#160;billion.</span></div><div style="text-align:justify;text-indent:24.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 16, 2022, w</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> repaid the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.0&#160;billion October 2021 Term Loan Agreement without a prepayment penalty due.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Revolving Credit Agreements</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we entered into a 5-year, $2.5&#160;billion unsecured revolving credit agreement. Under the 5-year revolving credit agreement, at our option, we can borrow on either a competitive advance basis or a revolving credit basis. The revolving credit portion bears interest at either LIBOR plus a spread or the base rate plus a spread. The competitive advance portion of any borrowings will bear interest at market rates prevailing at the time of borrowing on either a fixed rate or a floating rate based on LIBOR, at our option. The revolving credit agreement provides for the transition from LIBOR and does not require amendment in connection with such transition.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, we entered into a 364-day $1.5&#160;billion unsecured revolving credit agreement (replacing the 364-day $1.5&#160;billion unsecured revolving credit agreement entered in June 2021, which expired in accordance with its terms). Under the 364-day revolving credit agreement, at our option, we can borrow on either a competitive advance basis or a revolving credit basis. The revolving credit portion bears interest at Term SOFR or the base rate plus a spread. The competitive advance portion of any borrowings will bear interest at market rates prevailing at the time of borrowing on either a fixed rate or a floating rate based Term SOFR, at our option.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The LIBOR spread, currently 110.0 basis points under the 5-year revolving credit agreements and the SOFR spread, currently 115.0 basis points under the 364-day revolving credit agreement, varies depending on our credit ratings ranging from 91.0 to 140.0 basis points under the 5-year revolving credit agreement and from 94.0 to 135.0 basis points under the 364-day revolving credit agreement. We also pay an annual facility fee regardless of utilization. This facility fee, currently 15.0 basis points, under the 5-year revolving credit agreement and 10.0 basis points under the 364-day revolving agreement, varies depending on our credit ratings ranging from 9.0 to 22.5 basis points under the 5-year revolving credit agreement and from 6.0 to 15.0 basis points under the 364-day revolving credit agreement.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the revolving credit agreements include standard provisions related to conditions of borrowing which could limit our ability to borrow additional funds. In addition, the credit agreements contain customary restrictive covenants and a financial covenant regarding maximum debt to capitalization of 60%, as well as customary events of default. We are in compliance with this financial covenant, with actual debt to capitalization of 42.0% as measured in accordance with the revolving credit agreements as of December&#160;31, 2022. Upon our agreement with one or more financial institutions, we may expand the aggregate commitments under the revolving credit agreements by up to $750&#160;million in the aggregate, to a maximum of $4.75&#160;billion, across the 5-year and 364-day revolving credit agreements. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had no borrowings and approximately $45&#160;million of letters of credit outstanding under the revolving credit agreements, including those of KAH. Accordingly, as of December&#160;31, 2022, we had $2.4&#160;billion of remaining borrowing capacity under the 5-year revolving credit agreement and $1.5&#160;billion of remaining borrowing capacity under the 364-day revolving credit agreement (which excludes the uncommitted $750&#160;million of incremental loan facilities), none of which would be restricted by our financial covenant compliance requirement. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have other customary relationships, including financial advisory and banking, with some parties to the revolving credit agreements.</span></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Paper</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     Under our commercial paper program we may issue short-term, unsecured commercial paper notes privately placed on a discount basis through certain broker dealers at any time. On February 10, 2022, we increased the size of our commercial paper program to permit the issuance of commercial paper notes in an aggregate principal amount not to exceed $4&#160;billion compared to the prior amount not to exceed $2&#160;billion. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. The maximum principal amount outstanding at any one time during the year ended&#160;December&#160;31, 2022&#160;was $1,450 million, with $595 million outstanding at December&#160;31, 2022 compared to $955 million outstanding at December 31, 2021. The outstanding commercial paper at December&#160;31, 2022 had a weighted average annual interest rate of 4.92%.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Short-term Borrowings</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a member, through one subsidiary, of the Federal Home Loan Bank of Cincinnati, or FHLB. As a member we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. As of December&#160;31, 2022 and December&#160;31, 2021, we had no outstanding short-term FHLB borrowings</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337423632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock', window );">EMPLOYEE BENEFIT PLANS</a></td>
<td class="text">EMPLOYEE BENEFIT PLANS<div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Savings Plan</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have defined contribution retirement savings plans covering eligible employees which include matching contributions based on the amount of our employees&#8217; contributions to the plans. The cost of these plans amounted to approximately $286 million in 2022, $259 million in 2021, and $236 million in 2020. The Company&#8217;s cash match is invested pursuant to the participant&#8217;s contribution direction. Based on the closing price of our common stock of $512.19 on December&#160;31, 2022, approximately 11% of the retirement and savings plan&#8217;s assets were invested in our common stock, or approximately 1.4 million shares, representing approximately 1.1% of the shares outstanding as of December&#160;31, 2022. At December&#160;31, 2022, approximately 5.8 million shares of our common stock were reserved for issuance under our defined contribution retirement savings plans.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have plans under which options to purchase our common stock and restricted stock units have been granted to executive officers, directors and key employees. Awards generally require both a change in control and termination of employment within 2 years of the date of the change in control to accelerate the vesting, including those granted to retirement-eligible participants. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and vesting schedules for stock-based awards vary by type of grant. Generally, the awards vest upon time-based conditions. We have also granted awards to certain employees that vest upon a combination of time and performance-based conditions. The stock awards of retirement-eligible participants are generally earned ratably over the service period for each tranche. Accordingly, upon retirement the earned portion of the current tranche will continue to vest on the originally scheduled vest date and any remaining unearned portion of the award will be forfeited. Our equity award program includes a retirement provision that generally treats employees with a combination of age and years of services with the Company totaling 65 or greater, with a minimum required age of </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55 and a minimum requirement of 5 years of service, as retirement-eligible. Upon exercise, stock-based compensation awards are settled with authorized but unissued company stock or treasury stock. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation expense that has been charged against income for these plans was as follows for the years ended December 31, 2022, 2021, and 2020:</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:55.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense by type:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tax benefit recognized in our consolidated financial statements is based on the amount of compensation expense recorded for book purposes, subject to limitations on the deductibility of annual compensation in excess of $500,000 per employee as mandated by the Health Care Reform Law. The actual tax benefit realized in our tax return is based on the intrinsic value, or the excess of the market value over the exercise or purchase price, of stock options exercised and restricted stock vested during the period, subject to limitations on the deductibility of annual compensation in excess of $500,000 per employee as mandated by the Health Care Reform Law. The actual tax benefit realized for the deductions taken on our tax returns from option exercises and restricted stock vesting totaled $31 million in 2022, $28&#160;million in 2021, and $32 million in 2020. There was no capitalized stock-based compensation expense during these years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, there were 11.0 million shares reserved for stock award plans under the Humana Inc. 2011 Stock Incentive Plan, or 2011 Plan, and 15.3 million shares reserved for stock award plans under the Humana Inc. 2019 Stock Incentive Plan, or 2019 Plan. These reserved shares included giving effect to, under the 2011 Plan, 3.3 million shares of common stock available for future grants assuming all stock options were granted or 1.4 million shares available for future grants assuming all restricted stock were granted.&#160;These reserved shares included giving effect to, under the 2019 Plan, 11.2 million shares of common stock available for future grants assuming all stock options were granted or 3.4 million shares available for future grants assuming all restricted stock were granted. Shares may be issued from authorized but unissued company stock or treasury stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Restricted Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted stock is granted with a fair value equal to the market price of our common stock on the date of grant and generally vests in equal annual tranches over a three year period from the date of grant. Certain of our restricted stock grants also include performance-based conditions generally associated with return on invested capital and strategic membership growth. Restricted stock units have forfeitable dividend equivalent rights equal to the dividend paid on common stock. The weighted-average grant date fair value of our restricted stock was $430.06 in 2022, $381.34 in 2021, and $354.66 in 2020. Activity for our restricted stock was as follows for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:70.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.889%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approximately 36% of the nonvested restricted stock at December 31, 2022 included performance-based conditions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of shares vested was $244 million during 2022, $236 million during 2021, and $191 million during 2020. Total compensation expense not yet recognized related to nonvested restricted stock was $202 million at December&#160;31, 2022. We expect to recognize this compensation expense over a weighted-average period of approximately 1.7 years. There are no other contractual terms covering restricted stock once vested.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options are granted with an exercise price equal to the fair market value of the underlying common stock on the date of grant. Our stock plans, as approved by the Board of Directors and stockholders, define fair market value as the average of the highest and lowest stock prices reported on the composite tape by the New York Stock Exchange on a given date. Exercise provisions vary, but most options vest in whole or in part 1 to 3 years after grant and expire 7 years after grant.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average fair value of each option granted during 2022, 2021, and 2020 is provided below. The fair value was estimated on the date of grant using the Black-Scholes pricing model with the weighted-average assumptions indicated below:</span></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:55.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value at grant date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate at grant date</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate the expected term for our employee stock options based on historical employee exercise behavior and base the risk-free interest rate on a traded zero-coupon U.S. Treasury bond with a term substantially equal to the option&#8217;s expected term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The volatility used to value employee stock options is based on historical volatility. We calculate historical volatility using a simple-average calculation methodology based on daily price intervals as measured over the expected term of the option.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for our option plans was as follows for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:70.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160; Under<br/>Option</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at December&#160;31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.90&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of  December&#160;31, 2022, outstanding stock options, substantially all of which are expected to vest, had an aggregate intrinsic value of $26 million, and a weighted-average remaining contractual term of 4.9 years. As of December&#160;31, 2022, exercisable stock options had an aggregate intrinsic value of $8 million, and a weighted-average remaining contractual term of 4.1 years. The total intrinsic value of stock options exercised during 2022 was $32 million, compared with $18 million during 2021 and $51 million during 2020. Cash received from stock option exercises totaled $51 million in 2022, $30 million in 2021, and $61 million in 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total compensation expense not yet recognized related to nonvested options was $7 million at December&#160;31, 2022. We expect to recognize this compensation expense over a weighted-average period of approximately 1.7 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Compensation Related Costs Share Based Payments And Compensation And Retirement Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344584512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER COMMON SHARE COMPUTATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS PER COMMON SHARE COMPUTATION</a></td>
<td class="text">EARNINGS PER COMMON SHARE COMPUTATION<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Detail supporting the computation of basic and diluted earnings per common share was as follows for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except&#160;per<br/>common share results, number&#160;of<br/>shares/options in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income available for common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average outstanding shares of common stock used to <br/>&#160;&#160;&#160;&#160;compute basic earnings per common share</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,419&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,688&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,199&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted earnings per&#160;common share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,094&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.20&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.79&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.47&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.08&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.67&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.31&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of antidilutive stock options and restricted stock&#160;awards <br/>&#160;&#160;&#160;&#160;excluded from computation</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344602064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS' EQUITY</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY<div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of dividend payments, excluding dividend equivalent rights, in 2020, 2021, and 2022, under our Board approved quarterly cash dividend policy:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:64.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.487%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.43</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$322</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.73</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$351</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.06</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$390</span></td></tr></table></div><div style="margin-bottom:1pt;text-align:center"><span><br/></span></div><div style="margin-bottom:1pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, the Board declared a cash dividend of $0.79 per share payable on January&#160;27, 2023 to stockholders of record on December&#160;30, 2022 for an aggregate amount of $98 million. In February 2023, the Board declared a cash dividend of $0.8850 per share payable on April&#160;28, 2023 to stockholders of record on March&#160;31, 2023. Declaration and payment of future quarterly dividends is at the discretion of our Board and may be adjusted as business needs or market conditions change.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors may authorize the purchase of our common shares. Under our share repurchase authorization, shares may have been purchased from time to time at prevailing prices in the open market, by block purchases, through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or in privately-negotiated transactions (including pursuant to accelerated share repurchase agreements with investment banks), subject to certain regulatory restrictions on volume, pricing, and timing. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 22, 2020, we entered into separate accelerated stock repurchase agreements, ("the December 2020 ASR Agreements"), with Citibank, N.A., or Citi, and JPMorgan Chase Bank, or JPM, to repurchase $1.75&#160;billion of our common stock as part of the $3&#160;billion repurchase program authorized by the Board of Directors on July 30, 2019. On December 23, 2020, in accordance with the December 2020 ASR Agreements, we made a payment of $1.75&#160;billion ($875&#160;million to Citi and $875&#160;million to JPM) and received an initial delivery of 3.8&#160;million shares of our common stock (1.9&#160;million shares each from Citi and JPM). We recorded the payments to Citi and JPM as a reduction to stockholders&#8217; equity, consisting of an $1.5&#160;billion increase in treasury stock, which reflects the value of the initial 3.8&#160;million shares received upon initial settlement, and a $262.5&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Citi and JPM pending final settlement of the December 2020 ASR Agreements. Upon final settlement of the December 2020 ASR agreements with Citi and JPM on May 4, 2021 and May 5, 2021, respectively, we received an additional 0.3&#160;million shares and 0.3&#160;million shares, respectively, as determined by the average daily volume weighted-averages share price of our common stock during the term of the agreement, less a discount, of $400.07 and $401.49, respectively, bringing the total shares received under the December 2020 ASR agreements to 4.4&#160;million. In addition, upon settlement we reclassified the $262.5&#160;million value of stock initially held back by Citi and JPM from capital in excess of par value to treasury stock.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 18, 2021, the Board of Directors replaced the previous share repurchase authorization of up to $3&#160;billion (of which approximately $1&#160;billion remained unused) with a new authorization for repurchases of up to $3&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 18, 2024.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 11, 2022, we entered into separate accelerated stock repurchase agreements, the January 2022 ASR Agreements, with Mizuho Markets Americas LLC, or Mizuho, and Wells Fargo Bank, or Wells Fargo, to repurchase $1&#160;billion of our common stock as part of the $3&#160;billion repurchase program authorized by the Board of Directors on February 18, 2021. On January 12, 2022, in accordance with the January 2022 ASR Agreements, we made a </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payment of $1&#160;billion ($500&#160;million to Mizuho and $500&#160;million to Wells Fargo) and received an initial delivery of 2.2&#160;million shares of our common stock (1.08&#160;million shares each from Mizuho and Wells Fargo). We recorded the payments to Mizuho and Wells Fargo as a reduction to stockholders&#8217; equity, consisting of an $850&#160;million increase in treasury stock, which reflects the value of the initial 2.2&#160;million shares received upon initial settlement, and a $150&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Mizuho and Wells Fargo pending final settlement of the January 2022 ASR Agreements. Upon final settlement of the January 2022 ASR Agreements with Mizuho and Wells Fargo on March 29, 2022 and March 30, 2022, respectively, we received an additional 0.1&#160;million shares and 0.1&#160;million shares, respectively, as determined by the average daily volume weighted-averages share price of our common stock during the term of the agreement, less a discount, of $410.96 and $411.66, respectively, bringing the total shares received under the January 2022 ASR Agreements to 2.4&#160;million. In addition, upon settlement we reclassified the $150&#160;million value of stock initially held back by Mizuho and Wells Fargo from capital in excess of par value to treasury stock. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 2, 2022, we entered into separate accelerated stock repurchase agreements, the November 2022 ASR Agreements, with Goldman Sachs &amp; Co. LLC, or Goldman Sachs, and Mizuho Markets Americas LLC, or Mizuho, to repurchase $1&#160;billion of our common stock as part of the $3&#160;billion repurchase program authorized by the Board of Directors on February 18, 2021. In accordance with the November 2022 ASR Agreements, we made a payment of $1&#160;billion ($500&#160;million to Goldman Sachs on November 3, 2022 and $500&#160;million to Mizuho on November 4, 2022) and received an initial delivery of 1.5&#160;million shares of our common stock (0.760&#160;million shares each from Goldman Sachs and Mizuho). We recorded the payments to Goldman Sachs and Mizuho as a reduction to stockholders&#8217; equity, consisting of an $850&#160;million increase in treasury stock, which reflects the value of the initial 1.5&#160;million shares received upon initial settlement, and a $150&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Goldman Sachs and Mizuho pending final settlement of the November 2022 ASR Agreements. Upon final settlement of the November 2022 ASR Agreements with Goldman Sachs and Mizuho on December 15, 2022 and December 16, 2022, respectively, we received an additional 0.177&#160;million shares and 0.177&#160;million shares, respectively,  as determined by the average daily volume weighted-averages share price of our common stock during the term of the agreement, less a discount, of $534.16 and $533.87, respectively, bringing the total shares received under the November 2022 ASR Agreements to 1.8&#160;million. In addition, upon settlement we reclassified the $150&#160;million value of stock initially held back by Goldman Sachs and Mizuho from capital in excess of par value to treasury stock. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 15, 2023, the Board of Directors replaced the previous share repurchase authorization of up to $3&#160;billion (of which approximately $1&#160;billion remained unused) with a new authorization for repurchases of up to $3&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 15, 2026.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding shares acquired in connection with employee stock plans, share repurchases were as follows during the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:38.546%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.296%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.129%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Authorization Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Not to Exceed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with employee stock plans, we acquired 0.2 million common shares for $96 million in 2022, 0.2 million common shares for $79 million in 2021, and 0.2 million common shares for $70 million in 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information regarding our stockholders' equity, refer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2021 Form 10-K.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Requirements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our subsidiaries operate in states that regulate the payment of dividends, loans, or other cash transfers to Humana Inc., our parent company, and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid to Humana Inc. by these subsidiaries, without prior approval by state regulatory authorities, or ordinary dividends, is limited based on the entity&#8217;s level of statutory income and statutory capit</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">al and surplus. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an extraordinary dividend requiring prior regulatory approval. In most states, prior notification is provided before paying a dividend even if approval is not required. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although minimum required levels of equity are largely based on premium volume, product mix, and the quality of assets held, minimum requirements vary significantly at the state level. Our state regulated insurance subsidiaries had aggregate statutory capital and surplus of approximately $11.3 billion and $9.6 billion as of December&#160;31, 2022 and 2021, respectively, which exceeded aggregate minimum regulatory requirements of </span><span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8.4 billion and $7.6 billion, respectively.  The amount of ordinary dividends that may be paid to our parent company in 2023 is approximately $1.8 billion in the aggregate. The amount, timing and mix of ordinary and extraordinary dividend payments will vary due to state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory requirements, the level of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix. Actual dividends that were paid to our parent company were approximately  $1.3 billion in 2022, $1.6 billion in 2021, and $1.3 billion in 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344576336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS, GUARANTEES AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS, GUARANTEES AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS, GUARANTEES AND CONTINGENCIES<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">     Purchase Obligations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have agreements to purchase services, primarily information technology related services, or to make improvements to real estate, in each case that are enforceable and legally binding on us and that specify all significant terms, including: fixed or minimum levels of service to be purchased; fixed, minimum or variable price provisions; and the appropriate timing of the transaction. We have purchase obligation commitments of $687 million in 2023, $451 million in 2024, $288 million in 2025, $236 million in 2026, and $153 million in 2027. Purchase obligations exclude agreements that are cancellable without penalty.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our ongoing business, we do not participate or knowingly seek to participate in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, or SPEs, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of December&#160;31, 2022, we were not involved in any SPE transactions.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantees and Indemnifications</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through indemnity agreements approved by the state regulatory authorities, certain of our regulated subsidiaries generally are guaranteed by Humana Inc., our parent company, in the event of insolvency for (1)&#160;member coverage for which premium payment has been made prior to insolvency; (2)&#160;benefits for members then hospitalized until discharged; and (3)&#160;payment to providers for services rendered prior to insolvency. Our parent also has guaranteed the obligations of certain of our non-regulated subsidiaries and funding to maintain required statutory capital levels of certain regulated subsidiaries.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we enter into contractual arrangements under which we may agree to indemnify a third party to such arrangement from any losses incurred relating to the services they perform on behalf of us, or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. Such indemnification obligations may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Government Contracts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Medicare products, which accounted for approximately 81% of our total premiums and services revenue for the year ended December&#160;31, 2022, primarily consisted of products covered under the Medicare Advantage and Medicare Part D Prescription Drug Plan contracts with the federal government. These contracts are renewed generally for a calendar year term unless CMS notifies us of its decision not to renew by May 1 of the calendar year in which the contract would end, or we notify CMS of our decision not to renew by the first Monday in June of the calendar year in which the contract would end. All material contracts between Humana and CMS relating to our Medicare products have been renewed for 2023, and all of our product offerings filed with CMS for 2023 have been approved.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage, or MA, plans according to health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997 (BBA) and the Benefits Improvement and Protection Act of 2000 (BIPA), generally pays more where a plan's membership has higher expected costs. Under this model, rates paid to MA plans are based on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a "national average risk profile." That baseline payment amount is adjusted to account for certain demographic characteristics and health status of our enrolled members. Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data, collected from providers, to calculate the health status-related risk-adjusted premium payment to MA plans, which CMS further adjusts for coding pattern differences between the health plans and the government fee-for-service (FFS) program. We generally rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our health status-adjusted payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS and the Office of the Inspector General of Health and Human Services, or HHS-OIG, perform audits of various companies&#8217; risk adjustment diagnosis data submissions. We refer to these audits as Risk-Adjustment Data Validation Audits, or RADV audits. RADV audits review medical records in an attempt to validate provider medical record documentation and coding practices that influence the calculation of health status-related premium payments to MA plans.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2012, CMS released an MA contract-level RADV methodology that would extrapolate the results of each CMS RADV audit sample to the audited MA contract&#8217;s entire health status-related risk adjusted premium amount for the year under audit.  In doing so, CMS recognized &#8220;that the documentation standard used in RADV audits to determine a contract&#8217;s payment error (medical records) is different from the documentation standard used to develop the Part C risk-adjustment model (FFS claims).&#8221;  To correct for this difference, CMS stated that it would apply a &#8220;Fee-for-Service Adjuster (FFS Adjuster)&#8221; as &#8220;an offset to the preliminary recovery amount.&#8221;  This adjuster would be &#8220;calculated by CMS based on a RADV-like review of records submitted to support FFS claims data.&#8221;  CMS stated that this methodology would apply to audits beginning with PY 2011.  Humana relied on CMS&#8217;s 2012 guidance in submitting MA bids to CMS.  Humana also launched a &#8220;Self-Audits&#8221; program in 2013 that applied CMS&#8217;s 2012 RADV audit methodology and included an estimated FFS Adjuster.  Humana completed Self-Audits for PYs 2011-2016 and reported results to CMS.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, however, CMS issued a proposed rule announcing possible changes to the RADV audit methodology, including elimination of the FFS Adjuster.  CMS proposed applying its revised methodology, including extrapolated recoveries without application of a FFS Adjuster, to RADV audits dating back to PY 2011.  On January 30, 2023, CMS published a final rule related to the RADV audit methodology (Final RADV Rule).  The Final RADV Rule confirmed CMS&#8217;s decision to eliminate the FFS Adjuster. The Final RADV Rule states CMS&#8217;s intention to extrapolate results from CMS and HHS-OIG RADV audits beginning with PY 2018, rather than PY 2011 as proposed.  However, CMS&#8217;s Final RADV Rule does not adopt a specific sampling, extrapolation or audit methodology.  CMS instead stated its general plan to rely on &#8220;any statistically valid method . . . that is determined to be well-suited to a particular audit.&#8221;  </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana is considering its legal options with respect to CMS&#8217;s changed position on the FFS Adjuster and seeking clarity regarding our compliance obligations in light of the Final RADV Rule. We believe that the Final RADV Rule fails to address adequately the statutory requirement of actuarial equivalence. Further, Humana&#8217;s actuarially certified bids through PY 2023 preserved Humana&#8217;s position that CMS should apply an FFS Adjuster in any RADV audit that CMS intends to extrapolate. We expect CMS to apply the Final RADV Rule, including the first application of extrapolated audit results to determine audit settlements without a FFS Adjuster, to CMS and HHS-OIG RADV audits conducted for PY 2018 and subsequent years.  The Final RADV  Rule, including the lack of a FFS Adjuster, and any related regulatory, industry or company reactions, could have a material adverse effect on our results of operations, financial position, or cash flows.  </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as part of our internal compliance efforts, we routinely perform ordinary course reviews of our internal business processes related to, among other things, our risk coding and data submissions in connection with the risk adjustment model. These reviews may also result in the identification of errors and the submission of corrections to CMS that may, either individually or in the aggregate, be material. As such, the result of these reviews may have a material adverse effect on our results of operations, financial position, or cash flows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we explore our legal options and compliance obligations, we remain committed to working alongside CMS to promote the integrity of the MA program as well as affordability and cost certainty for our members.  It is critical that MA plans are paid accurately and that payment model principles, including the application of a FFS Adjuster, are in accordance with the requirements of the Social Security Act, which, if not implemented correctly could have a material adverse effect on our results of operations, financial position, or cash flows. </span></div><div style="margin-bottom:9pt;margin-top:4.5pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our state-based Medicaid business accounted for approximately 6% of our total premiums and services revenue for the year ended December 31, 2022 primarily serving members enrolled in Medicaid, and in certain circumstances members who qualify for both Medicaid and Medicare, under contracts with various states. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">     Our military services business, which accounted for approximately 1% of our total premiums and services revenue for the year ended December 31, 2022, primarily consisted of the TRICARE T2017 East Region contract. The T2017 East Region contract comprises 32 states and approximately six million TRICARE beneficiaries, under which delivery of health care services commenced on January 1, 2018. The T2017 East Region contract, which was originally set to expire on December 31, 2022, was subsequently extended by the DoD and is currently scheduled to expire on December 31, 2023, unless further extended. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2022, we were awarded the next generation of TRICARE Managed Care Support Contracts, or T-5, for the TRICARE East Region by the Defense Health Agency of the DoD. The contract is expected to go into effect in 2024. Until then the T2017 contract remains in place. Under the terms of the award, our service area covers approximately 4.6&#160;million beneficiaries in a region consisting of 24  states and Washington, D.C. The length of the contract is <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMyOA_c266142d-523a-4672-8755-4dc23319d78b">one</span> base year with eight  annual option periods, which, if all options are exercised, would result in a total contract length of  <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMzOA_961b1df7-1bbf-49b4-94e1-c81bd4087591">nine</span> years.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss of any of the contracts above or significant changes in these programs as a result of legislative or regulatory action, including reductions in premium payments to us, regulatory restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, or increases in member benefits or </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">member eligibility criteria without corresponding increases in premium payments to us, may have a material adverse effect on our results of operations, financial position, and cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings and Certain Regulatory Matters</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, the Civil Division of the United States Department of Justice provided us with an information request in December 2014, concerning our Medicare Part C risk adjustment practices. The request relates to our oversight and submission of risk adjustment data generated by providers in our Medicare Advantage network, as well as to our business and compliance practices related to risk adjustment data generated by our providers and by us, including medical record reviews conducted as part of our data and payment accuracy compliance efforts, the use of health and well-being assessments, and our fraud detection efforts. We believe that this request for information is in connection with a wider review of Medicare Risk Adjustment generally that includes a number of Medicare Advantage plans, providers and vendors. We cooperated with the Department of Justice, and we have not heard from the Department of Justice on this matter since 2020. </span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously disclosed, on January 19, 2016, an individual filed a qui tam suit captioned United States of America ex rel. Steven Scott v. Humana, Inc., in United States District Court, Central District of California, Western Division. The complaint alleges certain civil violations by us in connection with the actuarial equivalence of the plan benefits under Humana&#8217;s Basic PDP plan, a prescription drug plan offered by us under Medicare Part D. The action seeks damages and penalties on behalf of the United States under the False Claims Act. The court ordered the qui tam action unsealed on September 13, 2017, so that the relator could proceed, following notice from the U.S. Government that it was not intervening at that time. On January 29, 2018, the suit was transferred to the United States District Court, Western District of Kentucky, Louisville Division. We have substantially completed discovery with the relator who has pursued the matter on behalf of the United States following its unsealing. On March 31, 2022, the Court denied the parties' Motions for Summary Judgement. We take seriously our obligations to comply with applicable CMS requirements and actuarial standards of practice, and continue to vigorously defend against these allegations.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Lawsuits and Regulatory Matters</span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our current and past business practices are subject to review or other investigations by various state insurance and health care regulatory authorities and other state and federal regulatory authorities. These authorities regularly scrutinize the business practices of health insurance, health care delivery and benefits companies. These reviews focus on numerous facets of our business, including claims payment practices, statutory capital requirements, provider contracting, risk adjustment, competitive practices, commission payments, privacy issues, utilization management practices, pharmacy benefits, access to care, sales practices, and provision of care by our healthcare services businesses, among others. Some of these reviews have historically resulted in fines imposed on us and some have required changes to some of our practices. We continue to be subject to these reviews, which could result in additional fines or other sanctions being imposed on us or additional changes in some of our practices.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also are involved in various other lawsuits that arise, for the most part, in the ordinary course of our business operations, certain of which may be styled as class-action lawsuits. Among other matters, this litigation may include employment matters, claims of medical malpractice, bad faith, nonacceptance or termination of providers, anticompetitive practices, improper rate setting, provider contract rate and payment disputes, including disputes over reimbursement rates required by statute, disputes arising from competitive procurement process, general contractual matters, intellectual property matters, and challenges to subrogation practices. Under state guaranty assessment laws, including those related to state cooperative failures in the industry, we may be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of insolvent insurance companies that write the same line or lines of business as we do.</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a government contractor, we may also be subject to false claims litigation, such as qui tam lawsuits brought by individuals who seek to sue on behalf of the government, alleging that the government contractor submitted false claims to the government or related overpayments from the government, including, among other allegations, those resulting from coding and review practices under the Medicare risk adjustment model. Qui tam litigation is filed </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under seal to allow the government an opportunity to investigate and to decide if it wishes to intervene and assume control of the litigation. If the government does not intervene, the individual may continue to prosecute the action on his or her own, on behalf of the government. We also are subject to other allegations of nonperformance of contractual obligations to providers, members, and others, including failure to properly pay claims, improper policy terminations, challenges to our implementation of the Medicare Part D prescription drug program and other litigation.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A limited number of the claims asserted against us are subject to insurance coverage. Personal injury claims, claims for extra contractual damages, care delivery malpractice, and claims arising from medical benefit denials are covered by insurance from our wholly owned captive insurance subsidiary and excess carriers, except to the extent that claimants seek punitive damages, which may not be covered by insurance in certain states in which insurance coverage for punitive damages is not permitted. In addition, insurance coverage for all or certain forms of liability has become increasingly costly and may become unavailable or prohibitively expensive in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record accruals for the contingencies discussed in the sections above to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because of the inherently unpredictable nature of legal proceedings, which also may be exacerbated by various factors, including: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties (including where it is uncertain how liability, if any, will be shared among multiple defendants); or (vii) there is a wide range of potential outcomes.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting judgments, penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities or as a result of actions by third parties. Nevertheless, it is reasonably possible that any such outcome of litigation, judgments, penalties, fines or other sanctions could be substantial, and the outcome of these matters may have a material adverse effect on our results of operations, financial position, and cash flows, and may also affect our reputation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344704864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATION<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During December 2022, we realigned our businesses into two distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior period segment financial information has been recast to conform to the 2022 presentation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our  two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as our contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only, or ASO. In addition, our Insurance segment includes our military services business, primarily our T-2017 East Region contract, as well as the operations of our PBM business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CenterWell segment includes our pharmacy, provider services, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CenterWell intersegment revenues primarily relate to the operations of CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our CenterWell intersegment revenues includes revenues earned by certain owned providers (CenterWell Senior Primary Care) derived from certain value-based arrangements with our health plans. Under these value-based arrangements, our owned providers enter into agreements with our health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our members. In exchange, the owned provider receives a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our members. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present our consolidated results of operations from the perspective of the health plans. As a result, the cost of providing benefits to our members, whether provided via a third party provider or internally through a stand-alone subsidiary, is classified as benefits expense and excludes the portion of the cost for which the health plans do not bear responsibility, including member co-share amounts and government subsidies of $19.7 billion in 2022, $18.1 billion in 2021, and $16.5 billion in 2020. In addition, depreciation and amortization expense associated with certain businesses delivering benefits to our members, primarily associated with our provider services and pharmacy operations, are included with benefits expense. The amount of this expense was $122&#160;million in 2022, $108&#160;million in 2021, and $127&#160;million in 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than those described previously, the accounting policies of each segment are the same and are described in Note 2. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider, and home services, to our Insurance segment customers. Intersegment sales and expenses are recorded at fair value and eliminated in consolidation. Members served by our segments often use the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at a corporate level. These corporate amounts are reported separately from our reportable segments and are included with intersegment eliminations in the tables presenting segment results below. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premium and services revenues derived from our contracts with the federal government, as a percentage of our total premium and services revenues, were approximately 82% for 2022, 83% for 2021 and 83% for 2020.</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,476&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,476&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,562&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,488&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,588)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,429)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,841&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,307&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,278)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,765)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of KAH Hospice</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,568&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,040&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss) attributable to Humana</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,568&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,024)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,852&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,893)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,930&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,058&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,924)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,722)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings attributable to Humana</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,418&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,397&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,504)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,932)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,477&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,986&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504341201504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REINSURANCE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceTextBlock', window );">REINSURANCE</a></td>
<td class="text">REINSURANCE <div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain blocks of insurance assumed in acquisitions, primarily life and annuities in run-off status are subject to reinsurance where some or all of the underwriting risk related to these policies has been ceded to a third party. In addition, a large portion of our reinsurance takes the form of 100% coinsurance agreements where, in addition to all of the underwriting risk, all administrative responsibilities, including premium collections and claim payment, have also been ceded to a third party. We acquired these policies and related reinsurance agreements with the purchase of stock of companies in which the policies were originally written. We acquired these companies for business reasons unrelated to these particular policies, including the companies&#8217; other products and licenses necessary to fulfill strategic plans. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reinsurance agreement between two entities transfers the underwriting risk of policyholder liabilities to a reinsurer while the primary insurer retains the contractual relationship with the ultimate insured. As such, these reinsurance agreements do not completely relieve us of our potential liability to the ultimate insured. However, given the transfer of underwriting risk, our potential liability is limited to the credit exposure which exists should the reinsurer be unable to meet its obligations assumed under these reinsurance agreements.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance recoverables represent the portion of future policy benefits payable and benefits payable that are covered by reinsurance. Reinsurance recoverables, included in other current and long-term assets, were $181 million at December&#160;31, 2022 and $188 million at December&#160;31, 2021. The amount of these reinsurance recoverables resulting from 100% coinsurance agreements was approximately $181 million at December&#160;31, 2022 and approximately $188 million at December&#160;31, 2021. Premiums ceded were $5 million in 2022, $6 million in 2021 and $29 million in 2020. Benefits ceded were $2 million in 2022, $2 million in 2021, and $7 million in 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the financial condition of our reinsurers on a regular basis. Protective Life Insurance Company with $165 million in reinsurance recoverables is well-known and well-established with a AM Best rating of A+ at December&#160;31, 2022. The remaining reinsurance recoverables of $16 million are divided between 10 other reinsurers, with $1 million subject to funds withheld accounts or other financial guarantees supporting the repayment of these amounts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27830-158548<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -URI https://asc.fasb.org/topic&amp;trid=2303980<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6816-158387<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99379264&amp;loc=d3e27758-158548<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344579920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock', window );">SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION</a></td>
<td class="text"><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED BALANCE SHEETS</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"/><td style="width:63.185%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.341%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.344%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions,&#160;except&#160;share<br/>amounts)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Receivable from operating subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,807&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,316&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,195&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,393&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,898&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,969&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payable to operating subsidiaries</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,056&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of notes payable to operating subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Book overdraft</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,047&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,034&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,541&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,587&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,889&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $1 par; 10,000,000 shares authorized; none issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at December&#160;31, 2022 and 198,648,742 shares issued at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Capital in excess of par value</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,082&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive (loss) income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,304)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost, 73,691,955 shares at December&#160;31, 2022 and 69,846,758 shares at December&#160;31, 2021</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,156)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,163)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,311&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,080&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,898&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,969&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the parent company financial statements.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED STATEMENTS OF INCOME</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:58.224%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.922%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.922%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.926%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management fees charged to operating subsidiaries</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,633&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment and other (loss) income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,367&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,979&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Operating costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">488&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;Total expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,681&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,884&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before income taxes and equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,215)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Benefit) provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(266)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(259)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) income before equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(949)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings of subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings of equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,802&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the parent company financial statements.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:54.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.188%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Humana</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in gross unrealized investment (losses) gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,819)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(356)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of income taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total change in unrealized investment  <br/>&#160;&#160;&#160;&#160;(losses) gains, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,401)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(275)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification adjustment for net realized <br/>&#160;losses (gains) included in investment income </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total reclassification adjustment, net of tax</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive (loss) income, net of tax</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,346)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(355)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to equity method<br/>&#160;&#160;investments</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Humana</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,460&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,602&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the parent company financial statements.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONDENSED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:52.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.667%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(337)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(709)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions to operating subsidiaries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(538)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Purchases of property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(958)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(63)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(460)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of investment securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,317)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,732)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,068)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of senior notes, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,976&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,088&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Repayments of senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;(Repayments) proceeds from issuance of commercial paper, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Proceeds from issuance of term loan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Change in book overdraft</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Common stock repurchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,096)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,820)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;Dividends paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(354)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from stock option exercises and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,843)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,349&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,033)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(292)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(570)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">906&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the parent company financial statements.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SCHEDULE I&#8212;PARENT COMPANY FINANCIAL INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONDENSED FINANCIAL STATEMENTS</span></div>BASIS OF PRESENTATIONParent company financial information has been derived from our consolidated financial statements and excludes the accounts of all operating subsidiaries. This information should be read in conjunction with our consolidated financial statements.TRANSACTIONS WITH SUBSIDIARIES<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Services Fee</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through intercompany service agreements approved, if required, by state regulatory authorities, Humana Inc., our parent company, charges a services fee for reimbursement of certain centralized services provided to its subsidiaries including information systems, disbursement, investment and cash administration, marketing, legal, finance, and medical and executive management oversight.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash dividends received from subsidiaries and included as a component of net cash provided by operating activities were $1.3 billion in 2022, $1.6 billion in 2021, and $1.3 billion in 2020.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Guarantee</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through indemnity agreements approved by state regulatory authorities, certain of our regulated subsidiaries generally are guaranteed by our parent company in the event of insolvency for: (1) member coverage for which premium payment has been made prior to insolvency; (2) benefits for members then hospitalized until discharged; and (3)&#160;payment to providers for services rendered prior to insolvency. Our parent has also guaranteed the obligations of our military services subsidiaries and funding to maintain required statutory capital levels of certain other regulated subsidiaries.</span></div>REGULATORY REQUIREMENTS<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our subsidiaries operate in states that regulate the payment of dividends, loans, or other cash transfers to Humana Inc., our parent company, and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid to Humana Inc. by these subsidiaries, without prior approval by state regulatory authorities, or ordinary dividends, is limited based on the entity&#8217;s level of statutory income and statutory capit</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">al and surplus. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an extraordinary dividend requiring prior regulatory approval. In most states, prior notification is provided before paying a dividend even if approval is not required.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although minimum required levels of equity are largely based on premium volume, product mix, and the quality of assets held, minimum requirements vary significantly at the state level. Our state regulated insurance subsidiaries had aggregate statutory capital and surplus of approximately </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$11.3 billion and $9.6 billion as of December&#160;31, 2022 and 2021, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respectively, which exceeded aggregate minimum regulatory requirements of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$8.4 billion</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and $7.6 billion, respectively. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of ordinary dividends that may be paid to our parent company in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2023 </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is approximately</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1.8 billion </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the aggregate. The amount, timing and mix of ordinary and extraordinary dividend payments will vary due to state </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regulatory requirements, the level of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix. Actual dividends that were paid to our parent company were approximately  $1.3 billion in 2022, $1.6 billion in 2021, and $1.3 billion in 2020.</span></div>Our use of operating cash flows derived from our non-insurance subsidiaries, such as in our Healthcare Services segment, is generally not restricted by state departments of insurance (or comparable state regulators).ACQUISITIONSRefer to Note 3 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of certain acquisitions. During 2022, 2021 and 2020, we funded certain non-regulated subsidiary acquisitions with contributions from Humana Inc., our parent company, included in capital contributions in the condensed statement of cash flows.INCOME TAXESRefer to Note 12 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of income taxes.DEBTRefer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of debt.STOCKHOLDERS' EQUITYRefer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of stockholders&#8217; equity, including stock repurchases and stockholder dividends.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.5-04(Schedule I))<br> -URI https://asc.fasb.org/extlink&amp;oid=126898705&amp;loc=d3e5864-122674<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=d3e5283-111683<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337096864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Our consolidated financial statements include the accounts of Humana Inc. and subsidiaries that the Company controls, including variable interest entities associated with medical practices for which we are the primary beneficiary. We do not own many of our medical practices but instead enter into exclusive management agreements with the affiliated Professional Associations, or P.A.s, that operate these medical practices. Based upon the provisions of these agreements, these affiliated P.A.s are variable interest entities and we are the primary beneficiary, and accordingly we consolidate the affiliated P.A.s. All significant intercompany balances and transactions have been eliminated.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Value Creation Initiatives</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473&#160;million included within operating costs in the consolidated statement of income for the year ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_HealthCareReformPolicyTextBlock', window );">Health Care Reform</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health Care Reform</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Patient Protection and Affordable Care Act and The Health Care and Education Reconciliation Act of 2010 (which we collectively refer to as the Health Care Reform Law) enacted significant reforms to various aspects of the U.S. health insurance industry. Certain of these reforms became effective January 1, 2014, including an annual insurance industry premium-based fee. The Continuing Resolution bill, H.R. 195, enacted on January 22, 2018, included a one year suspension in 2019 of the health insurance industry fee, but the fee resumed in calendar year 2020. The Further Consolidated Appropriations Act, 2020, enacted on December 20, 2019, permanently repealed the health insurance industry fee beginning in calendar year 2021. </span></div>The annual premium-based fee on health insurers was not deductible for tax purposes. We estimated a liability for the health insurance industry fee and recorded it in full once qualifying insurance coverage was provided in the applicable calendar year in which the fee was payable with a corresponding deferred cost that was amortized ratably to expense over the same calendar year. We recorded the liability for the health insurance industry fee in trade accounts payable and accrued expenses and recorded the deferred cost in other current assets in our consolidated financial statements. We paid the health insurance industry fee in September or October of each year.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents include cash, time deposits, money market funds, commercial paper, other money market instruments, and certain U.S. Government securities with an original maturity of three months or less. Carrying value approximates fair value due to the short-term maturity of the investments.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investment Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investment Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities, which consist of debt and equity securities, are stated at fair value. Our debt securities have been categorized as available for sale. Debt securities available for current operations, as well as our equity securities, are classified as current assets, and debt securities available to fund our professional and other self-insurance liability requirements, as well as restricted statutory deposits, are classified as long-term assets. For the purpose of determining realized gross gains and losses for debt securities sold, that are included as a component of investment income in the consolidated statements of income, the cost of investment securities sold is based upon specific identification. Unrealized holding gains and losses for debt securities, net of applicable deferred taxes, are included in other comprehensive income or loss as a component of stockholders&#8217; equity until realized from a sale or an expected credit loss is recognized. For the purpose of determining gross gains and losses for equity securities, changes in fair value at the reporting date are included as a component of investment income in the consolidated statements of income.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning on January 1, 2020, we adopted the new current expected credit losses, or CECL, model which retained many similarities from the previous other-than-temporary impairment model except eliminating from consideration in the impairment analysis the length of time over which the fair value had been less than cost. Also, under the CECL model, expected losses on available for sale debt securities are recognized through an allowance for credit losses rather than as reductions in the amortized cost of the securities. For debt securities whose fair value is less than their amortized cost which we do not intend to sell or are not required to sell, we evaluate the expected cash flows to be received as compared to amortized cost and determine if an expected credit loss has occurred. In the event of an expected credit loss, only the amount of the impairment associated with the expected credit loss is recognized in income with the remainder, if any, of the loss recognized in other comprehensive income.  To the extent we have the intent to sell the debt security or it is more likely than not we will be required to sell the debt security before recovery of our amortized cost basis, we recognize an impairment loss in income in an amount equal to the full difference between the amortized cost basis and the fair value.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potential expected credit loss impairment is considered using a variety of factors, including the extent to which the fair value has been less than cost; adverse conditions specifically related to the industry, geographic area or financial condition of the issuer or underlying collateral of a debt security; changes in the quality of the debt security's credit enhancement; payment structure of the debt security; changes in credit rating of the debt security by the rating agencies; failure of the issuer to make scheduled principal or interest payments on the debt security and changes in prepayment speeds. For debt securities, we take into account expectations of relevant market and economic data. For example, with respect to mortgage and asset-backed securities, such data includes underlying loan level data and structural features such as seniority and other forms of credit enhancements. We estimate the amount of the expected credit loss component of a debt security as the difference between the amortized cost and the present value of the expected cash flows of the security. The present value is determined using the best estimate of future cash flows discounted at the implicit interest rate at the date of purchase. The expected credit loss cannot exceed the full difference between the amortized cost basis and the fair value.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsurancePremiumsRevenueRecognitionPolicy', window );">Premiums Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Premiums Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We receive monthly premiums from the federal government and various states according to government specified payment rates and various contractual terms. We bill and collect premium from employer groups and members in our Medicare and other individual products monthly.  Changes in premium revenues resulting from the periodic changes in risk-adjustment scores derived from medical diagnoses for our membership are estimated by projecting the ultimate annual premium and are recognized ratably during the year, with adjustments each period to reflect changes in the ultimate premium. Receivables or payables are classified as current or long-term in our consolidated balance sheet based on the timing of the expected settlement. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Premiums revenue is estimated by multiplying the membership covered under the various contracts by the contractual rates. Premiums revenue is recognized as income in the period members are entitled to receive services and is net of estimated uncollectible amounts, retroactive membership adjustments, and adjustments to recognize rebates under the minimum benefit ratios required under the Health Care Reform Law. We estimate policyholder rebates by projecting calendar year minimum benefit ratios for the small group and large group markets, as defined by the Health Care Reform Law using a methodology prescribed by Health and Human Services, or HHS, separately by state and legal entity. Medicare Advantage and Medicaid products are also subject to minimum benefit ratio requirements. Estimated calendar year rebates recognized ratably during the year are revised each period to reflect current experience. Retroactive membership adjustments result from enrollment changes not yet processed, or not yet reported by an employer group or the government. We routinely monitor the collectability of specific accounts, the aging of receivables, historical retroactivity trends, estimated rebates, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. Premiums received prior to the service period are recorded as unearned revenues.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare Part D</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with CMS. The payments we receive monthly from CMS and members, which are determined from our annual bid, represent amounts for providing prescription drug insurance coverage. We recognize premiums revenue for providing this insurance coverage ratably over the term of our annual contract. Our CMS payment is subject to risk sharing through the Medicare Part D risk corridor provisions. In addition, receipts for reinsurance and low-income cost subsidies as well as receipts for certain discounts on brand name prescription drugs in the coverage gap represent payments for prescription drug costs for which we are not at risk.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk corridor provisions compare costs targeted in our bids to actual prescription drug costs, limited to actual costs that would have been incurred under the standard coverage as defined by CMS. Variances exceeding certain thresholds may result in CMS making additional payments to us or require us to refund to CMS a portion of the premiums we received. As risk corridor provisions are considered in our overall annual bid process, we estimate and recognize an adjustment to premiums revenue related to these provisions based upon pharmacy claims experience. We record a receivable or payable at the contract level and classify the amount as current or long-term in our consolidated balance sheets based on the timing of expected settlement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reinsurance and low-income cost subsidies represent funding from CMS in connection with the Medicare Part D program for which we assume no risk. Reinsurance subsidies represent funding from CMS for its portion of prescription drug costs which exceed the member&#8217;s out-of-pocket threshold, or the catastrophic coverage level. Low-income cost subsidies represent funding from CMS for all or a portion of the deductible, the coinsurance and co-payment amounts above the out-of-pocket threshold for low-income beneficiaries. Monthly prospective payments from CMS for reinsurance and low-income cost subsidies are based on assumptions submitted with our annual bid. A reconciliation and related settlement of CMS&#8217;s prospective subsidies against actual prescription drug costs we paid is made after the end of the year. The Health Care Reform Law mandates consumer discounts of 50% on brand name prescription drugs for Part D plan participants in the coverage gap. These discounts are funded by CMS and pharmaceutical manufacturers while we administer the application of these funds. We account for these subsidies </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and discounts as a deposit in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits, net in our consolidated statements of cash flows. </span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"/><td style="width:56.896%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.472%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part D subsidy/discount payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part D subsidy/discount reimbursements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reimbursements (payments)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,968&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(938)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not recognize premiums revenue or benefit expenses for these subsidies or discounts. Receipt and payment activity is accumulated at the contract level and recorded in our consolidated balance sheets in other current assets or trade accounts payable and accrued expenses depending on the contract balance at the end of the reporting period.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlement of the reinsurance and low-income cost subsidies as well as the risk corridor payment is based on a reconciliation made approximately 9 months after the close of each calendar year. Settlement with CMS for brand name prescription drug discounts is based on a reconciliation made approximately 14 to 18 months after the close of each calendar year. We continue to revise our estimates with respect to the risk corridor provisions based on subsequent period pharmacy claims data. See Note 7 for detail regarding amounts recorded to our consolidated balance sheets related to the risk corridor settlement and subsidies from CMS with respect to the Medicare Part D program.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Services Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Services Revenue</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient services revenue </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patient services include services related to pharmacy, provider services, and home solutions services, such as home health and other services and capabilities to promote wellness and advance population health. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our pharmacy business, external pharmacy revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through our CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Services revenues related to product revenues from dispensing prescriptions are recorded when the prescription or product is shipped.</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provider services business recognizes revenues for certain value-based arrangements. Under these value-based arrangements, we enter into agreements with health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our patients. In exchange, we receive a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our patients. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our home solutions businesses, revenues include net patient services revenue recorded based upon established billing rates, net of contractual allowances, discounts, or other implicit price concessions, and are recognized as performance obligations are satisfied, which is in the period services are rendered.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the&#160;year ended December&#160;31, 2022, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price), was not material. Further, revenue expected to be recognized in any future year related to remaining performance obligations is not material.</span></div><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Administrative services fees </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Administrative services fees cover the processing of claims, offering access to our provider networks and clinical programs, and responding to customer service inquiries from members of self-funded groups. Revenues from providing administration services, also known as administrative services only, or ASO, are recognized in the period services are performed and are net of estimated uncollectible amounts. ASO fees are estimated by multiplying the membership covered under the various contracts by the contractual rates. Under ASO contracts, self-funded employers retain the risk of financing substantially all of the cost of health benefits. However, many ASO customers purchase stop loss insurance coverage from us to cover catastrophic claims or to limit aggregate annual costs. Accordingly, we have recorded premiums revenue and benefits expense related to these stop loss insurance contracts. We routinely monitor the collectability of specific accounts, the aging of receivables, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. ASO fees received prior to the service period are recorded as unearned revenues.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Under our TRICARE contracts with the Department of Defense (DoD) we provide administrative services, including offering access to our provider networks and clinical programs, claim processing, customer service, enrollment, and other services, while the federal government retains all of the risk of the cost of health benefits. We account for revenues under our contracts net of estimated health care costs similar to an administrative services fee only agreement. Our contracts include fixed administrative services fees and incentive fees and penalties. Administrative services fees are recognized as services are performed.&#160;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our TRICARE members are served by both in-network and out-of-network providers in accordance with our contracts. We pay health care costs related to these services to the providers and are subsequently reimbursed by the DoD for such payments. We account for the payments of the federal government&#8217;s claims and the related reimbursements under deposit accounting in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits,net in our consolidated statements of cash flows.  </span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:56.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost reimbursements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reimbursements (payments)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Receivables</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receivables</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Receivables, including premium receivables, patient services revenue receivables, and ASO fee receivables, are shown net of allowances for estimated uncollectible accounts, retroactive membership adjustments, and contractual allowances.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_OtherCurrentAssetsPolicyTextBlock', window );">Other Current Assets</a></td>
<td class="text">Other Current AssetsOther current assets include amounts associated with Medicare Part D as discussed above and in Note 7, rebates due from pharmaceutical manufacturers and other amounts due within one year.  We accrue pharmaceutical rebates as they are earned based on contractual terms and usage of the product.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_AcquisitionCostsPolicyPolicyTextBlock', window );">Policy Acquisition Costs</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy Acquisition Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Policy acquisition costs are those costs that relate directly to the successful acquisition of new and renewal insurance policies. Such costs include commissions, costs of policy issuance and underwriting, and other costs we incur to acquire new business or renew existing business. We expense policy acquisition costs related to our employer-group prepaid health services policies as incurred. These short-duration employer-group prepaid health services policies typically have a 1-year term and may be canceled upon 30 days notice by the employer group.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is recorded at cost. Gains and losses on sales or disposals of property and equipment are included in operating costs in our consolidated income statements. Certain costs related to the development or purchase of internal-use software are capitalized. Depreciation is computed using the straight-line method over estimated useful lives ranging from 3 to 10 years for equipment, 3 to 5 years for computer software, and 10 to 20 years for buildings. Improvements to leased facilities are depreciated over the shorter of the remaining lease term or the anticipated life of the improvement.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review long-lived assets, including property and equipment and other definite-lived intangible assets, for impairment whenever adverse events or changes in circumstances indicate the carrying value of the asset may not be recoverable. Losses are recognized for a long-lived asset to be held and used in our operations when the undiscounted future cash flows expected to result from the use of the asset are less than its carrying value. We recognize an impairment loss based on the excess of the carrying value over the fair value of the asset. A long-lived asset held for sale is reported at the lower of the carrying amount or fair value less costs to sell. Depreciation expense is not recognized on assets held for sale. Losses are recognized for a long-lived asset to be abandoned when the asset ceases to be used. In addition, we periodically review the estimated lives of all long-lived assets for reasonableness.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsPolicy', window );">Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investments</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the equity method of accounting for equity investments in companies where we are able to exercise significant influence, but not control, over operating and financial policies of the investee. Judgment regarding the level of influence over each equity method investment includes considering key factors such as our ownership interest, representation on the board of directors, organizational structure, participation in policy-making decisions and material intra-entity transactions.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by our share of equity in income or losses after the date of acquisition as well as capital contributions to and distributions from these companies. Our proportionate share of the net income or loss of these companies is included in consolidated net income.  Investment amounts in excess of our share of an investee&#8217;s net assets are amortized over the life of the related asset creating the excess. Excess goodwill is not amortized. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by us when reviewing an equity method investment for impairment include the length of time (duration) and the extent (severity) to which the fair value of the equity method investment has been less than carrying value, the investee&#8217;s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than-temporary is recognized in the period identified.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div style="text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the unamortized excess of cost over the fair value of the net tangible and other intangible assets acquired. We are required to test at least annually for impairment at a level of reporting referred to as the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. A reporting unit either is our operating segments or one level below the operating segments, referred to as a component, which comprise our reportable segments. A component is considered a reporting unit if the component constitutes a business for which discrete financial information is available that is regularly reviewed by management. We aggregate the components of an operating segment into one reporting unit if they have similar economic characteristics. Goodwill is assigned to the reporting units that are expected to benefit from the specific synergies of the business combination.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform a quantitative assessment to review goodwill for impairment to determine both the existence and amount of goodwill impairment, if any. Impairment tests are performed, at a minimum, in the fourth quarter of each year supported by our long-range business plan and annual planning process. We rely on an evaluation of future discounted cash flows to determine fair value of our reporting units. The fair value of our reporting units with significant goodwill exceeded carrying amounts. However, unfavorable changes in key assumptions or combinations of assumptions including a significant increase in the discount rate, decrease in the long-term growth rate or substantial reduction in our underlying cash flow assumptions, including revenue growth rates, medical and operating cost trends, and projected operating income could have a significant negative impact on the estimated fair value of our home solutions and provider reporting units, which accounted for $4.3&#160;billion and $1.1&#160;billion of goodwill, respectively. Impairment tests completed for 2022, 2021, and 2020 did not result in an impairment loss. </span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets with indefinite lives relate to Certificate of Needs (CON) and Medicare licenses acquired as part of our acquisition of Kindred at Home, or KAH, and are included within other long-term assets in the consolidated balance sheet at December&#160;31, 2022 and December&#160;31, 2021. See Note 3 for further information. We are required to annually compare the fair values of other indefinite-lived intangible assets to their carrying amounts. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized. Fair values of indefinite-lived intangible assets are determined based on the income approach. Impairment tests completed for 2022 did not result in a material impairment loss. These charges reflect the amount by which the carrying value exceeded its estimated fair value. Impairment tests completed for 2021 did not result in an impairment loss. The fair values of the assets were measured using Level 3 inputs, such as projected revenues and operating cash flows. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Definite-lived intangible assets primarily relate to acquired customer contracts/relationships and are included with other long-term assets in the consolidated balance sheets. Definite-lived intangible assets are amortized over the useful life generally using the straight-line method. We review definite-lived intangible assets for impairment under our long-lived asset policy.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock', window );">Benefits Payable and Benefits Expense Recognition</a></td>
<td class="text"><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefits Payable and Benefits Expense Recognition</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits expense includes claim payments, capitation payments, pharmacy costs net of rebates, allocations of certain centralized expenses and various other costs incurred to provide health insurance coverage to members, as well as estimates of future payments to hospitals and others for medical care and other supplemental benefits provided on or prior to the balance sheet date. Capitation payments represent monthly contractual fees disbursed to primary care and other providers who are responsible for providing medical care to members. Pharmacy costs represent payments for members&#8217; prescription drug benefits, net of rebates from drug manufacturers. Receivables for such pharmacy rebates are included in other current assets in our consolidated balance sheets. Other supplemental benefits include dental, vision, and other supplemental health products.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the costs of our benefits expense payments using actuarial methods and assumptions based upon claim payment patterns, medical cost inflation, historical developments such as claim inventory levels and claim receipt patterns, and other relevant factors, and record benefit reserves for future payments. We continually review estimates of future payments relating to claims costs for services incurred in the current and prior periods and make necessary adjustments to our reserves.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Benefits expense is recognized in the period in which services are provided and includes an estimate of the cost of services which have been incurred but not yet reported, or IBNR. Our reserving practice is to consistently recognize the actuarial best point estimate within a level of confidence required by actuarial standards. Actuarial standards of practice generally require a level of confidence such that the liabilities established for IBNR have a greater probability of being adequate versus being insufficient, or such that the liabilities established for IBNR are sufficient to cover obligations under an assumption of moderately adverse conditions. Adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of the estimate. Therefore, in many situations, the claim amounts ultimately settled will be less than the estimate that satisfies the actuarial standards of practice.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop our estimate for IBNR using actuarial methodologies and assumptions, primarily based upon historical claim experience. Depending on the period for which incurred claims are estimated, we apply a different method in determining our estimate. For periods prior to the most recent two months, a completion factor method uses historical paid claims patterns to estimate the percentage of claims incurred during a given period that have historically been adjudicated as of the reporting period. Changes in claim inventory levels and known changes in claim payment processes are taken into account in these estimates. For the most recent two months, the incurred claims are estimated primarily from a trend analysis based upon per member per month claims trends developed from our historical experience in the preceding months, adjusted for known changes in estimates of hospital admissions, recent hospital and drug utilization data, provider contracting changes, changes in benefit levels, changes in member cost sharing, changes in medical management processes, product mix, and workday seasonality.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completion factor method is used for the months of incurred claims prior to the most recent two months because the historical percentage of claims processed for those months is at a level sufficient to produce a consistently reliable result. Conversely, for the most recent two months of incurred claims, the volume of claims processed historically is not at a level sufficient to produce a reliable result, which therefore requires us to examine historical trend patterns as the primary method of evaluation. Changes in claim processes, including recoveries of overpayments, receipt cycle times, claim inventory levels, outsourcing, system conversions, and processing disruptions due to weather or other events affect views regarding the reasonable choice of completion factors. Claim payments to providers for services rendered are often net of overpayment recoveries for claims paid previously, as contractually allowed. Claim overpayment recoveries can result from many different factors, including retroactive enrollment activity, audits of provider billings, and/or payment errors. Changes in patterns of claim overpayment recoveries can be unpredictable and result in completion factor volatility, as they often impact older dates of service. The receipt cycle time measures the average length of time between when a medical claim was initially incurred and when the claim form was received. Increases in electronic claim submissions from providers decrease the receipt cycle time. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claim may be more (less) complete than originally estimated using our completion factors, which may result in reserves that are higher (lower) than required.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical cost trends potentially are more volatile than other segments of the economy. The drivers of medical cost trends include increases in the utilization of hospital facilities, physician services, new higher priced technologies and medical procedures, and new prescription drugs and therapies, as well as the inflationary effect on the cost per unit of each of these expense components. Other external factors such as government-mandated benefits or other regulatory changes, the tort liability system, increases in medical services capacity, direct to consumer advertising for prescription drugs and medical services, an aging population, lifestyle changes including diet and smoking, catastrophes, public health emergencies, epidemics and pandemics (such as the spread of COVID-19) also may impact medical cost trends. Internal factors such as system conversions, claims processing cycle times, changes in medical management practices and changes in provider contracts also may impact our ability to accurately predict estimates of historical completion factors or medical cost trends. All of these factors are considered in estimating IBNR and in estimating the per member per month claims trend for purposes of determining the reserve for the most recent two months. Additionally, we continually prepare and review follow-up studies to assess the reasonableness of the estimates generated by our process and methods over time. The results of these studies are also considered in determining the reserve for the most recent two months. Each of these factors requires significant judgment by management.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reassess the profitability of our contracts for providing insurance coverage to our members when current operating results or forecasts indicate probable future losses. We establish a premium deficiency reserve in current operations to the extent that the sum of expected future costs, claim adjustment expenses, and maintenance costs exceeds related future premiums under contracts without consideration of investment income. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with our method of acquiring, servicing, and measuring the profitability of such contracts. Losses recognized as a premium deficiency result in a beneficial effect in subsequent periods as operating losses under these contracts are charged to the liability previously established. Because the majority of our member contracts renew annually, we would not record a material premium deficiency reserve, except when unanticipated adverse events or changes in circumstances indicate otherwise.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our benefits payable are adequate to cover future claims payments required. However, such estimates are based on knowledge of current events and anticipated future events. Therefore, the actual liability could differ materially from the amounts provided.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock', window );">Future policy benefits payable</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future policy benefits payable</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future policy benefits payable includes liabilities for long-duration insurance policies primarily related to certain blocks of insurance assumed in acquisitions, primarily life and annuities in run-off status, and are included in our consolidated balance sheet within other long-term liabilities. Most of these policies are subject to reinsurance as detailed in Note 19.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BookOverdraftPolicyPolicyTextBlock', window );">Book Overdraft</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Book Overdraft</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our cash management system, checks issued but not yet presented to banks that would result in negative bank balances when presented are classified as a current liability in the consolidated balance sheets. Changes in book overdrafts from period to period are reported in the consolidated statement of cash flows as a financing activity.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize an asset or liability for the deferred tax consequences of temporary differences between the tax bases of assets or liabilities and their reported amounts in the consolidated financial statements. These temporary differences will result in taxable or deductible amounts in future years when the reported amounts of the assets or liabilities are recovered or settled. We also recognize the future tax benefits such as net operating and capital loss carryforwards as deferred tax assets. A valuation allowance is provided against these deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. Future years&#8217; tax expense may be increased or decreased by adjustments to the valuation allowance or to the estimated accrual for income taxes. Deferred tax assets and deferred tax liabilities are further adjusted for changes in the enacted tax rates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record tax benefits when it is more likely than not that the tax return position taken with respect to a particular transaction will be sustained. A liability, if recorded, is not considered resolved until the statute of limitations for the relevant taxing authority to examine and challenge the tax position has expired, or the tax position is ultimately settled through examination, negotiation, or litigation. We classify interest and penalties associated with uncertain tax positions in our provision for income taxes.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NoncontrollingInterestsPolicyTextBlock', window );">Noncontrolling Interests</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Noncontrolling Interests</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned affiliates that we control. Accordingly, we record noncontrolling interests in the earnings and equity of such entities. We record adjustments to noncontrolling interests for the allocable portion of income or loss to which the noncontrolling interest holders are entitled based upon their portion of the subsidiaries they own. Distributions to holders of noncontrolling interests are adjusted to the respective noncontrolling interest holders&#8217; balances. Noncontrolling interests, which relate to the minority ownership held by third party investors in certain of our businesses within our Insurance and CenterWell segments, are reported below net income under the heading &#8220;Net </span></div>income attributable to noncontrolling interests&#8221; in the consolidated statements of income and presented as a component of equity in the consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based CompensationWe generally recognize stock-based compensation expense, as determined on the date of grant at fair value, on a straight-line basis over the period during which an employee is required to provide service in exchange for the award (the vesting period). In addition, for awards with both time and performance-based conditions, we generally recognize compensation expense on a straight line basis over the vesting period when it is probable that the performance condition will be achieved. We estimate expected forfeitures and recognize compensation expense only for those awards which are expected to vest. We estimate the grant-date fair value of stock options using the Black-Scholes option-pricing model.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Common Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Earnings Per Common Share</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute basic earnings per common share on the basis of the weighted-average number of unrestricted common shares outstanding. Diluted earnings per common share is computed on the basis of the weighted-average number of unrestricted common shares outstanding plus the dilutive effect of outstanding employee stock options and restricted shares, or units, using the treasury stock method.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured at fair value are categorized into a fair value hierarchy based on whether the inputs to valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our own assumptions about the assumptions market participants would use. The fair value hierarchy includes three levels of inputs that may be used to measure fair value as described below.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 1 &#8211; Quoted prices in active markets for identical assets or liabilities. Level 1 assets and liabilities include securities that are traded in an active exchange market.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 2 &#8211; Observable inputs other than Level 1 prices such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments as well as debt securities whose value is determined using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level 3 &#8211; Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes assets and liabilities whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting our own assumptions about the assumptions market participants would use as well as those requiring significant management judgment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value of actively traded debt and equity securities are based on quoted market prices. Fair value of other debt securities are based on quoted market prices of identical or similar securities or based on observable inputs like interest rates generally using a market valuation approach, or, less frequently, an income valuation approach and are generally classified as Level 2. Fair value of privately held investment grade debt securities are estimated using a variety of valuation methodologies, including both market and income approaches, where an observable quoted market does not exist and are generally classified as Level 3. For privately-held investment grade debt securities, such methodologies include reviewing the value ascribed to the most recent financing, comparing the security with </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities of publicly-traded companies in similar lines of business with similar credit characteristics, and reviewing the underlying financial performance including estimating discounted cash flows.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain at least one price for each security from a third party pricing service. These prices are generally derived from recently reported trades for identical or similar securities, including adjustments through the reporting date based upon observable market information. When quoted prices are not available, the third party pricing service may use quoted market prices of comparable securities or discounted cash flow analysis, incorporating inputs that are currently observable in the markets for similar securities. Inputs that are often used in the valuation methodologies include benchmark yields, reported trades, credit spreads, broker quotes, default rates, and prepayment speeds. We are responsible for the determination of fair value and as such we perform analysis on the prices received from the third party pricing service to determine whether the prices are reasonable estimates of fair value. Our analysis includes a review of monthly price fluctuations as well as a quarterly comparison of the prices received from the pricing service to prices reported by our third party investment adviser. In addition, on a quarterly basis we examine the underlying inputs and assumptions for a sample of individual securities across asset classes, credit rating levels, and various durations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting Pronouncements Effective in Future Periods</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#8212;Insurance (Topic 944): Effective Date and Early Application (&#8220;ASU 2020-11&#8221;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#8212;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#8220;ASU 2018-12&#8221;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare supplement product which represent less than 1% of consolidated premiums and services revenue, is effective for us beginning with annual and interim periods in 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position and cash flows.</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_AcquisitionCostsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes an insurance entity's accounting policy for deferred policy acquisition costs, including the nature and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_AcquisitionCostsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describes the entity's accounting policies, methodologies, and assumptions for estimating its liability as of the balance sheet date for the cost of settling reported and unreported claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BookOverdraftPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of policies associated with the accounting treatment of book overdraft</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BookOverdraftPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Description of policies associated with the accounting treatment of future policy benefits payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_HealthCareReformPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health Care Reform</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_HealthCareReformPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NoncontrollingInterestsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NoncontrollingInterestsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_OtherCurrentAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_OtherCurrentAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21D<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=SL94080555-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsurancePremiumsRevenueRecognitionPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue recognition of insurance premium. Includes, but is not limited to, basis for measurement and timing of recognition of revenue from insurance premium received from contract holder and method used in performing premium deficiency testing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 60<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124509248&amp;loc=SL117422156-227712<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsurancePremiumsRevenueRecognitionPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344696768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock', window );">Schedule of Health Care Cost Payments and Reimbursements</a></td>
<td class="text">We account for these subsidies <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and discounts as a deposit in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits, net in our consolidated statements of cash flows. </span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"><tr><td style="width:1.0%"/><td style="width:56.896%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.470%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.446%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.472%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part D subsidy/discount payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,530)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,889)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,348)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Part D subsidy/discount reimbursements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,498&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reimbursements (payments)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,968&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(261)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(938)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>We account for the payments of the federal government&#8217;s claims and the related reimbursements under deposit accounting in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits,net in our consolidated statements of cash flows.  <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:56.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.450%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost payments</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,943)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,253)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health care cost reimbursements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,898&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net reimbursements (payments)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Health Care Cost Payments and Reimbursements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339090880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text">The assets, liabilities and noncontrolling interest disposed of on August 11, 2022 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:77.872%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.928%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">73&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Receivables, net of allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,331&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">3,622</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Trade accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">530</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Noncontrolling interest</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">11</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table>The final fair values of KAH&#8217;s assets acquired and liabilities assumed at the date of the acquisition are summarized as follows: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:77.838%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">172&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">9,049</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Current liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">410&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2,078&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">369&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Total liabilities assumed</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">2,857</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Net assets acquired</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">6,170</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344647904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY METHOD INVESTMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summarized balance sheet at December&#160;31, 2022 and statement of income for the period beginning August 11, 2022 through December&#160;31, 2022 of KAH Hospice were as follows:</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:77.195%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.605%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance sheet</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,386&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:76.516%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.284%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Statements of income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">August 11, 2022 through December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">652&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504343774352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Schedule of Investment Securities Classified as Current and Long-Term</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investment securities classified as current and long-term were as follows at December&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:1pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.682%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.646%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,697&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">765&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,809&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,551&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,946&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,261&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,265&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,394&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,440&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total investment securities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,972&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock', window );">Schedule of Gross Unrealized Losses and Fair Value of Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross unrealized losses and fair values aggregated by investment category and length of time that individual debt securities have been in a continuous unrealized loss position were as follows at December&#160;31, 2022 and 2021, respectively:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:37.201%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.519%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Less&#160;than&#160;12&#160;months</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12 months or more</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Unrealized<br/>Losses</span></td></tr><tr style="height:15pt"><td colspan="36" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">909&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,231&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(367)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,914&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(471)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">243&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(142)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(155)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,011&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,825&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(730)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(828)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,962&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,431)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government <br/>&#160;&#160;&#160;&#160;corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,082&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,638&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">695&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">530&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,225&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,990&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(94)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,537&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(161)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRealizedGainLossTableTextBlock', window );">Schedule of Realized Gains (Losses) Related to Investment Securities Included Within Investment Income</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The detail of realized gains (losses) related to investment securities and included within investment income was as follows for the years ended December&#160;31, 2022, 2021, and 2020:</span></div><div style="margin-bottom:7pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:57.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.222%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.222%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.226%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on investment securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross gains on equity securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross losses on equity securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(364)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net recognized (losses) gains on investment securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(205)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(130)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">838&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnInvestmentsTextBlock', window );">Gain (Loss) on Equity Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The gains and losses related to equity securities for the years ended December&#160;31, 2022, 2021 and 2020 was as follows:</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.515%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.517%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (losses) gains recognized on equity securities during the period</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(341)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net losses recognized on equity securities sold during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(105)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses) gains recognized on equity securities still held at the end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(328)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Contractual Maturities of Debt Securities Available for Sale</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contractual maturities of debt securities available for sale at December&#160;31, 2022, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.</span></div><div style="text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:75.909%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.993%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.995%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due within one year</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">529&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after one year through five years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after five years through ten years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,231&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due after ten years</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">994&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage and asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,761&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,946&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of realized and unrealized gain (loss) on investment in security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRealizedGainLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been included in earnings as a result of those sales.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRealizedGainLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unrealized gains and losses on investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504340709696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Financial Assets Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our fair value measurements at December&#160;31, 2022 and 2021, respectively, for financial assets measured at fair value on a recurring basis:</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:45.127%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.744%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices<br/>in Active<br/>Markets<br/>(Level 1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other<br/>Observable<br/>Inputs<br/>(Level 2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unobservable<br/>Inputs<br/>(Level 3)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,832&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,230&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,726&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,625&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,093&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,322&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt securities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and other U.S. government corporations and agencies:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Treasury and agency obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax-exempt municipal securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mortgage-backed securities:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Residential</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,700&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,497&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total invested assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,294&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,797&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text">During the years ended December&#160;31, 2022 and 2021, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:54.277%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.211%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.212%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the year ended December&#160;31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Private<br/>Placements</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance at January&#160;1</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gains or losses:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Realized in earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized in other comprehensive&#160;income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Assumptions Used For Inputs In Fair Value Measurement</a></td>
<td class="text">The table below presents the assumptions used for December&#160;31, 2022 and 2021, respectively: <div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:59.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.835%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.837%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7% - 20.8%</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Credit spread</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3% - 1.5%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue exit multiple</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5x - 2.5x </span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5x - 2.5x</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average cost of capital</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5% - 12.5%</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long term growth rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions used for annualized volatility, credit spread and weighted average cost of capital reflect the lowest and highest values where they differ significantly across the series of put and call options due to their expected exercise dates.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344630016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>MEDICARE PART D (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock', window );">Schedule of Balance Sheet Amounts Associated With Medicare Part D</a></td>
<td class="text">The accompanying consolidated balance sheets include the following amounts associated with Medicare Part D as of December&#160;31, 2022 and 2021. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to <div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:52.672%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.658%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Risk<br/>Corridor<br/>Settlement</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CMS<br/>Subsidies/<br/>Discounts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">240&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable and accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(166)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(466)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net current asset (liability)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net long-term liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(189)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net asset (liability)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(540)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Balance Sheet Account Associated With Medicare Part D</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344614080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment was comprised of the following at December&#160;31, 2022 and 2021. </span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:75.786%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.656%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and leasehold improvements</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,246&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer software</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,951&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,656&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,947&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,136)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,874)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337206064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Changes in Carrying Amount of Goodwill By Reportable Segments</a></td>
<td class="text">Changes in the carrying amount of goodwill for our reportable segments for the years ended December&#160;31, 2022 and 2021 were as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:53.635%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.185%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.189%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,892&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,555&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,645&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,092&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dispositions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December&#160;31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,142&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets Included in Other Long-Term Assets</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of our other intangible assets included in other long-term assets in the accompanying consolidated balance sheets at December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:7pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.791%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.592%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.957%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.116%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Life</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of need</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,771&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare licenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indefinite</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer contracts/relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">673&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names and technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.7 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncompetes and other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other intangible assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">883&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,765&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,443&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">804&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,639&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimate of Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our estimate of amortization expense for each of the five next succeeding fiscal years: </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:81.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.614%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in&#160;millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=SL108378252-109267<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344611648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Lease Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:80.601%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Maturity of&#160;Lease&#160;Liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ended December 31,</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">After 2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">608&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504434607920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BENEFITS PAYABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InsuranceAbstract', window );"><strong>Insurance [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense', window );">Schedule of Activity in Benefits Payable</a></td>
<td class="text"><div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:54.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at January&#160;1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,004&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Reinsurance recoverables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at January 1, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,936&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incurred related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(825)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(313)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total incurred</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,690&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,199&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,628&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paid related to:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current year</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(67,287)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,149)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,003)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,428)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,946)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,418)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total paid</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(74,715)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69,095)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,421)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December&#160;31</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,264&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,289&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,143&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock', window );">Schedule of Incurred and Paid Claims Development</a></td>
<td class="text">The following tables provide information about incurred and paid claims development as of December&#160;31, 2022, net of reinsurance.<div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:54.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.890%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incurred Claims, Net of Reinsurance</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Claims Incurred Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,258&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,066&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,698&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207,027&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:7pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:53.883%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.246%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.891%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cumulative Paid Claims, Net of Reinsurance</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Claims Incurred Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021<br/>Unaudited</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,886&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,224&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197,763&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All outstanding benefit liabilities before 2020, net of reinsurance</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr><tr><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Benefits payable, net of reinsurance</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,264&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InsuranceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InsuranceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339215360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes consisted of the following for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:55.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current provision:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">755&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,019&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States and Puerto Rico</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current provision</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">862&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,112&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred (benefit) expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">195&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Provision for Income Taxes Using Federal Statutory Rate</a></td>
<td class="text"><div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was different from the amount computed using the federal statutory rate for the years ended December&#160;31, 2022, 2021 and 2020 due to the following:</span></div><div style="margin-bottom:7pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:55.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax provision at federal statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">States, net of federal benefit, and Puerto Rico</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax exempt investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nondeductible executive compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-taxable KAH gain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax effect from sale of KAH Hospice</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health insurance industry fee </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">762&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Principal Components of Net Deferred Tax Balances</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal components of our net deferred tax balances at December&#160;31, 2022 and 2021 were as follows:</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:70.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Assets&#160;(Liabilities)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforward</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Compensation and other accrued expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jobs tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unearned revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">908&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">851&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">578&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciable property and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(740)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,072)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(132)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred income tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(878)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,276)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net deferred income tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(698)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504342840672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Carrying Value of Debt Outstanding</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of debt outstanding was as follows at December&#160;31, 2022 and 2021:</span></div><div style="margin-bottom:1pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:61.981%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.877%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500&#160;million, 0.65% due August 3, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600 million, 3.15% due December&#160;1, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400 million, 2.90% due December 15, 2022</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total senior notes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,497&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term debt</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,092&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,953&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt:</span></td><td colspan="9" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior notes:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,500&#160;million, 0.65% due August 3, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,492&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 3.85% due October 1, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">599&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">598&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 4.50% due April 1, 2025</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million 1.35% due February 3, 2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">745&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$600&#160;million, 3.95% due March 15, 2027</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 5.75% due March 1, 2028</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 3.70% due March 23, 2029</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 3.13% due August 15, 2029</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 4.88% due April 1, 2030</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 2.15% due February 3, 2032</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">743&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 5.88% due March 1, 2033</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">739&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$250&#160;million, 8.15% due June&#160;15, 2038</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400&#160;million, 4.63% due December&#160;1, 2042</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$750&#160;million, 4.95% due October 1, 2044</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$400&#160;million, 4.80% due March 15, 2047</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$500&#160;million, 3.95% due August 15, 2049</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loans:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term loan, due October 29, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delayed draw term loan, due May 28, 2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,034&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,541&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Maturities of Long-term Debt</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of the short-term and long-term debt for the years ending December 31, are as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"><tr><td style="width:1.0%"/><td style="width:79.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.094%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For the years ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,095&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,050&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339174800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation expense that has been charged against income for these plans was as follows for the years ended December 31, 2022, 2021, and 2020:</span></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:55.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense by type:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax benefit recognized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense, net of tax</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock', window );">Schedule of Restricted Stock Awards Activity</a></td>
<td class="text">Activity for our restricted stock was as follows for the year ended December&#160;31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"/><td style="width:70.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.887%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.603%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.889%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant-Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380.55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">430.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(449)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">342.42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292.28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nonvested restricted stock at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429.22&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Fair Value Assumptions</a></td>
<td class="text">The fair value was estimated on the date of grant using the Black-Scholes pricing model with the weighted-average assumptions indicated below:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:55.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.868%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average fair value at grant date</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.73&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected option life (years)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 years</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate at grant date</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Activity for Option Plans</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Activity for our option plans was as follows for the year ended December&#160;31, 2022:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:70.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.866%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares&#160; Under<br/>Option</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(shares in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">339.08&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319.27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370.26&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options outstanding at December&#160;31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">381.37&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercisable at December&#160;31, 2022</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">345.90&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344776528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER COMMON SHARE COMPUTATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Earnings Per Common Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Detail supporting the computation of basic and diluted earnings per common share was as follows for the years ended December&#160;31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.470%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in millions, except&#160;per<br/>common share results, number&#160;of<br/>shares/options in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income available for common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average outstanding shares of common stock used to <br/>&#160;&#160;&#160;&#160;compute basic earnings per common share</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,419&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,688&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,199&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">625&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares used to compute diluted earnings per&#160;common share</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,094&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129,396&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133,012&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings per common share</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.20&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.79&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.47&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per common share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.08&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.67&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.31&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of antidilutive stock options and restricted stock&#160;awards <br/>&#160;&#160;&#160;&#160;excluded from computation</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504342840672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock', window );">Schedule of Details of Dividend Payments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides details of dividend payments, excluding dividend equivalent rights, in 2020, 2021, and 2022, under our Board approved quarterly cash dividend policy:</span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:64.117%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.486%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.487%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Payment Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount<br/>per&#160;Share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Amount</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.43</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$322</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2.73</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$351</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.06</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$390</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock', window );">Schedule of Share Repurchases</a></td>
<td class="text"><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluding shares acquired in connection with employee stock plans, share repurchases were as follows during the years ended December 31, 2022, 2021 and 2020:</span></div><div style="margin-bottom:1pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:38.546%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.296%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.123%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.129%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Authorization Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Purchase Not to Exceed</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total repurchases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.30&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of all or some of the information related to dividends declared and paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfTreasuryStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23309-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfTreasuryStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344907664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Reporting Information, By Segment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.861%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,476&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,476&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,376&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,712&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,025&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,562&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,926&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,488&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,588)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,841)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,373&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,429)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,841&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,307&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,278)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,870&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,934&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,690&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,415)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">634&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,016&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,765)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,291&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(513)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on sale of KAH Hospice</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(237)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings (losses)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,022&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,528&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,568&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings (losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,040&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,506&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,564&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings (loss) attributable to Humana</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,045&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(982)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,568&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,654&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,955&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,371&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,980&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">853&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,055&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,675&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,877&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,869)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,024)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,852&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,893)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,930&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,058&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,924)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,064&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,639&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(440)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,187)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">539&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,722)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,916&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(202)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,354&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,003&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,419&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (income) loss attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings attributable to Humana</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,412&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,418&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.701%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Insurance</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">CenterWell</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Eliminations/<br/>Corporate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Consolidated</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in millions)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">External revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premiums:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Individual Medicare Advantage</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,697&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Group Medicare Advantage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,774&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare stand-alone PDP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,742&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,213&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fully-insured</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,449&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,051&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specialty</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,223&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total premiums</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,584&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services revenue:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provider</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASO and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacy</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total services revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,815&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total external revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,397&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,002&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,001&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,928)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intersegment revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,475&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,504)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">171&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">970&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,154&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,597&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,490&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,932)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,155&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,909&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(281)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,628&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,783)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(110)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">489&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,477&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,866&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,174)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,986&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">283&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes and equity in net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,120&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">698&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">856&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,674&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504338077856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REPORTING ENTITY (Details) - segment<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember', window );">Premiums and services revenue | Government contracts concentration risk | Federal government contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (percent)</a></td>
<td class="nump">82.00%<span></span>
</td>
<td class="nump">83.00%<span></span>
</td>
<td class="nump">83.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember', window );">Premiums and services revenue | Government contracts concentration risk | CMS, coverage for individual Medicare Advantage members in Florida</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (percent)</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GovernmentContractsConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GovernmentContractsConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_FederalGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_FederalGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504333141616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Nov. 02, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_CommercialMembershipContractTerm', window );">Health services term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies', window );">Number of days notice for employer group to cancel short-duration prepaid health services policies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs', window );">Consumer discounts on brand name prescription drugs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_AccruedPharmaceuticalRebatesCurrent', window );">Pharmaceutical rebates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies', window );">Typical term (in years) of short-duration employer-group prepaid health services policies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,142,000,000<span></span>
</td>
<td class="nump">11,092,000,000<span></span>
</td>
<td class="nump">$ 4,447,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=hum_ValueCreationInitiativesMember', window );">Value Creation Initiatives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges', window );">Restructuring and impairment charge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">473,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Assets held for abandonment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">248,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=hum_HomeSolutionsReportingUnitMember', window );">Home Solutions Reporting Unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=hum_ProviderReportingUnitMember', window );">Provider reporting unit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Long-lived assets estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Long-lived assets estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Computer software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Long-lived assets estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Computer software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Long-lived assets estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Long-lived assets estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Long-lived assets estimated useful life (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 291,000,000<span></span>
</td>
<td class="nump">$ 475,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hum_MedicareSupplementProductMember', window );">Medicare Supplement Product | Revenue Benchmark | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceContractAxis=CMS brand name prescription drug discounts', window );">Reinsurance Policy, Type [Axis]: CMS brand name prescription drug discounts | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SubsidyAndDiscountsSettlementPeriodAfterClose', window );">Settlement period after close</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">14 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceContractAxis=CMS brand name prescription drug discounts', window );">Reinsurance Policy, Type [Axis]: CMS brand name prescription drug discounts | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SubsidyAndDiscountsSettlementPeriodAfterClose', window );">Settlement period after close</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceContractAxis=CMS reinsurance subsidies and discounts', window );">Reinsurance Policy, Type [Axis]: CMS reinsurance subsidies and discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SubsidyAndDiscountsSettlementPeriodAfterClose', window );">Settlement period after close</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=hum_USRiskCorridorPremiumStabilizationProgramMember', window );">US Risk Corridor Premium Stabilization Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_GainContingencyRecoverySought', window );">Litigation recoveries sought</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 611,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Payment received upon judgement</a></td>
<td class="nump">$ 609,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">609,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Related legal fees and expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_RegulatoryMattersAxis=hum_HealthCareReformMember', window );">Health Care Reform</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SignificantAccountingPoliciesLineItems', window );"><strong>Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PaymentOfAnnualHealthInsuranceIndustryFee', window );">Payment of annual health insurance industry fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,180,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_AccruedPharmaceuticalRebatesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Pharmaceutical Rebates, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_AccruedPharmaceuticalRebatesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_CommercialMembershipContractTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commercial Membership Contract Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_CommercialMembershipContractTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Beginning in 2011, the Health Reform Legislation mandates consumer discounts of 50% on brand name prescription drugs for Part D plan participants in the coverage gap. These discounts are funded by CMS and pharmaceutical manufacturers while we administer the application of these funds.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_GainContingencyRecoverySought">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain Contingency, Recovery Sought</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_GainContingencyRecoverySought</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Days Notice For Employer Group To Cancel Short Duration Prepaid Health Services Policies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_PaymentOfAnnualHealthInsuranceIndustryFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Of Annual Health Insurance Industry Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_PaymentOfAnnualHealthInsuranceIndustryFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_SignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_SignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_SubsidyAndDiscountsSettlementPeriodAfterClose">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidy And Discounts, Settlement Period After Close</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_SubsidyAndDiscountsSettlementPeriodAfterClose</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Typical Term (In Years) Of Short-Duration Employer-Group Prepaid Health Services Policies</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=hum_ValueCreationInitiativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=hum_ValueCreationInitiativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=hum_HomeSolutionsReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=hum_HomeSolutionsReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=hum_ProviderReportingUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=hum_ProviderReportingUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hum_MedicareSupplementProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hum_MedicareSupplementProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceContractAxis=CMS brand name prescription drug discounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceContractAxis=CMS brand name prescription drug discounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceContractAxis=CMS reinsurance subsidies and discounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceContractAxis=CMS reinsurance subsidies and discounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=hum_USRiskCorridorPremiumStabilizationProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=hum_USRiskCorridorPremiumStabilizationProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_RegulatoryMattersAxis=hum_HealthCareReformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_RegulatoryMattersAxis=hum_HealthCareReformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504341210848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Part D Subsidy/Discount Payments, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SubsidyAndDiscountPayments', window );">Part D subsidy/discount payments</a></td>
<td class="num">$ (16,530)<span></span>
</td>
<td class="num">$ (14,889)<span></span>
</td>
<td class="num">$ (13,348)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SubsidyAndDiscountReimbursements', window );">Part D subsidy/discount reimbursements</a></td>
<td class="nump">18,498<span></span>
</td>
<td class="nump">14,628<span></span>
</td>
<td class="nump">12,410<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements', window );">Net reimbursements (payments)</a></td>
<td class="nump">$ 1,968<span></span>
</td>
<td class="num">$ (261)<span></span>
</td>
<td class="num">$ (938)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_SubsidyAndDiscountPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidy And Discount Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_SubsidyAndDiscountPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidy And Discount Payments In Excess Of Reimbursements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_SubsidyAndDiscountReimbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidy And Discount Reimbursements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_SubsidyAndDiscountReimbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337305264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Health Care Cost Payments, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_HealthCareCostPayments', window );">Health care cost payments</a></td>
<td class="num">$ (7,110)<span></span>
</td>
<td class="num">$ (6,943)<span></span>
</td>
<td class="num">$ (6,253)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_HealthCareCostReimbursements', window );">Health care cost reimbursements</a></td>
<td class="nump">7,135<span></span>
</td>
<td class="nump">6,898<span></span>
</td>
<td class="nump">6,252<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_HealthCareCostPaymentsAndReimbursementsNet', window );">Net reimbursements (payments)</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="num">$ (45)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_HealthCareCostPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Health care cost payments associated with the TRICARE South Region contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_HealthCareCostPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_HealthCareCostPaymentsAndReimbursementsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between health care cost payments and reimbursements related to the TRICARE South Region contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_HealthCareCostPaymentsAndReimbursementsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_HealthCareCostReimbursements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reimbursements for health care cost payments associated with the TRICARE South Region contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_HealthCareCostReimbursements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332387072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 11, 2022</div></th>
<th class="th"><div>Aug. 17, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember', window );">KAH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage', window );">Remaining ownership percentage acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree', window );">Enterprise value of acquiree including existing equity value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1', window );">Existing equity value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Minority ownership prior to acquisition (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Equity method investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest', window );">Transaction amount, net of existing equity stake</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Kindred at Home, Hospice and Personal Care Divisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold', window );">Equity interest to be sold</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Consideration to be received</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax', window );">Pre-tax gain, net of transaction costs</a></td>
<td class="nump">237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax', window );">Pretax earnings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 958<span></span>
</td>
<td class="nump">$ 582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Kindred at Home, Hospice and Personal Care Divisions | Medicare Licenses And Certificates Of Need</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent', window );">Identifiable intangibles</a></td>
<td class="nump">866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Kindred at Home, Hospice and Personal Care Divisions | Term loan, due October 29, 2023 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Per Agreement, Net Of Existing Equity Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Step Acquisition, Equity Interest in Acquiree, Subsequent Acquisition, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BusinessCombinationTotalEnterpriseValueOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Total Enterprise Value Of Acquiree</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BusinessCombinationTotalEnterpriseValueOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Equity Interest Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of income (loss) from an individually significant component disposed of or held-for-sale including the portion attributable to the noncontrolling interest. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_MedicareLicensesAndCertificatesOfNeedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_MedicareLicensesAndCertificatesOfNeedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_TermLoanDueOctober2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_TermLoanDueOctober2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504333003936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Assets, Liabilities And Noncontrolling Interest Disposed (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - Kindred at Home, Hospice and Personal Care Divisions<br> $ in Millions</strong></div></th>
<th class="th">
<div>Aug. 11, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet', window );">Receivables, net of allowances</a></td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets', window );">Other current assets</a></td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent', window );">Property and equipment, net</a></td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent', window );">Goodwill</a></td>
<td class="nump">2,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">960<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation', window );">Total assets</a></td>
<td class="nump">3,622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent', window );">Trade accounts payable and accrued expenses</a></td>
<td class="nump">245<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="nump">285<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Total liabilities</a></td>
<td class="nump">530<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest', window );">Noncontrolling interest</a></td>
<td class="nump">$ 11<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Noncontrolling interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2473-110228<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126905981&amp;loc=d3e2510-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337976144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACQUISITIONS AND DIVESTITURES - Preliminary Fair Value on Date of Acquisition (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 17, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 9,142<span></span>
</td>
<td class="nump">$ 11,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,447<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember', window );">Kindred at Home</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">172<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,049<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt', window );">Long term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,857<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Noncontrolling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Net assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504338884480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY METHOD INVESTMENT - Narrative (Details) - primary_care_center<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Aug. 11, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters', window );">Number of primary care centers in strategic partnership</a></td>
<td class="nump">50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened', window );">Number of additional primary care centers expected to be opened in strategic partnership</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by sale | Kindred at Home, Hospice and Personal Care Divisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold', window );">Equity interest to be sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=hum_WelshCarsonAndersonAndStoweMember', window );">WCAS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum', window );">Time frame for put and call option activity per partnership agreement, minimum</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum', window );">Time frame for put and call option activity per partnership agreement, maximum</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hum_KindredAtHomeMember', window );">Kindred at Home</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Equity method investment ownership (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Equity Interest Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Strategic Partnership Agreement, Number Of Additional Primary Care Centers Expected To Be Opened</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Strategic Partnership Agreement, Number Of Primary Care Centers</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Minimum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=hum_WelshCarsonAndersonAndStoweMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=hum_WelshCarsonAndersonAndStoweMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hum_KindredAtHomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hum_KindredAtHomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504333163152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EQUITY METHOD INVESTMENT - Summarized Balance Sheets and Statements of Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">5 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">$ 26,183<span></span>
</td>
<td class="nump">$ 26,183<span></span>
</td>
<td class="nump">$ 24,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">17,178<span></span>
</td>
<td class="nump">17,178<span></span>
</td>
<td class="nump">15,331<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="nump">15,311<span></span>
</td>
<td class="nump">15,311<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementRelatedDisclosuresAbstract', window );"><strong>Income Statement Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">92,870<span></span>
</td>
<td class="nump">83,064<span></span>
</td>
<td class="nump">$ 77,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Humana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,806<span></span>
</td>
<td class="nump">$ 2,933<span></span>
</td>
<td class="nump">$ 3,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=hum_KindredAtHomeMember', window );">Kindred at Home</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance sheet</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Current assets</a></td>
<td class="nump">297<span></span>
</td>
<td class="nump">297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrent', window );">Non-current assets</a></td>
<td class="nump">3,577<span></span>
</td>
<td class="nump">3,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Current liabilities</a></td>
<td class="nump">269<span></span>
</td>
<td class="nump">269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">Non-current liabilities</a></td>
<td class="nump">2,219<span></span>
</td>
<td class="nump">2,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Shareholders' equity</a></td>
<td class="nump">1,386<span></span>
</td>
<td class="nump">$ 1,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementRelatedDisclosuresAbstract', window );"><strong>Income Statement Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_Expenses', window );">Expenses</a></td>
<td class="nump">652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Humana</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_Expenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_Expenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=hum_KindredAtHomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis=hum_KindredAtHomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332587584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Classified as Current and Long-Term (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 15,946<span></span>
</td>
<td class="nump">$ 13,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">218<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,701)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">14,254<span></span>
</td>
<td class="nump">13,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Investments', window );">Total investment securities</a></td>
<td class="nump">14,261<span></span>
</td>
<td class="nump">13,972<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,093<span></span>
</td>
<td class="nump">611<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">3,697<span></span>
</td>
<td class="nump">3,265<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(471)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">3,230<span></span>
</td>
<td class="nump">3,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember', window );">Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">765<span></span>
</td>
<td class="nump">810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">728<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">477<span></span>
</td>
<td class="nump">373<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,554<span></span>
</td>
<td class="nump">1,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,809<span></span>
</td>
<td class="nump">1,346<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(79)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">1,731<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract', window );"><strong>Debt Securities Amortized Cost to Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">6,551<span></span>
</td>
<td class="nump">5,641<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(828)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 5,726<span></span>
</td>
<td class="nump">$ 5,700<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332693744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="nump">$ 4,419<span></span>
</td>
<td class="nump">$ 4,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">8,962<span></span>
</td>
<td class="nump">2,547<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">13,381<span></span>
</td>
<td class="nump">7,537<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="num">(270)<span></span>
</td>
<td class="num">(94)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(1,431)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(1,701)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="nump">512<span></span>
</td>
<td class="nump">201<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">397<span></span>
</td>
<td class="nump">355<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">909<span></span>
</td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(50)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(10)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">2,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">1,683<span></span>
</td>
<td class="nump">556<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">2,914<span></span>
</td>
<td class="nump">2,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="num">(104)<span></span>
</td>
<td class="num">(49)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(367)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(471)<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember', window );">Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="nump">64<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">615<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">679<span></span>
</td>
<td class="nump">102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(36)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="nump">124<span></span>
</td>
<td class="nump">358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">274<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">398<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(60)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(76)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="nump">243<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">1,157<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="nump">695<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(142)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(155)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="nump">620<span></span>
</td>
<td class="nump">530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">1,011<span></span>
</td>
<td class="nump">425<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">1,631<span></span>
</td>
<td class="nump">955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(46)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">1,456<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger', window );">12 months or more</a></td>
<td class="nump">3,825<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition', window );">Total</a></td>
<td class="nump">5,450<span></span>
</td>
<td class="nump">2,225<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss', window );">Less&#160;than&#160;12&#160;months</a></td>
<td class="num">(98)<span></span>
</td>
<td class="num">(28)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss', window );">12 months or more</a></td>
<td class="num">(730)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss', window );">Total</a></td>
<td class="num">$ (828)<span></span>
</td>
<td class="num">$ (59)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922890-210455<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27337-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504336174160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>position</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentLineItems', window );"><strong>Financing Receivable, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Book value</a></td>
<td class="nump">$ 15,946<span></span>
</td>
<td class="nump">$ 13,440<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 14,254<span></span>
</td>
<td class="nump">$ 13,497<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities', window );">Maximum individual state general bond obligation as a percentage of total debt securities (percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions', window );">Securities in unrealized loss position, number of positions | position</a></td>
<td class="nump">1,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions', window );">Securities, number of positions | position</a></td>
<td class="nump">1,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsAAMinusRatingMember', window );">Standard &amp; Poor's, AA- Rating</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentLineItems', window );"><strong>Financing Receivable, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality', window );">Percentage of debt securities considered to be of investment-grade (percent)</a></td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by sale | Kindred at Home, Hospice and Personal Care Divisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableRecordedInvestmentLineItems', window );"><strong>Financing Receivable, Credit Quality Indicator [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Book value</a></td>
<td class="nump">$ 280<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Securities, Number of Positions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Total Debt Securities, Investment Grade Quality</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27290-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableRecordedInvestmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableRecordedInvestmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsAAMinusRatingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CreditRatingStandardPoorsAxis=srt_StandardPoorsAAMinusRatingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504340577616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Realized Gains (Losses) Included Within Investment Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtAndEquitySecuritiesRealizedGain', window );">Gross gains on investment securities</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 219<span></span>
</td>
<td class="nump">$ 110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtAndEquitySecuritiesRealizedLoss', window );">Gross losses on investment securities</a></td>
<td class="num">(144)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(18)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGain', window );">Gross gains on equity securities</a></td>
<td class="nump">51<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedLoss', window );">Gross losses on equity securities</a></td>
<td class="num">(174)<span></span>
</td>
<td class="num">(364)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesGainLoss', window );">Net recognized (losses) gains on investment securities</a></td>
<td class="num">$ (205)<span></span>
</td>
<td class="num">$ (130)<span></span>
</td>
<td class="nump">$ 838<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtAndEquitySecuritiesRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt And Equity Securities, Realized Gain</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtAndEquitySecuritiesRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtAndEquitySecuritiesRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt And Equity Securities, Realized Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtAndEquitySecuritiesRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504340568496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Gains (Losses) on Equity Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiGainLoss', window );">Net (losses) gains recognized on equity securities during the period</a></td>
<td class="num">$ (123)<span></span>
</td>
<td class="num">$ (341)<span></span>
</td>
<td class="nump">$ 746<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss', window );">Less: Net losses recognized on equity securities sold during the period</a></td>
<td class="num">(105)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss', window );">Unrealized (losses) gains recognized on equity securities still held at the end of the period</a></td>
<td class="num">$ (18)<span></span>
</td>
<td class="num">$ (328)<span></span>
</td>
<td class="nump">$ 746<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126980263&amp;loc=SL75117546-209714<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504338911216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due within one year</a></td>
<td class="nump">$ 529<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">3,399<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through ten years</a></td>
<td class="nump">3,231<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost', window );">Due after ten years</a></td>
<td class="nump">1,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost', window );">Mortgage and asset-backed securities</a></td>
<td class="nump">7,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">15,946<span></span>
</td>
<td class="nump">$ 13,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">3,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years</a></td>
<td class="nump">2,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue', window );">Due after ten years</a></td>
<td class="nump">994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue', window );">Mortgage and asset-backed securities</a></td>
<td class="nump">6,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 14,254<span></span>
</td>
<td class="nump">$ 13,497<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -URI https://asc.fasb.org/extlink&amp;oid=126980459&amp;loc=SL120269850-112803<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332248192">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE - Financial Assets Measured on Recurring Basis (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 14,254<span></span>
</td>
<td class="nump">$ 13,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember', window );">U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember', window );">Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,230<span></span>
</td>
<td class="nump">3,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember', window );">Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">728<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember', window );">Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember', window );">Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,731<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">5,726<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">4,832<span></span>
</td>
<td class="nump">3,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">14,254<span></span>
</td>
<td class="nump">13,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total invested assets</a></td>
<td class="nump">19,093<span></span>
</td>
<td class="nump">17,294<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,230<span></span>
</td>
<td class="nump">3,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">728<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,731<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">5,726<span></span>
</td>
<td class="nump">5,700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">4,832<span></span>
</td>
<td class="nump">3,322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">475<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total invested assets</a></td>
<td class="nump">4,839<span></span>
</td>
<td class="nump">3,797<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Quoted&#160;Prices in Active Markets (Level 1) | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">14,153<span></span>
</td>
<td class="nump">13,429<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total invested assets</a></td>
<td class="nump">14,153<span></span>
</td>
<td class="nump">13,429<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,039<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">3,230<span></span>
</td>
<td class="nump">3,229<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">728<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,399<span></span>
</td>
<td class="nump">1,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">1,731<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Other Observable Inputs (Level 2) | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">5,625<span></span>
</td>
<td class="nump">5,632<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Common stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total invested assets</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | U.S. Treasury and agency obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Mortgage-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Tax-exempt municipal securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Residential</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Commercial</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Recurring Basis | Unobservable Inputs (Level 3) | Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI https://asc.fasb.org/extlink&amp;oid=123594786&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_NontaxableMunicipalNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ResidentialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialMortgageBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332955936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Aug. 11, 2022</div></th>
<th class="th"><div>Apr. 27, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Asset value</a></td>
<td class="nump">$ 101,000,000<span></span>
</td>
<td class="nump">$ 68,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_LossOnTerminationOfDerivatives', window );">Termination of put and call options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 377,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposed of by sale | Kindred at Home, Hospice and Personal Care Divisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold', window );">Equity interest to be sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=hum_FairValueRiskMember', window );">Fair Value Risk | Unobservable Inputs (Level 3) | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (percent)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_PutOptionMember', window );">Put option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Fair value of financial liability</a></td>
<td class="nump">$ 267,000,000<span></span>
</td>
<td class="nump">$ 202,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember', window );">Call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_FinancialAssetsFairValueDisclosure', window );">Fair value of financial asset</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">13,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term liabilities | Put option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialLiabilitiesFairValueDisclosure', window );">Fair value of financial liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 63,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember', window );">Other long-term assets | Call option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_FinancialAssetsFairValueDisclosure', window );">Fair value of financial asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 440,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember', window );">Kindred at Home</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage', window );">Equity interest to be acquired per agreement (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=hum_TermLoanAndCommercialPaperMember', window );">Term Loan And Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">1,100,000,000<span></span>
</td>
<td class="nump">3,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt outstanding</a></td>
<td class="nump">10,000,000,000<span></span>
</td>
<td class="nump">9,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt outstanding</a></td>
<td class="nump">$ 9,400,000,000<span></span>
</td>
<td class="nump">$ 10,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Definitive Agreement, Equity Interest To Be Acquired, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Equity Interest Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_FinancialAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Assets, Fair Value Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_FinancialAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_LossOnTerminationOfDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loss On Termination Of Derivatives</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_LossOnTerminationOfDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialLiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialLiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=hum_FairValueRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=hum_FairValueRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_PutOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_PutOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityEquityAxis=us-gaap_CallOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=hum_TermLoanAndCommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=hum_TermLoanAndCommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504333178816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Beginning balance at January&#160;1</a></td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract', window );"><strong>Total gains or losses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1', window );">Realized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Unrealized in other comprehensive&#160;income</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases', window );">Purchases</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales', window );">Sales</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements', window );">Settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue', window );">Balance at December&#160;31</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332513040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE - Put and Call Options Measured at Fair Value (Details) - Options - Level 3 fair value measurement<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.224<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Annualized volatility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Annualized volatility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Credit spread</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.009<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Credit spread | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Credit spread | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Revenue exit multiple | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Revenue exit multiple | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Weighted average cost of capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Weighted average cost of capital | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Weighted average cost of capital | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember', window );">Long term growth rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput', window );">Significant unobservable inputs</a></td>
<td class="nump">0.030<span></span>
</td>
<td class="nump">0.030<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetLiabilityNetMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure net derivative asset (liability).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetLiabilityNetMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_OptionOnSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputOptionVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_CreditSpreadOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_CreditSpreadOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=hum_RevenueExitMultipleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=hum_RevenueExitMultipleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputLongTermRevenueGrowthRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337109632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>MEDICARE PART D (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">$ 5,567<span></span>
</td>
<td class="nump">$ 6,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Trade accounts payable and accrued expenses</a></td>
<td class="num">(5,238)<span></span>
</td>
<td class="num">(4,509)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">3,380<span></span>
</td>
<td class="nump">4,379<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="num">(1,473)<span></span>
</td>
<td class="num">(2,383)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_RiskCorridorSettlementsMedicarePartDMember', window );">Risk Corridor Settlement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">240<span></span>
</td>
<td class="nump">363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Trade accounts payable and accrued expenses</a></td>
<td class="num">(166)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetCurrentLiabilityAsset', window );">Net current asset (liability)</a></td>
<td class="nump">74<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">19<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetNoncurrentAssetLiability', window );">Net long-term liability</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(189)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetAssetLiability', window );">Total net asset (liability)</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_CmsSubsidiesOrDiscountsMember', window );">CMS Subsidies/ Discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">696<span></span>
</td>
<td class="nump">1,894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Trade accounts payable and accrued expenses</a></td>
<td class="num">(1,236)<span></span>
</td>
<td class="num">(466)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetCurrentLiabilityAsset', window );">Net current asset (liability)</a></td>
<td class="num">(540)<span></span>
</td>
<td class="nump">1,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetNoncurrentAssetLiability', window );">Net long-term liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NetAssetLiability', window );">Total net asset (liability)</a></td>
<td class="num">$ (540)<span></span>
</td>
<td class="nump">$ 1,428<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NetAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Asset (Liability)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NetAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NetCurrentLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net current (liability) asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NetCurrentLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NetNoncurrentAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Noncurrent Asset (Liability)</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NetNoncurrentAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_RiskCorridorSettlementsMedicarePartDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_RiskCorridorSettlementsMedicarePartDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_CmsSubsidiesOrDiscountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_CmsSubsidiesOrDiscountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504333301072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET - Property and Equipment Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 6,357<span></span>
</td>
<td class="nump">$ 5,947<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(3,136)<span></span>
</td>
<td class="num">(2,874)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,221<span></span>
</td>
<td class="nump">3,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hum_BuildingsAndLeaseholdImprovementsMember', window );">Buildings and leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,143<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 3,951<span></span>
</td>
<td class="nump">$ 3,656<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=hum_BuildingsAndLeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=hum_BuildingsAndLeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337173744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT, NET - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="nump">$ 640<span></span>
</td>
<td class="nump">$ 528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization expense for capitalized internally developed and purchased software</a></td>
<td class="nump">$ 525<span></span>
</td>
<td class="nump">$ 443<span></span>
</td>
<td class="nump">$ 351<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337295360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill by Reportable Segments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 11,092<span></span>
</td>
<td class="nump">$ 4,447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">381<span></span>
</td>
<td class="nump">6,645<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Dispositions</a></td>
<td class="num">(2,331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">9,142<span></span>
</td>
<td class="nump">11,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember', window );">Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">2,290<span></span>
</td>
<td class="nump">1,892<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">182<span></span>
</td>
<td class="nump">398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Dispositions</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">2,472<span></span>
</td>
<td class="nump">2,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember', window );">CenterWell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">8,802<span></span>
</td>
<td class="nump">2,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Acquisitions</a></td>
<td class="nump">199<span></span>
</td>
<td class="nump">6,247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit', window );">Dispositions</a></td>
<td class="num">(2,331)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 6,670<span></span>
</td>
<td class="nump">$ 8,802<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332363616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Details of Intangible Assets Included in Other Long-Term Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">9 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 883<span></span>
</td>
<td class="nump">$ 804<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Total other intangible assets, cost</a></td>
<td class="nump">2,648<span></span>
</td>
<td class="nump">3,443<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total other intangible assets, net</a></td>
<td class="nump">1,765<span></span>
</td>
<td class="nump">2,639<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_CertificateOfNeedMember', window );">Certificates of need</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">1,132<span></span>
</td>
<td class="nump">1,771<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Medicare licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">$ 286<span></span>
</td>
<td class="nump">522<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember', window );">Customer contracts/relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">9 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 929<span></span>
</td>
<td class="nump">883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">673<span></span>
</td>
<td class="nump">620<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names and technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">6 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 142<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">97<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Provider contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">11 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 73<span></span>
</td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">63<span></span>
</td>
<td class="nump">57<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_NoncompetesAndOtherMember', window );">Noncompetes and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Other intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Life</a></td>
<td class="text">8 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">$ 46<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_CertificateOfNeedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_CertificateOfNeedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_NoncompetesAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=hum_NoncompetesAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337481008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense for other intangible assets</a></td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 88<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339116432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND OTHER INTANGIBLE ASSETS - Estimate of Amortization Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract', window );"><strong>Estimate of Amortization Expense</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 63<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">53<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">$ 31<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337327264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList', window );">ROU asset, balance sheet line item</a></td>
<td class="text">Other long-term assets<span></span>
</td>
<td class="text">Other long-term assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">ROU assets included within other long-term assets</a></td>
<td class="nump">$ 515<span></span>
</td>
<td class="nump">$ 678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease liabilities current, balance sheet line item</a></td>
<td class="text">Trade accounts payable and accrued expenses<span></span>
</td>
<td class="text">Trade accounts payable and accrued expenses<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities included within trade accounts payable and accrued expenses</a></td>
<td class="nump">$ 152<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Operating lease liabilities noncurrent, balance sheet line item</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities included within other long-term liabilities</a></td>
<td class="nump">$ 456<span></span>
</td>
<td class="nump">$ 546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Fixed operating lease costs</a></td>
<td class="nump">183<span></span>
</td>
<td class="nump">159<span></span>
</td>
<td class="nump">$ 141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease costs</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">94<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease rental income</a></td>
<td class="nump">$ 52<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years)</a></td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate (percent)</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease cash payments</a></td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332308592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Maturity of Lease Liabilities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Maturity of Lease Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2025</a></td>
<td class="nump">114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2026</a></td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2027</a></td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">After 2027</a></td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">663<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Interest</a></td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 608<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504340481472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BENEFITS PAYABLE - Activity in Benefits Payable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract', window );"><strong>Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Balances, beginning of period</a></td>
<td class="nump">$ 8,289<span></span>
</td>
<td class="nump">$ 8,143<span></span>
</td>
<td class="nump">$ 6,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Less: Reinsurance recoverables</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet', window );">Balances, beginning of period, net</a></td>
<td class="nump">8,289<span></span>
</td>
<td class="nump">8,143<span></span>
</td>
<td class="nump">5,936<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions', window );">Acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract', window );"><strong>Incurred related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense', window );">Current year</a></td>
<td class="nump">76,105<span></span>
</td>
<td class="nump">70,024<span></span>
</td>
<td class="nump">61,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense', window );">Prior years</a></td>
<td class="num">(415)<span></span>
</td>
<td class="num">(825)<span></span>
</td>
<td class="num">(313)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1', window );">Total incurred</a></td>
<td class="nump">75,690<span></span>
</td>
<td class="nump">69,199<span></span>
</td>
<td class="nump">61,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract', window );"><strong>Paid related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1', window );">Current year</a></td>
<td class="num">(67,287)<span></span>
</td>
<td class="num">(62,149)<span></span>
</td>
<td class="num">(54,003)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1', window );">Prior years</a></td>
<td class="num">(7,428)<span></span>
</td>
<td class="num">(6,946)<span></span>
</td>
<td class="num">(5,418)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense', window );">Total paid</a></td>
<td class="num">(74,715)<span></span>
</td>
<td class="num">(69,095)<span></span>
</td>
<td class="num">(59,421)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments', window );">Reinsurance recoverable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense', window );">Balances, end of period</a></td>
<td class="nump">$ 9,264<span></span>
</td>
<td class="nump">$ 8,289<span></span>
</td>
<td class="nump">$ 8,143<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(13)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForLossesAndLossAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForLossesAndLossAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (cc)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884095&amp;loc=d3e14764-158437<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504338879376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BENEFITS PAYABLE - Narrative (Details)<br> claim in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount', window );">Total IBNR | $</a></td>
<td class="nump">$ 5,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears', window );">Favorable&#160;medical&#160;claims&#160;reserve development related to prior fiscal years | $</a></td>
<td class="nump">$ 415<span></span>
</td>
<td class="nump">$ 825<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member', window );">2022 Claims Incurred Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported', window );">Cumulative number of reported claims</a></td>
<td class="nump">173.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member', window );">2021 Claims Incurred Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported', window );">Cumulative number of reported claims</a></td>
<td class="nump">173.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member', window );">2020 Claims Incurred Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported', window );">Cumulative number of reported claims</a></td>
<td class="nump">149.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Favorable medical claims reserve development related to prior fiscal years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability For Unpaid Claims And Claims Adjustment Expense, Cumulative Number Of Claims, Reported</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClaimsDevelopmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClaimsDevelopmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 5.W)<br> -URI https://asc.fasb.org/extlink&amp;oid=27015833&amp;loc=d3e570705-122907<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504333147872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BENEFITS PAYABLE - Incurred and Paid Claims Development (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Claims, Net of Reinsurance</a></td>
<td class="nump">$ 207,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Claims, Net of Reinsurance</a></td>
<td class="nump">197,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Benefits payable, net of reinsurance</a></td>
<td class="nump">9,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member', window );">2020 Claims Incurred Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Claims, Net of Reinsurance</a></td>
<td class="nump">61,224<span></span>
</td>
<td class="nump">$ 61,258<span></span>
</td>
<td class="nump">$ 61,941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Claims, Net of Reinsurance</a></td>
<td class="nump">61,224<span></span>
</td>
<td class="nump">60,886<span></span>
</td>
<td class="nump">$ 54,003<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member', window );">2021 Claims Incurred Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Claims, Net of Reinsurance</a></td>
<td class="nump">69,698<span></span>
</td>
<td class="nump">70,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Claims, Net of Reinsurance</a></td>
<td class="nump">69,252<span></span>
</td>
<td class="nump">$ 62,149<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member', window );">2022 Claims Incurred Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClaimsDevelopmentLineItems', window );"><strong>Claims Development [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Incurred Claims, Net of Reinsurance</a></td>
<td class="nump">76,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet', window );">Cumulative Paid Claims, Net of Reinsurance</a></td>
<td class="nump">$ 67,287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClaimsDevelopmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClaimsDevelopmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671315-158438<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 50<br> -Paragraph 4B<br> -URI https://asc.fasb.org/extlink&amp;oid=116884468&amp;loc=SL65671311-158438<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortdurationInsuranceContractsAccidentYearAxis=us-gaap_ShortDurationInsuranceContractAccidentYear2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504340510720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Provision for Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 755<span></span>
</td>
<td class="nump">$ 466<span></span>
</td>
<td class="nump">$ 1,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">States and Puerto Rico</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current provision</a></td>
<td class="nump">862<span></span>
</td>
<td class="nump">470<span></span>
</td>
<td class="nump">1,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred (benefit) expense</a></td>
<td class="num">(100)<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">195<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 762<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">$ 1,307<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332387840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Provision for Income Taxes Reconciliation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax provision at federal statutory rate</a></td>
<td class="nump">$ 750<span></span>
</td>
<td class="nump">$ 718<span></span>
</td>
<td class="nump">$ 982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">States, net of federal benefit, and Puerto Rico</a></td>
<td class="nump">49<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">63<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxExemptIncome', window );">Tax exempt investment income</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Nondeductible executive compensation</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">19<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain', window );">Non-taxable KAH gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(264)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness', window );">Tax effect from sale of KAH Hospice</a></td>
<td class="num">(72)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount', window );">Health insurance industry fee</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other, net</a></td>
<td class="nump">8<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">$ 762<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">$ 1,307<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Health Insurer Fee, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Non-Taxable KAH Gain</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationDispositionOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationDispositionOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxExemptIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxExemptIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339128624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Principal Components of Net Deferred Tax Balances (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">$ 291<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits', window );">Compensation and other accrued expense</a></td>
<td class="nump">158<span></span>
</td>
<td class="nump">186<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits', window );">Benefits payable</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost', window );">Deferred acquisition costs</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DeferredTaxAssetJobsTaxCredit', window );">Jobs tax credits</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve', window );">Unearned revenues</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInvestments', window );">Investment securities</a></td>
<td class="nump">454<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred income tax assets</a></td>
<td class="nump">908<span></span>
</td>
<td class="nump">643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred income tax assets, net of valuation allowance</a></td>
<td class="nump">851<span></span>
</td>
<td class="nump">578<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets', window );">Depreciable property and intangible assets</a></td>
<td class="num">(740)<span></span>
</td>
<td class="num">(1,072)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="num">(132)<span></span>
</td>
<td class="num">(102)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesInvestments', window );">Investment securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(98)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred income tax liabilities</a></td>
<td class="num">(878)<span></span>
</td>
<td class="num">(1,276)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total net deferred income tax liabilities</a></td>
<td class="num">$ (27)<span></span>
</td>
<td class="num">$ (698)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DeferredTaxAssetJobsTaxCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Jobs Tax Credit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DeferredTaxAssetJobsTaxCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of deferred tax balance as it relates to deferred acquisition costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Portion of deferred tax balance as it relates to depreciable property and intangible assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the unearned premiums reserve.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504340420256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowances on net operating loss carryforwards related to prior acquisitions</a></td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses to carryforward related to prior acquisitions</a></td>
<td class="nump">68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Puerto Rico</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating losses to carryforward related to prior acquisitions</a></td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504331947440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Debt Outstanding (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Total short-term debt</a></td>
<td class="nump">$ 2,092,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,953,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">9,034,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,541,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term debt, current maturities</a></td>
<td class="nump">1,497,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">998,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $1,500&#160;million, 0.65% due August 3, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">0.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term debt, current maturities</a></td>
<td class="nump">$ 1,497,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,492,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $600 million, 3.15% due December&#160;1, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term debt, current maturities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">599,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $400 million, 2.90% due December 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term debt, current maturities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">399,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $600&#160;million, 3.85% due October 1, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 599,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">598,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $600&#160;million, 4.50% due April 1, 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 597,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $750&#160;million 1.35% due February 3, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">1.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 745,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">742,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $600&#160;million, 3.95% due March 15, 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 597,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $500&#160;million, 5.75% due March 1, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 494,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $750&#160;million, 3.70% due March 23, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 743,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $500&#160;million, 3.13% due August 15, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 496,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">496,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $500&#160;million, 4.88% due April 1, 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 495,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">495,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $750&#160;million, 2.15% due February 3, 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">2.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 743,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">741,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $750&#160;million, 5.88% due March 1, 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">5.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 739,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $250&#160;million, 8.15% due June&#160;15, 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">8.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 261,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">261,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $400&#160;million, 4.63% due December&#160;1, 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.63%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 396,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">396,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $750&#160;million, 4.95% due October 1, 2044</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 740,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">740,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $400&#160;million, 4.80% due March 15, 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 396,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">395,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $500&#160;million, 3.95% due August 15, 2049</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">$ 493,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">493,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable | Term loan, due October 29, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable | Delayed draw term loan, due May 28, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt</a></td>
<td class="nump">$ 595,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 955,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A065PercentSeniorNotesDueAugust2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A065PercentSeniorNotesDueAugust2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3.15PercentSeniorNotesDueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3.15PercentSeniorNotesDueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A2.90PercentSeniorNotesDueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A2.90PercentSeniorNotesDueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3.85PercentSeniorNotesDueOctober2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3.85PercentSeniorNotesDueOctober2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A450PercentSeniorNotesDueApril2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A450PercentSeniorNotesDueApril2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A135PercentSeniorNotesDueFebruary2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A135PercentSeniorNotesDueFebruary2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3.95PercentSeniorNotesDueMarch2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3.95PercentSeniorNotesDueMarch2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A575PercentSeniorNotesDueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A575PercentSeniorNotesDueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A370PercentSeniorNotesDueMarch2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A370PercentSeniorNotesDueMarch2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A313PercentSeniorNotesDueAugust2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A313PercentSeniorNotesDueAugust2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A488PercentSeniorNotesDueApril2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A488PercentSeniorNotesDueApril2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A215PercentSeniorNotesDueFebruary2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A215PercentSeniorNotesDueFebruary2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A588PercentSeniorNotesDueMarch2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A588PercentSeniorNotesDueMarch2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A8.15PercentSeniorNotesDueJune2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A8.15PercentSeniorNotesDueJune2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A463PercentSeniorNotesDueDecember2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A463PercentSeniorNotesDueDecember2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A4.95PercentSeniorNotesDueOctober2044Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A4.95PercentSeniorNotesDueOctober2044Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A4.80PercentSeniorNotesDueMarch2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A4.80PercentSeniorNotesDueMarch2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3.95PercentSeniorNotesDueAugust2049Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3.95PercentSeniorNotesDueAugust2049Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_TermLoanDueOctober2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_TermLoanDueOctober2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504338996704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Maturities of Debt (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtByMaturityAbstract', window );"><strong>Maturities of debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 2,095<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2024</a></td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2025</a></td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2026</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive', window );">2027</a></td>
<td class="nump">1,350<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive', window );">Thereafter</a></td>
<td class="nump">$ 6,050<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtByMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtByMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123465755&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504331796992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Senior Notes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 15, 2022</div></th>
<th class="th"><div>Dec. 01, 2022</div></th>
<th class="th"><div>Nov. 30, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,982,000,000<span></span>
</td>
<td class="nump">$ 2,984,000,000<span></span>
</td>
<td class="nump">$ 1,088,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $250&#160;million, 8.15% due June&#160;15, 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 5.570 Percent Senior Notes Due March 2028 And 5.875 Percent Senior Notes Due March 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 5.570 Percent Senior Notes Due March 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | 5.875 Percent Senior Notes Due March 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.875%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $750&#160;million, 3.70% due March 23, 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 744,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $600 million, 3.15% due December&#160;1, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | $400 million, 2.90% due December 15, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayment of debt</a></td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI https://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A8.15PercentSeniorNotesDueJune2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A8.15PercentSeniorNotesDueJune2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A5570PercentSeniorNotesDueMarch2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A5570PercentSeniorNotesDueMarch2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A5875PercentSeniorNotesDueMarch2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A5875PercentSeniorNotesDueMarch2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A370PercentSeniorNotesDueMarch2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A370PercentSeniorNotesDueMarch2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A3.15PercentSeniorNotesDueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A3.15PercentSeniorNotesDueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_A2.90PercentSeniorNotesDueDecember2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_A2.90PercentSeniorNotesDueDecember2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504333030784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Delayed Draw Term Loan Credit Agreement (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 31, 2021</div></th>
<th class="th"><div>May 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 17, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember', window );">Kindred at Home</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest', window );">Transaction amount, net of existing equity stake</a></td>
<td class="nump">$ 5,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum', window );">Debt to capitalization percentage, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual', window );">Actual debt to capitalization percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2021Member', window );">Delayed Draw Term Loan May 2021 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from term loan</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2021Member', window );">Delayed Draw Term Loan May 2021 | Loans Payable | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis points spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2021Member', window );">Delayed Draw Term Loan May 2021 | Loans Payable | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis points spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2021Member', window );">Delayed Draw Term Loan May 2021 | Loans Payable | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis points spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Per Agreement, Net Of Existing Equity Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hum_KindredAtHomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_DelayedDrawTermLoanMay2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504340452304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - October 2021 Term Loan Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 29, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 16, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of term loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="nump">$ 2,078,000,000<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_October2021TermLoanAgreementMember', window );">October 2021 Term Loan Agreement | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Aggregate principal</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hum_GentivaTermLoanDue2025Member', window );">Gentiva Term Loan Due 2025 | Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of term loan</a></td>
<td class="nump">$ 1,900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_October2021TermLoanAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_October2021TermLoanAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_GentivaTermLoanDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_GentivaTermLoanDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504339066576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Revolving Credit Agreements (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember', window );">Loans Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum', window );">Debt to capitalization percentage, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual', window );">Actual debt to capitalization percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum', window );">Debt to capitalization percentage, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_LineOfCreditFacilityUncommittedIncrementalCapacity', window );">Uncommitted incremental loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity', window );">Maximum borrowing capacity including uncommitted incremental loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,750,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit, outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 Five Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Facility fee (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 Five Year | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Facility fee (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.09%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 Five Year | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Facility fee (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.225%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 Five Year | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis points spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 Five Year | LIBOR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis points spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.91%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 Five Year | LIBOR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis points spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 One Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Debt instrument term (in years)</a></td>
<td class="text">364 days<span></span>
</td>
<td class="text">364 days<span></span>
</td>
<td class="text">364 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Facility fee (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 One Year | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Facility fee (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.06%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 One Year | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Facility fee (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 One Year | SOFR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis points spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.15%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 One Year | SOFR | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis points spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.94%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Revolving Credit Agreement June 2021 One Year | SOFR | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis points spread on variable rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.35%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LinesOfCreditCurrent', window );">Line of credit, outstanding borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility including uncommitted incremental capacity and without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_LineOfCreditFacilityUncommittedIncrementalCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Uncommitted Incremental Capacity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_LineOfCreditFacilityUncommittedIncrementalCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LinesOfCreditCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LinesOfCreditCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_RevolvingCreditAgreementJune2021FiveYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_RevolvingCreditAgreementJune2021FiveYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hum_RevolvingCreditAgreementJune2021OneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hum_RevolvingCreditAgreementJune2021OneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=hum_SecuredOvernightFinancingRateSOFRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=hum_SecuredOvernightFinancingRateSOFRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504340258624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Commercial Paper and Other Short-term Borrowings (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Feb. 10, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000,000,000<span></span>
</td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod', window );">Maximum amount outstanding during period</a></td>
<td class="nump">$ 1,450,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt outstanding</a></td>
<td class="nump">$ 595,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">955,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtWeightedAverageInterestRate', window );">Weighted average annual interest rate (percent)</a></td>
<td class="nump">4.92%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember', window );">Federal Home Loan Bank Advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Short-term debt outstanding</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of short-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the form of debt having an initial term of less than one year or less than the normal operating cycle, if longer, the maximum amount borrowed at any time during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_FederalHomeLoanBankAdvancesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504333076624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Employee retirement and savings plan cost</a></td>
<td class="nump">$ 286,000,000<span></span>
</td>
<td class="nump">$ 259,000,000<span></span>
</td>
<td class="nump">$ 236,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_CompanyCommonStockClosingSharePrice', window );">Company common stock closing price (in dollars per share)</a></td>
<td class="nump">$ 512.19<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock', window );">Plan assets invested in Company common stock (percent)</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares', window );">Plan assets invested in Company common stock (in shares)</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding', window );">Shares of common stock plan assets as percentage of shares outstanding</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance', window );">Number of shares of common stock reserved for issuance under defined contribution retirement savings plan (in shares)</a></td>
<td class="nump">5.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod', window );">Accelerated vesting, termination of employment period</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram', window );">Combination of age and years necessary for retirement provision as related to our equity award program</a></td>
<td class="text">65 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram', window );">Minimum age required for retirement eligibility as related to our equity award program</a></td>
<td class="text">55 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram', window );">Minimum number of years of service for retirement eligibility as related to our equity award program</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting', window );">Actual realized tax benefit on tax returns from option exercises and restricted stock vesting</a></td>
<td class="nump">$ 31,000,000<span></span>
</td>
<td class="nump">28,000,000<span></span>
</td>
<td class="nump">32,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized stock-based compensation expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of shares vested</a></td>
<td class="nump">244,000,000<span></span>
</td>
<td class="nump">236,000,000<span></span>
</td>
<td class="nump">191,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value of stock options outstanding</a></td>
<td class="nump">$ 26,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual term of outstanding options (in years)</a></td>
<td class="text">4 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value of stock options exercisable</a></td>
<td class="nump">$ 8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-average remaining contractual term of exercisable options (in years)</a></td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Total intrinsic value of stock options exercised</a></td>
<td class="nump">$ 32,000,000<span></span>
</td>
<td class="nump">18,000,000<span></span>
</td>
<td class="nump">51,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock options exercised</a></td>
<td class="nump">$ 51,000,000<span></span>
</td>
<td class="nump">$ 30,000,000<span></span>
</td>
<td class="nump">$ 61,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value (in dollars per share)</a></td>
<td class="nump">$ 430.06<span></span>
</td>
<td class="nump">$ 381.34<span></span>
</td>
<td class="nump">$ 354.66<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions', window );">Percentage of restricted stock with performance-based conditions</a></td>
<td class="nump">36.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation expense not yet recognized related to nonvested awards</a></td>
<td class="nump">$ 202,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation expense recognition over a weighted-average period (in years)</a></td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total compensation expense not yet recognized related to nonvested awards</a></td>
<td class="nump">$ 7,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Compensation expense recognition over a weighted-average period (in years)</a></td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period (in years)</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hum_A2011PlanMember', window );">2011 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock shares reserved for stock award plans (in shares)</a></td>
<td class="nump">11.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hum_A2011PlanMember', window );">2011 Plan | Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants assuming all stock options or restricted stock are granted (in shares)</a></td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hum_A2011PlanMember', window );">2011 Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants assuming all stock options or restricted stock are granted (in shares)</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hum_A2019PlanMember', window );">2019 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Common stock shares reserved for stock award plans (in shares)</a></td>
<td class="nump">15.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hum_A2019PlanMember', window );">2019 Plan | Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants assuming all stock options or restricted stock are granted (in shares)</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hum_A2019PlanMember', window );">2019 Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grants assuming all stock options or restricted stock are granted (in shares)</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Combination of age and years necessary for retirement provision as related to our equity award program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_CompanyCommonStockClosingSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Company Common Stock, Closing Share Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_CompanyCommonStockClosingSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Number Of Shares Of Common Stock Reserved For Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Plan Assets Invested In Company Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Plan Assets Invested In Company Common Stock, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Defined Contribution Plan, Shares Of Common Stock In Plan As Percentage Of Shares Outstanding</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the aggregate tax benefit realized from the exercise of stock options and vesting of restricted stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum age required for retirement eligibility as related to our equity award program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum number of years of service for retirement eligibility as related to our equity award program</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Termination Of Employment Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation By Share Based Payment Award, Equity Instruments Other Than Options, Percent Of Stock With Performance Based Conditions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hum_A2011PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hum_A2011PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hum_A2019PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hum_A2019PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332198656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-based compensation expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 216<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Tax benefit recognized</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax', window );">Stock-based compensation expense, net of tax</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-based compensation expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">207<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Stock-based compensation expense [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of expense for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332063440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS - Restricted Stock Activity (Details) - Restricted stock - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested restricted stock, beginning balance (in shares)</a></td>
<td class="nump">873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">492<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(449)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested restricted stock, ending balance (in shares)</a></td>
<td class="nump">813<span></span>
</td>
<td class="nump">873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- Average Grant-Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested restricted stock, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 380.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">430.06<span></span>
</td>
<td class="nump">$ 381.34<span></span>
</td>
<td class="nump">$ 354.66<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">342.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">292.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested restricted stock, ending balance (in dollars per share)</a></td>
<td class="nump">$ 429.22<span></span>
</td>
<td class="nump">$ 380.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337398864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS - Weighted-Average Fair Value Assumptions for Stock Options (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average fair value at grant date (in dollars per share)</a></td>
<td class="nump">$ 113.35<span></span>
</td>
<td class="nump">$ 92.21<span></span>
</td>
<td class="nump">$ 69.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option life (years)</a></td>
<td class="text">3 years 7 months 6 days<span></span>
</td>
<td class="text">3 years 8 months 12 days<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">36.10%<span></span>
</td>
<td class="nump">33.80%<span></span>
</td>
<td class="nump">24.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate at grant date</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337451136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EMPLOYEE BENEFIT PLANS - Option Plans Activity (Details)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares&#160; Under Option</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, beginning balance (in shares) | shares</a></td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares) | shares</a></td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding, ending balance (in shares) | shares</a></td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options exercisable, ending balance (in shares) | shares</a></td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 339.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">425.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share) | $ / shares</a></td>
<td class="nump">319.27<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">370.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">381.37<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options exercisable, ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 345.90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337326624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER COMMON SHARE COMPUTATION (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income available for common stockholders</a></td>
<td class="nump">$ 2,806<span></span>
</td>
<td class="nump">$ 2,933<span></span>
</td>
<td class="nump">$ 3,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average outstanding shares of common stock used to compute basic earnings per common share (in shares)</a></td>
<td class="nump">126,419<span></span>
</td>
<td class="nump">128,688<span></span>
</td>
<td class="nump">132,199<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted earnings per&#160;common share (in shares)</a></td>
<td class="nump">127,094<span></span>
</td>
<td class="nump">129,396<span></span>
</td>
<td class="nump">133,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 22.20<span></span>
</td>
<td class="nump">$ 22.79<span></span>
</td>
<td class="nump">$ 25.47<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="nump">$ 22.08<span></span>
</td>
<td class="nump">$ 22.67<span></span>
</td>
<td class="nump">$ 25.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Number of antidilutive stock options and restricted stock&#160;awards excluded from computation (in shares)</a></td>
<td class="nump">205<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="nump">238<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of employee stock options and restricted stock (in shares)</a></td>
<td class="nump">50<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of employee stock options and restricted stock (in shares)</a></td>
<td class="nump">625<span></span>
</td>
<td class="nump">644<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504344598832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Dividend Payments (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Amount per share (in dollars per share)</a></td>
<td class="nump">$ 3.06<span></span>
</td>
<td class="nump">$ 2.73<span></span>
</td>
<td class="nump">$ 2.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Dividends', window );">Total Amount</a></td>
<td class="nump">$ 390<span></span>
</td>
<td class="nump">$ 351<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Dividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Dividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504326570960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Narrative (Details) - USD ($)<br> $ / shares in Units, shares in Thousands</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">4 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 16, 2022</div></th>
<th class="th"><div>Dec. 16, 2022</div></th>
<th class="th"><div>Dec. 15, 2022</div></th>
<th class="th"><div>Nov. 02, 2022</div></th>
<th class="th"><div>Mar. 30, 2022</div></th>
<th class="th"><div>Mar. 30, 2022</div></th>
<th class="th"><div>Mar. 29, 2022</div></th>
<th class="th"><div>Jan. 12, 2022</div></th>
<th class="th"><div>May 05, 2021</div></th>
<th class="th"><div>May 04, 2021</div></th>
<th class="th"><div>Dec. 23, 2020</div></th>
<th class="th"><div>Feb. 16, 2023</div></th>
<th class="th"><div>Oct. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>May 05, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 15, 2023</div></th>
<th class="th"><div>Nov. 04, 2022</div></th>
<th class="th"><div>Nov. 03, 2022</div></th>
<th class="th"><div>Jan. 11, 2022</div></th>
<th class="th"><div>Feb. 18, 2021</div></th>
<th class="th"><div>Dec. 22, 2020</div></th>
<th class="th"><div>Jul. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividend declared (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 98,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Increase in treasury stock from share repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,096,000,000<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="nump">$ 1,820,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares', window );">Common shares acquired in connection with employee stock plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue', window );">Common shares acquired in connection with employee stock plans, amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,000,000<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="nump">$ 70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Aggregate statutory capital and surplus in our state regulated insurance subsidiaries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,300,000,000<span></span>
</td>
<td class="nump">9,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired', window );">Aggregate minimum regulatory requirements of statutory capital and surplus</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,400,000,000<span></span>
</td>
<td class="nump">7,600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval', window );">Ordinary dividends that may be paid to parent company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DividendsToParentWithoutPriorStateRegulatoryApproval', window );">Actual dividends paid to parent company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="nump">$ 1,600,000,000<span></span>
</td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Cash dividend declared (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.8850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Remaining authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_December2020AcceleratedShareRepurchaseAgreementMember', window );">December 2020 ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_AcceleratedShareRepurchasesAgreementAmount', window );">Accelerated share repurchase agreement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Increase in treasury stock from share repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue', window );">Decrease in capital in excess of par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue', window );">Reclassification from capital in excess of par value to treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 262,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_December2020AcceleratedShareRepurchaseAgreementMember', window );">December 2020 ASR | Citi</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Average daily volume weighted-average share price of common stock during term of agreement (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_December2020AcceleratedShareRepurchaseAgreementMember', window );">December 2020 ASR | JPM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 875,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Average daily volume weighted-average share price of common stock during term of agreement (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 401.49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_January2022AcceleratedShareRepurchaseAgreementMember', window );">January 2022 ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_AcceleratedShareRepurchasesAgreementAmount', window );">Accelerated share repurchase agreement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Increase in treasury stock from share repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue', window );">Decrease in capital in excess of par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue', window );">Reclassification from capital in excess of par value to treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_January2022AcceleratedShareRepurchaseAgreementMember', window );">January 2022 ASR | Mizuho Markets Americas LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Average daily volume weighted-average share price of common stock during term of agreement (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_January2022AcceleratedShareRepurchaseAgreementMember', window );">January 2022 ASR | Wells Fargo Bank</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Average daily volume weighted-average share price of common stock during term of agreement (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 411.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_November2022AcceleratedShareRepurchaseProgramMember', window );">November 2022 ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_AcceleratedShareRepurchasesAgreementAmount', window );">Accelerated share repurchase agreement amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Increase in treasury stock from share repurchases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue', window );">Decrease in capital in excess of par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue', window );">Reclassification from capital in excess of par value to treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_November2022AcceleratedShareRepurchaseProgramMember', window );">November 2022 ASR | Mizuho Markets Americas LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares received (in shares)</a></td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Average daily volume weighted-average share price of common stock during term of agreement (in dollars per share)</a></td>
<td class="nump">$ 533.87<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_November2022AcceleratedShareRepurchaseProgramMember', window );">November 2022 ASR | Goldman Sachs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt', window );">Accelerated share repurchase payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares received (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare', window );">Average daily volume weighted-average share price of common stock during term of agreement (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 534.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_AcceleratedShareRepurchasesAgreementAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchases, Agreement Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_AcceleratedShareRepurchasesAgreementAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock Reclassified From Capital In Excess Of Par Value To Treasury Stock Upon Repurchase, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DividendsToParentWithoutPriorStateRegulatoryApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dividends paid to our parent company without prior approval by state regulatory authorities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DividendsToParentWithoutPriorStateRegulatoryApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TreasuryStockDecreaseInCapitalInExcessOfParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Decrease In Capital In Excess Of Par Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TreasuryStockDecreaseInCapitalInExcessOfParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=6405686&amp;loc=d3e22802-112653<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dividends that can be declared or paid without approval of regulatory agency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_December2020AcceleratedShareRepurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=hum_December2020AcceleratedShareRepurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=hum_CitibankNAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=hum_CitibankNAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=hum_JPMorganChaseBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=hum_JPMorganChaseBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_January2022AcceleratedShareRepurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=hum_January2022AcceleratedShareRepurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=hum_MizuhoMarketsAmericasLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=hum_MizuhoMarketsAmericasLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=hum_WellsFargoBankMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=hum_WellsFargoBankMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=hum_November2022AcceleratedShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=hum_November2022AcceleratedShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=hum_GoldmanSachsCoLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=hum_GoldmanSachsCoLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504333234656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS' EQUITY - Share Repurchases (Details) - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Feb. 18, 2021</div></th>
<th class="th"><div>Jul. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Cost of repurchases</a></td>
<td class="nump">$ 2,096,000,000<span></span>
</td>
<td class="nump">$ 79,000,000<span></span>
</td>
<td class="nump">$ 1,820,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember', window );">Excluding Employee Stock Plans and ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased (in shares)</a></td>
<td class="nump">4,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Cost of repurchases</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=hum_February2021ShareRepurchaseAuthorizationMember', window );">February 2021 Authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase authorization</a></td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased (in shares)</a></td>
<td class="nump">4,300<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Cost of repurchases</a></td>
<td class="nump">$ 2,000,000,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=hum_July2019ShareRepurchaseAuthorizationMember', window );">July 2019 Authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityClassOfTreasuryStockLineItems', window );"><strong>Equity, Class of Treasury Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Share repurchase authorization</a></td>
<td class="nump">$ 3,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Cost of repurchases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityClassOfTreasuryStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityClassOfTreasuryStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=hum_February2021ShareRepurchaseAuthorizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=hum_February2021ShareRepurchaseAuthorizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=hum_July2019ShareRepurchaseAuthorizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=hum_July2019ShareRepurchaseAuthorizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504326402672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>beneficiary </div>
<div>state </div>
<div>option_period</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary', window );">Purchase obligations in 2023</a></td>
<td class="nump">$ 687<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary', window );">Purchase obligations in 2024</a></td>
<td class="nump">451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary', window );">Purchase obligations in 2025</a></td>
<td class="nump">288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary', window );">Purchase obligations in 2026</a></td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears', window );">Purchase obligations in 2027</a></td>
<td class="nump">$ 153<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfStatesComprisingTRICAREBeneficiaries', window );">Number of states comprising TRICARE beneficiaries | state</a></td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfTRICAREBeneficiaries', window );">Number of TRICARE beneficiaries | beneficiary</a></td>
<td class="nump">6,000,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries', window );">Number of TRICARE Managed Care Support Contract beneficiaries | beneficiary</a></td>
<td class="nump">4,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries', window );">Number of states comprising TRICARE Managed Care Support Contract beneficiaries | state</a></td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TRICAREManagedCareSupportContractBaseTerm', window );">Contract base term</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods', window );">Annual option periods | option_period</a></td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_TRICAREManagedCareSupportContractTermWithOptionExercises', window );">Contract term with exercises</a></td>
<td class="text">9 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PercentageOfTotalPremiumAndServicesRevenues', window );">Percentage of premiums and services revenue</a></td>
<td class="nump">81.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MedicaidMember', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PercentageOfTotalPremiumAndServicesRevenues', window );">Percentage of premiums and services revenue</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MilitaryServiceMember', window );">Military services</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PercentageOfTotalPremiumAndServicesRevenues', window );">Percentage of premiums and services revenue</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfStatesComprisingTRICAREBeneficiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of States Comprising TRICARE Beneficiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfStatesComprisingTRICAREBeneficiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfTRICAREBeneficiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of TRICARE Beneficiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfTRICAREBeneficiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of TRICARE Managed Care Support Contract Beneficiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_PercentageOfTotalPremiumAndServicesRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Total Premium And Services Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_PercentageOfTotalPremiumAndServicesRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TRICAREManagedCareSupportContractBaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>TRICARE Managed Care Support Contract, Base Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TRICAREManagedCareSupportContractBaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>TRICARE Managed Care Support Contract, Number Of Option Periods</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_TRICAREManagedCareSupportContractTermWithOptionExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>TRICARE Managed Care Support Contract, Term With Option Exercises</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_TRICAREManagedCareSupportContractTermWithOptionExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MilitaryServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MilitaryServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504338909296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_GovernmentAndHealthPlanMemberSubsidiesAmount', window );">Member co-share amounts and government subsidies</a></td>
<td class="nump">$ 19,700<span></span>
</td>
<td class="nump">$ 18,100<span></span>
</td>
<td class="nump">$ 16,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense', window );">Depreciation and amortization classified as benefit expense</a></td>
<td class="nump">$ 122<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">$ 127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GovernmentContractsConcentrationRiskMember', window );">Government contracts concentration risk | Premiums and services revenue | Federal government contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (percent)</a></td>
<td class="nump">82.00%<span></span>
</td>
<td class="nump">83.00%<span></span>
</td>
<td class="nump">83.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DepreciationAndAmortizationClassifiedAsBenefitExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation and amortization expense that has been reclassified to be included with benefit expenses. The reclassification is the result of depreciation and amortization expense associated primarily from the delivery of pharmacy services by our wholly-owned pharmacy business included in our Healthcare Services segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DepreciationAndAmortizationClassifiedAsBenefitExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_GovernmentAndHealthPlanMemberSubsidiesAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of member co-share amounts and government subsidies that are excluded from benefits expense because the health plans do not bear responsibility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_GovernmentAndHealthPlanMemberSubsidiesAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GovernmentContractsConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GovernmentContractsConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueProductLineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_FederalGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_FederalGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504330338720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION - Segment Results (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">$ 87,712<span></span>
</td>
<td class="nump">$ 79,822<span></span>
</td>
<td class="nump">$ 74,186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">4,776<span></span>
</td>
<td class="nump">3,055<span></span>
</td>
<td class="nump">1,815<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">92,870<span></span>
</td>
<td class="nump">83,064<span></span>
</td>
<td class="nump">77,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment income</a></td>
<td class="nump">382<span></span>
</td>
<td class="nump">187<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="nump">75,690<span></span>
</td>
<td class="nump">69,199<span></span>
</td>
<td class="nump">61,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">12,671<span></span>
</td>
<td class="nump">10,121<span></span>
</td>
<td class="nump">10,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="nump">709<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="nump">489<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">89,070<span></span>
</td>
<td class="nump">79,916<span></span>
</td>
<td class="nump">72,169<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">3,800<span></span>
</td>
<td class="nump">3,148<span></span>
</td>
<td class="nump">4,986<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of KAH Hospice</a></td>
<td class="num">(237)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">68<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net (losses) earnings</a></td>
<td class="nump">3,568<span></span>
</td>
<td class="nump">3,354<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net (losses) earnings</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Segment earnings</a></td>
<td class="nump">3,564<span></span>
</td>
<td class="nump">3,419<span></span>
</td>
<td class="nump">4,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent', window );">Segment earnings (loss) attributable to Humana</a></td>
<td class="nump">3,568<span></span>
</td>
<td class="nump">3,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MedicareAdvantageMember', window );">Individual Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">65,591<span></span>
</td>
<td class="nump">58,654<span></span>
</td>
<td class="nump">51,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_GroupMedicareAdvantageMember', window );">Group Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">7,297<span></span>
</td>
<td class="nump">6,955<span></span>
</td>
<td class="nump">7,774<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MedicareStandAlonePrescriptionDrugPlanMember', window );">Medicare stand-alone PDP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">2,269<span></span>
</td>
<td class="nump">2,371<span></span>
</td>
<td class="nump">2,742<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MedicareMember', window );">Total Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">75,157<span></span>
</td>
<td class="nump">67,980<span></span>
</td>
<td class="nump">62,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_FullyInsuredMember', window );">Fully-insured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">4,476<span></span>
</td>
<td class="nump">5,002<span></span>
</td>
<td class="nump">6,051<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_SpecialtyMember', window );">Specialty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
<td class="nump">1,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_MedicaidAndOtherMember', window );">Medicaid and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">6,376<span></span>
</td>
<td class="nump">5,109<span></span>
</td>
<td class="nump">4,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_HomeSolutionsMember', window );">Home solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">2,333<span></span>
</td>
<td class="nump">1,166<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_ProviderMember', window );">Provider</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">568<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_ASOAndOtherMember', window );">ASO and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="nump">813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MajorCustomersAxis=hum_PharmacyMember', window );">Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">1,025<span></span>
</td>
<td class="nump">623<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember', window );">Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">88,841<span></span>
</td>
<td class="nump">80,930<span></span>
</td>
<td class="nump">74,597<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment income</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="nump">171<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">85,819<span></span>
</td>
<td class="nump">78,518<span></span>
</td>
<td class="nump">71,477<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember', window );">CenterWell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">17,307<span></span>
</td>
<td class="nump">14,058<span></span>
</td>
<td class="nump">11,490<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment income</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="nump">16,016<span></span>
</td>
<td class="nump">13,120<span></span>
</td>
<td class="nump">10,866<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">92,488<span></span>
</td>
<td class="nump">82,877<span></span>
</td>
<td class="nump">76,001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">87,712<span></span>
</td>
<td class="nump">79,822<span></span>
</td>
<td class="nump">73,584<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="nump">813<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">88,562<span></span>
</td>
<td class="nump">80,675<span></span>
</td>
<td class="nump">74,397<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="nump">75,934<span></span>
</td>
<td class="nump">69,639<span></span>
</td>
<td class="nump">61,909<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">9,251<span></span>
</td>
<td class="nump">8,340<span></span>
</td>
<td class="nump">9,129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="nump">634<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">3,022<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of KAH Hospice</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net (losses) earnings</a></td>
<td class="nump">3,022<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net (losses) earnings</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Segment earnings</a></td>
<td class="nump">3,040<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent', window );">Segment earnings (loss) attributable to Humana</a></td>
<td class="nump">3,045<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Individual Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">65,591<span></span>
</td>
<td class="nump">58,654<span></span>
</td>
<td class="nump">51,697<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Group Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">7,297<span></span>
</td>
<td class="nump">6,955<span></span>
</td>
<td class="nump">7,774<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Medicare stand-alone PDP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">2,269<span></span>
</td>
<td class="nump">2,371<span></span>
</td>
<td class="nump">2,742<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Total Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">75,157<span></span>
</td>
<td class="nump">67,980<span></span>
</td>
<td class="nump">62,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Fully-insured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">4,476<span></span>
</td>
<td class="nump">5,002<span></span>
</td>
<td class="nump">5,449<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Specialty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
<td class="nump">1,699<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Medicaid and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">6,376<span></span>
</td>
<td class="nump">5,109<span></span>
</td>
<td class="nump">4,223<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Home solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Provider</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | ASO and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">850<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="nump">813<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Insurance | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">3,926<span></span>
</td>
<td class="nump">2,202<span></span>
</td>
<td class="nump">1,002<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">3,926<span></span>
</td>
<td class="nump">2,202<span></span>
</td>
<td class="nump">1,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">15,835<span></span>
</td>
<td class="nump">12,968<span></span>
</td>
<td class="nump">10,706<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">1,291<span></span>
</td>
<td class="nump">938<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of KAH Hospice</a></td>
<td class="num">(237)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net (losses) earnings</a></td>
<td class="nump">1,528<span></span>
</td>
<td class="nump">938<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net (losses) earnings</a></td>
<td class="num">(22)<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Segment earnings</a></td>
<td class="nump">1,506<span></span>
</td>
<td class="nump">1,003<span></span>
</td>
<td class="nump">698<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent', window );">Segment earnings (loss) attributable to Humana</a></td>
<td class="nump">1,505<span></span>
</td>
<td class="nump">1,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Individual Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Group Medicare Advantage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Medicare stand-alone PDP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Total Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Fully-insured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Specialty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Medicaid and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Home solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">2,333<span></span>
</td>
<td class="nump">1,166<span></span>
</td>
<td class="nump">107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Provider</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">568<span></span>
</td>
<td class="nump">413<span></span>
</td>
<td class="nump">328<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | ASO and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | CenterWell | Pharmacy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Services revenue</a></td>
<td class="nump">1,025<span></span>
</td>
<td class="nump">623<span></span>
</td>
<td class="nump">567<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(13,278)<span></span>
</td>
<td class="num">(11,924)<span></span>
</td>
<td class="num">(8,932)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Investment income</a></td>
<td class="nump">151<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="nump">970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare', window );">Benefits</a></td>
<td class="num">(244)<span></span>
</td>
<td class="num">(440)<span></span>
</td>
<td class="num">(281)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="num">(12,415)<span></span>
</td>
<td class="num">(11,187)<span></span>
</td>
<td class="num">(9,783)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DepreciationAndAmortizationIncomeStatement', window );">Depreciation and amortization</a></td>
<td class="num">(106)<span></span>
</td>
<td class="num">(95)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BenefitsLossesAndExpenses', window );">Total operating expenses</a></td>
<td class="num">(12,765)<span></span>
</td>
<td class="num">(11,722)<span></span>
</td>
<td class="num">(10,174)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="num">(513)<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of KAH Hospice</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">68<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in net (losses) earnings</a></td>
<td class="num">(982)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net (losses) earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Segment earnings</a></td>
<td class="num">(982)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest', window );">Net (income) loss attributable to noncontrolling interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent', window );">Segment earnings (loss) attributable to Humana</a></td>
<td class="num">(982)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | Fully-insured</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PremiumsEarnedNet', window );">Premiums</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | Insurance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | Insurance | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">56<span></span>
</td>
<td class="nump">41<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | Insurance | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | CenterWell</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">13,373<span></span>
</td>
<td class="nump">11,852<span></span>
</td>
<td class="nump">10,475<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | CenterWell | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">3,532<span></span>
</td>
<td class="nump">2,828<span></span>
</td>
<td class="nump">2,547<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember', window );">Eliminations/ Corporate | CenterWell | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">9,841<span></span>
</td>
<td class="nump">9,024<span></span>
</td>
<td class="nump">7,928<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(13,429)<span></span>
</td>
<td class="num">(11,893)<span></span>
</td>
<td class="num">(10,504)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">(3,588)<span></span>
</td>
<td class="num">(2,869)<span></span>
</td>
<td class="num">(2,576)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations | Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="num">$ (9,841)<span></span>
</td>
<td class="num">$ (9,024)<span></span>
</td>
<td class="num">$ (7,928)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DepreciationAndAmortizationIncomeStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation and amortization expense excluding depreciation and amortization primarily from the delivery of pharmacy services by our wholly-owned pharmacy business (included in our Healthcare Services segment) which has been reclassified to benefit expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DepreciationAndAmortizationIncomeStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Loss From Continuing Operations Before Income Taxes Attributable To Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Loss From Continuing Operations Before Income Taxes Attributable To Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BenefitsLossesAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5,6,7)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BenefitsLossesAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(a),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04.5)<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PremiumsEarnedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 235<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.12-17(Column E))<br> -URI https://asc.fasb.org/extlink&amp;oid=120401096&amp;loc=d3e574992-122915<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PremiumsEarnedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_GroupMedicareAdvantageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_GroupMedicareAdvantageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicareStandAlonePrescriptionDrugPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicareStandAlonePrescriptionDrugPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_FullyInsuredMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_FullyInsuredMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_SpecialtyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_SpecialtyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_MedicaidAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_MedicaidAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_HomeSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_HomeSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_ProviderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_ProviderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_ASOAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_ASOAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=hum_PharmacyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=hum_PharmacyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_InsuranceSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=hum_CenterWellSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=hum_CorporateAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332593008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REINSURANCE (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>reinsurer</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectsOfReinsuranceLineItems', window );"><strong>Effects of Reinsurance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverables', window );">Reinsurance recoverables</a></td>
<td class="nump">$ 181<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CededPremiumsWritten', window );">Premiums ceded</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">$ 29<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded', window );">Benefits ceded</a></td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance', window );">Number of reinsurers comprising other reinsurance recoverables balance | reinsurer</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer', window );">Cash and securities in trusts held by certain reinsurers</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hum_ProtectiveLifeInsuranceCompanyMember', window );">Protective Life Insurance Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectsOfReinsuranceLineItems', window );"><strong>Effects of Reinsurance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverables', window );">Reinsurance recoverables</a></td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hum_AllOthersMember', window );">All others</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectsOfReinsuranceLineItems', window );"><strong>Effects of Reinsurance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverables', window );">Reinsurance recoverables</a></td>
<td class="nump">$ 16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_LongDurationInsuranceProductsAxis=hum_CoinsuranceAgreementMember', window );">100% coinsurance agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectsOfReinsuranceLineItems', window );"><strong>Effects of Reinsurance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_PercentageOfCoinsuranceAgreement', window );">Percentage of coinsurance agreement</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_ReinsuranceRecoverableMember', window );">Reinsurance recoverables | Reinsurer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectsOfReinsuranceLineItems', window );"><strong>Effects of Reinsurance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReinsuranceRecoverables', window );">Reinsurance recoverables</a></td>
<td class="nump">$ 181<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount held in cash and securities in trust, at least equal to the recoverable from the reinsurer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of reinsurers comprising other reinsurance recoverables balance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_PercentageOfCoinsuranceAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Coinsurance Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_PercentageOfCoinsuranceAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CededPremiumsWritten">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of written premiums ceded to other entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 605<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486672&amp;loc=d3e27261-158547<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CededPremiumsWritten</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectsOfReinsuranceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectsOfReinsuranceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reduction of provision for policy benefits and costs incurred for policies ceded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6811-158387<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceRecoverables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after valuation allowance, recoverable under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99397103&amp;loc=d3e6824-158387<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21409-158489<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceRecoverables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hum_ProtectiveLifeInsuranceCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hum_ProtectiveLifeInsuranceCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hum_AllOthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hum_AllOthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_LongDurationInsuranceProductsAxis=hum_CoinsuranceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_LongDurationInsuranceProductsAxis=hum_CoinsuranceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_ReinsuranceRecoverableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_ReinsuranceRecoverableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ReinsurerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ReinsurerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332915664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 5,061<span></span>
</td>
<td class="nump">$ 3,394<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investment securities</a></td>
<td class="nump">13,881<span></span>
</td>
<td class="nump">13,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">5,567<span></span>
</td>
<td class="nump">6,493<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">26,183<span></span>
</td>
<td class="nump">24,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,221<span></span>
</td>
<td class="nump">3,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">3,380<span></span>
</td>
<td class="nump">4,379<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">43,055<span></span>
</td>
<td class="nump">44,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt</a></td>
<td class="nump">2,092<span></span>
</td>
<td class="nump">1,953<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BookOverdraftLiability', window );">Book overdraft</a></td>
<td class="nump">298<span></span>
</td>
<td class="nump">326<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">17,178<span></span>
</td>
<td class="nump">15,331<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">9,034<span></span>
</td>
<td class="nump">10,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">1,473<span></span>
</td>
<td class="nump">2,383<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">27,685<span></span>
</td>
<td class="nump">28,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 17)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $1 par; 10,000,000 shares authorized; none issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at December 31, 2022 and 198,648,742 shares issued at December 31, 2021</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Capital in excess of par value</a></td>
<td class="nump">3,246<span></span>
</td>
<td class="nump">3,082<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">25,492<span></span>
</td>
<td class="nump">23,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(1,304)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 73,691,955 shares at December 31, 2022 and 69,846,758 shares at December 31, 2021</a></td>
<td class="num">(12,156)<span></span>
</td>
<td class="num">(10,163)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">15,311<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">43,055<span></span>
</td>
<td class="nump">44,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">614<span></span>
</td>
<td class="nump">906<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investment securities</a></td>
<td class="nump">320<span></span>
</td>
<td class="nump">428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedPartiesCurrent', window );">Receivable from operating subsidiaries</a></td>
<td class="nump">1,807<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">577<span></span>
</td>
<td class="nump">545<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">3,318<span></span>
</td>
<td class="nump">3,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">2,393<span></span>
</td>
<td class="nump">2,223<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_InvestmentInRelatedPartiesAndSubsidiaries', window );">Investment in subsidiaries</a></td>
<td class="nump">27,905<span></span>
</td>
<td class="nump">26,885<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other long-term assets</a></td>
<td class="nump">282<span></span>
</td>
<td class="nump">666<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">33,898<span></span>
</td>
<td class="nump">32,969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Payable to operating subsidiaries</a></td>
<td class="nump">5,421<span></span>
</td>
<td class="nump">2,056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtCurrent', window );">Short-term debt</a></td>
<td class="nump">2,092<span></span>
</td>
<td class="nump">1,953<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent', window );">Current portion of notes payable to operating subsidiaries</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_BookOverdraftLiability', window );">Book overdraft</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">1,425<span></span>
</td>
<td class="nump">1,460<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">9,047<span></span>
</td>
<td class="nump">5,573<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">9,034<span></span>
</td>
<td class="nump">10,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">506<span></span>
</td>
<td class="nump">775<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">18,587<span></span>
</td>
<td class="nump">16,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 17)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $1 par; 10,000,000 shares authorized; none issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at December 31, 2022 and 198,648,742 shares issued at December 31, 2021</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Capital in excess of par value</a></td>
<td class="nump">3,246<span></span>
</td>
<td class="nump">3,082<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">25,492<span></span>
</td>
<td class="nump">23,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive (loss) income</a></td>
<td class="num">(1,304)<span></span>
</td>
<td class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 73,691,955 shares at December 31, 2022 and 69,846,758 shares at December 31, 2021</a></td>
<td class="num">(12,156)<span></span>
</td>
<td class="num">(10,163)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">15,311<span></span>
</td>
<td class="nump">16,080<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 33,898<span></span>
</td>
<td class="nump">$ 32,969<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_BookOverdraftLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Book Overdraft Liability</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_BookOverdraftLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_InvestmentInRelatedPartiesAndSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in related parties and subsidiaries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_InvestmentInRelatedPartiesAndSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of debt and lease obligation, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableRelatedPartiesClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableRelatedPartiesClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504332985232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets Share Data) (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par (in dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par (in dollars per share)</a></td>
<td class="nump">$ 0.1667<span></span>
</td>
<td class="nump">$ 0.1667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">198,666,598<span></span>
</td>
<td class="nump">198,648,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">73,691,955<span></span>
</td>
<td class="nump">69,846,758<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par (in dollars per share)</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par (in dollars per share)</a></td>
<td class="nump">$ 0.1667<span></span>
</td>
<td class="nump">$ 0.1667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">300,000,000<span></span>
</td>
<td class="nump">300,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">198,666,598<span></span>
</td>
<td class="nump">198,648,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">73,691,955<span></span>
</td>
<td class="nump">69,846,758<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504337343344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 92,870<span></span>
</td>
<td class="nump">$ 83,064<span></span>
</td>
<td class="nump">$ 77,155<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">12,671<span></span>
</td>
<td class="nump">10,121<span></span>
</td>
<td class="nump">10,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">749<span></span>
</td>
<td class="nump">640<span></span>
</td>
<td class="nump">528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest</a></td>
<td class="nump">401<span></span>
</td>
<td class="nump">326<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">68<span></span>
</td>
<td class="num">(532)<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">(Benefit) provision for income taxes</a></td>
<td class="nump">762<span></span>
</td>
<td class="nump">485<span></span>
</td>
<td class="nump">1,307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net (losses) earnings</a></td>
<td class="num">(4)<span></span>
</td>
<td class="nump">65<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,802<span></span>
</td>
<td class="nump">2,934<span></span>
</td>
<td class="nump">3,367<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ManagementFeesChargedToOperatingSubsidiaries', window );">Management fees charged to operating subsidiaries</a></td>
<td class="nump">1,554<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
<td class="nump">2,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_InvestmentAndOtherIncomeNet', window );">Investment and other (loss) income, net</a></td>
<td class="num">(88)<span></span>
</td>
<td class="num">(266)<span></span>
</td>
<td class="nump">763<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,466<span></span>
</td>
<td class="nump">1,367<span></span>
</td>
<td class="nump">2,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Operating costs</a></td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">1,404<span></span>
</td>
<td class="nump">2,204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">581<span></span>
</td>
<td class="nump">488<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="nump">283<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">2,681<span></span>
</td>
<td class="nump">2,205<span></span>
</td>
<td class="nump">2,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense (income), net</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(672)<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries', window );">(Loss) income before income taxes and equity in net earnings of subsidiaries</a></td>
<td class="num">(1,215)<span></span>
</td>
<td class="num">(166)<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">(Benefit) provision for income taxes</a></td>
<td class="num">(266)<span></span>
</td>
<td class="num">(259)<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries', window );">(Loss) income before equity in net earnings of subsidiaries</a></td>
<td class="num">(949)<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_EquityInNetEarningsOfSubsidiaries', window );">Equity in net earnings of subsidiaries</a></td>
<td class="nump">3,751<span></span>
</td>
<td class="nump">2,761<span></span>
</td>
<td class="nump">3,269<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in net (losses) earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 2,802<span></span>
</td>
<td class="nump">$ 2,933<span></span>
</td>
<td class="nump">$ 3,367<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_EquityInNetEarningsOfSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity in net earnings of subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_EquityInNetEarningsOfSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (loss) before equity in net earnings of subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) Before Income Taxes And Equity In Net Earnings Of Subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_InvestmentAndOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment and other income, net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_InvestmentAndOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ManagementFeesChargedToOperatingSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Through intercompany service agreements approved, if required, by state regulatory authorities, Humana Inc., our parent company, charges a management fee for reimbursement of certain centralized services provided to its subsidiaries, including information systems, disbursement, investment and cash administration, marketing, legal, finance, and medical and executive management oversight</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ManagementFeesChargedToOperatingSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504326553936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Comprehensive Income) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Humana</a></td>
<td class="nump">$ 2,806<span></span>
</td>
<td class="nump">$ 2,933<span></span>
</td>
<td class="nump">$ 3,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Change in gross unrealized investment (losses) gains</a></td>
<td class="num">(1,819)<span></span>
</td>
<td class="num">(356)<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Effect of income taxes</a></td>
<td class="nump">418<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Total change in unrealized investment (losses) gains, net of tax</a></td>
<td class="num">(1,401)<span></span>
</td>
<td class="num">(275)<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Reclassification adjustment for net realized losses (gains) included in investment income</a></td>
<td class="nump">72<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax', window );">Effect of income taxes</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Total reclassification adjustment, net of tax</a></td>
<td class="nump">55<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(1,346)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments', window );">Comprehensive income attributable to equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Humana</a></td>
<td class="nump">1,460<span></span>
</td>
<td class="nump">2,584<span></span>
</td>
<td class="nump">3,602<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Humana</a></td>
<td class="nump">2,806<span></span>
</td>
<td class="nump">2,933<span></span>
</td>
<td class="nump">3,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax', window );">Change in gross unrealized investment (losses) gains</a></td>
<td class="num">(1,819)<span></span>
</td>
<td class="num">(356)<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Effect of income taxes</a></td>
<td class="nump">418<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="num">(89)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Total change in unrealized investment (losses) gains, net of tax</a></td>
<td class="num">(1,401)<span></span>
</td>
<td class="num">(275)<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax', window );">Reclassification adjustment for net realized losses (gains) included in investment income</a></td>
<td class="nump">72<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax', window );">Effect of income taxes</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Total reclassification adjustment, net of tax</a></td>
<td class="nump">55<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive (loss) income, net of tax</a></td>
<td class="num">(1,346)<span></span>
</td>
<td class="num">(355)<span></span>
</td>
<td class="nump">234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments', window );">Comprehensive income attributable to equity method investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Humana</a></td>
<td class="nump">$ 1,460<span></span>
</td>
<td class="nump">$ 2,584<span></span>
</td>
<td class="nump">$ 3,602<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Comprehensive Income (Loss), Net of Tax, Attributable To Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126970911&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504331804032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Cash Flows) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">$ 4,587<span></span>
</td>
<td class="nump">$ 2,262<span></span>
</td>
<td class="nump">$ 5,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Investing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash and cash equivalents acquired</a></td>
<td class="num">(337)<span></span>
</td>
<td class="num">(4,187)<span></span>
</td>
<td class="num">(709)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of investment securities</a></td>
<td class="num">(6,049)<span></span>
</td>
<td class="num">(7,197)<span></span>
</td>
<td class="num">(9,125)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sale of investment securities</a></td>
<td class="nump">2,434<span></span>
</td>
<td class="nump">3,547<span></span>
</td>
<td class="nump">2,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of investment securities</a></td>
<td class="nump">1,365<span></span>
</td>
<td class="nump">2,597<span></span>
</td>
<td class="nump">4,986<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment, net</a></td>
<td class="num">(1,120)<span></span>
</td>
<td class="num">(1,316)<span></span>
</td>
<td class="num">(964)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,006)<span></span>
</td>
<td class="num">(6,556)<span></span>
</td>
<td class="num">(3,065)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Financing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes, net</a></td>
<td class="nump">1,982<span></span>
</td>
<td class="nump">2,984<span></span>
</td>
<td class="nump">1,088<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issue costs</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(31)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayment of senior notes</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">(Repayments) proceeds from issuance of commercial paper, net</a></td>
<td class="num">(376)<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of term loan</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="num">(2,078)<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInBookOverdrafts', window );">Change in book overdraft</a></td>
<td class="num">(28)<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">95<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(2,096)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="num">(1,820)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(392)<span></span>
</td>
<td class="num">(354)<span></span>
</td>
<td class="num">(323)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(1,914)<span></span>
</td>
<td class="nump">3,015<span></span>
</td>
<td class="num">(1,955)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">1,667<span></span>
</td>
<td class="num">(1,279)<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">3,394<span></span>
</td>
<td class="nump">4,673<span></span>
</td>
<td class="nump">4,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">5,061<span></span>
</td>
<td class="nump">3,394<span></span>
</td>
<td class="nump">4,673<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember', window );">Parent Company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">4,868<span></span>
</td>
<td class="nump">2,853<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Investing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash and cash equivalents acquired</a></td>
<td class="num">(337)<span></span>
</td>
<td class="num">(4,187)<span></span>
</td>
<td class="num">(709)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_CapitalContributionsToOperatingSubsidiaries', window );">Capital contributions to operating subsidiaries</a></td>
<td class="num">(484)<span></span>
</td>
<td class="num">(2,580)<span></span>
</td>
<td class="num">(538)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of investment securities</a></td>
<td class="num">(63)<span></span>
</td>
<td class="num">(200)<span></span>
</td>
<td class="num">(460)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Proceeds from sale of investment securities</a></td>
<td class="nump">468<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of investment securities</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">122<span></span>
</td>
<td class="nump">411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment, net</a></td>
<td class="num">(931)<span></span>
</td>
<td class="num">(958)<span></span>
</td>
<td class="num">(785)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,317)<span></span>
</td>
<td class="num">(7,732)<span></span>
</td>
<td class="num">(2,068)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Net Cash Provided by (Used in) Financing Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt', window );">Proceeds from issuance of senior notes, net</a></td>
<td class="nump">1,976<span></span>
</td>
<td class="nump">2,953<span></span>
</td>
<td class="nump">1,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfSeniorDebt', window );">Repayment of senior notes</a></td>
<td class="num">(1,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper', window );">(Repayments) proceeds from issuance of commercial paper, net</a></td>
<td class="num">(376)<span></span>
</td>
<td class="nump">352<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromNotesPayable', window );">Proceeds from term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of term loan</a></td>
<td class="num">(2,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInBookOverdrafts', window );">Change in book overdraft</a></td>
<td class="nump">5<span></span>
</td>
<td class="num">(52)<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock repurchases</a></td>
<td class="num">(2,096)<span></span>
</td>
<td class="num">(79)<span></span>
</td>
<td class="num">(1,820)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Dividends paid</a></td>
<td class="num">(392)<span></span>
</td>
<td class="num">(354)<span></span>
</td>
<td class="num">(323)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_ProceedsFromStockOptionsExercisedAndOther', window );">Other, net</a></td>
<td class="nump">40<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash (used in) provided by financing activities</a></td>
<td class="num">(3,843)<span></span>
</td>
<td class="nump">5,349<span></span>
</td>
<td class="num">(1,033)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash and cash equivalents</a></td>
<td class="num">(292)<span></span>
</td>
<td class="nump">470<span></span>
</td>
<td class="num">(570)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">906<span></span>
</td>
<td class="nump">436<span></span>
</td>
<td class="nump">1,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">$ 614<span></span>
</td>
<td class="nump">$ 906<span></span>
</td>
<td class="nump">$ 436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_CapitalContributionsToOperatingSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capital contributions to operating subsidiaries</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_CapitalContributionsToOperatingSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_ProceedsFromStockOptionsExercisedAndOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Stock Options Exercised And Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_ProceedsFromStockOptionsExercisedAndOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInBookOverdrafts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash during the period due to the net increase or decrease in book overdrafts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInBookOverdrafts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfCommercialPaper">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3098-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfCommercialPaper</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_ParentCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140504338996576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Notes to Condensed Financial Statements) (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract', window );"><strong>Condensed Financial Information Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hum_DividendsToParentWithoutPriorStateRegulatoryApproval', window );">Actual dividends paid to parent company</a></td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance', window );">Aggregate statutory capital and surplus in our state regulated insurance subsidiaries</a></td>
<td class="nump">11.3<span></span>
</td>
<td class="nump">9.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired', window );">Aggregate minimum regulatory requirements of statutory capital and surplus</a></td>
<td class="nump">8.4<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval', window );">Ordinary dividends that may be paid to parent company</a></td>
<td class="nump">$ 1.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hum_DividendsToParentWithoutPriorStateRegulatoryApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dividends paid to our parent company without prior approval by state regulatory authorities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hum_DividendsToParentWithoutPriorStateRegulatoryApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hum_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of dividends that can be declared or paid without approval of regulatory agency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 505<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6486098&amp;loc=d3e24708-158529<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>hum-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:hum="http://www.humana.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="hum-20221231.xsd" xlink:type="simple"/>
    <context id="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iac825e81fd674052afb8ee0b15e037c5_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i197c35ec7c824ce1bc66227545a36037_I20230131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2023-01-31</instant>
        </period>
    </context>
    <context id="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia97140e6b0864c928e72d49d1130c508_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i28bf61673f944bc1ac5aa3fe90724e55_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iae3316eaa1ab4c63b284379afe39c1c3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0e3e965bd7f546cb8bdfffae17fa5c03_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99ec67bd37c741fcae4bda5f42e6b771_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i1d04f982d8e74a8d8291aa9c72da676e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i389e820acaed4f94986088bd4c6ee7e8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2fd1f8bbcda74c90a7dfd0297a038626_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i571f2e6b6e774b29a93ccb70f106840c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7285850bb8c54632823083969a16a30b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iae0e22f86a6949a8a48e01671ed1c284_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7781da092ad41ee8990573fd28577bd_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id7f017f098bd40b1a9bdb0c3ec9f1caa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibbcbb10618b845c1add87e9d45a78991_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1fe1870a9b49406daaf2ba671fa7e631_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibe78b6c543d6497ba9c3f17b26297551_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i47316da3a3ca4462a4861e765c936186_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2fe62d64db7e4bf4972bf02ec4c90535_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i65031e9551cb4c5e98bf719298231efb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i36906efe5bd14a959e87de9672f63b52_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i06d4dc5e79574b798135918a523c5afb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90fb72011b3b41c089fdc685a8b914a1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52688808256645f9b0b3dadea8649a92_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90291fd2d2ea45d0aff5e33822dee463_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i518fee92d21348d4bac22ba846904d99_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icc29f8ee3dbf4eca981b29f3496e9b8f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib31d3b30f3a84c83be93331f0c89a3b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie3e2a44f0beb4bac9ff346a4269524b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic7f3f59a5f394d4faae0211463973ead_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i53ef7bd107114170bc009542db1e7bcc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c643278b48c4671a48980681e36ec67_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i35f272177b134f6b8a1b91bc0c09280b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iaae6442e790a4944978a3019753b8334_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i287579c2615947bd90df9271fb6c17d1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i57dca7a5679246a790f3f371e95e7dd7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9143bd79088c45919a393886eedf2fed_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i42f85c8b4a084c0bbd1a7804fa2fb617_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i52d2b054f3fb47ad90e22fc446758bc3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2a0a21d7c6d4429b8a0de15cd71eb93f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if9a733dd9abd4513bb45837c142b7106_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i28901f9b5d9648d3bcdd517445a5b77e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3a3b5852afb54656981769e75c1661ed_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8521cad256a441f09269040aa936b3c2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff654d59997d4f00bf56601509888261_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i04f20e9ecbc842eb84ec33df7c1e03ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7cc33f8e79b44da9048bfcf1f0d1520_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iafc3e3d48014423a92047239f09e25bd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3ecfbb6c22b417ebc6482a6408f9cdb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9069595e8b1946288939814801ab0b92_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icb9c2813455d48969d1c9c193176fa13_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">hum:ValueCreationInitiativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3a4c2fcb56be4c3697d752d81e29b9d4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hum:RegulatoryMattersAxis">hum:HealthCareReformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic581aed5cfed42a7a2f64bd4ed501897_I20171102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">hum:USRiskCorridorPremiumStabilizationProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-11-02</instant>
        </period>
    </context>
    <context id="i72beb26dbcd64e57a53b102d2216d4e3_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">hum:USRiskCorridorPremiumStabilizationProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="ia736406081164b128479b1d1f0573b44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">hum:USRiskCorridorPremiumStabilizationProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98b5cd0e14da45a2a65ccbb7b999b126_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis">
                    <us-gaap:ReinsuranceContractAxis.domain>CMS reinsurance subsidies and discounts</us-gaap:ReinsuranceContractAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id0a1f1c3b72a40b3b4bdbf0a7f076fe1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis">
                    <us-gaap:ReinsuranceContractAxis.domain>CMS brand name prescription drug discounts</us-gaap:ReinsuranceContractAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie78f1bb938b8481f8841f9c8c53b4b44_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:typedMember dimension="us-gaap:ReinsuranceContractAxis">
                    <us-gaap:ReinsuranceContractAxis.domain>CMS brand name prescription drug discounts</us-gaap:ReinsuranceContractAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iea3fc08d0e0f43fe959d292fad010549_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2987740b0cdb40188339b7acd6a0181b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id079b2db40e84b14a641fb9b1eb51da6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iaaab669d71af421191ca3584d7396347_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i60d881bff54b49609993a08aa88212dd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i05e6d98d428a4d49940ae089d750047d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i864645f1e72a4441a86287765a3dae2b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i44ae02ca45e24424b2e1bd6d8003c7bb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ieab9cc19ff1c48b3834f6647ccd0c104_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">hum:HomeSolutionsReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i95a27ca7ed954826900c752a38aa4c67_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">hum:ProviderReportingUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19ce21448fc64f32b2239d5bd098448e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hum:MedicareSupplementProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if48fb53a53e34a27a1de24c4a5da8121_I20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-11</instant>
        </period>
    </context>
    <context id="ib2a53b141d0e477195c76cb94f076fd4_D20220811-20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:TermLoanDueOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <context id="i94ffd24e1fbd46079ca060beb77c46db_D20220811-20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-08-11</endDate>
        </period>
    </context>
    <context id="i82bf2d71677045cb89ab8202ad71abfb_I20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:MedicareLicensesAndCertificatesOfNeedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-11</instant>
        </period>
    </context>
    <context id="i52e9445cef15459ca1a4443266fda6db_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i794c5dbf39734709be53637e3659df79_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5f2bc940567f4a69ac536078fddf515b_I20210817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hum:KindredAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-17</instant>
        </period>
    </context>
    <context id="i5fe4d9a70fd54514aadcf5bc01daa43c_D20210817-20210817">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hum:KindredAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-17</startDate>
            <endDate>2021-08-17</endDate>
        </period>
    </context>
    <context id="i6e64b83f1ebc4e4c9cef19a100effeb3_I20210731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hum:KindredAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="i48a47654fd0f48f7903a22655de0905d_I20220811">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hum:KindredAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-11</instant>
        </period>
    </context>
    <context id="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">hum:KindredAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic9f8031ffe444ed9b9343359a58376a4_D20220811-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EquityMethodInvestmentNonconsolidatedInvesteeAxis">hum:KindredAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-11</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0243358af036489b9db890af0f19a8da_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:WelshCarsonAndersonAndStoweMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8badefbc5e124dd3aa6c797258e8343d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ied2d81e7a2cd4e198da75a1eabb29072_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib0c91010e34245c3976100a5e9202503_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0e2965061dfd4016a59dc6a327d22cf5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaaca4131ba9f4188af49410407b10d27_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i11cd665f1547467c8350d08512260dd4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i126217602c624f2ebda161c66e36c104_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16730b092e6c42b38643174820335d57_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie926287dd7f8457b97691b76be5611a9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1df5272756d4e92b091873e633f3429_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i58cabae69b214817826771be532892eb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ief49b2992b1d4ac9b764f4b88eede797_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">hum:KindredAtHomeHospiceAndPersonalCareDivisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35b2694e329a46c09a0bc95ee97db01c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CreditRatingStandardPoorsAxis">srt:StandardPoorsAAMinusRatingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb72dad613204f368ff4a26fd335a8af_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i19ce7d0320634c71911eb129b62cdd75_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if1d051e2a57c4934876ddc48b5f49744_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4600bbd96e654f4bb87bb99cc75e8721_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id37e3970a9a245bf992b7f2bf10aaf9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if4e412987c124923843c11133670979d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2d065eb8ec814e6fb943f186f38242fb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7a05fc957d0846f4b011a965962086b6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i568af216307e4b179878b2da53d4122b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i185a7e76a1d24172bb01a134f7adc9c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifa6ce38b809041c9968dfc78a7b6929e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i100f7d2a885e4239994500a96187a154_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i663f713df5004ce691b805cccc0c3c41_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35d173bcc08f401d8448c3429d521e73_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifa5a405115aa4a9e80c1d4170818b435_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia6fbd362be394a77a0bae5d4e503c621_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf95ac00e96b4da2b61537caecf2a63f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i01fe7de4b48b4757bdba67c3c30223dc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if7892d0ce35f4c4d809ca56ec7b8ed92_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6016170130d84d3f9c5fe6be1493ed7b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf26e22bb6694373b3ec116c8848c087_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id8f2d76839dc425e9923d094887a6852_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia42d9264fe60436397893746d07f5344_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i10a317cf3f8749508994c7c0895c690c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ffca985b624437598892a6a46f6e67f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib0951e2e238645f2ae9ad57771d70f73_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie2617a33f07e4ea1ae164ff1bd350258_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3f87bad1dca649f6acab6b67b66ef008_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifb5c00bb1f8b464b98779dcffeb0bc99_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i099d522bfaf0457cbb3b97f0e040976b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icf1e6a604f94423babd31a467494b284_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1173c14adecf46f78881e3a27f37aec1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7d65e744f83e4ad98d0958df7c78c34a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3faa3637d1e54906a31aad04f195a8ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i14db3e8f943f46e786c81127e5ea0564_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie60cdd956a6640969d47e0833e86ba9f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib385aa21fe4c4616838ee0d0ca6d2cba_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0146b48a0e5489eaa956daf6df2d528_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib6fc8277fc204250b7480ed77aecc8e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifa72a9d84a68409eac53fed976508820_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia64dce68a9ab4a58acdbb1db7d67bb70_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5acccdd82ff846ff8ef892b418bb1485_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i081e21499a8c458baa615ff77f0ac1cd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i20264b95ebc04dcabbb626a171f3e744_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3fa38cc574124cecb80a041e6b188e3d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia7d7ed7bd6f64ee0acfeb9cbb1fae2f9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0cfec53bb2494f19a47c713e3227de97_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:NontaxableMunicipalNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic2235b6260df49a1a6c11eed924939df_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1f54148e6d2c499a806b66f7dca47359_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0fb95db0bf242dbab96b217510a895a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id3c7b37cedae462f862afaec00b4bc46_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ResidentialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1cf29001a702470bacacce5139c387a6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3338f1806f36453abbd7a52e1b0790e9_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i29e0593849c444ccbbeb42e1512fa4a1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1fb42a9cbf7b4e7cba7da4a133439c55_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialMortgageBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i85753dd3a8f54f9fb0d831cf7c5c43f2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5bea5d25f6cd43a8a70162eca920c430_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibb0684f421e64ce79522d2eb9a6a8413_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i642f883149c04810939d034bfa0a52ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5f49ba358e744656a0580c671549df4d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i78acbd1a53b04291b66fdbb04a15ae30_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie39ae48296ce4b29aa8bbe2041ed8eb4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae1d525c8d394981a6e5be40d156b6c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i212f1e342411493daed02b16d1a256c7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">hum:FairValueRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9c27e561235648b8b13b0b1006fe90ec_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">hum:FairValueRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7d2d71ecd0c84d618d11b24ea25820ea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i57df0c8d81b2453f8a238e040f1b0da0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4e44bcbe607149f5b7f316440415c7f4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie46f4a357a2f4fbe87c10ff118d9a34d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6036a7082bf04c138376afbc99b33671_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">hum:TermLoanAndCommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i31961d11bba447c88c3178990212f2be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">hum:TermLoanAndCommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i02980ff246d1468a8e06860f6caca51d_I20210427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hum:KindredAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-27</instant>
        </period>
    </context>
    <context id="ice7f37fee78e4e338fbc8d1d06f7ae0e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="icd18e11d3c604b7da08f0fffe4565217_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9423060dcf3c49fabea691f0ed0b95eb_I20210427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-27</instant>
        </period>
    </context>
    <context id="i8ddafd8649e14ac7acac5c6ccd24d75f_I20210427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-27</instant>
        </period>
    </context>
    <context id="i7e890b4b6701420b99a2fd9eb4ec7e41_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia6cabb5822a048bd9df34c65a2029e22_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iff8e2116ff51438a81ec082998730629_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i176fb35f957e441dbdcafceaebb04e6d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityEquityAxis">us-gaap:CallOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i38aeda789d4a488e891a8aa87e9fa1ec_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ice2ed9f6fb0c49ae9a1285ff2740d4e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3403a6c0905646bcbd8ae9d599d80f52_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i041054aa105846e8ab6457532786e0e7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia18bd7b4631c4221ae708ae77650b442_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2900bedd1cd9421e97eb2d64e4d1be5a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:CreditSpreadOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1473eaa5ef804e48ae190d791e55e701_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib63312bf4c4342bca36791b5e65e4bc3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ieecc262ea3ca466c845eebf21b8c3520_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2124fe581b3f4e0ca125473df9d56093_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">hum:RevenueExitMultipleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i87973cc0bdc9461d9b56ed906827e2d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3739da0aa72d4c86b46499cbdae6ff38_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1e8a8f01d8ca4f3a9f406c722b7ef5ed_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2b64fefe292a43728aaf7bdfbede5152_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i300136ad24984a21be5bc1960dfedd31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:OptionOnSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputLongTermRevenueGrowthRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i695c6177b9d34b308e88de94acfdfd75_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:RiskCorridorSettlementsMedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2499aa5c390a4ceab2772d3ab384250f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CmsSubsidiesOrDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf67c76176744e759331c39da83016b0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:RiskCorridorSettlementsMedicarePartDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id943835508f94dd6b4417c2cbf63f67d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CmsSubsidiesOrDiscountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i19bf3378b91a427c9bd2f7c3566e26e4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie0c89853f8934b0cacaa85cfc6f9e825_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ibf28824348bc4dbfb4309ec50071a077_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hum:BuildingsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d4af6d0f5b84d3788f8727616c7344d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">hum:BuildingsAndLeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic0fdc098cf1b4a1692f37a4e684bcd29_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i066e82ee7851473e9db8d8cb4482f183_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib4f43a97ffb845e68f044d5213898ca7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idf6cc9bbe7804ebdada6913578e3ff0c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idf9a2488b89e4d7385e1a72bd47d1cad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6e5599c238174c3cb192e88685bcfea4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0db23ec2c8844ec19dd3156f925907d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i302e4dad57a14cdba91bf0b5047fed31_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i579d987c48294cf28cfd69d68d722ed7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83b359b7705141b5b92b56cd339b7eda_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i86624d4911c84d1a9f17caac59321ed0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:CertificateOfNeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia1d2e4631e134d44a429a68436144159_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:CertificateOfNeedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i352d3685fa15496082cf261060f9e998_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4996f726e98845bb84a13c49d761508d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4a73edc57e734d3e99b59268d52d843f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i596d5af4874645ad9e06d1eeedc6d071_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ba75b2fe59340d18dee27ba36caa465_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie8a6332bc1f446caa2303215ecd07bab_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7fc197775115474f9bce928cb7b416e1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i10ff00041a32480583c1b1682d015810_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i91f583da577445c788bbe9d989064307_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i14b2c5f58ee9471fb1efd368a5aec87d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i361ad41756ff4adf9c60e7e103ece2a3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie0b1cd6334db4784afa7ba96eaebbccd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8a9de5765b6b4f35884275a81dcd973c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0773d411ab7f4a27a5bd3070a458b15c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">hum:NoncompetesAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fc949bd76c94ac0acb9625d55ca5689_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if00d8760e6f64b3b890040f421a1920e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2cd99d5331f347e4b92782b89a82aeb2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idcf95e3840d049aab6f62e08d9ee6525_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i07a30ac3b99249dcab52ec26094b0a75_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icd981807e06146b9a8b7168780fa31e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortdurationInsuranceContractsAccidentYearAxis">us-gaap:ShortDurationInsuranceContractAccidentYear2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ia1c0825aa8d04ce187bd5863fbc3d91f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88c075a77c0b427e841063ff79561d21_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib173a9a9bf26418d85e8c702ffd7b911_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia2d89ea7a0994fdc830560ce43d6ccf3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i99fded64e274478ab73f5733933c5a78_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A065PercentSeniorNotesDueAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibd6ab2d56c9c482ab6bb5a898cdae46b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A065PercentSeniorNotesDueAugust2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8db13c66deb74bf2857e79213be4b395_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.15PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0dfdeedfdae442b6bb69fbd7a0e139f1_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.15PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic7f278945eb146999d7aa678fa21f058_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A2.90PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0356912bdf2b4aabaeaff5e2ca21abc6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A2.90PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59f9c510abc04bad91d14e68c501cf01_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i773c7af03af34a47b324353282df0bf3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5276601cfe0b4fac93dc9dddd8c95bea_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.85PercentSeniorNotesDueOctober2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i509fa063896747ef909206a07e142390_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.85PercentSeniorNotesDueOctober2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i36e388eca8694a32b6e8c72020b4c015_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A450PercentSeniorNotesDueApril2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibeb90e7ae11f495f937a25c066d3754b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A450PercentSeniorNotesDueApril2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8368074918ac49a18d7b9cd1a553e8ab_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A135PercentSeniorNotesDueFebruary2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id965da0f6c5b41cb887887c891386017_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A135PercentSeniorNotesDueFebruary2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie10cec06f87647a3a1fa3fa523fe76b1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueMarch2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ied2ca976e98543e08e6ba87196523dfe_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueMarch2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i232b89f9079741ccae985c3171fc7335_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A575PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i853adef442584550b2d101e6ecef03e3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A575PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic1b454e6cf714a3fa01d153c13807f69_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A370PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1af71980b56546dd9dfa3f27ecfb67a5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A370PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6eb98a6499094af98d17a8f638209725_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A313PercentSeniorNotesDueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia0ce78565c94456ab9c3991a4e4e4b5a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A313PercentSeniorNotesDueAugust2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i708adb6138b2495a89218e1aa2f9c270_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A488PercentSeniorNotesDueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4ca72929b8994051a4a074df8437680d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A488PercentSeniorNotesDueApril2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if64cdf61ab1842c79002bf0f3aa124c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A215PercentSeniorNotesDueFebruary2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i57de736a34744fdea94f1c8fdd485269_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A215PercentSeniorNotesDueFebruary2032Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic096f056f036465dba708996f2f7a90c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A588PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id0e1c1afc93c410d8219b30b59c4221f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A588PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A8.15PercentSeniorNotesDueJune2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i102f918dc90d487f9be67b46e5ad7593_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A8.15PercentSeniorNotesDueJune2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i62a760cb5c98497ab0e8bb6f03c6e29b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A463PercentSeniorNotesDueDecember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i853fb2ba319a40ae809f5f370473eb91_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A463PercentSeniorNotesDueDecember2042Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="if5c6d742cb8343b8a723dafa1d57d5ad_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.95PercentSeniorNotesDueOctober2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i50436e89d2dc4ae6aeff04066d91f1e4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.95PercentSeniorNotesDueOctober2044Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i667465604c864997be52308f84abe858_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.80PercentSeniorNotesDueMarch2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i83b3d29f254448849e71cacdfe49dd10_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A4.80PercentSeniorNotesDueMarch2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i10bb54eaa9364a17b55f021b93ed865f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueAugust2049Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5297e4cf2a114648b8e3b858f90ec33b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.95PercentSeniorNotesDueAugust2049Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i81c11504dac94900b47f3adec13f2eac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:TermLoanDueOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9dbea7f466654367bb2ffab6a0f398ae_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:TermLoanDueOctober2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6401b4f44735434682c78028a5989e89_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc85f1f2648a47f78a97ded8aed480aa_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8d2e5c35e8664d878870c2ac31cb5a7f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3d642b46f9f947e1908279e62e1137c4_D20221201-20221201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A3.15PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-01</startDate>
            <endDate>2022-12-01</endDate>
        </period>
    </context>
    <context id="id5f7b09cb2a44027b3040bd2bed6bdea_D20221215-20221215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A2.90PercentSeniorNotesDueDecember2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="i9d8c3540308f450bb7239d10b7acc3b7_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5570PercentSeniorNotesDueMarch2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i63948e729cd5446e9ecb1103f8d97342_I20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5875PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-30</instant>
        </period>
    </context>
    <context id="i0b66643fcfdc4bc3aac6fe89fd6d2c8e_D20221101-20221130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-01</startDate>
            <endDate>2022-11-30</endDate>
        </period>
    </context>
    <context id="i59c282fc7fc24fdfb266342670c5aa0e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A370PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6147469181034d3693ebd758a56db336_D20220301-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:A370PercentSeniorNotesDueMarch2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic09be7d135374636bb90d8a931991af6_I20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-31</instant>
        </period>
    </context>
    <context id="ibbb32b683c6d4c9389fc542d8b6ffe93_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="idbcdabf72f5c4bbfbf380741c218ce61_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i58d6462307654072a27dd04f0987456f_D20210501-20210531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-01</startDate>
            <endDate>2021-05-31</endDate>
        </period>
    </context>
    <context id="i1f8d88b80b864d978dcce7b20445315e_D20210801-20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:DelayedDrawTermLoanMay2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-01</startDate>
            <endDate>2021-08-31</endDate>
        </period>
    </context>
    <context id="i9699973b24d84dcaae4ebcf77e8bddfd_I20210831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hum:KindredAtHomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-31</instant>
        </period>
    </context>
    <context id="i112e4e9b6e9743f192f0c261f2174fb6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i387aa55175c54a05a686b101571c25cf_I20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:October2021TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-29</instant>
        </period>
    </context>
    <context id="i9d7e0a7171cf41f39322708915887790_D20211029-20211029">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:GentivaTermLoanDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-29</startDate>
            <endDate>2021-10-29</endDate>
        </period>
    </context>
    <context id="iacb7e7be2c134f1a9b7ce6ca2f0f913d_I20220816">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:October2021TermLoanAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-16</instant>
        </period>
    </context>
    <context id="ia4f21019238942898fb706ac9e7a0d38_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie41025c3734b426daf406df47fee29ea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iba715c5c2419471eaade517586321b41_D20220601-20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="ifa91146be05e483b86453c991c407783_I20220630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="i60d5d66074474c979c41340bd209ed02_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia2901fdf8be043b3b4ce7d10615715e0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id6aba1e961d1473e9cf526f0a1e804dc_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifd10b85dc8cd490b8688147f8bfb596e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hum:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1321063cfc7c48c188ce65d238c95fd0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i158dd71369834c93b0a4333493fb0b28_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6a26405ed8ae484ba52bfc3819cacf40_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hum:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibfe28b2f52e240d0be900bf3683893a3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">hum:SecuredOvernightFinancingRateSOFRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i146462488f28499dbcb4a352e9f0c578_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5740b2f51a534ecb852d304efddc5ba4_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia2e4d343c10f4aa9ad919a757b1244b8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4ec6325dd17e4a189e564e299a71923b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i42f921861ba949c0aa1605c0c528cd9d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i69a245a8dbe941efbcc60ad56f792d25_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id81d6fd6825341bd9dfae06ccdae8e2e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021FiveYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i927e6ff7d6e14022a0d65ca7195d8616_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hum:RevolvingCreditAgreementJune2021OneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i052c3330b4c2409992bdda8401167a8b_I20220210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-10</instant>
        </period>
    </context>
    <context id="i4e33a39278e94aba940321c53fbe7f78_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9061d9c9dbc8401d8cc25502ab63cf20_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i114dcf8181f5421f9df917dc4561297f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:FederalHomeLoanBankAdvancesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie8e5bc41112049779d5fbc3865a6beb0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia611810824824c4998cefac84618de1b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5ba6401654ae40689698616e02215fee_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib289b93fe6734476ab8f5d0c5798ec39_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f20dc8ac0564bccbfa9a003167f23df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iabaf7ad5365e4602a729a73898dd2781_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibed54bbe914a4277a816a361d2be8669_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2011PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i000c50d1006145feb954575f49af33a2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4357b2b8b1914d969c619a19a67d1b47_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hum:A2019PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ida62d357008f4ed0bc3246cc32b3771c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i5c29ece986e14d5fbc1af74aef0f594b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic5e4929afcc240d981441f4b646c3c65_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibd04deeb98f941698ee17f88f8a23fbf_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i992f903cecc5400f81dfb547116cb415_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i60f1ff28ff564a1ebbe436416a7471f0_D20221001-20221031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2022-10-01</startDate>
            <endDate>2022-10-31</endDate>
        </period>
    </context>
    <context id="i002fe084afec40a3b3544bd5ca40dff0_D20230201-20230216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-01</startDate>
            <endDate>2023-02-16</endDate>
        </period>
    </context>
    <context id="i0179480f2bae4075beb28f01cc367fc2_I20201222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-22</instant>
        </period>
    </context>
    <context id="iba989f1957d14bd5ad09090a3705faec_I20190730">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2019-07-30</instant>
        </period>
    </context>
    <context id="iafa1f29c11f64ee4a23c6d619014a6bb_I20201223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-23</instant>
        </period>
    </context>
    <context id="ic232bc3e290f4655953c1352a27704bc_I20201223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:CitibankNAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-23</instant>
        </period>
    </context>
    <context id="i19f92caa5fd741989e66515605b91004_I20201223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:JPMorganChaseBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-23</instant>
        </period>
    </context>
    <context id="i3c75a59f8572479c926935996bad608e_D20201223-20201223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-23</startDate>
            <endDate>2020-12-23</endDate>
        </period>
    </context>
    <context id="i53cd41e672c644b48afcbba07fd3e06f_D20201223-20201223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:CitibankNAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-23</startDate>
            <endDate>2020-12-23</endDate>
        </period>
    </context>
    <context id="ia0334069ef954f71908cae7a3e991ead_D20201223-20201223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:JPMorganChaseBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-23</startDate>
            <endDate>2020-12-23</endDate>
        </period>
    </context>
    <context id="ia0baee71e7f548278d68833140520ee3_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8fb3265c7324998bfb3a80ce36e5b0b_D20210504-20210504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:CitibankNAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-04</startDate>
            <endDate>2021-05-04</endDate>
        </period>
    </context>
    <context id="i350835a15d964c85bd84001ed39b4e0c_D20210505-20210505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:JPMorganChaseBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-05</startDate>
            <endDate>2021-05-05</endDate>
        </period>
    </context>
    <context id="i70684713b18a4b98947fa4e3302512a4_D20201222-20210505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-22</startDate>
            <endDate>2021-05-05</endDate>
        </period>
    </context>
    <context id="i73e1a9fbd6384960a77b548a06888967_D20210505-20210505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:December2020AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-05</startDate>
            <endDate>2021-05-05</endDate>
        </period>
    </context>
    <context id="i495ee173617d40c9a28f5030f6631472_I20210218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <instant>2021-02-18</instant>
        </period>
    </context>
    <context id="id0b96effe20c452e850f5e6c15c8f8d3_I20220111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-11</instant>
        </period>
    </context>
    <context id="i9dd45b09421342e6818a93611f04d810_I20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="i4aebd9fa2ef54f84820765f00217687b_I20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="ibed82a92406149c48f61066e76a21f70_I20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:WellsFargoBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-12</instant>
        </period>
    </context>
    <context id="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="ia10d21e8a157411e9877dc680a3ee356_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="i568119642532418a8e54da51e855e96f_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:WellsFargoBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="iefa207bd427f4a95a03f48bf711b1dba_D20220329-20220329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-29</startDate>
            <endDate>2022-03-29</endDate>
        </period>
    </context>
    <context id="i75ef00cf639a4623b3a5e417b7ffdf72_D20220330-20220330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:WellsFargoBankMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-30</startDate>
            <endDate>2022-03-30</endDate>
        </period>
    </context>
    <context id="ice757c7c8d4a460d95726e2ca454481e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4a532821749a4aa2adc6f2de7319e3f3_D20220329-20220330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:January2022AcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-29</startDate>
            <endDate>2022-03-30</endDate>
        </period>
    </context>
    <context id="id61359de4c6d40babbbcf4cb9a67c753_I20221102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-02</instant>
        </period>
    </context>
    <context id="i73fcbac85e68448ba128e118ba423e97_I20221103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:GoldmanSachsCoLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-03</instant>
        </period>
    </context>
    <context id="ie0a147a615a34ceebed3a230fbb94d7f_I20221104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-11-04</instant>
        </period>
    </context>
    <context id="i4b2588f5c36147e39712fb70b96204b3_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="ia5162c0c768943718eac311366829953_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="i703e9357eeda40b8bac63abad7404e77_D20220112-20220112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:GoldmanSachsCoLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-12</startDate>
            <endDate>2022-01-12</endDate>
        </period>
    </context>
    <context id="i54e117a2b2cb4096bee16f6734d08b94_D20221102-20221102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-11-02</startDate>
            <endDate>2022-11-02</endDate>
        </period>
    </context>
    <context id="i8cf37da4ca144f09a6227316724ff0d9_D20221215-20221215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:GoldmanSachsCoLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-15</endDate>
        </period>
    </context>
    <context id="ica8cb453a4214470aeb06e98f2e6defe_D20221216-20221216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">hum:MizuhoMarketsAmericasLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-16</startDate>
            <endDate>2022-12-16</endDate>
        </period>
    </context>
    <context id="i1a8cc08368eb4c8087ba95516ebd17f6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i428ce4f261d54aa99e91df6496710161_D20221215-20221216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">hum:November2022AcceleratedShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-15</startDate>
            <endDate>2022-12-16</endDate>
        </period>
    </context>
    <context id="i546d29dd98934753aadeaaaf3c309757_I20230215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-15</instant>
        </period>
    </context>
    <context id="i79ef21e520e24d9b86c34779aacb9bcb_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:February2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7cbb214573c842ca8b6e875c6ff4063d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:February2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icf5c867675b14eb099507bc46b1d3c8b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:February2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if6da3e5a26834dcc9735b2892ca0ecb0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:February2021ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idab11132473e41d4b78b5223d9404132_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:July2019ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie4f711d960cc4da69eb94de28d19a3f3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:July2019ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib058f69043374be79aeeb4ef7b5fc2dd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:July2019ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5e57aa821d834ff2a62e2f0f968132d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:July2019ShareRepurchaseAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2911e9195ca74da59efd95c2f2a079cb_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1d38c03d6b794fda984bd56ecc795514_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b418f12cccb453c9cf39ecc9a2f0251_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">hum:ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i12de401f78254a06a054b3031bb6db2c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie135078db20f4355a53c7fdca9bb2dc3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i61a07b55e80d459dac04cd0e5bf2f6bd_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MilitaryServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i659f9236e99f47089bc96dac2b1eec1d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i183a5acc1cbc41339a7e84c20d8eae47_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FederalGovernmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueProductLineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GovernmentContractsConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iad99ca704571480ba83888a5d38aa019_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic19eb7627fb348218e3375f5c66974a7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1d672fa23f814425b4471c1e5dc74b0f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if874def50df84ee38965dd2ff7e20dc8_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6acea9d1a84d4feba6bb5ed5ce9a2413_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i03a322c8d9d443e19ed5ba572d9572d3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4fc365aeef164ccba60189ae8e4be0c6_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i678e6634c1f641da9467a8467bb0d1fa_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ia600b949e2564d9499a7f90413acb269_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib3a1e7fbd9b740abb48da6c37c8669a5_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icba60622cbea46a4bea4ee9980cf49d0_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie5c59ec6e1b641aba95c635ef9ee9353_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i77000571fe484454b7cece9a261ff0d7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6a704e86f4b24c3aaa85d60048410091_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8b96d1b5772846aab2514b027450d532_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i851654ab87514d19bb07259c3e31ff6b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i88dbb625a14f473eb0ce08c9d6aff7e3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9a97e0cfebe44b6ca9f74bebc9aae41f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i321b22b5a8d64b4fa443b551c3f5ef42_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifac46bf8882f4afd8d1dff2e3d3664d3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d9b0e5592fc42a6b5a50cddd44bac9b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6c5f8b05d172420aa7d6e508a7c3261a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1ed102b89a1848bf8a260145b47bc56e_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i917edca86d004c958b32aa4199b5ea4b_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i32da3ea918f84f139a1ac455b07ebfda_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1cdfd66eeb7d4c938de2f60123537f11_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i47d0ebf962574d2da49de809c4eb19ba_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i03027c1fdaa8418fb517496371138dbe_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id6b045942f9d4e858da50fb74642864c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic5328222283c41c587cc828204de2027_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i897a9529650a4bb884a93b8cf59bd75a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7458a4e3b4284a1e924e76cd284a045d_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i596d1ad9ab314614a3930efbc769fbf3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1d8bdf2106784156b1b8947924736d88_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i590c72b5416448abb074967e44ff6ab1_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic7d56895373540d987a4fcd85111df8f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i01479ee240324dfda2f8366c4adb14e7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib9e4c5dc89ec4b73a775d2b544b21d0a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id179fa09e1214e46a546b7c140286685_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if4ff990b381946d494741a1374b90aed_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7df369d93b09472ba0bced59c36b413f_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id67dea91f3604bd78d2f964c679d21b3_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i796b3722619946a2866e39b5e61a9380_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie4ec4db66fd64bc8bbf344f75b65d318_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i52e79522cd64489888fa93b49c2e6243_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i299d79234a514ee99ef71046de2df3ef_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib51fd316c79f41bebb6fc344f6a46fea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i89314fb76bc24433859a3e2ed527bbee_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i27b8edba666c462dac30cab44012936f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i604d726215884cf397df3162b2320a54_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8388adc860dd445ba3de97b7ffe95782_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iadf23257f8df4815a1982e9a75f47ead_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i49240990811a4ffbb3f2a0dc683eee48_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i951e931c21c249828781deed9eee8a91_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i47a95cc29f594641874afe2ad127832b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0fc07acc77f4488bb515bb553edc0192_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i86a8d4d2792c484998a2be6ef7a5f7be_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i47c70b5427044960a0e01b33a278221e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7e4b19efa9e444958b038a59e21c75c4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic0fccf5c68e841ac97cab4f30966690c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i14fe41ab9d67459db2ad797f32f05552_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia4687e7689164bdb8320ac4f06953159_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if321fc68ab164282ba4bc0726aa93b10_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5b46f3ae730a431c893027c770d15680_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id4e8f651980b4cd48bca93f3614c15b2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if787c02ff9d64d0e86eb8be9f9c46de6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4f643826c3e2422b89a1571806de6508_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iacbb558c49be43379c68e6c711fbdf86_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idb33cf4ae55b44f2a3f18566f90accbf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5312c3184550451f928932ad398d9016_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7b44c1e415cb45b98e81cc9a0453f32e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i03cda4dc42e842a09d1fdc9b3ceef45f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i23dd140b009549a8ae4aa3a8fae36f29_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iba55647075e043b2b181dba0f49b1e76_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8547008a36864217a82b790897092dc0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2dc3f58523444595909416938e01f4b3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia427ffdd9dff49bf85f8ee91a5835796_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ide89fb74b6854034944d82f12a08655f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0654ac32fb3f48b58e198b661a0db5c2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib05710ff212440dfaeea8f28f8a00d3f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7142e963e6ee4d9c8c2e655388f8918f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie513cbe1edfa4c8dacc68ed1e879643b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad139752acf7480db3dd52727e06ef78_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic676151b15dd4c80a0f1e58f9d321c46_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i059d3ba987f746dca463069e8b556721_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i35acacb165204dcd9adc612f30611f25_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if39c9d28566e49fb94ca604dad0f7413_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6eaa0a4a53de41adbac051ef9fae2992_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1e964222588640aaa4fc9517b9915eb7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icae43fd407c4414b943b92f92c1a164a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i361c2054214544b3a52b1c8f570d1486_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i298fcaa6f9554c64bd5f075426eeb27d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:GroupMedicareAdvantageMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idb67851ec4dc4e8d82168000c4595810_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i98770db22e0b4594a796eee0640b15a3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3d182410af6d45d1810973f77992c508_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareStandAlonePrescriptionDrugPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4d69af6e550428ca1462f8259d169c1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib40497970a7d49a3a88ba998a48f7805_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9f7a2cf3d405471395d39b0680066ce9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8bd3273e77284e40b2171ed9f574fe18_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i56bb0fd352744b9b9971c20e238c2186_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8955c114fdc3489daa2dee4a9140f585_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idf9f80bbf5a6434ea08491bd367d4e20_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:FullyInsuredMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i138d886578ea47c5bdfc107eafd19fdf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id95534e4967c4794a2bec00ba0a1892d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i02af1f31fe144885b9fc028cec9cc8b7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:SpecialtyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7a6507afa1e242dcb28f8c57ad781f71_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3908bb51774249158321c4ed8ca6ac40_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5b2d04219b8943159debcd053092fe5b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:MedicaidAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0bad957ce43349d9871780e049801c78_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i04343d7d31a84ac79e44e3b54ac8536d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iee9aefc250a24fa2b78e41b534370e5b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i48e8960d40aa4748b405ee8aac3326b7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:HomeSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0c79c3029f1c466b82ea3f885f7dbd83_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9711652ed43c412f9b92e3193a318e66_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i44030fa27c974660bded54de8fb11a50_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ProviderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaec631922eab4df1b6048c710078b4c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id8f743f1a22644caac1e859fb29a7aa1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1ded12f91baa4171b745a570b579f67a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:ASOAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id2c8cfea28c541b7b645922d44fbf2f4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia3e7d86e1bea4d3f962cf462f8b5c6cc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f092984c5164c6d84492225b149eaa2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">hum:PharmacyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i948d525c3b334e34b62da49d9c7482fc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d8e5a12ecf549238eedf1a87c7d1e88_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i325ae4c732a24279a4460fdb5f2ce1b8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i25389e35fd5c4d46b3ce2e270d42eaa0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8d2420a864954324be79ba29b455d706_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i128c3bbb84cb4ebfa37efdd581ba4fb6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i54776761815d43f0b22c0e07b84bbe14_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i63dbef0b32684c9c8234fd4ad305f9d5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i17ef1ab00ada45a291c117cd6de96bcd_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">hum:CorporateAndEliminationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iea836c2c260040cc9a90acfff66f58e4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i58027b9122014dee871db47b91819791_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:InsuranceSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iabd8c18c4f8548ff9a23c8f591e89113_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">hum:CenterWellSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0dfbff48771b4638b79a2300493d8877_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hum:LongDurationInsuranceProductsAxis">hum:CoinsuranceAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4523ccf1b56c43b9960b083342924008_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:ReinsuranceRecoverableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ReinsurerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i704efe02ea3f46fdadbf3661e8fb4018_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:ReinsuranceRecoverableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ReinsurerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4eaa3ef983134ea9b906d1bd180d672d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hum:ProtectiveLifeInsuranceCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0c4d94cfc4be468a97bde38608cbc8a6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hum:AllOthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibda24e1355ca41dcad5d202558a258c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idca4a73570f341c190a700bcb5fc200a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b37d40697eb42ba8f7d32eb522463dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i349fa291d8d14aaa9e2386bb9b8b283a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:ParentCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>hum:segment</measure>
    </unit>
    <unit id="primary_care_center">
        <measure>hum:primary_care_center</measure>
    </unit>
    <unit id="position">
        <measure>hum:position</measure>
    </unit>
    <unit id="claim">
        <measure>hum:claim</measure>
    </unit>
    <unit id="state">
        <measure>hum:state</measure>
    </unit>
    <unit id="beneficiary">
        <measure>hum:beneficiary</measure>
    </unit>
    <unit id="option_period">
        <measure>hum:option_period</measure>
    </unit>
    <unit id="reinsurer">
        <measure>hum:reinsurer</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM180L2ZyYWc6NzcyZmI2Yjk3YWZhNDgzMGIyNmQ3MWNhZGRjYTE2ZjAvdGFibGU6OWI3MjFhNjMwMTlmNDI4Y2FlMmVkMWI2M2E5MDE5NTkvdGFibGVyYW5nZTo5YjcyMWE2MzAxOWY0MjhjYWUyZWQxYjYzYTkwMTk1OV8yLTEtMS0xLTE0MDY0NQ_269f71f8-953b-4d59-8c64-438110976f64">0000049071</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM180L2ZyYWc6NzcyZmI2Yjk3YWZhNDgzMGIyNmQ3MWNhZGRjYTE2ZjAvdGFibGU6OWI3MjFhNjMwMTlmNDI4Y2FlMmVkMWI2M2E5MDE5NTkvdGFibGVyYW5nZTo5YjcyMWE2MzAxOWY0MjhjYWUyZWQxYjYzYTkwMTk1OV80LTEtMS0xLTE0MDY0NQ_99671e65-2fd4-4565-b692-d4c2d65c9870">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM180L2ZyYWc6NzcyZmI2Yjk3YWZhNDgzMGIyNmQ3MWNhZGRjYTE2ZjAvdGFibGU6OWI3MjFhNjMwMTlmNDI4Y2FlMmVkMWI2M2E5MDE5NTkvdGFibGVyYW5nZTo5YjcyMWE2MzAxOWY0MjhjYWUyZWQxYjYzYTkwMTk1OV81LTEtMS0xLTE0MDY0NQ_dd82a8c7-75e7-42f5-af8a-8b6815bd5f0e">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM180L2ZyYWc6NzcyZmI2Yjk3YWZhNDgzMGIyNmQ3MWNhZGRjYTE2ZjAvdGFibGU6OWI3MjFhNjMwMTlmNDI4Y2FlMmVkMWI2M2E5MDE5NTkvdGFibGVyYW5nZTo5YjcyMWE2MzAxOWY0MjhjYWUyZWQxYjYzYTkwMTk1OV82LTEtMS0xLTE0MDY0NQ_e864da1e-b1a2-4aab-afb7-9b709003716b">false</dei:AmendmentFlag>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjcvZnJhZzpkMTUwMWZiODBmYmE0YjRjODEzM2FmMDcxODI4ZDI4MC90YWJsZTo0Nzk2MGFhNDkyNWQ0Mzg1YWYyNzBjYmYwYjBhMDdhZC90YWJsZXJhbmdlOjQ3OTYwYWE0OTI1ZDQzODVhZjI3MGNiZjBiMGEwN2FkXzEtMS0xLTEtMTQwNjQ1_420ffb7e-45fb-4b11-bac8-47a78c0ae39b"
      unitRef="usdPerShare">0.1667</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjcvZnJhZzpkMTUwMWZiODBmYmE0YjRjODEzM2FmMDcxODI4ZDI4MC90YWJsZTo0Nzk2MGFhNDkyNWQ0Mzg1YWYyNzBjYmYwYjBhMDdhZC90YWJsZXJhbmdlOjQ3OTYwYWE0OTI1ZDQzODVhZjI3MGNiZjBiMGEwN2FkXzEtMi0xLTEtMTQwNjQ1_bb945b37-be87-497e-ab9f-ca581e14d094"
      unitRef="usdPerShare">0.1667</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMC0xLTEtMTQwNjQ1_256dbbe4-e72d-43cb-856f-f86c3ab31032">http://fasb.org/us-gaap/2022#HealthCareMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMC0xLTEtMTQwNjQ1_63a0ed7e-2224-43f9-9b9a-e3b0d3ae6fad">http://fasb.org/us-gaap/2022#HealthCareMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMC0xLTEtMTQwNjQ1_e463531f-2ae3-4151-ab6a-b78870f1c964">http://fasb.org/us-gaap/2022#HealthCareMember</us-gaap:RevenueFromContractWithCustomerProductAndServiceExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_aa3c46cd-ae1d-4dbb-b466-6a345a4c4ee1">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_fb3c77fb-1c01-43eb-9b8e-b8c8b202045a">http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent</us-gaap:OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_0f510c82-dcff-42e3-bbab-71fc1ed8e909">http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_f7698f80-d9e2-4b51-aa84-637d028779f0">http://fasb.org/us-gaap/2022#AccountsPayableAndAccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_bc2d9dd9-e2c4-4f69-a280-01a78070d904">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_e06b9087-2af6-4553-b278-719cfd049d22">http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent</us-gaap:OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <hum:TRICAREManagedCareSupportContractBaseTerm
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMyOA_c266142d-523a-4672-8755-4dc23319d78b">P1Y</hum:TRICAREManagedCareSupportContractBaseTerm>
    <hum:TRICAREManagedCareSupportContractTermWithOptionExercises
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMzOA_961b1df7-1bbf-49b4-94e1-c81bd4087591">P9Y</hum:TRICAREManagedCareSupportContractTermWithOptionExercises>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDcvZnJhZzpjYjBiZDBhNjk0YjM0MTFiYWFmOWVhNGZlZWYyZmRkYy90YWJsZTo1NGZjNjViNmJmOWQ0NGJiODFhY2E3YzA1N2M4NzdkNi90YWJsZXJhbmdlOjU0ZmM2NWI2YmY5ZDQ0YmI4MWFjYTdjMDU3Yzg3N2Q2XzEtMS0xLTEtMTQwNjQ1_eb9b270e-8d82-444b-ba85-99c9fdb95e2e"
      unitRef="usdPerShare">0.1667</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDcvZnJhZzpjYjBiZDBhNjk0YjM0MTFiYWFmOWVhNGZlZWYyZmRkYy90YWJsZTo1NGZjNjViNmJmOWQ0NGJiODFhY2E3YzA1N2M4NzdkNi90YWJsZXJhbmdlOjU0ZmM2NWI2YmY5ZDQ0YmI4MWFjYTdjMDU3Yzg3N2Q2XzEtMi0xLTEtMTQwNjQ1_023d2074-a761-4158-9b9f-2fd2c1e15646"
      unitRef="usdPerShare">0.1667</us-gaap:CommonStockParOrStatedValuePerShare>
    <dei:DocumentType
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMzAw_35433c32-303e-4b67-a029-4f990eceff08">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6MWRiM2VhZjJjMDJiNGFjOGIyYzQzZmRlZmM0YzU0MmYvdGFibGVyYW5nZToxZGIzZWFmMmMwMmI0YWM4YjJjNDNmZGVmYzRjNTQyZl8wLTAtMS0xLTE0MDY0NQ_15dcab74-0ab5-4d30-8ac9-18ac902ca0d3">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18xMTY_e4464931-fb55-4ab6-a5ac-b399d8710131">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18xMTY_48ae4768-1892-4c24-aec4-72113ade5226">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6MmJmY2Q1NzRlY2YyNDRmMWJkMGIxY2Q3NzU3NjhmNDUvdGFibGVyYW5nZToyYmZjZDU3NGVjZjI0NGYxYmQwYjFjZDc3NTc2OGY0NV8wLTAtMS0xLTE0MDY0NQ_f297161f-c112-4faf-9203-c7d9157eee72">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjkx_a74ade95-9653-4844-afff-e813eadf6e28">1-5975</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg3_b51c471d-1b80-4e34-8cbd-5ddf2d183773">HUMANA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6OGEyYzJjZGQ5MDRkNGQ1MWJmMWY0NWE0MjRmZGYyN2YvdGFibGVyYW5nZTo4YTJjMmNkZDkwNGQ0ZDUxYmYxZjQ1YTQyNGZkZjI3Zl8wLTAtMS0xLTE0MDY0NQ_8a83fd24-5673-4765-882e-859d28d3be68">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6OGEyYzJjZGQ5MDRkNGQ1MWJmMWY0NWE0MjRmZGYyN2YvdGFibGVyYW5nZTo4YTJjMmNkZDkwNGQ0ZDUxYmYxZjQ1YTQyNGZkZjI3Zl8wLTItMS0xLTE0MDY0NQ_62a3d0e1-4e85-4d2b-a97e-70720be3edeb">61-0647538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk1_5584475c-1c91-47d4-97ed-e77dc903e9ed">500 West Main Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg2_03e89c46-1bc8-45bc-a5dd-21b8db8d310c">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk0_f8f2e0e9-28e2-4ef7-9bef-d9ab60c5c27a">KY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk2_fc3698a5-bbb6-4756-befa-8c0590268529">40202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg4_a4260959-1731-48bd-a356-92846c755fa7">502</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjky_74ed549a-2c91-4a2d-8795-f85bf9488786">580-1000</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NjcxYzlkZmM2OGQyNDZmMWE2YzE0ZWNjOWY3OGFiZDIvdGFibGVyYW5nZTo2NzFjOWRmYzY4ZDI0NmYxYTZjMTRlY2M5Zjc4YWJkMl8xLTAtMS0xLTE0MDY0NQ_06424555-5a5c-4db4-82eb-98661cfdd5a3">Common stock, $0.16 2/3 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NjcxYzlkZmM2OGQyNDZmMWE2YzE0ZWNjOWY3OGFiZDIvdGFibGVyYW5nZTo2NzFjOWRmYzY4ZDI0NmYxYTZjMTRlY2M5Zjc4YWJkMl8xLTEtMS0xLTE0MDY0NQ_09ad9df0-f18b-46b3-85ba-2223fca6fbde">HUM</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NjcxYzlkZmM2OGQyNDZmMWE2YzE0ZWNjOWY3OGFiZDIvdGFibGVyYW5nZTo2NzFjOWRmYzY4ZDI0NmYxYTZjMTRlY2M5Zjc4YWJkMl8xLTItMS0xLTE0MDY0NQ_e164336f-7067-4fdc-b037-949625a6cb34">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjkz_4121cf4c-b790-4d5e-b4d0-73b570fb5f40">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk3_0e165626-49f3-4aed-819e-ea4bb75a5122">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg1_04d6c5d2-d290-4cf6-9b71-5c1597ff8615">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjg5_d1c74f74-0a50-45f5-a1ed-9869d84d49bc">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NTg1YTRhMWFmYWE5NDU3NGE3NzQ5YWE4NmY2N2YzYzkvdGFibGVyYW5nZTo1ODVhNGExYWZhYTk0NTc0YTc3NDlhYTg2ZjY3ZjNjOV8wLTAtMS0xLTE0MDY0NQ_8c7c04ab-d6c7-468d-b7bc-45521eb5c1d1">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NTg1YTRhMWFmYWE5NDU3NGE3NzQ5YWE4NmY2N2YzYzkvdGFibGVyYW5nZTo1ODVhNGExYWZhYTk0NTc0YTc3NDlhYTg2ZjY3ZjNjOV8xLTQtMS0xLTE0MDY0NQ_4eef8be4-1d93-413f-86b4-d908205e3ecc">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGFibGU6NTg1YTRhMWFmYWE5NDU3NGE3NzQ5YWE4NmY2N2YzYzkvdGFibGVyYW5nZTo1ODVhNGExYWZhYTk0NTc0YTc3NDlhYTg2ZjY3ZjNjOV8yLTQtMS0xLTE0MDY0NQ_a17a5ffa-da74-4818-8542-d56ce44fd4d8">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjkw_d18ebee3-aef0-4178-af30-0dd00c969ad3">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk4_698f0e0d-f1c0-41d4-8085-47891f893a25">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="iac825e81fd674052afb8ee0b15e037c5_I20220630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18yNzAw_32964d77-f31d-45cc-8fe1-cee6f764a9fa"
      unitRef="usd">59158438222</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i197c35ec7c824ce1bc66227545a36037_I20230131"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18yODQw_d36f0b6e-ad41-408d-a468-307d9f91813d"
      unitRef="shares">124974862</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xL2ZyYWc6MDExMTUxOGM5MDJlNDA2ZTgwZmYwMTc1NTVjMGZhZTMvdGV4dHJlZ2lvbjowMTExNTE4YzkwMmU0MDZlODBmZjAxNzU1NWMwZmFlM18zMjk5_c02dab48-32fd-4dcb-9021-b76066a493ce">Parts II and III incorporate herein by reference portions of the Registrant&#x2019;s Definitive Proxy Statement to be filed pursuant to Regulation 14A with respect to the Annual Meeting of Stockholders scheduled to be held on April&#160;20, 2023. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this report relates.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzUtMS0xLTEtMTQwNjQ1_843fe5ae-0130-4b5a-83e1-59af8e10d248"
      unitRef="usd">5061000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzUtMy0xLTEtMTQwNjQ1_ffa4cceb-9ed0-471e-ba49-e269b21a3931"
      unitRef="usd">3394000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzYtMS0xLTEtMTQwNjQ1_09240dd0-462e-4ef4-b15e-e623850150cf"
      unitRef="usd">13881000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzYtMy0xLTEtMTQwNjQ1_46ea9b98-bee6-44a8-8c2b-3b61e45bde9e"
      unitRef="usd">13192000000</us-gaap:ShortTermInvestments>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzctMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246Yzk2MjA3NGU1OWJmNDQxMGI2ZGVjOGZjMmQ1NjM2MDJfNjI_4908f67a-6394-4e2b-992e-9971c552102a"
      unitRef="usd">70000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzctMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246Yzk2MjA3NGU1OWJmNDQxMGI2ZGVjOGZjMmQ1NjM2MDJfNzc_dbd330fb-e909-438a-8c17-7334fbc2865a"
      unitRef="usd">83000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzctMS0xLTEtMTQwNjQ1_9dbab0e9-d2dc-468b-9726-e54d7cb69b89"
      unitRef="usd">1674000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:ReceivablesNetCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzctMy0xLTEtMTQwNjQ1_df9fe458-a8c7-4dd1-a3d5-7110b41c7bf8"
      unitRef="usd">1814000000</us-gaap:ReceivablesNetCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzgtMS0xLTEtMTQwNjQ1_7ce67bc3-9f80-4bfe-9180-9a0fa68b29b3"
      unitRef="usd">5567000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzgtMy0xLTEtMTQwNjQ1_1d84631d-79a7-4780-8d82-13684e599fda"
      unitRef="usd">6493000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzktMS0xLTEtMTQwNjQ1_556ff9d4-f1df-4e8b-ba0f-4acebf85a831"
      unitRef="usd">26183000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzktMy0xLTEtMTQwNjQ1_f585ca51-b100-4b3f-a23c-050bb846c3bd"
      unitRef="usd">24893000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEwLTEtMS0xLTE0MDY0NQ_7ee82557-747f-4c86-9a91-fe84a68d5bfb"
      unitRef="usd">3221000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEwLTMtMS0xLTE0MDY0NQ_81c0a4af-e494-4251-94fe-62c1baca84f4"
      unitRef="usd">3073000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzExLTEtMS0xLTE0MDY0NQ_fdf0390c-a6fd-4767-af8d-428bb1fa4a7b"
      unitRef="usd">380000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzExLTMtMS0xLTE0MDY0NQ_f12aff4e-2115-4edd-997b-ce5126385fa9"
      unitRef="usd">780000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:Goodwill
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEyLTEtMS0xLTE0MDY0NQ_f27c5f77-bd69-426c-be98-76bfbfcf5983"
      unitRef="usd">9142000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEyLTMtMS0xLTE0MDY0NQ_ffcc0ba4-dbc6-4149-b152-de61a713d4fc"
      unitRef="usd">11092000000</us-gaap:Goodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEzLTEtMS0xLTE0MDY0NQ_49584df2-9ecc-4334-904a-b6ca88aaf4af"
      unitRef="usd">749000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzEzLTMtMS0xLTE0MDY0NQ_d689404f-4f0f-4fee-88a7-19f2600b86cc"
      unitRef="usd">141000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE0LTEtMS0xLTE0MDY0NQ_f8c155ec-4ee2-462d-b795-3824d1ccff1e"
      unitRef="usd">3380000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE0LTMtMS0xLTE0MDY0NQ_d330c48e-3ae5-469d-a69b-90c0b135108f"
      unitRef="usd">4379000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE1LTEtMS0xLTE0MDY0NQ_3b6b2680-90f5-48da-9001-57404c8b026c"
      unitRef="usd">43055000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE1LTMtMS0xLTE0MDY0NQ_fd8ee2da-72df-4766-b157-4b67c994b11a"
      unitRef="usd">44358000000</us-gaap:Assets>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE4LTEtMS0xLTE0MDY0NQ_3cd44d89-7c32-47ba-82ad-77d7361d92d8"
      unitRef="usd">9264000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE4LTMtMS0xLTE0MDY0NQ_257ee850-7e81-4154-9a4a-7be74859cae7"
      unitRef="usd">8289000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE5LTEtMS0xLTE0MDY0NQ_6ba82b24-c3c8-4b82-91e7-77ad3aed2f96"
      unitRef="usd">5238000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzE5LTMtMS0xLTE0MDY0NQ_e1b68b7b-a878-4251-b107-79ce3c60b7a5"
      unitRef="usd">4509000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <hum:BookOverdraftLiability
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIwLTEtMS0xLTE0MDY0NQ_b44e5107-902d-43b7-b052-1d26579089fc"
      unitRef="usd">298000000</hum:BookOverdraftLiability>
    <hum:BookOverdraftLiability
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIwLTMtMS0xLTE0MDY0NQ_989482b9-f9d3-4dc9-9518-2d2e77539991"
      unitRef="usd">326000000</hum:BookOverdraftLiability>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIxLTEtMS0xLTE0MDY0NQ_b17bfd1e-856a-4d4c-944c-3ef0d621b255"
      unitRef="usd">286000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIxLTMtMS0xLTE0MDY0NQ_32ffc258-7ed4-4280-bfe9-42e825d4579a"
      unitRef="usd">254000000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:DebtCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIyLTEtMS0xLTE0MDY0NQ_920c9b54-b531-4a88-a9f7-64b03b4f23a1"
      unitRef="usd">2092000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIyLTMtMS0xLTE0MDY0NQ_279c4455-0e06-4a23-91bb-33373045c67b"
      unitRef="usd">1953000000</us-gaap:DebtCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIzLTEtMS0xLTE0MDY0NQ_1498e970-a4cd-48c1-aea7-2c6cb77c2d34"
      unitRef="usd">17178000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzIzLTMtMS0xLTE0MDY0NQ_810f9c1a-b214-4d39-8e76-397f73442a1b"
      unitRef="usd">15331000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI0LTEtMS0xLTE0MDY0NQ_f40feb56-9ad0-4931-b476-4dbb01d0d213"
      unitRef="usd">9034000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI0LTMtMS0xLTE0MDY0NQ_db0dc1ce-5f1f-4617-93f7-5668671bfd18"
      unitRef="usd">10541000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI1LTEtMS0xLTE0MDY0NQ_fbed6209-07c5-4559-af07-8e5b2f6050f2"
      unitRef="usd">1473000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI1LTMtMS0xLTE0MDY0NQ_efcc9c59-d8d5-4a57-abdd-e6cd9bc54373"
      unitRef="usd">2383000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI2LTEtMS0xLTE0MDY0NQ_98ec4de0-fdaf-4b33-8264-a968e0fd79dc"
      unitRef="usd">27685000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI2LTMtMS0xLTE0MDY0NQ_2b9f4be1-9c33-4050-89f1-f3be21f5929c"
      unitRef="usd">28255000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI3LTEtMS0xLTE0MDY0NQ_a5982aed-fcf8-4341-94ff-e8331805abde"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI3LTMtMS0xLTE0MDY0NQ_6604b55a-225d-4111-a056-d3713b84d3fc"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzIx_3d4a8f9f-175d-41b3-b0ae-9e28daadf2e9"
      unitRef="usdPerShare">1</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzIx_91693683-12d2-4791-be7e-5be861923ed2"
      unitRef="usdPerShare">1</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzI5_28e3ada6-510b-42c8-a620-992be93c9c39"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzI5_88ae8b21-61a8-4f10-9205-ff33279acd94"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzUx_c190c4db-ec25-481d-927c-42d290c96e84"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg2MTAzNGQwMjZhMjQ3NWM4N2E3NThhZTc2YTU5NmIzXzUx_e32fbe8d-d9bf-4222-8982-b3100f25512e"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTEtMS0xLTE0MDY0NQ_0919ab0c-42c8-4274-9950-8fac5d88a77d"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzI5LTMtMS0xLTE0MDY0NQ_06a7b5ad-8c1b-440f-823c-c174fef32e06"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQ2YjdhMzY4NzRkMjQwOGRhZTE0N2JhNDQzMjVhMTVlXzMz_98702ca4-1762-4a1b-b161-98fbc3636bae"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQ2YjdhMzY4NzRkMjQwOGRhZTE0N2JhNDQzMjVhMTVlXzMz_9eb26840-d527-4637-a1d0-332c97e99d35"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQ2YjdhMzY4NzRkMjQwOGRhZTE0N2JhNDQzMjVhMTVlXzYw_acc8fc17-4718-44bc-9b7e-6456bc56bf1e"
      unitRef="shares">198666598</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQ2YjdhMzY4NzRkMjQwOGRhZTE0N2JhNDQzMjVhMTVlXzEwOTk1MTE2Mjc4OTk_0d445bf6-282d-47a8-92b1-abb6d601180b"
      unitRef="shares">198648742</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTEtMS0xLTE0MDY0NQ_761a324d-e152-454f-85f2-1dde2bbd8138"
      unitRef="usd">33000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMwLTMtMS0xLTE0MDY0NQ_ff392d93-fd09-4c93-8a96-c2d9c466adac"
      unitRef="usd">33000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMxLTEtMS0xLTE0MDY0NQ_307dc93f-7ce4-4773-a4b4-3539bb33697b"
      unitRef="usd">3246000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMxLTMtMS0xLTE0MDY0NQ_d7d5f28c-3c96-4a55-9441-a53040da60ff"
      unitRef="usd">3082000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMyLTEtMS0xLTE0MDY0NQ_83849948-e4a2-4255-a74a-b295f1817b87"
      unitRef="usd">25492000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMyLTMtMS0xLTE0MDY0NQ_f5e21153-8ea3-446d-b703-22f5804c76ca"
      unitRef="usd">23086000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMzLTEtMS0xLTE0MDY0NQ_3b060dbc-dc0e-4fde-a30c-2c7ea50194b5"
      unitRef="usd">-1304000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzMzLTMtMS0xLTE0MDY0NQ_0c2b69f5-fe24-452c-afe6-586262538938"
      unitRef="usd">42000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjdkZGJmM2IyYzkzODRiYzE4OTc5NjVlZTBhOTg1NWM1XzI5_626c5750-be95-4761-a8fa-b9d93f178f21"
      unitRef="shares">73691955</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjdkZGJmM2IyYzkzODRiYzE4OTc5NjVlZTBhOTg1NWM1XzY5_73e225c9-e3a2-4a36-85e3-56ec8037666d"
      unitRef="shares">69846758</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM0LTEtMS0xLTE0MDY0NQ_b19e98c7-c4a5-4017-9d4d-6fc7afd09385"
      unitRef="usd">12156000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM0LTMtMS0xLTE0MDY0NQ_c7527511-6c8f-4566-812a-6fe049b7792c"
      unitRef="usd">10163000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM1LTEtMS0xLTE3MzkwMQ_62ff0382-24e0-4b69-9a07-5fbc66665366"
      unitRef="usd">15311000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM1LTMtMS0xLTE3MzkwMQ_f20ae844-398b-42f1-bbad-1d7c474ded21"
      unitRef="usd">16080000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM1LTEtMS0xLTE0MDY0NQ_c669b207-e756-44aa-abf1-3c79473b38ed"
      unitRef="usd">59000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM1LTMtMS0xLTE0MDY0NQ_466ac0b2-e5ec-4cb7-902d-280c7a1e2144"
      unitRef="usd">23000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM2LTEtMS0xLTE0MDY0NQ_813ea8cb-2a7a-4a11-87e8-e7fb27a51786"
      unitRef="usd">15370000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM2LTMtMS0xLTE0MDY0NQ_76819915-58c9-4aaf-89be-7118f02ace7d"
      unitRef="usd">16103000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM3LTEtMS0xLTE0MDY0NQ_b2befb2f-2a2c-4617-bb3e-cbb3ffd58d84"
      unitRef="usd">43055000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMjQvZnJhZzpjMTk4NGRjYjRmMWM0NmMzYTY0MzBmZjA0YTNiY2Y3YS90YWJsZTowNGRhYjk4MjRlYzM0NmMwYjUwNzgzZjUxYWRjYzNmYy90YWJsZXJhbmdlOjA0ZGFiOTgyNGVjMzQ2YzBiNTA3ODNmNTFhZGNjM2ZjXzM3LTMtMS0xLTE0MDY0NQ_b2540f7c-c533-47de-8126-d965b17e74e2"
      unitRef="usd">44358000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:PremiumsEarnedNet
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzQtMS0xLTEtMTQwNjQ1_b388f011-6e0b-475a-be36-dcbfa024b10f"
      unitRef="usd">87712000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzQtMy0xLTEtMTQwNjQ1_ce38699d-dd32-42c6-b3a8-7645e70b07e3"
      unitRef="usd">79822000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzQtNS0xLTEtMTQwNjQ1_42f10aa6-e469-4cfc-80c7-ae9f92a62fd3"
      unitRef="usd">74186000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMS0xLTEtMTQwNjQ1_ac77f2ba-e094-4c3b-943c-98ad83dd570b"
      unitRef="usd">4776000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtMy0xLTEtMTQwNjQ1_91b5d893-5d0a-4d5e-91be-04660d7b6e3c"
      unitRef="usd">3055000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzUtNS0xLTEtMTQwNjQ1_9d9ca5fe-da99-4f3d-a9d8-00d2fcf5c5aa"
      unitRef="usd">1815000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzYtMS0xLTEtMTQwNjQ1_96042c9c-256e-494f-9d18-b1c92abbf7bf"
      unitRef="usd">382000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzYtMy0xLTEtMTQwNjQ1_fd0dbfaa-b74a-4a74-8f0d-230445250c98"
      unitRef="usd">187000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzYtNS0xLTEtMTQwNjQ1_0e454f22-5af5-4b6c-bfb3-79267f58201c"
      unitRef="usd">1154000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzctMS0xLTEtMTQwNjQ1_12e96cb6-b62a-466c-9be9-774e1c1996d4"
      unitRef="usd">92870000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzctMy0xLTEtMTQwNjQ1_321fec25-c193-48b9-bfd3-525a0a60fec7"
      unitRef="usd">83064000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzctNS0xLTEtMTQwNjQ1_21919683-71b5-43ac-8863-fec285d464d1"
      unitRef="usd">77155000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzktMS0xLTEtMTQwNjQ1_60cfa511-303c-4ca5-aa5c-de08cad135b6"
      unitRef="usd">75690000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzktMy0xLTEtMTQwNjQ1_a4e6bb82-75d5-44f4-b285-77a515af73be"
      unitRef="usd">69199000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzktNS0xLTEtMTQwNjQ1_ff36e8d1-af44-4608-8c57-3992e99ab57b"
      unitRef="usd">61628000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEwLTEtMS0xLTE0MDY0NQ_eb2ca466-3481-46fd-979a-75b305a0cec4"
      unitRef="usd">12671000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEwLTMtMS0xLTE0MDY0NQ_bd12f18e-4203-41bc-81f8-87de3af0e558"
      unitRef="usd">10121000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEwLTUtMS0xLTE0MDY0NQ_d94ad9e7-f5c3-49cb-bd19-1cdde00ce40a"
      unitRef="usd">10052000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEyLTEtMS0xLTE0MDY0NQ_161b7afa-e177-474c-820a-8b9b38e653c2"
      unitRef="usd">709000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEyLTMtMS0xLTE0MDY0NQ_9a6139c2-149a-425b-816b-1e31503d2e8e"
      unitRef="usd">596000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEyLTUtMS0xLTE0MDY0NQ_c7af2e60-e8f7-4a14-98ed-7cfebf490be3"
      unitRef="usd">489000000</hum:DepreciationAndAmortizationIncomeStatement>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEzLTEtMS0xLTE0MDY0NQ_da27a3a7-d1bc-4974-964e-db9826e7dd38"
      unitRef="usd">89070000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEzLTMtMS0xLTE0MDY0NQ_1791ad02-259f-41df-83ac-102444926707"
      unitRef="usd">79916000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzEzLTUtMS0xLTE0MDY0NQ_00ac2cb8-0d5b-4fa9-83be-fbd24d58c976"
      unitRef="usd">72169000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE0LTEtMS0xLTE0MDY0NQ_c12e1cbb-0cc3-4b85-be3f-e91fae90450c"
      unitRef="usd">3800000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE0LTMtMS0xLTE0MDY0NQ_b3d2a708-1255-47d3-9b2b-016de2a47f52"
      unitRef="usd">3148000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE0LTUtMS0xLTE0MDY0NQ_0a4af452-1c45-4532-b76f-992e8bb0243a"
      unitRef="usd">4986000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE1LTEtMS0xLTE0MDY0NQ_2bf49c51-755d-46c7-86fa-6985c22b1e87"
      unitRef="usd">237000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE1LTMtMS0xLTE0MDY0NQ_792549d5-3188-4b4e-9ec4-def84d50d91f"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE1LTUtMS0xLTE0MDY0NQ_342a3c80-492d-4b06-82d2-d027f40ab895"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:InterestExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE2LTEtMS0xLTE0MDY0NQ_f2001727-6ffa-4b3e-9e07-5fe933cb5ca1"
      unitRef="usd">401000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE2LTMtMS0xLTE0MDY0NQ_ba1778ff-ca4c-4496-ad05-7d994aea9911"
      unitRef="usd">326000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE2LTUtMS0xLTE0MDY0NQ_e76fb949-8af9-465a-bb6f-516f3d5aa8ce"
      unitRef="usd">283000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE3LTEtMS0xLTE0MDY0NQ_207c0ad3-063d-4553-8616-dccb7fc115fb"
      unitRef="usd">-68000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE3LTMtMS0xLTE0MDY0NQ_88129307-1c38-4f37-aa7a-a1604f26f77c"
      unitRef="usd">532000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE3LTUtMS0xLTE0MDY0NQ_dd9946b1-d834-4bb3-977d-fb9056c56dee"
      unitRef="usd">-103000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE4LTEtMS0xLTE0MDY0NQ_fb2ac635-0cc1-440c-8c25-626d24192bbd"
      unitRef="usd">3568000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE4LTMtMS0xLTE0MDY0NQ_d4d2b546-33e3-4c17-b212-6876dbb78f7c"
      unitRef="usd">3354000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE4LTUtMS0xLTE0MDY0NQ_53cba1ce-5221-4be6-9deb-261a5b56316b"
      unitRef="usd">4600000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE5LTEtMS0xLTE0MDY0NQ_e21fe71f-cdd3-4d4f-ba53-3045bdca66a2"
      unitRef="usd">762000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE5LTMtMS0xLTE0MDY0NQ_d5d70d5e-23cb-45a0-ad6e-32ae28949772"
      unitRef="usd">485000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzE5LTUtMS0xLTE0MDY0NQ_95822749-b3bc-4f16-b59e-3129dd633dc5"
      unitRef="usd">1307000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIwLTEtMS0xLTE0MDY0NQ_dcf2aa77-b82f-478f-8fb2-674b2cb927f3"
      unitRef="usd">-4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIwLTMtMS0xLTE0MDY0NQ_c300fd65-aaed-42a4-8fa3-3fa049bd7653"
      unitRef="usd">65000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIwLTUtMS0xLTE0MDY0NQ_eb26f460-6394-4be4-bdad-fa68fccd75b4"
      unitRef="usd">74000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIxLTEtMS0xLTE0MDY0NQ_d164e76f-d61a-435b-a89e-843502648f61"
      unitRef="usd">2802000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIxLTMtMS0xLTE0MDY0NQ_12037c26-9da6-48b7-856c-80274a74e827"
      unitRef="usd">2934000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIxLTUtMS0xLTE0MDY0NQ_3ec8dcca-558d-46b3-a506-8471b894a948"
      unitRef="usd">3367000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIyLTEtMS0xLTE0MDY0NQ_786104eb-da9e-40c5-828f-ccda4ee9a180"
      unitRef="usd">-4000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIyLTMtMS0xLTE0MDY0NQ_06ec0ec5-05b7-4f4e-8ade-a6e056aa8757"
      unitRef="usd">1000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIyLTUtMS0xLTE0MDY0NQ_69f906c8-1d16-4927-af36-763fb5c46664"
      unitRef="usd">0</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIzLTEtMS0xLTE0MDY0NQ_5c93cfef-f26d-4353-894d-b3be47d4397f"
      unitRef="usd">2806000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIzLTMtMS0xLTE0MDY0NQ_33c76633-2afc-43a1-919d-6b2787b74693"
      unitRef="usd">2933000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzIzLTUtMS0xLTE0MDY0NQ_2892dc23-1cc9-4cff-a43b-b0af04cb72f0"
      unitRef="usd">3367000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI0LTEtMS0xLTE0MDY0NQ_926e0682-92f4-4497-b58e-eb08439d96e8"
      unitRef="usdPerShare">22.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI0LTMtMS0xLTE0MDY0NQ_0f373657-c846-49a3-bf77-cbbaf4cb0f64"
      unitRef="usdPerShare">22.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI0LTUtMS0xLTE0MDY0NQ_44954585-4660-4703-bbe9-8571e7a16846"
      unitRef="usdPerShare">25.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI1LTEtMS0xLTE0MDY0NQ_0ae93125-a6b3-4e22-b822-3636446e238a"
      unitRef="usdPerShare">22.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI1LTMtMS0xLTE0MDY0NQ_1bc6a62e-1670-4dc5-82a4-800668f5acd8"
      unitRef="usdPerShare">22.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzAvZnJhZzoxZTA2ZDlmYTE0MTk0NDM3OTI2YjBkMGJkZGEwODQ4My90YWJsZTo3ZWYxOGYzZTgzZGE0ODljODk0NTVkMDJjZWM0M2ZmNy90YWJsZXJhbmdlOjdlZjE4ZjNlODNkYTQ4OWM4OTQ1NWQwMmNlYzQzZmY3XzI1LTUtMS0xLTE0MDY0NQ_dff9a4ec-f523-4e51-8df2-d050bd820254"
      unitRef="usdPerShare">25.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzMtMS0xLTEtMTQwNjQ1_5c93cfef-f26d-4353-894d-b3be47d4397f"
      unitRef="usd">2806000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzMtMy0xLTEtMTQwNjQ1_33c76633-2afc-43a1-919d-6b2787b74693"
      unitRef="usd">2933000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzMtNS0xLTEtMTQwNjQ1_2892dc23-1cc9-4cff-a43b-b0af04cb72f0"
      unitRef="usd">3367000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzUtMS0xLTEtMTQwNjQ1_8cc0286d-fed8-4c87-b553-2d34d028cafb"
      unitRef="usd">-1819000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzUtMy0xLTEtMTQwNjQ1_a64e52ed-e266-4321-b969-41f5c7d84463"
      unitRef="usd">-356000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzUtNS0xLTEtMTQwNjQ1_63b23004-6112-4515-a7ac-90b6d4dace86"
      unitRef="usd">393000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzYtMS0xLTEtMTQwNjQ1_a819f708-505b-4252-92da-024aaab6491d"
      unitRef="usd">-418000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzYtMy0xLTEtMTQwNjQ1_5fa8793b-8bdd-4417-a908-e28315515128"
      unitRef="usd">-81000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzYtNS0xLTEtMTQwNjQ1_438b9b64-c993-4219-9702-44f852c46219"
      unitRef="usd">89000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzctMS0xLTEtMTQwNjQ1_e6fa904a-d18c-4bb5-a3ed-7aedf6f5cb26"
      unitRef="usd">-1401000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzctMy0xLTEtMTQwNjQ1_4c4cabdf-3fba-4c19-832e-e5aa4db08268"
      unitRef="usd">-275000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzctNS0xLTEtMTQwNjQ1_45f1ac0d-f517-4d91-885e-c7259a774c63"
      unitRef="usd">304000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzgtMS0xLTEtMTQwNjQ1_1f419d12-4efc-442f-964d-96f6302ca731"
      unitRef="usd">-72000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzgtMy0xLTEtMTQwNjQ1_dbbe74fa-9129-433a-b8cf-06a602803dbd"
      unitRef="usd">103000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzgtNS0xLTEtMTQwNjQ1_4ee59957-0f09-4ac2-8a92-477a69e197dd"
      unitRef="usd">90000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzktMS0xLTEtMTQwNjQ1_2db2d40e-b411-479e-bafa-9b2679c6ed86"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzktMy0xLTEtMTQwNjQ1_25c35de7-982c-4eca-b867-d29d7d10a7bb"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzktNS0xLTEtMTQwNjQ1_48caa0f2-ed84-4423-aa4f-0927f147c657"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEwLTEtMS0xLTE0MDY0NQ_f89e27a7-1cf0-4d04-8ca1-3d8ceac6e8d6"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEwLTMtMS0xLTE0MDY0NQ_07049988-23f3-4ef3-a0d2-975d4e3b475e"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEwLTUtMS0xLTE0MDY0NQ_51c06ee4-c1ec-434a-a620-c7273c43bbea"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzExLTEtMS0xLTE0MDY0NQ_084ce757-eb0d-45bd-af2b-1931e97c8032"
      unitRef="usd">-1346000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzExLTMtMS0xLTE0MDY0NQ_363df253-61e0-472a-a4dd-ad0f6c649655"
      unitRef="usd">-355000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzExLTUtMS0xLTE0MDY0NQ_37e8f711-1f93-4d41-aca0-b5ef8dc02eda"
      unitRef="usd">234000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEyLTEtMS0xLTE0MDY0NQ_14e12ebd-9316-489d-a9d8-e487f2738109"
      unitRef="usd">0</hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments>
    <hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEyLTMtMS0xLTE0MDY0NQ_bbef3812-9d6f-42e4-a7e6-8b6a10a081e5"
      unitRef="usd">6000000</hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments>
    <hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEyLTUtMS0xLTE0MDY0NQ_e9982e42-c324-4241-821d-e346ff393eee"
      unitRef="usd">1000000</hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEzLTEtMS0xLTE0MDY0NQ_de6f4248-7d02-4086-b355-193eaace6d3b"
      unitRef="usd">1460000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEzLTMtMS0xLTE0MDY0NQ_404842b5-1b49-4ce0-a851-f8accfc4dc80"
      unitRef="usd">2584000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzMvZnJhZzphODgwNmExMGJjNzk0ZWU4ODAxMjZiNWE5NDM5Y2Y1Yy90YWJsZTpjZTYyYzdhZGM2MmU0YTE2YjRmZDdmNDEwNDI2OTQzMi90YWJsZXJhbmdlOmNlNjJjN2FkYzYyZTRhMTZiNGZkN2Y0MTA0MjY5NDMyXzEzLTUtMS0xLTE0MDY0NQ_e90b1d8d-81b6-4cb4-baa7-aa621abda531"
      unitRef="usd">3602000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i28bf61673f944bc1ac5aa3fe90724e55_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMS0xLTEtMTQwNjQ1_1d389c92-7dd9-44ae-bf9e-4020d6072cb4"
      unitRef="shares">198630000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28bf61673f944bc1ac5aa3fe90724e55_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMy0xLTEtMTQwNjQ1_42d1e44d-2a11-4e6f-9826-e75722f3d350"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae3316eaa1ab4c63b284379afe39c1c3_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtNS0xLTEtMTQwNjQ1_4a1e8eed-56be-44cf-bade-7222c9f7f90b"
      unitRef="usd">2820000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0e3e965bd7f546cb8bdfffae17fa5c03_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtNy0xLTEtMTQwNjQ1_bd190a5f-0081-496e-8c7e-5c13d4a0d4cf"
      unitRef="usd">17483000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99ec67bd37c741fcae4bda5f42e6b771_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtOS0xLTEtMTQwNjQ1_7f2471a2-9770-456a-a6e7-5e43da80248a"
      unitRef="usd">156000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d04f982d8e74a8d8291aa9c72da676e_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMTEtMS0xLTE0MDY0NQ_213519b5-acb9-4a65-b9ad-948defbfc92e"
      unitRef="usd">-8455000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i389e820acaed4f94986088bd4c6ee7e8_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMTMtMS0xLTE3MzkwNA_e32fc967-2eb8-4f87-933a-86b3c1acea02"
      unitRef="usd">12037000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2fd1f8bbcda74c90a7dfd0297a038626_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMTMtMS0xLTE0MDY0NQ_adf2b67a-6598-4578-814c-46acc6b63012"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMtMTUtMS0xLTE0MDY0NQ_13fc954e-a065-4afe-8067-fdb387b9f124"
      unitRef="usd">12037000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i7285850bb8c54632823083969a16a30b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzQtNy0xLTEtMTQwNjQ1_5c41b5ba-b77f-4def-b755-6963e262d1e7"
      unitRef="usd">3367000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzQtMTMtMS0xLTE3MzkwNg_50d92ce6-c212-45f5-bbae-2fb40db9c77f"
      unitRef="usd">3367000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzQtMTUtMS0xLTE0MDY0NQ_da87de99-5bbc-4e0c-8405-cbcfcf4f7f46"
      unitRef="usd">3367000000</us-gaap:ProfitLoss>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iae0e22f86a6949a8a48e01671ed1c284_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtNy0xLTEtMTU0ODkx_6b4cd521-3f01-4556-a829-bd6e9d669ec8"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7781da092ad41ee8990573fd28577bd_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtMTMtMS0xLTE3MzkwNg_add633a4-16d3-420a-ab25-e75267d0bd1b"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id7f017f098bd40b1a9bdb0c3ec9f1caa_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtMTUtMS0xLTE1NDg5MQ_896ac0fa-7ddb-4e77-affb-31a72eff860b"
      unitRef="usd">-2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibbcbb10618b845c1add87e9d45a78991_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtOS0xLTEtMTQwNjQ1_73a58fab-e498-4588-8c6e-668d9cdca334"
      unitRef="usd">235000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktMTMtMS0xLTE3MzkwNg_0626e276-0eee-445f-bf7d-e3de17571dbc"
      unitRef="usd">235000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzUtMTUtMS0xLTE0MDY0NQ_502f8de2-bdcd-4552-b37d-c911296ecb12"
      unitRef="usd">235000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzYtNS0xLTEtMTQwNjQ1_89535761-edcb-43d3-84ef-1334ade066c9"
      unitRef="usd">263000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1fe1870a9b49406daaf2ba671fa7e631_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzYtMTEtMS0xLTE0MDY0NQ_ad3ce80a-3832-4ed5-9448-4a5f4f6ac8db"
      unitRef="usd">1557000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEwLTEzLTEtMS0xNzM5MDY_a0fc0875-90d2-4bad-907a-a713279648fd"
      unitRef="usd">1820000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzYtMTUtMS0xLTE0MDY0NQ_5ba4f163-467d-4f47-a624-37bf620fc6ff"
      unitRef="usd">1820000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7285850bb8c54632823083969a16a30b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzctNy0xLTEtMTQwNjQ1_a4b838f9-767f-43ef-b812-4518c1a0e94f"
      unitRef="usd">331000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTEzLTEtMS0xNzM5MDY_17c151df-17ca-453d-8fa2-82b82010c7b0"
      unitRef="usd">331000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzctMTUtMS0xLTE0MDY0NQ_32526ee5-1978-418b-b271-82cb41f32c5a"
      unitRef="usd">331000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzgtNS0xLTEtMTQwNjQ1_73ddf348-27c4-44ee-aa0e-b8b029a79cc0"
      unitRef="usd">181000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEyLTEzLTEtMS0xNzM5MDY_db986eec-55be-4b97-b697-8db713b6c69f"
      unitRef="usd">181000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzgtMTUtMS0xLTE0MDY0NQ_9488da68-7be9-412e-8d74-83afb4719244"
      unitRef="usd">181000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="ibe78b6c543d6497ba9c3f17b26297551_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktMS0xLTEtMTQwNjQ1_da181f93-3cc8-4074-8f53-45448dcb14ee"
      unitRef="shares">19000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktNS0xLTEtMTQwNjQ1_270ec9db-7f75-479b-8b71-65244d88625b"
      unitRef="usd">-59000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i1fe1870a9b49406daaf2ba671fa7e631_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktMTEtMS0xLTE0MDY0NQ_3604990f-8d24-4d31-8a61-15c48315a1de"
      unitRef="usd">59000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzktMTUtMS0xLTE0MDY0NQ_a627c39d-c74b-4626-81b9-85d636ec88cd"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i33b8ec38626547d4b42c84074fb34475_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEwLTUtMS0xLTE0MDY0NQ_814529a9-e0ed-4a7a-af52-01256490ed35"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1fe1870a9b49406daaf2ba671fa7e631_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEwLTExLTEtMS0xNDA2NDU_703221ae-bb3f-49da-88dd-72ecad160d77"
      unitRef="usd">35000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1576a4aaa2d6412a9a95f6193f78bc92_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE0LTEzLTEtMS0xNzM5MDY_bf965939-f6ff-487b-9520-f1e0e7252048"
      unitRef="usd">61000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEwLTE1LTEtMS0xNDA2NDU_9edaef22-0cf6-4907-9b0a-6eb9b2b9e01f"
      unitRef="usd">61000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i47316da3a3ca4462a4861e765c936186_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTEtMS0xLTE0MDY0NQ_ccf9c539-7dfd-4332-af68-251fd4ec1370"
      unitRef="shares">198649000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i47316da3a3ca4462a4861e765c936186_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTMtMS0xLTE0MDY0NQ_485cc721-1b39-4ca7-b6ad-ca523a608ff4"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2fe62d64db7e4bf4972bf02ec4c90535_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTUtMS0xLTE0MDY0NQ_137a72e5-8ab8-4c98-9bde-f16e50d8941b"
      unitRef="usd">2705000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i65031e9551cb4c5e98bf719298231efb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTctMS0xLTE0MDY0NQ_cae865a4-6b4e-46ef-9618-dd9bb4ff7fc0"
      unitRef="usd">20517000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i36906efe5bd14a959e87de9672f63b52_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTktMS0xLTE0MDY0NQ_37ffc3c1-d84b-4464-8c94-9a7ea227a5f5"
      unitRef="usd">391000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i06d4dc5e79574b798135918a523c5afb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTExLTEtMS0xNDA2NDU_dc5354fa-dcf2-4d3c-a8c2-eb816f093bcd"
      unitRef="usd">-9918000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90fb72011b3b41c089fdc685a8b914a1_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE1LTEzLTEtMS0xNzM5MDQ_886b09fd-15d2-49ca-be3a-706443e01acc"
      unitRef="usd">13728000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i52688808256645f9b0b3dadea8649a92_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTEzLTEtMS0xNDA2NDU_067df4b4-2b10-4e16-96d5-866e774ebb44"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzExLTE1LTEtMS0xNDA2NDU_43e36563-5481-42af-9306-7dbd284d886b"
      unitRef="usd">13728000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i518fee92d21348d4bac22ba846904d99_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEyLTctMS0xLTE0MDY0NQ_4e42c1ad-5c64-4ff1-9745-e97fcafb8e88"
      unitRef="usd">2933000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE2LTEzLTEtMS0xNzM5MDY_b06f0f38-91f0-420c-b24c-1e3e8f02cb29"
      unitRef="usd">2933000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="icc29f8ee3dbf4eca981b29f3496e9b8f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE2LTEzLTEtMS0xNTQ5MzY_f5b71f9d-9884-4068-ab5b-0a83f2302a86"
      unitRef="usd">1000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEyLTE1LTEtMS0xNDA2NDU_11bd4b5e-4f11-410c-8ce4-40523c05be1f"
      unitRef="usd">2934000000</us-gaap:ProfitLoss>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="icc29f8ee3dbf4eca981b29f3496e9b8f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE5LTEzLTEtMS0xNTQ5MzY_db1bead5-e1f9-4830-b87f-2778315d0a49"
      unitRef="usd">22000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzEzLTE1LTEtMS0xNDA2NDU_17b18b57-5f62-4312-ac5d-fd568c8c57b2"
      unitRef="usd">22000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ib31d3b30f3a84c83be93331f0c89a3b9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE0LTktMS0xLTE0MDY0NQ_472e0df4-1e47-4bd5-84fb-f9e1aa962955"
      unitRef="usd">-349000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTEzLTEtMS0xNzM5MDY_62735154-ba40-49be-ba2e-3964fa9d4b0b"
      unitRef="usd">-349000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE0LTE1LTEtMS0xNDA2NDU_bbbd926b-d1f2-4cb5-b91f-aa7dc2b0a1e5"
      unitRef="usd">-349000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE1LTUtMS0xLTE0MDY0NQ_ec25602c-c20c-4b47-95bd-1d87c438eb2a"
      unitRef="usd">-262000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie3e2a44f0beb4bac9ff346a4269524b9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE1LTExLTEtMS0xNDA2NDU_a0405374-eacb-4482-9e3e-ed4b79f3038c"
      unitRef="usd">341000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIxLTEzLTEtMS0xNzM5MDY_db831a43-6eb4-43fe-8480-21a132441204"
      unitRef="usd">79000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE1LTE1LTEtMS0xNDA2NDU_b6a7993c-0748-4562-ad05-4f385bc44c96"
      unitRef="usd">79000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStockCash
      contextRef="i518fee92d21348d4bac22ba846904d99_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE2LTctMS0xLTE0MDY0NQ_501c2fbd-7685-4f91-b8ad-5aa859404695"
      unitRef="usd">364000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIyLTEzLTEtMS0xNzM5MDY_28a33182-1967-4557-8fe2-e38a821c7563"
      unitRef="usd">364000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE2LTE1LTEtMS0xNDA2NDU_81308298-4be3-45e3-b937-7e2f4462ec19"
      unitRef="usd">364000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE3LTUtMS0xLTE0MDY0NQ_66f1c07d-824e-4659-ac47-4deaee8e0e21"
      unitRef="usd">180000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIzLTEzLTEtMS0xNzM5MDY_1cc8a187-5e00-4985-9b93-402034063f39"
      unitRef="usd">180000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE3LTE1LTEtMS0xNDA2NDU_a5850db2-c145-4b5c-86ff-0cf52758f565"
      unitRef="usd">180000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE4LTUtMS0xLTE0MDY0NQ_6b8c7bfd-9ce2-4554-9755-ae0ab6a4e5e0"
      unitRef="usd">-81000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="ie3e2a44f0beb4bac9ff346a4269524b9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE4LTExLTEtMS0xNDA2NDU_cea7bb3f-1f67-4b52-a637-6043e9a4f55f"
      unitRef="usd">81000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI0LTEzLTEtMS0xNzM5MDY_6a074ace-c22e-4f75-944f-413ff62917b9"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE4LTE1LTEtMS0xNDA2NDU_b8e07b20-449f-4d42-ba0c-27bd62ad7890"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4559f24ae3e34f1cb08ed167e45eb31f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE5LTUtMS0xLTE0MDY0NQ_71f77a41-8eb7-4273-b808-d8c2f05cd4aa"
      unitRef="usd">16000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie3e2a44f0beb4bac9ff346a4269524b9_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE5LTExLTEtMS0xNDA2NDU_d4b5f64e-23fa-4117-b354-2c2af5457c2b"
      unitRef="usd">15000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic5e1bd7fd8cb4e418ddbf75538b3d915_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI1LTEzLTEtMS0xNzM5MDY_320e12c5-59b3-4142-b9a2-e111052cd186"
      unitRef="usd">31000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzE5LTE1LTEtMS0xNDA2NDU_3414e365-6579-4abb-8e2f-5d7b5628b75c"
      unitRef="usd">31000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ic7f3f59a5f394d4faae0211463973ead_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTEtMS0xLTE0MDY0NQ_ef653d61-e205-4266-b381-6fe9c8ed0919"
      unitRef="shares">198649000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic7f3f59a5f394d4faae0211463973ead_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTMtMS0xLTE0MDY0NQ_ba6c1ddc-b44a-437b-a13e-27bd1659be43"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53ef7bd107114170bc009542db1e7bcc_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTUtMS0xLTE0MDY0NQ_60c93a11-e9f2-4c44-b16f-d3206c08705e"
      unitRef="usd">3082000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5c643278b48c4671a48980681e36ec67_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTctMS0xLTE0MDY0NQ_125c2254-e32a-4bac-854d-0815a6911142"
      unitRef="usd">23086000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i35f272177b134f6b8a1b91bc0c09280b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTktMS0xLTE0MDY0NQ_16cef099-1caf-48ac-a16c-93fd102c04f3"
      unitRef="usd">42000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaae6442e790a4944978a3019753b8334_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTExLTEtMS0xNDA2NDU_abefcd86-298c-41e1-97db-19a6232f5a17"
      unitRef="usd">-10163000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i287579c2615947bd90df9271fb6c17d1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI2LTEzLTEtMS0xNzM5MDQ_b5ef4492-a69a-42f0-b891-5685faa00cda"
      unitRef="usd">16080000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i57dca7a5679246a790f3f371e95e7dd7_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTEzLTEtMS0xNDA2NDU_30adb7ad-5fd6-4c79-9026-1ec91c8496db"
      unitRef="usd">23000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIwLTE1LTEtMS0xNDA2NDU_43f01de0-cafe-46d3-bfc5-a74ccf4ebff8"
      unitRef="usd">16103000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i9143bd79088c45919a393886eedf2fed_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIxLTctMS0xLTE0MDY0NQ_8fb9c0d6-4adf-4b34-8f7c-1f7d0f506718"
      unitRef="usd">2806000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI3LTEzLTEtMS0xNzM5MDY_d8ef900f-b997-48bb-a5b5-b4271e4b4144"
      unitRef="usd">2806000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIxLTEzLTEtMS0xNDA2NDU_589a7bb6-bc62-48aa-9506-3900fb7bf863"
      unitRef="usd">-4000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIxLTE1LTEtMS0xNDA2NDU_9229904d-df04-4a3d-9a12-ead2bdec3664"
      unitRef="usd">2802000000</us-gaap:ProfitLoss>
    <hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders
      contextRef="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIyLTEzLTEtMS0xNDA2NDU_bff408bf-4bfb-4fb6-a8f0-1ec0bce8d61c"
      unitRef="usd">-1000000</hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders>
    <hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIyLTE1LTEtMS0xNDA2NDU_43f69734-4ebe-4d31-9d90-abe47a6f1dbf"
      unitRef="usd">-1000000</hum:NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTEzLTEtMS0xNTQ5NDQ_4bc0e557-162a-426c-a0f0-d77bcbcb208b"
      unitRef="usd">11000000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTE1LTEtMS0xNTQ5NDQ_f6dfb517-9be5-4313-860e-4d295f9de220"
      unitRef="usd">11000000</us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ic6f32a23416c4b1db184a28b8df22df2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMwLTEzLTEtMS0xNTQ5NDQ_a59f460c-9fa8-415f-bc29-d7ef844b1b06"
      unitRef="usd">52000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMwLTE1LTEtMS0xNTQ5NDQ_503c3dfa-d795-4366-94f1-0f6fb18d42f7"
      unitRef="usd">52000000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i42f85c8b4a084c0bbd1a7804fa2fb617_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIzLTktMS0xLTE0MDY0NQ_b8140bd9-ecd5-4831-92d5-22b0f0351f3b"
      unitRef="usd">-1346000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMxLTEzLTEtMS0xNzM5MDY_e8a8ad97-979b-4c14-9586-b18357c10a1e"
      unitRef="usd">-1346000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzIzLTE1LTEtMS0xNDA2NDU_514fd623-317f-47bb-8635-67eb79b5c14a"
      unitRef="usd">-1346000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i52d2b054f3fb47ad90e22fc446758bc3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI0LTExLTEtMS0xNDA2NDU_d7bbef27-3483-4dc2-8dba-c2dcd1eddad1"
      unitRef="usd">2096000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMyLTEzLTEtMS0xNzM5MDY_e52eaefc-4399-493b-93c9-5f00885526fd"
      unitRef="usd">2096000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI0LTE1LTEtMS0xNDA2NDU_0bcebfd6-5c02-4c97-beda-1c1a2af54de6"
      unitRef="usd">2096000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:DividendsCommonStockCash
      contextRef="i9143bd79088c45919a393886eedf2fed_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI1LTctMS0xLTE0MDY0NQ_a00119cf-be8d-41eb-a7f3-8c594c3b7dda"
      unitRef="usd">400000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzMzLTEzLTEtMS0xNzM5MDY_9bdf6c73-0d6c-44ff-aae1-89bfbed6d2a8"
      unitRef="usd">400000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI1LTE1LTEtMS0xNDA2NDU_e6b0f230-fa88-4096-b6cc-910f79ceaeb2"
      unitRef="usd">400000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2a0a21d7c6d4429b8a0de15cd71eb93f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI2LTUtMS0xLTE0MDY0NQ_07b336a7-c79d-4714-aed8-711626fc890f"
      unitRef="usd">216000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzM0LTEzLTEtMS0xNzM5MDY_2e26a434-cd2e-4cde-a78f-b48763a0396a"
      unitRef="usd">216000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI2LTE1LTEtMS0xNDA2NDU_38274fbb-1dc9-46ec-9ea0-e888be822691"
      unitRef="usd">216000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross
      contextRef="if9a733dd9abd4513bb45837c142b7106_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzM1LTEtMS0xLTE1NDk0NA_06ff9e33-13b8-4c41-bf13-a19e679bb927"
      unitRef="shares">18000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i2a0a21d7c6d4429b8a0de15cd71eb93f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI3LTUtMS0xLTE0MDY0NQ_33fa4fd4-d4eb-457b-a2de-193068f89cbf"
      unitRef="usd">-78000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="i52d2b054f3fb47ad90e22fc446758bc3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI3LTExLTEtMS0xNDA2NDU_517e88e9-913c-46c9-b22e-4ad22533bfa4"
      unitRef="usd">78000000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI3LTE1LTEtMS0xNDA2NDU_e06fb4f1-49a0-451a-860a-7b6e1cbd734d"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2a0a21d7c6d4429b8a0de15cd71eb93f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI4LTUtMS0xLTE0MDY0NQ_e1b66e13-a343-461c-9f63-0c1c9c4aafb0"
      unitRef="usd">26000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i52d2b054f3fb47ad90e22fc446758bc3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI4LTExLTEtMS0xNDA2NDU_e4664285-0a0f-448f-b2f0-57f37bef6db0"
      unitRef="usd">25000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ied07cffa536a48bb8c5f9feda9017e70_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzM2LTEzLTEtMS0xNzM5MDY_c90736ac-3d5d-4062-aa2a-4b6e63789013"
      unitRef="usd">51000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI4LTE1LTEtMS0xNDA2NDU_3e26563c-b427-4952-b0a2-43c16c6f889b"
      unitRef="usd">51000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i28901f9b5d9648d3bcdd517445a5b77e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTEtMS0xLTE0MDY0NQ_435a5a98-4de6-4ab3-9418-f130f69752a2"
      unitRef="shares">198667000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28901f9b5d9648d3bcdd517445a5b77e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTMtMS0xLTE0MDY0NQ_e7a8f8ea-f6f6-4e3e-91e6-2c576a3a6670"
      unitRef="usd">33000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a3b5852afb54656981769e75c1661ed_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTUtMS0xLTE0MDY0NQ_1c262258-bfa5-4417-806e-8df0c3e40a4a"
      unitRef="usd">3246000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8521cad256a441f09269040aa936b3c2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTctMS0xLTE0MDY0NQ_06ed2863-a31b-4546-9784-cdf6a5385261"
      unitRef="usd">25492000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iff654d59997d4f00bf56601509888261_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTktMS0xLTE0MDY0NQ_d1ec5093-7969-48d2-a018-a5dcd80e5f5e"
      unitRef="usd">-1304000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i04f20e9ecbc842eb84ec33df7c1e03ac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTExLTEtMS0xNDA2NDU_710c5f29-152b-4689-bc3c-f9349c0be7a5"
      unitRef="usd">-12156000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if7cc33f8e79b44da9048bfcf1f0d1520_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzM3LTEzLTEtMS0xNzM5MDQ_bf4f2c7b-cc1f-45d4-b0c6-eb9c80227840"
      unitRef="usd">15311000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iafc3e3d48014423a92047239f09e25bd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTEzLTEtMS0xNDA2NDU_b74a982c-e457-426a-bdfc-f45dbbbcce80"
      unitRef="usd">59000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzYvZnJhZzpmZGMyMGVmYWRkY2I0OGQ4OWI1M2Q3MTYyZTNjMjIyMy90YWJsZTo4YTEwOTczM2FlNmQ0MzI2YjI0NTc2MjhiZDRjZjEzMy90YWJsZXJhbmdlOjhhMTA5NzMzYWU2ZDQzMjZiMjQ1NzYyOGJkNGNmMTMzXzI5LTE1LTEtMS0xNDA2NDU_73e4581c-b928-4252-a804-ea72c643135a"
      unitRef="usd">15370000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQtMS0xLTEtMTQwNjQ1_93ec6ba9-732e-49c8-8a29-8ac175a629ab"
      unitRef="usd">2802000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQtMy0xLTEtMTQwNjQ1_a8771b64-1423-4ef5-885b-1f15d7ac34a3"
      unitRef="usd">2934000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQtNS0xLTEtMTQwNjQ1_a24eb484-2fc7-426b-8d00-7c49c54ada62"
      unitRef="usd">3367000000</us-gaap:ProfitLoss>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzYtMS0xLTEtMTQwNjQ1_ffe16040-2149-45d0-9697-5a3129094fc5"
      unitRef="usd">237000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzYtMy0xLTEtMTQwNjQ1_61eaba0e-7b53-465e-a8ef-6f212c5d281a"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzYtNS0xLTEtMTQwNjQ1_b8763cf0-3ed4-43b4-9f86-78945a7a33f7"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzctMS0xLTEtMTQwNjQ1_849b18ba-abf6-426b-8955-88f07877c463"
      unitRef="usd">-205000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzctMy0xLTEtMTQwNjQ1_f8c6a218-6c94-4a5d-ac09-59d93ade5770"
      unitRef="usd">-130000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzctNS0xLTEtMTQwNjQ1_27721ab2-3ddf-403a-baaa-bb0d28fa5b68"
      unitRef="usd">838000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzgtMS0xLTEtMTQwNjQ1_0038c57c-ceb2-4252-999a-2984484052fb"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzgtMy0xLTEtMTQwNjQ1_0885adda-1f87-4844-b076-37e5e4265691"
      unitRef="usd">1129000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzgtNS0xLTEtMTQwNjQ1_7ad1c2fa-650e-4321-a7cb-04f6671d83e0"
      unitRef="usd">0</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzktMS0xLTEtMTQwNjQ1_b9b6fcfb-aeca-483c-a6b2-be781f08771a"
      unitRef="usd">-4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzktMy0xLTEtMTQwNjQ1_b78b1fc3-854c-44fa-95bb-7923716ee982"
      unitRef="usd">65000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzktNS0xLTEtMTQwNjQ1_cb514168-7a36-4e1c-ae16-30a8cb039bfb"
      unitRef="usd">74000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ShareBasedCompensation
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEwLTEtMS0xLTE0MDY0NQ_94d1c860-6e3f-41d0-8291-16874b32c702"
      unitRef="usd">216000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEwLTMtMS0xLTE0MDY0NQ_17653d5c-6510-4fa0-94b4-1879639b4a01"
      unitRef="usd">180000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEwLTUtMS0xLTE0MDY0NQ_f9687e34-0315-4182-8877-db6a2b097c0b"
      unitRef="usd">181000000</us-gaap:ShareBasedCompensation>
    <us-gaap:Depreciation
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzExLTEtMS0xLTE0MDY0NQ_b77b9752-b245-4f33-a3a8-7b631a0eddec"
      unitRef="usd">749000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzExLTMtMS0xLTE0MDY0NQ_89c71e00-f960-4b4f-b23b-5d10967a3980"
      unitRef="usd">640000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzExLTUtMS0xLTE0MDY0NQ_b244d263-c9bf-47c4-a39c-25e4586990ca"
      unitRef="usd">528000000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEyLTEtMS0xLTE0MDY0NQ_2cac1c26-c9df-4ff7-8b3c-6b613904398b"
      unitRef="usd">96000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEyLTMtMS0xLTE0MDY0NQ_595de132-ac02-4cf0-bfef-5b23c0e1a96b"
      unitRef="usd">73000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEyLTUtMS0xLTE0MDY0NQ_9f34f73c-c4a5-45c1-a211-ef26bfb31c80"
      unitRef="usd">88000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTEtMS0xLTE0NjQzNA_09e58d72-dced-4fa2-bbb1-7fa8a953e716"
      unitRef="usd">248000000</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTMtMS0xLTE0NjQzNA_684a76be-6c12-4bbd-bf32-1683b6575195"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTUtMS0xLTE0NjQzNA_a0fd992d-6997-4337-b854-1d2dfb190239"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTEtMS0xLTE0MDY0NQ_57e49d61-1173-455a-85a4-4e825e3ade92"
      unitRef="usd">-100000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTMtMS0xLTE0MDY0NQ_9ef27153-fc2f-4575-99c3-8f4d69f4e449"
      unitRef="usd">15000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzEzLTUtMS0xLTE0MDY0NQ_c9166a7c-457e-4958-b95a-a4f909dc0ea4"
      unitRef="usd">195000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE1LTEtMS0xLTE0MDY0NQ_a2b1adeb-a4f1-49e4-b077-71240f712cb5"
      unitRef="usd">54000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE1LTMtMS0xLTE0MDY0NQ_ad2de764-1dba-4b5b-b9ab-81ce7115f2b2"
      unitRef="usd">280000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE1LTUtMS0xLTE0MDY0NQ_0c93e83a-062d-4e81-be03-ab5d11ac40f6"
      unitRef="usd">85000000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE2LTEtMS0xLTE0MDY0NQ_2d8af3f6-5cd2-40e9-ac37-2157c025f59d"
      unitRef="usd">463000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE2LTMtMS0xLTE0MDY0NQ_c9d81e3d-9ad2-472f-a51b-16c67ebf8b2b"
      unitRef="usd">491000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE2LTUtMS0xLTE0MDY0NQ_3843bc19-e76c-49a1-a976-07df2b52f724"
      unitRef="usd">581000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE3LTEtMS0xLTE0MDY0NQ_5a0140b3-1758-4a56-916a-c93d9db37973"
      unitRef="usd">975000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE3LTMtMS0xLTE0MDY0NQ_4c7c6028-9a4d-43af-852c-5496237ce165"
      unitRef="usd">104000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE3LTUtMS0xLTE0MDY0NQ_7fb15747-8bda-46a6-b695-fea0792c5333"
      unitRef="usd">2139000000</us-gaap:IncreaseDecreaseInHealthCareInsuranceLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE4LTEtMS0xLTE0MDY0NQ_f58ba61f-06a9-46de-926c-766505b5b1e5"
      unitRef="usd">44000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE4LTMtMS0xLTE0MDY0NQ_43bdfb53-6c9f-4d27-bf8d-835d39540cbc"
      unitRef="usd">176000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE4LTUtMS0xLTE0MDY0NQ_79b422fd-82bc-46e3-9192-2e6920f8c373"
      unitRef="usd">599000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE5LTEtMS0xLTE0MDY0NQ_4145c1d9-c1c3-4ca4-9219-4ffe8a8c0657"
      unitRef="usd">32000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE5LTMtMS0xLTE0MDY0NQ_0850750e-1041-4091-b5bd-2deb13803e44"
      unitRef="usd">-65000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzE5LTUtMS0xLTE0MDY0NQ_be21cca6-47b2-4758-b7f7-9c9fb12625dc"
      unitRef="usd">71000000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIwLTEtMS0xLTE0MDY0NQ_6b7b1320-8697-427c-ac82-219d53fc71da"
      unitRef="usd">70000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIwLTMtMS0xLTE0MDY0NQ_ed36bb85-6d3b-4cf9-8be5-62db430b45fa"
      unitRef="usd">40000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIwLTUtMS0xLTE0MDY0NQ_c5dd3a46-341c-41d1-bf28-03fca15a3d87"
      unitRef="usd">49000000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIxLTEtMS0xLTE0MDY0NQ_23aafb7c-e889-4859-9c22-8e0ced93cb5e"
      unitRef="usd">4587000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIxLTMtMS0xLTE0MDY0NQ_6044c6df-f9d9-4d82-a9dc-3af90500c655"
      unitRef="usd">2262000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzIxLTUtMS0xLTE0MDY0NQ_168e6218-f1e7-4d68-bbc3-5146055a8bc2"
      unitRef="usd">5639000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI0LTEtMS0xLTE0MDY0NQ_02603e3e-0827-4732-856c-969fab06de5a"
      unitRef="usd">2701000000</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI0LTMtMS0xLTE0MDY0NQ_afcbd236-89c6-4898-982e-0dcc8d797763"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI0LTUtMS0xLTE0MDY0NQ_c7f7e31a-7386-445b-972f-5ab8db15cb9e"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTEtMS0xLTE0NjQ0NA_d8b684b4-212f-4270-83cd-8b87e0af9da8"
      unitRef="usd">337000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTMtMS0xLTE0NjQ0NA_470b506f-ab3f-4822-8cc2-cbab09c83887"
      unitRef="usd">4187000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTUtMS0xLTE0NjQ0NA_044c6b26-c050-4fab-8a7f-2d7645994571"
      unitRef="usd">709000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI1LTEtMS0xLTE0MDY0NQ_3bc66ee6-cea7-4f93-ad37-b9a49f4762b4"
      unitRef="usd">1120000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI1LTMtMS0xLTE0MDY0NQ_5b413e19-d4bc-486c-8d8d-4d895e2a9d3e"
      unitRef="usd">1316000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI1LTUtMS0xLTE0MDY0NQ_9d0f0953-848f-4c77-8410-b0ff97ae9176"
      unitRef="usd">964000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTEtMS0xLTE0MDY0NQ_d5e79914-743c-4491-b8b2-8fcec4572879"
      unitRef="usd">6049000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTMtMS0xLTE0MDY0NQ_9053bc71-0ccb-4ed5-9e1e-0590fc4f2874"
      unitRef="usd">7197000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI2LTUtMS0xLTE0MDY0NQ_b363adeb-047d-4c6d-8a6a-86b95d45d696"
      unitRef="usd">9125000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI3LTEtMS0xLTE0MDY0NQ_44f99c76-0942-4fdd-a52b-42c35cc6a3d3"
      unitRef="usd">1365000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI3LTMtMS0xLTE0MDY0NQ_7c6eea45-faba-4ac3-ad3e-35c315999b1f"
      unitRef="usd">2597000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI3LTUtMS0xLTE0MDY0NQ_dbba739c-cacb-4486-a148-fc43a5670160"
      unitRef="usd">4986000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI4LTEtMS0xLTE0MDY0NQ_1130433f-964f-4d6e-83e8-f196634d1652"
      unitRef="usd">2434000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI4LTMtMS0xLTE0MDY0NQ_f95e9541-4890-443f-ba8e-86fb2c78805f"
      unitRef="usd">3547000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI4LTUtMS0xLTE0MDY0NQ_ca53c8db-663d-4bfd-adc5-69bf20d7d97b"
      unitRef="usd">2747000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI5LTEtMS0xLTE0MDY0NQ_20946dc0-1502-4a61-ad91-a36c5a1c5b06"
      unitRef="usd">-1006000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI5LTMtMS0xLTE0MDY0NQ_5292662c-0f86-457d-a9b0-4d862a651f38"
      unitRef="usd">-6556000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzI5LTUtMS0xLTE0MDY0NQ_88dc5e52-c913-4291-9275-860de0e5b9fa"
      unitRef="usd">-3065000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <hum:PaymentsForProceedsFromContractDeposits
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMxLTEtMS0xLTE0MDY0NQ_b6e657df-49da-4838-8263-08dd4227b8c7"
      unitRef="usd">-1993000000</hum:PaymentsForProceedsFromContractDeposits>
    <hum:PaymentsForProceedsFromContractDeposits
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMxLTMtMS0xLTE0MDY0NQ_4c3eabb7-de67-4395-b011-fb41ba2b1409"
      unitRef="usd">306000000</hum:PaymentsForProceedsFromContractDeposits>
    <hum:PaymentsForProceedsFromContractDeposits
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMxLTUtMS0xLTE0MDY0NQ_c3fe09c0-fa82-4cfc-bdb5-ca4f4c0eb918"
      unitRef="usd">939000000</hum:PaymentsForProceedsFromContractDeposits>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMyLTEtMS0xLTE0MDY0NQ_2510890d-5dbe-4cfe-9931-483756fc8db6"
      unitRef="usd">1982000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMyLTMtMS0xLTE0MDY0NQ_b69f8894-0c4d-4dcb-8798-5b427fa6a659"
      unitRef="usd">2984000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMyLTUtMS0xLTE0MDY0NQ_afcc88e1-7dfd-4512-9c22-bd0ab83b8219"
      unitRef="usd">1088000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMzLTEtMS0xLTE0MDY0NQ_449bc028-52b6-48f7-92f7-f080477ca2f7"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMzLTMtMS0xLTE0MDY0NQ_d8715c67-e5fb-4188-945e-5f9578316b54"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzMzLTUtMS0xLTE0MDY0NQ_2ed0d4c5-0cc7-4c58-8157-e0a0b18bda12"
      unitRef="usd">400000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM0LTEtMS0xLTE0MDY0NQ_e47eda72-c323-4038-b338-a5ef2ad247ba"
      unitRef="usd">-376000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM0LTMtMS0xLTE0MDY0NQ_1555511f-70f8-448e-90ca-1daf3acc0e05"
      unitRef="usd">352000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM0LTUtMS0xLTE0MDY0NQ_03dd11d2-4bc3-4305-93c9-e37eeefac022"
      unitRef="usd">295000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM1LTEtMS0xLTE0MDY0NQ_1c50942d-15de-4fba-a10a-3b70f175c17b"
      unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM1LTMtMS0xLTE0MDY0NQ_150978ea-9861-4463-9154-d1bb4ccb8a72"
      unitRef="usd">2500000000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM1LTUtMS0xLTE0MDY0NQ_af690694-fc15-4d0a-87ee-2ad8d511849a"
      unitRef="usd">1000000000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM2LTEtMS0xLTE0MDY0NQ_8950bbcb-b664-4a86-ab93-16d0e08f7532"
      unitRef="usd">2000000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM2LTMtMS0xLTE0MDY0NQ_72e8ff59-bd1c-47b9-9c0e-3ec53c5eaae2"
      unitRef="usd">2078000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM2LTUtMS0xLTE0MDY0NQ_3d732164-03ac-4c72-8be9-c8cad29a349f"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM3LTEtMS0xLTE0MDY0NQ_1028a237-d1ac-40d2-9e63-11b1011537cb"
      unitRef="usd">6000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM3LTMtMS0xLTE0MDY0NQ_4a8fb0ab-ad4d-4fa6-a7de-4f09614c20e8"
      unitRef="usd">31000000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM3LTUtMS0xLTE0MDY0NQ_d877d80f-21ab-41da-8926-f67312424d32"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM4LTEtMS0xLTE0MDY0NQ_db6198b9-0dfa-4d15-9699-eef45bcaad26"
      unitRef="usd">2096000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM4LTMtMS0xLTE0MDY0NQ_b484d14d-f626-4530-aee0-3243c21ba5ca"
      unitRef="usd">79000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM4LTUtMS0xLTE0MDY0NQ_c883edbc-f6f4-4ee7-a6f0-30ae785f1a9c"
      unitRef="usd">1820000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM5LTEtMS0xLTE0MDY0NQ_1c9e401f-0051-466b-b898-3bcc7a8b9692"
      unitRef="usd">392000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM5LTMtMS0xLTE0MDY0NQ_eb019a37-617e-4306-8faf-49d5c3a94cd2"
      unitRef="usd">354000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzM5LTUtMS0xLTE0MDY0NQ_561cbb14-5213-4bf9-b852-9e10c5f4b312"
      unitRef="usd">323000000</us-gaap:PaymentsOfDividends>
    <us-gaap:IncreaseDecreaseInBookOverdrafts
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQwLTEtMS0xLTE0MDY0NQ_dd151491-fde3-4dda-8d6b-b86d224c17ad"
      unitRef="usd">-28000000</us-gaap:IncreaseDecreaseInBookOverdrafts>
    <us-gaap:IncreaseDecreaseInBookOverdrafts
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQwLTMtMS0xLTE0MDY0NQ_59e4f463-5260-49ae-8c21-c7686ac57153"
      unitRef="usd">6000000</us-gaap:IncreaseDecreaseInBookOverdrafts>
    <us-gaap:IncreaseDecreaseInBookOverdrafts
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQwLTUtMS0xLTE0MDY0NQ_8f90a710-b9f3-4368-995a-75fa74c1233f"
      unitRef="usd">95000000</us-gaap:IncreaseDecreaseInBookOverdrafts>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQxLTEtMS0xLTE0MDY0NQ_90af5352-de76-40d2-ba49-8073618f55e9"
      unitRef="usd">9000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQxLTMtMS0xLTE0MDY0NQ_682f6c4a-2ff5-4ce2-8fdc-d1640af05a2a"
      unitRef="usd">21000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQxLTUtMS0xLTE0MDY0NQ_f6e930d3-2ca8-4da1-a1d3-721a8af8b0d4"
      unitRef="usd">49000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQyLTEtMS0xLTE0MDY0NQ_cf866aa1-e4fe-4362-8a69-5982553f984c"
      unitRef="usd">-1914000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQyLTMtMS0xLTE0MDY0NQ_2fda49a6-d6d3-4cdc-830f-c729ccae580f"
      unitRef="usd">3015000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQyLTUtMS0xLTE0MDY0NQ_ad81d62f-eb68-4b6e-8564-7516d370fe92"
      unitRef="usd">-1955000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQzLTEtMS0xLTE0MDY0NQ_4181a926-96e5-4e14-8f0c-5a0a9621af78"
      unitRef="usd">1667000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQzLTMtMS0xLTE0MDY0NQ_5491da10-faba-43ef-b2ce-2ddd6722d765"
      unitRef="usd">-1279000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQzLTUtMS0xLTE0MDY0NQ_65c056ed-485c-4f46-a97a-1d8f50bfc44c"
      unitRef="usd">619000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ0LTEtMS0xLTE0MDY0NQ_e51589e9-72a3-4105-9329-d6c4badf1239"
      unitRef="usd">3394000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ0LTMtMS0xLTE0MDY0NQ_d96e9616-d3a6-44d6-94a0-b624746d061e"
      unitRef="usd">4673000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ0LTUtMS0xLTE0MDY0NQ_22da40ac-2bcd-414c-b0d5-a3937ab44b16"
      unitRef="usd">4054000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ1LTEtMS0xLTE0MDY0NQ_6921972c-bd02-4ebe-831d-933b5dc4e46c"
      unitRef="usd">5061000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ1LTMtMS0xLTE0MDY0NQ_88a6a65c-2d31-4f2c-9125-59f1d477ab5d"
      unitRef="usd">3394000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTphOTU2MjhmZDExZDY0NTA1YjcyODI1NGRmYjY0NmZmNi90YWJsZXJhbmdlOmE5NTYyOGZkMTFkNjQ1MDViNzI4MjU0ZGZiNjQ2ZmY2XzQ1LTUtMS0xLTE0MDY0NQ_da5e4040-758a-41f0-bf6d-10a2db8defe3"
      unitRef="usd">4673000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzMtMS0xLTEtMTQwNjQ1_51e23dd0-f0ac-42b8-9759-966fb01f26ba"
      unitRef="usd">354000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzMtMy0xLTEtMTQwNjQ1_48eba089-a277-425f-bcf5-08ea390bf24b"
      unitRef="usd">285000000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzMtNS0xLTEtMTQwNjQ1_2255a9d2-d5e0-4620-bd5b-5f5121c86de8"
      unitRef="usd">258000000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzQtMS0xLTEtMTQwNjQ1_c246bc1a-21a1-4a05-81b3-f1351a26c0cc"
      unitRef="usd">758000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzQtMy0xLTEtMTQwNjQ1_05246d52-b404-4224-befd-473429195004"
      unitRef="usd">227000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzQtNS0xLTEtMTQwNjQ1_9d50d5a2-a268-421a-bfc1-f7df461d9479"
      unitRef="usd">1132000000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzYtMS0xLTEtMTQwNjQ1_342582d3-b2b3-48c3-bd63-2eef4129489f"
      unitRef="usd">460000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzYtMy0xLTEtMTQwNjQ1_4a18ecbc-1b65-4bfe-8c93-b882990d3f6d"
      unitRef="usd">9804000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzYtNS0xLTEtMTQwNjQ1_24290ea1-e92a-40ab-b3c1-05c517bbc6f0"
      unitRef="usd">819000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzctMS0xLTEtMTQwNjQ1_7beebb54-c45e-4304-a4db-ed7b585b4303"
      unitRef="usd">70000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzctMy0xLTEtMTQwNjQ1_65ccbcb1-d204-40b0-b2fc-3580f1ce915a"
      unitRef="usd">3235000000</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzctNS0xLTEtMTQwNjQ1_7609a3c9-8a8f-4cc3-9c00-5210998a8f15"
      unitRef="usd">110000000</us-gaap:LiabilitiesAssumed1>
    <hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzgtMS0xLTEtMTQwNjQ1_ab071f60-84eb-4c0f-ab2b-d87c04a089a1"
      unitRef="usd">53000000</hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired>
    <hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzgtMy0xLTEtMTQwNjQ1_fb541667-2b7b-424c-bac9-b60cd36b9a25"
      unitRef="usd">22000000</hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired>
    <hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzgtNS0xLTEtMTQwNjQ1_3eb2a009-e4cf-4900-97b4-e7006d348a14"
      unitRef="usd">0</hum:NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired>
    <hum:NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzktMS0xLTEtMTQwNjQ1_3dd39881-dd5a-4c0a-ae5d-866dc453bb7b"
      unitRef="usd">0</hum:NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment>
    <hum:NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzktMy0xLTEtMTQwNjQ1_e7ba51b3-7cdc-42db-b5ef-acb83f4627cb"
      unitRef="usd">2360000000</hum:NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment>
    <hum:NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzktNS0xLTEtMTQwNjQ1_0ea39e13-969c-46fb-807b-a87962eaa399"
      unitRef="usd">0</hum:NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzEwLTEtMS0xLTE0MDY0NQ_ed40aea1-c275-4f99-9999-a3f452a95268"
      unitRef="usd">337000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzEwLTMtMS0xLTE0MDY0NQ_975e90cb-4bda-40ae-854c-6829b5e19b82"
      unitRef="usd">4187000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xMzkvZnJhZzpkZGFlZDY0NWY1ZDc0YzVjOGQ5ZWIzOWVmZTI4MzQ3Mi90YWJsZTplZTg3ODU3YzI2YzQ0Y2YwOTIyNjU1MTYzYTY0MWU1Mi90YWJsZXJhbmdlOmVlODc4NTdjMjZjNDRjZjA5MjI2NTUxNjNhNjQxZTUyXzEwLTUtMS0xLTE0MDY0NQ_0d8be365-f37e-4f73-b29f-e1e3243b793d"
      unitRef="usd">709000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:NatureOfOperations
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDUvZnJhZzplNmVjMmJkOWRkMDE0NjY3YmViYzZmMjUxOTVkYmFkNS90ZXh0cmVnaW9uOmU2ZWMyYmQ5ZGQwMTQ2NjdiZWJjNmYyNTE5NWRiYWQ1XzY4MQ_f9d91198-83d3-491d-bf1e-464ebc2cf392">REPORTING ENTITY&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Humana Inc., headquartered in Louisville, Kentucky, is a leading health and well-being company committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well&#x2010;being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large. To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools, such as in&#x2010;home care, behavioral health, pharmacy services, data analytics and wellness solutions, combine to produce a simplified experience that makes health care easier to navigate and more effective. References throughout these notes to consolidated financial statements to &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; &#x201c;Company,&#x201d; and &#x201c;Humana,&#x201d; mean Humana Inc. and its subsidiaries. We derived approximately 82% of our total premiums and services revenue from contracts with the federal government in 2022, including 14% related to our federal government contracts with the Centers for Medicare and Medicaid Services, or CMS, to provide health insurance coverage for individual Medicare Advantage members in Florida. CMS is the federal government&#x2019;s agency responsible for administering the Medicare program.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Segment Realignment &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During December 2022, we realigned our businesses into two distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior period segment financial information has been recast to conform to the 2022 presentation. For a recast of prior period segment financial information, refer to Note 18 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie3ecfbb6c22b417ebc6482a6408f9cdb_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDUvZnJhZzplNmVjMmJkOWRkMDE0NjY3YmViYzZmMjUxOTVkYmFkNS90ZXh0cmVnaW9uOmU2ZWMyYmQ5ZGQwMTQ2NjdiZWJjNmYyNTE5NWRiYWQ1XzI4Mw_67944d94-d75a-4a09-b142-90d21a332476"
      unitRef="number">0.82</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9069595e8b1946288939814801ab0b92_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDUvZnJhZzplNmVjMmJkOWRkMDE0NjY3YmViYzZmMjUxOTVkYmFkNS90ZXh0cmVnaW9uOmU2ZWMyYmQ5ZGQwMTQ2NjdiZWJjNmYyNTE5NWRiYWQ1XzM4OQ_9bdd8b8a-f6a9-4eab-aa2f-d84441f544ed"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:NumberOfReportableSegments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDUvZnJhZzplNmVjMmJkOWRkMDE0NjY3YmViYzZmMjUxOTVkYmFkNS90ZXh0cmVnaW9uOmU2ZWMyYmQ5ZGQwMTQ2NjdiZWJjNmYyNTE5NWRiYWQ1XzEwOTk1MTE2MzM4MTE_fc569758-264f-4c5c-84e6-dab652519dda"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzU5_86c71d64-e894-4634-89b0-62aec5a20a17">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Our consolidated financial statements include the accounts of Humana Inc. and subsidiaries that the Company controls, including variable interest entities associated with medical practices for which we are the primary beneficiary. We do not own many of our medical practices but instead enter into exclusive management agreements with the affiliated Professional Associations, or P.A.s, that operate these medical practices. Based upon the provisions of these agreements, these affiliated P.A.s are variable interest entities and we are the primary beneficiary, and accordingly we consolidate the affiliated P.A.s. All significant intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Value Creation Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473&#160;million included within operating costs in the consolidated statement of income for the year ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;COVID-19 &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The emergence and spread of the novel coronavirus, or COVID-19, beginning in the first quarter of 2020 has impacted our business. During periods of increased incidences of COVID-19, a reduction in non-COVID-19 hospital admissions for non-emergent and elective medical care have resulted in lower overall healthcare system utilization. At the same time, COVID-19 treatment and testing costs increased utilization. During 2022, we experienced lower overall utilization of the healthcare system than anticipated, as the reduction in COVID-19 utilization following the increased incidence associated with the Omicron variant outpaced the increase in non-COVID-19 utilization. The significant disruption in utilization during 2020 also impacted our ability to implement clinical initiatives to manage health care costs and chronic conditions of our members, and appropriately document their risk profiles, and, as such, significantly affected our 2021 revenue under the risk adjustment payment model for Medicare Advantage plans. Finally, changes in utilization patterns and actions taken in 2020 and 2021 as a result of the COVID-19 pandemic, including the suspension of certain financial recovery programs for a period of time and shifting the timing of claim payments and provider capitation surplus payments, impacted our claim reserve development and operating cash flows for 2020 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Reform&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Patient Protection and Affordable Care Act and The Health Care and Education Reconciliation Act of 2010 (which we collectively refer to as the Health Care Reform Law) enacted significant reforms to various aspects of the U.S. health insurance industry. Certain of these reforms became effective January 1, 2014, including an annual insurance industry premium-based fee. The Continuing Resolution bill, H.R. 195, enacted on January 22, 2018, included a one year suspension in 2019 of the health insurance industry fee, but the fee resumed in calendar year 2020. The Further Consolidated Appropriations Act, 2020, enacted on December 20, 2019, permanently repealed the health insurance industry fee beginning in calendar year 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The annual premium-based fee on health insurers was not deductible for tax purposes. We estimated a liability for the health insurance industry fee and recorded it in full once qualifying insurance coverage was provided in the applicable calendar year in which the fee was payable with a corresponding deferred cost that was amortized ratably to expense over the same calendar year. We recorded the liability for the health insurance industry fee in trade accounts payable and accrued expenses and recorded the deferred cost in other current assets in our consolidated financial statements. We paid the health insurance industry fee in September or October of each year. We paid the federal government $1.18 billion for the annual health insurance industry fee attributed to calendar year 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2017, we filed suit against the United States of America in the United States Court of Federal Claims, on behalf of our health plans seeking recovery from the federal government of approximately $611&#160;million in payments under the risk corridor premium stabilization program established under Health Care Reform, for years 2014, 2015 and 2016. On April 27, 2020, the U.S. Supreme Court ruled that the government is obligated to pay the losses under this risk corridor program and that Congress did not implicitly repeal the obligation under its appropriations riders. In September 2020, we received a $609&#160;million payment from the U.S Government pursuant &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to the judgement issued by the Court of Federal Claims on July 7, 2020. The $609&#160;million payment received from the U.S Government and approximately $31&#160;million in related fees and expenses are reflected in Premiums revenue and Operating costs, respectively, in our consolidated statements of income for the year ended December 31, 2020 and reported in the Corporate segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash, time deposits, money market funds, commercial paper, other money market instruments, and certain U.S. Government securities with an original maturity of three months or less. Carrying value approximates fair value due to the short-term maturity of the investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment securities, which consist of debt and equity securities, are stated at fair value. Our debt securities have been categorized as available for sale. Debt securities available for current operations, as well as our equity securities, are classified as current assets, and debt securities available to fund our professional and other self-insurance liability requirements, as well as restricted statutory deposits, are classified as long-term assets. For the purpose of determining realized gross gains and losses for debt securities sold, that are included as a component of investment income in the consolidated statements of income, the cost of investment securities sold is based upon specific identification. Unrealized holding gains and losses for debt securities, net of applicable deferred taxes, are included in other comprehensive income or loss as a component of stockholders&#x2019; equity until realized from a sale or an expected credit loss is recognized. For the purpose of determining gross gains and losses for equity securities, changes in fair value at the reporting date are included as a component of investment income in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning on January 1, 2020, we adopted the new current expected credit losses, or CECL, model which retained many similarities from the previous other-than-temporary impairment model except eliminating from consideration in the impairment analysis the length of time over which the fair value had been less than cost. Also, under the CECL model, expected losses on available for sale debt securities are recognized through an allowance for credit losses rather than as reductions in the amortized cost of the securities. For debt securities whose fair value is less than their amortized cost which we do not intend to sell or are not required to sell, we evaluate the expected cash flows to be received as compared to amortized cost and determine if an expected credit loss has occurred. In the event of an expected credit loss, only the amount of the impairment associated with the expected credit loss is recognized in income with the remainder, if any, of the loss recognized in other comprehensive income.  To the extent we have the intent to sell the debt security or it is more likely than not we will be required to sell the debt security before recovery of our amortized cost basis, we recognize an impairment loss in income in an amount equal to the full difference between the amortized cost basis and the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potential expected credit loss impairment is considered using a variety of factors, including the extent to which the fair value has been less than cost; adverse conditions specifically related to the industry, geographic area or financial condition of the issuer or underlying collateral of a debt security; changes in the quality of the debt security's credit enhancement; payment structure of the debt security; changes in credit rating of the debt security by the rating agencies; failure of the issuer to make scheduled principal or interest payments on the debt security and changes in prepayment speeds. For debt securities, we take into account expectations of relevant market and economic data. For example, with respect to mortgage and asset-backed securities, such data includes underlying loan level data and structural features such as seniority and other forms of credit enhancements. We estimate the amount of the expected credit loss component of a debt security as the difference between the amortized cost and the present value of the expected cash flows of the security. The present value is determined using the best estimate of future cash flows discounted at the implicit interest rate at the date of purchase. The expected credit loss cannot exceed the full difference between the amortized cost basis and the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables and Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally establish one-year commercial membership contracts with employer groups, subject to cancellation by the employer group on 30-day written notice. Our Medicare contracts with CMS renew annually. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our military services contracts with the federal government and certain contracts with various state Medicaid programs generally are multi-year contracts subject to annual renewal provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Premiums Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive monthly premiums from the federal government and various states according to government specified payment rates and various contractual terms. We bill and collect premium from employer groups and members in our Medicare and other individual products monthly.  Changes in premium revenues resulting from the periodic changes in risk-adjustment scores derived from medical diagnoses for our membership are estimated by projecting the ultimate annual premium and are recognized ratably during the year, with adjustments each period to reflect changes in the ultimate premium. Receivables or payables are classified as current or long-term in our consolidated balance sheet based on the timing of the expected settlement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premiums revenue is estimated by multiplying the membership covered under the various contracts by the contractual rates. Premiums revenue is recognized as income in the period members are entitled to receive services and is net of estimated uncollectible amounts, retroactive membership adjustments, and adjustments to recognize rebates under the minimum benefit ratios required under the Health Care Reform Law. We estimate policyholder rebates by projecting calendar year minimum benefit ratios for the small group and large group markets, as defined by the Health Care Reform Law using a methodology prescribed by Health and Human Services, or HHS, separately by state and legal entity. Medicare Advantage and Medicaid products are also subject to minimum benefit ratio requirements. Estimated calendar year rebates recognized ratably during the year are revised each period to reflect current experience. Retroactive membership adjustments result from enrollment changes not yet processed, or not yet reported by an employer group or the government. We routinely monitor the collectability of specific accounts, the aging of receivables, historical retroactivity trends, estimated rebates, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. Premiums received prior to the service period are recorded as unearned revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare Part D&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with CMS. The payments we receive monthly from CMS and members, which are determined from our annual bid, represent amounts for providing prescription drug insurance coverage. We recognize premiums revenue for providing this insurance coverage ratably over the term of our annual contract. Our CMS payment is subject to risk sharing through the Medicare Part D risk corridor provisions. In addition, receipts for reinsurance and low-income cost subsidies as well as receipts for certain discounts on brand name prescription drugs in the coverage gap represent payments for prescription drug costs for which we are not at risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risk corridor provisions compare costs targeted in our bids to actual prescription drug costs, limited to actual costs that would have been incurred under the standard coverage as defined by CMS. Variances exceeding certain thresholds may result in CMS making additional payments to us or require us to refund to CMS a portion of the premiums we received. As risk corridor provisions are considered in our overall annual bid process, we estimate and recognize an adjustment to premiums revenue related to these provisions based upon pharmacy claims experience. We record a receivable or payable at the contract level and classify the amount as current or long-term in our consolidated balance sheets based on the timing of expected settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance and low-income cost subsidies represent funding from CMS in connection with the Medicare Part D program for which we assume no risk. Reinsurance subsidies represent funding from CMS for its portion of prescription drug costs which exceed the member&#x2019;s out-of-pocket threshold, or the catastrophic coverage level. Low-income cost subsidies represent funding from CMS for all or a portion of the deductible, the coinsurance and co-payment amounts above the out-of-pocket threshold for low-income beneficiaries. Monthly prospective payments from CMS for reinsurance and low-income cost subsidies are based on assumptions submitted with our annual bid. A reconciliation and related settlement of CMS&#x2019;s prospective subsidies against actual prescription drug costs we paid is made after the end of the year. The Health Care Reform Law mandates consumer discounts of 50% on brand name prescription drugs for Part D plan participants in the coverage gap. These discounts are funded by CMS and pharmaceutical manufacturers while we administer the application of these funds. We account for these subsidies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and discounts as a deposit in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits, net in our consolidated statements of cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Part D subsidy/discount payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Part D subsidy/discount reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net reimbursements (payments)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not recognize premiums revenue or benefit expenses for these subsidies or discounts. Receipt and payment activity is accumulated at the contract level and recorded in our consolidated balance sheets in other current assets or trade accounts payable and accrued expenses depending on the contract balance at the end of the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Settlement of the reinsurance and low-income cost subsidies as well as the risk corridor payment is based on a reconciliation made approximately 9 months after the close of each calendar year. Settlement with CMS for brand name prescription drug discounts is based on a reconciliation made approximately 14 to 18 months after the close of each calendar year. We continue to revise our estimates with respect to the risk corridor provisions based on subsequent period pharmacy claims data. See Note 7 for detail regarding amounts recorded to our consolidated balance sheets related to the risk corridor settlement and subsidies from CMS with respect to the Medicare Part D program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient services revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient services include services related to pharmacy, provider services, and home solutions services, such as home health and other services and capabilities to promote wellness and advance population health. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our pharmacy business, external pharmacy revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through our CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Services revenues related to product revenues from dispensing prescriptions are recorded when the prescription or product is shipped.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our provider services business recognizes revenues for certain value-based arrangements. Under these value-based arrangements, we enter into agreements with health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our patients. In exchange, we receive a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our patients. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our home solutions businesses, revenues include net patient services revenue recorded based upon established billing rates, net of contractual allowances, discounts, or other implicit price concessions, and are recognized as performance obligations are satisfied, which is in the period services are rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the&#160;year ended December&#160;31, 2022, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price), was not material. Further, revenue expected to be recognized in any future year related to remaining performance obligations is not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Administrative services fees &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Administrative services fees cover the processing of claims, offering access to our provider networks and clinical programs, and responding to customer service inquiries from members of self-funded groups. Revenues from providing administration services, also known as administrative services only, or ASO, are recognized in the period services are performed and are net of estimated uncollectible amounts. ASO fees are estimated by multiplying the membership covered under the various contracts by the contractual rates. Under ASO contracts, self-funded employers retain the risk of financing substantially all of the cost of health benefits. However, many ASO customers purchase stop loss insurance coverage from us to cover catastrophic claims or to limit aggregate annual costs. Accordingly, we have recorded premiums revenue and benefits expense related to these stop loss insurance contracts. We routinely monitor the collectability of specific accounts, the aging of receivables, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. ASO fees received prior to the service period are recorded as unearned revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Under our TRICARE contracts with the Department of Defense (DoD) we provide administrative services, including offering access to our provider networks and clinical programs, claim processing, customer service, enrollment, and other services, while the federal government retains all of the risk of the cost of health benefits. We account for revenues under our contracts net of estimated health care costs similar to an administrative services fee only agreement. Our contracts include fixed administrative services fees and incentive fees and penalties. Administrative services fees are recognized as services are performed.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our TRICARE members are served by both in-network and out-of-network providers in accordance with our contracts. We pay health care costs related to these services to the providers and are subsequently reimbursed by the DoD for such payments. We account for the payments of the federal government&#x2019;s claims and the related reimbursements under deposit accounting in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits,net in our consolidated statements of cash flows.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net reimbursements (payments)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables, including premium receivables, patient services revenue receivables, and ASO fee receivables, are shown net of allowances for estimated uncollectible accounts, retroactive membership adjustments, and contractual allowances.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At&#160;December&#160;31, 2022 and 2021, accounts receivable related to services were $291 million and $475 million, respectively. For the&#160;years ended December&#160;31, 2022, 2021 and 2020, we had no material bad-debt expense and there were no material contract assets, contract liabilities or deferred contract costs recorded on the consolidated balance sheet at&#160;December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Current Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current assets include amounts associated with Medicare Part D as discussed above and in Note 7, rebates due from pharmaceutical manufacturers and other amounts due within one year.  We accrue pharmaceutical rebates as they are earned based on contractual terms and usage of the product.  The balance of pharmaceutical rebates receivable was $2.0 billion at December&#160;31, 2022 and 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policy Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policy acquisition costs are those costs that relate directly to the successful acquisition of new and renewal insurance policies. Such costs include commissions, costs of policy issuance and underwriting, and other costs we incur to acquire new business or renew existing business. We expense policy acquisition costs related to our employer-group prepaid health services policies as incurred. These short-duration employer-group prepaid health services policies typically have a 1-year term and may be canceled upon 30 days notice by the employer group.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is recorded at cost. Gains and losses on sales or disposals of property and equipment are included in operating costs in our consolidated income statements. Certain costs related to the development or purchase of internal-use software are capitalized. Depreciation is computed using the straight-line method over estimated useful lives ranging from 3 to 10 years for equipment, 3 to 5 years for computer software, and 10 to 20 years for buildings. Improvements to leased facilities are depreciated over the shorter of the remaining lease term or the anticipated life of the improvement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically review long-lived assets, including property and equipment and other definite-lived intangible assets, for impairment whenever adverse events or changes in circumstances indicate the carrying value of the asset may not be recoverable. Losses are recognized for a long-lived asset to be held and used in our operations when the undiscounted future cash flows expected to result from the use of the asset are less than its carrying value. We recognize an impairment loss based on the excess of the carrying value over the fair value of the asset. A long-lived asset held for sale is reported at the lower of the carrying amount or fair value less costs to sell. Depreciation expense is not recognized on assets held for sale. Losses are recognized for a long-lived asset to be abandoned when the asset ceases to be used. In addition, we periodically review the estimated lives of all long-lived assets for reasonableness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the equity method of accounting for equity investments in companies where we are able to exercise significant influence, but not control, over operating and financial policies of the investee. Judgment regarding the level of influence over each equity method investment includes considering key factors such as our ownership interest, representation on the board of directors, organizational structure, participation in policy-making decisions and material intra-entity transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by our share of equity in income or losses after the date of acquisition as well as capital contributions to and distributions from these companies. Our proportionate share of the net income or loss of these companies is included in consolidated net income.  Investment amounts in excess of our share of an investee&#x2019;s net assets are amortized over the life of the related asset creating the excess. Excess goodwill is not amortized. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by us when reviewing an equity method investment for impairment include the length of time (duration) and the extent (severity) to which the fair value of the equity method investment has been less than carrying value, the investee&#x2019;s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than-temporary is recognized in the period identified.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional detail regarding our equity method investments is included in Note 4.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the unamortized excess of cost over the fair value of the net tangible and other intangible assets acquired. We are required to test at least annually for impairment at a level of reporting referred to as the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. A reporting unit either is our operating segments or one level below the operating segments, referred to as a component, which comprise our reportable segments. A component is considered a reporting unit if the component constitutes a business for which discrete financial information is available that is regularly reviewed by management. We aggregate the components of an operating segment into one reporting unit if they have similar economic characteristics. Goodwill is assigned to the reporting units that are expected to benefit from the specific synergies of the business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform a quantitative assessment to review goodwill for impairment to determine both the existence and amount of goodwill impairment, if any. Impairment tests are performed, at a minimum, in the fourth quarter of each year supported by our long-range business plan and annual planning process. We rely on an evaluation of future discounted cash flows to determine fair value of our reporting units. The fair value of our reporting units with significant goodwill exceeded carrying amounts. However, unfavorable changes in key assumptions or combinations of assumptions including a significant increase in the discount rate, decrease in the long-term growth rate or substantial reduction in our underlying cash flow assumptions, including revenue growth rates, medical and operating cost trends, and projected operating income could have a significant negative impact on the estimated fair value of our home solutions and provider reporting units, which accounted for $4.3&#160;billion and $1.1&#160;billion of goodwill, respectively. Impairment tests completed for 2022, 2021, and 2020 did not result in an impairment loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with indefinite lives relate to Certificate of Needs (CON) and Medicare licenses acquired as part of our acquisition of Kindred at Home, or KAH, and are included within other long-term assets in the consolidated balance sheet at December&#160;31, 2022 and December&#160;31, 2021. See Note 3 for further information. We are required to annually compare the fair values of other indefinite-lived intangible assets to their carrying amounts. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized. Fair values of indefinite-lived intangible assets are determined based on the income approach. Impairment tests completed for 2022 did not result in a material impairment loss. These charges reflect the amount by which the carrying value exceeded its estimated fair value. Impairment tests completed for 2021 did not result in an impairment loss. The fair values of the assets were measured using Level 3 inputs, such as projected revenues and operating cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Definite-lived intangible assets primarily relate to acquired customer contracts/relationships and are included with other long-term assets in the consolidated balance sheets. Definite-lived intangible assets are amortized over the useful life generally using the straight-line method. We review definite-lived intangible assets for impairment under our long-lived asset policy.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Benefits Payable and Benefits Expense Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefits expense includes claim payments, capitation payments, pharmacy costs net of rebates, allocations of certain centralized expenses and various other costs incurred to provide health insurance coverage to members, as well as estimates of future payments to hospitals and others for medical care and other supplemental benefits provided on or prior to the balance sheet date. Capitation payments represent monthly contractual fees disbursed to primary care and other providers who are responsible for providing medical care to members. Pharmacy costs represent payments for members&#x2019; prescription drug benefits, net of rebates from drug manufacturers. Receivables for such pharmacy rebates are included in other current assets in our consolidated balance sheets. Other supplemental benefits include dental, vision, and other supplemental health products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the costs of our benefits expense payments using actuarial methods and assumptions based upon claim payment patterns, medical cost inflation, historical developments such as claim inventory levels and claim receipt patterns, and other relevant factors, and record benefit reserves for future payments. We continually review estimates of future payments relating to claims costs for services incurred in the current and prior periods and make necessary adjustments to our reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefits expense is recognized in the period in which services are provided and includes an estimate of the cost of services which have been incurred but not yet reported, or IBNR. Our reserving practice is to consistently recognize the actuarial best point estimate within a level of confidence required by actuarial standards. Actuarial standards of practice generally require a level of confidence such that the liabilities established for IBNR have a greater probability of being adequate versus being insufficient, or such that the liabilities established for IBNR are sufficient to cover obligations under an assumption of moderately adverse conditions. Adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of the estimate. Therefore, in many situations, the claim amounts ultimately settled will be less than the estimate that satisfies the actuarial standards of practice.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We develop our estimate for IBNR using actuarial methodologies and assumptions, primarily based upon historical claim experience. Depending on the period for which incurred claims are estimated, we apply a different method in determining our estimate. For periods prior to the most recent two months, a completion factor method uses historical paid claims patterns to estimate the percentage of claims incurred during a given period that have historically been adjudicated as of the reporting period. Changes in claim inventory levels and known changes in claim payment processes are taken into account in these estimates. For the most recent two months, the incurred claims are estimated primarily from a trend analysis based upon per member per month claims trends developed from our historical experience in the preceding months, adjusted for known changes in estimates of hospital admissions, recent hospital and drug utilization data, provider contracting changes, changes in benefit levels, changes in member cost sharing, changes in medical management processes, product mix, and workday seasonality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The completion factor method is used for the months of incurred claims prior to the most recent two months because the historical percentage of claims processed for those months is at a level sufficient to produce a consistently reliable result. Conversely, for the most recent two months of incurred claims, the volume of claims processed historically is not at a level sufficient to produce a reliable result, which therefore requires us to examine historical trend patterns as the primary method of evaluation. Changes in claim processes, including recoveries of overpayments, receipt cycle times, claim inventory levels, outsourcing, system conversions, and processing disruptions due to weather or other events affect views regarding the reasonable choice of completion factors. Claim payments to providers for services rendered are often net of overpayment recoveries for claims paid previously, as contractually allowed. Claim overpayment recoveries can result from many different factors, including retroactive enrollment activity, audits of provider billings, and/or payment errors. Changes in patterns of claim overpayment recoveries can be unpredictable and result in completion factor volatility, as they often impact older dates of service. The receipt cycle time measures the average length of time between when a medical claim was initially incurred and when the claim form was received. Increases in electronic claim submissions from providers decrease the receipt cycle time. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claim may be more (less) complete than originally estimated using our completion factors, which may result in reserves that are higher (lower) than required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical cost trends potentially are more volatile than other segments of the economy. The drivers of medical cost trends include increases in the utilization of hospital facilities, physician services, new higher priced technologies and medical procedures, and new prescription drugs and therapies, as well as the inflationary effect on the cost per unit of each of these expense components. Other external factors such as government-mandated benefits or other regulatory changes, the tort liability system, increases in medical services capacity, direct to consumer advertising for prescription drugs and medical services, an aging population, lifestyle changes including diet and smoking, catastrophes, public health emergencies, epidemics and pandemics (such as the spread of COVID-19) also may impact medical cost trends. Internal factors such as system conversions, claims processing cycle times, changes in medical management practices and changes in provider contracts also may impact our ability to accurately predict estimates of historical completion factors or medical cost trends. All of these factors are considered in estimating IBNR and in estimating the per member per month claims trend for purposes of determining the reserve for the most recent two months. Additionally, we continually prepare and review follow-up studies to assess the reasonableness of the estimates generated by our process and methods over time. The results of these studies are also considered in determining the reserve for the most recent two months. Each of these factors requires significant judgment by management.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We reassess the profitability of our contracts for providing insurance coverage to our members when current operating results or forecasts indicate probable future losses. We establish a premium deficiency reserve in current operations to the extent that the sum of expected future costs, claim adjustment expenses, and maintenance costs exceeds related future premiums under contracts without consideration of investment income. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with our method of acquiring, servicing, and measuring the profitability of such contracts. Losses recognized as a premium deficiency result in a beneficial effect in subsequent periods as operating losses under these contracts are charged to the liability previously established. Because the majority of our member contracts renew annually, we would not record a material premium deficiency reserve, except when unanticipated adverse events or changes in circumstances indicate otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe our benefits payable are adequate to cover future claims payments required. However, such estimates are based on knowledge of current events and anticipated future events. Therefore, the actual liability could differ materially from the amounts provided.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Future policy benefits payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future policy benefits payable includes liabilities for long-duration insurance policies primarily related to certain blocks of insurance assumed in acquisitions, primarily life and annuities in run-off status, and are included in our consolidated balance sheet within other long-term liabilities. Most of these policies are subject to reinsurance as detailed in Note 19.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Book Overdraft&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our cash management system, checks issued but not yet presented to banks that would result in negative bank balances when presented are classified as a current liability in the consolidated balance sheets. Changes in book overdrafts from period to period are reported in the consolidated statement of cash flows as a financing activity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize an asset or liability for the deferred tax consequences of temporary differences between the tax bases of assets or liabilities and their reported amounts in the consolidated financial statements. These temporary differences will result in taxable or deductible amounts in future years when the reported amounts of the assets or liabilities are recovered or settled. We also recognize the future tax benefits such as net operating and capital loss carryforwards as deferred tax assets. A valuation allowance is provided against these deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. Future years&#x2019; tax expense may be increased or decreased by adjustments to the valuation allowance or to the estimated accrual for income taxes. Deferred tax assets and deferred tax liabilities are further adjusted for changes in the enacted tax rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record tax benefits when it is more likely than not that the tax return position taken with respect to a particular transaction will be sustained. A liability, if recorded, is not considered resolved until the statute of limitations for the relevant taxing authority to examine and challenge the tax position has expired, or the tax position is ultimately settled through examination, negotiation, or litigation. We classify interest and penalties associated with uncertain tax positions in our provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned affiliates that we control. Accordingly, we record noncontrolling interests in the earnings and equity of such entities. We record adjustments to noncontrolling interests for the allocable portion of income or loss to which the noncontrolling interest holders are entitled based upon their portion of the subsidiaries they own. Distributions to holders of noncontrolling interests are adjusted to the respective noncontrolling interest holders&#x2019; balances. Noncontrolling interests, which relate to the minority ownership held by third party investors in certain of our businesses within our Insurance and CenterWell segments, are reported below net income under the heading &#x201c;Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;income attributable to noncontrolling interests&#x201d; in the consolidated statements of income and presented as a component of equity in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally recognize stock-based compensation expense, as determined on the date of grant at fair value, on a straight-line basis over the period during which an employee is required to provide service in exchange for the award (the vesting period). In addition, for awards with both time and performance-based conditions, we generally recognize compensation expense on a straight line basis over the vesting period when it is probable that the performance condition will be achieved. We estimate expected forfeitures and recognize compensation expense only for those awards which are expected to vest. We estimate the grant-date fair value of stock options using the Black-Scholes option-pricing model. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Additional detail regarding our stock-based compensation plans is included in Note 14.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We compute basic earnings per common share on the basis of the weighted-average number of unrestricted common shares outstanding. Diluted earnings per common share is computed on the basis of the weighted-average number of unrestricted common shares outstanding plus the dilutive effect of outstanding employee stock options and restricted shares, or units, using the treasury stock method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Additional detail regarding earnings per common share is included in Note 15.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value are categorized into a fair value hierarchy based on whether the inputs to valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our own assumptions about the assumptions market participants would use. The fair value hierarchy includes three levels of inputs that may be used to measure fair value as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2013; Quoted prices in active markets for identical assets or liabilities. Level 1 assets and liabilities include securities that are traded in an active exchange market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 &#x2013; Observable inputs other than Level 1 prices such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments as well as debt securities whose value is determined using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 &#x2013; Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes assets and liabilities whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting our own assumptions about the assumptions market participants would use as well as those requiring significant management judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value of actively traded debt and equity securities are based on quoted market prices. Fair value of other debt securities are based on quoted market prices of identical or similar securities or based on observable inputs like interest rates generally using a market valuation approach, or, less frequently, an income valuation approach and are generally classified as Level 2. Fair value of privately held investment grade debt securities are estimated using a variety of valuation methodologies, including both market and income approaches, where an observable quoted market does not exist and are generally classified as Level 3. For privately-held investment grade debt securities, such methodologies include reviewing the value ascribed to the most recent financing, comparing the security with &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;securities of publicly-traded companies in similar lines of business with similar credit characteristics, and reviewing the underlying financial performance including estimating discounted cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We obtain at least one price for each security from a third party pricing service. These prices are generally derived from recently reported trades for identical or similar securities, including adjustments through the reporting date based upon observable market information. When quoted prices are not available, the third party pricing service may use quoted market prices of comparable securities or discounted cash flow analysis, incorporating inputs that are currently observable in the markets for similar securities. Inputs that are often used in the valuation methodologies include benchmark yields, reported trades, credit spreads, broker quotes, default rates, and prepayment speeds. We are responsible for the determination of fair value and as such we perform analysis on the prices received from the third party pricing service to determine whether the prices are reasonable estimates of fair value. Our analysis includes a review of monthly price fluctuations as well as a quarterly comparison of the prices received from the pricing service to prices reported by our third party investment adviser. In addition, on a quarterly basis we examine the underlying inputs and assumptions for a sample of individual securities across asset classes, credit rating levels, and various durations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Pronouncements Effective in Future Periods&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#x2014;Insurance (Topic 944): Effective Date and Early Application (&#x201c;ASU 2020-11&#x201d;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#x2014;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#x201c;ASU 2018-12&#x201d;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare supplement product which represent less than 1% of consolidated premiums and services revenue, is effective for us beginning with annual and interim periods in 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzE5_2929aaa2-4a3c-4d79-b038-b67d2b930e42">&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial statements and accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America. Our consolidated financial statements include the accounts of Humana Inc. and subsidiaries that the Company controls, including variable interest entities associated with medical practices for which we are the primary beneficiary. We do not own many of our medical practices but instead enter into exclusive management agreements with the affiliated Professional Associations, or P.A.s, that operate these medical practices. Based upon the provisions of these agreements, these affiliated P.A.s are variable interest entities and we are the primary beneficiary, and accordingly we consolidate the affiliated P.A.s. All significant intercompany balances and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. The areas involving the most significant use of estimates are the estimation of benefits payable, the impact of risk adjustment provisions related to our Medicare contracts, the valuation and related impairment recognition of investment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;securities, and the valuation and related impairment recognition of long-lived assets, including goodwill and indefinite-lived intangible assets. These estimates are based &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;on knowledge of current events and anticipated future events, and accordingly, actual results may ultimately differ materially from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Value Creation Initiatives&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, in order to create capacity to fund growth and investment in our Medicare Advantage business and further expansion of our healthcare services capabilities in 2023, we committed to drive additional value for the enterprise through cost saving, productivity initiatives, and value acceleration from previous investments. As a result of these initiatives, we recorded charges of $473&#160;million included within operating costs in the consolidated statement of income for the year ended December 31, 2022. These charges primarily relate to $248&#160;million in asset impairments, including software and abandonment, and $116&#160;million of severance charges in connection with workforce optimization. The remainder of the charges primarily relate to external consulting fees. These charges were recorded at the corporate level and not allocated to the segments.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:RestructuringCostsAndAssetImpairmentCharges
      contextRef="icb9c2813455d48969d1c9c193176fa13_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ5NDc4MDIzOTAzMzg_e56eed4c-1707-4185-b6f5-4cdfc441be93"
      unitRef="usd">473000000</us-gaap:RestructuringCostsAndAssetImpairmentCharges>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="icb9c2813455d48969d1c9c193176fa13_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzEwOTk1MTE2OTU3Nzk_5ab5b6d8-1f4e-4c2d-abe9-56938e983e45"
      unitRef="usd">248000000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:SeveranceCosts1
      contextRef="icb9c2813455d48969d1c9c193176fa13_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ5NDc4MDIzOTA0ODg_565661b0-78bd-4b13-9705-42a09224bea3"
      unitRef="usd">116000000</us-gaap:SeveranceCosts1>
    <hum:HealthCareReformPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1ODA0_0941f7e1-4d98-4461-af77-a90f2e90b7e0">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Health Care Reform&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Patient Protection and Affordable Care Act and The Health Care and Education Reconciliation Act of 2010 (which we collectively refer to as the Health Care Reform Law) enacted significant reforms to various aspects of the U.S. health insurance industry. Certain of these reforms became effective January 1, 2014, including an annual insurance industry premium-based fee. The Continuing Resolution bill, H.R. 195, enacted on January 22, 2018, included a one year suspension in 2019 of the health insurance industry fee, but the fee resumed in calendar year 2020. The Further Consolidated Appropriations Act, 2020, enacted on December 20, 2019, permanently repealed the health insurance industry fee beginning in calendar year 2021. &lt;/span&gt;&lt;/div&gt;The annual premium-based fee on health insurers was not deductible for tax purposes. We estimated a liability for the health insurance industry fee and recorded it in full once qualifying insurance coverage was provided in the applicable calendar year in which the fee was payable with a corresponding deferred cost that was amortized ratably to expense over the same calendar year. We recorded the liability for the health insurance industry fee in trade accounts payable and accrued expenses and recorded the deferred cost in other current assets in our consolidated financial statements. We paid the health insurance industry fee in September or October of each year.</hum:HealthCareReformPolicyTextBlock>
    <hum:PaymentOfAnnualHealthInsuranceIndustryFee
      contextRef="i3a4c2fcb56be4c3697d752d81e29b9d4_D20200101-20201231"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQzNDI_7a30de11-2283-46c0-886b-cb2f8c7b3509"
      unitRef="usd">1180000000</hum:PaymentOfAnnualHealthInsuranceIndustryFee>
    <hum:GainContingencyRecoverySought
      contextRef="ic581aed5cfed42a7a2f64bd4ed501897_I20171102"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ2MzU_d1178b40-e137-4cdd-a6ad-0296c27f2833"
      unitRef="usd">611000000</hum:GainContingencyRecoverySought>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="i72beb26dbcd64e57a53b102d2216d4e3_D20200901-20200930"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzUwMzA_44e7f70c-8ca1-4d5d-93a0-44a27939f84d"
      unitRef="usd">609000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty
      contextRef="ia736406081164b128479b1d1f0573b44_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzUxNTA_18ac6d19-3951-481f-be48-0f817dd94010"
      unitRef="usd">609000000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <us-gaap:LitigationSettlementExpense
      contextRef="ia736406081164b128479b1d1f0573b44_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzUyMTI_a50940cf-b5f7-4ac2-92bd-4af5d765c7fc"
      unitRef="usd">31000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzEy_8419713f-9434-40ad-b654-9319f5853404">&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents include cash, time deposits, money market funds, commercial paper, other money market instruments, and certain U.S. Government securities with an original maturity of three months or less. Carrying value approximates fair value due to the short-term maturity of the investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzQz_45096bba-fd1c-49b6-8c0c-5642947071c9">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Investment Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment securities, which consist of debt and equity securities, are stated at fair value. Our debt securities have been categorized as available for sale. Debt securities available for current operations, as well as our equity securities, are classified as current assets, and debt securities available to fund our professional and other self-insurance liability requirements, as well as restricted statutory deposits, are classified as long-term assets. For the purpose of determining realized gross gains and losses for debt securities sold, that are included as a component of investment income in the consolidated statements of income, the cost of investment securities sold is based upon specific identification. Unrealized holding gains and losses for debt securities, net of applicable deferred taxes, are included in other comprehensive income or loss as a component of stockholders&#x2019; equity until realized from a sale or an expected credit loss is recognized. For the purpose of determining gross gains and losses for equity securities, changes in fair value at the reporting date are included as a component of investment income in the consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning on January 1, 2020, we adopted the new current expected credit losses, or CECL, model which retained many similarities from the previous other-than-temporary impairment model except eliminating from consideration in the impairment analysis the length of time over which the fair value had been less than cost. Also, under the CECL model, expected losses on available for sale debt securities are recognized through an allowance for credit losses rather than as reductions in the amortized cost of the securities. For debt securities whose fair value is less than their amortized cost which we do not intend to sell or are not required to sell, we evaluate the expected cash flows to be received as compared to amortized cost and determine if an expected credit loss has occurred. In the event of an expected credit loss, only the amount of the impairment associated with the expected credit loss is recognized in income with the remainder, if any, of the loss recognized in other comprehensive income.  To the extent we have the intent to sell the debt security or it is more likely than not we will be required to sell the debt security before recovery of our amortized cost basis, we recognize an impairment loss in income in an amount equal to the full difference between the amortized cost basis and the fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potential expected credit loss impairment is considered using a variety of factors, including the extent to which the fair value has been less than cost; adverse conditions specifically related to the industry, geographic area or financial condition of the issuer or underlying collateral of a debt security; changes in the quality of the debt security's credit enhancement; payment structure of the debt security; changes in credit rating of the debt security by the rating agencies; failure of the issuer to make scheduled principal or interest payments on the debt security and changes in prepayment speeds. For debt securities, we take into account expectations of relevant market and economic data. For example, with respect to mortgage and asset-backed securities, such data includes underlying loan level data and structural features such as seniority and other forms of credit enhancements. We estimate the amount of the expected credit loss component of a debt security as the difference between the amortized cost and the present value of the expected cash flows of the security. The present value is determined using the best estimate of future cash flows discounted at the implicit interest rate at the date of purchase. The expected credit loss cannot exceed the full difference between the amortized cost basis and the fair value.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentPolicyTextBlock>
    <hum:CommercialMembershipContractTerm
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzU0OTc1NTg4ODc3Ng_6a6976a4-8085-4bd6-9291-d31fb67f1c99">P1Y</hum:CommercialMembershipContractTerm>
    <hum:NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzk5NzI_c2fbb6c4-4621-4ac6-9dc9-9b384f23cfbe">P30D</hum:NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies>
    <us-gaap:InsurancePremiumsRevenueRecognitionPolicy
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzA4_cc23a6ee-17c1-412c-bfe7-21c11ef19576">&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Premiums Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We receive monthly premiums from the federal government and various states according to government specified payment rates and various contractual terms. We bill and collect premium from employer groups and members in our Medicare and other individual products monthly.  Changes in premium revenues resulting from the periodic changes in risk-adjustment scores derived from medical diagnoses for our membership are estimated by projecting the ultimate annual premium and are recognized ratably during the year, with adjustments each period to reflect changes in the ultimate premium. Receivables or payables are classified as current or long-term in our consolidated balance sheet based on the timing of the expected settlement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premiums revenue is estimated by multiplying the membership covered under the various contracts by the contractual rates. Premiums revenue is recognized as income in the period members are entitled to receive services and is net of estimated uncollectible amounts, retroactive membership adjustments, and adjustments to recognize rebates under the minimum benefit ratios required under the Health Care Reform Law. We estimate policyholder rebates by projecting calendar year minimum benefit ratios for the small group and large group markets, as defined by the Health Care Reform Law using a methodology prescribed by Health and Human Services, or HHS, separately by state and legal entity. Medicare Advantage and Medicaid products are also subject to minimum benefit ratio requirements. Estimated calendar year rebates recognized ratably during the year are revised each period to reflect current experience. Retroactive membership adjustments result from enrollment changes not yet processed, or not yet reported by an employer group or the government. We routinely monitor the collectability of specific accounts, the aging of receivables, historical retroactivity trends, estimated rebates, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. Premiums received prior to the service period are recorded as unearned revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medicare Part D&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with CMS. The payments we receive monthly from CMS and members, which are determined from our annual bid, represent amounts for providing prescription drug insurance coverage. We recognize premiums revenue for providing this insurance coverage ratably over the term of our annual contract. Our CMS payment is subject to risk sharing through the Medicare Part D risk corridor provisions. In addition, receipts for reinsurance and low-income cost subsidies as well as receipts for certain discounts on brand name prescription drugs in the coverage gap represent payments for prescription drug costs for which we are not at risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risk corridor provisions compare costs targeted in our bids to actual prescription drug costs, limited to actual costs that would have been incurred under the standard coverage as defined by CMS. Variances exceeding certain thresholds may result in CMS making additional payments to us or require us to refund to CMS a portion of the premiums we received. As risk corridor provisions are considered in our overall annual bid process, we estimate and recognize an adjustment to premiums revenue related to these provisions based upon pharmacy claims experience. We record a receivable or payable at the contract level and classify the amount as current or long-term in our consolidated balance sheets based on the timing of expected settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance and low-income cost subsidies represent funding from CMS in connection with the Medicare Part D program for which we assume no risk. Reinsurance subsidies represent funding from CMS for its portion of prescription drug costs which exceed the member&#x2019;s out-of-pocket threshold, or the catastrophic coverage level. Low-income cost subsidies represent funding from CMS for all or a portion of the deductible, the coinsurance and co-payment amounts above the out-of-pocket threshold for low-income beneficiaries. Monthly prospective payments from CMS for reinsurance and low-income cost subsidies are based on assumptions submitted with our annual bid. A reconciliation and related settlement of CMS&#x2019;s prospective subsidies against actual prescription drug costs we paid is made after the end of the year. The Health Care Reform Law mandates consumer discounts of 50% on brand name prescription drugs for Part D plan participants in the coverage gap. These discounts are funded by CMS and pharmaceutical manufacturers while we administer the application of these funds. We account for these subsidies &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and discounts as a deposit in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits, net in our consolidated statements of cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Part D subsidy/discount payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Part D subsidy/discount reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net reimbursements (payments)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not recognize premiums revenue or benefit expenses for these subsidies or discounts. Receipt and payment activity is accumulated at the contract level and recorded in our consolidated balance sheets in other current assets or trade accounts payable and accrued expenses depending on the contract balance at the end of the reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Settlement of the reinsurance and low-income cost subsidies as well as the risk corridor payment is based on a reconciliation made approximately 9 months after the close of each calendar year. Settlement with CMS for brand name prescription drug discounts is based on a reconciliation made approximately 14 to 18 months after the close of each calendar year. We continue to revise our estimates with respect to the risk corridor provisions based on subsequent period pharmacy claims data. See Note 7 for detail regarding amounts recorded to our consolidated balance sheets related to the risk corridor settlement and subsidies from CMS with respect to the Medicare Part D program.&lt;/span&gt;&lt;/div&gt;</us-gaap:InsurancePremiumsRevenueRecognitionPolicy>
    <hum:ConsumerDiscountsOnBrandNamePrescriptionDrugs
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE0NzM2_6390a0e7-9d4e-4a26-9e19-091b7f10d403"
      unitRef="number">0.50</hum:ConsumerDiscountsOnBrandNamePrescriptionDrugs>
    <hum:ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njc0_146aee57-dcc7-4739-81d7-6581b98c4f04">We account for these subsidies &lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and discounts as a deposit in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits, net in our consolidated statements of cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.198%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.896%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.472%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Part D subsidy/discount payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,530)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,889)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Part D subsidy/discount reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net reimbursements (payments)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(938)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We account for the payments of the federal government&#x2019;s claims and the related reimbursements under deposit accounting in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits,net in our consolidated statements of cash flows.  &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net reimbursements (payments)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</hum:ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock>
    <hum:SubsidyAndDiscountPayments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzItMS0xLTEtMTQwNjQ1_ea0809a1-e667-4d63-ac56-2cd88f9274ef"
      unitRef="usd">16530000000</hum:SubsidyAndDiscountPayments>
    <hum:SubsidyAndDiscountPayments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzItMy0xLTEtMTQwNjQ1_57f01452-05e8-4b8b-9268-aa713bfa7c34"
      unitRef="usd">14889000000</hum:SubsidyAndDiscountPayments>
    <hum:SubsidyAndDiscountPayments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzItNS0xLTEtMTQwNjQ1_993a9342-4cb9-4239-83f1-7525a25f01ff"
      unitRef="usd">13348000000</hum:SubsidyAndDiscountPayments>
    <hum:SubsidyAndDiscountReimbursements
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzMtMS0xLTEtMTQwNjQ1_e8919289-ed61-46dc-8cce-0c45b6604de3"
      unitRef="usd">18498000000</hum:SubsidyAndDiscountReimbursements>
    <hum:SubsidyAndDiscountReimbursements
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzMtMy0xLTEtMTQwNjQ1_9a4d2119-c6c2-4612-97af-c116daa6341a"
      unitRef="usd">14628000000</hum:SubsidyAndDiscountReimbursements>
    <hum:SubsidyAndDiscountReimbursements
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzMtNS0xLTEtMTQwNjQ1_461ec9e1-ed4d-4059-93c5-d8330c90f71a"
      unitRef="usd">12410000000</hum:SubsidyAndDiscountReimbursements>
    <hum:SubsidyAndDiscountPaymentsInExcessOfReimbursements
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzQtMS0xLTEtMTQwNjQ1_87d4aa7e-19dc-4123-9fb5-6320ddb5272e"
      unitRef="usd">-1968000000</hum:SubsidyAndDiscountPaymentsInExcessOfReimbursements>
    <hum:SubsidyAndDiscountPaymentsInExcessOfReimbursements
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzQtMy0xLTEtMTQwNjQ1_8282da20-76f2-4fe8-954b-9c5517515025"
      unitRef="usd">261000000</hum:SubsidyAndDiscountPaymentsInExcessOfReimbursements>
    <hum:SubsidyAndDiscountPaymentsInExcessOfReimbursements
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZToyODhjMDZmMTM1YjE0NDhlYWU1ZjM3NDY1YmIyODYxMC90YWJsZXJhbmdlOjI4OGMwNmYxMzViMTQ0OGVhZTVmMzc0NjViYjI4NjEwXzQtNS0xLTEtMTQwNjQ1_249adc80-48dd-4b71-976d-81a3f4b91199"
      unitRef="usd">938000000</hum:SubsidyAndDiscountPaymentsInExcessOfReimbursements>
    <hum:SubsidyAndDiscountsSettlementPeriodAfterClose
      contextRef="i98b5cd0e14da45a2a65ccbb7b999b126_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE1NjU0_1a7025c2-0785-4f43-935e-fbfcb3fa141f">P9M</hum:SubsidyAndDiscountsSettlementPeriodAfterClose>
    <hum:SubsidyAndDiscountsSettlementPeriodAfterClose
      contextRef="id0a1f1c3b72a40b3b4bdbf0a7f076fe1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE1ODE0_dabafcb3-3223-4fe1-92a6-f1e5054873f0">P14M</hum:SubsidyAndDiscountsSettlementPeriodAfterClose>
    <hum:SubsidyAndDiscountsSettlementPeriodAfterClose
      contextRef="ie78f1bb938b8481f8841f9c8c53b4b44_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE1ODIw_1e1af58d-5a8a-4287-a891-7bf34a8f11ba">P18M</hum:SubsidyAndDiscountsSettlementPeriodAfterClose>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njc3_8dee89a8-cf1f-4cb2-a678-7e8ff8adab82">&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Services Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient services revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Patient services include services related to pharmacy, provider services, and home solutions services, such as home health and other services and capabilities to promote wellness and advance population health. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our pharmacy business, external pharmacy revenues include the cost of pharmaceuticals (net of rebates), a negotiated dispensing fee and customer co-payments for drugs dispensed through our CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. Pharmacy products are billed to customers based on the number of transactions occurring during the billing period. Services revenues related to product revenues from dispensing prescriptions are recorded when the prescription or product is shipped.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our provider services business recognizes revenues for certain value-based arrangements. Under these value-based arrangements, we enter into agreements with health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our patients. In exchange, we receive a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our patients. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our home solutions businesses, revenues include net patient services revenue recorded based upon established billing rates, net of contractual allowances, discounts, or other implicit price concessions, and are recognized as performance obligations are satisfied, which is in the period services are rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the&#160;year ended December&#160;31, 2022, revenue recognized from performance obligations related to prior periods (for example, due to changes in transaction price), was not material. Further, revenue expected to be recognized in any future year related to remaining performance obligations is not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Administrative services fees &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Administrative services fees cover the processing of claims, offering access to our provider networks and clinical programs, and responding to customer service inquiries from members of self-funded groups. Revenues from providing administration services, also known as administrative services only, or ASO, are recognized in the period services are performed and are net of estimated uncollectible amounts. ASO fees are estimated by multiplying the membership covered under the various contracts by the contractual rates. Under ASO contracts, self-funded employers retain the risk of financing substantially all of the cost of health benefits. However, many ASO customers purchase stop loss insurance coverage from us to cover catastrophic claims or to limit aggregate annual costs. Accordingly, we have recorded premiums revenue and benefits expense related to these stop loss insurance contracts. We routinely monitor the collectability of specific accounts, the aging of receivables, as well as prevailing and anticipated economic conditions, and reflect any required adjustments in current operations. ASO fees received prior to the service period are recorded as unearned revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Under our TRICARE contracts with the Department of Defense (DoD) we provide administrative services, including offering access to our provider networks and clinical programs, claim processing, customer service, enrollment, and other services, while the federal government retains all of the risk of the cost of health benefits. We account for revenues under our contracts net of estimated health care costs similar to an administrative services fee only agreement. Our contracts include fixed administrative services fees and incentive fees and penalties. Administrative services fees are recognized as services are performed.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our TRICARE members are served by both in-network and out-of-network providers in accordance with our contracts. We pay health care costs related to these services to the providers and are subsequently reimbursed by the DoD for such payments. We account for the payments of the federal government&#x2019;s claims and the related reimbursements under deposit accounting in our consolidated balance sheets and as a financing activity under receipts (withdrawals) from contract deposits,net in our consolidated statements of cash flows.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.448%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health care cost reimbursements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net reimbursements (payments)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <hum:HealthCareCostPayments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzItMS0xLTEtMTQwNjQ1_0f1bbaf8-0ecb-48a2-b282-ffe716c7c9c9"
      unitRef="usd">7110000000</hum:HealthCareCostPayments>
    <hum:HealthCareCostPayments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzItMy0xLTEtMTQwNjQ1_2dab1383-e870-464d-b5e7-6f5e8c6b42c6"
      unitRef="usd">6943000000</hum:HealthCareCostPayments>
    <hum:HealthCareCostPayments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzItNS0xLTEtMTQwNjQ1_80338290-a4e1-41a4-92d2-d73e00996931"
      unitRef="usd">6253000000</hum:HealthCareCostPayments>
    <hum:HealthCareCostReimbursements
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzMtMS0xLTEtMTQwNjQ1_b0d73e95-9b9b-44d6-8d8b-4e28ee604e17"
      unitRef="usd">7135000000</hum:HealthCareCostReimbursements>
    <hum:HealthCareCostReimbursements
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzMtMy0xLTEtMTQwNjQ1_e90af891-cbcd-4729-b959-ba71eb088953"
      unitRef="usd">6898000000</hum:HealthCareCostReimbursements>
    <hum:HealthCareCostReimbursements
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzMtNS0xLTEtMTQwNjQ1_16387a74-3b3f-4841-a48d-ccfdde82d57b"
      unitRef="usd">6252000000</hum:HealthCareCostReimbursements>
    <hum:HealthCareCostPaymentsAndReimbursementsNet
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzQtMS0xLTEtMTQwNjQ1_390f31ba-3a91-4df7-8e5e-c83dfea8b21d"
      unitRef="usd">-25000000</hum:HealthCareCostPaymentsAndReimbursementsNet>
    <hum:HealthCareCostPaymentsAndReimbursementsNet
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzQtMy0xLTEtMTQwNjQ1_02c0fc5f-037f-4872-8186-bd6af0b2e3c5"
      unitRef="usd">45000000</hum:HealthCareCostPaymentsAndReimbursementsNet>
    <hum:HealthCareCostPaymentsAndReimbursementsNet
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90YWJsZTo4Yzg2NmEzNjkyNDk0ZmRkODAzN2UzOWEzZTU2OGVjNS90YWJsZXJhbmdlOjhjODY2YTM2OTI0OTRmZGQ4MDM3ZTM5YTNlNTY4ZWM1XzQtNS0xLTEtMTQwNjQ1_880e8bc4-bc02-4387-9d29-e3a5757cbb0a"
      unitRef="usd">1000000</hum:HealthCareCostPaymentsAndReimbursementsNet>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzIx_b972feb5-46b5-433e-83a2-ac51435e631a">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Receivables, including premium receivables, patient services revenue receivables, and ASO fee receivables, are shown net of allowances for estimated uncollectible accounts, retroactive membership adjustments, and contractual allowances.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="iea3fc08d0e0f43fe959d292fad010549_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE5OTE4_dde0769c-e976-4599-8bd5-55cd6c588d4f"
      unitRef="usd">291000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2987740b0cdb40188339b7acd6a0181b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzE5OTI1_937a10a9-b38f-4e4b-a17b-853cb2a2a080"
      unitRef="usd">475000000</us-gaap:AccountsReceivableNetCurrent>
    <hum:OtherCurrentAssetsPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzMx_7bca4149-472c-4f4f-806d-baecb44cac2d">Other Current AssetsOther current assets include amounts associated with Medicare Part D as discussed above and in Note 7, rebates due from pharmaceutical manufacturers and other amounts due within one year.  We accrue pharmaceutical rebates as they are earned based on contractual terms and usage of the product.</hum:OtherCurrentAssetsPolicyTextBlock>
    <hum:AccruedPharmaceuticalRebatesCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIwNTMz_1a6d164d-4892-4479-a6eb-647523216362"
      unitRef="usd">2000000000</hum:AccruedPharmaceuticalRebatesCurrent>
    <hum:AccruedPharmaceuticalRebatesCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIwNTMz_51d0d341-372c-4d9d-b4d3-7b312284798a"
      unitRef="usd">2000000000</hum:AccruedPharmaceuticalRebatesCurrent>
    <hum:AcquisitionCostsPolicyPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njk5_df384ad2-1662-472e-8a85-07747fcc6932">&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Policy Acquisition Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Policy acquisition costs are those costs that relate directly to the successful acquisition of new and renewal insurance policies. Such costs include commissions, costs of policy issuance and underwriting, and other costs we incur to acquire new business or renew existing business. We expense policy acquisition costs related to our employer-group prepaid health services policies as incurred. These short-duration employer-group prepaid health services policies typically have a 1-year term and may be canceled upon 30 days notice by the employer group.&lt;/span&gt;&lt;/div&gt;</hum:AcquisitionCostsPolicyPolicyTextBlock>
    <hum:TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxMDc4_7f190590-3fe7-49ab-8f77-0c195759ddfa">P1Y</hum:TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies>
    <hum:NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxMTE2_a429f53a-a59b-4759-be36-89b38f5b2036">P30D</hum:NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzYx_c1b58500-ee16-4677-8ce2-818686c912cc">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is recorded at cost. Gains and losses on sales or disposals of property and equipment are included in operating costs in our consolidated income statements. Certain costs related to the development or purchase of internal-use software are capitalized. Depreciation is computed using the straight-line method over estimated useful lives ranging from 3 to 10 years for equipment, 3 to 5 years for computer software, and 10 to 20 years for buildings. Improvements to leased facilities are depreciated over the shorter of the remaining lease term or the anticipated life of the improvement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically review long-lived assets, including property and equipment and other definite-lived intangible assets, for impairment whenever adverse events or changes in circumstances indicate the carrying value of the asset may not be recoverable. Losses are recognized for a long-lived asset to be held and used in our operations when the undiscounted future cash flows expected to result from the use of the asset are less than its carrying value. We recognize an impairment loss based on the excess of the carrying value over the fair value of the asset. A long-lived asset held for sale is reported at the lower of the carrying amount or fair value less costs to sell. Depreciation expense is not recognized on assets held for sale. Losses are recognized for a long-lived asset to be abandoned when the asset ceases to be used. In addition, we periodically review the estimated lives of all long-lived assets for reasonableness.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id079b2db40e84b14a641fb9b1eb51da6_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTA2_2d9c2163-164e-4b7c-8e1a-ee29cf1ef631">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="iaaab669d71af421191ca3584d7396347_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTEy_83e20e48-e9dc-4ac8-8bee-386d102cedc2">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i60d881bff54b49609993a08aa88212dd_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTM2_206d08f5-67be-4bea-aa76-160399f645fe">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i05e6d98d428a4d49940ae089d750047d_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTQy_c0bed5cb-027c-44bb-aefe-2ec592501ef9">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i864645f1e72a4441a86287765a3dae2b_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTc4_cc26ce59-6ffd-4f18-baac-d86a5feafec6">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i44ae02ca45e24424b2e1bd6d8003c7bb_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzIxNTg0_d0a01556-c5d1-427d-9179-7feafb75550e">P20Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:EquityMethodInvestmentsPolicy
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzUy_c904d8db-5755-4aa2-a2cc-3ddee02df6e0">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Method Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We use the equity method of accounting for equity investments in companies where we are able to exercise significant influence, but not control, over operating and financial policies of the investee. Judgment regarding the level of influence over each equity method investment includes considering key factors such as our ownership interest, representation on the board of directors, organizational structure, participation in policy-making decisions and material intra-entity transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, under the equity method, original investments in these entities are recorded at cost and subsequently adjusted by our share of equity in income or losses after the date of acquisition as well as capital contributions to and distributions from these companies. Our proportionate share of the net income or loss of these companies is included in consolidated net income.  Investment amounts in excess of our share of an investee&#x2019;s net assets are amortized over the life of the related asset creating the excess. Excess goodwill is not amortized. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by us when reviewing an equity method investment for impairment include the length of time (duration) and the extent (severity) to which the fair value of the equity method investment has been less than carrying value, the investee&#x2019;s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than-temporary is recognized in the period identified.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzE0_fb98743b-e45a-4730-973e-0b754c7a7a84">&lt;div style="text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the unamortized excess of cost over the fair value of the net tangible and other intangible assets acquired. We are required to test at least annually for impairment at a level of reporting referred to as the &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reporting unit, and more frequently if adverse events or changes in circumstances indicate that the asset may be impaired. A reporting unit either is our operating segments or one level below the operating segments, referred to as a component, which comprise our reportable segments. A component is considered a reporting unit if the component constitutes a business for which discrete financial information is available that is regularly reviewed by management. We aggregate the components of an operating segment into one reporting unit if they have similar economic characteristics. Goodwill is assigned to the reporting units that are expected to benefit from the specific synergies of the business combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform a quantitative assessment to review goodwill for impairment to determine both the existence and amount of goodwill impairment, if any. Impairment tests are performed, at a minimum, in the fourth quarter of each year supported by our long-range business plan and annual planning process. We rely on an evaluation of future discounted cash flows to determine fair value of our reporting units. The fair value of our reporting units with significant goodwill exceeded carrying amounts. However, unfavorable changes in key assumptions or combinations of assumptions including a significant increase in the discount rate, decrease in the long-term growth rate or substantial reduction in our underlying cash flow assumptions, including revenue growth rates, medical and operating cost trends, and projected operating income could have a significant negative impact on the estimated fair value of our home solutions and provider reporting units, which accounted for $4.3&#160;billion and $1.1&#160;billion of goodwill, respectively. Impairment tests completed for 2022, 2021, and 2020 did not result in an impairment loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets with indefinite lives relate to Certificate of Needs (CON) and Medicare licenses acquired as part of our acquisition of Kindred at Home, or KAH, and are included within other long-term assets in the consolidated balance sheet at December&#160;31, 2022 and December&#160;31, 2021. See Note 3 for further information. We are required to annually compare the fair values of other indefinite-lived intangible assets to their carrying amounts. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment loss is recognized. Fair values of indefinite-lived intangible assets are determined based on the income approach. Impairment tests completed for 2022 did not result in a material impairment loss. These charges reflect the amount by which the carrying value exceeded its estimated fair value. Impairment tests completed for 2021 did not result in an impairment loss. The fair values of the assets were measured using Level 3 inputs, such as projected revenues and operating cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Definite-lived intangible assets primarily relate to acquired customer contracts/relationships and are included with other long-term assets in the consolidated balance sheets. Definite-lived intangible assets are amortized over the useful life generally using the straight-line method. We review definite-lived intangible assets for impairment under our long-lived asset policy.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:Goodwill
      contextRef="ieab9cc19ff1c48b3834f6647ccd0c104_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NDgw_22614c68-3ad3-47fe-9b38-8877567c0fac"
      unitRef="usd">4300000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i95a27ca7ed954826900c752a38aa4c67_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NDg3_e0bd15db-185a-4595-bd07-5dfbf4399d30"
      unitRef="usd">1100000000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NTY3_322dfa71-fc7e-45f2-940a-34169a0f4b19"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NTY3_64a6ce7f-cd93-4da5-91e6-45ac85481f0b"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzI2NTY3_dd8b7b55-acbe-41a2-87a2-eb79e83aad8f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <hum:BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njgw_74c7fd3a-25b2-453e-a260-d3546785f79a">&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Benefits Payable and Benefits Expense Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefits expense includes claim payments, capitation payments, pharmacy costs net of rebates, allocations of certain centralized expenses and various other costs incurred to provide health insurance coverage to members, as well as estimates of future payments to hospitals and others for medical care and other supplemental benefits provided on or prior to the balance sheet date. Capitation payments represent monthly contractual fees disbursed to primary care and other providers who are responsible for providing medical care to members. Pharmacy costs represent payments for members&#x2019; prescription drug benefits, net of rebates from drug manufacturers. Receivables for such pharmacy rebates are included in other current assets in our consolidated balance sheets. Other supplemental benefits include dental, vision, and other supplemental health products.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the costs of our benefits expense payments using actuarial methods and assumptions based upon claim payment patterns, medical cost inflation, historical developments such as claim inventory levels and claim receipt patterns, and other relevant factors, and record benefit reserves for future payments. We continually review estimates of future payments relating to claims costs for services incurred in the current and prior periods and make necessary adjustments to our reserves.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Benefits expense is recognized in the period in which services are provided and includes an estimate of the cost of services which have been incurred but not yet reported, or IBNR. Our reserving practice is to consistently recognize the actuarial best point estimate within a level of confidence required by actuarial standards. Actuarial standards of practice generally require a level of confidence such that the liabilities established for IBNR have a greater probability of being adequate versus being insufficient, or such that the liabilities established for IBNR are sufficient to cover obligations under an assumption of moderately adverse conditions. Adverse conditions are situations in which the actual claims are expected to be higher than the otherwise estimated value of such claims at the time of the estimate. Therefore, in many situations, the claim amounts ultimately settled will be less than the estimate that satisfies the actuarial standards of practice.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We develop our estimate for IBNR using actuarial methodologies and assumptions, primarily based upon historical claim experience. Depending on the period for which incurred claims are estimated, we apply a different method in determining our estimate. For periods prior to the most recent two months, a completion factor method uses historical paid claims patterns to estimate the percentage of claims incurred during a given period that have historically been adjudicated as of the reporting period. Changes in claim inventory levels and known changes in claim payment processes are taken into account in these estimates. For the most recent two months, the incurred claims are estimated primarily from a trend analysis based upon per member per month claims trends developed from our historical experience in the preceding months, adjusted for known changes in estimates of hospital admissions, recent hospital and drug utilization data, provider contracting changes, changes in benefit levels, changes in member cost sharing, changes in medical management processes, product mix, and workday seasonality.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The completion factor method is used for the months of incurred claims prior to the most recent two months because the historical percentage of claims processed for those months is at a level sufficient to produce a consistently reliable result. Conversely, for the most recent two months of incurred claims, the volume of claims processed historically is not at a level sufficient to produce a reliable result, which therefore requires us to examine historical trend patterns as the primary method of evaluation. Changes in claim processes, including recoveries of overpayments, receipt cycle times, claim inventory levels, outsourcing, system conversions, and processing disruptions due to weather or other events affect views regarding the reasonable choice of completion factors. Claim payments to providers for services rendered are often net of overpayment recoveries for claims paid previously, as contractually allowed. Claim overpayment recoveries can result from many different factors, including retroactive enrollment activity, audits of provider billings, and/or payment errors. Changes in patterns of claim overpayment recoveries can be unpredictable and result in completion factor volatility, as they often impact older dates of service. The receipt cycle time measures the average length of time between when a medical claim was initially incurred and when the claim form was received. Increases in electronic claim submissions from providers decrease the receipt cycle time. If claims are submitted or processed on a faster (slower) pace than prior periods, the actual claim may be more (less) complete than originally estimated using our completion factors, which may result in reserves that are higher (lower) than required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Medical cost trends potentially are more volatile than other segments of the economy. The drivers of medical cost trends include increases in the utilization of hospital facilities, physician services, new higher priced technologies and medical procedures, and new prescription drugs and therapies, as well as the inflationary effect on the cost per unit of each of these expense components. Other external factors such as government-mandated benefits or other regulatory changes, the tort liability system, increases in medical services capacity, direct to consumer advertising for prescription drugs and medical services, an aging population, lifestyle changes including diet and smoking, catastrophes, public health emergencies, epidemics and pandemics (such as the spread of COVID-19) also may impact medical cost trends. Internal factors such as system conversions, claims processing cycle times, changes in medical management practices and changes in provider contracts also may impact our ability to accurately predict estimates of historical completion factors or medical cost trends. All of these factors are considered in estimating IBNR and in estimating the per member per month claims trend for purposes of determining the reserve for the most recent two months. Additionally, we continually prepare and review follow-up studies to assess the reasonableness of the estimates generated by our process and methods over time. The results of these studies are also considered in determining the reserve for the most recent two months. Each of these factors requires significant judgment by management.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We reassess the profitability of our contracts for providing insurance coverage to our members when current operating results or forecasts indicate probable future losses. We establish a premium deficiency reserve in current operations to the extent that the sum of expected future costs, claim adjustment expenses, and maintenance costs exceeds related future premiums under contracts without consideration of investment income. For purposes of determining premium deficiencies, contracts are grouped in a manner consistent with our method of acquiring, servicing, and measuring the profitability of such contracts. Losses recognized as a premium deficiency result in a beneficial effect in subsequent periods as operating losses under these contracts are charged to the liability previously established. Because the majority of our member contracts renew annually, we would not record a material premium deficiency reserve, except when unanticipated adverse events or changes in circumstances indicate otherwise.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We believe our benefits payable are adequate to cover future claims payments required. However, such estimates are based on knowledge of current events and anticipated future events. Therefore, the actual liability could differ materially from the amounts provided.&lt;/span&gt;&lt;/div&gt;</hum:BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock>
    <hum:FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Njky_a8e49135-b779-40b1-bb99-3a4c0c23f9c7">&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Future policy benefits payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future policy benefits payable includes liabilities for long-duration insurance policies primarily related to certain blocks of insurance assumed in acquisitions, primarily life and annuities in run-off status, and are included in our consolidated balance sheet within other long-term liabilities. Most of these policies are subject to reinsurance as detailed in Note 19.&lt;/span&gt;&lt;/div&gt;</hum:FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock>
    <hum:BookOverdraftPolicyPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzU3_4dbc6414-8fac-4454-84ec-628598919d9d">&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Book Overdraft&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under our cash management system, checks issued but not yet presented to banks that would result in negative bank balances when presented are classified as a current liability in the consolidated balance sheets. Changes in book overdrafts from period to period are reported in the consolidated statement of cash flows as a financing activity.&lt;/span&gt;&lt;/div&gt;</hum:BookOverdraftPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzM1_94bb9113-2c5a-4860-a38e-d79f2053a92a">&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize an asset or liability for the deferred tax consequences of temporary differences between the tax bases of assets or liabilities and their reported amounts in the consolidated financial statements. These temporary differences will result in taxable or deductible amounts in future years when the reported amounts of the assets or liabilities are recovered or settled. We also recognize the future tax benefits such as net operating and capital loss carryforwards as deferred tax assets. A valuation allowance is provided against these deferred tax assets if it is more likely than not that some portion or all of the deferred tax assets will not be realized. Future years&#x2019; tax expense may be increased or decreased by adjustments to the valuation allowance or to the estimated accrual for income taxes. Deferred tax assets and deferred tax liabilities are further adjusted for changes in the enacted tax rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record tax benefits when it is more likely than not that the tax return position taken with respect to a particular transaction will be sustained. A liability, if recorded, is not considered resolved until the statute of limitations for the relevant taxing authority to examine and challenge the tax position has expired, or the tax position is ultimately settled through examination, negotiation, or litigation. We classify interest and penalties associated with uncertain tax positions in our provision for income taxes.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <hum:NoncontrollingInterestsPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzQ1_b6861f7c-1d66-474a-8c5a-e5035d1fa654">&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Noncontrolling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include all assets, liabilities, revenues and expenses of less than 100% owned affiliates that we control. Accordingly, we record noncontrolling interests in the earnings and equity of such entities. We record adjustments to noncontrolling interests for the allocable portion of income or loss to which the noncontrolling interest holders are entitled based upon their portion of the subsidiaries they own. Distributions to holders of noncontrolling interests are adjusted to the respective noncontrolling interest holders&#x2019; balances. Noncontrolling interests, which relate to the minority ownership held by third party investors in certain of our businesses within our Insurance and CenterWell segments, are reported below net income under the heading &#x201c;Net &lt;/span&gt;&lt;/div&gt;income attributable to noncontrolling interests&#x201d; in the consolidated statements of income and presented as a component of equity in the consolidated balance sheets.</hum:NoncontrollingInterestsPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1NzY4_76f7bc2b-60c2-4db1-a605-cf9a1e96f901">Stock-Based CompensationWe generally recognize stock-based compensation expense, as determined on the date of grant at fair value, on a straight-line basis over the period during which an employee is required to provide service in exchange for the award (the vesting period). In addition, for awards with both time and performance-based conditions, we generally recognize compensation expense on a straight line basis over the vesting period when it is probable that the performance condition will be achieved. We estimate expected forfeitures and recognize compensation expense only for those awards which are expected to vest. We estimate the grant-date fair value of stock options using the Black-Scholes option-pricing model.</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Nzcy_aa909cd9-d294-4419-8731-98b76e2fdacd">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Earnings Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We compute basic earnings per common share on the basis of the weighted-average number of unrestricted common shares outstanding. Diluted earnings per common share is computed on the basis of the weighted-average number of unrestricted common shares outstanding plus the dilutive effect of outstanding employee stock options and restricted shares, or units, using the treasury stock method.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Nzky_4185a05a-5501-42dd-a516-1abaef139330">&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured at fair value are categorized into a fair value hierarchy based on whether the inputs to valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our own assumptions about the assumptions market participants would use. The fair value hierarchy includes three levels of inputs that may be used to measure fair value as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 1 &#x2013; Quoted prices in active markets for identical assets or liabilities. Level 1 assets and liabilities include securities that are traded in an active exchange market.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 2 &#x2013; Observable inputs other than Level 1 prices such as quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 2 assets and liabilities include debt securities with quoted prices that are traded less frequently than exchange-traded instruments as well as debt securities whose value is determined using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level 3 &#x2013; Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. Level 3 includes assets and liabilities whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques reflecting our own assumptions about the assumptions market participants would use as well as those requiring significant management judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value of actively traded debt and equity securities are based on quoted market prices. Fair value of other debt securities are based on quoted market prices of identical or similar securities or based on observable inputs like interest rates generally using a market valuation approach, or, less frequently, an income valuation approach and are generally classified as Level 2. Fair value of privately held investment grade debt securities are estimated using a variety of valuation methodologies, including both market and income approaches, where an observable quoted market does not exist and are generally classified as Level 3. For privately-held investment grade debt securities, such methodologies include reviewing the value ascribed to the most recent financing, comparing the security with &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;securities of publicly-traded companies in similar lines of business with similar credit characteristics, and reviewing the underlying financial performance including estimating discounted cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We obtain at least one price for each security from a third party pricing service. These prices are generally derived from recently reported trades for identical or similar securities, including adjustments through the reporting date based upon observable market information. When quoted prices are not available, the third party pricing service may use quoted market prices of comparable securities or discounted cash flow analysis, incorporating inputs that are currently observable in the markets for similar securities. Inputs that are often used in the valuation methodologies include benchmark yields, reported trades, credit spreads, broker quotes, default rates, and prepayment speeds. We are responsible for the determination of fair value and as such we perform analysis on the prices received from the third party pricing service to determine whether the prices are reasonable estimates of fair value. Our analysis includes a review of monthly price fluctuations as well as a quarterly comparison of the prices received from the pricing service to prices reported by our third party investment adviser. In addition, on a quarterly basis we examine the underlying inputs and assumptions for a sample of individual securities across asset classes, credit rating levels, and various durations.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ1Nzk3_a6f50b24-c3af-4ec5-8510-a469b1d18a29">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting Pronouncements Effective in Future Periods&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2020, the FASB issued Accounting Standards Update No. 2020-11, Financial Services&#x2014;Insurance (Topic 944): Effective Date and Early Application (&#x201c;ASU 2020-11&#x201d;). The amendments in ASU 2020-11 make changes to the effective date and early application of Accounting Standards Update No. 2018-12, Financial Services&#x2014;Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (&#x201c;ASU 2018-12&#x201d;), which was issued in November 2018. The amendments in ASU 2020-11 have extended the original effective date by one year, and now the amendments are required for our interim and annual reporting periods beginning after December 15, 2022. The new guidance relates to accounting for long-duration contracts of insurers which revises key elements of the measurement models and disclosure requirements for long-duration contracts issued by insurers, including the amortization of deferred contract acquisition costs and the measurement of liabilities for future policy benefits using current, rather than locked-in, assumptions. The new guidance, limited to our Medicare supplement product which represent less than 1% of consolidated premiums and services revenue, is effective for us beginning with annual and interim periods in 2023 and is to be applied to contracts in force on the basis of their existing carrying value amounts at the beginning of the earliest period presented. The adoption of the new standard in 2023 did not have a material impact on our consolidated results of operations, financial position and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There are no other recently issued accounting standards that apply to us or that are expected to have a material impact on our results of operations, financial condition, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i19ce21448fc64f32b2239d5bd098448e_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNDgvZnJhZzpjZjcwMDFjZWViNjA0Y2ZjOTgwMjZkY2ZiNTU1NGIwYS90ZXh0cmVnaW9uOmNmNzAwMWNlZWI2MDRjZmM5ODAyNmRjZmI1NTU0YjBhXzQ5NDc4MDIzODE1MDY_2ae47c25-0d9e-4420-834a-de61bb16b256"
      unitRef="number">0.01</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzM1NDU_9f65faeb-5464-48ba-bacf-cff95f9e8314">ACQUISITIONS AND DIVESTITURES&#160;&#160;&#160;&#160;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;11, 2022, we completed the sale of a 60% i&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;nterest in Humana&#x2019;s Kindred at Home Hospice subsidiary, or KAH Hospice, to Clayton, Dubilier &amp;amp; Rice, or CD&amp;amp;R, for cash proceeds of approximately $2.7&#160;billion, net of cash disposed, including debt repayments from KAH Hospice to Humana of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.9&#160;billion. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the sale, we recognized a pre-tax gain, net of transaction costs, of $237&#160;million which is reported as a gain on sale of KAH Hospice in the accompanying consolidated statement of income for the year ended December 31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, we classified KAH Hospice as held-for-sale and aggregated KAH Hospice&#x2019;s assets and liabilities separately on the balance sheet. The assets, liabilities and noncontrolling interest disposed of on August 11, 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Receivables, net of allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;3,622&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Trade accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;530&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;padding-right:36pt;text-align:center;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets included $866&#160;million identifiable intangibles consisting of Medicare licenses and CON. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the sale of a 60% interest in KAH Hospice on August 11, 2022, as discussed above, KAH Hospice revenues and pretax earnings through the date of sale for the year ended December 31, 2022, were $958&#160;million and $150&#160;million, respectively. KAH Hospice revenues and pretax earnings for the year ended December 31, 2021, were $582&#160;million and $113&#160;million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 17, 2021, we acquired the remaining 60% interest in Kindred at Home, or KAH, the nation&#x2019;s largest home health and hospice provider, from TPG Capital, or TPG, and Welsh, Carson, Anderson &amp;amp; Stowe, or WCAS, two private equity funds, for an enterprise value of $8.2&#160;billion, which included our equity value of $2.4&#160;billion associated with our 40% minority ownership interest. The remeasurement to fair value of our previously held 40% equity method investment with a carrying value of approximately $1.3&#160;billion, resulted in a $1.1&#160;billion gain recognized in "Other (income) expense, net". We paid the approximate $5.8&#160;billion transaction price (net of our existing equity stake) through a combination of debt financing, the assumption of existing KAH indebtedness and parent company cash. The final fair values of KAH&#x2019;s assets acquired and liabilities assumed at the date of the acquisition are summarized as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;5,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;9,049&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;2,857&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;6,170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During 2022, 2021, and 2020 we acquired other health and wellness related businesses which other than the impacts to goodwill, individually or in the aggregate, have not had a material impact on our results of operations, financial condition, or cash flows.  The results of operations and financial condition of these businesses have been included in our consolidated statements of income and consolidated balance sheets from the respective acquisition dates. Acquisition-related costs recognized in each of 2022, 2021 and 2020 were not material to our results of operations. For asset acquisitions the goodwill acquired is partially amortizable as deductible expenses for tax purposes. The pro forma financial information assuming the acquisitions had occurred as of the beginning of the calendar year prior to the year of acquisition, as well as the revenues and earnings generated during the year of acquisition, were not material for disclosure purposes.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcwOTk_c756b1d8-c781-41eb-8bd2-2b9120596953"
      unitRef="number">0.60</hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcxMTQ_4f820175-8e78-4cd2-89c9-3adee45482d3"
      unitRef="usd">2700000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:RepaymentsOfDebt
      contextRef="ib2a53b141d0e477195c76cb94f076fd4_D20220811-20220811"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcxMzM_39c98a3a-9d3c-4f1b-966b-4efc01a5483f"
      unitRef="usd">1900000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
      contextRef="i94ffd24e1fbd46079ca060beb77c46db_D20220811-20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcxNTE_237d02d7-3e0a-48a1-82fc-f16fcd6d62d5"
      unitRef="usd">237000000</us-gaap:DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzM1NTE_aedc3816-53ca-4990-be16-dc90e0041212">The assets, liabilities and noncontrolling interest disposed of on August 11, 2022 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.928%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Receivables, net of allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;3,622&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Trade accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;530&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;11&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;The final fair values of KAH&#x2019;s assets acquired and liabilities assumed at the date of the acquisition are summarized as follows: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.838%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.962%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;5,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;172&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;9,049&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;2,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;2,857&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;6,170&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzMtMS0xLTEtMTQwNjQ1_fbe24630-bf0b-4d33-95d4-7f23b6d04587"
      unitRef="usd">73000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzQtMS0xLTEtMTQwNjQ1_b654f778-329c-4895-ab14-4fb8c60757a4"
      unitRef="usd">194000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzUtMS0xLTEtMTQwNjQ1_af981fd3-2f8c-40e1-b1f1-bc9cf67e87bf"
      unitRef="usd">20000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzYtMS0xLTEtMTQwNjQ1_2cb5aae3-6f71-4891-b2f5-f45bb39390b2"
      unitRef="usd">44000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzctMS0xLTEtMTQwNjQ1_85ab34fa-534e-42c6-8658-019f780445ea"
      unitRef="usd">2331000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzgtMS0xLTEtMTQwNjQ1_b3b8b7f3-19f0-4ef4-b6cb-8ce03167ee0c"
      unitRef="usd">960000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets>
    <us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzktMS0xLTEtMTQwNjQ1_016fc087-96de-4b55-a6f7-18ccaae19faf"
      unitRef="usd">3622000000</us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzEyLTEtMS0xLTE0MDY0NQ_c4d60101-c890-45c7-8135-8b0acdff5773"
      unitRef="usd">245000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzEzLTEtMS0xLTE0MDY0NQ_61d573a1-70ee-4138-b76a-c517ca24c2dd"
      unitRef="usd">285000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzE0LTEtMS0xLTE0MDY0NQ_5248c77c-5256-495b-96b8-56f1a4b11731"
      unitRef="usd">530000000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <hum:DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpjZDA2YTU1Y2E1Mzg0ZWViOWRlZTY1MDUzZDk1NWFiZS90YWJsZXJhbmdlOmNkMDZhNTVjYTUzODRlZWI5ZGVlNjUwNTNkOTU1YWJlXzE1LTEtMS0xLTE0MDY0NQ_71384338-876b-47e2-8b5b-0a379ee64ce5"
      unitRef="usd">11000000</hum:DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent
      contextRef="i82bf2d71677045cb89ab8202ad71abfb_I20220811"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDcxNjk_70074dce-92d1-4fd3-b9c4-c68e871a8022"
      unitRef="usd">866000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent>
    <hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzE2NDkyNjc0NTE0MDk_28c3a965-7ef2-432e-b6de-425d0bd2dac8"
      unitRef="number">0.60</hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i52e9445cef15459ca1a4443266fda6db_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc1ODk_daba424c-47e3-4dd1-aeeb-199682d9de08"
      unitRef="usd">958000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax
      contextRef="i52e9445cef15459ca1a4443266fda6db_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2MDg_3c26d981-9e32-477d-941b-0b9755c05a18"
      unitRef="usd">150000000</us-gaap:IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue
      contextRef="i794c5dbf39734709be53637e3659df79_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDgzODA_dde182d1-4a0e-4bb3-a1bd-8ddc6551b56e"
      unitRef="usd">582000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue>
    <us-gaap:IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax
      contextRef="i794c5dbf39734709be53637e3659df79_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDgzOTk_c5feacc0-ddf1-4328-adad-cff653dad633"
      unitRef="usd">113000000</us-gaap:IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax>
    <hum:BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2MTk_374435a9-fae6-4fc2-9f2f-fa3906460b84"
      unitRef="number">0.60</hum:BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage>
    <hum:BusinessCombinationTotalEnterpriseValueOfAcquiree
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2Nzg_8d8b4f03-e7f0-4403-8d6e-2c37ad44e81f"
      unitRef="usd">8200000000</hum:BusinessCombinationTotalEnterpriseValueOfAcquiree>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1
      contextRef="i5fe4d9a70fd54514aadcf5bc01daa43c_D20210817-20210817"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2NDE_2224fb3f-b470-4ab1-976b-d9d0cce942b0"
      unitRef="usd">2400000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2MjU_72a1d562-addf-41ff-8b82-7c445b0ef3b5"
      unitRef="number">0.40</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgyMzY1MA_85ddb747-8877-4396-b12b-6945ef976a28"
      unitRef="number">0.40</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDgxNDc_17a5fabd-c5f5-4cc1-a38c-a325a65de6ab"
      unitRef="usd">1300000000</us-gaap:EquityMethodInvestments>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i5fe4d9a70fd54514aadcf5bc01daa43c_D20210817-20210817"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDgxNjE_9b5d40d2-12be-40ab-8772-c263de3f6401"
      unitRef="usd">1100000000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <hum:BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90ZXh0cmVnaW9uOjkxZjY2NjQ2MWJkOTQxMmVhNGY2NWE2YTU4YmU1MjY5XzU0OTc1NTgxNDc2NjA_25928038-7ced-46fa-92a8-db9a68b1b7a1"
      unitRef="usd">5800000000</hum:BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzItMS0xLTEtMTcxMDYx_691f8dc2-76a4-437b-94bd-b406aec15bce"
      unitRef="usd">278000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzMtMS0xLTEtMTcxMDYx_2f662173-7164-48c9-92a6-0261e080822d"
      unitRef="usd">381000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzQtMS0xLTEtMTcxMDYx_24908e55-a679-486b-806c-dd144a2a266e"
      unitRef="usd">61000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzUtMS0xLTEtMTcxMDYx_d2c110f3-c3f3-43bb-b59d-14f8843b7d86"
      unitRef="usd">74000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:Goodwill
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzYtMS0xLTEtMTcxMDYx_aea30be0-61ec-470f-8556-038f06cb0fbe"
      unitRef="usd">5771000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzctMS0xLTEtMTcxMDYx_a46f6d5f-7c8e-4554-a590-e9a546b93fe8"
      unitRef="usd">2312000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzgtMS0xLTEtMTcxMDYx_336fc025-0a31-4f98-8734-fc68fe18d613"
      unitRef="usd">172000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzktMS0xLTEtMTcxMDYx_a30952ac-5578-4252-98fd-31a155bb06da"
      unitRef="usd">9049000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzEwLTEtMS0xLTE3MTA2MQ_b9f7db20-5c07-4f27-8abe-69add61d5ea4"
      unitRef="usd">410000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzExLTEtMS0xLTE3MTA2MQ_c84c20c1-a423-4124-91a8-f462e9000621"
      unitRef="usd">2078000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzEyLTEtMS0xLTE3MTA2MQ_fd19ef82-e4fc-4b12-804f-6915267cdbe1"
      unitRef="usd">369000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzEzLTEtMS0xLTE3MTA2MQ_79a77574-6605-4cb5-91c6-d165fda9bc21"
      unitRef="usd">2857000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzE0LTEtMS0xLTE3MTA2MQ_8f8971f8-4907-4e1f-b5eb-9b7cf3ee7460"
      unitRef="usd">22000000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="i5f2bc940567f4a69ac536078fddf515b_I20210817"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTEvZnJhZzo5MWY2NjY0NjFiZDk0MTJlYTRmNjVhNmE1OGJlNTI2OS90YWJsZTpkYmJmN2VmZmExZDI0ZGIwOWI1YWI1Mzc5N2NiYTcyZC90YWJsZXJhbmdlOmRiYmY3ZWZmYTFkMjRkYjA5YjVhYjUzNzk3Y2JhNzJkXzE1LTEtMS0xLTE3MTA2MQ_2cb7ea0b-6ded-42c6-913f-9134787b8dfc"
      unitRef="usd">6170000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzE1MTU_3b4b9e21-b8a4-421e-96dc-651104192bfb">EQUITY METHOD INVESTMENT&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to our acquisition of KAH in August 2021, we accounted for our 40%&#160;investment in KAH using the equity method of accounting. Our share of income or loss was reported as equity in net (losses) earnings in our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We completed the sale of a 60% interest in KAH Hospice on August 11, 2022 and account for our 40% minority ownership in hospice operations using the equity method of accounting. This investment was reflected in equity method investments in our December&#160;31, 2022 consolidated balance sheet, with our share of income or loss reported as equity in net (losses) earnings in our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The summarized balance sheet at December&#160;31, 2022 and statement of income for the period beginning August 11, 2022 through December&#160;31, 2022 of KAH Hospice were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shareholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Statements of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;August 11, 2022 through December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other insignificant equity method investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2020, our Primary Care Organization entered into a strategic partnership with Welsh, Carson, Anderson &amp;amp; Stowe, or WCAS, to accelerate the expansion of our primary care model. In May 2022, we established a second strategic partnership with WCAS to develop additional centers between 2023 and 2025. As of December 31, 2022, there were 50 primary care clinics operating under the partnership and we intend to open approximately 100 additional primary clinics in future periods under the existing arrangements. In addition, the agreements include a series of put and call options through which WCAS may require us to purchase their interest in the entity, and through which we may acquire WCAS&#x2019;s interest, over the next 3 to 10 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have several individually immaterial equity method investments, including our strategic partnership with WCAS as described above, included within equity method investments in our consolidated balance sheets as of December&#160;31, 2022 and 2021 with our share of income or loss reported as equity in net (losses) earnings in our consolidated statements of income for the years ended December&#160;31, 2022, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i6e64b83f1ebc4e4c9cef19a100effeb3_I20210731"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzEwMg_ab48440f-0152-4f45-9248-97b34c19c814"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzYwNDczMTM5NTUxNzc_25014b72-24e6-4175-bc76-f24cbcb284c3"
      unitRef="number">0.60</hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i48a47654fd0f48f7903a22655de0905d_I20220811"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzYwNDczMTM5NTUxNzI_73ad91f0-2f9f-402f-bc80-4cf71f9f6d0e"
      unitRef="number">0.40</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzE1MTY_712977a2-5ddb-4d7e-8615-34a1edefb634">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The summarized balance sheet at December&#160;31, 2022 and statement of income for the period beginning August 11, 2022 through December&#160;31, 2022 of KAH Hospice were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:77.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Balance sheet&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shareholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:76.516%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.284%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Statements of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;August 11, 2022 through December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:AssetsCurrent
      contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzMtMS0xLTEtMTQwNjQ1_d73d8de9-7209-40e4-a7fa-bf0915205e9d"
      unitRef="usd">297000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsNoncurrent
      contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzQtMS0xLTEtMTQwNjQ1_cc85f1b8-329a-47bd-b0a8-89b4f8bfa793"
      unitRef="usd">3577000000</us-gaap:AssetsNoncurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzUtMS0xLTEtMTQwNjQ1_99fac544-a3dc-4a76-b1d0-1ecea647595f"
      unitRef="usd">269000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzYtMS0xLTEtMTQwNjQ1_3e356bf8-9e3d-4fa2-8113-91c939fee29d"
      unitRef="usd">2219000000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:StockholdersEquity
      contextRef="ic8e88c0b63a84e6d8683ff6e3003a2f9_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTpiZmQ1MDYwMWE1YTg0Y2Q5YTc5ODk3NmU3ODRkMzRmMS90YWJsZXJhbmdlOmJmZDUwNjAxYTVhODRjZDlhNzk4OTc2ZTc4NGQzNGYxXzctMS0xLTEtMTQwNjQ1_246e2098-1c93-4ecd-aeab-3e62a281fe8d"
      unitRef="usd">1386000000</us-gaap:StockholdersEquity>
    <us-gaap:Revenues
      contextRef="ic9f8031ffe444ed9b9343359a58376a4_D20220811-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTo3OGEyYWIxMTVmY2Y0MjExOTg4NjdkZWNhOTUzMjFlNC90YWJsZXJhbmdlOjc4YTJhYjExNWZjZjQyMTE5ODg2N2RlY2E5NTMyMWU0XzMtMS0xLTEtMTQwNjQ1_b5588568-fdf2-4dc8-be47-b7f62427118e"
      unitRef="usd">654000000</us-gaap:Revenues>
    <hum:Expenses
      contextRef="ic9f8031ffe444ed9b9343359a58376a4_D20220811-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTo3OGEyYWIxMTVmY2Y0MjExOTg4NjdkZWNhOTUzMjFlNC90YWJsZXJhbmdlOjc4YTJhYjExNWZjZjQyMTE5ODg2N2RlY2E5NTMyMWU0XzQtMS0xLTEtMTQwNjQ1_9865694a-aaba-4fc4-9dfc-6c86d166fcd5"
      unitRef="usd">652000000</hum:Expenses>
    <us-gaap:NetIncomeLoss
      contextRef="ic9f8031ffe444ed9b9343359a58376a4_D20220811-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90YWJsZTo3OGEyYWIxMTVmY2Y0MjExOTg4NjdkZWNhOTUzMjFlNC90YWJsZXJhbmdlOjc4YTJhYjExNWZjZjQyMTE5ODg2N2RlY2E5NTMyMWU0XzUtMS0xLTEtMTQwNjQ1_54798a56-4469-45f8-a6e1-cb39d6adbcf1"
      unitRef="usd">2000000</us-gaap:NetIncomeLoss>
    <hum:StrategicPartnershipAgreementNumberOfPrimaryCareCenters
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzE1MTg_691497a8-ff91-485b-bd65-b892d37dd60b"
      unitRef="primary_care_center">50</hum:StrategicPartnershipAgreementNumberOfPrimaryCareCenters>
    <hum:StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzU0OTc1NTgxNjgzMw_b46c2f01-2a32-4bbb-8193-63c16f3f1ca2"
      unitRef="primary_care_center">100</hum:StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened>
    <hum:StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum
      contextRef="i0243358af036489b9db890af0f19a8da_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzExMzk_901c4b2e-3c55-472c-a111-bffab5466546">P3Y</hum:StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum>
    <hum:StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum
      contextRef="i0243358af036489b9db890af0f19a8da_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTQvZnJhZzoyZmQxMGVkNTNmZGU0ZDc5OWMyYmViNTlmZjA0MTM1OS90ZXh0cmVnaW9uOjJmZDEwZWQ1M2ZkZTRkNzk5YzJiZWI1OWZmMDQxMzU5XzExNDU_5c1e9d1a-1b33-4efd-b535-375747df5f29">P10Y</hum:StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NjM_5609063f-ddd2-40ce-89ba-364e8e726ae7">INVESTMENT SECURITIES&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment securities classified as current and long-term were as follows at December&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2022, we purchased certain corporate debt securities of KAH Hospice subsequent to the sale. The book value and fair value are $280&#160;million and $278&#160;million, respectively, at December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross unrealized losses and fair values aggregated by investment category and length of time that individual debt securities have been in a continuous unrealized loss position were as follows at December&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less&#160;than&#160;12&#160;months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or more&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="36" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately 96% of our debt securities were investment-grade quality, with a weighted average credit rating of AA- by S&amp;amp;P at December&#160;31, 2022. Most of the debt securities that were below investment-grade were rated BB-, the higher end of the below investment-grade rating scale. Tax-exempt municipal securities were diversified among general obligation bonds of states and local municipalities in the United States as well as special revenue bonds issued by municipalities to finance specific public works projects such as utilities, water and sewer, transportation, or education. Our general obligation bonds are diversified across the United States with no individual state exceeding 1% of our total debt securities. Our investment policy limits investments in a single issuer and requires diversification among various asset types. &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our unrealized loss from all debt securities was generated from approximately 1,625 positions out of a total of approximately 1,710 positions at December&#160;31, 2022. All issuers of debt securities we own that were trading at an &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;unrealized loss at December&#160;31, 2022 remain current on all contractual payments. After taking into account these and other factors previously described, we believe these unrealized losses primarily were caused by an increase in market interest rates in the current markets since the time the debt securities were purchased. At December&#160;31, 2022, we did not intend to sell any debt securities with an unrealized loss position in accumulated other comprehensive income, and it is not likely that we will be required to sell these debt securities before recovery of their amortized cost basis. Additionally, we did not record any material credit allowances for debt securities that were in an unrealized loss position at December&#160;31, 2022, 2021 or 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The detail of realized gains (losses) related to investment securities and included within investment income was as follows for the years ended December&#160;31, 2022, 2021, and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net recognized (losses) gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses related to equity securities for the years ended December&#160;31, 2022, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) gains recognized on equity securities during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net losses recognized on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses) gains recognized on equity securities still held at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All purchases of and proceeds from investment securities for the year ended December&#160;31, 2020 relate to debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contractual maturities of debt securities available for sale at December&#160;31, 2022, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.995%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage and asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NzQ_6d0f3ead-ff20-4257-9cc9-e509182b6a31">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Investment securities classified as current and long-term were as follows at December&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.682%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.643%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.646%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzQtMS0xLTEtMTQwNjQ1_c9ab489f-781f-4927-8572-6d84075e0bbd"
      unitRef="usd">1093000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzQtMy0xLTEtMTQwNjQ1_d4f39191-7a09-4c9c-9cf2-c7c60579e6d5"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzQtNS0xLTEtMTQwNjQ1_0b4fdadb-0ecd-4c7a-a4df-77e85621af91"
      unitRef="usd">55000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzQtNy0xLTEtMTQwNjQ1_5406f91f-af31-40ed-b5d9-0ce48c3ff85a"
      unitRef="usd">1039000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzUtMS0xLTEtMTQwNjQ1_ffebd72f-956d-4583-8fff-be2c6b31a25e"
      unitRef="usd">3697000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzUtMy0xLTEtMTQwNjQ1_fba65c13-9021-4a97-bce2-b231b509dc10"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzUtNS0xLTEtMTQwNjQ1_83ae9a47-cccd-4e3d-adff-432bc17472f7"
      unitRef="usd">471000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzUtNy0xLTEtMTQwNjQ1_ca3efaed-999d-4508-9331-d153cd9ff8c2"
      unitRef="usd">3230000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzYtMS0xLTEtMTQwNjQ1_1c0f013f-e728-467c-babf-b199fa1e954b"
      unitRef="usd">765000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzYtMy0xLTEtMTQwNjQ1_2f784d7b-74cd-47a0-bc79-5736642ca676"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzYtNS0xLTEtMTQwNjQ1_4960d612-8e3c-4753-8a44-5cf277053073"
      unitRef="usd">37000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzYtNy0xLTEtMTQwNjQ1_11c23e40-45f2-4d0d-8a79-fc867f3478a4"
      unitRef="usd">728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzgtMS0xLTEtMTQwNjQ1_6613a384-7eea-4308-8eb4-26ee138c734b"
      unitRef="usd">477000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzgtMy0xLTEtMTQwNjQ1_9833cfc2-af85-4497-8532-f484dc3e3f6d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzgtNS0xLTEtMTQwNjQ1_7db52900-ed42-405c-8d9b-766ae4f44e37"
      unitRef="usd">76000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzgtNy0xLTEtMTQwNjQ1_389ba8eb-151d-4656-b7d3-822959fb833d"
      unitRef="usd">401000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzktMS0xLTEtMTQwNjQ1_9f644d14-e1de-4136-b4b0-de482ec75f95"
      unitRef="usd">1554000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzktMy0xLTEtMTQwNjQ1_a6f2c8f1-8693-4215-962f-e272fc35cdd6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzktNS0xLTEtMTQwNjQ1_2f8f8cd0-9e37-4d20-bc22-d73698b7145d"
      unitRef="usd">155000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzktNy0xLTEtMTQwNjQ1_7c98ee82-5ba5-4657-b200-4093ef8c6798"
      unitRef="usd">1399000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEwLTEtMS0xLTE0MDY0NQ_ad16fa5e-1bd2-4fc8-b6d7-bcadd88dfd9f"
      unitRef="usd">1809000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEwLTMtMS0xLTE0MDY0NQ_847fe47b-5715-4407-8f0f-c8fbeec40908"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEwLTUtMS0xLTE0MDY0NQ_e89ea7c8-4188-4c2e-a1f8-2f78c0d8da91"
      unitRef="usd">79000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEwLTctMS0xLTE0MDY0NQ_d222b815-71bf-46d1-a917-ee4d72eabdfd"
      unitRef="usd">1731000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzExLTEtMS0xLTE0MDY0NQ_384a7252-e101-42b7-b2d7-4b2d6a153122"
      unitRef="usd">6551000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzExLTMtMS0xLTE0MDY0NQ_4545accb-cf0e-4e2c-945a-d1b2ba58a128"
      unitRef="usd">3000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzExLTUtMS0xLTE0MDY0NQ_26cef62c-96b3-4c55-bb6e-c7fcbba43461"
      unitRef="usd">828000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzExLTctMS0xLTE0MDY0NQ_daec43a4-de5d-4252-97fb-156e8d15b815"
      unitRef="usd">5726000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEyLTEtMS0xLTE0MDY0NQ_34097d16-d634-4d32-b496-188cece81072"
      unitRef="usd">15946000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEyLTMtMS0xLTE0MDY0NQ_c67e49d8-b2dd-4aae-8215-17fbc8400f74"
      unitRef="usd">9000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEyLTUtMS0xLTE0MDY0NQ_466e7414-f7c3-4f40-9082-475520f2550e"
      unitRef="usd">1701000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEyLTctMS0xLTE0MDY0NQ_7a00fe7f-7db7-4095-ad06-70a9eacd3b41"
      unitRef="usd">14254000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzEzLTctMS0xLTE0MDY0NQ_a6bd8984-38c8-47ac-9b06-3694cca067d0"
      unitRef="usd">7000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:Investments
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE0LTctMS0xLTE0MDY0NQ_64e3d230-d6a0-42bf-8b81-1ead1f0fd048"
      unitRef="usd">14261000000</us-gaap:Investments>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE4LTEtMS0xLTE0MDY0NQ_3976eefd-c046-4d41-b915-535cceb28ba0"
      unitRef="usd">611000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE4LTMtMS0xLTE0MDY0NQ_98d6ae3d-f6b4-4c55-a271-0c2a011aa51b"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE4LTUtMS0xLTE0MDY0NQ_a2cdeecd-54ec-419f-9fe5-927efcda9562"
      unitRef="usd">10000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE4LTctMS0xLTE0MDY0NQ_5c8586c9-b85e-4429-8b4d-ca1340163d46"
      unitRef="usd">602000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE5LTEtMS0xLTE0MDY0NQ_6de8e300-33e8-42f3-be1a-6e02d9e8ef39"
      unitRef="usd">3265000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE5LTMtMS0xLTE0MDY0NQ_4d4969e1-540e-4e12-afcf-3dc38806a118"
      unitRef="usd">33000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE5LTUtMS0xLTE0MDY0NQ_ffcbfd06-a5a2-4b13-bdbc-ca12aa41db01"
      unitRef="usd">69000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzE5LTctMS0xLTE0MDY0NQ_b8d3d80e-1bb7-4cbd-9174-ede30dc8f55a"
      unitRef="usd">3229000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIwLTEtMS0xLTE0MDY0NQ_533945fe-1642-455e-9462-5236d749aff6"
      unitRef="usd">810000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIwLTMtMS0xLTE0MDY0NQ_140afe13-0761-4f70-9b5e-5ceba45310a5"
      unitRef="usd">33000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIwLTUtMS0xLTE0MDY0NQ_8482038e-ad37-436a-81c5-b842f5b8dbb5"
      unitRef="usd">2000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIwLTctMS0xLTE0MDY0NQ_061197bc-4786-4bea-ad6f-f6306c9ed510"
      unitRef="usd">841000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIyLTEtMS0xLTE0MDY0NQ_2b654f6f-ce18-403e-b966-7eb4d35ee44d"
      unitRef="usd">373000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIyLTMtMS0xLTE0MDY0NQ_900e2b12-2fc9-4416-b11a-35f730a611c2"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIyLTUtMS0xLTE0MDY0NQ_dc9a48e0-de0b-40ed-849a-2d660b30389a"
      unitRef="usd">6000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIyLTctMS0xLTE0MDY0NQ_b345a574-30de-45c7-b041-c68275ac2968"
      unitRef="usd">367000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIzLTEtMS0xLTE0MDY0NQ_4eb2c3e3-4c8c-45d4-86ea-bc4b1cc2c90d"
      unitRef="usd">1394000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIzLTMtMS0xLTE0MDY0NQ_65e81f61-6d2f-4bcd-bec3-6f8ce2dd3ecf"
      unitRef="usd">27000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIzLTUtMS0xLTE0MDY0NQ_fc8bc481-e4b6-465c-a9e6-c1a428fd5ed7"
      unitRef="usd">11000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzIzLTctMS0xLTE0MDY0NQ_82e8530c-9bc1-497d-8425-97d6a6149c16"
      unitRef="usd">1410000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI0LTEtMS0xLTE0MDY0NQ_3f1a15db-3053-40bb-9031-4e0bf4307fa1"
      unitRef="usd">1346000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI0LTMtMS0xLTE0MDY0NQ_8ced1b86-4922-4a7e-a3b6-13df161b0373"
      unitRef="usd">6000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI0LTUtMS0xLTE0MDY0NQ_adaa990d-09ad-4f00-9a5e-653372c99c13"
      unitRef="usd">4000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI0LTctMS0xLTE0MDY0NQ_58c96d0a-beb1-4201-8dd1-d9a074a73dd2"
      unitRef="usd">1348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI1LTEtMS0xLTE0MDY0NQ_48386707-99a9-44cd-b43a-c95c7006c8ea"
      unitRef="usd">5641000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI1LTMtMS0xLTE0MDY0NQ_d0afd6b0-26f0-40bb-83e2-0d53a91842a2"
      unitRef="usd">118000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI1LTUtMS0xLTE0MDY0NQ_bc8cf12f-9e82-4578-a67c-f8e6c8bf41c2"
      unitRef="usd">59000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI1LTctMS0xLTE0MDY0NQ_b3c5f50e-f59f-47e7-843c-25eb9999fdf7"
      unitRef="usd">5700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI2LTEtMS0xLTE0MDY0NQ_0cff8a83-f67f-47cc-91a4-b8ef5b6e9538"
      unitRef="usd">13440000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI2LTMtMS0xLTE0MDY0NQ_2660407b-5414-4879-b3fa-66c352835256"
      unitRef="usd">218000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI2LTUtMS0xLTE0MDY0NQ_eddf0c38-71e6-4770-a5bf-626ff10827af"
      unitRef="usd">161000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI2LTctMS0xLTE0MDY0NQ_1334c2c9-7a5e-4da5-b2e9-4a555b279dcc"
      unitRef="usd">13497000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI3LTctMS0xLTE0MDY0NQ_c1ce9645-2567-4af5-868f-daad5f65ff58"
      unitRef="usd">475000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:Investments
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo5ODBiZTAyZjc3ZTg0NTkxYjc2YzVlZDA0YWJmODU5MC90YWJsZXJhbmdlOjk4MGJlMDJmNzdlODQ1OTFiNzZjNWVkMDRhYmY4NTkwXzI4LTctMS0xLTE0MDY0NQ_073b9db9-a885-4a13-a701-5089a87bbab6"
      unitRef="usd">13972000000</us-gaap:Investments>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="ief49b2992b1d4ac9b764f4b88eede797_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzQ5NDc4MDIzMjgxMjY_16608549-c888-4dbc-a5a6-bebf5fed4973"
      unitRef="usd">280000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ief49b2992b1d4ac9b764f4b88eede797_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzQ5NDc4MDIzMjgxMzg_b606114a-feff-4fd8-9e5a-923b38506a64"
      unitRef="usd">278000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NDk_415b5630-45f5-4b9d-858f-dab692dfa3b1">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Gross unrealized losses and fair values aggregated by investment category and length of time that individual debt securities have been in a continuous unrealized loss position were as follows at December&#160;31, 2022 and 2021, respectively:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.201%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Less&#160;than&#160;12&#160;months&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;12 months or more&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="36" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(367)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,914&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(471)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(60)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(76)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(142)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(155)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(730)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(828)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(270)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,431)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:17pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government &lt;br/&gt;&#160;&#160;&#160;&#160;corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(94)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(161)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtMS0xLTEtMTQwNjQ1_a87095d4-6e0f-4298-af80-f1b49e91fbbd"
      unitRef="usd">512000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtMy0xLTEtMTQwNjQ1_e1ae9589-8c9e-47e7-abd2-18107d3858ac"
      unitRef="usd">5000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtNS0xLTEtMTQwNjQ1_17054f42-81ed-4a99-b1da-55d9ca47c8d4"
      unitRef="usd">397000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtNy0xLTEtMTQwNjQ1_a4e068a0-d0fc-475b-92ea-aa26ab9b5bc6"
      unitRef="usd">50000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtOS0xLTEtMTQwNjQ1_c0964066-0859-413c-83b6-06e04f08ddc3"
      unitRef="usd">909000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i8badefbc5e124dd3aa6c797258e8343d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzYtMTEtMS0xLTE0MDY0NQ_19108de6-0908-4db1-9bbe-fdcee443a1c9"
      unitRef="usd">55000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctMS0xLTEtMTQwNjQ1_c3ec1d22-a062-442a-aa2f-cf87952e73b7"
      unitRef="usd">1231000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctMy0xLTEtMTQwNjQ1_d588e035-3422-4f71-9c40-08f80f85e1d4"
      unitRef="usd">104000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctNS0xLTEtMTQwNjQ1_e0120f1a-53bd-444e-bbce-e6975cfd74ac"
      unitRef="usd">1683000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctNy0xLTEtMTQwNjQ1_66714f7b-4de7-4ad7-827f-d8a891226f78"
      unitRef="usd">367000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctOS0xLTEtMTQwNjQ1_a0ea1852-369d-4f49-ab57-3d4d2fd09262"
      unitRef="usd">2914000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ied2d81e7a2cd4e198da75a1eabb29072_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzctMTEtMS0xLTE0MDY0NQ_f7829647-c188-4465-a5e8-d62214241c3a"
      unitRef="usd">471000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtMS0xLTEtMTQwNjQ1_e038e8a5-949f-4598-ba27-eadd076f8693"
      unitRef="usd">64000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtMy0xLTEtMTQwNjQ1_1b5e8352-ce1f-4afe-a6a0-421f83b164e5"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtNS0xLTEtMTQwNjQ1_55047f71-c8d9-4312-847e-adaa860f1a03"
      unitRef="usd">615000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtNy0xLTEtMTQwNjQ1_6426e09b-92a4-4d1e-8323-334c0826988e"
      unitRef="usd">36000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtOS0xLTEtMTQwNjQ1_f0045dcb-abf6-4527-8aa6-f6931294c519"
      unitRef="usd">679000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ib0c91010e34245c3976100a5e9202503_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzgtMTEtMS0xLTE0MDY0NQ_fc5d144f-d18c-4a57-984f-84ff4d788a77"
      unitRef="usd">38000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTEtMS0xLTE0MDY0NQ_50fd2c76-3b2e-4995-829d-0202f70ffc4f"
      unitRef="usd">124000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTMtMS0xLTE0MDY0NQ_93bd87b8-c0cf-4b66-b950-e2f8c2d7a735"
      unitRef="usd">16000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTUtMS0xLTE0MDY0NQ_72cd2574-4c2e-48ca-a168-691f41b4e5c7"
      unitRef="usd">274000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTctMS0xLTE0MDY0NQ_02f126ac-4fad-4490-8d11-c6563dc6ecdb"
      unitRef="usd">60000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTktMS0xLTE0MDY0NQ_9a3d7fa7-013d-4299-997f-d2e74b524ad2"
      unitRef="usd">398000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i0e2965061dfd4016a59dc6a327d22cf5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEwLTExLTEtMS0xNDA2NDU_750f1e98-64fb-4a76-978a-da15145fa813"
      unitRef="usd">76000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTEtMS0xLTE0MDY0NQ_b4b6b198-30ee-4171-bd6f-62be77f3f472"
      unitRef="usd">243000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTMtMS0xLTE0MDY0NQ_0ff65881-5081-4b39-b2ac-20b311a1abc1"
      unitRef="usd">13000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTUtMS0xLTE0MDY0NQ_05d67e04-4157-4a27-bf3b-38a9df8cb035"
      unitRef="usd">1157000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTctMS0xLTE0MDY0NQ_123e3ead-8c54-4d21-9573-ddc453aa5288"
      unitRef="usd">142000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTktMS0xLTE0MDY0NQ_17e01de7-8778-4073-b30c-c6f1224f60a3"
      unitRef="usd">1400000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="iaaca4131ba9f4188af49410407b10d27_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzExLTExLTEtMS0xNDA2NDU_589a4705-8f0d-419d-88f5-fe743cfd5606"
      unitRef="usd">155000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTEtMS0xLTE0MDY0NQ_720563a4-ff4a-4624-ae3d-ff8f56a255f3"
      unitRef="usd">620000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTMtMS0xLTE0MDY0NQ_4ed708df-ed16-4dab-9cf5-6da690a56878"
      unitRef="usd">32000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTUtMS0xLTE0MDY0NQ_8de8a8d5-fd23-4e49-8ccd-4e539e658537"
      unitRef="usd">1011000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTctMS0xLTE0MDY0NQ_a90ab2be-fbfd-4b72-9d41-c06d525fdbf1"
      unitRef="usd">46000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTktMS0xLTE0MDY0NQ_d4b4e42c-9e1f-4847-9e05-e703274ba77b"
      unitRef="usd">1631000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i11cd665f1547467c8350d08512260dd4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEyLTExLTEtMS0xNDA2NDU_538ba83b-f9fe-472e-a7c5-21214827b349"
      unitRef="usd">78000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTEtMS0xLTE0MDY0NQ_b6707394-8794-4f7c-a809-e97ae2ddb0cf"
      unitRef="usd">1625000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTMtMS0xLTE0MDY0NQ_312d0bbb-7198-4f6d-bc3b-7d046b385466"
      unitRef="usd">98000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTUtMS0xLTE0MDY0NQ_5fa2f02c-1ad3-4f3a-8d6f-94b1be649c93"
      unitRef="usd">3825000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTctMS0xLTE0MDY0NQ_a92eed41-bb7b-427d-88f3-9577766973d4"
      unitRef="usd">730000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTktMS0xLTE0MDY0NQ_0f08d9f9-965b-43e8-815a-6b9066189612"
      unitRef="usd">5450000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i5fdd0f875ea14a2a85334c8e8cf59e9e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzEzLTExLTEtMS0xNDA2NDU_aa7d1157-c650-4c59-b012-460afafd2a37"
      unitRef="usd">828000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTEtMS0xLTE0MDY0NQ_75f46767-dd05-4816-9f29-aaa1f06a879a"
      unitRef="usd">4419000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTMtMS0xLTE0MDY0NQ_c237b567-c7a6-4cb5-807c-46492c97a759"
      unitRef="usd">270000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTUtMS0xLTE0MDY0NQ_59094af3-b211-429f-aa18-50cfbed8125c"
      unitRef="usd">8962000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTctMS0xLTE0MDY0NQ_6dbcfc2a-7129-44af-9ad9-4f31e0db9b0b"
      unitRef="usd">1431000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTktMS0xLTE0MDY0NQ_8caf9b3b-fed8-4ed9-ada8-19a96d18583e"
      unitRef="usd">13381000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE0LTExLTEtMS0xNDA2NDU_5f19c42a-97e4-4ec8-b504-dc0bcad11e50"
      unitRef="usd">1701000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTEtMS0xLTE0MDY0NQ_7899e82b-9cc6-4b69-b200-c5de1a2b3d3c"
      unitRef="usd">201000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTMtMS0xLTE0MDY0NQ_9c5b7a6d-fcab-4688-9825-b56e8cfbcfbd"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTUtMS0xLTE0MDY0NQ_dd7bc15f-ee1d-4c26-b026-2dd00901544b"
      unitRef="usd">355000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTctMS0xLTE0MDY0NQ_b863e612-9410-4256-84d3-93e69342f274"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTktMS0xLTE0MDY0NQ_2b1ac615-e0b5-4f5a-baae-beb31e2615ba"
      unitRef="usd">556000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i5ab09bde6dde4c1eb5e4787b9c6a0d0f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE4LTExLTEtMS0xNDA2NDU_be3d5367-28c5-427c-b646-56ec927f9820"
      unitRef="usd">10000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTEtMS0xLTE0MDY0NQ_b2204c4d-5ca0-4113-9fc7-53d78d00ce20"
      unitRef="usd">2082000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTMtMS0xLTE0MDY0NQ_6152099c-a922-44f0-a002-05107c5ebd7c"
      unitRef="usd">49000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTUtMS0xLTE0MDY0NQ_b2f64951-955f-4f2f-a61d-675636fe0d09"
      unitRef="usd">556000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTctMS0xLTE0MDY0NQ_d900543f-b03e-4a65-964c-3e2c8c7488d6"
      unitRef="usd">20000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTktMS0xLTE0MDY0NQ_c40dd92b-11aa-48ed-aecf-b502b8f92fb1"
      unitRef="usd">2638000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i126217602c624f2ebda161c66e36c104_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzE5LTExLTEtMS0xNDA2NDU_ce997ae4-46d2-4c40-8cf6-81a98a820389"
      unitRef="usd">69000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTEtMS0xLTE0MDY0NQ_d6ec8af4-facd-4c6b-8905-2bf4e06dbd39"
      unitRef="usd">68000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTMtMS0xLTE0MDY0NQ_f4eb559c-1b90-4002-a2d4-5784225605cd"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTUtMS0xLTE0MDY0NQ_b9be14ea-b2ab-4247-8d4f-6b854e449195"
      unitRef="usd">34000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTctMS0xLTE0MDY0NQ_67f6aae3-13cc-4197-a9d2-bc3a38089709"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTktMS0xLTE0MDY0NQ_d0aa870d-a972-4153-a6a6-f13dd2e2390c"
      unitRef="usd">102000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i16730b092e6c42b38643174820335d57_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIwLTExLTEtMS0xNDA2NDU_41c7fdaf-86f0-45db-9211-c8af5099caf7"
      unitRef="usd">2000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTEtMS0xLTE0MDY0NQ_bd0c165f-50a2-4125-bedd-0468be80f26a"
      unitRef="usd">358000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTMtMS0xLTE0MDY0NQ_55759c9c-015e-434e-933b-c872dee4595a"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTUtMS0xLTE0MDY0NQ_e4c2fa77-626f-434d-9310-ab4641e75f82"
      unitRef="usd">8000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTctMS0xLTE0MDY0NQ_05aa07a1-3882-4e20-9e9b-87002fea171a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTktMS0xLTE0MDY0NQ_a898ef93-4ae9-486f-9e3b-6fbe72c7fa63"
      unitRef="usd">366000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ie926287dd7f8457b97691b76be5611a9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIyLTExLTEtMS0xNDA2NDU_6f6bde2e-875c-4879-a150-8cd2eaee63bb"
      unitRef="usd">6000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTEtMS0xLTE0MDY0NQ_0f826b9c-4dee-44d0-b38e-ad37392a0130"
      unitRef="usd">295000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTMtMS0xLTE0MDY0NQ_213ede8e-3b6c-43c3-97c0-c5442e26e0be"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTUtMS0xLTE0MDY0NQ_e1ef4f64-af8e-4e12-9efe-fceb577ac85d"
      unitRef="usd">400000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTctMS0xLTE0MDY0NQ_1737928b-1b8e-4ee0-8804-cdbe8f6047ed"
      unitRef="usd">7000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTktMS0xLTE0MDY0NQ_02e42a91-c6fc-446f-99ba-70fd9b64e9d8"
      unitRef="usd">695000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i37f1fb2ed05e4b3fa3c4fa169cd514f8_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzIzLTExLTEtMS0xNDA2NDU_9482feb6-0787-4cc1-933c-df7eaa7c68b6"
      unitRef="usd">11000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTEtMS0xLTE0MDY0NQ_54c4444a-f97e-4021-ada3-d8818945a28d"
      unitRef="usd">530000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTMtMS0xLTE0MDY0NQ_9d8608e1-396f-441d-adee-6b46ca0621a2"
      unitRef="usd">3000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTUtMS0xLTE0MDY0NQ_e324f996-20c5-4c1d-9ceb-227c616e25bf"
      unitRef="usd">425000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTctMS0xLTE0MDY0NQ_d4fad434-61ea-410c-852c-567ffe0c3798"
      unitRef="usd">1000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTktMS0xLTE0MDY0NQ_7cd95409-0c33-42e3-ae8a-499c83b875fe"
      unitRef="usd">955000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia1df5272756d4e92b091873e633f3429_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI0LTExLTEtMS0xNDA2NDU_3f609aff-29d4-4be0-b124-98fad26f07cd"
      unitRef="usd">4000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTEtMS0xLTE0MDY0NQ_0e98c390-4b3d-49a9-905e-4d37444e83d7"
      unitRef="usd">1456000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTMtMS0xLTE0MDY0NQ_11136c0e-89a8-4228-85ea-ea6d45211e86"
      unitRef="usd">28000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTUtMS0xLTE0MDY0NQ_5c118a76-a79c-46dc-8dfc-00547a878075"
      unitRef="usd">769000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTctMS0xLTE0MDY0NQ_8fa917f8-32df-4e17-8b3c-32a538276fe2"
      unitRef="usd">31000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTktMS0xLTE0MDY0NQ_b5947b0c-b465-4527-8e76-748c240a33f6"
      unitRef="usd">2225000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="i58cabae69b214817826771be532892eb_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI1LTExLTEtMS0xNDA2NDU_50772802-7ca0-4aae-8215-b053e9bb6f70"
      unitRef="usd">59000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTEtMS0xLTE0MDY0NQ_f0f2a964-6e9d-42c7-8de7-85e072356922"
      unitRef="usd">4990000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTMtMS0xLTE0MDY0NQ_66de0f7d-a20e-40d8-9296-236fa49d0aa5"
      unitRef="usd">94000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTUtMS0xLTE0MDY0NQ_8c78fd36-258e-4b29-977c-2ac3468f537a"
      unitRef="usd">2547000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger>
    <us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTctMS0xLTE0MDY0NQ_2eeb8270-dd92-48f3-99d8-95d566f591c4"
      unitRef="usd">67000000</us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTktMS0xLTE0MDY0NQ_94e35c33-ca38-40d6-b844-fa394c79a006"
      unitRef="usd">7537000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTo1NzFiZGFmYmE5OTU0ZGMyOWFlNTVmYzA3MjcxZjA3MC90YWJsZXJhbmdlOjU3MWJkYWZiYTk5NTRkYzI5YWU1NWZjMDcyNzFmMDcwXzI2LTExLTEtMS0xNDA2NDU_d0b6e0aa-7e88-4d8a-aef1-d5a903d1b5db"
      unitRef="usd">161000000</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <hum:PercentageOfTotalDebtSecuritiesInvestmentGradeQuality
      contextRef="i35b2694e329a46c09a0bc95ee97db01c_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzM3MQ_ede6fd32-57b3-4dd7-a316-0031f8095a71"
      unitRef="number">0.96</hum:PercentageOfTotalDebtSecuritiesInvestmentGradeQuality>
    <hum:MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzEwMjg_19212b6c-cfbc-4afe-adab-badbb41bfcf7"
      unitRef="number">0.01</hum:MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzEyNTc_277b8f14-6c65-4eb5-91ab-226699519947"
      unitRef="position">1625</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions>
    <hum:DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzEzMDI_522886f4-c0bc-40a1-96d2-28be3a59ac95"
      unitRef="position">1710</hum:DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions>
    <us-gaap:ScheduleOfRealizedGainLossTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NDU_b2e41b16-50b9-4590-a247-e77793ebe251">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The detail of realized gains (losses) related to investment securities and included within investment income was as follows for the years ended December&#160;31, 2022, 2021, and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.222%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.226%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(144)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross gains on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross losses on equity securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(364)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net recognized (losses) gains on investment securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(130)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRealizedGainLossTableTextBlock>
    <hum:DebtAndEquitySecuritiesRealizedGain
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzItMS0xLTEtMTQwNjQ1_c6c578cb-6e94-441e-a16f-362e02591abe"
      unitRef="usd">62000000</hum:DebtAndEquitySecuritiesRealizedGain>
    <hum:DebtAndEquitySecuritiesRealizedGain
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzItMy0xLTEtMTQwNjQ1_7831f913-fca7-4e44-82ae-7256429acde7"
      unitRef="usd">219000000</hum:DebtAndEquitySecuritiesRealizedGain>
    <hum:DebtAndEquitySecuritiesRealizedGain
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzItNS0xLTEtMTQwNjQ1_8946481f-bef6-4421-a5f9-97f6d7cbbabf"
      unitRef="usd">110000000</hum:DebtAndEquitySecuritiesRealizedGain>
    <hum:DebtAndEquitySecuritiesRealizedLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzMtMS0xLTEtMTQwNjQ1_025872cb-af49-4d79-a453-4524a3c3e20f"
      unitRef="usd">144000000</hum:DebtAndEquitySecuritiesRealizedLoss>
    <hum:DebtAndEquitySecuritiesRealizedLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzMtMy0xLTEtMTQwNjQ1_d6597982-2a7f-45b5-81c8-203019ed44a1"
      unitRef="usd">8000000</hum:DebtAndEquitySecuritiesRealizedLoss>
    <hum:DebtAndEquitySecuritiesRealizedLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzMtNS0xLTEtMTQwNjQ1_87c0ee6d-77f5-4024-8a36-9b2c97ee7166"
      unitRef="usd">18000000</hum:DebtAndEquitySecuritiesRealizedLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGain
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzQtMS0xLTEtMTQwNjQ1_d9a01837-4894-4ede-b1a7-6f8641e0236e"
      unitRef="usd">51000000</us-gaap:EquitySecuritiesFvNiRealizedGain>
    <us-gaap:EquitySecuritiesFvNiRealizedGain
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzQtMy0xLTEtMTQwNjQ1_70713921-b3b1-4440-a90e-eae55642f9f4"
      unitRef="usd">23000000</us-gaap:EquitySecuritiesFvNiRealizedGain>
    <us-gaap:EquitySecuritiesFvNiRealizedGain
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzQtNS0xLTEtMTQwNjQ1_a82af024-6a9f-4bc9-8b72-a149b184f92d"
      unitRef="usd">746000000</us-gaap:EquitySecuritiesFvNiRealizedGain>
    <us-gaap:EquitySecuritiesFvNiRealizedLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzUtMS0xLTEtMTQwNjQ1_8425c71b-a092-4e89-ac44-4126f5de3def"
      unitRef="usd">174000000</us-gaap:EquitySecuritiesFvNiRealizedLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzUtMy0xLTEtMTQwNjQ1_ffc517b2-d261-47eb-989c-7dc20540b6d4"
      unitRef="usd">364000000</us-gaap:EquitySecuritiesFvNiRealizedLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzUtNS0xLTEtMTQwNjQ1_765215e6-614a-44cd-9ecf-0a7f4f3b0be4"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzYtMS0xLTEtMTQwNjQ1_9b248c4e-9a67-49f6-9273-d3bd176ce1c1"
      unitRef="usd">-205000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzYtMy0xLTEtMTQwNjQ1_f0aba05d-2e64-4909-bcd3-f3a8617c828a"
      unitRef="usd">-130000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:DebtAndEquitySecuritiesGainLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTpjY2I3Mzg3ZmE5ZmU0NjA0YTE5NGRjMGJkNTljZWJmZS90YWJsZXJhbmdlOmNjYjczODdmYTlmZTQ2MDRhMTk0ZGMwYmQ1OWNlYmZlXzYtNS0xLTEtMTQwNjQ1_406a809a-52d8-4708-b225-08636ee967a6"
      unitRef="usd">838000000</us-gaap:DebtAndEquitySecuritiesGainLoss>
    <us-gaap:GainLossOnInvestmentsTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4NTg_de05a94f-38a2-46aa-940e-8e451445f3ce">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The gains and losses related to equity securities for the years ended December&#160;31, 2022, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.771%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.515%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.517%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (losses) gains recognized on equity securities during the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(341)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Net losses recognized on equity securities sold during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(105)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized (losses) gains recognized on equity securities still held at the end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(328)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GainLossOnInvestmentsTextBlock>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzItMS0xLTEtMTQwNjQ1_c44b9e47-7d97-45a4-a09a-7849b654f053"
      unitRef="usd">-123000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzItMy0xLTEtMTQwNjQ1_c37b9a2e-c362-4399-8926-27636974581e"
      unitRef="usd">-341000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiGainLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzItNS0xLTEtMTQ0ODI4_c7e78c1d-06ce-4eec-bdb4-92861a2d6994"
      unitRef="usd">746000000</us-gaap:EquitySecuritiesFvNiGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzMtMS0xLTEtMTQwNjQ1_0ce21a7c-429e-4d4e-a9fb-83dedd295c7e"
      unitRef="usd">-105000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzMtMy0xLTEtMTQwNjQ1_169e9d93-a8b2-4cc8-8ef6-1ee6dea66f78"
      unitRef="usd">-13000000</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiRealizedGainLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzMtNS0xLTEtMTQ0ODQ1_f11a7346-980f-45f2-a56b-435043b4662c"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNiRealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzQtMS0xLTEtMTQwNjQ1_b3191ba5-72f2-43f8-9886-b524df1492d6"
      unitRef="usd">-18000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzQtMy0xLTEtMTQwNjQ1_6da658e5-0599-489e-bee7-b8c0d34af206"
      unitRef="usd">-328000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZToyYjM5NDQ1MjljZWM0NDRjYWE4NTgwNGI3M2M3Nzk4NC90YWJsZXJhbmdlOjJiMzk0NDUyOWNlYzQ0NGNhYTg1ODA0YjczYzc3OTg0XzQtNS0xLTEtMTQ0ODI4_5dddad67-a50c-4f36-a805-58264465b23a"
      unitRef="usd">746000000</us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90ZXh0cmVnaW9uOmU0MDhkYzY3ZjliNjQ4NWNhNDBmZGM1YWYxMmE0ZDkyXzI4Njk_593495fb-5a73-44eb-8963-a6c30fc5e9ac">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contractual maturities of debt securities available for sale at December&#160;31, 2022, regardless of their balance sheet classification, are shown below. Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.909%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.995%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due after ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage and asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzItMS0xLTEtMTQwNjQ1_0ae2a072-3501-4869-a924-c54831ac3453"
      unitRef="usd">529000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzItMy0xLTEtMTQwNjQ1_0f30d429-0392-43ca-8dd0-71b6516c22a8"
      unitRef="usd">525000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzMtMS0xLTEtMTQwNjQ1_245f41cf-4506-44cd-9a8a-fb106204e5ef"
      unitRef="usd">3399000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzMtMy0xLTEtMTQwNjQ1_a0176a16-e895-4bdb-9771-dc64ec75ecb8"
      unitRef="usd">3210000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzQtMS0xLTEtMTQwNjQ1_46dd4f1c-7585-44c1-b54a-28a1187a0bd8"
      unitRef="usd">3231000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzQtMy0xLTEtMTQwNjQ1_d96bd015-d047-4c4a-824b-977298cac772"
      unitRef="usd">2764000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzUtMS0xLTEtMTQwNjQ1_d87649ab-2864-48ee-b7ba-75d814c24e05"
      unitRef="usd">1250000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzUtMy0xLTEtMTQwNjQ1_e2015669-33a9-4398-ab25-6bf9836097ed"
      unitRef="usd">994000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzYtMS0xLTEtMTQwNjQ1_ef58cac7-eb83-4b6d-b858-51a3da79454d"
      unitRef="usd">7537000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzYtMy0xLTEtMTQwNjQ1_b085ee09-3dc3-46ec-8d58-1f921b2b0042"
      unitRef="usd">6761000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzctMS0xLTEtMTQwNjQ1_9bb7be10-def5-4a2b-975a-55d6add7d5a9"
      unitRef="usd">15946000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNTcvZnJhZzplNDA4ZGM2N2Y5YjY0ODVjYTQwZmRjNWFmMTJhNGQ5Mi90YWJsZTozNWJhNzQyNzczM2Y0NTBjODJjOTZiYTU2ODJmYjFlYy90YWJsZXJhbmdlOjM1YmE3NDI3NzMzZjQ1MGM4MmM5NmJhNTY4MmZiMWVjXzctMy0xLTEtMTQwNjQ1_1948ead9-f918-4f3b-8b73-2e07ec2e893a"
      unitRef="usd">14254000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzUyOTA_e6bf9faa-176e-4503-be4a-73025acd5657">FAIR VALUE&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our fair value measurements at December&#160;31, 2022 and 2021, respectively, for financial assets measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.127%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Level 3 assets had fair values of $101 million, or 0.5% of total invested assets, and $68 million, or 0.4% of total invested assets, at December&#160;31, 2022 and 2021, respectively. During the years ended December&#160;31, 2022 and 2021, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:11.25pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.277%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the year ended December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the year ended December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Private&lt;br/&gt;Placements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance at January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gains or losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized in other comprehensive&#160;income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our debt is recorded at carrying value in our consolidated balance sheets. The carrying value of our senior notes debt outstanding, net of unamortized debt issuance costs, was $10.0&#160;billion at December&#160;31, 2022 and $9.0 billion at December&#160;31, 2021. The fair value of our senior note debt was $9.4 billion at December&#160;31, 2022 and $10.0 billion at December&#160;31, 2021. The fair value of our senior note debt is determined based on Level 2 inputs, including quoted market prices for the same or similar debt, or if no quoted market prices are available, on the current prices estimated to be available to us for debt with similar terms and remaining maturities. Carrying value approximates fair value for our term loans and commercial paper borrowings. The term loan and commercial paper borrowings&#160;were $1.1&#160;billion at December&#160;31, 2022 and $3.5 billion  at  December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Put and Call Options Measured at Fair Value&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our put and call options associated with our equity method investments are measured at fair value each period using a Monte Carlo simulation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective April 27, 2021, with the signing of the definitive agreement to acquire the remaining 60% interest of KAH, the respective put and call options were terminated. As such, the $63&#160;million put and $440&#160;million call fair values as of the first quarter of 2021 were reduced to zero, resulting in $377&#160;million in other expense (income),net in our consolidated statements of income for the year ended December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The put and call options fair values associated with our Primary Care Organization strategic partnership with WCAS, which are exercisable at a fixed revenue exit multiple and provide a minimum return on WCAS' investment if exercised, are measured at fair value each reporting period using a Monte Carlo simulation. The put and call options fair values, derived from the Monte Carlo simulation, were $267 million and $10 million, respectively, at December&#160;31, 2022. The put and call options fair values, derived from the Monte Carlo simulation, were $202 million and $13 million, respectively, at December&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant unobservable inputs utilized in these Level 3 fair value measurements (and selected values) include the enterprise value, annualized volatility and credit spread. Enterprise value was derived from a discounted cash flow model, which utilized significant unobservable inputs for long-term revenue, to measure underlying cash flows, weighted average cost of capital and long term growth rate. The table below presents the assumptions used for December&#160;31, 2022 and 2021, respectively: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7% - 20.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3% - 1.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue exit multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5x - 2.5x &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5x - 2.5x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average cost of capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5% - 12.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term growth rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used for annualized volatility, credit spread and weighted average cost of capital reflect the lowest and highest values where they differ significantly across the series of put and call options due to their expected exercise dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are measured at fair value on a non-recurring basis subject to fair value adjustment only in certain circumstances.  As disclosed in Note 3, &#x201c;Acquisitions&#x201d;, we completed our acquisition of KAH during the third quarter of 2021. The net assets acquired and resulting goodwill and other intangible assets were recorded at fair value primarily using Level 3 inputs.  The net tangible assets including receivables and accrued liabilities were recorded at their carrying value which approximated their fair value due to their short term nature. The fair value of goodwill and other intangible assets were internally estimated based on the income approach.  The income approach estimates fair value based on the present value of cash flow that the assets could be expected to generate in the future. We developed internal estimates for expected cash flows in the present value calculation using inputs and significant assumptions that include historical revenues and earnings, long-term growth rate, discount rate, contributory asset charges and future tax rates, among others.  The excess purchase price over the fair value of assets and liabilities acquired is recorded as goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As disclosed in Note 3, we completed the sale of a 60% interest in KAH Hospice on August 11, 2022. The carrying value of the assets and liabilities of KAH Hospice disposed approximates fair value. The amount of goodwill included in the carrying value is based on the relative fair value of KAH Hospice as compared to the total fair value of our home solutions reporting unit included within the CenterWell segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than the assets acquired and liabilities assumed in the KAH and other acquisitions in Note 3, there were no other material assets or liabilities measured at fair value on a recurring or nonrecurring basis during 2022, 2021, or 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzUyODg_2c6b3055-c485-4886-9c0c-639ab9973588">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our fair value measurements at December&#160;31, 2022 and 2021, respectively, for financial assets measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.127%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.741%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.744%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&lt;br/&gt;in Active&lt;br/&gt;Markets&lt;br/&gt;(Level 1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&lt;br/&gt;(Level 2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unobservable&lt;br/&gt;Inputs&lt;br/&gt;(Level 3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Debt securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and other U.S. government corporations and agencies:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;U.S. Treasury and agency obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax-exempt municipal securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mortgage-backed securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Residential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 55pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total invested assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="idb72dad613204f368ff4a26fd335a8af_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzQtMS0xLTEtMTQwNjQ1_07507c15-a69b-42b8-aaae-2f08fe48eddb"
      unitRef="usd">4832000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i19ce7d0320634c71911eb129b62cdd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzQtMy0xLTEtMTQwNjQ1_d2706967-379c-421d-a4f4-b26a70e2ef66"
      unitRef="usd">4832000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if1d051e2a57c4934876ddc48b5f49744_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzQtNS0xLTEtMTQwNjQ1_ab13b149-dfb8-48a6-8891-655220d69640"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzQtNy0xLTEtMTQwNjQ1_5f59671a-a7c1-4dfa-ad10-6fc5b648086d"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4600bbd96e654f4bb87bb99cc75e8721_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzctMS0xLTEtMTQwNjQ1_cf4f29de-9b0f-4707-b8f6-5bfa6434155b"
      unitRef="usd">1039000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id37e3970a9a245bf992b7f2bf10aaf9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzctMy0xLTEtMTQwNjQ1_464817d6-52a5-46e7-9d2a-4d3351e89130"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if4e412987c124923843c11133670979d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzctNS0xLTEtMTQwNjQ1_64a9cce1-6117-4fbd-88f7-e3218cf67841"
      unitRef="usd">1039000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i2d065eb8ec814e6fb943f186f38242fb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzctNy0xLTEtMTQwNjQ1_f93cae21-92ad-4293-9089-1deb8bf27bb6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7a05fc957d0846f4b011a965962086b6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzgtMS0xLTEtMTQwNjQ1_cb261eeb-e323-45cf-8bd4-449ba5260f65"
      unitRef="usd">3230000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i568af216307e4b179878b2da53d4122b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzgtMy0xLTEtMTQwNjQ1_bdd71961-19ae-4216-9596-e2c207202878"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i185a7e76a1d24172bb01a134f7adc9c0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzgtNS0xLTEtMTQwNjQ1_fd176b4d-d5c2-4af3-adec-8e5707104e34"
      unitRef="usd">3230000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa6ce38b809041c9968dfc78a7b6929e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzgtNy0xLTEtMTQwNjQ1_4774ec90-7c46-417a-836f-850dee1897c6"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i100f7d2a885e4239994500a96187a154_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzktMS0xLTEtMTQwNjQ1_ac2cda32-7f00-46aa-a744-e1cf86ce277e"
      unitRef="usd">728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i663f713df5004ce691b805cccc0c3c41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzktMy0xLTEtMTQwNjQ1_6b3671f1-b9d7-4902-b4aa-58c1bdde66cb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i35d173bcc08f401d8448c3429d521e73_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzktNS0xLTEtMTQwNjQ1_53f2cef4-a9e4-434e-99f3-b342ee41ea84"
      unitRef="usd">728000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa5a405115aa4a9e80c1d4170818b435_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzktNy0xLTEtMTQwNjQ1_a39d66e9-dcdb-46c4-994c-4ba0d792737a"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia6fbd362be394a77a0bae5d4e503c621_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzExLTEtMS0xLTE0MDY0NQ_48fc596e-1df0-43a4-9ee1-fd6f24e7b7e6"
      unitRef="usd">401000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idf95ac00e96b4da2b61537caecf2a63f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzExLTMtMS0xLTE0MDY0NQ_ff91d424-acf3-490b-af18-35be2f822dfb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i01fe7de4b48b4757bdba67c3c30223dc_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzExLTUtMS0xLTE0MDY0NQ_600027d0-2b0f-47cb-b996-297cf4fa64f1"
      unitRef="usd">401000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if7892d0ce35f4c4d809ca56ec7b8ed92_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzExLTctMS0xLTE0MDY0NQ_a45aa17e-ea5f-4471-bd4b-f50b7171a860"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i6016170130d84d3f9c5fe6be1493ed7b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEyLTEtMS0xLTE0MDY0NQ_0526e4d2-270f-4de4-ba5b-86e3227c735b"
      unitRef="usd">1399000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf26e22bb6694373b3ec116c8848c087_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEyLTMtMS0xLTE0MDY0NQ_2bfdcdc6-c587-4af1-bb04-6efb39a473a2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id8f2d76839dc425e9923d094887a6852_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEyLTUtMS0xLTE0MDY0NQ_f4a38848-d8fe-4cbe-b42d-b0e99feb3758"
      unitRef="usd">1399000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia42d9264fe60436397893746d07f5344_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEyLTctMS0xLTE0MDY0NQ_20b480e0-fa82-4605-921f-d521e1775f7d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i10a317cf3f8749508994c7c0895c690c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEzLTEtMS0xLTE0MDY0NQ_37c0d55a-26ac-4b41-a992-2cfed7e7cc99"
      unitRef="usd">1731000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4ffca985b624437598892a6a46f6e67f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEzLTMtMS0xLTE0MDY0NQ_40710f3b-d8c7-4357-8221-817671a04b6d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib0951e2e238645f2ae9ad57771d70f73_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEzLTUtMS0xLTE0MDY0NQ_903df4c6-ac38-4ffc-a542-00736950d7ff"
      unitRef="usd">1731000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie2617a33f07e4ea1ae164ff1bd350258_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzEzLTctMS0xLTE0MDY0NQ_52b65acc-0999-4c26-b6cc-561695bc27ba"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3f87bad1dca649f6acab6b67b66ef008_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE0LTEtMS0xLTE0MDY0NQ_8058db0f-3fff-4f8f-8679-76d17900980a"
      unitRef="usd">5726000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifb5c00bb1f8b464b98779dcffeb0bc99_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE0LTMtMS0xLTE0MDY0NQ_007d1720-54b0-4682-8dcd-fcd19eb2bf3d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i099d522bfaf0457cbb3b97f0e040976b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE0LTUtMS0xLTE0MDY0NQ_4b55bab2-9e86-4fe5-8970-ca65254dfb84"
      unitRef="usd">5625000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icf1e6a604f94423babd31a467494b284_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE0LTctMS0xLTE0MDY0NQ_07ce1ccb-105f-4109-a4f0-8142713aa300"
      unitRef="usd">101000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="idb72dad613204f368ff4a26fd335a8af_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE1LTEtMS0xLTE0MDY0NQ_d4d217c7-b414-48a0-aea6-c2b32fa667a3"
      unitRef="usd">14254000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i19ce7d0320634c71911eb129b62cdd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE1LTMtMS0xLTE0MDY0NQ_47a00a61-1096-47ac-911c-2a96a323cefb"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if1d051e2a57c4934876ddc48b5f49744_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE1LTUtMS0xLTE0MDY0NQ_65dadaf2-0902-49be-96ab-8c76d7d8d22e"
      unitRef="usd">14153000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE1LTctMS0xLTE0MDY0NQ_247d2e94-9900-46db-a901-d0f4d7f3ab4e"
      unitRef="usd">101000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="idb72dad613204f368ff4a26fd335a8af_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE2LTEtMS0xLTE0MDY0NQ_6860cb09-5f8f-4d75-bc48-0ab7d15bef17"
      unitRef="usd">7000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i19ce7d0320634c71911eb129b62cdd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE2LTMtMS0xLTE0MDY0NQ_6d406203-72fb-4902-8a58-0c964cd2543c"
      unitRef="usd">7000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="if1d051e2a57c4934876ddc48b5f49744_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE2LTUtMS0xLTE0MDY0NQ_2ebddc24-06e7-4577-a58e-806b2a865bf0"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE2LTctMS0xLTE0MDY0NQ_b254d1fe-b9a3-4c51-bf76-bb795a193222"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idb72dad613204f368ff4a26fd335a8af_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE3LTEtMS0xLTE0MDY0NQ_4be27326-6e1a-4ba3-9961-816c2466e40f"
      unitRef="usd">19093000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i19ce7d0320634c71911eb129b62cdd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE3LTMtMS0xLTE0MDY0NQ_44b9ca31-f8bf-4e95-a62a-19b930de04bb"
      unitRef="usd">4839000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="if1d051e2a57c4934876ddc48b5f49744_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE3LTUtMS0xLTE0MDY0NQ_a4beb6b7-0972-4728-96b8-0961b96de09f"
      unitRef="usd">14153000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i60e17ee3f33a4cdda1c6d5a0824a04cd_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzE3LTctMS0xLTE0MDY0NQ_ce20dfeb-10be-4020-bf35-e3f40352c921"
      unitRef="usd">101000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i1173c14adecf46f78881e3a27f37aec1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIwLTEtMS0xLTE0MDY0NQ_ec891db5-b397-42bc-8ffe-176c3f86a584"
      unitRef="usd">3322000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7d65e744f83e4ad98d0958df7c78c34a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIwLTMtMS0xLTE0MDY0NQ_755d8fea-5b44-4a69-8a30-46a35d561697"
      unitRef="usd">3322000000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3faa3637d1e54906a31aad04f195a8ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIwLTUtMS0xLTE0MDY0NQ_5ed136d0-9e84-4f6d-bc67-70260e5eeb34"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i14db3e8f943f46e786c81127e5ea0564_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIwLTctMS0xLTE0MDY0NQ_0ae62154-4f9e-4c0b-81ea-eb9a406a80b5"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie60cdd956a6640969d47e0833e86ba9f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIzLTEtMS0xLTE0MDY0NQ_563a92e6-28f0-46c2-a264-5d622ddc0587"
      unitRef="usd">602000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib385aa21fe4c4616838ee0d0ca6d2cba_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIzLTMtMS0xLTE0MDY0NQ_546ec494-221a-44f7-929a-53e475c9ac80"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie0146b48a0e5489eaa956daf6df2d528_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIzLTUtMS0xLTE0MDY0NQ_3c45830a-154b-4260-b698-0f7d24e56348"
      unitRef="usd">602000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ib6fc8277fc204250b7480ed77aecc8e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzIzLTctMS0xLTE0MDY0NQ_b1081b4d-0b18-4c15-a66c-0c45715bbb00"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ifa72a9d84a68409eac53fed976508820_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI0LTEtMS0xLTE0MDY0NQ_da574a7e-dd6d-4150-87d0-fabaafe56b22"
      unitRef="usd">3229000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia64dce68a9ab4a58acdbb1db7d67bb70_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI0LTMtMS0xLTE0MDY0NQ_9dbe08ce-0962-41cc-86cb-aaebdc09d0a2"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5acccdd82ff846ff8ef892b418bb1485_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI0LTUtMS0xLTE0MDY0NQ_6d7dcf87-59f6-47ac-a33e-9b4ec4810d27"
      unitRef="usd">3229000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i081e21499a8c458baa615ff77f0ac1cd_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI0LTctMS0xLTE0MDY0NQ_b2c65e8e-9cf9-4f36-b3fd-a6d6fb545987"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i20264b95ebc04dcabbb626a171f3e744_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI1LTEtMS0xLTE0MDY0NQ_9992cd8d-5721-42eb-aefe-31e84329571c"
      unitRef="usd">841000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3fa38cc574124cecb80a041e6b188e3d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI1LTMtMS0xLTE0MDY0NQ_825cdeb1-93fe-49e5-b592-dbb0485a0997"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ia7d7ed7bd6f64ee0acfeb9cbb1fae2f9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI1LTUtMS0xLTE0MDY0NQ_d0fd09da-3e5c-451c-ac2b-237d4b4e06a5"
      unitRef="usd">841000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0cfec53bb2494f19a47c713e3227de97_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI1LTctMS0xLTE0MDY0NQ_c3041ca2-0035-4544-b3ae-63ddf58060c4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic2235b6260df49a1a6c11eed924939df_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI3LTEtMS0xLTE0MDY0NQ_e1415d95-c6f8-4ce2-b6b1-fd4d68ed101d"
      unitRef="usd">367000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1f54148e6d2c499a806b66f7dca47359_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI3LTMtMS0xLTE0MDY0NQ_c1295e78-13e3-48d9-9c69-9ad4070c80e0"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie0fb95db0bf242dbab96b217510a895a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI3LTUtMS0xLTE0MDY0NQ_9a928292-1837-41e0-ab3c-9e075b89c42c"
      unitRef="usd">367000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id3c7b37cedae462f862afaec00b4bc46_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI3LTctMS0xLTE0MDY0NQ_5036d916-a2ef-4aa9-a8c3-a0fece898362"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1cf29001a702470bacacce5139c387a6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI4LTEtMS0xLTE0MDY0NQ_9a0e3bdd-fe44-442f-bcc2-54b0dfbb3007"
      unitRef="usd">1410000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3338f1806f36453abbd7a52e1b0790e9_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI4LTMtMS0xLTE0MDY0NQ_d3dff2fe-b3ea-47a3-b6c3-de55d061b64e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i29e0593849c444ccbbeb42e1512fa4a1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI4LTUtMS0xLTE0MDY0NQ_baa23cad-62ab-430d-b00b-7ce5c7f6eefd"
      unitRef="usd">1410000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1fb42a9cbf7b4e7cba7da4a133439c55_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI4LTctMS0xLTE0MDY0NQ_55adcdd5-ab51-472d-9e2d-98b54fe7db0f"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i85753dd3a8f54f9fb0d831cf7c5c43f2_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI5LTEtMS0xLTE0MDY0NQ_084e7837-7dc2-4a6e-bf3c-56767e89cf0b"
      unitRef="usd">1348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5bea5d25f6cd43a8a70162eca920c430_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI5LTMtMS0xLTE0MDY0NQ_e7cf02f4-ac9c-4677-90fd-4d8041bb927e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ibb0684f421e64ce79522d2eb9a6a8413_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI5LTUtMS0xLTE0MDY0NQ_864a7c1f-897c-4220-9db3-7c110cd67475"
      unitRef="usd">1348000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i642f883149c04810939d034bfa0a52ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzI5LTctMS0xLTE0MDY0NQ_df728430-6441-4d63-bf1e-80767dbdb341"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5f49ba358e744656a0580c671549df4d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMwLTEtMS0xLTE0MDY0NQ_d94fef9b-46e1-4bc1-b50d-fc5b7300822d"
      unitRef="usd">5700000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i78acbd1a53b04291b66fdbb04a15ae30_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMwLTMtMS0xLTE0MDY0NQ_09d481fb-690c-418b-b77d-17a72ea3fe95"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ie39ae48296ce4b29aa8bbe2041ed8eb4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMwLTUtMS0xLTE0MDY0NQ_7ec7a92d-d714-4274-89e0-81344f390fb9"
      unitRef="usd">5632000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iae1d525c8d394981a6e5be40d156b6c4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMwLTctMS0xLTE0MDY0NQ_5a3b64ec-d401-41c2-8213-5ab212a5f250"
      unitRef="usd">68000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i1173c14adecf46f78881e3a27f37aec1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMxLTEtMS0xLTE0MDY0NQ_cb316bb6-9ba1-4eea-a93a-d160e3cd648a"
      unitRef="usd">13497000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7d65e744f83e4ad98d0958df7c78c34a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMxLTMtMS0xLTE0MDY0NQ_7f3b3a7e-bb4c-49ab-92dc-085a5a2e6576"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3faa3637d1e54906a31aad04f195a8ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMxLTUtMS0xLTE0MDY0NQ_a20f0776-b30d-4b57-afc7-d9d81294d219"
      unitRef="usd">13429000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i14db3e8f943f46e786c81127e5ea0564_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMxLTctMS0xLTE0MDY0NQ_1df1731b-fc68-454e-807f-9c7bcbd61d90"
      unitRef="usd">68000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1173c14adecf46f78881e3a27f37aec1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMyLTEtMS0xLTE0MDY0NQ_b5888cc1-59cb-4923-a143-be476c959e1d"
      unitRef="usd">475000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i7d65e744f83e4ad98d0958df7c78c34a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMyLTMtMS0xLTE0MDY0NQ_0dd3404b-0d6f-424a-8110-52b87031faf4"
      unitRef="usd">475000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i3faa3637d1e54906a31aad04f195a8ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMyLTUtMS0xLTE0MDY0NQ_95b3433a-e9c1-40a3-8713-5c6e5837113d"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i14db3e8f943f46e786c81127e5ea0564_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMyLTctMS0xLTE0MDY0NQ_64f1578c-60a5-423e-ad61-38500b601bbd"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i1173c14adecf46f78881e3a27f37aec1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMzLTEtMS0xLTE0MDY0NQ_0e33dd88-aa1e-490e-813f-eee1084649a7"
      unitRef="usd">17294000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i7d65e744f83e4ad98d0958df7c78c34a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMzLTMtMS0xLTE0MDY0NQ_fd09280f-50bc-44d6-8dce-7e9ce8d4f502"
      unitRef="usd">3797000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3faa3637d1e54906a31aad04f195a8ed_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMzLTUtMS0xLTE0MDY0NQ_a4310d67-0bae-4fe1-86bd-73d1055dd19d"
      unitRef="usd">13429000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i14db3e8f943f46e786c81127e5ea0564_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTozZDc0MWMwNDE3OGU0ZGYzYTk1OGQ4MzhhZDA4YTA3Yy90YWJsZXJhbmdlOjNkNzQxYzA0MTc4ZTRkZjNhOTU4ZDgzOGFkMDhhMDdjXzMzLTctMS0xLTE0MDY0NQ_b9a4d77f-5b8f-4a77-8d13-46194b3419f1"
      unitRef="usd">68000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzIwNTY_d5114175-fc72-415f-a318-275ddb928b74"
      unitRef="usd">101000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i212f1e342411493daed02b16d1a256c7_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzIxMjE_6c6009f4-499b-44c8-a2c8-a1f92abbc38a"
      unitRef="number">0.005</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzIwNjQ_43e2bda9-4623-490e-a647-19fae5213e84"
      unitRef="usd">68000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9c27e561235648b8b13b0b1006fe90ec_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzIxODY_16fbdff3-d598-4bcb-bd54-d6f44c7cda72"
      unitRef="number">0.004</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzUyOTM_87d5036c-24c2-4800-8e21-0b19bcbd9803">During the years ended December&#160;31, 2022 and 2021, the changes in the fair value of the assets measured using significant unobservable inputs (Level 3) were comprised of the following:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.277%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.211%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.212%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the year ended December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the year ended December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Private&lt;br/&gt;Placements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance at January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gains or losses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Realized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unrealized in other comprehensive&#160;income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzQtMS0xLTEtMTQ0OTUz_ca657329-fddf-4778-b21a-bfb56c0b1570"
      unitRef="usd">68000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzQtMS0xLTEtMTQwNjQ1_79b086ba-a1ef-4ad7-bac1-a092c72bb9e4"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzYtMS0xLTEtMTQ0OTUz_6eb9ac51-2910-4c38-8edf-b7f8b0262586"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzYtMS0xLTEtMTQwNjQ1_fecc56ce-96da-4516-af0c-21f1f8c585dc"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzctMS0xLTEtMTQ0OTUz_858bbc17-fc44-4ff6-96cb-a1d340db5de3"
      unitRef="usd">-14000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzctMS0xLTEtMTQwNjQ1_fedcb7c7-5b47-460d-abf4-e80af3c0c6e4"
      unitRef="usd">-1000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzgtMS0xLTEtMTQ0OTUz_c7c7d0b9-8ab9-4855-82f1-1a618d0f5d09"
      unitRef="usd">47000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzgtMS0xLTEtMTQwNjQ1_6d0dac51-44cd-4ded-8e46-39b5563fc47b"
      unitRef="usd">69000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzktMS0xLTEtMTQ0OTUz_017256d1-c24e-4955-8e78-0fd7cb05036b"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzktMS0xLTEtMTQwNjQ1_8a16d893-49c9-4d01-96aa-e8348f51c3f6"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzEwLTEtMS0xLTE0NDk1Mw_7071edaa-42bd-4035-9dd0-f521b7b53915"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzEwLTEtMS0xLTE0MDY0NQ_afb50ecf-5270-4a34-91e1-4715c2bd3a75"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzExLTEtMS0xLTE0NDk1Mw_d5114175-fc72-415f-a318-275ddb928b74"
      unitRef="usd">101000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo1NzgxOTIwNThmM2I0MzkxOTczNjhkMWViMDdjMTYyMi90YWJsZXJhbmdlOjU3ODE5MjA1OGYzYjQzOTE5NzM2OGQxZWIwN2MxNjIyXzExLTEtMS0xLTE0MDY0NQ_43e2bda9-4623-490e-a647-19fae5213e84"
      unitRef="usd">68000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i7d2d71ecd0c84d618d11b24ea25820ea_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzEyODY_f409e9a8-6c71-41f6-aeec-8af1d9908b88"
      unitRef="usd">10000000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i57df0c8d81b2453f8a238e040f1b0da0_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzY1Mw_2df5c46a-896b-430c-8e6c-580704f1c04b"
      unitRef="usd">9000000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i4e44bcbe607149f5b7f316440415c7f4_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzcwNg_135b8a93-6363-45f7-83e5-b7f81d23eef9"
      unitRef="usd">9400000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie46f4a357a2f4fbe87c10ff118d9a34d_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzcxOQ_58cee6c1-1f1e-472e-8b88-4217daeead5e"
      unitRef="usd">10000000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:ShortTermBorrowings
      contextRef="i6036a7082bf04c138376afbc99b33671_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzQ5NDc4MDIzMzEyOTM_d9483c4e-90b1-4648-8524-4cd4aee4c400"
      unitRef="usd">1100000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i31961d11bba447c88c3178990212f2be_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzEyMTE_f813a6f3-0e44-4477-b3a2-d49da21ae989"
      unitRef="usd">3500000000</us-gaap:ShortTermBorrowings>
    <hum:DefinitiveAgreementEquityInterestToBeAcquiredPercentage
      contextRef="i02980ff246d1468a8e06860f6caca51d_I20210427"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE1MDc_7852f5f7-f3f7-4f74-b84f-0d4ae290af49"
      unitRef="number">0.60</hum:DefinitiveAgreementEquityInterestToBeAcquiredPercentage>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="ice7f37fee78e4e338fbc8d1d06f7ae0e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE1OTM_f0d00e55-d636-4063-85f6-7a3be11da400"
      unitRef="usd">63000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <hum:FinancialAssetsFairValueDisclosure
      contextRef="icd18e11d3c604b7da08f0fffe4565217_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2MDQ_8abc158b-f6fd-41c1-85b0-bcde6c156c1c"
      unitRef="usd">440000000</hum:FinancialAssetsFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i9423060dcf3c49fabea691f0ed0b95eb_I20210427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2NzI_ce6b9fb5-8482-47d9-8b8b-0fe438bc54b3"
      unitRef="usd">0</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <hum:FinancialAssetsFairValueDisclosure
      contextRef="i8ddafd8649e14ac7acac5c6ccd24d75f_I20210427"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2NzI_dd624781-63a4-43b0-81ba-a584f5f47516"
      unitRef="usd">0</hum:FinancialAssetsFairValueDisclosure>
    <hum:LossOnTerminationOfDerivatives
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2ODk_d22b9a0a-357f-406f-8dd1-2a0cfa40b3b3"
      unitRef="usd">377000000</hum:LossOnTerminationOfDerivatives>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="i7e890b4b6701420b99a2fd9eb4ec7e41_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzMxNTM_7d4e6167-bff7-41b0-aeef-0807b5692f2f"
      unitRef="usd">267000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <hum:FinancialAssetsFairValueDisclosure
      contextRef="ia6cabb5822a048bd9df34c65a2029e22_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzMxNjA_346f6ffd-5b79-4d2c-b7ab-d9100abeb1f6"
      unitRef="usd">10000000</hum:FinancialAssetsFairValueDisclosure>
    <us-gaap:FinancialLiabilitiesFairValueDisclosure
      contextRef="iff8e2116ff51438a81ec082998730629_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzMyNjk_99623f21-e2fa-4892-9528-3ade1a2892cb"
      unitRef="usd">202000000</us-gaap:FinancialLiabilitiesFairValueDisclosure>
    <hum:FinancialAssetsFairValueDisclosure
      contextRef="i176fb35f957e441dbdcafceaebb04e6d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzMyNzY_28afb19f-96f4-4438-b0f9-b372ab9cb932"
      unitRef="usd">13000000</hum:FinancialAssetsFairValueDisclosure>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzUyNzk_16be20cb-922e-4a35-bb40-72066ea86089">The table below presents the assumptions used for December&#160;31, 2022 and 2021, respectively: &lt;div style="margin-bottom:9pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.835%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.837%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7% - 20.8%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Credit spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3% - 1.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue exit multiple&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5x - 2.5x &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5x - 2.5x&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average cost of capital&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5% - 12.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long term growth rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The assumptions used for annualized volatility, credit spread and weighted average cost of capital reflect the lowest and highest values where they differ significantly across the series of put and call options due to their expected exercise dates.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i38aeda789d4a488e891a8aa87e9fa1ec_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzEtMS0xLTEtMTQ2MzUwL3RleHRyZWdpb246NzI1YTg2MWFhNWJkNGJmMjhiZmJkZTNiMWFjOTU1NTBfMTA5OTUxMTYyNzc4MA_46ca7835-3916-488d-af0a-8b229fdbcf00"
      unitRef="number">0.167</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="ice2ed9f6fb0c49ae9a1285ff2740d4e4_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzEtMS0xLTEtMTQ2MzUwL3RleHRyZWdpb246NzI1YTg2MWFhNWJkNGJmMjhiZmJkZTNiMWFjOTU1NTBfMTA5OTUxMTYyNzc4Ng_28980446-9825-4d42-93f1-481096dea7a0"
      unitRef="number">0.208</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i3403a6c0905646bcbd8ae9d599d80f52_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzEtMS0xLTEtMTQwNjQ1_22ddbcb8-e98e-4cbe-915d-d53294b5a93e"
      unitRef="number">0.224</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i041054aa105846e8ab6457532786e0e7_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzItMS0xLTEtMTQ2MzUwL3RleHRyZWdpb246MzFjNzQ4Y2RjM2FmNDIzNzg3ODhlNDQyZWI1OGFjNjZfMTA5OTUxMTYyNzc4MA_c46a75e4-55ef-48e7-92d0-b7e3115eff94"
      unitRef="number">0.013</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="ia18bd7b4631c4221ae708ae77650b442_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzItMS0xLTEtMTQ2MzUwL3RleHRyZWdpb246MzFjNzQ4Y2RjM2FmNDIzNzg3ODhlNDQyZWI1OGFjNjZfMTA5OTUxMTYyNzc4Ng_bc142a26-f9c2-49e3-9359-dfb84f353cb4"
      unitRef="number">0.015</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i2900bedd1cd9421e97eb2d64e4d1be5a_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzItMS0xLTEtMTQwNjQ1_e87b837c-0191-438d-9073-ac7004a3fc15"
      unitRef="number">0.009</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i1473eaa5ef804e48ae190d791e55e701_I20221231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzMtMS0xLTEtMTU1ODY5L3RleHRyZWdpb246NTkzZGM4ZTUyNjA3NDdhYTkzYjgzY2QxNDNhZjkwYTZfMTA5OTUxMTYyNzc4MA_ee4d1824-fadd-447d-854f-8d154d76eff5"
      unitRef="number">1.5</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="ib63312bf4c4342bca36791b5e65e4bc3_I20221231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzMtMS0xLTEtMTU1ODY5L3RleHRyZWdpb246NTkzZGM4ZTUyNjA3NDdhYTkzYjgzY2QxNDNhZjkwYTZfMTA5OTUxMTYyNzc4OA_8756899a-6890-49f0-ad6f-ebf7b2d2a6ed"
      unitRef="number">2.5</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="ieecc262ea3ca466c845eebf21b8c3520_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzMtMS0xLTEtMTQwNjQ1L3RleHRyZWdpb246MmIyZjFlYmI1NzM4NDU3NThjOGQ4NDViY2VmNGRkYTRfMTA5OTUxMTYyNzc5MA_45b60768-83a2-449e-97cc-a5f1541fe85a"
      unitRef="number">1.5</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i2124fe581b3f4e0ca125473df9d56093_I20211231"
      decimals="1"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzMtMS0xLTEtMTQwNjQ1L3RleHRyZWdpb246MmIyZjFlYmI1NzM4NDU3NThjOGQ4NDViY2VmNGRkYTRfMTA5OTUxMTYyNzc5Mw_7b247333-aaa9-4a6a-9c92-c9ef351d8ca3"
      unitRef="number">2.5</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i87973cc0bdc9461d9b56ed906827e2d6_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzQtMS0xLTEtMTQ2MzUyL3RleHRyZWdpb246YWYyNjdlZjA1NDg0NDZmOTgxNWZkNjU3M2UyMWE3ZmFfNA_ee900d36-675a-4d99-a6fb-586a93e3c965"
      unitRef="number">0.115</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i3739da0aa72d4c86b46499cbdae6ff38_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzQtMS0xLTEtMTQ2MzUyL3RleHRyZWdpb246YWYyNjdlZjA1NDg0NDZmOTgxNWZkNjU3M2UyMWE3ZmFfOQ_d299d3ad-877d-4e04-a315-939d6490f5cc"
      unitRef="number">0.125</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i1e8a8f01d8ca4f3a9f406c722b7ef5ed_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzQtMS0xLTEtMTQwNjQ1_8947c56a-95ef-4672-8e16-6ed0aac86cf4"
      unitRef="number">0.125</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i2b64fefe292a43728aaf7bdfbede5152_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzUtMS0xLTEtMTQ2MzUy_0fe4a677-ff83-4085-9474-acca6637b0fe"
      unitRef="number">0.030</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <us-gaap:DerivativeAssetLiabilityNetMeasurementInput
      contextRef="i300136ad24984a21be5bc1960dfedd31_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90YWJsZTo2NDYyNmM2ZGM3Nzk0MzJlYWQ4MjgwYmNhOTc3NzE5My90YWJsZXJhbmdlOjY0NjI2YzZkYzc3OTQzMmVhZDgyODBiY2E5Nzc3MTkzXzUtMS0xLTEtMTQwNjQ1_9c477c53-c310-4c32-9d81-da02cf5320df"
      unitRef="number">0.030</us-gaap:DerivativeAssetLiabilityNetMeasurementInput>
    <hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold
      contextRef="if48fb53a53e34a27a1de24c4a5da8121_I20220811"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjAvZnJhZzpmYWMyMzY4YWI0Mjg0MWY3YWU3OTlmYjIzOTM5NTBlZC90ZXh0cmVnaW9uOmZhYzIzNjhhYjQyODQxZjdhZTc5OWZiMjM5Mzk1MGVkXzE2NDkyNjc0NDg5OTY_3774dfe9-0f79-46c0-98c6-0f1a5c4b7663"
      unitRef="number">0.60</hum:DisposalGroupIncludingDiscontinuedOperationEquityInterestSold>
    <hum:MedicarePartDDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90ZXh0cmVnaW9uOmFmOWIyNDY3NTY5ODQ3ZTQ5ZTg0MDdlNTNhMjkwNWVjXzU4MQ_a05df16a-6b7a-4e97-9fb2-79e8ce2d99f6">MEDICARE PART DWe cover prescription drug benefits in accordance with Medicare Part D under multiple contracts with CMS. The accompanying consolidated balance sheets include the following amounts associated with Medicare Part D as of December&#160;31, 2022 and 2021. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to &lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk&lt;br/&gt;Corridor&lt;br/&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CMS&lt;br/&gt;Subsidies/&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk&lt;br/&gt;Corridor&lt;br/&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CMS&lt;br/&gt;Subsidies/&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net long-term liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hum:MedicarePartDDisclosureTextBlock>
    <hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90ZXh0cmVnaW9uOmFmOWIyNDY3NTY5ODQ3ZTQ5ZTg0MDdlNTNhMjkwNWVjXzU2OA_fa2688d8-7083-43d0-8f51-2e803702f099">The accompanying consolidated balance sheets include the following amounts associated with Medicare Part D as of December&#160;31, 2022 and 2021. CMS subsidies/discounts in the table below include the reinsurance and low-income cost subsidies funded by CMS for which we assume no risk as well as brand name prescription drug discounts for Part D plan participants in the coverage gap funded by CMS and pharmaceutical manufacturers. For additional information regarding our prescription drug benefits coverage in accordance with Medicare Part D, refer to Note 2 to &lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.672%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.658%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk&lt;br/&gt;Corridor&lt;br/&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CMS&lt;br/&gt;Subsidies/&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Risk&lt;br/&gt;Corridor&lt;br/&gt;Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CMS&lt;br/&gt;Subsidies/&lt;br/&gt;Discounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(466)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net current asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net long-term liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(189)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Total net asset (liability)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(540)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock>
    <us-gaap:OtherAssetsCurrent
      contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzMtMi0xLTEtMTQwNjQ1_7467888d-6f51-4beb-8ae6-4fb7e8eb7a8e"
      unitRef="usd">240000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzMtNC0xLTEtMTQwNjQ1_eb5a62c5-ddd1-48fb-bfd1-5e595d2541ce"
      unitRef="usd">696000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="idf67c76176744e759331c39da83016b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzMtNi0xLTEtMTQwNjQ1_4cdc0fff-b8ad-4f90-8d92-f8fd27ed0d57"
      unitRef="usd">363000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzMtOC0xLTEtMTQwNjQ1_adb39efd-cf6f-408a-a2eb-b173cbfdc045"
      unitRef="usd">1894000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzQtMi0xLTEtMTQwNjQ1_22d29fb5-d451-4d68-9e0d-44c186f0e43b"
      unitRef="usd">166000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzQtNC0xLTEtMTQwNjQ1_3e725a3e-7ab7-418f-993c-b5d91e72b71e"
      unitRef="usd">1236000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="idf67c76176744e759331c39da83016b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzQtNi0xLTEtMTQwNjQ1_7689a7df-fcc5-468a-ac2a-93081f632921"
      unitRef="usd">68000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzQtOC0xLTEtMTQwNjQ1_23155dd5-9994-48e4-82a2-ac774b7d8622"
      unitRef="usd">466000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <hum:NetCurrentLiabilityAsset
      contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzUtMi0xLTEtMTQwNjQ1_97eff864-a1f8-4cc0-8e9b-05c20d67f45f"
      unitRef="usd">74000000</hum:NetCurrentLiabilityAsset>
    <hum:NetCurrentLiabilityAsset
      contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzUtNC0xLTEtMTQwNjQ1_828276ba-29b0-480a-a1a9-0456dbf38969"
      unitRef="usd">-540000000</hum:NetCurrentLiabilityAsset>
    <hum:NetCurrentLiabilityAsset
      contextRef="idf67c76176744e759331c39da83016b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzUtNi0xLTEtMTQwNjQ1_bd7e21b1-11d4-4cd1-8e01-b8ea440d55ec"
      unitRef="usd">295000000</hum:NetCurrentLiabilityAsset>
    <hum:NetCurrentLiabilityAsset
      contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzUtOC0xLTEtMTQwNjQ1_2c145c0d-9af2-4262-a743-b943231e2635"
      unitRef="usd">1428000000</hum:NetCurrentLiabilityAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzYtMi0xLTEtMTQwNjQ1_9e35edea-174e-4698-ba37-5e50677dbd16"
      unitRef="usd">19000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzYtNC0xLTEtMTQwNjQ1_79ccb31e-0c90-4a62-8ec1-b4563063d4f0"
      unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="idf67c76176744e759331c39da83016b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzYtNi0xLTEtMTQwNjQ1_e4d9bd59-6970-470d-bf59-23b7880eedec"
      unitRef="usd">5000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzYtOC0xLTEtMTQwNjQ1_418f1448-e8ab-4301-b7f2-c88247db91eb"
      unitRef="usd">0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzctMi0xLTEtMTQwNjQ1_829c0eeb-3b7b-48a6-9c81-12c7ccfb1d05"
      unitRef="usd">78000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzctNC0xLTEtMTQwNjQ1_e8b9361b-4ac9-491a-ac09-5f42b4e313ed"
      unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="idf67c76176744e759331c39da83016b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzctNi0xLTEtMTQwNjQ1_cf081b82-4257-4511-a52b-65a81aad5b50"
      unitRef="usd">194000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzctOC0xLTEtMTQwNjQ1_35edcf54-3035-4f09-96b6-1a738bcaa294"
      unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <hum:NetNoncurrentAssetLiability
      contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzgtMi0xLTEtMTQwNjQ1_692a5bbf-cdd6-46c7-96ba-e86a959bad18"
      unitRef="usd">-59000000</hum:NetNoncurrentAssetLiability>
    <hum:NetNoncurrentAssetLiability
      contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzgtNC0xLTEtMTQwNjQ1_34aa81bf-953c-4b6e-976d-d8f09e25ff70"
      unitRef="usd">0</hum:NetNoncurrentAssetLiability>
    <hum:NetNoncurrentAssetLiability
      contextRef="idf67c76176744e759331c39da83016b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzgtNi0xLTEtMTQwNjQ1_2746cb06-b6e8-4b10-be53-222d690b2f97"
      unitRef="usd">-189000000</hum:NetNoncurrentAssetLiability>
    <hum:NetNoncurrentAssetLiability
      contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzgtOC0xLTEtMTQwNjQ1_c53c26f9-7a11-40d1-b2df-170ba60fa368"
      unitRef="usd">0</hum:NetNoncurrentAssetLiability>
    <hum:NetAssetLiability
      contextRef="i695c6177b9d34b308e88de94acfdfd75_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzktMi0xLTEtMTQwNjQ1_f77baae5-98de-4f9e-b034-69d8b0aeb800"
      unitRef="usd">15000000</hum:NetAssetLiability>
    <hum:NetAssetLiability
      contextRef="i2499aa5c390a4ceab2772d3ab384250f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzktNC0xLTEtMTQwNjQ1_b7286ef5-85d1-40c1-83cd-55480eb50b50"
      unitRef="usd">-540000000</hum:NetAssetLiability>
    <hum:NetAssetLiability
      contextRef="idf67c76176744e759331c39da83016b0_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzktNi0xLTEtMTQwNjQ1_e19d08f0-6d35-4b48-83d9-b9773f022265"
      unitRef="usd">106000000</hum:NetAssetLiability>
    <hum:NetAssetLiability
      contextRef="id943835508f94dd6b4417c2cbf63f67d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjMvZnJhZzphZjliMjQ2NzU2OTg0N2U0OWU4NDA3ZTUzYTI5MDVlYy90YWJsZTphYzNiMWUzM2ExOWQ0Y2U1OTc5ZDE0ODgzYTQwNDViZC90YWJsZXJhbmdlOmFjM2IxZTMzYTE5ZDRjZTU5NzlkMTQ4ODNhNDA0NWJkXzktOC0xLTEtMTQwNjQ1_d5f38a34-00fc-4af4-8d1b-0c470cb8db85"
      unitRef="usd">1428000000</hum:NetAssetLiability>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzI5Mw_576dff45-544b-4a4b-bd71-5a07ebbd030d">PROPERTY AND EQUIPMENT, NET&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment was comprised of the following at December&#160;31, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $749&#160;million in 2022, $640 million in 2021, and $528 million in 2020, including amortization expense for capitalized internally developed and purchased software of $525 million in 2022, $443 million in 2021, and $351 million in 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzMwMw_2be20318-c02d-46c1-8ef2-fbf6e686b3a6">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment was comprised of the following at December&#160;31, 2022 and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.786%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.656%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Buildings and leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,951&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,947&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,136)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i19bf3378b91a427c9bd2f7c3566e26e4_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzItMi0xLTEtMTQwNjQ1_25e0f996-8250-4503-a616-e7bffba4dfdb"
      unitRef="usd">17000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie0c89853f8934b0cacaa85cfc6f9e825_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzItNC0xLTEtMTQwNjQ1_68c87b8b-2c1d-4327-80e9-770fc3e1e599"
      unitRef="usd">17000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ibf28824348bc4dbfb4309ec50071a077_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzMtMi0xLTEtMTQwNjQ1_033c2799-88f2-4e60-b74e-4b73fd464d47"
      unitRef="usd">1143000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4d4af6d0f5b84d3788f8727616c7344d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzMtNC0xLTEtMTQwNjQ1_eda71047-90fb-40b9-ae9a-26a699b7ff3a"
      unitRef="usd">1126000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic0fdc098cf1b4a1692f37a4e684bcd29_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzQtMi0xLTEtMTQwNjQ1_5f4a106e-5e90-4d75-bff7-e113cd6dc9dd"
      unitRef="usd">1246000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i066e82ee7851473e9db8d8cb4482f183_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzQtNC0xLTEtMTQwNjQ1_d653cc29-fb29-4081-9370-a1844a801f86"
      unitRef="usd">1148000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib4f43a97ffb845e68f044d5213898ca7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzUtMi0xLTEtMTQwNjQ1_60d4068d-fef6-40c4-9efb-e4136d292695"
      unitRef="usd">3951000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="idf6cc9bbe7804ebdada6913578e3ff0c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzUtNC0xLTEtMTQwNjQ1_25e68973-8990-4887-ba4e-e0fc4bc3382c"
      unitRef="usd">3656000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzYtMi0xLTEtMTQwNjQ1_7e5cfc7e-8aba-487d-b19f-0a794f5d5dc3"
      unitRef="usd">6357000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzYtNC0xLTEtMTQwNjQ1_3b86fbae-1979-494f-8447-19f403e23166"
      unitRef="usd">5947000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzctMi0xLTEtMTQwNjQ1_aba8aefc-a6dd-4822-a593-191ff182a423"
      unitRef="usd">3136000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzctNC0xLTEtMTQwNjQ1_337fd606-dc0f-4c9c-8f5c-44b5e3e34986"
      unitRef="usd">2874000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzgtMi0xLTEtMTQwNjQ1_be7e6dad-95dd-462c-896f-f0c9f6e47db6"
      unitRef="usd">3221000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90YWJsZToxNDg0ZTc1Yzk0N2Q0OWU4ODFjMmM0YTgwN2I2N2NiNy90YWJsZXJhbmdlOjE0ODRlNzVjOTQ3ZDQ5ZTg4MWMyYzRhODA3YjY3Y2I3XzgtNC0xLTEtMTQwNjQ1_e1766e27-6af1-4783-b3d0-848033606306"
      unitRef="usd">3073000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzEzMg_fdc19c1b-726c-42fb-ad6f-da9bdf320d86"
      unitRef="usd">749000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzE0Mg_1aad8eba-11f9-4747-9175-c84d556fbc5e"
      unitRef="usd">640000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzE1Ng_a1d0a851-64ba-4dfc-b43d-b93a0915e18a"
      unitRef="usd">528000000</us-gaap:Depreciation>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzI2MA_03740c11-a825-4eec-95f0-9ac5879e1b59"
      unitRef="usd">525000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzI3MA_d2394b85-70c4-427a-8ced-c28b5142de3c"
      unitRef="usd">443000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjYvZnJhZzplMjJjMmI5OWZhODc0ZDM2OGY5ZDhjYjdiODYxNmQ2ZS90ZXh0cmVnaW9uOmUyMmMyYjk5ZmE4NzRkMzY4ZjlkOGNiN2I4NjE2ZDZlXzI4NA_2cbe6396-fc91-4e2a-957b-dbbc70faa430"
      unitRef="usd">351000000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzYwNQ_5a1fe5e0-36b7-4033-95eb-3b77d13e14e6">GOODWILL AND OTHER INTANGIBLE ASSETS&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amount of goodwill for our reportable segments has been retrospectively adjusted to conform to the 2022 business segment realignment as discussed in Note 1. There was no impairment. Changes in the carrying amount of goodwill for our reportable segments for the years ended December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents details of our other intangible assets included in other long-term assets in the accompanying consolidated balance sheets at December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of need&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetes and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for other intangible assets was approximately $81 million in 2022, $65&#160;million in 2021, and $88&#160;million in 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our estimate of amortization expense for each of the five next succeeding fiscal years: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzU5NQ_3d7f69db-7d60-482a-a972-a1d7dbf60433">Changes in the carrying amount of goodwill for our reportable segments for the years ended December&#160;31, 2022 and 2021 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.635%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.189%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,555&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="idf9a2488b89e4d7385e1a72bd47d1cad_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzItMi0xLTEtMTQwNjQ1_3fc04a1f-954c-4f52-8376-0a51b76c0cb2"
      unitRef="usd">1892000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i6e5599c238174c3cb192e88685bcfea4_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzItNC0xLTEtMTQwNjQ1_35a8a267-6723-4c22-a03c-73a4381fdc43"
      unitRef="usd">2555000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzItMTAtMS0xLTE0MDY0NQ_3fce161b-19f5-4882-8fc5-65a7b0142a3f"
      unitRef="usd">4447000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzMtMi0xLTEtMTQwNjQ1_0d4497d0-67f2-4a4f-95aa-151960df046e"
      unitRef="usd">398000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzMtNC0xLTEtMTQwNjQ1_110980ff-3ea7-482e-9ca6-a55892a91a48"
      unitRef="usd">6247000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzMtMTAtMS0xLTE0MDY0NQ_1ac50638-2f27-4554-af38-837c0ab01edc"
      unitRef="usd">6645000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i0db23ec2c8844ec19dd3156f925907d3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzYtMi0xLTEtMTQwNjQ1_de7904d2-97ff-4d6b-a6bb-5120caf3ecb6"
      unitRef="usd">2290000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i302e4dad57a14cdba91bf0b5047fed31_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzYtNC0xLTEtMTQwNjQ1_7d2933aa-862c-43f2-b6a8-ccf3c27f969c"
      unitRef="usd">8802000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzYtMTAtMS0xLTE0MDY0NQ_858e19a3-19ff-4975-bb7a-8c3dbbede44a"
      unitRef="usd">11092000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzctMi0xLTEtMTQwNjQ1_f5ad19e7-fcba-4a04-b66b-31f0ef91d186"
      unitRef="usd">182000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzctNC0xLTEtMTQwNjQ1_95b94809-7ab1-4abb-9234-1c615813d86e"
      unitRef="usd">199000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzctMTAtMS0xLTE0MDY0NQ_cd508f7f-336b-4fcb-bdec-5e7aa8a20f18"
      unitRef="usd">381000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzgtMi0xLTEtMTQwNjQ1_b434ccba-623a-42e7-bdea-00dd8e583e37"
      unitRef="usd">0</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzgtNC0xLTEtMTQwNjQ1_40bc0562-67b3-478b-a90c-4201b22d69b1"
      unitRef="usd">2331000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzgtMTAtMS0xLTE0MDY0NQ_416c629f-629e-4e2c-a44e-c1c4f7a0b503"
      unitRef="usd">2331000000</us-gaap:GoodwillWrittenOffRelatedToSaleOfBusinessUnit>
    <us-gaap:Goodwill
      contextRef="i579d987c48294cf28cfd69d68d722ed7_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzEwLTItMS0xLTE0MDY0NQ_3081ed07-e694-41df-8d67-231352859bd9"
      unitRef="usd">2472000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i83b359b7705141b5b92b56cd339b7eda_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzEwLTQtMS0xLTE0MDY0NQ_ee0145fa-3d92-4151-9523-a8132ef88ffc"
      unitRef="usd">6670000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZToyOTc2NGFhYWZiMmQ0YWViYmJkMDg5ZmYxZjM0OGZlMi90YWJsZXJhbmdlOjI5NzY0YWFhZmIyZDRhZWJiYmQwODlmZjFmMzQ4ZmUyXzEwLTEwLTEtMS0xNDA2NDU_4ce99881-ba0f-4051-be00-005c0e0e1ab3"
      unitRef="usd">9142000000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzU5MA_537820f5-953b-4dc0-bd7d-5871ce3d7142">&lt;div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents details of our other intangible assets included in other long-term assets in the accompanying consolidated balance sheets at December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:30.791%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.432%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.592%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.957%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Certificates of need&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer contracts/relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.3 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names and technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncompetes and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,765&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i86624d4911c84d1a9f17caac59321ed0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzQtNC0xLTEtMTQwNjQ1_7f084c10-c4a8-482e-8abb-a08a8d31140b"
      unitRef="usd">1132000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i86624d4911c84d1a9f17caac59321ed0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzQtOC0xLTEtMTQwNjQ1_e590ecfd-45ae-465e-ad24-0fc27f954095"
      unitRef="usd">1132000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia1d2e4631e134d44a429a68436144159_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzQtMTAtMS0xLTE0MDY0NQ_6d8075bf-52d3-43c7-a40d-11b937bbbafa"
      unitRef="usd">1771000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ia1d2e4631e134d44a429a68436144159_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzQtMTQtMS0xLTE0MDY0NQ_2baea689-f889-41db-b31c-a6b9bd89b96d"
      unitRef="usd">1771000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i352d3685fa15496082cf261060f9e998_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzUtNC0xLTEtMTQwNjQ1_2d98f554-8c74-4c51-ba8c-fa29d3f0b499"
      unitRef="usd">286000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i352d3685fa15496082cf261060f9e998_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzUtOC0xLTEtMTQwNjQ1_7e067726-49f2-421b-8399-9fd6639b6dba"
      unitRef="usd">286000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4996f726e98845bb84a13c49d761508d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzUtMTAtMS0xLTE0MDY0NQ_b9f73b49-5a5e-49b5-976d-17c9a69184da"
      unitRef="usd">522000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4996f726e98845bb84a13c49d761508d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzUtMTQtMS0xLTE0MDY0NQ_491b81ce-406f-4879-bdf3-fd59ff057ef5"
      unitRef="usd">522000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4a73edc57e734d3e99b59268d52d843f_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtMi0xLTEtMTQwNjQ1_61342444-3b6d-4d00-9ad9-b091c60a0218">P9Y3M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i596d5af4874645ad9e06d1eeedc6d071_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtNC0xLTEtMTQwNjQ1_00bc6f05-0da8-4efd-9bc7-28072f501f02"
      unitRef="usd">929000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i596d5af4874645ad9e06d1eeedc6d071_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtNi0xLTEtMTQwNjQ1_c7b870d8-b99e-4820-b563-174b45f6d3d3"
      unitRef="usd">673000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i596d5af4874645ad9e06d1eeedc6d071_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtOC0xLTEtMTQwNjQ1_56c5ea14-06f4-4fc9-98a4-5832d4d64882"
      unitRef="usd">256000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4ba75b2fe59340d18dee27ba36caa465_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtMTAtMS0xLTE0MDY0NQ_1f6714a0-622d-435a-8d8c-ea951e2d5f59"
      unitRef="usd">883000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4ba75b2fe59340d18dee27ba36caa465_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtMTItMS0xLTE0MDY0NQ_c23a64ee-ccfe-4b4f-b2ba-b21c53a36734"
      unitRef="usd">620000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4ba75b2fe59340d18dee27ba36caa465_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzYtMTQtMS0xLTE0MDY0NQ_a6cb4358-a8ca-4774-a166-bc5507dba2fd"
      unitRef="usd">263000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie8a6332bc1f446caa2303215ecd07bab_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctMi0xLTEtMTQwNjQ1_0afeb575-fa48-4e6d-a89a-c0f1a1114490">P6Y8M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7fc197775115474f9bce928cb7b416e1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctNC0xLTEtMTQwNjQ1_309a541b-d5fc-4365-81d5-3adafa091d97"
      unitRef="usd">142000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7fc197775115474f9bce928cb7b416e1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctNi0xLTEtMTQwNjQ1_0345cbe2-3417-45c2-ac13-a506a873a6bc"
      unitRef="usd">107000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i7fc197775115474f9bce928cb7b416e1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctOC0xLTEtMTQwNjQ1_ea0cb410-2781-4325-909f-349e06f8c947"
      unitRef="usd">35000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i10ff00041a32480583c1b1682d015810_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctMTAtMS0xLTE0MDY0NQ_4f17dd3c-cd2f-4edd-9fd6-5d18a9ab2b76"
      unitRef="usd">160000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i10ff00041a32480583c1b1682d015810_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctMTItMS0xLTE0MDY0NQ_cac40060-13a6-4abc-b47f-d406c85c2d2f"
      unitRef="usd">97000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i10ff00041a32480583c1b1682d015810_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzctMTQtMS0xLTE0MDY0NQ_2731393c-85a1-4f42-8f16-81a83f13f540"
      unitRef="usd">63000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i91f583da577445c788bbe9d989064307_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtMi0xLTEtMTQwNjQ1_ba6c6b5a-105f-46e5-8701-b87d8cd81490">P11Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i14b2c5f58ee9471fb1efd368a5aec87d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtNC0xLTEtMTQwNjQ1_53c99234-7613-4e9a-be26-293d67880ce0"
      unitRef="usd">73000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i14b2c5f58ee9471fb1efd368a5aec87d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtNi0xLTEtMTQwNjQ1_2523abfd-85c3-406a-b7d0-7880f6f6d580"
      unitRef="usd">63000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i14b2c5f58ee9471fb1efd368a5aec87d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtOC0xLTEtMTQwNjQ1_87e1514b-856f-4e93-9246-06c94c273f3f"
      unitRef="usd">10000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i361ad41756ff4adf9c60e7e103ece2a3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtMTAtMS0xLTE0MDY0NQ_a775ffcd-81eb-4088-a3c2-cfacaaa6d818"
      unitRef="usd">72000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i361ad41756ff4adf9c60e7e103ece2a3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtMTItMS0xLTE0MDY0NQ_1849908f-e8df-4131-b340-03dce5480bce"
      unitRef="usd">57000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i361ad41756ff4adf9c60e7e103ece2a3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzgtMTQtMS0xLTE0MDY0NQ_459b9896-d72a-46b0-ae35-a7400f0ec6e1"
      unitRef="usd">15000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie0b1cd6334db4784afa7ba96eaebbccd_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktMi0xLTEtMTQwNjQ1_56a38750-a74b-4ac4-9241-b1c7976ab662">P8Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8a9de5765b6b4f35884275a81dcd973c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktNC0xLTEtMTQwNjQ1_4f76e855-ce63-4219-bb06-01cf70ad9058"
      unitRef="usd">86000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8a9de5765b6b4f35884275a81dcd973c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktNi0xLTEtMTQwNjQ1_587b6668-3e5e-4204-a500-2449434cfc53"
      unitRef="usd">40000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8a9de5765b6b4f35884275a81dcd973c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktOC0xLTEtMTQwNjQ1_df43e055-19bb-4aaf-a417-ede13d35d23a"
      unitRef="usd">46000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0773d411ab7f4a27a5bd3070a458b15c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktMTAtMS0xLTE0MDY0NQ_b227bddd-0642-46a5-ae3b-0f83fb901c80"
      unitRef="usd">35000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0773d411ab7f4a27a5bd3070a458b15c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktMTItMS0xLTE0MDY0NQ_96d8bb46-b966-473e-a67a-d013f838f2bf"
      unitRef="usd">30000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0773d411ab7f4a27a5bd3070a458b15c_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzktMTQtMS0xLTE0MDY0NQ_b150a0af-70a6-4dea-aa63-847e04364fdf"
      unitRef="usd">5000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTItMS0xLTE0MDY0NQ_19630259-f862-4f40-9a02-f33b15c0e73c">P9Y1M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTQtMS0xLTE0MDY0NQ_c0b0ca1b-7104-4e8b-9947-69f0f9dc4103"
      unitRef="usd">2648000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTYtMS0xLTE0MDY0NQ_d3c9a04c-c93f-467a-afb4-39c4502140e9"
      unitRef="usd">883000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTgtMS0xLTE0MDY0NQ_c41fe778-c370-42d6-ba14-11e89d231430"
      unitRef="usd">1765000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTEwLTEtMS0xNDA2NDU_f02668a7-ada6-4514-b5bc-b7dd7f099793"
      unitRef="usd">3443000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTEyLTEtMS0xNDA2NDU_4ce06d2f-2773-4b32-8a26-bf80527bc52f"
      unitRef="usd">804000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpkY2JhODk0MjczNDg0MjNiODMyMzMzYzAyYzIyODVhNC90YWJsZXJhbmdlOmRjYmE4OTQyNzM0ODQyM2I4MzIzMzNjMDJjMjI4NWE0XzEwLTE0LTEtMS0xNDA2NDU_fa2f947e-21b9-4047-be4e-d5cf90a26dfb"
      unitRef="usd">2639000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzQyNw_b5148758-f2a2-4642-bf05-b23955ab7060"
      unitRef="usd">81000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzU0OTc1NTgxMzk0OTU_ca4807f8-7724-4f2a-bf10-4dbe03f7bcba"
      unitRef="usd">65000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzU0OTc1NTgxMzk1MDI_3fe3d176-5383-4db0-b151-12c929e9ce09"
      unitRef="usd">88000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90ZXh0cmVnaW9uOjBmY2ViNGU3OWJmNzRiOTc5Mjc2NTBlN2EwZTE1YmQ5XzYwMQ_86cec1dd-e836-4743-ba9e-9cbe2786f23b">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our estimate of amortization expense for each of the five next succeeding fiscal years: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzEtMS0xLTEtMTQwNjQ1_e1a2cacc-da4b-426b-afe6-fca50be3f6c0"
      unitRef="usd">63000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzItMS0xLTEtMTQwNjQ1_565a1ce9-244e-442f-95a6-7de77b6ff930"
      unitRef="usd">55000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzMtMS0xLTEtMTQwNjQ1_b777523f-4e43-414f-8926-63321e229d4a"
      unitRef="usd">53000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzQtMS0xLTEtMTQwNjQ1_84b53a61-f747-47c3-8da9-f9c9c7d3b710"
      unitRef="usd">41000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNjkvZnJhZzowZmNlYjRlNzliZjc0Yjk3OTI3NjUwZTdhMGUxNWJkOS90YWJsZTpjZDk5ZmJjZjI5YjI0ZjUxYWJkMTcwYmNlODdmZjFmNS90YWJsZXJhbmdlOmNkOTlmYmNmMjliMjRmNTFhYmQxNzBiY2U4N2ZmMWY1XzUtMS0xLTEtMTQwNjQ1_8c21a54a-3cc7-41ea-9d13-881027b83bf3"
      unitRef="usd">31000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTM_984b515e-65dd-4abd-9ae4-10b7ff4d947c">LEASES&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if a contract contains a lease by evaluating the nature and substance of the agreement. We lease facilities, computer hardware, and other furniture and equipment. Leases with an initial term of 12 months or less are not recorded on the balance sheet; we recognize lease expense for these leases on a straight-line basis over the lease term. For new lease agreements, we combine lease and nonlease components for all of our asset classes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When portions of the lease payments are not fixed or depend on an index or rate, we consider those payments to be variable in nature. Our variable lease payments include, but are not limited to, common area maintenance, taxes and insurance which are not dependent upon an index or rate. Variable lease payments are recorded in the period in which the obligation for the payment is incurred. Most leases include options to renew, with renewal terms that can extend the lease term. The exercise of lease renewal options is at our sole discretion. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets included within &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_aa3c46cd-ae1d-4dbb-b466-6a345a4c4ee1"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTA_fb3c77fb-1c01-43eb-9b8e-b8c8b202045a"&gt;other long-term assets&lt;/span&gt;&lt;/span&gt; in our consolidated balance sheets were $515 million and $678 million at December&#160;31, 2022 and December&#160;31, 2021, respectively. Operating lease liabilities included within &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_0f510c82-dcff-42e3-bbab-71fc1ed8e909"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODY_f7698f80-d9e2-4b51-aa84-637d028779f0"&gt;trade accounts payable and accrued expenses&lt;/span&gt;&lt;/span&gt; in our consolidated balance sheets were $152 million and $185 million at December&#160;31, 2022 and December&#160;31, 2021, respectively. Additionally, operating lease liabilities included within &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_bc2d9dd9-e2c4-4f69-a280-01a78070d904"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxODg_e06b9087-2af6-4553-b278-719cfd049d22"&gt;other long-term liabilities&lt;/span&gt;&lt;/span&gt; in our consolidated balance sheets were $456 million and $546 million at &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022 and December&#160;31, 2021, respectively. The classification of our operating lease liabilities is based on the remaining lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the years ended December&#160;31, 2022, 2021 and 2020, total fixed operating lease costs, excluding short-term lease costs, were $183 million, $159 million and $141 million, respectively, and are included within operating costs in our consolidated statements of income. Short-term lease costs were not material for the years ended December&#160;31, 2022, 2021 and 2020. In addition, for the years ended December&#160;31, 2022, 2021 and 2020, total variable operating lease costs were&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$101 million, $94 million and $92 million, respectively, and are included within operating costs in our consolidated statements of income. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sublease facilities or partial facilities to third party tenants for space not used in our operations. For the years ended December&#160;31, 2022, 2021 and 2020, sublease rental income was&lt;/span&gt;&lt;span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$52 million, $43 million and $36 million, respectively, and is included within operating costs in our consolidated statements of income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average remaining lease term is 5.4 years with a weighted average discount rate of 3.2% at December&#160;31, 2022 and December&#160;31, 2021. For the years ended December&#160;31, 2022, 2021 and 2020, cash paid for amounts included in the measurement of lease liabilities included within our operating cash flows was $191 million, $165 million and $146 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity of&#160;Lease&#160;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As most of our leases do not provide an implicit rate, we use our incremental borrowing rate, as adjusted for collateralized borrowings, based on the information available at date of adoption or commencement date in determining the present value of lease payments.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE0NzY_a21e6e7f-d04d-4a90-b470-840b913a602c"
      unitRef="usd">515000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE0ODM_6144f2cd-7aee-495f-88aa-f7200a041be0"
      unitRef="usd">678000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE2MDc_1fdd68d5-3aa1-409c-9256-64ea2e9a42e0"
      unitRef="usd">152000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE2MTQ_73333e8e-c6cd-42ab-b50a-0c73bb1eaa5b"
      unitRef="usd">185000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE3MzY_661ee99a-5368-4e42-817e-104668b4401a"
      unitRef="usd">456000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE3NDM_345e6f6d-3685-4aaa-8d60-6919a6b35ef7"
      unitRef="usd">546000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseCost
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE5NzE_95cb9b8c-6220-4990-ae5d-4a7f7cfa6704"
      unitRef="usd">183000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzE5Nzg_fcb9bb3b-16c0-441d-8ee2-3fdccfbad5fe"
      unitRef="usd">159000000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzQ5NDc4MDIzMjgyMDk_73fe4641-d4e7-44be-8103-3b595f160cf4"
      unitRef="usd">141000000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzIyMzY_abff7cc7-b851-48ad-9326-de013e4c2b6b"
      unitRef="usd">101000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzIyNDM_eb310957-5a5f-4f83-b0a4-bfb3380fa7ea"
      unitRef="usd">94000000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzQ5NDc4MDIzMjgyNzA_e2259570-3452-43eb-bae3-9a4092aba9fe"
      unitRef="usd">92000000</us-gaap:VariableLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI1MDg_0531748e-e32f-4dc4-85c1-2413eaa00835"
      unitRef="usd">52000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI1MTU_3f55d725-af9b-46bc-ae2f-a42c66056718"
      unitRef="usd">43000000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzQ5NDc4MDIzMjgzMDg_44bf3b54-f2c9-4c5d-8dcf-b7df0502d4de"
      unitRef="usd">36000000</us-gaap:SubleaseIncome>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI2NTk_73882f7f-8053-4f7b-99f9-48f26d634122">P5Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI2NTk_a5ba6c20-5ad6-4715-b487-be3dbaa17582">P5Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI3MTA_49a708ac-7fa5-4eb6-b3be-0cb03636050b"
      unitRef="number">0.032</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI3MTA_fa0c9af6-65e7-4a14-b96f-2ae0fafaccc5"
      unitRef="number">0.032</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI4OTQ_a2ac308f-8d65-48ad-aaff-629ca4e38ff9"
      unitRef="usd">191000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzI5MDE_7e024584-810f-4942-8cff-3776230d8400"
      unitRef="usd">165000000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzQ5NDc4MDIzMjgzNTE_d130a489-c7c2-4a86-8bc1-e5f88d312490"
      unitRef="usd">146000000</us-gaap:OperatingLeasePayments>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90ZXh0cmVnaW9uOjI0NjdjMjg5MmI0ODQ2YWU5NzU3OGQ3ZGVmOTMxNjdmXzMxOTI_d1edff0e-6d69-47a0-b13e-35d84a098e00">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Maturity of&#160;Lease&#160;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;After 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzItMi0xLTEtMTQwNjQ1_1386f5f0-f870-4ab2-914c-6709e09f8653"
      unitRef="usd">171000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzMtMi0xLTEtMTQwNjQ1_d68ae360-6322-4c89-94f4-302bff2f02fd"
      unitRef="usd">141000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzQtMi0xLTEtMTQwNjQ1_d701fcfc-daf6-4a67-b60f-aa720f690f67"
      unitRef="usd">114000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzUtMi0xLTEtMTQwNjQ1_542a960b-4ab8-43ef-b152-50c69068ceb6"
      unitRef="usd">72000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzYtMi0xLTEtMTQwNjQ1_b3230c69-9683-4f02-a732-72a06b54e67a"
      unitRef="usd">49000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzctMi0xLTEtMTQwNjQ1_8c780d8b-5fa3-4e21-be7d-d13369304fca"
      unitRef="usd">116000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzgtMi0xLTEtMTQwNjQ1_1727372e-c9e2-4edd-acbf-a5507f8c646c"
      unitRef="usd">663000000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzktMi0xLTEtMTQwNjQ1_97a9abd9-202d-4b8f-90a7-a088c68a58aa"
      unitRef="usd">55000000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzIvZnJhZzoyNDY3YzI4OTJiNDg0NmFlOTc1NzhkN2RlZjkzMTY3Zi90YWJsZToyZjYyOTkwZDkyYzY0MzhmYWM5MzdhNGJlNzA3ODhmYS90YWJsZXJhbmdlOjJmNjI5OTBkOTJjNjQzOGZhYzkzN2E0YmU3MDc4OGZhXzEwLTItMS0xLTE0MDY0NQ_385f5eef-8728-455b-b7c4-80eafdf140f5"
      unitRef="usd">608000000</us-gaap:OperatingLeaseLiability>
    <us-gaap:InsuranceDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzM3NTc_03bd27ba-6a1a-45b8-8f3c-5cda3eaf56af">BENEFITS PAYABLE&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at January 1, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total estimate of benefits payable for claims incurred but not reported, or IBNR, is included within the net &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;incurred claims amounts. At December&#160;31, 2022, benefits payable included IBNR of approximately $5.7&#160;billion, primarily associated with claims incurred in 2022. The cumulative number of reported claims as of December&#160;31, 2022 was approximately 173.5&#160;million for claims incurred in 2022, 173.3&#160;million for claims incurred in 2021, and 149.8&#160;million for claims incurred in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Amounts incurred related to prior years vary from previously estimated liabilities as the claims ultimately are settled. Negative amounts reported for incurred related to prior years result from claims being ultimately settled for amounts less than originally estimated (favorable development).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously discussed, our reserving practice is to consistently recognize the actuarial best estimate of our ultimate liability for claims. Actuarial standards require the use of assumptions based on moderately adverse experience, which generally results in favorable reserve development, or reserves that are considered redundant. We experienced favorable medical claims reserve development related to prior fiscal years of $415 million in 2022, $825 million in 2021, and $313 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:4pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The medical claims reserve development for 2022, 2021, and 2020 primarily reflects the consistent application of trend and completion factors estimated using an assumption of moderately adverse conditions. In addition, the higher prior year favorable development for the year ended December 31, 2021 was primarily attributable to the reversal of actions taken in 2020, including the suspension of certain financial recovery programs for a period of time impacting our claim payment patterns. The suspension during 2020 was intended to provide financial and administrative relief for providers facing unprecedented strain as a result of the COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;         &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Incurred and Paid Claims Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following discussion provides information about incurred and paid claims development as of December&#160;31, 2022, net of reinsurance, as well as cumulative claim frequency and the total of IBNR included within the net incurred claims amounts. The information about incurred and paid claims development for the years ended December 31, 2021 and 2020 is presented as supplementary information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Claims frequency is measured as medical fee-for-service claims for each service encounter with a unique provider identification number. Our claims frequency measure includes claims covered by deductibles as well as claims under capitated arrangements. Claim counts may vary based on product mix and the percentage of delegated capitation arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following tables provide information about incurred and paid claims development as of December&#160;31, 2022, net of reinsurance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incurred Claims, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Claims Incurred Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;br/&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;br/&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Claims, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Claims Incurred Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;br/&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;br/&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All outstanding benefit liabilities before 2020, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information regarding our benefits payable and benefits expense recognition, refer to Note 2 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in this Form 10-K.&lt;/span&gt;&lt;/div&gt;</us-gaap:InsuranceDisclosureTextBlock>
    <us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzM3ODE_4a1c5d8e-becb-4e26-b396-75f23297d211">&lt;div style="margin-bottom:3pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On a consolidated basis, which represents our Insurance segment net of eliminations, activity in benefits payable was as follows for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at January&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Reinsurance recoverables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at January 1, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Incurred related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(825)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(313)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Paid related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(67,287)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,149)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,003)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,428)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(74,715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59,421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at December&#160;31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzItMi0xLTEtMTQwNjQ1_d500f505-be80-4195-8da7-6176e6d7b71e"
      unitRef="usd">8289000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzItNC0xLTEtMTQwNjQ1_d0e5f8b9-c671-44fc-98ca-5c8002572cc5"
      unitRef="usd">8143000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzItNi0xLTEtMTQwNjQ1_db38861a-4eab-4036-b1c0-e0384739d004"
      unitRef="usd">6004000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzQtMi0xLTEtMTQwNjQ1_c3735661-b9c3-4497-8b57-b256c9026f77"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzQtNC0xLTEtMTQwNjQ1_b32d4dd7-870b-440b-a0d9-c381db791b70"
      unitRef="usd">0</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
      contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzQtNi0xLTEtMTQwNjQ1_49f418b6-5c48-4796-8fc6-e42e5bf70359"
      unitRef="usd">68000000</us-gaap:ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzUtMi0xLTEtMTQwNjQ1_39fa5e1b-154a-41f1-8653-4b309720ad7f"
      unitRef="usd">8289000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzUtNC0xLTEtMTQwNjQ1_5f6f26b1-8b3a-4e4e-b1e2-7acd82bf9e83"
      unitRef="usd">8143000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
      contextRef="i571f2e6b6e774b29a93ccb70f106840c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzUtNi0xLTEtMTQwNjQ1_bb55a45a-3c61-4c8b-95da-7069cd6d4cd3"
      unitRef="usd">5936000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzYtMi0xLTEtMTQwNjQ1_13500f77-57fd-4f16-a581-e1b2a41b4af9"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzYtNC0xLTEtMTQwNjQ1_f8ad0219-9ca6-4b07-ae0c-39b838aa9ae0"
      unitRef="usd">42000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzYtNi0xLTEtMTQwNjQ1_dd198f04-8b07-4b24-b6b8-2ebc6f9c3db4"
      unitRef="usd">0</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzgtMi0xLTEtMTQwNjQ1_4bb1ce6a-0113-481c-8c5a-bee1a0ac8e87"
      unitRef="usd">76105000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzgtNC0xLTEtMTQwNjQ1_f71ec1d4-9e5c-4309-b29e-297602dd21ab"
      unitRef="usd">70024000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzgtNi0xLTEtMTQwNjQ1_a0b0e9af-87ce-47cc-ade9-5f204ccdf75d"
      unitRef="usd">61941000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzktMi0xLTEtMTQwNjQ1_82ed9917-4d63-41eb-a5dc-ebaf5d7dca1e"
      unitRef="usd">-415000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzktNC0xLTEtMTQwNjQ1_e22015df-b924-45e1-9a1b-06c87f5f5a84"
      unitRef="usd">-825000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzktNi0xLTEtMTQwNjQ1_5bdf5d22-8ef6-466c-8fc3-50db9c77cf4b"
      unitRef="usd">-313000000</us-gaap:SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEwLTItMS0xLTE0MDY0NQ_dbbf509d-a6e9-4b8f-8d89-85b725857759"
      unitRef="usd">75690000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEwLTQtMS0xLTE0MDY0NQ_d31a0a6d-643a-4308-87f7-f14e45a8aba3"
      unitRef="usd">69199000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEwLTYtMS0xLTE0MDY0NQ_9854d830-cf76-466e-bccf-471a6d54c1e0"
      unitRef="usd">61628000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEyLTItMS0xLTE0MDY0NQ_24b5eb16-4271-4dcf-ac7e-ad89ab21faae"
      unitRef="usd">67287000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEyLTQtMS0xLTE0MDY0NQ_7736375d-c472-496a-956f-64df4dc1e7c6"
      unitRef="usd">62149000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEyLTYtMS0xLTE0MDY0NQ_9fff3f4d-1974-4865-954d-c0ba5decb5d8"
      unitRef="usd">54003000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEzLTItMS0xLTE0MDY0NQ_8d01244a-fa5b-466d-8c33-14c6a126d24a"
      unitRef="usd">7428000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEzLTQtMS0xLTE0MDY0NQ_9dd10f23-cf6e-4735-a14b-f7682d3f8f2a"
      unitRef="usd">6946000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzEzLTYtMS0xLTE0MDY0NQ_d2580672-c453-4cda-99cd-bf2962f8dd70"
      unitRef="usd">5418000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE0LTItMS0xLTE0MDY0NQ_cf2a70f2-e98c-4fb0-81f2-7239bc02ebf9"
      unitRef="usd">74715000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE0LTQtMS0xLTE0MDY0NQ_dd48f819-6b45-423d-97a6-28986363ed70"
      unitRef="usd">69095000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:PaymentsForLossesAndLossAdjustmentExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE0LTYtMS0xLTE0MDY0NQ_fed5f177-8373-4443-8e1a-ceb928b58742"
      unitRef="usd">59421000000</us-gaap:PaymentsForLossesAndLossAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE3LTItMS0xLTE0MDY0NQ_ee16b459-6eca-4e31-9cea-fd1751b5b842"
      unitRef="usd">9264000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE3LTQtMS0xLTE0MDY0NQ_e306eeec-0a31-45d7-8710-418eb71ac7be"
      unitRef="usd">8289000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense
      contextRef="i90291fd2d2ea45d0aff5e33822dee463_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTowZjViZWI3MDE1NDY0NmYwYmI4NzMxMWNjN2NkMWZjYy90YWJsZXJhbmdlOjBmNWJlYjcwMTU0NjQ2ZjBiYjg3MzExY2M3Y2QxZmNjXzE3LTYtMS0xLTE0MDY0NQ_5484d668-bd9e-4ff4-b09d-a03777e50b9f"
      unitRef="usd">8143000000</us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense>
    <us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzU0OTc1NTgxNDUwMTE_460551b3-6808-4f8a-966c-f13f2721f08b"
      unitRef="usd">5700000000</us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount>
    <hum:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported
      contextRef="i8fc949bd76c94ac0acb9625d55ca5689_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzU0OTc1NTgxNDUwMzk_aa8c6bdd-79b8-4f93-97b9-e62048af3de6"
      unitRef="claim">173500000</hum:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported>
    <hum:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported
      contextRef="if00d8760e6f64b3b890040f421a1920e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzU0OTc1NTgxNDUwNTg_a61aa5d7-3863-4fa2-9fb7-45366b010d92"
      unitRef="claim">173300000</hum:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported>
    <hum:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported
      contextRef="i2cd99d5331f347e4b92782b89a82aeb2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzU0OTc1NTgxNDUwODA_2a09a8e9-a225-4c0b-816b-606b4e8eeb21"
      unitRef="claim">149800000</hum:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported>
    <hum:FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1Xzg3MA_109194e5-b87d-4210-a748-9c3b2f79d48d"
      unitRef="usd">415000000</hum:FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears>
    <hum:FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1Xzg4MA_043f8c81-8329-4c45-9a2e-323d1327215e"
      unitRef="usd">825000000</hum:FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears>
    <hum:FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1Xzg5NA_9ff7af4b-8c9c-4f45-ac80-8f44ed33b006"
      unitRef="usd">313000000</hum:FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears>
    <us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90ZXh0cmVnaW9uOmIwOTE3MTgxZTBkOTRmY2I4MGNjNTI5ZWRjNDdmM2I1XzM3NDc_ebfeb68e-9ea5-42b4-9d0c-7da2f12d43b9">The following tables provide information about incurred and paid claims development as of December&#160;31, 2022, net of reinsurance.&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.527%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.890%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Incurred Claims, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Claims Incurred Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;br/&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;br/&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,066&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.883%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.246%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.891%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cumulative Paid Claims, Net of Reinsurance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the Years Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Claims Incurred Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;br/&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;br/&gt;Unaudited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197,763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;All outstanding benefit liabilities before 2020, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Benefits payable, net of reinsurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="idcf95e3840d049aab6f62e08d9ee6525_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzQtMi0xLTEtMTQwNjQ1_5d467392-00cb-4f06-87a8-b6c4ca7cb54b"
      unitRef="usd">61941000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i07a30ac3b99249dcab52ec26094b0a75_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzQtNC0xLTEtMTQwNjQ1_974a6126-848d-4cb4-8d66-6edf8f9531ac"
      unitRef="usd">61258000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i2cd99d5331f347e4b92782b89a82aeb2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzQtNi0xLTEtMTQwNjQ1_e55bed4c-9e42-4b44-b020-17d005e67198"
      unitRef="usd">61224000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="icd981807e06146b9a8b7168780fa31e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzUtNC0xLTEtMTQwNjQ1_d88aa218-e152-499b-96ad-1b2c2f10a9a5"
      unitRef="usd">70066000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="if00d8760e6f64b3b890040f421a1920e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzUtNi0xLTEtMTQwNjQ1_8724db81-88b5-48e0-b3b0-1454e1905cfe"
      unitRef="usd">69698000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i8fc949bd76c94ac0acb9625d55ca5689_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzYtNi0xLTEtMTQwNjQ1_aa398fbd-e9e7-4388-9fac-4a53d3605319"
      unitRef="usd">76105000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpjZTVjZjNmOTlkNDc0Y2FkOGNjZmEyM2ZmZWUzOWUzOS90YWJsZXJhbmdlOmNlNWNmM2Y5OWQ0NzRjYWQ4Y2NmYTIzZmZlZTM5ZTM5XzctNi0xLTEtMTQwNjQ1_fd434f1d-740d-49f1-9e42-2104ef4a3ec8"
      unitRef="usd">207027000000</us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="idcf95e3840d049aab6f62e08d9ee6525_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzQtMi0xLTEtMTQwNjQ1_ed5415b2-5076-4df5-9309-b22d59daa42e"
      unitRef="usd">54003000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i07a30ac3b99249dcab52ec26094b0a75_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzQtNC0xLTEtMTQwNjQ1_a7220879-4fb8-447e-836f-f566b7ddce41"
      unitRef="usd">60886000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i2cd99d5331f347e4b92782b89a82aeb2_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzQtNi0xLTEtMTQwNjQ1_03227288-b8a5-4603-8340-1b97c6f8e7e4"
      unitRef="usd">61224000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="icd981807e06146b9a8b7168780fa31e5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzUtNC0xLTEtMTQwNjQ1_3ab4ee4b-9d83-4e01-9ab4-bd9ac4f391c7"
      unitRef="usd">62149000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="if00d8760e6f64b3b890040f421a1920e_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzUtNi0xLTEtMTQwNjQ1_1c89b646-8288-448a-9772-423632bb6ec6"
      unitRef="usd">69252000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i8fc949bd76c94ac0acb9625d55ca5689_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzYtNi0xLTEtMTQwNjQ1_e865e637-090f-4b92-9e28-fa6b7181afda"
      unitRef="usd">67287000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzctNi0xLTEtMTQwNjQ1_fd1c8ac1-754f-4c38-ab79-5b3c85493312"
      unitRef="usd">197763000000</us-gaap:ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzUvZnJhZzpiMDkxNzE4MWUwZDk0ZmNiODBjYzUyOWVkYzQ3ZjNiNS90YWJsZTpiNDczMmE2YWY4M2Q0MmJjYmE2NTI4NWFlNzk0MjViNy90YWJsZXJhbmdlOmI0NzMyYTZhZjgzZDQyYmNiYTY1Mjg1YWU3OTQyNWI3XzktNi0xLTEtMTQwNjQ1_7c7c2955-f5ef-432f-ad2b-28ac0253aa7a"
      unitRef="usd">9264000000</us-gaap:ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzI0NTE_a3fcbd6b-e869-464e-b881-0e481444208f">INCOME TAXES &lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States and Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes was different from the amount computed using the federal statutory rate for the years ended December&#160;31, 2022, 2021 and 2020 due to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, net of federal benefit, and Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax exempt investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-taxable KAH gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect from sale of KAH Hospice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurance industry fee &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income tax balances reflect the impact of temporary differences between the tax bases of assets or liabilities and their reported amounts in our consolidated financial statements, and are stated at enacted tax rates expected to be in effect when the reported amounts are actually recovered or settled. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal components of our net deferred tax balances at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&#160;(Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and other accrued expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jobs tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciable property and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All deferred tax liabilities and assets are classified as noncurrent in our consolidated balance sheets as other long-term liabilities at December 31, 2022  and 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had approximately $68 million of federal net operating losses and approximately $1.6 billion of state and Puerto Rico net operating losses to carry forward. A portion of these loss carryforwards, if not used to offset future taxable income, will expire from 2031 through 2038. The balance of the net operating loss carryforwards has no expiration date. Due to limitations and uncertainty regarding our ability to use some of the loss carryforwards and certain other deferred tax assets, a valuation allowance of $57 million was established. For the remainder of the net operating loss carryforwards and other cumulative temporary differences, based on our historical record of producing taxable income and profitability, we have concluded that future operating income will be sufficient to recover these deferred tax assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file income tax returns in the United States and Puerto Rico.&#160;The U.S. Internal Revenue Service, or IRS, has completed its examinations of our consolidated income tax returns for 2020 and prior years. Our 2021 tax return is in the post-filing review period under the Compliance Assurance Process, or CAP. Our 2022 tax return is under advance review by the IRS under CAP. With a few exceptions, which are immaterial in the aggregate, we are no longer subject to state, local and foreign tax examinations for years before 2019.&#160;We are not aware of any material adjustments that may be proposed as a result of any ongoing or future examinations. We do not have material uncertain tax positions reflected in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;On August 16, 2022, the Inflation Reduction Act was signed into law. The Inflation Reduction Act includes various tax provisions, which are effective for the tax years beginning on or after January 1, 2023. There was no material impact on our consolidated financial statements at December 31, 2022.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzI0NTI_cb60e049-dcce-4187-9576-44ef4db0b31f">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes consisted of the following for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;755&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States and Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred (benefit) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(100)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzMtMS0xLTEtMTQwNjQ1_0a9f3397-f8ee-4ed5-aa8d-fd15b3b8d18e"
      unitRef="usd">755000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzMtMy0xLTEtMTQwNjQ1_dfcd7250-cf46-4ef0-827b-6e75c89f2ab4"
      unitRef="usd">466000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzMtNS0xLTEtMTQwNjQ1_cfc65274-d7a0-45b0-a995-7833018a8ced"
      unitRef="usd">1019000000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzQtMS0xLTEtMTQwNjQ1_f9018cfa-1203-454e-a3c6-5650dc055f3c"
      unitRef="usd">107000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzQtMy0xLTEtMTQwNjQ1_c0f47d79-3ab1-4c1a-b43c-7bc4297c01d0"
      unitRef="usd">4000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzQtNS0xLTEtMTQwNjQ1_10008244-831b-4584-98c8-71a80792eb81"
      unitRef="usd">93000000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzUtMS0xLTEtMTQwNjQ1_f704a483-60ad-4ca5-8f08-2f7cf71957d3"
      unitRef="usd">862000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzUtMy0xLTEtMTQwNjQ1_6ed9ffa6-a0a0-4b99-ab99-f6958bbc9a10"
      unitRef="usd">470000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzUtNS0xLTEtMTQwNjQ1_e0032272-b822-4590-b2dd-df85cbc0601d"
      unitRef="usd">1112000000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzYtMS0xLTEtMTQwNjQ1_dfef530c-920e-415d-a39d-eff998b3c29f"
      unitRef="usd">-100000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzYtMy0xLTEtMTQwNjQ1_be803b7e-3d9f-46f1-ac81-7eab4699959f"
      unitRef="usd">15000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzYtNS0xLTEtMTQwNjQ1_ced396ae-345a-421e-b34f-ff0b3155a704"
      unitRef="usd">195000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzctMS0xLTEtMTQwNjQ1_dc0a12a4-44e8-4363-b879-d9edd79830a6"
      unitRef="usd">762000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzctMy0xLTEtMTQwNjQ1_2ffddf78-3a86-4b98-9bac-f880a3118a89"
      unitRef="usd">485000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTpmODQ2NDg5NDczZTU0ZGU1YjVmNGE0NGRkMWFjZjc4Yi90YWJsZXJhbmdlOmY4NDY0ODk0NzNlNTRkZTViNWY0YTQ0ZGQxYWNmNzhiXzctNS0xLTEtMTQwNjQ1_4d57cfc3-6c41-44cf-b5ab-c8ad47cf0333"
      unitRef="usd">1307000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzI0NTk_76a362f6-b289-4132-9239-6e7ef9578068">&lt;div style="margin-bottom:12pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes was different from the amount computed using the federal statutory rate for the years ended December&#160;31, 2022, 2021 and 2020 due to the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax provision at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;States, net of federal benefit, and Puerto Rico&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax exempt investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nondeductible executive compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-taxable KAH gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax effect from sale of KAH Hospice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(72)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Health insurance industry fee &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzItMS0xLTEtMTQwNjQ1_ef3bc1e9-a6e1-4731-9eac-dc68d9ae7031"
      unitRef="usd">750000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzItMy0xLTEtMTQwNjQ1_73035aa1-9ce4-4d79-8bb5-4be5905b1132"
      unitRef="usd">718000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzItNS0xLTEtMTQwNjQ1_62c9e5c8-8dbd-4a2e-9a31-f37f7b2466d4"
      unitRef="usd">982000000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzMtMS0xLTEtMTQwNjQ1_44366329-de4d-4a35-8463-5a5e084687a9"
      unitRef="usd">49000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzMtMy0xLTEtMTQwNjQ1_3b3775bb-acb3-465e-a9fa-76f0c774748b"
      unitRef="usd">18000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzMtNS0xLTEtMTQwNjQ1_68d59346-c15d-49b6-8087-71112e24235c"
      unitRef="usd">63000000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzQtMS0xLTEtMTQwNjQ1_43b031d4-e9d5-4df6-a408-4da225f151e3"
      unitRef="usd">3000000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzQtMy0xLTEtMTQwNjQ1_adf0b53e-864e-41a5-b19f-29e4a68f6a9e"
      unitRef="usd">3000000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationTaxExemptIncome
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzQtNS0xLTEtMTQwNjQ1_f206510c-677f-4068-87d6-d5226f19e12b"
      unitRef="usd">5000000</us-gaap:IncomeTaxReconciliationTaxExemptIncome>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzUtMS0xLTEtMTQwNjQ1_50e4422f-6564-49cf-9843-b7df75de1b41"
      unitRef="usd">30000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzUtMy0xLTEtMTQwNjQ1_d89fa7b4-4132-41ff-b7f3-8d92f0301e81"
      unitRef="usd">33000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzUtNS0xLTEtMTQwNjQ1_f71865fe-b1f7-4dab-98a4-59eca11e932f"
      unitRef="usd">19000000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <hum:EffectiveIncomeTaxReconciliationNonTaxableKAHGain
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzYtMS0xLTEtMTQwNjQ1_ad5c7492-876c-4710-b8d8-7cd9a455511c"
      unitRef="usd">0</hum:EffectiveIncomeTaxReconciliationNonTaxableKAHGain>
    <hum:EffectiveIncomeTaxReconciliationNonTaxableKAHGain
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzYtMy0xLTEtMTQwNjQ1_38eb439f-3e0f-4e9e-b1d8-dd96de17cd28"
      unitRef="usd">264000000</hum:EffectiveIncomeTaxReconciliationNonTaxableKAHGain>
    <hum:EffectiveIncomeTaxReconciliationNonTaxableKAHGain
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzYtNS0xLTEtMTQwNjQ1_70ce610d-b517-4440-a04c-1d7cf68a4d80"
      unitRef="usd">0</hum:EffectiveIncomeTaxReconciliationNonTaxableKAHGain>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctMS0xLTEtMTYzNTI2_3c1ab9a3-e6c4-4bd3-8a08-e592fc9f3fd3"
      unitRef="usd">-72000000</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctMy0xLTEtMTYzNTI2_9282ae09-ba08-4c2d-bc9b-8d83d6d5a3b7"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <us-gaap:IncomeTaxReconciliationDispositionOfBusiness
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctNS0xLTEtMTYzNTI2_5dd2b480-c13c-4b7a-a0f7-2d856a6809a9"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationDispositionOfBusiness>
    <hum:EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctMS0xLTEtMTQwNjQ1_211fdc01-b949-45de-8cab-82563490a514"
      unitRef="usd">0</hum:EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount>
    <hum:EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctMy0xLTEtMTQwNjQ1_d9c0cce7-8b74-498d-9424-ba01e14f8240"
      unitRef="usd">0</hum:EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount>
    <hum:EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzctNS0xLTEtMTQwNjQ1_65d5c9ac-956f-4c30-9b43-cdd3d7c97ecf"
      unitRef="usd">268000000</hum:EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzktMS0xLTEtMTQwNjQ1_53cf661c-bee0-4ba4-ab15-6be8ace92c0e"
      unitRef="usd">8000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzktMy0xLTEtMTQwNjQ1_25e07f19-3124-4e93-844b-7b48abe81024"
      unitRef="usd">-17000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzktNS0xLTEtMTQwNjQ1_b0103df8-9331-41ad-b3c8-d218341e8b1c"
      unitRef="usd">-20000000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzEwLTEtMS0xLTE0MDY0NQ_4990eb07-8049-4a7a-8840-af138576cd5d"
      unitRef="usd">762000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzEwLTMtMS0xLTE0MDY0NQ_d028324b-b706-4259-9460-21d88e5741a0"
      unitRef="usd">485000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTo4MzNjYTc5OWIyMDY0YmJhODYwOGQzMDNmMDA0MmRkZS90YWJsZXJhbmdlOjgzM2NhNzk5YjIwNjRiYmE4NjA4ZDMwM2YwMDQyZGRlXzEwLTUtMS0xLTE0MDY0NQ_e24eed02-9d6e-408a-8cba-02f6ebb00e84"
      unitRef="usd">1307000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzI0NTA_4e71a5c5-94bf-474f-8655-4bd7b0bd4620">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal components of our net deferred tax balances at December&#160;31, 2022 and 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Assets&#160;(Liabilities)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforward&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Compensation and other accrued expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Jobs tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unearned revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciable property and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(740)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,072)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(132)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 43.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net deferred income tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(698)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzMtMS0xLTEtMTQwNjQ1_1b05af84-0cca-4b5b-8464-fe50ced68613"
      unitRef="usd">105000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzMtMy0xLTEtMTQwNjQ1_3278dea6-8064-4811-a571-a56a4ac2c3d1"
      unitRef="usd">291000000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzQtMS0xLTEtMTQwNjQ1_29d1dd7b-281d-4fdd-be08-d70f18a0708e"
      unitRef="usd">158000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzQtMy0xLTEtMTQwNjQ1_84fa56ac-1f0b-443e-b14d-a486528ece04"
      unitRef="usd">186000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzUtMS0xLTEtMTQwNjQ1_ca473702-2820-48c4-9d59-a19cbc9d4ae0"
      unitRef="usd">103000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzUtMy0xLTEtMTQwNjQ1_2bc61cdd-b7d5-46f7-b5fb-c9b4f40555e4"
      unitRef="usd">67000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits>
    <hum:DeferredTaxAssetsDeferredPolicyAcquisitionCost
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzYtMS0xLTEtMTQwNjQ1_40addb6e-10bd-4d3c-8fed-3de3118efdf0"
      unitRef="usd">43000000</hum:DeferredTaxAssetsDeferredPolicyAcquisitionCost>
    <hum:DeferredTaxAssetsDeferredPolicyAcquisitionCost
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzYtMy0xLTEtMTQwNjQ1_4d8d23b6-568b-439e-bd13-958accb38a76"
      unitRef="usd">33000000</hum:DeferredTaxAssetsDeferredPolicyAcquisitionCost>
    <hum:DeferredTaxAssetJobsTaxCredit
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzctMS0xLTEtMTQwNjQ1_0ae6c4c5-8573-4261-97a2-76acffca640f"
      unitRef="usd">22000000</hum:DeferredTaxAssetJobsTaxCredit>
    <hum:DeferredTaxAssetJobsTaxCredit
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzctMy0xLTEtMTQwNjQ1_a3fcb727-cf07-4768-bc20-4cd3ea8afd42"
      unitRef="usd">33000000</hum:DeferredTaxAssetJobsTaxCredit>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzgtMS0xLTEtMTQwNjQ1_fa4b04dd-e958-49fa-94de-60a4609564f5"
      unitRef="usd">16000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzgtMy0xLTEtMTQwNjQ1_d00494f5-55ea-439d-9d7a-f9a016309e09"
      unitRef="usd">25000000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzktMS0xLTEtMTQwNjQ1_9e7f3cc2-eacf-413e-85ca-962f15d4e0c2"
      unitRef="usd">7000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzktMy0xLTEtMTQwNjQ1_58f4ee56-8460-4489-b186-c6159a29a498"
      unitRef="usd">8000000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzExLTEtMS0xLTE0MDY0NQ_9c666066-28e2-4b06-9131-176d38f1cb05"
      unitRef="usd">454000000</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsInvestments
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzExLTMtMS0xLTE0MDY0NQ_593f8a38-1715-4f5b-b4c3-d05dcf330340"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsInvestments>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzEzLTEtMS0xLTE0MDY0NQ_33f24f0d-46ea-42a3-be20-9515bd91ddd7"
      unitRef="usd">908000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzEzLTMtMS0xLTE0MDY0NQ_e34ef57d-fd0d-41cb-8c20-078e354fdc4f"
      unitRef="usd">643000000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE0LTEtMS0xLTE0MDY0NQ_898568b5-8cbb-491c-9ec7-83f688dec02c"
      unitRef="usd">57000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE0LTMtMS0xLTE0MDY0NQ_690afe48-6b3a-4a5e-bf8e-2d58acf0c72c"
      unitRef="usd">65000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE1LTEtMS0xLTE0MDY0NQ_a570f573-fa26-4deb-a534-6139bf081fd4"
      unitRef="usd">851000000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE1LTMtMS0xLTE0MDY0NQ_9b85e58a-f1fb-4514-bfb9-70415cbc6951"
      unitRef="usd">578000000</us-gaap:DeferredTaxAssetsNet>
    <hum:DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE2LTEtMS0xLTE0MDY0NQ_ca5be8ae-c6da-4ae7-9616-c7bb115818b0"
      unitRef="usd">740000000</hum:DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets>
    <hum:DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE2LTMtMS0xLTE0MDY0NQ_dca07567-8f6d-4780-bd95-84a62874ece9"
      unitRef="usd">1072000000</hum:DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE3LTEtMS0xLTE0MDY0NQ_824bbc8b-deb2-4c52-b978-3fdb8cdae7f9"
      unitRef="usd">132000000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE3LTMtMS0xLTE0MDY0NQ_291cefab-4d86-4a08-94a0-c127d7303075"
      unitRef="usd">102000000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE4LTEtMS0xLTE0MDY0NQ_27bffcef-0878-4555-8349-04419d1e3d22"
      unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesInvestments
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE4LTMtMS0xLTE0MDY0NQ_0f81b005-b6d3-487e-9599-1001f8f0df78"
      unitRef="usd">98000000</us-gaap:DeferredTaxLiabilitiesInvestments>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE5LTEtMS0xLTE0MDY0NQ_0147bffe-f08c-43cb-a852-931f5aac4616"
      unitRef="usd">6000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzE5LTMtMS0xLTE0MDY0NQ_59ba2523-46b5-49af-991a-2f339908205c"
      unitRef="usd">4000000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzIwLTEtMS0xLTE0MDY0NQ_8078a919-40a7-436a-9003-cf5e39c347f3"
      unitRef="usd">878000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzIwLTMtMS0xLTE0MDY0NQ_ad54bde7-e9ac-4d00-983d-860495322885"
      unitRef="usd">1276000000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzIxLTEtMS0xLTE0MDY0NQ_f55af46b-9fbf-4f1d-a573-80671ae64c7d"
      unitRef="usd">27000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90YWJsZTozNGU2Y2M0NmFiODU0NWEyYWUxNTQwNWMwMDY5NGQxOC90YWJsZXJhbmdlOjM0ZTZjYzQ2YWI4NTQ1YTJhZTE1NDA1YzAwNjk0ZDE4XzIxLTMtMS0xLTE0MDY0NQ_826a620f-8642-46b9-b7e2-f72dfe68765d"
      unitRef="usd">698000000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ia1c0825aa8d04ce187bd5863fbc3d91f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzkyNQ_044b5c9e-363a-4058-8371-ad403d03b9ec"
      unitRef="usd">68000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i88c075a77c0b427e841063ff79561d21_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzk3OA_8bba5b51-8a3f-47c9-9597-cf18043ab6ef"
      unitRef="usd">1600000000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xNzgvZnJhZzpjNWExOTU0YjE2NGU0ZjE2YTg2MTRhZDRhMmFkMjI3Zi90ZXh0cmVnaW9uOmM1YTE5NTRiMTY0ZTRmMTZhODYxNGFkNGEyYWQyMjdmXzEzOTY_b07352b9-787b-423f-8c86-bbe29ab0b6e6"
      unitRef="usd">57000000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzgxMjA_980954fc-66c7-4090-a6da-fd1405010758">DEBT&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of debt outstanding was as follows at December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 0.65% due August 3, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600 million, 3.15% due December&#160;1, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400 million, 2.90% due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 0.65% due August 3, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.85% due October 1, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 4.50% due April 1, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million 1.35% due February 3, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.95% due March 15, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 5.75% due March 1, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 3.70% due March 23, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 3.13% due August 15, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 4.88% due April 1, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 2.15% due February 3, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 5.88% due March 1, 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$250&#160;million, 8.15% due June&#160;15, 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400&#160;million, 4.63% due December&#160;1, 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 4.95% due October 1, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400&#160;million, 4.80% due March 15, 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 3.95% due August 15, 2049&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, due October 29, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Delayed draw term loan, due May 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the short-term and long-term debt for the years ending December 31, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the years ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our senior notes, which are unsecured, may be redeemed at our option at any time at 100% of the principal amount plus accrued interest and a specified make-whole amount. The 8.15% senior notes are subject to an interest rate adjustment if the debt ratings assigned to the notes are downgraded (or subsequently upgraded). In addition, our senior notes contain a change of control provision that may require us to purchase the notes under certain circumstances. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, we repaid $600&#160;million aggregate principal amount of our 3.150% senior notes due on their maturity date of December 1, 2022 and $400 million aggregate principal amount of our 2.900% senior notes due on their maturity date of December 15, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2022, we issued $500&#160;million of 5.750% unsecured senior notes due March 1, 2028 and $750&#160;million of 5.875% unsecured senior notes due March 1, 2033. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $1.2&#160;billion. We used the net proceeds for general corporate purposes, which included the repayment of existing indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2022, we issued $750&#160;million of 3.700% unsecured senior notes due March 23, 2029. Our net proceeds, reduced for the underwriters' discounts and commissions paid, were $744&#160;million. We used the net proceeds for general corporate purposes, which included the repayment of existing indebtedness, including borrowings under our commercial paper program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Delayed Draw Term Loan Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2021, we entered into a $500&#160;million unsecured delayed draw term loan credit agreement. Under the term loan credit agreement, loans bear interest at either LIBOR plus a spread or the base rate plus a spread. The loans under the term loan credit agreement mature on the third anniversary of the funding date. The LIBOR spread, currently 125 basis points, varies depending on our credit ratings ranging from 100.0 to 162.5 basis points. The term loan credit agreement provides for the transition from LIBOR and does not require amendment in connection with such transition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; In August 2021, we borrowed $500&#160;million under the delayed draw term loan agreement, which was used, in combination with other debt financing, to fund the approximate $5.8&#160;billion transaction price of Kindred at Home. The term loan credit agreement contains customary restrictive covenants and a financial covenant regarding maximum debt to capitalization of 60%, as well as customary events of default. We are in compliance with this financial covenant, with actual debt to capitalization of 42.0% as measured in accordance with the term loan credit agreement as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have other customary relationships, including financial advisory and banking, with some parties to the term loan agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;October 2021 Term Loan Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 29, 2021, we entered into a $2.0&#160;billion term loan credit agreement, which we refer to as the October 2021 Term Loan Agreement, with certain lending banks and other financial institutions. Proceeds of the October 2021 Term Loan Agreement were applied to finance the repayment in full of the outstanding KAH debt of $1.9&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 16, 2022, w&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; repaid the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$2.0&#160;billion October 2021 Term Loan Agreement without a prepayment penalty due.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%"&gt;Revolving Credit Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, we entered into a 5-year, $2.5&#160;billion unsecured revolving credit agreement. Under the 5-year revolving credit agreement, at our option, we can borrow on either a competitive advance basis or a revolving credit basis. The revolving credit portion bears interest at either LIBOR plus a spread or the base rate plus a spread. The competitive advance portion of any borrowings will bear interest at market rates prevailing at the time of borrowing on either a fixed rate or a floating rate based on LIBOR, at our option. The revolving credit agreement provides for the transition from LIBOR and does not require amendment in connection with such transition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, we entered into a 364-day $1.5&#160;billion unsecured revolving credit agreement (replacing the 364-day $1.5&#160;billion unsecured revolving credit agreement entered in June 2021, which expired in accordance with its terms). Under the 364-day revolving credit agreement, at our option, we can borrow on either a competitive advance basis or a revolving credit basis. The revolving credit portion bears interest at Term SOFR or the base rate plus a spread. The competitive advance portion of any borrowings will bear interest at market rates prevailing at the time of borrowing on either a fixed rate or a floating rate based Term SOFR, at our option.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The LIBOR spread, currently 110.0 basis points under the 5-year revolving credit agreements and the SOFR spread, currently 115.0 basis points under the 364-day revolving credit agreement, varies depending on our credit ratings ranging from 91.0 to 140.0 basis points under the 5-year revolving credit agreement and from 94.0 to 135.0 basis points under the 364-day revolving credit agreement. We also pay an annual facility fee regardless of utilization. This facility fee, currently 15.0 basis points, under the 5-year revolving credit agreement and 10.0 basis points under the 364-day revolving agreement, varies depending on our credit ratings ranging from 9.0 to 22.5 basis points under the 5-year revolving credit agreement and from 6.0 to 15.0 basis points under the 364-day revolving credit agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms of the revolving credit agreements include standard provisions related to conditions of borrowing which could limit our ability to borrow additional funds. In addition, the credit agreements contain customary restrictive covenants and a financial covenant regarding maximum debt to capitalization of 60%, as well as customary events of default. We are in compliance with this financial covenant, with actual debt to capitalization of 42.0% as measured in accordance with the revolving credit agreements as of December&#160;31, 2022. Upon our agreement with one or more financial institutions, we may expand the aggregate commitments under the revolving credit agreements by up to $750&#160;million in the aggregate, to a maximum of $4.75&#160;billion, across the 5-year and 364-day revolving credit agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, we had no borrowings and approximately $45&#160;million of letters of credit outstanding under the revolving credit agreements, including those of KAH. Accordingly, as of December&#160;31, 2022, we had $2.4&#160;billion of remaining borrowing capacity under the 5-year revolving credit agreement and $1.5&#160;billion of remaining borrowing capacity under the 364-day revolving credit agreement (which excludes the uncommitted $750&#160;million of incremental loan facilities), none of which would be restricted by our financial covenant compliance requirement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have other customary relationships, including financial advisory and banking, with some parties to the revolving credit agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial Paper&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     Under our commercial paper program we may issue short-term, unsecured commercial paper notes privately placed on a discount basis through certain broker dealers at any time. On February 10, 2022, we increased the size of our commercial paper program to permit the issuance of commercial paper notes in an aggregate principal amount not to exceed $4&#160;billion compared to the prior amount not to exceed $2&#160;billion. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. The maximum principal amount outstanding at any one time during the year ended&#160;December&#160;31, 2022&#160;was $1,450 million, with $595 million outstanding at December&#160;31, 2022 compared to $955 million outstanding at December 31, 2021. The outstanding commercial paper at December&#160;31, 2022 had a weighted average annual interest rate of 4.92%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Short-term Borrowings&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a member, through one subsidiary, of the Federal Home Loan Bank of Cincinnati, or FHLB. As a member we have the ability to obtain short-term cash advances, subject to certain minimum collateral requirements. As of December&#160;31, 2022 and December&#160;31, 2021, we had no outstanding short-term FHLB borrowings&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzgxMTM_2f63ca4e-eb0a-42f6-be83-f2a9e52b90f4">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of debt outstanding was as follows at December&#160;31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.981%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.877%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.040%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 0.65% due August 3, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600 million, 3.15% due December&#160;1, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400 million, 2.90% due December 15, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Senior notes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1,500&#160;million, 0.65% due August 3, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.85% due October 1, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 4.50% due April 1, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million 1.35% due February 3, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;745&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$600&#160;million, 3.95% due March 15, 2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 5.75% due March 1, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 3.70% due March 23, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 3.13% due August 15, 2029&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 4.88% due April 1, 2030&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 2.15% due February 3, 2032&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 5.88% due March 1, 2033&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$250&#160;million, 8.15% due June&#160;15, 2038&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400&#160;million, 4.63% due December&#160;1, 2042&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$750&#160;million, 4.95% due October 1, 2044&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$400&#160;million, 4.80% due March 15, 2047&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$500&#160;million, 3.95% due August 15, 2049&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loans:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term loan, due October 29, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Delayed draw term loan, due May 28, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="ib173a9a9bf26418d85e8c702ffd7b911_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzMtMS0xLTEtMTQwNjQ1_9620f421-28a2-456d-b090-6a01cb5bfcc5"
      unitRef="usd">595000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ia2d89ea7a0994fdc830560ce43d6ccf3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzMtMy0xLTEtMTQwNjQ1_de2280ec-0a29-4098-a7fe-fc4bc9927087"
      unitRef="usd">955000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i99fded64e274478ab73f5733933c5a78_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMC0xLTEtMTUwMzE5L3RleHRyZWdpb246MWNlNDFjNmE2OTZmNGM3ZTkyODg3MjQyMjc4MjgwZTRfODc5NjA5MzAyMjIzOA_7161dffa-b778-4624-bbd5-0ea6339d1406"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i99fded64e274478ab73f5733933c5a78_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMC0xLTEtMTUwMzE5L3RleHRyZWdpb246MWNlNDFjNmE2OTZmNGM3ZTkyODg3MjQyMjc4MjgwZTRfODc5NjA5MzAyMjI0OA_261393ef-164d-4b9f-9b16-5326f501db27"
      unitRef="number">0.0065</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="i99fded64e274478ab73f5733933c5a78_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMS0xLTEtMTQ4NDI1_0cef5c68-66fb-4c47-8c16-0c3c2d22a273"
      unitRef="usd">1497000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ibd6ab2d56c9c482ab6bb5a898cdae46b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMy0xLTEtMTQ4NDI1_6676e611-72f3-4888-813f-6d9c5a03fc19"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8db13c66deb74bf2857e79213be4b395_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246NTU2YTAyOTk3YWJlNDVmNjg1NTM2NzA4OWI2OGYwNmZfNA_8ee764b4-84d5-4eb0-a55d-a0c5abb51a26"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8db13c66deb74bf2857e79213be4b395_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246NTU2YTAyOTk3YWJlNDVmNjg1NTM2NzA4OWI2OGYwNmZfOA_b9370ff1-0807-4799-ae95-eccbfec29fd8"
      unitRef="number">0.0315</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="i8db13c66deb74bf2857e79213be4b395_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMS0xLTEtMTQwNjQ1_eae86b62-56f2-4232-8a38-a644d0774836"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0dfdeedfdae442b6bb69fbd7a0e139f1_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzUtMy0xLTEtMTQwNjQ1_5b9863dc-05b6-4731-9c4a-681051aea1da"
      unitRef="usd">599000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic7f278945eb146999d7aa678fa21f058_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzYtMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246YjUwMmY1MDk1NTI4NDRjMTkyZDM2ZDQ3MGZhNzU5NWZfNA_67c7944f-d3c6-428f-9f2b-019ae2e1fa23"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic7f278945eb146999d7aa678fa21f058_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzYtMC0xLTEtMTQwNjQ1L3RleHRyZWdpb246YjUwMmY1MDk1NTI4NDRjMTkyZDM2ZDQ3MGZhNzU5NWZfOA_935577c1-1a74-48a7-9474-4065d82aac4a"
      unitRef="number">0.0290</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtCurrent
      contextRef="ic7f278945eb146999d7aa678fa21f058_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzYtMS0xLTEtMTQwNjQ1_51320699-1cdf-4aa6-bf73-1ebe85df3ea6"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0356912bdf2b4aabaeaff5e2ca21abc6_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzYtMy0xLTEtMTQwNjQ1_4a2be26d-3a44-485b-9808-5e3fbf4ab653"
      unitRef="usd">399000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i59f9c510abc04bad91d14e68c501cf01_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzctMS0xLTEtMTQwNjQ1_e8a54fde-1e02-4062-a883-13c87b3514b1"
      unitRef="usd">1497000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i773c7af03af34a47b324353282df0bf3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzctMy0xLTEtMTQwNjQ1_6152bf68-6e25-4517-afcf-12be5e1559d3"
      unitRef="usd">998000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzgtMS0xLTEtMTQwNjQ1_c4adb641-3bd1-4330-8e59-6fa83483d8e6"
      unitRef="usd">2092000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzgtMy0xLTEtMTQwNjQ1_db250834-db9c-4f64-a59f-5287bb579658"
      unitRef="usd">1953000000</us-gaap:DebtCurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i99fded64e274478ab73f5733933c5a78_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEyLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjQyYzJiOWM3MmM0MDQwYmVhMGM3MGViODYxYzQ3Mjk1Xzg3OTYwOTMwMjIyNjI_ac6505d5-e3ce-4835-a4f2-72bf34f6e108"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i99fded64e274478ab73f5733933c5a78_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEyLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjQyYzJiOWM3MmM0MDQwYmVhMGM3MGViODYxYzQ3Mjk1Xzg3OTYwOTMwMjIyNzA_c78bee87-d4d8-4c34-9852-886ca31441bf"
      unitRef="number">0.0065</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i99fded64e274478ab73f5733933c5a78_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEyLTEtMS0xLTE0MDY0NQ_37f883a4-1382-4be9-ba07-053ab30fbede"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibd6ab2d56c9c482ab6bb5a898cdae46b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEyLTMtMS0xLTE0MDY0NQ_522e60f0-3e05-4ad3-bffb-7ba7cdb46a68"
      unitRef="usd">1492000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i5276601cfe0b4fac93dc9dddd8c95bea_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEzLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmU2NWExODZhZGE4NzRjMDlhMDAwOGRkZWE2MDIxZDMxXzg3OTYwOTMwMjIyNjM_5b3f0d93-21c5-4605-b024-1f8bf5c97db1"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5276601cfe0b4fac93dc9dddd8c95bea_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEzLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmU2NWExODZhZGE4NzRjMDlhMDAwOGRkZWE2MDIxZDMxXzg3OTYwOTMwMjIyNzI_f1e86320-2bbb-4c59-bdea-cc3d370059c1"
      unitRef="number">0.0385</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5276601cfe0b4fac93dc9dddd8c95bea_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEzLTEtMS0xLTE0MDY0NQ_edb3846a-718a-4a6b-88a6-9daa157cb92d"
      unitRef="usd">599000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i509fa063896747ef909206a07e142390_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzEzLTMtMS0xLTE0MDY0NQ_5717a14e-c9da-433a-847f-4ef51b5e7a6f"
      unitRef="usd">598000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i36e388eca8694a32b6e8c72020b4c015_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmE2MjgzYzg4M2EwNjRkMmRiM2RlNTI2MzRlNmYyYjFlXzg3OTYwOTMwMjIyNTM_4f870c68-48a2-4088-a64c-365e17dac782"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i36e388eca8694a32b6e8c72020b4c015_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmE2MjgzYzg4M2EwNjRkMmRiM2RlNTI2MzRlNmYyYjFlXzg3OTYwOTMwMjIyNjE_3a7c6913-8a2f-46b1-926a-47087f6382b4"
      unitRef="number">0.0450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i36e388eca8694a32b6e8c72020b4c015_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE0LTEtMS0xLTE0MDY0NQ_5502831a-2331-46d6-83ea-1ee76b9d4195"
      unitRef="usd">597000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibeb90e7ae11f495f937a25c066d3754b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE0LTMtMS0xLTE0MDY0NQ_981a1560-64e2-4cdf-8069-f693ac7b3a1f"
      unitRef="usd">596000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8368074918ac49a18d7b9cd1a553e8ab_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjYxOTU1NTgzMmU0NzQ2YTQ5Y2ZmYWVkYTgwZjEzNDEzXzg3OTYwOTMwMjIyNjU_b25f2e48-eb4b-4d3d-ba51-69cdcd482b47"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8368074918ac49a18d7b9cd1a553e8ab_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjYxOTU1NTgzMmU0NzQ2YTQ5Y2ZmYWVkYTgwZjEzNDEzXzg3OTYwOTMwMjIyNzQ_1d700543-0d35-41d2-a1cb-282aabdba3ba"
      unitRef="number">0.0135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8368074918ac49a18d7b9cd1a553e8ab_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE1LTEtMS0xLTE0MDY0NQ_8b0eb939-8e2d-4e06-abba-e57a2b23a00b"
      unitRef="usd">745000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id965da0f6c5b41cb887887c891386017_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE1LTMtMS0xLTE0MDY0NQ_a5c75149-4f3e-417d-aa2c-0c277d40083d"
      unitRef="usd">742000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie10cec06f87647a3a1fa3fa523fe76b1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE2LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjkwOTdjOThiMGI0MDQ3ZWE4YjAyYmRjOTFlMWVkMGFkXzg3OTYwOTMwMjIyNjI_64db7430-0657-4e17-a427-42c97b1584f5"
      unitRef="usd">600000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie10cec06f87647a3a1fa3fa523fe76b1_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE2LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjkwOTdjOThiMGI0MDQ3ZWE4YjAyYmRjOTFlMWVkMGFkXzg3OTYwOTMwMjIyNzA_fb32164a-ce06-4b35-9b3e-51f30f751fb9"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie10cec06f87647a3a1fa3fa523fe76b1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE2LTEtMS0xLTE0MDY0NQ_8da1b3ae-07a2-41ac-87e5-934d8706b58a"
      unitRef="usd">597000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ied2ca976e98543e08e6ba87196523dfe_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE2LTMtMS0xLTE0MDY0NQ_538a4a47-7178-48f1-985a-6bef1462a292"
      unitRef="usd">596000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i232b89f9079741ccae985c3171fc7335_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTAtMS0xLTE2MTI0MC90ZXh0cmVnaW9uOjc1NWRiMzBmZDQ2ZDQ0ZjNhYzNhNzY4NGRkZTQyMTM3Xzg3OTYwOTMwMjIyMTI_535f56f3-eb0b-483b-b617-ce7dd9f85e21"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i232b89f9079741ccae985c3171fc7335_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTAtMS0xLTE2MTI0MC90ZXh0cmVnaW9uOjc1NWRiMzBmZDQ2ZDQ0ZjNhYzNhNzY4NGRkZTQyMTM3Xzg3OTYwOTMwMjIyMTc_5eda8237-755c-49ee-b4f4-08ce9f7201ba"
      unitRef="number">0.0575</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i232b89f9079741ccae985c3171fc7335_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTEtMS0xLTE2MTIyMQ_8bf587b7-6ad9-4e9c-8a7c-c74e14576774"
      unitRef="usd">494000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i853adef442584550b2d101e6ecef03e3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTMtMS0xLTE2MTIyMQ_7fac8935-465f-431f-bb29-803e2f8b1fe8"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic1b454e6cf714a3fa01d153c13807f69_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE3LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmM3ZWUyOGQ2Yjk5MzRlZDA5YjM5NWUzYjM0YTNmYjMzXzg3OTYwOTMwMjIyNjM_01ae9f05-a133-4284-a2a5-aa777b499e92"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic1b454e6cf714a3fa01d153c13807f69_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE3LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmM3ZWUyOGQ2Yjk5MzRlZDA5YjM5NWUzYjM0YTNmYjMzXzg3OTYwOTMwMjIyNzI_8b3074f1-4dad-4a82-bdad-fa810c2079bd"
      unitRef="number">0.0370</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic1b454e6cf714a3fa01d153c13807f69_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE3LTEtMS0xLTE0MDY0NQ_29ad515f-651b-4373-bf2a-d636fd0d1681"
      unitRef="usd">743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i1af71980b56546dd9dfa3f27ecfb67a5_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE3LTMtMS0xLTE0MDY0NQ_f564e8d4-9f69-4531-913c-dfd3df9519f7"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i6eb98a6499094af98d17a8f638209725_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmNlNGQ0MmE3ZTJlYTQ3MjViMjk5OTMyNzMzM2VmY2U4Xzg3OTYwOTMwMjIyNjQ_6f62e7a5-1789-485a-b3dd-aad60d836971"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6eb98a6499094af98d17a8f638209725_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmNlNGQ0MmE3ZTJlYTQ3MjViMjk5OTMyNzMzM2VmY2U4Xzg3OTYwOTMwMjIyNzM_7e6d78a6-55b1-40f2-8cb1-7d5ee0b1e8a1"
      unitRef="number">0.0313</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6eb98a6499094af98d17a8f638209725_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTEtMS0xLTE0MDY0NQ_75e58238-d8e5-44c5-badf-25437e346d29"
      unitRef="usd">496000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia0ce78565c94456ab9c3991a4e4e4b5a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE4LTMtMS0xLTE0MDY0NQ_8c29434f-ccf4-4a84-b4dc-09add83411bb"
      unitRef="usd">496000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i708adb6138b2495a89218e1aa2f9c270_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjZlZTFmN2Q5MTZkNjRkMzZiZWQ0NTFhYjU5NDdjZTllXzg3OTYwOTMwMjIyNjI_4d09569a-f73a-4f33-83bc-6879cf708062"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i708adb6138b2495a89218e1aa2f9c270_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE5LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjZlZTFmN2Q5MTZkNjRkMzZiZWQ0NTFhYjU5NDdjZTllXzg3OTYwOTMwMjIyNzI_d1a589c3-12c4-4701-99b8-c33e714d8b57"
      unitRef="number">0.0488</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i708adb6138b2495a89218e1aa2f9c270_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE5LTEtMS0xLTE0MDY0NQ_f35e0702-2e0c-4242-8825-5b583d62e629"
      unitRef="usd">495000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4ca72929b8994051a4a074df8437680d_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzE5LTMtMS0xLTE0MDY0NQ_6985ef22-2f2f-4f36-80b4-f9fcfff89c8e"
      unitRef="usd">495000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if64cdf61ab1842c79002bf0f3aa124c0_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjU4MzgwZjJjYmJmODQ0M2Q5MDYyZGYzNTZjOGFiNTVhXzg3OTYwOTMwMjIyNjQ_be9e3485-5a19-494a-9ce9-8cb7e2fe76f9"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if64cdf61ab1842c79002bf0f3aa124c0_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjU4MzgwZjJjYmJmODQ0M2Q5MDYyZGYzNTZjOGFiNTVhXzg3OTYwOTMwMjIyNzI_0f291ce4-6005-4494-8b25-a211a156d09b"
      unitRef="number">0.0215</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if64cdf61ab1842c79002bf0f3aa124c0_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIwLTEtMS0xLTE0MDY0NQ_f90c6652-5c09-470c-a47b-70e169df47c7"
      unitRef="usd">743000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i57de736a34744fdea94f1c8fdd485269_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIwLTMtMS0xLTE0MDY0NQ_752ab823-cdbc-46b0-9b3c-22f597081cdd"
      unitRef="usd">741000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic096f056f036465dba708996f2f7a90c_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTAtMS0xLTE2MTI1Mi90ZXh0cmVnaW9uOjU2ZmNhZGQ1OTQ4MjRmZjZhYTgyY2NmNDk3NWExOTQwXzg3OTYwOTMwMjIyMTI_4e04b4aa-92ef-4b01-9b23-9e8ac9e4903a"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic096f056f036465dba708996f2f7a90c_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTAtMS0xLTE2MTI1Mi90ZXh0cmVnaW9uOjU2ZmNhZGQ1OTQ4MjRmZjZhYTgyY2NmNDk3NWExOTQwXzg3OTYwOTMwMjIyMTc_28cc4b14-d8e1-4e3b-94cb-e802d5c87bcd"
      unitRef="number">0.0588</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic096f056f036465dba708996f2f7a90c_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTEtMS0xLTE2MTIyOQ_db35fefe-15f8-4b69-953e-a7086f899f54"
      unitRef="usd">739000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id0e1c1afc93c410d8219b30b59c4221f_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTMtMS0xLTE2MTIyOQ_34f2fadc-1641-4c8f-8d92-9d6cc21d752f"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg0ZGJlNDIyNTAwMzRmNmJiYzgyNTVmMDRiNDcxYzIyXzg3OTYwOTMwMjIyNjE_dfa33fb8-140d-4350-b529-5d8fbeace9de"
      unitRef="usd">250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjg0ZGJlNDIyNTAwMzRmNmJiYzgyNTVmMDRiNDcxYzIyXzg3OTYwOTMwMjIyNjk_6ff83a82-e963-4b91-b4f0-c41f993b9a8e"
      unitRef="number">0.0815</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIxLTEtMS0xLTE0MDY0NQ_18b9f556-5dc1-472f-98eb-017bb6d11dd8"
      unitRef="usd">261000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i102f918dc90d487f9be67b46e5ad7593_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIxLTMtMS0xLTE0MDY0NQ_7d19c040-6c3d-428d-9d22-79556f01c77d"
      unitRef="usd">261000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i62a760cb5c98497ab0e8bb6f03c6e29b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIyLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmRlNDdhNTcxYjAzYjQyNWE5ZWE3YmE3MDI4OGQyZTRhXzg3OTYwOTMwMjIyNjU_25aa9332-5c64-4cbf-b34c-cd64084c3613"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i62a760cb5c98497ab0e8bb6f03c6e29b_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIyLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmRlNDdhNTcxYjAzYjQyNWE5ZWE3YmE3MDI4OGQyZTRhXzg3OTYwOTMwMjIyNzQ_dfc4ff05-5299-40b1-892e-bc9f5bfe201a"
      unitRef="number">0.0463</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i62a760cb5c98497ab0e8bb6f03c6e29b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIyLTEtMS0xLTE0MDY0NQ_c6ed099a-0afd-4d7d-851a-595cfd62f9ee"
      unitRef="usd">396000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i853fb2ba319a40ae809f5f370473eb91_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIyLTMtMS0xLTE0MDY0NQ_a7f74952-6253-4858-8a96-309d17300f56"
      unitRef="usd">396000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="if5c6d742cb8343b8a723dafa1d57d5ad_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQwMmVlNWJhYTFlYzQxMGQ5MWQwMGUzZmFjZDZjOTUzXzg3OTYwOTMwMjIyNjM_b646dadf-2925-4b0f-b089-498eb5f3d51d"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if5c6d742cb8343b8a723dafa1d57d5ad_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmQwMmVlNWJhYTFlYzQxMGQ5MWQwMGUzZmFjZDZjOTUzXzg3OTYwOTMwMjIyNzI_c19cd4b0-6fd6-4c70-9655-ef1b6997fbac"
      unitRef="number">0.0495</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if5c6d742cb8343b8a723dafa1d57d5ad_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTEtMS0xLTE0MDY0NQ_c27e1631-8569-47a8-a847-8c91de510f4f"
      unitRef="usd">740000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i50436e89d2dc4ae6aeff04066d91f1e4_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzIzLTMtMS0xLTE0MDY0NQ_b76684dc-733d-48b2-8377-be012fa42f36"
      unitRef="usd">740000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i667465604c864997be52308f84abe858_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjZhZWQwMmQ0YWZkMTQwNmM4OTdmZjQwYWViN2E2OTdhXzg3OTYwOTMwMjIyNjI_ed680253-03c9-42f9-a958-e0f624af812d"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i667465604c864997be52308f84abe858_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI0LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjZhZWQwMmQ0YWZkMTQwNmM4OTdmZjQwYWViN2E2OTdhXzg3OTYwOTMwMjIyNzA_cd1b88b0-2603-4908-8243-f1255e6b2400"
      unitRef="number">0.0480</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i667465604c864997be52308f84abe858_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI0LTEtMS0xLTE0MDY0NQ_8d33f8ed-2c7a-4371-a484-0ad1a7d045e8"
      unitRef="usd">396000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i83b3d29f254448849e71cacdfe49dd10_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI0LTMtMS0xLTE0MDY0NQ_23361167-65d0-47dc-b695-ec61e69a08e9"
      unitRef="usd">395000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i10bb54eaa9364a17b55f021b93ed865f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjY1ZjQ0MTc4Mjk0YzRjODRhODZjZGYwZDgxNzZjY2UwXzg3OTYwOTMwMjIyNjM_72bd1a27-d175-4f2c-9187-aba5a9730328"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i10bb54eaa9364a17b55f021b93ed865f_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjY1ZjQ0MTc4Mjk0YzRjODRhODZjZGYwZDgxNzZjY2UwXzg3OTYwOTMwMjIyNzE_a825887c-b779-4603-8830-af21baecffea"
      unitRef="number">0.0395</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i10bb54eaa9364a17b55f021b93ed865f_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI1LTEtMS0xLTE0MDY0NQ_08b63675-cbf1-428a-b430-d487b95dba64"
      unitRef="usd">493000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5297e4cf2a114648b8e3b858f90ec33b_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI1LTMtMS0xLTE0MDY0NQ_0d2b2332-14de-4036-887a-7d2424a0b2a3"
      unitRef="usd">493000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i81c11504dac94900b47f3adec13f2eac_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI4LTEtMS0xLTE0MDY0NQ_efd7a3f5-0698-4b59-b00b-8e1c70d32277"
      unitRef="usd">0</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9dbea7f466654367bb2ffab6a0f398ae_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI4LTMtMS0xLTE0MDY0NQ_eabfa6ae-2cb2-43fe-a4de-cd47a882fc3c"
      unitRef="usd">2000000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i6401b4f44735434682c78028a5989e89_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI5LTEtMS0xLTE0MDY0NQ_18ab8d12-8a0d-4a69-8351-baa59aac8586"
      unitRef="usd">500000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idc85f1f2648a47f78a97ded8aed480aa_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzI5LTMtMS0xLTE0MDY0NQ_b0d4e5cc-8834-4cb5-8808-929ae06b16f8"
      unitRef="usd">500000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzMwLTEtMS0xLTE0MDY0NQ_0bbe3457-3779-475e-8758-22d77f14d18b"
      unitRef="usd">9034000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpkNTNjOGI5ZGViNTE0ODM2Yjc1MzBmOTI3MjgzNTcyNC90YWJsZXJhbmdlOmQ1M2M4YjlkZWI1MTQ4MzZiNzUzMGY5MjcyODM1NzI0XzMwLTMtMS0xLTE0MDY0NQ_da446fb5-3d9d-499a-80cd-f353879b11ad"
      unitRef="usd">10541000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzgxMTU_6070d5f6-706b-418c-ad5c-47ae05a3ebda">&lt;div style="margin-bottom:9pt;margin-top:7pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of the short-term and long-term debt for the years ending December 31, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.358%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:79.706%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;For the years ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzEtMS0xLTEtMTQwNjQ1_9f34d201-2dc5-4acc-ba81-0111e95afee1"
      unitRef="usd">2095000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzItMS0xLTEtMTQwNjQ1_2b486c2d-6f0a-437f-a259-85703b546457"
      unitRef="usd">1100000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzMtMS0xLTEtMTQwNjQ1_6528978a-c436-4d8f-9ded-5bc347b6fdc4"
      unitRef="usd">600000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzQtMS0xLTEtMTQwNjQ1_1ea1ecea-1d66-4a53-8e3d-803cc9559b44"
      unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzUtMS0xLTEtMTQwNjQ1_3c019d26-2a1e-4e7c-b9ca-16b64a48d90d"
      unitRef="usd">1350000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90YWJsZTpiY2U0MTI2ZDg4MDk0MzYxYjQzNmQ0OWQxMjM3ZDRmOS90YWJsZXJhbmdlOmJjZTQxMjZkODgwOTQzNjFiNDM2ZDQ5ZDEyMzdkNGY5XzYtMS0xLTEtMTQwNjQ1_903f6cad-a285-4be1-b57a-9f04775a15c8"
      unitRef="usd">6050000000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i8d2e5c35e8664d878870c2ac31cb5a7f_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NDk4Nzc_fc8d7410-c84a-42ee-a236-17008bf5d5f0"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i4b377db8d6ec4f0f9b0af840f183fee5_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NDk4ODM_8727c5a8-bdd1-4c2a-95d7-28958d2fb0ec"
      unitRef="number">0.0815</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="i3d642b46f9f947e1908279e62e1137c4_D20221201-20221201"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzU0OTc1NTgxNzEwMDE_5c1f4f08-16e3-4066-93cf-eb892500589a"
      unitRef="usd">600000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8db13c66deb74bf2857e79213be4b395_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzU0OTc1NTgxNzEwMTU_dc41aafc-de05-4a84-a523-16a945290043"
      unitRef="number">0.03150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RepaymentsOfDebt
      contextRef="id5f7b09cb2a44027b3040bd2bed6bdea_D20221215-20221215"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzU0OTc1NTgxNzEwMzE_966c2e73-8a39-4194-9313-c5a2c2ed7dd6"
      unitRef="usd">400000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ic7f278945eb146999d7aa678fa21f058_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzU0OTc1NTgxNzEwMjM_a25a5023-c272-49c1-aa2c-983d918e4162"
      unitRef="number">0.02900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i9d8c3540308f450bb7239d10b7acc3b7_I20221130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NjAyOTI_91d6d807-63b7-4ed4-9a04-74465bc62201"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9d8c3540308f450bb7239d10b7acc3b7_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTQwNTc_971b6c83-1f89-479e-8c97-dc023e22429c"
      unitRef="number">0.05750</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i63948e729cd5446e9ecb1103f8d97342_I20221130"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NjAzMzg_f65077a8-2f99-449f-b8f8-9da951c39745"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i63948e729cd5446e9ecb1103f8d97342_I20221130"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NjAzMTQ_fcb1d09b-1d1c-4eaa-aeb5-53ab116600d0"
      unitRef="number">0.05875</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i0b66643fcfdc4bc3aac6fe89fd6d2c8e_D20221101-20221130"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NjAzMjI_e7be1a28-7769-4ff3-b1f0-244202b21dd2"
      unitRef="usd">1200000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i59c282fc7fc24fdfb266342670c5aa0e_I20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE5MTA_df3b4cb4-c402-405d-ac1e-5c9307bce2a4"
      unitRef="usd">750000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i59c282fc7fc24fdfb266342670c5aa0e_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE5MzE_cafd9078-fd85-4cd1-9e54-37122b81c2fe"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i6147469181034d3693ebd758a56db336_D20220301-20220331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE5NTI_0e9369c5-6d96-47b9-bc1c-605a05c86106"
      unitRef="usd">744000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ic09be7d135374636bb90d8a931991af6_I20210531"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDYxMzc_ed4dd03c-e448-435c-aef7-f00b8c3ada52"
      unitRef="usd">500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibbb32b683c6d4c9389fc542d8b6ffe93_D20210501-20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDYxNTU_25a63fd3-d4fb-4900-9125-28b673b5439c"
      unitRef="number">0.0125</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="idbcdabf72f5c4bbfbf380741c218ce61_D20210501-20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDYxNjY_084c6516-3013-486d-b4c9-57efda847503"
      unitRef="number">0.01000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i58d6462307654072a27dd04f0987456f_D20210501-20210531"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDYxNzk_436d5fe8-a0e0-4f16-925c-165a53fd8dca"
      unitRef="number">0.01625</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="i1f8d88b80b864d978dcce7b20445315e_D20210801-20210831"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTM5ODU_19dfbac6-6b54-422c-b2f4-1a6487fffc97"
      unitRef="usd">500000000</us-gaap:ProceedsFromNotesPayable>
    <hum:BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest
      contextRef="i9699973b24d84dcaae4ebcf77e8bddfd_I20210831"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTM5OTk_deb005bf-23d9-43ca-92e6-0f4d8210ec06"
      unitRef="usd">5800000000</hum:BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest>
    <hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum
      contextRef="i112e4e9b6e9743f192f0c261f2174fb6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTQwMTM_5024d7ea-4a48-40a3-ba25-ef5b694e95f6"
      unitRef="number">0.60</hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum>
    <hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual
      contextRef="i112e4e9b6e9743f192f0c261f2174fb6_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTQwMjM_02b9efce-c59d-4782-8edb-7571e01effb7"
      unitRef="number">0.420</hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i387aa55175c54a05a686b101571c25cf_I20211029"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTE2NDc_38808cd0-67eb-43aa-9444-cd5441835b21"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i9d7e0a7171cf41f39322708915887790_D20211029-20211029"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTIyMDA_8d02affd-af9f-4585-825b-fb106331cd70"
      unitRef="usd">1900000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iacb7e7be2c134f1a9b7ce6ca2f0f913d_I20220816"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDY5MDA_8f950101-33d7-4b46-919d-e35892648b73"
      unitRef="usd">2000000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentTerm
      contextRef="ia4f21019238942898fb706ac9e7a0d38_D20210601-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkxNjg_949cc38c-6a6a-441e-a32c-e5b4a3c715ea">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ie41025c3734b426daf406df47fee29ea_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkxODQ_298741d9-a363-4468-8707-315bf8510433"
      unitRef="usd">2500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="ia4f21019238942898fb706ac9e7a0d38_D20210601-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDg1OTM_2bbd5c54-547b-4e1a-a76b-912c38716d17">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="iba715c5c2419471eaade517586321b41_D20220601-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4MjA_af6292a4-dd17-4148-88eb-7a002838aad4">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ifa91146be05e483b86453c991c407783_I20220630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4Mzg_6b84ab96-68e1-419b-b905-8f3efbf1c39e"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i60d5d66074474c979c41340bd209ed02_D20210601-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4NTY_41fc25b8-9388-499b-949d-bc169d0ea5f0">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia2901fdf8be043b3b4ce7d10615715e0_I20210630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4NzQ_c7ddcd6d-f337-472a-87b8-704b6b0b61b7"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="iba715c5c2419471eaade517586321b41_D20220601-20220630"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDE4OTI_b23b3125-e4c8-4bd5-8385-051870315a9e">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id6aba1e961d1473e9cf526f0a1e804dc_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyMDc_484b80a9-841a-414e-b8b6-dbf65f80bcc5"
      unitRef="number">0.01100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDY5Njk_4880cd37-acbc-4657-b04b-ae0d99c4e977">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ifd10b85dc8cd490b8688147f8bfb596e_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyMjk_59a1d204-522f-4da9-b71d-e9c1c0acf91d"
      unitRef="number">0.01150</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentTerm
      contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyMTg_d2f86968-5627-4b11-b530-d1c2daa67a6d">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1321063cfc7c48c188ce65d238c95fd0_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyNDE_1e17dbc0-44e7-4a5e-b897-6de37f36a119"
      unitRef="number">0.00910</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i158dd71369834c93b0a4333493fb0b28_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyNTM_365a7fe1-21f1-42c7-9a8e-3e6fb0a1660e"
      unitRef="number">0.01400</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyNjI_0df26871-0d74-4817-9804-eed287c4436c">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i6a26405ed8ae484ba52bfc3819cacf40_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyNzA_d5971ee1-aa01-438a-8f8e-3f6e6341f747"
      unitRef="number">0.00940</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ibfe28b2f52e240d0be900bf3683893a3_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyODI_ca6ad3e8-16fd-47c2-b711-de6d5c6b1d2e"
      unitRef="number">0.01350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentTerm
      contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkyOTM_a61add41-6a22-4153-ac94-24e81c9ba958">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMDM_baa6a0c7-efa5-4441-8aeb-25e45f3714f5"
      unitRef="number">0.00150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMTE_c25ffc9d-71d9-4edc-b1a0-04f92db044ba">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMTk_898953a8-18af-45bd-b09b-acb4783dab2f"
      unitRef="number">0.00100</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMjk_54313f1a-2358-4dad-89a7-4764c9003137">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i146462488f28499dbcb4a352e9f0c578_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzMzg_8fb296b6-481b-4c8e-a71e-bb50ff269017"
      unitRef="number">0.00090</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i5740b2f51a534ecb852d304efddc5ba4_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzNDg_8adbcccd-dbc8-4720-900c-34e9aad54378"
      unitRef="number">0.00225</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDc2MDI_d29e58af-16b2-42cb-a1c3-e20603bea7a4">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ia2e4d343c10f4aa9ad919a757b1244b8_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzNTg_ea848873-d905-46fd-8fd4-0c20067f4bec"
      unitRef="number">0.00060</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="i4ec6325dd17e4a189e564e299a71923b_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzNjg_6e501260-09e9-43a2-8bf8-5ee344148ab8"
      unitRef="number">0.00150</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzNzg_3bece305-2d35-44d3-847c-e54ea426e9d4">P364D</us-gaap:DebtInstrumentTerm>
    <hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum
      contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzODc_4327d3c9-6ef9-4fe3-ad6d-d0aab1e3deef"
      unitRef="number">0.60</hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum>
    <hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual
      contextRef="i112e4e9b6e9743f192f0c261f2174fb6_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDkzOTQ_02b9efce-c59d-4782-8edb-7571e01effb7"
      unitRef="number">0.420</hum:DebtInstrumentCovenantDebtToCapitalizationPercentageActual>
    <hum:LineOfCreditFacilityUncommittedIncrementalCapacity
      contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDk0MTQ_50a9d862-fec9-4a12-a4ea-e3651d885ad0"
      unitRef="usd">750000000</hum:LineOfCreditFacilityUncommittedIncrementalCapacity>
    <hum:LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity
      contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDk0NDI_94c814e5-e7b7-49cb-97c3-763deda0de3c"
      unitRef="usd">4750000000</hum:LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDk0NTk_f2881a6f-78a8-4337-9836-5116183149e1">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm
      contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDk0NjY_ab063656-8cd8-4e1a-9f50-7231f163cda3">P364D</us-gaap:DebtInstrumentTerm>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzNjM_def09ef3-72fe-42e4-a9fb-ec013d526ac9"
      unitRef="usd">0</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LinesOfCreditCurrent
      contextRef="i69a245a8dbe941efbcc60ad56f792d25_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzMDE_82cbdaea-327d-41fd-a975-a393f74e7302"
      unitRef="usd">45000000</us-gaap:LinesOfCreditCurrent>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="id81d6fd6825341bd9dfae06ccdae8e2e_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzMTQ_5f719171-1595-4ed5-a1e1-0e6ef09704ce"
      unitRef="usd">2400000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="i6a84f8b45cf1495da59705d4f6a79ff1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzODg_b951aaab-68e3-45e2-84be-82f8203d231b">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i927e6ff7d6e14022a0d65ca7195d8616_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzMjg_f0247186-7ca7-4658-bb11-694f2e7ffb9d"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentTerm
      contextRef="iad0d4137ea9a4a12bad3073a33bcb1e1_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzODc_b3af6bc0-a642-46f7-afe6-ff3b67fbfee2">P364D</us-gaap:DebtInstrumentTerm>
    <hum:LineOfCreditFacilityUncommittedIncrementalCapacity
      contextRef="i42f921861ba949c0aa1605c0c528cd9d_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzE2NDkyNjc0NTAzNDI_834172ae-343e-4b45-9a77-e4f36852decf"
      unitRef="usd">750000000</hum:LineOfCreditFacilityUncommittedIncrementalCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i052c3330b4c2409992bdda8401167a8b_I20220210"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2XzczMjM_5f1a7ebb-a763-481d-846d-38dd466c7c3a"
      unitRef="usd">4000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia2d89ea7a0994fdc830560ce43d6ccf3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNDIyNTE_a4e911a3-ce7d-43ec-8c7f-be8765e179c9"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod
      contextRef="i4e33a39278e94aba940321c53fbe7f78_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzc2NDY_1f2e6bd6-3ba9-4261-84aa-139542c8035e"
      unitRef="usd">1450000000</us-gaap:ShorttermDebtMaximumAmountOutstandingDuringPeriod>
    <us-gaap:ShortTermBorrowings
      contextRef="ib173a9a9bf26418d85e8c702ffd7b911_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzc2NTU_9620f421-28a2-456d-b090-6a01cb5bfcc5"
      unitRef="usd">595000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="ia2d89ea7a0994fdc830560ce43d6ccf3_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzc2ODg_7ad7841e-06c8-437f-b880-b3badb53a825"
      unitRef="usd">955000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermDebtWeightedAverageInterestRate
      contextRef="ib173a9a9bf26418d85e8c702ffd7b911_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzc4MDk_ba55a201-00b5-458a-b25b-ddd90a272238"
      unitRef="number">0.0492</us-gaap:ShortTermDebtWeightedAverageInterestRate>
    <us-gaap:ShortTermBorrowings
      contextRef="i9061d9c9dbc8401d8cc25502ab63cf20_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTMzMDY_73db6775-550e-47ab-8c40-e73f9102659e"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i114dcf8181f5421f9df917dc4561297f_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODEvZnJhZzphMGQzNmY2OWZkOTQ0ZWNmOGVlN2YzYzkyNDM3M2YxNi90ZXh0cmVnaW9uOmEwZDM2ZjY5ZmQ5NDRlY2Y4ZWU3ZjNjOTI0MzczZjE2Xzg3OTYwOTMwNTMzMDY_a06b286b-b01d-44a7-a820-54010cddae6f"
      unitRef="usd">0</us-gaap:ShortTermBorrowings>
    <hum:DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNjA_ffa2b542-47c2-4356-a01b-06abf5159204">EMPLOYEE BENEFIT PLANS&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Savings Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have defined contribution retirement savings plans covering eligible employees which include matching contributions based on the amount of our employees&#x2019; contributions to the plans. The cost of these plans amounted to approximately $286 million in 2022, $259 million in 2021, and $236 million in 2020. The Company&#x2019;s cash match is invested pursuant to the participant&#x2019;s contribution direction. Based on the closing price of our common stock of $512.19 on December&#160;31, 2022, approximately 11% of the retirement and savings plan&#x2019;s assets were invested in our common stock, or approximately 1.4 million shares, representing approximately 1.1% of the shares outstanding as of December&#160;31, 2022. At December&#160;31, 2022, approximately 5.8 million shares of our common stock were reserved for issuance under our defined contribution retirement savings plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have plans under which options to purchase our common stock and restricted stock units have been granted to executive officers, directors and key employees. Awards generally require both a change in control and termination of employment within 2 years of the date of the change in control to accelerate the vesting, including those granted to retirement-eligible participants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The terms and vesting schedules for stock-based awards vary by type of grant. Generally, the awards vest upon time-based conditions. We have also granted awards to certain employees that vest upon a combination of time and performance-based conditions. The stock awards of retirement-eligible participants are generally earned ratably over the service period for each tranche. Accordingly, upon retirement the earned portion of the current tranche will continue to vest on the originally scheduled vest date and any remaining unearned portion of the award will be forfeited. Our equity award program includes a retirement provision that generally treats employees with a combination of age and years of services with the Company totaling 65 or greater, with a minimum required age of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55 and a minimum requirement of 5 years of service, as retirement-eligible. Upon exercise, stock-based compensation awards are settled with authorized but unissued company stock or treasury stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The compensation expense that has been charged against income for these plans was as follows for the years ended December 31, 2022, 2021, and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense by type:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tax benefit recognized in our consolidated financial statements is based on the amount of compensation expense recorded for book purposes, subject to limitations on the deductibility of annual compensation in excess of $500,000 per employee as mandated by the Health Care Reform Law. The actual tax benefit realized in our tax return is based on the intrinsic value, or the excess of the market value over the exercise or purchase price, of stock options exercised and restricted stock vested during the period, subject to limitations on the deductibility of annual compensation in excess of $500,000 per employee as mandated by the Health Care Reform Law. The actual tax benefit realized for the deductions taken on our tax returns from option exercises and restricted stock vesting totaled $31 million in 2022, $28&#160;million in 2021, and $32 million in 2020. There was no capitalized stock-based compensation expense during these years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, there were 11.0 million shares reserved for stock award plans under the Humana Inc. 2011 Stock Incentive Plan, or 2011 Plan, and 15.3 million shares reserved for stock award plans under the Humana Inc. 2019 Stock Incentive Plan, or 2019 Plan. These reserved shares included giving effect to, under the 2011 Plan, 3.3 million shares of common stock available for future grants assuming all stock options were granted or 1.4 million shares available for future grants assuming all restricted stock were granted.&#160;These reserved shares included giving effect to, under the 2019 Plan, 11.2 million shares of common stock available for future grants assuming all stock options were granted or 3.4 million shares available for future grants assuming all restricted stock were granted. Shares may be issued from authorized but unissued company stock or treasury stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Restricted stock is granted with a fair value equal to the market price of our common stock on the date of grant and generally vests in equal annual tranches over a three year period from the date of grant. Certain of our restricted stock grants also include performance-based conditions generally associated with return on invested capital and strategic membership growth. Restricted stock units have forfeitable dividend equivalent rights equal to the dividend paid on common stock. The weighted-average grant date fair value of our restricted stock was $430.06 in 2022, $381.34 in 2021, and $354.66 in 2020. Activity for our restricted stock was as follows for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant-Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(shares in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Approximately 36% of the nonvested restricted stock at December 31, 2022 included performance-based conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of shares vested was $244 million during 2022, $236 million during 2021, and $191 million during 2020. Total compensation expense not yet recognized related to nonvested restricted stock was $202 million at December&#160;31, 2022. We expect to recognize this compensation expense over a weighted-average period of approximately 1.7 years. There are no other contractual terms covering restricted stock once vested.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options are granted with an exercise price equal to the fair market value of the underlying common stock on the date of grant. Our stock plans, as approved by the Board of Directors and stockholders, define fair market value as the average of the highest and lowest stock prices reported on the composite tape by the New York Stock Exchange on a given date. Exercise provisions vary, but most options vest in whole or in part 1 to 3 years after grant and expire 7 years after grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average fair value of each option granted during 2022, 2021, and 2020 is provided below. The fair value was estimated on the date of grant using the Black-Scholes pricing model with the weighted-average assumptions indicated below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected option life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate the expected term for our employee stock options based on historical employee exercise behavior and base the risk-free interest rate on a traded zero-coupon U.S. Treasury bond with a term substantially equal to the option&#x2019;s expected term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The volatility used to value employee stock options is based on historical volatility. We calculate historical volatility using a simple-average calculation methodology based on daily price intervals as measured over the expected term of the option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for our option plans was as follows for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&#160; Under&lt;br/&gt;Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(shares in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of  December&#160;31, 2022, outstanding stock options, substantially all of which are expected to vest, had an aggregate intrinsic value of $26 million, and a weighted-average remaining contractual term of 4.9 years. As of December&#160;31, 2022, exercisable stock options had an aggregate intrinsic value of $8 million, and a weighted-average remaining contractual term of 4.1 years. The total intrinsic value of stock options exercised during 2022 was $32 million, compared with $18 million during 2021 and $51 million during 2020. Cash received from stock option exercises totaled $51 million in 2022, $30 million in 2021, and $61 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total compensation expense not yet recognized related to nonvested options was $7 million at December&#160;31, 2022. We expect to recognize this compensation expense over a weighted-average period of approximately 1.7 years.&lt;/span&gt;&lt;/div&gt;</hum:DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzI5MA_1bb2c33a-a09f-4bc7-8378-bf4ae73ea520"
      unitRef="usd">286000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMwMA_a9abb732-f656-4b63-9bcf-f7f9ec813f62"
      unitRef="usd">259000000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxNA_5a95a1a1-6d61-4135-b87c-caa34534d5fa"
      unitRef="usd">236000000</us-gaap:DefinedContributionPlanCostRecognized>
    <hum:CompanyCommonStockClosingSharePrice
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ2NQ_922703b7-dd54-4d54-a2e9-61523c0e3178"
      unitRef="usdPerShare">512.19</hum:CompanyCommonStockClosingSharePrice>
    <hum:DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzUwMg_89b70963-766f-4903-9780-4a39bc6e8713"
      unitRef="number">0.11</hum:DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock>
    <hum:DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzYwMQ_d3bcf008-16ed-4484-a789-5e93ead11ac3"
      unitRef="shares">1400000</hum:DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares>
    <hum:DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzYzOQ_6e84b1dd-1f68-47e4-8b88-4fd3fe1c24c8"
      unitRef="number">0.011</hum:DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding>
    <hum:DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcyNQ_9c9bed2b-9d3c-4d39-b384-d93a48c2a58b"
      unitRef="shares">5800000</hum:DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance>
    <hum:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzExMTE_380c78a9-8d1f-4046-acc8-d6ca8e63a167">P2Y</hum:ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod>
    <hum:CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzE5Nzg_8829ac99-0aa7-40e5-a7b0-13f7f62c0e41">P65Y</hum:CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram>
    <hum:MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzIwMjQ_2b44d5ec-cc2a-424c-b8b2-4c9047a33339">P55Y</hum:MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram>
    <hum:MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzIwNTY_603076ac-9089-4d92-98f0-e8cc73bb0748">P5Y</hum:MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNTI_b4a45f6f-c25a-476d-8df2-ac34d5fe2b2a">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The compensation expense that has been charged against income for these plans was as follows for the years ended December 31, 2022, 2021, and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense by type:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax benefit recognized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation expense, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzMtMS0xLTEtMTQwNjQ1_79e2ed4e-c6ba-4720-9418-a569c8e794ea"
      unitRef="usd">207000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie8e5bc41112049779d5fbc3865a6beb0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzMtMy0xLTEtMTQwNjQ1_48daa978-c344-4ff6-9d49-37ad9d570d2a"
      unitRef="usd">171000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia611810824824c4998cefac84618de1b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzMtNS0xLTEtMTQwNjQ1_cbef87ff-8fe6-4cf2-8af7-76d17bed309d"
      unitRef="usd">171000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzQtMS0xLTEtMTQwNjQ1_0f7a540f-971f-40dd-b83c-031d78de0922"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzQtMy0xLTEtMTQwNjQ1_07cf2ee6-54eb-4443-b5ef-1b5d5e59320c"
      unitRef="usd">9000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzQtNS0xLTEtMTQwNjQ1_849b30d3-c0e7-4550-a9a2-2ae087e5bdbc"
      unitRef="usd">10000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzUtMS0xLTEtMTQwNjQ1_22cc4300-7311-4b18-b71f-9a340a035040"
      unitRef="usd">216000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzUtMy0xLTEtMTQwNjQ1_3007698e-eb23-46de-8d9d-1f662117b27f"
      unitRef="usd">180000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzUtNS0xLTEtMTQwNjQ1_faaf5cd0-de5d-4f5c-ab6f-e235d89c1154"
      unitRef="usd">181000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzYtMS0xLTEtMTQwNjQ1_059beb62-d3eb-4254-9cf4-113e2815c17c"
      unitRef="usd">28000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzYtMy0xLTEtMTQwNjQ1_e82bc799-e91f-4b28-a276-8a0b0582ab75"
      unitRef="usd">15000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzYtNS0xLTEtMTQwNjQ1_04ca5b23-8f02-4c2e-b37d-184ba91a1fbc"
      unitRef="usd">29000000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzctMS0xLTEtMTQwNjQ1_939dfb89-b14e-428a-8b27-6a609ca2f08b"
      unitRef="usd">188000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzctMy0xLTEtMTQwNjQ1_1bb26a21-e7e8-41f6-b145-3b889a54bbc9"
      unitRef="usd">165000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTo1MGEwZmM2ZmU0Yjc0OTRlYWM0YjljZGY1ZmYyZmI5NS90YWJsZXJhbmdlOjUwYTBmYzZmZTRiNzQ5NGVhYzRiOWNkZjVmZjJmYjk1XzctNS0xLTEtMTQwNjQ1_4773e122-e01e-40a0-8f90-e31f2fa39da3"
      unitRef="usd">152000000</us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax>
    <hum:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxNDE_4b64ba93-0d62-4b8c-89b1-02eeabee13af"
      unitRef="usd">31000000</hum:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting>
    <hum:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxNTE_0a297826-2dab-4862-bf93-f7d259d77e4b"
      unitRef="usd">28000000</hum:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting>
    <hum:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxNjU_89c4730d-3e46-4dd0-a441-107044b19484"
      unitRef="usd">32000000</hum:EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxODU_1396e9a7-5000-4552-b6bb-0a9f6863ea9f"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxODU_806300f3-49b1-4890-94dd-7a5ea8b636fc"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMxODU_b0379c8a-24f8-4274-bc31-8278efa9db3b"
      unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="ib289b93fe6734476ab8f5d0c5798ec39_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMyODQ_16b1ee9e-64c0-43c9-97b9-c2073d74201f"
      unitRef="shares">11000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="i6f20dc8ac0564bccbfa9a003167f23df_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzMzOTI_091ae8d0-f7c1-45be-a30d-79d640559af6"
      unitRef="shares">15300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iabaf7ad5365e4602a729a73898dd2781_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzM1NjY_49ed8694-fc1b-4fad-9299-bfe58a7cfb95"
      unitRef="shares">3300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ibed54bbe914a4277a816a361d2be8669_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzM2NjM_30991d3e-3a68-4c00-8295-8610fdbd513f"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i000c50d1006145feb954575f49af33a2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzM4MTU_cffe98fa-0ae2-4b7f-bc79-90c97adda509"
      unitRef="shares">11200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i4357b2b8b1914d969c619a19a67d1b47_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzM5MTI_2674ce41-b990-4141-8629-7de0319f86bc"
      unitRef="shares">3400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczMzQ_fed267de-1e4b-4ff3-8160-70a22d133954">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ2NDc_63b7280e-e6dc-45fd-a619-e78598c89ae5"
      unitRef="usdPerShare">430.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie8e5bc41112049779d5fbc3865a6beb0_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ2NTc_9bb4ccdd-6908-4cee-a935-84f86eb258ae"
      unitRef="usdPerShare">381.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia611810824824c4998cefac84618de1b_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ2NzE_77e425c8-6d7e-45df-805e-522fc9c4f274"
      unitRef="usdPerShare">354.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNDM_1ca03717-c38f-4546-8750-2332eaa4f43b">Activity for our restricted stock was as follows for the year ended December&#160;31, 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.121%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.887%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.889%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant-Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(shares in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;380.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;430.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(449)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;342.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;292.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Nonvested restricted stock at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;429.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ida62d357008f4ed0bc3246cc32b3771c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzItMS0xLTEtMTQwNjQ1_51b92849-523a-4b12-ae1d-19eaf7468cdf"
      unitRef="shares">873000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ida62d357008f4ed0bc3246cc32b3771c_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzItMy0xLTEtMTQwNjQ1_d6355772-0009-4d41-9ba6-383331f3f133"
      unitRef="usdPerShare">380.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzMtMS0xLTEtMTQwNjQ1_ed25fe14-ecf2-4034-a126-e0732f8ee5df"
      unitRef="shares">492000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzMtMy0xLTEtMTQwNjQ1_30b7e07e-b83b-49e2-8979-213cecad1cca"
      unitRef="usdPerShare">430.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzQtMS0xLTEtMTQwNjQ1_4316d528-1825-4e96-9c28-3d9cc1aa91ee"
      unitRef="shares">449000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzQtMy0xLTEtMTQwNjQ1_c14bdb31-54c9-4e9a-b67e-2b868009f5bc"
      unitRef="usdPerShare">342.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzUtMS0xLTEtMTQwNjQ1_8113c6f1-e155-4b10-a40b-5394c01c3c64"
      unitRef="shares">103000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzUtMy0xLTEtMTQwNjQ1_05b0654c-5cd9-4985-b6b4-268126f31ec2"
      unitRef="usdPerShare">292.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5c29ece986e14d5fbc1af74aef0f594b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzYtMS0xLTEtMTQwNjQ1_9eb1c32f-5800-42c9-a445-204dcd21f75b"
      unitRef="shares">813000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5c29ece986e14d5fbc1af74aef0f594b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphZTQ3NmEzYzkzMzk0NzBkYTA5NTVkYmY4OGM0NDRkZS90YWJsZXJhbmdlOmFlNDc2YTNjOTMzOTQ3MGRhMDk1NWRiZjg4YzQ0NGRlXzYtMy0xLTEtMTQwNjQ1_6c30b399-0612-418c-af4a-a67b6bdf3ca0"
      unitRef="usdPerShare">429.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <hum:ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions
      contextRef="i5c29ece986e14d5fbc1af74aef0f594b_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ3ODI_2001eaad-6f54-446f-86f1-2dedc503b813"
      unitRef="number">0.36</hum:ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ5MTM_a00411ae-6632-4e36-855e-5d00de74dfab"
      unitRef="usd">244000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ5Mjc_697c4548-5818-40f1-ba06-41b46e402acc"
      unitRef="usd">236000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzQ5NDU_b095a66e-e77f-46ee-8230-1e868fa39cfe"
      unitRef="usd">191000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i5c29ece986e14d5fbc1af74aef0f594b_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzUwNDc_cb8a345a-cdae-4d34-b982-5f778a704bff"
      unitRef="usd">202000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzUxNjc_67d896af-22dd-4db1-b25d-604969f53c43">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic5e4929afcc240d981441f4b646c3c65_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzU2OTM_6d7c6caa-74ed-4c91-8136-f23552cfd27d">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibd04deeb98f941698ee17f88f8a23fbf_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzU2OTk_ae75abd7-8a88-472d-a152-64492130e04a">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzU3MzE_b040752a-522b-4779-a60d-43397dc002b8">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNDE_d87f8e43-766f-47c3-8ec0-9fb22f5dfbe1">The fair value was estimated on the date of grant using the Black-Scholes pricing model with the weighted-average assumptions indicated below:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.868%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average fair value at grant date&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected option life (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate at grant date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzEtMS0xLTEtMTQwNjQ1_f66dad43-dafd-423e-9316-b8539e168fae"
      unitRef="usdPerShare">113.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzEtMy0xLTEtMTQwNjQ1_9200c256-797a-44b1-99e9-fd8d6e763d37"
      unitRef="usdPerShare">92.21</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzEtNS0xLTEtMTQwNjQ1_53097b46-08ba-437b-b8c1-65c01fc3b702"
      unitRef="usdPerShare">69.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzItMS0xLTEtMTQwNjQ1_2d0d9abd-aeb3-41bb-a61d-85feb38a81a4">P3Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzItMy0xLTEtMTQwNjQ1_8bdb515b-ca94-447e-a3ad-6f595c47b0e9">P3Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzItNS0xLTEtMTQwNjQ1_be3ea3cf-dfec-47e7-9163-6a9c5d0eb82c">P4Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzMtMS0xLTEtMTQwNjQ1_2ba9c4f7-ca35-4de3-ac80-96a6fb31c6e3"
      unitRef="number">0.361</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzMtMy0xLTEtMTQwNjQ1_58784b55-673a-40dc-b056-18dec656b12d"
      unitRef="number">0.338</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzMtNS0xLTEtMTQwNjQ1_e53e780a-a1e5-4a02-9587-d715c80bbfa8"
      unitRef="number">0.249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzQtMS0xLTEtMTQwNjQ1_b25c1ab4-9417-4f4c-b7b7-4332e274cff1"
      unitRef="number">0.018</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzQtMy0xLTEtMTQwNjQ1_f7eb08a3-4763-4a8b-8f86-af0b0fa9487b"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzQtNS0xLTEtMTQwNjQ1_6bfd6879-9fe9-47a8-9209-58399ba858e1"
      unitRef="number">0.012</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzUtMS0xLTEtMTQwNjQ1_8ddc38a0-c3ee-4c2d-8621-bfd44721fdea"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzUtMy0xLTEtMTQwNjQ1_a5ce95a7-2802-4e2f-b426-312725af6035"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZTphYmU2YjJlMDY2Yjk0ZTJiOTI4ZTNlNzQyNTk4NjM4ZS90YWJsZXJhbmdlOmFiZTZiMmUwNjZiOTRlMmI5MjhlM2U3NDI1OTg2MzhlXzUtNS0xLTEtMTQwNjQ1_bf4ad104-fc9c-4a2a-9a99-d7fe66b28c88"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczNTk_22384d44-6c9a-4808-a030-73f320ad2df5">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Activity for our option plans was as follows for the year ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.864%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.866%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&#160; Under&lt;br/&gt;Option&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(shares in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;339.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319.27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;370.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options outstanding at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;381.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercisable at December&#160;31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;345.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzItMS0xLTEtMTQwNjQ1_1bb04f8e-a4ec-464b-b318-aa26082a35ec"
      unitRef="shares">310000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzItMy0xLTEtMTQwNjQ1_afe25419-34b6-4fd4-bcfe-1a6921fe989d"
      unitRef="usdPerShare">339.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzMtMS0xLTEtMTQwNjQ1_fbeda628-c8e4-49cd-9957-a7e3fe8cc8f7"
      unitRef="shares">65000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzMtMy0xLTEtMTQwNjQ1_eecece81-af6a-4397-8bf6-e1146b9ceb09"
      unitRef="usdPerShare">425.32</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzQtMS0xLTEtMTQwNjQ1_03752eac-1869-44e4-b362-5f9b5745d407"
      unitRef="shares">163000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzQtMy0xLTEtMTQwNjQ1_f6afa59d-3483-4f60-a8a9-23d38c219fc2"
      unitRef="usdPerShare">319.27</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzUtMS0xLTEtMTQwNjQ1_e5dce04f-42ef-49b7-8d58-92d602db109b"
      unitRef="shares">8000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzUtMy0xLTEtMTQwNjQ1_44c222f9-b3d1-4812-853a-9f58e0939fd1"
      unitRef="usdPerShare">370.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzYtMS0xLTEtMTQwNjQ1_90f9d808-84b9-4810-9db1-93fab5dbb5f3"
      unitRef="shares">204000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzYtMy0xLTEtMTQwNjQ1_3c755f3f-f87d-4049-93dc-08603c4f334c"
      unitRef="usdPerShare">381.37</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzctMS0xLTEtMTQwNjQ1_722b2e51-8719-4f7d-a89f-7a598d66b6fe"
      unitRef="shares">48000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90YWJsZToyYTBmZmEwOGUwOGU0NmQ3YjY4ZTBmM2YzMGE5ZWRiZC90YWJsZXJhbmdlOjJhMGZmYTA4ZTA4ZTQ2ZDdiNjhlMGYzZjMwYTllZGJkXzctMy0xLTEtMTQwNjQ1_d4406839-e158-4baa-95c3-2d6a059057cf"
      unitRef="usdPerShare">345.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY3MTU_9a46b00d-dbdd-4107-93bd-275532caf9e0"
      unitRef="usd">26000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY3NzI_ab469a92-d1f1-4203-ab20-3db5ac45eb05">P4Y10M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY4NjE_52ead9c4-9faa-4ec8-91be-24b45a22d2e3"
      unitRef="usd">8000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY5MTg_abd32609-5d8a-4bf9-81b3-c88928b811bc">P4Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzY5ODk_4dc819d7-595d-46a3-b97d-51abbb5bf3d1"
      unitRef="usd">32000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcwMDc_500275be-5720-422a-9be7-b870ff15fcc5"
      unitRef="usd">18000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcwMjQ_23f049b0-a398-44c8-adb0-ac4a39fd5ad0"
      unitRef="usd">51000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcwODg_4997e985-bfd6-4ab9-beba-a21adf04aeea"
      unitRef="usd">51000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcwOTg_b395dbd6-459b-4b16-ab7c-bfbcd5b49780"
      unitRef="usd">30000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcxMTI_b41a7b6d-5d32-4ee0-8c46-03a4c858a7d2"
      unitRef="usd">61000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i992f903cecc5400f81dfb547116cb415_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzcyMDE_ceb30c32-c657-46da-8d13-a9d156fa65e5"
      unitRef="usd">7000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODQvZnJhZzo1YTA2NzY4MGU3NmE0N2VmYmEyY2ZkZTk4MjJmMTdhZi90ZXh0cmVnaW9uOjVhMDY3NjgwZTc2YTQ3ZWZiYTJjZmRlOTgyMmYxN2FmXzczMjE_7e332a8f-6c23-4025-be94-43937c6a4509">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90ZXh0cmVnaW9uOjE3MTQ0Y2MyM2U1ODQzODNhNGQ1MjNmZGZkNjIxOTk5XzIwNg_cdbcd068-2c51-4367-a7d9-8e6c4a6a5782">EARNINGS PER COMMON SHARE COMPUTATION&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Detail supporting the computation of basic and diluted earnings per common share was as follows for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(dollars in millions, except&#160;per&lt;br/&gt;common share results, number&#160;of&lt;br/&gt;shares/options in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income available for common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average outstanding shares of common stock used to &lt;br/&gt;&#160;&#160;&#160;&#160;compute basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted earnings per&#160;common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of antidilutive stock options and restricted stock&#160;awards &lt;br/&gt;&#160;&#160;&#160;&#160;excluded from computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90ZXh0cmVnaW9uOjE3MTQ0Y2MyM2U1ODQzODNhNGQ1MjNmZGZkNjIxOTk5XzE5Ng_417d2bda-8632-4e49-b3d6-83ba9782778d">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Detail supporting the computation of basic and diluted earnings per common share was as follows for the years ended December&#160;31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.470%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(dollars in millions, except&#160;per&lt;br/&gt;common share results, number&#160;of&lt;br/&gt;shares/options in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income available for common stockholders&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average outstanding shares of common stock used to &lt;br/&gt;&#160;&#160;&#160;&#160;compute basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares used to compute diluted earnings per&#160;common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129,396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Number of antidilutive stock options and restricted stock&#160;awards &lt;br/&gt;&#160;&#160;&#160;&#160;excluded from computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzItMS0xLTEtMTQwNjQ1_5c93cfef-f26d-4353-894d-b3be47d4397f"
      unitRef="usd">2806000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzItMy0xLTEtMTQwNjQ1_33c76633-2afc-43a1-919d-6b2787b74693"
      unitRef="usd">2933000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzItNS0xLTEtMTQwNjQ1_2892dc23-1cc9-4cff-a43b-b0af04cb72f0"
      unitRef="usd">3367000000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzMtMS0xLTEtMTQwNjQ1_b051d1a8-4f52-441d-a06a-8e8a23be012b"
      unitRef="shares">126419000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzMtMy0xLTEtMTQwNjQ1_6fb58185-e8dc-4b9f-84f0-38969181b425"
      unitRef="shares">128688000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzMtNS0xLTEtMTQwNjQ1_eebd22f7-2185-469e-877c-7f3728ba7ce7"
      unitRef="shares">132199000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzUtMS0xLTEtMTQwNjQ1_3cd45c0f-d430-474e-9f3b-61a0d2a0c65f"
      unitRef="shares">50000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i19c53c8a7e974590a7af2266140f8466_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzUtMy0xLTEtMTQwNjQ1_04e19936-cc1f-445d-96b9-51b144fddd09"
      unitRef="shares">64000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5ba6401654ae40689698616e02215fee_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzUtNS0xLTEtMTQwNjQ1_8b7ea799-da63-4142-ab7f-cd1da3c4a818"
      unitRef="shares">92000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i811980c7152043ce9c82e3dcba010f63_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzYtMS0xLTEtMTQwNjQ1_8a568fee-4c6f-4821-90fd-5affaa26ca16"
      unitRef="shares">625000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie8e5bc41112049779d5fbc3865a6beb0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzYtMy0xLTEtMTQwNjQ1_dcf1c091-d3fb-45b0-87d3-450b571c80a1"
      unitRef="shares">644000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia611810824824c4998cefac84618de1b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzYtNS0xLTEtMTQwNjQ1_56311fde-40e0-4b05-9869-7ec65057abda"
      unitRef="shares">721000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzctMS0xLTEtMTQwNjQ1_2e853f10-ebde-4515-b9ef-2dfc5142ac95"
      unitRef="shares">127094000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzctMy0xLTEtMTQwNjQ1_b3726b17-9584-46cd-ab99-9c5105381ac9"
      unitRef="shares">129396000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzctNS0xLTEtMTQwNjQ1_2c0bc5a9-b51f-4181-b2af-b864ddfa37c8"
      unitRef="shares">133012000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzgtMS0xLTEtMTQwNjQ1_926e0682-92f4-4497-b58e-eb08439d96e8"
      unitRef="usdPerShare">22.20</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzgtMy0xLTEtMTQwNjQ1_0f373657-c846-49a3-bf77-cbbaf4cb0f64"
      unitRef="usdPerShare">22.79</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzgtNS0xLTEtMTQwNjQ1_44954585-4660-4703-bbe9-8571e7a16846"
      unitRef="usdPerShare">25.47</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzktMS0xLTEtMTQwNjQ1_0ae93125-a6b3-4e22-b822-3636446e238a"
      unitRef="usdPerShare">22.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzktMy0xLTEtMTQwNjQ1_1bc6a62e-1670-4dc5-82a4-800668f5acd8"
      unitRef="usdPerShare">22.67</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzktNS0xLTEtMTQwNjQ1_dff9a4ec-f523-4e51-8df2-d050bd820254"
      unitRef="usdPerShare">25.31</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzEwLTEtMS0xLTE0MDY0NQ_71b6c153-ec16-4007-8c2f-efb81c4ed94d"
      unitRef="shares">205000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzEwLTMtMS0xLTE0MDY0NQ_b41465dc-edcf-478b-91a4-cc9953cbb543"
      unitRef="shares">216000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xODcvZnJhZzoxNzE0NGNjMjNlNTg0MzgzYTRkNTIzZmRmZDYyMTk5OS90YWJsZTo5YzQyM2FlM2IyMGM0ZjAxYjczMzEzODhjYjg2OTYzMS90YWJsZXJhbmdlOjljNDIzYWUzYjIwYzRmMDFiNzMzMTM4OGNiODY5NjMxXzEwLTUtMS0xLTE0MDY0NQ_75f87674-cb74-45ce-8f07-7a5accd9ca8e"
      unitRef="shares">238000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNTc1_c0d988b9-00f2-47ad-bc61-c7b499ffebd4">STOCKHOLDERS&#x2019; EQUITY&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of dividend payments, excluding dividend equivalent rights, in 2020, 2021, and 2022, under our Board approved quarterly cash dividend policy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$322&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$351&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$390&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2022, the Board declared a cash dividend of $0.79 per share payable on January&#160;27, 2023 to stockholders of record on December&#160;30, 2022 for an aggregate amount of $98 million. In February 2023, the Board declared a cash dividend of $0.8850 per share payable on April&#160;28, 2023 to stockholders of record on March&#160;31, 2023. Declaration and payment of future quarterly dividends is at the discretion of our Board and may be adjusted as business needs or market conditions change.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board of Directors may authorize the purchase of our common shares. Under our share repurchase authorization, shares may have been purchased from time to time at prevailing prices in the open market, by block purchases, through plans designed to comply with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, or in privately-negotiated transactions (including pursuant to accelerated share repurchase agreements with investment banks), subject to certain regulatory restrictions on volume, pricing, and timing. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 22, 2020, we entered into separate accelerated stock repurchase agreements, ("the December 2020 ASR Agreements"), with Citibank, N.A., or Citi, and JPMorgan Chase Bank, or JPM, to repurchase $1.75&#160;billion of our common stock as part of the $3&#160;billion repurchase program authorized by the Board of Directors on July 30, 2019. On December 23, 2020, in accordance with the December 2020 ASR Agreements, we made a payment of $1.75&#160;billion ($875&#160;million to Citi and $875&#160;million to JPM) and received an initial delivery of 3.8&#160;million shares of our common stock (1.9&#160;million shares each from Citi and JPM). We recorded the payments to Citi and JPM as a reduction to stockholders&#x2019; equity, consisting of an $1.5&#160;billion increase in treasury stock, which reflects the value of the initial 3.8&#160;million shares received upon initial settlement, and a $262.5&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Citi and JPM pending final settlement of the December 2020 ASR Agreements. Upon final settlement of the December 2020 ASR agreements with Citi and JPM on May 4, 2021 and May 5, 2021, respectively, we received an additional 0.3&#160;million shares and 0.3&#160;million shares, respectively, as determined by the average daily volume weighted-averages share price of our common stock during the term of the agreement, less a discount, of $400.07 and $401.49, respectively, bringing the total shares received under the December 2020 ASR agreements to 4.4&#160;million. In addition, upon settlement we reclassified the $262.5&#160;million value of stock initially held back by Citi and JPM from capital in excess of par value to treasury stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 18, 2021, the Board of Directors replaced the previous share repurchase authorization of up to $3&#160;billion (of which approximately $1&#160;billion remained unused) with a new authorization for repurchases of up to $3&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 18, 2024.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 11, 2022, we entered into separate accelerated stock repurchase agreements, the January 2022 ASR Agreements, with Mizuho Markets Americas LLC, or Mizuho, and Wells Fargo Bank, or Wells Fargo, to repurchase $1&#160;billion of our common stock as part of the $3&#160;billion repurchase program authorized by the Board of Directors on February 18, 2021. On January 12, 2022, in accordance with the January 2022 ASR Agreements, we made a &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payment of $1&#160;billion ($500&#160;million to Mizuho and $500&#160;million to Wells Fargo) and received an initial delivery of 2.2&#160;million shares of our common stock (1.08&#160;million shares each from Mizuho and Wells Fargo). We recorded the payments to Mizuho and Wells Fargo as a reduction to stockholders&#x2019; equity, consisting of an $850&#160;million increase in treasury stock, which reflects the value of the initial 2.2&#160;million shares received upon initial settlement, and a $150&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Mizuho and Wells Fargo pending final settlement of the January 2022 ASR Agreements. Upon final settlement of the January 2022 ASR Agreements with Mizuho and Wells Fargo on March 29, 2022 and March 30, 2022, respectively, we received an additional 0.1&#160;million shares and 0.1&#160;million shares, respectively, as determined by the average daily volume weighted-averages share price of our common stock during the term of the agreement, less a discount, of $410.96 and $411.66, respectively, bringing the total shares received under the January 2022 ASR Agreements to 2.4&#160;million. In addition, upon settlement we reclassified the $150&#160;million value of stock initially held back by Mizuho and Wells Fargo from capital in excess of par value to treasury stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 2, 2022, we entered into separate accelerated stock repurchase agreements, the November 2022 ASR Agreements, with Goldman Sachs &amp;amp; Co. LLC, or Goldman Sachs, and Mizuho Markets Americas LLC, or Mizuho, to repurchase $1&#160;billion of our common stock as part of the $3&#160;billion repurchase program authorized by the Board of Directors on February 18, 2021. In accordance with the November 2022 ASR Agreements, we made a payment of $1&#160;billion ($500&#160;million to Goldman Sachs on November 3, 2022 and $500&#160;million to Mizuho on November 4, 2022) and received an initial delivery of 1.5&#160;million shares of our common stock (0.760&#160;million shares each from Goldman Sachs and Mizuho). We recorded the payments to Goldman Sachs and Mizuho as a reduction to stockholders&#x2019; equity, consisting of an $850&#160;million increase in treasury stock, which reflects the value of the initial 1.5&#160;million shares received upon initial settlement, and a $150&#160;million decrease in capital in excess of par value, which reflects the value of stock held back by Goldman Sachs and Mizuho pending final settlement of the November 2022 ASR Agreements. Upon final settlement of the November 2022 ASR Agreements with Goldman Sachs and Mizuho on December 15, 2022 and December 16, 2022, respectively, we received an additional 0.177&#160;million shares and 0.177&#160;million shares, respectively,  as determined by the average daily volume weighted-averages share price of our common stock during the term of the agreement, less a discount, of $534.16 and $533.87, respectively, bringing the total shares received under the November 2022 ASR Agreements to 1.8&#160;million. In addition, upon settlement we reclassified the $150&#160;million value of stock initially held back by Goldman Sachs and Mizuho from capital in excess of par value to treasury stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 15, 2023, the Board of Directors replaced the previous share repurchase authorization of up to $3&#160;billion (of which approximately $1&#160;billion remained unused) with a new authorization for repurchases of up to $3&#160;billion of our common shares exclusive of shares repurchased in connection with employee stock plans, expiring as of February 15, 2026.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding shares acquired in connection with employee stock plans, share repurchases were as follows during the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Authorization Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Not to Exceed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with employee stock plans, we acquired 0.2 million common shares for $96 million in 2022, 0.2 million common shares for $79 million in 2021, and 0.2 million common shares for $70 million in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For additional information regarding our stockholders' equity, refer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" in our 2021 Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Regulatory Requirements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our subsidiaries operate in states that regulate the payment of dividends, loans, or other cash transfers to Humana Inc., our parent company, and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid to Humana Inc. by these subsidiaries, without prior approval by state regulatory authorities, or ordinary dividends, is limited based on the entity&#x2019;s level of statutory income and statutory capit&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;al and surplus. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an extraordinary dividend requiring prior regulatory approval. In most states, prior notification is provided before paying a dividend even if approval is not required. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although minimum required levels of equity are largely based on premium volume, product mix, and the quality of assets held, minimum requirements vary significantly at the state level. Our state regulated insurance subsidiaries had aggregate statutory capital and surplus of approximately $11.3 billion and $9.6 billion as of December&#160;31, 2022 and 2021, respectively, which exceeded aggregate minimum regulatory requirements of &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$8.4 billion and $7.6 billion, respectively.  The amount of ordinary dividends that may be paid to our parent company in 2023 is approximately $1.8 billion in the aggregate. The amount, timing and mix of ordinary and extraordinary dividend payments will vary due to state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;regulatory requirements, the level of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix. Actual dividends that were paid to our parent company were approximately  $1.3 billion in 2022, $1.6 billion in 2021, and $1.3 billion in 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <hum:ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNjA3_b2c9f77a-3ee1-40b7-b915-86ad68bd763f">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides details of dividend payments, excluding dividend equivalent rights, in 2020, 2021, and 2022, under our Board approved quarterly cash dividend policy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.117%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.486%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.487%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Payment Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;br/&gt;per&#160;Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;br/&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.43&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$322&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$2.73&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$351&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$3.06&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$390&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hum:ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzItMi0xLTEtMTQwNjQ1_41641260-0026-4a8d-a415-6f8395eda656"
      unitRef="usdPerShare">2.43</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:Dividends
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzItNC0xLTEtMTQwNjQ1_d77ca2f9-3e08-461c-bfa0-75826b924c1b"
      unitRef="usd">322000000</us-gaap:Dividends>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzMtMi0xLTEtMTQwNjQ1_7ec9aed2-bd1b-4bc9-a09d-5c60f5a89543"
      unitRef="usdPerShare">2.73</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:Dividends
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzMtNC0xLTEtMTQwNjQ1_1282f9ed-56a6-4513-94ba-741a2d9b50d9"
      unitRef="usd">351000000</us-gaap:Dividends>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzQtMi0xLTEtMTQwNjQ1_be9e3752-b9c3-4bad-b069-98d3a7d67379"
      unitRef="usdPerShare">3.06</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:Dividends
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTozZDhmM2Y4NzIwNTI0ZDAzOTVhN2UxODc0MzAzYzhhNy90YWJsZXJhbmdlOjNkOGYzZjg3MjA1MjRkMDM5NWE3ZTE4NzQzMDNjOGE3XzQtNC0xLTEtMTQwNjQ1_93c7168d-2fb2-4110-a68c-6aa5b785011d"
      unitRef="usd">390000000</us-gaap:Dividends>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i60f1ff28ff564a1ebbe436416a7471f0_D20221001-20221031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzI3MA_c43c8bd5-2751-44f1-ab37-0d82fb4362cf"
      unitRef="usdPerShare">0.79</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzM3MQ_bc1460a7-1d7d-437e-80b9-89286d0ca934"
      unitRef="usd">98000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i002fe084afec40a3b3544bd5ca40dff0_D20230201-20230216"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzQzMQ_b66dea91-e638-4c12-9a9f-2770f54e646b"
      unitRef="usdPerShare">0.8850</us-gaap:CommonStockDividendsPerShareDeclared>
    <hum:AcceleratedShareRepurchasesAgreementAmount
      contextRef="i0179480f2bae4075beb28f01cc367fc2_I20201222"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTM5NDE_c81c2541-1725-4c2c-b679-ed5f0964b1b1"
      unitRef="usd">1750000000</hum:AcceleratedShareRepurchasesAgreementAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="iba989f1957d14bd5ad09090a3705faec_I20190730"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTM5NTY_d57acdbe-45b1-459a-8670-411b8d6e72ad"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="iafa1f29c11f64ee4a23c6d619014a6bb_I20201223"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwMDI_ba45b9e8-4b5c-4bae-a502-f31cd016e77d"
      unitRef="usd">-1750000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="ic232bc3e290f4655953c1352a27704bc_I20201223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwMTc_009fe088-9fe4-4054-a459-913e3ec67dcd"
      unitRef="usd">-875000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i19f92caa5fd741989e66515605b91004_I20201223"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwMzE_98b384aa-e165-4fe2-9dcc-a426dd8e35cc"
      unitRef="usd">-875000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3c75a59f8572479c926935996bad608e_D20201223-20201223"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwNDU_50a90a94-2187-42e1-ba74-bf2a2272c676"
      unitRef="shares">3800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i53cd41e672c644b48afcbba07fd3e06f_D20201223-20201223"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwNTg_45973b06-5eed-45e5-a031-56f440d20012"
      unitRef="shares">1900000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia0334069ef954f71908cae7a3e991ead_D20201223-20201223"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwNTg_98e70f3b-5c21-45e1-b902-81ae0b305169"
      unitRef="shares">1900000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ia0baee71e7f548278d68833140520ee3_D20201201-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwNzE_6e3a3fed-da97-4702-9a22-540aa61ca032"
      unitRef="usd">1500000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i3c75a59f8572479c926935996bad608e_D20201223-20201223"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQwODU_a9dc432d-3b16-4dd8-a663-f1e281715d57"
      unitRef="shares">3800000</us-gaap:TreasuryStockSharesAcquired>
    <hum:TreasuryStockDecreaseInCapitalInExcessOfParValue
      contextRef="i3c75a59f8572479c926935996bad608e_D20201223-20201223"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5NjY_a694d9b4-c991-4cb5-bf01-3fe635556df4"
      unitRef="usd">262500000</hum:TreasuryStockDecreaseInCapitalInExcessOfParValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id8fb3265c7324998bfb3a80ce36e5b0b_D20210504-20210504"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxMzI_c1f3c6a1-641d-4051-a067-119c2b935bef"
      unitRef="shares">300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i350835a15d964c85bd84001ed39b4e0c_D20210505-20210505"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxNDU_37919bb3-bbd3-4229-970c-e28133f83f7b"
      unitRef="shares">300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="id8fb3265c7324998bfb3a80ce36e5b0b_D20210504-20210504"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxNTg_4187f3dc-a399-4e54-ad09-ad66ae99095f"
      unitRef="usdPerShare">400.07</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="i350835a15d964c85bd84001ed39b4e0c_D20210505-20210505"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxNjc_5d64ebc3-b167-46ce-9c1e-8c2174501ddd"
      unitRef="usdPerShare">401.49</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i70684713b18a4b98947fa4e3302512a4_D20201222-20210505"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQxNzY_43416f23-08bd-4c79-834d-af3ca0e08503"
      unitRef="shares">4400000</us-gaap:TreasuryStockSharesAcquired>
    <hum:CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue
      contextRef="i73e1a9fbd6384960a77b548a06888967_D20210505-20210505"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5ODk_625c3c3e-c8c1-49ff-b7fb-c1362c3bac3f"
      unitRef="usd">262500000</hum:CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i495ee173617d40c9a28f5030f6631472_I20210218"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQyMTY_6b077fff-5a85-41bc-bbac-ecc8d265af44"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i495ee173617d40c9a28f5030f6631472_I20210218"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTU2OTQ_22d760bc-6ed9-4c09-8f76-9826f1980e73"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i495ee173617d40c9a28f5030f6631472_I20210218"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQyMjg_46a2e430-c6ff-45bb-aded-b1cdd7b50124"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <hum:AcceleratedShareRepurchasesAgreementAmount
      contextRef="id0b96effe20c452e850f5e6c15c8f8d3_I20220111"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQyNjA_ea90e373-bcc6-4926-adc9-7966636bb408"
      unitRef="usd">1000000000</hum:AcceleratedShareRepurchasesAgreementAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i495ee173617d40c9a28f5030f6631472_I20210218"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQyNzI_a48c4e41-116f-42b5-868e-847a2ecdfd81"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i9dd45b09421342e6818a93611f04d810_I20220112"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzMjE_bad0f6b4-daee-4084-a97d-1c40cadd7686"
      unitRef="usd">-1000000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i4aebd9fa2ef54f84820765f00217687b_I20220112"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzMzM_34872fd9-24db-44f3-9c53-a2c1b7a25887"
      unitRef="usd">-500000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="ibed82a92406149c48f61066e76a21f70_I20220112"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5MjA_91610a0f-9383-4286-a6fb-70f57cb7ff7d"
      unitRef="usd">-500000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5NDY_5c091fbb-8bba-499b-ab64-9e64d2a0b4c4"
      unitRef="shares">2200000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia10d21e8a157411e9877dc680a3ee356_D20220112-20220112"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzNTM_3469a6b4-f3e0-41ca-8324-80f7e93d3dc3"
      unitRef="shares">1080000.00</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i568119642532418a8e54da51e855e96f_D20220112-20220112"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzNTM_d8f53307-82d6-49cd-b5b7-52662d25c67f"
      unitRef="shares">1080000.00</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzNjc_c68d8b76-be2d-448c-ad99-047df59d430d"
      unitRef="usd">850000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzODE_8f9d01be-87ee-4295-b6c9-700377ff1248"
      unitRef="shares">2200000</us-gaap:TreasuryStockSharesAcquired>
    <hum:TreasuryStockDecreaseInCapitalInExcessOfParValue
      contextRef="ice33f7229b9245c49ddbc72912a69d97_D20220112-20220112"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQzOTQ_f7072ed8-2685-4698-a45d-f8c186cec7cb"
      unitRef="usd">150000000</hum:TreasuryStockDecreaseInCapitalInExcessOfParValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="iefa207bd427f4a95a03f48bf711b1dba_D20220329-20220329"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0NDA_14921a9f-6616-4a5c-86a0-37d176ffee1e"
      unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i75ef00cf639a4623b3a5e417b7ffdf72_D20220330-20220330"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5MDI_b48a29ac-4714-4166-a9d0-bbfb1473b718"
      unitRef="shares">100000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="iefa207bd427f4a95a03f48bf711b1dba_D20220329-20220329"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0NTQ_856e7a0f-d5fa-4efb-ad7b-79abb64a61d1"
      unitRef="usdPerShare">410.96</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="i75ef00cf639a4623b3a5e417b7ffdf72_D20220330-20220330"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0NjM_23c135ec-a7ec-4a8b-905b-a62ce4f066ec"
      unitRef="usdPerShare">411.66</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ice757c7c8d4a460d95726e2ca454481e_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0NzI_552b926f-cf7d-492d-9285-785d323854ab"
      unitRef="shares">2400000</us-gaap:TreasuryStockSharesAcquired>
    <hum:CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue
      contextRef="i4a532821749a4aa2adc6f2de7319e3f3_D20220329-20220330"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ0ODU_0bf07f4a-edc8-417d-a6b9-f9aeaddaeb4a"
      unitRef="usd">150000000</hum:CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue>
    <hum:AcceleratedShareRepurchasesAgreementAmount
      contextRef="id61359de4c6d40babbbcf4cb9a67c753_I20221102"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ4MTg_cd2fdf5b-a691-4ed6-9e46-6941bd0e5695"
      unitRef="usd">1000000000</hum:AcceleratedShareRepurchasesAgreementAmount>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i495ee173617d40c9a28f5030f6631472_I20210218"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzYwNDczMTM5ODU5MzQ_78b848d0-0f76-4501-bf65-6681656a225f"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="id61359de4c6d40babbbcf4cb9a67c753_I20221102"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ4Njc_617d72fa-83e3-4607-8408-afcaa751ed8d"
      unitRef="usd">-1000000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="i73fcbac85e68448ba128e118ba423e97_I20221103"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ4Nzk_bf188663-0711-4cb9-a671-b251f501554b"
      unitRef="usd">-500000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt
      contextRef="ie0a147a615a34ceebed3a230fbb94d7f_I20221104"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ4OTM_a3b2f7e7-a5c3-4d20-92ad-37fffa78a7e0"
      unitRef="usd">-500000000</us-gaap:AcceleratedShareRepurchasesSettlementPaymentOrReceipt>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i4b2588f5c36147e39712fb70b96204b3_D20220112-20220112"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5MDc_8fabfe13-daf9-44dd-bdac-93084c3748ee"
      unitRef="shares">1500000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ia5162c0c768943718eac311366829953_D20220112-20220112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5MjA_18287d78-db26-41e9-8a1e-37cf4778e41b"
      unitRef="shares">760000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i703e9357eeda40b8bac63abad7404e77_D20220112-20220112"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5MjA_e4da41a3-de51-464f-8bbf-11db9e0ff0d7"
      unitRef="shares">760000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i54e117a2b2cb4096bee16f6734d08b94_D20221102-20221102"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5MzU_483e2ec5-03bb-44f0-a78a-33722b70ca9b"
      unitRef="usd">850000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i54e117a2b2cb4096bee16f6734d08b94_D20221102-20221102"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5NDk_6f2edbbd-f922-4561-b2a4-116f915dc8b8"
      unitRef="shares">1500000</us-gaap:TreasuryStockSharesAcquired>
    <hum:TreasuryStockDecreaseInCapitalInExcessOfParValue
      contextRef="i54e117a2b2cb4096bee16f6734d08b94_D20221102-20221102"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTQ5NjI_3a4ae674-a0e1-4ea8-a64a-5c2bfaf0ef2c"
      unitRef="usd">150000000</hum:TreasuryStockDecreaseInCapitalInExcessOfParValue>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i8cf37da4ca144f09a6227316724ff0d9_D20221215-20221215"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwMTQ_02a94708-029c-40a2-9f4a-50635265d841"
      unitRef="shares">177000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ica8cb453a4214470aeb06e98f2e6defe_D20221216-20221216"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwMjk_41618ea8-83d3-4f88-b3bf-a66a6cef2603"
      unitRef="shares">177000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="i8cf37da4ca144f09a6227316724ff0d9_D20221215-20221215"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwNDQ_165df361-08d3-4c11-ac63-6b3e97fcce37"
      unitRef="usdPerShare">534.16</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare
      contextRef="ica8cb453a4214470aeb06e98f2e6defe_D20221216-20221216"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwNTM_ae90f11d-eba2-41d9-a76c-7af3d2190352"
      unitRef="usdPerShare">533.87</us-gaap:AcceleratedShareRepurchasesFinalPricePaidPerShare>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1a8cc08368eb4c8087ba95516ebd17f6_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwNjI_24b8793c-8d7e-45ea-ac76-d118e4e4e775"
      unitRef="shares">1800000</us-gaap:TreasuryStockSharesAcquired>
    <hum:CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue
      contextRef="i428ce4f261d54aa99e91df6496710161_D20221215-20221216"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTUwNzU_e5fe681b-f461-4acf-ae52-51be59a0b233"
      unitRef="usd">150000000</hum:CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i546d29dd98934753aadeaaaf3c309757_I20230215"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTY5MzY_235b8e1a-3b6f-41c4-9c04-406d942f9b23"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i546d29dd98934753aadeaaaf3c309757_I20230215"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTY5NDg_17a94256-ae92-4049-9ef9-14bcb58416a9"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i546d29dd98934753aadeaaaf3c309757_I20230215"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3OTYwOTMwNTY5NjA_e08f113d-1eee-4ade-aec3-cc5ec7fb929d"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:ScheduleOfTreasuryStockByClassTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNjA2_7883ef71-d1d9-4068-89b4-11d17cb10fc9">&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluding shares acquired in connection with employee stock plans, share repurchases were as follows during the years ended December 31, 2022, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:38.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.296%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.123%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:6.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Authorization Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Purchase Not to Exceed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="39" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfTreasuryStockByClassTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i79ef21e520e24d9b86c34779aacb9bcb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtMi0xLTEtMTQwNjQ1_95e591eb-cb22-4c8d-8d9b-4db5d10c5031"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i7cbb214573c842ca8b6e875c6ff4063d_D20220101-20221231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtNC0xLTEtMTQwNjQ1_9b79d7d4-face-48dd-894e-b1fe26cd472e"
      unitRef="shares">4300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7cbb214573c842ca8b6e875c6ff4063d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtNi0xLTEtMTQwNjQ1_9577ecb0-1d05-4783-83f3-8ed2e0667eda"
      unitRef="usd">2000000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="icf5c867675b14eb099507bc46b1d3c8b_D20210101-20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtOC0xLTEtMTQwNjQ1_9f7645c4-c32e-470d-b83a-a945356733a8"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="icf5c867675b14eb099507bc46b1d3c8b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtMTAtMS0xLTE0MDY0NQ_f0fe4da9-70ff-409c-8a00-2ad85d9e01c9"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="if6da3e5a26834dcc9735b2892ca0ecb0_D20200101-20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtMTItMS0xLTE0MDY0NQ_614528f9-4e13-46d0-b068-e0a6a77bdc33"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if6da3e5a26834dcc9735b2892ca0ecb0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzMtMTQtMS0xLTE0MDY0NQ_c44fcb0b-3749-4468-b46c-fe4eb5e21fc6"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="idab11132473e41d4b78b5223d9404132_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtMi0xLTEtMTQwNjQ1_43074841-5338-4d8b-a086-b031c75c7789"
      unitRef="usd">3000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ie4f711d960cc4da69eb94de28d19a3f3_D20220101-20221231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtNC0xLTEtMTQwNjQ1_442eee0f-5df8-4e62-bf75-0340c2ee1f4d"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ie4f711d960cc4da69eb94de28d19a3f3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtNi0xLTEtMTQwNjQ1_c8146e34-20ff-4a9c-8f34-de04ef80c6f1"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ib058f69043374be79aeeb4ef7b5fc2dd_D20210101-20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtOC0xLTEtMTQwNjQ1_2016852b-cb09-437e-8f0b-e8489cf2142c"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ib058f69043374be79aeeb4ef7b5fc2dd_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtMTAtMS0xLTE0MDY0NQ_4de5d294-842b-4d6e-b69a-ef35d2032973"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i5e57aa821d834ff2a62e2f0f968132d0_D20200101-20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtMTItMS0xLTE0MDY0NQ_5f176995-d17a-425f-b1e7-183370194388"
      unitRef="shares">3800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i5e57aa821d834ff2a62e2f0f968132d0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzQtMTQtMS0xLTE0MDY0NQ_70c25da3-9601-4fe9-8b0c-2578d8e5f39c"
      unitRef="usd">1750000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i2911e9195ca74da59efd95c2f2a079cb_D20220101-20221231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtNC0xLTEtMTQwNjQ1_2bdf7655-5fbb-48ba-8d19-f2f3063089c3"
      unitRef="shares">4300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i2911e9195ca74da59efd95c2f2a079cb_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtNi0xLTEtMTQwNjQ1_debedc1e-8fbd-4000-aab8-4e39e2eb1fb9"
      unitRef="usd">2000000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1d38c03d6b794fda984bd56ecc795514_D20210101-20211231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtOC0xLTEtMTQwNjQ1_6a96e0e0-273e-4676-824e-0ba40072c97b"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1d38c03d6b794fda984bd56ecc795514_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtMTAtMS0xLTE0MDY0NQ_ec0d3ac5-f413-47b2-9a0a-dd9c6a65f506"
      unitRef="usd">0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i9b418f12cccb453c9cf39ecc9a2f0251_D20200101-20201231"
      decimals="-4"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtMTItMS0xLTE0MDY0NQ_c74f22df-9b40-450c-b294-4a360e4b8670"
      unitRef="shares">3800000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9b418f12cccb453c9cf39ecc9a2f0251_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90YWJsZTo5NTI2YjY2Y2ExNjE0OTE0YmZjNDcyNTQ3ODIzNzY4Ni90YWJsZXJhbmdlOjk1MjZiNjZjYTE2MTQ5MTRiZmM0NzI1NDc4MjM3Njg2XzUtMTQtMS0xLTE0MDY0NQ_2f1afd38-2d78-4888-a0c5-2a29a47ecc0b"
      unitRef="usd">1750000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg2NzA_8bd4eb72-8a74-4023-835c-5e0e30eefdd9"
      unitRef="shares">200000</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg2OTE_fed5d658-aaa8-412f-92a3-9cb5dc834f3a"
      unitRef="usd">96000000</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3MDE_ce426644-a5dc-4421-b44d-f8d30d98857a"
      unitRef="shares">200000</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3MjI_e081612b-5f34-4b28-87f8-d7d6230cd2f3"
      unitRef="usd">79000000</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3MzY_8da82279-883d-40cd-8723-45b41d1b9ecb"
      unitRef="shares">200000</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares>
    <hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzg3NTc_9ba7fc41-6c2f-4adc-914b-fe7128f62b61"
      unitRef="usd">70000000</hum:ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzk5NDg_cf8245e0-ecb7-4ce3-80ad-c751dbb0961a"
      unitRef="usd">11300000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzk5NTU_bbaa1b2f-0532-498e-82fd-4d5418d67a86"
      unitRef="usd">9600000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwMDYz_688407f5-9157-4ba4-b942-c4da1764ad84"
      unitRef="usd">8400000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwMDcw_cf44b787-27f1-4bb8-8d91-97855df20d02"
      unitRef="usd">7600000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwMTg0_a676963a-ec90-4015-9a1c-678762ec02b6"
      unitRef="usd">1800000000</us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval>
    <hum:DividendsToParentWithoutPriorStateRegulatoryApproval
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNTUx_5aa5f86c-b9ac-47e3-bc96-3c3059ee272c"
      unitRef="usd">1300000000</hum:DividendsToParentWithoutPriorStateRegulatoryApproval>
    <hum:DividendsToParentWithoutPriorStateRegulatoryApproval
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNTU5_50ff6e63-31bc-4ec8-a709-9c9140025b81"
      unitRef="usd">1600000000</hum:DividendsToParentWithoutPriorStateRegulatoryApproval>
    <hum:DividendsToParentWithoutPriorStateRegulatoryApproval
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTAvZnJhZzoyOGZmZTM2YWQ1Yzk0OWJjODYxNDE2OGVjY2Q5ODBmZC90ZXh0cmVnaW9uOjI4ZmZlMzZhZDVjOTQ5YmM4NjE0MTY4ZWNjZDk4MGZkXzEwNTY3_e0defaa9-f4f0-4f02-a286-a3d5e7d4d229"
      unitRef="usd">1300000000</hum:DividendsToParentWithoutPriorStateRegulatoryApproval>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzIwMTc2_0cf83e52-6c8f-4d1d-bc2f-1272a66e6655">COMMITMENTS, GUARANTEES AND CONTINGENCIES&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;     Purchase Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have agreements to purchase services, primarily information technology related services, or to make improvements to real estate, in each case that are enforceable and legally binding on us and that specify all significant terms, including: fixed or minimum levels of service to be purchased; fixed, minimum or variable price provisions; and the appropriate timing of the transaction. We have purchase obligation commitments of $687 million in 2023, $451 million in 2024, $288 million in 2025, $236 million in 2026, and $153 million in 2027. Purchase obligations exclude agreements that are cancellable without penalty.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Off-Balance Sheet Arrangements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of our ongoing business, we do not participate or knowingly seek to participate in transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, or SPEs, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of December&#160;31, 2022, we were not involved in any SPE transactions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantees and Indemnifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through indemnity agreements approved by the state regulatory authorities, certain of our regulated subsidiaries generally are guaranteed by Humana Inc., our parent company, in the event of insolvency for (1)&#160;member coverage for which premium payment has been made prior to insolvency; (2)&#160;benefits for members then hospitalized until discharged; and (3)&#160;payment to providers for services rendered prior to insolvency. Our parent also has guaranteed the obligations of certain of our non-regulated subsidiaries and funding to maintain required statutory capital levels of certain regulated subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we enter into contractual arrangements under which we may agree to indemnify a third party to such arrangement from any losses incurred relating to the services they perform on behalf of us, or for losses arising from certain events as defined within the particular contract, which may include, for example, litigation or claims relating to past performance. Such indemnification obligations may not be subject to maximum loss clauses. Historically, payments made related to these indemnifications have been immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Government Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Medicare products, which accounted for approximately 81% of our total premiums and services revenue for the year ended December&#160;31, 2022, primarily consisted of products covered under the Medicare Advantage and Medicare Part D Prescription Drug Plan contracts with the federal government. These contracts are renewed generally for a calendar year term unless CMS notifies us of its decision not to renew by May 1 of the calendar year in which the contract would end, or we notify CMS of our decision not to renew by the first Monday in June of the calendar year in which the contract would end. All material contracts between Humana and CMS relating to our Medicare products have been renewed for 2023, and all of our product offerings filed with CMS for 2023 have been approved.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS uses a risk-adjustment model which adjusts premiums paid to Medicare Advantage, or MA, plans according to health status of covered members. The risk-adjustment model, which CMS implemented pursuant to the Balanced Budget Act of 1997 (BBA) and the Benefits Improvement and Protection Act of 2000 (BIPA), generally pays more where a plan's membership has higher expected costs. Under this model, rates paid to MA plans are based on actuarially determined bids, which include a process whereby our prospective payments are based on our estimated cost of providing standard Medicare-covered benefits to an enrollee with a "national average risk profile." That baseline payment amount is adjusted to account for certain demographic characteristics and health status of our enrolled members. Under the risk-adjustment methodology, all MA plans must collect from providers and submit the necessary diagnosis code information to CMS within prescribed deadlines. The CMS risk-adjustment model uses the diagnosis data, collected from providers, to calculate the health status-related risk-adjusted premium payment to MA plans, which CMS further adjusts for coding pattern differences between the health plans and the government fee-for-service (FFS) program. We generally rely on providers, including certain providers in our network who are our employees, to code their claim submissions with appropriate diagnoses, which we send to CMS as the basis for our health status-adjusted payment received from CMS under the actuarial risk-adjustment model. We also rely on these providers to document appropriately all medical data, including the diagnosis data submitted with claims. In addition, we conduct medical record reviews as part of our data and payment accuracy compliance efforts, to more accurately reflect diagnosis conditions under the risk adjustment model. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CMS and the Office of the Inspector General of Health and Human Services, or HHS-OIG, perform audits of various companies&#x2019; risk adjustment diagnosis data submissions. We refer to these audits as Risk-Adjustment Data Validation Audits, or RADV audits. RADV audits review medical records in an attempt to validate provider medical record documentation and coding practices that influence the calculation of health status-related premium payments to MA plans.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2012, CMS released an MA contract-level RADV methodology that would extrapolate the results of each CMS RADV audit sample to the audited MA contract&#x2019;s entire health status-related risk adjusted premium amount for the year under audit.  In doing so, CMS recognized &#x201c;that the documentation standard used in RADV audits to determine a contract&#x2019;s payment error (medical records) is different from the documentation standard used to develop the Part C risk-adjustment model (FFS claims).&#x201d;  To correct for this difference, CMS stated that it would apply a &#x201c;Fee-for-Service Adjuster (FFS Adjuster)&#x201d; as &#x201c;an offset to the preliminary recovery amount.&#x201d;  This adjuster would be &#x201c;calculated by CMS based on a RADV-like review of records submitted to support FFS claims data.&#x201d;  CMS stated that this methodology would apply to audits beginning with PY 2011.  Humana relied on CMS&#x2019;s 2012 guidance in submitting MA bids to CMS.  Humana also launched a &#x201c;Self-Audits&#x201d; program in 2013 that applied CMS&#x2019;s 2012 RADV audit methodology and included an estimated FFS Adjuster.  Humana completed Self-Audits for PYs 2011-2016 and reported results to CMS.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2018, however, CMS issued a proposed rule announcing possible changes to the RADV audit methodology, including elimination of the FFS Adjuster.  CMS proposed applying its revised methodology, including extrapolated recoveries without application of a FFS Adjuster, to RADV audits dating back to PY 2011.  On January 30, 2023, CMS published a final rule related to the RADV audit methodology (Final RADV Rule).  The Final RADV Rule confirmed CMS&#x2019;s decision to eliminate the FFS Adjuster. The Final RADV Rule states CMS&#x2019;s intention to extrapolate results from CMS and HHS-OIG RADV audits beginning with PY 2018, rather than PY 2011 as proposed.  However, CMS&#x2019;s Final RADV Rule does not adopt a specific sampling, extrapolation or audit methodology.  CMS instead stated its general plan to rely on &#x201c;any statistically valid method . . . that is determined to be well-suited to a particular audit.&#x201d;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Humana is considering its legal options with respect to CMS&#x2019;s changed position on the FFS Adjuster and seeking clarity regarding our compliance obligations in light of the Final RADV Rule. We believe that the Final RADV Rule fails to address adequately the statutory requirement of actuarial equivalence. Further, Humana&#x2019;s actuarially certified bids through PY 2023 preserved Humana&#x2019;s position that CMS should apply an FFS Adjuster in any RADV audit that CMS intends to extrapolate. We expect CMS to apply the Final RADV Rule, including the first application of extrapolated audit results to determine audit settlements without a FFS Adjuster, to CMS and HHS-OIG RADV audits conducted for PY 2018 and subsequent years.  The Final RADV  Rule, including the lack of a FFS Adjuster, and any related regulatory, industry or company reactions, could have a material adverse effect on our results of operations, financial position, or cash flows.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, as part of our internal compliance efforts, we routinely perform ordinary course reviews of our internal business processes related to, among other things, our risk coding and data submissions in connection with the risk adjustment model. These reviews may also result in the identification of errors and the submission of corrections to CMS that may, either individually or in the aggregate, be material. As such, the result of these reviews may have a material adverse effect on our results of operations, financial position, or cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As we explore our legal options and compliance obligations, we remain committed to working alongside CMS to promote the integrity of the MA program as well as affordability and cost certainty for our members.  It is critical that MA plans are paid accurately and that payment model principles, including the application of a FFS Adjuster, are in accordance with the requirements of the Social Security Act, which, if not implemented correctly could have a material adverse effect on our results of operations, financial position, or cash flows. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:4.5pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our state-based Medicaid business accounted for approximately 6% of our total premiums and services revenue for the year ended December 31, 2022 primarily serving members enrolled in Medicaid, and in certain circumstances members who qualify for both Medicaid and Medicare, under contracts with various states. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;     Our military services business, which accounted for approximately 1% of our total premiums and services revenue for the year ended December 31, 2022, primarily consisted of the TRICARE T2017 East Region contract. The T2017 East Region contract comprises 32 states and approximately six million TRICARE beneficiaries, under which delivery of health care services commenced on January 1, 2018. The T2017 East Region contract, which was originally set to expire on December 31, 2022, was subsequently extended by the DoD and is currently scheduled to expire on December 31, 2023, unless further extended. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2022, we were awarded the next generation of TRICARE Managed Care Support Contracts, or T-5, for the TRICARE East Region by the Defense Health Agency of the DoD. The contract is expected to go into effect in 2024. Until then the T2017 contract remains in place. Under the terms of the award, our service area covers approximately 4.6&#160;million beneficiaries in a region consisting of 24  states and Washington, D.C. The length of the contract is &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMyOA_c266142d-523a-4672-8755-4dc23319d78b"&gt;one&lt;/span&gt; base year with eight  annual option periods, which, if all options are exercised, would result in a total contract length of  &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDMzOA_961b1df7-1bbf-49b4-94e1-c81bd4087591"&gt;nine&lt;/span&gt; years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loss of any of the contracts above or significant changes in these programs as a result of legislative or regulatory action, including reductions in premium payments to us, regulatory restrictions on profitability, including reviews by regulatory bodies that may compare our Medicare Advantage profitability to our non-Medicare Advantage business profitability, or compare the profitability of various products within our Medicare Advantage business, and require that they remain within certain ranges of each other, or increases in member benefits or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;member eligibility criteria without corresponding increases in premium payments to us, may have a material adverse effect on our results of operations, financial position, and cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings and Certain Regulatory Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously disclosed, the Civil Division of the United States Department of Justice provided us with an information request in December 2014, concerning our Medicare Part C risk adjustment practices. The request relates to our oversight and submission of risk adjustment data generated by providers in our Medicare Advantage network, as well as to our business and compliance practices related to risk adjustment data generated by our providers and by us, including medical record reviews conducted as part of our data and payment accuracy compliance efforts, the use of health and well-being assessments, and our fraud detection efforts. We believe that this request for information is in connection with a wider review of Medicare Risk Adjustment generally that includes a number of Medicare Advantage plans, providers and vendors. We cooperated with the Department of Justice, and we have not heard from the Department of Justice on this matter since 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As previously disclosed, on January 19, 2016, an individual filed a qui tam suit captioned United States of America ex rel. Steven Scott v. Humana, Inc., in United States District Court, Central District of California, Western Division. The complaint alleges certain civil violations by us in connection with the actuarial equivalence of the plan benefits under Humana&#x2019;s Basic PDP plan, a prescription drug plan offered by us under Medicare Part D. The action seeks damages and penalties on behalf of the United States under the False Claims Act. The court ordered the qui tam action unsealed on September 13, 2017, so that the relator could proceed, following notice from the U.S. Government that it was not intervening at that time. On January 29, 2018, the suit was transferred to the United States District Court, Western District of Kentucky, Louisville Division. We have substantially completed discovery with the relator who has pursued the matter on behalf of the United States following its unsealing. On March 31, 2022, the Court denied the parties' Motions for Summary Judgement. We take seriously our obligations to comply with applicable CMS requirements and actuarial standards of practice, and continue to vigorously defend against these allegations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Lawsuits and Regulatory Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Our current and past business practices are subject to review or other investigations by various state insurance and health care regulatory authorities and other state and federal regulatory authorities. These authorities regularly scrutinize the business practices of health insurance, health care delivery and benefits companies. These reviews focus on numerous facets of our business, including claims payment practices, statutory capital requirements, provider contracting, risk adjustment, competitive practices, commission payments, privacy issues, utilization management practices, pharmacy benefits, access to care, sales practices, and provision of care by our healthcare services businesses, among others. Some of these reviews have historically resulted in fines imposed on us and some have required changes to some of our practices. We continue to be subject to these reviews, which could result in additional fines or other sanctions being imposed on us or additional changes in some of our practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also are involved in various other lawsuits that arise, for the most part, in the ordinary course of our business operations, certain of which may be styled as class-action lawsuits. Among other matters, this litigation may include employment matters, claims of medical malpractice, bad faith, nonacceptance or termination of providers, anticompetitive practices, improper rate setting, provider contract rate and payment disputes, including disputes over reimbursement rates required by statute, disputes arising from competitive procurement process, general contractual matters, intellectual property matters, and challenges to subrogation practices. Under state guaranty assessment laws, including those related to state cooperative failures in the industry, we may be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of insolvent insurance companies that write the same line or lines of business as we do.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a government contractor, we may also be subject to false claims litigation, such as qui tam lawsuits brought by individuals who seek to sue on behalf of the government, alleging that the government contractor submitted false claims to the government or related overpayments from the government, including, among other allegations, those resulting from coding and review practices under the Medicare risk adjustment model. Qui tam litigation is filed &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;under seal to allow the government an opportunity to investigate and to decide if it wishes to intervene and assume control of the litigation. If the government does not intervene, the individual may continue to prosecute the action on his or her own, on behalf of the government. We also are subject to other allegations of nonperformance of contractual obligations to providers, members, and others, including failure to properly pay claims, improper policy terminations, challenges to our implementation of the Medicare Part D prescription drug program and other litigation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A limited number of the claims asserted against us are subject to insurance coverage. Personal injury claims, claims for extra contractual damages, care delivery malpractice, and claims arising from medical benefit denials are covered by insurance from our wholly owned captive insurance subsidiary and excess carriers, except to the extent that claimants seek punitive damages, which may not be covered by insurance in certain states in which insurance coverage for punitive damages is not permitted. In addition, insurance coverage for all or certain forms of liability has become increasingly costly and may become unavailable or prohibitively expensive in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record accruals for the contingencies discussed in the sections above to the extent that we conclude it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. No estimate of the possible loss or range of loss in excess of amounts accrued, if any, can be made at this time regarding the matters specifically described above because of the inherently unpredictable nature of legal proceedings, which also may be exacerbated by various factors, including: (i) the damages sought in the proceedings are unsubstantiated or indeterminate; (ii) discovery is not complete; (iii) the proceeding is in its early stages; (iv) the matters present legal uncertainties; (v) there are significant facts in dispute; (vi) there are a large number of parties (including where it is uncertain how liability, if any, will be shared among multiple defendants); or (vii) there is a wide range of potential outcomes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The outcome of any current or future litigation or governmental or internal investigations, including the matters described above, cannot be accurately predicted, nor can we predict any resulting judgments, penalties, fines or other sanctions that may be imposed at the discretion of federal or state regulatory authorities or as a result of actions by third parties. Nevertheless, it is reasonably possible that any such outcome of litigation, judgments, penalties, fines or other sanctions could be substantial, and the outcome of these matters may have a material adverse effect on our results of operations, financial position, and cash flows, and may also affect our reputation.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzUwNw_b93e1f7e-35fc-4d49-bc1a-92d161d910b4"
      unitRef="usd">687000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzUxNw_a475b92b-8819-4fce-b0e9-6675b01906db"
      unitRef="usd">451000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzUyNw_41d5da39-80bc-4786-8d69-821b55f21b80"
      unitRef="usd">288000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzUzNw_6aad2661-fd60-44fd-9d24-5e0214539be5"
      unitRef="usd">236000000</us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary>
    <us-gaap:UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU1MQ_119f1d88-709c-4762-9c60-b51d87f7256e"
      unitRef="usd">153000000</us-gaap:UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears>
    <hum:PercentageOfTotalPremiumAndServicesRevenues
      contextRef="i12de401f78254a06a054b3031bb6db2c_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzI0NDI_94172f0c-002c-4a3f-aa1f-9ee0f28ccfce"
      unitRef="number">0.81</hum:PercentageOfTotalPremiumAndServicesRevenues>
    <hum:PercentageOfTotalPremiumAndServicesRevenues
      contextRef="ie135078db20f4355a53c7fdca9bb2dc3_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzEwOTQ5_2fd4643e-ba57-437b-9131-23b58e9e749b"
      unitRef="number">0.06</hum:PercentageOfTotalPremiumAndServicesRevenues>
    <hum:PercentageOfTotalPremiumAndServicesRevenues
      contextRef="i61a07b55e80d459dac04cd0e5bf2f6bd_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzExMjcw_1fd7f182-d39f-46d1-a565-3dac57c59018"
      unitRef="number">0.01</hum:PercentageOfTotalPremiumAndServicesRevenues>
    <hum:NumberOfStatesComprisingTRICAREBeneficiaries
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzExNDMy_f968d057-9539-4dd3-83f3-0f91d753d514"
      unitRef="state">32</hum:NumberOfStatesComprisingTRICAREBeneficiaries>
    <hum:NumberOfTRICAREBeneficiaries
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzExNDYw_d1ec625e-e3e2-45b0-b276-587b1d2c9199"
      unitRef="beneficiary">6000000000000</hum:NumberOfTRICAREBeneficiaries>
    <hum:NumberOfTRICAREManagedCareSupportContractBeneficiaries
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzkzNDU4NDg4NjExOTI_1bc2471d-196d-4b70-883a-455565ed5203"
      unitRef="beneficiary">4600000</hum:NumberOfTRICAREManagedCareSupportContractBeneficiaries>
    <hum:NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzkzNDU4NDg4NjEyMDU_6b3f7383-e24e-4c81-a153-90cbd2d6dd8d"
      unitRef="state">24</hum:NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries>
    <hum:TRICAREManagedCareSupportContractNumberOfOptionPeriods
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTMvZnJhZzpjYzhlZTI3YzMyYzc0NjYzOGNlZmQyYzJhZmVhYTE5NS90ZXh0cmVnaW9uOmNjOGVlMjdjMzJjNzQ2NjM4Y2VmZDJjMmFmZWFhMTk1XzU0OTc1NTg3MDgwNA_1e544ea2-1ac3-482d-a16c-165b8b27d3b1"
      unitRef="option_period">8</hum:TRICAREManagedCareSupportContractNumberOfOptionPeriods>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzY1MTc_b1eb74ae-ba94-4df5-916c-88874f01612e">SEGMENT INFORMATION&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During December 2022, we realigned our businesses into two distinct segments: Insurance and CenterWell. The Insurance segment includes the businesses that were previously included in the Retail and Group and Specialty segments, as well as the Pharmacy Benefit Manager, or PBM, business which was previously included in the Healthcare Services segment. The CenterWell segment (formerly Healthcare Services) represents our payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. In addition to the new segment classifications being utilized to assess performance and allocate resources, we believe this simpler structure will create greater collaboration across the Insurance and CenterWell businesses and will accelerate work that is underway to centralize and integrate operations within the organization.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior period segment financial information has been recast to conform to the 2022 presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our  two&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;reportable segments, Insurance and CenterWell, are based on a combination of the type of health plan customer and adjacent businesses centered on well-being solutions for our health plans and other customers, as described below. These segment groupings are consistent with information used by our Chief Executive Officer, the Chief Operating Decision Maker, to assess performance and allocate resources. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as our contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which we refer to collectively as our state-based contracts. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only, or ASO. In addition, our Insurance segment includes our military services business, primarily our T-2017 East Region contract, as well as the operations of our PBM business. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CenterWell segment includes our pharmacy, provider services, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our CenterWell intersegment revenues primarily relate to the operations of CenterWell Pharmacy (our mail- order pharmacy business), CenterWell Specialty Pharmacy, and retail pharmacies jointly located within CenterWell Senior Primary Care clinics. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, our CenterWell intersegment revenues includes revenues earned by certain owned providers (CenterWell Senior Primary Care) derived from certain value-based arrangements with our health plans. Under these value-based arrangements, our owned providers enter into agreements with our health plans to stand ready to deliver, integrate, direct and control the administration and management of certain health care services for our members. In exchange, the owned provider receives a premium that is typically paid on a per-member per-month basis. These value-based arrangements represent a single performance obligation where revenues are recognized in the period in which we are obligated to provide integrated health care services to our members. Fee-for-service revenue is recognized at agreed upon rates, net of contractual allowances, as the performance obligation is completed on the date of service.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We present our consolidated results of operations from the perspective of the health plans. As a result, the cost of providing benefits to our members, whether provided via a third party provider or internally through a stand-alone subsidiary, is classified as benefits expense and excludes the portion of the cost for which the health plans do not bear responsibility, including member co-share amounts and government subsidies of $19.7 billion in 2022, $18.1 billion in 2021, and $16.5 billion in 2020. In addition, depreciation and amortization expense associated with certain businesses delivering benefits to our members, primarily associated with our provider services and pharmacy operations, are included with benefits expense. The amount of this expense was $122&#160;million in 2022, $108&#160;million in 2021, and $127&#160;million in 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other than those described previously, the accounting policies of each segment are the same and are described in Note 2. Transactions between reportable segments primarily consist of sales of services rendered by our CenterWell segment, primarily pharmacy, provider, and home services, to our Insurance segment customers. Intersegment sales and expenses are recorded at fair value and eliminated in consolidation. Members served by our segments often use the same provider networks, enabling us in some instances to obtain more favorable contract terms with providers. Our segments also share indirect costs and assets. As a result, the profitability of each segment is interdependent. We allocate most operating expenses to our segments. Assets and certain corporate income and expenses are not allocated to the segments, including the portion of investment income not supporting segment operations, interest expense on corporate debt, and certain other corporate expenses. These items are managed at a corporate level. These corporate amounts are reported separately from our reportable segments and are included with intersegment eliminations in the tables presenting segment results below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Premium and services revenues derived from our contracts with the federal government, as a percentage of our total premium and services revenues, were approximately 82% for 2022, 83% for 2021 and 83% for 2020.&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASO and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on sale of KAH Hospice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss) attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASO and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,024)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASO and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzU0OTc1NTgxNjYyOTk_fc569758-264f-4c5c-84e6-dab652519dda"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzU3_25b4f256-0104-416e-b4b4-c67c4ff0a698"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <hum:GovernmentAndHealthPlanMemberSubsidiesAmount
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzQ2OTk_ebcab375-9e29-405c-b32f-972b560c325f"
      unitRef="usd">19700000000</hum:GovernmentAndHealthPlanMemberSubsidiesAmount>
    <hum:GovernmentAndHealthPlanMemberSubsidiesAmount
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzQ3MDk_3694c94e-36da-40a6-9ce2-28f25f925296"
      unitRef="usd">18100000000</hum:GovernmentAndHealthPlanMemberSubsidiesAmount>
    <hum:GovernmentAndHealthPlanMemberSubsidiesAmount
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzQ3MjM_5ad3ff4d-2de8-47ce-b1f4-764823e72c29"
      unitRef="usd">16500000000</hum:GovernmentAndHealthPlanMemberSubsidiesAmount>
    <hum:DepreciationAndAmortizationClassifiedAsBenefitExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzUwMzA_51870bb0-6100-45de-8ef2-fceca2c34075"
      unitRef="usd">122000000</hum:DepreciationAndAmortizationClassifiedAsBenefitExpense>
    <hum:DepreciationAndAmortizationClassifiedAsBenefitExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzUwNDA_db42ff17-7211-4ef3-b6b5-d5bfce68f494"
      unitRef="usd">108000000</hum:DepreciationAndAmortizationClassifiedAsBenefitExpense>
    <hum:DepreciationAndAmortizationClassifiedAsBenefitExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzUwNTQ_a7a6adb6-7ee4-4757-85e7-30a8aabb2444"
      unitRef="usd">127000000</hum:DepreciationAndAmortizationClassifiedAsBenefitExpense>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie3ecfbb6c22b417ebc6482a6408f9cdb_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzEwOTk1MTE2NzM5Nzg_67944d94-d75a-4a09-b142-90d21a332476"
      unitRef="number">0.82</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i659f9236e99f47089bc96dac2b1eec1d_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzY0NjY_6b215b84-4afd-4147-9add-bcb6f6a0279c"
      unitRef="number">0.83</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i183a5acc1cbc41339a7e84c20d8eae47_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzY0ODA_45ee111a-655d-4db9-baad-94850314799f"
      unitRef="number">0.83</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90ZXh0cmVnaW9uOmE2ZDkwNjQ5YzY3NTQ0MGFhZmQ1MzBmM2Y3M2U1MGQzXzY1MTk_4051388a-8f0c-41e4-a3a1-07d724e12a5e">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.861%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,703&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,376&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASO and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,588)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,841)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,429)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,307&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,278)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,934&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,415)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,016&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,765)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(513)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on sale of KAH Hospice&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net earnings (losses)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,564&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings (loss) attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(982)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASO and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,869)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,024)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,893)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,924)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(440)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,722)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,916&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income (loss) from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,003&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,419&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (income) loss attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.598%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.601%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;CenterWell&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Eliminations/&lt;br/&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Consolidated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;External revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Premiums:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Individual Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Group Medicare Advantage&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare stand-alone PDP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fully-insured&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Specialty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total premiums&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services revenue:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Home solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provider&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;ASO and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pharmacy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 48.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total services revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,815&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total external revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,928)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intersegment revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,932)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income before income taxes and equity in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:PremiumsEarnedNet
      contextRef="iad99ca704571480ba83888a5d38aa019_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzUtMS0xLTEtMTQwNjQ1_74eca7e2-16c3-4f5f-a847-fd5c0c20b966"
      unitRef="usd">65591000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic19eb7627fb348218e3375f5c66974a7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzUtNS0xLTEtMTQwNjQ1_40263cbb-8419-4b26-8016-1f279e80f77d"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i1d672fa23f814425b4471c1e5dc74b0f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzUtOS0xLTEtMTQwNjQ1_d7dc205d-f5c9-4222-a898-04b1522ff3b7"
      unitRef="usd">65591000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if874def50df84ee38965dd2ff7e20dc8_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzYtMS0xLTEtMTQwNjQ1_ebbfbaef-3edd-4356-a690-2d6f6ff1665c"
      unitRef="usd">7297000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6acea9d1a84d4feba6bb5ed5ce9a2413_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzYtNS0xLTEtMTQwNjQ1_cd0689c0-786b-4944-80ed-8169f01afd07"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i03a322c8d9d443e19ed5ba572d9572d3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzYtOS0xLTEtMTQwNjQ1_dcf03d05-8baa-40b1-b144-f38ba4a3ce48"
      unitRef="usd">7297000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i4fc365aeef164ccba60189ae8e4be0c6_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzctMS0xLTEtMTQwNjQ1_a3c5af4a-b22f-427a-aa60-1996bf96eb52"
      unitRef="usd">2269000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i678e6634c1f641da9467a8467bb0d1fa_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzctNS0xLTEtMTQwNjQ1_cf5c9aad-16cd-4a2e-a93d-0b6e952c5d95"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia600b949e2564d9499a7f90413acb269_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzctOS0xLTEtMTQwNjQ1_c601278b-263f-48fe-994f-0988397c01cc"
      unitRef="usd">2269000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib3a1e7fbd9b740abb48da6c37c8669a5_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzgtMS0xLTEtMTQwNjQ1_996cf9bc-1676-457e-9a81-1b043eb460c2"
      unitRef="usd">75157000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="icba60622cbea46a4bea4ee9980cf49d0_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzgtNS0xLTEtMTQwNjQ1_f2fcf192-20ef-45d9-94c5-44987805ce8b"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i12de401f78254a06a054b3031bb6db2c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzgtOS0xLTEtMTQwNjQ1_39a23540-75c7-478e-8958-e3dd2853fa4d"
      unitRef="usd">75157000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie5c59ec6e1b641aba95c635ef9ee9353_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzktMS0xLTEtMTQwNjQ1_53cf4340-b960-4629-a1a6-6bfdb8351174"
      unitRef="usd">4476000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i77000571fe484454b7cece9a261ff0d7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzktNS0xLTEtMTQwNjQ1_83153cf4-249a-4745-b6c2-77da0d63d8ad"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6a704e86f4b24c3aaa85d60048410091_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzktOS0xLTEtMTQwNjQ1_2434e0a6-668c-4a83-9a0f-11bb7be280fc"
      unitRef="usd">4476000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i8b96d1b5772846aab2514b027450d532_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEwLTEtMS0xLTE0MDY0NQ_f9ce0c25-d3fd-4eac-b030-0e9bb55cea1c"
      unitRef="usd">1703000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i851654ab87514d19bb07259c3e31ff6b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEwLTUtMS0xLTE0MDY0NQ_7280a361-4679-4f7d-9d37-90e17a99f77b"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i88dbb625a14f473eb0ce08c9d6aff7e3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEwLTktMS0xLTE0MDY0NQ_d4c29e88-2636-4808-8359-2481af8d782e"
      unitRef="usd">1703000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i9a97e0cfebe44b6ca9f74bebc9aae41f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzExLTEtMS0xLTE0MDY0NQ_14b16b7f-8be9-4ab6-9f81-8f10472b96c2"
      unitRef="usd">6376000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i321b22b5a8d64b4fa443b551c3f5ef42_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzExLTUtMS0xLTE0MDY0NQ_29273261-43bc-413c-a416-09a0c9dd50cd"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ifac46bf8882f4afd8d1dff2e3d3664d3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzExLTktMS0xLTE0MDY0NQ_15bcffdd-94f8-4593-8329-6e15213974a5"
      unitRef="usd">6376000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEyLTEtMS0xLTE0MDY0NQ_984fdb11-174e-424d-a09e-39b506174730"
      unitRef="usd">87712000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEyLTUtMS0xLTE0MDY0NQ_251589f6-8f23-4983-bf74-54acfc90d3c7"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzEyLTktMS0xLTE0MDY0NQ_fc9898e6-dbed-4211-a985-0d38f3e89e95"
      unitRef="usd">87712000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9d9b0e5592fc42a6b5a50cddd44bac9b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE0LTEtMS0xLTE0MDY0NQ_020f54cf-e680-4b3b-8f63-dab7bd211c02"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i6c5f8b05d172420aa7d6e508a7c3261a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE0LTUtMS0xLTE0MDY0NQ_973f6f86-213a-4db1-88ed-ea65f2ddacc8"
      unitRef="usd">2333000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1ed102b89a1848bf8a260145b47bc56e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE0LTktMS0xLTE0MDY0NQ_b770e669-5357-4f72-aa8f-74f0e52b835b"
      unitRef="usd">2333000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i917edca86d004c958b32aa4199b5ea4b_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE1LTEtMS0xLTE0MDY0NQ_1a16d3aa-0abb-43fc-970b-958b2b3ecf36"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i32da3ea918f84f139a1ac455b07ebfda_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE1LTUtMS0xLTE0MDY0NQ_5707247a-b55b-4659-9003-fa27e490f7d5"
      unitRef="usd">568000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1cdfd66eeb7d4c938de2f60123537f11_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE1LTktMS0xLTE0MDY0NQ_86a5769d-f167-42cc-bb21-71f78aee4df5"
      unitRef="usd">568000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i47d0ebf962574d2da49de809c4eb19ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE2LTEtMS0xLTE0MDY0NQ_d7090c78-f891-4105-9616-fcb3452b51b9"
      unitRef="usd">850000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i03027c1fdaa8418fb517496371138dbe_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE2LTUtMS0xLTE0MDY0NQ_5ffc562d-62fd-48ff-8cae-f638effc6202"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id6b045942f9d4e858da50fb74642864c_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE2LTktMS0xLTE0MDY0NQ_b8248278-b6af-40a2-b09e-ec7ae44ba54b"
      unitRef="usd">850000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic5328222283c41c587cc828204de2027_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE3LTEtMS0xLTE0MDY0NQ_34298cab-62c6-4bd3-888e-9e52e19fdc3c"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i897a9529650a4bb884a93b8cf59bd75a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE3LTUtMS0xLTE0MDY0NQ_f8e629a2-e1b6-48df-96c5-fa9f295421eb"
      unitRef="usd">1025000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7458a4e3b4284a1e924e76cd284a045d_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE3LTktMS0xLTE0MDY0NQ_8ff6e1c0-52de-4557-920e-0d014f20b2b5"
      unitRef="usd">1025000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE4LTEtMS0xLTE0MDY0NQ_ca098cd3-c64f-45c3-88a8-0c9070cbebd0"
      unitRef="usd">850000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE4LTUtMS0xLTE0MDY0NQ_977fd7e9-554e-4d6a-81bc-0592fbf92002"
      unitRef="usd">3926000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE4LTktMS0xLTE0MDY0NQ_5afc4107-d939-4262-87aa-bed908291f1f"
      unitRef="usd">4776000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE5LTEtMS0xLTE0MDY0NQ_6a3d8114-c2e9-4b90-9d91-16445cea52f0"
      unitRef="usd">88562000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE5LTUtMS0xLTE0MDY0NQ_84ab6157-96dc-49e1-bf77-b819f6f6b814"
      unitRef="usd">3926000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i596d1ad9ab314614a3930efbc769fbf3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzE5LTktMS0xLTE0MDY0NQ_a43cac57-6849-4db1-8335-37f7b33e1c6e"
      unitRef="usd">92488000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1d8bdf2106784156b1b8947924736d88_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIxLTEtMS0xLTE0MDY0NQ_dfa60fea-1ba5-4831-aee3-0e8ee3c3e6f2"
      unitRef="usd">56000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i590c72b5416448abb074967e44ff6ab1_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIxLTUtMS0xLTE0MDY0NQ_56ed3823-f231-431d-ae18-4a64466f8410"
      unitRef="usd">3532000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic7d56895373540d987a4fcd85111df8f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIxLTctMS0xLTE0MDY0NQ_17007449-8b00-4519-824b-1815e9749c8a"
      unitRef="usd">-3588000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i01479ee240324dfda2f8366c4adb14e7_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIyLTEtMS0xLTE0MDY0NQ_b7128917-d347-4da2-b1a4-47c4b3187f51"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib9e4c5dc89ec4b73a775d2b544b21d0a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIyLTUtMS0xLTE0MDY0NQ_a21256bc-1d55-46ee-b69a-d20661082e4a"
      unitRef="usd">9841000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id179fa09e1214e46a546b7c140286685_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIyLTctMS0xLTE0MDY0NQ_43d123db-7e79-4c93-b798-2e1fa9555560"
      unitRef="usd">-9841000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if4ff990b381946d494741a1374b90aed_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIzLTEtMS0xLTE0MDY0NQ_77e1ec3d-3fe3-4d06-bb12-d938bbfeeb68"
      unitRef="usd">56000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7df369d93b09472ba0bced59c36b413f_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIzLTUtMS0xLTE0MDY0NQ_eddf82c7-f71b-49c1-bb36-ee653701a6b1"
      unitRef="usd">13373000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id67dea91f3604bd78d2f964c679d21b3_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzIzLTctMS0xLTE0MDY0NQ_23fba745-6122-4480-9666-90eb99af4aba"
      unitRef="usd">-13429000000</us-gaap:Revenues>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI0LTEtMS0xLTE0MDY0NQ_0726fd81-28eb-4e32-9de5-17238f21868b"
      unitRef="usd">223000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI0LTUtMS0xLTE0MDY0NQ_4337b6a0-9ecd-4314-9b68-2138e3d4bf78"
      unitRef="usd">8000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI0LTctMS0xLTE0MDY0NQ_85d80427-0307-4144-a601-14fa7efa669d"
      unitRef="usd">151000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI0LTktMS0xLTE0MDY0NQ_f7dd8094-eecb-4d5f-b7db-0748fcd52f05"
      unitRef="usd">382000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI1LTEtMS0xLTE0MDY0NQ_1e327f50-8395-45eb-82b0-708d1a5f2a58"
      unitRef="usd">88841000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI1LTUtMS0xLTE0MDY0NQ_337b00ce-96fd-470d-a62f-9e9b0d06edf9"
      unitRef="usd">17307000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI1LTctMS0xLTE0MDY0NQ_075a45b7-d25d-4a28-b69a-98f24431c7f3"
      unitRef="usd">-13278000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI1LTktMS0xLTE0MDY0NQ_0febf608-5c58-42d4-ab41-1535e0771a39"
      unitRef="usd">92870000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI3LTEtMS0xLTE0MDY0NQ_18741451-86b9-424c-958e-65f9510ef838"
      unitRef="usd">75934000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI3LTUtMS0xLTE0MDY0NQ_980d0ac4-8d81-4628-a838-c2e2980cf2b2"
      unitRef="usd">0</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI3LTctMS0xLTE0MDY0NQ_ef829dd2-2b2c-4daa-8c93-e067552f82e2"
      unitRef="usd">-244000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI3LTktMS0xLTE0MDY0NQ_00bc2f23-9d4c-4e59-84ad-0f6c4fe8c1de"
      unitRef="usd">75690000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI4LTEtMS0xLTE0MDY0NQ_f1730ac5-23b7-4bc6-a2cc-d5dd295deedc"
      unitRef="usd">9251000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI4LTUtMS0xLTE0MDY0NQ_14ea1c36-ef4d-441e-9b02-0a0a223322f0"
      unitRef="usd">15835000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI4LTctMS0xLTE0MDY0NQ_cb74f8e0-f325-4f7e-bfcd-26a913e1f4d1"
      unitRef="usd">-12415000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI4LTktMS0xLTE0MDY0NQ_ec53629b-1b19-4c3c-be52-f42a4dd76cee"
      unitRef="usd">12671000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI5LTEtMS0xLTE0MDY0NQ_1a4d58a3-39cb-4782-86ef-2a5cfb6231b9"
      unitRef="usd">634000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI5LTUtMS0xLTE0MDY0NQ_816d6d53-5c75-40d4-97ec-94c6ff7c354c"
      unitRef="usd">181000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI5LTctMS0xLTE0MDY0NQ_b2125269-6e44-4812-9dd8-86ef5a530ca8"
      unitRef="usd">-106000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzI5LTktMS0xLTE0MDY0NQ_7df7b35c-cdc4-4b3d-b5ca-493f308a85d5"
      unitRef="usd">709000000</hum:DepreciationAndAmortizationIncomeStatement>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i25c984b0af73453f8cd37e738951f02a_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMwLTEtMS0xLTE0MDY0NQ_48bc57e3-7fe2-48d6-9414-c6c3e8614c21"
      unitRef="usd">85819000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i89ff6707fcd14eb3b908270334348f22_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMwLTUtMS0xLTE0MDY0NQ_9e732bb7-8c51-46d1-a68f-c58e634996f1"
      unitRef="usd">16016000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMwLTctMS0xLTE0MDY0NQ_cf28850c-a6f5-4d9a-98cf-373d54742e47"
      unitRef="usd">-12765000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMwLTktMS0xLTE0MDY0NQ_e33848bd-5b88-4072-ac01-a87fe161789a"
      unitRef="usd">89070000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMxLTEtMS0xLTE0MDY0NQ_df710018-9637-4579-b0f1-81081333fd80"
      unitRef="usd">3022000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMxLTUtMS0xLTE0MDY0NQ_6a9a6aad-a96c-4441-9c1f-be38c0f7c7da"
      unitRef="usd">1291000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMxLTctMS0xLTE0MDY0NQ_e35ec0e9-82ae-4a91-b04b-dd8c7b710ee4"
      unitRef="usd">-513000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMxLTktMS0xLTE0MDY0NQ_dfdcd071-0e41-4052-b300-86d2f1bb7611"
      unitRef="usd">3800000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMyLTEtMS0xLTE0MDY0NQ_f423764c-a182-45c0-9aea-df33a21d7c0a"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMyLTUtMS0xLTE0MDY0NQ_e052215f-3834-4371-bf59-5dcfaa644ec2"
      unitRef="usd">237000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMyLTctMS0xLTE0MDY0NQ_93a4bd2d-334a-4f48-a9a4-42e25f6d4214"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMyLTktMS0xLTE0MDY0NQ_b286c0bf-2798-4f77-947c-f02166536d18"
      unitRef="usd">237000000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:InterestExpense
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMzLTEtMS0xLTE0MDY0NQ_9b87541c-1fd0-468e-a318-3d67a4cdab9a"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMzLTUtMS0xLTE0MDY0NQ_0c9b9ede-033c-4485-9433-65b1093421de"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMzLTctMS0xLTE0MDY0NQ_6db97075-7fc1-4f71-bf31-2de1267cbe60"
      unitRef="usd">401000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzMzLTktMS0xLTE0MDY0NQ_ee2b287c-c2d7-4f1a-8811-db386bcd28ca"
      unitRef="usd">401000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM0LTEtMS0xLTE0MDY0NQ_2718274b-f452-404e-acb9-3213bb30c4ad"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM0LTUtMS0xLTE0MDY0NQ_9e8e35b0-cd0c-4b96-8173-3f271b2f1a07"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM0LTctMS0xLTE0MDY0NQ_3deb0589-85a6-4561-ad6b-f4bc14d6c00b"
      unitRef="usd">-68000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM0LTktMS0xLTE0MDY0NQ_cfa107e2-598a-4cd3-bc33-73dc1876db68"
      unitRef="usd">-68000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM1LTEtMS0xLTE0MDY0NQ_0a1fdf2f-fa9b-43d1-9f0f-672d5dcf7cb5"
      unitRef="usd">3022000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM1LTUtMS0xLTE0MDY0NQ_9f9f1aef-381a-4b47-8725-8f6bccf8ba91"
      unitRef="usd">1528000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM1LTctMS0xLTE0MDY0NQ_e15b2f78-50af-4dbf-b4fc-780a398e10de"
      unitRef="usd">-982000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM1LTktMS0xLTE0MDY0NQ_0946a33c-eea4-4023-af04-2b78c2084ee3"
      unitRef="usd">3568000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM2LTEtMS0xLTE0MDY0NQ_30ce42bc-39af-4601-b141-0b868eb02b30"
      unitRef="usd">18000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM2LTUtMS0xLTE0MDY0NQ_cc5ce03a-762d-4c1e-ad3e-cff6e901a345"
      unitRef="usd">-22000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM2LTctMS0xLTE0MDY0NQ_0fa8e98c-4e5f-4254-bb1f-c7716de6e718"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM2LTktMS0xLTE0MDY0NQ_9b3f526f-f836-44e0-b9ba-a370a138dbd8"
      unitRef="usd">-4000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM3LTEtMS0xLTE0MDY0NQ_47dcdefc-db48-44ec-bb64-c623225f0c08"
      unitRef="usd">3040000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM3LTUtMS0xLTE0MDY0NQ_dc022e07-ee82-4ef1-a99c-ee776fecc80e"
      unitRef="usd">1506000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM3LTctMS0xLTE0MDY0NQ_3a4f9721-b43b-46cc-b228-caae0220a5b6"
      unitRef="usd">-982000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM3LTktMS0xLTE0MDY0NQ_35cccd34-2cd7-4b01-9f5e-17c4539dc682"
      unitRef="usd">3564000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM4LTEtMS0xLTE0MDY0NQ_81dd7f66-71d6-469d-9ff9-41d2065a03b5"
      unitRef="usd">-5000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM4LTUtMS0xLTE0MDY0NQ_175f8d4f-858a-496a-9db9-9475bdc79f15"
      unitRef="usd">1000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM4LTctMS0xLTE0MDY0NQ_3baccf4f-0af9-4a53-aca9-e791b959ac4f"
      unitRef="usd">0</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM4LTktMS0xLTE0MDY0NQ_e9571609-9363-40a3-9021-8a54e00de8a8"
      unitRef="usd">-4000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="i0a2305e55bf845f99ae92e16962d7055_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM5LTEtMS0xLTE0MDY0NQ_62b791c7-20b7-471d-9042-181cfd3b02b1"
      unitRef="usd">3045000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="i0313b9516d5e4933b7948b25ee23423e_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM5LTUtMS0xLTE0MDY0NQ_95fe5f6b-0e2f-4c07-bfd8-849fa5811804"
      unitRef="usd">1505000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="ie05c8647a2b641a2ac5eb5563696a0f2_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM5LTctMS0xLTE0MDY0NQ_dde96292-6f1f-4165-9cab-ff88ce7dc4fd"
      unitRef="usd">-982000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTozZDhhODZjZDUzYjE0NWQ5YWZjODdkMzI4N2FjMmJkYi90YWJsZXJhbmdlOjNkOGE4NmNkNTNiMTQ1ZDlhZmM4N2QzMjg3YWMyYmRiXzM5LTktMS0xLTE0MDY0NQ_6fd072bc-5c85-4bec-815b-d4f88b66c1c3"
      unitRef="usd">3568000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <us-gaap:PremiumsEarnedNet
      contextRef="i796b3722619946a2866e39b5e61a9380_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzUtMS0xLTEtMTQwNjQ1_f12dd765-8574-4e25-a64e-fe4aabc8f019"
      unitRef="usd">58654000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie4ec4db66fd64bc8bbf344f75b65d318_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzUtNS0xLTEtMTQwNjQ1_1f2f39c6-b546-44e8-8d61-ef7e914890fa"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i52e79522cd64489888fa93b49c2e6243_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzUtOS0xLTEtMTQwNjQ1_cb45021d-7dd5-4098-ae34-80daf2b07239"
      unitRef="usd">58654000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i299d79234a514ee99ef71046de2df3ef_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzYtMS0xLTEtMTQwNjQ1_7f896f44-fa8b-4080-8942-62effa37cbe7"
      unitRef="usd">6955000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib51fd316c79f41bebb6fc344f6a46fea_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzYtNS0xLTEtMTQwNjQ1_d42e1820-572a-40f4-901e-b553edf5cd59"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i89314fb76bc24433859a3e2ed527bbee_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzYtOS0xLTEtMTQwNjQ1_85258342-8035-4618-90b2-348fab802b9b"
      unitRef="usd">6955000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i27b8edba666c462dac30cab44012936f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzctMS0xLTEtMTQwNjQ1_201cff07-1546-462c-bb10-ae73784b4f9c"
      unitRef="usd">2371000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i604d726215884cf397df3162b2320a54_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzctNS0xLTEtMTQwNjQ1_04ed3541-48e0-472b-bda3-dcfeed2ab424"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i8388adc860dd445ba3de97b7ffe95782_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzctOS0xLTEtMTQwNjQ1_128d0bae-eb2f-45a0-957f-e801490dda2b"
      unitRef="usd">2371000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="iadf23257f8df4815a1982e9a75f47ead_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzgtMS0xLTEtMTQwNjQ1_6aa7c60e-7052-4e9f-9640-e97637569856"
      unitRef="usd">67980000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i49240990811a4ffbb3f2a0dc683eee48_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzgtNS0xLTEtMTQwNjQ1_9c2f1bf3-ee03-45c5-8d11-347badb1c245"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i951e931c21c249828781deed9eee8a91_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzgtOS0xLTEtMTQwNjQ1_aee23504-b2c5-4c38-9428-369d54c5d537"
      unitRef="usd">67980000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i47a95cc29f594641874afe2ad127832b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzktMS0xLTEtMTQwNjQ1_0f94d5bb-d114-4541-aa16-05f8166e0200"
      unitRef="usd">5002000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0fc07acc77f4488bb515bb553edc0192_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzktNS0xLTEtMTQwNjQ1_017cd2e4-0662-48b7-928d-2f2d69110c7a"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i86a8d4d2792c484998a2be6ef7a5f7be_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzktOS0xLTEtMTQwNjQ1_c6f1ebac-44e1-4b63-9218-c0bd31303019"
      unitRef="usd">5002000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i47c70b5427044960a0e01b33a278221e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEwLTEtMS0xLTE0MDY0NQ_530a6eb0-dc14-4fa6-9ed0-d414fb993f1f"
      unitRef="usd">1731000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7e4b19efa9e444958b038a59e21c75c4_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEwLTUtMS0xLTE0MDY0NQ_69a081fc-a762-4e7c-8d1e-fc8a4da1c367"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic0fccf5c68e841ac97cab4f30966690c_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEwLTktMS0xLTE0MDY0NQ_7dfb5d35-1813-4389-99b0-570802315ca0"
      unitRef="usd">1731000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i14fe41ab9d67459db2ad797f32f05552_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzExLTEtMS0xLTE0MDY0NQ_64fa11ae-c2b9-487d-b91f-69168a14bd71"
      unitRef="usd">5109000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia4687e7689164bdb8320ac4f06953159_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzExLTUtMS0xLTE0MDY0NQ_92f6edd2-1d24-4821-9991-402832e5ef54"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="if321fc68ab164282ba4bc0726aa93b10_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzExLTktMS0xLTE0MDY0NQ_6af57fd8-6070-45a1-a91b-bd906a3c72c0"
      unitRef="usd">5109000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEyLTEtMS0xLTE0MDY0NQ_d4ab1379-f123-4258-ba04-f37e5cc5712e"
      unitRef="usd">79822000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEyLTUtMS0xLTE0MDY0NQ_c1880fe4-6044-4e61-a44f-8bffbf3fe918"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzEyLTktMS0xLTE0MDY0NQ_c2b70e12-9804-484b-b2e3-33c31ad0163b"
      unitRef="usd">79822000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id4e8f651980b4cd48bca93f3614c15b2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE0LTEtMS0xLTE0MDY0NQ_e8909991-62d7-4f9a-bcbd-8a47c2b3d8db"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="if787c02ff9d64d0e86eb8be9f9c46de6_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE0LTUtMS0xLTE0MDY0NQ_9e1152c8-9371-406f-9435-f41c4cd6d604"
      unitRef="usd">1166000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4f643826c3e2422b89a1571806de6508_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE0LTktMS0xLTE0MDY0NQ_a36a4fbe-f4a7-4eba-b1a8-348f1d0322c6"
      unitRef="usd">1166000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iacbb558c49be43379c68e6c711fbdf86_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE1LTEtMS0xLTE0MDY0NQ_6ed21b50-17bc-470e-ba87-6ec49376a77a"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="idb33cf4ae55b44f2a3f18566f90accbf_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE1LTUtMS0xLTE0MDY0NQ_834b63b3-a018-436b-81e0-06742c39fcd3"
      unitRef="usd">413000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5312c3184550451f928932ad398d9016_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE1LTktMS0xLTE0MDY0NQ_a4efae49-db55-41a8-ba8e-0554cff99a84"
      unitRef="usd">413000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i7b44c1e415cb45b98e81cc9a0453f32e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE2LTEtMS0xLTE0MDY0NQ_464552e8-126b-433f-8eab-756a906c6c0c"
      unitRef="usd">853000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i03cda4dc42e842a09d1fdc9b3ceef45f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE2LTUtMS0xLTE0MDY0NQ_5fa99de1-b247-4043-acde-7195383e2eff"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i23dd140b009549a8ae4aa3a8fae36f29_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE2LTktMS0xLTE0MDY0NQ_a0f556e4-0f1c-4234-a4c7-f7d601d99817"
      unitRef="usd">853000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iba55647075e043b2b181dba0f49b1e76_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE3LTEtMS0xLTE0MDY0NQ_8e7514b6-1762-4615-a1c8-c5238886d4cc"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i8547008a36864217a82b790897092dc0_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE3LTUtMS0xLTE0MDY0NQ_477f5f95-1c98-48b4-8200-4cd948c11520"
      unitRef="usd">623000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2dc3f58523444595909416938e01f4b3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE3LTktMS0xLTE0MDY0NQ_91f08440-49a8-48ff-bd30-2a09987eb5d9"
      unitRef="usd">623000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE4LTEtMS0xLTE0MDY0NQ_fe6e3585-b873-48f4-b1da-800c352b3beb"
      unitRef="usd">853000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE4LTUtMS0xLTE0MDY0NQ_d9d1230e-6598-498c-8753-ed0794727815"
      unitRef="usd">2202000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE4LTktMS0xLTE0MDY0NQ_4ffff93a-8040-4d45-b36a-fb394f37ae9a"
      unitRef="usd">3055000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE5LTEtMS0xLTE0MDY0NQ_43724273-09c0-46f6-8388-8fe403cc8b07"
      unitRef="usd">80675000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE5LTUtMS0xLTE0MDY0NQ_d4940e45-9c78-4091-968d-4134bb297e17"
      unitRef="usd">2202000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia427ffdd9dff49bf85f8ee91a5835796_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzE5LTktMS0xLTE0MDY0NQ_943357c3-28c7-4105-ad64-41640e0ab286"
      unitRef="usd">82877000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ide89fb74b6854034944d82f12a08655f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIxLTEtMS0xLTE0MDY0NQ_1c66b7ba-8e59-43f9-8dc4-c86a8fc42b91"
      unitRef="usd">41000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0654ac32fb3f48b58e198b661a0db5c2_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIxLTUtMS0xLTE0MDY0NQ_3f5d2999-6472-4a6a-9ff6-89701af0a8dc"
      unitRef="usd">2828000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib05710ff212440dfaeea8f28f8a00d3f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIxLTctMS0xLTE0MDY0NQ_bfb01b6a-f6bd-4604-83c8-6f995b428d8a"
      unitRef="usd">-2869000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7142e963e6ee4d9c8c2e655388f8918f_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIyLTEtMS0xLTE0MDY0NQ_2253ab46-90b7-498c-833d-a6c939070a32"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie513cbe1edfa4c8dacc68ed1e879643b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIyLTUtMS0xLTE0MDY0NQ_23b44933-b654-4fc0-a84c-b381c79fd5a2"
      unitRef="usd">9024000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iad139752acf7480db3dd52727e06ef78_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIyLTctMS0xLTE0MDY0NQ_a08e7378-572f-470d-9c56-1f6ac08a0403"
      unitRef="usd">-9024000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic676151b15dd4c80a0f1e58f9d321c46_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIzLTEtMS0xLTE0MDY0NQ_e1d8327a-5a27-429a-ab20-d33e8808e1b8"
      unitRef="usd">41000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i059d3ba987f746dca463069e8b556721_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIzLTUtMS0xLTE0MDY0NQ_e83db29e-6771-452b-9ace-2f8e9d7f7e17"
      unitRef="usd">11852000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i35acacb165204dcd9adc612f30611f25_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzIzLTctMS0xLTE0MDY0NQ_de917726-0a33-443b-b78f-f00ad3888d19"
      unitRef="usd">-11893000000</us-gaap:Revenues>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI0LTEtMS0xLTE0MDY0NQ_8ec72b46-51ab-4e4a-9d32-c29d96e65389"
      unitRef="usd">214000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI0LTUtMS0xLTE0MDY0NQ_18acf8fe-6b43-4baf-bc7f-5dfff18a332a"
      unitRef="usd">4000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI0LTctMS0xLTE0MDY0NQ_6ca5dc33-3782-4e9f-903e-0f217a77216e"
      unitRef="usd">-31000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI0LTktMS0xLTE0MDY0NQ_7fed566f-5f58-4c37-8a50-be87063e3b88"
      unitRef="usd">187000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI1LTEtMS0xLTE0MDY0NQ_08d7b7f2-0f68-4d2a-8766-36ea3e8e95b0"
      unitRef="usd">80930000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI1LTUtMS0xLTE0MDY0NQ_9484dc2b-9e2a-43e5-9d6a-52c5a952701f"
      unitRef="usd">14058000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI1LTctMS0xLTE0MDY0NQ_e95f4a29-3179-434e-b287-ee40a461ff07"
      unitRef="usd">-11924000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI1LTktMS0xLTE0MDY0NQ_9993c9c9-87d2-4f56-9516-ad4ee471e8dc"
      unitRef="usd">83064000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI3LTEtMS0xLTE0MDY0NQ_1295e938-fdb7-427f-85c8-8758188fdaeb"
      unitRef="usd">69639000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI3LTUtMS0xLTE0MDY0NQ_ac10a249-63d5-4903-b2dd-1aa66a29ace3"
      unitRef="usd">0</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI3LTctMS0xLTE0MDY0NQ_37751f83-03ba-4b0a-a675-1d4befa421cc"
      unitRef="usd">-440000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI3LTktMS0xLTE0MDY0NQ_a8bf6fab-4e17-4ba4-b3a7-edb0c5bbcbec"
      unitRef="usd">69199000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI4LTEtMS0xLTE0MDY0NQ_974e9e80-3779-453a-9b1b-5ed52bfed6e3"
      unitRef="usd">8340000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI4LTUtMS0xLTE0MDY0NQ_21af9404-35e4-4b22-aac5-d6fcef976bbd"
      unitRef="usd">12968000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI4LTctMS0xLTE0MDY0NQ_20ec4d9f-d96a-4631-a402-e57972d3d9d3"
      unitRef="usd">-11187000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI4LTktMS0xLTE0MDY0NQ_2527ce51-93a8-4f36-9513-3ec6ae7900af"
      unitRef="usd">10121000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI5LTEtMS0xLTE0MDY0NQ_92e1665c-f584-4c70-90e2-b83bd8138e07"
      unitRef="usd">539000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI5LTUtMS0xLTE0MDY0NQ_b2d0c169-a21a-4123-a5db-0203a17499d2"
      unitRef="usd">152000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI5LTctMS0xLTE0MDY0NQ_5bca9581-c7a5-4b68-b11e-353561cb66af"
      unitRef="usd">-95000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzI5LTktMS0xLTE0MDY0NQ_1ba7aa90-0ece-43e3-b5fe-bd7b2bde7c28"
      unitRef="usd">596000000</hum:DepreciationAndAmortizationIncomeStatement>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i710b421224ef4907a74bfc0cef6a3911_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMwLTEtMS0xLTE0MDY0NQ_7fefce11-32f2-455e-b799-319772dda450"
      unitRef="usd">78518000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="ia7338d58c09f4bf5b092ec4fdc82a643_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMwLTUtMS0xLTE0MDY0NQ_f1c6ff8a-0a2a-498c-ad87-1b8378432d48"
      unitRef="usd">13120000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMwLTctMS0xLTE0MDY0NQ_279d1066-ad93-4353-a884-ff9bc6f16c79"
      unitRef="usd">-11722000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMwLTktMS0xLTE0MDY0NQ_0fbfbc90-43fa-4aaa-90ce-dd9c5f8d0fa8"
      unitRef="usd">79916000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMxLTEtMS0xLTE0MDY0NQ_24783320-9dab-49d1-a739-3a05de3e3a03"
      unitRef="usd">2412000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMxLTUtMS0xLTE0MDY0NQ_6da67ccb-ffb2-4237-96df-71117d8b4f71"
      unitRef="usd">938000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMxLTctMS0xLTE0MDY0NQ_7aa2db8a-5de1-42f1-bb4e-5253a953e1cd"
      unitRef="usd">-202000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMxLTktMS0xLTE0MDY0NQ_dbacbfb1-cdd6-438c-9d82-8a2e06fab915"
      unitRef="usd">3148000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMzLTEtMS0xLTE0MDY0NQ_ad3a4438-2b59-4c83-a9ce-24cbf36f53db"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMzLTUtMS0xLTE0MDY0NQ_9b3d38dd-a39d-45c0-9a35-2dfba0ca37f4"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMzLTctMS0xLTE0MDY0NQ_19093591-b95a-448d-a98a-f6fc16dcceca"
      unitRef="usd">326000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzMzLTktMS0xLTE0MDY0NQ_d4c6d52a-45ec-4433-ba9f-7f22d5889d3d"
      unitRef="usd">326000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM0LTEtMS0xLTE0MDY0NQ_ffa62b56-1c3c-4d87-a06a-5c5e8f2acfd5"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM0LTUtMS0xLTE0MDY0NQ_fb793466-f664-4db1-bb66-574ff7a5b583"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM0LTctMS0xLTE0MDY0NQ_f1ddf373-e761-406a-9f36-134bc972d649"
      unitRef="usd">532000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM0LTktMS0xLTE0MDY0NQ_fb853e8e-9426-438d-b28e-f11590e9d410"
      unitRef="usd">532000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM1LTEtMS0xLTE0MDY0NQ_cf2a1c8e-7b12-4135-990d-3fd3a2b44e77"
      unitRef="usd">2412000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM1LTUtMS0xLTE0MDY0NQ_242eeea1-bebd-4a63-becc-75dd49a2f06a"
      unitRef="usd">938000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM1LTctMS0xLTE0MDY0NQ_a56dcf88-78ee-444e-9e0c-d26f5cd9d85c"
      unitRef="usd">4000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM1LTktMS0xLTE0MDY0NQ_e7fab6fc-b9f5-4be8-aeb1-c1e98457c64c"
      unitRef="usd">3354000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM2LTEtMS0xLTE0MDY0NQ_9cb5209b-bcc0-457b-b404-a867f2a6daf5"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM2LTUtMS0xLTE0MDY0NQ_db92f229-8830-426c-99c3-0ebe9f00a867"
      unitRef="usd">65000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM2LTctMS0xLTE0MDY0NQ_ddc4ebf6-121d-43c5-b196-98556c9ecf63"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM2LTktMS0xLTE0MDY0NQ_6654ae79-082e-426e-8156-d363e6006ce8"
      unitRef="usd">65000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM3LTEtMS0xLTE0MDY0NQ_97093619-be10-4f91-bf87-f097c933b4a8"
      unitRef="usd">2412000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM3LTUtMS0xLTE0MDY0NQ_3320243d-b949-4126-8fc0-9e39e11c88b5"
      unitRef="usd">1003000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM3LTctMS0xLTE0MDY0NQ_0aceab51-ff95-4b3c-8d38-b3fa67d5c7e2"
      unitRef="usd">4000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM3LTktMS0xLTE0MDY0NQ_1295c1b9-8c78-4a28-90e1-08750f18227d"
      unitRef="usd">3419000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM4LTEtMS0xLTE0MDY0NQ_2aedaf94-9f04-4293-84b0-c2a88f4e19eb"
      unitRef="usd">0</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM4LTUtMS0xLTE0MDY0NQ_621a73f8-4e25-454b-af7a-47ad9858a5f3"
      unitRef="usd">1000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM4LTctMS0xLTE0MDY0NQ_05a52b4f-8234-4f97-b299-46918f06706b"
      unitRef="usd">0</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM4LTktMS0xLTE0MDY0NQ_73643982-6f7a-4de4-bda0-6a9476269335"
      unitRef="usd">1000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="ic0c0b23a15f84055bc000f2def3ffc44_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM5LTEtMS0xLTE0MDY0NQ_0fa7fd9b-c611-4742-b7b8-c6319d661715"
      unitRef="usd">2412000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="i5b46f3ae730a431c893027c770d15680_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM5LTUtMS0xLTE0MDY0NQ_9dcb0122-2a0b-42b2-aee0-ca1ea2aebf36"
      unitRef="usd">1002000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="i5ecbbcd2741a4d559d2278fe69745a4e_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM5LTctMS0xLTE0MDY0NQ_3cf3a267-ea71-4cf5-a7c8-c1da77881e08"
      unitRef="usd">4000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTowM2U3M2Y4YmEwMzY0YjNhOGM0MDM5MDdlZDA1Yjk3Mi90YWJsZXJhbmdlOjAzZTczZjhiYTAzNjRiM2E4YzQwMzkwN2VkMDViOTcyXzM5LTktMS0xLTE0MDY0NQ_f6cf482d-416f-4d33-b1fc-ea0006b321d8"
      unitRef="usd">3418000000</hum:IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent>
    <us-gaap:PremiumsEarnedNet
      contextRef="if39c9d28566e49fb94ca604dad0f7413_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzUtMS0xLTEtMTQwNjQ1_c4b0b7e3-8ff7-4677-be31-37b699350ade"
      unitRef="usd">51697000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i6eaa0a4a53de41adbac051ef9fae2992_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzUtNS0xLTEtMTQwNjQ1_5b050db5-8912-431c-abb3-c102b4d5d12f"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i1e964222588640aaa4fc9517b9915eb7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzUtOS0xLTEtMTQwNjQ1_1e778e77-27b1-4c05-b471-21e5b7a165ec"
      unitRef="usd">51697000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="icae43fd407c4414b943b92f92c1a164a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzYtMS0xLTEtMTQwNjQ1_b718d310-a073-4bbf-a56a-9b7f594d4c55"
      unitRef="usd">7774000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i361c2054214544b3a52b1c8f570d1486_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzYtNS0xLTEtMTQwNjQ1_8c683d86-423e-4ea8-967a-db71c5f06178"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i298fcaa6f9554c64bd5f075426eeb27d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzYtOS0xLTEtMTQwNjQ1_bd38b0ce-9f01-4a5f-85c1-bec108420cce"
      unitRef="usd">7774000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="idb67851ec4dc4e8d82168000c4595810_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzctMS0xLTEtMTQwNjQ1_6636fca6-12b7-48a5-a7c6-d24df200940a"
      unitRef="usd">2742000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i98770db22e0b4594a796eee0640b15a3_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzctNS0xLTEtMTQwNjQ1_ec9edb35-a421-40b9-bcba-4f151e54a752"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3d182410af6d45d1810973f77992c508_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzctOS0xLTEtMTQwNjQ1_ccd64de3-80d2-49e7-8d4b-c4f428efef18"
      unitRef="usd">2742000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="id4d69af6e550428ca1462f8259d169c1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzgtMS0xLTEtMTQwNjQ1_5bd2c6cd-ce1e-41a8-a81e-d788c8ace827"
      unitRef="usd">62213000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ib40497970a7d49a3a88ba998a48f7805_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzgtNS0xLTEtMTQwNjQ1_0f69c957-840a-4bd0-ba47-44f98761b0c2"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i9f7a2cf3d405471395d39b0680066ce9_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzgtOS0xLTEtMTQwNjQ1_1786c0b3-c64d-442e-a1cf-189f8e7a4b12"
      unitRef="usd">62213000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i8bd3273e77284e40b2171ed9f574fe18_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzktMS0xLTEtMTQwNjQ1_8119468e-63b5-43b1-b8b6-5baad0514e92"
      unitRef="usd">5449000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i56bb0fd352744b9b9971c20e238c2186_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzktNS0xLTEtMTQwNjQ1_54ce77cc-dcef-4e11-9dfb-fe9f30f18f83"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i8955c114fdc3489daa2dee4a9140f585_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzktNy0xLTEtMTQwNjQ1_ca4891b7-a814-4d03-bab3-48d4ead71215"
      unitRef="usd">602000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="idf9f80bbf5a6434ea08491bd367d4e20_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzktOS0xLTEtMTQwNjQ1_a2b4d908-9bac-4415-863f-5572eea02c03"
      unitRef="usd">6051000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i138d886578ea47c5bdfc107eafd19fdf_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEwLTEtMS0xLTE0MDY0NQ_b18dc69d-855c-4680-a476-15c6c2c3ee1e"
      unitRef="usd">1699000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="id95534e4967c4794a2bec00ba0a1892d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEwLTUtMS0xLTE0MDY0NQ_b99ae95a-c1ba-4e78-8536-0f34ab07ae61"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i02af1f31fe144885b9fc028cec9cc8b7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEwLTktMS0xLTE0MDY0NQ_a9acb20a-279f-469d-85d9-164dd861b111"
      unitRef="usd">1699000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i7a6507afa1e242dcb28f8c57ad781f71_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzExLTEtMS0xLTE0MDY0NQ_f0da7180-a271-4ae8-a170-bea608a7548d"
      unitRef="usd">4223000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i3908bb51774249158321c4ed8ca6ac40_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzExLTUtMS0xLTE0MDY0NQ_a3614041-2119-479c-b1f8-b840da9c397b"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i5b2d04219b8943159debcd053092fe5b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzExLTktMS0xLTE0MDY0NQ_a39babc3-479e-4fc1-8f45-f382cb4c87cc"
      unitRef="usd">4223000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEyLTEtMS0xLTE0MDY0NQ_6990a654-1302-47b3-93d8-2a5614765640"
      unitRef="usd">73584000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEyLTUtMS0xLTE0MDY0NQ_92637ab1-5132-433d-bbdc-1e1f1e9f88a4"
      unitRef="usd">0</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEyLTctMS0xLTE0MDY0NQ_7e54e722-0308-4503-b2aa-7f36d3157b99"
      unitRef="usd">602000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:PremiumsEarnedNet
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzEyLTktMS0xLTE0MDY0NQ_adcb9d3a-0634-4785-9431-9c48bfc6c75c"
      unitRef="usd">74186000000</us-gaap:PremiumsEarnedNet>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i04343d7d31a84ac79e44e3b54ac8536d_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE0LTEtMS0xLTE0MDY0NQ_c894d97b-1bfe-4735-9664-cf95d2308957"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iee9aefc250a24fa2b78e41b534370e5b_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE0LTUtMS0xLTE0MDY0NQ_d3890ad6-3004-4a98-98de-df1de271eb1a"
      unitRef="usd">107000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i48e8960d40aa4748b405ee8aac3326b7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE0LTktMS0xLTE0MDY0NQ_221c5630-7659-443d-9324-2d29c24451d3"
      unitRef="usd">107000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i0c79c3029f1c466b82ea3f885f7dbd83_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE1LTEtMS0xLTE0MDY0NQ_ec1964e7-1f81-4f83-b0a8-e22ba22a73dd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i9711652ed43c412f9b92e3193a318e66_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE1LTUtMS0xLTE0MDY0NQ_5a64ce9d-b4a1-4934-aa0d-9a98644ad579"
      unitRef="usd">328000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i44030fa27c974660bded54de8fb11a50_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE1LTktMS0xLTE0MDY0NQ_d75da88f-d4ff-4439-bc14-9de3c089a646"
      unitRef="usd">328000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="iaec631922eab4df1b6048c710078b4c7_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE2LTEtMS0xLTE0MDY0NQ_e2a21df0-e780-4c54-8087-34fe02e34c76"
      unitRef="usd">813000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id8f743f1a22644caac1e859fb29a7aa1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE2LTUtMS0xLTE0MDY0NQ_341669f1-d087-4677-9bce-58e01aaa47dc"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i1ded12f91baa4171b745a570b579f67a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE2LTktMS0xLTE0MDY0NQ_a72b4eb2-9a1e-49f1-8d3e-a0da9dfd71ec"
      unitRef="usd">813000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="id2c8cfea28c541b7b645922d44fbf2f4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE3LTEtMS0xLTE0MDY0NQ_bb464fef-d939-4b6b-803a-805ef43fd9e5"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia3e7d86e1bea4d3f962cf462f8b5c6cc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE3LTUtMS0xLTE0MDY0NQ_f8e11089-9448-443c-ad12-c057e94773af"
      unitRef="usd">567000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i2f092984c5164c6d84492225b149eaa2_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE3LTktMS0xLTE0MDY0NQ_f3f15248-5a0a-4d63-b6d9-e8e84197dcd0"
      unitRef="usd">567000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE4LTEtMS0xLTE0MDY0NQ_9aa1e144-5a6b-473f-bd11-a3bc87f8b111"
      unitRef="usd">813000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE4LTUtMS0xLTE0MDY0NQ_3fd4a9e8-93b0-411e-a6c9-1db620156abf"
      unitRef="usd">1002000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE4LTktMS0xLTE0MDY0NQ_c3a8d4a7-9bec-45dd-8c13-1b252c957c10"
      unitRef="usd">1815000000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:Revenues
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE5LTEtMS0xLTE0MDY0NQ_edc158c4-860f-465d-8792-b55d052a65dc"
      unitRef="usd">74397000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE5LTUtMS0xLTE0MDY0NQ_f756c7d8-84be-44ff-b4c6-a9fc96f1bc1f"
      unitRef="usd">1002000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8955c114fdc3489daa2dee4a9140f585_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE5LTctMS0xLTE0MDY0NQ_06e178f9-797b-4e76-a6ec-aef39d9e3c1b"
      unitRef="usd">602000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i948d525c3b334e34b62da49d9c7482fc_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzE5LTktMS0xLTE0MDY0NQ_fa3717f0-afcc-4d96-a6db-c0a8ef626bd6"
      unitRef="usd">76001000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d8e5a12ecf549238eedf1a87c7d1e88_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIxLTEtMS0xLTE0MDY0NQ_29a28887-486c-467f-b0ce-873236bae096"
      unitRef="usd">29000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i325ae4c732a24279a4460fdb5f2ce1b8_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIxLTUtMS0xLTE0MDY0NQ_d35f9799-b785-4e2d-9ae5-6eab4ee23fdd"
      unitRef="usd">2547000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i25389e35fd5c4d46b3ce2e270d42eaa0_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIxLTctMS0xLTE0MDY0NQ_1fb62f70-1ebc-4eb9-95b7-6648f842d78c"
      unitRef="usd">-2576000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8d2420a864954324be79ba29b455d706_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIyLTEtMS0xLTE0MDY0NQ_4c414858-02a4-44da-aea9-d0f5fe44f7e5"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i128c3bbb84cb4ebfa37efdd581ba4fb6_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIyLTUtMS0xLTE0MDY0NQ_3ecb01f4-8537-4634-a3fb-ed8f415f6b22"
      unitRef="usd">7928000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i54776761815d43f0b22c0e07b84bbe14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIyLTctMS0xLTE0MDY0NQ_9d8d2b19-825e-4cea-b027-51a7ecefbca3"
      unitRef="usd">-7928000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i63dbef0b32684c9c8234fd4ad305f9d5_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIzLTEtMS0xLTE0MDY0NQ_56bf0280-a469-4ccb-b88a-c1b6bf6eae9d"
      unitRef="usd">29000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i17ef1ab00ada45a291c117cd6de96bcd_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIzLTUtMS0xLTE0MDY0NQ_d0078175-6758-4101-b23e-0a3240f8a7b3"
      unitRef="usd">10475000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iea836c2c260040cc9a90acfff66f58e4_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzIzLTctMS0xLTE0MDY0NQ_19b046fd-74f2-4894-ac73-f9e73106370a"
      unitRef="usd">-10504000000</us-gaap:Revenues>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i58027b9122014dee871db47b91819791_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI0LTEtMS0xLTE0MDY0NQ_3fe7c912-41d6-4967-bea3-7b9c53a7f90b"
      unitRef="usd">171000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="iabd8c18c4f8548ff9a23c8f591e89113_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI0LTUtMS0xLTE0MDY0NQ_c9814023-fb8b-4e37-9240-e19685517862"
      unitRef="usd">13000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI0LTctMS0xLTE0MDY0NQ_95b947ce-2064-46d5-8686-31ee7c10e586"
      unitRef="usd">970000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI0LTktMS0xLTE0MDY0NQ_0d0117e5-c0ce-436a-b245-01509afd0c4d"
      unitRef="usd">1154000000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:Revenues
      contextRef="i58027b9122014dee871db47b91819791_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI1LTEtMS0xLTE0MDY0NQ_907b8848-cfe3-4d3b-a2c4-907e3640601d"
      unitRef="usd">74597000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iabd8c18c4f8548ff9a23c8f591e89113_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI1LTUtMS0xLTE0MDY0NQ_2ef5d13a-5fc3-4880-946c-0dd7c76188c9"
      unitRef="usd">11490000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI1LTctMS0xLTE0MDY0NQ_cdeee210-484a-4b74-8447-0d49c67154fb"
      unitRef="usd">-8932000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI1LTktMS0xLTE0MDY0NQ_9c0e7c03-9ee5-411a-a335-f46b21dc31da"
      unitRef="usd">77155000000</us-gaap:Revenues>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI3LTEtMS0xLTE0MDY0NQ_97336520-13c7-494d-a1dd-1118bf2bf804"
      unitRef="usd">61909000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI3LTUtMS0xLTE0MDY0NQ_3575416d-9148-4631-ab1e-f83b03a78de8"
      unitRef="usd">0</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI3LTctMS0xLTE0MDY0NQ_73b48fd0-525b-4a48-b207-9f3716da11cf"
      unitRef="usd">-281000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI3LTktMS0xLTE0MDY0NQ_030418cd-ce41-4116-ac00-ce05d878d5c8"
      unitRef="usd">61628000000</us-gaap:PolicyholderBenefitsAndClaimsIncurredHealthCare>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI4LTEtMS0xLTE0MDY0NQ_812ee6a8-ff6c-4665-87f4-ad8e77430be7"
      unitRef="usd">9129000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI4LTUtMS0xLTE0MDY0NQ_83a05164-ccc0-456a-938d-ace1e68e5eb6"
      unitRef="usd">10706000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI4LTctMS0xLTE0MDY0NQ_a1186585-5a37-415c-aaeb-10e50ddbd86c"
      unitRef="usd">-9783000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI4LTktMS0xLTE0MDY0NQ_156cdef6-8e54-49c2-b2ba-594350b534c3"
      unitRef="usd">10052000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI5LTEtMS0xLTE0MDY0NQ_cb14070d-9d38-4dca-8daa-8a4224a93dbe"
      unitRef="usd">439000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI5LTUtMS0xLTE0MDY0NQ_4eb966fa-0e2e-4809-8456-1643e7674a8d"
      unitRef="usd">160000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI5LTctMS0xLTE0MDY0NQ_77ffe0ed-633c-45d9-87e2-55d02ac0f05e"
      unitRef="usd">-110000000</hum:DepreciationAndAmortizationIncomeStatement>
    <hum:DepreciationAndAmortizationIncomeStatement
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzI5LTktMS0xLTE0MDY0NQ_49870b37-2e58-45c1-bf32-565f49f4ebe2"
      unitRef="usd">489000000</hum:DepreciationAndAmortizationIncomeStatement>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i58027b9122014dee871db47b91819791_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMwLTEtMS0xLTE0MDY0NQ_de4112b7-1648-4ae7-9c01-86d238e258f2"
      unitRef="usd">71477000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="iabd8c18c4f8548ff9a23c8f591e89113_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMwLTUtMS0xLTE0MDY0NQ_55e383fd-08a9-469d-bd8c-8fbd736f17f6"
      unitRef="usd">10866000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMwLTctMS0xLTE0MDY0NQ_d2f2250b-eb8c-4dea-914e-219897b65390"
      unitRef="usd">-10174000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:BenefitsLossesAndExpenses
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMwLTktMS0xLTE0MDY0NQ_0f6e20be-8e0d-4103-b5f5-75da6eaf8053"
      unitRef="usd">72169000000</us-gaap:BenefitsLossesAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMxLTEtMS0xLTE0MDY0NQ_a66cf6c9-469c-4557-8ade-61dd78a3f0ac"
      unitRef="usd">3120000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMxLTUtMS0xLTE0MDY0NQ_2d25e02b-8330-4ce9-a0b6-6d10cae27cf6"
      unitRef="usd">624000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMxLTctMS0xLTE0MDY0NQ_2f8f6666-f46e-4c69-97a6-4b4d0c8b4ce8"
      unitRef="usd">1242000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMxLTktMS0xLTE0MDY0NQ_74ba20c0-0991-47a7-9cb1-97a9b3ece66a"
      unitRef="usd">4986000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMzLTEtMS0xLTE0MDY0NQ_db058e89-45a4-4a3b-aaf8-9f91fe2e19e7"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMzLTUtMS0xLTE0MDY0NQ_535c928d-046c-481a-98a6-d80971fc6336"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMzLTctMS0xLTE0MDY0NQ_3e4ebf0f-86e5-4428-8f78-985c6daf5c72"
      unitRef="usd">283000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzMzLTktMS0xLTE0MDY0NQ_2e4689cc-9399-49f4-a39b-10cac299833e"
      unitRef="usd">283000000</us-gaap:InterestExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM0LTEtMS0xLTE0MDY0NQ_f88e84c6-eed0-4210-9378-b378451e8d92"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM0LTUtMS0xLTE0MDY0NQ_84df5ad5-1f26-4d58-ae6f-6ec12d55f147"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM0LTctMS0xLTE0MDY0NQ_43bc4519-48ac-47ca-9bb9-6ae5f516c8f3"
      unitRef="usd">-103000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM0LTktMS0xLTE0MDY0NQ_7961c3ce-8df1-404b-83ec-0732abf64dff"
      unitRef="usd">-103000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM1LTEtMS0xLTE0MDY0NQ_9a4ab787-8641-4395-b744-61bf1e205200"
      unitRef="usd">3120000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM1LTUtMS0xLTE0MDY0NQ_2b6d594d-953a-48b9-8975-88609972e54e"
      unitRef="usd">624000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM1LTctMS0xLTE0MDY0NQ_241f7b93-9ea2-4bac-b064-960d9b94bde2"
      unitRef="usd">856000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM1LTktMS0xLTE0MDY0NQ_8f0eea77-3185-46fc-9aaa-339bb002f16d"
      unitRef="usd">4600000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM2LTEtMS0xLTE0MDY0NQ_4f21ded6-327c-422f-bd7f-2df77155b614"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM2LTUtMS0xLTE0MDY0NQ_0beb47d8-9209-4674-bd9e-56a6ab2e0423"
      unitRef="usd">74000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM2LTctMS0xLTE0MDY0NQ_9f45c4c0-fe20-4d6d-b123-08d9dd9391a0"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM2LTktMS0xLTE0MDY0NQ_aceae095-72cf-4706-a0f7-07a7d21bba5b"
      unitRef="usd">74000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia1d2c6ba6615431290c2d92bb3101e14_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM3LTEtMS0xLTE0MDY0NQ_708edf75-add2-4a02-a5f2-6415c8a75166"
      unitRef="usd">3120000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i34b95ed166f7420dabdca3799131c05a_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM3LTUtMS0xLTE0MDY0NQ_e332ef9f-13cd-4d95-9532-8e9254e93151"
      unitRef="usd">698000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i0bad957ce43349d9871780e049801c78_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM3LTctMS0xLTE0MDY0NQ_aa356f48-cb4e-49bb-9c84-cbfcb6a60d0b"
      unitRef="usd">856000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTYvZnJhZzphNmQ5MDY0OWM2NzU0NDBhYWZkNTMwZjNmNzNlNTBkMy90YWJsZTo5ZjFmMGJkNmYyY2Q0OTQwYjdhY2E4ZTU4ZjE1NWM0Zi90YWJsZXJhbmdlOjlmMWYwYmQ2ZjJjZDQ5NDBiN2FjYThlNThmMTU1YzRmXzM3LTktMS0xLTE0MDY0NQ_e304ea31-3690-415a-8efe-87574237402e"
      unitRef="usd">4674000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ReinsuranceTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzI2MjE_f9b79a2e-d7b4-43f9-94dc-526fd7b7e6b9">REINSURANCE &lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain blocks of insurance assumed in acquisitions, primarily life and annuities in run-off status are subject to reinsurance where some or all of the underwriting risk related to these policies has been ceded to a third party. In addition, a large portion of our reinsurance takes the form of 100% coinsurance agreements where, in addition to all of the underwriting risk, all administrative responsibilities, including premium collections and claim payment, have also been ceded to a third party. We acquired these policies and related reinsurance agreements with the purchase of stock of companies in which the policies were originally written. We acquired these companies for business reasons unrelated to these particular policies, including the companies&#x2019; other products and licenses necessary to fulfill strategic plans. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reinsurance agreement between two entities transfers the underwriting risk of policyholder liabilities to a reinsurer while the primary insurer retains the contractual relationship with the ultimate insured. As such, these reinsurance agreements do not completely relieve us of our potential liability to the ultimate insured. However, given the transfer of underwriting risk, our potential liability is limited to the credit exposure which exists should the reinsurer be unable to meet its obligations assumed under these reinsurance agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reinsurance recoverables represent the portion of future policy benefits payable and benefits payable that are covered by reinsurance. Reinsurance recoverables, included in other current and long-term assets, were $181 million at December&#160;31, 2022 and $188 million at December&#160;31, 2021. The amount of these reinsurance recoverables resulting from 100% coinsurance agreements was approximately $181 million at December&#160;31, 2022 and approximately $188 million at December&#160;31, 2021. Premiums ceded were $5 million in 2022, $6 million in 2021 and $29 million in 2020. Benefits ceded were $2 million in 2022, $2 million in 2021, and $7 million in 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate the financial condition of our reinsurers on a regular basis. Protective Life Insurance Company with $165 million in reinsurance recoverables is well-known and well-established with a AM Best rating of A+ at December&#160;31, 2022. The remaining reinsurance recoverables of $16 million are divided between 10 other reinsurers, with $1 million subject to funds withheld accounts or other financial guarantees supporting the repayment of these amounts.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReinsuranceTextBlock>
    <us-gaap:ReinsuranceRecoverables
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE2MTU_1f9d3df6-9883-4d19-9654-f087445efee3"
      unitRef="usd">181000000</us-gaap:ReinsuranceRecoverables>
    <us-gaap:ReinsuranceRecoverables
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE2NDE_333f0c09-d523-4271-acf1-90f2c3c8efd9"
      unitRef="usd">188000000</us-gaap:ReinsuranceRecoverables>
    <hum:PercentageOfCoinsuranceAgreement
      contextRef="i0dfbff48771b4638b79a2300493d8877_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE3MjQ_0a961f50-2056-4651-abba-faa1f82c1a0d"
      unitRef="number">1</hum:PercentageOfCoinsuranceAgreement>
    <us-gaap:ReinsuranceRecoverables
      contextRef="i4523ccf1b56c43b9960b083342924008_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE3Njg_e50fd5d0-e9f6-438f-9ade-02c6a3a8595d"
      unitRef="usd">181000000</us-gaap:ReinsuranceRecoverables>
    <us-gaap:ReinsuranceRecoverables
      contextRef="i704efe02ea3f46fdadbf3661e8fb4018_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE4MDg_5ca5abe9-5fc9-4a3a-b822-8579609c4451"
      unitRef="usd">188000000</us-gaap:ReinsuranceRecoverables>
    <us-gaap:CededPremiumsWritten
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE4NTE_d14f5053-249e-4839-82d3-4eac4670600c"
      unitRef="usd">5000000</us-gaap:CededPremiumsWritten>
    <us-gaap:CededPremiumsWritten
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE4NjE_8e0031b2-7400-4342-bb29-3a32e1cb1b32"
      unitRef="usd">6000000</us-gaap:CededPremiumsWritten>
    <us-gaap:CededPremiumsWritten
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE4NzQ_07383c23-2080-4eee-b5c8-f4f3d131966f"
      unitRef="usd">29000000</us-gaap:CededPremiumsWritten>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE5MDQ_b99f938b-4593-4b19-9720-9666162ed64a"
      unitRef="usd">2000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE5MTQ_5f902740-5635-4261-a3a6-ee471e337ebc"
      unitRef="usd">2000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzE5Mjg_74bec75f-b66d-463d-a4ca-ceb22b0521c8"
      unitRef="usd">7000000</us-gaap:ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded>
    <us-gaap:ReinsuranceRecoverables
      contextRef="i4eaa3ef983134ea9b906d1bd180d672d_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzIzMDY_f921050e-51db-4ab1-a963-eb6b7ff74a35"
      unitRef="usd">165000000</us-gaap:ReinsuranceRecoverables>
    <us-gaap:ReinsuranceRecoverables
      contextRef="i0c4d94cfc4be468a97bde38608cbc8a6_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzI0NjI_d5f85d51-b634-47fa-b7e3-ffc36d59e382"
      unitRef="usd">16000000</us-gaap:ReinsuranceRecoverables>
    <hum:NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzI0ODU_c17572cc-b8ed-43f8-8590-0432f8721524"
      unitRef="reinsurer">10</hum:NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance>
    <hum:AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18xOTkvZnJhZzozOWJhODdlMWY1YzI0MTJlYjFjN2Q5ZTdjOTY5MjUxMS90ZXh0cmVnaW9uOjM5YmE4N2UxZjVjMjQxMmViMWM3ZDllN2M5NjkyNTExXzI1MTE_5d105261-9d92-4d9d-ad4b-ba20ab5af385"
      unitRef="usd">1000000</hum:AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer>
    <dei:AuditorName
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yMDIvZnJhZzpmYmI3ZTkyOTY1Yjk0NjhlODJkM2FiYjNmZDBjYWI3OC90ZXh0cmVnaW9uOmZiYjdlOTI5NjViOTQ2OGU4MmQzYWJiM2ZkMGNhYjc4XzE2MzI5_096ab417-93b6-46e0-a085-2276b60deff4">PricewaterhouseCoopers LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yMDIvZnJhZzpmYmI3ZTkyOTY1Yjk0NjhlODJkM2FiYjNmZDBjYWI3OC90ZXh0cmVnaW9uOmZiYjdlOTI5NjViOTQ2OGU4MmQzYWJiM2ZkMGNhYjc4XzE2MzI4_b2805068-af18-47e9-bade-fb256346d7c9">Louisville, Kentucky</dei:AuditorLocation>
    <dei:AuditorFirmId
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDEvZnJhZzo1ZjdjZTNmNDYzYjI0YWY4YmE0YjIzN2RiNWMyOTU4OC90YWJsZTplN2FlYWU4MjE0NTM0Y2ZjODZhNjBjOWNkOTQ3MjdkYi90YWJsZXJhbmdlOmU3YWVhZTgyMTQ1MzRjZmM4NmE2MGM5Y2Q5NDcyN2RiXzAtMi0xLTEtMTQwNjQ1L3RleHRyZWdpb246OTc4ZmVlYTg4Zjk4NDU3ZWE1N2FjODA5NDNkNzViZmVfOTY_480ebf3e-8e36-467b-bd04-f905cacbcbe4">238</dei:AuditorFirmId>
    <us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90ZXh0cmVnaW9uOmY4OTQ0OTBkZmJlNTQyNDM4MjVhYzY1NDg1ODk1ZmY0XzE2Mg_12ddfb22-90cb-45c8-b912-43aac8319613">&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE I&#x2014;PARENT COMPANY FINANCIAL INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CONDENSED BALANCE SHEETS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.630%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in&#160;millions,&#160;except&#160;share&lt;br/&gt;amounts)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Receivable from operating subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment in subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;LIABILITIES AND STOCKHOLDERS&#x2019; EQUITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payable to operating subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of notes payable to operating subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Book overdraft&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,889&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commitments and contingencies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stockholders&#x2019; equity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred stock, $1 par; 10,000,000 shares authorized; none issued&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at December&#160;31, 2022 and 198,648,742 shares issued at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Capital in excess of par value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Retained earnings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated other comprehensive (loss) income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,304)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Treasury stock, at cost, 73,691,955 shares at December&#160;31, 2022 and 69,846,758 shares at December&#160;31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,156)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,163)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total stockholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,311&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total liabilities and stockholders' equity&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See accompanying notes to the parent company financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE I&#x2014;PARENT COMPANY FINANCIAL INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CONDENSED STATEMENTS OF INCOME&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.224%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.922%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.603%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.926%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Management fees charged to operating subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Investment and other (loss) income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expenses:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Operating costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;Total expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other (income) expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) income before income taxes and equity in net earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,215)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(166)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Benefit) provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(259)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) income before equity in net earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(949)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net earnings of subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equity in net earnings of equity method investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See accompanying notes to the parent company financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE I&#x2014;PARENT COMPANY FINANCIAL INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CONDENSED STATEMENTS OF COMPREHENSIVE INCOME&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.758%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.188%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in gross unrealized investment (losses) gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(356)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total change in unrealized investment  &lt;br/&gt;&#160;&#160;&#160;&#160;(losses) gains, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,401)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(275)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassification adjustment for net realized &lt;br/&gt;&#160;losses (gains) included in investment income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total reclassification adjustment, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(70)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive (loss) income, net of tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,346)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(355)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income attributable to equity method&lt;br/&gt;&#160;&#160;investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Comprehensive income attributable to Humana&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See accompanying notes to the parent company financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE I&#x2014;PARENT COMPANY FINANCIAL INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;CONDENSED STATEMENTS OF CASH FLOWS&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.993%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.667%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.669%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the year ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net cash provided by operating activities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from investing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(337)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,187)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(709)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital contributions to operating subsidiaries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(538)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Purchases of property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(958)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchases of investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(63)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from sale of investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Maturities of investment securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash used in investing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,068)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash flows from financing activities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from issuance of senior notes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Repayments of senior notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;(Repayments) proceeds from issuance of commercial paper, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Proceeds from issuance of term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Repayment of term loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Change in book overdraft&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Common stock repurchases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,096)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,820)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;Dividends paid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proceeds from stock option exercises and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net cash (used in) provided by financing activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Decrease) increase in cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(292)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(570)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents at beginning of year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents at end of year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See accompanying notes to the parent company financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SCHEDULE I&#x2014;PARENT COMPANY FINANCIAL INFORMATION&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NOTES TO CONDENSED FINANCIAL STATEMENTS&lt;/span&gt;&lt;/div&gt;BASIS OF PRESENTATIONParent company financial information has been derived from our consolidated financial statements and excludes the accounts of all operating subsidiaries. This information should be read in conjunction with our consolidated financial statements.TRANSACTIONS WITH SUBSIDIARIES&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Services Fee&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through intercompany service agreements approved, if required, by state regulatory authorities, Humana Inc., our parent company, charges a services fee for reimbursement of certain centralized services provided to its subsidiaries including information systems, disbursement, investment and cash administration, marketing, legal, finance, and medical and executive management oversight.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash dividends received from subsidiaries and included as a component of net cash provided by operating activities were $1.3 billion in 2022, $1.6 billion in 2021, and $1.3 billion in 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Guarantee&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Through indemnity agreements approved by state regulatory authorities, certain of our regulated subsidiaries generally are guaranteed by our parent company in the event of insolvency for: (1) member coverage for which premium payment has been made prior to insolvency; (2) benefits for members then hospitalized until discharged; and (3)&#160;payment to providers for services rendered prior to insolvency. Our parent has also guaranteed the obligations of our military services subsidiaries and funding to maintain required statutory capital levels of certain other regulated subsidiaries.&lt;/span&gt;&lt;/div&gt;REGULATORY REQUIREMENTS&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of our subsidiaries operate in states that regulate the payment of dividends, loans, or other cash transfers to Humana Inc., our parent company, and require minimum levels of equity as well as limit investments to approved securities. The amount of dividends that may be paid to Humana Inc. by these subsidiaries, without prior approval by state regulatory authorities, or ordinary dividends, is limited based on the entity&#x2019;s level of statutory income and statutory capit&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;al and surplus. If the dividend, together with other dividends paid within the preceding twelve months, exceeds a specified statutory limit or is paid from sources other than earned surplus, it is generally considered an extraordinary dividend requiring prior regulatory approval. In most states, prior notification is provided before paying a dividend even if approval is not required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although minimum required levels of equity are largely based on premium volume, product mix, and the quality of assets held, minimum requirements vary significantly at the state level. Our state regulated insurance subsidiaries had aggregate statutory capital and surplus of approximately &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$11.3 billion and $9.6 billion as of December&#160;31, 2022 and 2021, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;respectively, which exceeded aggregate minimum regulatory requirements of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$8.4 billion&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and $7.6 billion, respectively. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amount of ordinary dividends that may be paid to our parent company in&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; 2023 &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is approximately&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $1.8 billion &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the aggregate. The amount, timing and mix of ordinary and extraordinary dividend payments will vary due to state &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;regulatory requirements, the level of excess statutory capital and surplus and expected future surplus requirements related to, for example, premium volume and product mix. Actual dividends that were paid to our parent company were approximately  $1.3 billion in 2022, $1.6 billion in 2021, and $1.3 billion in 2020.&lt;/span&gt;&lt;/div&gt;Our use of operating cash flows derived from our non-insurance subsidiaries, such as in our Healthcare Services segment, is generally not restricted by state departments of insurance (or comparable state regulators).ACQUISITIONSRefer to Note 3 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of certain acquisitions. During 2022, 2021 and 2020, we funded certain non-regulated subsidiary acquisitions with contributions from Humana Inc., our parent company, included in capital contributions in the condensed statement of cash flows.INCOME TAXESRefer to Note 12 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of income taxes.DEBTRefer to Note 13 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of debt.STOCKHOLDERS' EQUITYRefer to Note 16 to the audited Consolidated Financial Statements included in Part II, Item 8, "Financial Statements and Supplementary Data" of this Form 10-K for a description of stockholders&#x2019; equity, including stock repurchases and stockholder dividends.</us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzUtMS0xLTEtMTQwNjQ1_5b262c98-953d-4e6e-ae73-f6be2d44be78"
      unitRef="usd">614000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzUtMy0xLTEtMTQwNjQ1_f1fe4370-0b0b-4391-babd-958a3cd1982c"
      unitRef="usd">906000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzYtMS0xLTEtMTQwNjQ1_febbb318-22bb-48a2-b420-d85637d631fe"
      unitRef="usd">320000000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzYtMy0xLTEtMTQwNjQ1_eb6a7c79-1813-4d00-9a51-109ba1661534"
      unitRef="usd">428000000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzctMS0xLTEtMTQwNjQ1_144ecc2d-786a-4a54-86f1-714391dab068"
      unitRef="usd">1807000000</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:AccountsReceivableRelatedPartiesCurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzctMy0xLTEtMTQwNjQ1_ad2b23e7-78f7-4c38-98bc-057d3d348384"
      unitRef="usd">1316000000</us-gaap:AccountsReceivableRelatedPartiesCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzgtMS0xLTEtMTQwNjQ1_e07c9c01-be74-4345-9554-36ca13788197"
      unitRef="usd">577000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzgtMy0xLTEtMTQwNjQ1_eb763bc7-04e2-4c1c-a388-964a25d75db9"
      unitRef="usd">545000000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzktMS0xLTEtMTQwNjQ1_8853a3bc-8536-47ba-9dbe-88de73037daf"
      unitRef="usd">3318000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzktMy0xLTEtMTQwNjQ1_ec74b5e2-f293-4752-9228-f1424d46c654"
      unitRef="usd">3195000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzEwLTEtMS0xLTE0MDY0NQ_51a1e2b2-1d6c-4af7-bc6f-67c7903bc82e"
      unitRef="usd">2393000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzEwLTMtMS0xLTE0MDY0NQ_8dc03b2a-78cc-4f5d-aafd-1e68891db2ee"
      unitRef="usd">2223000000</us-gaap:PropertyPlantAndEquipmentNet>
    <hum:InvestmentInRelatedPartiesAndSubsidiaries
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzExLTEtMS0xLTE0MDY0NQ_b446667a-13c9-4230-8c45-0e167dfa93b3"
      unitRef="usd">27905000000</hum:InvestmentInRelatedPartiesAndSubsidiaries>
    <hum:InvestmentInRelatedPartiesAndSubsidiaries
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzExLTMtMS0xLTE0MDY0NQ_a9071c1a-d9ba-4d63-9a0e-97034bfce699"
      unitRef="usd">26885000000</hum:InvestmentInRelatedPartiesAndSubsidiaries>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzEzLTEtMS0xLTE0MDY0NQ_e4d5e8ca-15ef-4248-8086-64b9f663f70e"
      unitRef="usd">282000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzEzLTMtMS0xLTE0MDY0NQ_93d7d932-cffe-4835-aec2-2b2698ad922b"
      unitRef="usd">666000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE1LTEtMS0xLTE0MDY0NQ_56a6ccdb-d4d5-4832-9073-5088f7a5f878"
      unitRef="usd">33898000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE1LTMtMS0xLTE0MDY0NQ_27881596-5049-424f-8a28-df259252d9b2"
      unitRef="usd">32969000000</us-gaap:Assets>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE2LTEtMS0xLTE3NTY1Ng_8d90cea3-95e7-4cf2-881b-c184051ba1ae"
      unitRef="usd">5421000000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE2LTMtMS0xLTE3NTY1Ng_f1d77058-b9dd-44ee-8791-5598ee213d5f"
      unitRef="usd">2056000000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:DebtCurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE5LTEtMS0xLTE3MTcwNg_4d6cd5be-c407-475d-a5af-204d6ac8ca65"
      unitRef="usd">2092000000</us-gaap:DebtCurrent>
    <us-gaap:DebtCurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE5LTMtMS0xLTE3MTcwNg_7b6a717b-6efb-4440-946f-4439e30cc6ac"
      unitRef="usd">1953000000</us-gaap:DebtCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE5LTEtMS0xLTE0MDY0NQ_df71a8a5-071b-4fbc-ace1-7a8f9f62858f"
      unitRef="usd">36000000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <us-gaap:NotesPayableRelatedPartiesClassifiedCurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzE5LTMtMS0xLTE0MDY0NQ_8ee57cc2-a8e3-42e2-be28-4371d90f9607"
      unitRef="usd">36000000</us-gaap:NotesPayableRelatedPartiesClassifiedCurrent>
    <hum:BookOverdraftLiability
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIwLTEtMS0xLTE0MDY0NQ_28ebb3e1-f0cd-4fb6-822a-18edc9c9144b"
      unitRef="usd">73000000</hum:BookOverdraftLiability>
    <hum:BookOverdraftLiability
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIwLTMtMS0xLTE0MDY0NQ_50cc621b-5463-4a7c-98d8-a721c4d0028e"
      unitRef="usd">68000000</hum:BookOverdraftLiability>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIyLTEtMS0xLTE0MDY0NQ_658f2ec1-515e-4b51-90aa-8bf0a7bc7885"
      unitRef="usd">1425000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIyLTMtMS0xLTE0MDY0NQ_5a613cc9-9c77-4308-a9f0-f5707edb2412"
      unitRef="usd">1460000000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIzLTEtMS0xLTE0MDY0NQ_f52a643c-f6fa-4102-956a-aabd76a9a42f"
      unitRef="usd">9047000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzIzLTMtMS0xLTE0MDY0NQ_7365ca2b-fdb6-467e-9c20-d2de4228bb39"
      unitRef="usd">5573000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI0LTEtMS0xLTE0MDY0NQ_0e6fe73d-0609-4e13-a184-0a9fcacd708e"
      unitRef="usd">9034000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI0LTMtMS0xLTE0MDY0NQ_b0a3de5d-a3e4-422b-a22a-568ba12c60fd"
      unitRef="usd">10541000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI2LTEtMS0xLTE0MDY0NQ_a669fcca-21a3-4da3-beba-f9ed8e7bfa04"
      unitRef="usd">506000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI2LTMtMS0xLTE0MDY0NQ_882056b6-6fb2-4ee1-9770-4b10f67b562d"
      unitRef="usd">775000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI3LTEtMS0xLTE0MDY0NQ_b19f6e5b-5fff-4229-9280-c612aaef3871"
      unitRef="usd">18587000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI3LTMtMS0xLTE0MDY0NQ_059797f8-ac4c-4c87-ba74-eee8e88c43f3"
      unitRef="usd">16889000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI4LTEtMS0xLTE0MDY0NQ_341a7b99-2ae8-4cf5-b46d-4f42a14a5688"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzI4LTMtMS0xLTE0MDY0NQ_68da47d9-463b-46cc-a79c-e20eaa705fbb"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzIx_6bcbc69b-6e4f-4f27-8a7e-3d248cc4b4d8"
      unitRef="usdPerShare">1</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzIx_bd8c4e5d-8453-48a8-b25f-0ad1b0f3fe7d"
      unitRef="usdPerShare">1</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzI5_0db3eec5-c854-494e-afb9-14ead976b03d"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzI5_b9cdb11e-cd47-4a44-82be-2d282bd1222f"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzUx_2889d2f5-39bf-4fe7-b2d8-c808f5bc6fb1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOmYyZTFmZGQxNjFmMDRhMzRiNmM5NzQ2OGQyNWE3MDkxXzUx_d074a8ee-7d52-44df-8976-42ea084533d3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTEtMS0xLTE0MDY0NQ_03946bc2-42ad-4cf4-85b0-e80697937d49"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMwLTMtMS0xLTE0MDY0NQ_55175791-01d9-4654-b952-0aa38def4e23"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjhkYzJhNTgzOTA2NjRhODc5Y2NhZWY2NTIwYTNjMjA5XzU0OTc1NTgxMzkyMDQ_088f7df5-159b-436a-8def-4e0bac45f6d3"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjhkYzJhNTgzOTA2NjRhODc5Y2NhZWY2NTIwYTNjMjA5XzU0OTc1NTgxMzkyMDQ_9d388732-4c1e-46c8-bbea-94af22908e5f"
      unitRef="shares">300000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjhkYzJhNTgzOTA2NjRhODc5Y2NhZWY2NTIwYTNjMjA5XzU0OTc1NTgxMzkyMDg_27f87900-a686-41f1-a1de-22efe0eb1fc7"
      unitRef="shares">198666598</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjhkYzJhNTgzOTA2NjRhODc5Y2NhZWY2NTIwYTNjMjA5XzU0OTc1NTgxMzkyMTI_79c0ebc6-d19c-4804-bf8c-7320697f0687"
      unitRef="shares">198648742</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTEtMS0xLTE0MDY0NQ_283f8f05-6505-4284-bc0d-1e24e478f680"
      unitRef="usd">33000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMxLTMtMS0xLTE0MDY0NQ_dd2d013d-4fe2-4cd7-800e-89bdfc9c972e"
      unitRef="usd">33000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMyLTEtMS0xLTE0MDY0NQ_e11d4146-4952-4559-b2f4-41c9de2f3852"
      unitRef="usd">3246000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMyLTMtMS0xLTE0MDY0NQ_8cc9a70f-6b2b-4975-9c9d-9460f4976f24"
      unitRef="usd">3082000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMzLTEtMS0xLTE0MDY0NQ_22c1b5cf-967c-4ada-88c9-c7716d3ae2a3"
      unitRef="usd">25492000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzMzLTMtMS0xLTE0MDY0NQ_741add33-4d62-47d7-b501-3a50fe1ea6ec"
      unitRef="usd">23086000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM0LTEtMS0xLTE0MDY0NQ_b5eb7cce-cc26-41fe-a1c4-09d69bd84a1f"
      unitRef="usd">-1304000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM0LTMtMS0xLTE0MDY0NQ_5ba9d9c2-2596-4a32-8d0d-1b79e912c1b9"
      unitRef="usd">42000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjc0OTgxNWVhNzhkYjRmOGFiMTZlMGExZTQ0NzgzMTAwXzU0OTc1NTgxMzkwNjk_8123fa45-a2a8-4ee8-b599-36727a1ac52b"
      unitRef="shares">73691955</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM1LTAtMS0xLTE0MDY0NS90ZXh0cmVnaW9uOjc0OTgxNWVhNzhkYjRmOGFiMTZlMGExZTQ0NzgzMTAwXzU0OTc1NTgxMzkwNzM_20b8be45-b03b-42a3-b58a-30f57efb2f99"
      unitRef="shares">69846758</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM1LTEtMS0xLTE0MDY0NQ_3a357fed-4c3a-4d8f-a615-19852158d89f"
      unitRef="usd">12156000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM1LTMtMS0xLTE0MDY0NQ_1d9ef124-4fe5-442d-a110-07cff7120bb7"
      unitRef="usd">10163000000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM2LTEtMS0xLTE0MDY0NQ_844a4ebb-b996-4fbe-b887-74a7f5b427cd"
      unitRef="usd">15311000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM2LTMtMS0xLTE0MDY0NQ_5f9277cb-7c2b-44be-838d-2db201bd6b24"
      unitRef="usd">16080000000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM3LTEtMS0xLTE0MDY0NQ_a7f02b03-1dc5-48a5-8a3e-18c342a0bfff"
      unitRef="usd">33898000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNDQvZnJhZzpmODk0NDkwZGZiZTU0MjQzODI1YWM2NTQ4NTg5NWZmNC90YWJsZTozMWQ3YzY0ZjUyYjY0ODk2YWU2YjgwYTgzNjE4MDk0NS90YWJsZXJhbmdlOjMxZDdjNjRmNTJiNjQ4OTZhZTZiODBhODM2MTgwOTQ1XzM3LTMtMS0xLTE0MDY0NQ_0c1f8feb-7a5c-4f59-b6b0-805e64807eab"
      unitRef="usd">32969000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <hum:ManagementFeesChargedToOperatingSubsidiaries
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzQtMS0xLTEtMTQwNjQ1_e894524e-ec8f-4c80-b5c7-8ca42a5dd8d0"
      unitRef="usd">1554000000</hum:ManagementFeesChargedToOperatingSubsidiaries>
    <hum:ManagementFeesChargedToOperatingSubsidiaries
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzQtMy0xLTEtMTQwNjQ1_09c5d748-b28b-4699-aa44-2ff5735059e7"
      unitRef="usd">1633000000</hum:ManagementFeesChargedToOperatingSubsidiaries>
    <hum:ManagementFeesChargedToOperatingSubsidiaries
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzQtNS0xLTEtMTQwNjQ1_1f92bbd8-5d65-4bf7-b399-3d91ff18b93d"
      unitRef="usd">2216000000</hum:ManagementFeesChargedToOperatingSubsidiaries>
    <hum:InvestmentAndOtherIncomeNet
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzUtMS0xLTEtMTQwNjQ1_a5b23ed3-c33b-424b-9056-562c53e92dd5"
      unitRef="usd">-88000000</hum:InvestmentAndOtherIncomeNet>
    <hum:InvestmentAndOtherIncomeNet
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzUtMy0xLTEtMTQwNjQ1_d874f24d-2cb7-4b78-92e4-a4774082f837"
      unitRef="usd">-266000000</hum:InvestmentAndOtherIncomeNet>
    <hum:InvestmentAndOtherIncomeNet
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzUtNS0xLTEtMTQwNjQ1_faeb5fb2-63e5-4c01-b22a-084225002518"
      unitRef="usd">763000000</hum:InvestmentAndOtherIncomeNet>
    <us-gaap:Revenues
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzYtMS0xLTEtMTQwNjQ1_5aa28a70-98f4-41fb-bfa9-58714b0f12f2"
      unitRef="usd">1466000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzYtMy0xLTEtMTQwNjQ1_bf61902a-1fa8-40c8-b4ca-0d6258888c9d"
      unitRef="usd">1367000000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzYtNS0xLTEtMTQwNjQ1_08814786-d368-4b7d-a162-1d60df859c1b"
      unitRef="usd">2979000000</us-gaap:Revenues>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzgtMS0xLTEtMTQwNjQ1_47b4cf9e-7aee-4cce-9c30-1ffe19dd8d3e"
      unitRef="usd">1700000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzgtMy0xLTEtMTQwNjQ1_4205d753-1fda-4004-be56-b919b41278c9"
      unitRef="usd">1404000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzgtNS0xLTEtMTQwNjQ1_02e512b6-33cd-4ccd-8961-796421b89c86"
      unitRef="usd">2204000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:Depreciation
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzktMS0xLTEtMTQwNjQ1_5d7e7c36-bf16-4c73-9d8b-45178c1cbecd"
      unitRef="usd">581000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzktMy0xLTEtMTQwNjQ1_e9dcdf53-34f5-4be3-af44-0a52ad4769f8"
      unitRef="usd">488000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzktNS0xLTEtMTQwNjQ1_34a6c80d-1a4c-4aa1-8c83-e7649c7135f9"
      unitRef="usd">397000000</us-gaap:Depreciation>
    <us-gaap:InterestExpense
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEwLTEtMS0xLTE0MDY0NQ_2638ea25-dbd3-45e2-83b9-f9466c8b2ae5"
      unitRef="usd">400000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEwLTMtMS0xLTE0MDY0NQ_59aa6dce-84cf-49b4-95dd-69cb7c5fd8df"
      unitRef="usd">313000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEwLTUtMS0xLTE0MDY0NQ_1b9e630a-2b3b-4c92-b6ce-07fbfbbdc58a"
      unitRef="usd">283000000</us-gaap:InterestExpense>
    <us-gaap:CostsAndExpenses
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzExLTEtMS0xLTE0MDY0NQ_970ffb6c-e247-461d-bf8d-dc0208491cbe"
      unitRef="usd">2681000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzExLTMtMS0xLTE0MDY0NQ_a6dd6ff7-63be-4d8e-ac5f-c1daf4b7e7b1"
      unitRef="usd">2205000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzExLTUtMS0xLTE0MDY0NQ_1e2902b5-05ad-4466-80b7-d2c6f471781c"
      unitRef="usd">2884000000</us-gaap:CostsAndExpenses>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEyLTEtMS0xLTE0MDY0NQ_1b1f7ebb-33d1-4efd-90b1-f0408d90d8ad"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEyLTMtMS0xLTE0MDY0NQ_42dfa957-55c2-4266-a708-5080708c0b90"
      unitRef="usd">672000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEyLTUtMS0xLTE0MDY0NQ_17d9efd4-7402-4440-a382-c921e806391e"
      unitRef="usd">-60000000</us-gaap:OtherNonoperatingIncomeExpense>
    <hum:IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEzLTEtMS0xLTE0MDY0NQ_9d298bc7-d541-4a09-bc1f-8411aaff4dfb"
      unitRef="usd">-1215000000</hum:IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries>
    <hum:IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEzLTMtMS0xLTE0MDY0NQ_5b704d82-d071-413c-8626-3b07d4ffd2ae"
      unitRef="usd">-166000000</hum:IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries>
    <hum:IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzEzLTUtMS0xLTE0MDY0NQ_c171822f-cbda-4f11-b3af-70864ea4a9c7"
      unitRef="usd">35000000</hum:IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE0LTEtMS0xLTE0MDY0NQ_58503522-0111-485c-86e0-b24dbb5ef4d4"
      unitRef="usd">-266000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE0LTMtMS0xLTE0MDY0NQ_4195ae81-c07a-47c2-8ce5-759e5f8730c4"
      unitRef="usd">-259000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE0LTUtMS0xLTE0MDY0NQ_dba1d1cd-2c78-4596-b00e-9e746825d4ba"
      unitRef="usd">18000000</us-gaap:IncomeTaxExpenseBenefit>
    <hum:IncomeLossBeforeEquityInNetEarningsOfSubsidiaries
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE1LTEtMS0xLTE0MDY0NQ_4d765d93-77d1-45a9-95a2-404347ddce0f"
      unitRef="usd">-949000000</hum:IncomeLossBeforeEquityInNetEarningsOfSubsidiaries>
    <hum:IncomeLossBeforeEquityInNetEarningsOfSubsidiaries
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE1LTMtMS0xLTE0MDY0NQ_7800b41e-1928-4819-a1b1-7ddd51f22a47"
      unitRef="usd">93000000</hum:IncomeLossBeforeEquityInNetEarningsOfSubsidiaries>
    <hum:IncomeLossBeforeEquityInNetEarningsOfSubsidiaries
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE1LTUtMS0xLTE0MDY0NQ_a66978d3-0c61-4298-9d9a-c6f6b7e2bb27"
      unitRef="usd">17000000</hum:IncomeLossBeforeEquityInNetEarningsOfSubsidiaries>
    <hum:EquityInNetEarningsOfSubsidiaries
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE2LTEtMS0xLTE0MDY0NQ_cc6fca0d-e1ec-4f7e-bcdd-af033085eb88"
      unitRef="usd">3751000000</hum:EquityInNetEarningsOfSubsidiaries>
    <hum:EquityInNetEarningsOfSubsidiaries
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE2LTMtMS0xLTE0MDY0NQ_a77a4607-0a67-4b00-9026-5c2185bbee90"
      unitRef="usd">2761000000</hum:EquityInNetEarningsOfSubsidiaries>
    <hum:EquityInNetEarningsOfSubsidiaries
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE2LTUtMS0xLTE0MDY0NQ_c40442ac-9886-4da7-b0f9-c8301aea9079"
      unitRef="usd">3269000000</hum:EquityInNetEarningsOfSubsidiaries>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE3LTEtMS0xLTE0MDY0NQ_435b5dd3-3637-402f-b31f-e65ee0cc671c"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE3LTMtMS0xLTE0MDY0NQ_af19637a-1dc4-4ef3-b1ed-a2788ec19cd5"
      unitRef="usd">79000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE3LTUtMS0xLTE0MDY0NQ_b51e8a64-468d-41c6-9ac5-5cd03f463748"
      unitRef="usd">81000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE4LTEtMS0xLTE0MDY0NQ_ed2eb982-c2df-48a3-80e4-d0ebd486fc75"
      unitRef="usd">2802000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE4LTMtMS0xLTE0MDY0NQ_ed02403b-8050-42ed-bb7f-a9389fe0561b"
      unitRef="usd">2933000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTAvZnJhZzo3MjEzNTUwZWNjYTg0YmExOWFmNmM0OWE0ZWFjNzYyZS90YWJsZTpiM2E5OTc1NDUzNmE0M2VlOTJlOTZiYzQxYzk4N2I2MS90YWJsZXJhbmdlOmIzYTk5NzU0NTM2YTQzZWU5MmU5NmJjNDFjOTg3YjYxXzE4LTUtMS0xLTE0MDY0NQ_3c070c2c-cea4-4641-8563-b75c1b671e88"
      unitRef="usd">3367000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzMtMS0xLTEtMTQwNjQ1_b08db89e-4ec3-43d6-9c1c-9c2add215b85"
      unitRef="usd">2806000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzMtMy0xLTEtMTQwNjQ1_7ac485ab-9f3c-4810-a050-42b28bd81541"
      unitRef="usd">2933000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzMtNS0xLTEtMTQwNjQ1_d076f6e9-73bf-4d48-aa41-85009af4dc8f"
      unitRef="usd">3367000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzUtMS0xLTEtMTQwNjQ1_3e5e52cd-6f28-4f45-a85b-4c466498b926"
      unitRef="usd">-1819000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzUtMy0xLTEtMTQwNjQ1_6ad891c4-4f62-4c00-8446-4aeef9b7115b"
      unitRef="usd">-356000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzUtNS0xLTEtMTQwNjQ1_75b22510-c5df-4d1f-9081-d2f6c1c2c515"
      unitRef="usd">393000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzYtMS0xLTEtMTQwNjQ1_299f7691-48e5-429d-99cc-7f62cfa76ec2"
      unitRef="usd">-418000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzYtMy0xLTEtMTQwNjQ1_ca3f3c3a-b819-46e6-9feb-53112d5cf638"
      unitRef="usd">-81000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzYtNS0xLTEtMTQwNjQ1_4b1aaa13-ade6-43e8-8583-a56469164e34"
      unitRef="usd">89000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzctMS0xLTEtMTQwNjQ1_d95b42a7-802b-4733-9295-98c7ffbe709a"
      unitRef="usd">-1401000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzctMy0xLTEtMTQwNjQ1_89865be8-66b3-431e-9ec2-c49906306b89"
      unitRef="usd">-275000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzctNS0xLTEtMTQwNjQ1_5fae215b-0288-46e0-a5b8-43a9490af0e1"
      unitRef="usd">304000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzgtMS0xLTEtMTQwNjQ1_a4fc1f95-d469-402c-b796-a9de7c01558f"
      unitRef="usd">-72000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzgtMy0xLTEtMTQwNjQ1_2d6a0474-6cbd-45a2-9964-b7d8bf8b7a7d"
      unitRef="usd">103000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzgtNS0xLTEtMTQwNjQ1_7f320a87-a846-43ee-9f4c-c1e717ec398b"
      unitRef="usd">90000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzktMS0xLTEtMTQwNjQ1_8313f8cc-2bb2-4659-92ea-a2d13b9871b5"
      unitRef="usd">-17000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzktMy0xLTEtMTQwNjQ1_de9d7ef0-2c51-4509-8a04-f96fcab5fd16"
      unitRef="usd">23000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzktNS0xLTEtMTQwNjQ1_0818c1d5-6f86-4606-ab6b-d28b2a07b9a6"
      unitRef="usd">20000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEwLTEtMS0xLTE0MDY0NQ_37593e9a-fb6c-4032-b243-32dae0c5c14d"
      unitRef="usd">-55000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEwLTMtMS0xLTE0MDY0NQ_64c6a59c-3d74-488f-bc7f-f4b3c70b2ecb"
      unitRef="usd">80000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEwLTUtMS0xLTE0MDY0NQ_e713e4b8-607b-43b5-b597-5538a34e5b7f"
      unitRef="usd">70000000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzExLTEtMS0xLTE0MDY0NQ_3f826aea-42ab-4132-a5f9-cbb8cbfda4af"
      unitRef="usd">-1346000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzExLTMtMS0xLTE0MDY0NQ_18918261-9daa-4ea6-bcd6-5247320cf17f"
      unitRef="usd">-355000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzExLTUtMS0xLTE0MDY0NQ_0dc7c19c-76bf-4c03-ad4c-173d2492670d"
      unitRef="usd">234000000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEyLTEtMS0xLTE0MDY0NQ_ca698079-b187-4303-a7e1-429234d92d6c"
      unitRef="usd">0</hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments>
    <hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEyLTMtMS0xLTE0MDY0NQ_b5af0b1c-10e1-4692-a6c6-cb33d7ab173e"
      unitRef="usd">6000000</hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments>
    <hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEyLTUtMS0xLTE0MDY0NQ_f0f7c5ee-1818-43d6-91b0-0adb58185a62"
      unitRef="usd">1000000</hum:ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEzLTEtMS0xLTE0MDY0NQ_2e4c29fb-3006-4044-a376-abe36d6a3b09"
      unitRef="usd">1460000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEzLTMtMS0xLTE0MDY0NQ_5c740ba0-1064-4503-b045-2c1b117c5c8d"
      unitRef="usd">2584000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTMvZnJhZzpmNzMwZDVmNTU2MjA0MjMwYTcyMjIzNzAxYTMyN2JlZC90YWJsZTplNGE5M2VmZjYwMGU0NjY1OGIwYmEzMTA3MWI0NTU2Mi90YWJsZXJhbmdlOmU0YTkzZWZmNjAwZTQ2NjU4YjBiYTMxMDcxYjQ1NTYyXzEzLTUtMS0xLTE0MDY0NQ_018d6933-3f01-457a-9d1a-e402d3395c0c"
      unitRef="usd">3602000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzMtMS0xLTEtMTQwNjQ1_71663964-5b37-4a6e-a16b-d14cb0383036"
      unitRef="usd">4868000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzMtMy0xLTEtMTQwNjQ1_0c36f674-5590-408a-9108-9618aec3866c"
      unitRef="usd">2853000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzMtNS0xLTEtMTQwNjQ1_a624af5f-bcd3-4f81-b08c-ff7393597e41"
      unitRef="usd">2531000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzUtMS0xLTEtMTQwNjQ1_ed3f63c5-5977-46d7-bdbd-5741320f76c8"
      unitRef="usd">337000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzUtMy0xLTEtMTQwNjQ1_ff7df8e1-bda7-45f9-ad2a-54416c8b6b3f"
      unitRef="usd">4187000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzUtNS0xLTEtMTQwNjQ1_58cc2269-6161-490d-bda6-2f22cff0b9a9"
      unitRef="usd">709000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <hum:CapitalContributionsToOperatingSubsidiaries
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzYtMS0xLTEtMTQwNjQ1_9b85c849-d496-4ebc-bf9e-3e491cfb4d24"
      unitRef="usd">484000000</hum:CapitalContributionsToOperatingSubsidiaries>
    <hum:CapitalContributionsToOperatingSubsidiaries
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzYtMy0xLTEtMTQwNjQ1_902a0473-ca8f-4b84-b8db-6e44efc57763"
      unitRef="usd">2580000000</hum:CapitalContributionsToOperatingSubsidiaries>
    <hum:CapitalContributionsToOperatingSubsidiaries
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzYtNS0xLTEtMTQwNjQ1_9043c35e-2fb3-44c4-80ec-8ab647a3cbd7"
      unitRef="usd">538000000</hum:CapitalContributionsToOperatingSubsidiaries>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctMS0xLTEtMTc2MTU0_39908432-8100-4549-a0e6-852c5984e142"
      unitRef="usd">931000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctMy0xLTEtMTc2MTU0_4dfcc67a-f095-452c-ad16-e29252ca8d3d"
      unitRef="usd">958000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctNS0xLTEtMTc2MTU0_edf5027d-5aea-402e-bd9d-841016e03daf"
      unitRef="usd">785000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctMS0xLTEtMTQwNjQ1_23272414-eaa0-43a3-8286-dce2c42a83b9"
      unitRef="usd">63000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctMy0xLTEtMTQwNjQ1_64d1eabe-a5bc-44db-a303-76775925199e"
      unitRef="usd">200000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzctNS0xLTEtMTQwNjQ1_9327ee7a-6153-44d5-b8b4-b62f4ff46bc7"
      unitRef="usd">460000000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzgtMS0xLTEtMTQwNjQ1_e73989e1-a600-4b24-aa4c-e52b9abbbc49"
      unitRef="usd">468000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzgtMy0xLTEtMTQwNjQ1_a0aaf801-ca42-4164-888f-e3c3f59a160c"
      unitRef="usd">71000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzgtNS0xLTEtMTQwNjQ1_8074c064-f1f9-457b-b8db-ef65aa0364cf"
      unitRef="usd">13000000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzktMS0xLTEtMTQwNjQ1_8d48df9b-10f0-44c3-9674-9fdf85dbba6b"
      unitRef="usd">30000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzktMy0xLTEtMTQwNjQ1_0e93c2f3-2929-48a1-bd5e-1aa7d2e5a69e"
      unitRef="usd">122000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzktNS0xLTEtMTQwNjQ1_521761d4-4ece-48b6-bf47-6668299d8136"
      unitRef="usd">411000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzExLTEtMS0xLTE0MDY0NQ_fd234925-fc67-4024-8877-1d7b1e7a5569"
      unitRef="usd">-1317000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzExLTMtMS0xLTE0MDY0NQ_51717bad-570a-4d65-ab5f-46daf52e988d"
      unitRef="usd">-7732000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzExLTUtMS0xLTE0MDY0NQ_de500e4c-e1c3-4028-838e-c2ba2a843036"
      unitRef="usd">-2068000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzEzLTEtMS0xLTE0MDY0NQ_e273ba59-838d-4f9a-bb32-a37591c336f8"
      unitRef="usd">1976000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzEzLTMtMS0xLTE0MDY0NQ_4ef87e34-b905-4db3-8072-34a9f6f00a10"
      unitRef="usd">2953000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzEzLTUtMS0xLTE0MDY0NQ_387ed9c9-c012-4344-8965-c3534b62075b"
      unitRef="usd">1088000000</us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE0LTEtMS0xLTE0MDY0NQ_ec437b2c-ae6b-42da-a443-cfd3c194682f"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE0LTMtMS0xLTE0MDY0NQ_4e8201cb-756e-4fca-bdc2-00e253fa0388"
      unitRef="usd">0</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:RepaymentsOfSeniorDebt
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE0LTUtMS0xLTE0MDY0NQ_67d06ca7-e16d-41d9-931f-3cf8b37ab99c"
      unitRef="usd">400000000</us-gaap:RepaymentsOfSeniorDebt>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE1LTEtMS0xLTE0MDY0NQ_23fdfbdc-db8d-45f8-85c4-b34d81ee49c1"
      unitRef="usd">-376000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE1LTMtMS0xLTE0MDY0NQ_16700d39-c670-4774-b855-aeee5b9effa9"
      unitRef="usd">352000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromRepaymentsOfCommercialPaper
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE1LTUtMS0xLTE0MDY0NQ_ca1d424f-417f-4d81-a264-1347d7e77ff8"
      unitRef="usd">295000000</us-gaap:ProceedsFromRepaymentsOfCommercialPaper>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE2LTEtMS0xLTE0MDY0NQ_b9771bc3-1874-423b-81ea-1ad60ba9fe3a"
      unitRef="usd">0</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE2LTMtMS0xLTE0MDY0NQ_343ee092-d440-4ab8-85ff-703e10c4bf93"
      unitRef="usd">2500000000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:ProceedsFromNotesPayable
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE2LTUtMS0xLTE0MDY0NQ_66359d4f-6b68-473e-b93b-7d353f44413a"
      unitRef="usd">1000000000</us-gaap:ProceedsFromNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE3LTEtMS0xLTE0MDY0NQ_cab935c4-42a0-42ac-a064-55c5db015c5c"
      unitRef="usd">2000000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE3LTMtMS0xLTE0MDY0NQ_f522ff8d-6984-4154-becc-f6084951ddb2"
      unitRef="usd">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE3LTUtMS0xLTE0MDY0NQ_617816e7-7e30-4479-bb0a-6c11f603ef21"
      unitRef="usd">1000000000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:IncreaseDecreaseInBookOverdrafts
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE4LTEtMS0xLTE0MDY0NQ_ef68e6ab-f78f-40e2-8c51-913d80f3201b"
      unitRef="usd">5000000</us-gaap:IncreaseDecreaseInBookOverdrafts>
    <us-gaap:IncreaseDecreaseInBookOverdrafts
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE4LTMtMS0xLTE0MDY0NQ_3e747f93-97ac-465b-8425-b0e9de2fea33"
      unitRef="usd">-52000000</us-gaap:IncreaseDecreaseInBookOverdrafts>
    <us-gaap:IncreaseDecreaseInBookOverdrafts
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE4LTUtMS0xLTE0MDY0NQ_296955f4-b148-48dc-9c43-5232b0495c74"
      unitRef="usd">80000000</us-gaap:IncreaseDecreaseInBookOverdrafts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE5LTEtMS0xLTE0MDY0NQ_f9bbb7b6-fc7e-4f52-ae61-70f229cb19ae"
      unitRef="usd">2096000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE5LTMtMS0xLTE0MDY0NQ_74f26196-cdff-4a79-95a1-62ff0fd634db"
      unitRef="usd">79000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzE5LTUtMS0xLTE0MDY0NQ_0d7b7be5-f9c1-40fb-9487-38e8c470a161"
      unitRef="usd">1820000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfDividends
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIwLTEtMS0xLTE0MDY0NQ_989f069a-78e1-40ff-a916-04aeac2edde5"
      unitRef="usd">392000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIwLTMtMS0xLTE0MDY0NQ_67401460-aff3-412b-81af-721ad8a5ee7f"
      unitRef="usd">354000000</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIwLTUtMS0xLTE0MDY0NQ_cf4ce4fe-fb3e-417b-b368-2471e06fad64"
      unitRef="usd">323000000</us-gaap:PaymentsOfDividends>
    <hum:ProceedsFromStockOptionsExercisedAndOther
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIxLTEtMS0xLTE0MDY0NQ_b71f3724-1672-4241-8f3f-71633950532c"
      unitRef="usd">40000000</hum:ProceedsFromStockOptionsExercisedAndOther>
    <hum:ProceedsFromStockOptionsExercisedAndOther
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIxLTMtMS0xLTE0MDY0NQ_8e280396-f46f-42e7-a609-8c9c4d382d51"
      unitRef="usd">29000000</hum:ProceedsFromStockOptionsExercisedAndOther>
    <hum:ProceedsFromStockOptionsExercisedAndOther
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIxLTUtMS0xLTE0MDY0NQ_8b7fa102-1cf6-4637-805d-0b900f6a7377"
      unitRef="usd">47000000</hum:ProceedsFromStockOptionsExercisedAndOther>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIyLTEtMS0xLTE0MDY0NQ_4425b7f1-6703-4db0-8fe3-6256ae775e91"
      unitRef="usd">-3843000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIyLTMtMS0xLTE0MDY0NQ_96d60130-1814-4c0a-831b-2fc95774b89d"
      unitRef="usd">5349000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIyLTUtMS0xLTE0MDY0NQ_cce79fd5-2281-4106-9c2d-9b82ed84b670"
      unitRef="usd">-1033000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i97924a8c729a493e956ac7035fe25b73_D20220101-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIzLTEtMS0xLTE0MDY0NQ_8eefa904-47da-4fca-a033-d27e8bd8edf8"
      unitRef="usd">-292000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9d31e123aa484bcc96074ab80570367b_D20210101-20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIzLTMtMS0xLTE0MDY0NQ_bd3a2afc-7909-440b-9ad8-ce54868becd5"
      unitRef="usd">470000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8bc145c89bc448d3814bd57b3352cffb_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzIzLTUtMS0xLTE0MDY0NQ_279fb1ce-3d11-4e07-8557-1112f7251fb3"
      unitRef="usd">-570000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI0LTEtMS0xLTE0MDY0NQ_8a05c3bc-eea7-42e0-b464-ce182616c30c"
      unitRef="usd">906000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b37d40697eb42ba8f7d32eb522463dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI0LTMtMS0xLTE0MDY0NQ_614671b5-83e8-453d-8a96-3a928788401c"
      unitRef="usd">436000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i349fa291d8d14aaa9e2386bb9b8b283a_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI0LTUtMS0xLTE0MDY0NQ_e21cecf8-e0dd-4714-bbad-1381e476c97e"
      unitRef="usd">1006000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ibda24e1355ca41dcad5d202558a258c1_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI1LTEtMS0xLTE0MDY0NQ_96f7e581-d184-4e33-b71c-8ed4c339592c"
      unitRef="usd">614000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idca4a73570f341c190a700bcb5fc200a_I20211231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI1LTMtMS0xLTE0MDY0NQ_2540955a-4caa-4108-838f-028edce15443"
      unitRef="usd">906000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b37d40697eb42ba8f7d32eb522463dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNTYvZnJhZzoyMGMyNTVjMzA0Yjk0YWJhOTEwNmZhZjViYjIxMjM5NC90YWJsZToxNzZhMGU5ZTM3ODU0ZjBjYTcyNDdjM2RhZjBiNGU2Ny90YWJsZXJhbmdlOjE3NmEwZTllMzc4NTRmMGNhNzI0N2MzZGFmMGI0ZTY3XzI1LTUtMS0xLTE0MDY0NQ_465be648-1a15-408d-9d9b-61a9800f71f2"
      unitRef="usd">436000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <hum:DividendsToParentWithoutPriorStateRegulatoryApproval
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjUvZnJhZzo1ZDVhMDk0YjhlMzA0MzY0YjYzMTM0OTA0ODFjOTBkNS90ZXh0cmVnaW9uOjVkNWEwOTRiOGUzMDQzNjRiNjMxMzQ5MDQ4MWM5MGQ1XzU3NA_5aa5f86c-b9ac-47e3-bc96-3c3059ee272c"
      unitRef="usd">1300000000</hum:DividendsToParentWithoutPriorStateRegulatoryApproval>
    <hum:DividendsToParentWithoutPriorStateRegulatoryApproval
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjUvZnJhZzo1ZDVhMDk0YjhlMzA0MzY0YjYzMTM0OTA0ODFjOTBkNS90ZXh0cmVnaW9uOjVkNWEwOTRiOGUzMDQzNjRiNjMxMzQ5MDQ4MWM5MGQ1XzU4NA_50ff6e63-31bc-4ec8-a709-9c9140025b81"
      unitRef="usd">1600000000</hum:DividendsToParentWithoutPriorStateRegulatoryApproval>
    <hum:DividendsToParentWithoutPriorStateRegulatoryApproval
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjUvZnJhZzo1ZDVhMDk0YjhlMzA0MzY0YjYzMTM0OTA0ODFjOTBkNS90ZXh0cmVnaW9uOjVkNWEwOTRiOGUzMDQzNjRiNjMxMzQ5MDQ4MWM5MGQ1XzU5OA_e0defaa9-f4f0-4f02-a286-a3d5e7d4d229"
      unitRef="usd">1300000000</hum:DividendsToParentWithoutPriorStateRegulatoryApproval>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzQx_cf8245e0-ecb7-4ce3-80ad-c751dbb0961a"
      unitRef="usd">11300000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzQ4_bbaa1b2f-0532-498e-82fd-4d5418d67a86"
      unitRef="usd">9600000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzg0_688407f5-9157-4ba4-b942-c4da1764ad84"
      unitRef="usd">8400000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired
      contextRef="ia97140e6b0864c928e72d49d1130c508_I20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzkx_cf44b787-27f1-4bb8-8d91-97855df20d02"
      unitRef="usd">7600000000</us-gaap:StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired>
    <us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval
      contextRef="i484f6f147dba48df9c66f44b7ff0e4bb_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzExOA_a676963a-ec90-4015-9a1c-678762ec02b6"
      unitRef="usd">1800000000</us-gaap:StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval>
    <hum:DividendsToParentWithoutPriorStateRegulatoryApproval
      contextRef="if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzEyOQ_5aa5f86c-b9ac-47e3-bc96-3c3059ee272c"
      unitRef="usd">1300000000</hum:DividendsToParentWithoutPriorStateRegulatoryApproval>
    <hum:DividendsToParentWithoutPriorStateRegulatoryApproval
      contextRef="ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzEzNw_50ff6e63-31bc-4ec8-a709-9c9140025b81"
      unitRef="usd">1600000000</hum:DividendsToParentWithoutPriorStateRegulatoryApproval>
    <hum:DividendsToParentWithoutPriorStateRegulatoryApproval
      contextRef="ica2bc3279c874b77aee71aad76f580d1_D20200101-20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjEwZTg3ZTkwYTk2MjQ4ZGZiZDViMjA0ZjJiOGM0YjAzL3NlYzoxMGU4N2U5MGE5NjI0OGRmYmQ1YjIwNGYyYjhjNGIwM18yNjgvZnJhZzpmNjA4ZTM1MDlhMTA0OGFiODA3MTViZjUxNTJhODM5Zi90ZXh0cmVnaW9uOmY2MDhlMzUwOWExMDQ4YWI4MDcxNWJmNTE1MmE4MzlmXzE0NQ_e0defaa9-f4f0-4f02-a286-a3d5e7d4d229"
      unitRef="usd">1300000000</hum:DividendsToParentWithoutPriorStateRegulatoryApproval>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>120
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M>7E05N"EA6ON!P  TB\  !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6RU
MFFUOXK@6Q[^*Q:Y6N])0\L!39ULD"NU=[DR[J,SL:/;JOC") 6N2F&L[I?WV
M]S@)A%2.(2LS+P82<OZQ?[6=\X_/S8[Q'V)#B$2O<92(V]9&RNW'3D<$&Q)C
M<<6V)(%?5HS'6,(A7W?$EA,<9D%QU/$<I]^),4U:HYOLW)R/;E@J(YJ0.4<B
MC6/,W^Y(Q':W+;>U/_%,UQNI3G1&-UN\)@LBOV[G'(XZ!Y60QB01E"6(D]5M
M:^Q^G/H#%9!=\1<E.W'T':FN+!G[H0YFX6W+42TB$0FDDL#P\4(F)(J4$K3C
M?X5HZW!/%7C\?:_^D'4>.K/$@DQ8](V&<G/;&K902%8XC>0SV_U!B@[UE%[
M(I']CW;YM=UN"P6ID"PN@J$%,4WR3_Q:@#@*&#HU 5X1X+T+<.ONX!<!_ON
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M0?!*@^"=91"^D2AJ_T@@'X,9B@4L;2&:"9'JU[83FM^)T'*S:@ULJ56YE=;
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M"0>N6(Q2Z(AVW'D2>SWY+%>4J\5E/PML F-C["B*DX% TR@.,VP7F'0"$Z_
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M#'@%D/?GC(GM235 ^TUF] ]02P,$%     @ >7E05L',XYQ/!   _0\  !@
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6RME]]OXC@0Q_\5*[<ZM=+2Q$F
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M#S75.0()FR-A)A)F[6&C':RXTGJZ,J:3$>M?])Y>VABIZ2!A+A+F(6$^$A:
M8!5GLJ,S64MG-G'CGCE\>631/AM7#ZQ9O5675IO,&X',\R"KWH0QZ3BO-Z$3
M*IG!40QH/)A(*/?\@#P%:#BJMO$5F,E@.*RV"NJMRD%7]OG@N,\'NR[LQ#X7
MZTRQ5(B3L-C1NU>OBHLQY67&?V[$<D#$AYGG,%W^5W4L#)!G9B1LCH292)B%
MA-E(F(.$N4B8AX3Y2%@ @E6\/#QZ>:@]?W_DN?!N<=VH\N:P=@7 V$@^36L%
MVGJNB:*)5+20,!L)<YK,A8M4]) P'PD+0+"*1T9'CXRT'ME_UEI4/FNMQ6<L
ME6-&M7U&F;0@S[1J;0W30-!$"EI(F(V$.4B8BX1Y#7:2CQ0,0+"*7<9'NXRU
M=CG<]LF*RT&2\L=MNEB):T2E7<:UB>D:M8OJF5:OK6$:29I(20L)LQ7CIR/I
M X:#5'21, \)\U7[<CB4EL@ )%DQP^1HAHG6#//H*5KR>)F1,%Z2Y>$=X>+3
MT5.XYK%\>VQOBTE]NQ@S)%=HA=NZHHFBB52TD# ;"7.:S(6+5/20,!\)"T"P
MBG>F1^],M=[9W5#H%O7/Y>[J2UQZA<5==)5CIO5[E1/9,%JUMH9I(&@B!2TD
MS&XP>@<IZ")A'A+F(V$!"%:QB]$OZZQ]K6%N>):GT:*H#^VOOK9QE),G\=OB
M!NV+DHFR7JIEM[T1!Z7-H3032K,.M&J91+IU#%5TH#072O.@-!]*"U"TJCM?
MI"",'W>GTI%&[<B2/QGI)5O;#$DSH30+2K,54]L=2JYUH)(NE.9!:;YB.N39
M"%"*5?>4"0!#'P'870R2?8R"\*\\740G[BD8];KU2+X4U(NU]LUY11.J:$%I
MMF+\="2; 5J9A](\*,U7S(9\LRY *5;-4!;=#7W5W8R7S<(PQ7TMA4.T]-:7
M>DC:'$HSH33K0),3,8/:Y1Y2U8'27"C-@])\*"U T:H>+4,2AK9N*WNTD2\'
M]>.+C>E$7KR@*8=FHB94U#K0M'D;Q<#HN#^4UR5%J_[0D,NDT.%["E$VE59\
M7]&H.YT:$WDIJ3<[D<\QRJ*^L:^'_CT)'0-9R9U!:7,HS832+"C-AM(<*,V%
MTCPHS8?2 A2M:NPRB6#HHPCZN(ZAJ#-/V4!>/J#Y [4FDU</: 0!2K.A-*?1
M?+A030]*\Z&T0#$?QHGEK0P8&/J$P;N%6+JRZ%0MR*B7A2F530#-%$!I)I1F
M06DVE.9 :2Z4YD%I/I06Z(_PJJO*I(*ACRJTB;D9JAJY_#EXIA=L;;(FFB94
MTX+2;"C-@=)<*,UKM*]\J&: HE7M4X85#'U:H4WLS:C7W[OCFGN@>84FDB94
MTH+2;,4&T!&5[P9 0PM0F@>E^:K]R0:&?'/AKP@DT#*00/6!A!]+O]%Z1;W+
M1O+'&+UT6WLTTC2AFA:49D-I3J/Y<*&:'I3F0VD!BE8U4ID=H/KL0)LH'*T7
M<XV)'!S0Z[5V3P-)$RII06EVDPUPH)(NE.9!:3Z4%J!H5>^4R0&J3PZTSMW0
M>@&X9A_L(P#."II000M*LQ7#[];2I%!)%TKSH#1?,1WR; 0HQ:HEROP U><'
MFH=I:+WD7?M#!+U8:S.<5S2ABA:49BO&;\AA&JBB"Z5Y4)JOF@TY3(-2K)JA
M+-335H5Z39C&4#H$65F>06ES*,V$TBRJR!VHPC1050=*<Z$T#TKSH;0 1:MZ
MM PT4/UC"O1A&K4OZW\^;XR,/I,7+V@<02G:KW\4@N8,#C1MF$8Q,-:?R+?/
M%*VH:#:2/_9#R_T*T8$T,%_1IFOT#?GO7@/E!J@+([0LNM-]C?+O2=-09'EU
M!J7-H3032K.@-!M*<Z T%TKSH#0?2@M0M*JQRQP!U><(]&D:JBBR3OIRD$ O
MT=J 2LV1O'Q  P)0F@VE.8WFPX5J>E":#Z4%BOGH#DZL;V7AGYY[1D%Q@^SS
M=G<W($](7'V09W1XD"<YK'6O2<Q53R]]3Q5%W]J] F@D $HSH30+2K.A- =*
M<Z$T#TKSH;1 ?X17[5<&!^B9QQR$:UX\)-A_YQ GR1ZCA7HY4A1\C9J]H)D!
M*,V$TBPHS8;2'"C-A=(\*,V'TH(SAWCU ;5E"('I0PAGTJ*L7ND>RA=Y>H6V
MMH+23"C-@M)L*,V!TEPHS8/2?"@MT!_A55>5B02F3R2T28LRQ5_;&VPPDET&
MS20T$S6AHA:49D-I#I3F0FE>LYWE0T4#%*WJH#*7P/2YA#:!4:8HL=/^M.8@
M:"RAF:@)%;6@-!M*<Z T%TKSH#2_V:X/4*)5![WX[@%]C.''XJ6L7I+N#OIR
MPD<OW=I*331-J*8%I=E0FM-H/ERHI@>E^5!:@*)5C51&()@^ M$F7LKJ=7LJ
M!UQF>KW6[FD@:4(E+2C-;K(!#E32A=(\*,V'T@(4K>J=,IK ]-$$;;STW$,7
M]>RVQ6 H;0ZEF5":Q10Y"^G!&C94T8'27"C-@])\*"U T:KN++,;3/_ A-;A
M;U;_>_7:I2$T<P&EF5":!:79BJGMCB?R*@B-4D!I'I3F*Z9#GHT I5AU3QF0
M8/J 1/.<.*L7IH=R<4HOUMHWYQ5-J*(%I=F*\=<>N@A5=*$T#TKS5;-1^R*[
MO^*+'%@9DV#ZF$3SG#A5.@19B9Y!:7,HS832+%:ON1<Y<?F+L&RHJ@.EN5":
M!Z7Y4%J HE4]6F8IF#Y+H<^)JWVY)U:_:9.-:Q=]T&2%6E2.<YA044LA6O^2
M4T4;*M=A'$4K.AQ,J7S_#II<4(AV#=8?R#4B53-:^_+40-'NQ3.O]\=?[\67
MWC^&#_Q#F#Y$<4;6_%YTZK\9B]YI]+ ZOLF3Q\N.T2&?DSQ/-KN7*QXN>5HT
M$/]_GR3Y]S<]P7].TB\[C:O_ U!+ P04    " !Y>5!6,%G6TE$*  !O-
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M0_Q$8R\N+[1H,PH)S4SQ$E#1*+0L K%FH2.A3#7P4#_P#%ONKND.E\_>DR@
M./*<:28'(%D<1>:T@V0TB!UCDVH8HOA%.^Z:5UF5/\.=E[%>?'ERRFCIJ:*-
MFU1#&O5#6G=<W,I-Y^R)MYM5G3UE17/>-V\NJK:6+8M6K#N.NW/)U"8LG"3F
MH0Q0J6%A#AY E;AHC1Y=N_G32^/9SYMF)X=.AQ<-J[BH425:3[:<VMDAG,S-
M<P*@(LG</+%!L0)7 HUJ>*)^>/K"Y'GSD#\[-@7Z@1-+YCX+R$Q@@B*%@8.9
MJ&8FZF>FL\%.TV7/')V7B[)D=<ZS0IZVMYZC$H7 R3R'+@$5C<SS!" BKE0:
MU=1$?T%-(X\MJTM4B S,X])?WC4M 0F)S.Y- =5H$(RM:#ZB?CX:C42_$X!B
M"# ,0=EL;MH!9!X_FHFHGXE2=M]VHX[)\=; >2D*W"99HPO04#,I!8A<!C3Z
M4#_Z+.4L4=>=ZJX&U6Q[X%?0"'!-1 +KG@"2S<R[,TB$Y\3A)]2<$_HY)^4J
MH5"M5(J-@^>D$$*0Q+K[AU1F.C0%580Z3&B:"?VIG3YWKBA-/3.%Q".KY?Z[
M!E>OT$[07!#SD@,0F9LK('&M7*%FB-#/$/X<50A<.ID5!](XYK0 -*X45:BA
M(/1#P<#+9WM@/A\EJY[+EZ&]H5_@!)M' T!& ^NB!@X6N7KIZ$D9/Q[<5GG-
MY*1'9RO6OSI78\^9A@"- I=(<6QF'P#5!2;6X@#(8NSJ4LT-H9\;ENZT2HON
MV0.OU#5[EYE@-1?PX@%0 $VL[K1586S=E4*J('*D($)-"Z&?%KPVY<KX"X/V
MOA\%L9DM U1V,Z2 :M0,8X.:(<*9]ZQWM]MN"Z8@0J)=?CCXJ:O!O!#-KG8\
M[Q1ZR>2E1[V31DM/%6W<HIIB0C_%W%82Q5C3H@-7@^UGTX>U(2X!$9E;ZQB4
MZW$<<D)-,J&?9&Z'"_/!AGOGL>EC%EF;)I")(6:Z!A!A?'1+-'[^3V-,%'C'
M>,K:C!>-ZRI<KLX'4D/R(%XU6>Z^$H^\Q/3B)_U.&2T]5;1Q,VO0BOR@]3;C
M-9++XZX[,1Z>3MBWLI&/]Z3>(^"2+#9/*H HF5MWMH!J[MKZ(LUAD9_#WLOQ
M<XG&;H\N<)7S7>GP!B1=K)M$2"0YV)SXD QC!_-'FM4B/ZOU[CZ*JDM+B:)0
MVSC?KVG^2Y,(0*K(S$Y!(F(>_0&1RY@&L\@/9KVQ+W*OR]2^MD+L!^]SMO_/
MXX_1+S,W2T!R0:@YI%-OI+'GHT>?GT%IZNS6/0XUK'AZ%7S!M.R_:?QLMHFD
M@ BX#P-4]G78].B7&"6K'[I?M#0H%[NJ[7_4,'PZ_&KFIONMB/'Y:WR9]K]]
MT6'ZG^)\R&K)J0TJV%J&#%[-9(WJ_M<M_9M6;+O?>]R+MA5E]W+#LA6KE4#^
M_UJ(]O!&?<'P&Z/%_P!02P,$%     @ >7E05B_/#?0T!P  ^P\  !@   !X
M;"]W;W)K<VAE971S+W-H965T.2YX;6R55VUOVS80_BN$APX;X/JM61<T+T"3
MMFNPI0V2;L4P[ --G20B%*F25%SOU^\Y4I*]P@VZ+[9$\8YWS]T]=SS=.'\?
M:J(H/C?&AK-)'6/[8CX/JJ9&AIEKR>)+Z7PC(UY]-0^M)UDDH<;,5XO%\WDC
MM9V<GZ:U&W]^ZKIHM*4;+T+7--)O+\BXS=ED.1D6;G551UZ8GY^VLJ([BK^W
M-QYO\U%+H1NR03LK/)5GDY?+%Q='O#]M^$/3)NP]"_9D[=P]OUP59Y,%&T2&
M5&0-$G\/=$G&L"*8\:G7.1F/9,']YT'[F^0[?%G+0)?.?-1%K,\FQQ-14"D[
M$V_=YBWU_OS$^I0S(?V*3;]W,1&J"]$UO3 L:+3-__)SC\.W"*QZ@56R.Q^4
MK'PEHSP_]6XC/.^&-GY(KB9I&*<M!^4N>GS5D(OGMZ]OWM]^N'KWBWC][L/5
MAS]/YQ%:^=M<]1HNLH;55S0L5^+:V5@'\=H65/Q7P1SFC#:M!ILN5H]J?$5J
M)IXMIV*U6*T>T?=L]/%9TO?L*_K>^TI:_8_D-)B*2V>#,[J0.2ML(6X\!;(Q
M+[A2O-%66J6E$7=8)*1@#.*OE^L0/9+H[T,090..#AO A?4BM%+1V:3EL_P#
M3<Z__V[Y?''RB'M'HWM'CVG_IA#^/PWBG8R=)\;B?4L^ 1/$VZZ15HHKJV93
M48, /G721_)4"&W%;Z[3X4$;0U/Q*Q#KU/UV*G004ACLU;9B&1/K!/D&9?AT
M3;RJ7--*N^7_1L<(;=%AJVGYH^L\LMZ89 #,::C0"H%A':$E#E+<8K59D\=1
MJM;T0"+6I%&L%&)_YDR\[YB)E*(0RLZ(6J.R_)8-5Q*>%F1 #EA@Q;V=K9'(
MCP)%ISGR*3O@SV!:%X0"#4:"AQ;L<Z\A"A.UC51A.QQ)JC<:NF"1:-V&/#NG
MF]8[F/D%'M]_=[Q:')]D5'C1) 'E F@W.4 E6!BYR&H'4*%/PE4 YP4"8C3P
M@!5&ER2P6[3D6M-;<9W0\XA0*8&JIH (V4(_Z *2>.'%"&X6G*-:P6; ZJPE
M,TT6<8PZJR,DA8S"2%_13'R "8K#:'1@5V6<PB' W;8P5[3U-FA$"A%D'0Y8
M^,'WA!#0*!$7X LCA R,UC:Q.7O7AR9!Z)ECLQ BMUM!J%1V-X>^1;2X:J<Y
M@7)Z9 R]M%7*;(4J2+FD9"O7['C" _4)&479V.@<XX+,J=DP;?L@U:XAD:%<
M4RT?M//0E)V:PF.)AJ%&&*$!=".A49IMU"J,,;?P6X".NE1B4P9XC>)DOX%*
MT2G.KJ 9VE(CH^@S(@+7%"6<T0GN*?P'3))!YS2S,*M*^8G#&L??RI)2%YR)
M6RI1N9;]C+5W756C8S-Z@81UD9<=K!FH$D>7(RN&'2MB$R.R6IQL:)J>EB?#
M2A>^7 &P7RY=YNH?E]G6_E/FF_%+0RC'/0Y*6S5L"-TZZ$)+X((8?^1B]O"Q
M$+(%AI\U6C>9K3A>/>&P<T)$%^$&J+C179.#,40*\7\@VR&9O&L8@,3Y85?%
M)4$]I"M4L+>, J<B=RJN)66Z5)7+HR?09&1/9WSH <$#ZB^QSE3&N3R4:S(P
MO^A"W(TYA2V7UW?3/EE0Q".E:!LZ)#JR1/%IF*Z2PEVM[W2_+!XD>A]V#"P*
M=]X8YQ'V&>MGSCOL.$=F^?,) *R025LNG189H]<F'S=P)\+!1 4=XZFP%QS9
MS,1%%W0J@CNJ$B:W\$!7&9]779+$/)!,ZU$&M?B\"> RLNM>!['M "-NP!HX
M%^&("&S2&UX@:090&,\,]$?4( @,INV^]A)]-"E[OW=&*CPP,WM!J/PNF.VP
MN1AXZ9:BU+E/_8+R:M/3W=BQ!JNFS"I,!#WMB9N!.B[(4JFCN$:^5^13M&\N
MKJ>C)6)3:[#2!H*/V/$V)43"?$B<X?#L]PZ'T?$?>-8G#VT'I'\$^&T>F$)"
MOY5;YY_*RJ)/:=5G8!(9:\J!=SB28;]$1I)$J%J>\K&VX\L^H?W>4FK-S+O#
MT@Q!0Y(5.K5F#CS\X58\.**,1%LID7)Y@LFM%5QK]#^Y,"5'-'";2_>;(3FD
M,4XQ=8[=(*7=&JTHSQ>HB<3*;&#TG4KCT@:#RC 35.F/N[<Q<NWZ\4$J[T(.
M]->R<3_34I=@I6BON,?P4-&W14Y!V-!AXO8;N4UD34PF[%EFQF$,$6XWPC'-
M](GA]H;B&49@G68%_!4C?#O&US9?_]B'6C*0Q%<R)3%AY3[!WX<0<)F*=F^H
MGHDW3 >#!%BX_>;SN".7N:&]0U\2R^/A&(D\8GZ]W.]2!V?W_:*XP<PJKJZF
MX@I?Q?%43 Z*I'+% &/2.X]$?+V:L.TI^GPE%,O%TU]GAR;X^=Z%#)54I6LG
MYD77V9CO9N/J>+-]F2]TN^WY6GR-&0MTCGFOA.AB]O-/DSST#"_1M>EZMW81
ME\7TR,,Y>=Z [Z4#;/T+'S#>]\__!5!+ P04    " !Y>5!6I.2US78I  #J
MA   &0   'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6S%75MSVT:6_BLH;W;7
MKJ)DW>S8$\=5BFS'VHTO9263VMK:!Y!HDAB# (,&)&M^_9[O7+H;("C9V9G:
MA\G()-!]^O2YW_CBIFD_^[5S7?9E4]7^QP?KKMO^Y?%COUB[3>X/FZVKZ9ME
MTV[RCO[9KA[[;>OR@E_:5(]/CHZ>/M[D9?W@Y0O^[&/[\D73=U59NX]MYOO-
M)F]O?W)5<_/C@^,']L&G<K7N\,'CER^V^<I=N>ZW[<>6_O4XK%*4&U?[LJFS
MUBU_?'!^_)>?SO \/_#7TMWXY.\,)YDWS6?\X[+X\<$1 '*56W18(:?_NW87
MKJJP$('QAZ[Y(&R)%]._;?4W?'8ZRSSW[J*I?B^+;OWC@V</LL(M\[[J/C4W
M;YV>YPG66S25Y_]F-_+LV>F#;-'[KMGHRP3!IJSE__,OBH?DA6='>UXXT1=.
M&&[9B*%\E7?YRQ=M<Y.U>)I6PQ]\5'Z;@"MK7,I5U]*W);W7O;SZ[=V[\T__
ME7UXDUU=_OS^\LWEQ?G[7[/SBXL/O[W_]?+]S]G'#[]<7ER^OGKQN*/]\-;C
MA:[]DZQ]LF?MXY/L75-W:Y^]K@M7#!=X3( &:$\,VI].[ESQE5L<9J?'L^SD
MZ.3DCO5.P^E/>;W3/>N=+Q9-7W=EO<H^-E6Y*)W/_OM\[KN6J.5_IDXLZYU-
MKP<.^HO?Y@OWXP-B$>_::_?@Y;_]R_'3HQ_N@/8L0'MVU^K_Q[OZ1ZV=_93[
MTF?-,ON((]9=SNSUH6^S95GG]:+,J\S3IXYXM_-97A?$>XMFL\WK6V"Z;CI"
M<]ZZC'"TI?\OLK+F1]J"7G?$ =V:_ZU7LVU+6G5;T5LK5[LVKZI;?.^VG;S;
MK5WV6UWB7U?8F*$[W[BV7.2'#-FBJ3U=<)'CF4DP:8NJ+QROI7OS,F_[35[G
MV65-E(>C^'[NRZ+,6]!*M\X[?N-"CH=]NI98<J;K ?QK>C:?5XX^ZARAK,MH
MP[+#^[GW#0$"H/C0&U<0R!6=&-)J04^0V,UNUN5BG=TXQAEV(X1 @F9SPL:2
MJ);^/LQ^=UG1 +E9<U.3B"!H"/R&#K^[ZKSO"!K?D10',*X%;$WFOA#,GJ0D
M7B>1#,QD^:IUBB.&D1&T7):5P/VQ;9;.0T;3#N=Z'OH7H8! _WAX?DA_,9Y(
MD;3T"A;P;A>H0Q 6+=AOFUI/V5R76)CO0=Z*P,SLDP04;,9(N@OE=(=WHW(6
M2+;%_1&MT?,) >U@ -L>9N<5T5.YJDM:)J\[V5K)GA1'!=*6[4FZU#YGK>2S
M=4[HGCM79ZXJ2<!CR</LU[5QAW 7(6 /U?[3&(=4[A]]2<C+>B+TADCBL\L(
ME82O3@]"Y-MOMG(.OF+""FE;0=!&6(@.T;3)=O=SXK3 $)S0M>4X]7537>,K
MK+AIZ'Y3S/=$%G2.!%:];/U$$2I73AMN\UL0"U-45M*V= 3ZOBW]YRPO_D9*
MF!DAH<?650P_H04,]HYIN77"_O2Z4">18=7+=CB3O80=RI:7;-VB(;@-(CJ7
MT\V\6_0M4ZR0XY]9KFKJU4%%[,PWY;J!5%HU37%3$LUBK9+T,]T%$8(^3\2;
MUZL2+"2O,OJ]&R%USAQ+NWVNFYO*%2M&/$'> AQW'>^3")(H42Z][WIZ5[[=
M8;89#+6>*((HCRPK3W1WF]$?O"N1;U$2C9%,HW\1CX.@EVVS(?PT*72'V5\)
M6227B5X8'9= 2PX+T&>O"+.$ =@0P C)J8)6I+M<X&FZQ9Q(H.QN\=&R)_!6
MI*C!68RI<$5X,[W\\^*:CDEBD\2K)_7JY>C+OJ7+:TFX$CU[O1J\N'9YU:WY
M55@*+)BQ]9P$"XLJVH!@/)V)_-ELRDYIKF@AH_.BX*LF7%WS8:$KF,PA>8CW
M/:B^;?K5FEX'C^3@F1D(N>AA#>.,942,W(6L!2E1.94^C&$21]=ET_L$!9!Z
M=$B]JBBE!VL2\*!+PG&1+=9YNQ(I\]W9]Z=DT%85-E#E*UH0>&55@4L"X'Y2
M=@2)(9Q#"(H8N'4Y(1Q&9T8FH]O,"?]F-AHE&RRB 4HB).$H(/B[D[-G"7#"
M PFG#3C)-\ON!K?(E#RG_S8U'A)T?G=\_#0L19!ZHON6I;4!0.O3P6IU4UB&
MPY.AL]!##8G73?EWO@<1@:V#KP6*%7S?>1#WA4@!% +4@8L(WJ5S?HR$&]*2
M\9K4J*%_D>S&2A4!+9("]@5Q7;,P^8<'O5LI.5Q\^.OEJX/CYPPIW0XMCJ.R
MX<1.HP%=-UB1=B#ZO2[;7LP%>WU&PGE5UC7 U;M?EBV1\!]]WG9R=+K+(]*>
M7B4VY! QE;'>H7$Y45+9%%Z)!.J#Q=NB+!PK9/H\[@I29M:0:Z^;^B"<B 3,
MMNP(E7FQ*;WH = ;'M*3=GQ0\3BOHXG#+,YZ7AA%E"&YPSC(-:OE@3"X)<-L
MD_4=R0&[^'.Y$9\3D1-!D*X*<'406AO;O(,(3/C&3CQ8;2  B3])-!&6@(]B
M!%;RFMW<+J2D^NM4PA,>/3\Z0&8 .%USV1 MW9@FG[B@'1,9SWW8E LB'#'S
M( #Z#DY7,5ADYP('* !]IC9#4?JVWQJL*8A%0-814;YOAO0FTII5!7U>B4!:
MD'?%-Y\(0C&A8%4K!C.U&+RJR 6):GH+G"IRW4?['0+,5.66Q#>QNFK#9M'S
MEG3RLA63A;XGVU3%.=^%[Q?K67I<F(%LJNDIZ'#'=%NDD4GT]RQ<^/[&%E!^
MR_^_:0IB7A#_A/+;DJ5+[/>&3+L*ZIQ$3*UB+D4K40I$DYE[:D22C5FKWCOB
M;QBR?$?)1&HBI5HXHH=4(C.K]'[K@KY=N+8CJ9D8G!!V1.2W0->JS3?"S+G*
M"]Z&^$PDU[I<=K8NQ#']B36KO-P83N0<;"(">Z3'2W6,?=]NR:L*#\Z&!"2K
M:+ @*R!HFVU@YT01YGZ=+8E9!- !@@ZSMT)2%[B*3PZQ.J;PC_0NEB(GK;,P
M&+USOES"98!UQV^<+V0WO)*NA,]>$PO+03X1Q@AWE?AW_!*+X>.C[&%P41?$
MT"+^6 \MQ;!2>3 !Y2_YS2/2U(*/E"%;_I[9!FP.PR.G&UUTY@UFOQU>'1HO
MD3/;BU8EU4CD"H?X0N\\F"6VY-PM($<=<P $]7_D=0\GD"V$X[.4E%BRU3WS
M\G@+F$2;LM\<B!E,>E7DRD4#]ZO'ZY\<&2P]XXL$137+WAY^.LR.GS^9A4/3
M5[8_Q#$!\&P6#:*<OE=[)J%HYA B_H%(GH*08)JQM\\JU(D&VH@"(@%%)A(M
MS*N#H 3\-VJP7J36UGD0.\RH=/EL31T-SA%L+7P. &=@)Y)ZCD4.N8($J(KI
M.V$>JO\=0(_5&92+V;D%@)(N3[(SNR$2A.U2B$H"Z;.QF'_)ML2@Y#QX#J&8
M!P',$Z6K=#>[\FZ@Q2M3&ZID!V'9DQ)M\"19+E6YO)4CV>LL@B T 9X*C^ I
MDZ2OB!< ZA #]+WPFUTJORU.K,8 8%G156^A2VC' HR(0!O[ >RJXQWRT=NN
M_#M]3D*&WKX5DQ%4YM@$B$;'  +&5#@IGOE65.&(;5XDH3:#7]W!MJ>5%10_
MQ"Q6'QX(3,XD:YZG^*SFH=T;<N#SD&W_-91):UXA?L)T3F?]L.B:N5BD+J<[
M"?@)ZRU= 6.*/&["*'L&Y!0<'C]CB2!&D*!,Z?D>(NNZMB2.%NM[BH<_U-E[
MVDH8D?GP>[;R8!0@?EDBII<C_'=W_&<R/G1!"&6Y_T9/=0']!>N=))Q;Y]5R
MZ-Z*.4 >@OL,0@Q:5YWV2>S0 FSE?#&?_[NGQ\>I.Q9T[LA4 =&7!6%310*N
M>)Z8'*+IP>-$:J5?PR[F%785TXQO!5CUJA/HOT]4XQX_92R?DSRLLI/O31(&
MI735 P"GR&I[D7GJ524'11B= %F9+T7G$FYJ/*C>3D>/C8\G!Y' $*U+HGK5
M(N!0E.*BP18E<SQ*75Y7-P,N9&U$O_*A9&]AOQ!'7*9T+N<33]Y)0(DNY>AY
MN!2S#,.U$AZRG^-)2<;Z'FI=/<:_]86&E\F5 JO/;S6./DE>K"1[.HSB6N3_
M) 0!PGV@!",ZDM?I@+HLL 8_61RZ((;825Y68CC3HQ^%SGRPG?'XAV'P8@:=
MNS6;:#8IE)+HYS<%,XY4,@Y#K!?!;U?'G&PA6(]XEO]X_4=?7D-RT'[A&S8P
M7?*-943PQ4RLX8)V\B7.M"&SY)8<FO:SZSA(1I\A1N5:EJW;G) P4ZD\>!9R
MI^TW,?9GICES3G)/,0*J.@V!NG(%MP+1/WQW*P90ZQ $YD0CH:QB[Y]8N;V5
M[ N'L^*%D_V<DZLDGQ>]"T&,-2'Q@'R2S6AY-XQX7<8(X%4$\7(Z="MZ&G==
M>J;KPLTU2D"8IAT&<5ZXU)T8'UT"I:2P^,T$*3%Q@%C,BG#S=P[T9OEU7E:Y
M63B>;I,\_M'+PV=,;:JWP<F;'$$AA(<]D^L><,E[\9Y,=MEYJ'[E>L=@QYTM
MNHKEMVD6B1T?IASOJN5!5(31RM#<A)%1A!7)'M)>QE1]UY"RB62["S,'R?G6
M+=#]1OE.[4*Y-3Q1UJ+"R) #JE<MB>F,-2F#K%(;"!T?FCB]T"P8((C6O6=3
M;4-V6@AD)O%E%@-WQCX3>3'3Q_QXG1$<T#KSF&F#:(+/E2'>TK'W)1&2W^IP
MTC6]QCF#KSCK+*N=J7 S7X.U1N:V44[ 033>" ^M6\/%N79V>C TT+R+*=\U
MB\^ C-35O_W+LY/C[W\P*D7ZJXH7Q9H@9T[ >B1((-&91A8$%=E#O 74K"10
M_HX4W#UD<,?M3_!*$@1)I(]:!"*_V4Z'T/ZG4<AA]E-PJQ*O\W@6]7M>-)P;
MY!"MNXFIG F$.8W9OK[X9:8A(1%WK8- IX<Y">U+TJVY$F!0RB&;P'=_@! B
M<>$&>HM 2G):LK#[@J1E2)%R&!M+L60M+$^AB$C>SDF>W*)<@<TJ5Z](D5AH
MAQV<Q)&*][+."Y&LT"42W@1?(<?KFUEB=>+L N$LHD@I ;&6'4F\*PXU[BY4
M%_(U"#L@,LIBCT5TBG>X:VL& <_Y&&<-F9+HV9E D#B][2OD/0;FAI-H"2((
M<1$%$F(<K1P"/UI[@*QWS<:LAT0&N[6.OU&1';Z3R+/D-#4]&X@LQKKHX7EJ
M=GIFAES7&0$C^D9XE(!?[F5UI V:!1-WP:8N;W]MSL?T6_!QJMLDN1W,@X3>
M)J+5]PL;W)KR<G@KI'EF<A"R''4[?G_X\GX!2I9RHU!T /!&,Q%BUO!'=E?B
M5T>*N,7ME>RE$)JA?3\[/G]>\X7> %IZC^]G>+<3:\WA5KGH *J7.+K!.6J+
M0LZ0#XCK2# LV*L3V0<>D/MP"+*8/<>A%\D6<R)A[KH;\/0$>_"N(<V>&EX?
M&Z (%NWT+4:X2A^$$52KY^ AARZ=&)++?$'&B!_'J?5>".@]HLA/B:(?2%(3
M&KU+TP6FRCDKGI0HR%U+#&&6K1R<QRUMQM44N.08$PFK!=J&>\:!#I9ZU:WX
M-146AW\&=AG>] ^ILL,2'/F*QO3@X7_WAD]7KR'L@,L?@C,'5V'!U0)3+P]V
MTF74\YIZW'Q,?21':I*DW@] =Y7LH4>VDA?4P1;LPFLY3<YB+506A6"$EBT-
M]Y3,3H"2:WKT;%OGBFE!S R 7(B496F,3$DP#[DANF*'K(NY5NQ6T TV&[I;
M,@-R6=Q]R9&9FHEL46>4CT=,L$+T46MY7'<PSQ>?83TDH"!YQ*N94>)34JB:
MO-;T,#_#^1*]-4+4TL&5<I*"XE24J\LF8$;DED3ED5'9(85A4'9"]DZRY<!>
MRL<W(L; UTD&DPE;*754IMS9.^JKH::]#95<R=LD*8*2,DF!=^9<IV9'A<20
M0IED]:+T3 HQ1V^!GDB/[/CKMX6N1#8L$:'7_,0TSO(:0AV&EMI__Q !^HDU
M-VP@^?Z3!DH^):5*=,.Q/"T$YY#X..#81Q)7T%3HNMS&6BNA:[(=J^:6J(D,
M\W[+=#O_FQ+Z N0$D<5Y&)$"P^?!O*='!T5^F]VTJ+-A%5<NU/?>+?"232_>
M71%#P5"6V&UU*\]OX*7"D(V%/<,7]T0^TWC(Z U+@K%AKP"51<Q>)@5^!.<&
MM1Z&/5LGP8B&FAEV3J%8:=MAC&G95?T>["^)LE0A\>7O#.-*,5$"M8]U7H A
M>50U%V2LA?%"D:$M8>=@%4_<(Z)A;B5LFG@,H5^&;$04_*"2T$[Y5I1'I"O+
MZ[*0W!*72GD[^6%V,1#FO)4&_[RFJ(-SPH*#T\E(Z\?W$,P]2-+JQ-,0D83
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MSD]SA%)+S-<)/],5@V2QJ2R:<.DX!/M1N23G+O@?_'9<4@M'AJ;T<J$.(OR
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M:2U3%"0.!?T=Q&\.X,;H'Y/-%\/N_L%!NUI),96*FI)&53QZLV&P\:X;#][
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M%12I02?.LNWF+#T3L1^(]WJQ4*:D]X&7)/%V14!Z!%Y4%.+:6M7M42'P<K^
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MOK8U*7 [K"9634._5$DH_(RZ5VVO!L*UM;TKBL_(H99/ZU:V5.%IY[0NT25
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M=BX& 3U;W]7KA=.E[Z0+[:@O^VE&/T)H^ *=+S6E]';!"II?J]F_4$L#!!0
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MH78&=+Y5RAX7+D#_!YS_ U!+ P04    " !Y>5!6K_K1S"4%  !["P  &0
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M,$I[8-JG7KMPNO'/J[EV1'8_7='K& U?H/.%II].MV %N_?V]!]02P,$%
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MKJY&-[/W'Y:\7A;\9/0^'#P36[)Q[E=^^;:\&DT9D+:ZB"Q!X>].?]36LB#
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M]SSJ5=09%PIF*=:X0SG1T4;3G?)&;2P"ILTA,*9_ =@P?J3=M(7M2DC>='&
M8DUC(L!$)['0,!0<",1G0-0M.^><HKH'X<P+ K'SXK%];8IZ$),,@1KJ=B>L
M&=-/SX!B 4-0F!04.^V-D[>DA,?<QIJMDN*?(Z&7049,Z[S7Y1B%+,0^0K+!
MY';)*:#-:P3!>0I<><Y1B\E:P9L KN\C^^0X@'ZL.1:U+TR0Y$ISO8Q>!;!
M#(='<#"V-*'PFJ?&]%%[3N0>G++!G4*XZWQ1B]H>0$D[CX/;QX>$ ER#L<RF
MJ02-!&-RD>RIG06!#3;>Z4>B>V>CA,0ZI5;![X]VGE/72L)R_FLQAY!B;:@0
MA1S4)D(K'## 3-!!A JN!:8'*K*A6-X3E@+S./>H=!(\N<0!_0/B#C"XEJ!&
MF[+# ]<Z3=M. 4;46FK*X:KHC70#$'/' 8N^AJ0?>>.J-QTK3-QDKDMQ/L.3
M$F==NWTC=2LO@[5PB"H*US%$!)D0S<QBT'<0D$M2^$*$A5-R924<@;K98+H_
M!D7$\2A^80*[ 1;8[&"I*:8R18KW7&\X!%+-3SP>*H.?-A(IN:QZS?G[N/:Q
M!O+L@U8^$.?KEX#F"9: Q<,4R>\BB,XEZPA#@6Q#"=7W3"T/AQH5,)-QN&+/
MT70V>[= WV,MK#K'V^JB?Q-U9[/E[''ZD)9T)G$$?^'$ 9 HXIK!7''A=-:4
MBJ,;!V+, 0<J(<$U",C;DT@34 [*(<2J5[ VIF]A4UF:*+:\1D1/_%#-3W+?
M$SL]8.[L8OF4UXOYGT<KF@ST(,=]AE0,Y:5).!A%N8,Z7\H<:E)*7Z%+6C5Q
M1!?2R7"0 X#QVF@>P*%R,[T)-^U5H+/5 4]GR\53$A?KET@T)^K+JSGD&K"7
M*PB6*'0SN%&=3&E6NQHO,P6I&_MR)Q]"7,SD)&8]B_'\KWQ,_<$2]5JJ"Q5J
M>-:4J7-J4D$=:,J'?0-KT+K(23X<JT]JVS&O3VJA**EP'0W)A[.+PTR8K5?'
M)>89-Z)SX!;*( R!0OI;^N[%<OY_2?D[P&9=X2O>LZ SFKV=\>.2N-CA846S
MV9(?UO1VSO]O:7E!-Q6WY/(VFZWI1ZD$1YW3>KT SA#>H]9@-0Y"6JWH,]]M
M0&4Z-4\2>D;KZ3NZ">C10^Q/E]R5Y!.9^P;#QV#+380UA8F/72F?J;P%CDE^
M [:-\[@QL4/2,KA"E?_%E5<G[^-J:[F@*HO.OGQ<CJ/AR<%EVO1M0AQVIXQ-
MAR\:S!R[JLP-APAMH+Y(L2,+P'A_C^HO1[O3A/0TCD]=_B8'=_!&^ZU\:0@D
M692NX\/H\#'C)MWA'Y>G+R'?*[_EVYO5%;9.QV]7(_+IZT)ZB6XG-_J-B]$U
M\EAKM"">%V"^<B[V+ZQ@^,1S_3]02P,$%     @ >7E05DK\R^YF"   9A4
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M=\B&,)C/DV?&^&,1&1-/8\_%'YD:8Z+%+)@E8W8!A"+4;B(B3#1GA+W9="D
M#-%TG)=19;>C"W;Y[&QQ<&-[<"*GM)W5'01WP-. L,[:WO/BQ$) [!9I&BJ-
M:(=$WZ<Q.,"S:#JW"I-@W/92CBY)J7'5OTWXW/6C>\I(ER2[2@JGWW%MV<U-
MP&[P%:<\-CA(0EK=[U4UNLD:,%>'4<+H]HU%X<>_#0_=LXQZ=U^%T&MWPV=\
M)?#78-UJ=XEXX>_.=MO]#>0O7&,^IXE]!=)P.)L.F/:W>O[%JLK=I"V5M:IP
MCQO!499H [ZO%+S6O)" [FKU_-]02P,$%     @ >7E05LI=U](8"   ?!,
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MVW3J)VFU\6]?.NE-:+X5]Q7I2:,ZJ PO?:)2S%1835R0HB8XCU1\DL]@IBJ
MI4/?#\5-%P40IZ)Q/)%N^E6()GR&;<PSA7>^,Z6#80+E1C>+)3_,>GX.V< ?
M9[BG%N]; 2 YHD%SR \.8X_>A+FA5)5R?CV@UD"W<>B?CBOK BI8+Y,@Q/21
MA> 16>9@-.+ L:PK:HK\V"/C)GG%P;R%VE?C:1MMGJ^0:8!+@73 _UT<E(SD
M7Z'@P=]&8UM+LZ9J2N&'BH/]\M@W2.P.*;#$Y*R-RL X;CC&#]$@&&84/]7M
M1=,?@Y>HR1&UR&D_P=19V?!HYY:B9</6Z*C!TP'MT#9%H3+%R0C@8Z^+G#N
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MP5UL@ -O>!-<2DX\(8)R1V+-=SSRU8_4VB/RWYO0QVS@9"4>F7K<*;4-/4'
M?=N4;B,,,[4O#&;#X%U3_*&Y]F=ZTK=GM>4E_/K0829I!UE/D!^UG-ZA7]W]
MG2\BE30+_]V'V8F!,7P<:5?;3TN7X8O*=GOX+O51F 7&?"IE =%!;SKND G?
M>L*#TRO_?66NG=.5OUU* 2[P!KPOM':;!SZ@_>!V\1=02P,$%     @ >7E0
M5J/64\\)#0  S"H  !D   !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL[5K[
MC]O&$?Y7%I=S:@.T3J(>=W)L W=V#+NQ8\./YH>B/ZS(E<28Y#*[Y,F7O[[?
MS"Y?>MW%;ANT*&#Y*'%G=M[S[9"/-]I\MFNE2O$E2W/[Y&1=EL6CLS,;K54F
M[4 7*L>=I3:9+/'5K,YL892,F2A+S\+A<':6R20_>?J8?WMGGC[659DFN7IG
MA*VR3)J;*Y7JS9.3T4G]P_MDM2[IA[.GCPNY4A]4^:EX9_#MK.$2)YG*;:)S
M8=3RR<GEZ-'5A-;S@K\E:F,[UX(T66C]F;Z\BI^<#$D@E:JH) X2?Z[5,Y6F
MQ AB_.9YGC1;$F'WNN;^@G6'+@MIU3.=_I+$Y?K)R<6)B-525FGY7F]>*J_/
ME/A%.K7\O]BXM>'YB8@J6^K,$T."+,G=7_G%VZ%#<#$\0!!Z@I#E=ANQE,]E
M*9\^-GHC#*T&-[I@59D:PB4Y.>5#:7 W 5WY]/F/5Q\?GY7@1-_/(D]UY:C"
M U2C4+S1>;FVXL<\5G&?P1E$:.0(:SFNPJ,<GZMH(,:C0(3#,#S";]SH-69^
MXX/\%J5XGM@HU;8R2OS]<F%+@QCXQSYM':_)?EZ4%X]L(2/UY 2!;Y6Y5B=/
MO_]N-!O^<$3222/IY!CW@QZXG4I\7"L126-NDGPEKF5:*:&7B$FHCORSI<QC
MNK.15N#?4J=(05S","I2V4*9QN("2^EB],A]I4MQ/\D1<FF*[+$/Q(>U-N7#
M4IF,=W@DGNDL4R9*9"H*68#9J9C.I_A_/IV*#RI/M!&Y+I5])$Y'P70XK)D%
M8CB83>^)&/)>5BL$N1BS&&,Q"B;S<_']=Q?A*/Q!G,ZZ1./!R!,UXM?2UP33
M^5R<3KI$X6 ^W"::;E&-0?51E]##=J3VLLSG%_7-O@&@:!@,YR'^CH+Y="Q>
MZWS5M<]7FJ"6BK8/=TQPX8G>1J5N+3!AS:<0M;]^,IAZ[2\+DZ1^]10KS_&9
MB=/S:;-:C 9CS_R%6I@*)=K+="[.)U-\=J69>X(WTD3KVK#G+?N>QM/!>7\Y
MK[X0D_FD]7A'(-K@?-BE")T\<\C2VJF_"8)DW#.K%VJ.;6;\Z:^?#"XN=BPT
M'F+EE#]]@<(F!/LF&H<LTOEDM$4P;=AW=!YCY7C>*A!V*2Z:+?Y:Y<J+/[X0
MX6S$GWYX3P:S\;Z<@*_&T'6\Y6,BF.^+H,D$P@_YL[W!Q7#7QY-SSWZZ8_[Y
M=(_Y)V3^,7\^4H*D6N;(B>8ZZ$D4SK=2 7F&39ZK5-ZH6,1&;D39)WTC;T1X
M4><"%M/'I6W:2TLJ3\%P/*&L'093..R-+"N3E DR'L6S1$GM)#J5Q2T& $*\
MZD9)8X5R);974"7Z35MO'XD7MU+T*RWK[JK+U&DT"D;0AU-WYBYFK7$HXT;!
M&%Y&/P P6T)6,0N&^,&7H)^YGKVM3*_ !6*S3N!2$K?*K8K0)^, X.)&+!0
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MZ6'V=XF;K\'C\Y&'XY-OT8U5<_PFGM_XFY1Q<"^U&BB' ! =70C%+9'0*8U
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M$$"!.WZ0=JV.G_"43\_QY4H:_P_'UC<EY_Q@K*I.8%)0B;JU_/54ARO (/X
MP$X YG6W@;S*>V[Y=*S5$;3S)C8W\*EZ-(D3M=N4C=7T51#.3A>S]?)A^?L&
M5HLUW#T]/CXM8?-IMEZXR>K+Y]GGAZ?E.+(4R@&B_$0[;VG9![0)@T=5V]+
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M5-3.@;[OE++GB0MP>:6G_P!02P,$%     @ >7E05A]IJ$^\#   "RP  !D
M  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL[5IK<]LV%OTK&-73)C,*34JR
M9>?A&<=)MFZ;QFNGV]G9V0\0"4G<D 1+D+;57[_G7H /40^[3;;3SNP76R*!
M>R_.?1T(>'FGBT]FJ50I[M,D,Z\&R[+,GQ\>FG"I4FD\G:L,;^:Z2&6)K\7B
MT.2%DA%/2I/#D>\?'Z8RS@9G+_G957'V4E=E$F?JJA"F2E-9K%ZK1-^]&@2#
M^L%UO%B6].#P[&4N%^I&E3_E5P6^'392HCA5F8EU)@HU?S4X#YZ_GM!X'O"/
M6-V9SF=!*YEI_8F^7$:O!CX9I!(5EB1!XM^MNE!)0H)@QB].YJ!121.[GVOI
M[WCM6,M,&G6ADY_CJ%R^&IP,1*3FLDK*:WWWK7+K.2)YH4X,_Q5W=NP(&L/*
ME#IUD_$]C3/[7]X['#H33OP=$T9NPHCMMHK8RC>RE&<O"WTG"AH-:?2!E\JS
M85R<D5-NR@)O8\PKSVX^?KCX_ML//[QY>WWSC7C[]Y\N/_[SY6$)R?3^,'12
M7ELIHQU2@I%XK[-R:<3;+%+1NH!#F-38-:KM>CW:*_&-"CTQ#H9BY(]&>^2-
MFW6.6=YXA[RWOU1QN1+_.I^9LD H_'O;(JV(R781E![/32Y#]6J ^#>JN%6#
MLZ^_"H[]%WL,G#0&3O9)?[0C'B_EZZ].1L'TA9,EWL2W<:2RR(B/2R7F.D$^
MQME"E'*6*)$7FEX;1'0IX\0(/1>1FR%RN4(>EF8HU'V85!%-:UXJ('LK$[P7
M!:4 1L49N<UGY\&%$J/(C4-1(3H*H:M"O-:RB(3,2:^*Q"^5+$I5)"L12K/L
M:-9)'*Z>BRMK@4",*W&>Z@J?/^I2)N()E*5QDB#%S5-6*PY&WF0L#L:C$1M
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MBTN0:]NE:2MK7/'*NJKIW-B;XK\OYF[HH4'_LX\-NLFC_9O0JKYQF[(RWQW
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MC&P8/L-1M7W7-$8S"Y!ST IBTQ7[6(JRYLK4V>,#B!^1/NE@VAS#G')-6"[
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M/)#M4/^OUA40<BMFWW2^7C0%>,UG]R&PJHMAY]0/E'BWP@J42+.!Q.D[ IQ
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M?-YMZ,S6)T_$7^)R7?!A0+?%N@5.BX&<::(6HZ"D:P?ZJ">'HX:I>T'[24H
M976E)W2F4%!&AB!*G J):+=TN41-B(%CC=HES2[4?E OMR,G%:!JZP]YGE(G
M0*>51O6\-#7AH\&JL_9:_"J[GKUKR, C:<+N8;S-5"\X@ARN&:V6^@3F8-V7
M[Q?(+26"$J+2A<"/IJI04C?0=Q/[4:,F27)3H*.><%L9$=A7"9/5RY!V9:6P
MH^#\:C;H.=8;2@RJFZLH*PML3[NLH1(08'!@]!F1(C_T9LP'1:V:9F3Z<!'
M=S3#^8,=H?)0Z3)U722E*$H</@!5%( M-61+ZB]>QJV0SOVXO*HWW";GW"6S
M]C6Q5<%EJDUGUA/GUN(Z$)"5\187^G;DW JOK<FPI3#\W/*OO<DK<X+$"943
M\5F'$C %#FNRZZ,R(;T./$9G+(U-)[=VH+6I0&YVIBT.V]/SUY"(ZIS8WWRP
M@.E&JOY'Q57M73IL,MVAG%LXM.;S:)KA9+0/IAU,WB"6WSA5 7549&4M1X?#
MX9)&E8 ^"O%5" HMUMLJ(Z31N(FAN764Z_-;-18)M5]+E+%]K4X_4=S=<S0[
M=4*?G;9',=>' P:!*%/:^U!7DCAM=!Z==:;C[9OWI0>N:XQN_P\<-KL#-67C
MB/N57:H&>:L&V*X2A96K**T4.ZAY&0Z)!2=26HQ C&\A[E7BL46#:WUHRA7.
MY70*'V+>YR#PE_\888"R$5"^1Z*6!,UV3KE'"--A_I)K 74C8=US6?$&] =<
MN)=KBN_[ -4&]H9P>ZZ0@,Y33.C<+JH<0'TUAT 5XI#RD8*762ZEM<)&5#CM
M+=W_ ?+["X&<$;F_4NCCK?>LLXW4DGK58.BRQVYL2SX.I.IH/MLQPL!.5=)U
MK\,-T("$$XA-"S0137<0(M$DJ59':G5CJ+P;HT%_=NCJNQR;F,AE8^R9KR]U
M^AF=Y5WOD38R5VZHEDEQ]&A!1@>C;O8PW*,XIRQ9+.ER#9R%MZ@:YD\*[J$Z
M[:I]'];V.N,NU[GF=?_"4NJ.R<<1ZCA<7U(]Z+:,#_E#U>OF:*\M'M_/Z,PE
M52N9T#%J1%#<AW W1R<]1*H[Z38EG>2WIU0:ZDH]VB*+?P!7.$*A_3],K@J,
M0Z?_9K&0T0#S6 <K(["Z&\7H1GP<-S475*0*P.M+=6EY]T,U#T,@=)CXSP?=
MS<9PG76;/$?*T7/A>X:WL/#PYS^%MF7_9>])O_QY_S9L6!X8]B+HYW>?:K2?
M/NYB'CX]"-NP_<5LD1I]XHCW2P//L+P#"M3P3WO7/Z[A!OYLJAH=CH>6$9C.
M;)8:[>[)1E<ZON$<$*I&G\;948LP, ++GLW5PX^3Q'DC/N_?>0QQ<!QG\NVA
M@_-NV//#O>?;QV\CHT//G)N!L?YT/;AMVM[DF_)JFN>\WC$6MC^*;- '0<X2
M, P-S[<G2Q:VX8;A/E?V*_H(>3Z6>8XM+O 1AI?]\H?N?K"79X2N)2[X8YAV
M6#RD6@[VS1$7^'3MQ7C!%*UMVQ&AL#Q+.*&M?1R[1FJMP'#,@*79 :R$<V%@
MCJZW.SQ^T_U1K*;$73ANK_C"=MU+&O07XX6*,Q>&#?V69X2.!RT(G>5="GSZ
M@24^G>QW?>BP0D3&,GW(-[NZ.L"3(>1;"V'YAFGYK";PH29<&":<T5?6%UE9
M VL4J@X'*<<@\+%0[5#E6<XE1D+3%#\S.Q7<!A&4_O7V,[)=788-KCO!Y>3;
MERD!SHK9M/B?:E?57JDSYJQ"0_I/F[^4J[+J2;Z)?G3-V>\M=1PPED30K0S_
MO8.]I;\8=OYY=H@D"VT:H6J[>V6=A>FV/?(.F]S]M;R??4[B71.?4&#Z^%0J
MSEF)*[Y"](4R^5*09+!W@_ZY583;T &MT%<EW-=U[0-2'?LX:'?GNO5^3@5^
M;JE1T)9YVC)O8EGXQPG+^D.$Y86&[[E'"$N_/$I8OK'PO -X3J,G",M!R<T)
MBT8GA.4'QB*<HZ\>WB<LSS#-.5^HT3W"<N;*U>@!P@(SFG-R5:,3P@J F_;<
M #W\;Q.695B^/_DV(RS7<O:>IX0UIV0:FQ&6;SM[ST?)RJ%^8A1=9+3G'2<K
M$Z#J39:$A.?!:V0%(L \ @A\^(N39&7:+I$5/EXC*Z(7RP@]<"!]+IQ39*6K
MV;9<U/J%8Q$ !3/2,L$\IK!<!")DJ0LR(T1@ #8G2<M?&+ZS&*&9:U[2H+58
MS$@K-!Q@&EADX2LM, 7VF(9EOT9:'G18Y/$"_.,M_..<%:"W ,:">"W;9"T!
MP2T2=P$..\U91*.V6#BT828CNN6&KS./@RZ&_KW./!?H7"[U__\[_AE,=&&>
M S@[0CA])7CCQP-,HR02GIMH<\^%RUCN@O?_ ,OT#H^XAIYG^H_2S-@L>V36
M_P/%F'^,8BQT9,$QBE$O3YR)@L"=HRJ/GJ"8P)U#L1J=4@Q@RIKCI1Z>4HSK
M#I7K(\KH\]!5CNG%7\SY0HT>H!?7L.VY;C4ZI1?JWMT]Y8$+//#_ VHQ@[WG
M&:TX=KCW/*&5 V&BL1FM>'ZP]WR,5K#6VB-M8+-UG%;@KH-,44O8?T0?[>LK
ME&(OL/&>&Q"E>(%_@E+051#S\,=KE *I@&$WH.;01%_GGJ(4"YT-G%W@"  (
M!P)-V 2>>>299;@XN5R$X!8"X !SO5?(!,0S:E N[!"0@4$?CLQ/0):R.D!_
M#.(,0H>YQ 1+G.82E[C$9VX 5[GAB0-0 !] \Q ;^C['Q@KH4&:CD5ET"#X_
M^1#S^.!SG'Y0HB[:._]U%K%#A_\I%M&S#M.(!:"F?_\=A0SVA3CWNH:/4]DK
M)#+"K.# D>%<RSP'\X?X/\D])\F8?.@'NC>CWT_GLEKSK\3I[WEMT:B?4O>C
M_0_1;]7OKX?IZE?L]U&U!J")3*ZPU+P.O#-1J5^&JR]-N>5?8R_+IBES?MS(
M"#A!$_!^599-]X44]#_/?_]_4$L#!!0    ( 'EY4%:17-D_QP4  #X.   9
M    >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;(U7VW+;-A#]%8R2YJ6*;G8<
M-[$U(SOIQ#--QN,TS4.G#Q"Y%%&!  N EO7W/0N0DFQ+2AX2"\!>SIZ] +Q8
M6;?T)5$0#Y4V_K)7AE"_&PY]5E(E_<#69'!26%?)@*5;#'WM2.91J=+#R6AT
M-JRD,KWI1=R[==,+VP2M#-TZX9NJDFY]1=JN+GOC7K=QIQ9EX(WA]**6"_I*
MX5M]Z[ :;JSDJB+CE37"47'9FXW?79VR?!3X2]'*[_P6',G<VB4O;O++WH@!
MD:8LL 6)/_=T35JS(<#XK[79V[ADQ=W?G?7?8^R(92X]75O]7>6AO.R=]T1.
MA6QTN+.K3]3&\X;M95;[^+]8)=D)/&:-#[9JE;&NE$E_Y4/+PX["^>B PJ15
MF$3<R5%$^4$&.;UP=B4<2\,:_XBA1FV 4X:3\C4XG"KHA>G=QYLO7[_=S;Y<
M?[P8!ACD[6'6*E\EY<D!Y?%$?+8FE%Y\-#GECPT,@60#9]+!N9H<M?B!LH$X
M&??%9#29'+%WL@GO)-H[.6#OQOC&29.1^'LV]\&A"/[9%V>R<KK?"C?&.U_+
MC"Y[J'Q/[IYZTU<OQF>C]T<PGFXPGAZS_J,4_+2RN"87T(9BKFVV],(60FW"
MEQYM1SEVT C_-<HK;@K?%[53Z$:EUT*K G(FQS_3X)@\2[O&O+9%(7R0H?%"
M.D(#S_]%4XE@T99;%ZN2^-!6)*P34FM&$$H2#8K#K1Q,FH5PRB^AIF4 &EB
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MU?7MK_,_7C+R="3IDF07+YV.)A^.J%G@E+E&Z(>JA#S5SSS'4H>L55H\"75
M4A#M"[_#Z(3\B*12AS>=;FDXHCLTE0X<!V@;N(85!A(Y*(5F>*,I5^:+Y-]H
MN@,W=*DDD#Q"G^>@A][5)6J).A<-?F^<K@9CA^II[%'C#4+OE6AR\)PXH!%K
M8)MD#L@9TODMYGRIHR%PX#PN["*> >8O!_-%U7QX=+6#)HY4NI:U2ULM)"L<
MC+HL)4O&T@@<6\;%],/A7LHT8%^EK+\1&K2Q2&Y&\#PA/J$:4*'#"!OXQ*D
MAH5ADL[-.)*I5O5*@MPR*5[M:.#*Z.TD9/,^8AM%EO%25M<V0BIUZIQ ]G\
M71VACTBK8U<1Y:UQ0$4.1W1*:3WH+Z6P]?S5_N\ZPJ)_J@3Y>0@W1NKN 0GD
MN6WQ1#K'Q'(!=0=T"1L*+Q,JP7Q)Q]F$"F)L2QXD2#NVLX<MJ;782B+FSQ05
MH<<G-56Z)L+!<#1MX3+0>!GVZOU0_F$1YPW8Q!'!'<L].X1T4 L=9KCD;OF.
M A ??=(RL&D3;@#B\:@9''\F@^/,@J^3G(8?2H#D,WI XSJ^3)#_MC"G?6NQ
M[O.=4ZG@_\;@-[</TSE[N.U0^6YAA]3GO'Q,<#YE5_#T85,6]7J#T *&C5="
MK6#1NN1</P'84A[YTF#)"OA23&I03J7C^&A-Y]4"1T]]]J;<&DV[F^7QR&!%
M7;X*@*'/-S#06!5T[I%C1,F3;%&7@C>5$H-0(P(!KDL]7K12+<X0Z00>]^@:
M$$KK)64CZ3Q6%2\",8>7RT2TAHPN*;80B)99DB?TY)4D#99%Y5=.-&BPE*^C
MU-"IQ(A!,AE?8G!)%?D_@UGIT3_+=F<[JF%!#^Q'G6*4J%NVEZ5\(H@=J2+L
M[H?TJCW1,PF*'@6TR'6@\N]NMD\XA;%3:^2PA6K55&34R.FIS<A_]:FE=G=@
MO3EB?Z^C,@*,NJ!:\BRG:>D DKZ-G2;=V! A1R^CG'=#L<8Y#&!((8RMK!LG
MU);W $?N4AW2\5:/H:)(<1&_$.;>@7^&R)Z<:6)*$A(FP?BT26**)\^2.F,-
M?8-CP24<@TZT1'&7U'L(?ZU2D#A8::'.BD)J4MH%N9&S32'DX"&Q7.=5DA(8
M]:'_O8SV &S8V(-NG=)2*6OA7]) 1M/- 2=&['87"'(Y2D71#15%I%BDR3I2
M<X^.>$:/9Z+R96=E#X2K.I=E!7OT#9S,5T,/,KVUS&NLQZL4<4]%MY95 SF<
MVQ&[Z$.@9U[A678%B2.*:%2UJC3=MFVVK2M#-EO\09CTPS4J%91V+E8R,<6W
M:8OVKO=)WXHE&4"QVYP^(T147RD]\V9IDB55[UP-*VTI[&:O$8H'Q)L5]2NO
MU>:RZ 5@4EV[[R;!'9M!E^P&R6!/"2JJKC0LE$4DXIO%1\$ID5I*?R=TB=X*
MU5=$+;[0]03H5B_Z2;!0H9#S6 N!YCR4[^&"::(4=;E-:X1@MI(Z&[,&MKKF
M,E.T&YVT97^&H3NZMNF1$U>H1/B)=^6W?^JK'!IJT&NV/,;9LH=1E2)ZA*-5
M*MI%]@GYRBB2D,OG)KQU%S&I2&3'0SA#B$05(ZU^!K+V0JG!0TZJS'3SH).$
M0(!8"E%I?!MZ*0:*W;DXZ70^_40)H)<LOS-&;$>-NTT_I*"EK=01FZ0$$W!V
M ^:VB/=1#1,I\1.VVF*@(<;'(JWIG T[RQH'_2QY5L5"B?F]!M%! W3IKX$V
M/$5Z7]E4]?$HB2=9YW*O>44$7TDU"KC2+\5L/23+L1.YD9-XCS V$1*R1B=:
MT_)]<NI@4+I(P7I.,"O03D^M;M.377#<Z8^1%#G\0%TUSI(3Z&@.2,$?JITH
M0/*N6[M8M'CHA0563L.1V_<DV'G2-_2:3O9+^B"O'.Z;V(=#R'D=F%'8'08H
M0^UVNO91QJ@P B8-2,ESSQ\U*!VLE/9X]P0C"A;+6CY+V6.P;J0,Z4E+1/HK
MF;>SKKR@Z-'455?TA7MSKY>%DBND584AVS!_CK)M*G'?K0.IL%,*J+.X0A&\
M#K^<PMX(OKR_%_8_/K,=^M;_K/-;#AR U_(7*P*N((7J9QWMI^V/8B;JMR"[
MY>H7-5_ $O1P,N4KB)JCP#MAI?J5BKJHBJW\9<BBJ*HBDV\W')-420MP?U7@
M[*0OR$#[4Z%/_P-02P,$%     @ >7E05B F:)!L.   %[\  !D   !X;"]W
M;W)K<VAE971S+W-H965T,CDN>&ULQ7UI<]O&ENA?07DR\^PJ2C;E)7:V*EFV
M$\TDMI_EW-34U/L $DT2,0CPH@'1NK_^G;7[- !2LF]NS9?$(H!>3I]]ZQ_V
M3?O);YSKLL_;JO8_WMMTW>Z[AP_]<N.VN3]M=JZ&)ZNFW>8=_-FN'_I=Z_*"
M/MI6#\\>/7KV<)N7];V??J#?WK<__=#T7576[GV;^7Z[S=N;EZYJ]C_>F]_3
M'SZ4ZTV'/SS\Z8==OG97KOM]][Z%OQZ&48IRZVI?-G76NM6/]\[GW[T\>X(?
MT!M_*]W>FW]GN)5%TWS"/RZ+'^\]PA6YRBT['"*'_UV["U=5.!*LX^\RZ+TP
M)WYH_ZVCOZ'-PV86N7<73?5'672;'^\]OY<5;I7W5?>AV?_B9$-/<;QE4WGZ
M;[;G=Y\^N9<M>]\U6_D85K M:_Y__ED 83YX_NC !V?RP1FMFR>B5;[*N_RG
M']IFG[7X-HR&_Z"MTM>PN++&4[GJ6GA:PG?=3U>___;;^8?_SMZ]R:XN?WY[
M^>;RXOSMQ^S\XN+=[V\_7K[].7O_[M?+B\O75]G]]TU5+DOG'_SPL(.I<8"'
M2YGF)4]S=F":^5GV6U-W&Y^]K@M7I ,\A#6'A9_IPE^>'1WQE5N>9H_GL^SL
MT=G9D?$>!T \IO$>'QCO?+EL^KHKZW6F^\S^YWSANQ80Y_]-[9C'>S(]'E+3
M=WZ7+]V/]X!<O&NOW;V?_N/?YL\>?7]DM4_":I\<&_VGE[DO?=:LLO<X=MWE
MB.)3B_R*8;)W?9NMRCJOEV5>91Y^=4"'G<_RN@ R6C;;75[?(*3JI@,PY:W+
M8(\[^'^1E36]TA;PN0-D[C;TMX!VUY8PZJZ"K]:N=FU>53?XW.TZ_K;;N.SW
MNL2_KG!B6MWYUK7E,C^EE2V;VL,!%3F^,[E,F*+J"T=CR=PTS"_]-J_S[+(&
MS,&M^'[ARZ+,6SSK;I-W],4%;P_GZ5J@KIF,A\N_AG?S1>7@I\X!R+H,)BP[
M_#[WOH&%X*)HTUM7P)(KV#$RGB6\ 2PTVV_*Y2;;.X(9S@8 06Z8+0 :*\ Z
M^/=I]H?+B@:!FS7[&J@=5@/+;V#SXU$7?0>K\1UP9%R,:W%M3>8^PYH],#S\
M'-@K0B;+UZT3&-$:"4"K55GQNM^WS<IYY+<PP[GL!_X"$,#2WY^>G\*_"$X@
M%%KX! ?P;KRHTPP0"P;L=TTMNVRN2QR8SH&_BHN9Z2]F*3@9 >D8R.$,CX-R
M%E"VQ?,#7(/W#0*-((#3GF;G%>!3N:Y+&":O.YY:T!YD0(6HS=,#=ZA]3@+&
M9YL<P+UPKLY<50*OQB%/LX\;I0ZF+@#  :S]EQ$.B,^_]R4 +^L!T1M B4\N
M U "O#K9"*!OO]WQ/NB( 2H@.!E 6R8AV$33FNENI\1IAL$P@6/+<=?7376-
MCW#$;0/G:R'? UK /LQ:Y;#E%P$H'SE,N,MO$%D(H[(2IH4MP/.V])^RO/@3
MY"D1@L''UE6T?@ +$MAOA,NM8_*'SQD[ 0VKGJ?#/>E'.$/9TI"M6S:P;ET1
M[,O)9-XM^Y8PEM'Q:X:KFGI]4@$YTTFY+N%*ZZ8I]B7@+(Y5@GR%LP!$D/<!
M>?-Z72()\:<$?N\&0%T0Q<)LG^IF7[EB38"'E;>X''<=SQ,0$C"1#[WO>OB6
MGXZ(;88Z5P\8 9@'2I('O+O)X!\T*Z!O40*. 4^#OX#&$:%7;;,%^#1V=:?9
MWP!8P)<!7P@<EPB6')4YG[T"R ($4 = B "?*F!$.,LEO@VGF ,*E-T-_K3J
M87EK$+1(602I<$3XI3W\\^(:M@EL$]BK!YGI>>NKOH7#:X&Y CY[.1K\<./R
MJMO0IRCIB3'CU M@+,2J8 )8X^,9\Y_MMNP$YXH6>71>%'34 *MKVBS*"D)S
MY#Q ^QZQOFWZ]08^1QK)D69FB,A%CXHM[K&,@.&SX+&02U1.N ]!&-C1==GT
MWH  N1YL4HXJ<NED3%@\XB7 N,B6F[Q=,Y?YYLFWCT$WK2J<0(0O2T&$*XD*
M/"1<N)_D'8%C,.4 @"($;EP. $>E,0.5SVT7 ']5^Q23=2TL 4I )*8H!/ W
M9T^>F\4Q#1A*2RC)-ZMNCZ=(F+R _S8UOL3@_&8^?Q:&@I5ZP/N6N+4N ,:'
MC=5B<1 /1Z,$]@(O-<!>M^4_Z!R8!;8.[2;$6(;WT8VXSX *B"$(.J0B6._*
M.3\$PAZD9#PF46K@+^#=.%(%BV9.@?H%4%VS5/Z'+WJW9G0XHJ0^#4KJTZ/:
MY2]$%=D% O2#0PMR2D,].L:T&CT>F,#Y'D"+2 1Z3*=&'^SS?+5"J8H,D+XX
M!YF O^,G=B3\[350$Q/*!X @R+.*52#Z" [I[-'\478_:'%@?9%Y>>WHJ%;,
M>W)/H)Q8Y:_Y_@$@,[!%Q'HCYUIZ3L(9%1ZDS=SO8&A5F++?3Z].A<^@OM<S
MX@'V@$Q#G?'"M5U>UI%R=<B%6^9 3X[D.3*;_\SK'O4D(J+Y$XO_.4*L1I8]
MG@*YQK;LMR<L*0#U&(DO&M10>OS\@P.:[@E>P/FJ6?;+Z8?3;/[BZ2QL&A[I
M_,BR80'/9Y%GY/!<2-[WL']FLL0\YR\4$@>!@&N:D4*,K\$?Q,VVK+" @@I<
M! :FT8%[/.+EOQ&>?F$9TOD.&"L0(:N_>/C$<!XE^PCL"'_'!0([=BVHVX"#
MA X[6*@K;E\S'-&ZK&N$X-1"YZ?9$6)\%HCQV5%BO,@]BSWZQVO0!Z]QHLY/
MT>17#I6%)TO\AS-/U";#!Z!1E8"1!:B3OD0&O(53OP$]H/T$K!G%-/R&4A*4
M;E0H=SG %6P0.J?D731\VGX;M8^E4 %1R\\-\.=ZH(.)9HVJ0@E0A^%!R\!G
M-XQ?8)3@'.BJ  D$^C8P6"#A]H;M/Q*HB!V?17=:@1R1WXO>!3:Z 4WY!!CV
M=C"\2V3ND7/]-ISKMT</XS)J,5=ADU-G^A7#9)?36BSS/Y1#I2>V6+@%\U0\
M<MAJHO*B4M0168$PBN!B:YZ^-*<3;2@42VLXI'^0SIOEUWE9$1-'S< #6IT"
M!:8?I^^H[BH:"-FQ.<I'U)0]Z6T'EKNL0$L ULPSZSBJ>.,^A\N.,ZNBB</O
MK$&-GS$*>U>M3B(K !%#>N*-FFF*SW&M:/>"(:>Z4M\UP#DB_8S73/8"H9_J
M_&]$G]KUH FP554X?*,DQ@/J<D6@!@49M-TU$!'KO!7\*<Z+X::!7Q;B$, 5
M1"Z.BB0:?4T==#JC:I-Z=U0-]%$/G,EK?CC.8!U9Z<6$(:<#RDZ4K5E9H+L
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M>="LP>-H%:_W#8((5>OI4XSK*GU@1BA:/1F)9*(ZUFA78 XU;>)$,><"BS[
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M+,L&T1,-IH&S,S!LRE>;8!%W6?'\CB3Y<8PJ0=^4FQZVP)S[V)SQ5U(='\.
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M1B UE2C:7,?F=%"Z'^B"DOG&2?U4>#588,R>VV\:D7Z8C^Y+;1$=D\B3/48
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M4B8ES(/\OZ)V;H<GMDW?_B6+R'95SY&$ A=#.1@29ETE[P6J3Y%#TB-T'IZ
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M78LOP/-5 _JQ_($3T*6DN+R?_C]02P,$%     @ >7E05H/]J E5 P  /P<
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MW-"#CLI.H/&UE&;?L04.?Q$F_P%02P,$%     @ >7E05JJ%BR0% P  L08
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MM=-.RP-="F1I6)45HA0J2Q)7+!/ZIJ!V#G0^5\JN#9>@^DKU_P!02P,$%
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MQW% ;6)0/V,P>?<F'O3>'^&==;RS8^B3>^K*HA$(:@6['%Z2/\3X*.9AQB_
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M+&ELHW8&=+Y2RNX4%Z#[$4S^ 5!+ P04    " !Y>5!6S8')Q ,%  "["P
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M#,>XXQB?0Y\^HNS*AE,0*YB9EF7Z!5@-<UK3%=,*%N3%5.@4[[/(IWG_CL*
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MGU=3A5&_C9)F!9<ZDR4IGI]VSOSC\\C:.X,O&:_ULV>RE<RD_&H'U^EIQ[.
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M-:MR_47L?^.-/Y9@(G)E_V%?RX93!Y)*:5$T8&109&7]9#^:./0 D?<*@#0
M8GG7ABS+&Z;9<B[%'J211FUF8EVU:"27E693'K3$KQGB]/+FX]4CO'MDJYRK
M]_.Q1I7FPSAIX%<UG+P"]PG<B5)O%7PL4YX.%8R12T>(M(2NR%F--SP90>"[
M0#Q"SN@+.@<#JR]X5=]*PTVFDERH2G+X^W*EM,3#\,\I;VM=X6E=)D%F:L<2
MOG P Q273]Q9OGWC3[P/9YB&'=/PG/;E R9<6N4<Q!JNF93/6;F!KRRO[!OK
MQ^=**\W*%+^<8G]6_VGVCUL.26OLJ366&F/B8 SV3 '^UB+'+,8IAI0GO%AQ
MV>T5H*B9^+-Z::;P+BOQU.8Y)J!Z#P];(?6OFLO"6IC!M2@*+I.,Y;!C.U1V
M 32F^!]3"@^\S(2$4FBN9G#AN]3S6F4N>*,)_052Y'M9;3!/(+ T O#=,)["
MVS<1\<D'N)CT0<'(;T =_99]"Z!Q#!=A'T1&L7<,HD>H %&/0J,?JL>ZX1+'
M4?MQ& !TE+A>3/#INS$-X ]1;OKQ^9\A:%D9\^1%"*(&]#G1XA"!T'I.D>I0
M/AS1QOO+G<SR1IJBY!3'!"ZFM),&?Q0TRF_Y2E98Y1M.4YB&%,=+-G$#N&,R
MV;:!G1[4#SRFH^E0W$I'$,;A8<=[A(R!J=='D)I/C%P.<1H:P4,2#,+:D(K1
MS,2.H7PXBJ(7$0H\E*1V# F1[@@.0Q002VD:^D< VJGO^1R@9! ?'"!]1-29
M^%25O*$?1$ FOAW#XQV.)L&IG,"]"M#7X&B/#2 ^=8+"$,E[=AP;B+R7>QQ.
M&_7T1?AC>B+\H0E_8,>C29!<L!)SHIN[ T8D/DH%S#,T<L-S]LQ32"7;@QY"
M[]@SD*C-!10VHT[;?)"6ICRY7A":K/5<BAMVIOC3KOC3_US\[YBN9*8S+""X
M.M0$<P6<*OMG-9\N^T,3&B^!7FDRA?S(9>S^K-0S9U(!KR^%P17 \&X]W! S
MN/U7Q/!NL+M5UT-:[X'O^K@#MMA,ZLGDL)VF1OAN@.<2;S#L1M?(%2:NAR].
M[<:XUR'AC;.Q?:""1%2EKINE[FW7:E[6'=9!O.Y3\1!OLE)!SM<(]; B.2#K
MWJ]>:+&S_=9*:.S>['2+[3*71@"_KP66\V9A#'0-^/(G4$L#!!0    ( 'EY
M4%;PIB("]P0  +(,   9    >&PO=V]R:W-H965T<R]S:&5E=#0R+GAM;)57
M;4_C.!#^*Z/>BXJTI(F3OAY4:G?+W4H+5,#NZG2Z#VXR;2R2N&>[%.[7W]A)
MLX4-64Z XY>9QV//,^/A;"_5O4X1#3SF6:'/.ZDQVTFOI^,4<ZX]N<6"5M92
MY=S04&UZ>JN0)TXISWK,]P>]G(NB,SUS<TLU/9,[DXD"EPKT+L^Y>IIC)O?G
MG:!SF+@1F]38B=[T;,LW>(OF\W:I:-2K41*18Z&%+$#A^KPS"R;SH95W E\$
M[O51'^Q)5E+>V\''Y+SC6X,PP]A8!$Z?!WR/66:!R(Q_*LQ.O:55/.X?T"_<
MV>DL*Z[QO<R^BL2DYYU1!Q)<\UUF;N3^#ZS.T[=XL<RT:V%?RO99!^*=-C*O
ME,F"7!3EES]6]W"D,/)?46"5 G-VEQLY*S]PPZ=G2NY!66E"LQUW5*=-QHG"
M.N76*%H5I&>FB\OEI^L_%PN8+ZX6%Q_O8/EI=G4+W3N^RE"?G/4,;6)%>W$%
M."\!V2N  8-+69A4PZ)(,'D.T"/K:A/9P<0Y:T7\@+$'8? .F,]8"UY8'SET
M>.$K>#=HA$(BEH$Y%K@61L-?LY4VBBCR=].)2[RH&<^&S41O>8SG'8H+C>H!
M.]-??PH&_F\MUD:UM5$;^O26PC#990AR#>]E3L&HN>/SXM'VL<G>5L1F>^]2
MA/@8'DMX,"DWD'(-*\0"XI2K#2; -Q3OVH H2 F!D@,)$A9L,UYHV),\_:YE
M1D&O#\OPA%QI0,L+(*]BOD)5>]:UU.=%8GO^Q,VZ23>&KB@H K*,K-,G<&MD
M?']J S)I-GSU!.9IBQ.X07*MB T):JL$/Q/>D-I@&%2M P.YM0 :QO03^' G
M#<]*E;9]6#" 8.337P!W_)'NR7&*,E8L-X7XE_2Z;'0"W:!/#1O_V/1W4% V
M)G\;@B,#1R/;#OJV[3-H(56_)E7_S:0ZNI[R&F9[KA(-,YLOA7EJ(E@K>C/!
M#G".#'*GZ'Y>N*6%-*]Q9@*W1$C4\-5E7TQ.H:O+&2*+2>5.$YV(+5>R>*#]
M"..[;8G>+W$#& U#NNUPY'O]/ORN>&'EHS&#*/0]?P!?2K!N%)$_PXAY$0-Z
M)=8HW'3@AR? QLQCH_^Y-8-18+>.V-ACK;X>U+X>O-G7]37-'E#1FPL77"CX
MPK,=PDS3PUQ&0)/+VS>QZ6-ML1X<EG4E'5;0JTF'E85S9$(#:\3&7B?LM"@V
M;GZ><0H',E/2BP-;NB&[DLL$[6-H4B>T/UC.*\OY-W/)UXF(W58K6V5\ESF^
MOE0^,I5\4!KDS*,("T(OM*%FO6?SPV#L$1ELMG6>*Y,$9&*-T'4)C0C@#:K<
M%GK#JA=Y?M6K51]D1G&>V2 (!UX OT 8>B/ZL,@;T^=&Z/O3M4*D QFT; %E
MC7IN8N!4?"^B-O 8M1\HL!**$'@2F"6T-'0"==M"HF%-HN&;2?0LDJ_+ZUC:
MM-]$FU;8-V:*ZLI_^+3\,$M\IG7U?1 TIXSKBEQ4R6I#4Y:4C;DBI+>"<D4X
M]OQ1G2LH6T>L[X6,W(\J%MJEA0&EA3"@R!X>9PMZ',*A[['!6_>TW(Y<?@J\
M<%AK8;F3K=R:M2+[D(11WQO[C9FE=U1'YD@/O:V6-;U1N\*4)64]6Q?DL[(.
M_29>5O.75"=0A0 9KDF5:$A/ABHKY')@Y-95I2MIJ,9UW93^J4!E!6A]+:4Y
M#.P&];\IT_\ 4$L#!!0    ( 'EY4%:9#G#^B ,  +4'   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0S+GAM;(U5;8_B-A#^*Z.TJJY22EX)+P4DV.5Z^V$Y
M!'N]#U4_F&0@T3IQ:CO+[K_OV(&4K5A:"3$>9^:99\;C\>0HY+/*$36\EKQ2
M4R?7NAY[GDIS+)GJB1HK^K(7LF2:5'GP5"V19=:IY%[H^XE7LJ)R9A.[MY:S
MB6@T+RI<2U!-63+YMD NCE,G<,X;F^*0:[/AS28U.^ 6];=Z+4GS.I2L*+%2
MA:A XG[JS(/Q(C;VUN#W H_J8@TFDYT0ST9YR*:.;P@AQU0;!$;B!>^0<P-$
M-/XZ83I=2.-XN3ZC?[:Y4RX[IO!.\.]%IO.I,W0@PSUKN-Z(XQ<\Y=,W>*G@
MRO[#L;4=4,2T45J4)V?2RZ)J)7L]U>'"8>A_X!">'$++NPUD6=XSS683*8X@
MC36AF85-U7H3N:(RA[+5DKX6Y*=GR_EF];#Z;0OKY0;NOCX^?EW!]LM\LS3*
M^MO3_.F!=CX]L1U']?/$TQ33>'KI"7_1XH<?X <A/(I*YPJ658;9>P"/R':,
MPS/C17@3\1[3'D2!"Z$?AC?PHJX"D<6+/JH DU51'12L4<(V9Q+AC_E.:4D-
M\^>UA%NX^#J<N41C5;,4IP[=$H7R!9W93S\$B?_K#;)Q1S:^A3[;TJ7,&HX@
M]G GRKK1S#8WJ0NFBA18E<%]P1N-&;S+C*Q+,K0)7LOJ9MSK6=VC9@6G^US7
M0FJ*!#I'2-_3VG6TLA,M/-.JB5;:TE*V[D>F@'Y[P6E6&"DMXAMY*$#3/T"G
MC^6.',\=8/\#&X 6_MANMGM&AT\9H1G_HJ+[PSG14B[@:XJUM@Q6-/F*BG@@
ML!?*QW2Z#7VFID7ZG N>(8'\"*$[]!,K1U%$,G*C9 #?[>W'[!?V@I*&&=#\
M4YI(F:K8Y)0IQB4D-(KRT0*",''C8$1RZ";#(011Z :C47N,-+( ]WN:8>0_
MAF59<_&&>((0M2FS@KX/20RC$#9(C5NDILRM11+VZ5,, ZK'MN5QCML>%/Z/
M<PG"@>N/8I(C-QHEQ#!R?;K9;<M][$=5"GMT!E8.1D;V>_&@:]#_\/2'K:3Z
M6L\H@%5C#Y]*R2I=9.<*O:^&Z07Y[T*P(Y.9HI[H0Q@D$$9#N'8?O8M16J(\
MV =#$;FFTNU4[7:[-VG>CN)_S-L'[9')0T%T..[)U>\-^@[(]I%H%2UJ.YAW
M0M.8M\N<WE64QH"^[X709\4$Z%[JV=]02P,$%     @ >7E05@'@$V*+ P
M'0@  !D   !X;"]W;W)K<VAE971S+W-H965T-#0N>&ULC59M;QLW#/XKQ#7H
M6L#PO=E)ZMH&[,1%VZVK%[L;AF$?Y#O:)T1WNDBZ..ZO+Z5[F=LYWK[X2(E\
M2.HA)8_W4MWK#-' 4RX*/?$R8\J1[^LDPYSIOBRQH)VM5#DSI*J=KTN%+'5.
MN?"C(+CT<\8+;SIV:TLU'<O*"%[@4H&N\IRIPQR%W$^\T&L7[O@N,W;!GXY+
MML,5FB_E4I'F=R@IS['07!:@<#OQ9N%H/K3VSN!WCGM])(.M9"/EO54^I!,O
ML FAP,18!$:?1[Q!(2P0I?'08'I=2.MX++?H[USM5,N&:;R1X@^>FFSB77N0
MXI95PMS)_7MLZG$))E)H]PO[VG9 $9-*&YDWSJ3GO*B_[*DYAR.'Z^ 9AZAQ
MB%S>=2"7Y2TS;#I6<@_*6A.:%5RISIN2XX4E9644[7+R,]/5^O/-S^\__W*[
MN%O]!(O?OGQ8_PFOUFPC4+\>^X9"6$,_:>#F-5ST#%P8P2=9F$S#HD@Q_1[
MI]RZ!*,VP7ET%O$6DS[$80^B((K.X,5=P;'#BY_!6SQ4W!S@K]E&&T4]\?>I
M(FN(P6D(.R<C7;($)QX-@D;UB-[TY8OP,GA[)L%!E^#@'/IT17.75@)!;N$6
M#>-".Y$_\A2+%);L0$-A]*F\SR.O,X2M%#2'O-B!L1Q#J:3%U=3)7:BT#54V
MH7J 3XFH4NO6;2(=Y",3M _*MCY9\<*R%#BNB#%&5I:U'E34# IDI6 NF4J!
ME38NIO!0,650B0,D3&='D:7@R6'4%@O4VPBS7%8DKZ5A EY1L)P+0:.M7[NP
M<!'U!S%<Q%'D$K#ZE=6'H4N#I'YP2;]O@C,T#3N:AO^;IE7&%,(=EI5*,KHB
M3G)S%NYT3RVZ4]<V@J8[C Y=T;E1\8DLBN9JVW.3 >:ED =$H#LCN8=2L((H
M<8YT>W:IP1YI@>FF$XCX2KEVH.8X(%,:T$XNM5Z"^898:V>O9K4E-1C59^K6
MW.G/*I-)Q;\REY(C;-D$A5^E 2.!ZD&"7M7%W$AMGI6_I_<=;A1URJ$.%_>"
M((!!/R;*(7+*RQ?741B]);V5_KWRL1(6('S3 /QH^>,W[E\'$/:NAD'3<L>G
M^!_1G>]%XWVJV_RC*SM'M7,/DR92J</KV[M;[=Z^67WE_V->/YR?F-KQ0H/
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M?BV>/YLF'N'T38JLJO^39]]7\ &9+"M;S)O!\&">YOZ:O#1YZ S0X8X!K!G
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M>:*37:QH(7;#*D11%1M#M*OGZA"L  +T<P4"%QGOA57(N(,5+H=@Y?!" RW
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MG*]4;1C>31S6&!1<]C!:'9X.AXZ1F;NN5]+@Y>^:6WQN@;(3\/M:2O/2L2^
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M"7V7ZC@UO!K]^3"93NXG7V^FX.H& 31Y'$_O)_</=^,I> ]N!6%4Y]6+"'S
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MA5<U$RK9?*5L@2JVYDR8NYDPW[A%K @:+_;8;2W[0X)\>2H'"Z>(K2G<SMY
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MGL.5#4[7Q4'3@G).D^)RA9%8>/, \7Q)*7]JY!W4IZ&S_P%02P,$%     @
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MD(>0(7Q^>#ALAH]D8>KJH+HZJ,R'K?GN!%C0U9;'(J8Y^)@R+N+_9%'F+!=
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MB,Q,)S73B9/I[=GB#"SEU,NW_&>IW]*<L]5/P.Z2^"$2-IEV9NVJ7#TE:Q0
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MCRHQH/=C*<URD"0H_B?H_@]02P,$%     @ >7E05J]RW?$[ P  .PH  !D
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MSC 3CWK.;[Z<4W2\B#@=G\Q+327($_>G&;DOSMR'Y](/VP^J6*KN!\BF%9W
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MI>D'<$/7- (8+%3#==DPKNKET(NQ+V27U8W]L.[>QZI[:$_WKFAX!C#\#:
MH9;RV?O+H5GN2Z$:M5"C%BKQ>GOP+I.D(!'[5ZJQYA$1+&+B1QLK*XR:FA=Y
M2D(Z\>3<RVFVIM[TYY_@(/B]C:,C,(,Q;ACC$AWO\X<>\5L]D. Z20N1EV91
M%TDY)?^BX2IAWPN:@[]O) ZX%C3._VG3![O4QQ&8H4^OT:=G=<0#6R9LP4(B
M12D2_J3PR5-$ 2L5:N-N!3R4>P4&J^FMGMGK:7"&4&_LKUM8]1M6_<-]#OX#
MMRQA<1&WL;("'LK*$9C!?=!P'YS"\0.7^C@",_09-OH,73M^V&92.!@V)JU8
M6>_;D=6H837JYGCRO,_Q5L!#1]01F,']O.%^?@K'G[O4QQ&8H0\,=$@*7'N^
M1MQ],@>C'=/;[]R5V5;\@U9F,YGLF #5;X!6'M;Z0X?1%9K)5L<WB$[A=.@T
M[KE",S72@0]:\U(GKSN-<S7:SLP)@M&Y^=<><:!.;M >W0SKV\.-'>E@@H[0
M3-XZV\'^22:!TP3H"LW42&= :(U0G2;!H-6V$.\^\(\1WJ!.;] >WUZY?G_
ML2,=/*+'B'=0YSLX.HGKG:9 5VBF1CH'0FN,ZN3Z\W;7]W==?XP AW2 0_8
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M[:*KPR5&*>8Z0%V?,R:?!GHKW7PZB7\#4$L#!!0    ( 'EY4%;N$^E!W@(
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M=5FY_UP><+HNMG ?*><T*;ZNB%A)LKR!^'U!*=\>Y!>H_PM@^A]02P,$%
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M*D">7U$JGG;42F.[%!W^!U!+ P04    " !Y>5!6"8UO9B<#  "J"0  &0
M 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6RM5EUOVC 4_2M65DVMM#8?A(1V
M$ E(J_6!#95VFS3MP207L.K8S#8?^_>S$\@@":@/?0';.>?XGNOD^G8W7+S*
M!8!"VXPRV;,62BWO;%LF"\BPO.%+8/K)C(L,*ST5<ULN!> T)V74]APGL#-,
MF!5U\[6QB+I\I2AA,!9(KK(,B[\#H'S3LUQKO_!$Y@ME%NRHN\1SF(!Z68Z%
MGMFE2DHR8))PA@3,>E;?O8L[!I\#OA/8R(,Q,DZFG+^:R6/:LQP3$%!(E%'
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M"SPI"HPR!;[)2*?^;=2.I([Q.U4C=8S;.G@]"R?VP2V6@9CGW8!$"5\Q5=P
MY6K9</3S>[:R/M"-2-$W_)<INI@1%G/")*(PTY+.3:A#$D5G4$P47^9WY90K
M??/FPX5NID 8@'X^XUSM)V:#LCV+_@%02P,$%     @ >7E05G]Y"^3N P
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M$V%UHWA1'JI67.DC6GFYTZ=H$,9 O]]PKEYNS#FM.9?/_P%02P,$%     @
M>7E05AI[2'WF @  "PL  !D   !X;"]W;W)K<VAE971S+W-H965T.# N>&UL
MQ99M3]LP$,>_RBE#$Y,VDJ;/K(T$!32DP2H*;-*T%R:YMA9.7&RWA6^_<Q*B
M%-J(3D5[T]K.W=_W.Y^MZRVENM=31 ./L4ATWYD:,SMT71U.,6;Z0,XPH2]C
MJ6)F:*HFKIXI9%'J% O7][R6&S.>.$$O71NJH"?G1O $APKT/(Z9>CI&(9=]
MI^8\+USQR=38!3?HS=@$1VAN9D-%,[=0B7B,B>8R 87COG-4.QQTK7UJ<,MQ
MJ4MCL"1W4M[;R7G4=SP;$ H,C55@]+?  0IAA2B,AUS3*;:TCN7QL_I9RDXL
M=TSC0(J?/#+3OM-Q(,(QFPMS)9??,.=I6KU0"IW^PC*W]1P(Y]K(.'>F"&*>
M9/_L,<]#R:'6V.#@YP[^6QWJN4,]!<TB2[%.F&%!3\DE*&M-:G:0YB;U)AJ>
MV%,<&45?.?F9X/QR\./B%*Z/?IV.X M<,J6832SLGZ!A7.A/M'HS.H']O4^P
M!SR!"RX$'8#NN8;VMRINF.]UG.WE;]CK!,,#J-<^@^_Y_AKWP=O=:ZON+E$7
MZ'Z![J=Z]0UZU^P1!@HC;F! V$]T)99,1?#[.QG"N<%8_UD'F:DVUJO:6W>H
M9RS$OD/72J-:H!-\_%!K>5_7(>](;"4!]2(!]2KUX):).<LNDZ#;S)(0-= L
MH<>#G@E;",D$A-0:PE*"--U>P0Q&8"3,%)>*+N/#G&MN-M5%%D<SC<.^*XN@
MV>ZYBW(B7INTFH7)"EZCP&M4XIUA1 QB73R5CML>X8[$5AB;!6/S76JXN<L$
M[$AL)0&M(@&MRD.^?%6K5,-4E^6"W;Y>LSU;Y6+LO*C7RK#^$;I=0+<KH4>&
M<( E$0SGJ(CJBH=R'4>ES+;'O".Q%>).0=QYESKO[#(!.Q);24"W2$#W/]1Y
M]]6C2^%Z+RJ],K!ML=U2JV+;Q NF)CS1('!,\MY!FX)16>N538R<I=W+G334
M"Z7#*76KJ*P!?1]+:9XGMB$J^M_@+U!+ P04    " !Y>5!6ISE^(-H+   J
M@0  &0   'AL+W=O<FMS:&5E=',O<VAE970X,2YX;6RUG5V/V[@9A?^*X&Z+
M+)"U)9&4Q'1F@&341;-(L,$FVUX4O=!X&(\0VW)E.;,!^N-7LC6F*%(<,3[*
M1>(OGM<\$5\^IOAQ]5B47_8/0E3>'YOU=G\]>ZBJW:O%8K]\$)ML/R]V8EN_
M\[DH-UE5/RU7B_VN%-G]L=!FO0A]/UILLGP[N[DZOO:AO+DJ#M4ZWXH/I;<_
M;#99^>V-6!>/U[-@]O3";_GJH6I>6-Q<[;*5^"BJWW<?ROK9XJQRGV_$=I\7
M6Z\4GZ]GKX-7:>#'38GC1_Z5B\=]Y['7U.6N*+XT3][>7\_\YBN)M5A6C496
M__-5W(KUNI&JO\C_6M79.6A3L/OX2?WG8^WKVMQE>W%;K/^=WU</U[-DYMV+
MS]EA7?U6//Y3M#5BC=ZR6.^/?WN/I\^R>.8M#_NJV+2%ZV^PR;>G?[,_6B<Z
M!6H=<X&P+1#V"]"! J0M0,9&H&T!>G3F5)6C#VE693=79?'HE<VG:[7FP=',
M8^FZ^OFV^8__6)7UNWE=KKI)__'FD_>3EXJ[ROOU4.VK;'N?;U?>BU146;[>
M_UB_^?O'U'OQPX]7BZH.V!1;+%OQ-R?Q<$A<+.<>"5YZH1^&AN*W]N+OL]):
M/!T?/5"++VJ7SE:%9ZO"HQX9U*L]>KO=5^6AOO(K[S_OZ@]X;RNQV?_7Y,U)
MC9K5F@;]:K_+EN)Z5K?8O2B_BMG-W_X21/[?34XAQ5*0F.(B.;M(;.HWGXHJ
M6WO[AZ*L?JI$N:D;Z5UELN\DPXXR3?KZ>A/ZO,YGS9^KQ=>N.=:(KN;H<0/.
M2"^N4G5ZKCJU5OU=L5W9ZWPJ'W5B<Y]08YVMH5SKK,<-?$8#6Z79N=+,6NF/
M8IL7I;<M*K$W5=E:VK65(,52D)CB6G1V+8+FF@CI(E(L!8DI+L9G%V.'!O>R
M[D_+LG&SQH5#F5>Y^8J,]<9 >6QLA-;PKD[I<3E/;$TP.=N0C&Z"WO^]'X*7
MS/=/WV.3K]<U?KWT_'G$_NK='X3W^K"JL<,CQWZ3F RR1G.]V)!B*4A,<9F?
M7>;0)LN1+B+%4I"8XF+@2R#UK5?KZ]6J%*NL$MZNS+?+?)>MC>3IZ_TT\WUC
M,[5'=+4'I:;ZTP'VP-Z:J]J;>R_?UHE-U VU;*QZL1/ELK[JS)#>_@3P.U[Y
M\_J7(>O[9(WL[!-(3?5)TGI@Q=CO3/ZM*!N3_>U?P-FN4,O_ WD_D*P=V&'[
M>>)L!<Q1VVI"\=H0L#:XS_5J?25@!W;"[O=TD>][YRZ.S(.VBZM_&8K-G2A/
MWW+X!^8;>SC7) U52U%JJM42ZP,&[>X"*.A#U5*4FFJE9/W "L&C>[Q(2TW1
M4(<'17B4FFJ/A/C 3O'?T>'%Q@Z/!%J'!P5XE)KJDZ3\P([YW]GA)=I5I5U-
M4$9OU;H= ./<FO\E@@=6-M7R/^WF_W#.?37_>P&SY'XHH$/54I2:.@XJ$3WT
ML2.A2/Z^A:JE*#752DGSH9WF1^;^5J7;2NE [K<'=+9G"H@/.T/N=HAWS_VM
M8#_WA[QO$W9$?8HA]5!R?NC"^6-3?Z@/=6L7$Y3]0YW]B3WUAQ+]0V?T[PUQ
MD7G2\O^ORZHXIO]C]J=&;Z#D#U5+46JJTY+\0RSYAU#RAZJE*#752DG^(83\
MP_'D;P_H;,\4Y!]*\@_1Y!\.D'_2)W][9&>?IB#_4))_Z$+^1E]TRM>ANW4&
M2ONAB?:M=S5"2?NA&^WK*9_.68O\K^L&MFX3/C,Z!,5]J%J*4E-OV$O<)UC<
M)U#<AZJE*#752HG[!(+[1,?]H81O#^ALSQ2X3R3N$S3N$S/NTWZ^MP=VMFF2
M&32=*327#NL3'>W9P%T,>RQG9W3$9SRRY7LB$9^X(7[,U'SO!7/2$O[/XJX\
M9.6W]C9V;/0(BOA0M12EICHM$9]@$9] $1^JEJ+45"LEXA,(XA,=\6,VD/&A
MB(]24^V1B$_0B$_,B!\0+>5#$1^EIOHD$9]<BOA$1_R8,O,5!$5\HB-^3*TW
M=(E$?'(IXI,Y;W/^^ZQ</CP-Z9LS/I3QH6HI2DV=F2H9GV(9GT(9'ZJ6HM14
M*R7C4PCCT_&,;P_H;,\4C$\EXU,TXU,SXQ/>S_CVR,X^30'Y5$(^O13RZ7C(
MM\=R=L89\FEGCKP;Y.M35=D\5C/^,>$G1H>@B ]52U%JJL\2\2D6\2D4\:%J
M*4I-M5(B/H4@/M41?VC"JCV@LSU3(#Z5B$_1B$_-B,]B+>%#$1^EIOHD$9]>
MBOA41WS*!Y8'01&?ZH@_E.@EVE,WM.^/YC1H'_O=1!^>!G.XT1HHVD/54I2:
MNOY*HCW#HCV#HCU4+46IJ59*M&<0M&<ZV@\-YHS_:&K_;M];=\GM#,WM;(#;
MX[X'XSZ7VK_@]QH@@9Q="N1,!_*8]I>.MG6& CFSS>)7JRM!G%T*XF0>$&7-
M6#OV8DS0]FC.606*XB@UU>G."EDLBC/LFEGLHMDI4)Q)%&<0%&?C4=P>T-F>
M*5"<211G:!1G0U/I2=\G*(JCU%2?)(JS2U&<F5"\/P32.@-%<::CN!Y8K;9$
M<N:&Y'K*I_,DT2;4$-_H$)3(H6HI2DU=VR^)/,(2>00E<JA:BE)3K91$'D&(
M/-(Q>RCAVP,ZVS,%M$<2VB,TM$<#$VJ2I.\3=+ =I:;Z)-D^NI3M(YWM*3??
M7K7'<G9&9WL]L%IMR?C193-JFD53@7%*#3&NF;*'<TY44,A'J:E62\B/L) ?
M02$?JI:BU%0K.WOC0" _&C^EQA[0V9XI(#^2D!^A(3\R0WZHK9>U1W;V:0K(
MCR3D1Y="?F2:4F,>S[''<G;&-*7&NAU7)"$_NG3<G9TAOW.#E1BW K+'<LY2
M4,A'J:E;3TG(C[&0'T,A'ZJ6HM14*R7DQQ#(C\</N]L#.MLS!>3'$O)C-.3'
M9LAG&N3;(SO[- 7DQQ+RXTLA/S8,X!/S,BE[+&=G1@_@QQ+N8S>X#[5$GYSA
M_I?#5IS>/(WA$^-T&GM YQ0%Q7N4FFJVQ/L8B_<Q%.^A:BE*3;52XGT,P?M8
MQ_MP*-M#\1ZEIMK3V=,2C?>Q&>\3#>_MD9U]F@+O8XGW\:5X'^MX'T9]RFZ=
M@>)]K..]'EBMML3[V'D+'&T,/R*#^Z!1X[B./:9SMH)B/DI-W5I58GZ"Q?P$
MBOE0M12EIEHI,3^!8'XR?B\<>T!G>Z; _$1B?H+&_&1@+#_JW[RU1W;V:0K,
M3R3F)Y=B?J)C/AFX>6N/Y>R,:0,<Z\W;1.)^<NE8/CTOE5(VP*'&#7#LT9SS
M%)3U46JJTY+U$RSK)U#6AZJE*#752LGZ"83UD_%#^?: SO9,P?J)9/T$S?J)
MF?6IME;*'MG9IRE8/^EL<'\IZR>FH?R!*PB[);UI*+\?6*VV9/WD<M9/?'UU
M+#6NCK4'<TY34,A'J:D[^TO(YUC(YU#(AZJE*#752@GY' +Y?#SDVP,ZVS,%
MY',)^1P-^7QHPD[?)BCCH]14FR3C\TL9GX]G?'LL9V=,C&^=K\,EXW,WQC?-
MR>?,,">?&N?DVZ,YIRDHXZ/45*<EXW,LXW,HXT/54I2::J5D? YA?#Y^3KX]
MH+,]4S ^EXS/T8S/!^;D:XQOC^SLTQ2,SR7C\TL9GYOFY)NGZ]AC.3MCFI-O
M/3*0=TZ5LC/^NR+;[KT/V;?L;BWJG/^I<6!=O_A2&<D)^?!Y7?8(SKD)>];4
M-(=-=4^;PJ+]DQ[(3:Q<"I/K^=DYG<JW\_V((X=:!>N90_8H[K;H(4-?ZUUZ
ME0X[E7[NK"FUD:9BG7VKD_I]F3UZE=IBWV??O# 9WGG\F5CN%QCVE"J47,_K
MSI%6/@$W6"3>WV+E4IA<S\_.D5F^_3?%F 9+M=8S?-0>]%? N-"]NG?.L/+M
MA]/>%IM-#5IYMO9V68U<YMIC3ZZ"RJ4PN9Z'G<.K?.Q1M4]Z,#^Q9UVAY'I^
M=DZ[\I_Y/?#\T=A/$NK.7^;%2,^$<_='#\V9>7ACT3F6?I>MQ/NL7.5U/[D6
MG^NR_KR99U;FJX?SDZK8'4^JORNJJM@<'SZ([%Z4S0?J]S\71?7T9%'K/Q;E
MEV.,FS\!4$L#!!0    ( 'EY4%;&,NOS10(  "(&   9    >&PO=V]R:W-H
M965T<R]S:&5E=#@R+GAM;(6576^;,!B%_XK%JJF5MO 52)8!TM)LVBXB14V[
M73OP$JP:S&PG=/]^MB$H52"Y"?XZYSEVS$O4,/XJ"@")WDI:B=@JI*P7MBW2
M DHL)JR&2LWDC)=8JB[?VZ+F@#,C*JGM.4YHEYA45A*9L0U/(G:0E%2PX4@<
MRA+S?TN@K(DMUSH-/)%](?6 G40UWL,6Y$N]X:IG]RX9*:$2A%6(0QY;W]S%
M<J[7FP6_"33BK(WT3G:,O>K.KRRV'!T(**12.V#U.,(C4*J-5(R_G:?5([7P
MO'UR_V'VKO:RPP(>&?U#,EG$UMQ"&>3X0.43:WY"MY] ^Z6,"O.+FG9MX%@H
M/0C)RDZL$I2D:I_XK3N',X'GC0B\3N"9W"W(I%QAB9.(LP9QO5JYZ8;9JE&K
M<*32?\I6<C5+E$XFJ^_+9_09K;$\<"()",1RM(*=1/<KD)A0\8#N$*G0FE"J
MCE%$ME18+;;3#K%L$=X8 M()\MU/R',\#[UL5^C^[N&]C:U2]]&]/KIG?/T1
MW_>9,Y5Y*%OK,1WVT%=^(6J<0FRI.RV '\%*/GYP0^?KE81^G]"_YIZH#?M#
MF5I58%3ZK3FJE5^"R#X.L*8]:WJ+-1UBM:KPC.6ZCC/,"GI6<(L5#+&""U8X
MA@I[5'@+%0ZAP@O4"&C6@V:W0+,AT.SR_/Q@A#7O6?.KK.<"5 '-)? AXOSB
M=H3.!=$^>^5U]5QCOB>50!1R)7,F,Z7G;45J.Y+5I@KLF%0UQ30+5<2!ZP5J
M/F=,GCJZL/2?A>0_4$L#!!0    ( 'EY4%;@]*P.X0<  /%;   9    >&PO
M=V]R:W-H965T<R]S:&5E=#@S+GAM;+6<76_;-AB%_PKA=4,+9+8^+']DB8&F
M),4.2Q$TZW8Q[$*QF42H)7F2G+3 ?ORHCUJF+;/2>IJ+V)+X/J\4GXBO>$Q>
M/"?IQ^Q1RIQ\BM9Q=CEXS//-^6B4+1]E%&3#9"-C=>0^2:,@5YOIPRC;I#)8
ME4'1>N18UF04!6$\6%R4^V[2Q46RS==A+&]2DFVC*$@_7\EU\GPYL =?=KP/
M'Q[S8L=H<;$)'N2MS#]L;E*U-=I15F$DXRQ,8I+*^\O!:_M<N-,BH&SQ1RB?
ML[WWI+B4NR3Y6&R\75T.K.*,Y%HN\P(1J)<G^4:NUP5)G<<_-72PRUD$[K__
M0N?EQ:N+N0LR^299_QFN\L?+P6Q 5O(^V*[S]\FSD/4%>05OF:RS\C=YKMM:
M [+<9GD2U<'J#*(PKEZ#3_4?8B_ 'I\(<.H IVN 6P>XAP'>B8!Q'3#NFL&K
M [S#@,F)@$D=,.EZ2M,Z8-HU8%8'S,I/M_HXRL^2!GFPN$B39Y(6K16M>%,*
MHHQ6'V$8%]J]S5-U-%1Q^8*RJ]_)S^16QF&2DG=)+C/RDLH\"-?9*W7@PRTE
M+U^\NACE*ED1,EK68%J!G1-@FUPG<?Z8$1:OY*HEGG\EWC$ 1NHJ=Y?J?+G4
M*\=(I'(Y)+9W1AS+<5I.Z$V'<,L^&4[-X>^2IR%QK9/AS!Q^':0J_'1VWN'D
M#>%^]W"[)5QT#[<,GZ2[$ZU;\MR3O+N<O(VS/-VJVVA._OI--2!O<QEE?[><
MW55%&[?3BM[A/-L$2WDY4+?_3*9/<K#XZ0=[8OW2IA(DC")A# GC2)B/A D0
M3%/>>*>\L8F^N$F3I92KC-RG243"+-L&\5*2Y)YDU1TT+NZ@9R26>9L0C?"^
M0D3"*!+&D#!>P;P25E1B3PM[/E.E6?%S,7K:E]EQ4V<^&[<U%2U4:S8[:*I)
MQ-M)Q#-*Y'9/"&T:,$;WU0 21I$PAH1Q),Q'P@0(IBEMLE/:!-H-3I#*0\(H
M$L:0,(Z$^4B8 ,$TY4UWRIL:[W'OY4I&F_+A<Y.&2WE&-C)=*@VJQ]TVY1EI
M?96'A%$DC"%AO(+-]WNH@^X.F4Z 8)J<9CLYS3IWF>1?\L+QK(H=A>NU$MD9
MF0UM[T>RVDKRZS:6U<'J4<Z=M0G.F*^OX) PBH0Q)(PC83X2)D P39OSG3;G
MT$YVCE0>$D:1,(:$<23,1\($"*8IS[::L3G+?%_,@URN2!CG4N%SDJI-\K+N
M:MO&Y*[,P+[R@](HE,:@-%[3BI===VL-K9GM'?2YT+0"1=/UM3?V:QOU]?KA
M(94/A:A4%1<OPTVP;A65D=);5$@:A=(8E,9KFC8>X5FM(Q?0Q )%TV7E-+)R
M^I1SWM";6N2FNFOI3@-5!=UUD"X?BY'A&7D=KU3KV=3[>FO7;56J\<1Z*Q5)
MHU :@](XE.9#:0)%T\7<6 TVUFNPH68#E$:A- :E<2C-A]($BJ9+L/$<[.]J
M.ICIO14)M1WLEG'X>FS_L(]DT,P<2O.A-(&BZ7IK# R[NX/1I_]N%1_4[H#2
M*)3&H#0.I?E0FD#1='DVKH>-M3ULJ.\!I5$HC4%I'$KSH32!HND2;.P/V^Q_
M_(^!&:@% J71FG8X^.%-O<,>&&IP0&D^E"90-%U?C1]BFPV1K@,S4)L#2J,U
M;;^R\TX5=E ; TKSH32!HNFR:JP,VSA>?5S8?<M0"]3H@-(HE,:@- ZE^5":
M0-'TK^<V=H=C00L[!VIV0&D42F-0&H?2?"A-H&BZ!!M'Q#$[(OT+.S.PMPBA
MYDA-L]V#PFYV5-E!\W(HS8?2!(JF"ZSQ1ARS-]*QLC-3>JL*:F34M/W*;MIN
M:S%H8@ZE^5":0-%T634NA6,<@C[Z!M7TZ!M4[G!J5=^@JNLZMYR.,6]5']3#
M@-(HE,:@- ZE^5":0-%T@38>AC/&UG90TP)*HU :@](XE.9#:0)%TR78V!K.
M5VR-_K4=U+R TBB4QFK:X1"@.]4[=-ZQG0\].X&BZ<)I# ?'.)K<N6:#^@Q0
M&H726$WK4 'R[DU]Z#D*%$W73.,0.&:'X!L]>S.]MY:@=@&4QFJ:)I!QZYP]
M#DWL0VD"1=/EUA@&3K\9%!/+(GNE_Y?)$U0N970GTRKSZ>G@5^9TO?4'=1:@
M- :E<2C-A]($BJ9+M#$?'.Q$"@=J,$!I%$IC4!J'TGPH3:!H^JH1C<'@HN=3
MF(%]10BE42B-06G<;9]/X1[-IX"F%2B:KJ_&/7#-[L%[N0D^ES<W5>>MU/VN
M55)0P\ ]GF,P:;?9*30Q@](XE.9#:0)%TT75. 8NQ#$P4WK+"NH80&D,2N/N
ML9MQXA_(AR86*)HNJ[TEE/HY!N/])P9G.+?T)P;3PEE7YE2]M8==80F[Q!)V
MC27L(DO859:^AU_@-GZ!B_4+7*A? *51*(U!:1Q*\Z$T@:+I$FS\ A?M%YB!
MO44(]0N@- :E<;?=52C,:;T#AKH**)HNK\95<,VN0K>'A>/A\W%[=?+&G*ZW
M7*"& 93&H30?2A,HFBZJQG9PS;9#UX<%J+T I5$HC4%IW#TV*T[\._K0Q )%
MJV0UVELO.)+I0[EV=$:6R3;.JU58=WMWZU._+E=E/MA/[7-FM^SG]KFH5I]N
M\-5BV-=!^A#&&5G+>Y7*&D[5WS*MUI>N-O)D4ZY6?)?D>1*5;Q]EL))IT4 =
MOT_4$TN]4238K?*]^ ]02P,$%     @ >7E05@2=4][B!0  7C4  !D   !X
M;"]W;W)K<VAE971S+W-H965T.#0N>&ULK9O=;MLV (5?A="*H07:6)+_DBPQ
M$)N26JS!@J;=+H9=,#9M$Y5$EZ+C9-C#CY(5R7)D)M[.36W)/!\I\8043\6+
MC53?LR7GFCPD<9I=.DNM5^>=3C9=\H1E)W+%4_/+7*J$:7.H%IULI3B;%:(D
M[OBN.^@D3*3.Z*(X=Z-&%W*M8Y'R&T6R=9(P]3CFL=Q<.I[S=.*+6"QU?J(S
MNEBQ!;_E^MOJ1IFC3D69B82GF9 I47Q^Z5QYYY'?RP5%B=\%WV0[WTE^*7=2
M?L\//LTN'3=O$8_Y5.<(9C[N^83'<4XR[?A10IVJSERX^_V)'A87;R[FCF5\
M(N,_Q$PO+YU3A\SXG*UC_45N/O+R@OHY;RKCK/B7;,JRKD.FZTS+I!2;%B0B
MW7ZRA_)&[ @,IUW@EP)_7] ](.B6@NZ^8'! T"L%O7U![X"@7PKZKQ4,2L'@
MM8)A*1@6G;6]NT774*;9Z$+)#5%Y:4/+OQ3]6ZA-CX@TM^*M5N97871Z1(/Q
M5_*!4!ZS1SXC5+$-^<I50CY+EI*)XC.AR=5"<6[\I\E;RC43<?;.:+[=4O+V
MS3ORAHB47(LX-M;*+CK:M"IG=Z9E"\;;%O@'6N"1:YGJ94:"=,9G+7KZ@MZW
M #KF=E3WQ'^Z)V/?2KQ:+TY(UWM/?-?W6AHTL<NOV:--3>UJRJ=5Y7Z+/'B]
MO*WV\/5RMT4>O>+.><.VVAL]T:W<V2UXW0.\VZ54^H/._4CYG29_?C8%R"?-
MD^RO-J=M:;UV6CZJGV<K-N67CAFV,Z[NN3/Z^2=OX/[2ULM(&$7" B0L1,(B
M$*QAEEYEEIZ-/KI1<LKY+"-S)1-2F"8V@UB;3ZR@8WV"A-$MK%_ \L>(^Y'Y
M,[S?[?SG)?R^NU<H?%[(<_<+1:"&-SJK7W56W]I9OXIT9B87PC3Y*!/>UDE6
MP+&=A(11)"Q PD(D+ +!&OX85/X80$?^ =(L2!A%P@(D+$3"(A"L899A99:A
M=3#YJEB:L7)MD\AUJM^3U"SCY)SP!Y%ID2X(_[$6^I%DFGUO'6V&ST;,_NG^
MB#FQ-N-88R!A 1(6(F'1"S>VT>&G58>?6CL\7YQDY(8]LKNXM3>M\F.' R2,
M(F$!$A8B81$(UG#'6>6.,^C<<88T"Q)&D;  "0N1L @$:YC%<^L$Q+4.)H5'
MM"13MA*:Q>)O5DPD*ZZF/-5LP=_G@8M(UDEKN&&%'^L>*(V6M+/=U<3)8&\]
M :TRA-(B%*WIC)ULS+,ZXVJJURPFLY<,TNH+*_IH7R!IM*0U?='S]XV!K#.$
MTB(4K6D,OS:&_\*0T1J7YLE?GGR1?\B+3RCV&H[V!Y)&H;0 2@NAM A%:_JH
MCC<];+[I00-.*(U":0&4%D)I$8K6-$T=<WKVG/-JL5!\P30G*R72J5BQN-4K
MT)#3>YXH/DL=*;3* $H+H;0(16M:H Y//7MZ>D3479*L'3>Q5W?T2 #-1Z&T
M$$J+4+2F#>J,U+.F:L<^AN3'G\:_?6FU"31 A=(HE!9 :2&4%J%H33_5,:HW
MQ#Z.((/""91&H;0 2@NAM A%:YJFCF(]>Q8[9IG(R$J*5&=D^SX4,:OC>Z9$
M,>BH_$GE;;E8?M=J(VA:6]+RZ&!G=>MZ?G__:04:Q4)I(906H6A-A]1QK&<-
M\/[K-&4^KT5Z,'>#IK90&H72 B@MA-(B%*WYGE8=W?HN=,+RH6$ME$:AM !*
M"Z&T"$5KFJ9.=7U[JOO_)RQ[!4?;J"V-=;V]V0I:9P"EA5!:A*(U[5%GNSXT
MV]V=K0[_+Y&]SJ,= TU[H;0 2@NAM A%:SJK3GM];-KK0]->*(U":0&4%D)I
M$8K6-$V=]OKVM!<P6T&#X)+F=?>FJ\&S]16TW@!*"Z&T"$7;6J2SLYLCX6I1
M;-3)R#1_KVW[ZGQUMMH,=%5L@=D[/_;.)U[+>>J=A]NM/C5^N_/HFJF%,'-;
MS.>F*O=DV'>(VF[FV1YHN2KVDMQ)K652?%T:1W*5%S"_SZ743P=Y!=66JM&_
M4$L#!!0    ( 'EY4%:M1BC[? ,  *83   9    >&PO=V]R:W-H965T<R]S
M:&5E=#@U+GAM;*V876_:,!2&_XJ53=,J;>0#"*6#2)0D6Z5.J]INNYAV8<(A
M1$WBS#;02OOQLYTT(UW(0#(7$#M^GW/L-SZ )SM"']@:@*/'+,W9U%AS7ER8
M)HO6D&'6(P7DXLZ*T QST:2QR0H*>*E$66HZEN6:&4YRPYNHOAOJ3<B&ITD.
M-Q2Q399A^G0)*=E-#=MX[KA-XC67':8W*7 ,=\"_%C=4M,R:LDPRR%E"<D1A
M-35F]D5H6U*@1GQ+8,?VKI&<RH*0!]FX6DX-2V8$*41<(K#XV,(<TE221!Z_
M*JA1QY3"_>MG>J@F+R:SP SF)/V>+/EZ:IP;: DKO$GY+=E]@FI"0\F+2,K4
M.]J58UW+0-&&<9)58I%!EN3E)WZL%F)/(#CM J<2."\%[@%!OQ+TCXTPJ 2#
M8P7#2C \5N!6 E>M?;E8:J5]S+$WH62'J!PM:/)"V:748H&37#Y9=YR*NXG0
M<<\/+N_1>_0EXF0!%#F68Z-[H!FZ)CA'LY@"B.>(H[<^<)RD[$P,_GKGH[>O
MSR8F%PE(C!E5P>9E,.= ,-M!GTG.UPP%^1*638 I,J_3=Y[3OW0ZB2+O'G+&
M[U3B;0EURWV(>JAO*[G3(O>/E[=%#XZ76RWRL%L^V\0]9+MMR3?6LE\_"GW%
MZQ],9\'15<XXW2C+?UR+ >B*0\9^MF1W6=(&[319$2]8@2.8&J+D,:!;,+PW
MKVS7^M#FDTZ8KQ,6Z(2%FF -?P>UOX,NNG<+!7Y2SI(5XG*/IV*/MSG;R3G5
MV1(V5##Y/;?UQ+=>]9J8VWW?VH:.SMN&!O\.M0]00TVS::SYL%[S8>>:_[>N
M_E8=#-W@)[Q(H<V-S@BGNJ$3YNN$!3IAH298PW.W]MS56D==G?[JA/DZ88%.
M6*@)UO!W5/L[ZMS3LUCLWAAS0 5-\B@I<-IFZ^CHNC?OC'>J:3IA@4Y8>-2*
M-"PYKRTY[[3DH]AGR1;O55A_ [+H#H\IL)WL4S>@3IBO$Q;HA(6:8 VWQ[7;
M8ZT%=JS37YTP7R<LT D+-<$:_MK6WS^EEJ:?JA6H\4-P?*#,=@<]U3NMM$ K
M+=1%*^TS]XX7,J"Q.@AB*"*;G)=_U>O>^K!IIHY87O3/[8N@/#+ZBRE/L#YC
M&B>B2J>P$DBK-Q*&TO)0J&QP4JA#C 7AG&3J<@UX"50.$/=7A/#GA@Q0'\UY
M?P!02P,$%     @ >7E05FZKE2G0!P  H4L  !D   !X;"]W;W)K<VAE971S
M+W-H965T.#8N>&ULM9SO;Z,V&,?_%2N;IDZZ-6 @;;HVTK6^:C===56[VS1-
M>T&)TZ+C1P9.>YWVQ\\0@G%CGL3M0U_<!8*_-E_LQ_Y@QZ=/>?&U?.!<D&]I
MDI5GHP<AEB?C<1D]\#0L#_,ES^0WB[Q(0R$/B_MQN2QX.*\3I<F8.LYDG(9Q
M-IJ=UN>NB]EIOA))G/'K@I2K- V+YW.>Y$]G(W>T.7$3WS^(ZL1X=KH,[_DM
M%U^6UX4\&K<J\SCE61GG&2GXXFSTWCUAP5&5H+[B]Y@_E9W/I+J5NSS_6AU\
MG)^-G*I$/.&1J"1"^=\CO^!)4BG)<OS3B([:/*N$W<\;]<OZYN7-W(4EO\B3
M/^*Y>#@;'8_(G"_"52)N\J=?>'-#0:47Y4E9_TN>FFN=$8E6I<C3)K$L01IG
MZ__#;XT1G012QYR -@GHO@F\)H'W,L&D)X'?)/!K9]:W4OO 0A'.3HO\B135
MU5*M^E";6:>6MQ]GU7._%87\-I;IQ(Q]./^-_$1N^&.>/,;9/;DH^#P6Y/U]
MP;E\OJ(D!XR+,$[*'^5U7VX9.?C^Q].QD'E7"N.HR>=\G0_MR<<E5WDF'DKR
M(9OSN2$]VY&> @)C>=/MG=/-G9]34/'7579(/.<=H0ZEA@)=[)_<-=T/G)SQ
M2"9W3;EK=^.US]&K]?P>O4]YF)7D.GP.[Q)N>CQ@\BJZG)3+,.)G(QD^2EX\
M\M'LA^_<B?.SR1I,,88DIMGFM[;YM;K79YL\)OEB4^LOPRA.8O%,_JJ_^"AX
M6OYM<M/'=!-3C"&):6X&K9L!6 D9OQ-$Y"0*E[$(D_C?L([M2UY$,I+(;N1=
M%;KB=)6:/ 6U;3W%%&-KL6DM5G6DCS/G<'(Z?C18-6FMFH!6O8_$*DQD#[7#
M,9-1H+*M49AB;&(PRJ=FIXY:IXY I[:ZIDTC-5D#2ME:@RG&D,0T"X];"X\'
MB7+'F&YBBC$D,<W-:>OF=, H!VK;>HHIQJ;[1SG74<-+!S3K2Q;E:1H+P><D
MSJ*B'E/*P)?(\0I9 "T9UK4U"E6--6I!QZJCP%G_]1C6&8^[H&%7ZZI#[O)"
MIJW"GJQGTB?97*5_R6I>G5J]VE4P<VM7,=58HS;IN.KOLI4J6RD\/FY"8%2'
MP'=$(G IPJQVL[6Z-%H&"EM;AJG&&K5N1>QS2H&$"Y-$;W]+_@,PD4@>XC4+
MD4L)\N1/'A9&-U$Y!%6-8:GIQBL4<8=A$1<51E#5&)::;JGB$7</((FS4A2K
MNI(*7J3D(,[(LZR>I?DU!BJ&["A?L"Z(T;E7I-1=4BCBPBS2W^48#4+%CT:M
M&\'H)N:K4-98@I2S;I/B$!<&D;9!+C@G!\UPSUR'4#$$58TU:M40IC/.<QPW
MZ.DX%&2XX*A;=AS5>V:M0X4K$BI>H*JQ1DVKEOY6M=2-4OS@P@"!U\/*!%?2
M\A[4@(MA;3 J;&"IZ:]^%9909Y"^EJ)2":H:PU+3+57@0F%PV3\\PD+6)J)"
M2*.V%1Z=J;G54T4@%"80W%;?_X(!+H:UNZB\@J6F/P*%-M0;IM6C0@NJ&L-2
MTRU5T$+!$;Q-JT?%%%0UUJBYWHM63VG/J(@J!*'P0!VUV7_Z>/[YQF@N*K6@
MJC$L-?T!*+JADV$:/2KGH*HQ+#7=4D5"%":A\[",2[+,XVIYP'J]"<DS\A@6
M<37]3(I0[ H&J(2$JL:HF9!<MR<4*$"BNP ).Q3 XW^X.-8FHP(6EIK^*!2"
MT>DP00$5J5#5&)::OOY$(94'S_2\/2C &5BO44&%JT9MBPNF/5'!4]SDP=PT
M3%3HYP.X.-8NH](7EIK^*!2B>720J."A(A>J&L-2TRWM+$N#9Y,0H@+NRC7<
MI6N>>:C@]P0%A54>C%5O#@J?L_XY.#AO:T=120Q+3?==T9H7#!,!4/D+58UA
MJ>F6*O[RX-FE5\S![5#T)CZ9A\^F:;.+UR=EKTJJFZ((RH,)RF[*K1'KSD:X
M/9-D%Q;7,KB0KZT9BH<\F(?V?W<$"UDW+U22:=2V)]1Z^@#%*-ZN:2*[^318
MSMHD5#9IU';42GT)MR(/'R8/M,X2QFFX%-:+OE'Q!$M-?P**87QWD&[31V41
M5#6&I:9;JEC$AZ>+]@^.L)"UB:CTT:AM3Z<%4_VO)P8HSO '7K76C0']\ R7
MPMIK5!C!4M.?0.>7-,,L7_-1:015C6&IZ98J&O'AN2.+&(#*'ZAJK%';>\61
MK]#"AX?DF(W^]O.E<68-+H*ULZC30%AJNOT*8ORC85H\ZN0/JAK#4M,M54CD
MPTCT]M=E< ;6YJ*BDF]&);<W$BA6\@=>4O<B$NP@ 5320E5C6&KZ#T 5BP7#
M+*P+4.$*58UAJ>F6*K@*X FBM\<$. -K<U$Q*^A9<#?M>8<>*((*!EYP9X@)
MP*^742D,58UAJ>D/0K%9,,RRNP 5ME#5&)::;JF"K0">'T*(":C8A:K&&K6M
M<8+7,TX(.AL4P$3UB0O!"U49C<[@;D2 NQ/!$',Y@0*N8)BU= $J1*&J,2PU
MW5(%40$\$[2QU/Z'J;"PM:FH&!5LST+Y@?%M_[BS=U'*B_MZ#ZB21/DJ$^O-
M?-JS[3Y3[^O=E5Z</W=/+M:[12F9]>955V%Q'V<E2?A"2CJ'1[)8Q7H_J/6!
MR)?U#DEWN1!Y6G]\D!&5%]4%\OM%GHO-095!NRO7[']02P,$%     @ >7E0
M5JA?XDF( P  X0X  !D   !X;"]W;W)K<VAE971S+W-H965T.#<N>&ULK9=M
M;Z,X$,>_BL6=3EWI-CP$DJ:71&K"5KO25E=M]^'%Z5XX, E6L<W93M+]]F<;
MPD)+4".1%\$&SW]F?AC;,S]R\20S (6>:<[DPLF4*FY<5R894"Q'O "FGVRY
MH%CIKMBYLA" 4VM$<S?PO(E+,6'.<F[O/8CEG.]53A@\""3WE&+Q<P4Y/RX<
MWSG=^$)VF3(WW.6\P#MX!/6M>!"ZY]8J*:' ).$,"=@NG%O_)O:M@1WQG<!1
M-MK(I++A_,ET/J4+QS,100Z),A)87PZPACPW2CJ._RI1I_9I#)OMD_J=35XG
ML\$2UCS_05*5+9QK!Z6PQ?M<?>''CU E%!F]A.?2_J-C.78Z<5"REXK3REA'
M0 DKK_BY M$P\,\9!)5!\-(@.F,PK@S&;S4(*X/0DBE3L1QBK/!R+O@1"3-:
MJYF&A6FM=?J$F??^J(1^2K2=6L8?5E_1>[3FE()(",[1 RY (,Q2]+?*=.LQ
MXT*]5R H6G&AY0G;2705@\(DE^^T\;?'&%W]_F[N*AV0D763ROFJ=!Z<<>X'
MZ)XSE4GT@:60M@5<[:I.)SBELPIZ%6-(1FCL_XD"+P@Z EKWF]_!9H1\[ZQY
M_';O?D\VX_KEC*U>>$:O\58*\U:Z"/<JF%7C1A8X@86CEP4)X@#.\H_?_(GW
M5Q>=(<7B@<1:Y,*:7&C5QV?(-29M#!N%_OFL!Z!/"JC\MXMB."3%(<7B@<1:
M%*.:8M0[_^[Q,Z%[BC:G[QXE6#LCZF<7PUZM2QF68I$5,WO781EZI]_</30)
MO1X:O![:RG]2YS]Y4_Z8\CU32&^;4NF%T8!(]\)<]$=)>-I%8_(J*C^,.A-8
M]P9QZ7P92*S%:UKSFO;R:GQUJ?GJ&L"Z$$U?(8IF42>A7K>7$BK%)@VWL^BE
MVU;ZUW7ZU[WI_["'#$@1/H#0AR:]B;*]7KL)TTA *B2P G2EYTP"3'7NEZ4#
MWVL$YXV\<!:\ -(;R*5 !A)K,9O5S&:]S.X@U:QR])%30)\Y9FB%V1.Z30^8
M)2"[&/4*7KK.#"D6#R36 NE[OTYRWJ![7B4W$,A!U>*AU-HH&X=B?\B%K%)K
MKF0O5[!^AQ?CZ7-8YNPV:@)]B-S9VDJBQ.QD97E0WZWKMUM;M;B_AI?%WST6
M.\(DRF&K3;W15/L593U5=A0O;(6QX4K7*[:9Z1H4A!F@GV\Y5Z>.<5!7M<O_
M 5!+ P04    " !Y>5!66(W]'S(*  #730  &0   'AL+W=O<FMS:&5E=',O
M<VAE970X."YX;6S%7&MOVS@6_2N$=[!H@=:V7H[330(D5HHMT'2#9CJ#Q6 _
M,#+C"-7#0]%Y+/;'[Z6DB*)%4];@&LZ'UI;)0][#R\M[1$IGSSG_63PR)LA+
MFF3%^>A1B/6GR:2('EE*BW&^9AG\\I#SE KXRE>38LT979:5TF3B3J>S24KC
M;'1Q5EZ[Y1=G^48D<<9N.2DV:4KYZQ5+\N?SD3-ZN_ ]7CT*>6%R<;:F*W;'
MQ(_U+8=ODP9E&:<L*^(\(YP]G(\NG4]A,)<5RA*_Q>RY:'TFTI3[//\IOWQ9
MGH^FLD<L89&0$!3^>V(+EB02"?KQ9PTZ:MJ4%=N?W] _E\:#,?>T8(L\^3U>
MBL?ST7Q$ENR!;A+Q/7_^)ZL-"B1>E"=%^2]YKLM.1R3:%")/Z\K0@S3.JO_I
M2TU$JX([VU'!K2NX6Q4<?T<%KZ[@[5O!KROX)3.5*24/(17TXHSGSX3+TH F
M/Y1DEK7!_#B3XWXG./P:0SUQ<7US^_5?_[Z^)E?7WZX_?_F5W'Z]_'9'/I)O
ME',JQX2\"YF@<5*\AZL_[D+R[I?WY!<R(<4CY:P@<49^9+$H/K0NW,1) J-:
MG$T$]%&V-(GJ_EQ5_7%W],=QR4V>B<>"7&=+MM0!)F!<8Z'[9N&5:T4,630F
MGO.!N%/7-71HL7]UQU ]W+_ZU&*-UXR75^)Y._#N),<?I:<OR2)/8?H7M)Q
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M/UN<UDTN"63>)"Z*#<T@+FX@9>$RZP2X)53(!(_O-Z)*D9ME0ULR>ASXM.O
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M!O5T(>A,?7N_!K-X"*D6**D6V*5:,_7WU!EVN,$.B2K9L-!T*I5D"XY]%C!
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M]6W>Z%[X.)]-]@Z_%ZVU&4W/0S41U:1*>W[<?=M^CWD9[5A!-175-%334<U
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M^E4B*_2EZ$"$':%?S2KT9?W/9.F,&!V(KB/T>2NP43DXHA@<QA@> P;@R/*
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M57-9Z=.\O7<@B-RZ..=AU$-H&X4LH3# < ,P] +\5BJ1[0$PM*Y-0AS3'D+
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M0",29.:>D8CI*LB.65BTK:ZNS0M1P #_ N=[5*@C>>N&:]H(XF\C]A'=CMI
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MC8'^_K[4?<7Z3?.P[.;AZ/%_ 5!+ P04    " !Y>5!6K,U)#=$#  "S$
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M:-5T=SX1X/\C>OD\'U65#XI6K4KY)0!;9?57A2^/WJ9\K295ZE*M84^Y[K[
MY9$[J%\7RRI_J=VPIWAW6^5@79!KT&TF5=I2K6&[7/^*".:ACZK@<;LJ?"G@
ML(^"]^@3L[,2=C*MXI<R#OOH>,<VJ4OS(34\8-HBA["4<=BNX_T$$=:%^8 B
M-E@>D$1U9T<IM_-WB#X'8H4/\4JX:N>6:#J:[9"S 2=)NLE\(EQL6=/3-48^
MIM) W%\1PM\'<M]:_$[A_ 102P,$%     @ >7E05M478$;]!0  BAP  !H
M  !X;"]W;W)K<VAE971S+W-H965T,3 S+GAM;*U9;6^C.!#^*U9N=4JE[0:;
M]UX;*0VI-M(VK?IRI_M($Z=!"S@+3MK]]V=>"L$>W-U>OK1 GAGFF8&9Q_C\
MA67?\PVE'+TF<9I?##:<;\]&HWRYH4F8?V%;FHI?UBQ+0BY.L^=1OLUHN"J-
MDGA$#,,9)6&4#L;GY;7;;'S.=CR.4GJ;H7R7)&'V\Y+&[.5B@ =O%^ZBYPTO
M+HS&Y]OPF=Y3_KB]S<39J/&RBA*:YA%+44;7%X,)/@N(7QB4B+\C^I(?'*."
MRA-CWXN3^>IB8!01T9@N>>$B%/_V=$KCN/ DXOA1.QTT]RP,#X_?O%^5Y 69
MIS"G4Q;_$ZWXYF+@#="*KL-=S._8RU=:$[(+?TL6Y^5?]%)CC0%:[G+.DMI8
M1)!$:?4_?*T3<6" G1X#4AL0V<#J,3!K _-7#:S:P"HS4U$I\Q"$/!R?9^P%
M905:>"L.RF26UH)^E!9UO^>9^#42=GQ\/_TZ"QZ_S= <G:+;R=UL\8"F-]>W
MD\6_Z&J^F"RF\\DW-%]<W=Q=3Q[F-PLTG+)T)0I/5^B>AYR*AX#GB*W1/%VR
MA)Z@84!Y&,7YB?#X>!^@X:<3] E%*;J.XEC4.C\?<1%Y<?_1LH[RLHJ2]$2)
M";IF*=_D:";NO>HZ& G*#6_RQON2:#T&=/D%F?@S(@8A0$#37S?'@'GPZ^:&
MAHW95-$L_9D]_N[HGJ8[FI]!J:U,+=BTZ"MG^39<THN!:!PYS?9T,/[S#^P8
M?T%I.::SX$C..BFSFI19.N_C!\;#6'2N*G%0WBI[N[0OVN=^[!//%>7:'R9$
M17FFX5A=5*"B7!?;=H/J4+ ;"K:VZK/7;?$>PE6WCUGU8SH+CN2LDS*G29FC
MK?K-EF8AC])GM&0Y!\M>.7 .2H6)XV*I[ #*P$1"!1#*L E<=K?AX&HY!%0D
M9AF%Q=R$"+C*35W+E\)7,8XE/=F!BK&)!X?N-:%[VM#G*:>BJ!P*VU-N9QER
MUE6,21PI;!5#/!,.VV_"]O5/#=_0#-'J=4/#J!ITGU%*02:^FEQ/(J)"3FV3
M2$Q4$#9ZF&"CG?>&ELOPDJ9T'?$3M,W8/BKUFY"/J"*%>/@*=\/:;>>Q<J2(
MIP#(\FR)%@#"IN'V$#L0,EA+;/9C%_&?A<X094'#F.6B-9X@&F:I>-]A3E@M
M@R534C&.PDC%N%8/']+R(5H^"\&B*@H8.@$><T.I!X#R37DX 2C3=/H*TFH2
MK)W?X]LP$](035FR#=.?((FC2I.C>@N.Y:V;O%:=8.OCB@YKI<UOY^V8WH)C
M>>OFK95$6"L?QM=A*I:KQ9H$K2G-T7(39L]BJ<(98LWLSW=/>;2*PBSJZ76V
MVJ%L6^D, ,HQ3?GE4E&$8*?GY6IU#-8+F7FZ%W.TY!FF*\3*"54VO9.Z:_2.
M)ZRJDE-/'E 0B#CRK 50KM,WHEI]@_4"YWUICE5M@BTYNBF$.NQK-0<517S7
M[R'1*AWL?5R<8ZU,^NT7^)C>@F-YZ^:ME5KX':WUOD+'@#!R#7EA!J$L0YE]
M*HH0HV=XDU9E$;W*>D^C$U4#V9ZL=@&0);^H 0 R_9[935HQ1?1B2B?4B:IV
M+"7[ ,C$<F\$0+U:G;3"B>B%4]4^:K4./D $D$6.FGX 10Q9^T$HS^M[@%KQ
M1/3BZ3>7'+6WPRB4BJB04\>5UQP RC%ZR+1BANB_M0R_'<PE]$3%>H-V%ASE
M#*,= ?^FVXLOB^_-Z_KV'6IB,6[+&8!@RDP#4&;/AQK2RA*BER4?774153VH
M8W@*HFQ?)@;HE9[U/&EU"-'K$+"T_Z.2@.SPE:\7 ,I7>@OP[:6O+;;*A.B5
MR>SCQ%258;JVTG( +>(Z\E<ER!=Q>A0+:14+T7^<^< "FJ@?6Y2VHT)<Y<E4
M,0?=N$NG%1)$+R3TZ^?:V.ZT;67]#*%\1>(#*&#]/#K8I$FH6)04FUUB@<)V
M*:_V+9JKS8;:I-Q&DJY?XK.@VA9KW52[=-=BK1.E.8KI6K@TOK@BI*S:^*I.
M.-N66T%/C'.6E(<;&JYH5@#$[VO&^-M)<8-F^W'\'U!+ P04    " !Y>5!6
M_O,/2K4%   ='0  &@   'AL+W=O<FMS:&5E=',O<VAE970Q,#0N>&ULO5EK
M3^,X%/TK5G>T @EH[/3)EDJE 5$)"N*QJ]5J/YC4;;.3Q)W8+3"_?NTD)&U\
M$\I.=KY DYY[XW-]8Y]3#UYX]%4L&9/H-?!#<=982KDZ;3:%NV0!%2=\Q4+U
MS9Q' 97J,EHTQ2IB=!8'!7Z36%:G&5 O; P'\;V[:#C@:^E[(;N+D%@' 8W>
MSIG/7\X:N/%^X]Y;+*6^T1P.5G3!'IA\6MU%ZJJ999EY 0N%QT,4L?E98X1/
M'=+5 3'B=X^]B*W/2%-YYORKOIC,SAJ6'A'SF2MU"JK^;=B8^;[.I,;Q+4W:
MR)ZI [<_OV>_C,DK,L]4L#'W__!F<GG6Z#70C,WIVI?W_.6*I83:.I_+?1'_
M12\IUFH@=RTD#])@-8+ "Y/_]#4MQ%8 [I0$D#2 % -:)0%V&F#O&]!* UIQ
M91(J<1T<*NEP$/$7%&FTRJ8_Q,6,HQ5]+]3S_B C]:VGXN3P87QUX3Q=7Z )
M.D9WH_N+Z2,:W][<C:9_HLO)=#0=3T;7:#*]O+V_&3U.;J?H8,S#F9IX-D,/
MDDJFFD *Q.=HS /5>DO=$QN&)J'+ W:(#APFJ>>+0Y7_Z<%!!U\.T1?DA>C&
M\WTU\V+0E(J''DW33<=\GHR9E(P9$W3#0[D4Z$*-9+:;H*D*D%6!O%?AG%1F
M=)A[@FQ\A(A%"#"@\?[A& AW]@^W*MC8V9S:<3Z[)%\^09=>2$/7H_[65!VA
M,5WI=TZ@OZY5))JH+\3?T#0DCVG!C]$KTJE849>=-=2\"Q9M6&/XZR^X8_T&
ME;#.9$Y-R7;*V\K*VZK*/IRJU=B+NQM1*2/O>2WIL\^0Y.AJ'="00J5,4K;C
ME'HMW@Q)S^H,FIOM$@&@OFWO@AP39-N=;@;:H=3.*+4K.^96+EF$W)T7.*5X
MX',A#D\A3NTZVZ/.9$Y-R79JV<EJV:ELC_&2A@M=/K2(5.G0.E3[L>]]5Z^C
M%VZ8D/HM3,K*U*JX4'LSN 8F3^ELS?,Q[N%^H64 E-TN])5C@NR^#7=,-V/9
MK61Y,9^KG5LO^VF?2/K*0!Y=X^$MW"NP,#$]7.!@0HY[?9A#+^/0J^3PR*5:
M&=ULOO:9J2,4LIBVX@NQ[0&SUK(*9,8 BG3;!<8FR+9:,.-^QKA?R?B>N3X5
MPIM[+DUDU^R?=<I3:<B86U:#A#<ZB'D?ZGGVU[.X-MOE2:8?*D7?&'^7%.I@
M0HZQ55SP %#?@NN K5SV6#7U;YIH=Y#= A$ 1(H\($P9CRWYAO?HX:A\7C]J
MV#3_]JC:[2([$W/<LXKT %"WC!_)^9%*?M#.E&Q)Z<1]R(\ TV>WBELO!+.+
MA7  %+%+WDF<RS5<*5>&8VC?+4H+]FWMR3<4,+GDV^L3W+.V,4ZK2-B$%+<-
M ()+N.;:"5>+I[VXELNH-/O.D%H=@YN)(NU>JTC/1-D=BY0PS*44KE07PSL:
MZ751$Z7A&TBB5N%4:S:GKFR[Q<NU$^[\'.N"*T7:IVM<9S:GKFR[-<Z5&ZZ6
M;O_)OV!3?P$&!D*9#@9 E5L8G*LYW/L?3 RNU(B?;I0ZLSEU9=LM:"X6<;5:
MK,O)8$CFF58&@IE>!D"5FAF2RT%2EQPDIHHS_0P ,@P-@"EU-"37@V0?/5BO
MIR& L@-,#00S70V *K4U))>)I%HF_E1C0TP5:#@;  -8&PA5YFU(KB=)M9[\
M1#.;"L_T-@#(\#80IHQ'KA5)M5;\86]#3(5G>!L 8WH;"%3F;4BN%$FU4OQA
M;Y/F_\C;0##3VP"H4F]#<D%'/O@UK'9O0\Q?LXKZ'X 4MQ$ 4N)M2"ZL2+6P
M^D%ODV;?_F47\#8 "O V  KP-LVM<Z. 18OX_$VHCER',CD\R>YF9WRC^&2K
M</\<GSK)25V>)CDXO*'10JVRR&=SE=(ZZ:HA1<E97'(A^2H^G7KF4O(@_KAD
M=,8B#5#?SSF7[Q?Z =F)Z/!?4$L#!!0    ( 'EY4%8T$VJ%UP@  %,Q   :
M    >&PO=V]R:W-H965T<R]S:&5E=#$P-2YX;6R]6VMOVS@6_2N$=[!(@:86
M'WIU$P.NU6 ,-&F03'<P&.P'V:9CH;;DD>AD\N^7DAS3(B^9N!7F2RO;AU<\
MY.7EX9%R\524WZL5YP+]O5GGU>5@)<3VXW!8S5=\DU8?BBW/Y2_+HMRD0GXL
M'X;5MN3IHFFT60^)YP7#39KE@]%%\]UM.;HH=F*=Y?RV1-5NLTG+YT]\73Q=
M#O#@Y8N[[&$EZB^&HXMM^L#ON?BVO2WEI^$ARB+;\+S*BAR5?'DY&../B>_5
M#1K$?S/^5!U=HYK*K"B^UQ^FB\N!5_>(K_E<U"%2^=\CG_#UNHXD^_'7/NC@
M<,^ZX?'U2_2KAKPD,TLK/BG6OV<+L;H<1 .TX,MTMQ9WQ=.O?$_(K^/-BW75
M_(N>]EAO@.:[2A2;?6/9@TV6M_^G?^\'XJ@!#BP-R+X!T1LP2P.Z;T#?VH#M
M&[!F9%HJS3@DJ4A'%V7QA,H:+:/5%\U@-JTE_2ROY_U>E/+73+83H_O)KY^3
M;U\^HRDZ1[?CN\\WOZ')U^O;\<T?Z&IZ,[Z93,=?T/3FZNO=]?BWZ=<;=#8I
M\H6<>+Y ]R(57":!J%"Q1).T6J$KF4C5.W26<)%F:WEUCK[=)^CLEW?H%Y3E
MZ#I;K^5\5Q=#(7M?]V$XW_?T4]M38NDI)NBZR,6J0I_E_1?= $-)^\"=O'#_
M1)P1$S[_@"A^CXA'"-"AR=N;8Z!Y\O;FGH,-/<PD;>)12SPU+5=9GN;S+%T?
M3=![.3W;>J55Z,\OLB6:RA^J_T'3T-Z&P;>IZ]#':IO.^>5 %IJ*EX]\,/KW
MOW#@_0<:PCZ#)3T%ZPPO.PPO<T4?W<@:/*\S?%L6CYE,0#1[1K+\EJG(\H>V
M?F4BXV!FMZ'])G1=B1]'S(_"B^'C\5"9($("T@4E)L@/:'P =:CY!VJ^,W-J
M:LWBO3VB=O:M3J4L?X>F^2.O&I+C TGTYWA6B5*R!E/([S.%^@R6]!2L,\[!
M89P#9PJ-YW_MLBIK5N%[E,M1EU6SR:DT7[077"(>TW534M,:7NJ5KAW@]D;!
M41J<4ZHG% !B6$^[!$"%GB6CP@/3T,GT=E?.5W(W;O:%K,F?N@JABL]WI765
MA&9/ H_%&BL %>)89P6@8DQ\F%9TH!6Y:97%G/-%A99EL4&5G*>3^$5&GPBC
M3*-G@JC/='9 I/ (U"$7'\C%3G+7J=CW_212L=$53 -?(V6"B&],F0EB<13
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MH3!_3'NI2#HQ,7],^RQ-6OUVB@EDVD-ITMF6Z/,.8I5T)/^=C)A.IL0Z^7D
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M O2NJG<%Z%U5[PK0NZK>%:!W5;TK0.^J>E> WK49U@'H;4T[K@/PVYIF8,<
M!+>F&=DQ ,.M:89V#$!Q:YJQ'0-PW)IF<,< )+>F&=TQWVGY.'WLAO%:]+5N
M KY3[NGRV>'Z_9_+KXOM_?Z)=7^;,3[^!5!+ P04    " !Y>5!6H4#6(VT"
M  #_.P  $P   %M#;VYT96YT7U1Y<&5S72YX;6S-V]]NFS 4Q_%7B;BM MA@
M U/3FW:W6R_V @R<!H5_LMTN??LYI*VTJ8M69=*^-T&)[?,[^$B?NUQ_>YZ-
M6QV&?G2;:.?]_"E)7+,S0^WB:39C6-E.=JA]^&H?DKEN]O6#262:ZJ291F]&
MO_;'&M'-]9W9UH^]7WT^A)]=-XV;R)K>1:O;T\9CUB:JY[GOFMJ']>1I;']+
M6;\DQ.'DLL?MNME=A0U1\F["<>7/ 2_GOCX9:[O6K.YKZ[_40]B5'/K$^>?>
MN/A\B7=ZG+;;KC'MU#P.X4CL9FOJUNV,\4,?GXI>G4_VX8;-Z5-<G+^4.1<8
M=M[;:79A8M9\/.YU),?3ZSD4,M9WYU_Q+3&4OOC]S'':K6G_,CM<[X_)[I=Y
MN&1Y7'['O\[XK?X'^Y"0/C)('SFD#P7I0T/Z*"!]E) ^*D@?(J4T0A%54$@5
M%%,%!55!45506!445P4%5D&155)DE119)45629%54F25%%DE159)D5529)44
M63.*K!E%UHPB:T:1-:/(FE%DS2BR9A19,XJL&476G")K3I$UI\B:4V3-*;+F
M%%ESBJPY1=:<(FM.D5519%44615%5D6155%D5119%45619%54615%%DU159-
MD5539-44635%5DV155-DU119-45639&UH,A:4&0M*+(6%%D+BJP%1=:"(FM!
MD;6@R%I09"TILI8464N*K"5%UI(B:TF1M:3(6E)D+2FREA19*XJL%476BB)K
M19&UHLA:462M*+)6%%DKBJP515:14F@5*<56D5)P%2E%5Y%2>!4IQ5>1_D]@
MOT_3_A_'+\]XJ+OQ-3]9_O=[\Q-02P$"% ,4    " !Y>5!6!T%-8H$   "Q
M    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0
M   ( 'EY4%;RE&NC[0   "L"   1              "  :\   !D;V-0<F]P
M<R]C;W)E+GAM;%!+ 0(4 Q0    ( 'EY4%:97)PC$ 8  )PG   3
M      "  <L!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ >7E0
M5N"EA6ON!P  TB\  !@              ("!# @  'AL+W=O<FMS:&5E=',O
M<VAE970Q+GAM;%!+ 0(4 Q0    ( 'EY4%;,E6D6/P(  ,(%   8
M      " @3 0  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M" !Y>5!6D(WC_*X&  #D&P  &               @(&E$@  >&PO=V]R:W-H
M965T<R]S:&5E=#,N>&UL4$L! A0#%     @ >7E05E>)29XY P  (PH  !@
M             ("!B1D  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4
M Q0    ( 'EY4%82%BN@W@4  )\9   8              " @?@<  !X;"]W
M;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4    " !Y>5!6P<SCG$\$  #]
M#P  &               @($,(P  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL
M4$L! A0#%     @ >7E05G]G4^O-"P  %8,  !@              ("!D2<
M 'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( 'EY4%8P6=;2
M40H  &\T   8              " @90S  !X;"]W;W)K<VAE971S+W-H965T
M."YX;6Q02P$"% ,4    " !Y>5!6+\\-]#0'  #[#P  &
M@($;/@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ >7E0
M5J3DM<UV*0  ZH0  !D              ("!A44  'AL+W=O<FMS:&5E=',O
M<VAE970Q,"YX;6Q02P$"% ,4    " !Y>5!6D<)&3TD(   ,%   &0
M        @($R;P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0
M   ( 'EY4%8.X_CMC 4  .0-   9              " @;)W  !X;"]W;W)K
M<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ >7E05J2.Q;6N"@  1QT
M !D              ("!=7T  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q0
M2P$"% ,4    " !Y>5!6:K<R48L+  !H(0  &0              @(%:B
M>&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( 'EY4%:6(OJ"
M.P0  &8)   9              " @1R4  !X;"]W;W)K<VAE971S+W-H965T
M,34N>&UL4$L! A0#%     @ >7E05G(^"I0V P  #0<  !D
M ("!CI@  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4    " !Y
M>5!6K_K1S"4%  !["P  &0              @('[FP  >&PO=V]R:W-H965T
M<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( 'EY4%:7,-Y4[ 8  .X1   9
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M970R,BYX;6Q02P$"% ,4    " !Y>5!6DN5F-7(#  "Q!P  &0
M    @(&]TP  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (
M 'EY4%8?::A/O P   LL   9              " @6;7  !X;"]W;W)K<VAE
M971S+W-H965T,C0N>&UL4$L! A0#%     @ >7E05AB!$%#,'   \%   !D
M             ("!6>0  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"
M% ,4    " !Y>5!6ML0MWUT0  "J+P  &0              @(%< 0$ >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( 'EY4%:17-D_QP4
M #X.   9              " @? 1 0!X;"]W;W)K<VAE971S+W-H965T,C<N
M>&UL4$L! A0#%     @ >7E05H4A?-AT#0  -B0  !D              ("!
M[A<! 'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !Y>5!6
M("9HD&PX   7OP  &0              @(&9)0$ >&PO=V]R:W-H965T<R]S
M:&5E=#(Y+GAM;%!+ 0(4 Q0    ( 'EY4%:#_:@)50,  #\'   9
M      " @3Q> 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#%
M  @ >7E05EWY_Z.? P  +@@  !D              ("!R&$! 'AL+W=O<FMS
M:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !Y>5!6JH6+) 4#  "Q!@
M&0              @(&>90$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+
M 0(4 Q0    ( 'EY4%:O-LJ=0 @  "L8   9              " @=IH 0!X
M;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ >7E05HPOE:TX
M!@  #A$  !D              ("!47$! 'AL+W=O<FMS:&5E=',O<VAE970S
M-"YX;6Q02P$"% ,4    " !Y>5!6GQ_2+3P$   H"0  &0
M@(' =P$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( 'EY
M4%8TY'+@W0(  !0&   9              " @3-\ 0!X;"]W;W)K<VAE971S
M+W-H965T,S8N>&UL4$L! A0#%     @ >7E05LV!R<0#!0  NPL  !D
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M=#0Q+GAM;%!+ 0(4 Q0    ( 'EY4%;PIB("]P0  +(,   9
M  " @0*6 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @
M>7E05ID.</Z( P  M0<  !D              ("!,)L! 'AL+W=O<FMS:&5E
M=',O<VAE970T,RYX;6Q02P$"% ,4    " !Y>5!6 > 38HL#   ="   &0
M            @('OG@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4
M Q0    ( 'EY4%;&"Y9WP@<  ),7   9              " @;&B 0!X;"]W
M;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ >7E05IW3A#-? P
ME0X  !D              ("!JJH! 'AL+W=O<FMS:&5E=',O<VAE970T-BYX
M;6Q02P$"% ,4    " !Y>5!67XDI]40+   9=@  &0              @(%
MK@$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( 'EY4%8#
MU#FQ_@(  ( (   9              " @;NY 0!X;"]W;W)K<VAE971S+W-H
M965T-#@N>&UL4$L! A0#%     @ >7E05E2<.ZOT @  8 @  !D
M     ("!\+P! 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( 'EY4%;#-+P#X00  !D=   9              "
M@3_4 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ >7E0
M5I0'9W55!@  [R<  !D              ("!5]D! 'AL+W=O<FMS:&5E=',O
M<VAE970U-2YX;6Q02P$"% ,4    " !Y>5!66]%;B;X'  "[-P  &0
M        @('CWP$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0
M   ( 'EY4%;YI"90,@0  #,0   9              " @=CG 0!X;"]W;W)K
M<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ >7E05J]RW?$[ P  .PH
M !D              ("!0>P! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q0
M2P$"% ,4    " !Y>5!6JHA"ZA(#  #R"   &0              @(&S[P$
M>&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( 'EY4%8>1WM+
MA@,  /T.   9              " @?SR 0!X;"]W;W)K<VAE971S+W-H965T
M-C N>&UL4$L! A0#%     @ >7E05BEB*'(C#   ;H$  !D
M ("!N?8! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4    " !Y
M>5!6LM8F6: '  !730  &0              @($3 P( >&PO=V]R:W-H965T
M<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    ( 'EY4%;EXIX>@@,  ,(*   9
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M970V-RYX;6Q02P$"% ,4    " !Y>5!6UXTX)_,#  #@$   &0
M    @(%:'P( >&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    (
M 'EY4%;,CI,HQP4  !$@   9              " @80C @!X;"]W;W)K<VAE
M971S+W-H965T-CDN>&UL4$L! A0#%     @ >7E05H\3;ERJ @  S@8  !D
M             ("!@BD" 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"
M% ,4    " !Y>5!6()XI %("  #F!0  &0              @(%C+ ( >&PO
M=V]R:W-H965T<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( 'EY4%9E]UT;6 0
M ,L2   9              " @>PN @!X;"]W;W)K<VAE971S+W-H965T-S(N
M>&UL4$L! A0#%     @ >7E05E'EFD6> @  M0<  !D              ("!
M>S," 'AL+W=O<FMS:&5E=',O<VAE970W,RYX;6Q02P$"% ,4    " !Y>5!6
MO/0_T70$   #$@  &0              @(%0-@( >&PO=V]R:W-H965T<R]S
M:&5E=#<T+GAM;%!+ 0(4 Q0    ( 'EY4%:TVT]=R ,  $(3   9
M      " @?LZ @!X;"]W;W)K<VAE971S+W-H965T-S4N>&UL4$L! A0#%
M  @ >7E05GAN4J_E P  EA8  !D              ("!^CX" 'AL+W=O<FMS
M:&5E=',O<VAE970W-BYX;6Q02P$"% ,4    " !Y>5!6"8UO9B<#  "J"0
M&0              @($60P( >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+
M 0(4 Q0    ( 'EY4%9_>0OD[@,  !T-   9              " @71& @!X
M;"]W;W)K<VAE971S+W-H965T-S@N>&UL4$L! A0#%     @ >7E05K=H?U1-
M!   HP\  !D              ("!F4H" 'AL+W=O<FMS:&5E=',O<VAE970W
M.2YX;6Q02P$"% ,4    " !Y>5!6&GM(?>8"   +"P  &0
M@($=3P( >&PO=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( 'EY
M4%:G.7X@V@L  "J!   9              " @3I2 @!X;"]W;W)K<VAE971S
M+W-H965T.#$N>&UL4$L! A0#%     @ >7E05L8RZ_-% @  (@8  !D
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M=#@V+GAM;%!+ 0(4 Q0    ( 'EY4%:H7^))B ,  .$.   9
M  " @;)Z @!X;"]W;W)K<VAE971S+W-H965T.#<N>&UL4$L! A0#%     @
M>7E05EB-_1\R"@  UTT  !D              ("!<7X" 'AL+W=O<FMS:&5E
M=',O<VAE970X."YX;6Q02P$"% ,4    " !Y>5!6D);(^'<#   ]#P  &0
M            @(':B ( >&PO=V]R:W-H965T<R]S:&5E=#@Y+GAM;%!+ 0(4
M Q0    ( 'EY4%;0!.Z1ZP,  %D2   9              " @8B, @!X;"]W
M;W)K<VAE971S+W-H965T.3 N>&UL4$L! A0#%     @ >7E05@ VGS^3 P
MS@H  !D              ("!JI " 'AL+W=O<FMS:&5E=',O<VAE970Y,2YX
M;6Q02P$"% ,4    " !Y>5!6+.I<4'4#  !=#   &0              @(%T
ME ( >&PO=V]R:W-H965T<R]S:&5E=#DR+GAM;%!+ 0(4 Q0    ( 'EY4%89
M5/Y^L00  *D3   9              " @2"8 @!X;"]W;W)K<VAE971S+W-H
M965T.3,N>&UL4$L! A0#%     @ >7E05C8@MU:[ @  < <  !D
M     ("!")T" 'AL+W=O<FMS:&5E=',O<VAE970Y-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( 'EY4%8"EX48\A8  )KG   9              "
M@3+* @!X;"]W;W)K<VAE971S+W-H965T.3DN>&UL4$L! A0#%     @ >7E0
M5N,C;NQ[!   D!D  !H              ("!6^$" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,# N>&UL4$L! A0#%     @ >7E05HB $I]C"   *"T  !H
M         ("!#N8" 'AL+W=O<FMS:&5E=',O<VAE970Q,#$N>&UL4$L! A0#
M%     @ >7E05JS-20W1 P  LQ   !H              ("!J>X" 'AL+W=O
M<FMS:&5E=',O<VAE970Q,#(N>&UL4$L! A0#%     @ >7E05M478$;]!0
MBAP  !H              ("!LO(" 'AL+W=O<FMS:&5E=',O<VAE970Q,#,N
M>&UL4$L! A0#%     @ >7E05O[S#TJU!0  '1T  !H              ("!
MY_@" 'AL+W=O<FMS:&5E=',O<VAE970Q,#0N>&UL4$L! A0#%     @ >7E0
M5C03:H77"   4S$  !H              ("!U/X" 'AL+W=O<FMS:&5E=',O
M<VAE970Q,#4N>&UL4$L! A0#%     @ >7E05D4=. YS P  @@H  !H
M         ("!XP<# 'AL+W=O<FMS:&5E=',O<VAE970Q,#8N>&UL4$L! A0#
M%     @ >7E05EI:.TYA P  DA8   T              ( !C@L# 'AL+W-T
M>6QE<RYX;6Q02P$"% ,4    " !Y>5!6EXJ[',     3 @  "P
M    @ $:#P, 7W)E;',O+G)E;'-02P$"% ,4    " !Y>5!6T'-AZ\$'  !3
M10  #P              @ $#$ , >&PO=V]R:V)O;VLN>&UL4$L! A0#%
M  @ >7E05N,-K,?_ @  13X  !H              ( !\1<# 'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ >7E05J% UB-M @  _SL
M !,              ( !*!L# %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&
/ '( <@!<'P  QAT#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>563</ContextCount>
  <ElementCount>567</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>155</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>12</UnitCount>
  <MyReports>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOW</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - REPORTING ENTITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/REPORTINGENTITY</Role>
      <ShortName>REPORTING ENTITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - ACQUISITIONS AND DIVESTITURES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - EQUITY METHOD INVESTMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EQUITYMETHODINVESTMENT</Role>
      <ShortName>EQUITY METHOD INVESTMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - INVESTMENT SECURITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIES</Role>
      <ShortName>INVESTMENT SECURITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - FAIR VALUE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUE</Role>
      <ShortName>FAIR VALUE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - MEDICARE PART D</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/MEDICAREPARTD</Role>
      <ShortName>MEDICARE PART D</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - PROPERTY AND EQUIPMENT, NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/PROPERTYANDEQUIPMENTNET</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - BENEFITS PAYABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BENEFITSPAYABLE</Role>
      <ShortName>BENEFITS PAYABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - EMPLOYEE BENEFIT PLANS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EMPLOYEEBENEFITPLANS</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION</Role>
      <ShortName>EARNINGS PER COMMON SHARE COMPUTATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS, GUARANTEES AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - REINSURANCE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/REINSURANCE</Role>
      <ShortName>REINSURANCE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION</Role>
      <ShortName>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESTables</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - EQUITY METHOD INVESTMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EQUITYMETHODINVESTMENTTables</Role>
      <ShortName>EQUITY METHOD INVESTMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/EQUITYMETHODINVESTMENT</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - INVESTMENT SECURITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESTables</Role>
      <ShortName>INVESTMENT SECURITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/INVESTMENTSECURITIES</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - FAIR VALUE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUETables</Role>
      <ShortName>FAIR VALUE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/FAIRVALUE</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - MEDICARE PART D (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/MEDICAREPARTDTables</Role>
      <ShortName>MEDICARE PART D (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/MEDICAREPARTD</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/PROPERTYANDEQUIPMENTNETTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/PROPERTYANDEQUIPMENTNET</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/LEASES</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - BENEFITS PAYABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BENEFITSPAYABLETables</Role>
      <ShortName>BENEFITS PAYABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/BENEFITSPAYABLE</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/INCOMETAXES</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/DEBT</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EMPLOYEEBENEFITPLANSTables</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/EMPLOYEEBENEFITPLANS</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables</Role>
      <ShortName>EARNINGS PER COMMON SHARE COMPUTATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - STOCKHOLDERS' EQUITY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/STOCKHOLDERSEQUITYTables</Role>
      <ShortName>STOCKHOLDERS' EQUITY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/STOCKHOLDERSEQUITY</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.humana.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - REPORTING ENTITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/REPORTINGENTITYDetails</Role>
      <ShortName>REPORTING ENTITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/REPORTINGENTITY</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Part D Subsidy/Discount Payments, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Part D Subsidy/Discount Payments, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Health Care Cost Payments, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Health Care Cost Payments, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - ACQUISITIONS AND DIVESTITURES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - ACQUISITIONS AND DIVESTITURES - Assets, Liabilities And Noncontrolling Interest Disposed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Assets, Liabilities And Noncontrolling Interest Disposed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - ACQUISITIONS AND DIVESTITURES - Preliminary Fair Value on Date of Acquisition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails</Role>
      <ShortName>ACQUISITIONS AND DIVESTITURES - Preliminary Fair Value on Date of Acquisition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - EQUITY METHOD INVESTMENT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails</Role>
      <ShortName>EQUITY METHOD INVESTMENT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - EQUITY METHOD INVESTMENT - Summarized Balance Sheets and Statements of Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails</Role>
      <ShortName>EQUITY METHOD INVESTMENT - Summarized Balance Sheets and Statements of Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - INVESTMENT SECURITIES - Classified as Current and Long-Term (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Classified as Current and Long-Term (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - INVESTMENT SECURITIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - INVESTMENT SECURITIES - Realized Gains (Losses) Included Within Investment Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Realized Gains (Losses) Included Within Investment Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - INVESTMENT SECURITIES - Gains (Losses) on Equity Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Gains (Losses) on Equity Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails</Role>
      <ShortName>INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails</Role>
      <ShortName>FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - FAIR VALUE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUENarrativeDetails</Role>
      <ShortName>FAIR VALUE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details</Role>
      <ShortName>FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - FAIR VALUE - Put and Call Options Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails</Role>
      <ShortName>FAIR VALUE - Put and Call Options Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - MEDICARE PART D (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/MEDICAREPARTDDetails</Role>
      <ShortName>MEDICARE PART D (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/MEDICAREPARTDTables</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - PROPERTY AND EQUIPMENT, NET - Property and Equipment Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET - Property and Equipment Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - PROPERTY AND EQUIPMENT, NET - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT, NET - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill by Reportable Segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill by Reportable Segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Details of Intangible Assets Included in Other Long-Term Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Details of Intangible Assets Included in Other Long-Term Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Estimate of Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails</Role>
      <ShortName>GOODWILL AND OTHER INTANGIBLE ASSETS - Estimate of Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - LEASES - Maturity of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails</Role>
      <ShortName>LEASES - Maturity of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - BENEFITS PAYABLE - Activity in Benefits Payable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails</Role>
      <ShortName>BENEFITS PAYABLE - Activity in Benefits Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - BENEFITS PAYABLE - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails</Role>
      <ShortName>BENEFITS PAYABLE - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - BENEFITS PAYABLE - Incurred and Paid Claims Development (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails</Role>
      <ShortName>BENEFITS PAYABLE - Incurred and Paid Claims Development (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - INCOME TAXES - Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>0000078 - Disclosure - INCOME TAXES - Provision for Income Taxes Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails</Role>
      <ShortName>INCOME TAXES - Provision for Income Taxes Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>0000079 - Disclosure - INCOME TAXES - Principal Components of Net Deferred Tax Balances (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails</Role>
      <ShortName>INCOME TAXES - Principal Components of Net Deferred Tax Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>0000080 - Disclosure - INCOME TAXES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>0000081 - Disclosure - DEBT - Debt Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTDebtOutstandingDetails</Role>
      <ShortName>DEBT - Debt Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>0000082 - Disclosure - DEBT - Maturities of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTMaturitiesofDebtDetails</Role>
      <ShortName>DEBT - Maturities of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>0000083 - Disclosure - DEBT - Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.humana.com/role/DEBTSeniorNotesDetails</Role>
      <ShortName>DEBT - Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>0000084 - Disclosure - DEBT - Delayed Draw Term Loan Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails</Role>
      <ShortName>DEBT - Delayed Draw Term Loan Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>0000085 - Disclosure - DEBT - October 2021 Term Loan Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails</Role>
      <ShortName>DEBT - October 2021 Term Loan Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>0000086 - Disclosure - DEBT - Revolving Credit Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails</Role>
      <ShortName>DEBT - Revolving Credit Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>0000087 - Disclosure - DEBT - Commercial Paper and Other Short-term Borrowings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails</Role>
      <ShortName>DEBT - Commercial Paper and Other Short-term Borrowings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>0000088 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>0000089 - Disclosure - EMPLOYEE BENEFIT PLANS - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>0000090 - Disclosure - EMPLOYEE BENEFIT PLANS - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>0000091 - Disclosure - EMPLOYEE BENEFIT PLANS - Weighted-Average Fair Value Assumptions for Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS - Weighted-Average Fair Value Assumptions for Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>0000092 - Disclosure - EMPLOYEE BENEFIT PLANS - Option Plans Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails</Role>
      <ShortName>EMPLOYEE BENEFIT PLANS - Option Plans Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>0000093 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails</Role>
      <ShortName>EARNINGS PER COMMON SHARE COMPUTATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables</ParentRole>
      <Position>93</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>0000094 - Disclosure - STOCKHOLDERS' EQUITY - Dividend Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/STOCKHOLDERSEQUITYDividendPaymentsDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Dividend Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>0000095 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>0000096 - Disclosure - STOCKHOLDERS' EQUITY - Share Repurchases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails</Role>
      <ShortName>STOCKHOLDERS' EQUITY - Share Repurchases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>0000097 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES</ParentRole>
      <Position>97</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>0000098 - Disclosure - SEGMENT INFORMATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails</Role>
      <ShortName>SEGMENT INFORMATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>0000099 - Disclosure - SEGMENT INFORMATION - Segment Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails</Role>
      <ShortName>SEGMENT INFORMATION - Segment Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>0000100 - Disclosure - REINSURANCE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/REINSURANCEDetails</Role>
      <ShortName>REINSURANCE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/REINSURANCE</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>0000101 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails</Role>
      <ShortName>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>0000102 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets Share Data) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails</Role>
      <ShortName>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets Share Data) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION</ParentRole>
      <Position>102</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>0000103 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails</Role>
      <ShortName>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION</ParentRole>
      <Position>103</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>0000104 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Comprehensive Income) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails</Role>
      <ShortName>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Comprehensive Income) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION</ParentRole>
      <Position>104</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>0000105 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Cash Flows) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails</Role>
      <ShortName>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Cash Flows) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION</ParentRole>
      <Position>105</Position>
    </Report>
    <Report instance="hum-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>0000106 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Notes to Condensed Financial Statements) (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails</Role>
      <ShortName>SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Notes to Condensed Financial Statements) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION</ParentRole>
      <Position>106</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 6 fact(s) appearing in ix:hidden were eligible for transformation: hum:TRICAREManagedCareSupportContractBaseTerm, hum:TRICAREManagedCareSupportContractTermWithOptionExercises, us-gaap:CommonStockParOrStatedValuePerShare -  hum-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-K" original="hum-20221231.htm">hum-20221231.htm</File>
    <File>hum-20221231.xsd</File>
    <File>hum-20221231_cal.xml</File>
    <File>hum-20221231_def.xml</File>
    <File>hum-20221231_lab.xml</File>
    <File>hum-20221231_pre.xml</File>
    <File>hum-20221231x10kxex21.htm</File>
    <File>hum-20221231x10kxex23.htm</File>
    <File>hum-20221231x10kxex311.htm</File>
    <File>hum-20221231x10kxex312.htm</File>
    <File>hum-20221231x10kxex32.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>hum-20221231_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1974">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="37">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>126
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "hum-20221231.htm": {
   "axisCustom": 2,
   "axisStandard": 42,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 1974,
    "http://xbrl.sec.gov/dei/2022": 37
   },
   "contextCount": 563,
   "dts": {
    "calculationLink": {
     "local": [
      "hum-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hum-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "hum-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "hum-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hum-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "hum-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 924,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 13,
    "http://www.humana.com/20221231": 2,
    "http://xbrl.sec.gov/dei/2022": 4,
    "total": 19
   },
   "keyCustom": 105,
   "keyStandard": 462,
   "memberCustom": 81,
   "memberStandard": 72,
   "nsprefix": "hum",
   "nsuri": "http://www.humana.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.humana.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000100 - Disclosure - REINSURANCE (Details)",
     "menuCat": "Details",
     "order": "100",
     "role": "http://www.humana.com/role/REINSURANCEDetails",
     "shortName": "REINSURANCE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceRecoverables",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000101 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets) (Details)",
     "menuCat": "Details",
     "order": "101",
     "role": "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails",
     "shortName": "SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ibda24e1355ca41dcad5d202558a258c1_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000102 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets Share Data) (Details)",
     "menuCat": "Details",
     "order": "102",
     "role": "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails",
     "shortName": "SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Balance Sheets Share Data) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ibda24e1355ca41dcad5d202558a258c1_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000103 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Income) (Details)",
     "menuCat": "Details",
     "order": "103",
     "role": "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails",
     "shortName": "SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i97924a8c729a493e956ac7035fe25b73_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "hum:ManagementFeesChargedToOperatingSubsidiaries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000104 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Comprehensive Income) (Details)",
     "menuCat": "Details",
     "order": "104",
     "role": "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails",
     "shortName": "SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Comprehensive Income) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i97924a8c729a493e956ac7035fe25b73_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000105 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Cash Flows) (Details)",
     "menuCat": "Details",
     "order": "105",
     "role": "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails",
     "shortName": "SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Condensed Statements of Cash Flows) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i97924a8c729a493e956ac7035fe25b73_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "hum:DividendsToParentWithoutPriorStateRegulatoryApproval",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000106 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Notes to Condensed Financial Statements) (Details)",
     "menuCat": "Details",
     "order": "106",
     "role": "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails",
     "shortName": "SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION (Notes to Condensed Financial Statements) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - ACQUISITIONS AND DIVESTITURES",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES",
     "shortName": "ACQUISITIONS AND DIVESTITURES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - EQUITY METHOD INVESTMENT",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.humana.com/role/EQUITYMETHODINVESTMENT",
     "shortName": "EQUITY METHOD INVESTMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - INVESTMENT SECURITIES",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIES",
     "shortName": "INVESTMENT SECURITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - FAIR VALUE",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.humana.com/role/FAIRVALUE",
     "shortName": "FAIR VALUE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:MedicarePartDDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - MEDICARE PART D",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.humana.com/role/MEDICAREPARTD",
     "shortName": "MEDICARE PART D",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:MedicarePartDDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - PROPERTY AND EQUIPMENT, NET",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.humana.com/role/PROPERTYANDEQUIPMENTNET",
     "shortName": "PROPERTY AND EQUIPMENT, NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - LEASES",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.humana.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - BENEFITS PAYABLE",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.humana.com/role/BENEFITSPAYABLE",
     "shortName": "BENEFITS PAYABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InsuranceDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0000002 - Document - Audit Information",
     "menuCat": "Cover",
     "order": "2",
     "role": "http://www.humana.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - INCOME TAXES",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.humana.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - DEBT",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.humana.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - EMPLOYEE BENEFIT PLANS",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.humana.com/role/EMPLOYEEBENEFITPLANS",
     "shortName": "EMPLOYEE BENEFIT PLANS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION",
     "shortName": "EARNINGS PER COMMON SHARE COMPUTATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - STOCKHOLDERS' EQUITY",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.humana.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES",
     "shortName": "COMMITMENTS, GUARANTEES AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - SEGMENT INFORMATION",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.humana.com/role/SEGMENTINFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - REINSURANCE",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.humana.com/role/REINSURANCE",
     "shortName": "REINSURANCE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ReinsuranceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION",
     "menuCat": "Notes",
     "order": "28",
     "role": "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION",
     "shortName": "SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "menuCat": "Policies",
     "order": "29",
     "role": "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ReceivablesNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InsurancePremiumsRevenueRecognitionPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:InsurancePremiumsRevenueRecognitionPolicy",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - ACQUISITIONS AND DIVESTITURES (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESTables",
     "shortName": "ACQUISITIONS AND DIVESTITURES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - EQUITY METHOD INVESTMENT (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.humana.com/role/EQUITYMETHODINVESTMENTTables",
     "shortName": "EQUITY METHOD INVESTMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - INVESTMENT SECURITIES (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESTables",
     "shortName": "INVESTMENT SECURITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - FAIR VALUE (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.humana.com/role/FAIRVALUETables",
     "shortName": "FAIR VALUE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - MEDICARE PART D (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.humana.com/role/MEDICAREPARTDTables",
     "shortName": "MEDICARE PART D (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETTables",
     "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - LEASES (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.humana.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - BENEFITS PAYABLE (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.humana.com/role/BENEFITSPAYABLETables",
     "shortName": "BENEFITS PAYABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - INCOME TAXES (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.humana.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - DEBT (Tables)",
     "menuCat": "Tables",
     "order": "41",
     "role": "http://www.humana.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - EMPLOYEE BENEFIT PLANS (Tables)",
     "menuCat": "Tables",
     "order": "42",
     "role": "http://www.humana.com/role/EMPLOYEEBENEFITPLANSTables",
     "shortName": "EMPLOYEE BENEFIT PLANS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Tables)",
     "menuCat": "Tables",
     "order": "43",
     "role": "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables",
     "shortName": "EARNINGS PER COMMON SHARE COMPUTATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - STOCKHOLDERS' EQUITY (Tables)",
     "menuCat": "Tables",
     "order": "44",
     "role": "http://www.humana.com/role/STOCKHOLDERSEQUITYTables",
     "shortName": "STOCKHOLDERS' EQUITY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - SEGMENT INFORMATION (Tables)",
     "menuCat": "Tables",
     "order": "45",
     "role": "http://www.humana.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - REPORTING ENTITY (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.humana.com/role/REPORTINGENTITYDetails",
     "shortName": "REPORTING ENTITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i9069595e8b1946288939814801ab0b92_D20220101-20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:CommercialMembershipContractTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "hum:CommercialMembershipContractTerm",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "hum:SubsidyAndDiscountPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Part D Subsidy/Discount Payments, Net (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Part D Subsidy/Discount Payments, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "hum:SubsidyAndDiscountPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "hum:HealthCareCostPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Health Care Cost Payments, Net (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Health Care Cost Payments, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "hum:HealthCareCostPayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF INCOME",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - ACQUISITIONS AND DIVESTITURES - Narrative (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i5f2bc940567f4a69ac536078fddf515b_I20210817",
      "decimals": "2",
      "lang": "en-US",
      "name": "hum:BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if48fb53a53e34a27a1de24c4a5da8121_I20220811",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - ACQUISITIONS AND DIVESTITURES - Assets, Liabilities And Noncontrolling Interest Disposed (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Assets, Liabilities And Noncontrolling Interest Disposed (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if48fb53a53e34a27a1de24c4a5da8121_I20220811",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - ACQUISITIONS AND DIVESTITURES - Preliminary Fair Value on Date of Acquisition (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails",
     "shortName": "ACQUISITIONS AND DIVESTITURES - Preliminary Fair Value on Date of Acquisition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i5f2bc940567f4a69ac536078fddf515b_I20210817",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hum:StrategicPartnershipAgreementNumberOfPrimaryCareCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "primary_care_center",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - EQUITY METHOD INVESTMENT - Narrative (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
     "shortName": "EQUITY METHOD INVESTMENT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hum:StrategicPartnershipAgreementNumberOfPrimaryCareCenters",
      "reportCount": 1,
      "unique": true,
      "unitRef": "primary_care_center",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - EQUITY METHOD INVESTMENT - Summarized Balance Sheets and Statements of Income (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails",
     "shortName": "EQUITY METHOD INVESTMENT - Summarized Balance Sheets and Statements of Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ic9f8031ffe444ed9b9343359a58376a4_D20220811-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - INVESTMENT SECURITIES - Classified as Current and Long-Term (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
     "shortName": "INVESTMENT SECURITIES - Classified as Current and Long-Term (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails",
     "shortName": "INVESTMENT SECURITIES - Gross Unrealized Losses and Fair Values of Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:UnrealizedGainLossOnInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - INVESTMENT SECURITIES - Narrative (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails",
     "shortName": "INVESTMENT SECURITIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "2",
      "lang": "en-US",
      "name": "hum:MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRealizedGainLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "hum:DebtAndEquitySecuritiesRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - INVESTMENT SECURITIES - Realized Gains (Losses) Included Within Investment Income (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails",
     "shortName": "INVESTMENT SECURITIES - Realized Gains (Losses) Included Within Investment Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRealizedGainLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "hum:DebtAndEquitySecuritiesRealizedGain",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - INVESTMENT SECURITIES - Gains (Losses) on Equity Securities (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails",
     "shortName": "INVESTMENT SECURITIES - Gains (Losses) on Equity Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:GainLossOnInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNiGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails",
     "shortName": "INVESTMENT SECURITIES - Contractual Maturities of Debt Securities Available for Sale (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
     "shortName": "FAIR VALUE - Financial Assets Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "idb72dad613204f368ff4a26fd335a8af_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - FAIR VALUE - Narrative (Details)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.humana.com/role/FAIRVALUENarrativeDetails",
     "shortName": "FAIR VALUE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ie5e1e5e0077d46aeaf049e9157e3b4a3_D20210101-20211231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "hum:LossOnTerminationOfDerivatives",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ia97140e6b0864c928e72d49d1130c508_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details",
     "shortName": "FAIR VALUE - Significant Unobservable Inputs (Level 3) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i3403a6c0905646bcbd8ae9d599d80f52_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetLiabilityNetMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - FAIR VALUE - Put and Call Options Measured at Fair Value (Details)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
     "shortName": "FAIR VALUE - Put and Call Options Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i3403a6c0905646bcbd8ae9d599d80f52_I20211231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeAssetLiabilityNetMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - MEDICARE PART D (Details)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.humana.com/role/MEDICAREPARTDDetails",
     "shortName": "MEDICARE PART D (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i695c6177b9d34b308e88de94acfdfd75_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherAssetsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - PROPERTY AND EQUIPMENT, NET - Property and Equipment Balances (Details)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails",
     "shortName": "PROPERTY AND EQUIPMENT, NET - Property and Equipment Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - PROPERTY AND EQUIPMENT, NET - Narrative (Details)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails",
     "shortName": "PROPERTY AND EQUIPMENT, NET - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CapitalizedComputerSoftwareAmortization1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ia97140e6b0864c928e72d49d1130c508_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill by Reportable Segments (Details)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Carrying Amount of Goodwill by Reportable Segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Details of Intangible Assets Included in Other Long-Term Assets (Details)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Details of Intangible Assets Included in Other Long-Term Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i28bf61673f944bc1ac5aa3fe90724e55_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i28bf61673f944bc1ac5aa3fe90724e55_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - Estimate of Amortization Expense (Details)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails",
     "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - Estimate of Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - LEASES - Narrative (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.humana.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - LEASES - Maturity of Lease Liabilities (Details)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails",
     "shortName": "LEASES - Maturity of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ia97140e6b0864c928e72d49d1130c508_I20211231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - BENEFITS PAYABLE - Activity in Benefits Payable (Details)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails",
     "shortName": "BENEFITS PAYABLE - Activity in Benefits Payable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i571f2e6b6e774b29a93ccb70f106840c_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LiabilityForClaimsAndClaimsAdjustmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - BENEFITS PAYABLE - Narrative (Details)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails",
     "shortName": "BENEFITS PAYABLE - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - BENEFITS PAYABLE - Incurred and Paid Claims Development (Details)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails",
     "shortName": "BENEFITS PAYABLE - Incurred and Paid Claims Development (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - INCOME TAXES - Provision for Income Taxes (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails",
     "shortName": "INCOME TAXES - Provision for Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000078 - Disclosure - INCOME TAXES - Provision for Income Taxes Reconciliation (Details)",
     "menuCat": "Details",
     "order": "78",
     "role": "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails",
     "shortName": "INCOME TAXES - Provision for Income Taxes Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000079 - Disclosure - INCOME TAXES - Principal Components of Net Deferred Tax Balances (Details)",
     "menuCat": "Details",
     "order": "79",
     "role": "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails",
     "shortName": "INCOME TAXES - Principal Components of Net Deferred Tax Balances (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOW",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000080 - Disclosure - INCOME TAXES - Narrative (Details)",
     "menuCat": "Details",
     "order": "80",
     "role": "http://www.humana.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ia1c0825aa8d04ce187bd5863fbc3d91f_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000081 - Disclosure - DEBT - Debt Outstanding (Details)",
     "menuCat": "Details",
     "order": "81",
     "role": "http://www.humana.com/role/DEBTDebtOutstandingDetails",
     "shortName": "DEBT - Debt Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i59f9c510abc04bad91d14e68c501cf01_I20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000082 - Disclosure - DEBT - Maturities of Debt (Details)",
     "menuCat": "Details",
     "order": "82",
     "role": "http://www.humana.com/role/DEBTMaturitiesofDebtDetails",
     "shortName": "DEBT - Maturities of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfSeniorLongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000083 - Disclosure - DEBT - Senior Notes (Details)",
     "menuCat": "Details",
     "order": "83",
     "role": "http://www.humana.com/role/DEBTSeniorNotesDetails",
     "shortName": "DEBT - Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i8d2e5c35e8664d878870c2ac31cb5a7f_D20220101-20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromNotesPayable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000084 - Disclosure - DEBT - Delayed Draw Term Loan Credit Agreement (Details)",
     "menuCat": "Details",
     "order": "84",
     "role": "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
     "shortName": "DEBT - Delayed Draw Term Loan Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ic09be7d135374636bb90d8a931991af6_I20210531",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RepaymentsOfNotesPayable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000085 - Disclosure - DEBT - October 2021 Term Loan Agreement (Details)",
     "menuCat": "Details",
     "order": "85",
     "role": "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
     "shortName": "DEBT - October 2021 Term Loan Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i387aa55175c54a05a686b101571c25cf_I20211029",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i112e4e9b6e9743f192f0c261f2174fb6_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000086 - Disclosure - DEBT - Revolving Credit Agreements (Details)",
     "menuCat": "Details",
     "order": "86",
     "role": "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
     "shortName": "DEBT - Revolving Credit Agreements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i42f921861ba949c0aa1605c0c528cd9d_I20221231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "hum:DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i052c3330b4c2409992bdda8401167a8b_I20220210",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000087 - Disclosure - DEBT - Commercial Paper and Other Short-term Borrowings (Details)",
     "menuCat": "Details",
     "order": "87",
     "role": "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
     "shortName": "DEBT - Commercial Paper and Other Short-term Borrowings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i052c3330b4c2409992bdda8401167a8b_I20220210",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000088 - Disclosure - EMPLOYEE BENEFIT PLANS - Narrative (Details)",
     "menuCat": "Details",
     "order": "88",
     "role": "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanCostRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000089 - Disclosure - EMPLOYEE BENEFIT PLANS - Stock-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "89",
     "role": "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - REPORTING ENTITY",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.humana.com/role/REPORTINGENTITY",
     "shortName": "REPORTING ENTITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ida62d357008f4ed0bc3246cc32b3771c_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000090 - Disclosure - EMPLOYEE BENEFIT PLANS - Restricted Stock Activity (Details)",
     "menuCat": "Details",
     "order": "90",
     "role": "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i811980c7152043ce9c82e3dcba010f63_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000091 - Disclosure - EMPLOYEE BENEFIT PLANS - Weighted-Average Fair Value Assumptions for Stock Options (Details)",
     "menuCat": "Details",
     "order": "91",
     "role": "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS - Weighted-Average Fair Value Assumptions for Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i253b1ea57fcb4ce785fe1627bc4890b9_D20220101-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ia97140e6b0864c928e72d49d1130c508_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000092 - Disclosure - EMPLOYEE BENEFIT PLANS - Option Plans Activity (Details)",
     "menuCat": "Details",
     "order": "92",
     "role": "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails",
     "shortName": "EMPLOYEE BENEFIT PLANS - Option Plans Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "ia97140e6b0864c928e72d49d1130c508_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000093 - Disclosure - EARNINGS PER COMMON SHARE COMPUTATION (Details)",
     "menuCat": "Details",
     "order": "93",
     "role": "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails",
     "shortName": "EARNINGS PER COMMON SHARE COMPUTATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "hum:ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000094 - Disclosure - STOCKHOLDERS' EQUITY - Dividend Payments (Details)",
     "menuCat": "Details",
     "order": "94",
     "role": "http://www.humana.com/role/STOCKHOLDERSEQUITYDividendPaymentsDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Dividend Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "hum:ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i60f1ff28ff564a1ebbe436416a7471f0_D20221001-20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000095 - Disclosure - STOCKHOLDERS' EQUITY - Narrative (Details)",
     "menuCat": "Details",
     "order": "95",
     "role": "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i60f1ff28ff564a1ebbe436416a7471f0_D20221001-20221031",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i495ee173617d40c9a28f5030f6631472_I20210218",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000096 - Disclosure - STOCKHOLDERS' EQUITY - Share Repurchases (Details)",
     "menuCat": "Details",
     "order": "96",
     "role": "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails",
     "shortName": "STOCKHOLDERS' EQUITY - Share Repurchases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfTreasuryStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i2911e9195ca74da59efd95c2f2a079cb_D20220101-20221231",
      "decimals": "-4",
      "lang": "en-US",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000097 - Disclosure - COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)",
     "menuCat": "Details",
     "order": "97",
     "role": "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS, GUARANTEES AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "i484f6f147dba48df9c66f44b7ff0e4bb_I20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000098 - Disclosure - SEGMENT INFORMATION - Narrative (Details)",
     "menuCat": "Details",
     "order": "98",
     "role": "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
     "shortName": "SEGMENT INFORMATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-8",
      "lang": "en-US",
      "name": "hum:GovernmentAndHealthPlanMemberSubsidiesAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PremiumsEarnedNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000099 - Disclosure - SEGMENT INFORMATION - Segment Results (Details)",
     "menuCat": "Details",
     "order": "99",
     "role": "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails",
     "shortName": "SEGMENT INFORMATION - Segment Results (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "hum-20221231.htm",
      "contextRef": "if2c0ac02cb904b3fbf5f17356e9093ba_D20220101-20221231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 155,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r819",
      "r820",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r819",
      "r820",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r819",
      "r820",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r819",
      "r820",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r822"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r817"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r823"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r816"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r824"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r819",
      "r820",
      "r821"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r815"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r818"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.humana.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "hum_A065PercentSeniorNotesDueAugust2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "0.65 Percent Senior Notes Due August 2023",
        "label": "0.65 Percent Senior Notes Due August 2023 [Member]",
        "terseLabel": "$1,500\u00a0million, 0.65% due August 3, 2023"
       }
      }
     },
     "localname": "A065PercentSeniorNotesDueAugust2023Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A135PercentSeniorNotesDueFebruary2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "1.35 Percent Senior Notes Due February 2027",
        "label": "1.35 Percent Senior Notes Due February 2027 [Member]",
        "terseLabel": "$750\u00a0million 1.35% due February 3, 2027"
       }
      }
     },
     "localname": "A135PercentSeniorNotesDueFebruary2027Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A2.90PercentSeniorNotesDueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.90 Percent Senior Notes Due December 2022 [Member]",
        "label": "2.90 Percent Senior Notes Due December 2022 [Member]",
        "terseLabel": "$400 million, 2.90% due December 15, 2022"
       }
      }
     },
     "localname": "A2.90PercentSeniorNotesDueDecember2022Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A2011PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2011 Plan",
        "label": "2011 Plan [Member]",
        "terseLabel": "2011 Plan"
       }
      }
     },
     "localname": "A2011PlanMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A2019PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A2019 Plan [Member]",
        "label": "A2019 Plan [Member]",
        "terseLabel": "2019 Plan"
       }
      }
     },
     "localname": "A2019PlanMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A215PercentSeniorNotesDueFebruary2032Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2.15 Percent Senior Notes Due February 2032",
        "label": "2.15 Percent Senior Notes Due February 2032 [Member]",
        "terseLabel": "$750\u00a0million, 2.15% due February 3, 2032"
       }
      }
     },
     "localname": "A215PercentSeniorNotesDueFebruary2032Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A3.15PercentSeniorNotesDueDecember2022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.15 Percent Senior Notes Due December 2022 [Member]",
        "label": "3.15 Percent Senior Notes Due December 2022 [Member]",
        "terseLabel": "$600 million, 3.15% due December\u00a01, 2022"
       }
      }
     },
     "localname": "A3.15PercentSeniorNotesDueDecember2022Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A3.85PercentSeniorNotesDueOctober2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.85 Percent Senior Notes Due October 2024 [Member]",
        "label": "3.85 Percent Senior Notes Due October 2024 [Member]",
        "terseLabel": "$600\u00a0million, 3.85% due October 1, 2024"
       }
      }
     },
     "localname": "A3.85PercentSeniorNotesDueOctober2024Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A3.95PercentSeniorNotesDueAugust2049Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A 3.95 Percent Senior Notes Due August 2049 [Member]",
        "label": "A 3.95 Percent Senior Notes Due August 2049 [Member]",
        "terseLabel": "$500\u00a0million, 3.95% due August 15, 2049"
       }
      }
     },
     "localname": "A3.95PercentSeniorNotesDueAugust2049Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A3.95PercentSeniorNotesDueMarch2027Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.95 Percent Senior Notes Due March 2027 [Member]",
        "label": "3.95 Percent Senior Notes Due March 2027 [Member]",
        "terseLabel": "$600\u00a0million, 3.95% due March 15, 2027"
       }
      }
     },
     "localname": "A3.95PercentSeniorNotesDueMarch2027Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A313PercentSeniorNotesDueAugust2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.13 Percent Senior Notes Due August 2029",
        "label": "3.13 Percent Senior Notes Due August 2029 [Member]",
        "terseLabel": "$500\u00a0million, 3.13% due August 15, 2029"
       }
      }
     },
     "localname": "A313PercentSeniorNotesDueAugust2029Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A370PercentSeniorNotesDueMarch2029Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "3.70 Percent Senior Notes Due March 2029",
        "label": "3.70 Percent Senior Notes Due March 2029 [Member]",
        "terseLabel": "$750\u00a0million, 3.70% due March 23, 2029"
       }
      }
     },
     "localname": "A370PercentSeniorNotesDueMarch2029Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A4.80PercentSeniorNotesDueMarch2047Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.80 Percent Senior Notes Due March 2047 [Member]",
        "label": "4.80 Percent Senior Notes Due March 2047 [Member]",
        "terseLabel": "$400\u00a0million, 4.80% due March 15, 2047"
       }
      }
     },
     "localname": "A4.80PercentSeniorNotesDueMarch2047Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A4.95PercentSeniorNotesDueOctober2044Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.95 Percent Senior Notes Due October 2044 [Member]",
        "label": "4.95 Percent Senior Notes Due October 2044 [Member]",
        "terseLabel": "$750\u00a0million, 4.95% due October 1, 2044"
       }
      }
     },
     "localname": "A4.95PercentSeniorNotesDueOctober2044Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A450PercentSeniorNotesDueApril2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.50 Percent Senior Notes Due April 2025 [Member]",
        "label": "4.50 Percent Senior Notes Due April 2025 [Member]",
        "terseLabel": "$600\u00a0million, 4.50% due April 1, 2025"
       }
      }
     },
     "localname": "A450PercentSeniorNotesDueApril2025Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A463PercentSeniorNotesDueDecember2042Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.625 Percent Senior Notes Due December 2042 [Member]",
        "label": "4.63 Percent Senior Notes Due December 2042 [Member]",
        "terseLabel": "$400\u00a0million, 4.63% due December\u00a01, 2042"
       }
      }
     },
     "localname": "A463PercentSeniorNotesDueDecember2042Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A488PercentSeniorNotesDueApril2030Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "4.88 Percent Senior Notes Due April 2030",
        "label": "4.88 Percent Senior Notes Due April 2030 [Member]",
        "terseLabel": "$500\u00a0million, 4.88% due April 1, 2030"
       }
      }
     },
     "localname": "A488PercentSeniorNotesDueApril2030Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.570 Percent Senior Notes Due March 2028 And 5.875 Percent Senior Notes Due March 2033",
        "label": "5.570 Percent Senior Notes Due March 2028 And 5.875 Percent Senior Notes Due March 2033 [Member]",
        "terseLabel": "5.570 Percent Senior Notes Due March 2028 And 5.875 Percent Senior Notes Due March 2033"
       }
      }
     },
     "localname": "A5570PercentSeniorNotesDueMarch2028And5875PercentSeniorNotesDueMarch2033Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A5570PercentSeniorNotesDueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.570 Percent Senior Notes Due March 2028",
        "label": "5.570 Percent Senior Notes Due March 2028 [Member]",
        "terseLabel": "5.570 Percent Senior Notes Due March 2028"
       }
      }
     },
     "localname": "A5570PercentSeniorNotesDueMarch2028Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A575PercentSeniorNotesDueMarch2028Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.75 Percent Senior Notes Due March 2028",
        "label": "5.75 Percent Senior Notes Due March 2028 [Member]",
        "terseLabel": "$500\u00a0million, 5.75% due March 1, 2028"
       }
      }
     },
     "localname": "A575PercentSeniorNotesDueMarch2028Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A5875PercentSeniorNotesDueMarch2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.875 Percent Senior Notes Due March 2033",
        "label": "5.875 Percent Senior Notes Due March 2033 [Member]",
        "terseLabel": "5.875 Percent Senior Notes Due March 2033"
       }
      }
     },
     "localname": "A5875PercentSeniorNotesDueMarch2033Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A588PercentSeniorNotesDueMarch2033Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "5.88 Percent Senior Notes Due March 2033",
        "label": "5.88 Percent Senior Notes Due March 2033 [Member]",
        "terseLabel": "$750\u00a0million, 5.88% due March 1, 2033"
       }
      }
     },
     "localname": "A588PercentSeniorNotesDueMarch2033Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_A8.15PercentSeniorNotesDueJune2038Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "8.15 Percent Senior Notes Due June 2038 [Member]",
        "label": "8.15 Percent Senior Notes Due June 2038 [Member]",
        "terseLabel": "$250\u00a0million, 8.15% due June\u00a015, 2038"
       }
      }
     },
     "localname": "A8.15PercentSeniorNotesDueJune2038Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ASOAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ASO and Other [Member]",
        "label": "A S O And Other [Member]",
        "terseLabel": "ASO and other"
       }
      }
     },
     "localname": "ASOAndOtherMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_AcceleratedShareRepurchasesAgreementAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated Share Repurchases, Agreement Amount",
        "label": "Accelerated Share Repurchases, Agreement Amount",
        "terseLabel": "Accelerated share repurchase agreement amount"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesAgreementAmount",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_AccruedPharmaceuticalRebatesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Pharmaceutical Rebates, Current",
        "label": "Accrued Pharmaceutical Rebates, Current",
        "terseLabel": "Pharmaceutical rebates"
       }
      }
     },
     "localname": "AccruedPharmaceuticalRebatesCurrent",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_AcquisitionCostsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes an insurance entity's accounting policy for deferred policy acquisition costs, including the nature and amount of capitalized costs incurred to write or acquire insurance contracts, and the basis for and methodologies applied in capitalizing and amortizing such costs.",
        "label": "Acquisition Costs Policy [Policy Text Block]",
        "terseLabel": "Policy Acquisition Costs"
       }
      }
     },
     "localname": "AcquisitionCostsPolicyPolicyTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_AllOthersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All Others",
        "label": "All Others [Member]",
        "verboseLabel": "All others"
       }
      }
     },
     "localname": "AllOthersMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount held in cash and securities in trust, at least equal to the recoverable from the reinsurer",
        "label": "Amount Held In Cash And Securities In Trust At Least Equal To Recoverable From Reinsurer",
        "terseLabel": "Cash and securities in trusts held by certain reinsurers"
       }
      }
     },
     "localname": "AmountHeldInCashAndSecuritiesInTrustAtLeastEqualToRecoverableFromReinsurer",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.humana.com/20221231",
     "xbrltype": "stringItemType"
    },
    "hum_BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance Sheet Account Associated With Medicare Part D",
        "label": "Balance Sheet Account Associated With Medicare Part D [Table Text Block]",
        "terseLabel": "Schedule of Balance Sheet Amounts Associated With Medicare Part D"
       }
      }
     },
     "localname": "BalanceSheetAccountAssociatedWithMedicarePartDTableTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the entity's accounting policies, methodologies, and assumptions for estimating its liability as of the balance sheet date for the cost of settling reported and unreported claims.",
        "label": "Benefits Payable And Benefit Expense Recognition Policy [Policy Text Block]",
        "terseLabel": "Benefits Payable and Benefits Expense Recognition"
       }
      }
     },
     "localname": "BenefitsPayableAndBenefitExpenseRecognitionPolicyPolicyTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_BookOverdraftLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Book Overdraft Liability",
        "label": "Book Overdraft Liability",
        "terseLabel": "Book overdraft"
       }
      }
     },
     "localname": "BookOverdraftLiability",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_BookOverdraftPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of policies associated with the accounting treatment of book overdraft",
        "label": "Book Overdraft Policy [Policy Text Block]",
        "terseLabel": "Book Overdraft"
       }
      }
     },
     "localname": "BookOverdraftPolicyPolicyTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_BuildingsAndLeaseholdImprovementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Buildings And Leasehold Improvements",
        "label": "Buildings And Leasehold Improvements [Member]",
        "terseLabel": "Buildings and leasehold improvements"
       }
      }
     },
     "localname": "BuildingsAndLeaseholdImprovementsMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Per Agreement, Net Of Existing Equity Interest",
        "label": "Business Combination, Consideration Per Agreement, Net Of Existing Equity Interest",
        "terseLabel": "Transaction amount, net of existing equity stake"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationPerAgreementNetOfExistingEquityInterest",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Subsequent Acquisition, Percentage",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Subsequent Acquisition, Percentage",
        "terseLabel": "Remaining ownership percentage acquired"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeSubsequentAcquisitionPercentage",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_BusinessCombinationTotalEnterpriseValueOfAcquiree": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Total Enterprise Value Of Acquiree",
        "label": "Business Combination, Total Enterprise Value Of Acquiree",
        "terseLabel": "Enterprise value of acquiree including existing equity value"
       }
      }
     },
     "localname": "BusinessCombinationTotalEnterpriseValueOfAcquiree",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_CapitalContributionsToOperatingSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital contributions to operating subsidiaries",
        "label": "Capital Contributions To Operating Subsidiaries",
        "negatedLabel": "Capital contributions to operating subsidiaries"
       }
      }
     },
     "localname": "CapitalContributionsToOperatingSubsidiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_CenterWellSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CenterWell Segment",
        "label": "CenterWell Segment [Member]",
        "terseLabel": "CenterWell"
       }
      }
     },
     "localname": "CenterWellSegmentMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CertificateOfNeedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Certificate Of Need",
        "label": "Certificate Of Need [Member]",
        "terseLabel": "Certificates of need"
       }
      }
     },
     "localname": "CertificateOfNeedMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CitibankNAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Citibank NA",
        "label": "Citibank NA [Member]",
        "terseLabel": "Citi"
       }
      }
     },
     "localname": "CitibankNAMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CmsSubsidiesOrDiscountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CMS Subsidies Or Discounts [Member]",
        "label": "Cms Subsidies Or Discounts [Member]",
        "terseLabel": "CMS Subsidies/ Discounts"
       }
      }
     },
     "localname": "CmsSubsidiesOrDiscountsMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CoinsuranceAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Coinsurance Agreement [Member]",
        "label": "Coinsurance Agreement [Member]",
        "terseLabel": "100% coinsurance agreements"
       }
      }
     },
     "localname": "CoinsuranceAgreementMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Combination of age and years necessary for retirement provision as related to our equity award program",
        "label": "Combination Of Age And Years Necessary For Retirement Provision As Related To Our Equity Award Program",
        "terseLabel": "Combination of age and years necessary for retirement provision as related to our equity award program"
       }
      }
     },
     "localname": "CombinationOfAgeAndYearsNecessaryForRetirementProvisionAsRelatedToOurEquityAwardProgram",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_CommercialMembershipContractTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commercial Membership Contract Term",
        "label": "Commercial Membership Contract Term",
        "terseLabel": "Health services term"
       }
      }
     },
     "localname": "CommercialMembershipContractTerm",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Reclassified From Capital In Excess Of Par Value To Treasury Stock Upon Repurchase, Value",
        "label": "Common Stock Reclassified From Capital In Excess Of Par Value To Treasury Stock Upon Repurchase, Value",
        "terseLabel": "Reclassification from capital in excess of par value to treasury stock"
       }
      }
     },
     "localname": "CommonStockReclassifiedFromCapitalInExcessOfParValueToTreasuryStockUponRepurchaseValue",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_CompanyCommonStockClosingSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Company Common Stock, Closing Share Price",
        "label": "Company Common Stock, Closing Share Price",
        "terseLabel": "Company common stock closing price (in dollars per share)"
       }
      }
     },
     "localname": "CompanyCommonStockClosingSharePrice",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "hum_ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Comprehensive Income (Loss), Net of Tax, Attributable To Equity Method Investments",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable To Equity Method Investments",
        "terseLabel": "Comprehensive income attributable to equity method investments",
        "verboseLabel": "Comprehensive income attributable to equity method investments"
       }
      }
     },
     "localname": "ComprehensiveIncomeLossNetofTaxAttributableToEquityMethodInvestments",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_ConsumerDiscountsOnBrandNamePrescriptionDrugs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Beginning in 2011, the Health Reform Legislation mandates consumer discounts of 50% on brand name prescription drugs for Part D plan participants in the coverage gap. These discounts are funded by CMS and pharmaceutical manufacturers while we administer the application of these funds.",
        "label": "Consumer Discounts On Brand Name Prescription Drugs",
        "terseLabel": "Consumer discounts on brand name prescription drugs"
       }
      }
     },
     "localname": "ConsumerDiscountsOnBrandNamePrescriptionDrugs",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_CorporateAndEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate And Eliminations [Member]",
        "label": "Corporate And Eliminations [Member]",
        "terseLabel": "Eliminations/ Corporate"
       }
      }
     },
     "localname": "CorporateAndEliminationsMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_DebtAndEquitySecuritiesRealizedGain": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt And Equity Securities, Realized Gain",
        "label": "Debt And Equity Securities, Realized Gain",
        "terseLabel": "Gross gains on investment securities"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesRealizedGain",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DebtAndEquitySecuritiesRealizedLoss": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt And Equity Securities, Realized Loss",
        "label": "Debt And Equity Securities, Realized Loss",
        "negatedTerseLabel": "Gross losses on investment securities"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesRealizedLoss",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DebtInstrumentCovenantDebtToCapitalizationPercentageActual": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual",
        "label": "Debt Instrument, Covenant, Debt To Capitalization Percentage, Actual",
        "terseLabel": "Actual debt to capitalization percentage"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtToCapitalizationPercentageActual",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum",
        "label": "Debt Instrument, Covenant, Debt To Capitalization Percentage, Maximum",
        "terseLabel": "Debt to capitalization percentage, maximum"
       }
      }
     },
     "localname": "DebtInstrumentCovenantDebtToCapitalizationPercentageMaximum",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Securities, Number of Positions",
        "label": "Debt, Securities, Available-For-Sale, Securities, Number Of Positions",
        "terseLabel": "Securities, number of positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleSecuritiesNumberOfPositions",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_December2020AcceleratedShareRepurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 2020 Accelerated Share Repurchase Agreement",
        "label": "December 2020 Accelerated Share Repurchase Agreement [Member]",
        "terseLabel": "December 2020 ASR"
       }
      }
     },
     "localname": "December2020AcceleratedShareRepurchaseAgreementMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_DeferredTaxAssetJobsTaxCredit": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Jobs Tax Credit",
        "label": "Deferred Tax Asset, Jobs Tax Credit",
        "terseLabel": "Jobs tax credits"
       }
      }
     },
     "localname": "DeferredTaxAssetJobsTaxCredit",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DeferredTaxAssetsDeferredPolicyAcquisitionCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of deferred tax balance as it relates to deferred acquisition costs",
        "label": "Deferred Tax Assets, Deferred Policy Acquisition Cost",
        "terseLabel": "Deferred acquisition costs"
       }
      }
     },
     "localname": "DeferredTaxAssetsDeferredPolicyAcquisitionCost",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of deferred tax balance as it relates to depreciable property and intangible assets",
        "label": "Deferred Tax Liabilities Depreciable Property And Intangible Assets",
        "negatedLabel": "Depreciable property and intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciablePropertyAndIntangibleAssets",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Number Of Shares Of Common Stock Reserved For Issuance",
        "label": "Defined Contribution Plan, Number Of Shares Of Common Stock Reserved For Issuance",
        "terseLabel": "Number of shares of common stock reserved for issuance under defined contribution retirement savings plan (in shares)"
       }
      }
     },
     "localname": "DefinedContributionPlanNumberOfSharesOfCommonStockReservedForIssuance",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Plan Assets Invested In Company Common Stock",
        "label": "Defined Contribution Plan, Plan Assets Invested In Company Common Stock",
        "terseLabel": "Plan assets invested in Company common stock (percent)"
       }
      }
     },
     "localname": "DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Plan Assets Invested In Company Common Stock, Shares",
        "label": "Defined Contribution Plan, Plan Assets Invested In Company Common Stock, Shares",
        "terseLabel": "Plan assets invested in Company common stock (in shares)"
       }
      }
     },
     "localname": "DefinedContributionPlanPlanAssetsInvestedInCompanyCommonStockShares",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hum_DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined Contribution Plan, Shares Of Common Stock In Plan As Percentage Of Shares Outstanding",
        "label": "Defined Contribution Plan, Shares Of Common Stock In Plan As Percentage Of Shares Outstanding",
        "terseLabel": "Shares of common stock plan assets as percentage of shares outstanding"
       }
      }
     },
     "localname": "DefinedContributionPlanSharesOfCommonStockInPlanAsPercentageOfSharesOutstanding",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_DefinitiveAgreementEquityInterestToBeAcquiredPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Definitive Agreement, Equity Interest To Be Acquired, Percentage",
        "label": "Definitive Agreement, Equity Interest To Be Acquired, Percentage",
        "terseLabel": "Equity interest to be acquired per agreement (percent)"
       }
      }
     },
     "localname": "DefinitiveAgreementEquityInterestToBeAcquiredPercentage",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_DelayedDrawTermLoanMay2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Delayed Draw Term Loan May 2021",
        "label": "Delayed Draw Term Loan May 2021 [Member]",
        "terseLabel": "Delayed Draw Term Loan May 2021"
       }
      }
     },
     "localname": "DelayedDrawTermLoanMay2021Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_DelayedDrawTermLoanMay2024Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Delayed Draw Term Loan May 2024",
        "label": "Delayed Draw Term Loan May 2024 [Member]",
        "terseLabel": "Delayed draw term loan, due May 28, 2024"
       }
      }
     },
     "localname": "DelayedDrawTermLoanMay2024Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_DepreciationAndAmortizationClassifiedAsBenefitExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation and amortization expense that has been reclassified to be included with benefit expenses. The reclassification is the result of depreciation and amortization expense associated primarily from the delivery of pharmacy services by our wholly-owned pharmacy business included in our Healthcare Services segment.",
        "label": "Depreciation And Amortization Classified As Benefit Expense",
        "terseLabel": "Depreciation and amortization classified as benefit expense"
       }
      }
     },
     "localname": "DepreciationAndAmortizationClassifiedAsBenefitExpense",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DepreciationAndAmortizationIncomeStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation and amortization expense excluding depreciation and amortization primarily from the delivery of pharmacy services by our wholly-owned pharmacy business (included in our Healthcare Services segment) which has been reclassified to benefit expenses.",
        "label": "Depreciation And Amortization Income Statement",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortizationIncomeStatement",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure Of Compensation Related Costs Share Based Payments And Compensation And Retirement Disclosure [Text Block]",
        "label": "Disclosure Of Compensation Related Costs Share Based Payments And Compensation And Retirement Disclosure [Text Block]",
        "terseLabel": "EMPLOYEE BENEFIT PLANS"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsAndCompensationAndRetirementDisclosureTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_DisposalGroupIncludingDiscontinuedOperationEquityInterestSold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Equity Interest Sold",
        "label": "Disposal Group, Including Discontinued Operation, Equity Interest Sold",
        "terseLabel": "Equity interest to be sold"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationEquityInterestSold",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Noncontrolling interest",
        "label": "Disposal Group, Including Discontinued Operation, Noncontrolling interest",
        "terseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationNoncontrollingInterest",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_DividendsToParentWithoutPriorStateRegulatoryApproval": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of dividends paid to our parent company without prior approval by state regulatory authorities",
        "label": "Dividends To Parent Without Prior State Regulatory Approval",
        "terseLabel": "Actual dividends paid to parent company"
       }
      }
     },
     "localname": "DividendsToParentWithoutPriorStateRegulatoryApproval",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Health Insurer Fee, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Health Insurer Fee, Amount",
        "terseLabel": "Health insurance industry fee"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationHealthInsurerFeeAmount",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_EffectiveIncomeTaxReconciliationNonTaxableKAHGain": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Non-Taxable KAH Gain",
        "label": "Effective Income Tax Reconciliation, Non-Taxable KAH Gain",
        "negatedTerseLabel": "Non-taxable KAH gain"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationNonTaxableKAHGain",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the aggregate tax benefit realized from the exercise of stock options and vesting of restricted stock",
        "label": "Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options And Restricted Stock Vesting",
        "terseLabel": "Actual realized tax benefit on tax returns from option exercises and restricted stock vesting"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptionsAndRestrictedStockVesting",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_EquityInNetEarningsOfSubsidiaries": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity in net earnings of subsidiaries",
        "label": "Equity In Net Earnings Of Subsidiaries",
        "terseLabel": "Equity in net earnings of subsidiaries"
       }
      }
     },
     "localname": "EquityInNetEarningsOfSubsidiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excluding Employee Stock Plans And Accelerated Share Repurchase Agreement",
        "label": "Excluding Employee Stock Plans And Accelerated Share Repurchase Agreement [Member]",
        "terseLabel": "Excluding Employee Stock Plans and ASR"
       }
      }
     },
     "localname": "ExcludingEmployeeStockPlansAndAcceleratedShareRepurchaseAgreementMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_Expenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses",
        "label": "Expenses",
        "terseLabel": "Expenses"
       }
      }
     },
     "localname": "Expenses",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss)",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) [Abstract]",
        "terseLabel": "Total gains or losses:"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossAbstract",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "hum_FairValueRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Risk",
        "label": "Fair Value Risk [Member]",
        "terseLabel": "Fair Value Risk"
       }
      }
     },
     "localname": "FairValueRiskMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Favorable medical claims reserve development related to prior fiscal years",
        "label": "Favorable Medical Claims Reserve Development Related To Prior Fiscal Years",
        "terseLabel": "Favorable\u00a0medical\u00a0claims\u00a0reserve development related to prior fiscal years"
       }
      }
     },
     "localname": "FavorableMedicalClaimsReserveDevelopmentRelatedToPriorFiscalYears",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_February2021ShareRepurchaseAuthorizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "February 2021 Share Repurchase Authorization",
        "label": "February 2021 Share Repurchase Authorization [Member]",
        "terseLabel": "February 2021 Authorization"
       }
      }
     },
     "localname": "February2021ShareRepurchaseAuthorizationMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Government, Centers For Medicare And Medicaid Services, Florida Medicare Advantage [Member]",
        "label": "Federal Government, Centers For Medicare And Medicaid Services, Florida Medicare Advantage [Member]",
        "terseLabel": "CMS, coverage for individual Medicare Advantage members in Florida"
       }
      }
     },
     "localname": "FederalGovernmentCentersForMedicareAndMedicaidServicesFloridaMedicareAdvantageMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REPORTINGENTITYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_FederalGovernmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Federal Government [Member]",
        "label": "Federal Government [Member]",
        "terseLabel": "Federal government contracts"
       }
      }
     },
     "localname": "FederalGovernmentMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_FinancialAssetsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial Assets, Fair Value Disclosure",
        "label": "Financial Assets, Fair Value Disclosure",
        "terseLabel": "Fair value of financial asset"
       }
      }
     },
     "localname": "FinancialAssetsFairValueDisclosure",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_FullyInsuredMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fully Insured [Member]",
        "label": "Fully Insured [Member]",
        "terseLabel": "Fully-insured"
       }
      }
     },
     "localname": "FullyInsuredMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of policies associated with the accounting treatment of future policy benefits payable",
        "label": "Future Policy And Benefits Payable Policy [Policy Text Block]",
        "terseLabel": "Future policy benefits payable"
       }
      }
     },
     "localname": "FuturePolicyAndBenefitsPayablePolicyPolicyTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_GainContingencyRecoverySought": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gain Contingency, Recovery Sought",
        "label": "Gain Contingency, Recovery Sought",
        "terseLabel": "Litigation recoveries sought"
       }
      }
     },
     "localname": "GainContingencyRecoverySought",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_GentivaTermLoanDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gentiva Term Loan Due 2025",
        "label": "Gentiva Term Loan Due 2025 [Member]",
        "terseLabel": "Gentiva Term Loan Due 2025"
       }
      }
     },
     "localname": "GentivaTermLoanDue2025Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_GoldmanSachsCoLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Goldman Sachs &amp; Co. LLC",
        "label": "Goldman Sachs &amp; Co. LLC [Member]",
        "terseLabel": "Goldman Sachs"
       }
      }
     },
     "localname": "GoldmanSachsCoLLCMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_GovernmentAndHealthPlanMemberSubsidiesAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of member co-share amounts and government subsidies that are excluded from benefits expense because the health plans do not bear responsibility.",
        "label": "Government And Health Plan Member Subsidies Amount",
        "terseLabel": "Member co-share amounts and government subsidies"
       }
      }
     },
     "localname": "GovernmentAndHealthPlanMemberSubsidiesAmount",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_GroupMedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Group Medicare Advantage",
        "label": "Group Medicare Advantage [Member]",
        "terseLabel": "Group Medicare Advantage"
       }
      }
     },
     "localname": "GroupMedicareAdvantageMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_HealthCareCostPayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails": {
       "order": 1.0,
       "parentTag": "hum_HealthCareCostPaymentsAndReimbursementsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health care cost payments associated with the TRICARE South Region contract",
        "label": "Health Care Cost Payments",
        "negatedTerseLabel": "Health care cost payments"
       }
      }
     },
     "localname": "HealthCareCostPayments",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_HealthCareCostPaymentsAndReimbursementsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between health care cost payments and reimbursements related to the TRICARE South Region contract.",
        "label": "Health Care Cost Payments And Reimbursements, Net",
        "negatedTotalLabel": "Net reimbursements (payments)"
       }
      }
     },
     "localname": "HealthCareCostPaymentsAndReimbursementsNet",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_HealthCareCostReimbursements": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails": {
       "order": 2.0,
       "parentTag": "hum_HealthCareCostPaymentsAndReimbursementsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reimbursements for health care cost payments associated with the TRICARE South Region contract",
        "label": "Health Care Cost Reimbursements",
        "terseLabel": "Health care cost reimbursements"
       }
      }
     },
     "localname": "HealthCareCostReimbursements",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESHealthCareCostPaymentsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_HealthCareReformMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Reform [Member]",
        "label": "Health Care Reform [Member]",
        "terseLabel": "Health Care Reform"
       }
      }
     },
     "localname": "HealthCareReformMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_HealthCareReformPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Care Reform",
        "label": "Health Care Reform [Policy Text Block]",
        "terseLabel": "Health Care Reform"
       }
      }
     },
     "localname": "HealthCareReformPolicyTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_HomeSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Home Solutions",
        "label": "Home Solutions [Member]",
        "terseLabel": "Home solutions"
       }
      }
     },
     "localname": "HomeSolutionsMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_HomeSolutionsReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Home Solutions Reporting Unit",
        "label": "Home Solutions Reporting Unit [Member]",
        "terseLabel": "Home Solutions Reporting Unit"
       }
      }
     },
     "localname": "HomeSolutionsReportingUnitMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (loss) before equity in net earnings of subsidiaries",
        "label": "Income Loss Before Equity In Net Earnings Of Subsidiaries",
        "totalLabel": "(Loss) income before equity in net earnings of subsidiaries"
       }
      }
     },
     "localname": "IncomeLossBeforeEquityInNetEarningsOfSubsidiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails": {
       "order": 1.0,
       "parentTag": "hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) Before Income Taxes And Equity In Net Earnings Of Subsidiaries",
        "label": "Income (Loss) Before Income Taxes And Equity In Net Earnings Of Subsidiaries",
        "totalLabel": "(Loss) income before income taxes and equity in net earnings of subsidiaries"
       }
      }
     },
     "localname": "IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": 1.0,
       "parentTag": "hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Loss From Continuing Operations Before Income Taxes Attributable To Noncontrolling Interest",
        "label": "Income Loss From Continuing Operations Before Income Taxes Attributable To Noncontrolling Interest",
        "negatedTerseLabel": "Net (income) loss attributable to noncontrolling interests"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToNoncontrollingInterest",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income Loss From Continuing Operations Before Income Taxes Attributable To Parent",
        "label": "Income Loss From Continuing Operations Before Income Taxes Attributable To Parent",
        "totalLabel": "Segment earnings (loss) attributable to Humana"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_InsuranceSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Segment",
        "label": "Insurance Segment [Member]",
        "terseLabel": "Insurance"
       }
      }
     },
     "localname": "InsuranceSegmentMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_InvestmentAndOtherIncomeNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment and other income, net",
        "label": "Investment And Other Income Net",
        "terseLabel": "Investment and other (loss) income, net"
       }
      }
     },
     "localname": "InvestmentAndOtherIncomeNet",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_InvestmentInRelatedPartiesAndSubsidiaries": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in related parties and subsidiaries.",
        "label": "Investment In Related Parties And Subsidiaries",
        "terseLabel": "Investment in subsidiaries"
       }
      }
     },
     "localname": "InvestmentInRelatedPartiesAndSubsidiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_JPMorganChaseBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "JPMorgan Chase Bank",
        "label": "JPMorgan Chase Bank [Member]",
        "terseLabel": "JPM"
       }
      }
     },
     "localname": "JPMorganChaseBankMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_January2022AcceleratedShareRepurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "January 2022 Accelerated Share Repurchase Agreement",
        "label": "January 2022 Accelerated Share Repurchase Agreement [Member]",
        "terseLabel": "January 2022 ASR"
       }
      }
     },
     "localname": "January2022AcceleratedShareRepurchaseAgreementMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_July2019ShareRepurchaseAuthorizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "July 2019 Share Repurchase Authorization [Member]",
        "label": "July 2019 Share Repurchase Authorization [Member]",
        "terseLabel": "July 2019 Authorization"
       }
      }
     },
     "localname": "July2019ShareRepurchaseAuthorizationMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_KindredAtHomeHospiceAndPersonalCareDivisionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kindred At Home, Hospice And Personal Care Divisions",
        "label": "Kindred At Home, Hospice And Personal Care Divisions [Member]",
        "terseLabel": "Kindred at Home, Hospice and Personal Care Divisions"
       }
      }
     },
     "localname": "KindredAtHomeHospiceAndPersonalCareDivisionsMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_KindredAtHomeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Kindred At Home [Member]",
        "label": "Kindred At Home [Member]",
        "terseLabel": "Kindred at Home",
        "verboseLabel": "KAH"
       }
      }
     },
     "localname": "KindredAtHomeMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability For Unpaid Claims And Claims Adjustment Expense, Cumulative Number Of Claims, Reported",
        "label": "Liability For Unpaid Claims And Claims Adjustment Expense, Cumulative Number Of Claims, Reported",
        "terseLabel": "Cumulative number of reported claims"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseCumulativeNumberOfClaimsReported",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility including uncommitted incremental capacity and without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity Including Uncommitted Incremental Capacity",
        "terseLabel": "Maximum borrowing capacity including uncommitted incremental loan facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityIncludingUncommittedIncrementalCapacity",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_LineOfCreditFacilityUncommittedIncrementalCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Uncommitted Incremental Capacity",
        "label": "Line Of Credit Facility, Uncommitted Incremental Capacity",
        "terseLabel": "Uncommitted incremental loan facility"
       }
      }
     },
     "localname": "LineOfCreditFacilityUncommittedIncrementalCapacity",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_LongDurationInsuranceProductsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Duration Insurance Products [Axis]",
        "label": "Long Duration Insurance Products [Axis]",
        "terseLabel": "Long-Duration Insurance Products [Axis]"
       }
      }
     },
     "localname": "LongDurationInsuranceProductsAxis",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hum_LongDurationInsuranceProductsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Duration Insurance Products [Domain]",
        "label": "Long Duration Insurance Products [Domain]",
        "terseLabel": "Long-Duration Insurance Products [Domain]"
       }
      }
     },
     "localname": "LongDurationInsuranceProductsDomain",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_LossOnTerminationOfDerivatives": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss On Termination Of Derivatives",
        "label": "Loss On Termination Of Derivatives",
        "terseLabel": "Termination of put and call options"
       }
      }
     },
     "localname": "LossOnTerminationOfDerivatives",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_ManagementFeesChargedToOperatingSubsidiaries": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Through intercompany service agreements approved, if required, by state regulatory authorities, Humana Inc., our parent company, charges a management fee for reimbursement of certain centralized services provided to its subsidiaries, including information systems, disbursement, investment and cash administration, marketing, legal, finance, and medical and executive management oversight",
        "label": "Management Fees Charged To Operating Subsidiaries",
        "terseLabel": "Management fees charged to operating subsidiaries"
       }
      }
     },
     "localname": "ManagementFeesChargedToOperatingSubsidiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities",
        "label": "Maximum Individual State General Bond Obligation, As Percentage Of Total Debt Securities",
        "terseLabel": "Maximum individual state general bond obligation as a percentage of total debt securities (percent)"
       }
      }
     },
     "localname": "MaximumIndividualStateGeneralBondObligationAsPercentageOfTotalDebtSecurities",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_MedicaidAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid and Other [Member]",
        "label": "Medicaid And Other [Member]",
        "terseLabel": "Medicaid and other"
       }
      }
     },
     "localname": "MedicaidAndOtherMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid [Member]",
        "label": "Medicaid [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "MedicaidMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicareAdvantageMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Advantage [Member]",
        "label": "Medicare Advantage [Member]",
        "terseLabel": "Individual Medicare Advantage"
       }
      }
     },
     "localname": "MedicareAdvantageMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicareLicensesAndCertificatesOfNeedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Licenses And Certificates Of Need [Member]",
        "label": "Medicare Licenses And Certificates Of Need [Member]",
        "terseLabel": "Medicare Licenses And Certificates Of Need"
       }
      }
     },
     "localname": "MedicareLicensesAndCertificatesOfNeedMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare [Member]",
        "label": "Medicare [Member]",
        "terseLabel": "Total Medicare",
        "verboseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicarePartDDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Balance sheet amounts associated with Medicare Part D.",
        "label": "Medicare Part D Disclosure [Text Block]",
        "terseLabel": "MEDICARE PART D"
       }
      }
     },
     "localname": "MedicarePartDDisclosureTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTD"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_MedicareStandAlonePrescriptionDrugPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Stand Alone Prescription Drug Plan [Member]",
        "label": "Medicare Stand Alone Prescription Drug Plan [Member]",
        "terseLabel": "Medicare stand-alone PDP"
       }
      }
     },
     "localname": "MedicareStandAlonePrescriptionDrugPlanMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MedicareSupplementProductMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare Supplement Product",
        "label": "Medicare Supplement Product [Member]",
        "terseLabel": "Medicare Supplement Product"
       }
      }
     },
     "localname": "MedicareSupplementProductMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MilitaryServiceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Military Service [Member]",
        "label": "Military Service [Member]",
        "terseLabel": "Military services"
       }
      }
     },
     "localname": "MilitaryServiceMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum age required for retirement eligibility as related to our equity award program",
        "label": "Minimum Age Required For Retirement Eligibility As Related To Our Equity Award Program",
        "terseLabel": "Minimum age required for retirement eligibility as related to our equity award program"
       }
      }
     },
     "localname": "MinimumAgeRequiredForRetirementEligibilityAsRelatedToOurEquityAwardProgram",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum number of years of service for retirement eligibility as related to our equity award program",
        "label": "Minimum Number Of Years Of Service For Retirement Eligibility As Related To Our Equity Award Program",
        "terseLabel": "Minimum number of years of service for retirement eligibility as related to our equity award program"
       }
      }
     },
     "localname": "MinimumNumberOfYearsOfServiceForRetirementEligibilityAsRelatedToOurEquityAwardProgram",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_MizuhoMarketsAmericasLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mizuho Markets Americas LLC",
        "label": "Mizuho Markets Americas LLC [Member]",
        "terseLabel": "Mizuho Markets Americas LLC"
       }
      }
     },
     "localname": "MizuhoMarketsAmericasLLCMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_NetAssetLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Asset (Liability)",
        "label": "Net Asset (Liability)",
        "totalLabel": "Total net asset (liability)"
       }
      }
     },
     "localname": "NetAssetLiability",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NetCurrentLiabilityAsset": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 1.0,
       "parentTag": "hum_NetAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net current (liability) asset",
        "label": "Net Current (Liability) Asset",
        "totalLabel": "Net current asset (liability)"
       }
      }
     },
     "localname": "NetCurrentLiabilityAsset",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NetNoncurrentAssetLiability": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 2.0,
       "parentTag": "hum_NetAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Noncurrent Asset (Liability)",
        "label": "Net Noncurrent Asset (Liability)",
        "totalLabel": "Net long-term liability"
       }
      }
     },
     "localname": "NetNoncurrentAssetLiability",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Or Part Noncash Acquisition Noncontrolling Interest Acquired",
        "label": "Noncash Or Part Noncash Acquisition Noncontrolling Interest Acquired",
        "negatedTerseLabel": "Less: Noncontrolling interests acquired"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNoncontrollingInterestAcquired",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Or Part Noncash Acquisition Remeasurement Of Equity Investment",
        "label": "Noncash Or Part Noncash Acquisition Remeasurement Of Equity Investment",
        "negatedTerseLabel": "Less: Remeasured existing Kindred at Home equity method investment"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionRemeasurementOfEquityInvestment",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NoncompetesAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncompetes and Other [Member]",
        "label": "Noncompetes And Other [Member]",
        "terseLabel": "Noncompetes and other"
       }
      }
     },
     "localname": "NoncompetesAndOtherMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders",
        "label": "Noncontrolling Interest, Increase (Decrease) From Contributions Or Distributions To Noncontrolling Interest Holders",
        "terseLabel": "Distribution to noncontrolling interest holders, net"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseDecreaseFromContributionsOrDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_NoncontrollingInterestsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interests",
        "label": "Noncontrolling Interests [Policy Text Block]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestsPolicyTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_November2022AcceleratedShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "November 2022 Accelerated Share Repurchase Program",
        "label": "November 2022 Accelerated Share Repurchase Program [Member]",
        "terseLabel": "November 2022 ASR"
       }
      }
     },
     "localname": "November2022AcceleratedShareRepurchaseProgramMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Days Notice For Employer Group To Cancel Short Duration Prepaid Health Services Policies",
        "label": "Number Of Days Notice For Employer Group To Cancel Short Duration Prepaid Health Services Policies",
        "terseLabel": "Number of days notice for employer group to cancel short-duration prepaid health services policies"
       }
      }
     },
     "localname": "NumberOfDaysNoticeForEmployerGroupToCancelShortDurationPrepaidHealthServicesPolicies",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reinsurers comprising other reinsurance recoverables balance",
        "label": "Number Of Reinsurers Comprising Other Reinsurance Recoverables Balance",
        "terseLabel": "Number of reinsurers comprising other reinsurance recoverables balance"
       }
      }
     },
     "localname": "NumberOfReinsurersComprisingOtherReinsuranceRecoverablesBalance",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries",
        "label": "Number Of States Comprising Of TRICARE Managed Care Support Contract Beneficiaries",
        "terseLabel": "Number of states comprising TRICARE Managed Care Support Contract beneficiaries"
       }
      }
     },
     "localname": "NumberOfStatesComprisingOfTRICAREManagedCareSupportContractBeneficiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_NumberOfStatesComprisingTRICAREBeneficiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of States Comprising TRICARE Beneficiaries",
        "label": "Number Of States Comprising TRICARE Beneficiaries",
        "terseLabel": "Number of states comprising TRICARE beneficiaries"
       }
      }
     },
     "localname": "NumberOfStatesComprisingTRICAREBeneficiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_NumberOfTRICAREBeneficiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of TRICARE Beneficiaries",
        "label": "Number Of TRICARE Beneficiaries",
        "terseLabel": "Number of TRICARE beneficiaries"
       }
      }
     },
     "localname": "NumberOfTRICAREBeneficiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_NumberOfTRICAREManagedCareSupportContractBeneficiaries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of TRICARE Managed Care Support Contract Beneficiaries",
        "label": "Number Of TRICARE Managed Care Support Contract Beneficiaries",
        "terseLabel": "Number of TRICARE Managed Care Support Contract beneficiaries"
       }
      }
     },
     "localname": "NumberOfTRICAREManagedCareSupportContractBeneficiaries",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_October2021TermLoanAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "October 2021 Term Loan Agreement",
        "label": "October 2021 Term Loan Agreement [Member]",
        "terseLabel": "October 2021 Term Loan Agreement"
       }
      }
     },
     "localname": "October2021TermLoanAgreementMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_OtherCurrentAssetsPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Current Assets",
        "label": "Other Current Assets [Policy Text Block]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsPolicyTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_PaymentOfAnnualHealthInsuranceIndustryFee": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment Of Annual Health Insurance Industry Fee",
        "label": "Payment Of Annual Health Insurance Industry Fee",
        "terseLabel": "Payment of annual health insurance industry fee"
       }
      }
     },
     "localname": "PaymentOfAnnualHealthInsuranceIndustryFee",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_PaymentsForProceedsFromContractDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For (Proceeds From) Contract Deposits",
        "label": "Payments For (Proceeds From) Contract Deposits",
        "negatedTerseLabel": "Receipts (withdrawals) from contract deposits, net"
       }
      }
     },
     "localname": "PaymentsForProceedsFromContractDeposits",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_PercentageOfCoinsuranceAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Coinsurance Agreement",
        "label": "Percentage Of Coinsurance Agreement",
        "terseLabel": "Percentage of coinsurance agreement"
       }
      }
     },
     "localname": "PercentageOfCoinsuranceAgreement",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_PercentageOfTotalDebtSecuritiesInvestmentGradeQuality": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Total Debt Securities, Investment Grade Quality",
        "label": "Percentage Of Total Debt Securities, Investment Grade Quality",
        "terseLabel": "Percentage of debt securities considered to be of investment-grade (percent)"
       }
      }
     },
     "localname": "PercentageOfTotalDebtSecuritiesInvestmentGradeQuality",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_PercentageOfTotalPremiumAndServicesRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Of Total Premium And Services Revenues",
        "label": "Percentage Of Total Premium And Services Revenues",
        "terseLabel": "Percentage of premiums and services revenue"
       }
      }
     },
     "localname": "PercentageOfTotalPremiumAndServicesRevenues",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_PharmacyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacy",
        "label": "Pharmacy [Member]",
        "terseLabel": "Pharmacy"
       }
      }
     },
     "localname": "PharmacyMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ProceedsFromStockOptionsExercisedAndOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Stock Options Exercised And Other",
        "label": "Proceeds From Stock Options Exercised And Other",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercisedAndOther",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_ProtectiveLifeInsuranceCompanyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Protective Life Insurance Company [Member]",
        "label": "Protective Life Insurance Company [Member]",
        "verboseLabel": "Protective Life Insurance Company"
       }
      }
     },
     "localname": "ProtectiveLifeInsuranceCompanyMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ProviderMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provider",
        "label": "Provider [Member]",
        "terseLabel": "Provider"
       }
      }
     },
     "localname": "ProviderMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ProviderReportingUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provider Reporting Unit",
        "label": "Provider Reporting Unit [Member]",
        "terseLabel": "Provider reporting unit"
       }
      }
     },
     "localname": "ProviderReportingUnitMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_RegulatoryMattersAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory Matters [Axis]",
        "label": "Regulatory Matters [Axis]",
        "terseLabel": "Regulatory Matters [Axis]"
       }
      }
     },
     "localname": "RegulatoryMattersAxis",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hum_RegulatoryMattersDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Regulatory Matters [Domain]",
        "label": "Regulatory Matters [Domain]",
        "terseLabel": "Regulatory Matters [Domain]"
       }
      }
     },
     "localname": "RegulatoryMattersDomain",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ReinsuranceTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reinsurance [Table]",
        "label": "Reinsurance [Table]",
        "terseLabel": "Reinsurance [Table]"
       }
      }
     },
     "localname": "ReinsuranceTable",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hum_RevenueExitMultipleMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue Exit Multiple",
        "label": "Revenue Exit Multiple [Member]",
        "terseLabel": "Revenue exit multiple"
       }
      }
     },
     "localname": "RevenueExitMultipleMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_RevolvingCreditAgreementJune2021FiveYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Agreement June 2021 Five Year",
        "label": "Revolving Credit Agreement June 2021 Five Year [Member]",
        "terseLabel": "Revolving Credit Agreement June 2021 Five Year"
       }
      }
     },
     "localname": "RevolvingCreditAgreementJune2021FiveYearMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_RevolvingCreditAgreementJune2021OneYearMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Agreement June 2021 One Year",
        "label": "Revolving Credit Agreement June 2021 One Year [Member]",
        "terseLabel": "Revolving Credit Agreement June 2021 One Year"
       }
      }
     },
     "localname": "RevolvingCreditAgreementJune2021OneYearMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_RiskCorridorSettlementsMedicarePartDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk Corridor Settlements - Medicare Part D [Member]",
        "label": "Risk Corridor Settlements Medicare Part D [Member]",
        "terseLabel": "Risk Corridor Settlement"
       }
      }
     },
     "localname": "RiskCorridorSettlementsMedicarePartDMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of all or some of the information related to dividends declared and paid",
        "label": "Schedule Of Dividends Declared And Paid Table [Table Text Block]",
        "terseLabel": "Schedule of Details of Dividend Payments"
       }
      }
     },
     "localname": "ScheduleOfDividendsDeclaredAndPaidTableTableTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Health Care Cost Payments and Reimbursements",
        "label": "Schedule of Health Care Cost Payments and Reimbursements [Table Text Block]",
        "terseLabel": "Schedule of Health Care Cost Payments and Reimbursements"
       }
      }
     },
     "localname": "ScheduleOfHealthCareCostPaymentsAndReimbursementsTableTextBlock",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "hum_SecuredOvernightFinancingRateSOFRMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Overnight Financing Rate (SOFR)",
        "label": "Secured Overnight Financing Rate (SOFR) [Member]",
        "terseLabel": "SOFR"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSOFRMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Termination Of Employment Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Termination Of Employment Period",
        "terseLabel": "Accelerated vesting, termination of employment period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingTerminationOfEmploymentPeriod",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation By Share Based Payment Award, Equity Instruments Other Than Options, Percent Of Stock With Performance Based Conditions",
        "label": "Share Based Compensation By Share Based Payment Award, Equity Instruments Other Than Options, Percent Of Stock With Performance Based Conditions",
        "terseLabel": "Percentage of restricted stock with performance-based conditions"
       }
      }
     },
     "localname": "ShareBasedCompensationByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentOfStockWithPerformanceBasedConditions",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.",
        "label": "Share Repurchases Related To Employee Stock Based Compensation Awards Shares",
        "terseLabel": "Common shares acquired in connection with employee stock plans (in shares)"
       }
      }
     },
     "localname": "ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsShares",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "hum_ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of common stock that were repurchased in the administration of our employee share-based compensation plans. Under the terms of these plans, we accept shares of common stock from option holders if they elect to surrender previously-owned shares upon exercise of the option to cover the exercise price of the options or, in the case of restricted shares of common stock, the withholding of shares to satisfy tax withholding obligations associated with the vesting of such shares.",
        "label": "Share Repurchases Related To Employee Stock Based Compensation Awards Value",
        "terseLabel": "Common shares acquired in connection with employee stock plans, amount"
       }
      }
     },
     "localname": "ShareRepurchasesRelatedToEmployeeStockBasedCompensationAwardsValue",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_SignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Line Items]",
        "label": "Significant Accounting Policies [Line Items]",
        "terseLabel": "Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesLineItems",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hum_SignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Accounting Policies [Table]",
        "label": "Significant Accounting Policies [Table]",
        "terseLabel": "Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTable",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "hum_SpecialtyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty [Member]",
        "label": "Specialty [Member]",
        "terseLabel": "Specialty"
       }
      }
     },
     "localname": "SpecialtyMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Partnership Agreement, Number Of Additional Primary Care Centers Expected To Be Opened",
        "label": "Strategic Partnership Agreement, Number Of Additional Primary Care Centers Expected To Be Opened",
        "terseLabel": "Number of additional primary care centers expected to be opened in strategic partnership"
       }
      }
     },
     "localname": "StrategicPartnershipAgreementNumberOfAdditionalPrimaryCareCentersExpectedToBeOpened",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_StrategicPartnershipAgreementNumberOfPrimaryCareCenters": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Partnership Agreement, Number Of Primary Care Centers",
        "label": "Strategic Partnership Agreement, Number Of Primary Care Centers",
        "terseLabel": "Number of primary care centers in strategic partnership"
       }
      }
     },
     "localname": "StrategicPartnershipAgreementNumberOfPrimaryCareCenters",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Maximum",
        "label": "Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Maximum",
        "terseLabel": "Time frame for put and call option activity per partnership agreement, maximum"
       }
      }
     },
     "localname": "StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMaximum",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Minimum",
        "label": "Strategic Partnership Agreement, Timeframe For Put And Call Option Activity, Minimum",
        "terseLabel": "Time frame for put and call option activity per partnership agreement, minimum"
       }
      }
     },
     "localname": "StrategicPartnershipAgreementTimeframeForPutAndCallOptionActivityMinimum",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_SubsidyAndDiscountPayments": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails": {
       "order": 1.0,
       "parentTag": "hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidy And Discount Payments",
        "label": "Subsidy And Discount Payments",
        "negatedTerseLabel": "Part D subsidy/discount payments"
       }
      }
     },
     "localname": "SubsidyAndDiscountPayments",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidy And Discount Payments In Excess Of Reimbursements",
        "label": "Subsidy And Discount Payments In Excess Of Reimbursements",
        "negatedTotalLabel": "Net reimbursements (payments)"
       }
      }
     },
     "localname": "SubsidyAndDiscountPaymentsInExcessOfReimbursements",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_SubsidyAndDiscountReimbursements": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails": {
       "order": 2.0,
       "parentTag": "hum_SubsidyAndDiscountPaymentsInExcessOfReimbursements",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidy And Discount Reimbursements",
        "label": "Subsidy And Discount Reimbursements",
        "terseLabel": "Part D subsidy/discount reimbursements"
       }
      }
     },
     "localname": "SubsidyAndDiscountReimbursements",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPartDSubsidyDiscountPaymentsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_SubsidyAndDiscountsSettlementPeriodAfterClose": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidy And Discounts, Settlement Period After Close",
        "label": "Subsidy And Discounts, Settlement Period After Close",
        "terseLabel": "Settlement period after close"
       }
      }
     },
     "localname": "SubsidyAndDiscountsSettlementPeriodAfterClose",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_TRICAREManagedCareSupportContractBaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE Managed Care Support Contract, Base Term",
        "label": "TRICARE Managed Care Support Contract, Base Term",
        "terseLabel": "Contract base term"
       }
      }
     },
     "localname": "TRICAREManagedCareSupportContractBaseTerm",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_TRICAREManagedCareSupportContractNumberOfOptionPeriods": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE Managed Care Support Contract, Number Of Option Periods",
        "label": "TRICARE Managed Care Support Contract, Number Of Option Periods",
        "terseLabel": "Annual option periods"
       }
      }
     },
     "localname": "TRICAREManagedCareSupportContractNumberOfOptionPeriods",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "hum_TRICAREManagedCareSupportContractTermWithOptionExercises": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "TRICARE Managed Care Support Contract, Term With Option Exercises",
        "label": "TRICARE Managed Care Support Contract, Term With Option Exercises",
        "terseLabel": "Contract term with exercises"
       }
      }
     },
     "localname": "TRICAREManagedCareSupportContractTermWithOptionExercises",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_TermLoanAndCommercialPaperMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan And Commercial Paper",
        "label": "Term Loan And Commercial Paper [Member]",
        "terseLabel": "Term Loan And Commercial Paper"
       }
      }
     },
     "localname": "TermLoanAndCommercialPaperMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_TermLoanDueOctober2023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan Due October 2023",
        "label": "Term Loan Due October 2023 [Member]",
        "terseLabel": "Term loan, due October 29, 2023"
       }
      }
     },
     "localname": "TermLoanDueOctober2023Member",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_TreasuryStockDecreaseInCapitalInExcessOfParValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Treasury Stock, Decrease In Capital In Excess Of Par Value",
        "label": "Treasury Stock, Decrease In Capital In Excess Of Par Value",
        "terseLabel": "Decrease in capital in excess of par value"
       }
      }
     },
     "localname": "TreasuryStockDecreaseInCapitalInExcessOfParValue",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "hum_TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Typical Term (In Years) Of Short-Duration Employer-Group Prepaid Health Services Policies",
        "label": "Typical Term In Years Of Short Duration Employer Group Prepaid Health Services Policies",
        "terseLabel": "Typical term (in years) of short-duration employer-group prepaid health services policies"
       }
      }
     },
     "localname": "TypicalTermInYearsOfShortDurationEmployerGroupPrepaidHealthServicesPolicies",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "hum_USRiskCorridorPremiumStabilizationProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "US Risk Corridor Premium Stabilization Program",
        "label": "US Risk Corridor Premium Stabilization Program [Member]",
        "terseLabel": "US Risk Corridor Premium Stabilization Program"
       }
      }
     },
     "localname": "USRiskCorridorPremiumStabilizationProgramMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_ValueCreationInitiativesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value Creation Initiatives",
        "label": "Value Creation Initiatives [Member]",
        "terseLabel": "Value Creation Initiatives"
       }
      }
     },
     "localname": "ValueCreationInitiativesMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_WellsFargoBankMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Wells Fargo Bank",
        "label": "Wells Fargo Bank [Member]",
        "terseLabel": "Wells Fargo Bank"
       }
      }
     },
     "localname": "WellsFargoBankMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "hum_WelshCarsonAndersonAndStoweMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Welsh Carson Anderson And Stowe [Member]",
        "label": "Welsh Carson Anderson And Stowe [Member]",
        "terseLabel": "WCAS"
       }
      }
     },
     "localname": "WelshCarsonAndersonAndStoweMember",
     "nsuri": "http://www.humana.com/20221231",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Information Disclosure [Abstract]",
        "terseLabel": "Condensed Financial Information Disclosure [Abstract]"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract",
     "nsuri": "http://fasb.org/srt/2022",
     "xbrltype": "stringItemType"
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "terseLabel": "Condensed Financial Statements, Captions [Line Items]"
       }
      }
     },
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r358",
      "r635",
      "r636",
      "r640",
      "r641",
      "r687",
      "r773",
      "r883",
      "r886",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r358",
      "r635",
      "r636",
      "r640",
      "r641",
      "r687",
      "r773",
      "r883",
      "r886",
      "r887"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r358",
      "r397",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r419",
      "r492",
      "r493",
      "r494",
      "r495",
      "r497",
      "r498",
      "r500",
      "r502",
      "r503",
      "r884",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r358",
      "r397",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r419",
      "r492",
      "r493",
      "r494",
      "r495",
      "r497",
      "r498",
      "r500",
      "r502",
      "r503",
      "r884",
      "r885"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r356",
      "r357",
      "r508",
      "r534",
      "r779",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CreditRatingStandardPoorsAxis": {
     "auth_ref": [
      "r786",
      "r852",
      "r863",
      "r882",
      "r924"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Credit Rating, Standard &amp; Poor's [Axis]",
        "terseLabel": "Credit Rating, Standard &amp; Poor's [Axis]"
       }
      }
     },
     "localname": "CreditRatingStandardPoorsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r301",
      "r362",
      "r367",
      "r373",
      "r448",
      "r604",
      "r605",
      "r606",
      "r622",
      "r623",
      "r644",
      "r645",
      "r646",
      "r647",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r301",
      "r362",
      "r367",
      "r373",
      "r448",
      "r604",
      "r605",
      "r606",
      "r622",
      "r623",
      "r644",
      "r645",
      "r646",
      "r647",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r301",
      "r362",
      "r367",
      "r373",
      "r448",
      "r604",
      "r605",
      "r606",
      "r622",
      "r623",
      "r644",
      "r645",
      "r646",
      "r647",
      "r685"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ExternalCreditRatingStandardPoorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "External Credit Rating, Standard &amp; Poor's [Domain]",
        "terseLabel": "External Credit Rating, Standard &amp; Poor's [Domain]"
       }
      }
     },
     "localname": "ExternalCreditRatingStandardPoorsMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r424",
      "r797",
      "r890",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails",
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r488",
      "r489",
      "r490",
      "r491",
      "r570",
      "r719",
      "r751",
      "r774",
      "r775",
      "r795",
      "r803",
      "r812",
      "r888",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r488",
      "r489",
      "r490",
      "r491",
      "r570",
      "r719",
      "r751",
      "r774",
      "r775",
      "r795",
      "r803",
      "r812",
      "r888",
      "r931",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r424",
      "r797",
      "r890",
      "r942"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails",
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ParentCompanyMember": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Company [Member]",
        "terseLabel": "Parent Company"
       }
      }
     },
     "localname": "ParentCompanyMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r421",
      "r721",
      "r796",
      "r811",
      "r879",
      "r880",
      "r890",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r421",
      "r721",
      "r796",
      "r811",
      "r879",
      "r880",
      "r890",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r488",
      "r489",
      "r490",
      "r491",
      "r562",
      "r570",
      "r597",
      "r598",
      "r599",
      "r695",
      "r719",
      "r751",
      "r774",
      "r775",
      "r795",
      "r803",
      "r812",
      "r875",
      "r888",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r488",
      "r489",
      "r490",
      "r491",
      "r562",
      "r570",
      "r597",
      "r598",
      "r599",
      "r695",
      "r719",
      "r751",
      "r774",
      "r775",
      "r795",
      "r803",
      "r812",
      "r875",
      "r888",
      "r932",
      "r933",
      "r934",
      "r935",
      "r936"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r356",
      "r357",
      "r508",
      "r534",
      "r780",
      "r781"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "auth_ref": [
      "r358",
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Condensed Financial Statements [Table]",
        "terseLabel": "Condensed Financial Statements [Table]"
       }
      }
     },
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_StandardPoorsAAMinusRatingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Standard &amp; Poor's, AA- Rating [Member]",
        "terseLabel": "Standard &amp; Poor's, AA- Rating"
       }
      }
     },
     "localname": "StandardPoorsAAMinusRatingMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date of execution of accelerated share repurchases.",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date upon which the accelerated share repurchase agreement was executed.",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesFinalPricePaidPerShare": {
     "auth_ref": [
      "r160"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Final price paid per share for the purchase of the targeted number of shares, determined by an average market price over a fixed period of time.",
        "label": "Accelerated Share Repurchases, Final Price Paid Per Share",
        "terseLabel": "Average daily volume weighted-average share price of common stock during term of agreement (in dollars per share)"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesFinalPricePaidPerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesSettlementPaymentOrReceipt": {
     "auth_ref": [
      "r160"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash receipt from (payment to) bank; or stock received from (issuance to) bank in the settlement of the accelerated share repurchase agreement.",
        "label": "Accelerated Share Repurchases, Settlement (Payment) or Receipt",
        "negatedTerseLabel": "Accelerated share repurchase payment"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesSettlementPaymentOrReceipt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 2.0,
       "parentTag": "hum_NetCurrentLiabilityAsset",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "negatedLabel": "Trade accounts payable and accrued expenses",
        "terseLabel": "Trade accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/MEDICAREPARTDDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r235",
      "r249",
      "r275",
      "r843"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties.",
        "label": "Accounts Payable, Related Parties",
        "terseLabel": "Payable to operating subsidiaries"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r426",
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedPartiesCurrent": {
     "auth_ref": [
      "r235",
      "r237",
      "r320",
      "r843"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.",
        "label": "Accounts Receivable, Related Parties, Current",
        "terseLabel": "Receivable from operating subsidiaries"
       }
      }
     },
     "localname": "AccountsReceivableRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r137",
      "r312"
     ],
     "calculation": {
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r43",
      "r45",
      "r46",
      "r321",
      "r740",
      "r756",
      "r757"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive (loss) income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r42",
      "r46",
      "r207",
      "r686",
      "r752",
      "r753",
      "r828",
      "r829",
      "r830",
      "r844",
      "r845",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Capital in excess of par value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r604",
      "r605",
      "r606",
      "r844",
      "r845",
      "r846",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Capital\u00a0In Excess\u00a0of Par Value"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r74",
      "r126"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r176",
      "r177",
      "r572"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r601"
     ],
     "calculation": {
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, after Tax",
        "totalLabel": "Stock-based compensation expense, net of tax"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpenseNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r322",
      "r428",
      "r449"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Receivables, allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r74",
      "r120",
      "r126"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization expense for other intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Number of antidilutive stock options and restricted stock\u00a0awards excluded from computation (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r798",
      "r857"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-Backed Securities [Member]",
        "verboseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r240",
      "r265",
      "r316",
      "r353",
      "r405",
      "r411",
      "r417",
      "r446",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r503",
      "r504",
      "r635",
      "r640",
      "r662",
      "r810",
      "r884",
      "r885",
      "r929"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r307",
      "r324",
      "r353",
      "r446",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r503",
      "r504",
      "r635",
      "r640",
      "r662",
      "r810",
      "r884",
      "r885",
      "r929"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "terseLabel": "Current assets",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r215"
     ],
     "calculation": {
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total invested assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsNoncurrent": {
     "auth_ref": [
      "r353",
      "r446",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r503",
      "r504",
      "r635",
      "r640",
      "r662",
      "r884",
      "r885",
      "r929"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer.",
        "label": "Assets, Noncurrent",
        "terseLabel": "Non-current assets"
       }
      }
     },
     "localname": "AssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r140",
      "r305",
      "r306"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r430",
      "r455"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "terseLabel": "Book value",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss [Abstract]",
        "terseLabel": "Gross Unrealized Losses"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r104",
      "r433",
      "r734"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r104",
      "r432",
      "r733"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue": {
     "auth_ref": [
      "r104",
      "r434",
      "r735"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing after tenth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10",
        "terseLabel": "Due after ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Amortized Cost, Rolling Maturity [Abstract]",
        "terseLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasisRollingMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r104",
      "r431",
      "r732"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Amortized Cost",
        "terseLabel": "Mortgage and asset-backed securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue": {
     "auth_ref": [
      "r109",
      "r736"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), without single maturity date and not allocated over maturity grouping.",
        "label": "Debt Securities, Available-for-Sale, Maturity, without Single Maturity Date, Fair Value",
        "terseLabel": "Mortgage and asset-backed securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r101",
      "r429",
      "r455",
      "r725"
     ],
     "calculation": {
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Fair Value",
        "verboseLabel": "Debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESContractualMaturitiesofDebtSecuritiesAvailableforSaleDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "auth_ref": [
      "r100",
      "r310",
      "r455"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "terseLabel": "Long-term investment securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss [Abstract]",
        "terseLabel": "Debt Securities Amortized Cost to Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesFairValueToAmortizedCostBasisAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Securities, Available-for-Sale, Unrealized Gain (Loss) [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesGrossUnrealizedGainLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r210",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance sheet"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BenefitsLossesAndExpenses": {
     "auth_ref": [
      "r280"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs.",
        "label": "Benefits, Losses and Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "BenefitsLossesAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r633",
      "r801",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r189",
      "r190",
      "r633",
      "r801",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r193"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]",
        "terseLabel": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Other intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "totalLabel": "Total liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-Term Debt",
        "terseLabel": "Long term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r191",
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "auth_ref": [
      "r192"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest",
        "totalLabel": "Net assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1": {
     "auth_ref": [
      "r187"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value at acquisition-date of the equity interest in the acquiree held by the acquirer, immediately before the acquisition date for businesses combined in stages.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Fair Value",
        "terseLabel": "Existing equity value"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeFairValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Minority ownership prior to acquisition (percent)"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CallOptionMember": {
     "auth_ref": [
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial contract between two parties, the buyer and the seller of the option, where the buyer has the right but not the obligation to buy an agreed quantity of a particular commodity or financial instrument (the underlying instrument) from the seller of the option for a certain price (the strike price). Seller is obligated to sell the asset to the buyer, if the buyer exercises the option.",
        "label": "Call Option [Member]",
        "terseLabel": "Call option"
       }
      }
     },
     "localname": "CallOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r299",
      "r300"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Amortization expense for capitalized internally developed and purchased software"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r224",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "terseLabel": "Carrying Value"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r76",
      "r309",
      "r777"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r77"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r70",
      "r76",
      "r82"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "periodStartLabel": "Cash and cash equivalents at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r70",
      "r230"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CededPremiumsWritten": {
     "auth_ref": [
      "r294",
      "r295"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of written premiums ceded to other entities.",
        "label": "Ceded Premiums Written",
        "terseLabel": "Premiums ceded"
       }
      }
     },
     "localname": "CededPremiumsWritten",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClaimsDevelopmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Claims Development [Line Items]",
        "terseLabel": "Claims Development [Line Items]"
       }
      }
     },
     "localname": "ClaimsDevelopmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails",
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfTreasuryStockTable": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table]",
        "terseLabel": "Class of Treasury Stock [Table]"
       }
      }
     },
     "localname": "ClassOfTreasuryStockTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommercialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r109",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by commercial real estate mortgage loans.",
        "label": "Commercial Mortgage-Backed Securities [Member]",
        "terseLabel": "Commercial"
       }
      }
     },
     "localname": "CommercialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "verboseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r37",
      "r250",
      "r273"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 17)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r145",
      "r484",
      "r486",
      "r769",
      "r881"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS, GUARANTEES AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Amount per share (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYDividendPaymentsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Cash dividend declared (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r844",
      "r845",
      "r925"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r19",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r19",
      "r810"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at December 31, 2022 and 198,648,742 shares issued at December 31, 2021"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r166"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r48",
      "r331",
      "r333",
      "r341",
      "r728",
      "r744"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Humana"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer software"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r91",
      "r92",
      "r226",
      "r227",
      "r424",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/REINSURANCEDetails",
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r91",
      "r92",
      "r226",
      "r227",
      "r424",
      "r760",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/REINSURANCEDetails",
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r91",
      "r92",
      "r226",
      "r227",
      "r424",
      "r768",
      "r944"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/REINSURANCEDetails",
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REPORTINGENTITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r91",
      "r92",
      "r226",
      "r227",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r88",
      "r91",
      "r92",
      "r93",
      "r226",
      "r228",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REPORTINGENTITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r91",
      "r92",
      "r226",
      "r227",
      "r424",
      "r768"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/REINSURANCEDetails",
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock": {
     "auth_ref": [
      "r303",
      "r358",
      "r825"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document.",
        "label": "Condensed Financial Information of Parent Company Only Disclosure [Text Block]",
        "terseLabel": "SCHEDULE I - PARENT COMPANY FINANCIAL INFORMATION"
       }
      }
     },
     "localname": "CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r548",
      "r549",
      "r560"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Unearned revenues"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Provider contracts"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r798",
      "r800",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "verboseLabel": "Corporate debt securities"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails": {
       "order": 1.0,
       "parentTag": "hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditSpreadOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option on the yield spread on a bond.",
        "label": "Credit Spread Option [Member]",
        "terseLabel": "Credit spread"
       }
      }
     },
     "localname": "CreditSpreadOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r842",
      "r922",
      "r923"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r186",
      "r619",
      "r627",
      "r842"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current provision"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r842",
      "r922",
      "r923"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "States and Puerto Rico"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerContractsMember": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's established relationships with its customers through contracts.",
        "label": "Customer Contracts [Member]",
        "terseLabel": "Customer contracts/relationships"
       }
      }
     },
     "localname": "CustomerContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtAndEquitySecuritiesGainLoss": {
     "auth_ref": [
      "r53",
      "r54"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in debt and equity securities.",
        "label": "Debt and Equity Securities, Gain (Loss)",
        "negatedTerseLabel": "Loss (gain) on investment securities, net",
        "totalLabel": "Net recognized (losses) gains on investment securities"
       }
      }
     },
     "localname": "DebtAndEquitySecuritiesGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtCurrent": {
     "auth_ref": [
      "r318"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.humana.com/role/DEBTDebtOutstandingDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of debt and lease obligation, classified as current.",
        "label": "Debt, Current",
        "terseLabel": "Short-term debt",
        "totalLabel": "Total short-term debt"
       }
      }
     },
     "localname": "DebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r151",
      "r351",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r521",
      "r528",
      "r529",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r12",
      "r13",
      "r14",
      "r241",
      "r243",
      "r263",
      "r358",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r511",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r672",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis points spread on variable rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r232",
      "r234",
      "r505",
      "r672",
      "r791",
      "r792"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Aggregate principal"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r519",
      "r661",
      "r791",
      "r792"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt outstanding"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r34",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r35",
      "r358",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r511",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r672",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Redemption price, percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r35",
      "r154",
      "r155",
      "r156",
      "r157",
      "r231",
      "r232",
      "r234",
      "r258",
      "r358",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r511",
      "r517",
      "r518",
      "r519",
      "r520",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r530",
      "r672",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Debt instrument term (in years)"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger": {
     "auth_ref": [
      "r441",
      "r461",
      "r788"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for more than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer",
        "terseLabel": "12 months or more"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss": {
     "auth_ref": [
      "r441",
      "r461"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for 12 months or longer, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss",
        "negatedTerseLabel": "12 months or more"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months": {
     "auth_ref": [
      "r441",
      "r461",
      "r788"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months",
        "terseLabel": "Less\u00a0than\u00a012\u00a0months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss": {
     "auth_ref": [
      "r441",
      "r461"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in continuous unrealized loss position for less than 12 months, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss",
        "negatedTerseLabel": "Less\u00a0than\u00a012\u00a0months"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPosition": {
     "auth_ref": [
      "r438",
      "r457",
      "r788"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position without allowance for credit loss.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPosition",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss": {
     "auth_ref": [
      "r439",
      "r458"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable": {
     "auth_ref": [
      "r456",
      "r788"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Fair Value [Table]",
        "terseLabel": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions": {
     "auth_ref": [
      "r440",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of investments in debt securities measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions",
        "terseLabel": "Securities in unrealized loss position, number of positions"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r74",
      "r186",
      "r620",
      "r626",
      "r627",
      "r842"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred (benefit) expense",
        "verboseLabel": "(Benefit) provision for deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r16",
      "r17",
      "r242",
      "r262",
      "r614"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r615"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Assets, Investments",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "DeferredTaxAssetsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r920"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Total deferred income tax assets, net of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r184",
      "r921"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "auth_ref": [
      "r184",
      "r921"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.",
        "label": "Deferred Tax Assets, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits": {
     "auth_ref": [
      "r184",
      "r921"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensation and benefits costs.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits",
        "terseLabel": "Benefits payable"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits": {
     "auth_ref": [
      "r184",
      "r921"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from employee benefits, classified as other.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Benefits",
        "terseLabel": "Compensation and other accrued expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve": {
     "auth_ref": [
      "r184",
      "r921"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from the unearned premiums reserve.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Unearned Premiums Reserve",
        "terseLabel": "Unearned revenues"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsUnearnedPremiumsReserve",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r616"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Valuation allowances on net operating loss carryforwards related to prior acquisitions"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESNarrativeDetails",
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r178",
      "r920"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total net deferred income tax liabilities"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesInvestments": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from investments (excludes investments in subsidiaries and equity method investments).",
        "label": "Deferred Tax Liabilities, Investments",
        "negatedTerseLabel": "Investment securities"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r184",
      "r921"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "negatedLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESPrincipalComponentsofNetDeferredTaxBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "auth_ref": [
      "r569"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost for defined contribution plan.",
        "label": "Defined Contribution Plan, Cost",
        "terseLabel": "Employee retirement and savings plan cost"
       }
      }
     },
     "localname": "DefinedContributionPlanCostRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r74",
      "r135"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation",
        "verboseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETNarrativeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetLiabilityNetMeasurementInput": {
     "auth_ref": [
      "r653"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure net derivative asset (liability).",
        "label": "Derivative Asset (Liability) Net, Measurement Input",
        "terseLabel": "Significant unobservable inputs"
       }
      }
     },
     "localname": "DerivativeAssetLiabilityNetMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": {
     "auth_ref": [
      "r2",
      "r3",
      "r4"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.",
        "label": "Discontinued Operation, Gain (Loss) from Disposal of Discontinued Operation, before Income Tax",
        "terseLabel": "Pre-tax gain, net of transaction costs"
       }
      }
     },
     "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r133",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposed of by sale",
        "verboseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r140"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net",
        "terseLabel": "Receivables, net of allowances"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r134",
      "r140"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Trade accounts payable and accrued expenses"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r140"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Consideration to be received"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r131",
      "r140"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r131",
      "r140"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent",
        "terseLabel": "Identifiable intangibles"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r134",
      "r140"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r131",
      "r140"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r131",
      "r140"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r131",
      "r140"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": {
     "auth_ref": [
      "r5",
      "r306"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Revenue",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r801",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Dividends": {
     "auth_ref": [
      "r158",
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock.",
        "label": "Dividends",
        "terseLabel": "Total Amount"
       }
      }
     },
     "localname": "Dividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYDividendPaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends and dividend equivalents"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r342",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r374",
      "r376",
      "r382",
      "r383",
      "r384",
      "r388",
      "r647",
      "r648",
      "r729",
      "r745",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic earnings per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r342",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r376",
      "r382",
      "r383",
      "r384",
      "r388",
      "r647",
      "r648",
      "r729",
      "r745",
      "r783"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted earnings per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r85",
      "r86"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Common Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS PER COMMON SHARE COMPUTATION"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectsOfReinsuranceLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Effects of Reinsurance [Line Items]",
        "terseLabel": "Effects of Reinsurance [Line Items]"
       }
      }
     },
     "localname": "EffectsOfReinsuranceLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r602"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Capitalized stock-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Stock-based compensation expense [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r603"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Total compensation expense not yet recognized related to nonvested awards"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Compensation expense recognition over a weighted-average period (in years)"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "auth_ref": [
      "r601"
     ],
     "calculation": {
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "negatedTerseLabel": "Tax benefit recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options",
        "verboseLabel": "Employee stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityClassOfTreasuryStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Equity, Class of Treasury Stock [Line Items]",
        "terseLabel": "Equity, Class of Treasury Stock [Line Items]"
       }
      }
     },
     "localname": "EquityClassOfTreasuryStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r153",
      "r301",
      "r335",
      "r336",
      "r337",
      "r359",
      "r360",
      "r361",
      "r364",
      "r370",
      "r372",
      "r390",
      "r448",
      "r547",
      "r604",
      "r605",
      "r606",
      "r622",
      "r623",
      "r646",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r669",
      "r686",
      "r752",
      "r753",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": {
     "auth_ref": [
      "r306",
      "r353",
      "r446",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Axis]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Axis]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": {
     "auth_ref": [
      "r306",
      "r353",
      "r446",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.",
        "label": "Equity Method Investment, Nonconsolidated Investee [Domain]",
        "terseLabel": "Equity Method Investment, Nonconsolidated Investee [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "terseLabel": "Equity method investment ownership (percent)"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r831",
      "r832",
      "r838"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "negatedTerseLabel": "Gain on Kindred at Home equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r113",
      "r406",
      "r826"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Equity method investments"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "EQUITY METHOD INVESTMENT"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsPolicy": {
     "auth_ref": [
      "r69",
      "r115",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for equity method of accounting for investments and other interests. Investment includes, but is not limited to, unconsolidated subsidiary, corporate joint venture, noncontrolling interest in real estate venture, limited partnership, and limited liability company. Information includes, but is not limited to, ownership percentage, reason equity method is or is not considered appropriate, and accounting policy election for distribution received.",
        "label": "Equity Method Investments [Policy Text Block]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r317",
      "r659",
      "r778"
     ],
     "calculation": {
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      },
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_Investments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI), classified as current.",
        "label": "Equity Securities, FV-NI, Current",
        "terseLabel": "Common stock"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiGainLoss": {
     "auth_ref": [
      "r861"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized and realized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Gain (Loss)",
        "totalLabel": "Net (losses) gains recognized on equity securities during the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGain": {
     "auth_ref": [
      "r861"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain",
        "terseLabel": "Gross gains on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedGainLoss": {
     "auth_ref": [
      "r746",
      "r861"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Gain (Loss)",
        "terseLabel": "Less: Net losses recognized on equity securities sold during the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiRealizedLoss": {
     "auth_ref": [
      "r861"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DebtAndEquitySecuritiesGainLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized loss from sale of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Realized Loss",
        "negatedTerseLabel": "Gross losses on equity securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiRealizedLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESRealizedGainsLossesIncludedWithinInvestmentIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNiUnrealizedGainLoss": {
     "auth_ref": [
      "r746",
      "r861"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EquitySecuritiesFvNiGainLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) on investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI, Unrealized Gain (Loss)",
        "terseLabel": "Unrealized (losses) gains recognized on equity securities still held at the end of the period"
       }
      }
     },
     "localname": "EquitySecuritiesFvNiUnrealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESGainsLossesonEquitySecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r519",
      "r661",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r649",
      "r650",
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of Assumptions Used For Inputs In Fair Value Measurement"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r215",
      "r216"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Financial Assets Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r218",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.",
        "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r215",
      "r224",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r519",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r650",
      "r692",
      "r693",
      "r694",
      "r791",
      "r792",
      "r798",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r215",
      "r221",
      "r519",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r649",
      "r650",
      "r652",
      "r653",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Basis [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [
      "r519",
      "r791",
      "r792"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r519",
      "r563",
      "r568",
      "r650",
      "r692",
      "r798",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Prices in Active Markets (Level 1)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r519",
      "r563",
      "r568",
      "r650",
      "r693",
      "r791",
      "r792",
      "r798",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Other Observable Inputs (Level 2)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r519",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r650",
      "r694",
      "r791",
      "r792",
      "r798",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Unobservable Inputs (Level 3)",
        "verboseLabel": "Level 3 fair value measurement"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": {
     "auth_ref": [
      "r654"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings",
        "terseLabel": "Realized in earnings"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r655"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from asset measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "terseLabel": "Unrealized in other comprehensive\u00a0income"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": {
     "auth_ref": [
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": {
     "auth_ref": [
      "r219"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales",
        "negatedTerseLabel": "Sales"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements": {
     "auth_ref": [
      "r219"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlement of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements",
        "negatedTerseLabel": "Settlements"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value",
        "periodEndLabel": "Balance at December\u00a031",
        "periodStartLabel": "Beginning balance at January\u00a01",
        "terseLabel": "Asset value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/FAIRVALUESignificantUnobservableInputsLevel3Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r519",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r692",
      "r693",
      "r694",
      "r791",
      "r792",
      "r798",
      "r799",
      "r800"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r656",
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r79",
      "r80",
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired, net of cash acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r222",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FederalHomeLoanBankAdvancesMember": {
     "auth_ref": [
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowings from the Federal Home Loan Bank, which are primarily used to cover shortages in the required reserve balance and also in times of liquidity shortages. The member institution executes a promissory note, which is generally collateralized by government securities to the Federal Reserve or loans.",
        "label": "Federal Home Loan Bank Advances [Member]",
        "terseLabel": "Federal Home Loan Bank Advances"
       }
      }
     },
     "localname": "FederalHomeLoanBankAdvancesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r436",
      "r437",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r460",
      "r462",
      "r463",
      "r530",
      "r545",
      "r642",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r788",
      "r858",
      "r859",
      "r860",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialLiabilitiesFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities.",
        "label": "Financial Liabilities Fair Value Disclosure",
        "terseLabel": "Fair value of financial liability"
       }
      }
     },
     "localname": "FinancialLiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableRecordedInvestmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Financing Receivable, Credit Quality Indicator [Line Items]",
        "terseLabel": "Financing Receivable, Credit Quality Indicator [Line Items]"
       }
      }
     },
     "localname": "FinancingReceivableRecordedInvestmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Weighted Average Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r314",
      "r479"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r477",
      "r478",
      "r479",
      "r480",
      "r722",
      "r723"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract]",
        "terseLabel": "Estimate of Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseCurrentAndFiveSucceedingFiscalYearsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSEstimateofAmortizationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r125",
      "r723"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Cost"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r121",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r125",
      "r722"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Other intangible assets:"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GainLossOnInvestmentsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of realized and unrealized gain (loss) on investment in security.",
        "label": "Gain (Loss) on Securities [Table Text Block]",
        "terseLabel": "Gain (Loss) on Equity Securities"
       }
      }
     },
     "localname": "GainLossOnInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r639",
      "r838"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain on sale of KAH Hospice"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r313",
      "r464",
      "r724",
      "r789",
      "r810",
      "r864",
      "r871"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      },
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails",
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r467",
      "r789"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND OTHER INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r118",
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r74",
      "r465",
      "r470",
      "r476",
      "r789"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillWrittenOffRelatedToSaleOfBusinessUnit": {
     "auth_ref": [
      "r469",
      "r789"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Written off Related to Sale of Business Unit",
        "negatedTerseLabel": "Dispositions"
       }
      }
     },
     "localname": "GoodwillWrittenOffRelatedToSaleOfBusinessUnit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GovernmentContractsConcentrationRiskMember": {
     "auth_ref": [
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. Risk is the materially adverse effects of termination of a significant contract or group of contracts or from future loss of a significant portion of business with a specified political body or unit thereof, such as Department of Defense, US Navy, New York City.",
        "label": "Government Contracts Concentration Risk [Member]",
        "terseLabel": "Government contracts concentration risk"
       }
      }
     },
     "localname": "GovernmentContractsConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r74",
      "r132"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Assets held for abandonment"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r130",
      "r143"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r50",
      "r238",
      "r252",
      "r278",
      "r405",
      "r410",
      "r416",
      "r419",
      "r730",
      "r785"
     ],
     "calculation": {
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": 2.0,
       "parentTag": "hum_IncomeLossFromContinuingOperationsBeforeIncomeTaxesAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Segment earnings"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r405",
      "r410",
      "r416",
      "r419",
      "r785"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes and equity in net (losses) earnings"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r51",
      "r74",
      "r113",
      "r251",
      "r276",
      "r402"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      },
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedTerseLabel": "Equity in net losses (earnings)",
        "terseLabel": "Equity in net (losses) earnings"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax": {
     "auth_ref": [
      "r142"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of income (loss) from an individually significant component disposed of or held-for-sale including the portion attributable to the noncontrolling interest. Excludes discontinued operations.",
        "label": "Income (Loss) from Individually Significant Component Disposed of or Held-for-sale, Excluding Discontinued Operations, before Income Tax",
        "terseLabel": "Pretax earnings"
       }
      }
     },
     "localname": "IncomeLossFromIndividuallySignificantComponentDisposedOfOrHeldForSaleExcludingDiscontinuedOperationsBeforeIncomeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r801",
      "r802"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement Related Disclosures [Abstract]",
        "terseLabel": "Income Statement Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r354",
      "r611",
      "r612",
      "r618",
      "r624",
      "r628",
      "r630",
      "r631",
      "r632"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r355",
      "r371",
      "r372",
      "r403",
      "r609",
      "r625",
      "r629",
      "r747"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails": {
       "order": 2.0,
       "parentTag": "hum_IncomeLossBeforeEquityInNetEarningsOfSubsidiaries",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "(Benefit) provision for income taxes",
        "totalLabel": "Provision for income taxes",
        "verboseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesDetails",
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r334",
      "r607",
      "r608",
      "r612",
      "r613",
      "r617",
      "r621"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationDispositionOfBusiness": {
     "auth_ref": [
      "r919"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the disposition of a business not qualifying as a discontinued operation.",
        "label": "Effective Income Tax Rate Reconciliation, Disposition of Business, Amount",
        "terseLabel": "Tax effect from sale of KAH Hospice"
       }
      }
     },
     "localname": "IncomeTaxReconciliationDispositionOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r610"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax provision at federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r919"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "terseLabel": "Nondeductible executive compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r919"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r919"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "States, net of federal benefit, and Puerto Rico"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxExemptIncome": {
     "auth_ref": [
      "r919"
     ],
     "calculation": {
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Exempt Income, Amount",
        "negatedLabel": "Tax exempt investment income"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxExemptIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESProvisionforIncomeTaxesReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income tax payments, net"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInBookOverdrafts": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in cash during the period due to the net increase or decrease in book overdrafts.",
        "label": "Increase (Decrease) in Book Overdrafts",
        "terseLabel": "Change in book overdraft"
       }
      }
     },
     "localname": "IncreaseDecreaseInBookOverdrafts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r720",
      "r837"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Unearned revenues"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInHealthCareInsuranceLiabilities": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) in health care insurance liability balances during the period.",
        "label": "Increase (Decrease) in Health Care Insurance Liabilities",
        "terseLabel": "Benefits payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInHealthCareInsuranceLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effect of businesses acquired and dispositions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r377",
      "r378",
      "r379",
      "r384",
      "r574"
     ],
     "calculation": {
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Dilutive effect of employee stock options and restricted stock (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InsuranceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insurance [Abstract]",
        "terseLabel": "Insurance [Abstract]"
       }
      }
     },
     "localname": "InsuranceAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InsuranceDisclosureTextBlock": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the types of coverages and products sold, and the assets, obligations, recorded liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.",
        "label": "Insurance Disclosure [Text Block]",
        "terseLabel": "BENEFITS PAYABLE"
       }
      }
     },
     "localname": "InsuranceDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InsurancePremiumsRevenueRecognitionPolicy": {
     "auth_ref": [
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue recognition of insurance premium. Includes, but is not limited to, basis for measurement and timing of recognition of revenue from insurance premium received from contract holder and method used in performing premium deficiency testing.",
        "label": "Insurance Premiums Revenue Recognition, Policy [Policy Text Block]",
        "terseLabel": "Premiums Revenue"
       }
      }
     },
     "localname": "InsurancePremiumsRevenueRecognitionPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [
      "r313"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "totalLabel": "Total other intangible assets, cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r119",
      "r123"
     ],
     "calculation": {
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "totalLabel": "Total other intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r233",
      "r254",
      "r338",
      "r399",
      "r671"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      },
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest",
        "verboseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r345",
      "r348",
      "r349"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest payments"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r397",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.",
        "label": "Investment Income, Interest and Dividend",
        "terseLabel": "Investment income"
       }
      }
     },
     "localname": "InvestmentIncomeInterestAndDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r445",
      "r939"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investment Securities"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r274"
     ],
     "calculation": {
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "totalLabel": "Total investment securities"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Schedule of Contractual Maturities of Debt Securities Available for Sale"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]",
        "terseLabel": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r112",
      "r239",
      "r255",
      "r298",
      "r776"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "INVESTMENT SECURITIES"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held for their financial return, rather than for the entity's operations.",
        "label": "Investments [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r891"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r928"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Schedule of Maturity of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "After 2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r683"
     ],
     "calculation": {
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "terseLabel": "Less: Interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r684"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r31",
      "r353",
      "r446",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r503",
      "r504",
      "r636",
      "r640",
      "r641",
      "r662",
      "r784",
      "r884",
      "r929",
      "r930"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r24",
      "r245",
      "r270",
      "r810",
      "r841",
      "r862",
      "r927"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r79",
      "r80",
      "r81"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedLabel": "Less: Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r33",
      "r308",
      "r353",
      "r446",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r503",
      "r504",
      "r636",
      "r640",
      "r641",
      "r662",
      "r810",
      "r884",
      "r929",
      "r930"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "terseLabel": "Current liabilities",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r14",
      "r15",
      "r353",
      "r446",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r503",
      "r504",
      "r636",
      "r640",
      "r641",
      "r662",
      "r884",
      "r929",
      "r930"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "auth_ref": [
      "r0",
      "r1",
      "r6",
      "r140",
      "r305",
      "r306"
     ],
     "calculation": {
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r282",
      "r285"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to reflect the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the balance sheet date, whether or not reported to the insurer at that date.",
        "label": "Liability for Claims and Claims Adjustment Expense",
        "periodEndLabel": "Balances, end of period",
        "periodStartLabel": "Balances, beginning of period",
        "terseLabel": "Benefits payable"
       }
      }
     },
     "localname": "LiabilityForClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails",
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the cost of settling unpaid claims after deduction of reinsurance recoveries related to the acquisition of a business. Includes, but is not limited to, claims which have been incurred but not reported.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions",
        "terseLabel": "Acquisitions"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseBusinessAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid [Abstract]",
        "terseLabel": "Paid related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1": {
     "auth_ref": [
      "r284"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in the current period and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Current Year",
        "negatedLabel": "Current year"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1": {
     "auth_ref": [
      "r284"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PaymentsForLossesAndLossAdjustmentExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle claims incurred in prior periods and related claims settlement costs.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid, Prior Years",
        "negatedLabel": "Prior years"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated costs as of the balance sheet date of settling insured claims and costs incurred in the claims settlement process for claims that have not yet been submitted to the insurance company for reimbursement.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred but Not Reported (IBNR) Claims, Amount",
        "terseLabel": "Total IBNR"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1": {
     "auth_ref": [
      "r283"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred and costs incurred in the claim settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims",
        "totalLabel": "Total incurred"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims [Abstract]",
        "terseLabel": "Incurred related to:"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet": {
     "auth_ref": [
      "r261",
      "r282",
      "r285"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Liability as of the balance sheet date for amounts representing estimated cost of settling unpaid claims under the terms of the underlying insurance policies, less estimated reinsurance recoveries on such claims. This includes an estimate for claims which have been incurred but not reported. Claim adjustment expenses represent the costs estimated to be incurred in the settlement of unpaid claims.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Net",
        "periodStartLabel": "Balances, beginning of period, net"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]",
        "terseLabel": "Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]"
       }
      }
     },
     "localname": "LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r197"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Medicare licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Facility fee (percent)"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r28",
      "r840"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LinesOfCreditCurrent": {
     "auth_ref": [
      "r12",
      "r241"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.",
        "label": "Line of Credit, Current",
        "terseLabel": "Line of credit, outstanding borrowings"
       }
      }
     },
     "localname": "LinesOfCreditCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount awarded from other party in judgment or settlement of litigation.",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "terseLabel": "Payment received upon judgement"
       }
      }
     },
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Related legal fees and expenses"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Loans Payable"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebtByMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long-Term Debt, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Maturities of debt"
       }
      }
     },
     "localname": "LongTermDebtByMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://www.humana.com/role/DEBTDebtOutstandingDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "terseLabel": "Long-term debt, current maturities"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive": {
     "auth_ref": [
      "r149",
      "r358",
      "r889"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r149",
      "r358",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive": {
     "auth_ref": [
      "r149",
      "r358",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "auth_ref": [
      "r149",
      "r358",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "auth_ref": [
      "r149",
      "r358",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r149",
      "r358",
      "r523"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTMaturitiesofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r319"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r35",
      "r150"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r146",
      "r147",
      "r487",
      "r488",
      "r489",
      "r877",
      "r878"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Weighted average cost of capital"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputLongTermRevenueGrowthRateMember": {
     "auth_ref": [
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using compounded annualized rate of long-term growth in revenue.",
        "label": "Measurement Input, Long-Term Revenue Growth Rate [Member]",
        "terseLabel": "Long term growth rate"
       }
      }
     },
     "localname": "MeasurementInputLongTermRevenueGrowthRateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputOptionVolatilityMember": {
     "auth_ref": [
      "r926"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns.",
        "label": "Measurement Input, Option Volatility [Member]",
        "terseLabel": "Annualized volatility"
       }
      }
     },
     "localname": "MeasurementInputOptionVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r7",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "ACQUISITIONS AND DIVESTITURES"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r41",
      "r244",
      "r269",
      "r353",
      "r446",
      "r492",
      "r495",
      "r496",
      "r497",
      "r503",
      "r504",
      "r662"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember": {
     "auth_ref": [
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities collateralized by real estate mortgage loans (mortgages), issued by US Government Sponsored Enterprises, such as Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac).",
        "label": "Mortgage-Backed Securities, Issued by US Government Sponsored Enterprises [Member]",
        "terseLabel": "Mortgage-backed securities"
       }
      }
     },
     "localname": "MortgageBackedSecuritiesIssuedByUSGovernmentSponsoredEnterprisesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "REPORTING ENTITY"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REPORTINGENTITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r347"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash (used in) provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities",
        "verboseLabel": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r347"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities",
        "verboseLabel": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r70",
      "r72",
      "r75"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "terseLabel": "Net cash provided by operating activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r52",
      "r75",
      "r253",
      "r277",
      "r306",
      "r329",
      "r332",
      "r337",
      "r353",
      "r363",
      "r365",
      "r366",
      "r367",
      "r368",
      "r371",
      "r372",
      "r381",
      "r405",
      "r410",
      "r416",
      "r419",
      "r446",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r503",
      "r504",
      "r648",
      "r662",
      "r785",
      "r884"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Humana",
        "totalLabel": "Net income attributable to Humana",
        "verboseLabel": "Net income available for common stockholders"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r204",
      "r209",
      "r329",
      "r332",
      "r371",
      "r372",
      "r830"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Net loss (income) attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestDecreaseFromDeconsolidation": {
     "auth_ref": [
      "r159",
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the reduction or elimination during the period of a noncontrolling interest resulting from the parent's loss of control and deconsolidation of the entity in which one or more outside parties had a noncontrolling interest.",
        "label": "Noncontrolling Interest, Decrease from Deconsolidation",
        "negatedTerseLabel": "Sale of KAH Hospice"
       }
      }
     },
     "localname": "NoncontrollingInterestDecreaseFromDeconsolidation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r159",
      "r193",
      "r205"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Acquisition"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r200",
      "r547",
      "r844",
      "r845",
      "r846"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Noncontrolling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NontaxableMunicipalNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term debt securities issued by state, city or local governments or the agencies operated by state, city or local governments that are not taxable.",
        "label": "Nontaxable Municipal Notes [Member]",
        "verboseLabel": "Tax-exempt municipal securities"
       }
      }
     },
     "localname": "NontaxableMunicipalNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": {
     "auth_ref": [
      "r25",
      "r236",
      "r843"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Notes Payable, Related Parties, Current",
        "terseLabel": "Current portion of notes payable to operating subsidiaries"
       }
      }
     },
     "localname": "NotesPayableRelatedPartiesClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r850"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Expenses:",
        "verboseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r405",
      "r410",
      "r416",
      "r419",
      "r785"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r677",
      "r809"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Fixed operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, to be Paid [Abstract]",
        "terseLabel": "Maturity of Lease Liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r674"
     ],
     "calculation": {
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "verboseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r674"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities included within trade accounts payable and accrued expenses"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating lease liabilities current, balance sheet line item"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r674"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities included within other long-term liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes noncurrent operating lease liability.",
        "label": "Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Operating lease liabilities noncurrent, balance sheet line item"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r676",
      "r680"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease cash payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r673"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "ROU assets included within other long-term assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r675"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes operating lease right-of-use asset.",
        "label": "Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "ROU asset, balance sheet line item"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r682",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate (percent)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r681",
      "r809"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r182"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating losses to carryforward related to prior acquisitions"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityEquityAxis": {
     "auth_ref": [
      "r152",
      "r212",
      "r213",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of options indexed to an issuer's equity.",
        "label": "Option Indexed to Issuer's Equity [Axis]",
        "terseLabel": "Option Indexed to Issuer's Equity [Axis]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityEquityAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding.",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]"
       }
      }
     },
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OptionOnSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of a security at a specified price during a specified period or at a specified date.",
        "label": "Option on Securities [Member]",
        "terseLabel": "Options"
       }
      }
     },
     "localname": "OptionOnSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r323",
      "r810"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 1.0,
       "parentTag": "hum_NetCurrentLiabilityAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets",
        "verboseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r315"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 1.0,
       "parentTag": "hum_NetNoncurrentAssetLiability",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r49",
      "r153",
      "r330",
      "r333",
      "r340",
      "r663",
      "r668",
      "r669",
      "r727",
      "r743",
      "r828",
      "r829"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss):"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r202",
      "r203",
      "r206",
      "r330",
      "r333"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive (loss) income, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": {
     "auth_ref": [
      "r43",
      "r47",
      "r111",
      "r328"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax",
        "negatedLabel": "Reclassification adjustment for net realized losses (gains) included in investment income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r43",
      "r47",
      "r111",
      "r328"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTotalLabel": "Total reclassification adjustment, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax": {
     "auth_ref": [
      "r44",
      "r111"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax",
        "terseLabel": "Effect of income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r325",
      "r327",
      "r442"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax",
        "terseLabel": "Change in gross unrealized investment (losses) gains"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r325",
      "r327"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "totalLabel": "Total change in unrealized investment (losses) gains, net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r44",
      "r326"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before adjustment, of tax expense (benefit) for unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes tax expense (benefit) for unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax",
        "negatedLabel": "Effect of income taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r32",
      "r810"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.humana.com/role/MEDICAREPARTDDetails": {
       "order": 2.0,
       "parentTag": "hum_NetNoncurrentAssetLiability",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "negatedTerseLabel": "Other long-term liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent assets.",
        "label": "Other Noncurrent Assets [Member]",
        "terseLabel": "Other long-term assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      },
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails": {
       "order": 2.0,
       "parentTag": "hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other expense (income), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Total Stockholders' Equity"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForLossesAndLossAdjustmentExpense": {
     "auth_ref": [
      "r71",
      "r284"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of payments to settle insured claims and pay costs incurred in the claims settlement process.",
        "label": "Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid",
        "negatedTotalLabel": "Total paid"
       }
      }
     },
     "localname": "PaymentsForLossesAndLossAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Common stock repurchases"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedTerseLabel": "Debt issue costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedLabel": "Dividends paid",
        "negatedTerseLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "terseLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r61",
      "r99",
      "r343"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "negatedLabel": "Purchases of investment securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r62"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisitions, net of cash and cash equivalents acquired",
        "terseLabel": "Cash paid for acquired businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to Acquire Businesses, Net of Cash Acquired [Abstract]",
        "terseLabel": "Details of businesses acquired in purchase transactions:"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquiredAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment, net",
        "negatedTerseLabel": "Purchases of property and equipment, net"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r900",
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PolicyholderBenefitsAndClaimsIncurredHealthCare": {
     "auth_ref": [
      "r279"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effect of policies assumed or ceded, of expense related to provision for policy benefits and costs incurred for health insurance contracts.",
        "label": "Policyholder Benefits and Claims Incurred, Net, Health",
        "terseLabel": "Benefits"
       }
      }
     },
     "localname": "PolicyholderBenefitsAndClaimsIncurredHealthCare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r660"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r18",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r18",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r18",
      "r810"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $1 par; 10,000,000 shares authorized; none issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PremiumsEarnedNet": {
     "auth_ref": [
      "r726",
      "r742",
      "r748",
      "r759"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned.",
        "label": "Premiums Earned, Net",
        "terseLabel": "Premiums"
       }
      }
     },
     "localname": "PremiumsEarnedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinessesNetOfCashDivested": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the cash inflow during the period from the sale of a component of the entity.",
        "label": "Proceeds from Divestiture of Businesses, Net of Cash Divested",
        "terseLabel": "Proceeds from sale of KAH Hospice, net"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinessesNetOfCashDivested",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSeniorLongTermDebt": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing with the highest claim on the assets of the entity in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle, if longer).",
        "label": "Proceeds from Issuance of Senior Long-Term Debt",
        "terseLabel": "Proceeds from issuance of senior notes, net"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSeniorLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/DEBTSeniorNotesDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r99",
      "r343",
      "r344"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale",
        "terseLabel": "Maturities of investment securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromNotesPayable": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.",
        "label": "Proceeds from Notes Payable",
        "terseLabel": "Proceeds from term loan"
       }
      }
     },
     "localname": "ProceedsFromNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r834",
      "r836"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "verboseLabel": "Other, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfCommercialPaper": {
     "auth_ref": [
      "r833",
      "r835",
      "r839"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or cash outflow from issuing (borrowing) and repaying commercial paper.",
        "label": "Proceeds from (Repayments of) Commercial Paper",
        "terseLabel": "(Repayments) proceeds from issuance of commercial paper, net"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfCommercialPaper",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r59",
      "r99",
      "r343"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-Sale",
        "terseLabel": "Proceeds from sale of investment securities",
        "verboseLabel": "Proceeds from sales of investment securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r64",
      "r174"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock options exercised"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence.",
        "label": "Product Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "ProductConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProductMember": {
     "auth_ref": [
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery.",
        "label": "Product [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r306",
      "r329",
      "r332",
      "r346",
      "r353",
      "r363",
      "r371",
      "r372",
      "r405",
      "r410",
      "r416",
      "r419",
      "r446",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r503",
      "r504",
      "r634",
      "r637",
      "r638",
      "r648",
      "r662",
      "r730",
      "r785",
      "r807",
      "r808",
      "r830",
      "r884"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r144",
      "r770",
      "r771",
      "r772"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT, NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r136",
      "r311"
     ],
     "calculation": {
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r138",
      "r272",
      "r737",
      "r810"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Long-lived assets estimated useful life (in years)"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_PutOptionMember": {
     "auth_ref": [
      "r762",
      "r763",
      "r764",
      "r765",
      "r766",
      "r767"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A financial contract between two parties, the buyer and the seller (writer) of the option, where the buyer has the right but not the obligation to sell a commodity or financial instrument (the underlying instrument) to the seller (writer) at a certain time for a certain price (the strike price). The seller (writer) has the obligation to purchase the underlying asset at that strike price, if the buyer exercises the option.",
        "label": "Put Option [Member]",
        "terseLabel": "Put option"
       }
      }
     },
     "localname": "PutOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesNetCurrent": {
     "auth_ref": [
      "r271",
      "r297",
      "r810"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.",
        "label": "Receivables, Net, Current",
        "terseLabel": "Receivables, net of allowances of $70 in 2022 and $83 in 2021"
       }
      }
     },
     "localname": "ReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r851",
      "r853",
      "r854",
      "r855"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReinsuranceContractAxis": {
     "auth_ref": [
      "r937"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reinsurance contract.",
        "label": "Reinsurance Contract [Axis]",
        "terseLabel": "Reinsurance Policy, Type [Axis]"
       }
      }
     },
     "localname": "ReinsuranceContractAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reduction of provision for policy benefits and costs incurred for policies ceded.",
        "label": "Policyholder Benefits and Claims Incurred, Ceded",
        "terseLabel": "Benefits ceded"
       }
      }
     },
     "localname": "ReinsuranceEffectOnClaimsAndBenefitsIncurredAmountCeded",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments": {
     "auth_ref": [
      "r282",
      "r285",
      "r938",
      "r940"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts for losses reported to the ceding insurer but not yet paid and amounts expected for incurred losses and settlement expenses, which have not yet been reported to the ceding insurer.",
        "label": "Reinsurance Recoverable for Unpaid Claims and Claims Adjustments",
        "negatedPeriodStartLabel": "Less: Reinsurance recoverables",
        "periodEndLabel": "Reinsurance recoverable"
       }
      }
     },
     "localname": "ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceRecoverableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reinsurance recoverable, after valuation allowance, under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.",
        "label": "Reinsurance Recoverable Including Reinsurance Premium Paid [Member]",
        "terseLabel": "Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReinsuranceRecoverables": {
     "auth_ref": [
      "r260",
      "r281",
      "r741"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after valuation allowance, recoverable under reinsurance contracts including premium paid under reinsurance contracts. Examples include, but are not limited to, settled and unsettled claims, incurred but not reported losses, loss adjustment expense, premium paid, policy benefits and policy reserves.",
        "label": "Reinsurance Recoverables, Including Reinsurance Premium Paid",
        "verboseLabel": "Reinsurance recoverables"
       }
      }
     },
     "localname": "ReinsuranceRecoverables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReinsuranceTextBlock": {
     "auth_ref": [
      "r738",
      "r739",
      "r761",
      "r813",
      "r814"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure pertaining to the existence, magnitude and information about insurance that has been ceded to or assumed from another insurance company, including the methodologies and assumptions used in determining recorded amounts.",
        "label": "Reinsurance [Text Block]",
        "terseLabel": "REINSURANCE"
       }
      }
     },
     "localname": "ReinsuranceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REINSURANCE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReinsurerConcentrationRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Concentration risk of a reinsurer to a specified benchmark, such as reinsurance recoverables.",
        "label": "Reinsurer Concentration Risk [Member]",
        "terseLabel": "Reinsurer concentration risk"
       }
      }
     },
     "localname": "ReinsurerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REINSURANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r835"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayment of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedTerseLabel": "Repayment of term loan",
        "terseLabel": "Repayment of term loan"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/DEBTOctober2021TermLoanAgreementDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfSeniorDebt": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a long-term debt where the holder has highest claim on the entity's asset in case of bankruptcy or liquidation during the period.",
        "label": "Repayments of Senior Debt",
        "negatedLabel": "Repayment of senior notes"
       }
      }
     },
     "localname": "RepaymentsOfSeniorDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r475",
      "r476",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [
      "r475",
      "r476",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResidentialMortgageBackedSecuritiesMember": {
     "auth_ref": [
      "r856",
      "r892"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities collateralized by residential real estate mortgage loans.",
        "label": "Residential Mortgage-Backed Securities [Member]",
        "terseLabel": "Residential"
       }
      }
     },
     "localname": "ResidentialMortgageBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r85"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock",
        "verboseLabel": "Restricted stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan and expenses resulting from the write-down of assets. Excludes expenses related to a business combination, a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Costs and Asset Impairment Charges",
        "terseLabel": "Restructuring and impairment charge"
       }
      }
     },
     "localname": "RestructuringCostsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r21",
      "r158",
      "r267",
      "r755",
      "r757",
      "r810"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r301",
      "r359",
      "r360",
      "r361",
      "r364",
      "r370",
      "r372",
      "r448",
      "r604",
      "r605",
      "r606",
      "r622",
      "r623",
      "r646",
      "r752",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r396",
      "r397",
      "r409",
      "r414",
      "r415",
      "r421",
      "r422",
      "r424",
      "r558",
      "r559",
      "r721"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Services",
        "verboseLabel": "Services revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r561",
      "r782"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Services Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerProductAndServiceExtensibleList": {
     "auth_ref": [
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates product and service for revenue from satisfaction of performance obligation by transferring promised product and service to customer.",
        "label": "Revenue from Contract with Customer, Product and Service [Extensible Enumeration]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductAndServiceExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r339",
      "r353",
      "r396",
      "r397",
      "r409",
      "r414",
      "r415",
      "r421",
      "r422",
      "r424",
      "r446",
      "r492",
      "r493",
      "r495",
      "r496",
      "r497",
      "r499",
      "r501",
      "r503",
      "r504",
      "r662",
      "r730",
      "r884"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails": {
       "order": 3.0,
       "parentTag": "hum_IncomeLossBeforeIncomeTaxesAndEquityInNetEarningsOfSubsidiaries",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "totalLabel": "Total revenues",
        "verboseLabel": "Revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r424",
      "r849"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesRevenueProductLineMember": {
     "auth_ref": [
      "r848"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from specified product or service, when it serves as benchmark in concentration of risk calculation. Includes, but is not limited to, revenue from contract with customer and other sources.",
        "label": "Revenue, Product and Service Benchmark [Member]",
        "terseLabel": "Premiums and services revenue"
       }
      }
     },
     "localname": "SalesRevenueProductLineMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/REPORTINGENTITYDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-Sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-Sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Investment Securities Classified as Current and Long-Term"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r189",
      "r190",
      "r633"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESAssetsLiabilitiesAndNoncontrollingInterestDisposedDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESNarrativeDetails",
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESPreliminaryFairValueonDateofAcquisitionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Provision for Income Taxes"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Carrying Value of Debt Outstanding"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r181"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Principal Components of Net Deferred Tax Balances"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r847"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Earnings Per Common Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r84",
      "r87",
      "r376",
      "r380",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r179"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Provision for Income Taxes Using Federal Statutory Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r172",
      "r175"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": {
     "auth_ref": [
      "r97"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table]",
        "terseLabel": "Revenue from External Customers by Products and Services [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r116",
      "r306",
      "r353",
      "r446",
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTNarrativeDetails",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable": {
     "auth_ref": [
      "r787",
      "r863"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about credit quality indicator for financing receivable.",
        "label": "Financing Receivable, Credit Quality Indicator [Table]",
        "terseLabel": "Financing Receivable, Credit Quality Indicator [Table]"
       }
      }
     },
     "localname": "ScheduleOfFinancingReceivableRecordedInvestmentCreditQualityIndicatorTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r121",
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets Included in Other Long-Term Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476",
      "r789"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r789",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Changes in Carrying Amount of Goodwill By Reportable Segments"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the activity in the reserve for settling insured claims and expenses incurred in the claims settlement process for the period. The estimated liability includes the amount of money that will be required for future payments of (a) claims that have been reported to the insurer, (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated, and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees; outside adjuster fees; and costs to record, process, and adjust claims.",
        "label": "Schedule of Liability for Unpaid Claims and Claims Adjustment Expense [Table Text Block]",
        "terseLabel": "Schedule of Activity in Benefits Payable"
       }
      }
     },
     "localname": "ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "terseLabel": "Schedule of Maturities of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/PROPERTYANDEQUIPMENTNETPropertyandEquipmentBalancesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRealizedGainLossTableTextBlock": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the proceeds from sales of available-for-sale securities and the gross realized gains and gross realized losses that have been included in earnings as a result of those sales.",
        "label": "Schedule of Realized Gain (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Realized Gains (Losses) Related to Investment Securities Included Within Investment Income"
       }
      }
     },
     "localname": "ScheduleOfRealizedGainLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/ACQUISITIONSANDDIVESTITURESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r94",
      "r95",
      "r96",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r94",
      "r95",
      "r96",
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Reporting Information, By Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r571",
      "r573",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r167",
      "r168",
      "r169"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Activity for Option Plans"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r171"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Weighted-Average Fair Value Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock Awards Activity"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.",
        "label": "Schedule of Short-Term Debt [Table]",
        "terseLabel": "Schedule of Short-term Debt [Table]"
       }
      }
     },
     "localname": "ScheduleOfShortTermDebtTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": {
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.",
        "label": "Class of Treasury Stock [Table Text Block]",
        "terseLabel": "Schedule of Share Repurchases"
       }
      }
     },
     "localname": "ScheduleOfTreasuryStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r124"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimate of Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r393",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r424",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r482",
      "r483",
      "r789",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails",
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r393",
      "r394",
      "r395",
      "r405",
      "r408",
      "r413",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r423",
      "r424",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONNarrativeDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_BenefitsLossesAndExpenses",
       "weight": 1.0
      },
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Operating costs"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFINCOME",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedStatementsofIncomeDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/DEBTSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r796"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Services"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails",
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeveranceCosts1": {
     "auth_ref": [
      "r74"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.",
        "label": "Severance Costs",
        "terseLabel": "Severance costs"
       }
      }
     },
     "localname": "SeveranceCosts1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r804"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period (in years)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r589"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)",
        "verboseLabel": "Weighted-average grant date fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Nonvested restricted stock, ending balance (in shares)",
        "periodStartLabel": "Nonvested restricted stock, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r586",
      "r587"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Nonvested restricted stock, ending balance (in dollars per share)",
        "periodStartLabel": "Nonvested restricted stock, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted- Average Grant-Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r593"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of shares vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r598"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r599"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate at grant date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r806"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "terseLabel": "Common stock shares reserved for stock award plans (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for future grants assuming all stock options or restricted stock are granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Options exercisable, ending balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Options exercisable, ending balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r593"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Total intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r900"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average fair value at grant date (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Options outstanding, ending balance (in shares)",
        "periodStartLabel": "Options outstanding, beginning balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Shares\u00a0 Under Option"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r578",
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding, ending balance (in dollars per share)",
        "periodStartLabel": "Options outstanding, beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSRestrictedStockActivityDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSStockBasedCompensationExpenseDetails",
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r582"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r805"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Expiration period (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected option life (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSWeightedAverageFairValueAssumptionsforStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r173"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of stock options exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r173"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term of exercisable options (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term of outstanding options (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2020Member": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2020 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2020 [Member]",
        "terseLabel": "2020 Claims Incurred Year"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2020Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails",
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2021Member": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2021 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2021 [Member]",
        "terseLabel": "2021 Claims Incurred Year"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2021Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails",
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortDurationInsuranceContractAccidentYear2022Member": {
     "auth_ref": [
      "r750"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year 2022 in which covered event occurs under terms of short-duration insurance contract.",
        "label": "Short-Duration Insurance Contract, Accident Year 2022 [Member]",
        "terseLabel": "2022 Claims Incurred Year"
       }
      }
     },
     "localname": "ShortDurationInsuranceContractAccidentYear2022Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails",
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r11",
      "r241",
      "r266",
      "r810"
     ],
     "calculation": {
      "http://www.humana.com/role/DEBTDebtOutstandingDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-Term Debt",
        "terseLabel": "Short-term debt",
        "verboseLabel": "Short-term debt outstanding"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Short-Term Debt [Line Items]",
        "terseLabel": "Short-term Debt [Line Items]"
       }
      }
     },
     "localname": "ShortTermDebtLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-Term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-Term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails",
      "http://www.humana.com/role/DEBTDebtOutstandingDetails",
      "http://www.humana.com/role/FAIRVALUENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortTermDebtWeightedAverageInterestRate": {
     "auth_ref": [
      "r27"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time.",
        "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time",
        "verboseLabel": "Weighted average annual interest rate (percent)"
       }
      }
     },
     "localname": "ShortTermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r246",
      "r247",
      "r264",
      "r827"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-Term Investments",
        "terseLabel": "Investment securities"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearAxis": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Axis]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Axis]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails",
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsAccidentYearDomain": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accident year in which a covered event occurs under the terms of the short-duration insurance contract.",
        "label": "Short-Duration Insurance Contracts, Accident Year [Domain]",
        "terseLabel": "Short-duration Insurance Contracts, Accident Year [Domain]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsAccidentYearDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails",
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTable": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Claims Development [Table]",
        "terseLabel": "Short-duration Insurance Contracts, Claims Development [Table]"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails",
      "http://www.humana.com/role/BENEFITSPAYABLENarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted information about claims development by accident year for short-duration insurance contracts.",
        "label": "Short-Duration Insurance Contracts, Claims Development [Table Text Block]",
        "terseLabel": "Schedule of Incurred and Paid Claims Development"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsClaimsDevelopmentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r288"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reinsurance, of paid claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Cumulative Paid Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Cumulative Paid Claims, Net of Reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsCumulativePaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r287"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of incurred claims and allocated claim adjustment expense used in claims development for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Incurred Claims and Allocated Claim Adjustment Expense, Net",
        "terseLabel": "Incurred Claims, Net of Reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsIncurredClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet": {
     "auth_ref": [
      "r289",
      "r290"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Undiscounted amount, after reinsurance, of the liability for unpaid claims and allocated claim adjustment expense for short-duration insurance contracts. Excludes unallocated claim adjustment expense.",
        "label": "Short-Duration Insurance Contracts, Liability for Unpaid Claims and Allocated Claim Adjustment Expense, Net",
        "totalLabel": "Benefits payable, net of reinsurance"
       }
      }
     },
     "localname": "ShortdurationInsuranceContractsLiabilityForUnpaidClaimsAndAllocatedClaimAdjustmentExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEIncurredandPaidClaimsDevelopmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShorttermDebtMaximumAmountOutstandingDuringPeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the form of debt having an initial term of less than one year or less than the normal operating cycle, if longer, the maximum amount borrowed at any time during the period.",
        "label": "Short-Term Debt, Maximum Amount Outstanding During Period",
        "terseLabel": "Maximum amount outstanding during period"
       }
      }
     },
     "localname": "ShorttermDebtMaximumAmountOutstandingDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTCommercialPaperandOtherShorttermBorrowingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r83",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use.",
        "label": "Software and Software Development Costs [Member]",
        "terseLabel": "Computer software"
       }
      }
     },
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Puerto Rico"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r304",
      "r393",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r419",
      "r424",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r481",
      "r482",
      "r483",
      "r789",
      "r941"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSChangesinCarryingAmountofGoodwillbyReportableSegmentsDetails",
      "http://www.humana.com/role/MEDICAREPARTDDetails",
      "http://www.humana.com/role/SEGMENTINFORMATIONSegmentResultsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r39",
      "r153",
      "r301",
      "r335",
      "r336",
      "r337",
      "r359",
      "r360",
      "r361",
      "r364",
      "r370",
      "r372",
      "r390",
      "r448",
      "r547",
      "r604",
      "r605",
      "r606",
      "r622",
      "r623",
      "r646",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r669",
      "r686",
      "r752",
      "r753",
      "r754"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r359",
      "r360",
      "r361",
      "r390",
      "r721"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of dividends that can be declared or paid without approval of regulatory agency.",
        "label": "Statutory Accounting Practices, Statutory Amount Available for Dividend Payments without Regulatory Approval",
        "terseLabel": "Ordinary dividends that may be paid to parent company"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryAmountAvailableForDividendPaymentsWithoutRegulatoryApproval",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance": {
     "auth_ref": [
      "r268",
      "r292"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of statutory capital and surplus (stockholders' equity) as of the balance sheet date using prescribed or permitted statutory accounting practices (rather than GAAP, if different) of the state or country.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus, Balance",
        "terseLabel": "Aggregate statutory capital and surplus in our state regulated insurance subsidiaries"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired": {
     "auth_ref": [
      "r293"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of statutory capital required to be maintained as of the balance sheet date under prescribed or permitted statutory accounting practices.",
        "label": "Statutory Accounting Practices, Statutory Capital and Surplus Required",
        "terseLabel": "Aggregate minimum regulatory requirements of statutory capital and surplus"
       }
      }
     },
     "localname": "StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONNotestoCondensedFinancialStatementsDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "auth_ref": [
      "r153",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "terseLabel": "Restricted stock unit vesting (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r18",
      "r19",
      "r153",
      "r158",
      "r583"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EMPLOYEEBENEFITPLANSOptionPlansActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross": {
     "auth_ref": [
      "r18",
      "r19",
      "r153",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate value of stock related to Restricted Stock Awards issued during the period.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Gross",
        "terseLabel": "Restricted stock unit vesting"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r39",
      "r153",
      "r158"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option exercises"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Share repurchase authorization"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Remaining authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r19",
      "r22",
      "r23",
      "r98",
      "r810",
      "r841",
      "r862",
      "r927"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "terseLabel": "Shareholders' equity",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/EQUITYMETHODINVESTMENTSummarizedBalanceSheetsandStatementsofIncomeDetails",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r200",
      "r201",
      "r208",
      "r301",
      "r302",
      "r336",
      "r359",
      "r360",
      "r361",
      "r364",
      "r370",
      "r448",
      "r547",
      "r604",
      "r605",
      "r606",
      "r622",
      "r623",
      "r646",
      "r663",
      "r664",
      "r669",
      "r686",
      "r753",
      "r754",
      "r841",
      "r862",
      "r927"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r165",
      "r352",
      "r533",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r546",
      "r547",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS' EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r679",
      "r809"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "terseLabel": "Sublease rental income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r670",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r670",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r670",
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow disclosures:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r749"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense for claims incurred in the current reporting period and related claims settlement costs.",
        "label": "Current Year Claims and Claims Adjustment Expense",
        "terseLabel": "Current year"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense": {
     "auth_ref": [
      "r749"
     ],
     "calculation": {
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after effects of reinsurance, of expense (reversal of expense) for claims incurred in prior reporting periods and related claims settlement costs.",
        "label": "Prior Year Claims and Claims Adjustment Expense",
        "terseLabel": "Prior years"
       }
      }
     },
     "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/BENEFITSPAYABLEActivityinBenefitsPayableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r4",
      "r139"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Impairment of property and equipment"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Tax Credit Carryforward [Line Items]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Tax Credit Carryforward [Table]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names and technology"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/GOODWILLANDOTHERINTANGIBLEASSETSDetailsofIntangibleAssetsIncludedinOtherLongTermAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r436",
      "r437",
      "r530",
      "r545",
      "r642",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r858",
      "r859",
      "r860",
      "r945",
      "r946",
      "r947",
      "r948",
      "r949",
      "r950",
      "r951"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/FAIRVALUEPutandCallOptionsMeasuredatFairValueDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsShareDataDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r40",
      "r161",
      "r164"
     ],
     "calculation": {
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Treasury stock, at cost, 73,691,955 shares at December 31, 2022 and 69,846,758 shares at December 31, 2021"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.humana.com/role/SCHEDULEIPARENTCOMPANYFINANCIALINFORMATIONCondensedBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r38",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r19",
      "r153",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Shares received (in shares)",
        "verboseLabel": "Shares repurchased (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r153",
      "r158",
      "r161"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Common stock repurchases",
        "terseLabel": "Increase in treasury stock from share repurchases",
        "verboseLabel": "Cost of repurchases"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://www.humana.com/role/STOCKHOLDERSEQUITYShareRepurchasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r731",
      "r798",
      "r943"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "U.S. Treasury and agency obligations"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/FAIRVALUEFinancialAssetsMeasuredonRecurringBasisDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESClassifiedasCurrentandLongTermDetails",
      "http://www.humana.com/role/INVESTMENTSECURITIESGrossUnrealizedLossesandFairValuesofSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of unrealized gains and losses on investments.",
        "label": "Unrealized Gain (Loss) on Investments [Table Text Block]",
        "terseLabel": "Schedule of Gross Unrealized Losses and Fair Value of Securities"
       }
      }
     },
     "localname": "UnrealizedGainLossOnInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/INVESTMENTSECURITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One",
        "terseLabel": "Purchase obligations in 2023"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four",
        "terseLabel": "Purchase obligations in 2026"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two",
        "terseLabel": "Purchase obligations in 2024"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary": {
     "auth_ref": [
      "r485"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three",
        "terseLabel": "Purchase obligations in 2025"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears": {
     "auth_ref": [
      "r876"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, after Year Five",
        "terseLabel": "Purchase obligations in 2027"
       }
      }
     },
     "localname": "UnrecordedUnconditionalPurchaseObligationDueAfterFiveYears",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/COMMITMENTSGUARANTEESANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r678",
      "r809"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease costs"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/DEBTDelayedDrawTermLoanCreditAgreementDetails",
      "http://www.humana.com/role/DEBTRevolvingCreditAgreementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r375",
      "r384"
     ],
     "calculation": {
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "totalLabel": "Shares used to compute diluted earnings per\u00a0common share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r374",
      "r384"
     ],
     "calculation": {
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average outstanding shares of common stock used to compute basic earnings per common share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.humana.com/role/EARNINGSPERCOMMONSHARECOMPUTATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 12
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26626-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "https://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2443-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "63",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "https://asc.fasb.org/extlink&oid=126970277&loc=d3e23176-110880",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90193-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90198-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "https://asc.fasb.org/subtopic&trid=2176304",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13(3)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a)(5))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/subtopic&trid=2209399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(13)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(c))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04.5,6,7)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21409-158489",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(cc)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671315-158438",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "40",
   "Subparagraph": "(SAB TOPIC 5.W)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=27015833&loc=d3e570705-122907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "505",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486098&loc=d3e24708-158529",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(b)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "https://asc.fasb.org/topic&trid=2303980",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-06(3))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "https://asc.fasb.org/subtopic&trid=2324412",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-04(Schedule I))",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=126898705&loc=d3e5864-122674",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(21))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL34724391-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "https://asc.fasb.org/topic&trid=2134479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27161-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27198-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27290-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27337-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27357-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "https://asc.fasb.org/topic&trid=2196928",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "https://asc.fasb.org/topic&trid=2196965",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922890-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e689-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(a),(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594786&loc=SL75136599-209740",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594809&loc=d3e13220-108610",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r686": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r687": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r688": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r689": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=SL94080555-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r691": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/subtopic&trid=2122178",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(c))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(d)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=SL120269850-112803",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6816-158387",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(6))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(1))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(d))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120401096&loc=d3e574992-122915",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884095&loc=d3e14764-158437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671311-158438",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r752": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r753": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r754": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r755": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r756": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r757": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r758": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124509248&loc=SL117422156-227712",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r759": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "605",
   "Subparagraph": "(c)(3)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=6486672&loc=d3e27261-158547",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r760": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r761": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "944",
   "URI": "https://asc.fasb.org/topic&trid=2303980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r762": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r763": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r764": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r765": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r766": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r767": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611282-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r768": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r769": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r770": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r771": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r772": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r773": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r774": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r775": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r776": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r777": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r778": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r779": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r780": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r781": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r782": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r783": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r784": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r785": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r786": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82921842-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r787": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "79",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124267575&loc=SL82922352-210448",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r788": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r789": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r790": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r791": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r792": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r793": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r794": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r795": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r796": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r797": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r798": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r799": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r800": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r801": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r802": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r803": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r804": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r805": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r806": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r807": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r808": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r809": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r810": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r811": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r812": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r813": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99379264&loc=d3e27758-158548",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r814": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "605",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99379264&loc=d3e27830-158548",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r815": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r816": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r817": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r818": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r819": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r820": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r821": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r822": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r823": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r824": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r825": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=d3e5283-111683",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r826": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(10))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r827": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r828": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r829": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r830": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r831": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r832": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r833": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r834": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r835": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r836": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r837": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r838": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r839": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3098-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r840": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r841": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r842": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r843": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r844": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r845": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r846": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r847": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r848": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r849": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r850": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r851": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r852": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r853": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r854": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r855": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r856": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL6283291-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r857": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r858": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r859": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r860": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r861": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117546-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r862": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r863": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r864": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r865": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r866": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r867": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r868": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r869": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r870": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r871": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r872": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r873": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r874": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r875": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r876": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r877": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r878": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r879": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r880": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r881": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r882": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12069-110248",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r883": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r884": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r885": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r886": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r887": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r888": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r889": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r890": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r891": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r892": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r893": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r894": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r895": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r896": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r897": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r898": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r899": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r900": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r901": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r902": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r903": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r904": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r905": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r906": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r907": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r908": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r909": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r910": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r911": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r912": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r913": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r914": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r915": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r916": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r917": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r918": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r919": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r920": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r921": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r922": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r923": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r924": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5708775-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r925": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r926": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r927": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r928": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r929": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r930": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r931": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r932": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r933": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r934": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r935": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r936": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r937": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6811-158387",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r938": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99397103&loc=d3e6824-158387",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r939": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r940": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r941": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r942": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r943": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r944": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r945": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r946": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r947": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r948": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r949": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r950": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r951": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>127
<FILENAME>0000049071-23-000011-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000049071-23-000011-xbrl.zip
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M5:T()<Z=U9H5?\F*U_])69=82ARPSI)05!<'I(4D"L@'Y56)ZDO"<!$E/F)
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M,2KK32WB\;WD7RO#FRN9_IHM?\V6XJL"^1-;YJ 24$PEJ6PXQPJ9J+MLN>/
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M!S3C<^1^>]'\^(/)5"+99/ILRJ/AT4C4?]O<]?WB>''?KZ=T#9!^U(G.#T
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M%_&*65F'*>=4*9)2!IROVI0>)'278Q![A $EJIZ*-<XR.J7)ZTC>A!A*T3Y
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MKG.:N3S3/#?4VGND7=> Q*OII.AXII2@Q()FS7.J4NIH'N<R%2!P[7W2K&M
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M'PWFW[/G:C)5QW?",,"U=3DNK.?:YU-W6B_RZHLSM!W!N#P,:ZCOZK@<(J3
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MV^*X8;'L1JC(7&$EKUP(07.F<BLLL7E.76*3-&6#SQ+Y0O89) EC[#+#'>=
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M$T&L5G$.UB-QV5!0S7HA\'O?>&PU6<@<^#06*DE%RBC)E* ZD[&062RI-=L
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M#C_JA:SGJ7!^4+P;Y[7Y/!;=]Y6H<U6,NYRPN;_H)D=->,<\,QJ3_(IR5B.
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MSD:A!\\-ZXZ*&CCWN[@HX#C%(7S?7807_3W+/:#N)G!W&'PTG_$9EWG\[TR
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MVP=D698^FE*/++?>Q7 8A73TD(2,(N%!?#RH!LK&HJ51V\?_<]0Y#/IQDFA
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M7/LW9_ED@]@]^]*5$O@J\,7EY>5O5R]#??X_/EQ>=8(K6<B"E!*%MZT^1:,
M5"[GK^$@11QQ.^"(&]7GNC1_0#X/)9,H*AW1&02)A@IU$@VY!F)LK%(-*>2G
M?CN7\E!\7[X4WNG3:!<3@KA]]MQP0A ^/N9T@FIZ9UOA3MK#ZDP=4%#95 26
MDL05\H7UTQ76ZB+]RS0-Z/_.LQF<!^Q5#P[&&#(>2NTELS;\2-]5Y_!&5:CC
MK;">Q^0?8GQ<_LF(S_[;N^LP>']]PPO"Q+:4S$K9)SX1[4JR=\3P"X-?LZ/3
MDT[P6X5?9*-84HF-)?:W4:J$B N?KX 3Z2@\?5KR8IO3DC=1(F5"[VBS@+V>
MBYRN*+G )C:GJBF>PDRIT1/A0,^7,HGA"ES0T=$PSE@VOR7_"WT)O&"BM&+>
MY?IC/#UX/)]_[L'VN*#8:.0AX&%@G"-3V2P3!8#PF#O/L7D7AE!KA&W>C97E
MDA:FRB^.,MJK0219$;1H5Q?$3$D,O7[/.RB5X)QDHKO5[7B;JE]7F%N6J.ZQ
MD^B3A(31;G<!RH4$L$E??!E5Q]H&!"N,O4_RHIY\YY]1<O .RVEOP A >KY-
M!QWR;?4OH>U+6!0N)B4$O(;5?O#A[).C86:]] )WA\W"!02SE-&NJ(2**ZT#
MW8$%!=B46=+AN3?^4:LI"&]U"PAO'\\V]K#6"=7/LT_JE6-(HI3T>^T=C@,&
MUI-"KS*FN(=EW<6[) M\X(U4)F-U.Q?'8IV#]S;,B,(**BQ-%E>$V=;^GI_'
M&17V ]V'/$@?HJPK3L-LNUVBOP*[0*R8CJN)UFCZ)-&R 5B [)666,,-P5V6
M5!-3VU9.",V]A04@K,:]3N[VC@,&I\GKJK" =0#2+IM0W.5^8>4WA;-J7^<V
MP'X;N^8@W?-X4#0K._QE2B.&L\AX290G*]E4%I-92RAP&^ ;<$ENU;H)[LS@
M"I4Z6!KA4=>QB-;;"E$XLD<KX'>0+-'B74N9732'WSX@-96IM0Y9XG^<VI@S
M*M%B+-18=%*!O64K=*@4@)B "\CGZQ@Y]"@W&+I!WQFAQ#,#=?'%[H[MVMV1
MPUVF9"F7G"!'V*I->[S8@OZ$##/##BWP]?!VX@7-M.K5> UY[G6/R0AG@<\^
MF5+MJ) ).XKDFZT9G,E'VU^8SUHE7P M!V;A1]E45G]F54"]YXY-]??72U4C
M'TU)- VRHCQP;7CJW/CI+)N:ELBV56GXY:DQ0]YG=$\&I8LXU+:ZMG-$)+3O
M'M(18>V7+#FP[^-66O&4(*YUE!9A7U>*0D2V9*7H3O\[SP\B->A84JZUIYBT
M19LV\])FQUO:6K4UC536)&$_UCN[GBJD?HD$<_*^<2Q%5=)-(W8R9WU8MTMB
M8T$7NU-L2[1N56AZOX@F9J&U@Z\:Y'$?'8,^G'IKD,Y+D:?WS$]ZV^R94]DE
M-B4\Y))OKR%P$R/#]@Z[Q^Q OY<$S/L\*T7E(FM=CH!#AAHFIXCFI;11?VPD
M^_!WOP#K<+3G ^A%[,V1""G>!"P-[SL,77T(?&S">HD*+M 00 -V/I'XP6#<
M//@]N@\U7%E8BY %>BV8"T^Q54@!'(**-0E%O5,@H-5XJ.:R"K6E.3"?L:6;
M0^=B3HO&)H6G\>(#3&94!781D6JF)JH)NSJ7@P%5VMPFL_"A]5%/0(:-3?U_
M8F@"UEMY_ 2N1I6CU136?NVWP.L3K+?$4 2I[!VI[R6>9AA,9#*YAZ"0Y2XN
M: T),&XB5.->YM5+W-C ,>,A2*DSFF &.)X*9R1)P46MMU$^3"1=RK:#T"1S
MB1O.P,RV0/B<;+/PN<HF4U/&#[8K;*_L0<DA6V^M75@5+!)8,L8TW.V8.F#E
M(^\,%R[K+[*\D#:=69 07H+G':MW*:XG1=J':N=.X&L9442K!9SR]O[JLLHU
M)Z=N5_JKT4(W-C47((_\2,Z B;"XVBOR-.P(D,F>SN>D:G$T^M$3G?AV(8P'
M:6)-8GN(J4 B@W>Q&VWM7FDVM1@HG*C%S).DTET&RED-\(2WX/MPQ+%[V0G(
MN>F^"CY@J>$;N9'6#1N)X4B,FDR"[N'!W[;@4)]O\Z'^U4G9#U;*/HM8]6OL
M3T!WT-S&!7M.HHQO-6<:8R.2AOA*;H2C2N2Y2B<) $DS$S<3D7L+_(H.JNH7
M.>/6^ZX5<!*F2[U&:YG%H0T5NA)Z/ZTGB>YK)<ZT/BG.UF<"Y7,2&6AVU#HD
M/!0KBIQ$7G6!X3L0A0JNO+K^>Z@UT0]4S^\21Q! DT-"X<HA^,1(K4$,!*=4
MC^XE;!D3#(/@]JC@AN V>.Q$M@FS!.4>X%6N7_-/1FBI&,F)"G+1]$!@@?O
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M*L3EL>Q%-< \<M9X'NPJ7X6[>LO)<_QE;B89^(<=K'/#/ ;.C,\"_N* T\/
M62#0X'&3C,+R,YT?/S\W?IT8Q>I;\\BN[V%NNW>X/+>-RXV'__5#W#TTYV?F
MXC"Z..T=GP]'_>%)OW=X/.KUSP?'_<.C_ST[_&$+$^)D/#Q!]GMN0#%1^NW'
M7]X%W<M.$'QX>_.WX,WEU<?K#S>KL_D3+1OK30IPNO$(H >6!==5/M]T^?6G
M] @W?W,?24_\"8N*XL$JNS4*[DTPS$"&E<&0))VF)$"CH<R2B@(,M&53@\D1
MSOQ-I@:S%6#$@1J,.78[!>$85Q,,0P6#,2<_R'PK*I1W,>6/,[CYSG!*=H#:
ME)+(%-TB8\]&.88FP;I#=GIP*1-R<@IZW3T_NDJQ_P0OB,%,ISA8,-"0-ORG
MC$FD%7@%?, =Z&>P1?NFQ)2/_U;S&3Z.ZHPH0E9[79+=8YX-ULHZ))HB+7+4
M[T".83:H)IH9S[%""OXZBMFGJ#T'GAN+(@#&F,#M9)?TP408H7V+:P C06@&
MAO&_*K@FU&V :R(Q6"81Z#G,PV/%)FF]:(@Y)UQ/-!J1!NL$?QK[(DOM0E<U
M]]9I-*/L%%>E/,P+T6"0Y6@/X>979%)%@Q(,%33')Z8<9T,A55%4DRF;8'UJ
MB,#FCU!48U9B]0!65F/6'90HZ>D0=C"*)[H@^"_N%E7!D0.0,-O$Z8B5+2\8
MG&*XF?X\=)7P!:KW,5J9_,PXO8/?9CG6V<%%DL:F/Z%1%T_=ZTC#%\;;*[@Y
M2^Z05TJ@&*KQ?U;#6XF]4F[]SE Y G!93GP9IV@DP#>@0:J;US>#J"IH2V9L
M<GPNX> 8,HK3@@X5'1,J/B?W:3%!N,K'IPEE_#%#<NEO$&X=6#%L< OK^&?R
M6QHA&Q9O#RIYX'>D:P1[WB]*X"CD1K"S-8S&=  &J$0@1+/ZN5A7#%FO@/:G
M\([0@ H[Z<7Z2T\$@:GY F3ET, V3LC)@?-0X353=&^MB-0UO SK$F-4@3-E
M:D\>9P65DC)3T,'B/+/E#_PH>?_\I^!-ZC3QJ22B=-1_03:RTKV>B:8'V]H0
M_&$4?Y8RF RV"&,  0K7##FSQIA,^'OD1G ,\;GF,]5TUF44\_:4"SM)E-SJ
MJL3^)I<LXUV2U5%M"@@4BD'89K$QL N52_&G/"(CA<YV&;S+EL J.HLO$(&/
MRCA/O"T1;7,,N(YT"[W/: I@H@I5-"%5L2Q1=04L-](2I 83TDU(]%C\,,S+
MP;E^D'%SS]YJ4)DW E]D3R)QB;_%'$Q0)959-I/RQT_ &@;Y"1WH:(CRRIX7
M7R;ZA!3. $*S<!S,G.CD^@Y/^W>"W\ TN,,49KD974&-4G'14 QK:H-WZ(+*
MWI+\IZT'7R5%RX^5$?%N4CO3O /P/CR40/5[7 MU=,I7<B"N*EB>%*84(T'/
M%NM/_\5,9_/3B@KGJ)F9/][R\!M6+?1.7VU-!.Z8M;%$O@QM%IY#91/8&RTL
MUN (GC37K>/N5%.=["F]\%6[D4^YD;G=%3ATQ2"/2<T$P[RZK0FU0EN7%US7
M;N'WW4(^525[4F*8IO ZV4Q0G""VHU(T_*)]A2OQAE)+-.#TOEJU^*_=Q6^S
MBY[QC+FK2?RY/4??=P?(2DK9+%3K!4,@E6^?B!D,1XP$9:1IF2&7V.(QTIA&
MZ*Q<.&"XAL(O>G>M->J69\X_X5RF_*%EA._+"%Z8!&7KT$RRVSR:CN,!Q2"!
M->!=!35 P'Y&*06O*BPXS:5%JMVQI]DQRJ:)&K0^=U6"12HP"A-;W B>8RK7
M:4 /5&-4@9N=Z]546Z &+-;.BWLHCBB][5]5G/M%^.-9 6X>D"4W(Y/GX/2V
MJO3ISB^YCP*=$PSC8L!!,=HHJ0('K[J:&-BN/KG9%-:@IBO,GJ.!A$Q3H<]9
MY49ROO=C+"V)$HITW8-@&%/8R 61L,L,4[XI>]<Q\8?($ZS*)=8JC9ERI]W
M6UPK.[XSMT1E5(#U/!W7XS;1@,-V(.QS$ G%)-0.&PEIP*G/8<<',=YGIC'H
M"5()V&.8R@\O5+;@QA<H8*B"X.KZC[>O#[H79'E'6,>2( / .BB2JS>-0=Z
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M,)$F#PW]RX:&M<K.IIW+V05-;U($31(0-&9SA(W#% FKN9$@0'[4TG@CD<^
MS]/N'+BO<L,LU(RRE/2BHAJ4L2.X:<.HC$*V(\49([5N;S*?8YJ$(=PHWAS&
MIFH3'&=%:282HZ%WEQI*XI(9AF>C4=2.G>Q-ZWL^N[*%CWH>]KO5WZA+*9R@
MJ?[T(HI[3<:ZL?0;6&;"SY6$!>XSL@>!IF1!7J4ULK-0G=/$VH)?B&GF&X",
M&*#Q1BZ2B8H9:UY/]9/ PX.?:P6"_QUP]<284D1P:LQ0UN+773U8$5%ONM;8
MOZ,:)0]LH82F(84';>I6;(Z,2<=4C##IR^_-#5HN#&CA)]9)ORS=NKD39W="
MHG<+=E03,[K!4@^#YE.6WF:259_$I56S7M;32_5G]@R'>AZE?DB,/'NR?582
M; P[\8Y,9CKN>I5&":<1Y6$Q6\!Y6%J9ZT/Q/VW*8^8H(69!T</ (&]Q.D/J
M''A(K$V<H/TZC/*A[ X]G8=%\*ZA:3!" \^Z"F@4\JI(4_BE#ZB1XZ*FC>>4
ML0)A#4$>9J!2I4W ^Y1[C#K"[E(@8,%!P@Q4A'9+Q>Q$,$'*2 R("/?'6J,3
MUV2V&A3*I-IZF7ORV(NN+>$@WDCF,N$]2EVS?B5CUC=HAG&15U.Q5N']L#).
M12FTCI_WY:BI1>@@DFL-"[60N!)).JLT0\EN5S/%9/T]6,.T*G$3O=WW2\NY
M<(&6AFE&/,Z5].(C7(N.;L(E#^BG40XF4,A?Z^H \=@M*']*,A:4]DAX8L%[
M&6;=2@JPX#54)N*NLZM5[P!S^M290LRIPZ'8U/EN]5;/0U'^J>&X@)*=_&^N
M'X_S(?NG1H!N/&DHL%76#);S8>L^BXHB<[ Y(&*GC"OCT#R$EIS=%CO)1=7H
M? VD)LK;$_J]5*^$P5V&QQCE=95JQ6_ASXBP/7ETGY.3J 5BU2R4\4 HGJ+N
MC13!796D GV#)AR*O!I)_M-W;\4+\-6I2[YKZ!"^@"MJ9-YI0GFZS_)O"VYT
M*:*>ZLA$6CEC@"6-S^"2^?$O]PN K%1CDP6///S7)6TL$!57P;E#-.<MU"L<
MY> \GV- ND=#T+>YD3I9UL.V#,TSB=RN4)78B,"58Z%\XP&&4=K]I$694RB)
M )9U7MUTYNSXARU]M66L "\5?(R-1P3QXY_5:Q1Y'DSBPJD2+XSGO\-3?1R$
M6O,F58@Q'8)&S$N2GDS))%EL;DKYU69D^<IU#SOGH[KX'@FK Q16LP5B!,VM
M<391FRMLH)4.P?:SN37/HW!C=X!O*S*]K65T"[(<+)C!#%T8_2LH]6CPB?M8
MA?]8E=-0N0%9(B2?[1V@!^@@B7?CMM]>@>F#P5CC/6)C-<4W9:V)$* >,(SI
M3++"^$4.#KH,;BZDY\!]<E;G<:J?<$?=O]0S!/N4?,H4>:SF15@;;,08'AA"
M@I>R6DPLLAI%6,!PLZ9D- $?+V2587/U3U$+M(^YK:,MS6UMKT)]RX>/PIAX
M<.!@Y(5IYB5"J2D<T+\11E*JF,&'+"8(7<,HS0(_"G>SL<C.K$8"'A)T['%R
MV?;$U*NF'SSXWK2R%05 #2ZR%GC#6CY_G51A3_X3#L_ASR$_.8D_&2HA\LNO
MU7,#DP&IP720MBW,N2T4N*[$TOZI'&-^W&E6BI#W_RG);BM5;59O);D/]BKX
MG+:ZWK7]<T&FK 8G7W#DVJ1.9#4;<@5RY8MR/;;&_[49<%/U43>DX:JA5-?:
M^-5J80K#81W16J%LO(WV*O2!?NE2M2<U@7XL0:_B=!HE=WEG:ET?Y DL>"KM
M'>@,4W+< RB81#-J#[972K&][+5ONVD)(/P\P?',WTS]\7=$ @"AK$Y:32KF
MF6/J01%&]RS&58DY$?;UP3,#6SFXBW-)8< K:D7#$[2(J/ZRR$;EO5_1P4L0
M0GF.Z5)B<G_+C"!6V =\^W&.R6V!I/U#[2,7R!VM_O1C[:R8JT+=0+;2S*BD
M_H RY_I4#IF$"RQN1L*-"FVG<-M %E3&F?@$!X14[!/ EF* R@])9;6X.#!.
MX=4^4_$H!5+M'JDX0*IXQ$C![6"N(103XF:_A-K9+O3&G.-F:,*XBEI;/.Z%
M>CP">A*L! <=A\\].)'DF\T?V5ZE^G'LP=[.22B3Q&38&JDJSZG]I<;TO@K0
M (=VMO9Y?A;>B]:+E+?S\%MKUGJ5#YQ+P';2H7"HYF^]/*67@F4/MQZ]H$B(
MDP;,D"QK$1>Y@9O%/#$74409E95R%!3>X$GGH#WE&+1:KKJIU"TC3&BJJBGF
M!)O[PZ,23CU-<!L%Z Q4T.;\*U#-647RLXZBX91L4^T0L[$CQC$(;3/!4@9[
MOXQRMF/.:Z],?6ZUD!H(%6[M$0_$GI=-YXS$.CMK^/IJV3(I"6>?RKR=H_ 7
M*&0JF*EYF9Y'O(YC6<:W[IO<>7$>)X9X*PJS3C2;R'*;B:#RW(7C[]%^P"!K
M/=WYS 7TFE$9V]!,R=ZAWSS"H;O("]O5.L8T3Y@[& 390D%3T)0'M0)@.HY>
MX KR9]JHU)2Z?OG:)$OYY/&V$]\T(.^LO6![(+$B1I&>&YRUP##@U]?Z'K1/
M:DA)UWUAG54ZWRDA24-8L#(S"ECZDI! OC%L>]99AVU>%Z1WWK7S=ED3V$9<
M=-)L[QP'IWDX$3:OI(7;3TD3@NSE'*-WK;(#\!.!66F,NS$J@?SZP2>VW_C:
M>>\4)6$2W1?VGIHIZRY7H]9>QZ4%N;YLKUFHKOIEC(^41A PH/UIT6R44(=6
M>4&!!YAN>;##\]H=_S'P &JLT /8$2M?8$^D37T^&:#)#FU[<Z:D_J;F.?^D
M0SK\->*?>>Z)@)*3P@.MC=TMI3=;HWBU[';87U+X==@$Y79M#WWT=HIQ#,!.
M$@L)9QUQ,((JP2-$1[2M\[:35?:RX()MY_8RM6C*!>9(I/&4Z<D+6;B@9K/N
M@BZ)]UA(_-J!TKSRX)02>_B5'_H4?BEM'H#FB+%$\(N9R+T8@<5!:6(+<'L
MWC]?-S)$&'@+X2L@\'4DZ*=L]/$2>'(*JA>O@3R?6T55:+$0_#\:1QKOP0^4
M6I%1,SSGEON?"!)@;LW0_V1+3S@:A76;42-K#-Z5=+@ZA::;S=%Y:L9,!9Q
M+%S!L=* C9::V44Y@S7C'(.^SB+S^Q6^\&CF2OH2C;,ATG09'_B]BC0L!8R'
MV#O+A!)%TOG5?$5)0$.@:AH#(P-9>A"!TS?E5C'T+^I=I?8YMJ7FE7NDU@\
MAU[>7"_49-9@PN]QPX4:S$PXJ_#D491@P0AOF+-57,/XOZHX**,):1_68\I#
M?4Q&@>"/L1\#,^,X1,9\XG( 0N?H&SBF(Q6JSGH+W>*$WT+&2/70(/7KLQS7
MTI_$)7YW;;ER\KV;2'9@#!(/!/S6MJ3;R$UM$5Y3LK?[89,5!]E0JWP$C-JA
M7;@R!BL7T%DY</.*N,VC+F1T$KSQBR00E)AZ4DF&S5N5"^64*W#BLFL6_6+!
M>,77"V]&MD+WDU4+S:>8PQK@6/?!.*L8U%EOD/(18GVIQW2BR7E-#5& YU>+
M$>=@=FSOCJV2T62WHA60S?P=;)A]S.$=MSF\]>U).JH#1E'PW4:4\J"\TFP2
M#RC40#V8=\:ZD5[Z#-02JEG]BY,HBO3RAH3>%9^D2XQI?H@&GTQIX+JWZ2@A
M!<IQB*N,PH7!=7X;I8*L3_?4P\4E*1--<I$X?Z!0:0]< PO]Z";<2_UFT_;D
M4C]!5Y-^M+EH$<64Q"-;]$<_!*R##TF=RMM"_J>1N6NB_NT:;+Z%$[\N):F+
M]3MA4DX^^G-[+1."D3R<Z^:FCRMG4R,)9;HVI-SK'!^'CWT)/9N>^$_P8PO$
M[I',EM(339[FZ8@IJ3R.^[$TFR_<!=#9@6X&ZCE:KU,]7IR@2J,[4+1:^JS/
M%CPU*L;E+@<_O[C/Y^&C<X)M Y0ME=?T.^EE&>%0"[8NS'Z-$JF/=IH<#12T
MA,7RY8)W13"D*E3W +(QW.6V.H#FP3!8H'#>?.2M5M: _,!E$\"1,SX##8@S
M,>MGMB;<%@#5(I ZF63D2..% .?')S[06+2D!K")O^F:3;CTC_LSJL+-&UYZ
M2STL[5T\;VB&=?!3"NN[\'F_ IF1JIZRH%$<UC"*"]=<'0[K5:KS($U:$<7B
MN1L6=K'ON4%EC7P<S1A5N50+/!HK%9BX!53>0,G7'@B$&V."'WZG"-=[K$<R
M0VH%)9M#ZM0_.!YY1T--BQ]0HOX=%&#0/5,;GOP4@Y:*X@["#V\L\6\04T*[
MQ2EV17&;MU@9<=X)#A9?BLNXJ:;:?0\K>!V5$<^TK>/&4=%550YJ"GS"RVV
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M 2+'C&G/S&/C8$:\)I/..8Z32<<'@0V#&$9^+/5)N'G=S7+"!?>KSI+$.E/
M*7Q?AW49;8GOT@#(RI:%OK<,A/*Q?3=C$\ 3<!]-$\BW(\(+_=LI99F3:*F%
MA,'=.W*WZ%&27Q$16(/']X!I8JD1!FU3VAB7Y^GQKH&259K;I&!L&!_,.&A,
M4S35[661HE,'I,Y( (Z@1C<SSPKH*^K]2YW"WGX\E]D+-N&?//O%.Z^+RM^=
M.8U\"]6-Z'%Q6XLN_SQ9)4A>M/*D9QB7"VQ%-T59%9LP_1S,7G:<+&FW5CQH
M.;9<'*U#RE(/6ZQ_<N=^%X9JK.XVRTYS:HFE*8UGM(BR):FERR+/=YM+FT('
MOI6%YM3</8W"G[H9M]-*3?R]"_354D*\7X*'J6YT57X;]B],%'0_YEXK. J*
M\S3$J*9\USR -R3SRZ)_(I"AO'5HU@G-MO<F-/M,$(+CIB KLAD6D-.\%KFE
MH%VDHM;YGIJ'$S4+QYSN!D3/_WCMUO?(-&*<GF GQF(=/,AB5&<P%PX53.>Q
MRT5*LTZT[P(DW.4_%\$WE?U4N)!\#T@V.@5DB>BJ]+GVFK$BD94O#14@4<R+
M-:,H&6$B<!3.2&6D4E[8KF[DX;[<F:(NSAZ3,4.)Q,BEZ')+^3P=3K.W'9TE
M>], =;7_Y*WMNL0Y*>6IK'H\N".KX_$E6M0<JUSI)'?24E:XP)_C\NQ-)Y\[
M9@3HJ-3=^+*J'WI9S/B6!8WSXHXP&H]H\^A!7P;/TV3%C%_3$<%Y6G<^#60X
M_/5E JIA0!G=9+R89@6EE$;=PO6O,]N*5=9 TXA[)&RTPOE9H9FKW8%;D(DL
M %1;2JXTPR/1N,\EQ3VA#'"M;+I9X48!E4X@[/Q-.9)X]NM''4O"E3;!S9)[
MFMOE* ]@@><*<S(4YM@YARH3N5\?*&EC=FO0B_76S620\OTTP81),L^EZ+(P
MT8W :WI=<NDG;['A_>$T),.+SMF!B=NG39+X#+G<WG6VH1M.82189^LBZR6C
MAJK%+DQG)%$59701@@5?8,>YT9*VJRIC74FOE\)S",@PGK(&2FC@8D"I*9?F
M/7=M_<-24V3,,TPR5)LY:Q]MRMP"B%8=!5BV2?4,@CJ>JW.CK4,S*HULO WW
M<H+H%/492!\Q$85JH0\L0AX,69KL-:5>=YQ^Z[X=7K:Z):9N$JQ'U/'>J/^1
MC#[?S'?+O1JI\I7K]FCP-NL/%VE"OT#6*X.D0F<,E:UE?ISFYINF2.ZY</]<
M=(-(,Y4I!D$Y?[<T4<,T=BJT<PIMXQONTE)NW>2V9MH;4-XJ9W]57%+M]'\C
M+;74I,KX1CBHC;=J,4=F+RV?I!JU5#K#==?%?M."CZ6Q)M2+0'+)$F#;%]8,
M=J;D</QP'J2VN <8>*E;TIIF74[O([>SJW$+LQ?!,"QS--^+$DIDVNQXQKJF
M:T?>R:DDEA<.PJX#]H;CNK/%3";,4N\D^(*ZQIFI*SS QVDR09H!-0A29A!=
M*"70TFB]< [KZ,2:&F2 Q2T)4\[4&@!R[[QDD9=[BYF+LKKO+4GP!'UGF +O
M@#7,3"-C$!_8?C/6_:;@[/^>21!#/"[L.\5II3-EA!-_:'H*4A@SG4=26^%T
M-=8-T6@*H?;EA&:**"J)4VK<$)#)%-AF9I3V'T[M<650DRY\:6"G^ 79DAK0
M!%P$-#4IGBQTJ1<V<[#^(&RQG66W'T-G9G JIL3$]7<%C[OU//FL_7P/L*P=
MSPUV,=#651(M!')B" +9?6]X[\RVS<7$.3&6!FQL4)O((AS?DA?E+T49)1><
M% #;L^JX)%XX#-5ZC(G*3^T$GE/!_97;E:N8L6#&IRVD)B\W(-N&>^PL/?7=
MT=(Y6K8)-Z\\>WZYL*6(?9=<QQ<8_3'XGZ@1313FAH/9)7DF*&&1?"/^>JOY
MC@00!KQ%"&K/X0;-Z"LI866<A&8LND; *<:1@;A\:A>H>&.D"00-.F6ENCB"
MC;5G)ZN)$ZDQ#(.U2Y2N2^U@76N(*X5LOHBI,24W]=+%!WM&-E0:ETPMJ#'D
M$F8@_K#H33KR%4SRB0Y$H>PHFEZ_.T$S7Q_01&ZI_IHKKVE '58 &]@P6UW3
M_!*C1#3@7 _O!,#CVZ,06.9$/&6Z"LI?@H>*K\(TX4D8QES48-&[USW/) YA
M#.W\AOI'.88($+E*=8\48>)Z! AQK$4^EMY&9*]A=7&H;40WQL 2T#4@F6A,
M#ZJ2R3H#.S&9<),7-,VP8PYP+@YHV'ZN);@WO/=.[^ R4KC';4:1-(V+0F_&
M#=+_@#L0S/3SVGS7J<TV^,?0XAX/^M>IFN+\<':,NMN[,7D!.%'."<RMNFS.
MN#GKN9.NNDY1LFY;0_>R(%K2PC]1/E&?XDNJ\LAXWKH>V" M<\+"!/L\N<;L
M!:F0DRGQ? 41Q4EJ."T&/JG15C+^QNK!I>D,3OU_")NDD0<LIE<DY6SDY'V)
M\9A.1>,Q^^2O+4]D*-G;MLD%9\IJ"356VJ<QWEU,%II$11@E+?;4T+T9J M'
ML=$9[\ZP(97J%-J)UG8F*ZI"N.V&>4R",<D:'P2Q^U&2IE2GHG,#M!EG5%C,
MJ+8MIK#E%.5\K'B?LTT2B>0D7=C(CWD72)%OJ'GQ& '=E(9_S,V8)<(5T[H<
M6IHH_;-[5^2^;(69ZDF-62[1>D*D9&D2>&R&/EIH0<[T(SD,$GGW'3?AK?KT
M@8QW^1Q?)#0NR *$^N&4^Q+<#MU"I)3]0N;2(?>9@KA.J,3!-+0K_<I9'S4W
M[E7+_B'TTOYS ;8L%>"3]ULZ7,@, ,SX6N@^=JZSA[QK<%B=?@:WZA^+"9G/
M#>^#>*+U!"G*SK**)#N3X7I&9!!<8.:O9(]RG8YN 6"UB/)!V+N=B<>%5 9J
M'0$6M6Y4*.X1W@TQ6N?Y2Q5-?.Z8+88)F1\6-+@5J;- G?;Z4HDF!S^0ML"B
M6;I+4U:KC"L+^(%QD*8W/#6*>@DSCZ<01"ZM.^.<1V"!]KB\(&*,YUWQA"UB
MA;0ZJDWE,A2WA^*:!<5%A ?7?6^(Y\/Z.>&#($^TH*L9 TV4!!4,T)!I3&ZC
MOQ RF&O+^6IT'OMZ&:CC>IK,=X$#-;0/P/8P-$$OL@S9%L5H(2)^(HLQMB&U
M>PJ)(F,7&/;<5UR^SG;D4F*4;J*>../L'#SC>2F<9Q&+(/)-6,,8]IDA0DEJ
M+J1168OK0F'(9GZ)O7/AR%3>N.PF,,D5V/ 5?8_<^H6S(8")X>(R0M""\HUQ
M_CK#@:8NGX&?./9502B7?[G&LGI#'[IL;5J&F;R!P[O.ZY:OCWD7Z:,2A8O8
M;7N)9LN$YHVON,1T?\FXYL;!8RX58#^C]9P!%M25TYN+E 4 <C(#\,/B@3MQ
MBH.WPOS6<=O,,0YQ!I5^F(QD['W''4/5.**TW>*Q4?I)\AG%&AC7V$=61\L*
MET")0U.F3J2W70#31Q7'<;+Q:>N/0DQ8/@BYZBCII"^BHB8D0U=[A;QP[62K
MV(F#CL)KMMB,^RLY"JOI2$WWE+S+',#GI"Y*NPBO:- E7V*LR>.VM3[1)[I]
M+A07QIKF4U+&7&QQ2][?1/0&N^62[Z0X6Z?8HUL0[DRPF"/=+N+09E5J7;T0
M5Z=>6CEF#63LWHH!VUY^K2),LL;>6?BT#>10 CL?6)I48OLBO*(Z**2GIG"+
M2'?XNW-?- ^]30ER&2S2>#&O6Q3(Y22RJ:R",@HK(<V%+7AR1 G3OAS#&1SG
M65E>,#4J].^X[C(T.)S)C#I5SR3UV:YG,<(NR-@?: U.M.UB:I>T-"-X)3F:
MLM 1*P":5,J1!DN6*&?'R!WL%+A<>GUEFB&;]0^#6U!,G4N9J7N X;<"3@(B
MQX-9'U[6%TS$:(D<6545-_$:\O/!DN7&<^0DO2*/LBN,6,QHW6"%I6P\!7!Q
M@S'WYG$NXJ6>O2=&.[LFM>L ^[8+56G+6*JUL0\CQX#)T6Q25"BS(.%Y]MDE
M, ^NEW,,9=#?J4JGX9WS9)E(-FX!S5S5E&*8R;#3->%58B$E'ZWV$)",-YLU
M;>');LAU93!UAQP5.]9ERJ!0KR4Q'7&SR.71%Z;@51'/AT,Q]AXM>SD\9I^
MVJI.F-C%[M=YQYJE9V!H91RP,.R-Y&6&Y;.9\9=Q<8/4V"Y7^LM4"HRRC!*W
M_8Z(/G]#%JLY*T:'*:<QXU:Z>'W8#1V8YG78SY4RDK7$T<G'";4:M:G5^UB$
M?7OH[N$P]4@IP>W-4H*?M?W02;9:JINT4!$&DJA , 7U!\=Z(*>A!!=Q=V(0
MSL3^*:?B2BP?[?1PRWE,'P4I<&.#LM"2?55N_4C93E0C:G]PL\[^U=G[VIG
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MM!WS.')D;W]ZE_@(QM\N4A ZDR-!UGBLU'1:%3*_V^HE"FBU?^ZT?@8Z:&Z
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MD)E'^'L?DZV=O?T@O2!&/)]MU; ?G%4&Q\QU3O8/G>(CSFISSB?R@D5^F:2
M!DKUM@/>8(5W8:K&>8(#V>PD.$G[YM%M+1H2!Q"%^TWE)&8ZTQV 4]XLF "X
MW<%MY?.]_J&K&9*,I$. %,&=6/Q['4EM1PBO?%3 [CYSS,_PM"<XK0JO<.(;
M#ED*\S"(O(F*X*/T!C?8:G2+:])PNVPE(EXW&_U><^7/:5+3-$UFI;-8ROB)
MP%H (<&,A^(IGMXDD,N6@>*0&-!# (]-%I2R7QZF);.QI!+ QVEV60@\)[[
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M&Y_8Y;C )#,=@@'B!2X"I'^S-]2[I;9P'D0$SM^3;([,%V%_1@P8=4Z\W.^
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M].52\^MFH[N]4WIO"'G''+1=B+J"N 5.52W4[J$>OF_.;IF Z%&O/>]UL$0
M!YZ/,>@UMNU;?BCY&'7"SH8$\CQ)58='(%59XS )%52S+=)M#H5&#]Y15AQK
MJ.7T:#<YO;_9%JW.KMT5]Y[$ZW2<S09@;CT/KB:0[67L4ZYQH(2Z=7/[0Z'3
M@S>FWT^G:IR'5U3#A:+ZI36 ;;>V+F0\%$6T-E(V8G['+W9J:Q4MX9I0UQ:D
MOE@Z)2G]<QZ,(@5_3L*KO_T'_$?O:1:D%V%\Q/M%E[\^\!&*XE\ZH-T44?N/
M19:'TQO^*(PG*LY_.>*?/?UQV^0HL4[NIW]]$5SM9N.8KM47G,>; 6PR+Z<!
M?B/VRV>FB5V0>0$FR8SA1\$%-9J'1V;A8I9YJ;I2\4(U#![+6-L_'(TJ@Z/6
ML#$X7HFCI.":R7S U3A:X)/>Y+;YROXJ9/*2@LG,BU26>6%\I;)\!C^2@H3U
M&+X+FZV.@\V__<<H_?EO]5H'OI:0='= ]WV>9"%2WR^IB@(T4MY<AY/\4F2
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MI2O? '8!/% I_-I8OC.RXWBF*DXL(A0@C8?6*!>H@-.C*:F.TY _7D_MD[]
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MI/DY%%MJW\<5>=%L;?_$IM:#QSHO>)I,NVHW[#ZB!1=OS6_:#9/]9SX<MCV
MW6<6XZ:<:Y6FUJB'2'WKA_*V(=EJSWT2J=(82!T@BQXUZZXGBR\\#2%Y=Q4]
M>M4:1Y!TU\;(R$RBXTBZ:T,DU!HGD]*\(_>LS;3]"W86IG#U,=-)KV#^78>F
MW-GZ8'"9(0#GG,:H:*Y-9[-T:]QTSIBB.45SSZ6Y2>=I+E^CGW,^\(+R6B=]
MG,@CZH#Y^'GIQ"O'+?I@7,E,.DLW[=%%IB>JP8&'3WVVFUK#"D5G1M'0O,P,
M4H6BP[EH:%Q&TG50CW<V#/29&E^P."\GO++YFJ/Q5#D4[4;1T.I^;*OG*+)&
M336%0M&94328--;FRBO?/OA@TF9M_GN$C8\V.P,\QT4_.".C*VR@S^RF8>NF
MH.B06](W]-JZ?:QCJ=#;?O1:^L0>*O3V%;V3:>-9]F? ;@<-F/;F#M8?]Q/F
MN,I2^/@4B80GR\5^R:PZM<G+;?)ZKNKV9WKU/(@]&JFKH):C:#!25T$M1Y%M
M-LWH4"@ZMZ";-,ZZ4;=U75/ES\NZZ6[P>J9/AY?)*5,W# V09#8.SB@DG1E)
M4TLET+8<13.5/MM[G_PT:3?=M59M?3:9*9>B[4@:3HZ\*U5(.IO?9ZH 5\M1
M9)O'7FM=GT;?8\IT(?7&K[O(>HZSWK<K7FN@#R9'YG.VY@K_A/Y)[_!KZ=/&
M\7R%W^[@5Q_91[JG"KT=0*]M'%D/H3)P>IE"3+/!#S%J7C97K<-M%AJ?O]U\
M84UT>W9DZ*8U&D#E8.[&[U W1RK'MK?X'>CV\,BR7H7>]J/7'AR;!J(,N(ZD
M4->W7_T4NICG20/,Q-"S(_KZ[22"7IMHS0[?;K*WP#P[M8/>)N]<47#?*7@V
M.'4(0M&OHM]SYK.?^GZC3?1[DNAH%RWKP<0XLM_IB^&U@V9U?5RT#69U_7%_
MJYD??&6Y6C/K:ON J?R6@PC$OMK\EE,32%O6Z">AOC6-Z=;$HM[3*.GH[VG@
M[ \'SU'V0X^%L-[T(B-XZZ<6/Q'B.F9"]!D/N_=HI>G"\J+5KSTM?APS)V&>
M]AH<#3F(2]>B6$,+]8W.GW@-7K3\$I[1TB73< J@!BOYD:>ED?;:,@;:?.LG
MMOS).O8!A'!6S<O8QE_P./X\<7"'CIM&,>QLM89_H:F$7\E]XLJ;#:EVWRIK
M3J(](!3@?Y]X@7CT+XD61 \LEC"J6&IUQX*55U$,JV8!'H8E;NS/ 9QS!NL8
M3:FIC7SR=5?_KYYQR!99E7C#,B:2MHDWL+5,SANV8=<0?H4W!L;L<-X0W,#I
M4XL66I3%VK+2=J&@\(>E[R[AST7 X,?XG./^D?E\A#P^C!_%;.7X(1+SV'S#
M684E*!.TO]W^ N^,\:O;[ YP)+;N@/IQD**CQ2)AJ39_I(4 V_"@GV9 \6)M
M7#%Z"('YEOYZ:^U?HF0-0-U^A]V8-RY%1XW5RK[TEI:?M;E6J9.Z%<81SEZ9
M>S M+.<>RS)FE9_LU"\#8[CKA[LY"<#FW_M>Y@3:K\P#DPHH]]:[=VB,J+9B
MJ[F@7+#6'M*E#N)^-8>C>]J#GRXW&/$.C@4'UH";@AL*PVAK64.]9B%+N5K5
M%G#(W6_3!=,&S*&3+0'&Y94D'/6R^A(_*FFV)')]V(W8*-\^@@2EQ5H6A,VS
M! Z3)'WEMFI I1]\]CO07 VOU5HD'I.L-C6UN9/XB;:.@"L3SEWH2[_9P5 8
MB'FSGX=BM@9ASG Y_)$+F@>CC8[4+2CA2\8DDCW^#A[PX^J:P%6@4Y@GE9M0
M,)4]2=WGK_"00KW !N[]*$N0H_W$#2(\*_!9F*#Q%H6&AN#:V,C2N0<]N,^2
M2Y> URA=EE@$E2EPD@"(@#I?_I$Y\4T$/MD-_@LLR/LH=D *^>FC]@#,N<AB
M6HI+"K3^'CD;2I8N[:U.M?HAJM45 5HH3@"$,P?VED!($M"YB82*F\4QTD28
MQ0F>+'#F 'L6WOMQ%!*U;%B^.Q3WI=7U#W^=Q]__L'-IP1:CJ3&"9=<1MVK>
MQ2P 8-ZS]P^^ERZ%EUI^3NS%+!YQYF0[[7YD:T;RA9A_-*A"H_Q?W*[O_=<K
MWS+9=,)FIC,;V\.IMYA[H[EM#A?V?.H.Y^;@?RUS-AM9UGA@VN;LE7Q^&<O3
MK$$=W<Q!<GR[<19PV'=.\. \)J^^KV(6T"HV-QL2"C:AMQN+3Y/)^3-;N!5#
MDLA/N 3[PI(L2(FO?JL*,I),Z%G"/TRM%XKE XM3\ .TA1\ZH8OB%T2YHP$D
MG))L1_%%B@0/CY! 22;$89)[&J4/X3,Z+I<[\!!:/3%SG83$T"(*0! 7V@%%
M: *RRH,7?60NV43<KAM8>A7L[[; ?GZ[8Q<5%> ZD#8VXIFYE*%06B&YZ'(/
M#A8XZX2]D_]X#\IO'3B/[_R0-D,/O:^^ !ET\Z8+W\>_+GC7,#G_BHLV\6;Q
MM4%?;40S^7?#F3$QK9U?F\;N[_8M:YG&:#8]:MG]WXW59KNUV;%I'[3L$]?$
M#6^#7R:V/CTHM%Y_SY6?:=;#,VWC:>>UT4''YW+T,@"HSYW] +[%'6N2V-!G
M['8"96AUG()B2Y>E7)$7NG]_"GSKP6.>%SQ-R@?:#;N/:,'%N[LV;,'D^:VQ
M>P.[SRS&33G7*DVM40^1^M;C'($Q)W&EG.@:^]-E<"[PP2F8X$:K%?BER9+[
MDN2D;^5:G$0$-89H!VBH1^5)]6?^<HJA#FV9-J#6.&"-:VKFR%9^MCJ2MKN6
M&JC6.)FX[D [D$]ADL5.Z&X-$6QRU)Y6*W6H)FDRTZ?VD6VY6E1\I(BN4T0W
MT$?3[G>$5T37):(;Z_:Q]<,MHKF#"C&ZV^)^JF91][Z1W(<H7D<Q)D1=6;WD
M?_['U+;L]ZHK=[O1-#YV4+1"T=GJ]0!'YZ[74^@Y'#V4FG2E!94GBOZ,+6,R
M:K,:Y_U@UR+$N552=NU=09X36%']7EJ-V:%N3=O6\45A]A0C<_3Q0"&VAXA5
M'9JN>::>+'M_UC7LTY1PZ0M)M<.S[U!=]_8^('ULS\:.JOTNHLA2*&HYBH:F
MPE#+,60T'=VB+MZZIL.+3A17=O%FZ[:ZTVD[DBS=5$AJ/Y)LLZDN5T@Z-Y*L
M6>-AC5=R!2=[+X11R/83E?IE]9=7>+>YV492W6W*B0>Z.3HR3T_=D[09L98^
MM11B>XE8^]@8C$)LFQ$[GC8>L:"N-OMSM?DI;S<IVL(_)[+3*\:PII,3CSOM
MJ@?;+[3JULF'4"O$M@"Q;V?C2>.,88725J-T.CABK(ZR2_H40]D:FW!*@[VC
M?#$=Z.;XR/+GEQS&WCJ'K*/XG4S 2#EU&$7AMS7X'>DS\\AL"87>]J-W8C3U
M',^ W X:+_5!E?8:+,4 &O;GFH7)2R6,EZFAM?G.:I,OOLE3>@/MCE+^R$*V
M\--G.0$=5"3CF6[-+I-6J3)?#\>2I8]MU1BHY5B:Z*.)I9#4;B19S>>]JRSR
MKBGS77,:KR2WTM0MNZD@4AFPY\>2.5+)Y"W'TKBI;:PP=&8,F8U#82J/7/WR
M;'GD[3:4/N+(91SLC2.6:9CF*H*M_9L^N+)0R&AV9 ,6Y;R="T7#J0I5M1Q%
MEGGDS91"T;E09%NJD+[WA?0\M2G:NB]\D>3KKMZBS_29U53I-X5%A[R_WN'7
MUJUC'7B%WP[@5Y\,3UU!H=#;&O1:1X=V5);3 =9;>VV73U0FIBWB:"4MF"A4
MZ=DE" UT:WAD/D!K))]*[]P=Y]!G)^_>K=#;&O2^M?3IH$'5D4)M=U [&!NS
M5F&V]?9*^^Y_NO++WJ>[?\)FD"Q)9?3JRA)Y!O:1P:F..K =1)$];9I-J%!T
M;F-:8:CE&+)&QF42X5IO&W4_EO-;NF2Q]I9W_OE.*G)="UEZ9?DE;T>#!@,A
MU:WXV:/-:D1#RU$T'EQF\K9"48-*M;$:C]Y?=YSN9>9L$<5,-//34N=/> /F
MCK(_,C]]A,]1N6O,B4,XE4HXJ5S;#$[>&>[<P5]U8;WGVF9\[.0!A=[VH_<M
M=B@>GZY9G$)M>U!K3PRK59CMH#G3M=#$YSBZ]Q.L? %[IF+.7%ED8CA5?E7+
M463I U58T78DO9W:*L+78O2,[2-R,ZY/CQ\7EKCHB7\Z>>BA@_0];JK%U47G
MN0L6C@S^* R=34<T4! *.6</P-A& P-+Y0ATQ!'_.]LU&NAETX=;9\:\?KGS
MMYO@;7TVZ/FT 47*UT'* WTP;F%S=D7*BI0;VUO#P:!5M2RJ2NETAK2J4KJR
M[)V/?I"ES,NC8]J:Q7#2U2J"K2R=^'#C>_OZ<P 8]Z)L'K"KD//- =!N3K!M
MH['-TA@&%XZ-*&J^&FH>&8,CVU\K:E;4W#)J?@NR>?B<U*1V$_*166?'$'4+
M<6N91LMPVT%#O&OA;C%J2J.^1MI;9XL >IZ',1T?.[VP\[2M$G4.&SYL7&:.
M4O\(I"UK])-0!\9E6L9?GDY['RVKCI"2NGI^G*[N;LH%9EQ<:6L&E9-S$($,
M%(&<;X+O6=;H)Z&^M0Q3Y8[USIG^:;%@;NK?4^46JNGCFL1UUP:UAHT%<%^,
M4.6D'-:BSFA:E*X(1'G3E]#0 Z-Y5^3.$RFIZ.]39QXP^%_/O__AK_ ?N:>5
M$]_YX0W?+\;[Y8%O4 ^_&UC&J(K7_\N2U%\\\H_\T&-A^NZ&_^S\Q[4)KT6$
M^_ROKX++-HTA\=07''R8 &P2+:5)27,>E$]DASK-230'4V1<^)%SQ[1HH<$C
M*S];)5K,[EF8,2/'XR;6NH>C>6MP9,V,Z; 61U%UK+<.N'*##)_4O'V#+/4Z
M9/(E!283+6!)HOGA/4O2%?Q(U"/LQO!3V 195F#SA[_.X^]_N-!:ZKGG/"?(
M=#0E'EY'B8\4]2YF@8->Q_L'WTN70JZ7GQ,"VRP><>9)A!EX.Q\I;1'IE,47
MD@6C814:Y?\NXT+$W;&;><R<;S?. C;[S@D>G,?DU?=5]06Z2RP^&Q((-T^_
M&PM-^<2V7U: THKO?! ;OGL &#]+;?&%RYB3*HLF(J%J0LQJ5[\0J7&_9/N_
M'Z*0THL=3%C-U2[(9*"W!#YZ/3+&VMP/ I+N4:Q-C/$;G4\,>CT!CUA^B27A
MZ9)IMFF;J #\R /)#[\!)5/S&TO^9AW[ #8XL.9E#)]8PJY9+/=2Z UZY:_,
M ]LR9MJM=^]P#8,Z*$EA_S=SVK$+L(@=%W39BJWF+$Z6_EH#@_8A7>KYXO#_
M_-NZ%7,PD#(#S9@%*2DRV+J_6F,S&U"$'W[]BK:,NX3M?Z-X"'6WP;-1TUU\
M(E_\BY]\@S<@#9#2>_OKE]OOM"5SO <@M$2\!)>E8W[X[9^?/MY8,XVD'QPJ
M2_U Z%C-\Y,X6Z<"G@AO4KL/+ CP?W&72.?X ]"[?V1.#$(#-PY J6PJ87\
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M@]$TM@:ZK=#4=C2]'=G(3>=N2*DP=#B&IL;X2ON%]MQI+YI!50MMK\Q?'X
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M$"7>:&R6":ZM +3:"<!:7Q)%91 E!$B7Q:D#3F@ DHQICNO";M,$W5*IM;B
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M.H2-6N,7UGJG:\V@5FKG2M<83I^I<'H3*V!K< !/@R44_@NE]E>N+I]+K=P
MS>F+6N#"^0)GG;!W\A_O94<:/Z0]T4/OJV] -&RVAL,7\J\+#!DFQY+H3"?>
M++XVZ*N-]C_\N^' L&?6SJ]-8_=W^Y:U+&,ZW?WUOF7W?S<V7V"SMC$=VEW9
M;,<@:YO#@Y9]HJ]BP_:)+].,:GI0+ZKZQG#YF68]/-,VGG;V63OH^%RG7@8
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M,0%L0U0X):$/^PAH%PRI)_(R%S#@ _P 'Z"H$!VT/Z0R;L%*PMTV7_'8 M-
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MD,)%YPSIM[38 [UNSK20W9$BX6K5H4-NOTEHJ+UO^AG)LK#W^+_X>4LO7CD
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M04=@R(\@E]##XU\,+)V#A\<S!\90>^JWPF\"_1C>4;C.W;D;E&/(?X_, 70
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MDJO<&8;!Y-<55B,FL#E_ 4H*F[5@"GG,<]<I,3;/$-]$)2;\IX]K44*SHX8
M_IV7+(@BT8VB D(2KW3 &I6-WXJBG&2C#$4OX[GX,"^9X[5Q(:-RP)C-@8BP
M,"8((K=@4!<T,U(_*KP8,(2D712RPB;O@3,CH!E>#""K$+&HKEIUNF1.0*U
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M@V_JIQMQS%U.ZBZ"'2B"/3G!YJ8$2$0JHR,@=# :!6[%G 4^NV=$BF05SYT
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M*+CGM(,Z%F-*9,T#J6/9/1S$3WG+KZ^??]++V:Q@[.QG.@"R")R#,8] =DI
MWL4&DP[2_\6)H2'Y_W?F ")2)K)!/L$65]Q$KNG6O_<ZJDU >)YZN*O"Q-^
M25_(M2UWQDTIMBC?_R":&73Q;O%I*BS.*9LV))N7X[(3B*[]BMVZJ",C$@C_
MW.<]%7C0;"YR6?.5=A%Q5ZCX^?'] U/ZK%&;4_H^8' *F[C=\H;?2!J? 5^N
M[+KR$\ &?<%^Y,)1F_2"5RAB$CK!(]X="<8I0BM [3PB+ZZ!,0,U*871J!N>
M[$I$471^YUXB^ 9Q&EEDLG3N,6^ A;SZ,!86%5TOD@5$=W9.@2Z1<X\-U(L
M''S/UCRZ1NSXCY"XD7B(SG"[ @BZ#N_2SM^4>\CP0,(:Q9B$'X353SQZ_PT,
M/DDY_*%2ERB*TCB+!:O< I>:=HI-'PO*\FU"E"4 #G;O!)2D@!BJ;BQ=HG7J
M2CXH U;RP6:;10HKB7;-27X[PHGDGN$-ANAHRHFG\/%*BV.L  .&?KP91Q =
M'&M#R'=1Y#WX0:"36;' AH[L)J @+N^>A9.;^)])PM*$T)M4<%%NW?4MC!Y
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MNAV9)<!RSKL#Z7^CZC W,SBX<M.%AI)ATVUGG;!W\A_OY4A6/R3:I8?>5U^
M&GYSFBJ^CW\ME/]P/#3L$;&9&.8JWBQL \.L&S<IOK0L^6S]]WL?WO_EY&76
M53MNUX[%%.$-"]^R.4&61J3.\A&I>P8(<QXZS[#"Z5/!'SX_N)#3/Y,,T=XZ
MWQ428O<@V"=GQG85(%Q#_4X*0X)DO@&2>JJPS2VJ* W.W36]T=P>X-AN"'&@
MD \FID^_=;>&K!\+@4-&$%>F9&XOU1](?RRF.1*X<Z?I,V^5?0HVO4:X*@H^
M-P5S,_00,CY8X=I6#V7K6P_MYY@L>U&?DGQW"'R&^U3/5DJAZS)6FME^,&@
MPA>:J6P:,_/-(2SZU%F/FG%_++PN.YI[-)TJB#6!V, 8*2)K2&3#R>ST\DFD
M/'=*/DV/))V-LQY%.L?"Z\+RR;85Q)K))WNDB*RA?!J.E/V$\FFB5%M3TAE-
M%,2:R2=3$5E3(K,L93^A?!HK^ZDAZ0QFRGYJ!#';F"C[J2F13<;*?D+YI$(#
MC4G''BN(-9-/BL@:$]G05O83RJ>ALI\:DHX]MA3$FLDG%7]J+)_,J;*?4#X-
ME&IK2#K63-E/#>63BC\U5H*3H;*?4#[9RGYJ*I\&RGYJ!#%+Q9^:RZ?!"^07
M=-%^LI1J:T@ZXY$"6#/QI,)/C<63^0+I!5TTGTREV9I&!@8*8,W$DXH^-3;1
M)R^07=!%Z\D<*,W6D'14\*FA>%+!I^81A,FV>/J>:L6?+$\?8(L=?MR;@"W2
M=P.+>L8\T;+AYH(]&]XZ>2W/^5]?!=;8F!&5?9%3(NI:%)3:#.2MKM:\9FO/
M](JB<4'I^1W](/)&$*+7PP']( YMW]%%^IBWB#X&PW/2!Q_51+U_1(\0WK*#
M?HJ44FJC(1I]U/8YR0E*K"(??1XMS3I(2VZ+:(G+&NJZPBOJ\]G;V&44B2IF
M:^Q5A(U\1.,G1)5SQT2W)/Y ?UKW;':?$<VL:-23CY/BJ.<=@('FLN$$)FPF
M+Z;+44LI-\Y$)_G27!UL);/)B@;-^8A" JYHB95&*0U&VV86YKA+&C\B>S#E
MK1GIE8(;9:- ^F$A&K8;(I8:'WJ(!MZK"00\E_0;SXM3E2>?\*:R5KM:2 G=
ME<]*T9QYE*4%/#E6_!RP'G;VBM9\,.?>=NHX=8@&QN0C<2J#*MULE?%F@GQI
M;8$-PECH/N:]ACAJ92.D' JBRQ@?AIENH5X@6?4V+/'I>%R%1DM[&TYJ[?RR
MK..]A<_;MVDV,\:3&9YM1]NF-[OZ[XS&QG TWOFU:5A'?C<<#HYZ<M]F+=L8
MFD.UV1?:[.2@9454ZP0]4([X:2?Z2J!R.6^WF*Z!YY!4ABL&CUD71CZ"-= A
MN,S1ZD-0W/XZ!>ZM41_[T3S5A^:4$<HZVKC<G8$8Z41S7?^?$V;@#G!B.2[I
MZ8D@;Q.PF=I%&>O0X.XFF!H=L7RT&%=MU=FFNCV=U8N.AO2O-3RMHKGKI3EK
M.% TIVCNC&<;ZZ8YO!S-/6%CR%!%&(5L/YE>QR\;FV1/Y[2TRR3['Y8D[[0O
M16R4YBS ]C!(E;QH:I#=#(RUHJM]_/V?_S&U+?M]0PZO)YL7U2H*30I-K4?3
MV_%TJXOP.;!SC:ZX9M%=V8OF6^VC4K'&P9&>CI#P,QS;)D&O2WH@UXW>HWU(
MA=[VHW>DSP;CEJ*W]\[)K?M'YO,4!^6**!NWIV@:V@I#[<;0Q1FI]^[()YD[
M5PQL/F1BUED*/]0:>]8XD0W"Y<"LS23ZH92?JXR1QN";C'7+'"E-UW(LF;II
M-[V>4E@Z]QVBI<^&5N?-D0X(_<]Y2<5Q#N@)(RL=I-.W0VMT>/B^?9D5?4?/
MU%;H:3%Z!M;@(N@YI4T_F+19O/]>J=F[M%7?M]CY9*2/9^9Q9DIK[D84?G>;
MH3/=FC6]VE3X[0Y^+7UL3UN*W]Z'1#]CL7.+PJ$GF]2M-MEXDRK*JB)#!^;+
M371[.KE(SIS"T&$8LG5K.%,8:B^&1D/=-!NXWBJRJB*KYZ;1B3ZT&Z1&J^#=
MV<6\/AN.%8+:BZ"1/K0NPT'7%E_%MEV7MN7[%IMY.QGJDR:W:RKNUAW<CF>Z
M.5.X[25N1S.PW*SVX585AK]L87C7PL\[2L(O[:OMY(,N"H/C\LH;0:)#3H1"
MK4*M0FT;/,OV:J5RV?IFO^>7<#$/-,N*^0B:%V78$UB"XAF4W^&V3">&3KOE
MP4RWQT>FS)\(0!?VYQ23*"9YB2X8BDD4DUP9DS3O)=(.)FDR9:Q[DV22; 5'
M@$7X))W2C"4Y9Z4Z>4L, "F2]TJC6=!T36-_GO&EX3L<,/.-/6I. N]94[,+
M0[O%P5WLWH^R)'C4/):X\ SS]+I?@WP*$S^A*2=\Q!,.+JD9#U9,A<D2/!U
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MJ#(N=GMGL+4EQ'OG/2SP7[N_1[^W.Y=U?8MS<)W8Q;E)A@1T(:!B'/>Z[DB
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M_BKH !KJ#]!6KBQH%*@)ZSNO#NQ:65C%Q\SLT+_0=GJ9]PV57GU_J7B8(^=
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M_#S"$S*";T\3J(IUS0B>O*P\@D708<5%D,Z_S[(P&CQ'IDM@X1?#PF1NH8S
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M]H_#=U_8$?F2'+[;3XXN#N+C=Y^:I\V/^/3BX.KHW>GUZ<7YQ=&[@ZM#S'_
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MMJY(,$YK.%Y4>^_U\8^L@U(TTOC;5PZ;K23=L;]I2<K7%-9OVCV0RT%GPD?
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M*#"=ED8-D5G,$29)@EAF*!** "C@U%@B698GQ*$ 9HO*BP\HL%$HL'##)J#
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M[:[K;U? GUO^9N59(1O1I2RZ43N/NO!U$"P?^9;.Z,SK+=G2=?A*IPM_\-7
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MG;USF5$/F'5?:/_,FB!*QRR\ .8I 9&H JNB!*-4TEHD[TMUK6Y/F-T86*M
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MW<6[2(-G1QRC40<5A6#6&T=BHC)$C7+&\KPP^SZ)?QU/9X?%.;4W?H(C5^[
M';QRP[@]>NJ.AC-W\';?35*S:)]>6K-OTFGAA?0V33X,0WJ%SSZ.;U(8OQLU
M5VG\Q97%%V[S_.M5X4JTYVBC:PC:HG#55(!+T8"F5#&5@[$D;VPQNG2WFAIC
MJM>HA+P0(7<NHBLA]XJ07Y)Y8IPEAM/-!83($H@0$SAM,GAAM.*.<*M<9>3*
M0 ^R<$)EH%XQ4#$)V\*>&Z9%]AYH#!:$2JCIDR.0C#$^&<:4I7UCH%5/"WB3
M2IGZ,$OQ[$A'0>W@ [Z*=_]#9SH>K$?Q6OZ:%N*87J4PZS3G,5KGHY"4>R^D
MX3I0P;RF1'V/POA5"FO\+-O3Z7&*SXXG.'2G3-2PUO3+-#4?>_+13>*_)I>;
M-?)*3#<QC2Y(J1#4SK/W9.?)GT3E;!/G@+-HT#(2%'RF'!RU26GKO65Z8XN:
M'K5[JR&"FKNR(K.T2""G U?B-:=]KV'?QOC[/OE6J_"FG:U;CD+.LQ,Y"H@B
M>1!2>W ,M2FUG"B3C0VE;8MNDV\-$:_@-5:2X>[S'%WEM;OAM?;9.4DU"MMD
MP5(>4.VBY/6L>-Y<9$QR[I'WYA);M5=ZC>:5LRK[<HV57"WWZ13]0>Z_?#0J
M#S^E")_39%SWA,7WA'9J$U&XKV<*PCJ"QBYUI0V' ^U5HL%'S46\8)@>;0QK
MD>,T&!\U$$V?TB0,:TF;AQ[LJ[-49ZG_NW[GV7'?VO6;]W8;FIL^/Z.Y6'?V
MQ79V,<>+E:A7N(5S<%QP%'NTM(50'$B@P0;A7/9D8XOU*;+9Q[R(5;K&NA/;
MG;JR*K%U0VQM-U822@EF)!!',@A1,L98)B!UYMJGK&+#;'*%F6W=D=QYOFA%
M\BUG.;!Y":#!$HTS&(!'&4$0Q<"YTM/7JZ2X-CB;?&-+MGN K@Z2^W*-=6>4
M.W5U5D;IR#9H)W0FIJ3B ;Q@&H25##RJ61 \4!54-L;ZGC'*JN=S_N0.W"BD
MZ>;@60KIT*?)@-/-04'1,MF<?CR):0*G8_F8X^#'\;$_2(/S!SK[ #[WXS(U
M3?ONBS=7B,OFYH*RLG=FZV6T2IC(?8A14BV$=-)KG?[<OED*Z*73Y*=IG[O'
ML^G,C<K@W:QD7<T"O7&/]*LN',%QMIPU4$K3@7">@Q740*:<9&6U9(YM;%%K
M-I72'<5FNH-57X+)E4N6<@;_&)',-X?VQP<XC-/G_ST>SDZV1^'@N S<J_&D
MW,63V6PR],<SAP._-Y[?=[3:2 NSRLN68U@[DTURD%5&5DD\@:7(+RQ(K1QW
MR"5D8XOS2BB54&Z!4+CC7AK<NK*7 FUU:ZA6-FF)!KJB*=XUH=2RNUVR32L,
M10-3C$D#/CL)0E -AJ@$)F82>!+$E6Y)?)/-Z994":<2SO*$@UQ#@XM,*H?+
M+Q/+E"6X[ISERO/ *N$\9,)IU2=%<HG,J!+WIN7TAE!@M2DU!K)RDN-J4.5(
MK]P4=NG6Z95QUH=Q%JKNEY4445IK=129$)^E4H1*8HTQN/ZNIYQOG06KW-,S
M[FFUNXXT!9QD#MHJ"RB7&3A"#3@90S0DR2Q/F] 2L?SAL<HZE76^8ATB,B/)
MIN"#$2QY(U+@/&8=:"+<A<HZ*\$Z[80834F0F5F@DJ')HXP%'WB ;+FP@?BD
MG43:89M4=M"2MO+.&O#.(L:.#D@SV21MO1 E!4<8GT-&J15Q09*JKQXJV[SD
M[:2=UW_ZC/M,T!Y"H!D%5A3@25"0O T&9QK%%D&VD9N<+AUFKY13*6<.Y;@<
M>.)1&$*%8-Q91H1FW&9B$Y/^SGW(E546M6$^7[5AO!;.&A8@":E!,.7 QXPV
M#!*,]SZ$9)!5I*V,4AGE%AA%&)%5ID)'[U"W9QN4RD)XG3-)POMJQ#QHNFGE
M"6J./&-H &^90;J1#)PA I+3+"C!*9?NU(C1[:8.#Y5RFDS#?S0K#_^.PP];
M_X-_G-_XH9N\&X[.[\]^C>V0RM+L&L:4? _'K.!X;S\-7"B='MSH! =A,!K/
M\.IN@B^/!D.\LW<3=S X<I/98)P',_PX@JH9/U?*2.;AR(W"$#\RG>$+34W6
M1^T.DU>F]>KXG-V2-(\DWO71>-K48GT\20=N-OR0_OEQ&&?[Y\QSZ??.!I1\
M^17G\=Z.9]?_2E\&7NNO1^/RG^5V&_JA)!F=+'%6L4*=/DK/BB_*FR \X7]2
M;C?.?VM_<OX,1^Y= C])[CVXC(_XV!U\="?3C7]\O2AQ19[=DA7-P%\=L].1
MV6JZAK;FKE]OMI;4W<^SGCO//Q_C)=P MZI'UR[_OMSKT]V=M[N_;#][LO?\
MV>#M'O[U\OG.WMO![HO!TR=O?QZ\^&7WMVL?XFN.H]=P7,.07^#;L#(^WH$[
MFJ;'YS_\,PZG1P?NY/%PU-QD\TO__/H+RGJ]FH9=ON_T[2]+^1$Y7<YG6>!G
MWWSV]J/FK2N[S.E[4CX2^OJWR2-Z[7O?NBQECXQ@/W39;[^GR(_]YFK=K+C1
M9;]S+&#![/_;,</M#0M$S#.7+IZ)RIL\U"DX[^>Q6D34/-:+\:0Q-4Z2FPS2
M***A<?F PU?/NS:3>4G)+F#-?G^B#X<Q'J3[F>AOGE19\(%O<H;O*YW0OM1*
M#2RM WL[ TO6DW\N;2:K,YU_&XX&>-6#<EST[XO,:X^KH-WLR4L'TT$^&'^<
M#O)D?#@8'Z6)*WT@!L45\P'E]#=JHO7E:/5#OT9'!U1/7<:V%ZMM/K?LI-E@
M. KCP[1,1<.YOO&^T>C_6>H)[\GK?[-'N\]#_Z\FXSR<_=(J6MI?%_[[<Q?^
M^S_^]>+@CY+'^-OO](]G@?S^^3]_[?[KM?SCM^W/N[_]Y_"/O6WQ\O-K_G)X
M[L(_VM_=^[6XZ@__>/;\4_.[>T_P>\+)[K-MNE.^]R]\[?"/PYWA%1?^(=[;
M7G'5__'^Y=Z+]SM_O:8O\9EV/N-W_/4K*<^(K[$_#G]G__OY]7F>Y>SEWNN/
MY;-_6IZ"\LZ"YJ6 M0T&C&,6_PA42Z>8=1[MH$U#NDKR[E',K[+12K)1DHGB
M?X1H'85RR64B;+)4ZL2]<*?ER>@Y&]'*1O?&1B=7V,@9K:E7 JA@'$3*$HR1
M'FBF,FH7.,Y>82/+VWG?E8TJ&_61C8)C/G"F<6O5PFOM4M+4N:A5EH9$VK 1
M.6<C4MGHOMAHYZIMY)A(7A@!+(<FE<J#B82 #F@G2>$BFD?ER"WOK&A(CPJZ
M]U]E7FH,.YB-!Y.$L O#@S087<C/\GKY5RCNCZ/)^,.P1!?\R5S_Q^/J 'E
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M0=/HD']JBZS5!7#G<8(*X-L#<$L"I,B5]T:"BMR7WA@6C$_X3Q:]X,0+F1'
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MZ5.21,UUZKGB7Q[KM0/@$C!OUT7.P4?&%1@;% AC#5C#$/4Q!!.UU5KQSCH
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M6EJJ4,E T-R-((P,4#)IP5E=>FZ:+(G/011GM*)=!=[Z)PSG1^5Z*PR?7J<
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M1T>T';XQ[GCG4AT@Q%"6*;VUO GF%D9K4 P9'"Z.P)0&GEY#4MBF,AK9@DO
M7.H="6\/+K<+^S@DOAJ:MC5OOC,8/.L%S>A9NH"SU9!"-O]% 1J"_T%5U?T.
M^\0\!P:IA5E1K64^I]\:K"\Y(J9(G6YUT)O0 R+*>-N^7Q+V$"I4$[DQ>-$+
MN $<5^OGMDP[O$:G,K6C.CC7#;;EGF^-:@3+J&M:%X.K]M'ZF4A:W\4FIHWI
M?F^OJ:V@A+@I65A5^JK93@;MF5(SG>G7T<X.5JD7$6MM8?0CZ19>JB(>M7V1
MH(/W@H.B.!4]!_HC)P5LRG1QL[7&679W'^W-G>7ZY7[6C*A'W)R]%AFS_TAV
MD2QGK+0<L8ZQ!@K!6[>FQ*)[I_G$P,\0> )3IV"A]*R9"@.4UVV13G(UWIDC
MROQ8G<AJ5$E*IYL-+'\XA^VBR4\H0#]MNW1:=^5JS)M^C/B"# >NXK /Z^_9
M?D_[FL>;TN[V' 'U3BU9[A@1,_6_.?#.Y4)$V]'UQJP>JDT,G:O9V52"\)Z2
MFF^K9E3RC_4/\5'D??1YTO_UK]=#6#LBX<$\)/R #4,:FCK%3!6N-JC0%1AO
M/?YUJW1)+2-"GF,GKIR47HW4SN"YE97^A)I)WZSVM'8$$Q0Q.=8H/*?Z@L$.
M4<=M$D(#.\?GTZ0!46:(/ZT^,=9]I8A IT)26TFS:SZUU?KE%27"%T)8S4+O
M,J.63.<@7+@F<(B-9OHBO8=,D1D6&9GJ* -0PE56XE3KT:;3W\/!V:B%.]$)
MU6T\PBV$.<&"XVZ_ZEGOE:YA@8F )Q/V4I\6P2:*N@3B4'<J\+QCV8K=@N[,
MHHNR5-W7TU.Z3H')9"U&+$FQ66!S+#:Z(FD^ 7&8T&OP(?\U*17NVGR]]N2P
MVY 8;O<>Q6GX5@,,&=7% )RRF9]V#%8K:, 6ID(K=GURKHK_Z?29R;!>+IO(
MM+\Q4NC8G*9&%I_D9-KH4JJV8"NM',EA1QINR<%JQA0 RY3IRA9?<!ECR8(6
M\0%WL7A@]^]($ 8K@)J,BK3H2&2.F0(1'K*9(0Z<XFL;0W[4\_()(:$]$UK9
M<CD5WG-Q!9:@%$PTP*4P'_*L7^C):=2HQQ$^GEYZV@1AO@EF5"0Z1*>(UKF#
MB728=";ESLN&\*41$FIITAWT?SU;I^+"63LK(3S5BTO&8*U+U(N$93VC.7@P
M!"X;40K7K:@I&=.3,4,K1O>C$?[R2)*=IFW/-7,X'&#MH2XKT9?J^Q'RUW0^
MEDX5.4@%59<Y%AP8*V@HR&XE^Z83;?H_"1\8C5-.1Y/-IF4&>UU:M.Z8JD<?
M\XA3#+OA7!!\CD.18B4#!CPGATB?:9I!$$Z[.9?JD1(94-EL5_YB][(#]T'L
M)VNG62<R3"&0GEZ#R]RI'F-Y< 5@:QU(V:_Y<MQ7Q$195"W]*I^V1[+I5&1?
M@"HX%]45H]:V/5O* JXQ$;RV/1S7L8.#9^7CH,%K?[)7#_C%CF6[SK-<Y54^
MBOWZZL::M%-U**XV\H$RNX(^8)6F-S Y?2V(9)FH"%D)#MP!W>CA]91Q<YQM
MLT[]\D.=^A(^K76=/;:$S+QI[5U,*ZQELMM\:,SM"L['%DQ@JERSVH-D<6?P
M^Y?,' %'Z_K<Q8W?H3F:)HC^4E53SQR]QG 0Y527E*YY%7J@L\8=1RT5(Q_8
MJ-_4]"([!YL[Z%N<P)89<CKI4:/")9I8BB2F;Q:!AB.=X #4NC27W38D%/Z#
MUW8-W:$[@] P:M>?+2B/A&.(E;8$X(C)20XK32S_ (-$'J]WL,_Q?)EQX@6%
MNW&MC'JP%C=@0I4#"] !7Y3JZ* #]@]?]&M;>$1[9D!'DU_1Z#F$*UXZD[*'
M%H\%"_#"'RX)\MP__'P0GJ11X0M?95XAD;%'A*E7J*#P_"(HLSKP9>Q'3YXF
M_A)<P/_9;$_B-C*:$<X@D+R&?>/);*6Q:0A3.F%"N4.58NT61I+GDU;-9^2T
M@S3.L?!70\6>C1!'51$5Q01<>RW?NJ_)T3\MWQNTPAT6R[S6E:U'=8?SCLQ
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M]T=[[\)WQP?AT3&,\?C5^5^__1$?[!W NQXD[XX/QX?'[^*_WAX$*REM?.Q
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MS9HIM57W\&0<L(]A!R*Z!%*X 0KN02"_[LXXFKP:]X]>'F-@PXY_J%L"%Q3
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MJ.8-6S>.8:>&E8@3%<9Q&)>A"DJ9RMSWHRHKM\MY!\MYZI](7_A!DJ1>E<C
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M\&BRVY0(%JO@4;*X^.9LTMDMG0V_'0Q@65154-1U4,5Y&>517*=IG%65]*O
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MV4=EBW>CNL5N$3LQM:<SCIGC+T8F#*P RNO2E/6\/Q.O@M]TK UZ$KKO$#
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M7C^'&J\ 4?F[D?#0AT'W^_ ^/KU^]0%NY'L7SMS\EE/'L9HYC73:"?VA'A'
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M"IX:AR57<!\<UG(%FMEH+%?(^YPKR,K=-H!)Y(PZ3Q0':ZD AZJ>S[PI65!
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M2/A$E<*"8<4@<*@GLU=YH7_-X;P$:+XY#5  .Q]@)RTQ(9ZRR''N@9Z58G
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M([(D:92W0WD<=+"Y#:*J6^JR#KZT@%X"/)<LP./@V4_B.5!*G0;[K(A+B,M
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M/76M^)/08J7[+>@)BE13*')X9T!)>:<%H.(E/$OLY:,VMK:CCVT7>^"(;3:
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M3SAL_%!7KO;UM#]HIK/A#30[N>W\2Z(K9AV.A^O]8^MB;*I+73G1"&-"OQ
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MM'>X6A+;A+\6@UH,:DEX/P9*:PEO>(6111N0]B+OSZ $&:$8"L%SP:P55&M
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M0CKPA*33@D?.#3%B8XOQ8L57#-VK9\5+=GW1:*]W\U5)6AL9(LQ[Q(E1R)I
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M_Q4%<4Z\/1$NINZ7GA-$T,;N89X&QFW<'OS%D74#V4)B)+ -O_[-VA)7"8-
M@ 35$8VY2%M[5U6N7)E5N9(XZP(Q,7"J)/4Z(MT7NMKL MGLO%+]H<E>%/'(
M[1\IDI/4[U53GM*4QT( HQ5G*FFBF02,W$,D+H5,*)@LL_#4)S3ED3S ?<.
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MC()@)F21K9%.45O.\1ADYDX%[>@#)-(K*Y@9&IU,")8%3EY4"@C74 YD248
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MR,-0M4D-]I06X'C2A-M<$D2!$^!:$A4UYS$&JJQ96M%TRD11[=BS2(;KA54
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M^."66#H?AQ@MS]E*C5]2MHY[R2P:I+0/S,2K6[RO.8Z+X4<30[:&*)='#3)
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M9J[#H%,KO-1>?7"VQ&;1H.ZQ8?<ZB+L$8\/.IIWAV$RYE9NES5X)4"()"=P
MBXG+($%%L(R/#F%3R]CU/;V0YO7P\W_'$/I@_11YBH[LJ;;8UD&Q![R9R[V^
MWO<Z<?&S(O?JPK'V]7CS2Z";:[MJ:WOGLS!&QIP<H;F(6.M B;-!XX\,5)#>
M:"UNZO*%JZ0XL7_V!@>-#75;JT>[N*I;[))^]15T'W7ON<:T1H[Q])JQF?%B
M79,[T@X_ <V\@,1%D!]!SZG Z]6;0,.]!,2G4HY7[/_BK<"@,03H#Z&W\=F]
MPIW'>POO%3?0"#TV6'C>9:!8R/FME?8(H]M[W>A@?4QXYX.T6SC)#1@R=4?+
M.8&9K<;QHG?H7EH%%VG-):0M+N5\%LM\G+OO"X1J<!&R#ILPI7'EW=[HM67A
M]$O'X=$G%@7<"Y_S,T9YSB:;?M'=J^QR1.+*@C_MF8@OQ&_HPT8P-T]]@W*,
MIJ+L1,%I+FW,/BK/J<S<6[1S*CZS8NFWB!F>2&G2/)AT<'$I&Q@J(S:D?R/O
M7CM7))\?Q=^-4U>Q]^E+!Z_YCF^>?.!;V[L4KT&W/N*UUE;Q\S^<[&ROJXVU
MOSH[QU==Q=O]K8_KQYMK.V)S>T>AJ\#7OU-XWW1C+78VMS?W-KY\_;[Y\:\O
M_SGY(#?>?0:J8F8:B/8&B$S.$)<])\8E&Q*/SF5]5? 7%U5BZ.,-*) 27\.%
M%UQS*PUP)_55P=^--VOKKU?_?-/Z]^J?VZVUG\OS+F@L.UF>].:1NCRR(NK@
M0C8F $@KN=.661V83T4M@IMRM!7?4BAL8>ZAWVY(>"OVCQ"C,$3([292*R$9
M<M42U Y;\YPN_E99_:VUH>KW>?.=AFZCVQ\,7_UZX_V#FN)OT"FW]GXOI</5
MT/#^U;,F1!_Q#B[9ZIP)<S^ZF?*MU<\9N+8V6F)HV9L6D1*;%8YNLE08RC-U
M8[K<'OD>>@$;O60R,.>\U=IZ98)5'E?F)%WNLFZ0^72'>O 7VVGYX9QA!)[.
MLP%#.?S<ZW2:7NDC>C;>4NKJ\ANV=KQ!UGNYK,.2T1FT(WKNOY^&B&?!ZT41
M\8OWTT_M+D)[<[M#F?KO9!2Q-]G0LTMB'-FT //'S4>56'F8D?@^2L,VM*+?
M'GPM=_R]<#;\U_?+1<MJGF"$YS=9KC9ZW ,<NJ9=5CNT<7#/GZ QY9*EW86#
M*S?3],/"D'<?0CIJM@*1V72/,EHI>JT2Y+XM>>$8&U8$A0</6VN46^FG7>@W
MN9I"4G\"%6<W<#-F%)7UD@A&1MS0+][TW!S#\C'F<QVZOT"I=;RSJK5>M=:?
M6&O]9I)Q#9FYR9],3=Z>R R;</0(@1/1]O5%'W?6OZCU_KQYY,7\0H.$Z^NO
M6NOXUY9]U5J:^):"W>^/#I!9E9]+'\4U.(2E84($XTA$[OT6H^3_W;8-ST0M
M[:=0IK?B;LKT?%D;?B<)^9__3=.[7?5G-^N6M9+U7E_\O=ZND\(MNP,\Z3GO
MJWKXDX]Y33[/=I>.!VXQ&P),V>3@&3[^Y18(=6G_M$+X.B5=^O.& _,W\7]B
M@-NP_=>]?K\=>_WFA_?I\'!(8&Y3+GV;P;C]H)[3GBN7>CZ#CC'^<)C/\AO-
MCVNG^8,'6:PO8%SK8I[WQ5S=RH3R&?8,_<HO&#&/&M,._C;-$IA5U22.X1.5
M3 PWO\ON<>J>'NF;A9[CU05T[YJKN2LV_9_[%-3,>2'-%.VXM5-!,V.\BT)Z
M06VR-B8G(>28HU&3*TC'V[$W"W%XY/CU<#7.49?MNVVE#4O&#O9V3DHSF@\G
M&_S-CZV/[^@._\"VMH/ZM/:&;JWMXGO>?2_B3F=E9J<E8_MOOVSP]1^?MC?P
M-6_P]7]^P<]0FR>=KQO;[^36VN8>?BXMS6\:<:GVE9(Q([6QI9&2+EMPTB=/
M+"1-9/8FV>0-V-*T0\Y)R5C%FXHW-^(-E\X!J" <!1D2>&X,CP*\L)(KFBO>
M/!K>;+Z^*ECN%6@>%(DQED9:V1.?\3N5E%.1*\D"XHUVNN)-Q9L%P9N8M0D&
M&8XV4B:CG! L% 4P*RC3_AH)UXHW#X$W5_F-##'0G#/Q%B*R&D>)C8Z3;'/D
M)D4:E5E:$7J\14W%FXHW<XHW3@HKE*(V.QFC]E(R$WCP60N$HFO$T&Z'-\-S
M5_@A/PY_[1[MD]@[)*-K5#":$HRVKI(?B%ZXE'&59IV+*@\0X!AQ>68$SAXB
ME2PBE*^LFU6+Q%G T2.I[#Y=@FN[#W%X7+0Y['@ Q\U1E(OEH*7LL#M(=\M[
M71F/ZQ.GSU+H\9<GR!2-#F(/_CV<RM5N7!U.Y(4J]4JQ[H)J[\932)Q'[K+'
MD$Z6%%+4EKA$2[^2P*S.-$GA2U?N\9#N;[>&L]D(/%:K?1"KG56^92JKK41E
M=B8]EJ41R7 %(A$#WA#);";.B4"\BH[AW[QAJ1 5+JI1/U.CGE52H[KB![3;
ML=T<;1V8F$D.01&I2X 1.!"'5(IA=,@=9TLKVE:C?:9&.Z/,0#7:AS/:L:P
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M^!@,<D8IEL!T49DK/^!E]>0J(%E LH#D(^_NWK6G6VKG/ Q!IS9V@TA,6W#
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M22"$5!JQMLG6C2!EVV'%%# DZ;UQ+N; S.B"#>"I$B:4CBPE[ L!6#T%G"(
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MSQF*F'FDF.6PA"EXSG+JDQ#39_4O'H16SI>[>_.E@.5K TN#J0$=HX$",HJ
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M1#DWG'&?O&!KF[Q$;1?]+;[VT^KJU$E42)Q%#+:6&)<IJTW(YDS&&")A@8E
MF05=+;;V%>LJ5HH%3HAU*G%+E14N, Q,BPOMB/#E).JY',P9?8,H52Z$@+#D
M%'%I1=X9<P@GS9(S0)%SE$=)82SZ6KCQ2FCPU$F4D4$[QR5R1DK$%8O(2F51
MP(2!$NM$70(-+NRX:'!AQT^MK5,G4; :V&)@Q; XH*TA6F2M9$AS%3%GDJ<
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MDW&(2^>1C;#JEE,O)192$;VV.:,_U.I0EK+<"_.5BZSFG+O$G. (P-8@[D5
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MQ8SR(B3D#.6(@T0@8XE#6 )]!J,@K.9KFYH6$'BE(+ $=ZF P L#@4DF(%P
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M9ZAV A:<@GMDUCF=KERR8I!0.I@OLX/YZ@UXI:?KY<<=7^^LN!U];+O8&\6
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MI%XQ_'N69$WHW\@)D$Y&&D@D*0F.O74L,.,I^#58,.O#VDLQO+?MUX[MW'?
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MW&$> HH@)A WR2+#0T026RZQ$9(GL;9!EBFS688$EFSF+WUTOCXZL;L.QMR
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M9'?KX$?MT\=OM4]YXMV[J)Z&UG\OOUWDS#,H.^%-1$SF%B=8:*29(L@&CEG
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MLC)E-YU7S>(252:^"87$9&1:1V^U--PRZF3>4B)OI>VXQZ3LI;54'HKOYZG
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MNDX>UOZ.T3*%M CD+[G7POQK4B(9[*44% F/30X9>&2Y<DCA2*0)B2NOYE*
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M8.0$-4@$G5R$034AKFW0>6NGQUEAJ9U6QO*^'<F4-,L]':*1#+BB(;DS'D;
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MWPN0CUK'^S[8<\^-DAI[7@3V3(8$0BO-G1!(JMR[$0>/'!82$0U3*X5TA ;
M'K:QI&1FC3TU]BRAC'2_[88:>UX"]DR%4E$PH+C8(DLB\!Z+*3* 1R@H(H#_
M.)>LSNHM&]/=0]XH]KR6+8Q/K?XWE'HQ-EJY6#6? .WEXP@WUD:^<L'SEQ<0
MYEG\ ).X4\UA#8O+P^*,GDJ."D^LX\APHA!/'"B9<BJ?G*.1*NY3(EG?X&E%
MS)\?_.KV""\ZA*O1XD'08C* 2RHZK"U#7$GXPVJ'=-(2V80=3M9PK=S:.[PQ
M+8%7H\7;1HN5#KIJM'@(M)@*N:1+06IED$G1 &18C0S%!@G-C'%6"QT+;O&T
M/:.?'RU>_4[<5BL+!71"XZ(5VV^MG^TKBKF&R:CA?-:XN#PNSFH(%X)GVF+D
M68R(>QJ0EI0@@$O.%24I1)M9E*HS4746_$V&;S7P/ CP3(9O5OAHA%6(:IP5
MS&E"CE.)&*&*"ILD9J(&GAIXWFXD6 //0P#/=!UCXC80S%'RQB-NJ47&&H."
M2E%*1[77N@:>R1#QSFV-5EN=[J_8@#'WYUD)OM#WBL/"S2R&G$N(&]WS7B-6
MNM=#A=M*[ZML2 ,H<]R"%WIY^J[>.M+4=?'8?F_!E;* 7?Y(\46].3N!A:+L
MH&>SN-UE['7!FL[/X)=?-CYO-/9[T?;/>Q<-U^T,U7O+.^V?N_[ PKS8=OOB
MNH!O>;?_][\T)>H?_>M/.*$Q.#V[8_-:#9S0&UD'K!#)A;?\6LCHM[['2OZK
M@N&QSU6&@*\^8EV_VSX?S/_(+/6SYS /DKM'7AN@L3^/>U=9H*.(',S--U3H
M-_YJVS_L17_M[]?7!2R*ZNJ&%V,X^?CE0[[[']?[^WRMN'EC<\>//=Z03FDB
M%4/ZSW.XA&WL=/RM^I;Y1"2;J?$TCAX<;SRJ?/B-3]/<V]_^W-C?:[S?:W[>
M^_?.UN;^]E;CPTYSL_E^9_/?C<_[\(O=[>;^YV+]T7_\\KY;Z1O^;99ES93X
MB\8KRPGQN?T6SR+^VAGCDY,I."7$VHN%WRS7>%4AWSCOE^TX2KVH.:#;FHV[
M5Y<IVBQ<H?K,]U2RC[;1;\&WQ)%<U?!C>>Q/X^"X&V DCBZNOC%8&(5*)KT
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M"?=P=.@#$%HL-:)>$#!XF267@D$Z2@B7)8":IJ4;+KI$;&;,\!(<,:9.&&;
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MN-7J^W:W?]Z+^_!EO[7A/<_MN_<WA[[[8N_WKZ=?]W?IP5_PWLMO>.^O?YV
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M*2ZJ.<>VU-U5A0)RSR<SRP#,6&A9$$Z-!3])@W=DK73@$>C ^>5PN1^ *E)
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MNV[PR\(=8W@W'N: *E4.?OCEE]T?&R3(+W58X66+@XE?OIY.YE7;W^IJ!H<
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M7["61"]4<)D(4 4#LK(2(Y"(!^UUH)A$*\0]=7WCDBUS7%UNZN,BU[?SV:'
MY?.==GIR]"$/<G(\3%<7TD/Q<_?*Q6IU:AML-B.;_;@F\U%;D(77!-'; .A"
MA*R:!M**M+6V55*[^W9/%G!;7)B& ]M6EDP,%K@U%IBD/'R*R:=4(45? !$U
MQ*(;9+945 LEU#ZV<,_$8<+\<%A@&1F/M7PP(+\AY*=^#=9Q41R!3&+ %+5L
M_)BA5BHA2U# C+O[3D\'PPW/U7N(];O,98P=_\;A/\EBU%9+54&#8MGL43D#
MV2H%Y*MI.N?@M>YQ/ZGAOKH@F/XU'1SO"#S/Y/G?.6D[_^^CO^W\[>3L]4&Y
MUF#;^TU8LR<J^BITEGI^_$+6X7G[RYLSN;Z/66O8QEV5L-ZM<W80,1D\%DB:
M#* K"F0=$]1F;3*Z!MF49K.-&VVA"Y8:LV<</@WG =L-83O)+(@NE"5P#2Q9
M!+02<4B\&,'5TE+RB%RZ+9R=#G@93=R+1>M=SI(=>^^-@WB2*X@V8:ZF@K68
M !L2I)@$SH:-:[ZBT3CVWFU%\R9[[^S:?^R]L\%VHO&S(5]4;F!"I.ZA$B!B
M*-"4T=X[ZZNF!>V]#Z (X6+^\8?&B^&C<&N*_<.M7^OQ,H*%J[+.3VN$>LP4
M'.H"NE4%Z(DA64U@JP\)2TTYSB?41Q_G@D$\MTX?(+XI$$]DNRHQ1ZX,RMI>
M$$!.0@=KP;NL)="3@+^;/0\0WWL0SZ[?)R >8-T0K!-Y[FN.004'H17=X_R>
M8[.R()6U\:%D]FIW']6P/KG'0)U=F0^@7A>HT]8!-J+)18$7D3$"5)V 2&NH
MV9+/I1HJ:6E ?0BGZL_/7_'ISL&J^F1OYYC/QUGZ[17]]WO_[.3XY+=%0"/&
MGY6-U!JA;H(F$S!#0V< %8I0E]T#K!'=EJTJF.K(ZC\$3,]>PC\P?3N87N-=
M0&Q=5E"J$MV>HP>2*!!L$[1G(Q&'"@/3#P#3-UB/_P?@'B#>$,03/6\K9^4H
M KGD 9W7D*KO^W0N&JLO2N7=?4\#O_<7OS/(^8'?V\'O1.:7EK0*;,!%2H"E
M6LC%6@BV%DW!U^QI8?A] &?O*P. S!)[\GNIOW.>?I2_T,<;\/^\.3A_)U_O
MZG^'T^FQO*NS"[\ /IN40XQ.H;LZQO_0(/3-Z<G15_*W#H[?R/U[_K.7PU]6
M"WSQ<R_[\CX].#XYE;7]D,Y\=%Q_^RJ/5TO_E,]?G<AWWLJ/=#?8T8$T)TOJ
M->D'E72KS31Y2F,&M%5#;*J!#Z;VZN!0LAO. X-=;K.^8+#+EK++-!'28M.)
M>]^!EA@L8P *Q@$UGTMIE%/L)HY[SEP[#!OLLC7LL@Q'@UOEF4$E&U+)U"E!
MNVQ:(' J-<":&V1L!0*I9".Q5KT6*M(T3!E."?>00^ZV)F-$*%M**Y,LD8KH
M4Z^N9.ZM5,I82$TAF!RH&$7(;+O^<==/%-TS!X:[RR(]OH$TT8-(9]]P)FA$
M/[/0E%F3IK&J,)I<P,8>_7A9H:Q1@\KDB;,RV:H^5V]!R>QQ&+5 RX5+::&!
MX[EP/$F(E.(**YL@".4"%LV0JF4HK?5P5">+;G=_3:YU^# L%L)WV\>QL8@8
MI5[7 /0D+:%:(HY4 -G)QFP<0LZZ00E!>)H]A][=/4J]MA/:MVS*,';G6P7S
M)!D09=F<\0T:60^(K"#'G"#9H)*V5',5,$]GS]]GHX8[Q=\+_KX_W#]K_-ER
M+7],1HN[%__KAM[\LAEX.=F-2^5Y'_]X?IKDOA\<I]-W3\[YZ.S9R7&_RM.3
MP\-5E=]%_G?D=6>D<KMNEFBHI7(K4#-2I_(B<9GOLT2--<8U512MZEKPQIUU
MEW1D- AS$.:B2G<&8=X-84XR4U6DBV$5@+D[^W+3D&+LYV(A^,:ED.)5J8ZZ
M]KC509B#,)?SKK>V&NGRU#G8<4-VG#:#)6PQ& T9;0;T1<))8PA*2MQ7/+GL
M;[KZ:-#BH,5%QI%+*+ :<>3=,.4DAVI=*:5:!%.ZNTY6O:'$,>A0T-E8BR=S
M45 US:,N,8Y\",X[S_A\Y[.+;KS/=WH5U4XZ/S\]R&_.4S[DG?.3G>/?@&GG
MX#V:KC:T=WO/@VXW&_E1J/CJS=%5F/'1KY;RY<D($><@/ER3<21=:VC>0]#5
M2X@8JQ!?BX"Z&N5=4K9WTKEQ!KQEF+^3H3@#ZTO"^B19IH-K5+$!N>XM(.(?
M8LVQ&_N[7$N(30O6IP:"HXIKL3"_BRJN&T7YJ/F:"?W39) \]Z4)^E7J^WMR
M%E))$3A$+>P?4\$V:KX> !',7_(U]OTE(7]J'1Q=$/3*1F^]!53)0E1& R6'
MK%1E2FL+Q.Z]I="BJL0N.L$^GR0Q_O9&_E2Z8GKIXAU^:64=ZLF;_HJK%--(
M=%_WUMR;W6"V^K-9-H%OTZE@8J2[9]P1W)JLCS>B\74)LJ0Y  9=94=  YIT
M:=7VSCQ]46=V[<S/C*#;CM/#0;F#<K<IWS8H]R8H=VHJY1J[YC,H-@VPJ "Y
M50+"V)(CK4GA1:7:H-Q!N8-R%U\#-ROY#G[=D%\GZ<U:621+-.";%G[5WD$L
M*4-K1(5#+=CJO+5N@U@'L=Y/8KV+*KH1RRZ6:R<)9=^J"MW71_94!YBY &F7
MH:*0;?:^Z'(S]F-W0KFK9/2?5D_8_H>W\^S-D4"K7'Q>+A[4U1,J7ZD';_?_
M2_[Y\*;>0\O1%T[0]_KD[*#_X)>G?"B_\9;__,-!/7_U 7F_^KWW;U;]\BLI
MRUM[<_[I7_G5&RO<3U!NGT!,OR:!^<\KO+H=O_[WU>F'RWF=OF?(IYS^ ZG)
MU7Z9#G]([\YV__2;-W5T</SAU2.N[N'';__B3>[_5SZ5W_S-W[W$O;GBK]W<
M+0UK;^G%,<".4-\7G[S6HW3ZO=RLC@/[VVWWXM(OOG)P7.4S6;E^+^_HW3Q[
M_O+QBYV7SW>^>O[LQ?._/_GZT<O'7^]\\^39HV=?/7GT]YT7+^4+3Q\_>_GB
M_8'T9^]W ZZ?KWNRIC?A/7KTNOMPL</]&K876X&H<&TY)$LI8Y7PD9(SEFHB
M4YN)[6+O6UW%H[Z[8&E!ONQ0U8:AN939U:!\9%N[4?2G_HXCI;6IWJI*Z))-
MV5B/7B0)RM=4^/CON*@;VJ8R<L2D.47C52Q1Z9JS5DG^SL5QT<_,L>)#6<S#
M]/J,O_SPP9_KP=GKP_3NRX/CU9*L?NG/O[UA'5\?>R;V^W?Q[5^@]X6Z@-_[
M4[KW?_G]M[]8?>LC<K_X'L8O@M*?_+;ZXM/?^[V7U?(T1[K2R_[^]_RXV.VZ
M6*_,I5[V#\Z8_[".9/JC:^3.>]Z]E>">_HAYWP^S.7MSFHX+?[((_DKWX+<!
MVA]:Q"[['GVUNJ)_\N'AN$F?O$F/#P\D,KN097]:Q5!?G9R^/A&A-AZMWWFT
MY&[UJY>[5']SFRY)1W>:4OGX+:[/'JQ7>+_4W^F/5_92IM++7M;/#HYWY%4/
M.Q@^WV1=%^QK?;EW;I31E\#[U>LUQVLLYS7N_:B_QS\*L1RGPYU3?LNBOS[=
M*CC'!(SQ&LMYC9EX^N+,PWQAW)(?\V]/^>C@S='9EX.Y'\AKS,3<J\?;N"_"
MHA_O)\?UX.U!?2,\_I2K7-(I[SRJ;]/Q>?I^(DXVN0/W]$CS?AY-ANBS#<9X
M'?NX'$/>LXW9L=<I6E*KHTG]X6A2_['!QP?6?)Q.C[D^XX=QT/C#4_._[5/S
M'7YW]/B'IS]])]?Q[%6_GJ=?/Y77JH?_^OJ1_-W_V*>3@\9'/_WK9?GI7_]^
M=?#=RT<_/?OW?Q\\-8_QNY_^(:_SGQ^>F?_O/T_E/3Y_6=[]GY]^+I@[?_KR
M'S\\^_<_]/]MVM0:O -R 0'9.$@>&1IC2KE04SKN[CO:\VXN5XXM*M$8O+2D
M][9)*1IRP9J];]6C/,8Y-XO8@LO>5:MI;EZZ?VVTMT9)SSZF)-U,L[%XR Y7
M7NL$5+T&;H&C1HJJI=F:: <G#4ZZSGM[_QB.IVX\=<O<"9WA$)TQ139"X4XB
M:A*99XS%L#=H1X2^K.WP^<?;8<GH9&$JA%H=H(H$B2T"J9J:R2H8N\0(?<Y<
MWR63(7<*R;_*FWE]B53(+V=T#]TCP\180S06D]/('*,$>%JAKVQJL]P&,RV)
MF;Z;Y@Y"H^@;HCQ)E(692 %%-."-/+S)AI(Y[.[[O>B&M]T]QG%VNHFF]MW<
M#'7FG'TK76W[A+YQ&EI[,1">:.V*AC49!2Z8)!!N"%%I%NGM+-?F2G5Q&%9M
M*XBO)D[',BV7:RE:C2T'GXM!M)9<3)8-5V="SLPC9EH6X4[4'#GCR$J01,J*
MFO.:A'"S 8NBRS,IDV->7LSTH$ZV?]9P9^=)WE$Z/#GFG6^__O9*2NZRZ;.M
M9B7A'N*:D_>^H#<U%:M*RHA*FVC]4'*+8J4R57)&Z=*:"J!71R[>])F(6D'B
M8 -AQA;+[K[9LV'J7+SUJ>^!XP\X]@IK,-YH1X2EV1AJ$V%GLK%]D!$.);<8
M"$^4G$*NUJ$&)%: P63(-5FHI3%7(VQL\!Z?FMYS$-^78\9[ODR;*#E+E&HA
MKVI%=#G9RC'DT%JW$B8S8J9E$>Y$R6E#5>7$P+F;S;FD0!:N 9/2&&55D\G+
MBYGF/)9#6G@)_LN3\U^5)U_G).[2773WCZA2;1+^R9--M2%IEW0DPS$%US!P
MJH.HED14WT_%G4\I%*\8@G)]?G-L$#TJD.W&V^!\).=W]WW8BW3MB?>;PF6+
M$LL/F (P&E0Q*M(Z86LYVV:2Z@,;+3/CJ*9=#OHGNC 6TW1N%IB5E3"E.*"J
M-5@,.=6LBT$W]PG?@/_RX7^ML\&QP,M?X WX/3K-T0H5=#:0Z(X"Z<I<H[ [
MI:A'B+<LDI]HT=1M[9U"R$;X'8LEB&@(K(_587'5V;!M(=Z#.G/\YLWAX3LX
MZ+Y1'WG6;)@T>\ LAB%%5THW"XSH45/ U-BDJDT@:_)@L26QV'^F0E6UB-7E
M#!*?HH2JJ"$E[4&Y1MI[5D:IW7VWI]348'SF ?&W'<?,F#9_P R@6E$AE1)"
M0R3*V6EYG%:EC$7I.'M.?>C4*X-_>GZI0ZF&$93W!I!R@&BH@FFF^JBU*F'V
MKL\!_^7#_UHGGV.!E[_ FYR9^D05JPG1%"2,D9+)[+F%Y%K(H_IU820_[67T
M3;,\V;VK7P-F;X7D-4%1N5IME;UP&]FF".\.^ASO3J:^>"U(2(?G[T97XZ=5
M: DJ.S1!(4:ODF*EL[5)1*@Q>G#4HCCJ\0]K)K<ZJY+GK*"6KD-;\A"YRJ?8
M>R]BM$VW/D8PV&M7=HQ>F^4B.3!F';FER"A0=I25I>0B&UV"*Z,:=DD@GLP"
M]3$ITJU "EU/<BC]W).A%4I8DR[6A]'9N*TP'IV-6[%,&[!M4:V4YHHG)M2I
MQ- [B)I5T7L?51EQT](H=S*R+M267;6NC[BW@)8BQ)A[;[DB)>OE2E++BYL>
MU#GC12VL2.!T7'=.SE_QZ>AJ_!0C2;#/PD0Y5A_0Q9I-JB&&9DU3SKE1H;\L
M1OIQC9+S(MZT3@S%Y A(H4*.NH&/VE/2F&O0/=^D55Q0C?[HM9F[A!T]!0Z>
M9-EES3/U=L:"3?GH9%N*0\DM",03)1=-\URK 5T-"HB-EK B:D!E9"'9<7.C
MLW%K83PZ&[=BF3895VZ-;J+C4A:V-61RPEQ4,#YUXU$]9@(LCG*GP\=3<Z%5
M J^"ZKV-&E+4O:,\*I]L"::HY<5-#["W\?5[:(S>QBLFG8K*QB;M&J&(.N$I
MI9JIW&QK!6=/\0^JNA95O5LC\2K*/F-#A":K V@<04X*H=G KA07M.'=_1#W
MR%R[IF!TO]Q'$G 9?;/=ZD@EM+I0M,J$$H*JVOGY9Q@-=7@-_$_48=%$JC%*
MJ()]@)&74 6Q >76LM X1TVCO_'A$<#H;[SG"[S)-"C'6OZG5 @5?>+4%$8A
M!A?89DQC!L;B:'ZB2(O)0;$V$$GU)""*&#5LP=IB=:I*>YNW+<R;\^1Q\>-P
M7_#IVX,BK_=^ZO/5QN)N4M5[UR.0QT7>W44^J*KLOYT<<;\I;SK972L5=+_#
M@(I,S3LM6TC&4I%R2=$VZS46[?+F!_K_?4%EWYR>''TE?ZA?PC\/SE]]]>9,
M[@>?/CDNAV_Z_7QT=L;RW_HR_3BDX#PQ@EJ3"F**:G4RZ$T-@"TFR"57H(1!
MX@=;J>91\OD @-X"A:),:[%ZK(K)<Z;,L<72QTOYVP?Z4 371?NT+("U=J80
M1!MZ,8!O$-$Z:*B+L+NO7F&O-M3>#ZQO&=9'>?=6+-,F;7'-HR7CBV6#QF2*
M2;N@274^=FIS"\%!R7=.R9,D3;(^8<LL')PD .,L 9A.M!INHZNRQA2_/$I^
M4 7@WYZ>O#VHH^S[=XI%2[>,H8(Q,UH;8F])\25HW7)M= ?!XU")5R4IO:XF
MG*O1V2G0(1? H!ARH@">9<EM\"G,;S0SZA07"/2:K2VR4[%S&;&99)LFYWV+
M*I62-Y]:=26@#T!O".B)$"3;C42RA:0T 5J?@30K4#Z@*3:V4NWN/FH[P+QE
M8!ZUX5NQ3)O46EDMD-2$SBETND5#T9I4;:0:E;ZEX&IP[H:<.U5ZR"TQ1J@2
M*P-VD2=!%(-R#DMK,2;"I7'N@SH3?/3B^35[?!]$6BI(Y%<THW8EH\N1F'0I
M,0DYV6;-YFY-@X]NG(_,&E&'7G84PP3:2/@GLKT!<<H0G$]1^>*+*KO[Y*[-
M1R/'O%PP*UMJPEI0'@0T2<6J6RTQV_[FT=V2H!N9FYE /A%ZKJ48*VO(!@.@
M0I%\I3($'9TERT8>\7&^OZU 'V=^6[%,FXR%M[5J5%FIZ% 4@0B&E&PB40[6
M-[.Y[<((KFZ#=Z=B3S7G?+=F;[H &HN0L 1HH7JE:XRDP]*"JX=UJ/<J2<Q1
MKN;*^R#R3CG)$XQ!!<<2-F23->F:Y<'&F#6'<:BW111EU^@_XN T9@]ZY?;I
MM8.D"T%QQA*1KUC*.-1[ $ G)RA7E*PGCT:'1":'J"@&%4TMFS?SCICC-@ ]
MT7H80G,M.M E4A\'@T!&*<!2(U+II9]J=]^;)268!YC'H=Z]6:9-=%XMMCF2
MK18177111=0^6F*E&^;-VVL'Y]X&YTYT7M1-$:*0K(AUX=S6(%>KH*=2(P7.
MKL:E<>X#]'PZ^ZB3=G@_+</[:;#6C;,6KI%^C3U;V7T@4["=M1"RK@E(J6*=
MR39SGC,[-;Q![A4-S.[^-!I3[IPC)FJRQBH+IQB\ZVHR4@$*S@)7%2(&$TB[
MW7VS9ZX_=VZPQ-:PQ+"(NN<+?)<646,;N/-M8")PL<O.:'MLV%5N10D:K4_0
MLHW8;$@<T^Z^W1,UL"W;P$SGG$O7O')U?'HL'[S7O%=SN=G$3NA^TMQ-B=ZS
MP5TS<I=;5^%J@T$C"E?%(MSEFP>R1$"-4=E2**M>A*'V?+@V>6V*DRW*Q#]@
M[-^4TAW8GQG[4_F*$15+M!)+$/FJHH;HJ0)JBSF;&+@78,TB7P?TMP;ZUSI(
M'0N\_ 7>:,*9":W5&FOK)6V-)+YCD:_)D74A7KF^;7#[S-P^/71%*RM4+!@J
M01A=.4C5HWSDA?-5RH:\Q'5FCT+8%G*?Z5!VN:+TB4#O](R_/^+C\S^6I)=X
MYS=GPWO9]."XR$5?Y(/T"A_U[)_TKF&*+0?,GIS(?]$'6,DT;9(B[Z[>ZG@V
MMO2-MO0GZZ8.Z^)]#CD!L8N MD6@6A *^42MH,E1=W.$!951C9K(N7N1O<-4
MK&G9-J3LB'6D[+U.JF97KNPU/@+RF=$[2;;8YJJ),8+'8 "33Q!;S[;&H'1J
M*@F6>[*%# T ;QF /]ND94RYH%5K1AM$55MB%O8VU"@I5>UEMM@S></RT8#R
M[4"Y? SEW++2N1_P^EP!O4(@6PA\B]%E-%0IK:#LIV-L/Q\H7BJ*[[R#9,ZB
M\\6+L6]/3^J;<C[FRGS:1$JCX>@M>V:LL5 Q+"+,DNP54=-UQ-CH&)YC;U@W
M-]@89U-&#U'E\+XDU-H*R9=HHPHJ63/,9!X >MEI6S)KEA /"]54NN%WU4PA
M>K1Y*+6%0'BBU(S-B-%:R"*V 5M1D @+9$NZA-BJ2P+AN*<,#@!O&8 W46JI
M:AN#,ZFT@*1JMK4Z$TQ@Y;F%R\P6&4KM5J$\46I)$0<;"%PPK9OR5XC%>=#-
MIZ)$<:.RGX+RY97:0/%6*+7EV4 M5YUM=A(]BFA^MSC:!Z^=SMK5*I&@2JII
M=M1BM487O$X1S=@A-MDA?EHWW%-7LB8DD*!.])J)"5(V"JJU3"3;A\XTXZ':
MJ(^[5]!63D"<4Z0@(:*O):&WRD>F[)P/1@^1MQ#<3T0>DZW91 8?^IA/9S+$
M5!A,(XY5EG-5^ZSU'KE1_/QPL+^)/K0NE52R]LXHK*7&5(O7I@D#:-V,&_IP
M:2PPT8>5HP[!>%#)6D"T&7*@!DVI5+O#8]7Q@@7BU.=CXZ.\00#+)X!E=S\\
M@ KHMWQVOE*=!\?EY(AW/CL\.3N;0&W8#USR"%%EE.?9(#>,*J2 N155N/ED
MH]X\/OUE?9ZLEF>5)Y"O/#JN7Q_T";#'=>Q+F^U+:JWO< FFGR(ZG3(@8X*>
M+8!B8HV>O;,D^Y+1<QU +&9G&JXCL[1M!6NI.BHJ-@&\RRH:+MAJ(9,\;NXZ
M,F!_$["?B%)-J31J(DHS2CB:4X-<0@-7);J0;UIKTN[^ /W# ?TF>M1QR;E4
M$U GK,[%:HR(&?8QH$MXF:%SG]"C _XW ?^)&O4EN5I$B-I 1G;]V" JRZ!:
M=YP7G:H][^[;:2YZXZ/* ?WE0_\N7<8&X&\"\),F[="X]LGPX)HCP&(#4'(*
M,E-0WLKB$>WN:[IVA_:6V89M1P7SA878.!Q?5H9BY,YO@+STFAR%HAIR:$;"
M$R_D54T""MZ#]9PL$T>1G2OGL&C5.$$;V+^%-,7 _LU@?Y*HB$A82S\S9X$]
M6G80JT_@3'$I.A.4;A*XX)YR<W6S#NPO'_O+R%8,%K@9%ICD*V2+;YA,!*M#
M-Z1 AFPH #.JA%ZWIBYJ:.*URJL' 6P- 2S &7W ?F;83ZWE8K0EEBCA?C6
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M9D@M),"0:B1'R36[NZ]GG;DRR&&!Y' 7N:D16VP#9TQS52XYD[$!&8O]P#-
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M$>:SSX@9F_V-<\ D?6$:-2__Z;:*+!S@(\20/&#&J@IE807JPR$,7KO6>K#
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M?^P0QO?*ENU0? [3KZ*P.]-B)4,XVKCH5BXX93ATLS#:)##Q6P#H4Q =<5^
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M$,8 HDA!5+)D5W@(#*;.&.:C:*!/K8N0'9S+C-JY*X:,VGFC=G); BFFO43
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MFII$>#ME%;!QU  EE *I. .6,$(-QU PDU9P*)?ID,%<PQI7)I':P>4F_+@
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M:$.5T/DCI+:UL)@)2F SA'FG0.KG@'I+%@SHFOD;.F=2.?S\%T(0&VN]<;V
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M:DZD<CI2Z++/#>0\ZM/X>30CZ.@V)NS>0[NJ_:)(3 I=-OM_+G01=1*1;R2
MXVY_,'F 6:C=K8153CT)+.=G&=]/BD@CA3]IWW8[#W?=_@AV0X,I;H>,P9=>
M?P 2Z1MW*6UMNXZ)_LW=E,?51M>1F$EASCAR8LZDCP%RG#N)V),M_]VWTK9-
MV,NPW,P</(="QVW%#@WHGZHP&:Y2S<FX@8ZH.9'!C.UY52)%. ],WWY4CE+E
MR?B=#E*>O"SNKWI3 T4\I?/8"KX'&_G/5Z(2]E*-RCK!CJ=1.^UZU:\# *;^
MJF>[WY[=&"IE*M6EK%ONB+H$K2&\.:\:5 XF#XD-W*T@>W'VU42@SZ1&%3A+
M=2GK(JRN2R(X.'!)HE3;)J74Z]]>H7XZ_>Y_HIN-Y2Q<_$9\=AQ7M)U_!=\P
M6P1MHKJ!$OQNO/OP;L2\.7R7CMP.V3WUYJN+LXNK>[:>,>^$T)G/LSQ_/@F\
MD)T0AZ[9YQ/U^HYE\]3/<?WO,\^V/FV89[DF=N/SB1EZO*TGQ ^!F16$^.G&
M<\/-YQ-1W (X3T@@B@=>"__R/YGNFEI.'WY#0B>G19U-6_7&G#^;:?B^"ZH2
MB"S[]\RTYF!=\Y<^^3/74_8]N+;=^=>T !;4]K<2.(SH,THEB+G(!2-2D]TR
MV^P[. D;CIED[>X[4R_T R/ 7 E!]X^0VE,7[P!BT (TO>>YZS&S'!S#7J&8
MCLFBBM#$;S,!$OS 9E:@*$KQS=IU8.+PGN12C+-(//5<[\'9;*]60U>C/\S_
M"\7#"5&45SM<\SGBD0U"'"7#A2@HDL(QLU":S\%*+E4 (*!.-?%93L"6S)-+
M;P+]A*+6',>)PSQ_96VVT<IQFPW3Y',CM4>>M094^-NJ#)\O]+&C&&4U=:_9
M$/I<(KYGX?7"\C/>OK_,G8D[;,ZGX(NSMQ>2R;P*"0WF\^F8I]B]!U-FR4R$
M9Q)N4)WC%PDPOA*O+!0J0@4*1^^O^":N)._M@ 4\8]]V[!?V*J=D!>7\$V?,
MO4PP,'M%WT23%BX!2V$-C5S;FC^)_RHLR@<3UF-AWL8E1JF]\4>T*;*9Y'<O
MY>\^\<"5 9]SP;=<C$AB19/ L[)\ID&$ ;;.4F&-23+D1Z8:5./0@Q'"3;,B
MJ:C4/$+GS.#3"DIZ\W#&^K6[:5R^N<JWRI.;8F\E2T$5$AHL!??TN[4.UWW'
MQ$"N,-J.WL"@]ZA]#5O#X<RVEKP-AA_U"Z;\X6(*&R1[]\6<PEGEN$R>46H;
MP5MA0,Q7S QM:&(<  >[][D-ZZ!IB.Q 8L.BMA6J24V/J;;H$MXOH</P[F,/
M3.<OC'KEXZ8J%0V&SG5HV9B+ #<//!W>RH5-VGKCP>Z+^T[*>ZQ<78>NNN[7
M(>PI38\N@HH6A4)5/119:M.B/8LKN@A![W[':X1^R;17G^"+V\S&NZNK,O?4
MY:7,O:5:7P/M;KOKF>5P'K![7:+5BU.-/X#=F^_C6_*N-V:!)6RZ;8(G PPY
MF_+-[##TQ!M_QC?JF5!BZ='BS=.S\7MYM;E\\S'?^C'"9>@'L _^*+6?E"EH
MH#IHF_1A ^B%^'4;IFZ'8NZ 63!UVW1C!?@R*&]"8M9$UE"A>AQ$\]C.E!JV
MT2VC=K#B3A_7#^)[ 87=+2JNJ;.2;_' 2!$C K?"W#DH6>QEM310Y:G']ZU/
M_,(<F)_XD:'/F6M<'Y8GG)V&BQ$5V]SB9:\R(4VA3KQW%V>P>86?T?MI[D7V
M;TW5<@VH24P#Q1BS)7K 7>_IGF(V!K_#*Q9;\@7%->A*&P;>C#I?!T8Y6-ER
M&C2^@R><>,\>C$=KQJGC+4C\-WY.!=^79GA0Y*XWU'G"7!>NP\<AU[/B2?@H
MM)_'D>]SZ@JV1^&@\K>C2ARF%9^U52!1WS$\YSO<9YJSC+/WY>;3A<QR5R>@
MP9@HR^!4WD^5FAIT,#X$-\Q'*BR]TEX5%M>@*^VU/P'*EFDQ?^AA_ J.)(GA
M)*FD0;>,JS?G^2-&^*XN99$@RO4UZ&Q.!KQ[^B1WB\OK:="Y 0O:F'/=20X
M^>)7=EY84$'/8\,Q@[UDR+K?K> ^M -K8TNFDY(*&N#U&[-]W#CZKF,X)HO^
M#R;)-TFW%"IJT+W",7-><ZR=:]2YZ] '@]/W4[XP,#YAGF=>[-I( DM8,%R
M#OIX=BC\7GV,)@&#M-CM?"SZFMIY-QCBY7"#U#&%"P6-=8'P=L64V+O5B&BZ
M2S<N/YR51E)*/8ZJ]348-O?6/\.5"RW["GLR8PVLY]2_NVM+K$))+0TZ%OG]
MA@O#<4)J"V7L8^ B:E#?,6'OX3WU6+';J0*% S3Y60=U)XIA?DS\0+O3$8;-
M&7/X"EJ1.'_+=_5UZ&G@1:[C!3?F 2!_5,=Z3%(#B8@)^0FFZG@;%#O+$Y_J
MF%GK6>CYK-SG7H>4QH,F?LR#&]^_N#,?_FY'/(N'1EDM/>WW[F+!,.,9VSYC
M,Z8!VPTG2\U[S(/93F("'$)24X-@X&)7-@Q6<2-*)%R^/)94T&%E], >X1#=
M60NV7= B-VQYS]3J:M#).':<!X;Y_&ZD!0;\<KB01QKS -6Y1;VR$+3C,7CA
M<'5<KD!+Q3J>A,6-&2Y>S,2PT=(%4%I7TU&]<QLHN?PF#T"25]0C_$A,P(C!
M-5NX'DL]5;;%K._ 7K5+/0?CQD"9Q1:M7/,/IJOOPI^."S4>J<6;V7.]";59
M\DL\]$>NSP/7R\='38HO/"OP)0RF*]>V,=(Y,N\!:G[X'A_"XW6P]!&?\*@G
M'Z=N/IU;UT8O6?'D^N=PUU41C<E0S=#(*:C!VMMCZ!2S$V=0>2<*BVO0%>/R
M//\BUO;P4NH,4B:@07>C2SG% S,IH.FJWJ./+K^I*E9I.[Y;B1=F6.JEVVWD
MXP@:[/5@%:<VCYDL[/H1*&LJLX)8C:V%R^,EAHM4@$;4:Q,6LK[OA]C$JI$@
M5:F_;"Q(UK]1VS%R1#?(<RK%-H;!,?<>TRF?\.3U-)CG)AN&S0HDN]U,,0V:
M;EP6G>ZG @)EUXLKT="@T_%DT:%//C35FJ,)W5UO;/>)>9P/.EQA3-C\R:5.
MU)Z1Q_!&OG W36!.@8I^?%=0NK,_+K,7#Z7_973O>DOJM#'\[)HZ7\MUI+"X
M!NH0SS$[ER E86CE=33H5.Q6F."+M(8-$S5HE#_W+'Z7I^.%R^0H51:MI49#
M@TX;YY?Y$U&/S;P0%BH Z8-D,JM"0H<NOWLG.1^69OI1)J!!=]NN%7N)%0,I
MRVIHT*'D>LD8W5]KU7N+TGIZ> VCA8Y%*Q@WSS//L>$[]R*-0^SJ15],?-\0
MG>+)<TU@".X]\?4KXX$QQ9O,/[$)VKJ +MY\S!_D%<R\2C0T&%JQY;7-,)4^
M5T$G5_0#RC^5E,J/,G])+;K:=)_)>%/VQMY;#M[&,Y;0/!%<L7.CLVM;2RL.
M%ZUYA_28+%[<UA7)H7YCMAUEY)>L.$7%-1@3/)I&G K@=4:_VF5YQ=IZ+#W%
M020UXD[TG=JCD19/2MPW".N56.R>:UP?F]N+#_$L\OZ$!8$H->+M,!8PJMNV
MZQ>O#!6IO'BOMQ$72O-:46D-IK6'R=CRO[9=S[-,UX-=ZMH*U[!M1?V+0N:$
MJI7WL#(9#;INS.? VAR!6;NF<P;DY]0>LQF/(Q&W/\HN%,KKZAEK9H0PI?8=
MW/J(Q$RS\O1GQ>5?.'>9))^4N-B*-6X\:K*_A[0T16!-:AJ$CZ;\*^?[M\[#
M8.5ZT0B4G?Y6HZ+! $Y/.<EJX>_$!4FN056@H$&'V\P+>,Z] )1TP)@I,Z<+
MBFO0E6U2181 HIEY137HPIWE@%Q%8'&/SKG!]H Q6&LKX!?JY\*>HW:;;N#W
MDLFG#BE-[R_A[LWO46_IRL\V\LMJ "W&*U%_-?1P!H@^I+9P^>%,\7V+TFBJ
M ZCJNH^2QMG&>Y[H'7'>X .2JQ60>^% /;!OYS#%^NC]3/L\8T^H&0>(%5L@
MZA0TC57(N7.P<]]@P-W%V/"_&;<W>ZEF9+<79)1T'1["F+!,M4C"HM*:3(K9
M^<E7=8&I5M?#!]:Q_(WK4YM3!26T0TSIR9T3F.D8]G[#373C>/?FW<2UBU>
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MNQUA!_*X$QR=EOKFBX]AS!D[PVFZSNL^QG$;8@VD2<XY7^^+CX%H1>%[E+%
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M<YP2Y(N/T\G5AX]OAI\7Z&=?X=?#+'6S#%+Q]50+#21(0P/1IF2*MEQ*K=W
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M9(RM]J87;[[-9KP>SM)H4E$,ZN9%%BF!3I+,L#(>?)8%N).!"Z9YR<WCBN?
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M&/O4YJ!_5%M7B#NGVJ*+R"U4:75F+"(8)NMF$DI:%25"XLF:Q"SSK/5QSXV
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M5'%+)G4OAJY5VV(>\/+3=:PRT"R%0O\';Z*M%^YP<%[2I 2)/@:7BMR1SGJ
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M.&O(8A-37? :..JB!+GI0;1N,K@Z.38. >XUD_XTQ32LQ6HW'<(HO'UX\=E
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M^_/Z(R%?3T[?Q*Z=%+/.T5QKQZ TG#D-490 "J4"+[.&%+*SDF7CFK<3_ 9
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M;X]LV<0+761=WI&H?X.WAS;:Z&0,1348:8>O(D01&!2NBM %I8W-;T*7 3D
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MD@6W*H(N7(+22,N/\@B66YZ<UFADIQDJ^V;N832HW0=Q-_'\_AO41HG!LL"
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M9GG,('.HDD.<YFY7$%))T>2<5?L<\5X'>$0$/5QB=% :UG*PRVO?8@R<J1C
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M\Y#^@?DV,GDUG5YB?O[US_>WB-]_KMD,$\POYVUU)\,I7C?1<"H6YF(!(V0
ME9RC(+C4D"50,..E3J5URFT;Y#\P+_?@^@ZFP3>T@PE_U;CYC\L1V?)S.'\S
MGMV@0W0^*A3 LJ)8FCN$$+BGO3=A8V0A45K7>S^.Z <F7$-7=7 N\@ZGPTPC
MI6&O>C.N&9\0A:3ARZJ_J'*4X WMU(PP0NN<1 RM3TK7!O<#TZL;!W9PL?-B
M?'&!D_0TSLQL*BIZT'F>(F@3A;HTTSJGG,J&.?IQ8Z*MB^T'YEDG[NO@EF?>
MDF,%M!)U]E8GT+1*TUS+D% 5 SGK)*,)M&JWKE9Y!,X/3*963NJ@>/[%>/)Y
M7&5DOSVSO$XYSL5;Z1(4HR4H$P4$HQU$KKS@4D>TK2NA'P7T W.HG:,>LLCT
MDAN^) T#:S>]FRO[Z;C<O4QOF2N^W;,[R1UO8(9[N>0U?QQET=)HI6R443I+
MNS47E3;UVGEI+OEV,+I*=GFQ:!0ZOKP'Z>UX.C?Z#:H[/4R$\#)(**[>G_AH
MB>RI@+=*TH2:C4]=Y[;N +^[M*$EV7D5R8W=4#$>G,M09;U!!53@DJCM4*,U
MI7@56.MP<VNPAY18U"U#UT\R:NG?+N2I'KWZ?,J(KW$Z_? IC+CX@W[STW1@
MN,C*U>0)PV@3IQ.-RU"<[27C7#(97&Z=.MQV!(=$X:;4V2C)H5._=]&<?J?1
M7(_B;%)+LR@Z8\8;X;0 +AW%^!@8."$L,,FS8K5UIFR]5K4=P8G%G?N]]R2P
MY6,8)&5+C#K2JL4%[20T[4=5_39:S0UWTMO[ 7BW7%V.\\3(1C[L-:?]J3?H
M3M+^-Q8,R;OL"X*LO:>4JK<&M-^CKT)T*1>F;?.&OJT'<4B,/91@M@\^'%QX
M<#_8N3?(@3#2(*\E ['FOJ"DF:*$ %([ACI8$7WKFZ=.!_0]$;\)X3H-C7=A
MR\&]"O<CION#"[%P7QL/AF!K@VDR>Y1&@LU<9BM<E*%UT5.G SJ]"H?"E@,)
MM^\/07OG1-867$ZTS#+%(&@T@-;J[!6W6?2[4UP+]HG6_7J^"ZGP+89P6VLY
MKVB(7*5$=J+H4!90EA8A)YB';)E#B;415K]G=>N@[JO<Z%!B\9[]?.BU2CPS
MSR/MRIFHU=].:_ Y&U!<51N[P$WK"^[OJE:I/2'6+&7:Q#&'7ABRSEA.I4PK
M^-F$(%U6B&SCW4-GK"E!%UM/#.?IWL%P\,YHP(RYV$3#M:TS_0^?J5N6,AT,
M43=Q:N^E3#:C,DP*R$[0WLW1:N*R<6"TB-)K5-FVWO@<<RG31K[>J)1I$T<=
M;BE30+*/M![87+'0<P912 4Z6*Y0":^:9P^=2IEVY.4>7-]_*9/US&I)FSF;
MYNGDF,%'%<A*(K$0--/8NGG"49<R[4*XAJ[::RF3L5HA*@<4BD100FH(F=>>
M?())%)IC<TW,'Z64:1=Z=>/ ?98R>:3 P!@%(G*L38]J@RO%P/A4;.'*MA=?
M_4%*F7;A62?NZ[N4B?N,@BO@*=*B+:IJC @%$@9DPND22NO>&L=;RK0+F5HY
MJ?=2IEP2YQP%1!<S*$E+=M N )>:#*"RDZGU5?(QES+M-B&U<M2^2IG>A GA
M'W[!ME5*#SZVDP*DQ\'?JRVR(2@K&"O"*I69\YI)>JEM?:%5]GQI;=&#)S2Y
MO!E]?(<)AU]J0$Y?58??T6%Y?=.K+Z+UI:JCE,*)0$DS\%I0M)2+3-&HG)K?
M0VZ&L'<=@,0*&E5X;7=++ZLS 4*L31?(G=4>7*#M.'WR\'0 .F35SFW_-W%8
M#T(3*UL<2Q6*#<F#M,[7Y#,'$9D%[TV(*JKD NLM+W??3:GW2*@F#FHL!_:6
M]AQ5H.@CGI4/XUDX_Q;:K4E^GX2,_W89SJN6? J2FY#]U:%*B :<LPFDLRZI
MJD8L[X=IRP3#MGKX45*F'U<T/-^J@/\(?PTO+B]>C?+PRS 3GKD"\N\XPDDX
M?SX>Y;-X/OP8YLZ9/C&Z@5/.:=I]@%&:QB$,A984S- KP2BD,3(F?;]X8!FE
M6F(Z6J;MS7$'DA+WYK*ZX:Q<?S\=L*!4LDZ#C/7L+MD 4=%&B4O%JOYR=+[U
M57H3X$=)T?VYMN%Y67W/'A_ [=\\!)U\2JK( C;X&EI&O]A>HPL86&#"/-"V
M638;;@W@*'G5GTLZ.#>[[82_EJ5>3# /9U=!0IWHYY^_R 1,HI3HA:I)U#77
MQ4N(F6Q7:E,2)F4THO4A6SOT?:4"]SC/[<FUAY+U^^MP^GD\#>>_3\:7GZ_%
M4],B^JBI6<EJ967.D#5+B^S5F)2 K+)@)B6'L;D"QN.0]I4%O"^BW%^7&SJL
MBV*WU?"NCL77 =A1JN^3X/:3O]O4I>O390=_[(4XP=I2K+=0?"STULSO7F4D
M^W*K _?&A=87G'LBS!-IM/OERR9NZ)HGBV\PGY7G7VL(^68\HQ^E1;D0_9BF
M]SGTN_E(LK "G/;-]>*L-IS@$DS,-O-@K!*M3_EWP=O_1J"Q^Q\C5Y>^Z^#
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MMU/ZXJ]ZG,>33]_=2?3B%$05F%>2Z-6E]L.G-ZP8'2O-)35/'=Z5QB.,2QQ
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M*2NWR#D,TE;PYKW3JZ7@E@]JTD[P(0(W6@DF+)RLYVS1!GHL5;16I:1C<B!
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M,X3\=O)WF(UK'*+FF0JZI)VW@>Y/2"80L1E9S$$RY>@_GF,M<!T4$'?3=H8
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MRN>"E(%Y?ALAMC5"[M+<B?3+JTQ_\<!V8K)>!V&9$"4R'0-QKE:Z.:VT)J"
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MQ\.0PK*%8&$2)'""B4!:KL[$4N".U!*>C,Q:Y90V*W^V*8S[K'T^\#H(][?
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M&3J@M.=+.ND"D2>RR>!C=B)86[JTOS_M[:=H$'T(OO$,JGW[U<%KT#E%&W0
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ML%&8YJ6.*@B-.I&CQJTOTC!47CG/.=-A1V':[I<,4)V&.>9EMZ@N LDDO8*
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M*@=#*Z^G4HHQ,@HY4O-J\OUHAM\N^M'@?C,Y1OP]&,;Z N)#^+'W]H'D<N=
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M>&HY0N";=; 02.[CA_YW=Q'',_]^_O?SOY___?SOYW\___OY?\+G_77UG/
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MO&9S;?Y1J?7-,H!A62; )E.[8)>0=B' T_XB!-Z?))TER?[+Q9OEG_ZG+21
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M'LU%#.8L2 'IUS06T\[>)D!<SCS+G.3,&%LO^>-%V*:ZP'WI\Q(Y2W&?/82
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MG"]8Y=MI:!-/;7^6(5:\36QGZ&=W4><-VK]_;DE:/DXHZ0R^/@=O$P(?ZX3
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M3DVX% 5GOD$+K8<,Q<"72[$(\QH6*FC"B\<%:L237?0P<G\)/^(,(V@#V#M
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M;*P*E-=89-QM%\D:/\)U_S 3L45SW,2SZGQI#6WMDPNK/%,_'8KQ1CU:0'_
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M2L&W>X3AG31L4U2YPN=O8YL76CX9JB]OQP7!SYD/8\=."Q83,+#*[-@5$,6
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MMUPL"I$<Z@V&?XR:#K<@)#2^DI#AG;__>:Y#E]WE93M.5D66)T;6]_9=W D
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M3@X-R?HJ#O0L_'4[?-L-X]-=@(T,(!0#&;"LB2"0P%>AS3O7GL54Y=\IW#)
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M3!4JA)ITE\T7RBFO0#59&R]X>:YI'7GSK/)QMHCW\ZS/(2()Z[4GLTJB_Z6
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M"NYZ4(=1[<$S\9WVVJJ4U+]FS"C.6R(2ED@299N!/,3>Y@9^MKH\:Q!Q".W
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MWWTQ3W^L>)99&BQ64KMJ3]K)G7-+T:AY I[NYKE>JQ[8Q]T1! I2ES/@_+-
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ML84216"Z*DTH160H;X%K^U)%,U7JFDY2Z*3&SMN>8Y])K <Q6RV'/X^:I,%
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MDM;:,^!-7?;WR9KN&P+/&3*ZUZ?DA845=ZJ3CV&\?Q(!-R2H5X7G9>>2K?Y
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M?,@T1')@W2GI3=P$'>$G!;=*Y]<'')COM'(PTLM:D7+ R12@T/_2^>4_]2R
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MWLU*.S*SNG>CXH8"3YM3,NDF*5=Z/OT%0%*B95D"*()F;T1WEBR1P#F_0_X
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MTS4/6V<T.@6^RQQ&>_C-G[BH%V"IV8KV #HC1=%^2V<ZUG<Q41\;?G=YIS*
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MDZCI#HXPI8$7$VY\?GB4!$N;1@Y3;[_C#<[7.CM:K]&VU*]%B<=1ACE.F;/
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MOA? ,QL-QD/BF*LMT+"FSL-*3T1L>XW/2CN'%=LGA1>N&IG';.<25-496\_
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M) ZIGZ6T>\S>%^S_YH>L5^]U'C&N'4;_]SU?CAWMK_3$+-_UOBUQOT4&:&A
M(['9.>:W\!QPRVN(@,(([,X8+L E[\#FK^VDGU*E?PRWO0,C3N;(=R&;_2'-
M0X=!53CI+T5):EX]J$/M'XO[35,_/84C_]I4E1Q,I%YYK5>V?Y8+616-LTT:
MF854)%B.]7&<!JJ>C =3/_(@2_V$88JH%QO5DW$LY]*6LVUQO!LI9:TB]-92
M5%[_R?P\H4N3'A]H%V0HUTZ\[5!U 0:*MF'V0U5!J^NS@XE;=8'6]Z)U_UT
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MY-BEXU[]S[QYB^O;:U4KAW'VYO&76AU6^Y 7<G(KB>92G;_7-EV%F1=S^7#
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M[#2JFA$"^@*T4J!Z[WK1TFDS:NB=CC5/0[NQ@T^1O>?K EI7+O))LHSK2[N
M[9W3[>2A]M[Y]XTR_R3;5Y5TJO-5K&G+EB0T2$D*8^HCB A+(!4Q@9F?9%G&
M4IRFQ-0A[QIH:G1:R:IMD;K $&V+:^X:=J)[W--VA=G U%;#=;6#Z], <)D[
MSZY@&\E?[@N?E9=L@DF'8]QY^VB^L(D2;??7Z/J>>8J"KG=%!=Z6&SBO\F]6
MF_*7I32C%^K0N6K,WO3H_2HD<S^0I1]\DU<^E&=,?M,VNK29NFSN)5@5>"$P
MBI2Q&V<!Q!ZF,,YH%N'$#S$.>QSU'U1HHS=K_ H 2NHJGKJ6LE>?_*".L&H]
M+),=!YUX,YOXX^=Q0I5B=NJ"G;Y :;)MK#X#2F>@O@# #T"EMGS:3G%]O</D
MR3$FR%52Y:"RCIML.0;L[Y(P1QFTQ[X;^CGU]@9_O\GG/ 0>2NIM"2_@B6 Q
MAYP',4111*I3,+&OBBAFJO]R8+SO9CKJU&S^/Z!W^VY*E6K?3<M>;[NAQ&)K
MR'@.#+;=AD!V8 )7(A_>"JI058+WV74SAM9BUVT(B$?R(MQ!;;?[9@M9U^Z;
M\;/&VWVS5>_5[IOUS?8LK_(TOJ[(\FRI2N4\RL%RLK@F3Z*HO_W,SS!A*8.>
M1P5$5#4<C$4(21A&(8F0CU*CEJ@F@TV-TW72D!)8E_/>B0RTS.9<<Q3DX^SM
M$KJ!2;L;M1Y4?10^<X9V">-89<_[?0FM6-@4E@[R/?J(T3C75)DVU1K?TW/K
M4MRK;\J->%)5(:LC5F_;(&.6(!1$%/)093H$*( D\#V]5<E$$ ;4,[*B+<:<
M&M_>7OSUV\7W.W#Y_<O5S;>SN\NK[Y8;B@8X&VX;ND5OZ,W!2EJP%7>$!M/F
M +G:XC,8<=R-/',(WFW76=S:8U-NI4JC/0EI+$I"TT<WFQ19X474XQ0BPA/I
MJ@L&J4J1]3POR,+$HR0TWY$[-,K4:*4EJ*[IO5*B6NPJ'4338 ?.!49#;[^U
MX%$F1G5 W-Y,.XR3Q=:;"[S&VG=[\[4RQ,UNV^T8'EU[;@?O'6_#[9CXKW;;
MCE[<LWSVOS;Y^N6;6#^L^.Y(@AYM6:X6.5?!TNH/0M2=RF-?)"C@,8R4ZRMY
M,H&I\G^]( HX\KT4QU9IISUDF!J+5BJ 2H?649JJ?$1+#=#H8=E%_I3Y,C/J
M!IZ%@7EZB FPKX?='T)7Q:][2#!NI>O^$+TK:WW"HSXB+Z'9A;HJOJZ6]Z)X
MNSU-0C^6?J[D41QRZ=G&&20<^U @SJ(L3B,69J/G)1P1>J)Y"7X JO0#.;WR
M4V%9:GO8>3:CXX^?MG^W-(1M\H&:]$KMZ:8A&$[0)-(0CLGZ;Y2&8 B[VS0$
MTT'[+DJ9* K)J^1'N^*;YQ$:4IY"+PHR::2K E&^BIBF6>3S.!,X"RU:^W:/
MUF<9&*&5KQX#+,4:\%KLNO,"6),?)Y3DVX^X*:_W!G L0JZA4BUC7E?"ZVC1
MVX,^NW!PQGM[!QF9L+H4?<\TG5?WHXC6D\Z67)\Y>U@MY/UE94.?T5(W]9US
M/X[]- Z@QU07K( 32$22PCB,.,8$"9)E-IZ]Z<!3<^>_7IY]NOQZ>7=Y<0O.
MOG\&MW=7Y__UMZNOGR]N;O\(+O[[E\N[?]AQAO$4I#[!J0@(9"K"@E)?\K8@
MT@M(4I0%/B*>']K51!]B$L8IE/Z!TV!&YD- .S"]MT36@=DZ</);(ZK#<(@M
M.HY(WWC849<!6S#>+@S6]_>,!Y?K_%':9U?9%Y(7OY+%1FP_[/;AFMQ6'L5^
M1 1,@U3:F)2',/4\!GTJ?(^QC$2I4>G1/H-/;<E0@@(MJ65 UP9PPTCN0# .
M'<*MQ59' W=H@F_ZI+PNC.9P_^@4K%S%:FV&'C=(VP.4=]'9/L_HQUG;Y^H#
MO(H>6V19?WWXU?)&.?"J)Y"\X/M*>NKUCY](F=>GYCD7(F*1!Z-,FKXH8ZFJ
MJHQ@%),0>4G@86&4S^E<LNFRW0QLI=?V1%O^?H4/W$VG&5U^R"0-S*6.YL>:
M3IUCZ8AKW<DU*A$[A_,M2[L?H&]WV*>GA5[CR>)RF:V*1YV?\F557!>K)U&L
M7\ZE+&2Q?KE<2IF(1.^7I7S\[T6NZ.Z\*KS_#T%4X8;\42E2?^#_LZDV!IM6
MT8'(/$QC#V9<.]AI DGB^<IR31DB,47(*L8QGNA36P1JT<&+E-VVE^UHTVVV
M!DQS$@=>))KY4V*#2ER]1-0?=Z(W;<1==ND=&V]G'8!'$WSD[L)C3\C[SL6C
M2]#C1%A5[.(;69)[P<])(938JV*M]@!5^$6=E?A[OGZX>JI:IZO#$J4HYYD7
M(R_+(ICX&$G/0OB0A$1 /V8XQHS&)#'NTM)7B,FM'[6X0'?(^ET*#$0CJ\4!
MJ+Y3TKTRC 7TP!S?5+VI=0!*"5!K 1HU9D"?HU*:@$H5<#'B1%B<4!MA0L8Z
MN3;8Q-@=;CL1T:Y#;WT?/=YAN!.5?W5([M1G]2P.7#]=+HPWJL]-V9PJB)@7
M^2F#89(QB!AB,$T2Z>J@F#(4QRFAJ55IX/WC3&U)D:;"<R[1 ZR6US*UXQ"<
M9EZ$ Y"&-OEW$H)*Q %BZD=@<%4!^, HX];_[5;U7?7?(Y?WXX!+G=-T1WZ<
M;=8/*]4O]NQ'7LX#2E 2A2G$7)F<.@,L2# ,6!!G(64)B[$-!>P?9FH,4$FI
MDY>V<H+?E*268>@#J)HQP>E8#4P$?6"R)H)N%!SQP(%!1J6!;D7?LL"1J^U;
MT9T7@N?K&Z(.R]ZNR9*3@E^O5D6IO[$)%U@5\(9IB*ET/;D/:>QQ2)(HR9#T
M2BE/3)O/=8XT-2JHA 65M#/0R O^@SP^_04HL?]86E'#<:R[V<$I@D-;"@[
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ML?QU6:Z?[\L;HKR:&SV5#^LZ5^)N*9Y)P?\JR'SUV%+873DOF$YGE2S %(M
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M-78"VAH*6&.I(]6Y3( EQ0T$Z]#4ILPV=0K&<-!:KCFNAGIC/+@Y!;4[U_7
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M68?A6<ACDC,82RPA$C*':K,=0LKCF&=YQ+"T"L-M!YP:9V]M!K715Z V6Y]
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M6B<\2C3U6NP?D3,UWJ[5!/E2K\U2PC-6YQB:CD?-YV,T].%R#<]6Q0%B9D[
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M'U3Z ]XTP#VRPVL^VEEJ2)2'/K4L ;[5H%0<7.T#_&X$@-V#988">J3PF/X
M]XJ%Z8):2_2+UW"CQ;MT,;(9X=+I_BX].)+V4&Y:;;N(E,=$FI5IDB@,L: $
MI@QKJ#0)E?DZ)&$<N/?@<!,ZM2_ /Y&]7!KR2T+V>G @ZM,JPG$"3M/^$+ .
M3/D6/H?L#MJI!X<CL#X]./H'>+0>'&Y ]]6#PP^HUAX<CD.-V(/#S[B7/3@\
M[^W8@Z/(<WZOGM5\693U_[@M^T<E2DA*(J@U1Q"K0$.*;%OUB%!$4JP3O_H6
MQT5-C;VKY.^&JF<45VQ!V&T7H1_<!J;GKI#Y=^@XB49?33J."QJW3\=)@_=:
M=9R^H^/>I/BFY&:NC*]9GG?<J:?E:ET$%.KEZK'X,KW[4?WQWNY#SV0LBTP;
MJ(DT+()5"JG@%#(B-8U"+D3HQ2(==)@:O=0FV V"2D^PM0(TS+BP_3CJ*WXO
M;/'=S.PP8XY[F\/.P]!;G8-,@?_N9W<0^]H,[:#!N'NCW2':VRH]8RC_O.3+
MC<S,['\V3^$L"=-(2&+[E>,88J(C0X)FA<Q9*HEBC/'$Z;SFU;A3([9*-6!U
M<\\W;@+5SCUGF#\PGSA9[I5'?,#.3KG#S7%&RQ<^H'PS1_C0G\],,_BXS/-F
MR6BS?"%$HU0E,$!)8!V/ +)0*Q@SI;$T:QC,=*=X^#U14WL-/ZLU6&XCO^=+
M6Y:_3/1M5#M?J;E-W+*_?UK9-7Y1_K4\-_(,KVB9!#=?HA]H!W[%=['T5LL7
MI>-[V.UVAZ+O6/I]06\33'_4X*/1],?O\-_=_OJ-K93Q!\S3\HV9]^6N?#WN
ME]>/3_/E#Z6*B)MWYD_2[K"K15YX"Y>%W.+F?):@D 5$:!@K*LQ7'G-($TJ@
MUABEC&/$ J<F2#WI,S5:,GH^+A<@+Y2KJTV7'=&6BX4218Q!T4A&53:"W!H)
MGLPP.?@IJ^_]V7UKMX]I/;V=/O)D#;TVL@J!ACF@LL<FP=<6@<(D4-@$FD:!
MTBI0FC7N3+GOSX\\8^.>TMJX@_(E,S^)ZJTKIFO]C:W!'VIE>P?6MA=OH&TG
MR*1-=+$1(\4\FGN-8HUWT0YI5BSV#M&<\.+U_ 7\MC!,6PQDR.2QD&W^D:OR
M[Q=&K'GG[1?AF')%HO'RJ1BS"FT$63'(#Z#FAA^LKY+;<IR%I*>5>LZ6FWS^
M R[_6!BEJF$W3^9^]5VMA*WD76I1#VN=(-LRK_C=]AKC_XA75QKM5A<U,(*5
M ]GH/G/I>B?KE0D7Q>66PJS^UE783875W>"5ZQ]@S;Z_O(C/LX<JEIOE^5)D
MQ=M64*$=\%F51?CM8!OQK1KQEWX.8'I\$UK.9OJ0,MJQ38^0-$]T^ARV8ULM
MF^R]6?TH!)6?XXHY<40"+H($(HR,ZZ*3"-)484@Y2E J9!)HY=51ZYBDJ3DE
MM:(5!WD[&:>A=5L"]0+8P([!%JNO)=F5:EZ<^M3[M\PZA45?W;*.RAFW4=8I
M<_=Z9)V\H4.1M>S9%M^5^?WRBQEJ473X6V[67^S>0!%9=+?-?KU\>EHMG]E\
M%DE--;&)*(GMPZ>2$%)&*-1!3'B<$(FQ<TN=+@I,C4SJPFJU*>")9>4.2V%1
MX3:QQ0^/.EY=9N7T>F5HK ?FH:WZ=D%2&@ J"T!A0AFD"'9&@-J*@:'W*)XV
M\!2,V]K<>*;[#[U=/;Q\\ N7ULY2M>-8V66/V(I Z6:&/=N82\OFUSW553L#
M\;:*:EV&':^6VAE&OZBB=LXXW9Q5F]161"]4P7<AE30A:00C2JD-*^60:YU
MDLI8Q312FG@U?7TU_M2^)5OU_/S0UZBY>9]G8#$PUV\U&R#+^8C5/7F7KT<?
MU:<\8MIK3_+89?[^XY5A:LX6?_]\63UXE*=44(I@'&F;"\1CR.*$0Q*D04(X
M1C*6KK[AZ\&G]JY:_=P]BSVH3CMLYP P\ M:JP8^7W8(O=[#PMV#.@>3D;RC
M!C;]^##';&[Q3_9N&<WW.*9LTZ\X>DTWG^%]EC\M<S;_=;7</%W-69YG.A/E
M-MKW+)\1%,8\E HB&MAMKEA 3EAHZ$EACFC$>.BUS75"WM1XJE87%/J"EPJ#
MWZW*GO&%IP!W<S]ZA''PI><9"'H[*(ZX].2PG)(VJ@/C:/IKA\;UM@[I;YC2
M@_D8EV8Q.T=!%%1?,(Z40HC:1O)<FG5*%$$>QQ+*&,DPQ5)&R-GQ<14Z-:(Y
MD/Z&?Z&T3'\K="_3WZ+ (TO+=0).NU-#P#HP\5CXCF=EE9!:Q;NDO[D"ZY'^
M-@# (_ELKD#WE/[F"51;^IOK4..EOWD:]R+]S?=>/T;/5^O9]7=#A0LVOUHI
MF:WOBI"RKVNVD&PEORR7J[Q^["E"F#(&(X&P+:P<0A8D*8SC5*3$)CDKIT)]
M'C*GQN>UVJ#4&Y2*%]4U"]7!O[#'I_\ UH)_S<'O[Y>/+%LX4I#/5+13^T
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M873CRO/ &9@JO[YXO*K\JLOU>I7Q31FVMJ[[*_48>G44D;XBKO8%C!MH==3
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MNA>A3' H"514(HA#NYZB,H4TUC0@(F!I[+5!LB=A:E_(AH*=ZSUX[8R<A<C
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MJ;!:JL<1T2EG&E(2FT51$DO(TA1!D2)),8\2KD)7A^:4L*F]^96^P"H,K,;
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M%Z%38X5*9[!5&C2T/B,=UFD"''<P>X9UZ!W+\Q'UWYWT@*BOW4@7D>/N/GJ
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M_?@VG=>.&WAT8W;_RJZ+FZ&Z!']>%OU8E"R+X<^$Y$22.(%)8G.4N?F)!X&
MB*8RE!%1BB6SIZ*EL+%RM79=&HVDO\_[]MJ*X5Z]K9+ C+I>9<+^F)>E +AZ
MR!8+&V?&R^#+[M44QGM*M"1(A93!5"4$8MO(@$4TAII)3 B2,4V#ZBFY7L@_
M_3-2V_ V3XA:R#_9X^&Z7)_@A ^^S#<&P7*O]N7V[,YLP'^ YG65Z:"P_0)4
M9[ -\T$9L;HV ( *@:*W0XE!W:ZFSWV"D2>NM_V%L?0>>5]BY.G8W\\86X%N
M7M1?V2HK.MT:[ZS>!3&?L5!H A-AVUZPQ+;>9A'DD<9<F'<8$Z^Z"/LBIK9
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M=R/9Z<[IP&1=&PX:EMO:O;7MH&E\72FS-O]B6RCSHB#Y!@:@ N$"6!C 2QQ
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MVV)5]=>PI;'>*;U<*4-TLT11KA,9PBC5$<0I9C 5+(2Q%!))RHE4X6RA'NQ
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MG=HK_4\)"?[E_X1Q\!^/V7Q>[$NB7T+RST!N%*C5!Y'YK3'!/?[79R;:&6%
M? ?F"HLCJ-0&I=Z@4!R\;V)K=>\08>V#L'OD]4!(CQ21[8%X/]':'>!JB>+V
M&6VTZ.X.)C:COKO<WC'Q;AM,E-\O;<V=A<CFZK-:[_;2[I=7+/]FUIS/F53R
MW8_?<EL <[OI5FVRVU1!GA<]"6=)%!(M*(*:VKIN"FE(DT! C869/8[,%P1Y
MY>@-H.34/BD-&VVFV:JVLH@_+0-*[>_MOX2Q%#Q5IMK^'\OM?C/;VOGOGBE_
M0SP';E[K6\_NP!^T5Q.[-1#84GTOS@?LGZV=X$MC;G^RMIH'X&>P.U78V0M^
MKRWN,QEQP GI*V]Q"!7'37$<$.2];,@A977[[C1*M[TNIGR@V_<LQCA$&'/(
MB>(0IQ&&:9 F$$54<":(Q"CU^:+XB9_:M^+7V]OW?[OY^!%<?GX/;N__<GT'
M;C[?7W[^]>;=QVMP^?7K]?U7/_KWG XW8A\.Y($INU:\V*[<J\8.=LJ#WP<Y
M4>D&7$_4ZBE\5-+L!LQK.NPXBO_.RN$(E<[]K:H5P:TN8ES^EJV_F=_HY>K1
MMK.HQ"QD$1:<SQ"/6()P#(46!&*M$&1IA& D.*<HE!@+[KI3\X9V3(UZ*]W9
M0Q$R^+K]8E&Q#3SMK(&\B&@36WO<MRK>\N$YO;GT)WDDAM[8MM:" PT:WU5-
M&8%?4\;[%TT9ZSV96PT*6(#%!32 V4K^<SU=[AMK?Y*G;*2-NC_-T^:U&SB!
M.6[977Q+[4;;K9S %#1W/Z>@3K=5[9=554"W$/6%K6Y7Q;&Z+$IX&+&%";,X
M"K@.9-$'+(:8!10RBC@,)>$!3S@1V*N/J)O8R;E2M=9UZ^HGMBKZ5<OE?,Y6
MN?6CRM[5GN7+'&?!;1';/[8#^R0[6+^6L!J=@<U6+[2N2N\8O<M/1G^+5C^@
M>EJL.@H==9'J!\3KQ:GGW=UXRO9&4.IE.=ZZ@\*/BESM<=-_*[;Z8)[,&<<X
ML7U18<J9@C@2$M*(8%N>.TPUCAF.G5:37168&G>9!S'V(R5OR-WH:4@@!R:J
M4O4+L%>N>ZO_A3T1X8:M6&;\6&L"L#;TQUE=T>N)O;S%C\IC7<%YS6B=Q^G&
M;>691L&9A8]8'T:&81K&J= 0"8YLGS$$4\IB*$E,",,!YM*K#>L1.5-CJNJ$
M<:NGRXFA%ZYN/-4#6@/341>@O GG! P]\<HQ*:/2QPE37[/$J<N[AK>4"SLV
MM]^0F\45>\K6;%Y%>!&AD(@,)9! V#B5 $&*@P"R1!J2D#'2B5<8<JNTJ1%#
MI5P9QGBS -??A2'J\I]+7:P:"I?3-XZD#7#7@)">8!P\LJ/6L_!0H%FZ5JH.
M42':!93>HBO:9(T<)N%@]GZ\@\M-'9=.F; %NA8/EP\K529@50]W@$7":,IA
M0%+#)F9-!+G0'#(FA0JHBM+0*^KMJ*2I,<DG)3-AMY_GA<:^F0['$75< O6!
MT]!KG5I'L%-R )(X"45?"Y>C<L9=H9PR=V\I<O*&[E7R/F2YK?^C5ME2?C"_
MRV=IG#*.!(5*!0IBGA!(X]BP0BHIBA.B)(M\R^3M29D:&6RKP)6:@E)54.CJ
M7REO']1V3N@-JH'YH!-*G:KE'47AK')Y^Z..7B_OJ&&'"N8=O[AC.N/!(ZI&
MP:)CIU75F=3U=[42F?E4WBQ*I>YMR9:;Q7J5&7X2A>,]0PG! 4$2QDQ:_B 2
MTC .8:(3%0=)R@+AY5",H?34Z*A0$62UCN"Y./XPZYLR7F=96@9499IGL_11
M'@,W+VAJDSLP@3;KA;V(A6A8;,/G#]85*^,BMI$/6]-M&>_2^ NPM?S$*M@_
M977$B>HK$W8,E<=-L!UQ$O;R=L>4[1^T6J_F+N4S*P(=J\48#I&F2%%(!.:V
MN7D(6: 3R$G (ZI)%*;:-:#TB(RI?3QN%C)[SN3&?$&V:]RMRNZQ=L<0;2?V
MGG :F(?W<>F0E7L,(/= P1Z &BF(KPM@7O%T)Z!HB74[=N=H<6@G5&_&B)VZ
MM)M;W^A_7I]09BK_LE)/+)/7WY^*W:T908Q@K"F,#15"G'()F<84,LXPP3))
MXP3Y]5MQDNOT,(_:.J52T'C/3QWV_=S =O-^^P-PK)Z]58R641@T-+X -:;7
MIS#U=CR],.K)<W23.:KKYP7#:]_-[^9N)/0W91NC*WGYK%:&V,IBXK?Z?3;?
MF-\6KF%^NUGG:V;<D\7#C(=(!9%@D I-(*9"0*["$"J=(L5$*!#R*C[K*=_+
M:1NA,&VI(-C8%=]Z"83QL8W>0);J \56"Z-U$5U:'G::*Q[-PK&(-"WB3XN?
M?'OF^LZ:&Z\-.!<#,URM.:A4K[H*%/V2RAEJZ'T!*HOZ8[N.R/7$>[[21V7
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M#$6B-I L%3 E6$!/!HFG:,GG++6Q^88(,3<;3TNF6PYFCZ7^GK:5!UF+;$=
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M1KHWBAES"NWIB#*WPPRM65.'L@G^HIAR4:A/H_*#O7O>7W);[]>N?B<%;XH
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MUTIJ[?>^54]M/R/+GAIF>)MY$=RC.#*C[@#<BSQ-NQ\[I%QUMC ;=-K>%59
MO.I.87?W,$JZ;=)=;M6KLU&,]Z'->/DJU)Y$QFF" ]U%VM-$A @DL?HG#BF)
M$D0#'EL14=]@<Z.?VZ-Y0 NP%I;)0+T(BY2E$?:YHGJA(VX]'Q(6^C!BL4\1
MC7P42)L6'\X0GJ#'QS0(FY&[*]Q&IO163,7C6M *N0][Y+[V(&?-XB:0..+N
MWJ$F96P3I0]YVN@>^[UUIRF16@3NA7JR3MHMOPHFRI(4SQ_SXIO89$7E=55"
M_,A*[8DMOXE5M<'-;[9%W;^H\K^J*^X+\KCDQ$>Q%"GTXQA!% CM$-75.)!'
MJ$S4?V%LZA =2<:YK04=-;4]1>Y%]>4]:U45736Z5N5@BYVV.I.T5A>04OV\
M4EA7-%5BM7WBB%9:7ZBU-M_DCO5JG'<ES&#"1Z;8[ES?*-M9S;7>65=:@IV:
M0.D)]HJ"G:;@J@2-KN N!TK;MN]<I2^XG<M<FWM#9C#G$[E2WO@[M_+)C#PK
M/0Z=L4:>S!LT,G1=5]+80UT6FYO+C]DZVXBJ5O,G]7EUTL7+C]N-+FCSJ(NU
M_G>E0=/@_B!$,XI"/] UO0*AMH9(QAA2C#Q(0B%)@ /LQU;%:%P*-S=#XD41
MOW*3/:HYKCPT'45 H\FPP%LG4VJV9WJKB1K[(*(S1[5B34WZO6I-T.T"U-H=
MG;Y) FY=0N\XVM:):&\2:NL2U%-QMD['&+8(_+HN!-,W\%]U^@>O^MV2U:WZ
MCAY(*6[HJNG?]*Z.^[M9?\R*4FUPUTKF0J]=RXA'A*9)"/6V$2)?1) F-(9A
MF,8TC5GH)Z$-]5\NTMP(OQ4=Y#O92]UX6GTVH1W!.Y@N,UJ?=A)&)O.],N"%
M-F W,7M]%DV[D5N2\45=(.UF[3#OVAVPCJC:@4"3$K0[  ]IV>&3AY'Q^^R'
M;G+)RV6$(IER/X8^"4.(F/1A$D@.0Y^+T$=Q2E.K6FR[)\^-&N_T$8,VG;:V
MY=7V8)DQVB (1B:FG4SN^.65FHYH8O_<2;_V5^H<?K2O+[!WLM^P34Z%[BOK
MZ^*+GW.ROKHO1+4;;^H^!7'$U$86P=1+4HA0@B&)?/5I(D_X,6>1[R>F_O+S
MP\WM*VTDU@:+#ZHRHEIHL)/:W)%I /5Y_[-; $?^QL]A-Z!8F0&(YHY=MV!.
MY*,=_$):>5?-H>EQE!H\9#*?I[E"7?>EQ5T39WK6/M%/ZW)3;.MR/;JIS-T#
M63=Y)A_S0@JUPU:[Z]LJ>6Z)J4\2)F,HTR#6%01B2)G:O(8\P8A2&:5IV$8D
M&[HJIY/>Z$M\&>$\\LJP$_$-$@('S+ZA3W-F,_JG22)L#CD[ ("ZR=9&0;!/
M,=R_-.J=J7&808KA\,E[Z^3# 9+_.=(2AT^)LX3%"T2XH)?AUWR=UX5Y="D>
MEC^*QOF[%&F @B1((-*-EY' $M+03R%.8A%'/"7!?OVRJ,[9/^J =6>*S)J:
M6T1SU*(6("WR7P;$#I[!W&S5< #AE'T/NY*"6E3P4R/LZ15\6 /$LZBX[(-X
M>K#IVR&>5?QH5\3S=PW-/*G\EM\?A-A\UC.G*?"/K%QRRGSB1S'T0B8@0F$(
M$Y(J4J'8YXAZ* R,H@'/#30WOT8C)Z@$!:VDX#<MJV6WPI/8FI&'"\1&IHUA
M8 W(&^E'PEFFR(EA)LX-Z5?V=3;(F>OMG9__>?M%24_6U_J,XQU9_Z/Q('DT
M$BC",122*$,#11127W(8)#A@*?9$P(V.=7O&F!L=*#'-G7"G<#OOOG2 QLB?
M>BLAJ$0$6L8!;LI3")G[)AT@-9%#\@AB;GR09R#H<3R>NG,R;^,9T;LNQG.7
M#K-WKIB:^VT50EG957KK5X@'94EE/T1M6'W.R_*KV-S(._+'$A$AHBAFT*=<
MJKU5%$ :40\*%OH4Q8R+R+<Q@RS'GQL==L0'>=U2OJL ^&FEA/\+J+===M:2
M[<R8&5$CXCTRX7:AKK=G+V3?[<^T^'^I4KQT8*+2P9W=-1 \1^:8[>B36FD#
MH3DTWH8^QMZF^R)XQD@A=.F1]_N^I/O8WI#[-/$##CD7BNFP'\*4101&RK:+
MD& !5D\R-.[.#38W6OORX?VGZZMO'\#MU;<[\-[<GCF+ZGG3SR56(U-2*RIH
MZM=T&QZ;A#/;PV=N%[J$<:JF6LWNN:QVSZ0*>"H!*<N<917M_YYM'L !Z#^[
ML2%-X>HQ)L\^8C*KTE29KGEI?,] .[,*V&YKN,DXI+X74RAPPB$B:0P)$@(2
MDDH>,AS1(+3)YG_Q="LRG2!]OX[?8[5P^G46IG6:CH.7IDRJM4E ZD616I@B
M#&FHL QBDK $1R@A1DUN+@=OBHQB9[ 9VL=#P1C;^FT2:9Q5_^M5V)7%^N+9
MT]JCQ]1Z96T>O<C>EMP;IN^$S O1'H@J,_4#*73M[_)&UL6R,E)DHEP&?B@H
MC3PHN2<@"IBO"\9$,,4LHM+W B\U(L!!H\^-(.LM6[-)!K12HDT(SM;ZJ!*(
M1A&]I2L[JIB;5O9S=-Y4'17YD0FEV2YKX4$M_3XTI=H\MQKHY/[O$T%N;MZ.
M"OU$]F[KL:A]1&[>>RNC=S"(/5:P_3,G,XL'J]NUDX<_9)CA7(]W1_[0'18S
MKBLU191X))$^Y %7BT=*"4QYQ"$E@4 X#A'!5C[8UT/,S0ILOI0-^6-7$G9
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MWZR_"1W*G*WO*U?X/C4AB/TH(DA1IXYF1%&*84J] /(P2CF1".$P'73P92C
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ML>0'/'0RXWZXPEU[_X*GN&FSL"\(LUOB[O+7-;AW/5YQD*:48@9]S^<ZZ8U
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M@%944+2R@JT2UMP7W(?I>;>Y(Z1&IH =2#LQ@99S@.>\#RUSU[DCU";RG9]
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MQ[SX3E;BNU"O=U7 5M<_^T(VS;^NI.*J.['6Q%SNDRA8R)C'O  *3W+=[9!
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MUL@B<9A&1#O00V7#XU39\&$B8$BYEX8H25EL7"/KY:/G1A.M=.85F Z@ZJ>
MRP 8^^"L;?QB7X;J  3S2E/#P9BHF-39%\*J0M1Q=7N*0!W<,%F=I^."=DLY
MG;ABX"Z$_%'70[@F1?$L\^)W4O J]GQ)(LSBE!(818PKJT41$"$)@PF) TZ3
MB..$6NU'3@XU-R[234^:JA]=69L4#,L\W1Z$#3<J3G ;>\LR$#+[W<M9-%SM
M8TX/-.V.YJS"K_8VY^\86 98<?Y6-WMHR@]GZ_O;@K"-;L.P_UT59=3MW?@^
MT_T9UKQM*JYK%>?;S;==[XBKJLL$62V)"+R8>0GT>>)!1$0*$Q[&D",FP@CQ
M.!96\0)C"SPWXKHI>+8FQ3/@C08EV#R0#7@DSX *\$2RJDO&RV8<EH6*QWX'
MS$AQ3C,[,K7NU %[7<%.V07H_+Z.,]TI7#53:55N0U-+\'NM--AK#5JU'59@
MGFB"7-5Q'EO<::M!3P3^JYK24XT[;/WZ0MA#MA;J>6NN-_!/G6)/./8%"9':
M9,=8_4]9OFKIP2G$ J<HPHA%Q*I63<]8<ULU=N+9K01]:)J1N".,1N;?G91U
M_E,KYPB>>0,\'-%=WTB3,I6!RH<D8W++T(#8;*5;A34O<90HDU/Z%*8T#B&B
MB,,DQ"%D4H94^JF0R#)ZM?OXN;% *YUM<.D+R,R^^^% C/RIMX*-\&T?U]E9
M&.2+AT\<LWA,L=<!AD>O&O:=_KHN!-,W\%_72DJUT\WR-5G=-JTL;N@JNZ^\
MDTW+G)OUW4-6\*OU6G?D+M4&:4D(]0))"$SC-(((Z\/V&#$%K?0(2T0<^U;+
M_>4BS8T/6M%!OI.]U&W(U<L7V7&$@^DRXY5I)V%D+MHK UYH W83L]=G4?=W
M5UN\C"_ WP4IP)VB%H?1/^Z@=41Y#@2:E";= 7A(K0Z?/(R.CP9\-P:![W.2
M<H0@#;0-E:H-%J5<0B\EF$C*9!1:5=_K&6MN!.HB=Z</6C-.= 38R&1W(K%E
M!#O,  ]'#-4WTJ348Z#R(:>8W&(?W' M= 3E?XG5ZKNX[W@+D)<PF2A^$!+K
M-,&00\JC%.H0<(E0FI+ *%*Y9XRYD<->3/.S_E/P]1.!(U!&)H"]A* 1<4 P
MQ"F S*,B'  U47C$:\#<!$J<0: G8N+4G9.%3IP1O1M#<>[288;0>R&%XDO^
M2=EAC^*._-%)CENRD)#0"RED(=+A%"R!U$MBB*FD1$9Q0*-@N1;WNIOKG7G=
MK;XQC5[;M'YM7XT\8JQ 58&+-X*K/:66'&S('V UM,)H+_)FAM+%0$Y#E*V8
M0$=<=$1<@%^*O'28"FR"AR-+J7>H24TE$Z4/;26C>X81RFV1,R%X^5$)6O7K
MNR7/5>10FF(2^%$((ZQ+=V+?@\3'$<0DD3)&@2\3J]K%IP::F]G4R@GTU(%J
M6[7*B65Y\Y.HFA&%"ZQ&)HF7,-4M.!LIW1'$.1P<D</)828EAG/*'I+"V>OM
M=T]M>_?OVZ>G5559K*D)TUBYL8S3B'$&(T&KXRH!4Y3&D'@,1X&R/GQL5(C)
M8*RYT4(K+MC+"QJ!S7</Y_ ]O\URB-K(!-$#V(!]USGDS/=?#A&<:!\VY-6S
MVI 90M*S,3OWA,DV:(:J=#=JIK<,[57\^"@*EI'5+7D21>N.HEZ08D1@)'T,
M4< 83%B00J3412P16._4+'L4'QG'YF6>JC=Q*R9XTG+:MB0^!J:9374Q0&.[
MI_;(5 *.TGFX!P)G'8>/C3%QI^$>-5]W&.Z[>-@W_S%;9QOQ.?NA=VP;-<G9
MOJQ1IR%-D^2OSU(_JFN7@J=I[-$$IE6W&#\*($T2!"6+ ^P+Q!-F56QHF!AS
M,[S4&X;M6&(@_&8T,CZH(_-,K0"L- ![%>KCL$55U(-MU*^ZVC0'_EH3=VQT
M&9*.Z&J@$)/RV65 '1+>A4\;R(@D*_Y&5EOQ[OE+U9JOLK,^%N*?6[%FSU5Q
M6LY"YB&$( \#!A$/?)CBE,($Q]S7K;(P2JWH[_R8<^.ZCIS@'2FSTJKLKPW8
MAF3G%L+1=YQ[]'8R.BL//  35QQE,.*TA&0.P2OVL;AU8 ;A\2+F^V+Y[Y[W
MES3I(%<Z?;&NM_!I76Z*:E=?5A$*=P]D?5-U-RZ_YE45!L'_2V3W#^K/*[5G
M(O?B%_7HS7NR$3OEON6KU<<Z*7+)9,(0XQ+&@<\A"E.D&$UZ,,)<^!AA$1&K
M'.>9Z3<W"FUEAZ"1'E3B0RT_T J 2@/+C,1Y86Z:P#@OJ6>T4G3;:72QZ?;4
M /09'&V[H759@*: 3@>DIG3R1L$$&IP68(?4 K18O7PQP<&+J=8KJAY)V,;A
MFC73-\%58N7,M)LV#W-FRI]8]^<JYL HG*Q\RDNR^J7(MT^?UFRUU8DGZJ=J
MTC;9>BMXTWHS7Q\O9Q\Q+XB99%#&G@<1\B-(JX.TB-, QX3RR"IF^5*!YK:*
MUU0Z))SYXJDQ6UNG!'SDQ;!5!52Z+,!.&]!5!^ST:7L$U(HL.B'5#B.#','K
M*GKH4G&FC3!R!-ZK*"17SQW8@#U?W^MPG/>";N[4(][GCR1;+R6+6)+X*0SK
MRM,I5RQ*0YA*+D,9(QYX5I4OCP\S-X+\O,OYT'(N@)84_%;+:NDN.H&K&0]>
MCM;([%8!=6<+E'U[\UX<7'4P/S[(M$W*>Q5]U8>\_^K!1^I["W+-OXE-5KN1
M-!6M<NU4:O=0RR"*1,BDKQO&88A81"$)6 QC*7P>Q8' Q"K!WF+LN5'&7E;0
M]GLUV6Q>/ 7&Q_-C #LRNPS$=,C)O2TZ[L[SC4>>^I3?%I(C9__6C[ /JKQB
M3*RT721XM<7])IZ:O-GRZKX0U8!-NUND.];YG$(J"%6V#,>0>EX$)0Y\%!'U
M0V%T!&8W[-R(JB,Y*+7HH-C)#D@K.R"5\.8AA!;ST$]9XZ$[,EMU@:VD!AVQ
M%V G>%/E;11HS0,UQX%XHIA-5U!;Q7':(]83TFGQL,FB.^T5[ 9Z#KA[>!'3
MZFDW\KMNL_Z0K]3-9>W*W-E%)))Q3#P?"BY3B"@/E&GJ(4BP3V(<A)[G&073
M6XTZ-Z[?"0UR";IB___M"<M0$]5L$@Q/TEQ#._;YE@M4!]7C-$;)85'-\V-.
M7AG3&(9CY2W-;[XP&*L3@:'K8?ZZSFDIBA\ZB>C3^FF[*76#SC7+5EG;KG-;
M%-GZO@I-JGQZU6.6V/=(2CT.!>82H@@I Q8S"H,TIJ'$ZE>Q7>"J8P'G1GJ5
M9."'?1R"\YE+(Q8Q',60,=^#R$LI)%PPB&G 4X$#G@3I\DD46<[5FUELYC]_
MA\*.-XOOQ'VV7NMS$EI7/0)D _Z3K+>D>/[7_^G'WG_X;SR[7/B15&8$C$6L
M+(Q8$!U:SJ$R]%+)>90DDC6S^V'-_RQSVXHZXLSNY_.]8%5&0#VAX5O/J)FY
M\I9S-+)ELP^468!NO*<N. ZZ^H%:0?!2PZI!>JUC'6"[J(\QSP2%#0\2=3P#
MKB-*78GW-N&GCL$]&:OJ>IP!/L3 \]-;]24T*6\D2JB0(H8T$*%:MWD,$XY\
MZ)&(RT"Q?DB,XD>./'MNQI*6#FCQ+-Q1!V@9N/.&8S"VSVZG_X"LZ4,@+)QO
MPP&9RL-F 8R=%^VXZGVNLH,[IO.''1?UA=/KQ"5#.Z@W!6A>,M[NQTW64',6
M=K7Y*-2SR6K7F&%_O]KF+B5!1%FE:L^1JBTCBA(,$Y\+& 1QB$.?I8A;><"<
M2C<W'ORTKV&E.U5DI8Y75A:JK)4 Y:Y'B_9PVK8H=SFM9D;JFTW6R(3]04K!
M-MD/;8%6,Z:K:&D9#TQ1/7>-3IW^.@?W+)R=#XP*N[,.[2YEF[B_^PBPONX.
M/\8@E]<-^Z*>7U3%R&X+\=1TV+E:\VNR6I4WLMN'YSM9B>_:/J[KYOE1Y&/?
MYY"K?39$*(@@Q0F'OJX^EE+")+*JD>]$JKDQ_UX1[<[/=JV 0;D3>7AULN%S
M9T;SD\_(R/3^LN[97J,%Z.A4M?&IM-(SIH/?P%Z9Q;Y[&I1Y ;6JXY1,NQCO
M$>JK#9?IS8JQ70QC7^6VRQ\^C+^_BLTU*1]NM2G)!7_W_&NI"P)\S-9$K2SK
M^RMMPU0#[0^LTR#%,24P)8A!1*,0IC$6,&1"IC+&/DU\&[*V%V%NS*S%!W*5
M_][0@6Q%!V0GNQTU#YB6 ''F,:;V3DD@(6(R@D37CO%#DD1!A*A@EK6DQIV8
M:0I-*1U -3VM%CJ?\R>MB%I!_P)VNH"],H-##09,FMGB.>Y$C+Q2CC0#UBOB
M<! =+7\#!)ATK1L.T.'"=L&3AJUBOY!L_3DORQNU"6K-XO)._+%YIQ3\Q]*3
M,O 0]V$8,EVOE$E(6!Q"J;WG"?$\Z5E%__</-[?524L+?M+R_@7DZS;RY_O
M3<,9J,T(S1V (Y/7 79[T)IV\T +#2JI'5*5&3R.:.G,8)-2D)GBAW1C>->
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M9)117H;*P+I[=PM&3Q6X[,3,!D!0=.C\V\<T_SR)JWX@GMVX#N2 LG)Q/RK
MYL AHG\8.>K9:%\JGMT%$\^0TH+=4P4B-5C= &)6[/H5W<><$-F%TJX23U[!
MM01#%LVTB<_&\,#S2Y?2>[I0KSQ_JM=)=8"6_=G< %:6] ]L=EH;D\'D,NXM
M2PTN*0W*9"N-#9&FVLID^>9^6M9W=G_P*D8VX"5]&#H_'"W,)#37%R4<GR<C
M9/ILJ0OO61-M<BP[ EGQ,KDG)S 1#2G";-+:(V->;/&R"T"VI:U?[ZGSV\M.
M1-2 YEE9UWK0(I#DI2I]*T3)VPRE;1;A%GA0(>M@ GFQX>B>8&OJAK,;Z3\/
ML7U$T1"HOJ%/>#ARP^O"M=LOXG_=+ VZXS^_I/&L3!91C$:7(/LR=TH$"BY&
M"L2H2!EZAR:]E&F_#\RVH:\9X.V%B6>@5EU #8#O((0R@&1V[KZ5L 0N#'\R
MO4$ZGO!RX'SF+D<+M(37!<-5>24Y*"XY,T90^6*"\$X&U_;D]7ND=@2]KL33
M(_)* N:[R>0?9U_3-$Y=GM]OKT% G>^$<\!]&59@4@)/LP:>O!$N.XM?;)$H
MO_GI_<80*^.C$A,;4$"'D_&"#7\?SC\?HBZ=7*?I_6+NH$TBR3:$"#)X-!2\
MX.!3Q"5REAPZ.M3ZVD'J;>CJ-\[8D<JI+I &0%:"ZW>DHV<;;68!A-,)U21+
M8%$U@@U,.:<"B;YV7'KE]?W&'3N"S*[L;0 9&\Y191WA*D<DN53D>JY++VP&
MP9O,"0DTY-JIS3M:,YU%'#LVI'=D=@NQI\GX4TEN*XA?":"JQ*TOICYW1(*(
M 1U98R@PR2070N*Y6]TKVTA),T9PAX[__B)H0.\L O$K_%J]\&5>1",SZ*!+
M+WZ?P4B5<4OX*'"5/)+:*4'/4].,U=P=H"J)H@%0K2QBX&@TEF8'R5(/(ID
MGB4-CEN'E"LF7NQ&N^<IUHQE_"8!R%<QNX%3K#2_&B[OB4LD"PW^X?A3&H>R
M%)Z2, ;M>>E5N0N4);5?18@<CV-E#/[W4M>YW5RM9\EIQESN#D>UA-& _GF!
M0R0(+K0M<X0H1]] >G &#<BLC32:2$U9[4-MS]NWMS"NNT-5)5$T *KSN_<N
MEK2L/S+2$YE)@)#0OQ2R9/BZ@"=TMEKQ&)EFM>-!&\CHNP2UCH2?I,/NQ^X&
M$+/2VW%)/QIJ3G'T"&PN_"@S2IQ.OO1=LRR@AG6J?OCP,0U]7_AW@I6]&-T
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M:8&EW8+A) %':S<*HH.RM;/XMJ.L[\NCCK'7@7B: ]URR-S!S?PSNE3_G>+
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M"7ZM)>?UT[$W$=((9O87]'IF[=Y<;P Z2Q?V8[KV:3J@3%EIR^1OEE +)Y/
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M5GO8@T?#V9?)S(T&EHDHI70@'2^M7DH^-'<"_PA*$T.\3+5-S]?2V&_!1G/
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MQ]G_-^"X<4#0(51Z,_M;##2U)0MN501=N 2E,=?=Z@B66YYJAF#DH"/M_V_
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M[FZP<CVQ\DAZ;9$'1ZEY%NO;2!=4 ,&3)-DXS*)U]>Q=&D;>Q'<HQ.PH] Y
M<V-XUR7L,4M1?)80L0Z5IU  *!"P8"*A7R>E2FD]+/H^%2/OJ1L>.'L*OB_H
MW,"_E\P&C0EB-J5.!<T050I SMMP'5()KO4X_@<)&7F+VT$!M*/X.\#0U^4L
M_>O'[+BV9*_#PR.38O*I<,I!$F6E1=>.,"L@B")X-E&%?/?Q<^\L[AX5(^]D
M&QX]>PJ^ ^C<Z7EY0DZ%"RNX5A2]801B(X/+9%R%9T%)A3DTWQ"R,7&=7PNT
MR<V&454'&/R"/W%ZAHLC;V5(V0@0I:8*S'F(DFRO3Q@4!82!Q]:+M"^_W57G
M62O5SAK(>6=\_,1YG#6XU:ZE=],%49TSAL3(E&)],E7)<_"(DG0:+6,J67LO
MHG[H*OORYXUK,X;5^,YRZ\ :?,3E6C@?9HO%4>*6RQ@L8'!$O":ZH[0(/B1G
MI$TI^-8E%[<(&#>#.HQ=V%WB?59?W2@T>O>&_O&W]^^^7LYK($%<9HIAFJ\7
M]^Q:;;7[MQI45S5BM%$UU8V IRY"NEAHO3S_BI16K0>;7Z+59Y>*] S0U$$9
MONZ[2$E!2BFZXAD+I?6>Z,VIV[M-GW[\C9_ZDP1>GX5^F\WK*(_U$Y&+*;-B
M/61M20"VS@Q!SH$9R;2))7#>.CW;@*RQ@Z!!\'.OA;ZQ>CIPF;]-II3I3L+Q
M^RD)Z*R*<%4K06;?2!<T(*L--S)'B,DH"%)E94ABW+:^@WR$E)$;Y5NK?-9>
M_AW Z-L\3!?TY5JP^!7G/R=I,OW^J3S W>(;_<C%PW]U46RA#$.F%$4@JDZY
MB(*B3L4C9*9D<2RRG%LOEVY)_[B ;0*H62?:[0#9?W[]-L= $?,Y,?_[C%+3
M:>7FHI;'U(8'A77*<BB@5.+@:BVNT3SG&#7#V#K'>)*@<;$W'DYF0RFM P3^
M,9LOOX?O^#JD?V&^=D;O%XLSS*_/__QZS>'7TUK#1C2^6PUOG4\HB[_@VJE8
MF(L%C)"!<GG*T (KU4L%\E]>ZE1:%]ZWH7S<VY9N,#T"##H _\<9Z?JO&F;]
M<38EV9^&XX^SY14WB,Y'A0)85A1Z<8<0 O=@)/'"2**BM*ZP>)JB<2]]N@%K
M0[6->HM\??^]F*Q6L87CQ\[AY?E*B$*2P&3ME%4Y2O"&T@(CC- Z)Q%#Z^%.
M&Q,W[I-\-^ <1ID=&,LWLY,3G*?G^<K,IJ*B!YU7Y>PV43) /L$YY50VS-$?
M-P;IIK2-^_#?#48'464'$%V5ZSW"2HDZ>ZL3:(I%R"LP)"Z*@9QUDM$$BDU:
MUV\_0<ZX3??= +&5PKIPXV]F\]-9'35P^UKOLC$G%V^E2U",EJ!,%!",=A"Y
M\H)+'=&VKB%XDJ"-$&A_>02V4UH7&+PN^;E[FWS-VX>KJI\BDA8V2 A^M2".
MU;U@=0*;3!QEL,:4X5JJ-B!PW.1\Z-OYX735@RM^E*6KG>O?9J].*/RHXS;>
MS!;D!A:3ZY<T5B=5)8J+Q6H?>Y %HH@(AG-T!;V/S9^(]B2YESZLYF"ZZ[,/
MJ-D.@7S'*MSC\T@%G6SB BRK,7/V@=R%89 32\''; )O78^Z+8WC0O6@ 'H&
MO$VUV6RC_6!H3>GLY&Q5J_7[?+98_#F=8SBN#/].<=1K++,Y^;6_CE (66S4
M@#8)4-H&"GM, F*\3@_,DHG6<4$3PL>-%SK&]0!Z[]\T/\IT+2>\9CIIQPQF
MBO%S<B3V2+Y0N@Q2LN0-)J^:5W(V(7S<QX"7"/;=];X]V/T:[%/\7@GY=H"X
M^K84CIBTW#@9P/H4ZQI64P>!9&!2\9S(HS'7>@K_IK2-^U+0$W*;:*\#2WRW
M(/*WGQ\G1X6G+%TT8$RHR]_J7E<L=,I<3N1F7 ZI]6/50W3TTH,U=%ZVMPXZ
MP-&-4MLC53PZ78AT8IQDD23$@ 8L%NZX=ZE6A@]6B]W+L/RA4;.KQ)OE.H-W
M6#P0!& =Z7IE[1>S<M,.M^RXV.W; W5@-!#$X3LR! O)%5X7R=>4)!D)7@@'
ME)9S'03CI?DZJUXZ,FZKZO-LL=H"<!VDK"Z@(U<I%:9!>0I$E T!G& >LF4.
M)=:AA*U3]?VI?C']'-N@;[M^CN;*[<![/U8=SC/S/%*(S$3-M)S6X'.F<(0K
M(;QT@9O63Y\OL-VC/2(V[ ;91CT=H*SIT[$I01>K(Y15P6HP'+PS&I"<7+&)
MQ&);URW_^MT@6P%JR&Z0;;3; ;*?;BRP&95A4D!V DFJ9 1<-@Z,%E%ZC2K;
MUOG0WZ4;9"N<;-4-LHW2.D!@HS: @"1/:3VPU6A%SQE$(17H8+E");Q*K:'Z
M?]T@#3$] @PZ /\S;076,ZME*F#3JA86,_BH DE5)!:"9AI;5Z3\;;I!]@%K
M0[5U4<*W>0.!L5HA*@<4<$500FH(F=?G6L$D"LVQ^2C/OV,WR#[@'$:9'1C+
MC5L(/%+X8XP"$3G62^7Z^* 8&)^*+5S9]O-F_X;=(/M@=!!5=@#1)YL+N,\H
MN *>(H4FHJY"$*% PH!,.%U":3T%XN_1#;(/$%LIK LW_G1C02Z)<XX"HHL9
ME*30)&@7@$M-(E/9R=2Z.N/OT@VRGRELI;0N,/CXX_$;"IHGT[/9V>*9:^<;
MXXCKW5V04%SM=/#10N3D ;Q5,GN;R0D,7=:\!_D]=Y(,?O$_%@QZB $>9?V!
M0MC*^16CJ!@/SE&V6(N[5$ %+@E=:[VLH4!'!=:ZBWEG8GNMYQ\87AO#O*6N
M.P#UT^;D.:%_P,7BVX\PY>(/^I<_%D>&BZQ<+?8QS(#2B>1@R+=YR3B73 :7
M#UM"L"T'O<*_*>RVJBX8% ,O_@1<<OUI7L?/4F#'C#>40PB*Y%RDQ#8P<J["
M I,\*U:W1,G6L4U;#GIM?.GW!.R%@>Y/P,,\'R5E2XPU-7)<@#(:P:GZVV@U
M-]Q);^]6.8Y1+-9K9\MX:&Z@SPZ;$S</%&_T]-R2>$C>95\09%T<H%0=]<5%
M_56(+F7*EVSS'7BMF>C5=O<2O!\"&]T;]&T#NCM".1)&&N2UE2C6 ;THR2J5
M$$!JQU '*Z)O748]*$.]AOP' >N@J< ^R.FG3;)M<'A7)B$6[NO2FA!L7>5(
MVHK22+"9RVR%BS*TOKT?E*&7ZH+Z.TTMD?-23M-&NCG2WCF1M067$P4'3#$(
M&@V@M3I[Q6T6A\VQ-R*[UU2DOY/1'@5[X__0G88?PWQ./_8GMFTBO/=C!^H/
M?)K\P[?^\<A95$$!MYJ!D@18'WF!F&QRVJ#6LO5@CL.U_EUW^%X\94^_?\&$
MDY_U2-&OJFFYL:KS#6%_LOS/,SIAR_/WTSQ9_?SUTV 2I40O5#W3M=W"2XA9
M)"A11LFDC$:TCD;:4?]B6@&W0>/CD_X.JNP>LMK)XG2V",>_SV=GIY<KX-):
MO[55*%FMK,P9LF9I_;9-:8: K+)@)B6'L?F^L:=)ZF6,WV&1<M?5-U1;WRB\
M*!H*UI9BO87B8R%AK4H;982,=-P#]\:%UO6 SQ(U<K-J2PAL#J\=]-$;P-:_
MP?RIO#ZOD?''V;)N1EU'[/3'ISA?L7JS0T$65H"KNMA4AOJ P"68F"DM#,8J
M88?$WI;T=@O+7:#S%#"'U&,'F+VSP_=U."9_@U]_(-8XZ%7.JP0N'-_8ZOOZ
M_): %O0CCL\R^:B'Y;*V$SP&9UR"Y)6B/%.3.E(D.R&54]%:[U7[E:J'X*R7
MN5*C!@H=@JB#H[45@Q_#"5Z8+N\=9_1_P+PWH"+30"E'@AR+""PQ7GSS>^7=
M2!T[;>L/=4]YDH$@,"+2?YR='/W'9)KIBZ^6_R!E_&.V.)TD)/%_IA]>A?^&
M5/EV\G.RN.$B!5>)!:.!G#29&K&Z_G8<F,W1Z%0$_=<S-V2[?;FCH&4H,,P.
MIID1<;>8+X_6ONP+26OZ_6M=(A_F^?-L-E\?VI"S3+DX0)<RJ!0MN) ,A&@L
MXR1063:Z-:0OW;"?]+MKV_DL$;T,#QPE-&BKHI&Q]NXO^CGUR#S&T-7Q8<4S
M1'(0&>L*&F*)J0P:670Z,Y[T1O45SZ!N0W+&L7:-%3\;5@LC ^NV<%[]04Y@
ML6;LLMG,&&F*C5 *9;"J;AT*5CK0FHEHE;*XV1J)9Q#U'!WC06D0I<\&TD '
M2<=&QO[#U=#8B-87)15QQ^M9U R\)M/.<Y$I&I53\\&1VU$X[@2)3O+K 97:
M 62WWL:26$&C"J^SUP.)T@3R'76UK_.Z<L<%MKXJ?5F[=8;$R[ZK=+917H?@
M?'16OU2AV) \2.M\K9!T$)%9H)PM1!55<J'U#6?330N#W5&.",8FRAKY?H72
M]535]9V<T*J6Z38KUR+\?1XR7OB>HQ0D-R'[BWE7%%J#<S:!=-8EE3,&>?<.
M\:$KEIT^/F[>>P"X'48M(^/NC_#7Y.3LI$8Q/R>9Z%]=M/Z.4YR'X]>S:?X4
MCR??UVI=/".-(Z><TTX7,$H3W\((J+$S'3^F5#8RIHUN_%K2-&Y@>2"4CJ;$
M#CSW+H6J'\]JSO>I7/Y^<<2"4LDZ#3+6@6S)!HB4! *7BO&H0W2^]6CH)H2/
M.]7L@#[_\&H>V3 _S?#UW]QG,OF45)$%;/ U](Y^/;D(7<#  A/FWHZ[AZSP
MS@2,.^#L0";W,.IIAL'!R^&_W.B37JRWS:R?OC#_UV3Y8S*]%O[Z0;=MV?S.
MGQ^HO+Z-. Y?AA^#I80I:S"2<5"6K&3$*$&D9$Q(MC#;NBAA^#+\R_/ZP(^^
MJ:<CEW+,04@*=:P )6,!SSF"L,(H$PV9BKNWI(\9SF<^-79%Q2!XN&L>6XJ[
M V?\!#NK;B?BQ8CB.1BOZM,$\>1Y82"%BBDZQK39U.T^\ZEQ+WK&1\_6XNZG
MN?*AO8VW#H5 ;W7BB:(09RC[RHI$IAVXX(42-B,3K=<G/4?3N!<] \-M$,5T
MD!8_Q<_J_$B!9':8!:?KLE!4'B(KE.L73F=')*[B(1:V;FW7!KNKZ0!H6RNF
M'\/VB,@NQR8=>46)E-<!O*D=R-+30;*.0Y).>I*9Q^9V[1F2QKTZ.1#:6JKE
M!6V!O<ZZ9M.[O#=>^KK)IX;:\;HUFR/T=1?.+4L9DI$15%#D-C-SD',.7(;D
M$$7C<W^XONZ';/G5T2I><;<Z6L4PLN/600S2@G6A=@CYJ,4A'.Q6YJZ'E',;
MQ&SB7'=22 <#])Z+2%<\V9)8"CQ#5(SL=_:4!6FKP!4;-0:+,1\RBML*;#UD
MJ*W!MI>".DT;[@_!/+)<2QV+!>U"G9]J$!QZ RQ(7H35#F/K:1V;4?9B<M76
MP-M322_GH:$.0ZH2/ O'?X3EA01FY9'WF')9KM8RYMN+A(%BP79B.7R,F+.U
MO$0$8_FJE]J"SY2$9(5%Y!!*:%[H>;@8\>EBM6M=?9U,OQ_CQ>_/WU)V?K^J
M\LOL^+B6K%_\HRL!.J5M\)AJAEAW=;$,0>L$6%\P$_VWYZU?;0[ UHN)6+?!
M[W:UC(>'1P<QR*8B63^D?IKB?V.8WY+&D:;@REI!OJ[$!,IF UZD M(7GFU!
MKN3A]KEL2G6O8VY' N*.!Z41*E[0.7A5Z)O$\+<?\]G9]Q^_37ZN>+]=E7^D
M?$G9:@VZ]C8I16)P+ 0H)O)<T-K4_ *V*0.]CJU]6:>C/59>VD&I+%]P_PVG
M#S#/:A^^M :LJ)TKY-,A>D00E$T%EU2(>JQ@:B,&>IUB^P(/2E.LO+2#\C#'
MTC!M,*KZ#,Y!>6XAY#JOPA=KK'/%R]:%TOM3/>[#\B]U)/9'Q0LZ!S66G)TM
MGU$,Q96IV! =E&!(^%(4XCY;D#'+K+FT)(\1LXWG.1CW*?Q7.1\#H*7#L_)L
MYR\W+@>%!9#)>AOB&#B'@9@L(4J7K @OHFU[L Z%EX;WIAKOX&%U#_E?BE?E
M5)#7!STF69T6HB$F+X %9UBR*4@\;!?X)E2_F$?9D>Y3=U%NAP9ZHXNQJWUN
M1U';@C6%8<D3MX%%")*\D_ \<^U,5FFL@/YABE_L->E.^&IQ"[J;LE\0M!^[
MU;IFW(=L%3IRA3:H6KU=99X<.$1'Z0HF._@LF9V)?[$WGX<$?%L(O#3L/W!1
M=<TX0\65RS4EKTO]=/$0@R^@A?7!)\K<FZ^,:4;\B[W,/#CVFT'@I6'_/K<B
MN!QM<!0U"EM763*(VM%)S]HGY9#IS:8I#GU'N1W*>[R?/#C*]U/V"X+VHY=)
MUYQ+R1Q*M""1D^13IHS;1$XI?Q)99"=+'@OFSU/_8J\<#QW%-P1!]_"_,85(
MQ]H+;C2XE%,=],H@<"- 8)&>23KQINLY>SW>'@X/W1T5V&=GV6^OWG_YYZL/
M?[Z[&"D3CE\M%KA<_(&A;IG(L^F7RNZ<!+VZ!]V]R'C7+S6H)6["9*.2X2NK
M=F.5QQ5HC<M"(PKR\W69LE,*/!DW0!$%>A>X4*V]W5/T[#W ^?)GK\7]:IH_
M3$*<'*\.SZ7P/UT+G_[!Q]ET?DL7ZXG#06ITC@4H3$2*[>O>",L%R(P^B%QG
M7+:N=6Q&_,CS<UOA[=X@YU&4VX%[OV+\]?D%F_7"_[<Y_L\93M/Y:B] 8:6N
M!J" G8<"BD<!T3@%EJ>ZE83+Q%JWK&U 5B=(/"Q@'H-M(^WU!,B'&+I8O%,B
MLY)A .-L%1D/X)@T$ IB]B4(EP8SH(^3U0D@6T'A,:@UTDNG4%M<G=B+-1/!
M".>P7L3I*&O;'P>'*E'\[;(Q-CDG6K?#;T)7)V!K!88-P+:79GI"V^OSJU_^
M8X)S(NK'^0?\B<>K,ZI+T1F3 9&-I2B&XIE8KX!]T<A0!,E,Z[O_S2@;>5A]
M;_ZVE0Y[0N;-TW:?O\NM=THZ%0N=ZZ2(.5/WI9@L0.?@+&I1M&R]$WXK CNQ
MC T1LHEQ;**NGK#X?GIZMERL),8O#'YDWFCO*,%C(H-2I=2Q2JY.HXPARJBS
M;'W#^ 0YG>"L/0@>@]N>&ND47.*"%<;('S 90#I)(I)20,A2@=8YA2Q<S*+Y
MPJW'R>G$V8X"KETTTBFXY 4K)"$;-84;)9=ZM<YY#5HSQ#K)W%OI4CR$Y9);
M@&NX/3"C@FL7C?0 KLN[_O?3Q7)^5F6VBB.LXSS[Y"!C5A1'D 'VC'BI!=R2
M&(P"F]^Q/TQ*)Z :-SUHH*4.P/9M'J8+^G(5XU><_YS4Y0Q7FQ9O<K?X1C]R
M\?!?75X#)$S9!4<G5A/O1CIPNBBP*!4F:WD.K?/9EO1WL2]P/T#-.M%N!\C^
M\^NW^<H8G!/SO\]^XGQ:N;E<5>MBG2SH(2O+0&7E("AN(&$4]!N9K&P]<.%)
M@L;%WG@XF0VEM X0^,=LOOP>ON/KD/Z%^<9>NL7B#//K\S^_7G/X]70V7<R(
MQG=3(N!T/EG@Y59E5!XEHXC8*')0RM21TU;5!BY.@M8V<G-W;]N^4&U#^;B)
M33>8'@$&'8"?0JYE^*N&67^<34GVI^'XXVQYQ8U6TB#/"#Y&0UXM!/ N)["Q
M6)ND25JU?FIYFJ)Q8]INP-I0;3N#D Y#G#6"X1=<3#+)A@3UV#F\8*W$(J5#
M2@M3G>S/389@A8: @7*$A-XT7ZZT,7'CEJ!W \YAE-F!L7PS.SG!>7J>+Z6T
M=MH6")+25F5Y'>K!"^A@2]22:V%:]X-N2MNX->/=8'00578 T=5ERR.L6**>
MR50@<XV@ OW*$6O@N IT$@4ZUKQ+^7%RQJT [P:(K136A1M_,YN?SN9A>6?<
MQ04[*;J4(M%O EN]'B1P6 S$H"4KT:;2/)A\DJ"-$&A_>02V4UH7&&QQ[_SA
M:K4MUYHR-N; :$X1"B.9ABP1D@B.R6 U4X.]0;9@8.35[7V\ 8R&B X"@C=A
M\8,8JO]39\7\#,>W'O>NJ_:/4$LEG'* NKZ_E10A<A6!^RA%R>2,0NLJHHV)
MZZ2RX_  NFNK!]%F!S#=N"7.E"Q(>!$8KBZ7K:28R#F@--(8;B27S?/_ICV-
M79=CM@'I(+KL(K9X:&G,4<@:L[<9)*_3.E&R6K*0(:3HK92QH+[;NSC$'I^7
M_]K?!GU[ZZ@':[@2XD-FO2A9A*D#>'PL=1^1A*@D!4-9>61.%=5\5]FCQ+S\
MV+*1O6NBK<[[MS^&.>6(DY][K(%Z_&>U[,%^FM!#=%D[4Y)5,H"I6V#5ZD*;
MB0"<!\9T$#PT#U$.TF7]^OQU. [3A%]_("Y_G\_.3ND@K?,S8Z(C-$<04A#/
M0B<(,3(H027&F<Z*^^%Z9!ZEJY.\85^4/-'TTD8E'?B\A[LE5V9Z56#%L]2&
M"0H1/:=@D1PYA,(,($O6.VDQB=9AUC,D=0*N9AC8J)-Y-X7TA*_KPUA=_ZN3
MV=GU/2HRZZS-&AQ&#<J9 )Y+\MK:"VN3S2JU'G&Y"5W=(&U_(#P&LE9:Z0!I
MG^MP;U+-\HJY![B\N%Z71F;#Z$1Z+1-%B!E)BB1*YE'%()1@OG7?_!;D=8*[
M9MB8'491'6#P#47!Y^0&ON I,8EY+;0GV'/9Y[K,S0:GZUYO#C[5WZ(M,69I
M4V[=#K,EB>-B<3"HW+O@'4YO'<#RW6(Y.0E+_%0VD*,-RF>=$'3RE#U'&R!:
MS8'E8I35B:78?"_[%O2->]U[*$ .IK$.T/CU!PGQ&\Y/ZKUT?61?A3.4>5$,
MDQ.@3Q0SQUJ45D1=2L9"*5FSR%O#[D%".GE.&"J]V%_X/2+H(BJ1WENM-&7S
MK,Z*9EC JZ A%H7:(:/3T+IOY1%2QG6;#93\'&QVD/B(P/EQ=G)4J?\P"]/Z
MD'M5AO@YG.+\LN;&^RB=5,"]KZM#HP%G30'N$BN(-L=P%SUW[UHW^4YGT-A%
MD;.!I-J!:7E]MIA,<;%XE?[G;+*8K-12#X^C?)I;[T%E3L[<)<J[H]1@LI4I
MZ!)3+HU-RR.D=/+B.)2#:J& 3G%4?SG'RQ/G.*=<@8QP2E: *G6A34J!9(:8
MF$W2V=9W$,\2-:YM:J+Z#>"TNQY&=F'_,9EF^N*KY3]F)Y?!OXO6%\8L%);R
M>MBKTR&!$4::S ,Q<-<P/>2U'OC1_8%A#\7-VDFQ!^MRP_1^J/_Z\JB(DDOP
M-H%0NEX*UWLY5Q!2R'6G<Y"Z>;/!8[1T4J<PF)]JH8).H71QP)*1+-8,04H*
M!U52$;QPD0X%D\%H0U%AZW3J<6I&MD9-M+T!A'80?0<@^K3\@?./LVFM\B%I
MWBH)6ME7[T+R)2K0)8FZ4B&!YY[,+>46.GB7BVA]N_,<3?T!:A?=SP941'_
MNESPL+Y?#27;C!R\KJP$"A!#W04271)!1Z=(6,-BZB8YX]X;'@9..XN_!R2=
M5IF\GV;\"_.WV6J^Q'RQ+EM=__?Z55THQ:)#R+%0PF&S(X:* 8'6,ZD\*FS=
MCK$99>-V$ \>3@V@GLY!=^/R31@>G2L:9-UVKB*G(^HE'=$DG/7<Q>S4 4'7
MRS7V$)C8 G8[*J@#V'T^6ZX9NS#5/")J#!%RT.0"LLC@I$G@#&:TRK(<6I>)
MWB&A7R#MJN6[12U[B+P#Q+P)Q\>WZ!=":E$? &3PFO(:BY7^.EW/&XLJ6V=:
ME^3=I6'<B.H F-E+Z#V A@)#DN1\I9,OD\6_7I]?/3;*7'0ARPLQIE"K$PWE
M&9A!</32\!28;C]UX%%RQIUZ,7CPU$H1/6+JQEDSUIA2BH DK*MSBRCWB%E"
MLG0Z;,I)R-9ATA/DC.O2FJG\.2CM*/^17TJNCEQEX3)AM2$(2=8UVVJJ>>"4
ML!8+3%I5A!8QEKLCHA]Z*7G@1W<&A5U5-FLGOPXLR88+2% Q99#",UYJ-W30
M"($' 8XB-"6(08K8ANH]V'_-T&!S<@[9Y])*/3V!;J.9_JD4.DLN@2UUI7&0
M'J)("-9*:Y2+Q<3!VO=^F0U"6R%DKPU"VZBK)RP^L/5!RRQUH?S"5U$I5A@$
M.K% B8:R9.55TJW+F?;=P]')!J&M0+#%'HYM--(!N!Z(/U_C-/TX"?-_K8-0
MK.L-*=3($6VM?H\0I6>0T(3DM2]2MG[Q>XZFC6#F7JQ';:J2+B%VR<W%452:
MS#[7&:2R%)"*PB'FNN<:LS.%&\)'\SNJ9VCJ+!/8"P'/PFL/=70 K_?3G[A8
MKHS]98+CM?8^(*18A\X*JX'^I$ L+/I2%*52K<.Q>T3T!J!]=#QK*? .$/-V
MLCB=+<+QRF2_.0Z+Q:1,;M0"Z<"*(F<-W/@Z6X*3\>;&0,%DHD#-T+9V><^0
MM!&:_(OU>"T5TC>^+E\;2E2*U1I7YQ0HDA#XX#/)3GEE>$XZMKX!?9:H<2U6
M4PAL#J\=]-$;P-:_P?RIO#ZO\P(_SI:ULW0V74ZF9_3'I[AV Y?&VBF=8Y8)
M4/!"O)*QCH$I"$$:*40NQ;2NC-F'WFYAN0MTG@+FD'KL +/OIVEV@E])=1?S
M3ZX=R:MI?I7SJC4@'-\8]O3Z_): %O0CCL\R>9R'Y;*R$S%B4KJ.:]6ZCBIT
M*X$4"-J8G'4=3==Z$L-A.-OL'+ 7&P-TB(\.3LU6#'X,)U<]-3I8S<D6!3)+
MH.I&K>@T@K8BHM<JQ-1Z\/J.I(YKWWM$W5-.8B (]-0/]X_9XG22D,3_F7YX
M%?X;4N7;R<_)XH;W*T5$R;RK-R 15 HD6YL\&!:#*99<XKVZE&?;Y3;Z<D?Q
MR%!@>*S'KKUF.K"PUX[M ;=VM3/DRD*\":M"KQNS;YU2)EDE"%P&R>EQA"B=
M >-U8EYEYG/K"JE]:=X,P[_"[,4#Z+0G#-]X^?JOR?+'G]-97.#\9Q7H^JGJ
M"Y*=2)/CR?IF\-8XYU57R.K''*7HLY0D;;E:G:1-A&"X A=)(Y8;Y,UG1[7F
MH9.WR(,@<(/7\(/!H8/C<._VF]Q5_8/P'?F1R9:KF!4(4W3UA!J\)!_%4_ J
M,!:Y;/TX\!0]O8RI&@&FS=34 >3J%)[KO6)78CURUI5H2304%%E0ACL(-B(D
MR2)*Z5W4K9\V'R&EEW$S(P"MA7(ZP-C5R*?7L_E\]F\2W.*HB,239@ELO?I3
MCE+,P*2$5"2W/JG"4NMA^0^0T<N(B!&PM:]21LZ\WV*93"=UW\.K[W-<R6?=
M&O.^KF;'Q?+;[#5>S&O)U_;YB+E$P3ESH'VL+[X\@E.:TTEBMA1TWMQ+>AY*
MOW?\?"\]M ?$VZ&4U8&=NQ+AC:D'#ZV'2<A4]DJ"*YK,=Z X(02&E# :F343
M5L7FB?=FI/72IC1&[C& \L;N0;EDZ?%-14DQ%"458,$PDA@&B$9[D(PQ(Y6@
MWVPRO.OY+_723'!@R]=8!2,#ZL-LL?@TK4$#L54E]*F\Q?GDYVKOTN((O1:R
M,$]&6A90UC-P5B(EWRZ8F)E*]V*ZA\#T]%=ZJ:$],) :BG[LR.WF2\#3#P&W
M@X2OL^-\1&AQW/DZ(5;5__(.O&5T>#*7RC@G3+C[/OA@_+8/$;T4M1TZBCN8
MXIHA=)B=>%\GWZ>K:IKI\O[-Y+JGHL&VO"V^TG*/WJ[,'6+#'J9L;, "!I,C
M*Y<\!)DLQ&(<IF0RNA>Y8>]RK-6]Y96K^^Q[:KA]^?TF'*>SX_5=Y.SX^+?9
M_-]AGH\\\PGKI1"S.8+*TM1V'@%!A:R5I[P^MJXG&I*?3EY%]D7E,SOJQX-
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M?31L'LF9W6V%]_6>,1>+U;2=YZP3*,$4.&$\\! TYX4SIEIGV4]+-&TV?33
M#3)\OS"J[Y$'KZ!LI9.<\A\?:V^%H17DZU#E+#S3W(F(KO5KM8;B3YL.CP_0
MT5UZ"FB>)95BY(&!*-I1L,(%."8\J!+K,!7#4+4N'STKU+3]SL=$WB#S=X>G
MUTM:$84;IH5 2*9.T'%10TB6@0[!%VN38W%< %4IIFU7'@TQ@PW< 43^'E;S
MRKCP4P$>4PJ<:9#69%!,1_"ESFQ#$YDO9)#<&B$/A-@)(.X$ '*8>3O Q^\7
M)#W)_JX2O.",<VZ98!%<X)RR#%L'KXG*1%8*+YGKX.Z341[,+'U'@IV0X4\
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MDR'G'^3C7<GYAQA\ZH>5.[,>)%ZP&HH5)VD+KN=UC J\S<70CLPP'Y]=XCA
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M\JN[*)G)FK?>TIZ29_I'D0<BX<%,UE;&[^"TO*O!]4L;EB-:[QGX6"B3QL"
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M3B^_UH;Y;?YB]0&_X_P25Y.$"J6-!GA(M6,^2 IKBX106X%USMGPNX]"^Q)
M!WSEL$."&P.K3W$/C*)WES7'=5$VW;UU5<6WY71%8OOTX>WYV8?7KW".99JF
M84E"G!C+F9:6@4\9B2]#7K0N";C*DDRZB.S>H(%],#KD.X>= ]P#CGH3^$B
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MVHY3G1B7O%?%0@I,T.U/DO(I%<B&F:R9Y/='*N^[Z [YSH%31WV!J%?1#[V
M#NE;TW2KI'D=Q4NRVTX;WXS2G)8IYK/5MO9P_?KON@H8)Z%PDEQ!X)9I.C-U
M(77)!E+.T06F&'D5';!UU)</'*3U";+^E3&"&_%>6N1G<Q&?&(%99^L@%6)(
M62?!YYIPHZ/C;3 BV]:3,QZC9V#_J^];L9DJ7DHEU;5$5Y>$B9;E5/L_N9>:
MJ@Y,]%U890M37MD$AM=G92QD<G+P8'-4##V7@C=?Y=9[8=7K^7JZ_O&O:<8;
M!VV78GU#A_,U"74Y#[/K),NK'[O,Z^I&'^0V#*(+'HUF%GB0Y &D6'O7Z'SJ
MFN\5JJZ&:2Z@/A@95UAP%/X>+LX:2N$#9T_)ZJ\6LVG>L+NY1+:E(APCUN<"
MIU,&%60!7XNUH["(GI$[RSH]WCR1.MW_[6,ITAH,$HNF^AD=PG:IR""==:;6
M:["ZN$;EZJHR"5:A3$)YGTNGW;$'8VSH['P+G3X*D2,$/()8X.);W:E%EOTJ
M&W.58G;<AA(+""TMJ)("^"(HI+%::D:!38FM9S4^0,J8('.,CA?M!3YPQN)\
ML21W(*R1#.[KV?3K=+Z1T!4G(CIM++D&UM:^2/(3P!LA(4490R0V/7996??X
MMPPW[[<I*AJ+<P0&Y>U\\UD;;-_@9L=,J*,!?.)06$Z@9$)PS%CPC)Q&BPQ5
M:>V5/TK0<..#>S$N[80_ B1M&K0K)Z\N5],YKE97%G-S<7M;0B+XU_5!Q$QR
M F))I6[_9)9S7V)N?4$]2M!8BC:']I_;:V\,4-S2OCNA+',;<Y2 (HFZ:9:!
MMW2L$H:4!2O.Y9YR+V.HUFRHV/VOST=(>6"'Z.U\=;FLHP=W'%QMB96:6& )
M&+/U$4JP6@ 2@='AR26AL:++V*']GSZ*O- QJEHTE=O0KC#6&_=?.)O=9B$5
M73?:T3&P,8**OA9A> $B2%V(.1W<W65:>WW@_1\_BE?>$W7?0G+C*YR-L2@B
M,$,M_P7EA *O*(J++O*8+:*^]RS[:Q7.#NU^--#+:$MK15"))TPD!>1UZ8^"
MF*4#Q[EA7I1LY;_/]JR#--JIM/80\0Z]9V>W#>HL?P^;Q^(KXYFD194#%+H_
MZYQY4Y<D<,B2&19E"4IW&;3ZP,>/L;3V(*7MV:=UB@2'KD5;+BZ_/<1'\=*H
MPB4D8>K2J.J">[I0A4TJU%90T<D!>>P[QKARZU@X-)/E2 P#!6GS?#9;S/$]
MZ24MIYLA/;\M+S__K)F;%*L#D^1B2^WJ4/02*5:C7PFI' ;RM]2]MZ#'K$67
M[QSCNJY334AS68\$0U>=;$:QPDT&XXP'Q3U"R-:"3U+ZPI5'UJ5=XXC5C,W+
MNOK%P1'R&KI#YW(V^[$)PO%JV2!#ASK467&,&U 4B(,OV@!=?CFRP*VZMZ%U
M;W/.O4\>9M1_/QH_46X#:_WCMUKA.EO_N'I@XJQH5 YX75*HF*X1/(59R$HI
MG*.UG5R%.Q\[S 3^?O1]BL1&8<RGF8+KB_477.XXB#XQ&[TEO[9F;8RLCXIT
M'<F@K,"(/)LN.M__Z<,,S>_3N)\DOX$1\$^2PL?%[/+6F[+Q.J)$R+Z.5JM#
M9REX9F!(#KI$NL%D%\]OST</,P>_']V?*KFA-[0L%]^G^1JRPHL<90A@%9&O
MB@C@'(E"&NLSDRFY</?!=.\2EEN?.LRD^G[4?8*\!M;TV<>+._;)B"A31E^K
M1#*Y(YF<4&<86*EU[8TB671QVN]]\$#CX/M1^&EB&_IT?PG+KR%=N21UB211
M6<!B"J P2JC!!FBIA'7!1Q:[]!K>_M2!AK/W=+R/%]C +P*[!Y*+Y>YY9)/_
MU@4EST0P:D$^J/(,0JT7M$[8*%"0)]JI=_F)QX!]WSV6GO@QO#6=K)MQ8.NF
M0';G+*+*R5*0(XW0Y.(*<G$SN3N.?NFD-YY[TPY@]PD8[K7A=)W>!\B) AY%
M#=2&^JL **!SA7G(&BTHKFJ6RR<PHACTVI:D6H]-O$7 X.@X5:'W:I^.E>X(
MH+$3R8YX[91R'K'6Z]!)J6O"@A4<0I!1I%BD%'=S"Z="XQ8!P[U+]0.-XZ4[
M FATZJ#&'/-F\XTN@D(MYA4$9)KTC(6+8$(LS6MY6\W^Z6T[[7C\G-YT.0)\
M[M:HKEZ'Y1SS.UQ/9& 8<H[ G?:@) 4&,:D$A<FBH@P60^M!5/>(&$5Q9T,]
MW[-HIPA]!*BY<?BN!F;753A7!_#M/,TN<VV77JV0_C]_"G]/I%?1$3? ,J_Y
M)%6?!#G=[C+0F9-&"M;Z6CR"S%&4EO:'O+X5=S0VO^,R+MJB<S7QS J-D0/C
MM9!:ID0Q2T(0M10AN2 ][]3L>SCDAJY'?28<'2;BXPU77?C=J#OO.Z[6538$
M=4+\IF&,_H3\A-^F-?L]SQ->,)$]#A7@=:9DT=M:;&&-=]+9[$.G,M.#>O2>
M).L%# (Z!5"M%3."2_+]8C9-/[XL9J2:W<"LZH^>S\+TZXJXO*PT;0>YU?5R
MDQBM\*DF5[@JE<="KJFSD).*R1@D5CLEG YQO XC<>" H'>WK$>%C0"/'W%&
M/_K\#^)L&69UNEO^.IU/5^OM?KRK86ZBT"'CWH--2!;=*@:!10:\*.,U,A%-
M\Q'ZG2@;IJ+FV=#7@WK&.]EQ:^2O6RDG19%XHB;/TJ.O906"N)(.F-'9.*:5
M%%T*,KI_XS U.KV#J4>QC\""71GENNX5JVG>'8K51#&6N",>2M3D'UAK()J8
M@#/+6.'1JVZCHPXP6@\2,TP)T+/9J39*&$$L<#V)9GLJ*C\39"5'CQ(2.KK7
M,7OPN@3@=!I,3I'^H'628@\9PU05/1N"3A7\"+#SCS"=5[HOYG4-SD6YF@4P
M02E=R8I#4B)!'9\%D3F2D&<4O-@L9/,!+P_1,E"MTK/!J(D.#L>2WV)ICI_I
M%LV?V@X.HHCWRM%+3@;)Z[2:R#(0)P$BA@!:J&Q128_=6JD/'17TDX2!RI^>
M,>=PO,1'D>C<E.Z]6\P7MPWJ%3_>N*CI($#19K-]QX(3T4*4@J3&R;MK/LKZ
M<8JZ >KE9M<;ZF-,=NGJDKYZ-9C.+XFWW2V^F*]>(<D1M__>I_ WKOZ8SA?+
MZ?K'C23>[4]Y_9^7T]I-LOZRR#\S?ZL)4]FA"PR$5Q3<.DP4F4A><RLY)6&C
MUZU38,_(7C?XO]Q'@;$B903^8C>FDG=625U'2=<JF5A+[I%\XIR=#SESCK+]
ME=\,N"_Y\:&U=D:0+#GB-+[^>[T,I,[I/"Q_;,1*EUFJ[\2+36[RZI1.G!#*
M):U!AU W%B$G#YL<;E>T#B[D&+'UXJ@>V>D&[Y?[KC$6) QHA[?3U@X6P]EZ
MO9S&R\VZKD^+!T3@1=9!"@:E\$TWK('H:]<[&I$Y&@HDU)W#L'_,72_D=0/W
MRWLV&8M&AW?4FTCB_4:;$^4UQUAG2<7J3(4L(5JG0'+-O972BTZ-L8W(Z8;=
ME_E*,X3&FAG@IDN2/KQ^^^[CGQ_.WIV_/GX?TIX/:;#ZZ"G2&FTYNIX#>KU>
M)I4897$!&$\%%$<%SB/]*M _E(WH]-T[Y70'ZPX1I]BC#SB]^KA=W74=%%"<
M :;J6$NOD.(U%8'169$E1>WYW<A^GV&Y^[G#%@J?IK>;UN D>8T@V+BWQ^W5
MCU<X3U^^AN5?F_8QZT*IM8*0F*[BX Z<5 J,3HG1#P.[M_3Z5$ _1=,PV#E=
MVT^MT#M%]*.$TA4WNUXBK9(L/F@(MM8"(D.(.AC@+"0B6:7\#%"Z3=.P9J@M
M IZ$UPGJ& &\;IR]#YCJ3MUZ J\G;X?L67:0N*O;Y26=0S06+&>,HZ^1;>MK
M]S%ZQ@:K4S1_KX"\D1I& *D]Y^\3_:?;MFG!E2N)SIKPM6VZ3FOP*0%J+YPN
MO%C=NJ#D$7*&Z6YYCBOO*(&/$3N5D=WY(H^1_$;"?1:U"[ID2\XD19K,.$4_
M,T$T?PU[A)RQ&:,C5?X4E(Z4_PB@M#MBN+S'T]5DSJB8]-*"MXKLM<D(SE%P
MPK-VZ)1"T[PVZ2F:1@:J8Y6__W)KHXF!B[A_7\P__W:YW)4/[TSX=7MU/7[<
MR,(R&M!:)KJME29+3O=V5,5G[XT5J<O(U">_:)B6NF:75WMACAD9NU.$+G(Z
M1AE*%+XN<_/D(C(#UGJ,(@DA59<Y;!V^:KAHOK%2N\+E" D/O2QH<7V,SCXO
M$6]NO=$"Z] Q\(:.D3(HP$OA0'.G#*LBDEW&MSW\#2.%QS%*7#27Z#AF<-V>
M-Q44VIASAIQKGQ/=EQ"=")!\BH);C)EWFHGR8N:[-;MHFHAT')#8,TE(H?0A
M<00>2ITDY*M?E@,(+[@QPG#LUI[XBXQE.TBGG<:R'2+@H6> +A=K3+4[\O=I
MP6OC>K[X^BW,KX>5BYR#)HO*$1THQA490LW!"FFR,,Z;TF4=<Y?O&AP;IZIS
MT:-L!ZV8WXR[G<TV!=K7&\=YR-XZ#372 R6EA,"2!$D1'RK+N8J=9@3?_M@Q
M3E\[%@.G2&P4#1*O2R$,KR[*C8OU]^O2#7+!A>,$7"R&;&=!#RX7!P6YCAAU
M+N&N93@U'_(H0<.,5VB>G6TG]/$DU>Z\4ZPFV7D1;6"0DK:@LBS@4HC@.)V#
M8&P(N?7\SP=(&3:%UE#9G5Z(#I/\X'?.>US6!&#XC!=E7[ V83+160M()M57
MD\K(-.>:<-0J:<Q9%'TW)[O7.WGB>X8=:]8>),UE.P)3<XX9\]5HP'\MI^LU
MSB=<VQ2EK[DBGT#91,)QC$%PK!:BRL#-W8V6)[\![:%CV'%F_1F9DV4^ MS<
M$,I64!?S[<@B<@2OAC5<32\Z^[JXG*\W7$\"8\DDAV1((U9OCM@,9%*+]G3W
M>Y[3O66I#:^P0T@==O;9LUQQO6ENX!#]W66-'*YE1Y]9(\CE=%5+G6ML\< U
M_RK,ZA]-5/*66$K@2JTQX<Z"S['^5KKLL^1:= G23B1CV,%G_5R?SZF9H?<#
M;<[./W&6W\[/P^K+)D*F8S5=3Y$.V*?EY6I]MOX=PVK]^C\OP^S3X@;#M3S_
M6D83C-(XH0LPDFX=AAH@NE) %YL#KYV!JLN&Z784#3L5K1]H#J2O9BAMVA[Q
M\?R?KW_[\_?7;]^??7C][M/YQ1_OS][]QYNW[\[>G;\]^_WMNS<7'_XX^_3V
MXMWY8I[KH(&\.Z(?OR"N5\?W5+3ZY@:-&+T(X<3NC9ISN_ZV-],Y?=LTS&XT
M"5V4;8_.+F=Z,9_]^&VZ2K-%A>9URT .P81 ""VF-O!DK2'PJ,&;B#)D98KM
M5"'XQ(/&Z92>\I[S<YC_?3JNQ]'M1O1;R92*@<R$"K6UG[/ZI&& JVQ$MJRX
MW*E,Z0F!'$#2<'G]9\;7S1>BOE0V\,LB,;-:S*:Y]EZ^KHLEZ$K9%LD'5K P
M"OA"(7\FFP !/8<4C7 ^&F-2I[:"I\_AWN\?#F.]*7K16.HC1,[N@264)!G/
MY%MLME\7H>E7A0Z:EW4G7Q2:=1HT?P1VAGZ5;J/9)Z!RA)B'+F"X:9EWSV><
M:>&,=R B_4W%S,$Y2UYIHA JZ\BS[;19Y:G2A?M?/2YX'*/-13O1#F]&'C2R
MY^';IO7[9P@E'/W7IM9WI,H82:DNSM+@A).U"-FZ;AU)!WN'CQ UW!/W,UU5
M/>EG!+GBNM=EO;KV#2D"YTC_!]K+VFA5.R>4C^",U<$8KR1OG0*^3<&8/.MF
M:EXTD_EH$'-><]#S]343,FHGHD2(T=8^=[>QW8+.6N2NT!%SIO4 J+V$#/OX
M?8IF]X+D%#&/ "N[7%W]1QVB]CW,ZFDZ6Y^'Y?+'=/[Y_X39)4Z\30%5W1;$
M,S%%-W:=HX;@F+,RQ.BQ^?"P3H2- 4LG >#NVV9S;8P 8A^_+);K3[C\>G,R
MGRUTNH(DG\^BJ;7N%GRQ#F0N-D3.F7.MK[%]= Q;9-$>0"?+>@1X.4NIOB6L
M/F!".@*QYMUG-1BA**+&(CMY$5NAV*SH1O=&4[0J,KCL)&@RX%[ZR-O/)^E(
MVK"E%^U1U8=&1@"TS9/I+6E-HM(L,26!&4%2LMJ!*[6(4D@5E%(VN=:;5.]3
M,6SM1'OXG"CG$2#E-O&%5)BR<1!47<'#"EE6E@-D&3,*813#?D*P0_#16VE#
M#^;E:.F.8$ST^V4=';_^\7X6YG46=O7;OM5[M^X(KNL-F?:UG+%.&DQ>DFFT
MFQW!-?7%LFN^$.(Q>L;@[30)O9H)?> JEYLK-&]?J;5^XC*NIGD:EO3;"4;%
M?'0%9*&SH 3+Y,-A 1T+ISO6<0Q=BE@Z?^$87)B3H-*?>$=P']VX4>L\W)WE
MY-$GLI>)S&_@=*G6_F$G P02DR@*'5.]+ ^Y2\@8_)<F9N9T,8\ *UOZ)X'N
MY**+!\^+WQ:@AN0X,!GH6Y4ER+?N?ME^\QB\E8;YOH,$.0+_Y/=IB-/9],KH
MK1?IK^VZW-5V:<)/T4AM=(D<A UU*G(B#DU]VQ,I8)$L9M-ZAW97VH9[O7J^
M)X=>]#2*CLX;G-V+&JQRJ3 /0E13FH,A6=6[-\48&06#J?EXJX>I&3:9W(_^
M'P;9*:H8PZVV2TF]#S\>S$>1'&]<VS&SXA(Q:".)3"%&"%%GD-9KZ7(V)G>:
M3G)$NK SD:.!X$GH>"![V(^J1H#%WS"NK[(7V=O(=5:@F<+J(2;P.BE(WDL9
MG2:?H;5%N_'UPP;X/>'G6/&. !GO%FM\ />SL%I-RQ3S=?)<,R.TRQ!%77R:
MA 172MT/H6W):$/QG0H2#T#. >0-FP_H"5E]J6?@K-*KQ>*O"_+@\C*4]97H
M?DQ\T4IH,JA%1/).99+@ R9P/@6)Q$3$+DN/]G_ZL#%_8WPT$N((#- F@W%?
M.I-LLU8R:J!@5=8MRV1'E53 8]'9BI*";3VG^ %2ADT/]&186HA]!.C9PP&7
M02CM)2#C@3@H'AR+",XD1V<#3;DW.;9]Q#9L V5/F#E1V&-(-2WFGVOM2778
M;GCS07%3D/#N;>5"V)H5T85 SYTP3'!F6P=>^RD9C7?<8X!_N@I&8'?NFL\;
MG&1N<O(H0)O-/#,1@#Q_ T'FJ(T0=%):I[$?IF8T3G%_@&JDBA& Z@83DQP#
M=_0_,,XR4,7466F<;F3&ZOPA[:-J7>9SX^M'XRL_2Z+Q(&&/X!8[7WS].MU6
M3M92W,V6Q\\X3Y65)(QT615"N\V@,'%R_*6#8D.RRAI"??OU'@^2,QK7N3\<
MM5+&".S/(Q**=2@K-PQ2KBL(,PL0=2PU_2F5T58EUOI2._&Q[3F<Z_Y0U4@5
M(P#5^ZOOW;"T;0_ 6/?*>@\R(-W+*M4@,T3 7+3F)2>E6N^OVD/&L$\9K31\
MK^[L-'&/ #'5HB[F-^@73EAMHP(NO0!%H0*$0-<S$1^,IJ#!M>_MN4/#L(%9
M3U@Y2= C ,I9SM.J@C!['Z:;J4[?IN1CW6!K(F/06A@#SC"RP>@\1*$4.)V0
M\^*+#*W+6Y^F:MB@K"<P-5;&".#UH8YWFF-^'99S\NE69RE=?KW<O,'\AF6:
MINN)48J[)#/D6.<"U(1[Q*#!RBPTTT)C\SK[IZD:-GCK"5Z-E3$">-W@8)/"
MV Q*Q"\X7TV_X]MY6GS%WQ>KU3M<7Y1/X>^)Y:@5W=O@T*N:S)#@G6!TJ<?,
M:^HLJ-9K9 \D<=AHKR^[UJ.:1H#"3TL,J\OECXWTML9ZZPO87(3A/($T.I',
MD$$D:PU)R*)JC4.^MV3M5+@]1,NP\5Y/N&HB^,,!Y+< FN/GBNB>T@:3$D(.
MHM#]3C*@0\ 9>.$2,#2>S'3*PK6V5?>IZ 0;^\)@<Z*P1Y"]?"I_0A8TQ^QC
M!(DB@V+>4!12-]AIDSB340MF&X/G*9J&A=)SY\-/5TLSF(UJZ.W'+Z2NW\(Z
M##?]]AX)(QB#^[A8QC$/UR,/4FHDHU@KX@KJ;95<QIAB8<RE>Q.V?^UYN-JF
MDC.9BN22 64#A>%U^+\1S-M@BZ>[J8% _EWFX1Z"KV/GX1ZBLN''$>Z?WYDE
M%F43.3S*U!B=/%QG30#.14:*W8LW=TWHO]\\W(,4W64>[B%2'R%R=J,]K3&*
MNVR@UK#2&?,2@K,%7'&(P3/=\6G[5YJ'>Y!FN\W#/43,(YR'RW*QC,M08Z!Z
M>&*&R.@L22-<ME@"CRUN^I<R#_<@;3XQ#_<0T0YO1@[HBE7)1F=T[9(O]11A
M!,>DJR/MD6632VQE67ZU>;@G7%4]Z6<$.=7;;_!TDBZ6&^[R)L'W'I>;B&F"
M/!LO?:ZK TEVNC"(OA:AI>(L)F&P>=5Q-\K&Y(DW@\6C=1)-=#0ZY&U86)U=
MKK\LEM/_PCR)7&9E/()R4M=,H8)0>(0<-%J74%G3.K/V.$4O96Q".Z2=I).1
M(NSM:G5)G$BIR#F(U1?5M>LP2!(2G1J!UD>M.1.\4VQW(KJVU Q38S$\LH[0
MQ0A0=:-*Y$%3+'Q@POA:S&_(% O'P(EHP'C%E<X9%;8V7AW(&J;8XGEQUEH[
MXP+</8OLB_!2ZPR6S@DHY0U$PRS(0G;:)2M4\YJQ1\@9IJAB,("=I(TQ FMG
MD$-,W!>C@5BIZY\I@'9<%F#T%\\V<XNM2YX?(&68:HJ! 76$%D8 ICTU(EMV
M)LZ2%)1.P'1=<^3HDO>F+B35$E.21>K0>HC+@\0,\SC^O(!JHXE?9A?L3S$O
MRK8&[EF?Q!_^^F&>PSN*8QQ/X9F"2I$# ZERG5[M WBZ2D$['4(M,@NJ4]KI
MEWD*3X'QJ(0"R5UMU8L%G..UC!A1%*91=-O2\-]/X0?CZ]BG\$-4-OQ+Q/ZG
M.QYY="Q&2+[4[(^A8-W6B*GD;*SC)J86&XE?]E/X08KN\A1^B-1'B)S=JY[1
M'G5, JRJ1>:I4+2]F<*2=+"!>Z=\IW;<7^DI_"#-=GL*/T3,(WP*-]*J9+"
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MC*HJHJYI\K&RG1/0):=T%LFA[-3!_%P'9)BLXPO"^T$:/1J^WS:GB@2P7(\
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MTKIZK>Z(QPOUSU3.DH__!E!+ P04    " !Y>5!6F7%4D%0#  "4"@  &0
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M?EKOENMW<+/<?H1GH=?(>)$85&-O5.K/#\SS#;![A PE[B\0BT+9G-8"=(;
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M%/*3"=LKD5?ZL<EO3$CMVLQK]>0X_1%02P,$%     @ >7E05GUJX_4I"
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M?3Z%!L B-ZM3?O!^4/'IWU9R[TT=_P502P,$%     @ >7E05F-V(2I7!0
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MEWEG?P-02P$"% ,4    " !Y>5!6N\C?*1*T!0"CI$( $
M@ $     :'5M+3(P,C(Q,C,Q+FAT;5!+ 0(4 Q0    ( 'EY4%87O.8*/R,
M #** 0 0              "  4"T!0!H=6TM,C R,C$R,S$N>'-D4$L! A0#
M%     @ >7E05CZR+ >G/0  #H0" !0              ( !K=<% &AU;2TR
M,#(R,3(S,5]C86PN>&UL4$L! A0#%     @ >7E05H-%YL^QRP  DV$) !0
M             ( !AA4& &AU;2TR,#(R,3(S,5]D968N>&UL4$L! A0#%
M  @ >7E05M-D1:F>V@  R$<! !,              ( !:>$& &AU;2TR,#(R
M,3(S,5]G,2YJ<&=02P$"% ,4    " !Y>5!6[O]PJCK2 0! U!( %
M        @ $XO < :'5M+3(P,C(Q,C,Q7VQA8BYX;6Q02P$"% ,4    " !Y
M>5!62G[1Z7LI 0!#<@T %               @ &DC@D :'5M+3(P,C(Q,C,Q
M7W!R92YX;6Q02P$"% ,4    " !Y>5!6F4.D2_(.  #Y\   &0
M    @ %1N H :'5M+3(P,C(Q,C,Q>#$P:WAE>#(Q+FAT;5!+ 0(4 Q0    (
M 'EY4%:9<5205 ,  )0*   9              "  7K'"@!H=6TM,C R,C$R
M,S%X,3!K>&5X,C,N:'1M4$L! A0#%     @ >7E05GUJX_4I"   F24  !H
M             ( !!<L* &AU;2TR,#(R,3(S,7@Q,&MX97@S,3$N:'1M4$L!
M A0#%     @ >7E05D?2@YD:"   DB4  !H              ( !9M,* &AU
M;2TR,#(R,3(S,7@Q,&MX97@S,3(N:'1M4$L! A0#%     @ >7E05F-V(2I7
M!0  )Q0  !D              ( !N-L* &AU;2TR,#(R,3(S,7@Q,&MX97@S
;,BYH=&U02P4&      P #  J P  1N$*

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
